PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Randolph, AG				Randolph, Adrienne G.			Pragmatic trials in critically ill children are CATCHing on	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; CENTRAL VENOUS CATHETERS; BLOOD-STREAM INFECTION; CARE		[Randolph, Adrienne G.] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Crit Care Div, Boston, MA 02115 USA; [Randolph, Adrienne G.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Randolph, Adrienne G.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Randolph, AG (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Crit Care Div, Boston, MA 02115 USA.; Randolph, AG (corresponding author), Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA.; Randolph, AG (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.	adrienne.randolph@childrens.harvard.edu		Randolph, Adrienne/0000-0002-3084-3071				Duffett M, 2013, CRIT CARE, V17, DOI 10.1186/cc13083; Gilbert RE, 2016, LANCET; Gilbert RE, 2008, CURR OPIN INFECT DIS, V21, P235, DOI 10.1097/QCO.0b013e3282ffd6e0; Harron K, 2015, PEDIATRICS, V136, pE1316, DOI 10.1542/peds.2015-0512; Harron K, 2015, CRIT CARE MED, V43, P1070, DOI 10.1097/CCM.0000000000000941; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Ramos ER, 2011, CRIT CARE MED, V39, P245, DOI 10.1097/CCM.0b013e3181feb83e; Randolph Adrienne G., 2002, Pediatr Crit Care Med, V3, P102, DOI 10.1097/00130478-200204000-00002; Randolph AG, 2003, AM J RESP CRIT CARE, V167, P1334, DOI 10.1164/rccm.200210-1175OC; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Wang H, 2010, J HOSP INFECT, V76, P1, DOI 10.1016/j.jhin.2010.04.025	13	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1697	1698		10.1016/S0140-6736(16)00566-3	http://dx.doi.org/10.1016/S0140-6736(16)00566-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ9OD	26946924				2022-12-28	WOS:000374541900005
J	Nissen, SE; Wolski, KE; Prcela, L; Wadden, T; Buse, JB; Bakris, G; Perez, A; Smith, SR				Nissen, Steven E.; Wolski, Kathy E.; Prcela, Lisa; Wadden, Thomas; Buse, John B.; Bakris, George; Perez, Alfonso; Smith, Steven R.			Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE; ADULTS; TRENDS	IMPORTANCE Few cardiovascular outcomes trials have been conducted for obesity treatments. Withdrawal of 2 marketed drugs has resulted in controversy about the cardiovascular safety of obesity agents. OBJECTIVE To determine whether the combination of naltrexone and bupropion increases major adverse cardiovascular events (MACE, defined as cardiovascular death, nonfatal stroke, or nonfatalmyocardial infarction) compared with placebo in overweight and obese patients. DESIGN, SETTING, AND PARTICIPANTS Randomized, multicenter, placebo-controlled, double-blind noninferiority trial enrolling 8910 overweight or obese patients at increased cardiovascular risk from June 13, 2012, to January 21, 2013, at 266 US centers. After public release of confidential interim data by the sponsor, the academic leadership of the study recommended termination of the trial and the sponsor agreed. INTERVENTIONS An Internet-based weight management program was provided to all participants. Participants were randomized to receive placebo (n=4454) or naltrexone, 32mg/d, and bupropion, 360mg/d (n=4456). MAIN OUTCOMES AND MEASURES Time from randomization to first confirmed occurrence of a MACE. The primary analysis planned to assess a noninferiority hazard ratio (HR) of 1.4 after 378 expected events, with a confidential interim analysis after approximately 87 events (25% interim analysis) to assess a noninferiority HR of 2.0 for consideration of regulatory approval. RESULTS Among the 8910 participants randomized, mean age was 61.0 years (SD, 7.3 years), 54.5% were female, 32.1% had a history of cardiovascular disease, and 85.2% had diabetes, with a median body mass index of 36.6 (interquartile range, 33.1-40.9). For the 25% interim analysis, MACE occurred in 59 placebo-treated patients (1.3%) and 35 naltrexone-bupropiontreated patients (0.8%; HR, 0.59; 95% CI, 0.39-0.90). After 50% of planned events, MACE occurred in 102 patients (2.3%) in the placebo group and 90 patients (2.0%) in the naltrexone-bupropion group (HR, 0.88; adjusted 99.7% CI, 0.57-1.34). Adverse effects were more common in the naltrexone-bupropion group, including gastrointestinal events in 14.2% vs 1.9% (P<.001) and central nervous system symptoms in 5.1% vs 1.2%(P<.001). CONCLUSIONS AND RELEVANCE Among overweight or obese patients at increased cardiovascular risk, based on the interim analyses performed after 25% and 50% of planned events, the upper limit of the 95% CI of the HR for MACE for naltrexone-bupropion treatment, compared with placebo, did not exceed 2.0. However, because of the unanticipated early termination of the trial, it is not possible to assess noninferiority for the prespecified upper limit of 1.4. Accordingly, the cardiovascular safety of this treatment remains uncertain and will require evaluation in a new adequately powered outcome trial.	[Nissen, Steven E.; Wolski, Kathy E.; Prcela, Lisa] Cleveland Clin, Cardiovasc Res Ctr, Cleveland, OH 44195 USA; [Wadden, Thomas] Univ Penn, Dept Psychiat, Ctr Weight & Eating Disorders, Perelman Sch Med, Philadelphia, PA 19104 USA; [Buse, John B.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Bakris, George] Univ Chicago Med, ASH Comprehens Hypertens Ctr, Chicago, IL USA; [Perez, Alfonso] Takeda Pharmaceut, Deerfield, IL USA; [Smith, Steven R.] Florida Hosp, Sanford Burnham Med Res Inst, Translat Res Inst Metab & Diabet, Orlando, FL USA	Cleveland Clinic Foundation; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Adventist Health Services; AdventHealth; Sanford Burnham Prebys Medical Discovery Institute	Nissen, SE (corresponding author), Cleveland Clin, 8500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org	Buse, John Bernard/J-9742-2019; Venkateswararao, Gollakaram/B-5490-2015; Smith, Steven/HDM-9496-2022	Buse, John Bernard/0000-0002-9723-3876; Venkateswararao, Gollakaram/0000-0002-0327-7764; Smith, Steven/0000-0002-5098-8147	Orexigen Therapeutics Inc, La Jolla, California; Takeda Pharmaceuticals International, Deerfield, Illinois	Orexigen Therapeutics Inc, La Jolla, California; Takeda Pharmaceuticals International, Deerfield, Illinois	The study was sponsored by Orexigen Therapeutics Inc, La Jolla, California, and Takeda Pharmaceuticals International, Deerfield, Illinois.	[Anonymous], 2012, GUID CLIN TRIAL SPON, V31, P3; Center for Drug Evaluation and Research US Food and Drug Administration, SUMM REV APPL 200006; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Feuerstein A., 2015, OREXIGEN WEIGHT LOSS; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gadde KM, 2001, OBES RES, V9, P544, DOI 10.1038/oby.2001.71; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; Greenway FL, 2009, OBESITY, V17, P30, DOI 10.1038/oby.2008.461; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; O'Riordan M., 2015, LIGHT STOPPED CONTRA; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Orexigen Therapeutics Inc, OR FDA ID CLEAR FEAS; Somerville R, 2015, CLIN OBES, V5, P12, DOI 10.1111/cob.12081; US Food and Drug Administration, 2008, GUID IND DIAB MELL E; US Securities and Exchange Commission, 2015, FORM 8K; WADDEN T A, 1992, American Journal of Clinical Nutrition, V56, p203S, DOI 10.1093/ajcn/56.1.203S; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wood S, 2011, FDA DECLINES APPROVA	19	108	112	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					990	1004		10.1001/jama.2016.1558	http://dx.doi.org/10.1001/jama.2016.1558			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954408	Bronze			2022-12-28	WOS:000371540200012
J	de Jong, KP				de Jong, Krijn P.			Surprised by selectivity	SCIENCE			English	Editorial Material							CONVERSION; CATALYSTS; METHANE		[de Jong, Krijn P.] Univ Utrecht, Debye Inst Nanomat Sci, Inorgan Chem & Catalysis, Utrecht, Netherlands	Utrecht University	de Jong, KP (corresponding author), Univ Utrecht, Debye Inst Nanomat Sci, Inorgan Chem & Catalysis, Utrecht, Netherlands.	k.p.dejong@uu.nl	de Jong, Krijn P/C-5319-2009					Galvis HMT, 2013, ACS CATAL, V3, P2130, DOI 10.1021/cs4003436; Galvis HMT, 2012, SCIENCE, V335, P835, DOI 10.1126/science.1215614; Guo XG, 2014, SCIENCE, V344, P616, DOI 10.1126/science.1253150; Horn R, 2015, CATAL LETT, V145, P23, DOI 10.1007/s10562-014-1417-z; Jiao F, 2016, SCIENCE, V351, P1065, DOI 10.1126/science.aaf1835; Olsbye U, 2012, ANGEW CHEM INT EDIT, V51, P5810, DOI 10.1002/anie.201103657; Tian P, 2015, ACS CATAL, V5, P1922, DOI 10.1021/acscatal.5b00007; Tullo AH, 2014, CHEM ENG NEWS, V92, P12; Zecevic J, 2015, NATURE, V528, P245, DOI 10.1038/nature16173	9	26	26	2	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1030	+		10.1126/science.aaf3250	http://dx.doi.org/10.1126/science.aaf3250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941306				2022-12-28	WOS:000371597500023
J	Estes, ML; McAllister, AK				Estes, Myka L.; McAllister, A. Kimberley			Maternal T(H)17 cells take a toll on baby's brain	SCIENCE			English	Editorial Material							AUTISM; PREGNANCY; SPECIFICITY; INFECTION; DISORDERS		[Estes, Myka L.; McAllister, A. Kimberley] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA.	kmcallister@ucdavis.edu		McAllister, A. Kimberley/0000-0001-9177-9889	NIMH NIH HHS [P50 MH106438] Funding Source: Medline; NINDS NIH HHS [R01 NS060125] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060125] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AL-Ayadhi LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-158; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Bedoya SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/986789; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Mandal M, 2011, BRAIN BEHAV IMMUN, V25, P863, DOI 10.1016/j.bbi.2010.09.011; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020470; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	15	19	20	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					919	920		10.1126/science.aaf2850	http://dx.doi.org/10.1126/science.aaf2850			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917755	Green Accepted			2022-12-28	WOS:000370821400021
J	Gheewala, CD; Collins, BE; Lambert, TH				Gheewala, Chirag D.; Collins, Bridget E.; Lambert, Tristan H.			An aromatic ion platform for enantioselective Bronsted acid catalysis	SCIENCE			English	Article							MECHANISM	Chiral acid catalysts are useful for the synthesis of enantioenriched small molecules, but the standard catalysts require laborious and expensive preparations. Here, we describe a chiral Bronsted acid prepared in one step from naturally occurring (-)-menthol and readily available 1,2,3,4,5-pentacarbomethoxycyclopentadiene. Aromatic stabilization serves as a key contributing factor to the potent acidity of the resulting compound, which is shown to catalyze both Mukaiyama-Mannich and oxocarbenium aldol reactions with high efficiency and enantioselectivity. Catalyst loadings as low as 0.01 mole percent and preparative scalability (25 grams) are demonstrated. Alternative amide catalysts are also shown to be promising platforms. In addition to proton catalysis, a chiral anion pathway is demonstrated to be viable with this catalyst system.	[Gheewala, Chirag D.; Collins, Bridget E.; Lambert, Tristan H.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Lambert, TH (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	tl2240@columbia.edu		Collins, Bridget/0000-0001-8740-7230; Gheewala, Chirag/0000-0002-8607-8348	National Science Foundation [CHE-0953259]; National Science Foundation; Direct For Mathematical & Physical Scien [1464992] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding for this work was provided by the National Science Foundation under CHE-0953259. C.D.G. is grateful for a National Science Foundation Graduate Fellowship. We thank. P. Quinlivan and the Parkin group, as well as D. Paley, for x-ray structure determination and the National Science Foundation (CHE-0619638) for acquisition of an x-ray diffractometer. We are grateful to M. Vetticatt (State University of New York, Binghamton) and V. Roytman for assistance with the stereochemical models. Metrical parameters for the structures of 7 center dot NMe<INF>4</INF> and the oxocarbenium Aldol product are available free of charge from the Cambridge Crystallographic Data Centre under CCDC 1450055 and 1450056 respectively.	Ahmed I, 2014, ORG LETT, V16, P4332, DOI 10.1021/ol502126r; Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Akiyama T., 2008, ACID CATALYSIS MODER, P62; Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Akiyama T, 2015, CHEM REV, V115, P9277, DOI 10.1021/acs.chemrev.5b00041; Akiyama T, 2006, ADV SYNTH CATAL, V348, P999, DOI 10.1002/adsc.200606074; Berkessel A, 2010, EUR J ORG CHEM, V2010, P5165, DOI 10.1002/ejoc.201000810; BORDWELL FG, 1981, J ORG CHEM, V46, P632, DOI 10.1021/jo00316a032; Borovika A, 2013, ANGEW CHEM INT EDIT, V52, P13424, DOI 10.1002/anie.201307133; Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; Bronsted JN, 1923, RECL TRAV CHIM PAY-B, V42, P718; BRUCE MI, 1990, AUST J CHEM, V43, P949, DOI 10.1071/CH9900949; Burns NZ, 2011, J AM CHEM SOC, V133, P14578, DOI 10.1021/ja206997e; Coric I, 2012, NATURE, V483, P315, DOI 10.1038/nature10932; Diels O, 1944, LIEBIGS ANN CHEM, V556, P38; Diels O, 1942, BER DTSCH CHEM GES, V75, P1452, DOI 10.1002/cber.19420751206; Hamilton GL, 2007, SCIENCE, V317, P496, DOI 10.1126/science.1145229; Hashimoto T, 2012, ASYMMETRIC ORGANOCAT, V2, P279; James T, 2015, CHEM REV, V115, P9388, DOI 10.1021/acs.chemrev.5b00128; Kampen D, 2009, TOP CURR CHEM, V291, P395, DOI 10.1007/128_2009_1; Kaupmees K, 2013, ANGEW CHEM INT EDIT, V52, P11569, DOI 10.1002/anie.201303605; Kim JH, 2013, ANGEW CHEM INT EDIT, V52, P4474, DOI 10.1002/anie.201300120; LEGOFF E, 1964, J ORG CHEM, V29, P423; Lowry T.M, 1923, J SOC CHEM IND, V42, P43, DOI DOI 10.1002/JCTB.5000420302; Mahlau M, 2013, ANGEW CHEM INT EDIT, V52, P518, DOI 10.1002/anie.201205343; Mikhailov I. E., 1984, J ORG CHEM USSR, V20, P1509; Nakashima D, 2006, J AM CHEM SOC, V128, P9626, DOI 10.1021/ja062508t; Parmar D, 2014, CHEM REV, V114, P9047, DOI 10.1021/cr5001496; Ratjen L, 2011, ANGEW CHEM INT EDIT, V50, P754, DOI 10.1002/anie.201005954; Reisman SE, 2008, J AM CHEM SOC, V130, P7198, DOI 10.1021/ja801514m; Rowland GB, 2005, J AM CHEM SOC, V127, P15696, DOI 10.1021/ja0533085; Treskow M, 2009, EUR J ORG CHEM, V2009, P3693, DOI 10.1002/ejoc.200900548; Tsui GC, 2015, ANGEW CHEM INT EDIT, V54, P7703, DOI 10.1002/anie.201500219; Uraguchi D, 2004, J AM CHEM SOC, V126, P5356, DOI 10.1021/ja0491533; Witten MR, 2014, ANGEW CHEM INT EDIT, V53, P5912, DOI 10.1002/anie.201402834; Xu FX, 2010, J ORG CHEM, V75, P8677, DOI 10.1021/jo101640z; Yamamoto H., 2008, ACID CATALYSIS MODER, V1, P35; Yanai H, 2015, J FLUORINE CHEM, V174, P108, DOI 10.1016/j.jfluchem.2014.11.006	38	76	78	13	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					961	965		10.1126/science.aad0591	http://dx.doi.org/10.1126/science.aad0591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917768				2022-12-28	WOS:000370821400038
J	Adashi, EY; Cohen, IG				Adashi, Eli Y.; Cohen, I. Glenn			Going Germline: Mitochondrial Replacement as a Guide to Genome Editing	CELL			English	Editorial Material							DNA DISEASE; TRANSMISSION; PREVENT; EMBRYOS	Mitochondrial replacement (MR) serves as a crucial test case and learning guide for the scientific, ethical, and regulatory challenges of future reproductive breakthroughs. The lessons learned from the regulatory review process of MR over the last decade promise to enrich the emerging dialog over genome editing.	[Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA; [Cohen, I. Glenn] Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA	Brown University; Harvard University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA.	igcohen@law.harvard.edu						Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960; Herbert M, 2015, EMBO REP, V16, P539, DOI 10.15252/embr.201540354; Human Fertilisation and Embryology Authority, 2014, 3 SCI REV SAF EFF ME; Human-Fertilisation and Embryology Authority, 2013, MIT REPL CONS ADV GO; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; National Institutes of Health, 2015, NIH DIR STAT NIH FUN; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368	15	16	17	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					832	835		10.1016/j.cell.2016.02.018	http://dx.doi.org/10.1016/j.cell.2016.02.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919419	Bronze			2022-12-28	WOS:000370867300004
J	Evans, AR; Daly, ES; Catlett, KK; Paul, KS; King, SJ; Skinner, MM; Nesse, HP; Hublin, JJ; Townsend, GC; Schwartz, GT; Jernvall, J				Evans, Alistair R.; Daly, E. Susanne; Catlett, Kierstin K.; Paul, Kathleen S.; King, Stephen J.; Skinner, Matthew M.; Nesse, Hans P.; Hublin, Jean-Jacques; Townsend, Grant C.; Schwartz, Gary T.; Jernvall, Jukka			A simple rule governs the evolution and development of hominin tooth size	NATURE			English	Article							MAMMALIAN DENTITION; INHIBITORY CASCADE; MODEL; PATTERNS; SYSTEM; TEETH	The variation in molar tooth size in humans and our closest relatives (hominins) has strongly influenced our view of human evolution. The reduction in overall size and disproportionate decrease in third molar size have been noted for over a century, and have been attributed to reduced selection for large dentitions owing to changes in diet or the acquisition of cooking(1,2). The systematic pattern of size variation along the tooth row has been described as a 'morphogenetic gradient' in mammal, and more specifically hominin, teeth since Butler(3) and Dahlberg(4). However, the underlying controls of tooth size have not been well understood, with hypotheses ranging from morphogenetic fields(3) to the clone theory(5). In this study we address the following question: are there rules that govern how hominin tooth size evolves? Here we propose that the inhibitory cascade, an activator-inhibitor mechanism that affects relative tooth size in mammals(6), produces the default pattern of tooth sizes for all lower primary postcanine teeth (deciduous premolars and permanent molars) in hominins. This configuration is also equivalent to a morphogenetic gradient, finally pointing to a mechanism that can generate this gradient. The pattern of tooth size remains constant with absolute size in australopiths (including Ardipithecus, Australopithecus and Paranthropus). However, in species of Homo, including modern humans, there is a tight link between tooth proportions and absolute size such that a single developmental parameter can explain both the relative and absolute sizes of primary postcanine teeth. On the basis of the relationship of inhibitory cascade patterning with size, we can use the size at one tooth position to predict the sizes of the remaining four primary postcanine teeth in the row for hominins. Our study provides a development-based expectation to examine the evolution of the unique proportions of human teeth.	[Evans, Alistair R.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Evans, Alistair R.] Museum Victoria, Geosci, Melbourne, Vic 3001, Australia; [Daly, E. Susanne; Catlett, Kierstin K.; Schwartz, Gary T.] Arizona State Univ, Inst Human Origins, Tempe, AZ 85287 USA; [Daly, E. Susanne; Catlett, Kierstin K.; Paul, Kathleen S.; Nesse, Hans P.; Schwartz, Gary T.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Paul, Kathleen S.] Arizona State Univ, Ctr Bioarchaeol Res, Tempe, AZ 85287 USA; [King, Stephen J.] Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA; [Skinner, Matthew M.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England; [Skinner, Matthew M.; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Townsend, Grant C.] Univ Adelaide, Sch Dent, Adelaide, SA 5005, Australia; [Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	Monash University; Museum Victoria; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Massachusetts System; University of Massachusetts Amherst; University of Kent; Max Planck Society; University of Adelaide; University of Helsinki	Evans, AR (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.; Evans, AR (corresponding author), Museum Victoria, Geosci, Melbourne, Vic 3001, Australia.	alistair.evans@monash.edu	Evans, Alistair R/D-4239-2011; Skinner, Matthew/D-1104-2010	Evans, Alistair R/0000-0002-4078-4693; Skinner, Matthew/0000-0001-8321-3543	National Health Grant (Canada) [605-7-299]; Province of Ontario [PR 33]; Varsity Fund; Australian Research Council [FT130100968]; Academy of Finland; National Science Foundation (GRFP) [2011121784]; Max Planck Society; Wenner-Gren Foundation; Graduate and Professional Student Association at ASU; ASU Sigma XI chapter; John Templeton Foundation [48952]	National Health Grant (Canada); Province of Ontario; Varsity Fund; Australian Research Council(Australian Research Council); Academy of Finland(Academy of Finland); National Science Foundation (GRFP)(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Wenner-Gren Foundation; Graduate and Professional Student Association at ASU; ASU Sigma XI chapter; John Templeton Foundation	This contribution is dedicated to the late Professor Percy Butler, the inspiration for much of this work and discoverer of the morphogenetic gradient in teeth, who unfortunately did not see this work completed. We thank M. Fortelius, G. Evans, A.-L. Khoo, F. Grine, P. Trusler, J. Adams, J. Clutterbuck, L. Chieu, D. Hocking, M. McCurry, Q. Nasrullah, T. Park and the Evans EvoMorph Laboratory for discussions and criticism of the manuscript. Thanks to M. Collard for supplementary information on the hominin phylogeny. We thank the Powell-Cotton Museum (M. Harman), American Museum of Natural History, Cleveland Museum of Natural History (L. Jellema), Museum of Comparative Zoology (J. Chupasko), Royal Belgian Institute of Natural Sciences (G. Lenglet), Royal Museum for Central Africa (E. Gilissen and W. Wendelen), National Museum of Natural History (USA), The Bavarian State Collection of Zoology (M. Hiermeier and C. Lang) and Anthropological Institute and Museum (Switzerland) (M. Ponce de Leon and C. Zollikofer) for access to great ape material. For access to computed tomography scans of fossil hominin material we thank the following individuals and institutions: National Museums of Kenya (E. Mbua), Ditsong National Museum of Natural History (S. Potze), University of Witwatersrand (C. Menter and B. Zipfel), Senckenberg Natural History Museum (F. Schrenk and O. Kullmer) and the Royal Belgian Institute of Natural Sciences (M. Toussaint). This study was made possible by use of material from the Burlington Growth Centre, Faculty of Dentistry, University of Toronto, which was supported by funds provided by grant (1) (number 605-7-299) National Health Grant (Canada), (data collection); (2) Province of Ontario Grant PR 33 (duplicating); and (3) the Varsity Fund (for housing and collection). All research protocols were reviewed and granted exemption by Arizona State University's (ASU) Institutional Review Board and the Burlington Growth Centre, and informed consent was obtained for all human subjects. This research was financially supported by grants from the Australian Research Council Future Fellowship (A.R.E., FT130100968), Academy of Finland (J. J.), National Science Foundation (GRFP number 2011121784; K. S. P.), Max Planck Society (M. M. S.), Wenner-Gren Foundation (K. K. C.), Graduate and Professional Student Association at ASU (E. S. D., K. K. C.), and ASU Sigma XI chapter (E. S. D., K. K. C.). This research was also facilitated in part by a grant (48952) from the John Templeton Foundation (G. T. S.). The opinions expressed in this publication do not necessarily reflect the views of the John Templeton Foundation.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Bernal V, 2013, EVOL BIOL, V40, P532, DOI 10.1007/s11692-013-9229-4; BRACE CL, 1967, J DENT RES, V46, P809, DOI 10.1177/00220345670460053501; Butler PM, 1937, P ZOOL SOC LOND B-SY, V107, P103; Butler PM, 1939, P ZOOL SOC LOND B-SY, V109, P1; DAHLBERG AA, 1945, J AM DENT ASSOC, V32, P676, DOI 10.14219/jada.archive.1945.0112; DECASTRO JMB, 1995, AM J PHYS ANTHROPOL, V96, P335, DOI 10.1002/ajpa.1330960403; Dembo M, 2015, P ROY SOC B-BIOL SCI, V282, P133, DOI 10.1098/rspb.2015.0943; GARN SM, 1963, SCIENCE, V142, P1060, DOI 10.1126/science.142.3595.1060; GREAVES WS, 1978, J ZOOL, V184, P271, DOI 10.1111/j.1469-7998.1978.tb03282.x; Haile-Selassie Y, 2015, NATURE, V521, P483, DOI 10.1038/nature14448; Halliday TJD, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-79; JOHANSON DC, 1974, AM J PHYS ANTHROPOL, V41, P39, DOI 10.1002/ajpa.1330410106; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Kegley A. D. T., 2005, SCI ESSAYS S AFRICAN, P35; Kieser J A, 1986, Anthropol Anz, V44, P175; Lucas L., 2012, THESIS ARIZONA STATE; Lucas P., 2004, DENT FUNCTIONAL MORP; Osbord J.W., 1978, P171; Owen R., 1840, ODONTOGRAPHY; Perinetti G., 2018, S EUR J ORTHOD DENTO, V5, P3; Polly PD, 2007, NATURE, V449, P413, DOI 10.1038/449413a; Renvoise E, 2009, EVOLUTION, V63, P1327, DOI 10.1111/j.1558-5646.2009.00639.x; Schroer K, 2015, J ANAT, V226, P150, DOI 10.1111/joa.12264; Selmer-Olsen R, 1949, SKRIFT NORSKE VIDENS, V3, P1; Spencer MA, 1998, J HUM EVOL, V34, P25, DOI 10.1006/jhev.1997.0180; Townsend G C, 1981, Aust Orthod J, V7, P3; Wilson LAB, 2012, PALEOBIOLOGY, V38, P308, DOI 10.1666/11001.1; Wolpoff M.H., 1971, CASE W RESERVE U STU, V2; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Young NM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7690	31	61	63	6	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					477	+		10.1038/nature16972	http://dx.doi.org/10.1038/nature16972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911784	Green Accepted			2022-12-28	WOS:000370690800035
J	Stern, N				Stern, Nicholas			Current climate models are grossly misleading	NATURE			English	Editorial Material									[Stern, Nicholas] London Sch Econ & Polit Sci LSE, Grantham Res Inst Climate Change & Environm, London, England; [Stern, Nicholas] British Acad, London, England	University of London; London School Economics & Political Science	Stern, N (corresponding author), London Sch Econ & Polit Sci LSE, Grantham Res Inst Climate Change & Environm, London, England.; Stern, N (corresponding author), British Acad, London, England.	n.stern@lse.ac.uk			Economic and Social Research Council [ES/K006576/1] Funding Source: researchfish; ESRC [ES/K006576/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Aghion P, 2014, PATH DEPENDENCE INNO; Dechezlepretre A., 2013, KNOWLEDGE SPILLOVERS; Dietz S., 2015, ECON J, V583, P574; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Gillingham K., 2015, 21637 NAT BUR EC RES; Golosov M, 2014, ECONOMETRICA, V82, P41, DOI 10.3982/ECTA10217; IPCC, 2014, CLIMATE CHANGE MITIG; Schaeffer M, 2012, NAT CLIM CHANGE, V2, P867, DOI [10.1038/nclimate1584, 10.1038/NCLIMATE1584]; Stern, 2015, WHY ARE WE WAITING L	9	152	154	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					407	409		10.1038/530407a	http://dx.doi.org/10.1038/530407a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911765	Bronze			2022-12-28	WOS:000370690800015
J	Tuthill, JC; Wilson, RI				Tuthill, John C.; Wilson, Rachel I.			Parallel Transformation of Tactile Signals in Central Circuits of Drosophila	CELL			English	Article							SPIKING LOCAL INTERNEURONS; SENSORY NEURONS; AFFERENT-PROJECTIONS; RECEPTIVE-FIELDS; LOCUST; ORGANIZATION; RESPONSES; INPUTS; ARCHITECTURE; STIMULATION	To distinguish between complex somatosensory stimuli, central circuits must combine signals from multiple peripheral mechanoreceptor types, as well as mechanoreceptors at different sites in the body. Here, we investigate the first stages ofsomatosensory integration in Drosophila using in vivo recordings from genetically labeled central neurons in combination with mechanical and optogenetic stimulation of specific mechanoreceptor types. We identify three classes of central neurons that process touch: one compares touch signals on different parts of the same limb, one compares touch signals on right and left limbs, and the third compares touch and proprioceptive signals. Each class encodes distinct features of somatosensory stimuli. The axon of an individual touch receptor neuron can diverge to synapse onto all three classes, meaning that these computations occur in parallel, not hierarchically. Representing a stimulus as a set of parallel comparisons is a fast and efficient way to deliver somatosensory signals to motor circuits.	[Tuthill, John C.; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA; [Tuthill, John C.] Univ Washington, Dept Physiol & Biophys, 1705 NE Pacific St, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu		Wilson, Rachel/0000-0001-8573-9266; Tuthill, John/0000-0002-5689-5806	NRSA fellowship from the NIH [F32-NS089259]; NIH [U01-NS090514]; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS089259, U01NS090514, U19NS104655] Funding Source: NIH RePORTER	NRSA fellowship from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Barret Pfeiffer, David Anderson, and Brian Duistermars for sharing flies prior to publication. Daryl Gohl, Marion Silies, and Tom Clandinin created the InSITE GAL4 collection and provided advice on the LexA swap. Ofer Mazor and Pavel Gorelik provided technical assistance. We thank David Ginty, Michael Dickinson, Philip Holmes, Jan Ache, and members of the R.I.W. lab for feedback on the manuscript, and Robin Harris and Andy Seeds for helpful discussions. J.C.T. is the recipient of an NRSA fellowship from the NIH (F32-NS089259). This work was partly funded by NIH grant U01-NS090514 to R.I.W. R.I.W. is an HHMI Investigator.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Ahn AN, 2006, J EXP BIOL, V209, P3370, DOI 10.1242/jeb.02392; Baek M, 2009, J NEUROSCI, V29, P6904, DOI 10.1523/JNEUROSCI.1585-09.2009; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Brierley DJ, 2012, J COMP NEUROL, V520, P1629, DOI 10.1002/cne.23003; BROWN AG, 1969, EXP BRAIN RES, V7, P231; BURROWS M, 1988, J COMP PHYSIOL A, V164, P207, DOI 10.1007/BF00603951; BURROWS M, 1992, J NEUROSCI, V12, P1477; BURROWS M, 1984, J COMP NEUROL, V224, P483, DOI 10.1002/cne.902240403; Burrows M., 1996, NEUROBIOLOGY INSECT; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; CORFAS G, 1990, J NEUROSCI, V10, P491; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Harris RM, 2015, ELIFE, V4, DOI 10.7554/eLife.04493; Heckscher ES, 2015, NEURON, V88, P314, DOI 10.1016/j.neuron.2015.09.009; HENGSTEN.R, 1973, Z NATURFORSCH C, VC 28, P593; Holtje M, 2003, J EXP BIOL, V206, P2715, DOI 10.1242/jeb.00492; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jindrich DL, 2002, J EXP BIOL, V205, P2803; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Jorntell H, 2014, NEURON, V83, P1444, DOI 10.1016/j.neuron.2014.07.038; Kim SS, 2015, NEURON, V86, P555, DOI 10.1016/j.neuron.2015.03.020; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; LAURENT G, 1988, J COMP NEUROL, V275, P1, DOI 10.1002/cne.902750102; Lundberg A, 1979, Prog Brain Res, V50, P11; MAXWELL DJ, 1985, NEUROSCIENCE, V16, P375, DOI 10.1016/0306-4522(85)90010-7; MERRITT DJ, 1992, J COMP NEUROL, V322, P16, DOI 10.1002/cne.903220103; MURPHEY RK, 1989, J COMP NEUROL, V290, P185, DOI 10.1002/cne.902900203; MURPHEY RK, 1989, J NEUROSCI, V9, P3209; NAGAYAMA T, 1990, J COMP PHYSIOL A, V166, P471, DOI 10.1007/BF00192017; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Ohyama T, 2015, NATURE, V520, P633, DOI 10.1038/nature14297; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; Ramdya P, 2015, NATURE, V519, P233, DOI 10.1038/nature14024; Ridgel AL, 2001, J COMP PHYSIOL A, V187, P405, DOI 10.1007/s003590100213; Saal HP, 2014, TRENDS NEUROSCI, V37, P689, DOI 10.1016/j.tins.2014.08.012; Sakurai K, 2013, CELL REP, V5, P87, DOI 10.1016/j.celrep.2013.08.051; SCHAEFER PL, 1994, J EXP BIOL, V190, P287; Seeds AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02951; Shuler MG, 2002, CEREB CORTEX, V12, P86, DOI 10.1093/cercor/12.1.86; Smith SA, 1996, J COMP NEUROL, V364, P311; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; WALL PD, 1967, J PHYSIOL-LONDON, V188, P403, DOI 10.1113/jphysiol.1967.sp008146; Zill S, 2004, ARTHROPOD STRUCT DEV, V33, P273, DOI 10.1016/j.asd.2004.05.005	47	45	45	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					1046	1059		10.1016/j.cell.2016.01.014	http://dx.doi.org/10.1016/j.cell.2016.01.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919434	Bronze, Green Accepted			2022-12-28	WOS:000370867300025
J	Bynum, B; Bynum, H				Bynum, Bill; Bynum, Helen			The matula	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk							0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					638	638		10.1016/S0140-6736(16)00289-0	http://dx.doi.org/10.1016/S0140-6736(16)00289-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26885550				2022-12-28	WOS:000369837100013
J	Bintu, L; Yong, J; Antebi, YE; McCue, K; Kazuki, Y; Uno, N; Oshimura, M; Elowitz, MB				Bintu, Lacramioara; Yong, John; Antebi, Yaron E.; McCue, Kayla; Kazuki, Yasuhiro; Uno, Narumi; Oshimura, Mitsuo; Elowitz, Michael B.			Dynamics of epigenetic regulation at the single-cell level	SCIENCE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; RECRUITMENT; METHYLATION; ACTIVATION; MODEL; PRC2	Chromatin regulators play a major role in establishing and maintaining gene expression states. Yet how they control gene expression in single cells, quantitatively and over time, remains unclear. We used time-lapse microscopy to analyze the dynamic effects of four silencers associated with diverse modifications: DNA methylation, histone deacetylation, and histone methylation. For all regulators, silencing and reactivation occurred in all-or-none events, enabling the regulators tomodulate the fraction of cells silenced rather than the amount of gene expression. These dynamics could be described by a three-state model involving stochastic transitions between active, reversibly silent, and irreversibly silent states. Through their individual transition rates, these regulators operate over different time scales and generate distinct types of epigenetic memory. Our results provide a framework for understanding and engineering mammalian chromatin regulation and epigenetic memory.	[Bintu, Lacramioara; Yong, John; Antebi, Yaron E.; McCue, Kayla; Elowitz, Michael B.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Kazuki, Yasuhiro; Uno, Narumi; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, 86 Nishicho, Yonago, Tottori, Japan; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; Tottori University; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Elowitz, MB (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.; Elowitz, MB (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Narumi, Uno/AAP-3936-2021	Narumi, Uno/0000-0002-4218-1167; Yong, John/0000-0002-4914-2259; Antebi, Yaron/0000-0002-5771-6814	NIH [R01 HD075335A, R01 HD075605A]; Defense Advanced Research Projects Agency [W911NF-11-2-0055]; Human Frontier Science Program [RGP0020/2012]; Jane Coffin Childs Memorial Fund for Medical Research; Beckman Institute at California Institute of Technology; Burroughs Wellcome Fund; Gordon and Betty Moore Foundation [GBMF2809]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075605, R01HD075335] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Human Frontier Science Program(Human Frontier Science Program); Jane Coffin Childs Memorial Fund for Medical Research; Beckman Institute at California Institute of Technology; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank G. M. Abadi, J. Cao, L. Santat, and the Caltech Flow Cytometry Facility for technical assistance and U. Alon, L. Cai, J. Garcia-Ojalvo, A. I. Geraschenko, M. Guttman, B. A. Hay, R. Kishony, A. Moses, R. Phillips, K. Plath, E. Rothenberg, M.-H. Sung, and members of the Elowitz lab for discussions and feedback. This work was supported by the NIH (grants R01 HD075335A and R01 HD075605A to M. B. E.), the Defense Advanced Research Projects Agency (grant W911NF-11-2-0055 to M. B. E.), the Human Frontier Science Program (grant RGP0020/2012 to M. B. E. and Y.E.A.), the Jane Coffin Childs Memorial Fund for Medical Research (postdoctoral fellowship to L. B.), the Beckman Institute at California Institute of Technology (equipment grant to L. B.), the Burroughs Wellcome Fund (Career at the Scientific Interface Award to L. B.), the Gordon and Betty Moore Foundation (through grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative), and HHMI (M. B. E.). M. B. E., L. B., J.Y., and California Institute of Technology filed a provisional patent application (CIT-7162-P) that relates to fractional control devices based on CRs.	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Busslinger Meinrad, 2014, Cold Spring Harb Perspect Biol, V6, DOI 10.1101/cshperspect.a019307; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P1203, DOI 10.1038/81208; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Keung AJ, 2015, NAT REV GENET, V16, P159, DOI 10.1038/nrg3900; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kringstein AM, 1998, P NATL ACAD SCI USA, V95, P13670, DOI 10.1073/pnas.95.23.13670; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pirrotta V, 2005, MOL CELL, V18, P395, DOI 10.1016/j.molcel.2005.04.013; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Stewart-Ornstein J, 2013, CURR BIOL, V23, P2336, DOI 10.1016/j.cub.2013.09.043; Sutherland HGE, 2000, MAMM GENOME, V11, P347, DOI 10.1007/s003350010066; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	35	233	236	3	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					720	724		10.1126/science.aab2956	http://dx.doi.org/10.1126/science.aab2956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912859	Green Accepted			2022-12-28	WOS:000369810000043
J	French, JB; Jones, SA; Deng, HY; Pedley, AM; Kim, D; Chan, CY; Hu, HB; Pugh, RJ; Zhao, H; Zhang, YX; Huang, TJ; Fang, Y; Zhuang, XW; Benkovic, SJ				French, Jarrod B.; Jones, Sara A.; Deng, Huayun; Pedley, Anthony M.; Kim, Doory; Chan, Chung Yu; Hu, Haibei; Pugh, Raymond J.; Zhao, Hong; Zhang, Youxin; Huang, Tony Jun; Fang, Ye; Zhuang, Xiaowei; Benkovic, Stephen J.			Spatial colocalization and functional link of purinosomes with mitochondria	SCIENCE			English	Article							NOVO PURINE BIOSYNTHESIS; MULTIENZYME COMPLEX; CELL-GROWTH; MTOR; INHIBITION; METABOLISM; NUCLEOTIDE; PATHWAYS; NETWORK; CANCER	Purine biosynthetic enzymes organize into dynamic cellular bodies called purinosomes. Little is known about the spatiotemporal control of these structures. Using super-resolution microscopy, we demonstrated that purinosomes colocalized with mitochondria, and these results were supported by isolation of purinosome enzymes with mitochondria. Moreover, the number of purinosome-containing cells responded to dysregulation of mitochondrial function and metabolism. To explore the role of intracellular signaling, we performed a kinome screen using a label-free assay and found that mechanistic target of rapamycin (mTOR) influenced purinosome assembly. mTOR inhibition reduced purinosome-mitochondria colocalization and suppressed purinosome formation stimulated by mitochondria dysregulation. Collectively, our data suggest an mTOR-mediated link between purinosomes and mitochondria, and a general means by which mTOR regulates nucleotide metabolism by spatiotemporal control over protein association.	[French, Jarrod B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Dept Chem, Stony Brook, NY 11794 USA; [Jones, Sara A.; Kim, Doory; Zhang, Youxin; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Deng, Huayun; Hu, Haibei; Fang, Ye] Corning Inc, Div Sci & Technol, Biochem Technol, Corning, NY 14831 USA; [Pedley, Anthony M.; Pugh, Raymond J.; Zhao, Hong; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Chan, Chung Yu; Huang, Tony Jun] Penn State Univ, Dept Engn Sci & Mech, 227 Hammond Bldg, University Pk, PA 16802 USA; [Kim, Doory; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Jones, Sara A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hu, Haibei] Jefferson Coll Hlth Sci, Med Lab Sci, Roanoke, VA 24013 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Corning Inc; State University of New York (SUNY) System; SUNY Community College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	French, JB (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Dept Chem, Stony Brook, NY 11794 USA.; Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Fang, Y (corresponding author), Corning Inc, Div Sci & Technol, Biochem Technol, Corning, NY 14831 USA.; Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.; Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; Zhuang, XW (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	jarrod.french@stonybrook.edu; fangy2@corning.com; zhuang@chemistry.harvard.edu; sjb1@psu.edu	French, Jarrod/K-6669-2014; Huang, Tony Jun/A-1546-2009	French, Jarrod/0000-0002-6762-1309; Huang, Tony Jun/0000-0003-1205-3313; Kim, Doory/0000-0002-2675-106X; Pedley, Anthony/0000-0003-1034-5072	Pennsylvania Department of Health Tobacco Settlement Funds; Canadian Institutes of Health Research; National Institutes of Health [NIH GM024129, 1R33EB019785-01]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB019785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024129, R37GM024129] Funding Source: NIH RePORTER	Pennsylvania Department of Health Tobacco Settlement Funds; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Laremore at the Proteomics and Mass Spectrometry Core Facility of the Huck Institutes of the Life Sciences at The Pennsylvania State University for assistance with data collection and analyses. The Orbitrap mass spectrometer was funded by a grant from the Pennsylvania Department of Health Tobacco Settlement Funds. J.B.F. acknowledges the Canadian Institutes of Health Research for fellowship support. This work was funded by the National Institutes of Health grants NIH GM024129 (S.J.B.) and 1R33EB019785-01 (T.J.H. and S.J.B.) as well as the Howard Hughes Medical Institute (X.Z.). J.B.F., S.A.J., Y.F., X.Z., and S.J.B. designed the experiments; J.B.F., S.A.J., H.D., H.H., A.M.P., C.Y.C., D.K., R.J.P., H.Z., and Y.Z. performed the experiments and analyzed the data; J.B.F., S.A.J., A.M.P., R.J.P., and Y.F. prepared the manuscript; J.B.F., Y.F., X.Z., and S.J.B. directed the research; all authors have reviewed and edited the manuscript. The authors declare that they have no competing interests. Additional data reported in this manuscript are available in the supplementary materials.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Chan CY, 2015, P NATL ACAD SCI USA, V112, P1368, DOI 10.1073/pnas.1423009112; Deng YJ, 2012, J BIOL CHEM, V287, P36201, DOI 10.1074/jbc.M112.407056; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fang Y, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00052; Fang Y, 2013, BIOTECHNOL GENET ENG, V29, P31, DOI 10.1080/02648725.2013.801237; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Fu R, 2015, MOL GENET METAB, V114, P55, DOI 10.1016/j.ymgme.2014.11.001; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Masson N, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-3; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Meyer FM, 2011, METAB ENG, V13, P18, DOI 10.1016/j.ymben.2010.10.001; NATSUMEDA Y, 1984, CANCER RES, V44, P2475; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Straight PD, 2007, P NATL ACAD SCI USA, V104, P305, DOI 10.1073/pnas.0609073103; Verrier F, 2011, NAT CHEM BIOL, V7, P909, DOI [10.1038/NCHEMBIO.690, 10.1038/nchembio.690]; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111; Yamaoka T, 1997, J BIOL CHEM, V272, P17719, DOI 10.1074/jbc.272.28.17719; Yamaoka T, 2001, J BIOL CHEM, V276, P21285, DOI 10.1074/jbc.M011103200; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhao H, 2015, J BIOL CHEM, V290, P6705, DOI 10.1074/jbc.M114.628701; Zhao H, 2013, CHEM COMMUN, V49, P4444, DOI 10.1039/c3cc41437j	39	112	115	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					733	737		10.1126/science.aac6054	http://dx.doi.org/10.1126/science.aac6054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912862	Green Accepted			2022-12-28	WOS:000369810000046
J	Tao, AR				Tao, Andrea R.			Nanoparticles meet their sticky ends	SCIENCE			English	Editorial Material							DNA NANOTECHNOLOGY		[Tao, Andrea R.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Tao, AR (corresponding author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.	atao@ucsd.edu						Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Kim Y, 2016, SCIENCE, V351, P579, DOI 10.1126/science.aad2212; Liu WY, 2016, SCIENCE, V351, P582, DOI 10.1126/science.aad2080; Lu CH, 2013, ACS NANO, V7, P8320, DOI 10.1021/nn404613v; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/NNANO.2011.187, 10.1038/nnano.2011.187]; Prasad BLV, 2008, CHEM SOC REV, V37, P1871, DOI 10.1039/b712175j; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586	8	1	1	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					561	562		10.1126/science.aae0455	http://dx.doi.org/10.1126/science.aae0455			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912688				2022-12-28	WOS:000369291600022
J	Du Toit, G; Sayre, PH; Roberts, G; Sever, ML; Lawson, K; Bahnson, HT; Brough, HA; Santos, AF; Harris, KM; Radulovic, S; Basting, M; Turcanu, V; Plaut, M; Lack, G				Du Toit, George; Sayre, Peter H.; Roberts, Graham; Sever, Michelle L.; Lawson, Kaitie; Bahnson, Henry T.; Brough, Helen A.; Santos, Alexandra F.; Harris, Kristina M.; Radulovic, Suzana; Basting, Monica; Turcanu, Victor; Plaut, Marshall; Lack, Gideon		Immune Tolerance Network LEAP-On	Effect of Avoidance on Peanut Allergy after Early Peanut Consumption	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM CLINICAL-EFFICACY; FOOD ALLERGY; ORAL IMMUNOTHERAPY; ANAPHYLAXIS; EPIDEMIOLOGY; MANAGEMENT; CHILDREN; INFANTS; PROTEIN; EUROPE	BACKGROUND In a randomized trial, the early introduction of peanuts in infants at high risk for allergy was shown to prevent peanut allergy. In this follow-up study, we investigated whether the rate of peanut allergy remained low after 12 months of peanut avoidance among participants who had consumed peanuts during the primary trial (peanut-consumption group), as compared with those who had avoided peanuts (peanut-avoidance group). METHODS At the end of the primary trial, we instructed all the participants to avoid peanuts for 12 months. The primary outcome was the percentage of participants with peanut allergy at the end of the 12-month period, when the participants were 72 months of age. RESULTS We enrolled 556 of 628 eligible participants (88.5%) from the primary trial; 550 participants (98.9%) had complete primary-outcome data. The rate of adherence to avoidance in the follow-up study was high (90.4% in the peanut-avoidance group and 69.3% in the peanut-consumption group). Peanut allergy at 72 months was significantly more prevalent among participants in the peanut-avoidance group than among those in the peanut-consumption group (18.6% [52 of 280 participants] vs. 4.8% [13 of 270], P< 0.001). Three new cases of allergy developed in each group, but after 12 months of avoidance there was no significant increase in the prevalence of allergy among participants in the consumption group (3.6% [10 of 274 participants] at 60 months and 4.8% [13 of 270] at 72 months, P = 0.25). Fewer participants in the peanut-consumption group than in the peanut-avoidance group had high levels of Ara h2 (a component of peanut protein)-specific IgE and peanut-specific IgE; in addition, participants in the peanut-consumption group continued to have a higher level of peanut-specific IgG4 and a higher peanut-specific IgG4: IgE ratio. CONCLUSIONS Among children at high risk for allergy in whom peanuts had been introduced in the first year of life and continued until 5 years of age, a 12-month period of peanut avoidance was not associated with an increase in the prevalence of peanut allergy. Longer-term effects are not known.	[Du Toit, George; Brough, Helen A.; Santos, Alexandra F.; Radulovic, Suzana; Basting, Monica; Turcanu, Victor; Lack, Gideon] Kings Coll London, Div Asthma Allergy & Lung Biol, Dept Pediat Allergy, London, England; [Du Toit, George; Brough, Helen A.; Santos, Alexandra F.; Radulovic, Suzana; Basting, Monica; Turcanu, Victor; Lack, Gideon] Guys & St Thomas NHS Fdn Trust, London, England; [Roberts, Graham] Univ Southampton, Southampton, Hants, England; [Roberts, Graham] Natl Inst Hlth Res Resp, Biomed Res Unit, Southampton, Hants, England; [Roberts, Graham] David Hide Ctr, Newport, Isle Of Wight, England; [Sayre, Peter H.] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Sever, Michelle L.; Lawson, Kaitie; Bahnson, Henry T.] Rho Fed Syst Div, Chapel Hill, NC USA; [Harris, Kristina M.] Immune Tolerance Network, Bethesda, MD USA; [Plaut, Marshall] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Southampton; University of California System; University of California San Francisco; Immune Tolerance Network; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lack, G (corresponding author), Guys & St Thomas NHS Fdn Trust, Childrens Allergy Unit, 2nd Fl,South Wing,Westminster Bridge Rd, London SE1 7EH, England.	gideon.lack@kcl.ac.uk		Brough, Helen/0000-0001-7203-0813; Roberts, Graham/0000-0003-2252-1248; Asare, Adam/0000-0002-9299-3518; Santos, Alexandra/0000-0002-7805-1436; Lack, Gideon/0000-0001-7350-4021	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [NO1-AI-15416, UM1AI109565, HHSN272200800029C, UM2AI117870]; Food Allergy Research and Education; Medical Research Council; Asthma U.K. Centre; U.K. Department of Health through a National Institute for Health Research comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; National Peanut Board, Atlanta; U.K. Food Standards Agency; MRC [MR/M008517/1, G0902018] Funding Source: UKRI; Medical Research Council [G0902018, MR/M008517/1, G1000758] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416, UM1AI109565, UM2AI117870] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Food Allergy Research and Education; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma U.K. Centre; U.K. Department of Health through a National Institute for Health Research comprehensive Biomedical Research Centre; King's College London(General Electric); King's College Hospital NHS Foundation Trust; National Peanut Board, Atlanta; U.K. Food Standards Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants (NO1-AI-15416, UM1AI109565, HHSN272200800029C, and UM2AI117870) from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health and by Food Allergy Research and Education, the Medical Research Council and Asthma U.K. Centre, and the U.K. Department of Health through a National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust, in partnership with King's College London and King's College Hospital NHS Foundation Trust. The clinical trials unit was supported by the National Peanut Board, Atlanta. The U.K. Food Standards Agency provided additional support for the costs of phlebotomy.	Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P630, DOI 10.1016/j.jaci.2013.02.034; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P623, DOI 10.1016/j.jaci.2013.02.035; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; de Silva D, 2014, ALLERGY, V69, P159, DOI 10.1111/all.12314; Dhami S, 2014, ALLERGY, V69, P168, DOI 10.1111/all.12318; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Du Toit G, 2013, J ALLERGY CLIN IMMUN, V131, P135, DOI 10.1016/j.jaci.2012.09.015; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 2010, J ALLERGY CLIN IMMUN, V125, P131, DOI 10.1016/j.jaci.2009.10.035; Hatzler L, 2012, J ALLERGY CLIN IMMUN, V130, P894, DOI 10.1016/j.jaci.2012.05.053; Muraro A, 2014, ALLERGY, V69, P590, DOI 10.1111/all.12398; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Ozdemir C, 2011, CLIN EXP ALLERGY, V41, P1226, DOI 10.1111/j.1365-2222.2011.03812.x; Panesar SS, 2013, ALLERGY, V68, P1353, DOI 10.1111/all.12272; Sofianou-Katsoulis A, 2011, WORLD ALLERGY ORGAN, V4, P38, DOI 10.1097/WOX.0b013e318205ab27; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007	16	246	255	5	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1435	1443		10.1056/NEJMoa1514209	http://dx.doi.org/10.1056/NEJMoa1514209			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	26942922	Bronze			2022-12-28	WOS:000374128400007
J	Siegert, T; Diehl, R; Greiner, J; Krause, MGH; Beloborodov, AM; Bel, MC; Guglielmetti, F; Rodriguez, J; Strong, AW; Zhang, XL				Siegert, Thomas; Diehl, Roland; Greiner, Jochen; Krause, Martin G. H.; Beloborodov, Andrei M.; Bel, Marion Cadolle; Guglielmetti, Fabrizia; Rodriguez, Jerome; Strong, Andrew W.; Zhang, Xiaoling			Positron annihilation signatures associated with the outburst of the microquasar V404 Cygni	NATURE			English	Article							X-RAY BINARIES; BLACK-HOLE BINARIES; PAIR PRODUCTION; EMISSION; ACCRETION; GALAXY; NOVA; LINE; SPI; SPECTROSCOPY	Microquasars(1-4) are stellar-mass black holes accreting matter from a companion star(5) and ejecting plasma jets at almost the speed of light. They are analogues of quasars that contain supermassive black holes of 10(6) to 10(10) solar masses. Accretion in microquasars varies on much shorter timescales than in quasars and occasionally produces exceptionally bright X-ray flares(6). How the flares are produced is unclear, as is the mechanism for launching the relativistic jets and their composition. An emission line near 511 kiloelectronvolts has long been sought in the emission spectrum of microquasars as evidence for the expected electron-positron plasma. Transient high-energy spectral features have been reported in two objects(7,8), but their positron interpretation(9) remains contentious. Here we report observations of gamma-ray emission from the microquasar V404 Cygni during a recent period of strong flaring activity(10). The emission spectrum around 511 kiloelectronvolts shows clear signatures of variable positron annihilation, which implies a high rate of positron production. This supports the earlier conjecture that microquasars may be the main sources of the electron-positron plasma responsible for the bright diffuse emission of annihilation gamma-rays in the bulge region of our Galaxy(11). Additionally, microquasars could be the origin of the observed megaelectronvolt continuum excess in the inner Galaxy.	[Siegert, Thomas; Diehl, Roland; Greiner, Jochen; Krause, Martin G. H.; Guglielmetti, Fabrizia; Strong, Andrew W.; Zhang, Xiaoling] Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85748 Garching, Germany; [Krause, Martin G. H.] Univ Munich, Univ Sternwarte Munchen, Scheinerstr 1, D-81679 Munich, Germany; [Beloborodov, Andrei M.] Columbia Univ, Dept Phys, 550 West 120th St, New York, NY 10027 USA; [Beloborodov, Andrei M.] Columbia Univ, Columbia Astrophys Lab, 550 West 120th St, New York, NY 10027 USA; [Bel, Marion Cadolle] Max Planck Comp & Data Facil, Giessenbachstr 2, D-85748 Garching, Germany; [Rodriguez, Jerome] Univ Paris Diderot, CNRS, CEA,IRFU,SAp, Lab Astrophys Instrumentat Modelisat,UMR 7158,DSM, F-91191 Gif Sur Yvette, France	Max Planck Society; University of Munich; Columbia University; Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; CEA; Universite Paris Saclay	Siegert, T (corresponding author), Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85748 Garching, Germany.	tsiegert@mpe.mpg.de	Rodriguez, Jerome/GMX-5000-2022; Krause, Martin/AAT-7574-2021; Diehl, Roland/K-4496-2016	Krause, Martin/0000-0002-9610-5629; Diehl, Roland/0000-0002-8337-9022; Siegert, Thomas/0000-0002-0552-3535	Munich excellence cluster 'Origin and evolution of the Universe'; Deutsche Forschungsgemeinschaft [PR 569/10-1, 1573]; French Research National Agency; CHAOS project [ANR-12-BS05-0009]; UnivEarthS Labex program of Sorbonne Paris Cite	Munich excellence cluster 'Origin and evolution of the Universe'; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); French Research National Agency(French National Research Agency (ANR)); CHAOS project; UnivEarthS Labex program of Sorbonne Paris Cite	The INTEGRAL/SPI project has been completed under the responsibility and leadership of CNES; we are grateful to ASI, CEA, CNES, DLR, ESA, INTA, NASA and OSTC for support of this ESA space science mission. R.D. and J.G. are also supported by the Munich excellence cluster 'Origin and evolution of the Universe'. M.G.H.K. is supported by the Deutsche Forschungsgemeinschaft, project number PR 569/10-1, as part of DFG Priority Program 1573. J.R. acknowledges funding support from the French Research National Agency, CHAOS project ANR-12-BS05-0009, and from the UnivEarthS Labex program of Sorbonne Paris Cite.	Beloborodov AM, 1999, ASTROPHYS J, V510, pL123, DOI 10.1086/311810; Beloborodov AM, 1999, MON NOT R ASTRON SOC, V305, P181, DOI 10.1046/j.1365-8711.1999.02384.x; Bouchet L, 2008, ASTROPHYS J, V679, P1315, DOI 10.1086/529489; BOUCHET L, 1991, ASTROPHYS J, V383, pL45, DOI 10.1086/186237; CASARES J, 1992, NATURE, V355, P614, DOI 10.1038/355614a0; CRANNELL CJ, 1976, ASTROPHYS J, V210, P582, DOI 10.1086/154863; Done C, 2007, ASTRON ASTROPHYS REV, V15, P1, DOI 10.1007/s00159-007-0006-1; Fabian AC, 2015, MON NOT R ASTRON SOC, V451, P4375, DOI 10.1093/mnras/stv1218; Fender RP, 2004, MON NOT R ASTRON SOC, V355, P1105, DOI 10.1111/j.1365-2966.2004.08384.x; Gallo E, 2003, MON NOT R ASTRON SOC, V344, P60, DOI 10.1046/j.1365-8711.2003.06791.x; GOLDWURM A, 1992, ASTROPHYS J, V389, pL79, DOI 10.1086/186353; Greiner J, 1996, ASTROPHYS J, V473, pL107, DOI 10.1086/310402; Grenier IA, 2015, ANNU REV ASTRON ASTR, V53, P199, DOI 10.1146/annurev-astro-082214-122457; Khargharia J, 2010, ASTROPHYS J, V716, P1105, DOI 10.1088/0004-637X/716/2/1105; King AL, 2015, ASTROPHYS J LETT, V813, DOI 10.1088/2041-8205/813/2/L37; Kuulkers E., 2015, ASTRON TELEGR, V7647; MACIOLEKNIEDZWIECKI A, 1995, MON NOT R ASTRON SOC, V276, P273; Malzac Julien, 2012, International Journal of Modern Physics: Conference Series, V8, P73, DOI 10.1142/S2010194512004448; Miller-Jones JCA, 2009, ASTROPHYS J LETT, V706, pL230, DOI 10.1088/0004-637X/706/2/L230; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; MIRABEL IF, 1992, NATURE, V358, P215, DOI 10.1038/358215a0; Natalucci L, 2015, ASTROPHYS J LETT, V813, DOI 10.1088/2041-8205/813/1/L21; ORE A, 1949, PHYS REV, V75, P1696, DOI 10.1103/PhysRev.75.1696; Prantzos N, 2011, REV MOD PHYS, V83, P1001, DOI 10.1103/RevModPhys.83.1001; Rodriguez J, 2015, ASTRON ASTROPHYS, V581, DOI 10.1051/0004-6361/201527043; Roques JP, 2015, ASTROPHYS J LETT, V813, DOI 10.1088/2041-8205/813/1/L22; Roques JP, 2003, ASTRON ASTROPHYS, V411, pL91, DOI 10.1051/0004-6361:20031501; Sadowski A, 2008, AIP CONF PROC, V1010, P404, DOI 10.1063/1.2945086; SHARMA SC, 1978, PHYS REV A, V18, P1426, DOI 10.1103/PhysRevA.18.1426; Strong AW, 2005, ASTRON ASTROPHYS, V444, P495, DOI 10.1051/0004-6361:20053798; SUNYAEV R, 1992, ASTROPHYS J, V389, pL75, DOI 10.1086/186352; SVENSSON R, 1987, MON NOT R ASTRON SOC, V227, P403, DOI 10.1093/mnras/227.2.403; Svensson R., 1996, A AS, V120, P587; Vedrenne G, 2003, ASTRON ASTROPHYS, V411, pL63, DOI 10.1051/0004-6361:20031482; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288	38	60	60	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					341	+		10.1038/nature16978	http://dx.doi.org/10.1038/nature16978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26934231	Green Submitted, Green Accepted			2022-12-28	WOS:000372064300046
J	Kern, LM; Edwards, A; Kaushal, R				Kern, Lisa M.; Edwards, Alison; Kaushal, Rainu			The Patient-Centered Medical Home and Associations With Health Care Quality and Utilization A 5-Year Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Effects of the patient-centered medical home (PCMH) are unclear. Previous studies had relatively short follow-up and may not have distinguished effects of the PCMH (which involves electronic health records [EHRs] plus organizational changes) from those of EHRs alone. Objective: To determine effects of the PCMH on health care quality and utilization compared with paper records alone and EHRs alone, with extended follow-up. Design: Prospective cohort study (2008 to 2012), including 3 years after PCMH implementation. (ClinicalTrials.gov: NCT00793065) Setting: The Hudson Valley, a multipayer, multiprovider region in New York. Participants: 438 primary care physicians in 226 practices, with 136 480 patients across 5 health plans. Intervention: Level III PCMH, as defined by the National Committee for Quality Assurance. Measurements: Claims-based outcomes included 8 quality and 7 utilization measures. Generalized estimating equations were used to compare adjusted differences in rates of change across study groups. Results: Patterns of quality were fairly similar across groups. Utilization patterns were similar across groups from 2008 to 2011 but showed modest differences between the PCMH and control groups on most measures in 2012. For example, hospitalizations were relatively stable from 2008 to 2011 (approximately 3.9 to 5.2 per 100 patients per year) but decreased in the PCMH group in 2012 (incidence rate ratio, 0.79 [95% CI, 0.69 to 0.90] compared with paper records). Emergency department visits were highest for the PCMH group (16.7 per 100 patients at baseline and 15.4 per 100 patients at the end of the study period) and lowest for the paper group (14.3 per 100 patients at baseline and 12.2 per 100 patients at the end of the study period), but the rate of change did not differ across groups. Limitation: Possible unmeasured confounding. Conclusion: The PCMH was associated with modest changes in most utilization measures and provided similar quality compared with EHRs and paper records.	Weill Cornell Med Coll, New York, NY 10065 USA; Hlth Informat Technol Evaluat Collaborat, New York, NY USA; New York Presbyterian Hosp, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital	Kern, LM (corresponding author), Weill Cornell Med Coll, Dept Healthcare Policy & Res, 402 East 67th St, New York, NY 10065 USA.	lmk2003@med.cornell.edu	Kern, Lisa/AAI-9781-2021	Kern, Lisa/0000-0003-1191-8100	Commonwealth Fund [20130685]; New York State Department of Health [C025877]	Commonwealth Fund; New York State Department of Health	By The Commonwealth Fund (grant 20130685) and the New York State Department of Health (contract C025877).	Berenson RA, 2010, J GEN INTERN MED, V25, P619, DOI 10.1007/s11606-010-1290-4; Bitton A, 2010, J GEN INTERN MED, V25, P584, DOI 10.1007/s11606-010-1262-8; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Centers for Medicare & Medicaid Services, 2015, EHR INCENTIVE PROGRA; Fifield J, 2013, J GEN INTERN MED, V28, P778, DOI 10.1007/s11606-013-2386-4; Fontaine P, 2011, J AMBUL CARE MANAG, V34, P10, DOI 10.1097/JAC.0b013e3181ff7019; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Hoff T, 2012, MED CARE RES REV, V69, P619, DOI 10.1177/1077558712447688; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Jaen Carlos Roberto, 2010, Ann Fam Med, V8 Suppl 1, pS57, DOI 10.1370/afm.1121; [Johns Hopkins Bloomberg School of Public Health Health Services Research and Development Center], 2011, J HOPK ACG SYST TECH; Kaplan RS, 2011, HARVARD BUS REV, V89, P46; Kaplan RS, 2011, HARVARD BUS REV, V89, P54; Kaplan RS, 2011, HARVARD BUS REV, V89, P56; Kaushal R, 2015, AM J MANAG CARE, V21, P378; Kern LM, 2014, ANN INTERN MED, V160, P741, DOI 10.7326/M13-1798; Long J.S., 2006, REGRESSION MODELS CA; McCormick D, 2012, HEALTH AFFAIR, V31, P488, DOI 10.1377/hlthaff.2011.0876; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; National Committee for Quality Assurance, 2008, STAND GUID PHYS PRAC; New York State Department of Health, 2014, NY MED EHR INC PROGR; Peikes D, 2012, AM J MANAG CARE, V18, P105; Reid RJ, 2014, ANN INTERN MED, V160, P802, DOI 10.7326/M14-0863; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Rosenthal MB, 2013, JAMA INTERN MED, V173, P1907, DOI 10.1001/jamainternmed.2013.10063; Stuard SS, 2011, J GEN INTERN MED, V26, P1371, DOI 10.1007/s11606-011-1817-3; Werner RM, 2013, MED CARE, V51, P487, DOI 10.1097/MLR.0b013e31828d4d29; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	24	24	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					395	+		10.7326/M14-2633	http://dx.doi.org/10.7326/M14-2633			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG6PG	26882534				2022-12-28	WOS:000372207200013
J	Makin, S				Makin, Simon			Memory games	NATURE			English	Editorial Material							IMPROVING FLUID INTELLIGENCE; WORKING-MEMORY											Au J., 2015, PSYCHON B REV; Au J, 2015, PSYCHON B REV, V22, P366, DOI 10.3758/s13423-014-0699-x; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Melby-Lervag M., 2015, PSYCHON B REV; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Noack H, 2014, PSYCHOL RES-PSYCH FO, V78, P773, DOI 10.1007/s00426-014-0564-6	7	10	10	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S10	S11		10.1038/531S10a	http://dx.doi.org/10.1038/531S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2YW	26934518	Bronze			2022-12-28	WOS:000371211900005
J	Barer, D				Barer, David			The NHS: national religion or national football? Just as with our national game, everyone is an expert	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WEEKEND		[Barer, David] Sunderland Royal Hosp, Sunderland SR4 7TP, England	Sunderland Royal Hospital	Barer, D (corresponding author), Sunderland Royal Hosp, Sunderland SR4 7TP, England.	david.barer@ncl.ac.uk						Aylin P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4652; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Hogan H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3239; Rimmer A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5624	4	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2016	352								i1023	10.1136/bmj.i1023	http://dx.doi.org/10.1136/bmj.i1023			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1RH	26915510				2022-12-28	WOS:000371116400005
J	Nishikawa, JL; Boeszoermenyi, A; Vale-Silva, LA; Torelli, R; Posteraro, B; Sohn, YJ; Ji, F; Gelev, V; Sanglard, D; Sanguinetti, M; Sadreyev, RI; Mukherjee, G; Bhyravabhotla, J; Buhrlage, SJ; Gray, NS; Wagner, G; Naar, AM; Arthanari, H				Nishikawa, Joy L.; Boeszoermenyi, Andras; Vale-Silva, Luis A.; Torelli, Riccardo; Posteraro, Brunella; Sohn, Yoo-Jin; Ji, Fei; Gelev, Vladimir; Sanglard, Dominique; Sanguinetti, Maurizio; Sadreyev, Ruslan I.; Mukherjee, Goutam; Bhyravabhotla, Jayaram; Buhrlage, Sara J.; Gray, Nathanael S.; Wagner, Gerhard; Naeaer, Anders M.; Arthanari, Haribabu			Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction	NATURE			English	Article							CANDIDA-GLABRATA; PROTEIN; PDR1	Eukaryotic transcription activators stimulate the expression of specific sets of target genes through recruitment of co-activators such as the RNA polymerase II-interacting Mediator complex(1,2). Aberrant function of transcription activators has been implicated in several diseases. However, therapeutic targeting efforts have been hampered by a lack of detailed molecular knowledge of the mechanisms of gene activation by disease-associated transcription activators. We previously identified an activator-targeted three-helix bundle KIX domain in the human MED15 Mediator subunit that is structurally conserved in Gal11/Med15 Mediator subunits in fungi(3,4). The Gal11/Med15 KIX domain engages pleiotropic drug resistance transcription factor (Pdr1) orthologues, which are key regulators of the multidrug resistance pathway in Saccharomyces cerevisiae and in the clinically important human pathogen Candida glabrata(5,6). The prevalence of C. glabrata is rising, partly owing to its low intrinsic susceptibility to azoles, the most widely used antifungal agent(7,8). Drug-resistant clinical isolates of C. glabrata most commonly contain point mutations in Pdr1 that render it constitutively active(9-14), suggesting that this transcriptional activation pathway represents a linchpin in C. glabrata multidrug resistance. Here we perform sequential biochemical and in vivo high-throughput screens to identify small-molecule inhibitors of the interaction of the C. glabrata Pdr1 activation domain with the C. glabrata Gal11A KIX domain. The lead compound (iKIX1) inhibits Pdr1-dependent gene activation and re-sensitizes drug-resistant C. glabrata to azole antifungals in vitro and in animal models for disseminated and urinary tract C. glabrata infection. Determining the NMR structure of the C. glabrata Gal11A KIX domain provides a detailed understanding of the molecular mechanism of Pdr1 gene activation and multidrug resistance inhibition by iKIX1. We have demonstrated the feasibility of small-molecule targeting of a transcription factor-binding site in Mediator as a novel therapeutic strategy in fungal infectious disease.	[Nishikawa, Joy L.; Sohn, Yoo-Jin; Naeaer, Anders M.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Nishikawa, Joy L.; Sohn, Yoo-Jin; Naeaer, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Boeszoermenyi, Andras; Buhrlage, Sara J.; Gray, Nathanael S.; Wagner, Gerhard; Arthanari, Haribabu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Vale-Silva, Luis A.; Sanglard, Dominique] Univ Lausanne Hosp, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Vale-Silva, Luis A.; Sanglard, Dominique] Univ Hosp Ctr, CH-1011 Lausanne, Switzerland; [Torelli, Riccardo; Sanguinetti, Maurizio] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy; [Posteraro, Brunella] Univ Cattolica Sacro Cuore, Inst Publ Hlth, I-00168 Rome, Italy; [Ji, Fei; Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ji, Fei] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gelev, Vladimir] Univ Sofia, Fac Chem & Pharm, Sofia 1164, Bulgaria; [Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sadreyev, Ruslan I.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Mukherjee, Goutam; Bhyravabhotla, Jayaram] Indian Inst Technol Delhi, Dept Chem, New Delhi 110016, India; [Mukherjee, Goutam; Bhyravabhotla, Jayaram] Indian Inst Technol Delhi, Supercomp Facil Bioinformat & Computat Biol, New Delhi 110016, India; [Bhyravabhotla, Jayaram] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 110016, India; [Buhrlage, Sara J.; Gray, Nathanael S.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Sofia; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Harvard University; Dana-Farber Cancer Institute	Naar, AM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.; Naar, AM (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.; Wagner, G; Arthanari, H (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu; naar@helix.mgh.harvard.edu; hari_arthanari@hms.harvard.edu	Torelli, Riccardo/K-8822-2018; Jayaram, B/G-9130-2011; Sohn, Yoojin/M-4616-2018; Torelli, Riccardo/N-8813-2019; Boeszoermenyi, Andras/AAD-9808-2020; Sanglard, Dominique/K-6032-2017; Sanguinetti, Maurizio/A-1453-2019; Mukherjee, G/B-2622-2017; Mukherjee, Goutam/B-6478-2017; Posteraro, Brunella/K-8499-2018	Torelli, Riccardo/0000-0001-7927-4343; Jayaram, B/0000-0002-5495-2213; Sohn, Yoojin/0000-0002-1934-2073; Boeszoermenyi, Andras/0000-0001-9810-7241; Sanglard, Dominique/0000-0002-5244-4178; Sanguinetti, Maurizio/0000-0002-9780-7059; Mukherjee, G/0000-0003-2422-1601; Mukherjee, Goutam/0000-0002-4620-2770; Posteraro, Brunella/0000-0002-1663-7546; Arthanari, Haribabu/0000-0002-7281-1289	National Institute of Health [GM047467, EB002026]; NSERC fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, K01DK085198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to P. Coote, E. Papadopoulos, R. Oh and R. E. Luna for helpful discussions and advice with data analysis and manuscript preparation. We acknowledge the ICCB-Longwood Screening Facility at Harvard Medical School for assistance with the high-throughput screens and access to the compound libraries, and the MGH Next Gen sequencing core for RNA-seq library construction. Mouse plasma and microsomal stability experiments were carried out at the Scripps Research Institute and iKIX1 pharmacokinetic parameters were assessed by Sai Life Sciences Limited. We acknowledge support from the National Institute of Health (grants GM047467 to G.W. and A.M.N. and EB002026 to G.W.). J.L.N. was supported by an NSERC fellowship.	Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Caudle KE, 2011, EUKARYOT CELL, V10, P373, DOI 10.1128/EC.00073-10; Chen YL, 2012, G3-GENES GENOM GENET, V2, P675, DOI 10.1534/g3.112.002279; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; Farmakiotis D, 2014, EMERG INFECT DIS, V20, P1833, DOI 10.3201/eid2011.140685; Ferrari S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017589; Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3185, DOI 10.1128/JCM.00946-09; Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodriguez-Tudela JL, 2008, CLIN MICROBIOL INFEC, V14, P398, DOI 10.1111/j.1469-0691.2007.01935.x; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Sanguinetti M, 2005, ANTIMICROB AGENTS CH, V49, P668, DOI 10.1128/AAC.49.2.668-679.2005; Silva LV, 2013, ANTIMICROB AGENTS CH, V57, P873, DOI 10.1128/AAC.02040-12; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Vale-Silva L, 2013, INFECT IMMUN, V81, P1709, DOI 10.1128/IAI.00074-13; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	25	87	90	5	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					485	+		10.1038/nature16963	http://dx.doi.org/10.1038/nature16963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26886795	Green Accepted, Green Submitted			2022-12-28	WOS:000370690800037
J	Hartmann-Boyce, J; Aveyard, P				Hartmann-Boyce, Jamie; Aveyard, Paul			THERAPEUTICS Drugs for smoking cessation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NICOTINE REPLACEMENT THERAPY; VARENICLINE; REDUCTION; SAFETY; RISK		[Hartmann-Boyce, Jamie; Aveyard, Paul] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford OX2 6GG, England	University of Oxford	Hartmann-Boyce, J (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford OX2 6GG, England.	Jamie.hartmann-boyce@phc.ox.ac.uk		Aveyard, Paul/0000-0002-1802-4217	Medical Research Council [MR/K023195/1] Funding Source: researchfish; National Institute for Health Research [09/110/01] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Barnes J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001008.pub2; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Coleman T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010078; Ebbert JO, 2015, JAMA-J AM MED ASSOC, V313, P687, DOI 10.1001/jama.2015.280; Etter JF, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015487; Ferguson SG, 2012, ADDICTION, V107, P1349, DOI 10.1111/j.1360-0443.2012.03801.x; Gibbons RD, 2013, AM J PSYCHIAT, V170, P1460, DOI 10.1176/appi.ajp.2013.12121599; Hajek P, 2011, ARCH INTERN MED, V171, P770, DOI 10.1001/archinternmed.2011.138; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Joseph AM, 1996, NEW ENGL J MED, V335, P1792, DOI 10.1056/NEJM199612123352402; Lindson N, 2011, PSYCHOPHARMACOLOGY, V214, P579, DOI 10.1007/s00213-010-2069-3; McRobbie Hayden, 2014, Cochrane Database Syst Rev, pCD010216, DOI 10.1002/14651858.CD010216.pub2; Mills Edward J, 2010, Tob Induc Dis, V8, P8, DOI 10.1186/1617-9625-8-8; Moore David, 2009, BMJ, V338, pb1024, DOI 10.1136/bmj.b1024; National Institute for Health and Care Excellence, 2008, SMOK CESS SERV; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Shahab L., 2012, COST EFFECTIVENESS P; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; Stapleton J, 1998, Stat Methods Med Res, V7, P187, DOI 10.1191/096228098671391775; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub2; Thase ME, 2008, J CLIN PSYCHOPHARM, V28, P302, DOI 10.1097/JCP.0b013e318172424e; Tobacco Use and Dependence Guideline Panel, 2008, TREATING TOBACCO USE; White AR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000009.pub4; Woolacott N F, 2002, Health Technol Assess, V6, P1; Zimovetz EA, 2011, J EVAL CLIN PRACT, V17, P288, DOI 10.1111/j.1365-2753.2010.01439.x	26	12	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2016	352								i571	10.1136/bmj.i571	http://dx.doi.org/10.1136/bmj.i571			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1QU	26907501				2022-12-28	WOS:000371115100002
J	Ordman, R				Ordman, Roc			Room for a new generation	SCIENCE			English	Editorial Material									[Ordman, Roc] Beloit Coll, Chem & Biochem, Beloit, WI 53511 USA	Beloit College	Ordman, R (corresponding author), Beloit Coll, Chem & Biochem, Beloit, WI 53511 USA.								0	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					886	886		10.1126/science.351.6275.886	http://dx.doi.org/10.1126/science.351.6275.886			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DE0PB	26912897				2022-12-28	WOS:000370325700049
J	Calenda, BW; Granger, CB				Calenda, Brandon W.; Granger, Christopher B.			In atrial fibrillation, the ATRIA risk score better predicted stroke than CHADS(2) and CHA(2)DS(2)-VASc scores Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Calenda, Brandon W.] Icahn Sch Med Mt Sinai, New York, NY USA; [Granger, Christopher B.] Duke Clin Res Inst, Durham, NC USA	Icahn School of Medicine at Mount Sinai; Duke University	Calenda, BW (corresponding author), Icahn Sch Med Mt Sinai, New York, NY USA.							Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584	1	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					JC23	JC23		10.7326/ACPJC-2016-164-4-023	http://dx.doi.org/10.7326/ACPJC-2016-164-4-023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26882308				2022-12-28	WOS:000370135300010
J	Yadav, AK; Nelson, CT; Hsu, SL; Hong, Z; Clarkson, JD; Schleputz, CM; Damodaran, AR; Shafer, P; Arenholz, E; Dedon, LR; Chen, D; Vishwanath, A; Minor, AM; Chen, LQ; Scott, JF; Martin, LW; Ramesh, R				Yadav, A. K.; Nelson, C. T.; Hsu, S. L.; Hong, Z.; Clarkson, J. D.; Schleputz, C. M.; Damodaran, A. R.; Shafer, P.; Arenholz, E.; Dedon, L. R.; Chen, D.; Vishwanath, A.; Minor, A. M.; Chen, L. Q.; Scott, J. F.; Martin, L. W.; Ramesh, R.			Observation of polar vortices in oxide superlattices (vol 530, pg 198, 2016)	NATURE			English	Correction													Ramesh, Ramamoorthy/ABI-4883-2020; Schlepütz, Christian/C-4696-2008; Vishwanath, Ashvin/AAO-6878-2020; Martin, Lane W./H-2409-2011	Schlepütz, Christian/0000-0002-0485-2708; Martin, Lane W./0000-0003-1889-2513				Yadav AK, 2016, NATURE, V530, P198, DOI 10.1038/nature16463	1	8	8	6	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					138	138		10.1038/nature17420	http://dx.doi.org/10.1038/nature17420			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	26934222	Bronze			2022-12-28	WOS:000376962300050
J	Gilbert, RE; Mok, Q; Dwan, K; Harron, K; Moitt, T; Millar, M; Ramnarayan, P; Tibby, SM; Hughes, D; Gamble, C				Gilbert, Ruth E.; Mok, Quen; Dwan, Kerry; Harron, Katie; Moitt, Tracy; Millar, Mike; Ramnarayan, Padmanabhan; Tibby, Shane M.; Hughes, Dyfrig; Gamble, Carrol		CATCH Trial Investigators	Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial	LANCET			English	Article							PEDIATRIC INTENSIVE-CARE; QUALITY; RISK; COST; UNIT	Background Impregnated central venous catheters are recommended for adults to reduce bloodstream infections but not for children because there is not enough evidence to prove they are effective. We aimed to assess the effectiveness of any type of impregnation (antibiotic or heparin) compared with standard central venous catheters to prevent bloodstream infections in children needing intensive care. Methods We did a randomised controlled trial of children admitted to 14 English paediatric intensive care units. Children younger than 16 years were eligible if they were admitted or being prepared for admission to a participating paediatric intensive care unit and were expected to need a central venous catheter for 3 or more days. Children were randomly assigned (1: 1: 1) to receive a central venous catheter impregnated with antibiotics, a central venous catheter impregnated with heparin, or a standard central venous catheter with computer generated randomisation in blocks of three and six, stratified by method of consent, site, and envelope storage location within the site. The clinician responsible for inserting the central venous catheter was not masked to allocation, but allocation was concealed from patients, their parents, and the paediatric intensive care unit personnel responsible for their care. The primary outcome was time to first bloodstream infection between 48 h after randomisation and 48 h after central venous catheter removal with impregnated (antibiotic or heparin) versus standard central venous catheters, assessed in the intention-to-treat population. Safety analyses compared central venous catheter-related adverse events in the subset of children for whom central venous catheter insertion was attempted (per-protocol population). This trial is registered with ISRCTN number, ISRCTN34884569. Findings Between Nov 25, 2010, and Nov 30, 2012, 1485 children were recruited to this study. We randomly assigned 502 children to receive standard central venous catheters, 486 to receive antibiotic-impregnated catheters, and 497 to receive heparin-impregnated catheters. Bloodstream infection occurred in 18 (4%) of those in the standard catheters group, 7 (1%) in the antibiotic-impregnated group, and 17 (3%) assigned to heparin-impregnated catheters. Primary analyses showed no effect of impregnated (antibiotic or heparin) catheters compared with standard central venous catheters (hazard ratio [HR] for time to first bloodstream infection 0.71, 95% CI 0.37-1.34). Secondary analyses showed that antibiotic central venous catheters were better than standard central venous catheters (HR 0.43, 0.20-0.96) and heparin central venous catheters (HR 0.42, 0.19-0.93), but heparin did not differ from standard central venous catheters (HR 1.04, 0.53-2.03). Clinically important and statistically significant absolute risk differences were identified only for antibiotic-impregnated catheters versus standard catheters (-2.15%, 95% CI -4.09 to -0.20; number needed to treat [NNT] 47, 95% CI 25-500) and antibiotic-impregnated catheters versus heparin-impregnated catheters (-1.98%, -3.90 to -0.06, NNT 51, 26-1667). Nine children (2%) in the standard central venous catheter group, 14 (3%) in the antibiotic-impregnated group, and 8 (2%) in the heparin-impregnated group had catheter-related adverse events. 45 (8%) in the standard group, 35 (8%) antibiotic-impregnated group, and 29 (6%) in the heparin-impregnated group died during the study. Interpretation Antibiotic-impregnated central venous catheters significantly reduced the risk of bloodstream infections compared with standard and heparin central venous catheters. Widespread use of antibiotic-impregnated central venous catheters could help prevent bloodstream infections in paediatric intensive care units.	[Gilbert, Ruth E.; Harron, Katie] UCL Inst Child Hlth, London WC1N 1EH, England; [Mok, Quen] Great Ormond St Hosp Sick Children, Paediat & Neonatal Intens Care Unit, Great Ormond St, London WC1N 3JH, England; [Ramnarayan, Padmanabhan] Great Ormond St Hosp Sick Children, Childrens Acute Transport Serv, Great Ormond St, London WC1N 3JH, England; [Dwan, Kerry; Gamble, Carrol] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Moitt, Tracy] Univ Liverpool, Med Children Clin Trials Unit Univ, Liverpool L69 3BX, Merseyside, England; [Millar, Mike] Barts Hlth NHS Trust, Dept Infect, London, England; [Tibby, Shane M.] St Thomas Hosp, Evelina Childrens Hosp, London, England; [Hughes, Dyfrig] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Liverpool; University of Liverpool; Barts Health NHS Trust; Guy's & St Thomas' NHS Foundation Trust; Bangor University	Gilbert, RE (corresponding author), UCL Inst Child Hlth, London WC1N 1EH, England.	r.gilbert@ucl.ac.uk	Dwan, Kerry/AAG-4726-2022; Gamble, Carrol/AAE-9895-2019; Mok, Quen/AAA-2648-2019; Ramnarayan, Padmanabhan/AAI-6783-2020; Dwan, Kerry/AFK-6469-2022; Hughes, Dyfrig/H-5252-2012	Dwan, Kerry/0000-0001-6918-1215; Gamble, Carrol/0000-0002-3021-1955; Mok, Quen/0000-0003-4807-9275; Ramnarayan, Padmanabhan/0000-0003-0784-8154; Dwan, Kerry/0000-0001-6918-1215; Harron, Katie/0000-0002-3418-2856; Hughes, Dyfrig/0000-0001-8247-7459; Tasker, Robert/0000-0003-3647-8113; Gilbert, Ruth/0000-0001-9347-2709; Macrae, Duncan/0000-0002-7158-6585	National Institute for Health Research, UK; National Institute for Health Research Health Technology Assessment (NIHR HTA) programme [08/13/47]; ESRC [ES/L007517/1] Funding Source: UKRI; Economic and Social Research Council [ES/L007517/1] Funding Source: researchfish; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [08/13/47] Funding Source: researchfish	National Institute for Health Research, UK(National Institute for Health Research (NIHR)); National Institute for Health Research Health Technology Assessment (NIHR HTA) programme(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research, UK.; We thank the children and families who participated in the CATCH trial and the principal investigators and research nurses at each study site. We thank Roger Parslow and the Healthcare Quality Improvement Partnership for contributing data from the PICANet audit. We also thank the Local Research Networks in England for supporting the trial implementation the Trial Steering Committee and the Independent Data Safety and Monitoring Committee for their oversight of the study. The CATCH trial was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number 08/13/47). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, National Health Service (NHS), or the Department of Health. No funding was provided by the manufacturer (Cook) of the central venous catheters, although participating units could purchase central venous catheters at a discount of 20% during recruitment to the study. Neither the funder nor the manufacturer had any involvement in the study design, interpretation of the results, or writing of the report.	Abdelkefi Abderrahman, 2007, J Support Oncol, V5, P273; Abou Elella R, 2010, PEDIATR CARDIOL, V31, P483, DOI 10.1007/s00246-009-9624-x; Bhutta A, 2007, BRIT MED J, V334, P362, DOI 10.1136/bmj.39064.457025.DE; Bion J, 2013, BMJ QUAL SAF, V22, P110, DOI 10.1136/bmjqs-2012-001325; Cook Incorporated, COOK SPECTR CENTR VE; Cox EG, 2013, J PEDIAT INF DIS SOC, V2, P67, DOI 10.1093/jpids/pis066; Department of Health, 2007, SAV LIV RED INF DEL; Elward AM, 2005, PEDIATRICS, V115, P868, DOI 10.1542/peds.2004-0256; Falagas ME, 2007, J ANTIMICROB CHEMOTH, V59, P359, DOI 10.1093/jac/dkl522; Geffers C, 2003, INTENS CARE MED, V29, P403, DOI 10.1007/s00134-003-1646-x; Gilbert RE, 2008, CURR OPIN INFECT DIS, V21, P235, DOI 10.1097/QCO.0b013e3282ffd6e0; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Harron K, HLTH TECHNO IN PRESS; Harron K, 2015, PEDIATRICS, V136, pE1316, DOI 10.1542/peds.2015-0512; Harron K, 2015, CRIT CARE MED, V43, P1070, DOI 10.1097/CCM.0000000000000941; Harron K, 2014, INTENS CARE MED, V40, P1916, DOI 10.1007/s00134-014-3516-0; Harron K, 2013, INTENS CARE MED, V39, P1080, DOI 10.1007/s00134-013-2841-z; Harron K, 2011, INTENS CARE MED, V37, P1641, DOI 10.1007/s00134-011-2343-9; HM Treasury, 2007, PREB REP COMPR SPEND; Hockenhull JC, 2008, HEALTH TECHNOL ASSES, V12, P1; Lai NM, 2013, COCHRANE DB SYST REV, V6; MERMEL LA, 1993, J INFECT DIS, V167, P920, DOI 10.1093/infdis/167.4.920; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Pierce CM, 2000, INTENS CARE MED, V26, P967, DOI 10.1007/s001340051289; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Shah PS, 2014, COCHRANE DB SYST REV, V17; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Universities of Leeds and Leicester, 2013, PAED INT CAR AUD NET; Wang H, 2010, J HOSP INFECT, V76, P1, DOI 10.1016/j.jhin.2010.04.025	31	59	65	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1732	1742		10.1016/S0140-6736(16)00340-8	http://dx.doi.org/10.1016/S0140-6736(16)00340-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ9OD	26946925	Green Accepted			2022-12-28	WOS:000374541900026
J	Bonsignori, M; Zhou, TQ; Sheng, ZZ; Chen, L; Gao, F; Joyce, MG; Ozorowski, G; Chuang, GY; Schramm, CA; Wiehe, K; Alam, SM; Bradley, T; Gladden, MA; Hwang, KK; Iyengar, S; Kumar, A; Lu, XZ; Luo, K; Mangiapani, MC; Parks, RJ; Song, HS; Acharya, P; Bailer, RT; Cao, A; Druz, A; Georgiev, IS; Kwon, YD; Louder, MK; Zhang, BS; Zheng, AQ; Hill, BJ; Kong, R; Soto, C; Mullikin, JC; Douek, DC; Montefiori, DC; Moody, MA; Shaw, GM; Hahn, BH; Kelsoe, G; Hraber, PT; Korber, BT; Boyd, SD; Fire, AZ; Kepler, TB; Shapiro, L; Ward, AB; Mascola, JR; Liao, HX; Kwong, PD; Haynes, BF				Bonsignori, Mattia; Zhou, Tongqing; Sheng, Zizhang; Chen, Lei; Gao, Feng; Joyce, M. Gordon; Ozorowski, Gabriel; Chuang, Gwo-Yu; Schramm, Chaim A.; Wiehe, Kevin; Alam, S. Munir; Bradley, Todd; Gladden, Morgan A.; Hwang, Kwan-Ki; Iyengar, Sheelah; Kumar, Amit; Lu, Xiaozhi; Luo, Kan; Mangiapani, Michael C.; Parks, Robert J.; Song, Hongshuo; Acharya, Priyamvada; Bailer, Robert T.; Cao, Allen; Druz, Aliaksandr; Georgiev, Ivelin S.; Kwon, Young D.; Louder, Mark K.; Zhang, Baoshan; Zheng, Anqi; Hill, Brenna J.; Kong, Rui; Soto, Cinque; Mullikin, James C.; Douek, Daniel C.; Montefiori, David C.; Moody, Michael A.; Shaw, George M.; Hahn, Beatrice H.; Kelsoe, Garnett; Hraber, Peter T.; Korber, Bette T.; Boyd, Scott D.; Fire, Andrew Z.; Kepler, Thomas B.; Shapiro, Lawrence; Ward, Andrew B.; Mascola, John R.; Liao, Hua-Xin; Kwong, Peter D.; Haynes, Barton F.		NISC Comparative Sequencing Progra	Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody	CELL			English	Article							HUMAN MONOCLONAL-ANTIBODIES; B-CELL RECEPTORS; VACCINE DEVELOPMENT; IMMUNOGEN DESIGN; FOUNDER VIRUS; AUTOREACTIVITY; INFECTION; INDUCTION; MEMBRANE; BINDING	Antibodies with ontogenies from V(H)1-2 or V(H)1-46-germline genes dominate the broadly neutralizing response against the CD4-binding site (CD4bs) on HIV-1. Here, we define with longitudinal sampling from time-of-infection the development of a V(H)1-46-derived antibody lineage that matured to neutralize 90% of HIV-1 isolates. Structures of lineage antibodies CH235 (week 41 from time-of-infection, 18% breadth), CH235.9 (week 152, 77%), and CH235.12 (week 323, 90%) demonstrated the maturing epitope to focus on the conformationally invariant portion of the CD4bs. Similarities between CH235 lineage and five unrelated CD4bs lineages in epitope focusing, length-of-time to develop breadth, and extraordinary level of somatic hypermutation suggested commonalities in maturation among all CD4bs antibodies. Fortunately, the required CH235-lineage hypermutation appeared substantially guided by the intrinsic mutability of the V(H)1-46 gene, which closely resembled V(H)1-2. We integrated our CH235-lineage findings with a second broadly neutralizing lineage and HIV-1 co-evolution to suggest a vaccination strategy for inducing both lineages.	[Bonsignori, Mattia; Gao, Feng; Wiehe, Kevin; Alam, S. Munir; Bradley, Todd; Gladden, Morgan A.; Hwang, Kwan-Ki; Iyengar, Sheelah; Kumar, Amit; Lu, Xiaozhi; Luo, Kan; Mangiapani, Michael C.; Parks, Robert J.; Song, Hongshuo; Montefiori, David C.; Moody, Michael A.; Kelsoe, Garnett; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Bonsignori, Mattia; Gao, Feng; Wiehe, Kevin; Alam, S. Munir; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA; [Zhou, Tongqing; Chen, Lei; Joyce, M. Gordon; Chuang, Gwo-Yu; Acharya, Priyamvada; Bailer, Robert T.; Cao, Allen; Druz, Aliaksandr; Georgiev, Ivelin S.; Kwon, Young D.; Louder, Mark K.; Zhang, Baoshan; Zheng, Anqi; Hill, Brenna J.; Kong, Rui; Soto, Cinque; Douek, Daniel C.; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Sheng, Zizhang; Schramm, Chaim A.; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Sheng, Zizhang; Schramm, Chaim A.; Shapiro, Lawrence] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, CAVD, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Mullikin, James C.; NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Montefiori, David C.] Duke Univ, Sch Med, Dept Surg, Durham, NC 27710 USA; [Montefiori, David C.; Moody, Michael A.] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27710 USA; [Montefiori, David C.; Moody, Michael A.; Kelsoe, Garnett; Haynes, Barton F.] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Hraber, Peter T.; Korber, Bette T.] Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87544 USA; [Boyd, Scott D.; Fire, Andrew Z.] Stanford Sch Med, Dept Pathol, Palo Alto, CA 94305 USA; [Kepler, Thomas B.] Boston Univ, Dept Microbiol, Boston, MA 02118 USA; [Kepler, Thomas B.] Boston Univ, Dept Math & Stat, Boston, MA 02118 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Duke Global Hlth Inst, Durham, NC 27710 USA	Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Columbia University; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Duke University; Duke University; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; United States Department of Energy (DOE); Los Alamos National Laboratory; Stanford University; Boston University; Boston University; Duke University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA.; Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Duke Global Hlth Inst, Durham, NC 27710 USA.	pdkwong@nih.gov; barton.haynes@duke.edu	Zhou, Tongqing/A-6880-2010; Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021; Do Kwon, Young/A-6957-2010; Ozorowski, Gabriel/HCH-0634-2022; Alam, S. Munir/AAC-6711-2019; Mascola, John/AAI-7193-2021; Shapiro, Lawrence/AAE-7172-2019; Bradley, Todd/AAB-3550-2020; Sheng, Zizhang/AFR-8049-2022; Bonsignori, Mattia/AAE-7678-2019; Moody, M/AAB-6947-2020	Zhou, Tongqing/0000-0002-3935-4637; Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Do Kwon, Young/0000-0002-1188-7458; Sheng, Zizhang/0000-0002-3253-3309; Bonsignori, Mattia/0000-0003-2973-2101; Moody, M/0000-0002-3890-5855; Acharya, Priyamvada/0000-0002-0089-277X; Hraber, Peter/0000-0002-2920-4897; Korber, Bette/0000-0002-2026-5757; Hahn, Beatrice/0000-0002-9400-9887; Fire, Andrew/0000-0001-6217-8312; Kelsoe, Garnett/0000-0002-8770-040X	Division of AIDS, NIAID, NIH Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery [UM1 AI100645]; Scripps CHAVI-ID [UM1 AI100663]; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation; Intramural Research Program of the Vaccine Research Center, NIAID, NIH; NIH [P01-AI104722]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005033, ZICAI005114, ZIAAI005034, UM1AI100645, P01AI104722, P30AI045008, ZICAI005111, ZIAAI005022, ZICAI005113, UM1AI100663, ZIAAI005066] Funding Source: NIH RePORTER	Division of AIDS, NIAID, NIH Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery; Scripps CHAVI-ID; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank K. Lloyd, A. Eaton, T. Von Holle, T. Gurley, L. Armand, D. Kozink, A. Cooper, F. Perrin, J. Pritchett, A. Foulger, G. Hernandez, S. Arora, R. Kauffman, A. Trama of the Duke Human Vaccine Institute, J. Whitesides, D. Marshall and the DHVI Flow Cytometry Core for technical assistance, and K. Soderberg for project coordination; members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript; J. Baalwa, D. Ellenberger, K. Hong, J. Kim, F. McCutchan, L. Morris, J. Overbaugh, E. Sanders-Buell, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing HIV-1 Envelope plasmids. The authors also thank Gift Kamanga, Michael S. Cohen, and the CHAVI clinical team for clinical trial participant recruitment and sample provision. Supported by a grant from the Division of AIDS, NIAID, NIH Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery UM1 AI100645 (Duke CHAVI-ID), the Scripps CHAVI-ID (UM1 AI100663), the International AIDS Vaccine Initiative, and the Bill and Melinda Gates Foundation (CAVD) to A.B.W. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH, and by NIH grant P01-AI104722. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science (contract W-31-109-Eng-38). M.B., P.T.H., B.T.K., H.-X.L. and B.F.H. have filed patent applications directed to antibodies and use of various envelopes as immunogens. None of the authors declared conflicts of interest.	Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Bonsignori M, 2014, J CLIN INVEST, V124, P1835, DOI 10.1172/JCI73441; Bonsignori M, 2012, TRENDS MICROBIOL, V20, P532, DOI 10.1016/j.tim.2012.08.011; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Haynes BF, 2015, CURR OPIN IMMUNOL, V35, P39, DOI 10.1016/j.coi.2015.05.007; Haynes BF, 2015, JAMA-J AM MED ASSOC, V313, P2419, DOI 10.1001/jama.2015.2427; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hraber P, 2015, VIRUSES-BASEL, V7, P5443, DOI 10.3390/v7102881; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kepler TB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00170; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Sui ZW, 2010, ARCH VIROL, V155, P535, DOI 10.1007/s00705-010-0621-4; Verkoczy L, 2013, J IMMUNOL, V191, P2538, DOI 10.4049/jimmunol.1300971; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	44	204	213	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					449	463		10.1016/j.cell.2016.02.022	http://dx.doi.org/10.1016/j.cell.2016.02.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	26949186	Green Accepted, Bronze			2022-12-28	WOS:000374123000022
J	Camerer, CF; Dreber, A; Forsell, E; Ho, TH; Huber, J; Johannesson, M; Kirchler, M; Almenberg, J; Altmejd, A; Chan, TZ; Heikensten, E; Holzmeister, F; Imai, T; Isaksson, S; Nave, G; Pfeiffer, T; Razen, M; Wu, H				Camerer, Colin F.; Dreber, Anna; Forsell, Eskil; Ho, Teck-Hua; Huber, Juergen; Johannesson, Magnus; Kirchler, Michael; Almenberg, Johan; Altmejd, Adam; Chan, Taizan; Heikensten, Emma; Holzmeister, Felix; Imai, Taisuke; Isaksson, Siri; Nave, Gideon; Pfeiffer, Thomas; Razen, Michael; Wu, Hang			Evaluating replicability of laboratory experiments in economics	SCIENCE			English	Article							REPLICATION; REPRODUCIBILITY; EXCHANGE; POLICY; CANCER	The replicability of some scientific findings has recently been called into question. To contribute data about replicability in economics, we replicated 18 studies published in the American Economic Review and the Quarterly Journal of Economics between 2011 and 2014. All of these replications followed predefined analysis plans that weremade publicly available beforehand, and they all have a statistical power of at least 90% to detect the original effect size at the 5% significance level. We found a significant effect in the same direction as in the original study for 11 replications (61%); on average, the replicated effect size is 66% of the original. The replicability rate varies between 67% and 78% for four additional replicability indicators, including a prediction market measure of peer beliefs.	[Camerer, Colin F.; Imai, Taisuke; Nave, Gideon] CALTECH, Div Humanities & Social Sci, 1200 East Calif Blvd,MC 228-77, Pasadena, CA 91125 USA; [Dreber, Anna; Forsell, Eskil; Johannesson, Magnus; Altmejd, Adam; Heikensten, Emma; Isaksson, Siri] Stockholm Sch Econ, Dept Econ, Box 6501, SE-11383 Stockholm, Sweden; [Ho, Teck-Hua] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Ho, Teck-Hua; Wu, Hang] Natl Univ Singapore, NUS Business Sch, Singapore 119245, Singapore; [Huber, Juergen; Kirchler, Michael; Holzmeister, Felix; Razen, Michael] Univ Innsbruck, Dept Banking & Finance, Univ Str 15, A-6020 Innsbruck, Austria; [Kirchler, Michael] Univ Gothenburg, Dept Econ, Ctr Finance, SE-40530 Gothenburg, Sweden; [Almenberg, Johan] Sveriges Riksbank, SE-10337 Stockholm, Sweden; [Chan, Taizan] Natl Univ Singapore, Off Deputy President Res & Technol, Singapore 119077, Singapore; [Pfeiffer, Thomas] New Zealand Inst Adv Study, North Shore Mail Ctr, Private Bag 102904, Auckland 0745, New Zealand; [Pfeiffer, Thomas] Inst Adv Study, Wissensch Kolleg Berlin, D-14193 Berlin, Germany	California Institute of Technology; Stockholm School of Economics; University of California System; University of California Berkeley; National University of Singapore; University of Innsbruck; University of Gothenburg; Sveriges Riksbank; National University of Singapore	Camerer, CF (corresponding author), CALTECH, Div Humanities & Social Sci, 1200 East Calif Blvd,MC 228-77, Pasadena, CA 91125 USA.	camerer@hss.caltech.edu	Imai, Taisuke/X-7757-2019; Altmejd, Adam/N-7887-2016; Ho, Teck-Hua/D-1630-2013; Johannesson, Magnus/E-9680-2011; Holzmeister, Felix/G-8051-2018; Pfeiffer, Thomas/R-1339-2019	Imai, Taisuke/0000-0002-0610-8093; Altmejd, Adam/0000-0002-4248-0677; Ho, Teck-Hua/0000-0001-5210-4977; Johannesson, Magnus/0000-0001-8759-6393; Holzmeister, Felix/0000-0001-9606-0427; Pfeiffer, Thomas/0000-0002-0592-577X; Huber, Juergen/0000-0003-0073-0321	Austrian Science Fund (START) [Y617-G11]; Austrian National Bank [OeNB 14953]; Behavioral and Neuroeconomics Discovery Fund; Jan Wallander and Tom Hedelius Foundation [P2015-0001:1, P2013-0156:1]; Knut and Alice Wallenberg Foundation; Swedish Foundation for Humanities and Social Sciences [NHS14-1719:1]; Sloan Foundation [G-2015-13929]	Austrian Science Fund (START); Austrian National Bank; Behavioral and Neuroeconomics Discovery Fund; Jan Wallander and Tom Hedelius Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Humanities and Social Sciences; Sloan Foundation(Alfred P. Sloan Foundation)	For financial support, we thank the Austrian Science Fund (START grant Y617-G11), the Austrian National Bank (grant OeNB 14953), the Behavioral and Neuroeconomics Discovery Fund (grant to C.F.C.), the Jan Wallander and Tom Hedelius Foundation (grants P2015-0001:1 and P2013-0156:1), the Knut and Alice Wallenberg Foundation (Wallenberg Academy Fellows grant to A.D.), the Swedish Foundation for Humanities and Social Sciences (grant NHS14-1719:1), and the Sloan Foundation (grant G-2015-13929). We thank the following experimental laboratories for kindly allowing us to use them for replication experiments: the Center for Behavioral Economics at the National University of Singapore, the Center for Neuroeconomics Studies at Claremont Graduate University, the Frankfurt Laboratory for Experimental Economic Research, the Harvard Decision Science Laboratory, the Innsbruck EconLab, and the Nuffield Centre for Experimental Social Sciences. We thank the following persons for assistance with the experiments: J. Barraza, A. Berge, R. Bhui, A. Born, N. Cohodes, H. K. Dat, C. Dohmen, Z. Faiayd, M. Heissel, A. Henderson, G. Mansur, J. Preussler, L. Schultze, G. Thoelen, and E. Warner. The data reported in this paper are tabulated in tables S1, S3, and S4, and the replication reports, analyses code, and the data from the replications are available at www.experimentaleconreplications.com and at Open Science Framework (osf.io/bzm54). The authors report no potential conflicts of interest. No material transfer agreements, patents, or patent applications apply to methods or data in the paper. C.F.C., A.D., J.H., T.-H.H., M.J., and M.K. designed the research; C.F.C., A.D., E.F., J.H., T.-H.H., M.J., and M.K. wrote the paper; E.F., J.A., T.C., T.-H.H., and T.P. helped design the prediction market part; E.F., F.H., J.H., M.K., M.R., T.P., and H.W. analyzed data; A.A., E.H., F.H., T.I., S.I., G.N., M.R., and H.W. carried out the replications (including re-estimating the original estimate with the replication data); and all authors approved the final manuscript.	Abeler J, 2011, AM ECON REV, V101, P470, DOI 10.1257/aer.101.2.470; Ambrus A, 2012, AM ECON REV, V102, P3317, DOI 10.1257/aer.102.7.3317; [Anonymous], 2015, SCIENCE, DOI [DOI 10.1126/SCIENCE.AAC4716, DOI 10.1126/science.aac4716]; Arrow KJ, 2008, SCIENCE, V320, P877, DOI 10.1126/science.1157679; Bartling B, 2012, AM ECON REV, V102, P834, DOI 10.1257/aer.102.2.834; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bohannon J, 2014, SCIENCE, V344, P788, DOI 10.1126/science.344.6186.788; Brodeur A, 2016, AM ECON J-APPL ECON, V8, P1, DOI 10.1257/app.20150044; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carpenter S, 2012, SCIENCE, V335, P1558, DOI 10.1126/science.335.6076.1558; Charness G, 2011, AM ECON REV, V101, P1211, DOI 10.1257/aer.101.4.1211; Chen R, 2011, AM ECON REV, V101, P2562, DOI 10.1257/aer.101.6.2562; Cumming G, 2008, PERSPECT PSYCHOL SCI, V3, P286, DOI 10.1111/j.1745-6924.2008.00079.x; de Clippel G, 2014, AM ECON REV, V104, P3434, DOI 10.1257/aer.104.11.3434; DEWALD WG, 1986, AM ECON REV, V76, P587; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Dreber A, 2015, P NATL ACAD SCI USA, V112, P15343, DOI 10.1073/pnas.1516179112; Duffy J, 2014, AM ECON REV, V104, P1735, DOI 10.1257/aer.104.6.1735; Dulleck U, 2011, AM ECON REV, V101, P526, DOI 10.1257/aer.101.2.526; Ericson KMM, 2011, Q J ECON, V126, P1879, DOI 10.1093/qje/qjr034; Fehr E, 2013, AM ECON REV, V103, P1325, DOI 10.1257/aer.103.4.1325; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Friedman D, 2012, AM ECON REV, V102, P337, DOI 10.1257/aer.102.1.337; Fudenberg D, 2012, AM ECON REV, V102, P720, DOI 10.1257/aer.102.2.720; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Hewitt JK, 2012, BEHAV GENET, V42, P1, DOI 10.1007/s10519-011-9504-z; Huck S, 2011, AM ECON REV, V101, P819, DOI 10.1257/aer.101.2.819; Ifcher J, 2011, AM ECON REV, V101, P3109, DOI 10.1257/aer.101.7.3109; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kessler JB, 2012, AM ECON REV, V102, P2018, DOI 10.1257/aer.102.5.2018; Kirchler M, 2012, AM ECON REV, V102, P865, DOI 10.1257/aer.102.2.865; Kogan S, 2011, AM ECON REV, V101, P927, DOI 10.1257/aer.101.2.927; Kuziemko I, 2014, Q J ECON, V129, P105, DOI 10.1093/qje/qjt035; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LEAMER EE, 1983, AM ECON REV, V73, P31; Maniadis Z, 2014, AM ECON REV, V104, P277, DOI 10.1257/aer.104.1.277; McCullough BD, 2006, J MONEY CREDIT BANK, V38, P1093, DOI 10.1353/mcb.2006.0061; McCullough BD, 2003, AM ECON REV, V93, P873, DOI 10.1257/000282803322157133; McNutt M, 2014, SCIENCE, V343, P231, DOI 10.1126/science.1250475; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Ritchie SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033423; Roth A, 1994, EMPIR ECON, V19, P279, DOI DOI 10.1007/BF01175875; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; Verhagen J, 2014, J EXP PSYCHOL GEN, V143, P1457, DOI 10.1037/a0036731; Wolfers J., 2006, 12200 NAT BUR EC RES	48	485	486	10	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1433	1436		10.1126/science.aaf0918	http://dx.doi.org/10.1126/science.aaf0918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH4KZ	26940865	Green Submitted			2022-12-28	WOS:000372756200044
J	Johnston, N; Christersson, C				Johnston, Nina; Christersson, Christina			Sex-Specific Research: A Key Component in Improving Prognosis After Transcatheter Aortic Valve Replacement	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OUTCOMES; IMPLANTATION; METAANALYSIS; MANAGEMENT; MORTALITY; STENOSIS; HEART		[Johnston, Nina; Christersson, Christina] Uppsala Univ, S-75185 Uppsala, Sweden	Uppsala University	Johnston, N (corresponding author), Uppsala Univ, Dept Med Sci, Cardiol, Akad Sjukhuset, S-75185 Uppsala, Sweden.		Christersson, Christina/ABD-4294-2021	Christersson, Christina/0000-0001-9116-8084				Debonnaire P, 2015, AM J CARDIOL, V115, P234, DOI 10.1016/j.amjcard.2014.10.029; Fazal L, 2014, BRIT J PHARMACOL, V171, P555, DOI 10.1111/bph.12279; Kodali S, 2016, ANN INTERN MED, V164, P377, DOI 10.7326/M15-0121; Lerakis S, 2013, CIRCULATION, V127, P397, DOI 10.1161/CIRCULATIONAHA.112.142000; O'Connor SA, 2015, J AM COLL CARDIOL, V66, P221, DOI 10.1016/j.jacc.2015.05.024; Panchal HB, 2013, AM J CARDIOL, V112, P850, DOI 10.1016/j.amjcard.2013.05.015; Piazza N, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.026; Regitz-Zagrosek V, 2016, EUR HEART J, V37, P24, DOI 10.1093/eurheartj/ehv598; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455; Williams M, 2014, J AM COLL CARDIOL, V63, P1522, DOI 10.1016/j.jacc.2014.01.036	10	0	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					442	+		10.7326/M16-0105	http://dx.doi.org/10.7326/M16-0105			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26903210				2022-12-28	WOS:000372207200018
J	Jiao, F; Li, JJ; Pan, XL; Xiao, JP; Li, HB; Ma, H; Wei, MM; Pan, Y; Zhou, ZY; Li, MR; Miao, S; Li, J; Zhu, YF; Xiao, D; He, T; Yang, JH; Qi, F; Fu, Q; Bao, XH				Jiao, Feng; Li, Jinjing; Pan, Xiulian; Xiao, Jianping; Li, Haobo; Ma, Hao; Wei, Mingming; Pan, Yang; Zhou, Zhongyue; Li, Mingrun; Miao, Shu; Li, Jian; Zhu, Yifeng; Xiao, Dong; He, Ting; Yang, Junhao; Qi, Fei; Fu, Qiang; Bao, Xinhe			Selective conversion of syngas to light olefins	SCIENCE			English	Article							PHOTOIONIZATION MASS-SPECTROMETRY; SYNTHESIS GAS; CO HYDROGENATION; CATALYSTS; KETENE; TRANSFORMATION; NANOPARTICLES; HYDROCARBONS; CHEMISTRY	Although considerable progress has been made in direct synthesis gas (syngas) conversion to light olefins (C-2(=)-C-4(=)) via Fischer-Tropsch synthesis (FTS), the wide product distribution remains a challenge, with a theoretical limit of only 58% for C-2-C-4 hydrocarbons. We present a process that reaches C-2(=)-C-4(=) selectivity as high as 80% and C-2-C-4 94% at carbon monoxide (CO) conversion of 17%. This is enabled by a bifunctional catalyst affording two types of active sites with complementary properties. The partially reduced oxide surface (ZnCrOx) activates CO and H-2, and C-C coupling is subsequently manipulated within the confined acidic pores of zeolites. No obvious deactivation is observed within 110 hours. Furthermore, this composite catalyst and the process may allow use of coal-and biomass-derived syngas with a low H-2/CO ratio.	[Jiao, Feng; Li, Jinjing; Pan, Xiulian; Xiao, Jianping; Li, Haobo; Ma, Hao; Wei, Mingming; Li, Mingrun; Miao, Shu; Li, Jian; Zhu, Yifeng; Xiao, Dong; He, Ting; Yang, Junhao; Fu, Qiang; Bao, Xinhe] Chinese Acad Sci, Dalian Inst Chem Phys, Collaborat Innovat Ctr Chem Energy Mat 2011, State Key Lab Catalysis, Zhongshan Rd 457, Dalian 116023, Peoples R China; [Pan, Yang; Zhou, Zhongyue; Qi, Fei] Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Hefei 230029, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; State Key Laboratory of Catalysis, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Pan, XL; Bao, XH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Collaborat Innovat Ctr Chem Energy Mat 2011, State Key Lab Catalysis, Zhongshan Rd 457, Dalian 116023, Peoples R China.	panxl@dicp.ac.cn; xhbao@dicp.ac.cn	Li, Haobo/GXG-2873-2022; Xiao, Jian/GYU-4351-2022; Zhou, Zhongyue/AAI-1846-2021; jiao, feng/M-8047-2013; Fu, Qiang/E-7109-2015; Ma, Hao/N-7388-2016; Zhu, Yifeng/AAY-4864-2020; Bao, Xinhe/P-5373-2014; Qi, Fei/A-3722-2012	Li, Haobo/0000-0002-9448-6771; Zhou, Zhongyue/0000-0002-5576-1400; jiao, feng/0000-0001-9376-7208; Fu, Qiang/0000-0001-5316-6758; Ma, Hao/0000-0001-6025-3315; Bao, Xinhe/0000-0001-9404-6429; Qi, Fei/0000-0003-3638-714X; Yifeng, Zhu/0000-0001-8965-5051; XIAO, DONG/0000-0003-1485-4915; Xiao, Jianping/0000-0003-1779-6140	National Natural Science Foundation of China [21425312, 21321002, 91545204]; Ministry of Science and Technology of China [2013CB933100]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA09030101]; Dalian Institute of Chemical Physics Fundamental Research Program for Clean Energy [DICP M201308]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); Dalian Institute of Chemical Physics Fundamental Research Program for Clean Energy; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was financially supported by the National Natural Science Foundation of China (grant nos. 21425312, 21321002, and 91545204), the Ministry of Science and Technology of China (no. 2013CB933100), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (grant XDA09030101), and Dalian Institute of Chemical Physics Fundamental Research Program for Clean Energy (DICP M201308). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. A Chinese patent and an international patent application under the Patent Cooperation Treaty are pending.	CHANMUGAM J, 1956, J AM CHEM SOC, V78, P509, DOI 10.1021/ja01584a001; Chen D, 2012, MICROPOR MESOPOR MAT, V164, P239, DOI 10.1016/j.micromeso.2012.06.046; Chen XQ, 2015, CHEM COMMUN, V51, P217, DOI [10.1039/c4cc06600f, 10.3778/j.issn.1002-8331.1401-0315]; Cool TA, 2003, J CHEM PHYS, V119, P8356, DOI 10.1063/1.1611173; Erena J, 1998, IND ENG CHEM RES, V37, P1211, DOI 10.1021/ie970568p; FRIEDEL RA, 1950, J AM CHEM SOC, V72, P1212, DOI 10.1021/ja01159a039; FUJIMOTO K, 1985, J CATAL, V94, P16, DOI 10.1016/0021-9517(85)90078-8; Galvis HMT, 2013, ACS CATAL, V3, P2130, DOI 10.1021/cs4003436; Galvis HMT, 2012, SCIENCE, V335, P835, DOI 10.1126/science.1215614; Ge QJ, 2007, J MOL CATAL A-CHEM, V278, P215, DOI 10.1016/j.molcata.2007.09.008; Jia CY, 2014, PHYS CHEM CHEM PHYS, V16, P7538, DOI 10.1039/c4cp00004h; Melaet G, 2014, J AM CHEM SOC, V136, P2260, DOI 10.1021/ja412447q; Mohanty P, 2011, FUEL PROCESS TECHNOL, V92, P600, DOI 10.1016/j.fuproc.2010.11.017; Puskas I, 2003, CATAL TODAY, V84, P99, DOI 10.1016/S0920-5861(03)00305-5; Qi F, 2013, P COMBUST INST, V34, P33, DOI 10.1016/j.proci.2012.09.002; Savee JD, 2015, SCIENCE, V347, P643, DOI 10.1126/science.aaa1495; SNEL R, 1987, CATAL REV, V29, P361, DOI 10.1080/01614948708078612; TAMAURA Y, 1990, NATURE, V346, P255, DOI 10.1038/346255a0; Williams JW, 1940, J ORG CHEM, V5, P122, DOI 10.1021/jo01208a005; Xiao JP, 2012, J PHYS CHEM LETT, V3, P2638, DOI 10.1021/jz301119k; Xu Y. D., 1994, CATAL LETT, V24, P31; Yang B, 2012, INT J MASS SPECTROM, V309, P118, DOI 10.1016/j.ijms.2011.09.006; Yang GH, 2010, J AM CHEM SOC, V132, P8129, DOI 10.1021/ja101882a; Yang ZQ, 2011, ENERG ENVIRON SCI, V4, P4500, DOI 10.1039/c1ee01428e; Yu YY, 2014, REACT KINET MECH CAT, V112, P489, DOI 10.1007/s11144-014-0707-1; Zhang ZH, 2011, ACS CATAL, V1, P1621, DOI 10.1021/cs200434s	26	774	865	128	2391	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1065	1068		10.1126/science.aaf1835	http://dx.doi.org/10.1126/science.aaf1835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941314				2022-12-28	WOS:000371597500039
J	Aragones, AC; Haworth, NL; Darwish, N; Ciampi, S; Bloomfield, NJ; Wallace, GG; Diez-Perez, I; Coote, ML				Aragones, Albert C.; Haworth, Naomi L.; Darwish, Nadim; Ciampi, Simone; Bloomfield, Nathaniel J.; Wallace, Gordon G.; Diez-Perez, Ismael; Coote, Michelle L.			Electrostatic catalysis of a Diels-Alder reaction	NATURE			English	Article							DISTONIC RADICAL-ANIONS; EXTERNAL ELECTRIC-FIELD; SOMO-HOMO CONVERSION; NORBORNYLOGOUS BRIDGES; MOLECULAR JUNCTIONS; VALENCE-BOND; SELECTIVITY; RULERS	It is often thought that the ability to control reaction rates with an applied electrical potential gradient is unique to redox systems. However, recent theoretical studies suggest that oriented electric fields could affect the outcomes of a range of chemical reactions, regardless of whether a redox system is involved(1-4). This possibility arises because many formally covalent species can be stabilized via minor charge-separated resonance contributors. When an applied electric field is aligned in such a way as to electrostatically stabilize one of these minor forms, the degree of resonance increases, resulting in the overall stabilization of the molecule or transition state. This means that it should be possible to manipulate the kinetics and thermodynamics of non-redox processes using an external electric field, as long as the orientation of the approaching reactants with respect to the field stimulus can be controlled. Here, we provide experimental evidence that the formation of carboncarbon bonds is accelerated by an electric field. We have designed a surface model system to probe the Diels-Alder reaction, and coupled it with a scanning tunnelling microscopy break-junction approach(5-7). This technique, performed at the single-molecule level, is perfectly suited to deliver an electric-field stimulus across approaching reactants. We find a fivefold increase in the frequency of formation of single-molecule junctions, resulting from the reaction that occurs when the electric field is present and aligned so as to favour electron flow from the dienophile to the diene. Our results are qualitatively consistent with those predicted by quantum-chemical calculations in a theoretical model of this system, and herald a new approach to chemical catalysis.	[Aragones, Albert C.; Darwish, Nadim; Diez-Perez, Ismael] Univ Barcelona, Dept Quim Fis, Diagonal 645, E-08028 Barcelona, Catalonia, Spain; [Aragones, Albert C.; Darwish, Nadim; Diez-Perez, Ismael] Inst Bioengn Catalunya IBEC, Baldiri Reixac 15-21, Barcelona 08028, Catalonia, Spain; [Aragones, Albert C.; Diez-Perez, Ismael] Ctr Invest Biomed Red CIBER BBN, Campus Rio Ebro Edificio I D, Zaragoza 50018, Spain; [Haworth, Naomi L.; Bloomfield, Nathaniel J.; Coote, Michelle L.] Australian Natl Univ, Res Sch Chem, ARC Ctr Excellence Electromat Sci, Canberra, ACT 2601, Australia; [Ciampi, Simone; Wallace, Gordon G.] Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, Wollongong, NSW 2500, Australia	University of Barcelona; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Australian National University; University of Wollongong	Darwish, N; Diez-Perez, I (corresponding author), Univ Barcelona, Dept Quim Fis, Diagonal 645, E-08028 Barcelona, Catalonia, Spain.; Darwish, N; Diez-Perez, I (corresponding author), Inst Bioengn Catalunya IBEC, Baldiri Reixac 15-21, Barcelona 08028, Catalonia, Spain.; Diez-Perez, I (corresponding author), Ctr Invest Biomed Red CIBER BBN, Campus Rio Ebro Edificio I D, Zaragoza 50018, Spain.; Coote, ML (corresponding author), Australian Natl Univ, Res Sch Chem, ARC Ctr Excellence Electromat Sci, Canberra, ACT 2601, Australia.; Ciampi, S (corresponding author), Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, Wollongong, NSW 2500, Australia.	ndarwish@ibecbarcelona.eu; sciampi@uow.edu.au; isma_diez@ub.edu; michelle.coote@anu.edu.au	Díez-Pérez, Ismael/F-6402-2014; Coote, Michelle L/B-2267-2010; Haworth, Naomi L/G-5254-2011; Ciampi, Simone/D-9129-2014; Aragonès, Albert C/P-8182-2018; Wallace, Gordon G/H-1123-2011	Díez-Pérez, Ismael/0000-0003-0513-8888; Coote, Michelle L/0000-0003-0828-7053; Haworth, Naomi L/0000-0002-3299-3137; Aragonès, Albert C/0000-0002-1829-6941; Wallace, Gordon G/0000-0002-0381-7273; ciampi, simone/0000-0002-8272-8454; Darwish, Nadim/0000-0002-6565-1723	MINECO Spanish National Project [CTQ2012-36090]; EU Reintegration Grant [FP7-PEOPLE-2010-RG-277182]; Australian Government; European Union; Ramon y Cajal program (MINECO) [RYC-2011-07951]; University of Wollongong; Australian National Fabrication Facility; Spanish Ministerio de Educacion; Australian Research Council (ARC); ARC; ARC Centre of Excellence Scheme [CE 140100012]	MINECO Spanish National Project; EU Reintegration Grant; Australian Government(Australian GovernmentCGIAR); European Union(European Commission); Ramon y Cajal program (MINECO); University of Wollongong; Australian National Fabrication Facility; Spanish Ministerio de Educacion(Spanish Government); Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council); ARC Centre of Excellence Scheme(Australian Research Council)	This research was supported by the MINECO Spanish National Project (no. CTQ2012-36090) and an EU Reintegration Grant (FP7-PEOPLE-2010-RG-277182), and by resources provided at the NCI National Facility systems at the Australian National University through the National Computational Merit Allocation Scheme, supported by the Australian Government. N.D. thanks the European Union for a Marie Curie IIF Fellowship. I. D.-P. thanks the Ramon y Cajal program (MINECO, no. RYC-2011-07951) for financial support. S.C. thanks the University of Wollongong for a Vice Chancellor Fellowship, and the Australian National Fabrication Facility for financial support. A.C.A. thanks the Spanish Ministerio de Educacion for an FPU fellowship. M.L.C acknowledges financial support from the Australian Research Council (ARC) and an ARC Future Fellowship, and discussions with M. Banwell. We also acknowledge funding from the ARC Centre of Excellence Scheme (project no. CE 140100012).	Alemani M, 2006, J AM CHEM SOC, V128, P14446, DOI 10.1021/ja065449s; Claridge SA, 2011, ACS NANO, V5, P693, DOI 10.1021/nn103298x; Darwish N, 2014, ACCOUNTS CHEM RES, V47, P385, DOI 10.1021/ar400127g; Darwish N, 2012, J AM CHEM SOC, V134, P18401, DOI 10.1021/ja307665k; Darwish N, 2012, ANGEW CHEM INT EDIT, V51, P3203, DOI 10.1002/anie.201107765; Darwish N, 2012, CHEM-EUR J, V18, P283, DOI 10.1002/chem.201101588; Diez-Perez I, 2009, NAT CHEM, V1, P635, DOI [10.1038/NCHEM.392, 10.1038/nchem.392]; Donhauser ZJ, 2001, SCIENCE, V292, P2303, DOI 10.1126/science.1060294; Fischer H, 2001, ANGEW CHEM INT EDIT, V40, P1340, DOI 10.1002/1521-3773(20010417)40:8<1340::AID-ANIE1340>3.0.CO;2-#; Franchi P, 2014, J AM CHEM SOC, V136, P1250, DOI 10.1021/ja411662a; Fried SD, 2014, SCIENCE, V346, P1510, DOI 10.1126/science.1259802; Gorin CF, 2012, J AM CHEM SOC, V134, P186, DOI 10.1021/ja210365j; Gryn'ova G, 2013, J AM CHEM SOC, V135, P15392, DOI 10.1021/ja404279f; Gryn'ova G, 2013, NAT CHEM, V5, P474, DOI [10.1038/NCHEM.1625, 10.1038/nchem.1625]; Haiss W, 2004, PHYS CHEM CHEM PHYS, V6, P4330, DOI 10.1039/b404929b; Haiss W, 2006, NAT MATER, V5, P995, DOI 10.1038/nmat1781; Hirao H, 2008, J AM CHEM SOC, V130, P3319, DOI 10.1021/ja070903t; Klinska M, 2015, CHEM SCI, V6, P5623, DOI 10.1039/c5sc01307k; Lai WZ, 2012, ANGEW CHEM INT EDIT, V51, P5556, DOI 10.1002/anie.201108398; Lai WZ, 2010, J PHYS CHEM LETT, V1, P2082, DOI 10.1021/jz100695n; Meir R, 2010, CHEMPHYSCHEM, V11, P301, DOI 10.1002/cphc.200900848; Nicolaou KC, 2002, ANGEW CHEM INT EDIT, V41, P1668, DOI 10.1002/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO;2-Z; PADDONROW MN, 1994, ACCOUNTS CHEM RES, V27, P18, DOI 10.1021/ar00037a003; Shaik S, 2004, J AM CHEM SOC, V126, P11746, DOI 10.1021/ja047432k; Shaik S, 2009, NAT CHEM, V1, P443, DOI [10.1038/NCHEM.327, 10.1038/nchem.327]; Shurki A, 1999, J AM CHEM SOC, V121, P822, DOI 10.1021/ja982218f; SINI G, 1991, J MOL STRUC-THEOCHEM, V75, P163, DOI 10.1016/0166-1280(91)90144-9; Tao NJ, 2006, NAT NANOTECHNOL, V1, P173, DOI 10.1038/nnano.2006.130; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481	30	422	425	22	476	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					88	91		10.1038/nature16989	http://dx.doi.org/10.1038/nature16989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26935697	Green Accepted, Green Submitted			2022-12-28	WOS:000371211900045
J	Silas, S; Mohr, G; Sidote, DJ; Markham, LM; Sanchez-Amat, A; Bhaya, D; Lambowitz, AM; Fire, AZ				Silas, Sukrit; Mohr, Georg; Sidote, David J.; Markham, Laura M.; Sanchez-Amat, Antonio; Bhaya, Devaki; Lambowitz, Alan M.; Fire, Andrew Z.			Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase-Cas1 fusion protein	SCIENCE			English	Article							DEPENDENT DNA-POLYMERASE; INTRON; EVOLUTION; ELEMENTS; REPEATS; SYSTEM; CLASSIFICATION; REPLICATION; CLEAVAGE; BACTERIA	CRISPR systems mediate adaptive immunity in diverse prokaryotes. CRISPR-associated Cas1 and Cas2 proteins have been shown to enable adaptation to new threats in type I and II CRISPR systems by the acquisition of short segments of DNA (spacers) from invasive elements. In several type III CRISPR systems, Cas1 is naturally fused to a reverse transcriptase (RT). In the marine bacterium Marinomonas mediterranea (MMB-1), we showed that a RT-Cas1 fusion protein enables the acquisition of RNA spacers in vivo in a RT-dependent manner. In vitro, the MMB-1 RT-Cas1 and Cas2 proteins catalyze the ligation of RNA segments into the CRISPR array, which is followed by reverse transcription. These observations outline a host-mediated mechanism for reverse information flow from RNA to DNA.	[Silas, Sukrit; Fire, Andrew Z.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Silas, Sukrit] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Mohr, Georg; Sidote, David J.; Markham, Laura M.; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Sanchez-Amat, Antonio] Univ Murcia, Dept Genet & Microbiol, E-30100 Murcia, Spain; [Bhaya, Devaki] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Texas System; University of Texas Austin; University of Murcia; Carnegie Institution for Science	Fire, AZ (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Lambowitz, AM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu; afire@stanford.edu	Paniagua, Enrique/H-3536-2015; Sanchez-Amat, Antonio/L-2695-2014	Paniagua, Enrique/0000-0001-5006-6428; Sanchez-Amat, Antonio/0000-0001-8597-9235; Fire, Andrew/0000-0001-6217-8312; Mohr, Georg/0000-0002-6411-0685; Silas, Sukrit/0000-0003-3251-8579	Howard Hughes Medical Institute; NIH [R01-GM37706, R01-GM37949, R01-GM37951]; Welch Foundation [F-1607]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037951, R01GM037949, R01GM037706, R01GM037951] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Shor, S. Cohen, M. Bagdasarian, C. Pourcel, L. Mindich, C.P. Wolk, M. Poranen, and laboratory colleagues for help and advice; the Howard Hughes Medical Institute and Stanford for fellowship support (S.S.); NIH (grants R01-GM37706 to A.Z.F., R01-GM37949 to A.M.L., and R01-GM37951 to A.M.L.); and the Welch Foundation (grant F-1607 to A.M.L.). Sequencing data are archived in the Sequence Read Archive under SRA ID-SRP066108. S.S. and A.Z.F. conceived the project. S.S., G.M., A.M.L., and A.Z.F. designed experiments, analyzed data, and wrote the paper with inputs from other authors. S.S. performed all genetics experiments. G.M., D.J.S., and L.M.M. performed all biochemistry experiments. A.S.-A. and D.B. provided protocols and conceptual guidance.	BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BELFORT M, 1987, COLD SPRING HARB SYM, V52, P181, DOI 10.1101/SQB.1987.052.01.023; BIEBRICH.CK, 1973, P NATL ACAD SCI USA, V70, P934, DOI 10.1073/pnas.70.3.934; Blocker FJH, 2005, RNA, V11, P14, DOI 10.1261/rna.7181105; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Flores R, 2014, ANNU REV MICROBIOL, V68, P395, DOI 10.1146/annurev-micro-091313-103416; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Grynberg M, 2004, TRENDS BIOCHEM SCI, V29, P106, DOI 10.1016/j.tibs.2004.01.002; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Kim TY, 2013, BIOCHEM BIOPH RES CO, V441, P720, DOI 10.1016/j.bbrc.2013.10.122; Kojima KK, 2008, MOL BIOL EVOL, V25, P1395, DOI 10.1093/molbev/msn081; KONARSKA MM, 1989, CELL, V57, P423, DOI 10.1016/0092-8674(89)90917-3; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Ludwig W, 2005, BERGEYS MANUAL SYSTE, V2, P49, DOI DOI 10.1007/978-0-387-21609-6_8; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mohr G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000391; Mohr S, 2013, RNA, V19, P958, DOI 10.1261/rna.039743.113; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; Solano F, 2000, J BACTERIOL, V182, P3754, DOI 10.1128/JB.182.13.3754-3760.2000; Solano F, 1999, INT J SYST BACTERIOL, V49, P1241, DOI 10.1099/00207713-49-3-1241; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Toro N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114083; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; ZIMMERLY S, 1995, CELL, V82, P545, DOI 10.1016/0092-8674(95)90027-6	49	113	128	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276							aad4234	10.1126/science.aad4234	http://dx.doi.org/10.1126/science.aad4234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917774	Green Accepted			2022-12-28	WOS:000370821400031
J	Kuhlwilm, M; Gronau, I; Hubisz, MJ; de Filippo, C; Prado-Martinez, J; Kircher, M; Fu, QM; Burbano, HA; Lalueza-Fox, C; de la Rasilla, M; Rosas, A; Rudan, P; Brajkovic, D; Kucan, Z; Gusic, I; Marques-Bonet, T; Andres, AM; Viola, B; Paabo, S; Meyer, M; Siepel, A; Castellano, S				Kuhlwilm, Martin; Gronau, Ilan; Hubisz, Melissa J.; de Filippo, Cesare; Prado-Martinez, Javier; Kircher, Martin; Fu, Qiaomei; Burbano, Hernan A.; Lalueza-Fox, Carles; de la Rasilla, Marco; Rosas, Antonio; Rudan, Pavao; Brajkovic, Dejana; Kucan, Zeljko; Gusic, Ivan; Marques-Bonet, Tomas; Andres, Aida M.; Viola, Bence; Paeaebo, Svante; Meyer, Matthias; Siepel, Adam; Castellano, Sergi			Ancient gene flow from early modern humans into Eastern Neanderthals	NATURE			English	Article							GENOME SEQUENCE; TRANSCRIPTION FACTOR; SELECTION; SOUTHERN; INFERENCE; ANCESTRY; PATTERNS; HISTORY; CAVE	It has been shown that Neanderthals contributed genetically to modern humans outside Africa 47,000-65,000 years ago. Here we analyse the genomes of a Neanderthal and a Denisovan from the Altai Mountains in Siberia together with the sequences of chromosome 21 of two Neanderthals from Spain and Croatia. We find that a population that diverged early from other modern humans in Africa contributed genetically to the ancestors of Neanderthals from the Altai Mountains roughly 100,000 years ago. By contrast, we do not detect such a genetic contribution in the Denisovan or the two European Neanderthals. We conclude that in addition to later interbreeding events, the ancestors of Neanderthals from the Altai Mountains and early modern humans met and interbred, possibly in the Near East, many thousands of years earlier than previously thought.	[Kuhlwilm, Martin; de Filippo, Cesare; Kircher, Martin; Fu, Qiaomei; Burbano, Hernan A.; Andres, Aida M.; Paeaebo, Svante; Meyer, Matthias; Castellano, Sergi] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Gronau, Ilan] Herzliya Interdisciplinary Ctr IDC, Efi Arazi Sch Comp Sci, IL-46150 Herzliyya, Israel; [Hubisz, Melissa J.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Prado-Martinez, Javier; Lalueza-Fox, Carles; Marques-Bonet, Tomas] Inst Evolutionary Biol UPF CSIC, Barcelona 08003, Spain; [Kircher, Martin] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Fu, Qiaomei] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Fu, Qiaomei] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins Chinese, IVPP, Beijing 100044, Peoples R China; [Burbano, Hernan A.] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [de la Rasilla, Marco] Univ Oviedo, Dept Hist, Area Prehist, Oviedo 33011, Spain; [Rosas, Antonio] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Plaza Murillo 2, E-28006 Madrid, Spain; [Rudan, Pavao; Kucan, Zeljko; Gusic, Ivan] Croatian Acad Sci & Arts, Anthropol Ctr, Zagreb 10000, Croatia; [Brajkovic, Dejana] Croatian Acad Sci & Arts, Inst Quaternary Paleontol & Geol, Zagreb 10000, Croatia; [Marques-Bonet, Tomas] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain; [Marques-Bonet, Tomas] Ctr Nacl Anal Genom CRG CNAG, Barcelona 08028, Spain; [Viola, Bence] Univ Toronto, Dept Anthropol, Toronto, ON M5S 2S2, Canada; [Viola, Bence] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Siepel, Adam] Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, Cold Spring Harbor, NY 11724 USA	Max Planck Society; Reichman University; Cornell University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Max Planck Society; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Croatian Academy of Sciences & Arts; Croatian Academy of Sciences & Arts; ICREA; University of Toronto; Max Planck Society; Cold Spring Harbor Laboratory	Castellano, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.; Siepel, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.; Siepel, A (corresponding author), Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, Cold Spring Harbor, NY 11724 USA.	asiepel@cshl.edu; sergi.castellano@eva.mpg.de	Marques-Bonet, Tomas/ABF-3734-2020; Kircher, Martin/H-6909-2019; Prado-Martinez, Javier/AAA-6341-2020; Andres, Aida/B-4088-2014; Kircher, Martin/HDL-9392-2022; Rosas, Antonio/D-9742-2016; LALUEZA-FOX, CARLES/AAG-5341-2020; Castellano, Sergi/A-7437-2016	Marques-Bonet, Tomas/0000-0002-5597-3075; Kircher, Martin/0000-0001-9278-5471; Prado-Martinez, Javier/0000-0001-5402-2721; Andres, Aida/0000-0002-8590-9672; Rosas, Antonio/0000-0002-5829-9952; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Kuhlwilm, Martin/0000-0002-0115-1797; Siepel, Adam/0000-0002-3557-7219; Hubisz, Melissa/0000-0002-9561-6830; Castellano, Sergi/0000-0002-5819-4210; Viola, Bence/0000-0001-8052-707X	National Science Foundation [DGE-1144153]; Special Foundation of the President of the Chinese Academy of Sciences; ICREA; EMBO YIP; Fundacio Barcelona Zoo; Max Planck Society; Krekeler Foundation; MINECO [BFU2014-55090-P FEDER, BFU2015-7116-ERC, BFU2015-6215-ERC, BFU2012-34157 FEDER]; US National Institutes of Health [GM102192, U01 MH106874]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106874] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Special Foundation of the President of the Chinese Academy of Sciences(Chinese Academy of Sciences); ICREA(ICREA); EMBO YIP(European Molecular Biology Organization (EMBO)); Fundacio Barcelona Zoo; Max Planck Society(Max Planck SocietyFoundation CELLEX); Krekeler Foundation; MINECO(Spanish Government); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ICREA(ICREA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Slatkin, F. Racimo, J. Kelso, K. Prufer, M. Stoneking and D. Reich for comments; the MPI-EVA sequencing group, B. Nickel and R. Schultz for technical support; A. Heinze, S. Sawyer and J. Dabney for sequencing library preparation; U. Stenzel and G. Renaud for help with sequence processing. M. J. H. was supported by the National Science Foundation Graduate Research Fellowship under grant DGE-1144153. Q. F. was funded in part by the Special Foundation of the President of the Chinese Academy of Sciences. T. M-B. was supported by ICREA, EMBO YIP 2013 and Fundacio Barcelona Zoo. The Max Planck Society, the Krekeler Foundation, MINECO (grants BFU2014-55090-P FEDER, BFU2015-7116-ERC and BFU2015-6215-ERC to T. M-B. and BFU2012-34157 FEDER to C. L.-F.) and the US National Institutes of Health (grant GM102192 to A. S. and U01 MH106874 to T. M-B.) provided financial support.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arbiza L, 2013, NAT GENET, V45, P723, DOI 10.1038/ng.2658; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Fu Q, 2015, NATURE; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; Hublin JJ, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P295; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; MERCIER N, 1993, J ARCHAEOL SCI, V20, P169, DOI 10.1006/jasc.1993.1012; Meyer M., 2010, COLD SPRING HARB PRO; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Rausa FM, 1999, MECH DEVELOP, V89, P185, DOI 10.1016/S0925-4773(99)00209-9; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Rose J.I., 2014, QUARTAR, V61, P49, DOI DOI 10.7485/QU61-03; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Veeramah KR, 2014, MOL BIOL EVOL, V31, P2267, DOI 10.1093/molbev/msu166	44	233	242	5	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					429	+		10.1038/nature16544	http://dx.doi.org/10.1038/nature16544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26886800	Green Accepted			2022-12-28	WOS:000370690800025
J	Friedman, EM				Friedman, Ellen M.			Removal of Foreign Bodies from the Ear and Nose	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Friedman, Ellen M.] Texas Childrens Hosp, Houston, TX 77030 USA; [Friedman, Ellen M.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Friedman, EM (corresponding author), Texas Childrens Hosp, Dept Otolaryngol, 6701 Fannin St,CC610-22, Houston, TX 77030 USA.	ellenf@bcm.tmc.edu						Fritz S, 1987, Emerg Med Clin North Am, V5, P183; Gomes Claudio Cidade, 1994, Rhinology (Utrecht), V32, P98; Kalan A, 2000, POSTGRAD MED J, V76, P484, DOI 10.1136/pmj.76.898.484; Kim AH, 2014, BLUESTONE STOOLS PED, P880; Passali D, 2014, BLUESTONE STOOLS PED, P1089; Schulze SL, 2002, OTOLARYNG HEAD NECK, V127, P73, DOI 10.1067/mhn.2002.126724; Werman H A, 1987, Emerg Med Clin North Am, V5, P253	7	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					E7	U6		10.1056/NEJMvcm1207469	http://dx.doi.org/10.1056/NEJMvcm1207469			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26886547				2022-12-28	WOS:000370229000001
J	Gillam, S; Newbould, J				Gillam, Stephen; Newbould, Jennifer			Patient participation groups in general practice: what are they for, where are they going?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gillam, Stephen] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Newbould, Jennifer] RAND Europe, Cambridge, England	University of Cambridge; RAND Corporation; RAND Europe	Gillam, S (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.	sjg67@medschl.cam.ac.uk						AGASS M, 1991, BRIT J GEN PRACT, V41, P198; Box Graham, 2009, Qual Prim Care, V17, P291; Care Quality Commission, GUID WORK TOG; Carter M, 2009, USING GP PATIENT SUR; Coulter A, 2014, BMJ-BRIT MED J, V348, pg2225; Department of Health, PAT PART DIR ENH SER; Doyle A, 2014, PROPOSED NEXT STEPS; MANN RG, 1985, BRIT MED J, V290, P209, DOI 10.1136/bmj.290.6463.209; Nagraj S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2333; Newbould J, 2015, QUAL PRIMARY CARE, V23, P4; NHS Employers, 2014, GMS CONTR CHANG 2015; Peckham Stephen, 2014, Healthc Policy, V10, P154; Pollard Lorraine, 2014, Qual Prim Care, V22, P189; Smiddy J, 2015, BRIT J GEN PRACT, V65, pE177, DOI 10.3399/bjgp15X683989; Withers N., MAKING PPGS HAPPEN; Wood J, 1980, J R Coll Gen Pract, V30, P538	16	11	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2016	352								i673	10.1136/bmj.i673	http://dx.doi.org/10.1136/bmj.i673			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6FB	26893458				2022-12-28	WOS:000370728000005
J	Carpenter, CR				Carpenter, Christopher R.			In acute low back pain, adding opioids or cyclobenzaprine to naproxen did not improve pain or function Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EMERGENCY-DEPARTMENT		[Carpenter, Christopher R.] Washington Univ, St Louis, MO USA	Washington University (WUSTL)	Carpenter, CR (corresponding author), Washington Univ, St Louis, MO USA.		Carpenter, Christopher R./E-3720-2013	Carpenter, Christopher R./0000-0002-2603-7157				Cantrill SV, 2012, ANN EMERG MED, V60, P499, DOI 10.1016/j.annemergmed.2012.06.013; Dickason RM, 2015, WEST J EMERG MED, V16, P372, DOI 10.5811/westjem.2015.3.23893; Downie AS, 2016, PAIN, V157, P225, DOI 10.1097/j.pain.0000000000000351; Gill SD, 2013, EMERG MED AUSTRALAS, V25, P558, DOI 10.1111/1742-6723.12134; Kim GM, 2015, PHYSIOTHER RES INT, V20, P16, DOI 10.1002/pri.1591	5	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					JC19	JC19		10.7326/ACPJC-2016-164-4-019	http://dx.doi.org/10.7326/ACPJC-2016-164-4-019			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26882304				2022-12-28	WOS:000370135300006
J	Lang, E				Lang, Eddy			Some risk scores plus high-sensitivity troponin may identify patients with chest pain for early discharge Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lang, Eddy] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada	University of Calgary	Lang, E (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.							Crowder KR, 2015, AM J EMERG MED; Hess EP, 2010, CAN MED ASSOC J, V182, P1039, DOI 10.1503/cmaj.092119; Worster A, 2012, ANN EMERG MED, V59, P126, DOI 10.1016/j.annemergmed.2011.11.035	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					JC22	JC22		10.7326/ACPJC-2016-164-4-022	http://dx.doi.org/10.7326/ACPJC-2016-164-4-022			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26882307				2022-12-28	WOS:000370135300009
J	Cao-Lormeau, VM; Blake, A; Mons, S; Lastere, S; Roche, C; Vanhomwegen, J; Dub, T; Baudouin, L; Teissier, A; Larre, P; Vial, AL; Decam, C; Choumet, V; Halstead, SK; Willison, HJ; Musset, L; Manuguerra, JC; Despres, P; Fournier, E; Mallet, HP; Musso, D; Fontanet, A; Neil, J; Ghawche, F				Cao-Lormeau, Van-Mai; Blake, Alexandre; Mons, Sandrine; Lastere, Stephane; Roche, Claudine; Vanhomwegen, Jessica; Dub, Timothee; Baudouin, Laure; Teissier, Anita; Larre, Philippe; Vial, Anne-Laure; Decam, Christophe; Choumet, Valerie; Halstead, Susan K.; Willison, Hugh J.; Musset, Lucile; Manuguerra, Jean-Claude; Despres, Philippe; Fournier, Emmanuel; Mallet, Henri-Pierre; Musso, Didier; Fontanet, Arnaud; Neil, Jean; Ghawche, Frederic			Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study	LANCET			English	Article							CAMPYLOBACTER; INFLUENZA; DENGUE; CHIKUNGUNYA; DIAGNOSIS; CRITERIA	Background Between October, 2013, and April, 2014, French Polynesia experienced the largest Zika virus outbreak ever described at that time. During the same period, an increase in Guillain-Barre syndrome was reported, suggesting a possible association between Zika virus and Guillain-Barre syndrome. We aimed to assess the role of Zika virus and dengue virus infection in developing Guillain-Barre syndrome. Methods In this case-control study, cases were patients with Guillain-Barre syndrome diagnosed at the Centre Hospitalier de Polynesie Francaise (Papeete, Tahiti, French Polynesia) during the outbreak period. Controls were age-matched, sex-matched, and residence-matched patients who presented at the hospital with a non-febrile illness (control group 1; n=98) and age-matched patients with acute Zika virus disease and no neurological symptoms (control group 2; n=70). Virological investigations included RT-PCR for Zika virus, and both microsphere immunofluorescent and seroneutralisation assays for Zika virus and dengue virus. Anti-glycolipid reactivity was studied in patients with Guillain-Barre syndrome using both ELISA and combinatorial microarrays. Findings 42 patients were diagnosed with Guillain-Barre syndrome during the study period. 41 (98%) patients with Guillain-Barre syndrome had anti-Zika virus IgM or IgG, and all (100%) had neutralising antibodies against Zika virus compared with 54 (56%) of 98 in control group 1 (p<0.0001). 39 (93%) patients with Guillain-Barre syndrome had Zika virus IgM and 37 (88%) had experienced a transient illness in a median of 6 days (IQR 4-10) before the onset of neurological symptoms, suggesting recent Zika virus infection. Patients with Guillain-Barre syndrome had electrophysiological findings compatible with acute motor axonal neuropathy (AMAN) type, and had rapid evolution of disease (median duration of the installation and plateau phases was 6 [IQR 4-9] and 4 days [3-10], respectively). 12 (29%) patients required respiratory assistance. No patients died. Anti-glycolipid antibody activity was found in 13 (31%) patients, and notably against GA1 in eight (19%) patients, by ELISA and 19 (46%) of 41 by glycoarray at admission. The typical AMAN-associated anti-ganglioside antibodies were rarely present. Past dengue virus history did not differ significantly between patients with Guillain-Barre syndrome and those in the two control groups (95%, 89%, and 83%, respectively). Interpretation This is the first study providing evidence for Zika virus infection causing Guillain-Barre syndrome. Because Zika virus is spreading rapidly across the Americas, at risk countries need to prepare for adequate intensive care beds capacity to manage patients with Guillain-Barre syndrome.	[Cao-Lormeau, Van-Mai; Roche, Claudine; Teissier, Anita; Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Tahiti, France; [Blake, Alexandre; Dub, Timothee; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, 25 Rue Docteur Roux, F-75015 Paris, France; [Mons, Sandrine; Baudouin, Laure] Ctr Hosp Polynesie Francaise, Serv Reanimat Polyvalente, Tahiti, France; [Lastere, Stephane] Ctr Hosp Polynesie Francaise, Clin Lab, Tahiti, France; [Vanhomwegen, Jessica; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France; [Vanhomwegen, Jessica; Choumet, Valerie; Manuguerra, Jean-Claude] Inst Pasteur, Unit Environm & Infect Risks, Paris, France; [Larre, Philippe; Ghawche, Frederic] Ctr Hosp Polynesie Francaise, Serv Neurol, Papeete, Tahiti, France; [Vial, Anne-Laure; Mallet, Henri-Pierre] Bur Veille Sanit, Direct Sante, Papeete, France; [Decam, Christophe] Serv Sante Forces Armees, Papeete, France; [Halstead, Susan K.; Willison, Hugh J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Musset, Lucile; Neil, Jean] Grp Hosp Pitie Salpetriere, AP HP, Dept Immunol, Lab Immunochem & Autoimmun, F-75634 Paris, France; [Despres, Philippe] Univ Reunion Island, St Denis, Reunion, France; [Fournier, Emmanuel] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurophysiol, F-75634 Paris, France; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France; [Fontanet, Arnaud] Inst Pasteur, Ctr Global Hlth Res & Educ, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Glasgow; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fontanet, A (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, 25 Rue Docteur Roux, F-75015 Paris, France.	fontanet@pasteur.fr	willison, hugh/HCI-7819-2022; Dub, Timothee/AAX-4663-2020; Cao-Lormeau, Van-Mai/H-4879-2018; Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020	Dub, Timothee/0000-0002-1819-518X; Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; , arnaud/0000-0002-5239-6110; Halstead, Susan/0000-0001-7396-8969; Blake, Alexandre/0000-0002-1627-4992	Labex Integrative Biology of Emerging Infectious Diseases; EU; Wellcome Trust	Labex Integrative Biology of Emerging Infectious Diseases; EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	Labex Integrative Biology of Emerging Infectious Diseases, EU 7th framework programme PREDEMICS, and Wellcome Trust.	Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Aubry M, 2015, 64 ANN M AM SOC TROP; Beck C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/678084; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983; European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Hiraga A, 2003, NEUROLOGY, V61, P471, DOI 10.1212/01.WNL.0000081231.08914.A1; Ho TW, 1997, NEUROLOGY, V48, P717, DOI 10.1212/WNL.48.3.717; Kokubun N, 2013, CLIN NEUROPHYSIOL, V124, P1671, DOI 10.1016/j.clinph.2013.02.010; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; Mallet HP, B INFORM SANITAIRES; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Monos DS, 1997, J INFECT DIS, V176, pS180, DOI 10.1086/513786; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Neil J, 2012, J NEUROIMMUNOL, V242, P72, DOI 10.1016/j.jneuroim.2011.11.007; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; RAVI V, 1994, ACTA NEUROL SCAND, V90, P67; Rinaldi S, 2008, CURR OPIN NEUROL, V21, P540, DOI 10.1097/WCO.0b013e32830b84b7; Rinaldi S, 2012, METHODS MOL BIOL, V808, P413, DOI 10.1007/978-1-61779-373-8_28; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344; Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025; van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121; Willison HJ, 2007, J NEUROCHEM, V103, P143, DOI 10.1111/j.1471-4159.2007.04718.x; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	41	1471	1545	8	193	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1531	1539		10.1016/S0140-6736(16)00562-6	http://dx.doi.org/10.1016/S0140-6736(16)00562-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	26948433	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000373741600029
J	Blumenthal, D				Blumenthal, David			Better Health Care A Way Forward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Blumenthal, David] Commonwealth Fund, 1 E 75th St, New York, NY 10021 USA	Commonwealth Fund	Blumenthal, D (corresponding author), Commonwealth Fund, 1 E 75th St, New York, NY 10021 USA.	db@cmwf.org						Blumenthal D, 2015, JAMA-J AM MED ASSOC, V313, P1901, DOI 10.1001/jama.2015.4862; Davis K, 2014, MIRRO MIRROR WALL; Martinez ME, 2015, HLTH INSURANCE COVER; McCarthy D, AIMING HIGHER RESULT; Saltzman E, 2015, RAMIFICATIONS REPEAL; Spitalnic P, CERTIFICATION PIONEE; Squires D, ROAD NOT TAKEN COST	7	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1333	1334		10.1001/jama.2016.0590	http://dx.doi.org/10.1001/jama.2016.0590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	26940511				2022-12-28	WOS:000373381500012
J	Wang, DL; Garcia, H; Huang, W; Tran, DD; Jain, AD; Yi, DH; Gong, Z; Jech, JM; Godo, OR; Makris, NC; Ratilal, P				Wang, Delin; Garcia, Heriberto; Huang, Wei; Tran, Duong D.; Jain, Ankita D.; Yi, Dong Hoon; Gong, Zheng; Jech, J. Michael; Godo, Olav Rune; Makris, Nicholas C.; Ratilal, Purnima			Vast assembly of vocal marine mammals from diverse species on fish spawning ground	NATURE			English	Article							PASSIVE SOURCE LOCALIZATION; HERRING CLUPEA-HARENGUS; HUMPBACK WHALE SONGS; FIN WHALES; TRANSMISSION SCINTILLATION; EUBALAENA-GLACIALIS; FORAGING BEHAVIOR; LONG-DISTANCE; ORCINUS-ORCA; OCEAN	Observing marine mammal (MM) populations continuously in time and space over the immense ocean areas they inhabit is challenging but essential for gathering an unambiguous record of their distribution, as well as understanding their behaviour and interaction with prey species(1-6). Here we use passive ocean acoustic waveguide remote sensing (POAWRS)(7,8) in an important North Atlantic feeding ground(9,10) to instantaneously detect, localize and classify MM vocalizations from diverse species over an approximately 100,000 km(2) region. More than eight species of vocal MMs are found to spatially converge on fish spawning areas containing massive densely populated herring shoals at night-time(11-16) and diffuse herring distributions during daytime. We find the vocal MMs divide the enormous fish prey field into species-specific foraging areas with varying degrees of spatial overlap, maintained for at least two weeks of the herring spawning period. The recorded vocalization rates are diel (24 h)-dependent for all MM species, with some significantly more vocal at night and others more vocal during the day. The four key baleen whale species of the region: fin, humpback, blue and minke have vocalization rate trends that are highly correlated to trends in fish shoaling density and to each other over the diel cycle. These results reveal the temporospatial dynamics of combined multi-species MM foraging activities in the vicinity of an extensive fish prey field that forms a massive ecological hotspot, and would be unattainable with conventional methodologies. Understanding MM behaviour and distributions is essential for management of marine ecosystems and for accessing anthropogenic impacts on these protected marine species(1-5,17,18).	[Wang, Delin; Garcia, Heriberto; Huang, Wei; Tran, Duong D.; Gong, Zheng; Ratilal, Purnima] Northeastern Univ, Lab Ocean Acoust & Ecosyst Sensing, 360 Huntington Ave, Boston, MA 02115 USA; [Jain, Ankita D.; Yi, Dong Hoon; Gong, Zheng; Makris, Nicholas C.] MIT, Lab Undersea Remote Sensing, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Jech, J. Michael] Northeast Fisheries Sci Ctr, 166 Water St, Woods Hole, MA 02543 USA; [Godo, Olav Rune] Inst Marine Res, POB 1870, N-5817 Bergen, Norway	Northeastern University; Massachusetts Institute of Technology (MIT); Institute of Marine Research - Norway	Ratilal, P (corresponding author), Northeastern Univ, Lab Ocean Acoust & Ecosyst Sensing, 360 Huntington Ave, Boston, MA 02115 USA.	purnima@ece.neu.edu		Godo, Olav Rune/0000-0001-8826-8068	National Oceanographic Partnership Program [321RF/096/06]; US National Science Foundation; US Office of Naval Research (Ocean Acoustics Program); National Oceanographic Partnership Program; US Presidential Early Career Award for Scientists and Engineers; Alfred P. Sloan Foundation; Census of Marine Life; Northeastern University; Directorate For Geosciences [1550294] Funding Source: National Science Foundation	National Oceanographic Partnership Program; US National Science Foundation(National Science Foundation (NSF)); US Office of Naval Research (Ocean Acoustics Program)(Office of Naval Research); National Oceanographic Partnership Program; US Presidential Early Career Award for Scientists and Engineers; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Census of Marine Life; Northeastern University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Permission for this National Oceanographic Partnership Program experiment was given in the Office of Naval Research document 5090 Ser 321RF/096/06. This research was supported by the US National Science Foundation, the US Office of Naval Research (Ocean Acoustics Program), the National Oceanographic Partnership Program, the US Presidential Early Career Award for Scientists and Engineers, the Alfred P. Sloan Foundation, the Census of Marine Life, and Northeastern University. The authors thank J. R. Preston for assistance with GOM 2006 experiment, D. H. Cato and P. L. Tyack for discussions.	Ainslie MA, 2013, J ACOUST SOC AM, V134, P3506, DOI 10.1121/1.4823804; Andrews M, 2011, J ACOUST SOC AM, V130, P1253, DOI 10.1121/1.3614542; Andrews M, 2009, J ACOUST SOC AM, V125, P111, DOI 10.1121/1.3037228; [Anonymous], 2012, 54 NE REG STOCK AS A; [Anonymous], 2011, PROBABILITY STAT RAN; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Baumgartner MF, 2008, J ACOUST SOC AM, V124, P1339, DOI 10.1121/1.2945155; Baumgartner MF, 2011, J ACOUST SOC AM, V129, P2889, DOI 10.1121/1.3562166; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Becker K., 2003, P OCEANS 03, V5; Berchok CL, 2006, J ACOUST SOC AM, V120, P2340, DOI 10.1121/1.2335676; Bergmann P.G., 1968, PHYS SOUND SEA; Bertsatos I, 2010, J ACOUST SOC AM, V128, P2635, DOI 10.1121/1.3488303; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Buckland S.T., 2001, pi; Burdic W. S., 1984, UNDERWATER ACOUSTIC, P322; Cato D., 2006, P ACOUSTICS, V2006, P453; Cerchio Salvatore, 2001, Bioacoustics, V11, P277; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Clark R., 2006, ECOLOGICAL CHARACTER, V45, P356; Clay CS, 1977, ACOUSTICAL OCEANOGRA, P494; Collins M. D., 1983, J ACOUST SOC AM, V93, P1736; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; deYoung B, 2004, SCIENCE, V304, P1463, DOI 10.1126/science.1094858; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; DiFranco J.V., 1980, RADAR DETECTION; DOLPHIN WF, 1987, EXPERIENTIA, V43, P468, DOI 10.1007/BF01940459; Duda R. O., 2001, PATTERN CLASSIFICATI; Tran D, 2012, J ACOUST SOC AM, V132, P3659, DOI 10.1121/1.4763547; EDDS P L, 1988, Bioacoustics, V1, P131; Edds-Walton Peggy L., 2000, Bioacoustics, V11, P31; Filatova OA, 2012, ANIM BEHAV, V83, P595, DOI 10.1016/j.anbehav.2011.12.013; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Gong Z, 2015, J ACOUST SOC AM, V138, P2649, DOI 10.1121/1.4932547; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104733; Gong Z, 2013, J ACOUST SOC AM, V134, P3705, DOI 10.1121/1.4821989; Gong Z, 2010, J ACOUST SOC AM, V127, P104, DOI 10.1121/1.3268595; Jagannathan S, 2012, J ACOUST SOC AM, V132, P680, DOI 10.1121/1.4726073; Jagannathan S, 2009, MAR ECOL PROG SER, V395, P137, DOI 10.3354/meps08266; Jain AD, 2014, REMOTE SENS-BASEL, V6, P180, DOI 10.3390/rs6010180; Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355; Jech JM, 2012, AQUAT LIVING RESOUR, V25, P1, DOI 10.1051/alr/2012003; Jensen FB, 2011, MOD ACOUST SIGN PROC, P705, DOI 10.1007/978-1-4419-8678-8_10; Johnson D. H., 1992, ARRAY SIGNAL PROCESS; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Kay, 1998, FUNDAMENTALS STAT SI; Kusel ET, 2011, J ACOUST SOC AM, V129, P3610, DOI 10.1121/1.3583504; Lee S, 2006, J ACOUST SOC AM, V119, P336, DOI 10.1121/1.2139074; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; Makris NC, 1996, J ACOUST SOC AM, V100, P769, DOI 10.1121/1.416239; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Marques Tiago A., 2011, Endangered Species Research, V13, P163, DOI 10.3354/esr00325; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; Martin SW, 2013, MAR MAMMAL SCI, V29, P142, DOI 10.1111/j.1748-7692.2011.00561.x; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; MAYO CA, 1990, CAN J ZOOL, V68, P2214, DOI 10.1139/z90-308; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; McDonald MA, 2001, J ACOUST SOC AM, V109, P1728, DOI 10.1121/1.1353593; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; Mellinger DK, 2000, MAR MAMMAL SCI, V16, P739, DOI 10.1111/j.1748-7692.2000.tb00969.x; Melvin GD, 2007, ICES J MAR SCI, V64, P69, DOI 10.1093/icesjms/fsl018; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Nemiroff L, 2009, BIOACOUSTICS, V19, P67, DOI 10.1080/09524622.2009.9753615; Newhall AE, 2012, J ACOUST SOC AM, V131, P1814, DOI 10.1121/1.3666015; Nieukirk SL, 2012, J ACOUST SOC AM, V131, P1102, DOI 10.1121/1.3672648; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Nottestad L, 2002, ICES J MAR SCI, V59, P393, DOI 10.1006/jmsc.2001.1172; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; Oliveira C, 2013, J ACOUST SOC AM, V133, P3135, DOI 10.1121/1.4795798; Oppenheim A.V., 1997, SIGNALS SYSTEMS; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Overholtz W. J., 2004, NE FISHERIES SCI CTR, V4, P1; Overholtz W, 2009, ECOL MODEL, V220, P2491, DOI 10.1016/j.ecolmodel.2009.06.034; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Rankin S, 2007, BIOACOUSTICS, V16, P137, DOI 10.1080/09524622.2007.9753572; Read AJ, 2003, CONSERV ECOL, V7; Risch D, 2013, MAR ECOL PROG SER, V489, P279, DOI 10.3354/meps10426; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Shapiro AD, 2009, J ACOUST SOC AM, V126, P451, DOI 10.1121/1.3132525; Simila Tiu, 1997, Aquatic Mammals, V23, P119; Simon M, 2006, BIOACOUSTICS, V16, P57, DOI 10.1080/09524622.2006.9753564; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Thode A, 2002, J ACOUST SOC AM, V112, P1890, DOI 10.1121/1.1496765; Thode AM, 2000, J ACOUST SOC AM, V107, P1286, DOI 10.1121/1.428417; THOMPSON PO, 1992, J ACOUST SOC AM, V92, P3051, DOI 10.1121/1.404201; Tiemann CO, 2006, J ACOUST SOC AM, V120, P2355, DOI 10.1121/1.2335577; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tran DD, 2014, J ACOUST SOC AM, V135, P3352, DOI 10.1121/1.4874601; Tyson RB, 2007, J ACOUST SOC AM, V122, P1365, DOI 10.1121/1.2756263; Urick RJ, 1983, PRINCIPLES UNDERWATE, P29; Wang C, 2000, INT CONF ACOUST SPEE, P1343, DOI 10.1109/ICASSP.2000.861827; Waring G. T., 2014, NOAA TECH MEMO NMFS, V231; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; WATKINS WA, 1977, J ACOUST SOC AM, V62, P1485, DOI 10.1121/1.381678; WEILGART LS, 1990, BEHAV ECOL SOCIOBIOL, V26, P399; Weirathmueller MJ, 2013, J ACOUST SOC AM, V133, P741, DOI 10.1121/1.4773277; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161; Wursig B., 1986, P347	100	33	33	6	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					366	+		10.1038/nature16960	http://dx.doi.org/10.1038/nature16960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26934221				2022-12-28	WOS:000372064300052
J	Thornton, J				Thornton, Jacqui			UGANDA Health challenges of war and peace	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacqui@jacquithornton.com						[Anonymous], 2015, GUARDIAN; Astill J, 2001, GUARDIAN; Child War, LORDS RES ARM; Teasdale L, 2013, COMMUNICATION; Uganda WHO, 2015, WHO STAT PROF	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2016	352								i1203	10.1136/bmj.i1203	http://dx.doi.org/10.1136/bmj.i1203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LO	26940075				2022-12-28	WOS:000371756700003
J	Inghammar, M; Svanstrom, H; Melbye, M; Pasternak, B; Hviid, A				Inghammar, Malin; Svanstrom, Henrik; Melbye, Mads; Pasternak, Bjorn; Hviid, Anders			Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QT INTERVAL PROLONGATION; TORSADES-DE-POINTES; CARDIAC-ARRHYTHMIA; PROPENSITY SCORES; RISK; LEVOFLOXACIN; SAFETY; MORTALITY; ANTIBACTERIALS; CIPROFLOXACIN	OBJECTIVE To evaluate if oral fluoroquinolone use is associated with an increased risk of serious arrhythmia. DESIGN Bi-national cohort study, linking register data on filled prescriptions, cases of serious arrhythmia, and patient characteristics. SETTING Denmark, 1997-2011; Sweden, 2006-13. PARTICIPANTS The study cohort was derived from a source population of all Danish and Swedish adults, aged 40 to 79 years. 909 656 courses of fluoroquinolone use (ciprofloxacin 82.6%, norfloxacin 12.1%, ofloxacin 3.2%, moxifloxacin 1.2%, and other fluoroquinolones 0.9%) and 909 656 courses of penicillin V use, matched 1: 1 on propensity score, were included. MAIN OUTCOME MEASURE The main outcome was risk of serious arrhythmia (fatal and non-fatal), comparing courses of fluoroquinolone use with courses of penicillin V use (an antibiotic with no pro-arrhythmic effect). The risk period of interest was current use, defined as days 0-7 of treatment. Subgroup analyses were conducted according to country, sex, age, underlying cardiovascular disease, concomitant use of drugs known to increase the risk of torsades de pointes, fluoroquinolone type, and levels of arrhythmia risk score. RESULTS 144 cases of serious arrhythmia occurred during follow-up, 66 among current fluoroquinolone users (incidence rate 3.4 per 1000 person years) and 78 among current penicillin users (4.0 per 1000 person years); comparing oral fluoroquinolone treatment with penicillin V, the rate ratio was 0.85 (95% confidence interval 0.61 to 1.18). Compared with penicillin V, the absolute risk difference was -13 (95% confidence interval -35 to 16) cases of serious arrhythmia per 1 000 000 courses of fluoroquinolones. The risk of serious arrhythmia was not statistically significantly increased in any of the subgroups, including analyses by fluoroquinolone type. CONCLUSIONS Contrary to previous reports, oral fluoroquinolone treatment was not associated with an increased risk of serious arrhythmia in the general adult populations of Denmark and Sweden. Given the statistical power of the study, even small increases in relative and absolute risk could be ruled out. Since ciprofloxacin was the most commonly used fluoroquinolone in our study, we cannot exclude that intraclass differences influence the risk of serious arrhythmia associated with other less frequently used fluoroquinolones.	[Inghammar, Malin] Lund Univ, Dept Clin Sci Lund, Sect Infect Med, Lund, Sweden; [Svanstrom, Henrik; Melbye, Mads; Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Lund University; Statens Serum Institut	Inghammar, M (corresponding author), Lund Univ, Dept Clin Sci Lund, Sect Infect Med, Lund, Sweden.	malin.inghammar@med.lu.se	Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466; melbye, mads/0000-0001-8264-6785; Inghammar, Malin/0000-0003-2995-1312	Swedish Government Funds for Clinical Research (ALF); Scandinavian Society for Antimicrobial Chemotherapy Foundation, (SSAC); Royal Physiographic Society in Lund; Danish Council for Independent Research (Medical Sciences)	Swedish Government Funds for Clinical Research (ALF); Scandinavian Society for Antimicrobial Chemotherapy Foundation, (SSAC); Royal Physiographic Society in Lund; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF))	This study was supported by grants from the Swedish Government Funds for Clinical Research (ALF), Scandinavian Society for Antimicrobial Chemotherapy Foundation, (SSAC), Royal Physiographic Society in Lund, and Danish Council for Independent Research (Medical Sciences). The funders played no role in the design of the study, data collection or analysis, decision to publish, or preparation of the manuscript.	Abo-Salem E, 2014, CARDIOVASC THER, V32, P19, DOI 10.1111/1755-5922.12054; Anderson ME, 2001, J PHARMACOL EXP THER, V296, P806; Chou HW, 2015, CLIN INFECT DIS, V60, P566, DOI 10.1093/cid/ciu914; Clark DWJ, 2001, DRUG SAFETY, V24, P1143, DOI 10.2165/00002018-200124150-00005; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Frothingham R, 2001, PHARMACOTHERAPY, V21, P1468, DOI 10.1592/phco.21.20.1468.34482; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Jaillon P, 1996, J ANTIMICROB CHEMOTH, V37, P161, DOI 10.1093/jac/37.suppl_A.161; Justo D, 2006, MYCOSES, V49, P463, DOI 10.1111/j.1439-0507.2006.01278.x; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Lapi F, 2012, CLIN INFECT DIS, V55, P1457, DOI 10.1093/cid/cis664; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Makaryus AN, 2006, SOUTH MED J, V99, P52, DOI 10.1097/01.smj.0000197124.31174.7e; Milberg P, 2007, J CARDIOVASC ELECTR, V18, P647, DOI 10.1111/j.1540-8167.2007.00793.x; Morganroth J, 2005, CHEST, V128, P3398, DOI 10.1378/chest.128.5.3398; Noel GJ, 2003, CLIN PHARMACOL THER, V73, P292, DOI 10.1016/S0009-9236(03)00009-2; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; Parsons LS., 2001, P 26 ANN SAS US GROU, P214; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Rao GA, 2014, ANN FAM MED, V12, P121, DOI 10.1370/afm.1601; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Sturmer T, 2005, AM J EPIDEMIOL, V161, P891, DOI 10.1093/aje/kwi106; Tsikouris JP, 2006, ANN NONINVAS ELECTRO, V11, P52, DOI 10.1111/j.1542-474X.2006.00082.x; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Winkel BG, 2011, EUR HEART J, V32, P983, DOI 10.1093/eurheartj/ehq428; Zambon A, 2009, DRUG SAFETY, V32, P159, DOI 10.2165/00002018-200932020-00008	32	20	22	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2016	352								i843	10.1136/bmj.i843	http://dx.doi.org/10.1136/bmj.i843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1RM	26920666	Green Published, hybrid			2022-12-28	WOS:000371116900002
J	Ilyina, T				Ilyina, Tatiana			CLIMATE SCIENCE Hidden trends in the ocean carbon sink	NATURE			English	Editorial Material									[Ilyina, Tatiana] Max Planck Inst Meteorol, D-20146 Hamburg, Germany	Max Planck Society	Ilyina, T (corresponding author), Max Planck Inst Meteorol, D-20146 Hamburg, Germany.	tatiana.ilyina@mpimet.mpg.de	Ilyina, Tatiana/ABE-9164-2020	Ilyina, Tatiana/0000-0002-3475-4842				[Anonymous], 2013, CONTRIBUTION WORKING, P1535; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Dobrynin M, 2015, J CLIMATE, V28, P1578, DOI 10.1175/JCLI-D-13-00664.1; Heinze C, 2015, EARTH SYST DYNAM, V6, P327, DOI 10.5194/esd-6-327-2015; Keller KM, 2014, BIOGEOSCIENCES, V11, P3647, DOI 10.5194/bg-11-3647-2014; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P349, DOI 10.5194/essd-7-349-2015; Marotzke J, 2015, NATURE, V517, P565, DOI 10.1038/nature14117; McKinley GA, 2016, NATURE, V530, P469, DOI 10.1038/nature16958; Rodenbeck C, 2015, BIOGEOSCIENCES, V12, P7251, DOI 10.5194/bg-12-7251-2015	9	4	4	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					426	+		10.1038/530426a	http://dx.doi.org/10.1038/530426a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911779				2022-12-28	WOS:000370690800023
J	Hansen-Flaschen, J				Hansen-Flaschen, John			What Now? What Next?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hansen-Flaschen, John] Univ Penn, Dept Med, Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	University of Pennsylvania	Hansen-Flaschen, J (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA.	jflash@uphs.upenn.edu							0	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					755	756		10.1001/jama.2016.0227	http://dx.doi.org/10.1001/jama.2016.0227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903332				2022-12-28	WOS:000370700500009
J	Hudry, B; Khadayate, S; Miguel-Aliaga, I				Hudry, Bruno; Khadayate, Sanjay; Miguel-Aliaga, Irene			The sexual identity of adult intestinal stem cells controls organ size and plasticity	NATURE			English	Article							DROSOPHILA-MELANOGASTER; GENETIC FEMINIZATION; CYTOGENETIC ANALYSIS; NERVOUS-SYSTEM; DOUBLESEX GENE; MALE COURTSHIP; FRUITLESS; BEHAVIOR; PROTEIN; MIDGUT	Sex differences in physiology and disease susceptibility are commonly attributed to developmental and/or hormonal factors, but there is increasing realization that cell-intrinsic mechanisms play important and persistent roles(1,2). Here we use the Drosophila melanogaster intestine to investigate the nature and importance of cellular sex in an adult somatic organ in vivo. We find that the adult intestinal epithelium is a cellular mosaic of different sex differentiation pathways, and displays extensive sex differences in expression of genes with roles in growth and metabolism. Cellspecific reversals of the sexual identity of adult intestinal stem cells uncovers the key role this identity has in controlling organ size, reproductive plasticity and response to genetically induced tumours. Unlike previous examples of sexually dimorphic somatic stem cell activity, the sex differences in intestinal stem cell behaviour arise from intrinsic mechanisms that control cell cycle duration and involve a new doublesex-and fruitless-independent branch of the sex differentiation pathway downstream of transformer. Together, our findings indicate that the plasticity of an adult somatic organ is reversibly controlled by its sexual identity, imparted by a new mechanism that may be active in more tissues than previously recognized.	[Hudry, Bruno; Khadayate, Sanjay; Miguel-Aliaga, Irene] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Hammersmith Campus,Du Cane Rd, London W12 0NN, England	Imperial College London	Hudry, B; Miguel-Aliaga, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	bruno.hudry@imperial.ac.uk; i.miguel-aliaga@imperial.ac.uk	HUDRY, Bruno/S-4330-2018	HUDRY, Bruno/0000-0003-1299-843X; Khadayate, Sanjay/0000-0003-4278-6403; Miguel-Aliaga, Irene/0000-0002-1082-5108	BBSRC [BB/N000528/1] Funding Source: UKRI; MRC [MC_UP_1102/3] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N000528/1] Funding Source: researchfish; European Research Council [310411] Funding Source: Medline; Medical Research Council [MC_UP_1102/3] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Anand A, 2001, GENETICS, V158, P1569; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, LANG ENV STAT COMP; Arnold AP, 2012, TRENDS GENET, V28, P55, DOI 10.1016/j.tig.2011.10.004; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; BAKER BS, 1991, GENETICS, V127, P125; Balakireva M, 1998, J NEUROSCI, V18, P4335; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; BELOTE JM, 1990, GENETICS, V125, P783; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Caldwell JC, 2007, FLY, V1, P146, DOI 10.4161/fly.4562; Camara N, 2008, CURR TOP DEV BIOL, V83, P65, DOI 10.1016/S0070-2153(08)00403-1; Cande J, 2014, CELL REP, V8, P362, DOI 10.1016/j.celrep.2014.06.023; Christiansen AE, 2002, TRENDS GENET, V18, P510, DOI 10.1016/S0168-9525(02)02769-5; Clough E, 2014, DEV CELL, V31, P761, DOI 10.1016/j.devcel.2014.11.021; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Cook MB, 2009, CANCER EPIDEM BIOMAR, V18, P1174, DOI 10.1158/1055-9965.EPI-08-1118; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; DUNCAN IW, 1975, GENETICS, V80, P733; Evans DS, 2013, P NATL ACAD SCI USA, V110, pE4474, DOI 10.1073/pnas.1319063110; Ruiz MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065171; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Finley KD, 1997, P NATL ACAD SCI USA, V94, P913, DOI 10.1073/pnas.94.3.913; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Ghazi A, 2000, DEVELOPMENT, V127, P5309; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; GOWEN JOHN W., 1957, HEREDITY, V11, P397, DOI 10.1038/hdy.1957.31; Green EW, 2014, NAT METHODS, V11, P222, DOI 10.1038/nmeth.2856; HAENLIN M, 1990, DEVELOPMENT, V110, P905; Handke B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067208; Jiang HQ, 2012, CURR OPIN GENET DEV, V22, P354, DOI 10.1016/j.gde.2012.04.002; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kawamura K, 1999, DEVELOPMENT, V126, P211; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kohl J, 2013, CELL, V155, P1610, DOI 10.1016/j.cell.2013.11.025; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee G, 2002, J NEUROGENET, V16, P229, DOI 10.1080/01677060216292; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Lucchesi JC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019398; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Ma Q, 2014, DEV CELL, V31, P474, DOI 10.1016/j.devcel.2014.10.004; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martorell O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088413; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; MATTOX W, 1991, GENE DEV, V5, P786, DOI 10.1101/gad.5.5.786; Mellert DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051489; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Merrill CE, 2005, J NEUROBIOL, V63, P15, DOI 10.1002/neu.20113; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Morel V, 2000, GENE DEV, V14, P377; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Pan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021144; Patel PH, 2015, NAT CELL BIOL, V17, P1182, DOI 10.1038/ncb3214; Patel PH, 2014, SEMIN CELL DEV BIOL, V28, P86, DOI 10.1016/j.semcdb.2014.03.012; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Reiff T, 2015, ELIFE, V4, DOI 10.7554/eLife.06930; Riabinina O, 2015, NAT METHODS, V12, P219, DOI [10.1038/NMETH.3250, 10.1038/nmeth.3250]; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shapiro-Kulnane L, 2015, DEVELOPMENT, V142, P1073, DOI 10.1242/dev.116590; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Siudeja K, 2015, CELL STEM CELL, V17, P663, DOI 10.1016/j.stem.2015.09.016; Spradling AC, 1999, GENETICS, V153, P135; Steegenga WT, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0011-9; STURTEVANT AH, 1945, GENETICS, V30, P297; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Wang LF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004568; XU T, 1993, DEVELOPMENT, V117, P1223; Yeo Su Ling, 1995, Genes and Development, V9, P1223, DOI 10.1101/gad.9.10.1223; Zeng XK, 2010, GENESIS, V48, P607, DOI 10.1002/dvg.20661; Zielke N, 2014, CELL REP, V7, P588, DOI 10.1016/j.celrep.2014.03.020	94	96	96	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					344	+		10.1038/nature16953	http://dx.doi.org/10.1038/nature16953			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887495	Green Submitted, Green Accepted			2022-12-28	WOS:000370327100039
J	Villalobos, EM				Villalobos, Ethel M.			The mite that jumped, the bee that traveled, the disease that followed	SCIENCE			English	Editorial Material							HONEYBEE APIS-MELLIFERA; PROVIDES; INSIGHT		[Villalobos, Ethel M.] Univ Hawaii, Plant & Environm Protect Sci, Manoa, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Villalobos, EM (corresponding author), Univ Hawaii, Plant & Environm Protect Sci, Manoa, HI 96822 USA.							Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; Jayakodi M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1868-7; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; Mordecai GJ, 2016, ISME J, V10, P1264, DOI 10.1038/ismej.2015.178; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976	12	15	19	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					554	556		10.1126/science.aaf0938	http://dx.doi.org/10.1126/science.aaf0938			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912684				2022-12-28	WOS:000369291600018
J	Warren, TK; Jordan, R; Lo, MK; Ray, AS; Mackman, RL; Soloveva, V; Siegel, D; Perron, M; Bannister, R; Hui, HC; Larson, N; Strickley, R; Wells, J; Stuthman, KS; Van Tongeren, SA; Garza, NL; Donnelly, G; Shurtleff, AC; Retterer, CJ; Gharaibeh, D; Zamani, R; Kenny, T; Eaton, BP; Grimes, E; Welch, LS; Gomba, L; Wilhelmsen, CL; Nichols, DK; Nuss, JE; Nagle, ER; Kugelman, JR; Palacios, G; Doerffler, E; Neville, S; Carra, E; Clarke, MO; Zhang, LJ; Lew, W; Ross, B; Wang, Q; Chun, K; Wolfe, L; Babusis, D; Park, Y; Stray, KM; Trancheva, I; Feng, JY; Barauskas, O; Xu, YL; Wong, P; Braun, MR; Flint, M; McMullan, LK; Chen, SS; Fearns, R; Swaminathan, S; Mayers, DL; Spiropoulou, CF; Lee, WA; Nichol, ST; Cihlar, T; Bavari, S				Warren, Travis K.; Jordan, Robert; Lo, Michael K.; Ray, Adrian S.; Mackman, Richard L.; Soloveva, Veronica; Siegel, Dustin; Perron, Michel; Bannister, Roy; Hui, Hon C.; Larson, Nate; Strickley, Robert; Wells, Jay; Stuthman, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Donnelly, Ginger; Shurtleff, Amy C.; Retterer, Cary J.; Gharaibeh, Dima; Zamani, Rouzbeh; Kenny, Tara; Eaton, Brett P.; Grimes, Elizabeth; Welch, Lisa S.; Gomba, Laura; Wilhelmsen, Catherine L.; Nichols, Donald K.; Nuss, Jonathan E.; Nagle, Elyse R.; Kugelman, Jeffrey R.; Palacios, Gustavo; Doerffler, Edward; Neville, Sean; Carra, Ernest; Clarke, Michael O.; Zhang, Lijun; Lew, Willard; Ross, Bruce; Wang, Queenie; Chun, Kwon; Wolfe, Lydia; Babusis, Darius; Park, Yeojin; Stray, Kirsten M.; Trancheva, Iva; Feng, Joy Y.; Barauskas, Ona; Xu, Yili; Wong, Pamela; Braun, Molly R.; Flint, Mike; McMullan, Laura K.; Chen, Shan-Shan; Fearns, Rachel; Swaminathan, Swami; Mayers, Douglas L.; Spiropoulou, Christina F.; Lee, William A.; Nichol, Stuart T.; Cihlar, Tomas; Bavari, Sina			Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys	NATURE			English	Article							INFECTED NONHUMAN-PRIMATES; ANTIVIRAL ACTIVITY; T-705 FAVIPIRAVIR; HIGH-THROUGHPUT; POLYMERASE; INHIBITOR; MODEL; PROTECTION; MACAQUES; PROMOTER	The most recent Ebola virus outbreak in West Africa, which was unprecedented in the number of cases and fatalities, geographic distribution, and number of nations affected, highlights the need for safe, effective, and readily available antiviral agents for treatment and prevention of acute Ebola virus (EBOV) disease (EVD) or sequelae(1). No antiviral therapeutics have yet received regulatory approval or demonstrated clinical efficacy. Here we report the discovery of a novel small molecule GS-5734, a monophosphoramidate prodrug of an adenosine analogue, with antiviral activity against EBOV. GS-5734 exhibits antiviral activity against multiple variants of EBOV and other filoviruses in cell-based assays. The pharmacologically active nucleoside triphosphate (NTP) is efficiently formed in multiple human cell types incubated with GS-5734 in vitro, and the NTP acts as an alternative substrate and RNA-chain terminator in primer-extension assays using a surrogate respiratory syncytial virus RNA polymerase. Intravenous administration of GS-5734 to nonhuman primates resulted in persistent NTP levels in peripheral blood mononuclear cells (half-life, 14 h) and distribution to sanctuary sites for viral replication including testes, eyes, and brain. In a rhesus monkey model of EVD, once-daily intravenous administration of 10 mg kg(-1) GS-5734 for 12 days resulted in profound suppression of EBOV replication and protected 100% of EBOV-infected animals against lethal disease, ameliorating clinical disease signs and pathophysiological markers, even when treatments were initiated three days after virus exposure when systemic viral RNA was detected in two out of six treated animals. These results show the first substantive post-exposure protection by a small-molecule antiviral compound against EBOV in nonhuman primates. The broad-spectrum antiviral activity of GS-5734 in vitro against other pathogenic RNA viruses, including filoviruses, arenaviruses, and coronaviruses, suggests the potential for wider medical use. GS-5734 is amenable to large-scale manufacturing, and clinical studies investigating the drug safety and pharmacokinetics are ongoing.	[Warren, Travis K.; Soloveva, Veronica; Wells, Jay; Stuthman, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Donnelly, Ginger; Shurtleff, Amy C.; Retterer, Cary J.; Gharaibeh, Dima; Zamani, Rouzbeh; Kenny, Tara; Eaton, Brett P.; Grimes, Elizabeth; Welch, Lisa S.; Gomba, Laura; Wilhelmsen, Catherine L.; Nichols, Donald K.; Nuss, Jonathan E.; Nagle, Elyse R.; Kugelman, Jeffrey R.; Palacios, Gustavo; Mayers, Douglas L.; Bavari, Sina] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Warren, Travis K.; Soloveva, Veronica; Gomba, Laura; Nuss, Jonathan E.; Bavari, Sina] US Army, Med Res Inst Infect Dis, Therapeut Dev Ctr, Ft Detrick, MD 21702 USA; [Jordan, Robert; Ray, Adrian S.; Mackman, Richard L.; Siegel, Dustin; Perron, Michel; Bannister, Roy; Hui, Hon C.; Larson, Nate; Strickley, Robert; Doerffler, Edward; Neville, Sean; Carra, Ernest; Clarke, Michael O.; Zhang, Lijun; Lew, Willard; Ross, Bruce; Wang, Queenie; Chun, Kwon; Wolfe, Lydia; Babusis, Darius; Park, Yeojin; Stray, Kirsten M.; Trancheva, Iva; Feng, Joy Y.; Barauskas, Ona; Xu, Yili; Wong, Pamela; Chen, Shan-Shan; Swaminathan, Swami; Lee, William A.; Cihlar, Tomas] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Lo, Michael K.; Flint, Mike; McMullan, Laura K.; Spiropoulou, Christina F.; Nichol, Stuart T.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Braun, Molly R.; Fearns, Rachel] Boston Univ, Sch Med, Boston, MA 02118 USA; [Welch, Lisa S.] LOKET Consulting, Clarksburg, MD 20871 USA; [Mayers, Douglas L.] Cocrystal Pharma, Tucker, GA 30084 USA	Gilead Sciences; Centers for Disease Control & Prevention - USA; Boston University	Bavari, S (corresponding author), US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.; Bavari, S (corresponding author), US Army, Med Res Inst Infect Dis, Therapeut Dev Ctr, Ft Detrick, MD 21702 USA.; Cihlar, T (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	tomas.cihlar@gilead.com; sina.bavari.civ@mail.mil	McMullan, Laura/AAI-1404-2021; Palacios, Gustavo/I-7773-2015; Eaton, Brett/G-1796-2019; Bavari, Sina/L-3642-2019; Flint, Mike/L-8355-2019; Wilhelmsen, Catherine/M-7560-2019	McMullan, Laura/0000-0003-2748-5151; Palacios, Gustavo/0000-0001-5062-1938; Eaton, Brett/0000-0002-3060-2913; Bavari, Sina/0000-0001-8424-5635; Wilhelmsen, Catherine/0000-0003-4695-7177; Fearns, Rachel/0000-0003-0783-7498; Lo, Michael/0000-0002-0409-7896; Ray, Adrian/0000-0002-3508-3008; Braun, Molly/0000-0002-7730-565X; Zamani, Rouzbeh/0000-0001-9559-6828	Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) of the Defense Threat Reduction Agency (DTRA) [CB10218]; NIH [R01AI113321]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113321] Funding Source: NIH RePORTER	Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) of the Defense Threat Reduction Agency (DTRA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T. Bocan, A. Duplantier, R. Panchal, and C. Kane provided scientific input. B. Norquist assisted with manuscript preparation. C. Cooper provided scientific input with human macrophage cultures for high-content image assessments. S. Tritsch and G. Gomba assisted with GS-5734 dose preparations for efficacy studies. C. Rice provided animal husbandry support services. X. Wei, W. Garner, and L. Zhong provided additional support for statistical analyses. K. Wang, K. Brendza, T. Alfredson, and L. Serafini assisted with analytical methods; S. Bondy and R. Seemayer procured key raw materials; L. Heumann, R. Polniaszeck, E. Rueden, A. Chtchemelinine, K. Brak, and B. Hoang contributed to synthesis; and Y. Zherebina helped with chiral separations. G. Lee supported the RSV antiviral assay, and G. Stepan, S. Ahmadyar, and H. Yu conducted part of the cytotoxicity testing. J. Knox contributed to polymerase modelling. A. L. Rheingold performed the X-ray crystallographic analysis (Supplementary Information). Studies at USAMRIID were in part supported by The Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) of the Defense Threat Reduction Agency (DTRA) under plan #CB10218. Work in the Fearns laboratory was supported by NIH R01AI113321. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the US Army or the Centers for Disease Control and Prevention, US Department of Health and Human Services.	Bahar FG, 2012, J PHARM SCI-US, V101, P3979, DOI 10.1002/jps.23258; BioCryst Pharmaceuticals, 2014, BIOCRYST ANN STUD RE; Chimerix, 2015, BRINC WILL NOT BE CO; Cho A, 2012, BIOORG MED CHEM LETT, V22, P2705, DOI 10.1016/j.bmcl.2012.02.105; Deen GF, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1511410, DOI 10.1056/NEJM0A1511410, http://dx.doi.org/10.1056/NEJMoa1511410]; Durand-Gasselin L, 2009, MOL PHARMACEUT, V6, P1145, DOI 10.1021/mp900036s; Hunt L, 2015, LANCET INFECT DIS, V15, P1292, DOI 10.1016/S1473-3099(15)00144-9; Jacome R., 2015, PLOS ONE, V10; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Kuhn JH, 2008, FILOVIRUSES COMPENDI; Kupferschmidt K, 2015, SCIENCE, V347, P701, DOI 10.1126/science.347.6223.701; Lodeiro MF, 2010, J BIOL CHEM, V285, P16387, DOI 10.1074/jbc.M109.092676; Mackman RL., 2011, Patent, Patent No. 2011045102; Martins K, 2015, VIRAL IMMUNOL, V28, P32, DOI 10.1089/vim.2014.0085; Mason SW, 2004, NUCLEIC ACIDS RES, V32, P4758, DOI 10.1093/nar/gkh809; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; McMullan LK, 2016, ANTIVIR RES, V125, P71, DOI 10.1016/j.antiviral.2015.10.010; Murakami E, 2008, ANTIMICROB AGENTS CH, V52, P458, DOI 10.1128/AAC.01184-07; Nanyonga M, 2016, CLIN INFECT DIS, V62, P125, DOI 10.1093/cid/civ795; Noton SL, 2015, J VIROL, V89, P7786, DOI 10.1128/JVI.00530-15; Noton SL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002980; Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Sissoko D, 2015, C RETR OPP INF SEATT; Smither SJ, 2014, ANTIVIR RES, V104, P153, DOI 10.1016/j.antiviral.2014.01.012; Tekmira Pharmaceuticals Corporation, 2015, TEKM PROV UPD TKM EB; Thi EP, 2015, NATURE, V521, P362, DOI 10.1038/nature14442; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Tremaglio CZ, 2013, J VIROL, V87, P3196, DOI 10.1128/JVI.02862-12; Uebelhoer LS, 2014, ANTIVIR RES, V106, P86, DOI 10.1016/j.antiviral.2014.03.018; Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306; Warren TK, 2014, VIRUSES-BASEL, V6, P4666, DOI 10.3390/v6114666; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027; World Health Organization (WHO), 2016, EB SIT REP 3 FEBR 20	37	879	932	12	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					381	+		10.1038/nature17180	http://dx.doi.org/10.1038/nature17180			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26934220	Green Published			2022-12-28	WOS:000372064300055
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Glasgow's lost hospital beds	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Scotland ISDN, 2016, WEEKL UPD EM DEP ACT	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2016	352								i1267	10.1136/bmj.i1267	http://dx.doi.org/10.1136/bmj.i1267			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NH	26951064	Green Published, hybrid			2022-12-28	WOS:000372048400003
J	Ahmad, SSY; Amin, TN; Ustianowski, A				Ahmad, Shazaad S. Y.; Amin, Tejal N.; Ustianowski, Andrew			PRACTICE POINTER Zika virus: management of infection and risk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERIM GUIDELINES; UNITED-STATES; SEXUAL TRANSMISSION; PREGNANT-WOMEN		[Ahmad, Shazaad S. Y.; Ustianowski, Andrew] Pennine Acute Hosp Trust, North Manchester Gen Hosp, Northwest Reg Infect Dis Unit, Manchester M8 5RB, Lancs, England; [Ahmad, Shazaad S. Y.] Cent Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Royal Infirm, Virol Dept, Manchester M13 9WL, Lancs, England; [Amin, Tejal N.] Univ Coll London Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, London, England	University of Manchester; University College London Hospitals NHS Foundation Trust; University of London; University College London	Ustianowski, A (corresponding author), Pennine Acute Hosp Trust, North Manchester Gen Hosp, Northwest Reg Infect Dis Unit, Manchester M8 5RB, Lancs, England.	Andrew.Ustianowski@pat.nhs.uk		Ahmad, Shazaad/0000-0002-0400-8937; Ustianowski, Andrew/0000-0002-6134-7855				Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107; Australian Government Department of Health, 2016, ZIK VIR INF CLIN PUB; Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049; European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2; Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1; Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1; Royal College of Obstetricians and Gynaecologists Royal College of Midwives Public Health England, 2016, INT RCOG RCM PHE HPS; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2	15	17	17	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2016	352								i1062	10.1136/bmj.i1062	http://dx.doi.org/10.1136/bmj.i1062			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1RM	26920038	Green Published, Bronze			2022-12-28	WOS:000371116900004
J	Chan, JK; Brady, MF; Penson, RT; Huang, H; Birrer, MJ; Walker, JL; DiSilvestro, PA; Rubin, SC; Martin, LP; Davidson, SA; Huh, WK; O'Malley, DM; Boente, MP; Michael, H; Monk, BJ				Chan, J. K.; Brady, M. F.; Penson, R. T.; Huang, H.; Birrer, M. J.; Walker, J. L.; DiSilvestro, P. A.; Rubin, S. C.; Martin, L. P.; Davidson, S. A.; Huh, W. K.; O'Malley, D. M.; Boente, M. P.; Michael, H.; Monk, B. J.			Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; EVERY 3 WEEKS; EPITHELIAL OVARIAN; BREAST-CANCER; OPEN-LABEL; ADJUVANT TREATMENT; PRIMARY PERITONEAL; FALLOPIAN-TUBE; SOLID TUMORS; BEVACIZUMAB	BACKGROUND A dose-dense weekly schedule of paclitaxel (resulting in a greater frequency of drug delivery) plus carboplatin every 3 weeks or the addition of bevacizumab to paclitaxel and carboplatin administered every 3 weeks has shown efficacy in ovarian cancer. We proposed to determine whether dose-dense weekly paclitaxel and carboplatin would prolong progression-free survival as compared with paclitaxel and carboplatin administered every 3 weeks among patients receiving and those not receiving bevacizumab. METHODS We prospectively stratified patients according to whether they elected to receive bevacizumab and then randomly assigned them to receive either paclitaxel, administered intravenously at a dose of 175 mg per square meter of body-surface area every 3 weeks, plus carboplatin (dose equivalent to an area under the curve [AUC] of 6) for six cycles or paclitaxel, administered weekly at a dose of 80 mg per square meter, plus carboplatin (AUC, 6) for six cycles. The primary end point was progression-free survival. RESULTS A total of 692 patients were enrolled, 84% of whom opted to receive bevacizumab. In the intention-to-treat analysis, weekly paclitaxel was not associated with longer progression-free survival than paclitaxel administered every 3 weeks (14.7 months and 14.0 months, respectively; hazard ratio for disease progression or death, 0.89; 95% confidence interval [CI], 0.74 to 1.06; P=0.18). Among patients who did not receive bevacizumab, weekly paclitaxel was associated with progression-free survival that was 3.9 months longer than that observed with paclitaxel administered every 3 weeks (14.2 vs. 10.3 months; hazard ratio, 0.62; 95% CI, 0.40 to 0.95; P=0.03). However, among patients who received bevacizumab, weekly paclitaxel did not significantly prolong progression-free survival, as compared with paclitaxel administered every 3 weeks (14.9 months and 14.7 months, respectively; hazard ratio, 0.99; 95% CI, 0.83 to 1.20; P=0.60). A test for interaction that assessed homogeneity of the treatment effect showed a significant difference between treatment with bevacizumab and without bevacizumab (P=0.047). Patients who received weekly paclitaxel had a higher rate of grade 3 or 4 anemia than did those who received paclitaxel every 3 weeks (36% vs. 16%), as well as a higher rate of grade 2 to 4 sensory neuropathy (26% vs. 18%); however, they had a lower rate of grade 3 or 4 neutropenia (72% vs. 83%). CONCLUSIONS Overall, weekly paclitaxel, as compared with paclitaxel administered every 3 weeks, did not prolong progression-free survival among patients with ovarian cancer. (Funded by the National Cancer Institute and Genentech; GOG-0262 ClinicalTrials.gov number, NCT01167712.)	[Chan, J. K.] Calif Pacific Palo Alto Med Fdn, Sutter Canc Res Inst, 3838 Calif St,Unit 410, San Francisco, CA 94118 USA; [Brady, M. F.; Huang, H.] Roswell Pk Canc Inst, Stat & Data Ctr, NRG Oncol Gynecol Oncol Grp, Buffalo, NY 14263 USA; [Penson, R. T.; Birrer, M. J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Walker, J. L.] Univ Oklahoma, Oklahoma City, OK USA; [DiSilvestro, P. A.] Brown Univ, Women & Infants Hosp, Providence, RI USA; [Rubin, S. C.] Univ Penn, Philadelphia, PA 19104 USA; [Martin, L. P.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Davidson, S. A.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Huh, W. K.] Univ Alabama Birmingham, Birmingham, AL USA; [O'Malley, D. M.] Ohio State Univ, James Canc Ctr, Columbus, OH 43210 USA; [Boente, M. P.] Minnesota Oncol Hematol Oncol Serv, Edina, MN USA; [Michael, H.] Indiana Univ Sch Med, Carmel, IN USA; [Monk, B. J.] Univ Arizona, Ctr Canc, Phoenix, AZ USA; [Monk, B. J.] Creighton Univ, Sch Med, Phoenix, AZ USA; [Monk, B. J.] St Josephs Hosp, Phoenix, AZ USA	Roswell Park Cancer Institute; Harvard University; Massachusetts General Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; Brown University; Women & Infants Hospital Rhode Island; University of Pennsylvania; Fox Chase Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Indiana University System; University of Arizona; Creighton University; St. Joseph's Hospital and Medical Center	Chan, JK (corresponding author), Calif Pacific Palo Alto Med Fdn, Sutter Canc Res Inst, 3838 Calif St,Unit 410, San Francisco, CA 94118 USA.	chanjohn@sutterhealth.org	Rubin, Stephen/U-8535-2019; OMalley, David/E-3789-2011	Rubin, Stephen/0000-0003-3688-5333; OMalley, David/0000-0002-2828-0177	National Cancer Institute; Genentech; NATIONAL CANCER INSTITUTE [U10CA180868, UG1CA189867, U10CA037517, U10CA027469, U10CA101165, U10CA180822, U10CA180855, U10CA180850, P30CA006927] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute and Genentech; GOG-0262 ClinicalTrials.gov number, NCT01167712.	Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Basen-Engquist K, 2001, J CLIN ONCOL, V19, P1809, DOI 10.1200/JCO.2001.19.6.1809; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Boso V, 2014, PHARMACOGENOMICS, V15, P1845, DOI [10.2217/pgs.14.127, 10.2217/PGS.14.127]; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Chan JK, 2006, OBSTET GYNECOL, V108, P521, DOI 10.1097/01.AOG.0000231680.58221.a7; Chan JK, 2014, ONCOLOGIST, V19, P523, DOI 10.1634/theoncologist.2013-0322; Cohn DE, 2011, J CLIN ONCOL, V29, P1247, DOI 10.1200/JCO.2010.32.1075; Dalton HJ, 2012, GYNECOL ONCOL, V124, P199, DOI 10.1016/j.ygyno.2011.09.028; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fuh KC, 2015, GYNECOL ONCOL, V136, P491, DOI 10.1016/j.ygyno.2014.10.009; Green MC, 2005, J CLIN ONCOL, V23, P5983, DOI 10.1200/JCO.2005.06.232; Griffon-Etienne G, 1999, CANCER RES, V59, P3776; Hertz DL, 2013, PHARMACOGENOMICS, V14, P1065, DOI [10.2217/PGS.13.90, 10.2217/pgs.13.90]; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Jain RK, 2014, SCI AM, V310, P46, DOI 10.1038/scientificamerican0214-46; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Lau DH, 1999, CANCER BIOTHER RADIO, V14, P31, DOI 10.1089/cbr.1999.14.31; LOPES NM, 1993, CANCER CHEMOTH PHARM, V32, P235, DOI 10.1007/BF00685842; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pignata S, 2014, LANCET ONCOL, V15, P396, DOI 10.1016/S1470-2045(14)70049-X; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Rustin GJS, 2001, J CLIN ONCOL, V19, P4054, DOI 10.1200/JCO.2001.19.20.4054; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; Seidman AD, 2013, CLIN BREAST CANCER, V13, P239, DOI 10.1016/j.clbc.2013.02.008; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Yost KJ, 2005, EVAL HEALTH PROF, V28, P172, DOI 10.1177/0163278705275340	36	233	245	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					738	748		10.1056/NEJMoa1505067	http://dx.doi.org/10.1056/NEJMoa1505067			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6BB	26933849	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000370716600007
J	Sturm, D; Orr, BA; Toprak, UH; Hovestadt, V; Jones, DTW; Capper, D; Sill, M; Buchhalter, I; Northcott, PA; Leis, I; Ryzhova, M; Koelsche, C; Pfaff, E; Allen, SJ; Balasubramanian, G; Worst, BC; Pajtler, KW; Brabetz, S; Johann, PD; Sahm, F; Reimand, J; Mackay, A; Carvalho, DM; Remke, M; Phillips, JJ; Perry, A; Cowdrey, C; Drissi, R; Fouladi, M; Giangaspero, F; Lastowska, M; Grajkowska, W; Scheurlen, W; Pietsch, T; Hagel, C; Gojo, J; Loetsch, D; Berger, W; Slavc, I; Haberler, C; Jouvet, A; Holm, S; Hofer, S; Prinz, M; Keohane, C; Fried, I; Mawrin, C; Scheie, D; Mobley, BC; Schniederjan, MJ; Santi, M; Buccoliero, AM; Dahiya, S; Kramm, CM; von Bueren, AO; von Hoff, K; Rutkowski, S; Herold-Mende, C; Fruehwald, MC; Milde, T; Hasselblatt, M; Wesseling, P; Rossler, J; Schuller, U; Ebinger, M; Schittenhelm, J; Frank, S; Grobholz, R; Vajtai, I; Hans, V; Schneppenheim, R; Zitterbart, K; Collins, VP; Aronica, E; Varlet, P; Puget, S; Dufour, C; Grill, J; Figarella-Branger, D; Wolter, M; Schuhmann, MU; Shalaby, T; Grotzer, M; van Meter, T; Monoranu, CM; Felsberg, J; Reifenberger, G; Snuderl, M; Forrester, LA; Koster, J; Versteeg, R; Volckmann, R; van Sluis, P; Wolf, S; Mikkelsen, T; Gajjar, A; Aldape, K; Moore, AS; Taylor, MD; Jones, C; Jabado, N; Karajannis, MA; Eils, R; Schlesner, M; Lichter, P; von Deimling, A; Pfister, SM; Ellison, DW; Korshunov, A; Kool, M				Sturm, Dominik; Orr, Brent A.; Toprak, Umut H.; Hovestadt, Volker; Jones, David T. W.; Capper, David; Sill, Martin; Buchhalter, Ivo; Northcott, Paul A.; Leis, Irina; Ryzhova, Marina; Koelsche, Christian; Pfaff, Elke; Allen, Sariah J.; Balasubramanian, Gnanaprakash; Worst, Barbara C.; Pajtler, Kristian W.; Brabetz, Sebastian; Johann, Pascal D.; Sahm, Felix; Reimand, Jueri; Mackay, Alan; Carvalho, Diana M.; Remke, Marc; Phillips, Joanna J.; Perry, Arie; Cowdrey, Cynthia; Drissi, Rachid; Fouladi, Maryam; Giangaspero, Felice; Lastowska, Maria; Grajkowska, Wieslawa; Scheurlen, Wolfram; Pietsch, Torsten; Hagel, Christian; Gojo, Johannes; Loetsch, Daniela; Berger, Walter; Slavc, Irene; Haberler, Christine; Jouvet, Anne; Holm, Stefan; Hofer, Silvia; Prinz, Marco; Keohane, Catherine; Fried, Iris; Mawrin, Christian; Scheie, David; Mobley, Bret C.; Schniederjan, Matthew J.; Santi, Mariarita; Buccoliero, Anna M.; Dahiya, Sonika; Kramm, Christof M.; von Bueren, Andre O.; von Hoff, Katja; Rutkowski, Stefan; Herold-Mende, Christel; Fruehwald, Michael C.; Milde, Till; Hasselblatt, Martin; Wesseling, Pieter; Roessler, Jochen; Schueller, Ulrich; Ebinger, Martin; Schittenhelm, Jens; Frank, Stephan; Grobholz, Rainer; Vajtai, Istvan; Hans, Volkmar; Schneppenheim, Reinhard; Zitterbart, Karel; Collins, V. Peter; Aronica, Eleonora; Varlet, Pascale; Puget, Stephanie; Dufour, Christelle; Grill, Jacques; Figarella-Branger, Dominique; Wolter, Marietta; Schuhmann, Martin U.; Shalaby, Tarek; Grotzer, Michael; van Meter, Timothy; Monoranu, Camelia-Maria; Felsberg, Joerg; Reifenberger, Guido; Snuderl, Matija; Forrester, Lynn Ann; Koster, Jan; Versteeg, Rogier; Volckmann, Richard; van Sluis, Peter; Wolf, Stephan; Mikkelsen, Tom; Gajjar, Amar; Aldape, Kenneth; Moore, Andrew S.; Taylor, Michael D.; Jones, Chris; Jabado, Nada; Karajannis, Matthias A.; Eils, Roland; Schlesner, Matthias; Lichter, Peter; von Deimling, Andreas; Pfister, Stefan M.; Ellison, David W.; Korshunov, Andrey; Kool, Marcel			New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs	CELL			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; GENOMIC ANALYSIS; ABUNDANT NEUROPIL; TRUE ROSETTES; MUTATIONS; DNA; MEDULLOBLASTOMA; METHYLATION; AMPLIFICATION	Primitive neuroectodermal tumors of the central nervous system (CNS-PNETs) are highly aggressive, poorly differentiated embryonal tumors occurring predominantly in young children but also affecting adolescents and adults. Herein, we demonstrate that a significant proportion of institutionally diagnosed CNS-PNETs display molecular profiles indistinguishable from those of various other well-defined CNS tumor entities, facilitating diagnosis and appropriate therapy for patients with these tumors. From the remaining fraction of CNS-PNETs, we identify four new CNS tumor entities, each associated with a recurrent genetic alteration and distinct histopathological and clinical features. These new molecular entities, designated "CNS neuroblastoma with FOXR2 activation (CNS NB-FOXR2)," "CNS Ewing sarcoma family tumor with CIC alteration (CNS EFT-CIC)," "CNS high-grade neuroepithelial tumor with MN1 alteration (CNS HGNET-MN1)," and "CNS high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)," will enable meaningful clinical trials and the development of therapeutic strategies for patients affected by poorly differentiated CNS tumors.	[Sturm, Dominik; Jones, David T. W.; Capper, David; Northcott, Paul A.; Pfaff, Elke; Worst, Barbara C.; Pajtler, Kristian W.; Brabetz, Sebastian; Johann, Pascal D.; Pfister, Stefan M.; Kool, Marcel] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Sturm, Dominik; Toprak, Umut H.; Hovestadt, Volker; Jones, David T. W.; Sill, Martin; Buchhalter, Ivo; Northcott, Paul A.; Koelsche, Christian; Pfaff, Elke; Balasubramanian, Gnanaprakash; Worst, Barbara C.; Pajtler, Kristian W.; Brabetz, Sebastian; Johann, Pascal D.; Sahm, Felix; Milde, Till; Wolf, Stephan; Eils, Roland; Schlesner, Matthias; Lichter, Peter; von Deimling, Andreas; Pfister, Stefan M.; Korshunov, Andrey; Kool, Marcel] German Canc Consortium DKTK Core Ctr Heidelberg, D-69120 Heidelberg, Germany; [Sturm, Dominik; Pfaff, Elke; Worst, Barbara C.; Johann, Pascal D.; Milde, Till; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Orr, Brent A.; Allen, Sariah J.; Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Toprak, Umut H.; Buchhalter, Ivo; Eils, Roland; Schlesner, Matthias] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Hovestadt, Volker; Lichter, Peter] German Canc Res Ctr DKFZ Heidelberg, Div Mol Genet, D-69120 Heidelberg, Germany; [Capper, David; Leis, Irina; Koelsche, Christian; Sahm, Felix; von Deimling, Andreas; Korshunov, Andrey] Univ Heidelberg Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany; [Capper, David; Koelsche, Christian; Sahm, Felix; von Deimling, Andreas; Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Sill, Martin] German Canc Res Ctr DKFZ Heidelberg, Div Biostat, D-69120 Heidelberg, Germany; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Moscow 125047, Russia; [Balasubramanian, Gnanaprakash] German Canc Res Ctr DKFZ Heidelberg, Div Appl Bioinformat, D-69120 Heidelberg, Germany; [Reimand, Jueri] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Reimand, Jueri] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Mackay, Alan; Carvalho, Diana M.; Jones, Chris] Inst Canc Res, Div Mol Pathol, London SW7 3RP, England; [Remke, Marc; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg,Program Dev & Stem Cell Biol, Toronto, ON M4N IX8, Canada; [Phillips, Joanna J.; Perry, Arie; Cowdrey, Cynthia] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94158 USA; [Phillips, Joanna J.; Perry, Arie] Univ Calif San Francisco, Dept Pathol, Neuropathol, San Francisco, CA 94143 USA; [Phillips, Joanna J.; Perry, Arie] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Drissi, Rachid; Fouladi, Maryam] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH 45229 USA; [Giangaspero, Felice] Sapienza Univ Rome, Dept Radiol Oncol & Anat Pathol Sci, I-00185 Rome, Italy; [Giangaspero, Felice] IRCCS Neuromed, I-86077 Pozzilli, Molise, Italy; [Lastowska, Maria; Grajkowska, Wieslawa] Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland; [Scheurlen, Wolfram] Nurnberg Childrens Hosp, Cnopfsche Kinderklin, D-90419 Nurnberg, Germany; [Pietsch, Torsten] Univ Bonn, Sch Med, Dept Neuropathol, D-53105 Bonn, Germany; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Gojo, Johannes; Slavc, Irene] Med Univ Vienna, Dept Pediat & Adolescent Med, A-1090 Vienna, Austria; [Gojo, Johannes; Loetsch, Daniela; Berger, Walter] Med Univ Vienna, Inst Canc Res & Comprehens Canc Ctr, Dept Med 1, A-1090 Vienna, Austria; [Haberler, Christine] Med Univ Vienna, Inst Neurol, A-1097 Vienna, Austria; [Jouvet, Anne] Univ Lyon 1, Neurosci Ctr, Inserm U1028, CNRS UMR 5292,Neuro Oncol & Neuro Inflammat Team, F-69000 Lyon, France; [Jouvet, Anne] Hosp Civils Lyon, Ctr Pathol & Neuropathol Est, F-69003 Lyon, France; [Holm, Stefan] Karolinska Inst, Dept Womens & Childrens Hlth KBH, S-17177 Stockholm, Sweden; [Hofer, Silvia] Luzerner Kantonsspital, Dept Oncol, CH-6000 Luzern 16, Switzerland; [Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Keohane, Catherine] Univ Coll Cork, Dept Pathol, Cork T12 YN60, Ireland; [Keohane, Catherine] Cork Univ Hosp Wilton, Cork T12 YN60, Ireland; [Fried, Iris] Hadassah Med Ctr, Dept Pediat Hematol & Oncol, IL-91120 Jerusalem, Israel; [Mawrin, Christian] Otto Von Guericke Univ, Univ Hosp, Inst Neuropathol, D-39120 Magdeburg, Germany; [Scheie, David] Copenhagen Univ Hosp, Dept Pathol, DK-2100 Copenhagen O, Denmark; Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Schniederjan, Matthew J.] Childrens Healthcare Atlanta, Dept Pathol & Lab Adm, Atlanta, GA 30322 USA; [Santi, Mariarita] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Buccoliero, Anna M.] Anna Meyer Childrens Univ Hosp, Pathol Unit, I-50141 Florence, Italy; [Dahiya, Sonika] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kramm, Christof M.; von Bueren, Andre O.] Univ Med Ctr Gottingen, Dept Child & Adolescent Hlth, Div Pediat Hematol & Oncol, D-37075 Gottingen, Germany; [von Hoff, Katja; Rutkowski, Stefan; Schneppenheim, Reinhard] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Haematol & Oncol, D-20246 Hamburg, Germany; [Herold-Mende, Christel] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany; [Milde, Till] Klinikum Augsburg, Pediat Hosp, D-86156 Augsburg, Germany; [Milde, Till] German Canc Res Ctr DKFZ Heidelberg, Clin Cooperat Unit Pediat Oncol, D-69120 Heidelberg, Germany; [Hasselblatt, Martin] Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany; [Wesseling, Pieter] VU Univ Med Ctr Amsterdam, Dept Pathol, NL-1008 MB Amsterdam, Netherlands; [Wesseling, Pieter] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Pathol, NL-6525 GA Nijmegen, Netherlands; [Roessler, Jochen] Univ Med Ctr Freiburg, Ctr Pediat & Adolescent Med, Dept Pediat Hematol Oncol, D-79106 Freiburg, Germany; [Schueller, Ulrich] Univ Munich, Dept Neuropathol, D-81377 Munich, Germany; German Canc Consortium DKTK Partner Site Munich, D-81377 Munich, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; St Jude Children's Research Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Helmholtz Association; German Cancer Research Center (DKFZ); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cincinnati Children's Hospital Medical Center; Sapienza University Rome; IRCCS Neuromed; Children's Memorial Health Institute; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; CHU Lyon; Karolinska Institutet; Lucerne Cantonal Hospital; University of Freiburg; University of Freiburg; University College Cork; Hebrew University of Jerusalem; Hadassah University Medical Center; Otto von Guericke University; University Hospital Magdeburg; University of Copenhagen; Vanderbilt University; Children's Healthcare of Atlanta (CHOA); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Washington University (WUSTL); University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Klinikum Augsburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munster; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; University of Freiburg; University of Munich	Kool, M (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany.	m.kool@dkfz.de	Koster, Jan/C-5934-2008; Ebinger, Martin/O-4936-2016; Grill, Jacques/R-8093-2019; Ryzhova, Marina/G-4178-2014; Ellison, David/N-4806-2018; Gajjar, Amar/N-8059-2018; Moore, Andrew S/I-6275-2012; Pajtler, Kristian/AAN-9029-2020; Sturm, Dominik/AAL-3689-2020; Kölsche, Christian/Q-8854-2019; Eils, Roland/B-6121-2009; Pfister, Stefan M/F-6860-2013; Giangaspero, Felice/Z-4961-2019; Giangaspero, Felice/AAH-9253-2020; Reifenberger, Guido/AAE-3599-2019; Sahm, Felix/GQY-8202-2022; Orr, Brent/N-8068-2018; Jabado, Nada/AAN-4026-2020; Karajannis, Matthias A/H-8845-2019; Versteeg, Rogier/AAQ-1765-2020; Jones, David TW/G-9588-2013; Johann, Pascal David/AAT-9368-2021; von Deimling, Andreas/F-7774-2013; Reimand, Jüri/U-9264-2019; Dahiya, Sonika/J-8359-2019; Jones, David T. W./Z-1963-2019; Milde, Till/AAR-4528-2021; von Bueren, Andre/AAF-2065-2020; Wesseling, P./H-8114-2014; Jones, Chris/ABE-6059-2021; Capper, David/I-8500-2014; Northcott, Paul A/N-4022-2018; Schlesner, Matthias/I-4030-2013	Koster, Jan/0000-0002-0890-7585; Ebinger, Martin/0000-0002-4229-8058; Ryzhova, Marina/0000-0001-7206-6365; Moore, Andrew S/0000-0001-8062-1779; Sturm, Dominik/0000-0003-0250-1696; Eils, Roland/0000-0002-0034-4036; Pfister, Stefan M/0000-0002-5447-5322; Giangaspero, Felice/0000-0001-5382-2380; Giangaspero, Felice/0000-0001-5382-2380; Sahm, Felix/0000-0001-5441-1962; Karajannis, Matthias A/0000-0002-7151-6528; Jones, David TW/0000-0002-2036-5141; von Deimling, Andreas/0000-0002-5863-540X; Reimand, Jüri/0000-0002-2299-2309; Dahiya, Sonika/0000-0002-5585-0964; Milde, Till/0000-0002-7267-1052; Wesseling, P./0000-0001-5453-5201; Jones, Chris/0000-0001-8118-2296; Capper, David/0000-0003-1945-497X; Northcott, Paul A/0000-0002-1220-5252; Hasselblatt, Martin/0000-0003-2707-8484; Sill, Martin/0000-0001-7616-7665; Remke, Marc/0000-0002-9404-9993; Rossler, Jochen/0000-0003-4022-4917; Grobholz, Rainer/0000-0002-1901-7967; Taylor, Michael/0000-0001-7009-3466; Gojo, Johannes/0000-0002-8113-3416; Schuller, Ulrich/0000-0002-8731-1121; Hovestadt, Volker/0000-0002-3480-6649; Lastowska, Maria/0000-0003-0632-6995; Korshunov, Andrey/0000-0002-5257-3623; Buchhalter, Ivo/0000-0003-0764-5832; von Bueren, Andre/0000-0003-4197-6264; Allen, Sariah J./0000-0001-8118-2413; von Hoff, Katja/0000-0002-5669-8546; Berger, Walter/0000-0003-0014-1658; Grotzer, Michael/0000-0002-1154-2732; Grajkowska, Wieslawa/0000-0001-8318-5781; Orr, Brent/0000-0003-0997-4728; Schlesner, Matthias/0000-0002-5896-4086; Carvalho, Diana/0000-0001-6881-6151; VARLET, pascale/0000-0002-8164-1517; Forrester, Lynn Ann/0000-0002-8795-6173; Koelsche, Christian/0000-0001-8763-8864; Mobley, Bret/0000-0002-8138-5330; Versteeg, Rogier/0000-0001-7172-0388; Aronica, Eleonora/0000-0002-3542-3770; Snuderl, Matija/0000-0003-0752-0917; Pajtler, Kristian W./0000-0002-3562-6121	PedBrain Tumor Project; German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, MedSys 0315416C, NGFNplus 01GS0883]; Illumina Medical Research Grant; German Childhood Cancer Foundation; Institut National du Cancer (INCa) [2013-113]; NYU Langone Human Specimen Resource Center; Laura and Isaac Perlmutter Cancer Center; Clinical and Translational Science Institute (CTSI), Cancer Center Support Grant [P30CA016087]; National Center for the Advancement of Translational Science (NCATS) [UL 1 TR000038]; NIH; Making Headway Foundation; Friedberg Foundation; "IRP" funds from the Faculty of Medicine MU; Helmholtz International Graduate School for Cancer Research Stipend;  [HIPO_036];  [P01CA096832]; Cancer Research UK [13982] Funding Source: researchfish; Rosetrees Trust [M200-F1] Funding Source: researchfish; The Brain Tumour Charity [6/78, 16/193] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA096832, P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER	PedBrain Tumor Project; German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Illumina Medical Research Grant; German Childhood Cancer Foundation; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); NYU Langone Human Specimen Resource Center; Laura and Isaac Perlmutter Cancer Center; Clinical and Translational Science Institute (CTSI), Cancer Center Support Grant; National Center for the Advancement of Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Making Headway Foundation; Friedberg Foundation; "IRP" funds from the Faculty of Medicine MU; Helmholtz International Graduate School for Cancer Research Stipend; ; ; Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); The Brain Tumour Charity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Andrea Wittmann, Laura Sieber, and Fabian Kratochwil from the Division of Pediatric Neurooncology at the DKFZ for technical support and the DKFZ Genomics and Proteomics Core Facility, DKFZ Heidelberg, Germany, and the AMC Department of Oncogenomics, Amsterdam, the Netherlands, for performing high-throughput sequencing and microarray analyses to a very high standard. The work at the DKFZ was supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by the German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C, and NGFNplus 01GS0883). We thank the DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO) for technical support and funding through HIPO_036. This work was in part supported by the Illumina Medical Research Grant and the German Childhood Cancer Foundation for MNP2.0. The work at St. Jude Children's Research Hospital was supported in part by a grant to the Neurobiology and Brain Tumor Program (P01CA096832) (to D.W.E and B.A.O). The St. Jude SJMB03 protocol investigators are acknowledged for patient recruitment and tissue collection. We acknowledge Annie Huang and Daniel Picard from the Hospital for Sick Children, Toronto, Canada, for providing samples and expertise. We also thank Jonathan Serrano at the NYU Molecular Pathology Laboratory for technical assistance. Neuropathological diagnosis for cases from France was performed by the GENOP. The French GENOP network is supported by the Institut National du Cancer (INCa, ref no2013-113). This study was supported by the NYU Langone Human Specimen Resource Center, Laura and Isaac Perlmutter Cancer Center, and Clinical and Translational Science Institute (CTSI), which were partially supported by the Cancer Center Support Grant (P30CA016087) and a grant from the National Center for the Advancement of Translational Science (NCATS) (UL 1 TR000038), NIH, and grants from The Making Headway Foundation and Friedberg Foundation. This work was further supported by "IRP" funds from the Faculty of Medicine MU to junior researcher K.Z. U.H.T. is supported by a Helmholtz International Graduate School for Cancer Research Stipend.	Abhiman S, 2008, BIOINFORMATICS, V24, P458, DOI 10.1093/bioinformatics/btn007; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Danielsson A, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0103-3; Eberhart CG, 2000, PEDIATR DEVEL PATHOL, V3, P346, DOI 10.1007/s100249910049; French C, 2014, NAT REV CANCER, V14, P149, DOI 10.1038/nrc3659; Haidar A, 2015, AM J CASE REP, V16, P87, DOI 10.12659/AJCR.892551; Hasselblatt M, 2013, GENE CHROMOSOME CANC, V52, P185, DOI 10.1002/gcc.22018; Jakacki RI, 2015, PEDIATR BLOOD CANCER, V62, P776, DOI 10.1002/pbc.25405; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Ju YS, 2015, GENOME RES, V25, P814, DOI 10.1101/gr.190470.115; Korshunov A, 2014, ACTA NEUROPATHOL, V128, P279, DOI 10.1007/s00401-013-1228-0; Korshunov A, 2012, ACTA NEUROPATHOL, V124, P875, DOI 10.1007/s00401-012-1068-3; Korshunov A, 2010, ACTA NEUROPATHOL, V120, P253, DOI 10.1007/s00401-010-0688-8; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Louis DN, 2014, BRAIN PATHOL, V24, P429, DOI 10.1111/bpa.12171; Margol AS, 2014, CANCER GENET-NY, V207, P358, DOI 10.1016/j.cancergen.2014.07.004; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Rahrmann EP, 2013, NAT GENET, V45, P756, DOI 10.1038/ng.2641; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; RORKE LB, 1983, J NEUROPATH EXP NEUR, V42, P1, DOI 10.1097/00005072-198301000-00001; Rorke LB, 1997, BRAIN PATHOL, V7, P765, DOI 10.1111/j.1750-3639.1997.tb01063.x; Santo EE, 2012, ONCOGENE, V31, P1571, DOI 10.1038/onc.2011.344; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Schwalbe EC, 2013, ACTA NEUROPATHOL, V126, P943, DOI 10.1007/s00401-013-1206-6; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Specht K, 2014, GENE CHROMOSOME CANC, V53, P622, DOI 10.1002/gcc.22172; Spence T, 2014, ACTA NEUROPATHOL, V128, P291, DOI 10.1007/s00401-014-1291-1; The WHO, 2020, CLASSIFICATION TUMOU; Ueno-Yokohata H, 2015, NAT GENET, V47, P861, DOI 10.1038/ng.3338; van Wely K, 2007, ONCOGENE, V26, P5733, DOI 10.1038/sj.onc.1210382; Venneti S, 2013, BRAIN PATHOL, V23, P558, DOI 10.1111/bpa.12042; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	39	470	480	2	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					1060	1072		10.1016/j.cell.2016.01.015	http://dx.doi.org/10.1016/j.cell.2016.01.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919435	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000370867300026
J	Seymour, CW; Liu, VX; Iwashyna, TJ; Brunkhorst, FM; Rea, TD; Scherag, A; Rubenfeld, G; Kahn, JM; Shankar-Hari, M; Singer, M; Deutschman, CS; Escobar, GJ; Angus, DC				Seymour, Christopher W.; Liu, Vincent X.; Iwashyna, Theodore J.; Brunkhorst, Frank M.; Rea, Thomas D.; Scherag, Andre; Rubenfeld, Gordon; Kahn, Jeremy M.; Shankar-Hari, Manu; Singer, Mervyn; Deutschman, Clifford S.; Escobar, Gabriel J.; Angus, Derek C.			Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORGAN FAILURE; SOFA SCORE; CARE; MORTALITY; PREDICTION; OUTCOMES	IMPORTANCE The Third International Consensus Definitions Task Force defined sepsis as "life-threatening organ dysfunction due to a dysregulated host response to infection." The performance of clinical criteria for this sepsis definition is unknown. OBJECTIVE To evaluate the validity of clinical criteria to identify patients with suspected infection who are at risk of sepsis. DESIGN, SETTINGS, AND POPULATION Among 1.3 million electronic health record encounters from January 1, 2010, to December 31, 2012, at 12 hospitals in southwestern Pennsylvania, we identified those with suspected infection in whom to compare criteria. Confirmatory analyses were performed in 4 data sets of 706 399 out-of-hospital and hospital encounters at 165 US and non-US hospitals ranging from January 1, 2008, until December 31, 2013. EXPOSURES Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score, systemic inflammatory response syndrome (SIRS) criteria, Logistic Organ Dysfunction System (LODS) score, and a new model derived using multivariable logistic regression in a split sample, the quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) score (range, 0-3 points, with 1 point each for systolic hypotension [<= 100 mm Hg], tachypnea [>= 22/min], or altered mentation). MAIN OUTCOMES AND MEASURES For construct validity, pairwise agreement was assessed. For predictive validity, the discrimination for outcomes (primary: in-hospital mortality; secondary: in-hospital mortality or intensive care unit [ICU] length of stay >= 3 days) more common in sepsis than uncomplicated infection was determined. Results were expressed as the fold change in outcome over deciles of baseline risk of death and area under the receiver operating characteristic curve (AUROC). RESULTS In the primary cohort, 148 907 encounters had suspected infection (n = 74 453 derivation; n = 74 454 validation), of whom 6347 (4%) died. Among ICU encounters in the validation cohort (n = 7932 with suspected infection, of whom 1289 [16%] died), the predictive validity for in-hospital mortality was lower for SIRS (AUROC = 0.64; 95% CI, 0.62-0.66) and qSOFA (AUROC = 0.66; 95% CI, 0.64-0.68) vs SOFA (AUROC = 0.74; 95% CI, 0.73-0.76; P < .001 for both) or LODS (AUROC = 0.75; 95% CI, 0.73-0.76; P < .001 for both). Among non-ICU encounters in the validation cohort (n = 66 522 with suspected infection, of whom 1886 [3%] died), qSOFA had predictive validity (AUROC = 0.81; 95% CI, 0.80-0.82) that was greater than SOFA (AUROC = 0.79; 95% CI, 0.78-0.80; P < .001) and SIRS (AUROC = 0.76; 95% CI, 0.75-0.77; P < .001). Relative to qSOFA scores lower than 2, encounters with qSOFA scores of 2 or higher had a 3- to 14-fold increase in hospital mortality across baseline risk deciles. Findings were similar in external data sets and for the secondary outcome. CONCLUSIONS AND RELEVANCE Among ICU encounters with suspected infection, the predictive validity for in-hospital mortality of SOFA was not significantly different than the more complex LODS but was statistically greater than SIRS and qSOFA, supporting its use in clinical criteria for sepsis. Among encounters with suspected infection outside of the ICU, the predictive validity for in-hospital mortality of qSOFA was statistically greater than SOFA and SIRS, supporting its use as a prompt to consider possible sepsis.	[Seymour, Christopher W.; Kahn, Jeremy M.; Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15261 USA; [Seymour, Christopher W.; Kahn, Jeremy M.; Angus, Derek C.] Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Liu, Vincent X.] Kaiser Permanente, Div Res, Oakland, CA USA; [Iwashyna, Theodore J.; Escobar, Gabriel J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.; Escobar, Gabriel J.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Iwashyna, Theodore J.; Escobar, Gabriel J.] Monash Univ, Dept Epidemiol & Prevent Med, Australia & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Brunkhorst, Frank M.] Jena Univ Hosp, Ctr Clin Studies, Jena, Germany; [Rea, Thomas D.] Univ Washington, Div Gen Internal Med, Seattle, WA 98195 USA; [Scherag, Andre] Jena Univ Hosp, Ctr Sepsis Control & Care, Res Grp Clin Epidemiol Integrated Res & Treatment, Jena, Germany; [Rubenfeld, Gordon] Sunnybrook Hlth Sci Ctr, Trauma Emergency & Crit Care Program, Toronto, ON M4N 3M5, Canada; [Rubenfeld, Gordon] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Shankar-Hari, Manu] Guys & St Thomas NHS Fdn Trust, Crit Care Med, London, England; [Singer, Mervyn] UCL, Bloomsbury Inst Intens Care Med, London, England; [Deutschman, Clifford S.] Steven & Alexandra Cohen Childrens Med Ctr, Hofstra North Shore Long Isl Jewish Sch Med, Feinstein Inst Med Res, New Hyde Pk, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente; University of Michigan System; University of Michigan; Monash University; Friedrich Schiller University of Jena; University of Washington; University of Washington Seattle; Friedrich Schiller University of Jena; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Hofstra University; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York	Seymour, CW (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Sch Med, Clin Res Invest & Syst Modeling Acute Illness CRI, 3550 Terrace St,Scaife Hall,Ste 639, Pittsburgh, PA 15261 USA.; Seymour, CW (corresponding author), Univ Pittsburgh, Dept Emergency Med, Sch Med, Clin Res Invest & Syst Modeling Acute Illness CRI, 3550 Terrace St,Scaife Hall,Ste 639, Pittsburgh, PA 15261 USA.	seymourcw@upmc.edu	Deutschman, Clifford/AAN-2742-2021; Angus, Derek C/E-9671-2012; Singer, Mervyn/Q-6142-2019; Shankar-Hari, Manu/I-6948-2012	Singer, Mervyn/0000-0002-1042-6350; Shankar-Hari, Manu/0000-0002-5338-2538; Kahn, Jeremy/0000-0001-9688-5576	National Institutes of Health [K23GM104022, K23GM112018]; Department of Veterans Affairs [HSRD 11-109]; Permanente Medical Group; Center of Sepsis Control and Care; German Federal Ministry of Education and Research [01 E0 1002/01 E0 1502]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM112018, K23GM104022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Permanente Medical Group; Center of Sepsis Control and Care; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (grants K23GM104022 and K23GM112018), the Department of Veterans Affairs (grant HSR&D 11-109), the Permanente Medical Group, and the Center of Sepsis Control and Care, funded by the German Federal Ministry of Education and Research (grant 01 E0 1002/01 E0 1502).	[Anonymous], CRIT CARE MED; Barnato AE, 2008, AM J RESP CRIT CARE, V177, P279, DOI 10.1164/rccm.200703-480OC; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; Center for Medicare/Medicaid Services, 2014, EL PROF MEAN US COR, DOI DOI 10.1007/s00134-012-2769-8; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Escobar GJ, 2013, MED CARE, V51, P446, DOI 10.1097/MLR.0b013e3182881c8e; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Hagel S, 2013, DEUT MED WOCHENSCHR, V138, P1717, DOI 10.1055/s-0033-1349481; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; LIU V, 2013, ANN AM THORAC SOC, V10, P466, DOI DOI 10.1513/AnnalsATS.201304-099OC; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Opal Steven M, 2005, Pediatr Crit Care Med, V6, pS55, DOI 10.1097/01.PCC.0000161580.79526.4C; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rhee C, 2015, CLIN INFECT DIS, V60, P88, DOI 10.1093/cid/ciu750; Royston P, 2005, METHOD INFORM MED, V44, P561; Seymour CW, 2012, AM J RESP CRIT CARE, V186, P1264, DOI 10.1164/rccm.201204-0713OC; Seymour CW, 2010, JAMA-J AM MED ASSOC, V304, P747, DOI 10.1001/jama.2010.1140; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	36	1883	2067	10	191	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					762	774		10.1001/jama.2016.0288	http://dx.doi.org/10.1001/jama.2016.0288			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903335	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000370700500012
J	Barnett, R				Barnett, Richard			Attention deficit hyperactivity disorder	LANCET			English	Editorial Material												richard@richardbarnettwriter.com						CONNERS CK, 1963, AM J PSYCHIAT, V120, P458, DOI 10.1176/ajp.120.5.458; Scull A, 2015, MADNESS CIVILISATION; Smith M., 2012, HYPERACTIVE HIST ADH	3	6	7	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					737	737		10.1016/S0140-6736(16)00332-9	http://dx.doi.org/10.1016/S0140-6736(16)00332-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26913307				2022-12-28	WOS:000370418000014
J	Gao, JX; Barzel, B; Barabasi, AL				Gao, Jianxi; Barzel, Baruch; Barabasi, Albert-Laszlo			Universal resilience patterns in complex networks	NATURE			English	Article							DYNAMICS; INTERNET	Resilience, a system's ability to adjust its activity to retain its basic functionality when errors, failures and environmental changes occur, is a defining property of many complex systems(1). Despite widespread consequences for human health(2), the economy(3) and the environment(4), events leading to loss of resilience-from cascading failures in technological systems(5) to mass extinctions in ecological networks(6)-are rarely predictable and are often irreversible. These limitations are rooted in a theoretical gap: the current analytical framework of resilience is designed to treat low-dimensional models with a few interacting components(7), and is unsuitable for multi-dimensional systems consisting of a large number of components that interact through a complex network. Here we bridge this theoretical gap by developing a set of analytical tools with which to identify the natural control and state parameters of a multi-dimensional complex system, helping us derive effective one-dimensional dynamics that accurately predict the system's resilience. The proposed analytical framework allows us systematically to separate the roles of the system's dynamics and topology, collapsing the behaviour of different networks onto a single universal resilience function. The analytical results unveil the network characteristics that can enhance or diminish resilience, offering ways to prevent the collapse of ecological, biological or economic systems, and guiding the design of technological systems resilient to both internal failures and environmental changes.	[Gao, Jianxi; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA; [Barzel, Baruch] Bar Ilan Univ, Dept Math, IL-52900 Ramat Gan, Israel; [Barabasi, Albert-Laszlo] Harvard Univ, Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Cent European Univ, Ctr Network Sci, H-1051 Budapest, Hungary	Northeastern University; Bar Ilan University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Central European University	Barabasi, AL (corresponding author), Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Harvard Univ, Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA.; Barabasi, AL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Cent European Univ, Ctr Network Sci, H-1051 Budapest, Hungary.	alb@neu.edu	Barabasi, Albert-Laszlo/S-6474-2017; Gao, Jianxi/C-8494-2015; Gao, Jianxi/I-1300-2013	Gao, Jianxi/0000-0002-3952-208X; Gao, Jianxi/0000-0002-3952-208X; Barabasi, Albert/0000-0002-4028-3522				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allee W., 1949, PRINCIPLES ANIMAL EC; Alon U., 2006, INTRO SYSTEMS BIOL D; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Barzel B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8186; Barzel B, 2013, NAT PHYS, V9, P673, DOI [10.1038/nphys2741, 10.1038/NPHYS2741]; Barzel B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046104; Ben-Naim E, 2004, LECT NOTES PHYS, V650, P211; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Cornelius SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2939; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Helbing D, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/313; Holland JN, 2002, AM NAT, V159, P231, DOI 10.1086/338510; Hui C, 2006, ECOL MODEL, V192, P317, DOI 10.1016/j.ecolmodel.2005.07.001; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perrings C, 1998, ENVIRON RESOUR ECON, V11, P503, DOI 10.1023/A:1008255614276; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Wilhelm T., 2004, Systems Biology, V1, P114, DOI 10.1049/sb:20045004	29	516	532	64	623	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					307	312		10.1038/nature16948	http://dx.doi.org/10.1038/nature16948			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887493				2022-12-28	WOS:000370327100031
J	Granvik, M; Morbidelli, A; Jedicke, R; Bolin, B; Bottke, WF; Beshore, E; Vokrouhlicky, D; Delbo, M; Michel, P				Granvik, Mikael; Morbidelli, Alessandro; Jedicke, Robert; Bolin, Bryce; Bottke, William F.; Beshore, Edward; Vokrouhlicky, David; Delbo, Marco; Michel, Patrick			Super-catastrophic disruption of asteroids at small perihelion distances	NATURE			English	Article							NEAR-EARTH OBJECTS; POPULATION; ORIGIN	Most near-Earth objects came from the asteroid belt and drifted via non-gravitational thermal forces into resonant escape routes that, in turn, pushed them onto planet-crossing orbits(1-3). Models predict that numerous asteroids should be found on orbits that closely approach the Sun, but few have been seen. In addition, even though the near-Earth-object population in general is an even mix of low-albedo (less than ten per cent of incident radiation is reflected) and high-albedo (more than ten per cent of incident radiation is reflected) asteroids, the characterized asteroids near the Sun typically have high albedos(4). Here we report a quantitative comparison of actual asteroid detections and a near-Earth-object model (which accounts for observational selection effects). We conclude that the deficit of low-albedo objects near the Sun arises from the super-catastrophic breakup (that is, almost complete disintegration) of a substantial fraction of asteroids when they achieve perihelion distances of a few tens of solar radii. The distance at which destruction occurs is greater for smaller asteroids, and their temperatures during perihelion passages are too low for evaporation to explain their disappearance. Although both bright and dark (high-and low-albedo) asteroids eventually break up, we find that low-albedo asteroids are more likely to be destroyed farther from the Sun, which explains the apparent excess of high-albedo near-Earth objects and suggests that low-albedo asteroids break up more easily as a result of thermal effects.	[Granvik, Mikael] Univ Helsinki, Dept Phys, POB 64, FIN-00014 Helsinki, Finland; [Granvik, Mikael] Finnish Geospatial Res Inst, POB 15, Masala 02430, Finland; [Morbidelli, Alessandro; Bolin, Bryce; Delbo, Marco; Michel, Patrick] Observ Cote Azur, Blvd Observ, F-06304 Nice 4, France; [Jedicke, Robert] Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA; [Bottke, William F.] Southwest Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA; [Beshore, Edward] Univ Arizona, 933 North Cherry Ave, Tucson, AZ 85721 USA; [Vokrouhlicky, David] Charles Univ Prague, Inst Astron, V Holesovickach 2, CZ-18000 Prague 8, Czech Republic	University of Helsinki; The National Land Survey of Finland; Finnish Geospatial Research Institute (FGI); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Hawaii System; Southwest Research Institute; University of Arizona; Charles University Prague	Granvik, M (corresponding author), Univ Helsinki, Dept Phys, POB 64, FIN-00014 Helsinki, Finland.; Granvik, M (corresponding author), Finnish Geospatial Res Inst, POB 15, Masala 02430, Finland.	mgranvik@iki.fi	Vokrouhlický, David/Q-4359-2017; Michel, Patrick/AGX-0167-2022	Vokrouhlický, David/0000-0002-6034-5452; Michel, Patrick/0000-0002-0884-1993; Granvik, Mikael/0000-0002-5624-1888; Jedicke, Robert/0000-0001-7830-028X				Bottke WF, 2002, ICARUS, V156, P399, DOI 10.1006/icar.2001.6788; Bottke WF, 2000, SCIENCE, V288, P2190, DOI 10.1126/science.288.5474.2190; Brown P, 2008, ICARUS, V195, P317, DOI 10.1016/j.icarus.2007.12.002; Brown P, 2010, ICARUS, V207, P66, DOI 10.1016/j.icarus.2009.11.015; Campins H, 1996, ASTR SOC P, V107, P85; Delbo M, 2014, NATURE, V508, P233, DOI 10.1038/nature13153; Feigelson ED, 2012, MODERN STATISTICAL METHODS FOR ASTRONOMY: WITH R APPLICATIONS, P105; Greenstreet S, 2012, ICARUS, V217, P355, DOI 10.1016/j.icarus.2011.11.010; Harris AW, 2015, ICARUS, V257, P302, DOI 10.1016/j.icarus.2015.05.004; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; Jedicke R, 2016, ICARUS, V266, P173, DOI 10.1016/j.icarus.2015.10.021; Jewitt D, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/2/L36; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Kuppers M, 2014, NATURE, V505, P525, DOI 10.1038/nature12918; Lewis J. S., 2004, PHYS CHEM SOLAR SYST, P257; Mainzer A, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/110; Mainzer A, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/156; Morbidelli A, 2003, ICARUS, V163, P120, DOI 10.1016/S0019-1035(03)00047-2; Morbidelli A., 2002, ASTEROIDS 3, P409; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; Steckloff JK, 2016, ICARUS, V264, P160, DOI 10.1016/j.icarus.2015.09.021; Vokrouhlicky D., 2015, ASTEROIDS, P509, DOI DOI 10.2458/AZU_UAPRESS_9780816532131-CH027	22	129	130	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					303	306		10.1038/nature16934	http://dx.doi.org/10.1038/nature16934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887492				2022-12-28	WOS:000370327100030
J	Varoni, E; Decani, S				Varoni, Elena; Decani, Sem			Geographic Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Varoni, Elena] Univ Milan, Milan, Italy; [Decani, Sem] Azienda Osped San Paolo, Milan, Italy	University of Milan	Varoni, E (corresponding author), Univ Milan, Milan, Italy.	elena.varoni@unimi.it	bakshi, satvinder singh/H-3460-2019; Varoni, Elena M./T-5417-2019	bakshi, satvinder singh/0000-0003-4859-9588; Varoni, Elena Maria/0000-0002-7287-2188					0	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					670	670		10.1056/NEJMicm1502932	http://dx.doi.org/10.1056/NEJMicm1502932			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26886524	Green Published			2022-12-28	WOS:000370229000013
J	Kainz, QM; Matier, CD; Bartoszewicz, A; Zultanski, SL; Peters, JC; Fu, GC				Kainz, Quirin M.; Matier, Carson D.; Bartoszewicz, Agnieszka; Zultanski, Susan L.; Peters, Jonas C.; Fu, Gregory C.			Asymmetric copper-catalyzed C-N cross-couplings induced by visible light	SCIENCE			English	Article							PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; ALKYL-HALIDES; ARYLATIONS; ALKALOIDS; REAGENTS; AMIDES	Despite a well-developed and growing body of work in copper catalysis, the potential of copper to serve as a photocatalyst remains underexplored. Here we describe a photoinduced copper-catalyzed method for coupling readily available racemic tertiary alkyl chloride electrophiles with amines to generate fully substituted stereocenters with high enantioselectivity. The reaction proceeds at -40 degrees C under excitation by a blue light-emitting diode and benefits from the use of a single, Earth-abundant transition metal acting as both the photocatalyst and the source of asymmetric induction. An enantioconvergent mechanism transforms the racemic starting material into a single product enantiomer.	[Kainz, Quirin M.; Matier, Carson D.; Bartoszewicz, Agnieszka; Zultanski, Susan L.; Peters, Jonas C.; Fu, Gregory C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Peters, JC; Fu, GC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	jpeters@caltech.edu; gcfu@caltech.edu			NIH (National Institute of General Medical Sciences) [R01-GM109194]; Gordon and Betty Moore Foundation; Alexander von Humboldt Foundation; Bengt Lundqvist Memorial Foundation of the Swedish Chemical Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109194] Funding Source: NIH RePORTER	NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Bengt Lundqvist Memorial Foundation of the Swedish Chemical Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support has been provided by NIH (National Institute of General Medical Sciences, grant R01-GM109194), the Gordon and Betty Moore Foundation, the Alexander von Humboldt Foundation (fellowship for Q.M.K.), and the Bengt Lundqvist Memorial Foundation of the Swedish Chemical Society (fellowship for A.B.). We thank J. M. Ahn, L. M. Henling (Caltech X-Ray Crystallography Facility), M. W. Johnson, N. D. Schley, M. Shahgholi (Caltech Mass Spectrometry Facility), M. K. Takase (Caltech X-Ray Crystallography Facility), N. Torian (Caltech Mass Spectrometry Facility), D. G. VanderVelde (Caltech NMR Facility), and S. C. Virgil (Caltech Center for Catalysis and Chemical Synthesis) for assistance and helpful discussions. Experimental procedures and characterization data are provided in the supplementary materials. Metrical parameters for the structures of compounds 1 to 4 are available free of charge from the Cambridge Crystallographic Data Centre under accession numbers CCDC 1435979, 1435978, 1435977, and 1435980.	Albini A, 2013, PHOTOCHEMICALLY-GENERATED INTERMEDIATES IN SYNTHESIS, P1, DOI 10.1002/9781118689202; Balasubramaniam S, 2008, SYNTHESIS-STUTTGART, P3707, DOI 10.1055/s-0028-1083226; Bauer A, 2005, NATURE, V436, P1139, DOI 10.1038/nature03955; BERRISFORD DJ, 1995, ANGEW CHEM INT EDIT, V34, P1059, DOI 10.1002/anie.199510591; Bissember AC, 2013, ANGEW CHEM INT EDIT, V52, P5129, DOI 10.1002/anie.201301202; Brimioulle R, 2015, ANGEW CHEM INT EDIT, V54, P3872, DOI 10.1002/anie.201411409; Creutz SE, 2012, SCIENCE, V338, P647, DOI 10.1126/science.1226458; Fischer C, 2005, J AM CHEM SOC, V127, P4594, DOI 10.1021/ja0506509; Gribble G.W., 2010, HETEROCYCLIC SCAFFOL; Hartwig J.F., 2007, CHEM ANILINES, P455; Do HQ, 2014, J AM CHEM SOC, V136, P2162, DOI 10.1021/ja4126609; Huo HH, 2015, J AM CHEM SOC, V137, P9551, DOI 10.1021/jacs.5b06010; Huo HH, 2014, NATURE, V515, P100, DOI 10.1038/nature13892; Jiang L., 2004, METAL CATALYZED CROS, V2, P699, DOI DOI 10.1002/9783527619535.CH13; Jin M, 2015, J AM CHEM SOC, V137, P7128, DOI 10.1021/jacs.5b02277; Lawrence S.A., 2004, AMINES SYNTHESIS; Liang YF, 2015, J AM CHEM SOC, V137, P9523, DOI 10.1021/jacs.5b04725; Lundin PM, 2010, J AM CHEM SOC, V132, P11027, DOI 10.1021/ja105148g; Nicewicz DA, 2014, ACS CATAL, V4, P355, DOI 10.1021/cs400956a; Paria S, 2014, CHEMCATCHEM, V6, P2477, DOI 10.1002/cctc.201402237; Pellissier H, 2014, SEPARATION OF ENANTIOMERS: SYNTHETIC METHODS, P75; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Schmidt AW, 2012, CHEM REV, V112, P3193, DOI 10.1021/cr200447s; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Schuster C, 2015, J ORG CHEM, V80, P5666, DOI 10.1021/acs.joc.5b00630; Vallakati R, 2012, J AM CHEM SOC, V134, P6936, DOI 10.1021/ja301387k; Wang CY, 2015, CHEM-EUR J, V21, P7355, DOI 10.1002/chem.201500998	29	436	438	19	558	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					681	684		10.1126/science.aad8313	http://dx.doi.org/10.1126/science.aad8313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912852	Green Accepted			2022-12-28	WOS:000369810000033
J	Villiger, PM; Adler, S; Kuchen, S; Wermelinger, F; Dan, D; Fiege, V; Butikofer, L; Seitz, M; Reichenbach, S				Villiger, Peter M.; Adler, Sabine; Kuchen, Stefan; Wermelinger, Felix; Dan, Diana; Fiege, Veronika; Butikofer, Lukas; Seitz, Michael; Reichenbach, Stephan			Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; POLYMYALGIA-RHEUMATICA; GASTROINTESTINAL PERFORATIONS; METHOTREXATE; EPIDEMIOLOGY	Background Giant cell arteritis is an immune-mediated disease of medium and large-sized arteries that affects mostly people older than 50 years of age. Treatment with glucocorticoids is the gold-standard and prevents severe vascular complications but is associated with substantial morbidity and mortality. Tocilizumab, a humanised monoclonal antibody against the interleukin-6 receptor, has been associated with rapid induction and maintenance of remission in patients with giant cell arteritis. We therefore aimed to study the efficacy and safety of tocilizumab in the first randomised clinical trial in patients with newly diagnosed or recurrent giant cell arteritis. Methods In this single centre, phase 2, randomised, double-blind, placebo-controlled trial, we recruited patients aged 50 years and older from University Hospital Bern, Switzerland, who met the 1990 American College of Rheumatology criteria for giant cell arteritis. Patients with new-onset or relapsing disease were randomly assigned (2: 1) to receive either tocilizumab (8 mg/kg) or placebo intravenously. 13 infusions were given in 4 week intervals until week 52. Both groups received oral prednisolone, starting at 1 mg/kg per day and tapered down to 0 mg according to a standard reduction scheme defined in the study protocol. Allocation to treatment groups was done using a central computerised randomisation procedure with a permuted block design and a block size of three, and concealed using central randomisation generated by the clinical trials unit. Patients, investigators, and study personnel were masked to treatment assignment. The primary outcome was the proportion of patients who achieved complete remission of disease at a prednisolone dose of 0.1 mg/kg per day at week 12. All analyses were intention to treat. This trial is registered with ClinicalTrials. gov, number NCT01450137. Results Between March 3, 2012, and Sept 9, 2014, 20 patients were randomly assigned to receive tocilizumab and prednisolone, and ten patients to receive placebo and glucocorticoid; 16 (80%) and seven (70%) patients, respectively, had new-onset giant cell arteritis. 17 (85%) of 20 patients given tocilizumab and four (40%) of ten patients given placebo reached complete remission by week 12 (risk difference 45%, 95% CI 11-79; p=0.0301). Relapse-free survival was achieved in 17 (85%) patients in the tocilizumab group and two (20%) in the placebo group by week 52 (risk difference 65%, 95% CI 36-94; p=0.0010). The mean survival-time difference to stop glucocorticoids was 12 weeks in favour of tocilizumab (95% CI 7-17; p<0.0001), leading to a cumulative prednisolone dose of 43 mg/kg in the tocilizumab group versus 110 mg/kg in the placebo group (p=0.0005) after 52 weeks. Seven (35%) patients in the tocilizumab group and five (50%) in the placebo group had serious adverse events. Interpretation Our findings show, for the first time in a trial setting, the efficacy of tocilizumab in the induction and maintenance of remission in patients with giant cell arteritis.	[Villiger, Peter M.; Adler, Sabine; Kuchen, Stefan; Wermelinger, Felix; Dan, Diana; Seitz, Michael] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, CH-3010 Bern, Switzerland; [Fiege, Veronika; Butikofer, Lukas] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Reichenbach, Stephan] Univ Bern, Inst Primary Care, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern	Villiger, PM (corresponding author), Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, CH-3010 Bern, Switzerland.; Villiger, PM (corresponding author), Univ Bern, CH-3010 Bern, Switzerland.	peter.villiger@insel.ch	Villiger, Peter/AAV-8132-2021	Dan, Diana/0000-0003-1749-3238; Butikofer, Lukas/0000-0002-0801-746X; Kuchen, Stefan/0000-0003-4899-8132; Reichenbach, Stephan/0000-0001-8098-6567	Roche; University of Bern	Roche(Roche Holding); University of Bern	Roche and the University of Bern.	BALDURSSON O, 1994, ARTHRITIS RHEUM-US, V37, P1007, DOI 10.1002/art.1780370705; Curtis JR, 2011, ARTHRITIS RHEUM-US, V63, P346, DOI 10.1002/art.30107; EMILIE D, 1994, HUM IMMUNOL, V39, P17, DOI 10.1016/0198-8859(94)90096-5; Gout T, 2011, CLIN RHEUMATOL, V30, P1471, DOI 10.1007/s10067-011-1827-x; Hernandez-Rodriguez J, 2004, RHEUMATOLOGY, V43, P294, DOI 10.1093/rheumatology/keh058; Hoffman GS, 2007, ANN INTERN MED, V146, P621, DOI 10.7326/0003-4819-146-9-200705010-00004; Hunder GG, 2002, CLEV CLIN J MED, V69, P79, DOI 10.3949/ccjm.69.Suppl_2.SII79; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Iking-Konert C, 2016, RHEUMATOLOGY, V55, P624, DOI 10.1093/rheumatology/kev372; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; Loricera J, 2014, ANN RHEUM DIS, V73, P694, DOI 10.1136/annrheumdis-2014-eular.2984; Loricera J, 2015, SEMIN ARTHRITIS RHEU, V44, P717, DOI 10.1016/j.semarthrit.2014.12.005; Mahr AD, 2007, ARTHRITIS RHEUM, V56, P2789, DOI 10.1002/art.22754; Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010; Nishimoto N, 2009, ANN RHEUM DIS, V68, P1580, DOI 10.1136/ard.2008.092866; Nordborg C, 2003, RHEUMATOLOGY, V42, P549, DOI 10.1093/rheumatology/keg172; Oliveira F, 2014, CLIN EXP RHEUMATOL, V32, pS76; Pfeil J, 2014, RHEUMATOLOGY, V53, P1713, DOI 10.1093/rheumatology/keu032; ROCHE NE, 1993, ARTHRITIS RHEUM, V36, P1286, DOI 10.1002/art.1780360913; Seitz M, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13156; Seror R, 2014, ANN RHEUM DIS, V73, P2074, DOI 10.1136/annrheumdis-2013-203586; SONNENBLICK M, 1994, BRIT J RHEUMATOL, V33, P938; Unizony S, 2012, ARTHRIT CARE RES, V64, P1720, DOI 10.1002/acr.21750; van der Geest KSM, 2015, RHEUMATOLOGY, V54, P1397, DOI 10.1093/rheumatology/keu526; Weyand CM, 2014, NEW ENGL J MED, V371, P1653, DOI [10.1056/NEJMcp1214825, 10.1056/NEJMc1409206]; Yokota S, 2014, J RHEUMATOL, V41, P759, DOI 10.3899/jrheum.130690	26	334	343	4	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1921	1927		10.1016/S0140-6736(16)00560-2	http://dx.doi.org/10.1016/S0140-6736(16)00560-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	26952547				2022-12-28	WOS:000375374200036
J	Zuckerman, RB; Sheingold, SH; Orav, EJ; Ruhter, J; Epstein, AM				Zuckerman, Rachael B.; Sheingold, Steven H.; Orav, E. John; Ruhter, Joel; Epstein, Arnold M.			Readmissions, Observation, and the Hospital Readmissions Reduction Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REHOSPITALIZATIONS	BACKGROUND The Hospital Readmissions Reduction Program, which is included in the Affordable Care Act (ACA), applies financial penalties to hospitals that have higher-than-expected readmission rates for targeted conditions. Some policy analysts worry that reductions in readmissions are being achieved by keeping returning patients in observation units instead of formally readmitting them to the hospital. We examined the changes in readmission rates and stays in observation units over time for targeted and nontargeted conditions and assessed whether hospitals that had greater increases in observation-service use had greater reductions in readmissions. METHODS We compared monthly, hospital-level rates of readmission and observation-service use within 30 days after hospital discharge among Medicare elderly beneficiaries from October 2007 through May 2015. We used an interrupted time-series model to determine when trends changed and whether changes differed between targeted and nontargeted conditions. We assessed the correlation between changes in readmission rates and use of observation services after adoption of the ACA in March 2010. RESULTS We analyzed data from 3387 hospitals. From 2007 to 2015, readmission rates for targeted conditions declined from 21.5% to 17.8%, and rates for nontargeted conditions declined from 15.3% to 13.1%. Shortly after passage of the ACA, the readmission rate declined quickly, especially for targeted conditions, and then continued to fall at a slower rate after October 2012 for both targeted and nontargeted conditions. Stays in observation units for targeted conditions increased from 2.6% in 2007 to 4.7% in 2015, and rates for nontargeted conditions increased from 2.5% to 4.2%. Within hospitals, there was no significant association between changes in observation-unit stays and readmissions after implementation of the ACA. CONCLUSIONS Readmission trends are consistent with hospitals' responding to incentives to reduce readmissions, including the financial penalties for readmissions under the ACA. We did not find evidence that changes in observation-unit stays accounted for the decrease in readmissions.	[Zuckerman, Rachael B.; Sheingold, Steven H.; Orav, E. John; Ruhter, Joel; Epstein, Arnold M.] Off Assistant Secreary Planning & Evaluat, Dept Hlth & Human Serv, Washington, DC USA; [Orav, E. John] Brigham & Womens Hosp, Div Gen Internal Med, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Zuckerman, RB (corresponding author), ASPE Off Hlth Policy, Dept Hlth & Human Serv, 200 Independence Ave SW,Rm 447D, Washington, DC 20201 USA.	rachael.zuckerman@hhs.gov						[Anonymous], 2007, REP C MED PAYM POL; [Anonymous], 2014, 2014 MEASURES UPDATE; [Anonymous], 2014, 2014 MEASURE UPDATES; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Carey K, 2015, HEALTH AFFAIR, V34, P978, DOI 10.1377/hlthaff.2014.1408; Centers for Medicare and Medicaid Services, 2015, ACC CAR ORG 2015 PRO; Centers for Medicare & Medicaid Services, 2011, HOSP ENG NETW CONN H; Centers for Medicare Medicaid Services, 2014, MED HOSP QUAL CHARTB; *CTR MED MED SERV, HOSP COMP DOWNL DAT; Gerhardt G, 2014, MED MED RES REV, V4; Gerhardt G, 2013, MED MED RES REV, V3; Himmelstein D, 2015, HLTH AFF BLOD   0817; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Medicare Payment Advisory Commission, 2008, REP C REF DEL SYST; Medicare Payment Advisory Commission, 2013, ECLINICALMEDICINE, DOI DOI 10.1016/J.ECLINM.2020.100495; Weaver C., 2015, WALL STREET J; Carlson Joe, 2013, Mod Healthc, V43, P8	17	565	568	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1543	1551		10.1056/NEJMsa1513024	http://dx.doi.org/10.1056/NEJMsa1513024			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7IA	26910198	Bronze			2022-12-28	WOS:000374383900007
J	Seddon, AWR; Macias-Fauria, M; Long, PR; Benz, D; Willis, KJ				Seddon, Alistair W. R.; Macias-Fauria, Marc; Long, Peter R.; Benz, David; Willis, Kathy J.			Sensitivity of global terrestrial ecosystems to climate variability	NATURE			English	Article							CARBON DYNAMICS; FOREST; TEMPERATURE; RESILIENCE	The identification of properties that contribute to the persistence and resilience of ecosystems despite climate change constitutes a research priority of global relevance(1). Here we present a novel, empirical approach to assess the relative sensitivity of ecosystems to climate variability, one property of resilience that builds on theoretical modelling work recognizing that systems closer to critical thresholds respond more sensitively to external perturbations2. We develop a new metric, the vegetation sensitivity index, that identifies areas sensitive to climate variability over the past 14 years. The metric uses time series data derived from the moderate-resolution imaging spectroradiometer (MODIS) enhanced vegetation index(3), and three climatic variables that drive vegetation productivity(4) (air temperature, water availability and cloud cover). Underlying the analysis is an autoregressive modelling approach used to identify climate drivers of vegetation productivity on monthly timescales, in addition to regions with memory effects and reduced response rates to external forcing(5). We find ecologically sensitive regions with amplified responses to climate variability in the Arctic tundra, parts of the boreal forest belt, the tropical rainforest, alpine regions worldwide, steppe and prairie regions of central Asia and North and South America, the Caatinga deciduous forest in eastern South America, and eastern areas of Australia. Our study provides a quantitative methodology for assessing the relative response rate of ecosystems-be they natural or with a strong anthropogenic signature-to environmental variability, which is the first step towards addressing why some regions appear to be more sensitive than others, and what impact this has on the resilience of ecosystem service provision and human well-being.	[Seddon, Alistair W. R.; Willis, Kathy J.] Univ Bergen, Dept Biol, Allegaten 41, N-500 Bergen, Norway; [Macias-Fauria, Marc] Univ Oxford, Sch Geog & Environm, S Parks Rd, Oxford OX1 3QY, England; [Long, Peter R.; Benz, David; Willis, Kathy J.] Univ Oxford, Dept Zool, Oxford Martin Sch, Long Term Ecol Lab,Biodivers Inst, S Parks Rd, Oxford OX1 3PS, England; [Willis, Kathy J.] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	University of Bergen; University of Oxford; University of Oxford; Royal Botanic Gardens, Kew	Seddon, AWR (corresponding author), Univ Bergen, Dept Biol, Allegaten 41, N-500 Bergen, Norway.	alistair.seddon@bio.uib.no	Macias-Fauria, Marc/A-4591-2009	Macias-Fauria, Marc/0000-0002-8438-2223; Willis, Katherine/0000-0002-6763-2489; Seddon, Alistair/0000-0002-8266-0947	Statoil ASA, Norway [4501995279]; European Commission [LIFE12 ENV/UK/000473]; Oxford Martin School Fellowship; Natural Environment Research Council Independent Research Fellowship [NE/L011859/1]; Research Council of Norway Postdoctoral Fellowship within a FRIMEDBIO project grant [FRIMEDBIO-214359]; Natural Environment Research Council [NE/L011859/1] Funding Source: researchfish; NERC [NE/L011859/1] Funding Source: UKRI	Statoil ASA, Norway; European Commission(European CommissionEuropean Commission Joint Research Centre); Oxford Martin School Fellowship; Natural Environment Research Council Independent Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Research Council of Norway Postdoctoral Fellowship within a FRIMEDBIO project grant; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Statoil ASA, Norway, Contract number 4501995279 (K. J. W., A. W. R. S., D. B.), and by the European Commission LIFE12 ENV/UK/000473 (K. J. W., D. B. and P. R. L.). P. R. L. was also supported by an Oxford Martin School Fellowship. M.M.-F. was supported by a Natural Environment Research Council Independent Research Fellowship (NE/L011859/1) and A. W. R. S. was supported by a Research Council of Norway Postdoctoral Fellowship within a FRIMEDBIO project grant (FRIMEDBIO-214359) during analysis and write-up of this work.	Ackerman S., 2010, DISCRIMINATING CLEAR; Barbosa HA, 2006, J ARID ENVIRON, V67, P288, DOI 10.1016/j.jaridenv.2006.02.022; Bivand, 2015, PACKAGE RGDAL BINDIN; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Cleugh HA, 2007, REMOTE SENS ENVIRON, V106, P285, DOI 10.1016/j.rse.2006.07.007; Convention on Biological Diversity, AICH BIOD TARG; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; De Keersmaecker W, 2015, GLOBAL ECOL BIOGEOGR, V24, P539, DOI 10.1111/geb.12279; Doughty CE, 2015, NATURE, V519, P78, DOI 10.1038/nature14213; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Harris A, 2014, INT J APPL EARTH OBS, V28, P131, DOI 10.1016/j.jag.2013.11.014; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2015, PACKAGE RASTER R PAC; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holmgren M, 2013, NAT CLIM CHANGE, V3, P755, DOI [10.1038/nclimate1906, 10.1038/NCLIMATE1906]; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Intergovernmental Panel on Climate Change, 2013, CLIM CHANG 2013 PHYS; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Macias-Fauria M, 2012, NAT CLIM CHANGE, V2, P613, DOI 10.1038/NCLIMATE1558; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pederson N, 2014, ECOL MONOGR, V84, P599, DOI 10.1890/13-1025.1; Pinheiro J., 2020, PACKAGE NLME LINEAR, DOI DOI 10.1016/S0006-3207(01)00201-4; Pope N., 2013, CORHAVERSINE FUNCTIO; Richard Y, 1998, INT J REMOTE SENS, V19, P2907, DOI 10.1080/014311698214343; Sala OE, 2012, PHILOS T R SOC B, V367, P3135, DOI 10.1098/rstb.2011.0347; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seeman S. W., 2006, MODIS ATMOSPHERIC PR; Solano R., 2010, MODIS VEGETATION IND, DOI DOI 10.1007/978-1-4419-6749-7_26; Team RC., 2013, R LANG ENV STAT COMP; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Warnes G. R., 2015, GTOOLS VARIOUS R PRO; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	41	603	651	64	893	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					229	+		10.1038/nature16986	http://dx.doi.org/10.1038/nature16986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26886790	Green Accepted, Green Submitted			2022-12-28	WOS:000371665100040
J	Jack, A				Jack, Andrew			PHARMACEUTICALS Can anyone stop the illegal sale of medicines online?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jack, Andrew] Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				European Medicines Agency, FALS MED; NHS Choices, DANG BUYING YOUR MED	2	6	6	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2016	352								i1317	10.1136/bmj.i1317	http://dx.doi.org/10.1136/bmj.i1317			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NH	26951841				2022-12-28	WOS:000372048400004
J	Gilbert, DT; King, G; Pettigrew, S; Wilson, TD				Gilbert, Daniel T.; King, Gary; Pettigrew, Stephen; Wilson, Timothy D.			Comment on "Estimating the reproducibility of psychological science"	SCIENCE			English	Editorial Material								A paper from the Open Science Collaboration (Research Articles, 28 August 2015, aac4716) attempting to replicate 100 published studies suggests that the reproducibility of psychological science is surprisingly low. We show that this article contains three statistical errors and provides no support for such a conclusion. Indeed, the data are consistent with the opposite conclusion, namely, that the reproducibility of psychological science is quite high.	[Gilbert, Daniel T.; King, Gary; Pettigrew, Stephen] Harvard Univ, Cambridge, MA 02138 USA; [Wilson, Timothy D.] Univ Virginia, Charlottesville, VA USA	Harvard University; University of Virginia	Gilbert, DT (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	gilbert@wjh.harvard.edu		Della Penna, Nicolas/0000-0002-9545-5731				[Anonymous], 2015, SCIENCE, DOI [DOI 10.1126/SCIENCE.AAC4716, DOI 10.1126/science.aac4716]; Carey B., 2015, NY TIMES, pA1; Gilbert D. T., 2016, HARVARD DATAVERSE, VV1; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Koo M, 2008, J PERS SOC PSYCHOL, V94, P183, DOI 10.1037/0022-3514.94.2.183; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; Masicampo EJ, 2008, PSYCHOL SCI, V19, P255, DOI 10.1111/j.1467-9280.2008.02077.x; Payne BK, 2008, J PERS SOC PSYCHOL, V94, P16, DOI 10.1037/0022-3514.94.1.16; Risen JL, 2008, J PERS SOC PSYCHOL, V95, P293, DOI 10.1037/0022-3514.95.2.293; Shnabel N, 2008, J PERS SOC PSYCHOL, V94, P116, DOI 10.1037/0022-3514.94.1.116; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632	11	266	271	16	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277								10.1126/science.aad7243	http://dx.doi.org/10.1126/science.aad7243			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF8HE	26941311				2022-12-28	WOS:000371597500030
J	Voichek, Y; Bar-Ziv, R; Barkai, N				Voichek, Yoav; Bar-Ziv, Raz; Barkai, Naama			Expression homeostasis during DNA replication	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HISTONE H3; CELL-CYCLE; RNA-SYNTHESIS; SCHIZOSACCHAROMYCES-POMBE; ESCHERICHIA-COLI; MAMMALIAN-CELLS; GENE-EXPRESSION; ACETYLATION; LYSINE-56	Genome replication introduces a stepwise increase in the DNA template available for transcription. Genes replicated early in S phase experience this increase before late-replicating genes, raising the question of how expression levels are affected by DNA replication. We show that in budding yeast, messenger RNA (mRNA) synthesis rate is buffered against changes in gene dosage during S phase. This expression homeostasis depends on acetylation of H3 on its internal K56 site by Rtt109/Asf1. Deleting these factors, mutating H3K56 or up-regulating its deacetylation, increases gene expression in S phase in proportion to gene replication timing. Therefore, H3K56 acetylation on newly deposited histones reduces transcription efficiency from replicated DNA, complementing its role in guarding genome stability. Our study provides molecular insight into the mechanism maintaining expression homeostasis during DNA replication.	[Voichek, Yoav; Bar-Ziv, Raz; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il	Bar-Ziv, Raz/AAK-3340-2020	Bar-Ziv, Raz/0000-0003-2615-1942; Voichek, Yoav/0000-0001-8460-7018	European Research Council; Israel Science Foundation; Binational Science Foundation	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Binational Science Foundation(US-Israel Binational Science Foundation)	We thank D. Rosin and M. Krupkin for technical assistance and J. Karagiannis for yeast strains. We also thank members of our laboratory and B. Z. Shilo for fruitful discussions and comments on the manuscript. This work was supported by the European Research Council, Israel Science Foundation, and Binational Science Foundation. RNA-seq, ChIP-seq, and DNA-seq data are deposited in the European Nucleotide Archive (ENA) under accession number PRJEB11977.	Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; CHANDLER MG, 1975, MOL GEN GENET, V138, P127, DOI 10.1007/BF02428117; Clemente-Ruiz M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002376; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; ELLIOTT SG, 1983, MOL GEN GENET, V192, P204, DOI 10.1007/BF00327667; ELLIOTT SG, 1978, P NATL ACAD SCI USA, V75, P4384, DOI 10.1073/pnas.75.9.4384; FRASER RSS, 1976, J CELL SCI, V21, P497; FRASER RSS, 1978, NATURE, V271, P726, DOI 10.1038/271726a0; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; KILLANDER D, 1965, EXP CELL RES, V38, P272, DOI 10.1016/0014-4827(65)90403-9; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; PFEIFFER SE, 1968, J CELL PHYSIOL, V71, P95, DOI 10.1002/jcp.1040710111; Radovani E, 2013, EUKARYOT CELL, V12, P654, DOI 10.1128/EC.00291-12; SCHMID MB, 1987, J BACTERIOL, V169, P2872, DOI 10.1128/jb.169.6.2872-2875.1987; Sousa C, 1997, MICROBIOL-SGM, V143, P2071, DOI 10.1099/00221287-143-6-2071; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Yamane K, 2011, MOL CELL, V41, P56, DOI 10.1016/j.molcel.2010.12.009; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]	29	65	65	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1087	1090		10.1126/science.aad1162	http://dx.doi.org/10.1126/science.aad1162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941319				2022-12-28	WOS:000371597500045
J	Chavda, SJ; Dearden, C				Chavda, Selina J.; Dearden, Claire			SPOT DIAGNOSIS Interesting case of lymphocytosis and splenomegaly	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HAIRY-CELL LEUKEMIA; VARIANT FORM		[Chavda, Selina J.; Dearden, Claire] Royal Marsden NHS Fdn Trust, Dept Haematooncol, Sutton SM2 5PT, Surrey, England	Royal Marsden NHS Foundation Trust	Chavda, SJ (corresponding author), Royal Marsden NHS Fdn Trust, Dept Haematooncol, Sutton SM2 5PT, Surrey, England.	selinachavda@doctors.org.uk			National Institute for Health Research [ACF-2014-22-002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Burger JA, 2012, BLOOD, V119, P3193, DOI 10.1182/blood-2012-01-403659; Hockley SL, 2011, LEUKEMIA, V25, P1189, DOI 10.1038/leu.2011.47; Jones G, 2012, BRIT J HAEMATOL, V156, P186, DOI 10.1111/j.1365-2141.2011.08931.x; Matutes E, 2003, BEST PRACT RES CL HA, V16, P41, DOI 10.1016/S1521-6926(02)00086-5; Matutes E, 2001, LEUKEMIA, V15, P184, DOI 10.1038/sj.leu.2401999	7	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2016	352								i1227	10.1136/bmj.i1227	http://dx.doi.org/10.1136/bmj.i1227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LO	26940880				2022-12-28	WOS:000371756700004
J	Gupta, S				Gupta, Sujata			Clever eating	NATURE			English	Editorial Material							LIFETIME DIETARY PATTERNS											Chouinard-Watkins R, 2014, NUTRIENTS, V6, P4452, DOI 10.3390/nu6104452; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Dominguez-Rodrigo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046414; Hosking D, 2013, BRIT J NUTR, V110, P2069, DOI 10.1017/S000711451300144X; Hosking DE, 2014, BRIT J NUTR, V112, P228, DOI 10.1017/S0007114514000646; Hulett JL, 2014, BRIT J NUTR, V111, P875, DOI 10.1017/S0007114513003310; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; Monk C., 2015, PEDIAT RES; Neumann CG, 1992, FINAL REPORT PHASE 2; Neumann CG, 2007, J NUTR, V137, P1119, DOI 10.1093/jn/137.4.1119	10	26	26	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S12	S13		10.1038/531S12a	http://dx.doi.org/10.1038/531S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2YW	26934519	Bronze			2022-12-28	WOS:000371211900006
J	King, A				King, Anthony			Rise of resilience	NATURE			English	Editorial Material																		Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; LUPIEN S, 1994, J NEUROSCI, V14, P2893, DOI 10.1523/jneurosci.14-05-02893.1994; Muroy S., 2016, NEUROPSYCHOPHARMACOL; Taliaz D, 2011, J NEUROSCI, V31, P4475, DOI 10.1523/JNEUROSCI.5725-10.2011; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	5	17	18	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S18	S19		10.1038/531S18a	http://dx.doi.org/10.1038/531S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2YW	26934522	Bronze			2022-12-28	WOS:000371211900009
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING Bottled water for all, all the time?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Robert Graham Ctr Policy Studies Primary Care, Washington, DC USA; [Kamerow, Douglas] Georgetown Univ, Washington, DC 20057 USA	Georgetown University	Kamerow, D (corresponding author), Robert Graham Ctr Policy Studies Primary Care, Washington, DC USA.; Kamerow, D (corresponding author), Georgetown Univ, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Carroll AE, 2015, NY TIMES; Vreeman RC, 2007, BRIT MED J, V335, P1288, DOI 10.1136/bmj.39420.420370.25; Wines Michael, 2016, NY TIMES	3	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2016	352								i1214	10.1136/bmj.i1214	http://dx.doi.org/10.1136/bmj.i1214			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LJ	26932928				2022-12-28	WOS:000371756000006
J	Bongaarts, J				Bongaarts, John			Slow down population growth	NATURE			English	Editorial Material							FERTILITY		[Bongaarts, John] Populat Council, 1230 York Ave, New York, NY 10021 USA	Population Council	Bongaarts, J (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.	jbongaarts@popcouncil.org						Abbasi-Shavazi MJ, 2006, ASIAN POPULATION STU, V2, P217, DOI DOI 10.1080/17441730601073789; [Anonymous], 2012, WORLD POPULATION POL; [Anonymous], 1994, DETERMINANTS REPROD; Bloom D., 2003, DEMOGRAPHIC DIVIDEND; Bongaarts J., 2012, FAMILY PLANNING PROG; PRITCHETT LH, 1994, POPUL DEV REV, V20, P1, DOI 10.2307/2137629; Singh S., 2014, ADDING IT COSTS BENE; United Nations Department of Economic and Social Affairs (DESA), 2015, WORLD POP PROSP 2015; Westoff CF, 2013, POPUL DEV REV, V38, P169, DOI 10.1111/j.1728-4457.2013.00558.x; Wexler A., 2015, DONOR GOVT ASSISTANC	10	60	60	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					409	412		10.1038/530409a	http://dx.doi.org/10.1038/530409a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DE5RW	26911766	Bronze			2022-12-28	WOS:000370690800016
J	Prescott, HM				Prescott, Heather M.			"An Uncommonly Silly Law" - Contraception and Disparities in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Prescott, Heather M.] Cent Connecticut State Univ, Dept Hist, New Britain, CT 06050 USA	Connecticut State University System; Central Connecticut State University	Prescott, HM (corresponding author), Cent Connecticut State Univ, Dept Hist, New Britain, CT 06050 USA.							BUXTON C L, 1964, Conn Med, V28, P581; CURRAN WJ, 1965, NEW ENGL J MED, V273, P322, DOI 10.1056/NEJM196508052730609; Tone A., 2001, DEVICES DESIRES HIST	3	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					706	708		10.1056/NEJMp1508816	http://dx.doi.org/10.1056/NEJMp1508816			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE6BB	26933846				2022-12-28	WOS:000370716600003
J	Edwards, KM; Maldonado, Y; Byington, CL; Jefferson, T; Demicheli, V				Edwards, Kathryn M.; Maldonado, Yvonne; Byington, Carrie L.; Jefferson, Tom; Demicheli, Vittorio			Is the timing of recommended childhood vaccines evidence based?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EFFICACY; SAFETY		[Edwards, Kathryn M.; Maldonado, Yvonne; Byington, Carrie L.] Amer Acad Pediat Comm Infect Dis, New York, NY 10010 USA; [Jefferson, Tom] Ctr Evidence Based Med, Oxford OX2 6GG, England; [Demicheli, Vittorio] Cochrane Acute Resp Infect Grp, Rome, Italy	University of Oxford	Byington, CL (corresponding author), Amer Acad Pediat Comm Infect Dis, New York, NY 10010 USA.; Jefferson, T (corresponding author), Ctr Evidence Based Med, Oxford OX2 6GG, England.	carrie.byington@hsc.utah.edu; jefferson.tom@gmail.com						Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Centers for Disease Control and Prevention. New Vaccine Surveillance Network (NSVN), 2013, NEW VACC SURV NETW N; Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, 2013, CHILDH IMM SCHED SAF; Doshi P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5966; European Medicine Agency, BEXS SUMM PROD CHAR; Institute of Medicine, 2013, CHILDH IMM SCHED SAF; Marshall V, 2011, PEDIATRICS, V127, pS23, DOI 10.1542/peds.2010-1722E; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Watt J, 2012, HAEMOPHILUS INFLUENZ; World Health Organization, 2015, IMM VACC BIOL	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2016	352								i867	10.1136/bmj.i867	http://dx.doi.org/10.1136/bmj.i867			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1QU	26907183				2022-12-28	WOS:000371115100003
J	Schmalz, HG				Schmalz, Hans-Guenther			CHEMISTRY A molecular shuttle for hydrogen cyanide	SCIENCE			English	Editorial Material							HYDROCYANATION		[Schmalz, Hans-Guenther] Univ Cologne, Dept Chem, D-50939 Cologne, Germany	University of Cologne	Schmalz, HG (corresponding author), Univ Cologne, Dept Chem, D-50939 Cologne, Germany.	schmalz@uni-koeln.de	Schmalz, Hans-Guenther/S-4940-2016	Schmalz, Hans-Guenther/0000-0003-0489-1827				Bini L, 2010, CHEMCATCHEM, V2, P590, DOI 10.1002/cctc.201000034; Falk A, 2013, ANGEW CHEM INT EDIT, V52, P1576, DOI 10.1002/anie.201208082; Fang XJ, 2016, SCIENCE, V351, P832, DOI 10.1126/science.aae0427; Murphy SK, 2015, SCIENCE, V347, P56, DOI 10.1126/science.1261232; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Wang D, 2015, CHEM REV, V115, P6621, DOI 10.1021/acs.chemrev.5b00203	6	7	7	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					817	817		10.1126/science.aaf2215	http://dx.doi.org/10.1126/science.aaf2215			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912881				2022-12-28	WOS:000370325700025
J	Ballandras-Colas, A; Browne, M; Cook, NJ; Dewdney, TG; Domeler, B; Cherepanov, P; Lyumkis, D; Engelman, AN				Ballandras-Colas, Allison; Browne, Monica; Cook, Nicola J.; Dewdney, Tamaria G.; Domeler, Barrios; Cherepanov, Peter; Lyumkis, Dmitry; Engelman, Alan N.			Cryo-EM reveals a novel octameric integrase structure for betaretroviral intasome function	NATURE			English	Article							SARCOMA-VIRUS INTEGRASE; VIRAL-DNA ENDS; PHOTO-CROSS-LINKING; DIVISION-OF-LABOR; HIV-1 INTEGRASE; IN-VITRO; MACROMOLECULAR STRUCTURES; RETROVIRAL INTEGRATION; CRYSTAL-STRUCTURE; STRAND TRANSFER	Retroviral integrase catalyses the integration of viral DNA into host target DNA, which is an essential step in the life cycle of all retroviruses(1). Previous structural characterization of integrase-viral DNA complexes, or intasomes, from the spumavirus prototype foamy virus revealed a functional integrase tetramer(2-)5, and it is generally believed that intasomes derived from other retroviral genera use tetrameric integrase(6-9). However, the intasomes of orthoretroviruses, which include all known pathogenic species, have not been characterized structurally. Here, using single-particle cryo-electron microscopy and X-ray crystallography, we determine an unexpected octameric integrase architecture for the intasome of the betaretrovirus mouse mammary tumour virus. The structure is composed of two core integrase dimers, which interact with the viral DNA ends and structurally mimic the integrase tetramer of prototype foamy virus, and two flanking integrase dimers that engage the core structure via their integrase carboxy-terminal domains. Contrary to the belief that tetrameric integrase components are sufficient to catalyse integration, the flanking integrase dimers were necessary for mouse mammary tumour virus integrase activity. The integrase octamer solves a conundrum for betaretroviruses as well as alpharetroviruses by providing critical carboxy-terminal domains to the intasome core that cannot be provided in cis because of evolutionarily restrictive catalytic core domain-carboxy-terminal domain linker regions. The octameric architecture of the intasome of mouse mammary tumour virus provides new insight into the structural basis of retroviral DNA integration.	[Ballandras-Colas, Allison; Dewdney, Tamaria G.; Engelman, Alan N.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Canc Immunol & Virol, 450 Brookline Ave, Boston, MA 02215 USA; [Ballandras-Colas, Allison; Dewdney, Tamaria G.; Engelman, Alan N.] Harvard Univ, Dept Med, Sch Med, 450 Brookline Ave, Boston, MA 02215 USA; [Browne, Monica; Lyumkis, Dmitry] Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Browne, Monica; Lyumkis, Dmitry] Salk Inst Biol Studies, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Cook, Nicola J.; Cherepanov, Peter] Imperial Canc Res Fund, Clare Hall Labs, Francis Crick Inst, Potters Bar EN6 3LD, Herts, England; [Domeler, Barrios] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Cherepanov, Peter] Univ London Imperial Coll Sci Technol & Med, Div Med, St Marys Campus,Norfolk Pl, London W2 1PG, England	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Salk Institute; Salk Institute; University of Texas System; University of Texas Health San Antonio; Imperial College London	Engelman, AN (corresponding author), Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Canc Immunol & Virol, 450 Brookline Ave, Boston, MA 02215 USA.; Engelman, AN (corresponding author), Harvard Univ, Dept Med, Sch Med, 450 Brookline Ave, Boston, MA 02215 USA.; Lyumkis, D (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Lyumkis, D (corresponding author), Salk Inst Biol Studies, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dlyumkis@salk.edu; alan.engelman@dfci.harvard.edu	Cherepanov, Peter P/F-6859-2010	Cherepanov, Peter P/0000-0002-0634-538X; Demeler, Borries/0000-0002-2414-9518; Ballandras-Colas, Allison/0000-0003-4735-4984	US National Institutes of Health (NIH) [R01 AI070042]; NIH [P50 GM103368, P50 GM082251, P30 AI060354, P41 GM103331]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; US National Science Foundation [NSF-ACI-1339649, TG-MCB070039]; San Antonio Cancer Institute [CA054174]; Cancer Research UK [15272] Funding Source: researchfish; The Francis Crick Institute [10062, 10061] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA054174, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070042, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251, P30GM103331, P50GM103368, P41GM103310] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; US National Science Foundation(National Science Foundation (NSF)); San Antonio Cancer Institute; Cancer Research UK(Cancer Research UK); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from US National Institutes of Health (NIH) grants R01 AI070042 (to A.N.E.), NIH P50 GM103368 and the Leona M. and Harry B. Helmsley Charitable Trust grant number 2012-PG-MED002 (to D.L., both funding sources provided equal support), NIH P50 GM082251 (to P.C.), NIH P30 AI060354 (Harvard University Center for AIDS Research), and US National Science Foundation grants NSF-ACI-1339649 and TG-MCB070039 (to B.D.). B.D. acknowledges support from San Antonio Cancer Institute grant CA054174 for the Center for Analytical Ultracentrifugation of Macromolecular Assemblies at the University of Texas Health Science Center at San Antonio. Molecular graphics and analyses were performed with the USCF Chimera package (supported by NIH P41 GM103331). CryoEM data collection was in part facilitated by the National Resource for Automated Molecular Microscopy (9 P41 GM103310). We thank B. Anderson and J.-C. Ducom at The Scripps Research Institute for help with EM data collection and network infrastructure, J. Fitzpatrick and F. Dwyer for computational support at The Salk Institute, V. Pye for help with X-ray structure refinement and the staff of BM14 (European Synchrotron Radiation Facility, Grenoble, France) and I03 (Diamond Light Source, Oxfordshire, UK) beamlines for assistance with data collection.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; Ballandras-Colas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076638; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Brookes E.H., 2007, P 9 ANN C GEN EV COM, P361; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; BUJACZ G, 1995, J MOL BIOL, V253, P333, DOI 10.1006/jmbi.1995.0556; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Demeler B., 2014, ULTRASCAN 3 VERSION; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler Borries, 2010, Curr Protoc Protein Sci, VChapter 7, DOI 10.1002/0471140864.ps0713s60; Diamond TL, 2005, J VIROL, V79, P15376, DOI 10.1128/JVI.79.24.15376-15387.2005; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; DiMaio F, 2013, PROTEIN SCI, V22, P865, DOI 10.1002/pro.2267; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Lyumkis D, 2013, J STRUCT BIOL, V184, P417, DOI 10.1016/j.jsb.2013.10.009; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MAJORS JE, 1981, NATURE, V289, P253, DOI 10.1038/289253a0; Maskell DP, 2015, NATURE, V523, P366, DOI 10.1038/nature14495; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROTH MJ, 1989, CELL, V58, P47, DOI 10.1016/0092-8674(89)90401-7; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Serrao E, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0167-3; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wang RYR, 2015, NAT METHODS, V12, P335, DOI [10.1038/nmeth.3287, 10.1038/NMETH.3287]; Yang F, 2001, J VIROL, V75, P9561, DOI 10.1128/JVI.75.20.9561-9570.2001; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463	60	60	60	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					358	+		10.1038/nature16955	http://dx.doi.org/10.1038/nature16955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887496	Green Submitted, Green Accepted			2022-12-28	WOS:000370327100042
J	Snyder, PJ; Bhasin, S; Cunningham, GR; Matsumoto, AM; Stephens-Shields, AJ; Cauley, JA; Gill, TM; Barrett-Connor, E; Swerdloff, RS; Wang, C; Ensrud, KE; Lewis, CE; Farrar, JT; Cella, D; Rosen, RC; Pahor, M; Crandall, JP; Molitch, ME; Cifelli, D; Dougar, D; Fluharty, L; Resnick, SM; Storer, TW; Anton, S; Basaria, S; Diem, SJ; Hou, X; Mohler, ER; Parsons, JK; Wenger, NK; Zeldow, B; Landis, JR; Ellenberg, SS				Snyder, P. J.; Bhasin, S.; Cunningham, G. R.; Matsumoto, A. M.; Stephens-Shields, A. J.; Cauley, J. A.; Gill, T. M.; Barrett-Connor, E.; Swerdloff, R. S.; Wang, C.; Ensrud, K. E.; Lewis, C. E.; Farrar, J. T.; Cella, D.; Rosen, R. C.; Pahor, M.; Crandall, J. P.; Molitch, M. E.; Cifelli, D.; Dougar, D.; Fluharty, L.; Resnick, S. M.; Storer, T. W.; Anton, S.; Basaria, S.; Diem, S. J.; Hou, X.; Mohler, E. R., III; Parsons, J. K.; Wenger, N. K.; Zeldow, B.; Landis, J. R.; Ellenberg, S. S.		Testosterone Trials Investigators	Effects of Testosterone Treatment in Older Men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; PHYSICAL FUNCTION; BODY-COMPOSITION; MUSCLE STRENGTH; THERAPY; RISK; MORTALITY; COGNITION; EVENTS	BACKGROUND Serum testosterone concentrations decrease as men age, but benefits of raising testosterone levels in older men have not been established. METHODS We assigned 790 men 65 years of age or older with a serum testosterone concentration of less than 275 ng per deciliter and symptoms suggesting hypoandrogenism to receive either testosterone gel or placebo gel for 1 year. Each man participated in one or more of three trials - the Sexual Function Trial, the Physical Function Trial, and the Vitality Trial. The primary outcome of each of the individual trials was also evaluated in all participants. RESULTS Testosterone treatment increased serum testosterone levels to the mid-normal range for men 19 to 40 years of age. The increase in testosterone levels was associated with significantly increased sexual activity, as assessed by the Psychosexual Daily Questionnaire (P<0.001), as well as significantly increased sexual desire and erectile function. The percentage of men who had an increase of at least 50 m in the 6-minute walking distance did not differ significantly between the two study groups in the Physical Function Trial but did differ significantly when men in all three trials were included (20.5% of men who received testosterone vs. 12.6% of men who received placebo, P = 0.003). Testosterone had no significant benefit with respect to vitality, as assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue scale, but men who received testosterone reported slightly better mood and lower severity of depressive symptoms than those who received placebo. The rates of adverse events were similar in the two groups. CONCLUSIONS In symptomatic men 65 years of age or older, raising testosterone concentrations for 1 year from moderately low to the mid-normal range for men 19 to 40 years of age had a moderate benefit with respect to sexual function and some benefit with respect to mood and depressive symptoms but no benefit with respect to vitality or walking distance. The number of participants was too few to draw conclusions about the risks of testosterone treatment. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00799617.)	[Snyder, P. J.] Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Stephens-Shields, A. J.; Farrar, J. T.; Hou, X.; Zeldow, B.; Landis, J. R.; Ellenberg, S. S.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Cifelli, D.; Dougar, D.; Fluharty, L.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Mohler, E. R., III] Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc Dis,Sect Vasc Med, Philadelphia, PA 19104 USA; [Bhasin, S.; Storer, T. W.; Basaria, S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Res Program Mens Hlth Aging & Metab, Boston, MA 02115 USA; [Rosen, R. C.] New England Res Inst, Watertown, MA USA; [Cunningham, G. R.] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Cunningham, G. R.] Baylor Coll Med, Dept Mol & Cellular Biol, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Cunningham, G. R.] Baylor St Lukes Med Ctr, Houston, TX USA; [Matsumoto, A. M.] Univ Washington, Sch Med, Dept Vet Affairs VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Matsumoto, A. M.] Univ Washington, Sch Med, Dept Internal Med, Div Gerontol & Geriatr Med, Seattle, WA USA; [Cauley, J. A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Gill, T. M.] Yale Univ, Sch Med, Div Geriatr Med, New Haven, CT USA; [Barrett-Connor, E.] Univ Calif San Diego, Sch Med, Dept Internal Med, La Jolla, CA 92093 USA; [Barrett-Connor, E.] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, Div Epidemiol, La Jolla, CA 92093 USA; [Swerdloff, R. S.; Wang, C.] Harbor UCLA Med Ctr, Div Endocrinol, Torrance, CA 90509 USA; [Swerdloff, R. S.; Wang, C.] Los Angeles Biomed Res Inst, Torrance, CA USA; [Parsons, J. K.] Univ Calif San Diego, Moores Comprehens Canc Ctr, Dept Urol, San Diego, CA 92103 USA; [Ensrud, K. E.; Diem, S. J.] Univ Minnesota, Dept Med, Div Epidemiol & Community Hlth, Box 736 UMHC, Minneapolis, MN 55455 USA; [Ensrud, K. E.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Lewis, C. E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Cella, D.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Molitch, M. E.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Pahor, M.; Anton, S.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Crandall, J. P.] Albert Einstein Coll Med, Div Endocrinol, Bronx, NY 10467 USA; [Crandall, J. P.] Albert Einstein Coll Med, Div Geriatr, Bronx, NY 10467 USA; [Resnick, S. M.] NIA, NIH, Lab Behav Neurosci, Baltimore, MD 21224 USA; [Wenger, N. K.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; HealthCore, Inc; Baylor College of Medicine; Baylor College of Medicine; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; State University System of Florida; University of Florida; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Emory University	Snyder, PJ (corresponding author), Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	pjs@mail.med.upenn.edu	Gill, Thomas M./H-7043-2019; Farrar, John T/AAP-4788-2021; Matsumoto, Alvin/AAH-6096-2020; Cauley, Jane A/N-4836-2015	Gill, Thomas M./0000-0002-6450-0368; Farrar, John T/0000-0001-8656-5157; Cauley, Jane A/0000-0003-0752-4408; Ensrud, Kristine/0000-0002-9069-3036; Basaria, Shehzad/0000-0003-1749-8549; Landis, J Richard/0000-0001-8099-0988	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, P60DK079626, T32DK060455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342, R01AG037679, K24AG021507, K07AG043587, P30AG028740, U01AG030644, P30AG024827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00799617.	Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Cauley JA, 2015, J GERONTOL A-BIOL, V70, P1105, DOI 10.1093/gerona/glv031; Cella D, 2002, J PAIN SYMPTOM MANAG, V24, P547, DOI 10.1016/S0885-3924(02)00529-8; Corona G, 2014, EXPERT OPIN DRUG SAF, V13, P1327, DOI 10.1517/14740338.2014.950653; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; FOLLMANN D, 1995, BIOMETRICS, V51, P151, DOI 10.2307/2533322; Gray PB, 2005, J CLIN ENDOCR METAB, V90, P3838, DOI 10.1210/jc.2005-0247; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee KK, 2003, J ANDROL, V24, P688; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Liverman CT, 2004, TESTOSTERONE AGING C; Muller A, 2007, BJU INT, V100, P117, DOI 10.1111/j.1464-410X.2007.06915.x; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; Rosen RC, 2002, INT J IMPOT RES, V14, P226, DOI 10.1038/sj.ijir.3900857; Sharma R, 2015, EUR HEART J, V36, P2706, DOI 10.1093/eurheartj/ehv346; Snyder PJ, 2014, CLIN TRIALS, V11, P362, DOI 10.1177/1740774514524032; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Srinivas-Shankar U, 2010, J CLIN ENDOCR METAB, V95, P639, DOI 10.1210/jc.2009-1251; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Travison TG, 2011, J GERONTOL A-BIOL, V66, P1090, DOI 10.1093/gerona/glr100; Vaughan C, 2007, J ANDROL, V28, P875, DOI 10.2164/jandrol.107.002931; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Ware JE, 2005, SF 36 PHYS MENTAL HL; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108	34	473	485	2	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					611	624		10.1056/NEJMoa1506119	http://dx.doi.org/10.1056/NEJMoa1506119			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26886521	Green Accepted, Bronze			2022-12-28	WOS:000370229000007
J	Kennard, L; O'Shaughnessy, KM				Kennard, Lucinda; O'Shaughnessy, Kevin M.			PRACTICE POINTER Treating hypertension in patients with medical comorbidities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONVERTING ENZYME-INHIBITORS; CHRONIC KIDNEY-DISEASE; RECEPTOR BLOCKERS; SPIRONOLACTONE; METAANALYSIS		[Kennard, Lucinda; O'Shaughnessy, Kevin M.] Univ Cambridge, Dept Med, Addenbrookes Hosp, Div Expt Med & Immunotherapeut, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	O'Shaughnessy, KM (corresponding author), Univ Cambridge, Dept Med, Addenbrookes Hosp, Div Expt Med & Immunotherapeut, Cambridge CB2 2QQ, England.	kmo22@medschl.cam.ac.uk						Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bejan-Angoulvant T, 2010, J HYPERTENS, V28, P1366, DOI 10.1097/HJH.0b013e328339f9c5; Brilleman SL, 2013, BRIT J GEN PRACT, V63, pE274, DOI 10.3399/bjgp13X665242; Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Gwadry-Sridhar FH, 2013, VALUE HEALTH, V16, P863, DOI 10.1016/j.jval.2013.03.1631; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; KidneyDisease Outcomes Quality Initiative (K/DOQI), 2004, AM J KIDNEY DIS, V43, pS1; KRAUSE T, 2011, BRIT MED J, V343, DOI DOI 10.1136/BMJ.D4891; Lapi F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8525; Lv JC, 2013, CAN MED ASSOC J, V185, P949, DOI 10.1503/cmaj.121468; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; Morales DR, 2014, CHEST, V145, P779, DOI 10.1378/chest.13-1235; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; National Institute for Health and Clinical Excellence, 2010, CHRON HEART FAIL AD; National Institute for Health and Clinical Excellence, 2014, CHRON KIDN DIS AD AS; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB MAN TYP 2; National Institute for Health and Clinical Excellence, 2004, TYP 1 DIAB DIAGN MAN; National Institute for Health and Clinical Excellence, 2014, ATR FIBR MAN; National Institute for Health and Clinical Excellence, 2010, HYP PREGN DIAGN MAN; National Institute for Health and Clinical Excellence, 2011, HYP AD DIAGN MAN; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2; Sciarretta S, 2011, ARCH INTERN MED, V171, P384, DOI 10.1001/archinternmed.2010.427	25	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2016	352								i101	10.1136/bmj.i101	http://dx.doi.org/10.1136/bmj.i101			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EW	26884124				2022-12-28	WOS:000370727500001
J	Whitsett, JA; Morrisey, EE				Whitsett, Jeffrey A.; Morrisey, Edward E.			Modulating pulmonary inflammation	SCIENCE			English	Editorial Material							NEUROENDOCRINE CELLS; NEUROEPITHELIAL BODIES		[Whitsett, Jeffrey A.] Cincinnati Childrens Hosp, Perinatal Inst, Div Neonatol & Pulm Biol, Cincinnati, OH 45229 USA; [Morrisey, Edward E.] Univ Penn, Penn Ctr Pulm Biol, Philadelphia, PA 19104 USA	Cincinnati Children's Hospital Medical Center; University of Pennsylvania	Whitsett, JA (corresponding author), Cincinnati Childrens Hosp, Perinatal Inst, Div Neonatol & Pulm Biol, Cincinnati, OH 45229 USA.; Morrisey, EE (corresponding author), Univ Penn, Penn Ctr Pulm Biol, Philadelphia, PA 19104 USA.	jef.whitsett@cchmc.org; emorrise@upenn.edu						Branchfield K, 2016, SCIENCE, V351, P707, DOI 10.1126/science.aad7969; Chang AJ, 2015, NATURE, V527, P240, DOI 10.1038/nature15721; Cutz E, 2015, SEMIN DIAGN PATHOL, V32, P420, DOI 10.1053/j.semdp.2015.08.001; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Kuo CS, 2015, CELL, V163, P394, DOI 10.1016/j.cell.2015.09.021; Malagoli D, 2017, BIOL REV, V92, P369, DOI 10.1111/brv.12234; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Noguchi M, 2015, CELL REP, V13, P2679, DOI 10.1016/j.celrep.2015.11.058; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Xie WL, 2011, J CLIN INVEST, V121, P3144, DOI 10.1172/JCI41857	12	2	2	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					662	663		10.1126/science.aaf1429	http://dx.doi.org/10.1126/science.aaf1429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912844				2022-12-28	WOS:000369810000020
J	Liu, WY; Tagawa, M; Xin, HLL; Wang, T; Emamy, H; Li, HL; Yager, KG; Starr, FW; Tkachenko, AV; Gang, O				Liu, Wenyan; Tagawa, Miho; Xin, Huolin L.; Wang, Tong; Emamy, Hamed; Li, Huilin; Yager, Kevin G.; Starr, Francis W.; Tkachenko, Alexei V.; Gang, Oleg			Diamond family of nanoparticle superlattices	SCIENCE			English	Article							LIQUID-LIQUID TRANSITION; DNA; CRYSTALS; PARTICLES; SYSTEMS; SHAPES; FLUID	Diamond lattices formed by atomic or colloidal elements exhibit remarkable functional properties. However, building such structures via self-assembly has proven to be challenging because of the low packing fraction, sensitivity to bond orientation, and local heterogeneity. We report a strategy for creating a diamond superlattice of nano-objects via self-assembly and demonstrate its experimental realization by assembling two variant diamond lattices, one with and one without atomic analogs. Our approach relies on the association between anisotropic particles with well-defined tetravalent binding topology and isotropic particles. The constrained packing of triangular binding footprints of truncated tetrahedra on a sphere defines a unique three-dimensional lattice. Hence, the diamond self-assembly problem is solved via its mapping onto two-dimensional triangular packing on the surface of isotropic spherical particles.	[Liu, Wenyan; Xin, Huolin L.; Yager, Kevin G.; Tkachenko, Alexei V.; Gang, Oleg] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Tagawa, Miho] Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan; [Wang, Tong; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Emamy, Hamed; Starr, Francis W.] Wesleyan Univ, Dept Phys, Middletown, CT 06459 USA; [Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Nagoya University; United States Department of Energy (DOE); Brookhaven National Laboratory; Wesleyan University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gang, O (corresponding author), Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA.	ogang@bnl.gov	Xin, Huolin L./E-2747-2010; Tkachenko, Alexei V/I-9040-2012; liu, wen/HGE-3071-2022; Yager, Kevin G./F-9804-2011; TAGAWA, MIHO/GQZ-6161-2022; Starr, Francis W/C-7703-2012; Emamy, Hamed/AAR-8995-2020	Xin, Huolin L./0000-0002-6521-868X; Tkachenko, Alexei V/0000-0003-1291-243X; Yager, Kevin G./0000-0001-7745-2513; TAGAWA, MIHO/0000-0003-3739-8836; Starr, Francis W/0000-0002-2895-6595; Emamy, Hamed/0000-0002-5078-5569; Li, Huilin/0000-0001-8085-8928	U.S. Department of Energy, Office of Basic Energy Sciences [DE-SC0012704]; National Institutes of Health [AG029979]; National Institute of Standards and Technology [70NANB13H202]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029979] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research carried out at the Center for Functional Nanomaterials, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Basic Energy Sciences (contract DE-SC0012704). H. L. was supported by a National Institutes of Health R01 grant (AG029979). F. W. S. was supported by National Institute of Standards and Technology award 70NANB13H202. We thank K. Kisslinger for help with sample preparation for TEM and J. Neitzel for the contribution to the simulation work.	Capone B, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.238301; Casey MT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2206; Chi C, 2012, ACS NANO, V6, P6793, DOI 10.1021/nn301528h; Dai W, 2010, LANGMUIR, V26, P3601, DOI 10.1021/la903031p; Damasceno PF, 2012, ACS NANO, V6, P609, DOI 10.1021/nn204012y; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Field JE, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126505; Hynninen AP, 2007, NAT MATER, V6, P202, DOI 10.1038/nmat1841; Jain A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031049; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kern N, 2003, J CHEM PHYS, V118, P9882, DOI 10.1063/1.1569473; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Lu F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7912; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Marcotte E, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790634; Nykypanchuk D, 2007, LANGMUIR, V23, P6305, DOI 10.1021/la0637566; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Romano F, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3393777; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Smallenburg F, 2014, NAT PHYS, V10, P653, DOI [10.1038/nphys3030, 10.1038/NPHYS3030]; Starr FW, 2014, SOFT MATTER, V10, P9413, DOI 10.1039/c4sm01835d; THOMAS EL, 1986, MACROMOLECULES, V19, P2197, DOI 10.1021/ma00162a016; Tkachenko AV, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.148303; Vo T, 2015, P NATL ACAD SCI USA, V112, P4982, DOI 10.1073/pnas.1420907112; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; YABLONOVITCH E, 1993, J OPT SOC AM B, V10, P283, DOI 10.1364/JOSAB.10.000283; Yager KG, 2014, J APPL CRYSTALLOGR, V47, P118, DOI 10.1107/S160057671302832X; Zhang C, 2014, ACS NANO, V8, P1130, DOI 10.1021/nn406039p; Zhang ZL, 2005, LANGMUIR, V21, P11547, DOI 10.1021/la0513611; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	30	266	273	17	452	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					582	586		10.1126/science.aad2080	http://dx.doi.org/10.1126/science.aad2080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912698	Green Accepted			2022-12-28	WOS:000369291600035
J	van Vliet, EOG; Nijman, TAJ; Schuit, E; Heida, KY; Opmeer, BC; Kok, M; Gyselaers, W; Porath, MM; Woiski, M; Bax, CJ; Bloemenkamp, KWM; Scheepers, HCJ; Jacquemyn, Y; van Beek, E; Duvekot, JJ; Franssen, MTM; Papatsonis, DN; Kok, JH; van der Post, JAM; Franx, A; Mol, BW; Oudijk, MA				van Vliet, Elvira O. G.; Nijman, Tobias A. J.; Schuit, Ewoud; Heida, Karst Y.; Opmeer, Brent C.; Kok, Marjolein; Gyselaers, Wilfried; Porath, Martina M.; Woiski, Mallory; Bax, Caroline J.; Bloemenkamp, Kitty W. M.; Scheepers, Hubertina C. J.; Jacquemyn, Yves; van Beek, Erik; Duvekot, Johannes J.; Franssen, Maureen T. M.; Papatsonis, Dimitri N.; Kok, Joke H.; van der Post, Joris A. M.; Franx, Arie; Mol, Ben W.; Oudijk, Martijn A.			Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial	LANCET			English	Article							MATERNAL HEMODYNAMICS; TOCOLYTIC TREATMENT; FETAL; LABOR; THERAPY; PREGNANCY; OUTCOMES; FLOW	Background In women with threatened preterm birth, delay of delivery by 48 h allows antenatal corticosteroids to improve neonatal outcomes. For this reason, tocolytics are often administered for 48 h; however, there is no consensus about which drug results in the best maternal and neonatal outcomes. In the APOSTEL III trial we aimed to compare the effectiveness and safety of the calcium-channel blocker nifedipine and the oxytocin inhibitor atosiban in women with threatened preterm birth. Methods We did this multicentre, randomised controlled trial in ten tertiary and nine teaching hospitals in the Netherlands and Belgium. Women with threatened preterm birth (gestational age 25-34 weeks) were randomly assigned (1:1) to either oral nifedipine or intravenous atosiban for 48 h. An independent data manager used a web-based computerised programme to randomly assign women in permuted block sizes of four, with groups stratified by centre. Clinicians, outcome assessors, and women were not masked to treatment group. The primary outcome was a composite of adverse perinatal outcomes, which included perinatal mortality, bronchopulmonary dysplasia, sepsis, intraventricular haemorrhage, periventricular leukomalacia, and necrotising enterocolitis. Analysis was done in all women and babies with follow-up data. The study is registered at the Dutch Clinical Trial Registry, number NTR2947. Findings Between July 6, 2011, and July 7, 2014, we randomly assigned 254 women to nifedipine and 256 to atosiban. Primary outcome data were available for 248 women and 297 babies in the nifedipine group and 255 women and 294 babies in the atosiban group. The primary outcome occurred in 42 babies (14%) in the nifedipine group and in 45 (15%) in the atosiban group (relative risk [RR] 0.91, 95% CI 0.61-1.37). 16 (5%) babies died in the nifedipine group and seven (2%) died in the atosiban group (RR 2.20, 95% CI 0.91-5.33); all deaths were deemed unlikely to be related to the study drug. Maternal adverse events did not differ between groups. Interpretation In women with threatened preterm birth, 48 h of tocolysis with nifedipine or atosiban results in similar perinatal outcomes. Future clinical research should focus on large placebo-controlled trials, powered for perinatal outcomes.	[van Vliet, Elvira O. G.; Nijman, Tobias A. J.; Heida, Karst Y.; Bloemenkamp, Kitty W. M.; Franx, Arie; Oudijk, Martijn A.] Univ Med Ctr Utrecht, Dept Obstet, Wilhelmina Hosp, Birth Ctr,Div Woman & Baby, Utrecht, Netherlands; [Schuit, Ewoud] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schuit, Ewoud] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Opmeer, Brent C.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Kok, Marjolein; van der Post, Joris A. M.; Oudijk, Martijn A.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Kok, Joke H.] Univ Amsterdam, Acad Med Ctr, Dept Neonatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Gyselaers, Wilfried] Ziekenhuis Oost Limburg, Dept Obstet & Gynecol, Genk, Belgium; [Gyselaers, Wilfried] Hasselt Univ, Dept Physiol, Diepenbeek, Belgium; [Porath, Martina M.] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [Woiski, Mallory] Univ Med Ctr Nijmegen, Dept Obstet & Gynaecol, Nijmegen, Netherlands; [Bax, Caroline J.] Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Bloemenkamp, Kitty W. M.] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [Scheepers, Hubertina C. J.] Maastricht Univ, Med Ctr, Dept Obstet & Gynecol, NL-6200 MD Maastricht, Netherlands; [Jacquemyn, Yves] Univ Antwerp Hosp, Dept Gynecol & Obstet, Antwerp, Belgium; [van Beek, Erik] St Antonius Hosp, Dept Obstet & Gynaecol, Nieuwegein, Netherlands; [Duvekot, Johannes J.] Erasmus Univ, Med Ctr, Dept Obstet & Gynecol, Rotterdam, Netherlands; [Franssen, Maureen T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet, Groningen, Netherlands; [Papatsonis, Dimitri N.] Amphia Hosp, Dept Obstet & Gynecol, Breda, Netherlands; [Mol, Ben W.] Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Mol, Ben W.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Stanford University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam; East Limburg Hospital; Hasselt University; Maxima Medical Center; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; University of Antwerp; St. Antonius Hospital Utrecht; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Amphia Hospital; Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Oudijk, MA (corresponding author), Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands.	m.a.oudijk@amc.uva.nl	Woiski, Mallory D/L-4763-2015; Woiski, Mallory D/AAN-6632-2021; Oudijk, Martijn A/C-1520-2019; van der Post, Joris A M/A-8991-2008; Franx, Arie/AAA-1739-2021; Schuit, Ewoud/N-1869-2014; jacquemyn, yves/B-7313-2017	Woiski, Mallory D/0000-0002-7553-5929; Woiski, Mallory D/0000-0002-7553-5929; Oudijk, Martijn A/0000-0001-8672-4365; Schuit, Ewoud/0000-0002-9548-3214; van der Post, Joris/0000-0003-3311-2116; jacquemyn, yves/0000-0003-3172-5672; Kok, Marjolein/0000-0001-9420-2313	ZonMw (the Netherlands Organisation for Health Research and Development); ZonMw, the Netherlands Organization for Health Research and Development Healthcare Rational Medicine program [836011005]	ZonMw (the Netherlands Organisation for Health Research and Development)(Netherlands Organization for Health Research and Development); ZonMw, the Netherlands Organization for Health Research and Development Healthcare Rational Medicine program	ZonMw (the Netherlands Organisation for Health Research and Development).r This study was funded by ZonMw, the Netherlands Organization for Health Research and Development Healthcare Rational Medicine program, project number 836011005. We thank the research nurses, midwives, and administrative assistants of our consortium; and the residents, nurses, midwives, and gynaecologists of the participating centres for their help with participant recruitment and data collection. We give special thanks to the members of the data safety monitoring committee J G P Tijssen, F M Helmerhorst, T R de Haan, and J H van der Lee, for monitoring the trial and evaluating the interim analysis. We thank H A A Brouwers, J J H M Erwich, L van Toledo, and A C C Evers for their evaluation of perinatal mortality in our study. We give many thanks to all the women who participated in this study.	Al-Omari WR, 2006, EUR J OBSTET GYN R B, V128, P129, DOI 10.1016/j.ejogrb.2005.12.010; Alfirevic Z, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6531; American College of Obstetricians and Gynecologists, 2012, OBSTET GYNECOL, V119, P1308, DOI DOI 10.1097/AOG.0B013E31825AF2F0; Ananth CV, 2006, J MATERN-FETAL NEO M, V19, P773, DOI 10.1080/14767050600965882; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Berkman ND, 2003, AM J OBSTET GYNECOL, V188, P1648, DOI 10.1067/mob.2003.356; Blea CW, 1997, AM J OBSTET GYNECOL, V176, P922, DOI 10.1016/S0002-9378(97)70622-7; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bolisetty S, 2006, AUST NZ J OBSTET GYN, V46, P189, DOI 10.1111/j.1479-828X.2006.00564.x; De Heus R, 2009, J MATERN-FETAL NEO M, V22, P485, DOI 10.1080/14767050802702349; de Heus R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b744; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Flenady V, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD002255.PUB2; Flenady V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004452.pub3; FURUHASHI N, 1991, GYNECOL OBSTET INVES, V32, P1, DOI 10.1159/000292979; Gates S, 2004, BJOG-INT J OBSTET GY, V111, P213, DOI 10.1111/j.1471-0528.2004.00059.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Guclu S, 2004, ULTRASOUND OBST GYN, V24, P761, DOI 10.1002/uog.1770; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Haas DM, 2009, OBSTET GYNECOL, V113, P585, DOI 10.1097/AOG.0b013e318199924a; Hammers AL, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.1091; HARAKE B, 1987, AM J OBSTET GYNECOL, V157, P1003, DOI 10.1016/S0002-9378(87)80104-7; Hehir MP, 2012, J MATERN-FETAL NEO M, V25, P2234, DOI 10.3109/14767058.2012.684171; HOLBROOK RH, 1987, OBSTET GYNECOL, V69, P83; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kashanian M, 2005, INT J GYNECOL OBSTET, V91, P10, DOI 10.1016/j.ijgo.2005.06.005; Keirse MJNC, 2003, BJOG-INT J OBSTET GY, V110, P94, DOI 10.1016/S1470-0328(03)00051-X; Khan K, 2010, J MATERN-FETAL NEO M, V23, P1030, DOI 10.3109/14767050903572182; MARI G, 1989, AM J OBSTET GYNECOL, V161, P1514, DOI 10.1016/0002-9378(89)90915-0; Ment LR, 2002, NEUROLOGY, V58, P1726, DOI 10.1212/WNL.58.12.1726; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; PIRHONEN JP, 1990, OBSTET GYNECOL, V76, P807, DOI 10.1097/00006250-199011000-00016; Reinebrant HE, 2015, COCHRANE DB SYST REV, V6; Royal College of Obstetricians and Gynaecologists (RCOG), 2011, TOC WOM PRET LAB; Salim R, 2012, OBSTET GYNECOL, V120, P1323, DOI [10.1097/AOG.0b013e3182755dff, http://10.1097/AOG.0b013e3182755dff]; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Treyvaud K, 2014, J PEDIATR-US, V164, P515, DOI 10.1016/j.jpeds.2013.11.001; van Veen AJ, 2005, BJOG-INT J OBSTET GY, V112, P509, DOI 10.1111/j.1471-0528.2004.00480.x; van Vliet EOG, 2014, EXPERT OPIN PHARMACO, V15, P787, DOI 10.1517/14656566.2014.889684; van Vliet EOG, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-93; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE589, DOI 10.1016/S2214-109X(15)00183-7	42	42	48	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2117	2124		10.1016/S0140-6736(16)00548-1	http://dx.doi.org/10.1016/S0140-6736(16)00548-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	26944026				2022-12-28	WOS:000376450800035
J	Awasaki, T; Ito, K				Awasaki, Takeshi; Ito, Kei			NEURODEVELOPMENT Regeneration switch is a gas	NATURE			English	Editorial Material							NUCLEAR RECEPTOR E75; NITRIC-OXIDE; DROSOPHILA; AXON; REGROWTH		[Awasaki, Takeshi] Kyorin Univ, Sch Med, Dept Biol, Mitaka, Tokyo 1818611, Japan; [Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Yayoi, Tokyo 1130032, Japan	Kyorin University; University of Tokyo	Awasaki, T (corresponding author), Kyorin Univ, Sch Med, Dept Biol, Mitaka, Tokyo 1818611, Japan.; Ito, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Yayoi, Tokyo 1130032, Japan.	awasakit@ks.kyorin-u.ac.jp; itokei@iam.u-tokyo.ac.jp	AWASAKI, Takeshi/AAO-7579-2021	AWASAKI, Takeshi/0000-0003-2662-6389				Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Hardingham N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00190; Lee T, 1999, DEVELOPMENT, V126, P4065; Rabinovich D, 2016, CELL, V164, P170, DOI 10.1016/j.cell.2015.11.047; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Riccomagno MM, 2015, ANNU REV CELL DEV BI, V31, P779, DOI 10.1146/annurev-cellbio-100913-013038; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Yaniv SP, 2012, CURR BIOL, V22, P1774, DOI 10.1016/j.cub.2012.07.044; Yu FW, 2014, CURR OPIN NEUROBIOL, V27, P192, DOI 10.1016/j.conb.2014.04.005	14	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					182	183		10.1038/nature17308	http://dx.doi.org/10.1038/nature17308			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26934228				2022-12-28	WOS:000371665100030
J	Wu, J; Albert, LP; Lopes, AP; Restrepo-Coupe, N; Hayek, M; Wiedemann, KT; Guan, KY; Stark, SC; Christoffersen, B; Prohaska, N; Tavares, JV; Marostica, S; Kobayashi, H; Ferreira, ML; Campos, KS; da Silva, R; Brando, PM; Dye, DG; Huxman, TE; Huete, AR; Nelson, BW; Saleska, SR				Wu, Jin; Albert, Loren P.; Lopes, Aline P.; Restrepo-Coupe, Natalia; Hayek, Matthew; Wiedemann, Kenia T.; Guan, Kaiyu; Stark, Scott C.; Christoffersen, Bradley; Prohaska, Neill; Tavares, Julia V.; Marostica, Suelen; Kobayashi, Hideki; Ferreira, Mauricio L.; Campos, Kleber Silva; da Silva, Rodrigo; Brando, Paulo M.; Dye, Dennis G.; Huxman, Travis E.; Huete, Alfredo R.; Nelson, Bruce W.; Saleska, Scott R.			Leaf development and demography explain photosynthetic seasonality in Amazon evergreen forests	SCIENCE			English	Article							DRY; PHENOLOGY; SURFACE	In evergreen tropical forests, the extent, magnitude, and controls on photosynthetic seasonality are poorly resolved and inadequately represented in Earth system models. Combining camera observations with ecosystem carbon dioxide fluxes at forests across rainfall gradients in Amazonia, we show that aggregate canopy phenology, not seasonality of climate drivers, is the primary cause of photosynthetic seasonality in these forests. Specifically, synchronization of new leaf growth with dry season litterfall shifts canopy composition toward younger, more light-use efficient leaves, explaining large seasonal increases (similar to 27%) in ecosystem photosynthesis. Coordinated leaf development and demography thus reconcile seemingly disparate observations at different scales and indicate that accounting for leaf-level phenology is critical for accurately simulating ecosystem-scale responses to climate change.	[Wu, Jin; Albert, Loren P.; Restrepo-Coupe, Natalia; Wiedemann, Kenia T.; Christoffersen, Bradley; Prohaska, Neill; Saleska, Scott R.] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA; [Lopes, Aline P.; Tavares, Julia V.; Marostica, Suelen; Nelson, Bruce W.] Brazils Natl Inst Amazon Res INPA, Manaus, Amazonas, Brazil; [Restrepo-Coupe, Natalia; Huete, Alfredo R.] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Hayek, Matthew; Wiedemann, Kenia T.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Guan, Kaiyu] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61081 USA; [Guan, Kaiyu] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94025 USA; [Stark, Scott C.] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA; [Christoffersen, Bradley] Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA; [Kobayashi, Hideki] Japan Agcy Marine Earth Sci & Technol, Dept Environm Geochem Cycle Res, Yokohama, Kanagawa, Japan; [Ferreira, Mauricio L.] Univ Sao Paulo, Ctr Energia Nucl Agr, Piracicaba, SP, Brazil; [Ferreira, Mauricio L.] Univ Nove Julho, Smart & Intelligent Cities Programme, Sao Paulo, SP, Brazil; [Campos, Kleber Silva; da Silva, Rodrigo] Univ Western UFOPA, Dept Environm Phys, Santarem, Para, Brazil; [Brando, Paulo M.] IPAM, Belem, Para, Brazil; [Brando, Paulo M.] Woods Hole Res Ctr, Falmouth, MA 02450 USA; [Dye, Dennis G.] US Geol Survey, Western Geog Sci Ctr, Flagstaff, AZ 86001 USA; [Huxman, Travis E.] Univ Calif Irvine, Ecol & Evolutionary Biol, Irvine, CA 92629 USA; [Huxman, Travis E.] Univ Calif Irvine, Ctr Environm Biol, Irvine, CA 92629 USA	University of Arizona; Institute Nacional de Pesquisas da Amazonia; University of Technology Sydney; Harvard University; University of Illinois System; University of Illinois Urbana-Champaign; Stanford University; Michigan State University; United States Department of Energy (DOE); Los Alamos National Laboratory; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Universidade de Sao Paulo; Universidade Nove de Julho; Universidade Federal do Oeste do Para; Woods Hole Research Center; United States Department of the Interior; United States Geological Survey; University of California System; University of California Irvine; University of California System; University of California Irvine	Wu, J; Saleska, SR (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.	jinwu@email.arizona.edu; saleska@email.arizona.edu	Nelson, Bruce/G-4562-2013; Kobayashi, Hideki/A-9616-2010; Wu, Jin/P-7389-2019; Ferreira, Maurício Lamano/M-6333-2013; Restrepo-Coupe, Natalia/C-3507-2015; Brando, Paulo/AAC-9396-2019; Albert, Loren/ABI-3168-2020; Guan, Kaiyu/N-5772-2015; Pontes-Lopes, Aline/I-4043-2016; Huete, Alfredo R/C-1294-2008; Hayek, Matthew/GYV-5565-2022; Saleska, Scott R/K-1733-2016; Wu, Jin/H-2582-2017; Brando, Paulo M/C-4302-2012	Nelson, Bruce/0000-0002-0488-6895; Kobayashi, Hideki/0000-0001-9319-0621; Wu, Jin/0000-0001-8991-3970; Ferreira, Maurício Lamano/0000-0002-7647-3635; Restrepo-Coupe, Natalia/0000-0003-3921-1772; Brando, Paulo/0000-0001-8952-7025; Albert, Loren/0000-0002-9674-6071; Guan, Kaiyu/0000-0002-3499-6382; Pontes-Lopes, Aline/0000-0001-7668-1226; Huete, Alfredo R/0000-0003-2809-2376; Saleska, Scott R/0000-0002-4974-3628; Wu, Jin/0000-0001-8991-3970; Brando, Paulo M/0000-0001-8952-7025; Stark, Scott C/0000-0002-1579-1648; Hayek, Matthew/0000-0001-9792-4362	NSF PIRE [0730305]; NASA Terra-Aqua Science program [NNX11AH24G]; Agnese Nelms Haury Program in Environment and Social Justice; GoAmazon project - U.S. Department of Energy (DOE) [DE-SC0008383]; GoAmazon project - Brazilian state science foundations in Sao Paulo state (FAPESP); Amazonas state (FAPEAM); NASA Earth and Space Science fellowship; DOE (BER) NGEE-Tropics projects at Los Alamos National Laboratory; Brazilian Long-term Ecological Research Program (PELD-Brazil); Max Planck Society; INPA; Amazonas State University; Amazonas State Government; German Federal Ministry of Education and Research; Brazilian Ministry of Science Technology and Innovation	NSF PIRE(National Science Foundation (NSF)NSF - Office of the Director (OD)); NASA Terra-Aqua Science program; Agnese Nelms Haury Program in Environment and Social Justice; GoAmazon project - U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); GoAmazon project - Brazilian state science foundations in Sao Paulo state (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Amazonas state (FAPEAM); NASA Earth and Space Science fellowship; DOE (BER) NGEE-Tropics projects at Los Alamos National Laboratory; Brazilian Long-term Ecological Research Program (PELD-Brazil); Max Planck Society(Max Planck SocietyFoundation CELLEX); INPA; Amazonas State University; Amazonas State Government; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Brazilian Ministry of Science Technology and Innovation	Funding was provided by NSF PIRE (no. 0730305), NASA Terra-Aqua Science program (NNX11AH24G), the Agnese Nelms Haury Program in Environment and Social Justice, and the GoAmazon project, funded jointly by U.S. Department of Energy (DOE) (no. DE-SC0008383) and the Brazilian state science foundations in Sao Paulo state (FAPESP), and Amazonas state (FAPEAM). J.W. was supported by a NASA Earth and Space Science fellowship. B.C. was supported in part by DOE (BER) NGEE-Tropics projects at Los Alamos National Laboratory. We thank our GoAmazon co-principal investigators V. Ivanov, M. Ferreira, R. Oliveira, and L. Aragao for discussions, the Brazilian Large Scale Biosphere-Atmosphere experiment in Amazonia (LBA) project and A. Araujo for data from the Brazilian flux tower network, and the LBA office in Santarem for logistical support at the k67 tower site. We thank F. Luizao for sharing the litterfall data at Manaus k34 site, funded by Brazilian Long-term Ecological Research Program (PELD-Brazil). We thank the Max Planck Society, INPA, Amazonas State University, Amazonas State Government, the German Federal Ministry of Education and Research, and the Brazilian Ministry of Science Technology and Innovation for support at the ATTO tower site. Eddy flux data at k67 site are available at http://ameriflux-data.lbl.gov:8080/SitePages/siteInfo.aspx?BR-Sa1. All other data published here are available at http://dx.doi.org/10.5061/dryad.8fb47. J.W., L.P.A., and S.R.S. designed the phenology experiment and analysis. J.W., N.R.C, K.T.W., M.H., K.S.C., B.C., R.d.S., and S.R.S. contributed to the installation, maintenance, or analysis of data of the k67 eddy flux system. J.W., N.P., M.L.F., and P.M.B. contributed to or analyzed ground-based phenology data, and J.W. and S.R.S. developed the leaf demography-ontogeny model. N.R.C. and S.RS. engineered and installed the k67 camera system, and J.W., B.W.N., A.P.L, S.M., and J.V.T. analyzed the camera-based phenology data. L. P. A. collected and analyzed leaf-level gas exchange data with advice from T.E.H. K.G. analyzed MAIAC EVI data. J.W. drafted the manuscript, and S.R.S, L.P.A, T.E.H, S.C.S, B.W.N, N.R.C, K.G., A.R.H., H.K., and D.G.D. contributed to writing the final version. The authors declare no competing financial interests.	Baker IT, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000644; Bi J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/6/064014; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Christoffersen BO, 2014, AGR FOREST METEOROL, V191, P33, DOI 10.1016/j.agrformet.2014.02.008; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Domingues TF, 2014, PLANT ECOL DIVERS, V7, P189, DOI 10.1080/17550874.2012.748849; Doughty C. E., 2008, J GEOPHYS RES, V114; DOUGHTY CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI DOI 10.1029/2007JG000590; Elliott S, 2006, GLOBAL ECOL BIOGEOGR, V15, P248, DOI 10.1111/j.1466-822x.2006.00213.x; Fauset S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7857; Fu R, 2004, THEOR APPL CLIMATOL, V78, P97, DOI 10.1007/s00704-004-0046-7; Fu R, 2016, SPRINGER CLIMATE, P187, DOI 10.1007/978-3-319-21650-8_9; Gu LH, 2003, TASK VEG SC, V39, P467; Guan KY, 2015, NAT GEOSCI, V8, P284, DOI 10.1038/NGEO2382; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Ivanov VY, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011972; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; KIKUZAWA K, 1995, CAN J BOT, V73, P158, DOI 10.1139/b95-019; Kim Y, 2012, GLOBAL CHANGE BIOL, V18, P1322, DOI 10.1111/j.1365-2486.2011.02629.x; Kitajima K, 1997, AM J BOT, V84, P702, DOI 10.2307/2445906; Lee JE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0171; Lieberei R, 2007, ANN BOT-LONDON, V100, P1125, DOI 10.1093/aob/mcm133; Lyapustin AI, 2012, REMOTE SENS ENVIRON, V127, P385, DOI 10.1016/j.rse.2012.09.002; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Restrepo-Coupe N, 2013, AGR FOREST METEOROL, V182, P128, DOI 10.1016/j.agrformet.2013.04.031; Richardson AD, 2009, ECOL APPL, V19, P1417, DOI 10.1890/08-2022.1; Stark SC, 2016, LANDSCAPE ECOL, V31, P181, DOI 10.1007/s10980-015-0282-5; WRIGHT SJ, 1994, AM NAT, V143, P192, DOI 10.1086/285600	28	263	268	22	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					972	976		10.1126/science.aad5068	http://dx.doi.org/10.1126/science.aad5068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917771	Green Published			2022-12-28	WOS:000370821400041
J	Knowlton, WM; Jin, YS				Knowlton, Wendy M.; Jin, Yishi			Ground Control to Major Tom: The Cell Body Signals Axon Degeneration	CELL			English	Editorial Material								Axon degeneration in response to trophic deprivation was thought to be locally restricted to the axon. However, increasing evidence points to a requirement for the cell body in the degenerative program. Now, Simon et al. identify the pro-apoptotic protein Puma as a key factor in this cell body-derived signal.	[Knowlton, Wendy M.; Jin, Yishi] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Jin, Yishi] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Knowlton, WM; Jin, YS (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.; Jin, YS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	wknowlton@ucsd.edu; yijin@ucsd.edu		Jin, Yishi/0000-0002-9371-9860	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; Freeman MR, 2014, CURR OPIN NEUROBIOL, V27, P224, DOI 10.1016/j.conb.2014.05.001; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Ghosh AS, 2011, J CELL BIOL, V194, P751, DOI 10.1083/jcb.201103153; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Simon DJ, 2016, CELL, V164, P1031, DOI 10.1016/j.cell.2016.01.032; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	9	1	1	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					842	844		10.1016/j.cell.2016.02.013	http://dx.doi.org/10.1016/j.cell.2016.02.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919423	Bronze			2022-12-28	WOS:000370867300008
J	[Anonymous]				[Anonymous]			FUTURE GENERATIONS	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					397	397		10.1038/530397a	http://dx.doi.org/10.1038/530397a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911762	Bronze			2022-12-28	WOS:000370690800043
J	Watts, G				Watts, Geoff			Xueqing Yu: a driving force in Chinese nephrology	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					741	741		10.1016/S0140-6736(16)00336-6	http://dx.doi.org/10.1016/S0140-6736(16)00336-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26906657				2022-12-28	WOS:000370418000018
J	Ohta, S; Glancy, D; Chan, WCW				Ohta, Seiichi; Glancy, Dylan; Chan, Warren C. W.			DNA-controlled dynamic colloidal nanoparticle systems for mediating cellular interaction	SCIENCE			English	Article							GOLD NANOPARTICLES; PROTEIN CORONA; IN-VIVO; DELIVERY; SHAPE; SIZE; FUNCTIONALIZATION	Precise control of biosystems requires development of materials that can dynamically change physicochemical properties. Inspired by the ability of proteins to alter their conformation to mediate function, we explored the use of DNA as molecular keys to assemble and transform colloidal nanoparticle systems. The systems consist of a core nanoparticle surrounded by small satellites, the conformation of which can be transformed in response toDNAvia a toe-hold displacementmechanism. The conformational changes can alter the optical properties and biological interactions of the assembled nanosystem. Photoluminescent signal is altered by changes in fluorophore-modified particle distance, whereas cellular targeting efficiency is increased 2.5 times by changing the surface display of targeting ligands. These concepts provide strategies for engineering dynamic nanotechnology systems for navigating complex biological environments.	[Ohta, Seiichi; Glancy, Dylan; Chan, Warren C. W.] Univ Toronto, Inst Biomat & Biomed Engn, Donnelly Ctr Cellular & Biomol Res, 164 Coll St, Toronto, ON M5S 3G9, Canada; [Ohta, Seiichi] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Glancy, Dylan; Chan, Warren C. W.] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada; [Chan, Warren C. W.] Univ Toronto, Dept Chem Engn, 200 Coll St, Toronto, ON M5S 3E5, Canada; [Chan, Warren C. W.] Univ Toronto, Dept Mat Sci & Engn, 160 Coll St,Room 450, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Tokyo; University of Toronto; University of Toronto; University of Toronto	Chan, WCW (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Donnelly Ctr Cellular & Biomol Res, 164 Coll St, Toronto, ON M5S 3G9, Canada.; Chan, WCW (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.; Chan, WCW (corresponding author), Univ Toronto, Dept Chem Engn, 200 Coll St, Toronto, ON M5S 3E5, Canada.; Chan, WCW (corresponding author), Univ Toronto, Dept Mat Sci & Engn, 160 Coll St,Room 450, Toronto, ON M5S 3E1, Canada.	warren.chan@utoronto.ca			Natural Sciences and Engineering Research Council (NSERC) [2014-06397]; Japan Society for the Promotion of Science (JSPS) [5621]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26820356]; NSERC	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	W.C.W.C. acknowledges the Natural Sciences and Engineering Research Council (NSERC) for support (2014-06397), Canadian Institute of Health Research (MOP-130143), and Prostate Cancer Canada (D2014-12). S.O. acknowledges the Japan Society for the Promotion of Science (JSPS) for a Research Fellowship (PD, no. 5621) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for a Grant-in-Aid for Young Scientists (B, no. 26820356). D.G. acknowledges NSERC for a graduate fellowship. The authors thank the Advanced Bioimaging Centre at Mount Sinai Hospital for the use of the TEM and Toronto Nanofabrication Center at University of Toronto for the use of ICP-MS. The authors also thank L. Chou for interesting discussions.	Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Chauhan VP, 2011, ANGEW CHEM INT EDIT, V50, P11417, DOI 10.1002/anie.201104449; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chou LYT, 2014, NAT NANOTECHNOL, V9, P148, DOI [10.1038/NNANO.2013.309, 10.1038/nnano.2013.309]; Chou LYT, 2012, ADV HEALTHC MATER, V1, P714, DOI 10.1002/adhm.201200084; Dai Q, 2014, ANGEW CHEM INT EDIT, V53, P5093, DOI 10.1002/anie.201309464; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Howes PD, 2014, SCIENCE, V346, P53, DOI 10.1126/science.1247390; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Tian Y, 2004, J AM CHEM SOC, V126, P11410, DOI 10.1021/ja046507h; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]; Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q; Wong C, 2011, P NATL ACAD SCI USA, V108, P2426, DOI 10.1073/pnas.1018382108; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b; Xu ZH, 2012, INT J PHARMACEUT, V426, P182, DOI 10.1016/j.ijpharm.2012.01.009; Yoo JW, 2010, P NATL ACAD SCI USA, V107, P11205, DOI 10.1073/pnas.1000346107; Yoon JH, 2012, ACS NANO, V6, P7199, DOI 10.1021/nn302264f; Yu X, 2013, NANO TODAY, V8, P480, DOI 10.1016/j.nantod.2013.09.001; Yun CS, 2005, J AM CHEM SOC, V127, P3115, DOI 10.1021/ja043940i; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957; Zhang X, 2012, J AM CHEM SOC, V134, P7266, DOI 10.1021/ja3014055; Zhang YG, 2015, NAT MATER, V14, P840, DOI [10.1038/NMAT4296, 10.1038/nmat4296]; Zhu JY, 2014, BIOMATERIALS, V35, P7635, DOI 10.1016/j.biomaterials.2014.05.046	28	152	152	18	419	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					841	845		10.1126/science.aad4925	http://dx.doi.org/10.1126/science.aad4925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912892	Green Submitted			2022-12-28	WOS:000370325700040
J	Shi, Y; Chen, X; Elsasser, S; Stocks, BB; Tian, G; Lee, BH; Shi, YH; Zhang, NX; de Poot, SAH; Tuebing, F; Sun, SW; Vannoy, J; Tarasov, SG; Engen, JR; Finley, D; Walters, KJ				Shi, Yuan; Chen, Xiang; Elsasser, Suzanne; Stocks, Bradley B.; Tian, Geng; Lee, Byung-Hoon; Shi, Yanhong; Zhang, Naixia; de Poot, Stefanie A. H.; Tuebing, Fabian; Sun, Shuangwu; Vannoy, Jacob; Tarasov, Sergey G.; Engen, John R.; Finley, Daniel; Walters, Kylie J.			Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome	SCIENCE			English	Article							MULTIUBIQUITIN-CHAIN-BINDING; EXCHANGE MASS-SPECTROMETRY; 26S PROTEASOME; SACCHAROMYCES-CEREVISIAE; UBIQUITIN RECEPTORS; PROTEIN DDI1; H/D EXCHANGE; CYCLIN B1; DEGRADATION; SUBUNIT	Hundreds of pathways for degradation converge at ubiquitin recognition by a proteasome. Here, we found that the five known proteasomal ubiquitin receptors in yeast are collectively nonessential for ubiquitin recognition and identified a sixth receptor, Rpn1. A site (T1) in the Rpn1 toroid recognized ubiquitin and ubiquitin-like (UBL) domains of substrate shuttling factors. T1 structures with monoubiquitin or lysine 48 diubiquitin show three neighboring outer helices engaging two ubiquitins. T1 contributes a distinct substrate-binding pathway with preference for lysine 48-linked chains. Proximal to T1 within the Rpn1 toroid is a second UBL-binding site (T2) that assists in ubiquitin chain disassembly, by binding the UBL of deubiquitinating enzyme Ubp6. Thus, a two-site recognition domain intrinsic to the proteasome uses distinct ubiquitin-fold ligands to assemble substrates, shuttling factors, and a deubiquitinating enzyme.	[Shi, Yuan; Elsasser, Suzanne; Tian, Geng; Lee, Byung-Hoon; de Poot, Stefanie A. H.; Tuebing, Fabian; Sun, Shuangwu; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Chen, Xiang; Shi, Yanhong; Vannoy, Jacob; Walters, Kylie J.] NCI, Prot Proc Sect, Struct Biophys Lab, Ctr Canc Res, Frederick, MD 21702 USA; [Stocks, Bradley B.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Shi, Yanhong; Zhang, Naixia] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, Shanghai 201203, Peoples R China; [Vannoy, Jacob] Linganore High Sch, Frederick, MD 21701 USA; [Tarasov, Sergey G.] NCI, Biophys Resource, Struct Biophys Lab, Ctr Canc Res, Frederick, MD 21702 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northeastern University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Engen, JR; Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.; Walters, KJ (corresponding author), NCI, Prot Proc Sect, Struct Biophys Lab, Ctr Canc Res, Frederick, MD 21702 USA.; Engen, JR (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.	j.engen@neu.edu; daniel_finley@hms.harvard.edu; walters@nih.gov		Lee, Byung-Hoon/0000-0002-7101-0471; Engen, John R./0000-0002-6918-9476; Stocks, Bradley/0000-0002-7265-9344	National Institutes of Health [R37-GM043601, CA136472, R01-GM101135]; NIH, National Cancer Institute, Center for Cancer Research; Waters Corporation; NATIONAL CANCER INSTITUTE [R01CA136472, ZIABC011490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601, R01GM101135, R01GM043601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Waters Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For advice, assistance, or comments on the manuscript, we thank D. Chandler-Militello, M. Gill, J. Hanna, A. Kajava, R. King, Y. Lu, Y. Li, M. Pahre, and J. Roelofs. For gifts of reagents we thank D. Clarke, M. Glickman, F. He, Y. Ye, D. Komander, C. Larsen, J. Li, U. Nowicka, S. Sadis, and W. Tansey. This research was funded by grants from the National Institutes of Health (R37-GM043601 to D. F., CA136472 to K.J.W., and R01-GM101135 to J.R.E.), by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research to K.J.W., and by a research collaboration with the Waters Corporation (J.R.E). Atomic coordinates for the Rpn1 T1 site, Rpn1 T1: ubiquitin, and Rpn1 T1: K48 diubiquitin are available through the Protein Data Bank with accession codes 2n3t, 2n3u, and 2n3v/2n3w, respectively.	Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Chen X, 2012, METHODS MOL BIOL, V832, P279, DOI 10.1007/978-1-61779-474-2_20; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; He J, 2012, STRUCTURE, V20, P513, DOI 10.1016/j.str.2011.12.015; Hui X, 2005, PROTEIN SCI, V14, P543, DOI 10.1110/ps.0411001705; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kajava AV, 2002, J BIOL CHEM, V277, P49791, DOI 10.1074/jbc.M204982200; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Lambertson D, 1999, GENETICS, V153, P69; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu F, 2010, TRENDS BIOCHEM SCI, V35, P352, DOI 10.1016/j.tibs.2010.01.002; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Nowicka U, 2016, PROTEINS, V84, P193, DOI 10.1002/prot.24970; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; Percy AJ, 2012, ANAL CHIM ACTA, V721, P7, DOI 10.1016/j.aca.2012.01.037; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Skinner JJ, 2012, PROTEIN SCI, V21, P987, DOI 10.1002/pro.2082; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Voloshin O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039210; Wales TE, 2006, J MOL BIOL, V357, P1592, DOI 10.1016/j.jmb.2006.01.075; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zhang TP, 2014, MED SCI MONITOR, V20, P2250, DOI 10.12659/MSM.891030	49	171	175	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275							aad9421	10.1126/science.aad9421	http://dx.doi.org/10.1126/science.aad9421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912900	Green Accepted			2022-12-28	WOS:000370325700037
J	Alkama, R; Cescatti, A				Alkama, Ramdane; Cescatti, Alessandro			Biophysical climate impacts of recent changes in global forest cover	SCIENCE			English	Article							TROPICAL DEFORESTATION; LAND; ALBEDO	Changes in forest cover affect the local climate by modulating the land-atmosphere fluxes of energy and water. The magnitude of this biophysical effect is still debated in the scientific community and currently ignored in climate treaties. Here we present an observation-driven assessment of the climate impacts of recent forest losses and gains, based on Earth observations of global forest cover and land surface temperatures. Our results show that forest losses amplify the diurnal temperature variation and increase the mean and maximum air temperature, with the largest signal in arid zones, followed by temperate, tropical, and boreal zones. In the decade 2003-2012, variations of forest cover generated a mean biophysical warming on land corresponding to about 18% of the global biogeochemical signal due to CO2 emission from land-use change.	[Alkama, Ramdane; Cescatti, Alessandro] European Commiss, Inst Environm & Sustainabil, Joint Res Ctr, Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Cescatti, A (corresponding author), European Commiss, Inst Environm & Sustainabil, Joint Res Ctr, Ispra, Italy.	alessandro.cescatti@jrc.ec.europa.eu	Alkama, Ramdane/ABF-9937-2021; Cescatti, Alessandro/ABE-6319-2020	Alkama, Ramdane/0000-0001-9864-2084; 	European Commission [JRC-IES-H07 ClimEcos (995), EU-FP7-LUC4C (603542)]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors gratefully acknowledge G. Duveiller and F. Achard for inspiring discussions and valuable inputs. The authors acknowledge the use of forest cover data from the University of Maryland (http://earthenginepartners.appspot.com/science-2013-global-forest); gridded air surface temperature data TS.3.22 from the Climatic Research Unit, University of East Anglia (http://catalogue.ceda.ac.uk/uuid/3f8944800cc48e1cbc29a5ee12d8542d); and in situ monthly data of air temperature from the Global Historical Climatology Network (GHCN-Monthly, http://www.ncdc.noaa.gov/ghcnm/v3.php) of the National Oceanic and Atmospheric Administration's National Climatic Data Center. The MODIS products LST MYD11C3 and NDVI MYD13C2 were retrieved through the online data pool of the NASA Land Processes Distributed Active Archive Center (https://lpdaac.usgs.gov). The authors are grateful to C. Martinez for the linguistic revision. The work was supported by the European Commission JRC-IES-H07 ClimEcos (995) and EU-FP7-LUC4C (603542). The authors contributed equally to the conception of the work, design of the analysis, development of the methodology, and interpretation of results. R. A. was responsible for the data processing and artwork, and A. C. finalized the writing of the text.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Ban-Weiss GA, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034032; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boysen LR, 2014, EARTH SYST DYNAM, V5, P309, DOI 10.5194/esd-5-309-2014; Brovkin V, 2013, J ADV MODEL EARTH SY, V5, P48, DOI 10.1029/2012MS000169; Carvalhais N, 2014, NATURE, V514, P213, DOI 10.1038/nature13731; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; de Noblet-Ducoudre N, 2012, J CLIMATE, V25, P3261, DOI 10.1175/JCLI-D-11-00338.1; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; LEAN J, 1989, NATURE, V342, P411, DOI 10.1038/342411a0; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Li Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7603; Loranty MM, 2014, GLOBAL CHANGE BIOL, V20, P594, DOI 10.1111/gcb.12391; Luyssaert S, 2014, NAT CLIM CHANGE, V4, P389, DOI [10.1038/nclimate2196, 10.1038/NCLIMATE2196]; Peng SS, 2014, P NATL ACAD SCI USA, V111, P2915, DOI 10.1073/pnas.1315126111; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Snyder PK, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI280.1; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; Teuling AJ, 2010, NAT GEOSCI, V3, P722, DOI 10.1038/NGEO950; Wan ZM, 2014, REMOTE SENS ENVIRON, V140, P36, DOI 10.1016/j.rse.2013.08.027; Zhang M, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034002; Zhao KG, 2014, ECOL MONOGR, V84, P329, DOI 10.1890/12-1705.1	27	372	386	51	489	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					600	604		10.1126/science.aac8083	http://dx.doi.org/10.1126/science.aac8083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912702				2022-12-28	WOS:000369291600040
J	Gabitto, MI; Pakman, A; Bikoff, JB; Abbott, LF; Jessell, TM; Paninski, L				Gabitto, Mariano I.; Pakman, Ari; Bikoff, Jay B.; Abbott, L. F.; Jessell, Thomas M.; Paninski, Liam			Bayesian Sparse Regression Analysis Documents the Diversity of Spinal Inhibitory Interneurons	CELL			English	Article							NEURON POOL IDENTITY; RENSHAW CELLS; EXPRESSION DECONVOLUTION; CLASSIFICATION; SPECIALIZATION; SPECIFICATION; LOCALIZATION; ENGRAILED-1; ABUNDANCE; INSIGHTS	Documenting the extent of cellular diversity is a critical step in defining the functional organization of tissues and organs. To infer cell-type diversity from partial or incomplete transcription factor expression data, we devised a sparse Bayesian framework that is able to handle estimation uncertainty and can incorporate diverse cellular characteristics to optimize experimental design. Focusing on spinal V1 inhibitory interneurons, for which the spatial expression of 19 transcription factors has been mapped, we infer the existence of similar to 50 candidate V1 neuronal types, many of which localize in compact spatial domains in the ventral spinal cord. We have validated the existence of inferred cell types by direct experimental measurement, establishing this Bayesian framework as an effective platform for cell-type characterization in the nervous system and elsewhere.	[Gabitto, Mariano I.; Bikoff, Jay B.; Abbott, L. F.; Jessell, Thomas M.; Paninski, Liam] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Pakman, Ari; Paninski, Liam] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Pakman, Ari; Paninski, Liam] Columbia Univ, Grossman Ctr Stat Mind, New York, NY 10027 USA; [Abbott, L. F.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Gabitto, Mariano I.; Bikoff, Jay B.; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Biochem & Mol Biophys,Zuckerman Mind Brain B, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Gabitto, MI; Paninski, L (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.; Paninski, L (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.; Paninski, L (corresponding author), Columbia Univ, Grossman Ctr Stat Mind, New York, NY 10027 USA.; Gabitto, MI (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Biochem & Mol Biophys,Zuckerman Mind Brain B, New York, NY 10032 USA.	mig2118@columbia.edu; liam@stat.columbia.edu	Pakman, Ari/AAV-7752-2021; Bikoff, Jay/N-8107-2018	Pakman, Ari/0000-0001-8047-2240; 	National Science Foundation through a GRFP fellowship; NIH [NS033245, MH093338]; Harold and Leila Y. Mathers Foundation; Brain Research Foundation; Project A.L.S.; Gatsby Foundation; Swartz Foundation; Mathers Foundation; ONR [N00014-14-1-0243]; ARO MURI grant [W911NF-12-1-0594]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033245, R01NS033245, R01NS080932] Funding Source: NIH RePORTER	National Science Foundation through a GRFP fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Leila Y. Mathers Foundation; Brain Research Foundation; Project A.L.S.; Gatsby Foundation; Swartz Foundation; Mathers Foundation; ONR(Office of Naval Research); ARO MURI grant(MURI); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Lee for sharing advice on qPCR experiments. R. Axel, W. Fischler, A. Miri, D. Gutnisky, and J.C. Tapia provided valuable discussions and comments on the manuscript. C. Zuker suggested validation experiments. We thank A. Karpova and S. Druckman for quantitative insight. M.I.G. was supported by the National Science Foundation through a GRFP fellowship. T.M.J. was supported by NIH grant NS033245, the Harold and Leila Y. Mathers Foundation, the Brain Research Foundation, and Project A.L.S. and is an investigator of the Howard Hughes Medical Institute. L.F.A. was supported by NIH grant MH093338 and by the Gatsby, Swartz, and Mathers Foundations. L.P. and A.P. were supported by ONR grant N00014-14-1-0243 and ARO MURI grant W911NF-12-1-0594.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200; Amamoto R, 2014, SCIENCE, V343, P504, DOI 10.1126/science.1239882; [Anonymous], 2013, TEXTS STAT SCI SERIE; Armananzas R, 2015, TRENDS NEUROSCI, V38, P307, DOI 10.1016/j.tins.2015.02.004; Ascoli GA, 2008, NEUROINFORMATICS, V6, P1, DOI 10.1007/s12021-008-9010-5; Augen J., 2005, BIOINFORMATICS POSTG; Bazot C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-99; Benito-Gonzalez A, 2012, J NEUROSCI, V32, P1156, DOI 10.1523/JNEUROSCI.3630-12.2012; Bikoff JB, 2016, CELL, V165, P207, DOI 10.1016/j.cell.2016.01.027; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dehorter N, 2015, SCIENCE, V349, P1216, DOI 10.1126/science.aab3415; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Erkkila T, 2010, BIOINFORMATICS, V26, P2571, DOI 10.1093/bioinformatics/btq406; FYFFE REW, 1990, BRAIN RES, V536, P301, DOI 10.1016/0006-8993(90)90038-D; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Gaujoux R, 2012, INFECT GENET EVOL, V12, P913, DOI 10.1016/j.meegid.2011.08.014; Gong T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027156; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P613, DOI 10.1113/jphysiol.1971.sp009488; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ishwaran H, 2005, ANN STAT, V33, P730, DOI 10.1214/009053604000001147; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618; Krook-Magnuson E, 2012, TRENDS NEUROSCI, V35, P175, DOI 10.1016/j.tins.2011.10.005; Liebner DA, 2014, BIOINFORMATICS, V30, P682, DOI 10.1093/bioinformatics/btt566; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Molyneaux B. J., 2007, NOVART FDN SYMP, V288, P96; Molyneaux B. J., 2007, NOVART FDN SYMP, V288, P15; Molyneaux Bradley J, 2007, Novartis Found Symp, V288, P3; Pakman A., 2013, ADV NEURAL INFORM PR, V26, P2490; Pakman A, 2014, J COMPUT GRAPH STAT, V23, P518, DOI 10.1080/10618600.2013.788448; Philippidou P, 2015, NEURON, V88, P437, DOI 10.1016/j.neuron.2015.10.035; RENSHAW B, 1946, J NEUROPHYSIOL, V9, P191, DOI 10.1152/jn.1946.9.3.191; Repsilber D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-27; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Shen Y, 2015, BIOINFORMATICS, V31, P1745, DOI 10.1093/bioinformatics/btv031; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; THOMAS RC, 1965, NATURE, V206, P211, DOI 10.1038/206211b0; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013; Zhong Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-89; Zuk O, 2013, LECT NOTES COMPUT SC, V8214, P279, DOI 10.1007/978-3-319-02432-5_31	59	42	42	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					220	233		10.1016/j.cell.2016.01.026	http://dx.doi.org/10.1016/j.cell.2016.01.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	26949187	Green Accepted, Bronze			2022-12-28	WOS:000372785600022
J	Bailey, P; Chang, DK; Nones, K; Johns, AL; Patch, AM; Gingras, MC; Miller, DK; Christ, AN; Bruxner, TJC; Quinn, MC; Nourse, C; Murtaugh, LC; Harliwong, I; Idrisoglu, S; Manning, S; Nourbakhsh, E; Wani, S; Fink, L; Holmes, O; Chin, V; Anderson, MJ; Kazakoff, S; Leonard, C; Newell, F; Waddell, N; Wood, S; Xu, QY; Wilson, PJ; Cloonan, N; Kassahn, KS; Taylor, D; Quek, K; Robertson, A; Pantano, L; Mincarelli, L; Sanchez, LN; Evers, L; Wu, JM; Pinese, M; Cowley, MJ; Jones, MD; Colvin, EK; Nagrial, AM; Humphrey, ES; Chantrill, LA; Mawson, A; Humphris, J; Chou, A; Pajic, M; Scarlett, CJ; Pinho, AV; Giry-Laterriere, M; Rooman, I; Samra, JS; Kench, JG; Lovell, JA; Merrett, ND; Toon, CW; Epari, K; Nguyen, NQ; Barbour, A; Zeps, N; Moran-Jones, K; Jamieson, NB; Graham, JS; Duthie, F; Oien, K; Hair, J; Grutzmann, R; Maitra, A; Iacobuzio-Donahue, CA; Wolfgang, CL; Morgan, RA; Lawlor, RT; Corbo, V; Bassi, C; Rusev, B; Capelli, P; Salvia, R; Tortora, G; Mukhopadhyay, D; Petersen, GM; Munzy, DM; Fisher, WE; Karim, SA; Eshleman, JR; Hruban, RH; Pilarsky, C; Morton, JR; Sansom, OJ; Scarpa, A; Musgrove, EA; Bailey, UMH; Hofmann, O; Sutherland, RL; Wheeler, DA; Gill, AJ; Gibbs, RA; Pearson, JV; Waddell, N; Biankin, AV; Grimmond, SM				Bailey, Peter; Chang, David K.; Nones, Katia; Johns, Amber L.; Patch, Ann-Marie; Gingras, Marie-Claude; Miller, David K.; Christ, Angelika N.; Bruxner, Tim J. C.; Quinn, Michael C.; Nourse, Craig; Murtaugh, L. Charles; Harliwong, Ivon; Idrisoglu, Senel; Manning, Suzanne; Nourbakhsh, Ehsan; Wani, Shivangi; Fink, Lynn; Holmes, Oliver; Chin, Vencssa; Anderson, Matthew J.; Kazakoff, Stephen; Leonard, Conrad; Newell, Felicity; Waddell, Nick; Wood, Scott; Xu, Qinying; Wilson, Peter J.; Cloonan, Nicole; Kassahn, Karin S.; Taylor, Darrin; Quek, Kelly; Robertson, Alan; Pantano, Lorena; Mincarelli, Laura; Sanchez, Luis N.; Evers, Lisa; Wu, Jianmin; Pinese, Mark; Cowley, Mark J.; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chantrill, Lorraine A.; Mawson, Amanda; Humphris, Jeremy; Chou, Angela; Pajic, Marina; Scarlett, Christopher J.; Pinho, Andreia V.; Giry-Laterriere, Marc; Rooman, Ilse; Samra, Jaswinder S.; Kench, James G.; Lovell, Jessica A.; Merrett, Neil D.; Toon, Christopher W.; Epari, Krishna; Nguyen, Nam Q.; Barbour, Andrew; Zeps, Nikolajs; Moran-Jones, Kim; Jamieson, Nigel B.; Graham, Janet S.; Duthie, Fraser; Oien, Karin; Hair, Jane; Gruetzmann, Robert; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Wolfgang, Christopher L.; Morgan, Richard A.; Lawlor, Rita T.; Corbo, Vincenzo; Bassi, Claudio; Rusev, Borislav; Capelli, Paola; Salvia, Roberto; Tortora, Giampaolo; Mukhopadhyay, Debabrata; Petersen, Gloria M.; Munzy, Donna M.; Fisher, William E.; Karim, Saadia A.; Eshleman, James R.; Hruban, Ralph H.; Pilarsky, Christian; Morton, Jennifer R.; Sansom, Owen J.; Scarpa, Aldo; Musgrove, Elizabeth A.; Bailey, Ulla-Maja Hagbo; Hofmann, Oliver; Sutherland, Robert L.; Wheeler, David A.; Gill, Anthony J.; Gibbs, Richard A.; Pearson, John V.; Waddell, Nicola; Biankin, Andrew V.; Grimmond, Sean M.		Australian Pancreatic Canc Genome	Genomic analyses identify molecular subtypes of pancreatic cancer	NATURE			English	Article							DUCTAL ADENOCARCINOMA; MUTATIONS; PACKAGE; TUMOR; DIFFERENTIATION; METASTASIS; PATHWAYS	Integrated genomic analysis of 456 pancreatic ductal adenocarcinomas identified 32 recurrently mutated genes that aggregate into 10 pathways: KRAS, TGF-beta, WNT, NOTCH, ROBO/SLIT signalling, G1/S transition, SWI-SNF, chromatin modification, DNA repair and RNA processing. Expression analysis defined 4 subtypes: (1) squamous; (2) pancreatic progenitor; (3) immunogenic; and (4) aberrantly differentiated endocrine exocrine (ADEX) that correlate with histopathological characteristics. Squamous tumours are enriched for TP53 and KDM6A mutations, upregulation of the TP63 Delta N transcriptional network, hypermethylation of pancreatic endodermal cell-fate determining genes and have a poor prognosis. Pancreatic progenitor tumours preferentially express genes involved in early pancreatic development (FOXA2/3, PDX1 and MNX1). ADEX tumours displayed upregulation of genes that regulate networks involved in KRAS activation, exocrine (NR5A2 and RBPJL), and endocrine differentiation (NEUROD1 and NKX2-2). Immunogenic tumours contained upregulated immune networks including pathways involved in acquired immune suppression. These data infer differences in the molecular evolution of pancreatic cancer subtypes and identify opportunities for therapeutic development.	[Bailey, Peter; Nones, Katia; Patch, Ann-Marie; Miller, David K.; Christ, Angelika N.; Bruxner, Tim J. C.; Quinn, Michael C.; Nourse, Craig; Harliwong, Ivon; Idrisoglu, Senel; Manning, Suzanne; Nourbakhsh, Ehsan; Wani, Shivangi; Fink, Lynn; Holmes, Oliver; Anderson, Matthew J.; Kazakoff, Stephen; Leonard, Conrad; Newell, Felicity; Waddell, Nick; Wood, Scott; Xu, Qinying; Wilson, Peter J.; Cloonan, Nicole; Kassahn, Karin S.; Taylor, Darrin; Quek, Kelly; Robertson, Alan; Pearson, John V.; Waddell, Nicola; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia; [Bailey, Peter; Chang, David K.; Nourse, Craig; Mincarelli, Laura; Sanchez, Luis N.; Evers, Lisa; Jones, Marc D.; Moran-Jones, Kim; Jamieson, Nigel B.; Graham, Janet S.; Musgrove, Elizabeth A.; Bailey, Ulla-Maja Hagbo; Hofmann, Oliver; Biankin, Andrew V.; Grimmond, Sean M.] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland; [Chang, David K.; Johns, Amber L.; Miller, David K.; Chin, Vencssa; Wu, Jianmin; Pinese, Mark; Cowley, Mark J.; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chantrill, Lorraine A.; Mawson, Amanda; Humphris, Jeremy; Chou, Angela; Pajic, Marina; Scarlett, Christopher J.; Pinho, Andreia V.; Giry-Laterriere, Marc; Rooman, Ilse; Kench, James G.; Lovell, Jessica A.; Toon, Christopher W.; Oien, Karin; Sutherland, Robert L.; Gill, Anthony J.; Biankin, Andrew V.] Kinghorn Canc Ctr, 370 Victoria St, Darlinghurst, NSW 2010, Australia; [Chang, David K.; Johns, Amber L.; Miller, David K.; Chin, Vencssa; Wu, Jianmin; Pinese, Mark; Cowley, Mark J.; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chantrill, Lorraine A.; Mawson, Amanda; Humphris, Jeremy; Chou, Angela; Pajic, Marina; Scarlett, Christopher J.; Pinho, Andreia V.; Giry-Laterriere, Marc; Rooman, Ilse; Kench, James G.; Lovell, Jessica A.; Toon, Christopher W.; Oien, Karin; Sutherland, Robert L.; Gill, Anthony J.; Biankin, Andrew V.] Garvan Inst Med Res, Canc Res Program, 384 Victoria St, Sydney, NSW 2010, Australia; [Chang, David K.; Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Eldridge Rd, Sydney, NSW 2200, Australia; [Chang, David K.; Merrett, Neil D.; Biankin, Andrew V.] Univ New S Wales, Fac Med, South Western Sydney Clin Sch, Liverpool, Merseyside 2170, England; [Nones, Katia; Patch, Ann-Marie; Quinn, Michael C.; Wani, Shivangi; Holmes, Oliver; Kazakoff, Stephen; Leonard, Conrad; Wood, Scott; Xu, Qinying; Cloonan, Nicole; Pearson, John V.; Waddell, Nicola] QIMR Berghofer Med Res Inst, Herston, Qld 4006, Australia; [Gingras, Marie-Claude; Munzy, Donna M.; Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gingras, Marie-Claude; Munzy, Donna M.; Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Michael DeBakey Dept Surg, Houston, TX 77030 USA; [Gingras, Marie-Claude] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Murtaugh, L. Charles] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Kassahn, Karin S.] SA Pathol, Genet & Mol Pathol, Adelaide, SA 5000, Australia; [Kassahn, Karin S.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5000, Australia; [Pantano, Lorena; Hofmann, Oliver] Harvard Univ, TH Chan Sch Publ Hlth, Harvard Chan Bioinformat Core, Boston, MA 02115 USA; [Chantrill, Lorraine A.] Campbelltown Hosp, Macarthur Canc Therapy Ctr, Campbelltown, NSW 2560, Australia; [Chou, Angela] St Vincents Hosp, SydPath, Dept Pathol, Sydney, NSW 2010, Australia; [Pajic, Marina] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW 2258, Australia; [Samra, Jaswinder S.] Royal N Shore Hosp, Dept Surg, Sydney, NSW 2065, Australia; [Samra, Jaswinder S.; Kench, James G.; Gill, Anthony J.] Univ Sydney, Sydney, NSW 2006, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Camperdown, NSW 2050, Australia; [Merrett, Neil D.] Univ Western Sydney, Sch Med, Penrith, NSW 2175, Australia; [Epari, Krishna] Fiona Stanley Hosp, Robin Warren Dr, Murdoch, WA 6150, Australia; [Nguyen, Nam Q.] Royal Adelaide Hosp, Dept Gastroenterol, Adelaide, SA 5000, Australia; [Barbour, Andrew] Princess Alexandra Hosp, Dept Surg, Ipswich Rd, Woollongabba, Qld 4102, Australia; [Zeps, Nikolajs] Univ Western Australia, Sch Surg M507, 35 Stirling Hwy, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] St John God Pathol, 12 Salvado Rd, Subiaco, WA 6008, Australia; [Jamieson, Nigel B.] Univ Glasgow, Glasgow Royal Infirm, Coll Med Vet & Life Sci, Sch Med,Acad Unit Surg, Glasgow G4 OSF, Lanark, Scotland; [Jamieson, Nigel B.; Biankin, Andrew V.] Glasgow Royal Infirm, West Scotland Pancreat Unit, Glasgow G31 2ER, Lanark, Scotland; [Graham, Janet S.] Beatson West Scotland Canc Ctr, Dept Med Oncol, 1053 Great Western Rd, Glasgow G12 0YN, Lanark, Scotland; [Duthie, Fraser; Oien, Karin] Greater Glasgow & Clyde NHS, So Gen Hosp, Dept Pathol, Glasgow G51 4TF, Lanark, Scotland; [Hair, Jane] So Gen Hosp, Dept Pathol, GGC Biorepository, 1345 Govan Rd, Glasgow G51 4TY, Lanark, Scotland; [Gruetzmann, Robert; Pilarsky, Christian] Tech Univ Dresden, Dept Surg, Fetscherstr 74, D-01307 Dresden, Germany; [Maitra, Anirban] UT MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Maitra, Anirban] UT MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, David M Rubenstein Pancreat Canc Res Ctr, New York, NY 10065 USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Wolfgang, Christopher L.; Morgan, Richard A.; Eshleman, James R.; Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [Wolfgang, Christopher L.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA; [Lawlor, Rita T.; Corbo, Vincenzo; Rusev, Borislav; Scarpa, Aldo] Univ & Hosp Trust Verona, ARC Net Appl Res Canc Ctr, I-37134 Verona, Italy; [Lawlor, Rita T.; Capelli, Paola; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37134 Verona, Italy; [Bassi, Claudio; Salvia, Roberto] Univ & Hosp Trust Verona, Pancreas Inst, Dept Surg, I-37134 Verona, Italy; [Tortora, Giampaolo] Univ & Hosp Trust Verona, Ctr Comprehens Canc, Dept Med Oncol, I-37134 Verona, Italy; [Mukhopadhyay, Debabrata; Petersen, Gloria M.] Mayo Clin, Rochester, MN 55905 USA; [Fisher, William E.] Baylor Coll Med, Elkins Pancreas Ctr, One Baylor Plaza,MS226, Houston, TX 77030 USA; [Karim, Saadia A.; Morton, Jennifer R.; Sansom, Owen J.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Sansom, Owen J.] Univ Glasgow, Inst Canc Sci, Glasgow G12 8QQ, Lanark, Scotland; [Grimmond, Sean M.] Univ Melbourne, Melbourne, Vic 3010, Australia; [Gruetzmann, Robert] Univ Klinikum Erlangen, Dept Surg, D-91054 Erlangen, Germany	University of Queensland; University of Glasgow; Garvan Institute of Medical Research; University of Liverpool; QIMR Berghofer Medical Research Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah; SA Pathology; University of Adelaide; Harvard University; Harvard T.H. Chan School of Public Health; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Newcastle; Royal North Shore Hospital; University of Sydney; University of Sydney; University of Sydney; Western Sydney University; Royal Adelaide Hospital; University of Western Australia; St John of God Health Care; University of Glasgow; University of Glasgow; Beatson Oncology Centre; University of Glasgow; University of Glasgow; Technische Universitat Dresden; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins University; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Mayo Clinic; Baylor College of Medicine; Beatson Institute; University of Glasgow; University of Melbourne; University of Erlangen Nuremberg	Grimmond, SM (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia.; Biankin, AV; Grimmond, SM (corresponding author), Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.; Biankin, AV (corresponding author), Kinghorn Canc Ctr, 370 Victoria St, Darlinghurst, NSW 2010, Australia.; Biankin, AV (corresponding author), Garvan Inst Med Res, Canc Res Program, 384 Victoria St, Sydney, NSW 2010, Australia.; Biankin, AV (corresponding author), Bankstown Hosp, Dept Surg, Eldridge Rd, Sydney, NSW 2200, Australia.; Biankin, AV (corresponding author), Univ New S Wales, Fac Med, South Western Sydney Clin Sch, Liverpool, Merseyside 2170, England.; Biankin, AV (corresponding author), Glasgow Royal Infirm, West Scotland Pancreat Unit, Glasgow G31 2ER, Lanark, Scotland.; Grimmond, SM (corresponding author), Univ Melbourne, Melbourne, Vic 3010, Australia.	andrew.biankin@glasgow.ac.uk; sean.grimmond@unimelb.edu.au	Pearson, John V/F-2249-2011; Chantrill, Lorraine/GXF-5117-2022; Salvia, Roberto/J-1773-2018; Cowley, Mark/K-8731-2019; Oien, Karin/AAH-3849-2019; Pearson, John/AAT-4211-2020; Fink, Lynn/C-2031-2008; Waddell, Nicola/H-4929-2015; Morton, Jennifer P/E-1633-2011; Nones, Katia/AAX-6453-2021; Grimmond, Sean M/J-5304-2016; Gill, Anthony J./M-5015-2019; Wheeler, David A/M-9740-2018; Leonard, Conrad/AAD-2587-2020; scarpa, aldo/K-6832-2016; Wolfgang, Christopher/HGD-0863-2022; Tortora, Giampaolo/AAA-1252-2019; Newell, Felicity/AAN-1253-2020; Sánchez, Luis Navarro/H-6671-2019; Cloonan, Nicole/B-5272-2008; Merrett, Neil/H-8033-2019; Patch, Ann-Marie/C-4201-2018; Zeps, Nikolajs/AAF-3186-2021; Gill, Anthony/D-4215-2015; Merrett, Neil/ABB-4342-2021; Corbo, Vincenzo/J-7754-2016; Grimmond, Sean/K-3246-2019; Iacobuzio-Donahue, Christine/ABF-1295-2020; Morton, Jennifer/AAJ-5113-2021; Jamieson, Nigel/X-1071-2019; Wu, Jianmin/G-3629-2010; Hofmann, Oliver/F-1800-2013; Zarnowiecki, Dorota/C-9878-2015	Pearson, John V/0000-0003-0904-4598; Cowley, Mark/0000-0002-9519-5714; Fink, Lynn/0000-0003-2912-6048; Waddell, Nicola/0000-0002-3950-2476; Morton, Jennifer P/0000-0001-5766-9141; Nones, Katia/0000-0003-1925-5196; Grimmond, Sean M/0000-0002-8102-7998; Wheeler, David A/0000-0002-9056-6299; Leonard, Conrad/0000-0002-4131-2065; scarpa, aldo/0000-0003-1678-739X; Sánchez, Luis Navarro/0000-0003-3962-8615; Cloonan, Nicole/0000-0001-7802-6647; Merrett, Neil/0000-0002-8370-0293; Patch, Ann-Marie/0000-0001-6121-4019; Zeps, Nikolajs/0000-0002-6404-6839; Gill, Anthony/0000-0002-9447-1967; Merrett, Neil/0000-0002-8370-0293; Corbo, Vincenzo/0000-0002-6340-8009; Grimmond, Sean/0000-0002-8102-7998; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Morton, Jennifer/0000-0001-5766-9141; Jamieson, Nigel/0000-0002-9552-4725; Jones, Marc/0000-0002-3078-8359; Robertson, Alan/0000-0002-3631-5894; Murphy, Angela/0000-0002-8910-7626; Colvin, Emily/0000-0002-5435-5902; Chin, Venessa/0000-0002-4630-4451; Pinho, Andreia V./0000-0003-0647-4015; SALVIA, Roberto/0000-0002-3514-8473; Daly, Roger/0000-0002-5739-8027; Christophi, Christopher/0000-0002-1349-0884; Pilarsky, Christian/0000-0002-7968-3283; Bailey, Peter/0000-0002-0857-2041; Kench, James Geoffrey/0000-0001-8687-4988; Rooman, Ilse/0000-0001-7264-2246; Brancato, Mary-Anne/0000-0002-5439-4549; Chang, David/0000-0002-4821-3078; Wu, Jianmin/0000-0002-8876-128X; Scarlett, Christopher/0000-0002-4140-7785; Chantrill, Lorraine/0000-0002-5790-0208; Hofmann, Oliver/0000-0002-7738-1513; Nikfarjam, Mehrdad/0000-0003-4866-276X; Chou, Angela/0000-0001-9212-6927; Kassahn, Karin/0000-0002-1662-3355; Spry, Nigel/0000-0001-8659-5065; Bruxner, Timothy/0000-0002-8088-316X; Biankin, Andrew/0000-0002-0362-5597; Pajic, Marina/0000-0002-3871-3829; Christ, Angelika/0000-0002-8680-2367; lawlor, Rita/0000-0003-3160-0634; Pinese, Mark/0000-0001-5078-6687; Zarnowiecki, Dorota/0000-0003-0874-7830; Barbour, Andrew/0000-0002-0991-7662; Sansom, Owen J./0000-0001-9540-3010; Wood, Scott/0000-0003-4543-8850; Gobbo, Stefano/0000-0001-5247-5233	National Health and Medical Research Council of Australia (NHMRC) [631701, 535903, 427601]; Queensland Government (NIRAP); University of Queensland; Australian Government: Department of Innovation, Industry, Science and Research (DIISR); Australian Cancer Research Foundation (ACRF); Cancer Council NSW [SRP06-01, SRP11-01. ICGC]; Cancer Institute NSW [10/ECF/2-26, 06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26]; Garvan Institute of Medical Research; Cancer Research UK Glasgow Centre Program [A18076]; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Wellcome Trust Senior Investigator Award [103721/Z/14/Z]; Cancer Research UK Programme Grant [C29717/A17263, A12481]; Pancreatic Cancer UK; Howat Foundation; University of Glasgow; European Research Council Starting Grant [311301]; Italian Ministry of University and Research (Cancer Genome Project) [FIRB RBAP10AHJB]; Associazione Italiana Ricerca Cancro [12182]; Fondazione Italiana Malattie Pancreas - Ministry of Health [CUP_J33G13000210001]; European Community Grant FP7 Cam-Pac [602783]; MRC [MR/N005813/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER; Academy of Medical Sciences (AMS) [AMS-SGCL9-Jamieson] Funding Source: researchfish; Cancer Research UK [12946, 22533, 11650, 17263] Funding Source: researchfish; Medical Research Council [MR/N005813/1] Funding Source: researchfish; Versus Arthritis [20409, 21139] Funding Source: researchfish; Wellcome Trust [103721/Z/14/Z] Funding Source: researchfish; Pancreatic Cancer UK [RIF2015_A06_Jamieson] Funding Source: researchfish	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government (NIRAP); University of Queensland(University of Queensland); Australian Government: Department of Innovation, Industry, Science and Research (DIISR)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Cancer Research Foundation (ACRF); Cancer Council NSW(Cancer Council New South Wales); Cancer Institute NSW; Garvan Institute of Medical Research; Cancer Research UK Glasgow Centre Program; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Wellcome Trust Senior Investigator Award(Wellcome Trust); Cancer Research UK Programme Grant(Cancer Research UK); Pancreatic Cancer UK; Howat Foundation; University of Glasgow; European Research Council Starting Grant(European Research Council (ERC)); Italian Ministry of University and Research (Cancer Genome Project); Associazione Italiana Ricerca Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Malattie Pancreas - Ministry of Health; European Community Grant FP7 Cam-Pac; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); Pancreatic Cancer UK	We would like to thank C. Axford, M.-A. Brancato, S. Rowe, M. Thomas, S. Simpson and G. Hammond for central coordination of the Australian Pancreatic Cancer Genome Initiative, data management and quality control; M. Martyn-Smith, L. Braatvedt, H. Tang, V. Papangelis and M. Beilin for biospecimen acquisition; and Deborah Gwynne for support at the Queensland Centre for Medical Genomics. We also thank M. Hodgins, M. Debeljak and D. Trusty for technical assistance at Johns Hopkins University. Funding support was from: National Health and Medical Research Council of Australia (NHMRC; 631701, 535903, 427601); Queensland Government (NIRAP); University of Queensland; Australian Government: Department of Innovation, Industry, Science and Research (DIISR); Australian Cancer Research Foundation (ACRF); Cancer Council NSW: (SRP06-01, SRP11-01. ICGC); Cancer Institute NSW: (10/ECF/2-26; 06/ECF/1-24; 09/CDF/2-40; 07/CDF/1-03; 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26,10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26); Garvan Institute of Medical Research; Cancer Research UK Glasgow Centre Program, A18076; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Wellcome Trust Senior Investigator Award 103721/Z/14/Z; Cancer Research UK Programme Grant C29717/A17263; Cancer Research UK Programme Grant A12481; Pancreatic Cancer UK; The Howat Foundation; University of Glasgow; European Research Council Starting Grant, 311301, Italian Ministry of University and Research (Cancer Genome Project FIRB RBAP10AHJB), Associazione Italiana Ricerca Cancro (n. 12182), Fondazione Italiana Malattie Pancreas - Ministry of Health (CUP_J33G13000210001), European Community Grant FP7 Cam-Pac, grant agreement number 602783.	Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Brody JR, 2009, MODERN PATHOL, V22, P651, DOI 10.1038/modpathol.2009.15; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Engelmann D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005699; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0064-8; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Hale MA, 2014, DEVELOPMENT, V141, P3123, DOI 10.1242/dev.109405; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Horn S, 2012, P NATL ACAD SCI USA, V109, P7356, DOI 10.1073/pnas.1203605109; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kuehn H., 2008, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/0471250953.BI0712S22, 10.1002/0471250953.bi0712s22]; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maguire SL, 2015, J PATHOL, V235, P571, DOI 10.1002/path.4483; Miller BW, 2015, EMBO MOL MED, V7, P1063, DOI 10.15252/emmm.201404827; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Nones K, 2014, INT J CANCER, V135, P1110, DOI 10.1002/ijc.28765; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Scott LM, 2013, JNCI-J NATL CANCER I, V105, P1540, DOI 10.1093/jnci/djt257; Shain AH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-624; Tan EH, 2014, ONCOGENE, V33, P3325, DOI 10.1038/onc.2013.287; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; von Figura G, 2014, GUT, V63, P656, DOI 10.1136/gutjnl-2012-304287; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wu GM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r112; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612	50	1865	1920	14	570	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					47	+		10.1038/nature16965	http://dx.doi.org/10.1038/nature16965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26909576				2022-12-28	WOS:000371211900037
J	Nasr, LA; Haydar, AA				Nasr, Layla A.; Haydar, Ali A.			SPOT DIAGNOSIS Back pain after trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nasr, Layla A.; Haydar, Ali A.] Amer Univ, Beirut Med Ctr, Dept Diagnost Radiol, Beirut, Lebanon	American University of Beirut; Beirut Medical Center	Haydar, AA (corresponding author), Amer Univ, Beirut Med Ctr, Dept Diagnost Radiol, Beirut, Lebanon.	ah24@aub.edu.lb						DENIS F, 1984, CLIN ORTHOP RELAT R, P65; Heinzelmann H, 2008, SPINAL DISORDERS FUN, P883; Lee JY, 2005, J ORTHOP SCI, V10, P671, DOI 10.1007/s00776-005-0956-y; Vaccaro AR, 2003, J BONE JOINT SURG AM, V85A, P2456, DOI 10.2106/00004623-200312000-00029	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2016	352								i825	10.1136/bmj.i825	http://dx.doi.org/10.1136/bmj.i825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LO	26941187				2022-12-28	WOS:000371756700001
J	Siu, AL; Bibbins-Domingo, K; Grossman, DC; Baumann, LC; Davidson, KW; Ebell, M; Garcia, FAR; Gillman, M; Herzstein, J; Kemper, AR; Krist, AH; Kurth, AE; Owens, DK; Phillips, WR; Phipps, MG; Pignone, MP				Siu, Albert L.; Bibbins-Domingo, Kirsten; Grossman, David C.; Baumann, Linda Ciofu; Davidson, Karina W.; Ebell, Mark; Garcia, Francisco A. R.; Gillman, Matthew; Herzstein, Jessica; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Owens, Douglas K.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.		USPSTF	Screening for Impaired Visual Acuity in Older Adults US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTRAOCULAR-LENS IMPLANTATION; RANDOMIZED CONTROLLED-TRIAL; EYE CATARACT-SURGERY; MACULAR DEGENERATION; UNITED-STATES; CONTRAST SENSITIVITY; HEALTH-STATUS; PEOPLE; FALLS; RISK	DESCRIPTION Update of the US Preventive Services Task Force (USPSTF) recommendation on screening for impaired visual acuity in older adults. METHODS The USPSTF reviewed the evidence on screening for visual acuity impairment associated with uncorrected refractive error, cataracts, and age-related macular degeneration among adults 65 years or older in the primary care setting; the benefits and harms of screening; the accuracy of screening; and the benefits and harms of treatment of early vision impairment due to uncorrected refractive error, cataracts, and age-related macular degeneration. POPULATION This recommendation applies to asymptomatic adults 65 years or older who do not present to their primary care clinician with vision problems. RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for impaired visual acuity in older adults. (I statement)	[Siu, Albert L.] Mt Sinai Sch Med, New York, NY USA; [Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Baumann, Linda Ciofu] Univ Wisconsin, Madison, WI 53706 USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Ebell, Mark] Univ Georgia, Athens, GA 30602 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Gillman, Matthew] Harvard Univ, Sch Med, Boston, MA USA; [Gillman, Matthew] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] NYU, New York, NY USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ N Carolina, Chapel Hill, NC USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; Columbia University; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Duke University; Virginia Commonwealth University; New York University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Washington; University of Washington Seattle; Brown University; University of North Carolina; University of North Carolina Chapel Hill	Siu, AL (corresponding author), Mt Sinai Sch Med, New York, NY USA.; Siu, AL (corresponding author), James J Peters Vet Affairs Med Ctr, Bronx, NY USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Phillips, William R./V-1065-2017	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Phillips, William R./0000-0003-2802-4349; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	American Academy of Family Physicians, CLIN PREV SERV REC V; [Anonymous], AG 65 YEARS OLD HLTH; [Anonymous], AD VIS 19 40 YEARS A; Centers for Disease Control and Prevention, IMPR NAT VIS HLTH CO; Chew EY, 2009, OPHTHALMOLOGY, V116, P297, DOI 10.1016/j.ophtha.2008.09.019; Chou R, 2016, AHRQ PUBLICATION; Chou R., 2009, AHRQ PUBLICATION; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Eekhof JAH, 2000, FAM PRACT, V17, P329, DOI 10.1093/fampra/17.4.329; Evans JR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000254.pub2; Foss AJE, 2006, AGE AGEING, V35, P66, DOI 10.1093/ageing/afj005; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; Jessa Z, 2012, OPHTHAL PHYSL OPT, V32, P332, DOI 10.1111/j.1475-1313.2012.00919.x; Lord SR, 2002, J AM GERIATR SOC, V50, P1760, DOI 10.1046/j.1532-5415.2002.50502.x; Lum F, 2016, OPHTHALMOLOGY, V123, P928, DOI [10.1016/j.ophtha.2016.01.024, 10.1016/j.ophtha.2015.10.047]; Meads C, 2003, HEALTH TECHNOL ASSES, V7, p[v, 1], DOI [10.3310/hta7090, DOI 10.3310/hta7090]; Moore AA, 1997, AM J MED, V102, P371, DOI 10.1016/S0002-9343(97)00089-2; MURRAY A, 2005, SYSTEMATIC REV SAFET; POWE NR, 1994, ARCH OPHTHALMOL-CHIC, V112, P228, DOI 10.1001/archopht.1994.01090140104032; POWE NR, 1994, ARCH OPHTHALMOL-CHIC, V112, P239, DOI 10.1001/archopht.1994.01090140115033; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3; Smeeth L, 2003, BMJ-BRIT MED J, V327, P1027; Swanson MW, 2009, J AM GERIATR SOC, V57, P486, DOI 10.1111/j.1532-5415.2008.02144.x; Vedula SS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub2; Virgili G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004763.pub2; Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158; Wormald R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002030.pub3; Zhang XZ, 2007, ARCH OPHTHALMOL-CHIC, V125, P411, DOI 10.1001/archopht.125.3.411	31	27	27	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					908	914		10.1001/jama.2016.0763	http://dx.doi.org/10.1001/jama.2016.0763			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934260	Bronze			2022-12-28	WOS:000371077500021
J	van Griethuysen, J; Dubrey, SW				van Griethuysen, Jennifer; Dubrey, Simon W.			SPOT DIAGNOSIS Fever in an intravenous drug user	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[van Griethuysen, Jennifer] Kings Coll Hosp NHS Fdn Trust, London, England; [Dubrey, Simon W.] Hillingdon Hosp NHS Fdn Trust, Uxbridge, Middx, England	King's College Hospital NHS Foundation Trust	van Griethuysen, J (corresponding author), Kings Coll Hosp NHS Fdn Trust, London, England.	Jennifer.vangriethuysen04@alumni.imperial.ac.uk						KUHLMAN JE, 1990, RADIOLOGY, V174, P211, DOI 10.1148/radiology.174.1.2294550; Millaire A, 1997, EUR HEART J, V18, P677; Stawicki Stanislaw P, 2013, Int J Crit Illn Inj Sci, V3, P58, DOI 10.4103/2229-5151.109423	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2016	352								i1137	10.1136/bmj.i1137	http://dx.doi.org/10.1136/bmj.i1137			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LJ	26932979				2022-12-28	WOS:000371756000003
J	Arrigoni, C; Rohaim, A; Shaya, D; Findeisen, F; Stein, RA; Nurva, SR; Mishra, S; Mchaourab, HS; Minor, DL				Arrigoni, Cristina; Rohaim, Ahmed; Shaya, David; Findeisen, Felix; Stein, Richard A.; Nurva, Shailika Reddy; Mishra, Smriti; Mchaourab, Hassane S.; Minor, Daniel L., Jr.			Unfolding of a Temperature-Sensitive Domain Controls Voltage-Gated Channel Activation	CELL			English	Article							C-TERMINAL DOMAIN; PROKARYOTIC SODIUM-CHANNEL; TRPA1 ION-CHANNEL; CRYSTAL-STRUCTURE; COILED-COIL; K+ CHANNEL; PORE; RECEPTOR; INACTIVATION; MECHANISMS	Voltage-gated ion channels (VGICs) are outfitted with diverse cytoplasmic domains that impact function. To examine how such elements may affect VGIC behavior, we addressed how the bacterial voltage-gated sodium channel (BacNa(V)) C-terminal cytoplasmic domain (CTD) affects function. Our studies show that the BacNa(V) CTD exerts a profound influence on gating through a temperature-dependent unfolding transition in a discrete cytoplasmic domain, the neck domain, proximal to the pore. Structural and functional studies establish that the BacNa(V) CTD comprises a bi-partite four-helix bundle that bears an unusual hydrophilic core whose integrity is central to the unfolding mechanism and that couples directly to the channel activation gate. Together, our findings define a general principle for how the widespread four-helix bundle cytoplasmic domain architecture can control VGIC responses, uncover a mechanism underlying the diverse BacNaV voltage dependencies, and demonstrate that a discrete domain can encode the temperature-dependent response of a channel.	[Arrigoni, Cristina; Rohaim, Ahmed; Shaya, David; Findeisen, Felix; Nurva, Shailika Reddy; Minor, Daniel L., Jr.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Minor, Daniel L., Jr.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Stein, Richard A.; Mishra, Smriti; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Rohaim, Ahmed] Cairo Univ, Fac Sci, Dept Biophys, Giza, Egypt	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Vanderbilt University; Egyptian Knowledge Bank (EKB); Cairo University	Minor, DL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.; Minor, DL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.; Minor, DL (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Minor, DL (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA.; Minor, DL (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	daniel.minor@ucsf.edu	Mishra, Smriti/D-4034-2009; Arrigoni, Cristina/AAG-8176-2020	Mishra, Smriti/0000-0002-6765-5007; Arrigoni, Cristina/0000-0003-1917-1750	American Heart Association [U54 GM087519, R01-HL080050, R01-DC007664, U54-GM094625]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, U54GM094625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007664] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Grabe, L. Jan, A. Moroni, and the D.L.M. lab members for manuscript comments. This work was supported by grants U54 GM087519 to H.S.M., R01-HL080050, R01-DC007664, and U54-GM094625 to D.L.M., and to C.A. from the American Heart Association. C.A. is an AHA postdoctoral fellow.	Bagneris C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3465; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Berova N., 2000, CIRCULAR DICHROISM P, DOI DOI 10.1038/natrevmats.2016.21; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Chowdhury S, 2014, CELL, V158, P1148, DOI 10.1016/j.cell.2014.07.026; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; DeCaen PG, 2014, ELIFE, V3, DOI 10.7554/eLife.04387; Fujiwara Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1823; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Irie K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1797; Irie K, 2010, J BIOL CHEM, V285, P3685, DOI 10.1074/jbc.M109.057455; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Mio K, 2010, PROG BIOPHYS MOL BIO, V103, P111, DOI 10.1016/j.pbiomolbio.2010.05.002; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Morais-Cabral JH, 2015, J MOL BIOL, V427, P67, DOI 10.1016/j.jmb.2014.08.008; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Payandeh J, 2015, J MOL BIOL, V427, P3, DOI 10.1016/j.jmb.2014.08.010; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Powl AM, 2010, P NATL ACAD SCI USA, V107, P14064, DOI 10.1073/pnas.1001793107; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Scheuer Todd, 2014, Handb Exp Pharmacol, V221, P269, DOI 10.1007/978-3-642-41588-3_13; Schneider ER, 2014, CURR TOP MEMBR, V74, P113, DOI 10.1016/B978-0-12-800181-3.00005-1; Shaya D, 2014, J MOL BIOL, V426, P467, DOI 10.1016/j.jmb.2013.10.010; Shaya D, 2011, P NATL ACAD SCI USA, V108, P12313, DOI 10.1073/pnas.1106811108; Takeshita K, 2014, NAT STRUCT MOL BIOL, V21, P352, DOI 10.1038/nsmb.2783; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tsai CJ, 2013, J MOL BIOL, V425, P4074, DOI 10.1016/j.jmb.2013.06.036; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Yang HG, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00029; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Yu Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2257; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	52	52	52	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					922	936		10.1016/j.cell.2016.02.001	http://dx.doi.org/10.1016/j.cell.2016.02.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919429	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-28	WOS:000370867300016
J	Brunstrom, M; Carlberg, B				Brunstrom, Mattias; Carlberg, Bo			Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONVERTING-ENZYME-INHIBITION; LEFT-VENTRICULAR DYSFUNCTION; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR MORBIDITY; MICROVASCULAR OUTCOMES; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; RECURRENT STROKE; URINARY ALBUMIN; DOUBLE-BLIND	OBJECTIVE To assess the effect of antihypertensive treatment on mortality and cardiovascular morbidity in people with diabetes mellitus, at different blood pressure levels. DESIGN Systematic review and meta-analyses of randomised controlled trials. DATA SOURCES CENTRAL, Medline, Embase, and BIOSIS were searched using highly sensitive search strategies. When data required according to the protocol were missing but trials were potentially eligible, we contacted researchers, pharmaceutical companies, and authorities. ELIGIBILITY CRITERIA Randomised controlled trials including 100 or more people with diabetes mellitus, treated for 12 months or more, comparing any antihypertensive agent against placebo, two agents against one, or different blood pressure targets. RESULTS 49 trials, including 73 738 participants, were included in the meta-analyses. Most of the participants had type 2 diabetes. If baseline systolic blood pressure was greater than 150 mm Hg, antihypertensive treatment reduced the risk of all cause mortality (relative risk 0.89, 95% confidence interval 0.80 to 0.99), cardiovascular mortality (0.75, 0.57 to 0.99), myocardial infarction (0.74, 0.63 to 0.87), stroke (0.77, 0.65 to 0.91), and end stage renal disease (0.82, 0.71 to 0.94). If baseline systolic blood pressure was 140-150 mm Hg, additional treatment reduced the risk of all cause mortality (0.87, 0.78 to 0.98), myocardial infarction (0.84, 0.76 to 0.93), and heart failure (0.80, 0.66 to 0.97). If baseline systolic blood pressure was less than 140 mm Hg, however, further treatment increased the risk of cardiovascular mortality (1.15, 1.00 to 1.32), with a tendency towards an increased risk of all cause mortality (1.05, 0.95 to 1.16). Metaregression analyses showed a worse treatment effect with lower baseline systolic blood pressures for cardiovascular mortality (1.15, 1.03 to 1.29 for each 10 mm Hg lower systolic blood pressure) and myocardial infarction (1.12, 1.03 to 1.22 for each 10 mm Hg lower systolic blood pressure). Patterns were similar for attained systolic blood pressure. CONCLUSIONS Antihypertensive treatment reduces the risk of mortality and cardiovascular morbidity in people with diabetes mellitus and a systolic blood pressure more than 140 mm Hg. If systolic blood pressure is less than 140 mm Hg, however, further treatment is associated with an increased risk of cardiovascular death, with no observed benefit.	[Brunstrom, Mattias; Carlberg, Bo] Umea Univ, Dept Publ Hlth & Clin Med, Med, SE-90187 Umea, Sweden	Umea University	Brunstrom, M (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Med, SE-90187 Umea, Sweden.	mattias.brunstrom@umu.se	Brunström, Mattias/AAB-2512-2021	Brunström, Mattias/0000-0002-7054-0905	Vasterbotten County Council	Vasterbotten County Council	This study was funded by Vasterbotten County Council. The design and conduct of the study, the interpretation of data, and the writing of the manuscript, was done solely by the authors, independent of the funder.	AMERY A, 1985, LANCET, V1, P1349; [Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; [Anonymous], 1974, JAMA-J AM MED ASSOC, V229, P409; [Anonymous], BMJ; Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Berthet K, 2004, BLOOD PRESSURE, V13, P7, DOI 10.1080/08037050410029605; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Daly CA, 2005, EUR HEART J, V26, P1369, DOI 10.1093/eurheartj/ehi225; de Galan BE, 2009, J AM SOC NEPHROL, V20, P883, DOI 10.1681/ASN.2008070667; Deedwania PC, 2005, AM HEART J, V149, P159, DOI 10.1016/j.ahj.2004.05.056; Deedwania PC, 2011, CIRCULATION, V123, P2776, DOI 10.1161/CIRCULATIONAHA.111.033704; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Estacio RO, 2006, AM J HYPERTENS, V19, P1241, DOI 10.1016/j.amjhyper.2006.05.011; Estacio RO, 2000, DIABETES CARE, V23, pB54; Fogari R, 2002, AM J HYPERTENS, V15, P1042, DOI 10.1016/S0895-7061(02)03017-0; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Gerstein HC, 2000, LANCET, V355, P253; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Higgins J., 2011, COCHRANE HDB SYST RE; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Imai E, 2011, DIABETOLOGIA, V54, P2978, DOI 10.1007/s00125-011-2325-z; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Kowey PR, 2005, CLIN CARDIOL, V28, P136, DOI 10.1002/clc.4960280307; LAFFEL LMB, 1995, AM J MED, V99, P497, DOI 10.1016/S0002-9343(99)80226-5; LANGFORD HG, 1986, PROG CARDIOVASC DIS, V29, P29, DOI 10.1016/0033-0620(86)90033-2; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mancia G, 2010, CIRCULATION, V122, P847, DOI 10.1161/CIRCULATIONAHA.110.960120; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Messerli FH, 2009, J AM COLL CARDIOL, V54, P279, DOI [10.1016/j.jacc.2009.03.053, 10.1016/j.jacc.2009.05.073]; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; O'Hare JP, 2000, DIABETES CARE, V23, P1823, DOI 10.2337/diacare.23.12.1823; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; Rabkin SW, 2013, J HYPERTENS, V31, P975, DOI 10.1097/HJH.0b013e32835e831c; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Ravid M, 1998, ANN INTERN MED, V128, P982, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00004; Reboldi G, 2011, J HYPERTENS, V29, P1253, DOI 10.1097/HJH.0b013e3283469976; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 2011, HYPERTENSION, V58, P776, DOI 10.1161/HYPERTENSIONAHA.111.174474; Ruggenenti P, 2011, J HYPERTENS, V29, P207, DOI 10.1097/HJH.0b013e32834069bd; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Shindler DM, 1996, AM J CARDIOL, V77, P1017, DOI 10.1016/S0002-9149(97)89163-1; Shu W, 2013, AM J HYPERTENS, V26, P630, DOI 10.1093/ajh/hps096; Sipahi I, 2012, STROKE, V43, P432, DOI 10.1161/STROKEAHA.111.636829; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Sundstrom J, 2013, J HYPERTENS, V31, P1603, DOI 10.1097/HJH.0b013e32836123aa; Thomopoulos C, 2015, J HYPERTENS, V33, P1321, DOI 10.1097/HJH.0000000000000614; Thompson AM, 2011, JAMA-J AM MED ASSOC, V305, P913, DOI 10.1001/jama.2011.250; Tillin T, 2011, J HYPERTENS, V29, P1457, DOI 10.1097/HJH.0b013e3283480db9; Trenkwalder P, 2005, BLOOD PRESSURE, V14, P31, DOI 10.1080/08037050510008823; Wagener G, 2007, CALCIUM ANTAGONISTS; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Zanchetti A, 2009, J HYPERTENS, V27, P923, DOI 10.1097/HJH.0b013e32832aa6b5; Zhang YQ, 2011, EUR HEART J, V32, P1500, DOI 10.1093/eurheartj/ehr039; Zhao WH, 2013, DIABETES CARE, V36, P3287, DOI 10.2337/dc13-0189; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	80	238	251	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2016	352								i717	10.1136/bmj.i717	http://dx.doi.org/10.1136/bmj.i717			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1RH	26920333	Green Published, hybrid			2022-12-28	WOS:000371116400002
J	Mei, Y; Monteiro, P; Zhou, Y; Kim, JA; Gao, X; Fu, ZY; Feng, GP				Mei, Yuan; Monteiro, Patricia; Zhou, Yang; Kim, Jin-Ah; Gao, Xian; Fu, Zhanyan; Feng, Guoping			Adult restoration of Shank3 expression rescues selective autistic-like phenotypes	NATURE			English	Article							SPECTRUM DISORDER; RETT-SYNDROME; MUTANT MICE; BEHAVIORS; MUTATIONS; PROTEINS; FAMILY; DYSFUNCTION; DEFECTS; MOUSE	Because autism spectrum disorders are neurodevelopmental disorders and patients typically display symptoms before the age of three(1), one of the key questions in autism research is whether the pathology is reversible in adults. Here we investigate the developmental requirement of Shank(3) in mice, a prominent monogenic autism gene that is estimated to contribute to approximately 1% of all autism spectrum disorder cases(2-6). SHANK3 is a postsynaptic scaffold protein that regulates synaptic development, function and plasticity by orchestrating the assembly of postsynaptic density macromolecular signalling complex(7-9). Disruptions of the Shank3 gene in mouse models have resulted in synaptic defects and autistic-like behaviours including anxiety, social interaction deficits, and repetitive behaviour(10-13). We generated a novel Shank3 conditional knock-in mouse model, and show that re-expression of the Shank3 gene in adult mice led to improvements in synaptic protein composition, spine density and neural function in the striatum. We also provide behavioural evidence that certain behavioural abnormalities including social interaction deficit and repetitive grooming behaviour could be rescued, while anxiety and motor coordination deficit could not be recovered in adulthood. Together, these results reveal the profound effect of post-developmental activation of Shank3 expression on neural function, and demonstrate a certain degree of continued plasticity in the adult diseased brain.	[Mei, Yuan; Monteiro, Patricia; Zhou, Yang; Kim, Jin-Ah; Gao, Xian; Fu, Zhanyan; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA; [Monteiro, Patricia] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed PDBEB, P-3004517 Coimbra, Portugal; [Monteiro, Patricia; Fu, Zhanyan; Feng, Guoping] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Gao, Xian] E China Normal Univ, Sch Psychol & Cognitve Sci, Key Lab Brain Funct Genom,Inst Cognit Neurosci, Minist Educ & Sci & Technol,Commiss Shanghai Muni, Shanghai 200062, Peoples R China	Massachusetts Institute of Technology (MIT); Universidade de Coimbra; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; East China Normal University	Feng, GP (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.; Feng, GP (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	fengg@mit.edu	Feng, Guoping/Y-2827-2019; Monteiro, Patricia/Q-7646-2017	Monteiro, Patricia/0000-0003-3288-4560	'Programa Doutoral em Biologia Experimental e Biomedicina' (CNC, Coimbra, Portugal); National Science Foundation Graduate Fellowship; Integrative Neuronal Systems; Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard; Portuguese Foundation for Science and Technology [SFRH/BD/33894/2009]; Simons Center for the Social Brain at MIT; Nancy Lurie Marks Family Foundation; Shenzhen Overseas Innovation Team Project [KQTD20140630180249366]; China Scholarship Council; Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard; NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation; Poitras Center for Affective Disorders Research at MIT; National Institute of Health [NIMH R01MH097104]; Simons Foundation Autism Research Initiative (SFARI); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097104] Funding Source: NIH RePORTER	'Programa Doutoral em Biologia Experimental e Biomedicina' (CNC, Coimbra, Portugal); National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); Integrative Neuronal Systems; Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Simons Center for the Social Brain at MIT; Nancy Lurie Marks Family Foundation; Shenzhen Overseas Innovation Team Project; China Scholarship Council(China Scholarship Council); Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard; NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation(NARSAD); Poitras Center for Affective Disorders Research at MIT; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative (SFARI); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Dalia, A. Lim, S. Feng, K. Han, W. Stockton, H. Zaniewski and B. Clear for technical support. We thank Q. Zhang for designing the pAAV-hSYN1-EGFP-P2A-EGFPf-WPRE-HGHpA construct. We thank all members of the Feng laboratory for their support and discussions. Y. M. would like to thank T. Littleton, Y. Lin and K. Tye. P. M. would like to thank C. Duarte and the late S. Chaterjee, and acknowledge support from the 'Programa Doutoral em Biologia Experimental e Biomedicina' (CNC, Coimbra, Portugal). This work was funded by the National Science Foundation Graduate Fellowship and Integrative Neuronal Systems to Y. M.; the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard and a doctoral fellowship from the Portuguese Foundation for Science and Technology to P. M. (SFRH/BD/33894/2009). Y. Z. is supported by postdoc fellowships from the Simons Center for the Social Brain at MIT, Nancy Lurie Marks Family Foundation and Shenzhen Overseas Innovation Team Project (no. KQTD20140630180249366). X. G. was supported by the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard and a graduate fellowship from China Scholarship Council. Z. F. is supported by Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard and NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation. Research in the Feng laboratory is supported by the Poitras Center for Affective Disorders Research at MIT, Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard, National Institute of Health (NIMH R01MH097104), Nancy Lurie Marks Family Foundation, Simons Foundation Autism Research Initiative (SFARI) and Simons Center for the Social Brain at MIT.	Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; De Zeeuw CI, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021683; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Poirier Miriam C., 2003, Mutagenesis, V18, P395, DOI 10.1093/mutage/geg005; Rothwell PE, 2014, CELL, V158, P198, DOI 10.1016/j.cell.2014.04.045; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Sheng M, 2000, J CELL SCI, V113, P1851; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tomblin J. B., 2011, AUTISM SPECTRUM DISO, P315, DOI [10.1093/MED/9780195371826.003.0022, DOI 10.1093/MED/9780195371826.003.0022]; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012	29	224	228	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					481	+		10.1038/nature16971	http://dx.doi.org/10.1038/nature16971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26886798	Green Published, Green Accepted			2022-12-28	WOS:000370690800036
J	Nepal, P; Kumar, D				Nepal, Pankaj; Kumar, Devendra			Eggshell Calcifications of the Bladder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nepal, Pankaj; Kumar, Devendra] Al Wakra Hosp, Doha, Qatar	Hamad Medical Corporation	Nepal, P (corresponding author), Al Wakra Hosp, Doha, Qatar.	pankaj-123@live.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					E9	E9		10.1056/NEJMicm1504759	http://dx.doi.org/10.1056/NEJMicm1504759			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6BB	26933870				2022-12-28	WOS:000370716600011
J	Sokol, D				Sokol, Daniel			ETHICS MAN Doctors in danger	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Sokol@12kbw.co.uk						[Anonymous], 2016, WASHINGTON POST; [Anonymous], 2011, CANADIAN        1006; [Anonymous], 2016, ECONOMIST; O'Dowd A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5324; Osler W, 1905, AEQUANIMITAS	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2016	352								i1075	10.1136/bmj.i1075	http://dx.doi.org/10.1136/bmj.i1075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1QU	26908353				2022-12-28	WOS:000371115100015
J	Berger, D				Berger, David			REFUGEE HEALTHCARE When doctors start civil disobedience it's time to take notice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Berger, David] Broome Hosp, Broome, WA 6725, Australia		Berger, D (corresponding author), Broome Hosp, Broome, WA 6725, Australia.							[Anonymous], 2016, LANCET, V387, P620; [Anonymous], 2011, CHAIRMANS STATEMENT; Australian Human Rights Commission, 2014, FORG CHILDR NAT INQ; Australian Medical Association, HLTH CAR AS SEEK REF; Cobain I., 2012, GUARDIAN; Dyer C., 2012, BMJ-BRIT MED J, V345; Gage W., 2011, REPORT BAHA MOUSA IN; Newhouse G, 2015, GUARDIAN; Sanggaran JP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001960; Woodhead M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i930; Woodhead M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3008	11	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2016	352								i996	10.1136/bmj.i996	http://dx.doi.org/10.1136/bmj.i996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6FD	26896255				2022-12-28	WOS:000370728200009
J	Asch, DA; Pauly, MV; Muller, RW				Asch, David A.; Pauly, Mark V.; Muller, Ralph W.			Asymmetric Thinking about Return on Investment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Asch, David A.; Muller, Ralph W.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asch, David A.; Pauly, Mark V.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Asch, DA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.; Asch, DA (corresponding author), Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA.; Asch, DA (corresponding author), Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA.			Asch, David/0000-0002-7970-286X	NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG034546] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))			0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					606	608		10.1056/NEJMp1512297	http://dx.doi.org/10.1056/NEJMp1512297			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD9ER	26886519				2022-12-28	WOS:000370229000005
J	Tavare, AN; Murray, D				Tavare, Aniket N.; Murray, Diane			Central Pontine Myelinolysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tavare, Aniket N.] Royal Free London NHS Fdn Trust, London, England; [Murray, Diane] Whittington Hosp, London N19 5NF, England	University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London	Tavare, AN (corresponding author), Royal Free London NHS Fdn Trust, London, England.	aniket.tavare@gmail.com							0	6	7	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					E8	E8		10.1056/NEJMicm1504134	http://dx.doi.org/10.1056/NEJMicm1504134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26886548				2022-12-28	WOS:000370229000002
J	Li, L; Li, SY; Deng, K; Liu, JL; Vandvik, PO; Zhao, PJ; Zhang, LH; Shen, JT; Bala, MM; Sohani, ZN; Wong, E; Busse, JW; Ebrahim, S; Malaga, G; Rios, LP; Wang, YQ; Chen, QF; Guyatt, GH; Sun, X				Li, Ling; Li, Sheyu; Deng, Ke; Liu, Jiali; Vandvik, Per Olav; Zhao, Pujing; Zhang, Longhao; Shen, Jiantong; Bala, Malgorzata M.; Sohani, Zahra N.; Wong, Evelyn; Busse, Jason W.; Ebrahim, Shanil; Malaga, German; Rios, Lorena P.; Wang, Yingqiang; Chen, Qunfei; Guyatt, Gordon H.; Sun, Xin			Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPROVES GLYCEMIC CONTROL; INITIAL COMBINATION THERAPY; DRUG-NAIVE PATIENTS; PLACEBO-CONTROLLED TRIAL; ADD-ON THERAPY; DOUBLE-BLIND; CARDIOVASCULAR OUTCOMES; JAPANESE PATIENTS; METFORMIN MONOTHERAPY; RENAL IMPAIRMENT	OBJECTIVES To examine the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of heart failure or hospital admission for heart failure in patients with type 2 diabetes. DESIGN Systematic review and meta-analysis of randomised and observational studies. DATA SOURCES Medline, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov searched up to 25 June 2015, and communication with experts. ELIGIBILITY CRITERIA Randomised controlled trials, non-randomised controlled trials, cohort studies, and case-control studies that compared DPP-4 inhibitors against placebo, lifestyle modification, or active antidiabetic drugs in adults with type 2 diabetes, and explicitly reported the outcome of heart failure or hospital admission for heart failure. DATA COLLECTION AND ANALYSIS Teams of paired reviewers independently screened for eligible studies, assessed risk of bias, and extracted data using standardised, pilot tested forms. Data from trials and observational studies were pooled separately; quality of evidence was assessed by the GRADE approach. RESULTS Eligible studies included 43 trials (n= 68 775) and 12 observational studies (nine cohort studies, three nested case-control studies; n= 1 777 358). Pooling of 38 trials reporting heart failure provided low quality evidence for a possible similar risk of heart failure between DPP-4 inhibitor use versus control (42/15 701 v 33/12 591; odds ratio 0.97 (95% confidence interval 0.61 to 1.56); risk difference 2 fewer (19 fewer to 28 more) events per 1000 patients with type 2 diabetes over five years). The observational studies provided effect estimates generally consistent with trial findings, but with very low quality evidence. Pooling of the five trials reporting admission for heart failure provided moderate quality evidence for an increased risk in patients treated with DPP-4 inhibitors versus control (622/18 554 v 552/ 18 474; 1.13 (1.00 to 1.26); 8 more (0 more to 16 more)). The pooling of adjusted estimates from observational studies similarly suggested (with very low quality evidence) a possible increased risk of admission for heart failure (adjusted odds ratio 1.41, 95% confidence interval 0.95 to 2.09) in patients treated with DPP-4 inhibitors (exclusively sitagliptin) versus no use. CONCLUSIONS The relative effect of DPP-4 inhibitors on the risk of heart failure in patients with type 2 diabetes is uncertain, given the relatively short follow-up and low quality of evidence. Both randomised controlled trials and observational studies, however, suggest that these drugs may increase the risk of hospital admission for heart failure in those patients with existing cardiovascular diseases or multiple risk factors for vascular diseases, compared with no use.	[Li, Ling; Liu, Jiali; Zhao, Pujing; Zhang, Longhao; Shen, Jiantong; Sun, Xin] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Sichuan, Peoples R China; [Li, Sheyu] West China Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China; [Deng, Ke] Sichuan Univ, West China Sch Pharm, Chengdu 610064, Peoples R China; [Vandvik, Per Olav] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Vandvik, Per Olav] Innlandet Hosp Trust, Dept Med, Gjovik, Norway; [Bala, Malgorzata M.] Jagiellonian Univ, Coll Med, Dept Hyg & Dietet, Krakow, Poland; [Sohani, Zahra N.; Busse, Jason W.; Ebrahim, Shanil; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Sohani, Zahra N.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Wong, Evelyn] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Busse, Jason W.; Ebrahim, Shanil] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Busse, Jason W.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada; [Ebrahim, Shanil] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ebrahim, Shanil] Hosp Sick Children, Dept Anaesthesia & Pain Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Malaga, German] Univ Peruana Cayetano Heredia, Dept Med, Lima, Peru; [Rios, Lorena P.] Hosp Clin FUSAT, Internal Med Unit, Rancagua, Chile; [Wang, Yingqiang] 363 Hosp, Dept Med Adm, Chengdu, Sichuan, Peoples R China; [Chen, Qunfei] Lanzhou Univ, Hosp 2, Lanzhou 730000, Gansu, Peoples R China; [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada	Sichuan University; Sichuan University; Norwegian Knowledge Centre for Health Services; Innlandet Hospital Trust; Jagiellonian University; Collegium Medicum Jagiellonian University; McMaster University; University of Toronto; University of British Columbia; McMaster University; McMaster University; Stanford University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universidad Peruana Cayetano Heredia; Lanzhou University; McMaster University	Sun, X (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Sichuan, Peoples R China.	sunx26@gmail.com	Busse, Jason/CAH-3696-2022; Li, Sheyu/O-3242-2016	Busse, Jason/0000-0002-0178-8712; Li, Sheyu/0000-0003-0060-0287; Malaga, German/0000-0002-7828-300X; Li, Ling/0000-0001-7689-1856	National Natural Science Foundation of China [71573183, 81400811, 21534008]; "Thousand Youth Talents Plan" of China [D1024002]; "Thousand Youth Talents Plan" of Sichuan Province; Young Investigator Award of Sichuan University [2013SCU04A37]; Canadian Diabetes Association; New Investigator Award from the Canadian Institutes of Health Research; Canadian Chiropractic Research Foundation; MITACS Elevate and Restracomp Postdoctoral Awards	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Thousand Youth Talents Plan" of China; "Thousand Youth Talents Plan" of Sichuan Province; Young Investigator Award of Sichuan University; Canadian Diabetes Association; New Investigator Award from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Chiropractic Research Foundation; MITACS Elevate and Restracomp Postdoctoral Awards	This study was supported by the National Natural Science Foundation of China (grant no 71573183), "Thousand Youth Talents Plan" of China (grant no D1024002) and Sichuan Province, and Young Investigator Award of Sichuan University (grant no. 2013SCU04A37). These funders had no role in the study design, writing of the manuscript, or decision to submit this or future manuscripts for publication. SL is funded by the National Natural Science Foundation of China (grant No 81400811 and 21534008). ZNS is funded by the Canadian Diabetes Association. JWB is funded by a New Investigator Award from the Canadian Institutes of Health Research and Canadian Chiropractic Research Foundation. SE is funded by MITACS Elevate and Restracomp Postdoctoral Awards.	Ahren B, 2014, DIABETES CARE, V37, P2141, DOI 10.2337/dc14-0024; Akl EA, 2012, J CLIN EPIDEMIOL, V65, P262, DOI 10.1016/j.jclinepi.2011.04.015; AstraZeneca, 2000, TREATM EFF SAX COMP; AstraZeneca. Bristol-Myers Squibb, 2000, SAX COMP GLIM ELD TY; AstraZeneca. Bristol-Myers Squibb, 2000, 52 WEEK ADD ON METF; Barnett AH, 2012, CURR MED RES OPIN, V28, P513, DOI 10.1185/03007995.2012.665046; Boehringer Ingelheim Pharmaceuticals, 2000, EFF SAF BI 1356 COMB; Boehringer Ingelheim Pharmaceuticals, 2000, SAF EFF LIN BI 1356; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company, 2000, EFF SAF LIN COMB INS; Bosi E, 2011, DIABETES OBES METAB, V13, P1088, DOI 10.1111/j.1463-1326.2011.01463.x; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Bristol-Myers Squibb, 2000, STUD ASS SAX TREATM; Bristol-Myers Squibb, 2000, SAX TREATM SUBJ TYP; Bristol-Myers Squibb, 2000, PHAS 3 STUD BMS 4771; Bristol-Myers Squibb. AstraZeneca, 2000, SAF EFF SAX PLUS INS; Chen DY, 2015, INT J CARDIOL, V181, P200, DOI 10.1016/j.ijcard.2014.12.029; Clifton P, 2014, CLIN THER, V36, P2072, DOI 10.1016/j.clinthera.2014.10.009; Clinical Trials. gov, WHY SHOULD REG SUBM; DeFronzo RA, 2009, DIABETES CARE, V32, P1649, DOI 10.2337/dc08-1984; Del Prato S, 2014, DIABETES OBES METAB, V16, P1239, DOI 10.1111/dom.12377; Esposito K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005442; Eurich DT, 2014, AM DIAB ASS 74 SCI S; Fadini GP, 2015, EUR HEART J, V36, P2454, DOI 10.1093/eurheartj/ehv301; Ferrannini E, 2009, DIABETES OBES METAB, V11, P157, DOI 10.1111/j.1463-1326.2008.00994.x; Ferreira JCA, 2013, AM J KIDNEY DIS, V61, P579, DOI 10.1053/j.ajkd.2012.11.043; Ferreira JCA, 2013, DIABETES CARE, V36, P1067, DOI 10.2337/dc12-1365; Fonseca V, 2013, J DIABETES COMPLICAT, V27, P177, DOI 10.1016/j.jdiacomp.2012.09.007; Fu AZ, 2015, AM DIAB ASS 75 SCI S; Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6; Garber AJ, 2007, DIABETES OBES METAB, V9, P166, DOI 10.1111/j.1463-1326.2006.00684.x; Gitt AK, 2013, INT J CLIN PRACT, V67, P1005, DOI 10.1111/ijcp.12179; GlaxoSmithKline, 2000, EFF SAF ALB TREATM T; Goke B, 2013, INT J CLIN PRACT, V67, P307, DOI 10.1111/ijcp.12119; Goke B, 2010, INT J CLIN PRACT, V64, P1619, DOI 10.1111/j.1742-1241.2010.02510.x; Goldstein BJ, 2007, DIABETES CARE, V30, P1979, DOI 10.2337/dc07-0627; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Haak T, 2012, DIABETES OBES METAB, V14, P565, DOI 10.1111/j.1463-1326.2012.01590.x; Henry RR, 2014, DIABETES OBES METAB, V16, P223, DOI 10.1111/dom.12194; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hollander P, 2009, J CLIN ENDOCR METAB, V94, P4810, DOI 10.1210/jc.2009-0550; Hollander PL, 2011, DIABETES VASC DIS RE, V8, P125, DOI 10.1177/1479164111404575; International Diabetes Federation, IDF DIABETES ATLAS, V10th; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Iwamoto Y, 2010, ENDOCR J, V57, P383, DOI 10.1507/endocrj.K09E-272; Jadzinsky M, 2009, DIABETES OBES METAB, V11, P611, DOI 10.1111/j.1463-1326.2009.01056.x; Johnson & Johnson Pharmaceutical Research & Development, 2000, EFF SAF TOL STUD CAN; Kannan S, 2016, J DIABETES, V8, P279, DOI 10.1111/1753-0407.12301; Karagiannis T, 2012, BMJ-BRIT MED J, V344, pe1369, DOI DOI 10.1136/BMJ.E1369; Kawalec P, 2014, DIABETES-METAB RES, V30, P269, DOI 10.1002/dmrr.2494; Krum K, 2014, AM DIAB ASS 74 SCI S; Laakso M, 2015, DIABETES CARE, V38, pE15, DOI 10.2337/dc14-1684; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Merck, 2000, STUD INV DRUG SIT TY; Merck, 2000, SIT ADD ON INS STUD; Merck, 2000, MK0431 PIOGL COADM F; Merck, 2000, SAF EFF SIT COMP GLI; Merck, 2000, MEDICINE; Merck, 2000, INV DRUG STUD PAT TY; Merck, 2000, MK0431A COMP STUD PA; Merck, 2000, SIT VERS GLIP PART T; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Monami M, 2014, NUTR METAB CARDIOVAS, V24, P689, DOI 10.1016/j.numecd.2014.01.017; Monami M, 2013, DIABETES OBES METAB, V15, P112, DOI 10.1111/dom.12000; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Nauck MA, 2009, INT J CLIN PRACT, V63, P46, DOI 10.1111/j.1742-1241.2008.01933.x; Nowicki M, 2011, INT J CLIN PRACT, V65, P1230, DOI 10.1111/j.1742-1241.2011.02812.x; Nowicki M, 2011, DIABETES OBES METAB, V13, P523, DOI 10.1111/j.1463-1326.2011.01382.x; Olansky L, 2011, DIABETES OBES METAB, V13, P841, DOI 10.1111/j.1463-1326.2011.01416.x; Patil HR, 2012, AM J CARDIOL, V110, P826, DOI 10.1016/j.amjcard.2012.04.061; Pfutzner A, 2011, DIABETES OBES METAB, V13, P567, DOI 10.1111/j.1463-1326.2011.01385.x; Pratley RE, 2014, DIABETES OBES METAB, V16, P613, DOI 10.1111/dom.12258; Pratley RE, 2009, DIABETES OBES METAB, V11, P167, DOI 10.1111/j.1463-1326.2008.01016.x; Pratley RE, 2009, CURR MED RES OPIN, V25, P2361, DOI 10.1185/03007990903156111; Reasner C, 2011, DIABETES OBES METAB, V13, P644, DOI 10.1111/j.1463-1326.2011.01390.x; Rosenstock J, 2013, DIABETES OBES METAB, V15, P906, DOI 10.1111/dom.12102; Rosenstock J, 2009, CURR MED RES OPIN, V25, P2401, DOI 10.1185/03007990903178735; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; Rosenstock J, 2010, DIABETES CARE, V33, P2406, DOI 10.2337/dc10-0159; Savarese G, 2015, INT J CARDIOL, V181, P239, DOI 10.1016/j.ijcard.2014.12.017; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Seck T, 2010, INT J CLIN PRACT, V64, P562, DOI 10.1111/j.1742-1241.2010.02353.x; Seino Y, 2012, DIABETES OBES METAB, V14, P927, DOI 10.1111/j.1463-1326.2012.01620.x; Seino Y, 2011, CURR MED RES OPIN, V27, P21, DOI 10.1185/03007995.2011.614936; Seong JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124287; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suh S, 2015, DIABETES METAB J, V39, P247, DOI 10.4093/dmj.2015.39.3.247; Takeda, 2000, STUD AL COMB SULF SU; Takeda, 2000, EFF SAF AL COMB METF; Takeda, 2000, EFF SAF AL PLUS METF; Takeda, 2000, CARD OUTC STUD AL PA; Takeda, 2000, EFF SAF AL COMP GL E; Takeda Pharmaceutical Company Limited, 2000, EFF SAF AL US COMB A; U.S. Food and Drug Administration, SAX MARK ONGL KOMB X; Velez M, 2015, J CARD FAIL, V21, P2, DOI 10.1016/j.cardfail.2014.10.012; Vilsboll T, 2010, DIABETES OBES METAB, V12, P167, DOI 10.1111/j.1463-1326.2009.01173.x; Wang KL, 2014, INT J CARDIOL, V177, P86, DOI 10.1016/j.ijcard.2014.09.038; Weir DL, 2014, JACC-HEART FAIL, V2, P573, DOI 10.1016/j.jchf.2014.04.005; Wells G., NEWCASTLE OTTAWA SCA; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wu SY, 2014, CARDIOVASC THER, V32, P147, DOI 10.1111/1755-5922.12075; Yang HK, 2015, ENDOCR J, V62, P449, DOI 10.1507/endocrj.EJ14-0544; Yu OHY, 2015, DIABETES CARE, V38, P277, DOI 10.2337/dc14-1459; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X	106	166	171	1	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2016	352								i610	10.1136/bmj.i610	http://dx.doi.org/10.1136/bmj.i610			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EY	26888822	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000370727700007
J	Moist, L				Moist, Louise			In patients with hypertension, beta-blockers in the 120 d before noncardiac surgery were linked to CV events and death Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Moist, Louise] London Hlth Sci Ctr, London, ON, Canada; [Moist, Louise] Univ Western Ontario, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario)	Moist, L (corresponding author), London Hlth Sci Ctr, London, ON, Canada.; Moist, L (corresponding author), Univ Western Ontario, London, ON, Canada.							Blessberger H, 2014, COCHRANE DB SYST REV, V9; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Wijeysundera DN, 2014, CIRCULATION, V130, P2246, DOI 10.1161/CIR.0000000000000104	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					JC21	JC21		10.7326/ACPJC-2016-164-4-021	http://dx.doi.org/10.7326/ACPJC-2016-164-4-021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26882306				2022-12-28	WOS:000370135300008
J	van der Wouden, CH; Carere, DA; Maitland-van der Zee, AH; Ruffin, MT; Roberts, JS; Green, RC				van der Wouden, Cathelijne H.; Carere, Deanna Alexis; Maitland-van der Zee, Anke H.; Ruffin, Mack T.; Roberts, J. Scott; Green, Robert C.		Impact Personal Genomics Study Grp	Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing	ANNALS OF INTERNAL MEDICINE			English	Article							EDUCATIONAL-NEEDS; GENETIC TESTS; PHYSICIANS; PROFESSIONALS; CUSTOMERS; DISEASE; IMPACT; RISK; KNOWLEDGE; ATTITUDES	Background: Direct-to-consumer (DTC) personal genomic testing (PGT) allows individuals to learn about their genetic makeup without going through a physician, but some consumers share their results with their primary care provider (PCP). Objective: To describe the characteristics and perceptions of DTC PGT consumers who discuss their results with their PCP. Design: Longitudinal, prospective cohort study. Setting: Online survey before and 6 months after results. Participants: DTC PGT consumers. Measurements: Consumer satisfaction with the DTC PGT experience; whether and, if so, how many results could be used to improve health; how many results were not understood; and beliefs about the PCP's understanding of genetics. Participants were asked with whom they had discussed their results. Genetic reports were linked to survey responses. Results: Among 1026 respondents, 63% planned to share their results with a PCP. At 6-month follow-up, 27% reported having done so, and 8% reported sharing with another health care provider only. Common reasons for not sharing results with a health care provider were that the results were not important enough (40%) or that the participant did not have time to do so (37%). Among participants who discussed results with their PCP, 35% were very satisfied with the encounter, and 18% were not at all satisfied. Frequently identified themes in participant descriptions of these encounters were actionability of the results or use in care (32%), PCP engagement or interest (25%), and lack of PCP engagement or interest (22%). Limitation: Participants may not be representative of all DTC PGT consumers. Conclusion: A comprehensive picture of DTC PGT consumers who shared their results with a health care provider is presented. The proportion that shares results is expected to increase with time after testing as consumers find opportunities for discussion at later appointments or if results become relevant as medical needs evolve.	Harvard Univ, Brigham & Womens Hosp, Broad Inst, Sch Med, Boston, MA 02115 USA; Partners HealthCare Personalized Med, Boston, MA USA; Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands; McMaster Univ, Hamilton, ON, Canada; Hamilton Hlth Sci, Genet & Mol Epidemiol Lab, Populat Hlth Res Inst, Hamilton, ON, Canada; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Green, Robert C.] Brigham & Womens Hosp, Res Program Genomes2People, EC Alumnae Bldg,Suite 301,41 Ave Louis Pasteur, Boston, MA 02115 USA; [van der Wouden, Cathelijne H.] Univ Utrecht, Fac Sci, POB 80082, NL-3508 TB Utrecht, Netherlands; [Carere, Deanna Alexis] David Braley Cardiac Vasc & Stroke Res Inst, Genet & Mol Epidemiol Lab, 237 Barton St East, Hamilton, ON L8L 2X2, Canada; [Maitland-van der Zee, Anke H.] Fac Farmaceut Wetenschappen, Univ Weg 99, NL-3584 CG Utrecht, Netherlands; [Ruffin, Mack T.] Univ Michigan Hlth Syst, Dept Family Med, 1018 Fuller St, Ann Arbor, MI 48104 USA; [Roberts, J. Scott] Univ Michigan, Sch Publ Hlth, Sch Publ Hlth 1 Bldg,Room 2834,109 South Observ, Ann Arbor, MI 48109 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Partners Healthcare System; Utrecht University; McMaster University; McMaster University; Population Health Research Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Utrecht University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Green, RC (corresponding author), Brigham & Womens Hosp, Res Program Genomes2People, EC Alumnae Bldg,Suite 301,41 Ave Louis Pasteur, Boston, MA 02115 USA.	rcgreen@genetics.med.harvard.edu	; Maitland-van der Zee, Anke/I-9572-2016	van der Wouden, Cathelijne/0000-0002-7728-8802; Kraft, Peter/0000-0002-4472-8103; Gray, Stacy/0000-0001-6948-0143; Maitland-van der Zee, Anke/0000-0002-0414-3442	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health.	Baars MJH, 2005, GENET MED, V7, P605, DOI 10.1097/01.gim.0000182895.28432.c7; Beck Rainer S, 2002, J Am Board Fam Pract, V15, P25; Bell RA, 2002, J GEN INTERN MED, V17, P817, DOI 10.1046/j.1525-1497.2002.10319.x; Bernhardt BA, 2012, PERS MED, V9, P683, DOI 10.2217/PME.12.80; Boguski MS, 2013, GENOME MED, V5, DOI 10.1186/gm426; Bottorff JL, 2005, COMMUNITY GENET, V8, P80, DOI 10.1159/000084775; Burke W, 2002, NAT REV GENET, V3, P561, DOI 10.1038/nrg845; Carere DA, 2016, GENET MED, V18, P65, DOI 10.1038/gim.2015.34; Carere DA, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0096-0; Darst BF, 2014, HEALTH COMMUN, V29, P105, DOI 10.1080/10410236.2012.717216; Ebell MH, 2008, AM FAM PHYSICIAN, V78, P501; Evans JP, 2009, GENET MED, V11, P568, DOI 10.1097/GIM.0b013e3181afbaed; Feero WG, 2008, GENET MED, V10, P81, DOI 10.1097/GIM.0b013e3181639a6d; Feero WG, 2011, JAMA-J AM MED ASSOC, V306, P989, DOI 10.1001/jama.2011.1245; Frueh FW, 2011, NAT REV GENET, V12, P511, DOI 10.1038/nrg3026; Frueh FW, 2004, PHARMACOGENOMICS, V5, P571, DOI 10.1517/14622416.5.5.571; Goldsmith L, 2013, J COMMUN GENET, V4, P169, DOI 10.1007/s12687-012-0135-8; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Green RC, 2014, NATURE, V505, P286, DOI 10.1038/505286a; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Houwink EJF, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-5; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Jackson JL, 2001, SOC SCI MED, V52, P609, DOI 10.1016/S0277-9536(00)00164-7; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Janssens A Cecile Jw, 2010, Investig Genet, V1, P10, DOI 10.1186/2041-2223-1-10; Kaufman DJ, 2012, J GENET COUNS, V21, P413, DOI 10.1007/s10897-012-9483-0; Lehmann LS, 2012, GENET MED, V14, P268, DOI 10.1038/gim.2011.59; McGuire AL, 2009, AM J BIOETHICS, V9, P3, DOI 10.1080/15265160902928209; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; Nelson EA, 2010, GENOME MED, V2, DOI 10.1186/gm139; Offit K, 2008, JAMA-J AM MED ASSOC, V299, P1353, DOI 10.1001/jama.299.11.1353; Ostergren JE, 2015, PUBLIC HEALTH GENOM, V18, P216, DOI 10.1159/000431250; Pinkhasov RM, 2010, INT J CLIN PRACT, V64, P475, DOI 10.1111/j.1742-1241.2009.02290.x; Powell KP, 2012, J GENET COUNS, V21, P469, DOI 10.1007/s10897-011-9471-9; Powell KP, 2012, J GENET COUNS, V21, P113, DOI 10.1007/s10897-011-9390-9; Rosenberg L, 2009, AM J BIOETHICS, V9, P22, DOI 10.1080/15265160802716852; Safran DG, 1998, J FAM PRACTICE, V47, P213; Samuel GN, 2010, INTERN MED J, V40, P220, DOI 10.1111/j.1445-5994.2010.02190.x; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X	39	69	69	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					513	+		10.7326/M15-0995	http://dx.doi.org/10.7326/M15-0995			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	26928821				2022-12-28	WOS:000374257900010
J	Petzold, G; Fischer, ES; Thoma, NH				Petzold, Georg; Fischer, Eric S.; Thomae, Nicolas H.			Structural basis of lenalidomide-induced CK1 alpha degradation by the CRL4(CRBN) ubiquitin ligase	NATURE			English	Article							THALIDOMIDE; COMPLEX; TARGET; IDENTIFICATION; ARCHITECTURE; VALIDATION; ACTIVATION; CEREBLON; IKAROS; CELLS	Thalidomide and its derivatives, lenalidomide and pomalidomide, are immune modulatory drugs (IMiDs) used in the treatment of haematologic malignancies(1,2). IMiDs bind CRBN, the substrate receptor of the CUL4-RBX1-DDB1-CRBN (also known as CRL4(CRBN)) E3 ubiquitin ligase(3), and inhibit ubiquitination of endogenous CRL4CRBN substrates(4). Unexpectedly, IMiDs also repurpose the ligase to target new proteins for degradation. Lenalidomide induces degradation of the lymphoid transcription factors Ikaros and Aiolos (also known as IKZF1 and IKZF3)(5-7), and casein kinase 1 alpha (CK1 alpha)(8), which contributes to its clinical efficacy in the treatment of multiple myeloma(5) and 5q-deletion associated myelodysplastic syndrome (del(5q) MDS)(8), respectively. How lenalidomide alters the specificity of the ligase to degrade these proteins remains elusive. Here we present the 2.45 angstrom crystal structure of DDB1-CRBN bound to lenalidomide and CK1 alpha. CRBN and lenalidomide jointly provide the binding interface for a CK1 alpha beta-hairpin-loop located in the kinase N-lobe. We show that CK1 alpha binding to CRL4(CRBN) is strictly dependent on the presence of an IMiD. Binding of IKZF1 to CRBN similarly requires the compound and both, IKZF1 and CK1 alpha, use a related binding mode. Our study provides a mechanistic explanation for the selective efficacy of lenalidomide in del(5q) MDS therapy(8,9). We anticipate that high-affinity protein-protein interactions induced by small molecules will provide opportunities for drug development, particularly for targeted protein degradation.	[Petzold, Georg; Fischer, Eric S.; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland; [Petzold, Georg; Fischer, Eric S.; Thomae, Nicolas H.] Univ Basel, Peterspl 10, CH-4003 Basel, Switzerland; [Fischer, Eric S.] Dana Farber Canc Inst, Dept Canc Biol, LC-4312,360 Longwood Ave, Boston, MA 02215 USA; [Fischer, Eric S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Friedrich Miescher Institute for Biomedical Research; University of Basel; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.; Thoma, NH (corresponding author), Univ Basel, Peterspl 10, CH-4003 Basel, Switzerland.	nicolas.thoma@fmi.ch		Thoma, Nicolas/0000-0003-2685-906X; Fischer, Eric S./0000-0001-7337-6306; Petzold, Georg/0000-0001-5649-1716	Novartis Research Foundation; Swiss National Science Foundation [31003A_144020]; European Research Council [ERC-2014-ADG 666068]; European Molecular Biology Organization (EMBO) [ALTF-1350-2013]; Human Frontier Science Program (HFSP) [LT000210/2014]	Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program)	This work was supported by the Novartis Research Foundation, the Swiss National Science Foundation (31003A_144020) and the European Research Council (ERC-2014-ADG 666068 CsnCRL). G.P. was supported by Long-Term Fellowships of the European Molecular Biology Organization (EMBO; ALTF-1350-2013) and the Human Frontier Science Program (HFSP; LT000210/2014). We thank G. M. Lingaraju for the DDB1<SUP>Delta BPB</SUP> construct, M. Faty for assistance with protein purifications, J. Rabl and S. Kassube for help during diffraction data collection, R. Bunker for support with data processing and model building, W. A. Rahman and A. Potenza for assistance with fluorescence polarization, W. C. Forrester for help and comments, and J. Seebacher, R. Sack, D. Hess and M. Stadler for help with mass spectrometry experiments. We acknowledge the Paul Scherrer Institute for provision of synchrotron radiation beam time at beamline PXII and PXIII of the SLS and would like to thank M. Wang for assistance.	Abdulrahman W, 2009, ANAL BIOCHEM, V385, P383, DOI 10.1016/j.ab.2008.10.044; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Blanc E., 2011, BUSTER VERSION 2 11; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Hartmann MD, 2014, J STRUCT BIOL, V188, P225, DOI 10.1016/j.jsb.2014.10.010; Hofmeister CC, 2011, J CLIN ONCOL, V29, P3427, DOI 10.1200/JCO.2010.32.4962; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; KRENN M, 1992, J PHARM SCI, V81, P685, DOI 10.1002/jps.2600810719; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mahon C, 2014, BIOMOLECULES, V4, P897, DOI 10.3390/biom4040897; Marks BD, 2005, ASSAY DRUG DEV TECHN, V3, P613, DOI 10.1089/adt.2005.3.613; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milroy LG, 2014, CHEM REV, V114, P4695, DOI 10.1021/cr400698c; Roche S, 2012, J CHROMATOGR B, V902, P16, DOI 10.1016/j.jchromb.2012.06.008; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Sekeres Mikkael A, 2005, Curr Hematol Rep, V4, P182; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Zhou SF, 2005, EUR J DRUG METAB PH, V30, P49, DOI 10.1007/BF03226408	41	258	266	7	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					127	+		10.1038/nature16979	http://dx.doi.org/10.1038/nature16979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	26909574				2022-12-28	WOS:000373555500047
J	Omer, SB; Beigi, RH				Omer, Saad B.; Beigi, Richard H.			Pregnancy in the Time of Zika Addressing Barriers for Developing Vaccines and Other Measures for Pregnant Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MATERNAL IMMUNIZATION; PEDIATRIC RESEARCH; LIABILITY ISSUES		[Omer, Saad B.] Emory Univ, Dept Global Hlth, Atlanta, GA 30322 USA; [Omer, Saad B.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Omer, Saad B.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Beigi, Richard H.] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Omer, Saad B.] 1518 Clifton Rd NE,Room 7017 CNR Bldg, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Omer, SB (corresponding author), 1518 Clifton Rd NE,Room 7017 CNR Bldg, Atlanta, GA 30322 USA.	somer@emory.edu						Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Fulton TR, 2015, VACCINE, V33, P6453, DOI 10.1016/j.vaccine.2015.08.043; Gruber MF, 2015, VACCINE, V33, P6499, DOI 10.1016/j.vaccine.2015.05.107; Jackson LA, 2015, JAMA-J AM MED ASSOC, V314, P237, DOI 10.1001/jama.2015.7916; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Paradiso PR, 2001, VACCINE, V20, pS73, DOI 10.1016/S0264-410X(01)00302-4; Ren ZX, 2015, SEMIN PERINATOL, V39, P530, DOI 10.1053/j.semperi.2015.08.006; Shah S, 2004, JAMA-J AM MED ASSOC, V291, P476, DOI 10.1001/jama.291.4.476; Trannoy E, 1998, VACCINE, V16, P1482, DOI 10.1016/S0264-410X(98)80005-4	9	24	24	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1227	1228		10.1001/jama.2016.2237	http://dx.doi.org/10.1001/jama.2016.2237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	26914692	Bronze			2022-12-28	WOS:000372511100003
J	McDonald, MJ; Rice, DP; Desai, MM				McDonald, Michael J.; Rice, Daniel P.; Desai, Michael M.			Sex speeds adaptation by altering the dynamics of molecular evolution	NATURE			English	Article							EXPERIMENTAL YEAST POPULATIONS; BENEFICIAL MUTATIONS; SACCHAROMYCES-CEREVISIAE; ASEXUAL POPULATIONS; CLONAL INTERFERENCE; DELETERIOUS MUTATIONS; NATURAL-SELECTION; RECOMBINATION; ADVANTAGE; HITCHHIKING	Sex and recombination are pervasive throughout nature despite their substantial costs(1). Understanding the evolutionary forces that maintain these phenomena is a central challenge in biology(2,3). One longstanding hypothesis argues that sex is beneficial because recombination speeds adaptation(4). Theory has proposed several distinct population genetic mechanisms that could underlie this advantage. For example, sex can promote the fixation of beneficial mutations either by alleviating interference competition (the Fisher-Muller effect)(5,6) or by separating them from deleterious load (the ruby in the rubbish effect)(7,8). Previous experiments confirm that sex can increase the rate of adaptation(9-17), but these studies did not observe the evolutionary dynamics that drive this effect at the genomic level. Here we present the first, to our knowledge, comparison between the sequence-level dynamics of adaptation in experimental sexual and asexual Saccharomyces cerevisiae populations, which allows us to identify the specific mechanisms by which sex speeds adaptation. We find that sex alters the molecular signatures of evolution by changing the spectrum of mutations that fix, and confirm theoretical predictions that it does so by alleviating clonal interference. We also show that substantially deleterious mutations hitchhike to fixation in adapting asexual populations. In contrast, recombination prevents such mutations from fixing. Our results demonstrate that sex both speeds adaptation and alters its molecular signature by allowing natural selection to more efficiently sort beneficial from deleterious mutations.	[McDonald, Michael J.; Rice, Daniel P.; Desai, Michael M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [McDonald, Michael J.; Rice, Daniel P.; Desai, Michael M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Desai, Michael M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Desai, MM (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Desai, MM (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.; Desai, MM (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	mmdesai@fas.harvard.edu		Desai, Michael/0000-0002-9581-1150	NSF; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Harvard Milton Fund; Simons Foundation [376196]; National Science Foundation [PHY 1313638]; National Institutes of Health [GM104239]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104239] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Harvard Milton Fund; Simons Foundation; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.-Y. Leu and S. Akle-Serrano for help with strain construction and experimental evolution; S. Kryazhimskiy, E. Jerison, and J. Piper for help with sequencing library preparation; G. Lang, A. Murray, B. Good, D. van Dyken, K. Kosheleva, I. Cvijovic, and other members of the Desai laboratory for discussions and comments on the manuscript; and P. Rogers and C. Daly for technical support. D.P.R. acknowledges support from an NSF graduate research fellowship. M.M.D. acknowledges support from the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, the Harvard Milton Fund, the Simons Foundation (grant 376196), grant PHY 1313638 from the National Science Foundation, and grant GM104239 from the National Institutes of Health. Computational work was performed on the Odyssey cluster supported by the Research Computing Group at Harvard University.	ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; Becks L, 2010, NATURE, V468, P89, DOI 10.1038/nature09449; BELL G, 1982, MASTERPIECE NATURE E; BIRKY CW, 1988, P NATL ACAD SCI USA, V85, P6414, DOI 10.1073/pnas.85.17.6414; Chang SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003232; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; FISHER RA, 1930, GENETICAL THEORY NAT, pCH6; Frenkel EM, 2015, P NATL ACAD SCI USA, V112, P11306, DOI 10.1073/pnas.1506184112; Frenkel EM, 2014, GENETICS, V196, P1217, DOI 10.1534/genetics.113.160069; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Good BH, 2014, GENETICS, V198, P1183, DOI 10.1534/genetics.114.170233; Gray JC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-43; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hartfield M, 2011, EVOLUTION, V65, P2421, DOI 10.1111/j.1558-5646.2011.01311.x; Johnson T, 2002, GENETICS, V162, P395; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Kryazhimskiy S, 2014, SCIENCE, V344, P1519, DOI 10.1126/science.1250939; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; PECK JR, 1994, GENETICS, V137, P597; Poon A, 2004, GENETICS, V166, P19, DOI 10.1534/genetics.166.1.19; Rice WR, 2001, SCIENCE, V294, P555, DOI 10.1126/science.1061380; Schiffels S, 2011, GENETICS, V189, P1361, DOI 10.1534/genetics.111.132027; Sella G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000495; Shim H, 2015, ANN APPL STAT, V9, P665, DOI 10.1214/14-AOAS776; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Weismann A., 1889, ESSAYS HEREDITY KIND; Weissman DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002740; Zeyl C, 1997, NATURE, V388, P465, DOI 10.1038/41312	43	183	188	3	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					233	+		10.1038/nature17143	http://dx.doi.org/10.1038/nature17143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26909573	Green Accepted, Green Submitted			2022-12-28	WOS:000371665100041
J	Kerr, EM; Gaude, E; Turrell, FK; Frezza, C; Martins, CP				Kerr, Emma M.; Gaude, Edoardo; Turrell, Frances K.; Frezza, Christian; Martins, Carla P.			Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities	NATURE			English	Article							K-RAS; ONCOGENE; CANCER; P53; DYSFUNCTION; MUTATIONS; GLUCOSE; MOUSE	The RAS/MAPK (mitogen-activated protein kinase) signalling pathway is frequently deregulated in non-small-cell lung cancer, often through KRAS activating mutations(1-3). A single endogenous mutant Kras allele is sufficient to promote lung tumour formation in mice but malignant progression requires additional genetic alterations(4-7.) We recently showed that advanced lung tumours from KrasG12D/+; p53-null mice frequently exhibit KrasG12D allelic enrichment (KrasG12D/Kraswild-type > 1) (ref. 7), implying that mutant Kras copy gains are positively selected during progression. Here we show, through a comprehensive analysis of mutant Kras homozygous and heterozygous mouse embryonic fibroblasts and lung cancer cells, that these genotypes are phenotypically distinct. In particular, KrasG12D/G12D cells exhibit a glycolytic switch coupled to increased channelling of glucose-derived metabolites into the tricarboxylic acid cycle and glutathione biosynthesis, resulting in enhanced glutathione-mediated detoxification. This metabolic rewiring is recapitulated in mutant KRAS homozygous nonsmall- cell lung cancer cells and in vivo, in spontaneous advanced murine lung tumours (which display a high frequency of KrasG12D copy gain), but not in the corresponding early tumours (KrasG12D heterozygous). Finally, we demonstrate that mutant Kras copy gain creates unique metabolic dependences that can be exploited to selectively target these aggressive mutant Kras tumours. Our data demonstrate that mutant Kras lung tumours are not a single disease but rather a heterogeneous group comprising two classes of tumours with distinct metabolic profiles, prognosis and therapeutic susceptibility, which can be discriminated on the basis of their relative mutant allelic content. We also provide the first, to our knowledge, in vivo evidence of metabolic rewiring during lung cancer malignant progression.	[Kerr, Emma M.; Gaude, Edoardo; Turrell, Frances K.; Frezza, Christian; Martins, Carla P.] Univ Cambridge, MRC, Canc Unit, Box 197,Cambridge Biomed Campus, Cambridge CB2 0XZ, England	University of Cambridge	Martins, CP (corresponding author), Univ Cambridge, MRC, Canc Unit, Box 197,Cambridge Biomed Campus, Cambridge CB2 0XZ, England.	c.martins@mrc-cu.cam.ac.uk	Frezza, Christian/G-2174-2010	Frezza, Christian/0000-0002-3293-7397; Kerr, Emma/0000-0002-1952-4213; Turrell, Frances/0000-0002-6649-6198; Gaude, Edoardo/0000-0001-8523-7792	Medical Research Council; MRC [MC_UU_12022/4, MC_UU_12022/6, MC_UP_1101/1] Funding Source: UKRI; Medical Research Council [MC_UU_12022/6, 1390328, MC_UP_1101/1, MC_UU_12022/4] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Jacks (Kras<SUP>LSL-G12D</SUP>), A. Berns (p53<SUP>Fx</SUP>) and the National Cancer Institute Mouse Repository for mice. We also thank S. Kleeman, P. Ogger and S. Costa for assistance with redox cell profiling, cell viability assays and LC-MS, respectively. We are very grateful to Cancer Research UK Cambridge Institute Biological Resources Unit staff for support with in vivo work and all the members of the Martins laboratory for comments and advice. This work was supported by the Medical Research Council.	Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu YM, 2012, CELL RES, V22, P399, DOI 10.1038/cr.2011.145; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Modrek B, 2009, MOL CANCER RES, V7, P1244, DOI 10.1158/1541-7786.MCR-08-0532; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Wagner PL, 2011, LUNG CANCER, V74, P118, DOI 10.1016/j.lungcan.2011.01.029; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	29	201	207	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					110	+		10.1038/nature16967	http://dx.doi.org/10.1038/nature16967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26909577	Green Accepted			2022-12-28	WOS:000371211900050
J	Filardo, G; da Graca, B; Sass, DM; Pollock, BD; Smith, EB; Martinez, MAM				Filardo, Giovanni; da Graca, Briget; Sass, Danielle M.; Pollock, Benjamin D.; Smith, Emma B.; Martinez, Melissa Ashley-Marie			Trends and comparison of female first authorship in high impact medical journals: observational study (1994-2014)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENDER-GAP; ACADEMIC MEDICINE; WOMEN; BIAS	OBJECTIVE To examine changes in representation of women among first authors of original research published in high impact general medical journals from 1994 to 2014 and investigate differences between journals. DESIGN Observational study. Study sample All original research articles published in Annals of Internal Medicine, Archives of Internal Medicine, The BMJ, JAMA, The Lancet, and the New England Journal of Medicine (NEJM) for one issue every alternate month from February 1994 to June 2014. MAIN EXPOSURES Time and journal of publication. Main outcome measures Prevalence of female first authorship and its adjusted association with time of publication and journal, assessed using a multivariable logistic regression model that accounted for number of authors, study type and specialty/topic, continent where the study was conducted, and the interactions between journal and time of publication, study type, and continent. Estimates from this model were used to calculate adjusted odds ratios against the mean across the six journals, with 95% confidence intervals and P values to describe the associations of interest. RESULTS The gender of the first author was determined for 3758 of the 3860 articles considered; 1273 (34%) were women. After adjustment, female first authorship increased significantly from 27% in 1994 to 37% in 2014 (P<0.001). The NEJM seemed to follow a different pattern, with female first authorship decreasing; it also seemed to decline in recent years in The BMJ but started substantially higher (approximately 40%), and The BMJ had the highest total proportion of female first authors. Compared with the mean across all six journals, first authors were significantly less likely to be female in the NEJM (adjusted odds ratio 0.68, 95% confidence interval 0.53 to 0.89) and significantly more likely to be female in The BMJ (1.30, 1.01 to 1.66) over the study period. CONCLUSIONS The representation of women among first authors of original research in high impact general medical journals was significantly higher in 2014 than 20 years ago, but it has plateaued in recent years and has declined in some journals. These results, along with the significant differences seen between journals, suggest that underrepresentation of research by women in high impact journals is still an important concern. The underlying causes need to be investigated to help to identify practices and strategies to increase women's influence on and contributions to the evidence that will determine future healthcare policies and standards of clinical practice.	[Filardo, Giovanni; Sass, Danielle M.; Pollock, Benjamin D.] Baylor Scott & White Hlth, Off Chief Qual Officer, Dept Epidemiol, 8080 North Cent Expressway, Dallas, TX 75206 USA; [da Graca, Briget] Baylor Scott & White Hlth, Off Chief Qual Officer, Ctr Clin Effectiveness, Dallas, TX USA; [Smith, Emma B.] Yale Univ, New Haven, CT 06520 USA; [Martinez, Melissa Ashley-Marie] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA	Baylor Health Care System; Baylor Health Care System; Yale University; University of New Mexico	Filardo, G (corresponding author), Baylor Scott & White Hlth, Off Chief Qual Officer, Dept Epidemiol, 8080 North Cent Expressway, Dallas, TX 75206 USA.	giovanfi@baylorhealth.edu		Pollock, Benjamin/0000-0003-4544-3158	Bradley Family Endowment	Bradley Family Endowment	This work was funded in part by the Bradley Family Endowment to the Baylor Health Care System Foundation. The funder played no role in this study, and the research team operated independently.	Amering M, 2011, ACAD MED, V86, P946, DOI 10.1097/ACM.0b013e3182222887; Amrein K, 2011, GENDER MED, V8, P378, DOI 10.1016/j.genm.2011.10.007; Association of American Medical Colleges, 2013, THE STATE OF WOMEN I; Bergeron JL, 2012, OTOLARYNG HEAD NECK, V147, P40, DOI 10.1177/0194599812438171; British Medical Association, 2015, 2014 UK MEDICAL WORK; BRODER IE, 1993, AM ECON REV, V83, P964; Budden AE, 2008, TRENDS ECOL EVOL, V23, P4, DOI 10.1016/j.tree.2007.07.008; Campion EW, 2000, NEW ENGL J MED, V343, P1485, DOI 10.1056/NEJM200011163432009; Ceci SJ, 2009, PSYCHOL BULL, V135, P218, DOI 10.1037/a0014412; Center for Workforce Studies, 2014, PHYSICIAN SPECIALTY; Centre for Workforce Intelligence, 2012, SHAPE OF THE MEDICAL; Dotson B, 2011, AM J HEALTH-SYST PH, V68, P1736, DOI 10.2146/ajhp100597; European Commission, 2013, SHE FIGURES 2012 GEN; Feramisco JD, 2009, J AM ACAD DERMATOL, V60, P63, DOI 10.1016/j.jaad.2008.06.044; Filardo G, 2007, J CLIN EPIDEMIOL, V60, P1132, DOI 10.1016/j.jclinepi.2007.01.008; Fitzpatrick S., 2015, SURVEY STAFFING LEVE; General Medical Council, 2014, THE STATE OF MEDICAL; GILBERT JR, 1994, JAMA-J AM MED ASSOC, V272, P139, DOI 10.1001/jama.272.2.139; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Heckenberg A, 2010, WIEN KLIN WOCHENSCHR, V122, P141, DOI 10.1007/s00508-010-1302-8; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; JAMA, 2015, JAMA; Jump P., 2015, FEMALE SUCCESS RATE; Kaatz A, 2014, TRENDS PHARMACOL SCI, V35, P371, DOI 10.1016/j.tips.2014.06.005; Kurichi JE, 2005, ARCH SURG-CHICAGO, V140, P1074, DOI 10.1001/archsurg.140.11.1074; Long MT, 2015, GASTROINTEST ENDOSC, V81, P1440, DOI 10.1016/j.gie.2015.01.032; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Okoshi K, 2014, TOHOKU J EXP MED, V234, P221, DOI 10.1620/tjem.234.221; Penny M, 2014, J ROY SOC MED, V107, P259, DOI 10.1177/0141076814528893; Pohlhaus JR, 2011, ACAD MED, V86, P759, DOI 10.1097/ACM.0b013e31821836ff; Ramakrishnan A, 2014, J WOMENS HEALTH, V23, P927, DOI 10.1089/jwh.2014.4736; Ranga M, 2012, GENDER EFFECTS IN RE; Redberg RF, 2009, ARCH INTERN MED, V169, P828, DOI 10.1001/archinternmed.2009.131; Reed DA, 2011, ACAD MED, V86, P43, DOI 10.1097/ACM.0b013e3181ff9ff2; Rose SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129197; Royal Society of Medicine, 2014, WOMEN UNDER REPRESEN; Schrager S, 2011, FAM MED, V43, P155; Sidhu R, 2009, J ROY SOC MED, V102, P337, DOI 10.1258/jrsm.2009.080378; Tinjum BE, 2011, J EMERG MED, V41, P723, DOI 10.1016/j.jemermed.2010.04.014; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Tregenza T, 2002, TRENDS ECOL EVOL, V17, P349, DOI 10.1016/S0169-5347(02)02545-4; Waisbren SE, 2008, J WOMENS HEALTH, V17, P207, DOI 10.1089/jwh.2007.0412	42	249	253	2	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2016	352								i847	10.1136/bmj.i847	http://dx.doi.org/10.1136/bmj.i847			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LN	26935100	Green Published, hybrid			2022-12-28	WOS:000371756500002
J	Chou, R; Dana, T; Bougatsos, C; Grusing, S; Blazina, I				Chou, Roger; Dana, Tracy; Bougatsos, Christina; Grusing, Sara; Blazina, Ian			Screening for Impaired Visual Acuity in Older Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; MACULAR DEGENERATION; CATARACT-SURGERY; REFRACTIVE ERROR; MICROBIAL KERATITIS; BETA-CAROTENE; RISK-FACTORS; VISION; AGE; FALLS	IMPORTANCE Impaired visual acuity is common among older adults and can adversely affect function and quality of life. OBJECTIVE To update a 2009 systematic review on screening for impaired visual acuity among older adults for the US Preventive Services Task Force (USPSTF). DATA SOURCES Ovid MEDLINE (2008 to January 2016), Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews. STUDY SELECTION Randomized clinical trials of screening; diagnostic accuracy studies of screening tests in primary care settings; and randomized clinical trials of treatment vs placebo or no treatment for uncorrected refractive errors, cataracts, and dry (atrophic) or wet (exudative) age-related macular degeneration (AMD). Studies of screening and diagnostic accuracy were limited to asymptomatic adults 65 years or older; studies of treatment included asymptomatic adults of any age. DATA EXTRACTION AND SYNTHESIS One investigator abstracted data, a second checked data for accuracy, and 2 investigators independently assessed study quality using predefined criteria. Random-effects meta-analysis was used to estimate the relative and absolute benefits of vascular endothelial growth factor inhibitors (anti-VEGF) for wet AMD. MAIN OUTCOMES AND MEASURES Visual acuity, vision-related function, functional capacity, harms, and diagnostic accuracy. RESULTS Three trials (n = 4728) from the 2009 USPSTF review found that screening for impaired visual acuity was not associated with improved visual or clinical outcomes. In 1 good-quality trial (n = 3346), universal screening identified 27% of persons with impaired visual acuity and correctable impairment vs 3.1% with targeted screening, but there was no difference in the likelihood of visual acuity worse than 20/60 after 3 to 5 years (37% vs 35%; relative risk [RR], 1.07; 95% CI, 0.84-1.36). The 2009 review found that effective treatments are available for uncorrected refractive errors and cataracts. Ten-year trial results of dry AMD found an antioxidant/zinc combination was associated with decreased risk of visual acuity loss (46% vs 54%; odds ratio, 0.71; 95% CI, 0.57-0.88). An updated meta-analysis found anti-VEGF for wet AMD was associated with greater likelihood of having vision 20/200 or better vs sham injection (4 trials; RR, 1.47; 95% CI, 1.30-1.66; 12 = 42%; absolute risk difference, 24%; 95%O. 12%-37% after 1 year). New evidence on the diagnostic accuracy of visual acuity screening tests was limited and consistent with previous findings that screening questions or a visual acuity test was associated with suboptimal accuracy. CONCLUSIONS AND RELEVANCE Screening can identify persons with impaired visual acuity, and effective treatments are available for common causes of impaired visual acuity, such as uncorrected refractive error, cataracts, and dry or wet AMD. However, direct evidence found no significant difference between vision screening in older adults in primary care settings vs no screening for improving visual acuity or other clinical outcomes.	[Chou, Roger] Oregon Hlth & Sci Univ, Dept Med, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97201 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Dana, Tracy; Bougatsos, Christina; Grusing, Sara; Blazina, Ian] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Chou, R (corresponding author), Mail Code BICC, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Blazina, Ian/0000-0003-0164-6674	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded by the Agency for Healthcare Research and Quality (AHRQ) under a contract to support the USPSTF.	[Anonymous], SUMM HLTH STAT US AD; Ariyasu RG, 1996, OPHTHALMOLOGY, V103, P1751, DOI 10.1016/S0161-6420(96)30431-4; Bressler NM, 2013, OPHTHALMOLOGY, V120, P160, DOI 10.1016/j.ophtha.2012.07.027; Calonge N, 2009, ANN INTERN MED, V151, P37, DOI 10.7326/0003-4819-151-1-200907070-00007; Chang TS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1460, DOI 10.1001/archopht.125.11.1460; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; Chew EY, 2013, OPHTHALMOLOGY, V120, P1604, DOI 10.1016/j.ophtha.2013.01.021; Chou R, 2009, ANN INTERN MED, V1511, pW11; Chou R, 2016, AHRQ PUBLICATION; Chou R., 2009, AHRQ PUBLICATION; Chou R, 2009, ANN INTERN MED, V151, P44, DOI 10.7326/0003-4819-151-1-200907070-00008; Coleman AL, 2006, J AM GERIATR SOC, V54, P883, DOI 10.1111/j.1532-5415.2006.00817.x; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cumming RG, 2007, J AM GERIATR SOC, V55, P175, DOI 10.1111/j.1532-5415.2007.01046.x; Eekhof JAH, 2000, SCAND J PRIM HEALTH, V18, P203; Eekhof JAH, 2000, FAM PRACT, V17, P329, DOI 10.1093/fampra/17.4.329; Elliott AF, 2009, J AM GERIATR SOC, V57, P202, DOI 10.1111/j.1532-5415.2008.02099.x; Evans JR, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000253.pub2; Evans JR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000254.pub3; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Guymer RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083759; Hall TA, 2005, J AM GERIATR SOC, V53, P2140, DOI 10.1111/j.1532-5415.2005.00499.x; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; HILLER R, 1983, AM J PUBLIC HEALTH, V73, P93, DOI 10.2105/AJPH.73.1.93; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Ivers RQ, 2001, OPHTHALMOLOGY, V108, P968, DOI 10.1016/S0161-6420(00)00649-7; Jessa Z, 2012, OPHTHAL PHYSL OPT, V32, P332, DOI 10.1111/j.1475-1313.2012.00919.x; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Lord SR, 2002, J AM GERIATR SOC, V50, P1760, DOI 10.1046/j.1532-5415.2002.50502.x; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; Ma L, 2012, OPHTHALMOLOGY, V119, P2290, DOI 10.1016/j.ophtha.2012.06.014; McDonnell PJ, 2003, OPHTHALMOLOGY, V110, P2302, DOI 10.1016/j.ophtha.2003.02.004; McGwin G, 2000, ACCIDENT ANAL PREV, V32, P735, DOI 10.1016/S0001-4575(99)00123-2; MCMURDO M E T, 1988, Health Bulletin (Edinburgh), V46, P327; Moore AA, 1997, AM J MED, V102, P371, DOI 10.1016/S0002-9343(97)00089-2; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Murray A, 2005, SYSTEMATIC REV SAFET, P149; Murray IJ, 2013, INVEST OPHTH VIS SCI, V54, P1781, DOI 10.1167/iovs.12-10715; Nilsson Sven Erik G., 1994, CLAO Journal, V20, P225; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Owsley C, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.118547; Owsley C, 2007, ARCH OPHTHALMOL-CHIC, V125, P1471, DOI 10.1001/archopht.125.11.1471; POWE NR, 1994, ARCH OPHTHALMOL-CHIC, V112, P239, DOI 10.1001/archopht.1994.01090140115033; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3; Schein OD, 2001, J CATARACT REFR SURG, V27, P665, DOI 10.1016/S0886-3350(01)00844-6; Schein OD, 2005, OPHTHALMOLOGY, V112, P2172, DOI 10.1016/j.ophtha.2005.09.014; Sims RV, 1998, J AM GERIATR SOC, V46, P556, DOI 10.1111/j.1532-5415.1998.tb01070.x; Smeeth L, 2003, BMJ-BRIT MED J, V327, P1027, DOI 10.1136/bmj.327.7422.1027; Souied EH, 2013, OPHTHALMOLOGY, V120, P1619, DOI 10.1016/j.ophtha.2013.01.005; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; STONE DH, 1978, BRIT MED J, V2, P859, DOI 10.1136/bmj.2.6141.859; Swamy B, 2009, BRIT J OPHTHALMOL, V93, P736, DOI 10.1136/bjo.2007.134650; Swanson MW, 2009, J AM GERIATR SOC, V57, P486, DOI 10.1111/j.1532-5415.2008.02144.x; Taban M, 2005, ARCH OPHTHALMOL-CHIC, V123, P613, DOI 10.1001/archopht.123.5.613; Tahzib NG, 2005, J CATARACT REFR SURG, V31, P1943, DOI 10.1016/j.jcrs.2005.08.022; Teh RCA, 2006, J AM GERIATR SOC, V54, P370, DOI 10.1111/j.1532-5415.2005.00592_4.x; US Preventive Services Task Force, 2009, ANN INTERN MED, V151, pW10; Vedula SS, 2008, COCHRANE DB SYST REV, V2; Wang F, 1998, Ophthalmic Epidemiol, V5, P69, DOI 10.1076/opep.5.2.69.1575; Williams MA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009300.pub2; Woods RL, 1998, OPHTHALMOLOGY, V105, P2318, DOI 10.1016/S0161-6420(98)91235-0	66	60	60	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					915	933		10.1001/jama.2016.0783	http://dx.doi.org/10.1001/jama.2016.0783			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF1DB	26934261	Bronze			2022-12-28	WOS:000371077500022
J	Clemente-Casares, X; Blanco, J; Ambalavanan, P; Yamanouchi, J; Singha, S; Fandos, C; Tsai, S; Wang, JG; Garabatos, N; Izquierdo, C; Agrawal, S; Keough, MB; Yong, VW; James, E; Moore, A; Yang, Y; Stratmann, T; Serra, P; Santamaria, P				Clemente-Casares, Xavier; Blanco, Jesus; Ambalavanan, Poornima; Yamanouchi, Jun; Singha, Santiswarup; Fandos, Cesar; Tsai, Sue; Wang, Jinguo; Garabatos, Nahir; Izquierdo, Cristina; Agrawal, Smriti; Keough, Michael B.; Yong, V. Wee; James, Eddie; Moore, Anna; Yang, Yang; Stratmann, Thomas; Serra, Pau; Santamaria, Pere			Expanding antigen-specific regulatory networks to treat autoimmunity	NATURE			English	Article							SUBUNIT-RELATED PROTEIN; CD8(+) T-CELLS; C-MAF; TOLERANCE; DIFFERENTIATION; AUTOANTIGEN; INSTABILITY; ACTIVATION; GENERATION; ARTHRITIS	Regulatory T cells hold promise as targets for therapeutic intervention in autoimmunity, but approaches capable of expanding antigen-specific regulatory T cells in vivo are currently not available. Here we show that systemic delivery of nanoparticles coated with autoimmune-disease-relevant peptides bound to major histocompatibility complex class II (pMHCII) molecules triggers the generation and expansion of antigen-specific regulatory CD4(+) T cell type 1 (T(R)1)-like cells in different mouse models, including mice humanized with lymphocytes from patients, leading to resolution of established autoimmune phenomena. Ten pMHCII-based nanomedicines show similar biological effects, regardless of genetic background, prevalence of the cognate T-cell population or MHC restriction. These nanomedicines promote the differentiation of disease-primed autoreactive T cells into T(R)1-like cells, which in turn suppress autoantigen-loaded antigen-presenting cells and drive the differentiation of cognate B cells into disease-suppressing regulatory B cells, without compromising systemic immunity. pMHCII-based nanomedicines thus represent a new class of drugs, potentially useful for treating a broad spectrum of autoimmune conditions in a disease-specific manner.	[Clemente-Casares, Xavier; Ambalavanan, Poornima; Yamanouchi, Jun; Singha, Santiswarup; Tsai, Sue; Yang, Yang; Santamaria, Pere] Univ Calgary, Snyder Inst Chron Dis & Hotchkiss Brain Inst, Cumming Sch Med, JMDRC, Calgary, AB T2N 4N1, Canada; [Clemente-Casares, Xavier; Ambalavanan, Poornima; Yamanouchi, Jun; Singha, Santiswarup; Tsai, Sue; Wang, Jinguo; Yang, Yang; Santamaria, Pere] Univ Calgary, Snyder Inst Chron Dis & Hotchkiss Brain Inst, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Blanco, Jesus; Fandos, Cesar; Serra, Pau; Santamaria, Pere] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona 08036, Spain; [Blanco, Jesus] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades, Metab Asociadas CIBERDEM, Madrid 28029, Spain; [Garabatos, Nahir; Izquierdo, Cristina; Stratmann, Thomas] Univ Barcelona, Fac Biol, Dept Physiol & Immunol, E-08028 Barcelona, Spain; [Agrawal, Smriti; Keough, Michael B.; Yong, V. Wee] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Agrawal, Smriti; Keough, Michael B.; Yong, V. Wee] Univ Calgary, Fac Med, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [James, Eddie] Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA; [Moore, Anna] Massachusetts Gen Hosp, Dept Radiol, Mol Imaging Lab, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA 02129 USA; [Yang, Yang] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; University of Barcelona; University of Calgary; University of Calgary; Benaroya Research Institute; Virginia Mason Medical Center; Harvard University; Massachusetts General Hospital; University of Calgary	Santamaria, P (corresponding author), Univ Calgary, Snyder Inst Chron Dis & Hotchkiss Brain Inst, Cumming Sch Med, JMDRC, Calgary, AB T2N 4N1, Canada.; Santamaria, P (corresponding author), Univ Calgary, Snyder Inst Chron Dis & Hotchkiss Brain Inst, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada.; Santamaria, P (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona 08036, Spain.	psantama@ucalgary.ca	Blanco, Jesús/Q-8296-2019; James, Eddie/V-4929-2019; Blanco Carrasco, Antonio Jesús/H-8938-2015; Santamaria, Pere/ABF-6823-2021	Blanco, Jesús/0000-0001-5903-430X; James, Eddie/0000-0002-7217-5729; Blanco Carrasco, Antonio Jesús/0000-0001-5903-430X; Garabatos, Nahir/0000-0003-4094-9862; Yong, V. Wee/0000-0002-2600-3563; Stratmann, Thomas/0000-0001-6196-1487	Canadian Institutes of Health Research (CIHR); Diabetes Research Foundation; Juvenile Diabetes Research Foundation (JDRF); Canadian Diabetes Association (CDA); Multiple Sclerosis Society of Canada (MSSC); Brawn Family Foundation; National Research Council of Canada-Industrial Research Assistance Program (NRC-IRAP); Instituto de Investigaciones Sanitarias Carlos III (ISCIII) Integrated Project of Excellence; Instituto de Investigaciones Sanitarias Carlos III (ISCIII) Integrated Project of FEDER; Ministerio de Economia y Competitividad of Spain (MINECO); European Association for the study of diabetes (EASD); Sarda Farriol Research Programme; European Community; AXA Research Fund; endMS network; Rio Hortega fellowship; Spanish Society for Diabetes; Alberta Heritage Foundation of Medical Research (AHFMR); CDA; JDRF Career Development Award; Diabetes Association (Foothills); Alberta Innovates [201300669, 201200614] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Diabetes Research Foundation; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Canadian Diabetes Association (CDA); Multiple Sclerosis Society of Canada (MSSC); Brawn Family Foundation; National Research Council of Canada-Industrial Research Assistance Program (NRC-IRAP); Instituto de Investigaciones Sanitarias Carlos III (ISCIII) Integrated Project of Excellence; Instituto de Investigaciones Sanitarias Carlos III (ISCIII) Integrated Project of FEDER; Ministerio de Economia y Competitividad of Spain (MINECO)(Spanish Government); European Association for the study of diabetes (EASD); Sarda Farriol Research Programme; European Community(European Commission); AXA Research Fund(AXA Research Fund); endMS network; Rio Hortega fellowship; Spanish Society for Diabetes; Alberta Heritage Foundation of Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); CDA; JDRF Career Development Award(Juvenile Diabetes Research Foundation); Diabetes Association (Foothills); Alberta Innovates	We thank S. Thiessen, J. DeLongchamp, J. Erickson, J. Luces, R. Barasi and K. Umeshappa for technical contributions; L. Kennedy, L. Robertson and Y. Liu for flow cytometry; F. Jirik for help with histological analyses of arthritic mice; J. Elliott and K. Suzuki for Meso Scale measurements; M. Fritzler for Luminex; and P. Colarusso for assistance with microscopy. This work was funded by the Canadian Institutes of Health Research (CIHR), the Diabetes Research Foundation, the Juvenile Diabetes Research Foundation (JDRF), the Canadian Diabetes Association (CDA), the Multiple Sclerosis Society of Canada (MSSC), the Brawn Family Foundation, National Research Council of Canada-Industrial Research Assistance Program (NRC-IRAP), Instituto de Investigaciones Sanitarias Carlos III (ISCIII) Integrated Projects of Excellence and FEDER, the Ministerio de Economia y Competitividad of Spain (MINECO), the European Association for the study of diabetes (EASD), the Sarda Farriol Research Programme, and the European Community's Seventh Framework Programme. X. C. C. was supported by studentships from the AXA Research Fund and the endMS network. P. A. was supported by the endMS network. J. B. was suported by a Rio Hortega fellowship and by a grant from the Spanish Society for Diabetes. S. T. was supported by a studentship from the Alberta Heritage Foundation of Medical Research (AHFMR). J. W. was funded by a fellowship from the CDA. P. Se. is an investigator of the Ramon y Cajal reintegration program and is supported by a JDRF Career Development Award. P. Sa. is a Scientist of the Alberta Innovates-Health Solutions and a scholar of ISCIII. The JMDRC is supported by the Diabetes Association (Foothills) and the CDA.	Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Burton BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5741; Desreumaux P, 2012, GASTROENTEROLOGY, V143, P1207, DOI 10.1053/j.gastro.2012.07.116; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434; Giuliani F, 2005, J NEUROIMMUNOL, V158, P213, DOI 10.1016/j.jneuroim.2004.09.006; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Leavenworth JW, 2013, J CLIN INVEST, V123, P1382, DOI 10.1172/JCI66938; McLarnon Andy, 2012, Nat Rev Gastroenterol Hepatol, V9, P559, DOI 10.1038/nrgastro.2012.167; Moore A, 2004, DIABETES, V53, P1459, DOI 10.2337/diabetes.53.6.1459; Mukherjee R, 2005, J IMMUNOL, V174, P5306, DOI 10.4049/jimmunol.174.9.5306; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Roncarolo MG, 2011, IMMUNOL REV, V241, P145, DOI 10.1111/j.1600-065X.2011.01010.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Santamaria P, 2010, IMMUNITY, V32, P437, DOI 10.1016/j.immuni.2010.04.003; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sato K, 2011, J BIOL CHEM, V286, P14963, DOI 10.1074/jbc.M111.218867; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Stratmann T, 2003, J CLIN INVEST, V112, P902, DOI 10.1172/JCI200318337; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Wang JG, 2010, P NATL ACAD SCI USA, V107, P9317, DOI 10.1073/pnas.0913835107; Yang JB, 2008, J AUTOIMMUN, V31, P30, DOI 10.1016/j.jaut.2008.02.001; Yang JB, 2006, J IMMUNOL, V176, P2781, DOI 10.4049/jimmunol.176.5.2781; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	31	307	314	4	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					434	+		10.1038/nature16962	http://dx.doi.org/10.1038/nature16962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26886799				2022-12-28	WOS:000370690800026
J	David, CJ; Huang, YH; Chen, M; Su, J; Zou, YL; Bardeesy, N; Iacobuzio-Donahue, CA; Massague, J				David, Charles J.; Huang, Yun-Han; Chen, Mo; Su, Jie; Zou, Yilong; Bardeesy, Nabeel; Iacobuzio-Donahue, Christine A.; Massague, Joan			TGF-beta Tumor Suppression through a Lethal EMT	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LINEAGE-SURVIVAL ONCOGENES; GROWTH-FACTOR; TRANSCRIPTION FACTOR; PANCREATIC-CANCER; ENHANCED EXPRESSION; SELF-RENEWAL; STEM-CELLS; SOX4; KLF5	TGF-beta signaling can be pro-tumorigenic or tumor suppressive. We investigated this duality in pancreatic ductal adenocarcinoma (PDA), which, with other gastrointestinal cancers, exhibits frequent inactivation of the TGF-beta mediator Smad4. We show that TGF-beta induces an epithelial-mesenchymal transition (EMT), generally considered a pro-tumorigenic event. However, in TGF-beta-sensitive PDA cells, EMT becomes lethal by converting TGF-beta-induced Sox4 from an enforcer of tumorigenesis into a promoter of apoptosis. This is the result of an EMT-linked remodeling of the cellular transcription factor landscape, including the repression of the gastrointestinal lineage-master regulator Klf5. Klf5 cooperates with Sox4 in oncogenesis and prevents Sox4-induced apoptosis. Smad4 is required for EMT but dispensable for Sox4 induction by TGF-beta. TGF-beta-induced Sox4 is thus geared to bolster progenitor identity, whereas simultaneous Smad4-dependent EMT strips Sox4 of an essential partner in oncogenesis. Our work demonstrates that TGF-beta tumor suppression functions through an EMT-mediated disruption of a lineage-specific transcriptional network.	[David, Charles J.; Huang, Yun-Han; Su, Jie; Zou, Yilong; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Chen, Mo] Rockefeller Univ, New York, NY 10065 USA; [Bardeesy, Nabeel] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Harvard University; Massachusetts General Hospital	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org	Iacobuzio-Donahue, Christine/ABF-1295-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Zou, Yilong/0000-0001-8198-6067; Huang, Yun-Han/0000-0002-3431-2163; Chen, Mo/0000-0002-6647-8483; Massague, Joan/0000-0001-9324-8408; Su, Jie/0000-0002-3071-7139	NIH [R01-CA34610, P30-CA008748]; MSKCC Translational Research Oncology Training Program; NIH Medical Scientist Training Program [T32GM007739]; NATIONAL CANCER INSTITUTE [T32CA160001, R01CA034610, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Translational Research Oncology Training Program; NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Lowe, A. Lujambio, J. Ahn, R. Garippa, and Q. Xiang for help and advice with shRNA screening. We thank C. Huang for the tandem shRNA vector and K. Xu, M. Overholtzer, and S.E. Kim for help with time-lapse videos. This work was supported by NIH grants R01-CA34610 (J.M.) and P30-CA008748 (MSKCC) and MSKCC Translational Research Oncology Training Program (C.J.D.). Y.-H.H. was supported by NIH Medical Scientist Training Program grant T32GM007739 to the Tri-Institutional MD/PhD Program.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bialkowska AB, 2014, J BIOL CHEM, V289, P5997, DOI 10.1074/jbc.M113.508549; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Campos FG, 2015, WORLD J GASTRO SURG, V7, P25, DOI 10.4240/wjgs.v7.i3.25; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Chia NY, 2015, GUT, V64, P707, DOI 10.1136/gutjnl-2013-306596; Cicchini C, 2006, J CELL PHYSIOL, V209, P230, DOI 10.1002/jcp.20730; DaCosta BS, 2004, MOL PHARM, V65, P744, DOI DOI 10.1124/M0L.65.3.744; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Duda DG, 2003, ONCOGENE, V22, P6857, DOI 10.1038/sj.onc.1206751; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Goggins M, 1998, CANCER RES, V58, P5329; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kim SK, 2000, GENE DEV, V14, P1866; Konturek PC, 1998, DIGESTION, V59, P110, DOI 10.1159/000007483; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; Ohnishi S, 2000, DEV DYNAM, V217, P421, DOI 10.1002/(SICI)1097-0177(200004)217:4<421::AID-DVDY9>3.0.CO;2-1; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Ramachandra M, 2002, CANCER RES, V62, P6045; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Stepanenko AA, 2013, GENE, V529, P199, DOI 10.1016/j.gene.2013.07.047; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vervoort SJ, 2013, ONCOGENE, V32, P3397, DOI 10.1038/onc.2012.506; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wagner M, 1999, PANCREAS, V19, P370, DOI 10.1097/00006676-199911000-00008; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wiater E, 2012, MOL CELL ENDOCRINOL, V359, P23, DOI 10.1016/j.mce.2012.02.015; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Zhang BT, 2013, MOL CELL BIOL, V33, P4919, DOI 10.1128/MCB.00787-13; Zhang H, 2013, CANCER CELL, V24, P575, DOI 10.1016/j.ccr.2013.09.018; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	59	369	383	1	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					1015	1030		10.1016/j.cell.2016.01.009	http://dx.doi.org/10.1016/j.cell.2016.01.009			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26898331	Green Accepted, Bronze			2022-12-28	WOS:000370867300023
J	Toda, C; Kim, JD; Impellizzeri, D; Cuzzocrea, S; Liu, ZW; Diano, S				Toda, Chitoku; Kim, Jung Dae; Impellizzeri, Daniela; Cuzzocrea, Salvatore; Liu, Zhong-Wu; Diano, Sabrina			UCP2 Regulates Mitochondrial Fission and Ventromedial Nucleus Control of Glucose Responsiveness	CELL			English	Article							UNCOUPLING PROTEIN-2; SKELETAL-MUSCLE; NERVOUS-SYSTEM; NEURONS; LEPTIN; HOMEOSTASIS; METABOLISM; RESPONSES; ENERGY; BRAIN	The ventromedial nucleus of the hypothalamus (VMH) plays a critical role in regulating systemic glucose homeostasis. How neurons in this brain area adapt to the changing metabolic environment to regulate circulating glucose levels is ill defined. Here, we show that glucose load results in mitochondrial fission and reduced reactive oxygen species in VMH neurons mediated by dynamin-related peptide 1 (DRP1) under the control of uncoupling protein 2 (UCP2). Probed by genetic manipulations and chemical-genetic control of VMH neuronal circuitry, we unmasked that this mitochondrial adaptation determines the size of the pool of glucose-excited neurons in the VMH and that this process regulates systemic glucose homeostasis. Thus, our data unmasked a critical cellular biological process controlled by mitochondrial dynamics in VMH regulation of systemic glucose homeostasis.	[Toda, Chitoku; Kim, Jung Dae; Impellizzeri, Daniela; Cuzzocrea, Salvatore; Liu, Zhong-Wu; Diano, Sabrina] Yale Univ, Yale Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Toda, Chitoku; Kim, Jung Dae; Impellizzeri, Daniela; Liu, Zhong-Wu; Diano, Sabrina] Yale Univ, Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Diano, Sabrina] Yale Univ, Yale Sch Med, Dept Neurosci, New Haven, CT 06520 USA; [Diano, Sabrina] Yale Univ, Yale Sch Med, Sect Comparat Med, New Haven, CT 06520 USA; [Impellizzeri, Daniela; Cuzzocrea, Salvatore] Univ Messina, Dept Biol & Environm Sci, I-98166 Messina, Italy	Yale University; Yale University; Yale University; Yale University; University of Messina	Diano, S (corresponding author), Yale Univ, Yale Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.; Diano, S (corresponding author), Yale Univ, Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.; Diano, S (corresponding author), Yale Univ, Yale Sch Med, Dept Neurosci, New Haven, CT 06520 USA.; Diano, S (corresponding author), Yale Univ, Yale Sch Med, Sect Comparat Med, New Haven, CT 06520 USA.	sabrina.diano@yale.edu		Toda, Chitoku/0000-0002-1641-6217; Impellizzeri, Daniela/0000-0001-9492-3161; Kim, Jung Dae/0000-0002-4750-6856; Cuzzocrea, Salvatore/0000-0001-6131-3690	NIH [DK097566, DK107293]; Manpei Suzuki Diabetes Foundation; JSPS Postdoctoral Fellowships for Research Abroad; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107293, R01DK097566] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; JSPS Postdoctoral Fellowships for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Klara Szigeti-Buck, Mariana Mattos, and Jin Kwon Jeong for their technical assistance. This work was supported by NIH grant DK097566 and DK107293 (to S.D.) and the Manpei Suzuki Diabetes Foundation and JSPS Postdoctoral Fellowships for Research Abroad (to C.T.).	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; BORG WP, 1994, J CLIN INVEST, V93, P1677, DOI 10.1172/JCI117150; Carneiro L, 2012, ANTIOXID REDOX SIGN, V17, P433, DOI 10.1089/ars.2011.4254; Chan O, 2013, TRENDS ENDOCRIN MET, V24, P616, DOI 10.1016/j.tem.2013.08.005; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Franklin K., 2007, MOUSE BRAIN STEREOTA; Grayson BE, 2013, NAT REV NEUROSCI, V14, P24, DOI 10.1038/nrn3409; Horvath TL, 1999, J NEUROSCI, V19, P10417; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kim JD, 2014, P NATL ACAD SCI USA, V111, P11876, DOI 10.1073/pnas.1406000111; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Liu ZW, 2011, J PHYSIOL-LONDON, V589, P4157, DOI 10.1113/jphysiol.2011.212514; Long LH, 2014, J CLIN INVEST, V124, P4017, DOI 10.1172/JCI76220; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Richard D, 1998, J COMP NEUROL, V397, P549; Sandoval DA, 2009, NAT REV DRUG DISCOV, V8, P386, DOI 10.1038/nrd2874; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Toda C, 2013, DIABETES, V62, P2295, DOI 10.2337/db12-1629; Toda C, 2009, DIABETES, V58, P2757, DOI 10.2337/db09-0638	26	100	104	3	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					872	883		10.1016/j.cell.2016.02.010	http://dx.doi.org/10.1016/j.cell.2016.02.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919426	Green Accepted, Bronze			2022-12-28	WOS:000370867300012
J	Telem, DA				Telem, Dana A.			Shared Decision Making in Uncomplicated Appendicitis It Is Time to Include Nonoperative Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Current evidence suggests that nonoperative management of uncomplicated appendicitis is safe, but overall effectiveness is determined by combining medical outcomes with the patient's and family's perspective, goals, and expectations. OBJECTIVE To determine the effectiveness of patient choice in nonoperative vs surgical management of uncomplicated acute appendicitis in children. DESIGN, SETTING, AND PARTICIPANTS Prospective patient choice cohort study in patients aged 7 to 17 years with acute uncomplicated appendicitis presenting at a single pediatric tertiary acute care hospital from October 1, 2012, through March 6, 2013. Participating patients and families gave informed consent and chose between nonoperative management and urgent appendectomy. INTERVENTIONS Urgent appendectomy or nonoperative management entailing at least 24 hours of inpatient observation while receiving intravenous antibiotics and, on demonstrating improvement of symptoms, completion of 10 days of treatment with oral antibiotics. MAIN OUTCOMES AND MEASURES The primary outcome was the 1-year success rate of nonoperative management. Successful nonoperative management was defined as not undergoing an appendectomy. Secondary outcomes included comparisons of the rates of complicated appendicitis, disability days, and health care costs between nonoperative management and surgery. RESULTS A total of 102 patients were enrolled; 65 patients/families chose appendectomy (median age, 12 years; interquartile range [IQR], 9-13 years; 45 male [69.2%]) and 37 patients/families chose nonoperative management (median age, 11 years; IQR, 10-14 years; 24 male [64.9%]). Baseline characteristics were similar between the groups. The success rate of nonoperative management was 89.2%(95% CI, 74.6%-97.0%) at 30 days (33 of 37 children) and 75.7%(95% CI, 58.9%-88.2%) at 1 year (28 of 37 children). The incidence of complicated appendicitis was 2.7% in the nonoperative group (1 of 37 children) and 12.3% in the surgery group (8 of 65 children) (P = .15). After 1 year, children managed nonoperatively compared with the surgery group had fewer disability days (median [IQR], 8 [5-18] vs 21 [15-25] days, respectively; P <.001) and lower appendicitis-related health care costs (median [IQR], $4219 [$2514-$7795] vs $5029 [$4596-$5482], respectively; P = .01). CONCLUSIONS AND RELEVANCE When chosen by the family, nonoperative management is an effective treatment strategy for children with uncomplicated acute appendicitis, incurring less morbidity and lower costs than surgery.	[Telem, Dana A.] SUNY Stony Brook, Med Ctr, Dept Surg, Div Bariatr Foregut & Adv Gastrointestinal Surg, 100 Nichols Rd,HSC T18-040, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Telem, DA (corresponding author), SUNY Stony Brook, Med Ctr, Dept Surg, Div Bariatr Foregut & Adv Gastrointestinal Surg, 100 Nichols Rd,HSC T18-040, Stony Brook, NY 11794 USA.	dana.telem@stonybrookmedicine.edu			Cook Medical; SurgiQuest	Cook Medical; SurgiQuest	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Telem reported having received research funding from Cook Medical and SurgiQuest, having a consulting agreement with Medtronic, and serving on an advisory board for Ethicon and course faculty for Gore.	Di Saverio S, 2014, ANN SURG, V260, P109, DOI 10.1097/SLA.0000000000000560; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Livingston Edward H, 2015, JAMA, V313, P2394, DOI 10.1001/jama.2015.6201; McCutcheon BA, 2014, J AM COLL SURGEONS, V218, P905, DOI 10.1016/j.jamcollsurg.2014.01.003; Minneci PC, 2016, JAMA SURG, V151, P408, DOI 10.1001/jamasurg.2015.4534; Minneci PC, 2014, J AM COLL SURGEONS, V219, P272, DOI 10.1016/j.jamcollsurg.2014.02.031; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154	7	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					811	+		10.1001/jama.2016.0168	http://dx.doi.org/10.1001/jama.2016.0168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903339				2022-12-28	WOS:000370700500016
J	Lewitus, E; Kelava, I; Kalinka, AT; Tomancak, P; Huttner, WB				Lewitus, Eric; Kelava, Iva; Kalinka, Alex T.; Tomancak, Pavel; Huttner, Wieland B.			BRAIN STRUCTURE Comment on "Cortical folding scales universally with surface area and thickness, not number of neurons"	SCIENCE			English	Editorial Material							SUBVENTRICULAR ZONE; RADIAL GLIA; EXPANSION	Mota and Herculano-Houzel (Reports, 3 July 2015, p. 74) assign power functions to neuroanatomical data and present a model to account for evolutionary patterns of cortical folding in the mammalian brain. We detail how the model assumptions are in conflict with experimental and observational work and show that the model itself does not accurately fit the data.	[Lewitus, Eric] Ecole Normale Super, Inst Biol, 24 Rue Lhomond, F-75231 Paris, France; [Kelava, Iva] MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England; [Kalinka, Alex T.] Vetmeduni, Inst Populat Genet, Vienna, Austria; [Tomancak, Pavel; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); MRC Laboratory Molecular Biology; Max Planck Society	Lewitus, E (corresponding author), Ecole Normale Super, Inst Biol, 24 Rue Lhomond, F-75231 Paris, France.; Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	lewitus@biologie.ens.fr; huttner@mpi-cbg.de	Tomancak, Pavel/C-2109-2009; Huttner, Wieland B./P-4080-2018	Tomancak, Pavel/0000-0002-2222-9370; 	MRC [MC_UP_1201/9] Funding Source: UKRI; Medical Research Council [MC_UP_1201/9] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		de Juan Romero C, 2015, EMBO J, V34, P1859, DOI 10.15252/embj.201591176; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Kelava I, 2012, CEREB CORTEX, V22, P469, DOI 10.1093/cercor/bhr301; Lewitus E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002000; Lewitus E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00424; Mota B, 2015, SCIENCE, V349, P74, DOI 10.1126/science.aaa9101; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; PARDO CAMPO ELÍAS, 2007, Rev.Colomb.Estad., V30, P231; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238	9	11	11	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275								10.1126/science.aad2029	http://dx.doi.org/10.1126/science.aad2029			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912886	Green Accepted			2022-12-28	WOS:000370325700032
J	Uyeki, TM; Mehta, AK; Davey, RT; Liddell, AM; Wolf, T; Vetter, P; Schmiedel, S; Grunewald, T; Jacobs, M; Arribas, JR; Evans, L; Hewlett, AL; Brantsaeter, AB; Ippolito, G; Rapp, C; Hoepelman, AIM; Rapp, C; Hoepelman, AIM; Gutman, J				Uyeki, Timothy M.; Mehta, Aneesh K.; Davey, Richard T., Jr.; Liddell, Allison M.; Wolf, Timo; Vetter, Pauline; Schmiedel, Stefan; Gruenewald, Thomas; Jacobs, Michael; Arribas, Jose R.; Evans, Laura; Hewlett, Angela L.; Brantsaeter, Arne B.; Ippolito, Giuseppe; Rapp, Christophe; Hoepelman, Andy I. M.; Rapp, Christophe; Hoepelman, Andy I. M.; Gutman, Julie		US-European Clinical Network	Clinical Management of Ebola Virus Disease in the United States and Europe	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVALESCENT PLASMA; CRITICAL-CARE; PATIENT; FEATURES	BACKGROUND Available data on the characteristics of patients with Ebola virus disease (EVD) and clinical management of EVD in settings outside West Africa, as well as the complications observed in those patients, are limited. METHODS We reviewed available clinical, laboratory, and virologic data from all patients with laboratory-confirmed Ebola virus infection who received care in U.S. and European hospitals from August 2014 through December 2015. RESULTS A total of 27 patients (median age, 36 years [range, 25 to 75]) with EVD received care; 19 patients (70%) were male, 9 of 26 patients (35%) had coexisting conditions, and 22 (81%) were health care personnel. Of the 27 patients, 24 (89%) were medically evacuated from West Africa or were exposed to and infected with Ebola virus in West Africa and had onset of illness and laboratory confirmation of Ebola virus infection in Europe or the United States, and 3 (11%) acquired EVD in the United States or Europe. At the onset of illness, the most common signs and symptoms were fatigue (20 patients [80%]) and fever or feverishness (17 patients [68%]). During the clinical course, the predominant findings included diarrhea, hypoalbuminemia, hyponatremia, hypokalemia, hypocalcemia, and hypomagnesemia; 14 patients (52%) had hypoxemia, and 9 (33%) had oliguria, of whom 5 had anuria. Aminotransferase levels peaked at a median of 9 days after the onset of illness. Nearly all the patients received intravenous fluids and electrolyte supplementation; 9 (33%) received noninvasive or invasive mechanical ventilation; 5 (19%) received continuous renalreplacement therapy; 22 (81%) received empirical antibiotics; and 23 (85%) received investigational therapies (19 [70%] received at least two experimental interventions). Ebola viral RNA levels in blood peaked at a median of 7 days after the onset of illness, and the median time from the onset of symptoms to clearance of viremia was 17.5 days. A total of 5 patients died, including 3 who had respiratory and renal failure, for a mortality of 18.5%. CONCLUSIONS Among the patients with EVD who were cared for in the United States or Europe, close monitoring and aggressive supportive care that included intravenous fluid hydration, correction of electrolyte abnormalities, nutritional support, and critical care management for respiratory and renal failure were needed; 81.5% of these patients who received this care survived.	[Uyeki, Timothy M.; Gutman, Julie] Ctr Dis Control & Prevent, Mail Stop A-20,1600 Clifton Rd NE, Atlanta, GA 30329 USA; [Mehta, Aneesh K.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [Davey, Richard T., Jr.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Liddell, Allison M.] Texas Hlth Presbyterian Hosp Dallas, Dallas, TX USA; [Wolf, Timo] Univ Hosp Frankfurt, Dept Infect Dis, Frankfurt, Germany; [Schmiedel, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Gruenewald, Thomas] Klinikum St Georg, Leipzig Treatment Ctr Highly Contagious Dis, Leipzig, Germany; [Vetter, Pauline] Univ Hosp Geneva, Div Infect Dis & Lab Virol, Geneva, Switzerland; [Jacobs, Michael] Royal Free London NHS Fdn Trust, Dept Infect, London, England; [Arribas, Jose R.] Hosp La Paz Carlos III IdiPAZ, Infect Dis Unit Madrid, Dept Internal Med, Madrid, Spain; [Evans, Laura] NYU, Bellevue Hosp Ctr, Sch Med, New York, NY 10016 USA; [Hewlett, Angela L.] Univ Nebraska Med Ctr, Omaha, NE USA; [Brantsaeter, Arne B.] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Brantsaeter, Arne B.] Oslo Univ Hosp, Dept Acute Med, Oslo, Norway; [Ippolito, Giuseppe] Lazzaro Spallanzani Natl Inst Infect Dis, Rome, Italy; [Rapp, Christophe] Begin Mil Hosp, Infect & Trop Dis Dept, St Mande, France; [Hoepelman, Andy I. M.] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands	Centers for Disease Control & Prevention - USA; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Geneva; University of London; University College London; Royal Free London NHS Foundation Trust; Bellevue Hospital Center; New York University; University of Nebraska System; University of Nebraska Medical Center; University of Oslo; University of Oslo; IRCCS Lazzaro Spallanzani; Utrecht University; Utrecht University Medical Center	Uyeki, TM (corresponding author), Ctr Dis Control & Prevent, Mail Stop A-20,1600 Clifton Rd NE, Atlanta, GA 30329 USA.	tuyeki@cdc.gov	Wiesch, Julian Schulze zur/AAT-8452-2021; Di Caro, Antonino/K-6854-2016; Ippolito, Giuseppe/J-7207-2017; Arnalich, Francisco/J-8184-2017; Martin, Daniel S/F-7997-2010; Wolf, Timo/AAQ-3521-2021; Anda, Pedro/V-8436-2019; Castilletti, Concetta/B-6545-2016; Vetter, Pauline/AAT-8066-2021; nicastri, emanuele/K-7780-2016; Arribas, Jose/A-1595-2015; Mehta, Aneesh/B-8054-2012; Mora-Rillo, Marta/E-8211-2015	Di Caro, Antonino/0000-0001-6027-3009; Wolf, Timo/0000-0002-3819-9540; Anda, Pedro/0000-0001-9081-8188; Castilletti, Concetta/0000-0001-9819-236X; Vetter, Pauline/0000-0002-9902-5069; nicastri, emanuele/0000-0002-5606-8712; Arsuaga Vicente, Marta/0000-0001-5522-3728; Brantsaeter, Arne Broch/0000-0003-1723-0577; Gruenewald, Thomas/0000-0002-2955-3085; Martin, Daniel/0000-0001-6220-8235; Arribas, Jose/0000-0002-7410-9450; Salzer, Helmut J.F./0000-0003-0146-8310; de la Calle-Prieto, Fernando/0000-0003-2544-3492; Hopkins, Susan/0000-0001-5179-5702; Ippolito, Giuseppe/0000-0002-1076-2979; Addo, Marylyn/0000-0003-2836-9224; Mehta, Aneesh/0000-0002-6552-9162; Gunther, Stephan/0000-0002-6562-0230; Mora-Rillo, Marta/0000-0002-2735-5931; Luth, Stefan/0000-0001-9946-0960; Taglietti, Fabrizio/0000-0001-6950-6040	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000984] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansumana R, 2015, NEW ENGL J MED, V372, P587, DOI 10.1056/NEJMc1413685; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Barry M, 2015, CLIN INFECT DIS, V60, P1821, DOI 10.1093/cid/civ202; Brett-Major DM, 2015, AM J TROP MED HYG, V92, P233, DOI 10.4269/ajtmh.14-0746; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Connor MJ, 2015, J AM SOC NEPHROL, V26, P31, DOI 10.1681/ASN.2014111057; Florescu DF, 2015, CLIN INFECT DIS, V61, P969, DOI 10.1093/cid/civ395; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Hunt L, 2015, LANCET INFECT DIS, V15, P1292, DOI 10.1016/S1473-3099(15)00144-9; Johnson DW, 2015, CRIT CARE MED, V43, P1157, DOI 10.1097/CCM.0000000000000935; Kraft CS, 2015, CLIN INFECT DIS, V61, P496, DOI 10.1093/cid/civ334; Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677; Lamontagne F, 2014, NEW ENGL J MED, V371, P1565, DOI 10.1056/NEJMp1411310; Liddell AM, 2015, ANN INTERN MED, V163, P81, DOI 10.7326/M15-0530; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Parra JM, 2014, NEW ENGL J MED, V371, P2439, DOI 10.1056/NEJMc1412662; Martines RB, 2015, J PATHOL, V235, P153, DOI 10.1002/path.4456; Mora-Rillo M, 2015, LANCET RESP MED, V3, P554, DOI 10.1016/S2213-2600(15)00180-0; O'Dempsey T, 2015, AM J TROP MED HYG, V92, P238, DOI 10.4269/ajtmh.14-0719; Qin EQ, 2015, CLIN INFECT DIS, V61, P491, DOI 10.1093/cid/civ319; Schibler M, 2015, LANCET INFECT DIS, V15, P1034, DOI 10.1016/S1473-3099(15)00229-7; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Sueblinvong V, 2015, CRIT CARE MED, V43, P2066, DOI 10.1097/CCM.0000000000001197; WHO, 2015, EB SIT REP; Wolf T, 2015, LANCET, V385, P1428, DOI 10.1016/S0140-6736(14)62384-9	26	228	233	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					636	646		10.1056/NEJMoa1504874	http://dx.doi.org/10.1056/NEJMoa1504874			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26886522	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000370229000009
J	Matsumura, H; Mohri, Y; Binh, NT; Morinaga, H; Fukuda, M; Ito, M; Kurata, S; Hoeijmakers, J; Nishimura, EK				Matsumura, Hiroyuki; Mohri, Yasuaki; Nguyen Thanh Binh; Morinaga, Hironobu; Fukuda, Makoto; Ito, Mayumi; Kurata, Sotaro; Hoeijmakers, Jan; Nishimura, Emi K.			Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1	SCIENCE			English	Article							DNA-DAMAGE; IN-VIVO; C-MYC; SKIN; DIFFERENTIATION; REPAIR; NICHE; AGE; MECHANISMS; ALOPECIA	Hair thinning and loss are prominent aging phenotypes but have an unknown mechanism. We show that hair follicle stem cell (HFSC) aging causes the stepwise miniaturization of hair follicles and eventual hair loss in wild-type mice and in humans. In vivo fate analysis of HFSCs revealed that the DNA damage response in HFSCs causes proteolysis of type XVII collagen (COL17A1/BP180), a critical molecule for HFSC maintenance, to trigger HFSC aging, characterized by the loss of stemness signatures and by epidermal commitment. Aged HFSCs are cyclically eliminated from the skin through terminal epidermal differentiation, thereby causing hair follicle miniaturization. The aging process can be recapitulated by Col17a1 deficiency and prevented by the forced maintenance of COL17A1 in HFSCs, demonstrating that COL17A1 in HFSCs orchestrates the stem cell-centric aging program of the epithelial mini-organ.	[Matsumura, Hiroyuki; Mohri, Yasuaki; Nguyen Thanh Binh; Morinaga, Hironobu; Fukuda, Makoto; Nishimura, Emi K.] Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan; [Nguyen Thanh Binh] Kanazawa Univ, Canc Res Inst, Dept Stem Cell Med, Kanazawa, Ishikawa 9200934, Japan; [Ito, Mayumi] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Ito, Mayumi] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Kurata, Sotaro] Kurata Clin, Beppu Garden Hill Clin, Beppu, Oita 8740831, Japan; [Hoeijmakers, Jan] Erasmus MC, Dept Genet, Canc Genom Ctr, Room Ee 722,Dr Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands	Tokyo Medical & Dental University (TMDU); Kanazawa University; New York University; New York University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Nishimura, EK (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	nishscm@tmd.ac.jp	Matsumura, Hiroyuki/AHH-2478-2022; Hoeijmakers, Jan/AAX-6972-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [26221303, 26115003, LS042]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [26221303, 26115003, LS042]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Y. Nishimori, K. Inomata, Y. Tadokoro, R. Yajima, D. Nanba, H. Shimizu, K. Yancey, I. Morita, F. Ishino, M. Kanai, M. Ohyama, S. Inui, S. Itami, and M. Amagai for their helpful support and DASS Manuscript for editing. E.K.N. has been supported by a Grant-in-Aid for Scientific Research S (26221303), a Grant-in-Aid for Scientific Research on Innovative Areas "Stem Cell Aging and Disease"(26115003), Funding Program for Next Generation World-Leading Researchers (NEXT Program) (LS042), Grant-in-Aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and also by the Takeda Science Foundation. E.N. and H.M. are authors on a patent applied for by Tokyo Medical and Dental University that relates to drugs that modulate COL17A1 or ELANE expression or function for alopecia.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Arking R., 1998, THE BIOL OF AGING; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; BERTELL R, 1977, J SURG ONCOL, V9, P379, DOI 10.1002/jso.2930090409; Bhattacharyya Tapan K, 2004, Arch Facial Plast Surg, V6, P21, DOI 10.1001/archfaci.6.1.21; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen CC, 2014, J INVEST DERMATOL, V134, P2086, DOI 10.1038/jid.2014.139; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; de Lacharriere O, 2001, ARCH DERMATOL, V137, P641; Deschene ER, 2014, SCIENCE, V343, P1353, DOI 10.1126/science.1248373; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Franzke CW, 2009, J BIOL CHEM, V284, P23386, DOI 10.1074/jbc.M109.034090; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Giangreco A, 2008, AGING CELL, V7, P250, DOI 10.1111/j.1474-9726.2008.00372.x; Gilbert S.F, 2013, DEV BIOL, VTenth; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Heilmann S, 2013, J INVEST DERMATOL, V133, P1489, DOI 10.1038/jid.2013.43; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hofer AC, 2005, J GERONTOL A-BIOL, V60, P10, DOI 10.1093/gerona/60.1.10; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ishikawa Y, 2013, ONCOGENE, V32, P1921, DOI 10.1038/onc.2012.213; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110; KLIGMAN AM, 1988, CLIN DERMATOL, V6, P108, DOI 10.1016/0738-081X(88)90074-0; Kumar V, 2002, ROBBINS BASIC PATHOL; Laval S, 2014, ONCOGENE, V33, P1934, DOI 10.1038/onc.2013.146; Lawenda BD, 2004, INT J RADIAT ONCOL, V60, P879, DOI 10.1016/j.ijrobp.2004.04.031; Lin L, 2012, MATRIX BIOL, V31, P38, DOI 10.1016/j.matbio.2011.09.003; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Olasz EB, 2007, J INVEST DERMATOL, V127, P2807, DOI 10.1038/sj.jid.5700970; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Schaffitzel E, 2006, EXP GERONTOL, V41, P557, DOI 10.1016/j.exger.2006.02.008; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; SMITH L, 1989, CUTIS, V43, P414; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Wen CS, 2003, CLIN NEUROL NEUROSUR, V105, P215, DOI 10.1016/S0303-8467(03)00007-6; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105	74	176	180	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273								10.1126/science.aad4395	http://dx.doi.org/10.1126/science.aad4395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5UQ	26912707				2022-12-28	WOS:000407595700001
J	Costa, F; Sarno, M; Khouri, R; Freitas, BD; Siqueira, I; Ribeiro, GS; Ribeiro, HC; Campos, GS; Alcantara, LC; Reis, MG; Weaver, SC; Vasilakis, N; Ko, AI; Almeida, AR				Costa, Federico; Sarno, Manoel; Khouri, Ricardo; Freitas, Bruno de Paula; Siqueira, Isadora; Ribeiro, Guilherme S.; Ribeiro, Hugo C.; Campos, Gubio S.; Alcantara, Luiz C.; Reis, Mitermayer G.; Weaver, Scott C.; Vasilakis, Nikos; Ko, Albert I.; Almeida, Antonio Raimundo			Emergence of Congenital Zika Syndrome: Viewpoint From the Front Lines	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS; DENGUE		[Khouri, Ricardo; Ribeiro, Guilherme S.; Alcantara, Luiz C.] Minist Saude, Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil; [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil; Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil; [Freitas, Bruno de Paula; Ribeiro, Hugo C.] Secretaria Estadual Saude Bahia, Hosp Geral Roberto Santos, Ave Paulo 6,2240,Apt 1004, BR-41810001 Salvador, BA, Brazil; Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA; Univ Texas Med Branch, Galveston, TX 77555 USA; [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St,POB 208034, New Haven, CT 06520 USA; [Costa, Federico] Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil; [Sarno, Manoel] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia & Maternidade Clime, Rua Limoeiro 137, BR-41055150 Salvador, BA, Brazil; [Siqueira, Isadora; Reis, Mitermayer G.] Funda, Ctr Pesquisas Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil; [Campos, Gubio S.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil; [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA; [Almeida, Antonio Raimundo] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia, Ave Santa Luzia 149-302,Ed Bosque Italia, BR-40295050 Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal da Bahia; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Yale University; Universidade Federal da Bahia; Fundacao Oswaldo Cruz; Universidade Federal da Bahia; University of Texas System; University of Texas Medical Branch Galveston; Universidade Federal da Bahia	Costa, F (corresponding author), Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.	fcosta2001@gmail.com	Alcantara, Luiz Carlos Júnior/AAK-9468-2021; Campos, Gúbio Soares/AAM-1183-2021; Ko, Albert/P-2343-2015; Costa, Federico/G-1838-2015; Vasilakis, Nikos/ABE-7318-2020; Weaver, Scott C/D-6490-2011; Reis, Mitermayer/AAO-9742-2020; de Siqueira, Isadora Cristina/R-9953-2016; Ribeiro, Guilherme/B-6624-2008; Khouri, Ricardo/M-3184-2018	Ko, Albert/0000-0001-9023-2339; Costa, Federico/0000-0001-6951-2336; Weaver, Scott C/0000-0001-8016-8556; Reis, Mitermayer/0000-0002-3051-9060; de Siqueira, Isadora Cristina/0000-0002-2520-4099; Ribeiro, Guilherme/0000-0002-6798-2059; Khouri, Ricardo/0000-0001-5664-4436; Alcantara, Luiz/0000-0002-6769-9931	FOGARTY INTERNATIONAL CENTER [R01TW009504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121207] Funding Source: NIH RePORTER; FIC NIH HHS [R01 TW009504] Funding Source: Medline; NIAID NIH HHS [R01 AI121207] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Oehler E, 2014, Euro Surveill, V19; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7	9	62	64	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					689	+		10.7326/M16-0332	http://dx.doi.org/10.7326/M16-0332			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	26914810	Green Accepted, Green Published			2022-12-28	WOS:000375878500019
J	Levine, DA; Karlan, BY; Strauss, JF				Levine, Douglas A.; Karlan, Beth Y.; Strauss, Jerome F., III			Evolving Approaches in Research and Care for Ovarian Cancers A Report From the National Academies of Sciences, Engineering, and Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Karlan, Beth Y.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Strauss, Jerome F., III] Virginia Commonwealth Univ, Sch Med, Dept Obstet & Gynecol, Richmond, VA 23284 USA	Memorial Sloan Kettering Cancer Center; Cedars Sinai Medical Center; Virginia Commonwealth University	Levine, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, Gynecol Res Lab, 1275 York Ave, New York, NY 10065 USA.	levine2@mskcc.org		Levine, Douglas/0000-0003-1038-8232				Bookman MA, 2014, JNCI-J NATL CANCER I, V106; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Bristow RE, 2014, GYNECOL ONCOL, V134, P60, DOI 10.1016/j.ygyno.2014.03.561; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; National Academies of Sciences Engineering and Medicine, 2016, OV CANC EV PAR RES C; Perets R, 2016, CANCER RES, V76, P10, DOI 10.1158/0008-5472.CAN-15-1382; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]	7	10	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1943	1944		10.1001/jama.2016.2640	http://dx.doi.org/10.1001/jama.2016.2640			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	26934631				2022-12-28	WOS:000375461100007
J	Lavizzo-Mourey, R				Lavizzo-Mourey, Risa			Halfway There? Health Reform Starts Now	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lavizzo-Mourey, Risa] Robert Wood Johnson Fdn, Princeton, NJ 08540 USA	Robert Wood Johnson Foundation (RWJF)	Lavizzo-Mourey, R (corresponding author), Robert Wood Johnson Fdn, Princeton, NJ 08540 USA.	rlavizz@rwjf.org						Crespo R, PARTNERSHIP COMMUNIT, DOI [10.1177/2325160315569046, DOI 10.1177/2325160315569046]; Hunter WG, 2016, MED DECIS MAKING, V36, P900, DOI 10.1177/0272989X15626384; Martin J, 2015, HLTH AFFAIRS BLOG BL; Wright E, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4872	4	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1335	1336		10.1001/jama.2016.1732	http://dx.doi.org/10.1001/jama.2016.1732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	26940727				2022-12-28	WOS:000373381500013
J	Bredlau, AL				Bredlau, Amy-Lee			Where Do You Put the Pain?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bredlau, Amy-Lee] Med Univ S Carolina, Pediat Brain Tumor Program, Dept Pediat, Charleston, SC 29412 USA	Medical University of South Carolina	Bredlau, AL (corresponding author), Med Univ S Carolina, Pediat Brain Tumor Program, Dept Pediat, Charleston, SC 29412 USA.	bredlau@musc.edu							0	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					983	983		10.1001/jama.2015.17474	http://dx.doi.org/10.1001/jama.2015.17474			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954404				2022-12-28	WOS:000371540200008
J	Lee, JH; Ozorowski, G; Ward, AB				Lee, Jeong Hyun; Ozorowski, Gabriel; Ward, Andrew B.			Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer	SCIENCE			English	Article							DEPENDENT EPITOPE; CRYSTAL-STRUCTURE; ANTIBODIES; ENV; NEUTRALIZATION; RECOGNITION; VIRUS; GP41; GLYCOPROTEIN; MECHANISM	The envelope glycoprotein trimer (Env) on the surface of HIV-1 recognizes CD4(+) Tcells and mediates viral entry. During this process, Env undergoes substantial conformational rearrangements, making it difficult to study in its native state. Soluble stabilized trimers have provided valuable insights into the Env structure, but they lack the hydrophobic membrane proximal external region (MPER, an important target of broadly neutralizing antibodies), the transmembrane domain, and the cytoplasmic tail. Here we present (i) a cryogenic electron microscopy (cryo-EM) structure of a clade B virus Env, which lacks only the cytoplasmic tail and is stabilized by the broadly neutralizing antibody PGT151, at a resolution of 4.2 angstroms and (ii) a reconstruction of this form of Env in complex with PGT151 and MPER-targeting antibody 10E8 at a resolution of 8.8 angstroms. These structures provide new insights into the wild-type Env structure.	[Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA	International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute	Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.	abward@scripps.edu	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014; Ozorowski, Gabriel/HCH-0634-2022	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Lee, Jeong Hyun/0000-0001-7371-845X	NIH [UM1 AI100663]; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery [OPP1084519, OPP1115782]; California HIV/AIDS Research Program Dissertation Award; IAVI; U.S. Agency for International Development (USAID); Ministry of Foreign Affairs of the Netherlands; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery; California HIV/AIDS Research Program Dissertation Award; IAVI; U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Ministry of Foreign Affairs of the Netherlands; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Blattner for the PGT151 and JR-FL Env Delta CT plasmids, J. Torres and N. Overney for helping with plasmid preparations, T. Nieusma for technical assistance, A. Sarkar and L. Kong for advice on glycan modeling, and I. A. Wilson for helpful comments and discussion. The data from this study are tabulated in the main paper and in the supplementary materials. The cryo-EM reconstructions of JR-FL Env Delta CT-PGT151 and JR-FL Env Delta CT-PGT151 Fab-10E8 Fab and the model of JR-FL Env Delta CT-PGT151 have been submitted to the PDB and the Electron Microscopy Data Bank with accession codes PDB-5FUU, EMD-3308, EMD-3309, and EMD-3312. This work was supported by the NIH (grant UM1 AI100663), the International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery (grants OPP1084519 and OPP1115782), and the California HIV/AIDS Research Program Dissertation Award (to J.H.L.). This work was partially funded by IAVI with the generous support of the U.S. Agency for International Development (USAID), the Ministry of Foreign Affairs of the Netherlands, and the Bill and Melinda Gates Foundation; a full list of IAVI donors is available at www.iavi.org. The contents of this manuscript are the responsibility of the authors and do not necessarily reflect the views of USAID or the U.S. government. The EM work was conducted at the cryogenic electron microscopy facility at The Scripps Research Institute. This is manuscript number 29175 from the Scripps Research Institute.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Crooks Emma T., 2005, Human Antibodies, V14, P101; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Go EP, 2015, J VIROL, V89, P8245, DOI 10.1128/JVI.00628-15; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Julien JP, 2015, P NATL ACAD SCI USA, V112, P11947, DOI 10.1073/pnas.1507793112; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kim AS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004271; Leaman DP, 2015, J VIROL, V89, P6725, DOI 10.1128/JVI.03738-14; Lee JH, 2015, STRUCTURE, V23, P1943, DOI 10.1016/j.str.2015.07.020; Lee JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9167; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Pritchard LK, 2015, J VIROL, V89, P6952, DOI 10.1128/JVI.00230-15; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Sun ZYJ, 2014, J MOL BIOL, V426, P1095, DOI 10.1016/j.jmb.2013.09.030; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0	43	304	312	5	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1043	1048		10.1126/science.aad2450	http://dx.doi.org/10.1126/science.aad2450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941313	Green Accepted			2022-12-28	WOS:000371597500034
J	Luo, C; Puigserver, P				Luo, Chi; Puigserver, Pere			Dietary fat promotes intestinal dysregulation	NATURE			English	Editorial Material							STEM-CELL	In mice, a high-fat diet has now been found to induce intestinal progenitor cells to adopt a more stem-cell-like fate, altering the size of the gut and increasing tumour incidence.	[Luo, Chi; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Luo, Chi; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Puigserver, P (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.; Puigserver, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	pere_puigserver@dfci.harvard.edu		LUO, CHI/0000-0001-7669-9506				Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Gruber L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071661; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Kesse E, 2006, AM J EPIDEMIOL, V164, P1085, DOI 10.1093/aje/kwj324; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Nihaylova M. M., 2014, CELL STEM CELL, V14, P292; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	11	5	5	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					42	43		10.1038/531042a	http://dx.doi.org/10.1038/531042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26935693				2022-12-28	WOS:000371211900034
J	Ismail, LC; Bishop, DC; Pang, RY; Ohuma, EO; Kac, G; Abrams, B; Rasmussen, K; Barros, FC; Hirst, JE; Lambert, A; Papageorghiou, AT; Stones, W; Jaffer, YA; Altman, DG; Noble, JA; Giolito, MR; Gravett, MG; Purwar, M; Kennedy, SH; Bhutta, ZA; Villar, J				Ismail, Leila Cheikh; Bishop, Deborah C.; Pang, Ruyan; Ohuma, Eric O.; Kac, Gilberto; Abrams, Barbara; Rasmussen, Kathleen; Barros, Fernando C.; Hirst, Jane E.; Lambert, Ann; Papageorghiou, Aris T.; Stones, William; Jaffer, Yasmin A.; Altman, Douglas G.; Noble, J. Alison; Giolito, Maria Rosa; Gravett, Michael G.; Purwar, Manorama; Kennedy, Stephen H.; Bhutta, Zulfiqar A.; Villar, Jose			Gestational weight gain standards based on women enrolled in the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: a prospective longitudinal cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; INTERNATIONAL STANDARDS; PREGNANCY; AGE; DESIGN; CHARTS; RISK; BMI; CIRCUMFERENCE; CONSTRUCTION	OBJECTIVE To describe patterns in maternal gestational weight gain (GWG) in healthy pregnancies with good maternal and perinatal outcomes. DESIGN Prospective longitudinal observational study. SETTING Eight geographically diverse urban regions in Brazil, China, India, Italy, Kenya, Oman, United Kingdom, and United States, April 2009 to March 2014. PARTICIPANTS Healthy, well nourished, and educated women enrolled in the Fetal Growth Longitudinal Study component of the INTERGROWTH-21stProject, who had a body mass index (BMI) of 18.50-24.99 in the first trimester of pregnancy. MAIN OUTCOME MEASURES Maternal weight measured with standardised methods and identical equipment every five weeks (plus/minus one week) from the first antenatal visit (<14 weeks' gestation) to delivery. After confirmation that data from the study sites could be pooled, a multilevel, linear regression analysis accounting for repeated measures, adjusted for gestational age, was applied to produce RESULTS 13 108 pregnant women at <14 weeks' gestation were screened, and 4607 met the eligibility criteria, provided consent, and were enrolled. The variance within sites (59.6%) was six times higher than the variance between sites (9.6%). The mean GWGs were 1.64 kg, 2.86 kg, 2.86 kg, 2.59 kg, and 2.56 kg for the gestational age windows 14-18(+6) weeks, 19-23(+6) weeks, 24-28(+6) weeks, 29-33(+6) weeks, and 34-40(+0) weeks, respectively. Total mean weight gain at 40 weeks' gestation was 13.7 (SD 4.5) kg for 3097 eligible women with a normal BMI in the first trimester. Of all the weight measurements, 71.7% (10 639/14 846) and 94.9% (14 085/14 846) fell within the expected 1 SD and 2 SD thresholds, respectively. Data were used to determine fitted 3rd, 10th, 25th, 50th, 75th, 90th, and 97th smoothed GWG centiles by exact week of gestation, with equations for the mean and standard deviation to calculate any desired centiles according to gestational age in exact weeks. CONCLUSIONS Weight gain in pregnancy is similar across the eight populations studied. Therefore, the standards generated in this study of healthy, well nourished women may be used to guide recommendations on optimal gestational weight gain worldwide.	[Ismail, Leila Cheikh; Bishop, Deborah C.; Ohuma, Eric O.; Hirst, Jane E.; Lambert, Ann; Papageorghiou, Aris T.; Kennedy, Stephen H.; Villar, Jose] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Green Templeton Coll, Oxford, England; [Ismail, Leila Cheikh; Bishop, Deborah C.; Ohuma, Eric O.; Hirst, Jane E.; Lambert, Ann; Papageorghiou, Aris T.; Kennedy, Stephen H.; Villar, Jose] Univ Oxford, Oxford Maternal & Perinatal Hlth Inst, Green Templeton Coll, Oxford, England; [Pang, Ruyan] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Ohuma, Eric O.; Altman, Douglas G.] Univ Oxford, Botnar Res Ctr, Ctr Stat Med, Oxford, England; [Kac, Gilberto] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Inst Nutr, Dept Nutr Social & Aplicada, Rio De Janeiro, Brazil; [Abrams, Barbara] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Rasmussen, Kathleen] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Barros, Fernando C.] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, RS, Brazil; [Barros, Fernando C.] Univ Catolica Pelotas, Programa Posgrad Saude Comportamento, Pelotas, RS, Brazil; [Stones, William] Aga Khan Univ, Fac Hlth Sci, Nairobi, Kenya; [Stones, William] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Jaffer, Yasmin A.] Minist Hlth, Dept Family & Community Hlth, Muscat, Oman; [Noble, J. Alison] Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England; [Giolito, Maria Rosa] Direttore SC Consultori Familiari & Pediat Comuni, Turin, Italy; [Gravett, Michael G.] Seattle Childrens, GAPPS, Seattle, WA USA; [Purwar, Manorama] Ketkar Hosp, Nagpur INTERGROWTH Res Ctr 21, Nagpur, Maharashtra, India; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada	University of Oxford; University of Oxford; Peking University; University of Oxford; Universidade Federal do Rio de Janeiro; University of California System; University of California Berkeley; Cornell University; Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas; Aga Khan University; University of St Andrews; University of Oxford; Seattle Children's Hospital; Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ismail, LC (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Green Templeton Coll, Oxford, England.; Ismail, LC (corresponding author), Univ Oxford, Oxford Maternal & Perinatal Hlth Inst, Green Templeton Coll, Oxford, England.	cheikhismail@obs-gyn.ox.ac.uk	Hirst, Jane/AAM-9891-2020; Hirst, Jane Elizabeth/L-8863-2019; Stones, William/R-8618-2016; Kac, Gilberto/H-6862-2012; Bhutta, Zulfiqar/L-7822-2015	Hirst, Jane/0000-0002-0176-2651; Stones, William/0000-0003-0699-2381; Kac, Gilberto/0000-0001-8603-9077; Noble, Alison/0000-0002-3060-3772; Bhutta, Zulfiqar/0000-0003-0637-599X; Barros, Fernando/0000-0001-5973-1746; Papageorghiou, Aris T./0000-0001-8143-2232; Cheikh Ismail, Leila/0000-0003-3048-7481	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This project was supported by the Bill and Melinda Gates Foundation to the University of Oxford. The sponsor played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	ABRAMS B, 1990, OBSTET GYNECOL, V76, P1; Alavi N, 2013, OBES REV, V14, P68, DOI 10.1111/j.1467-789X.2012.01059.x; Altman DG, 2013, BJOG-INT J OBSTET GY, V120, P71, DOI 10.1111/1471-0528.12031; ALTMAN DG, 1993, ULTRASOUND OBST GYN, V3, P378, DOI 10.1046/j.1469-0705.1993.03060378.x; [Anonymous], 2010, WEIGHT MAN PREGN; [Anonymous], 2012, ANTHR HDB; [Anonymous], 2008, ANTENATAL CARE UNCOM; Calvo EB, 2009, J MATERN-FETAL NEO M, V22, P36, DOI 10.1080/14767050802464502; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Carmichael S, 1997, AM J PUBLIC HEALTH, V87, P1984, DOI 10.2105/AJPH.87.12.1984; Casanueva E, 2008, FOOD NUTR BULL, V29, P334, DOI 10.1177/156482650802900410; Caulfield LE, 1996, OBSTET GYNECOL, V87, P760, DOI 10.1016/0029-7844(96)00023-3; Cedergren M, 2006, INT J GYNECOL OBSTET, V93, P269, DOI 10.1016/j.ijgo.2006.03.002; Chu SY, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.879; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Drehmer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054704; Ee TX, 2014, J OBSTET GYNAECOL RE, V40, P1002, DOI 10.1111/jog.12307; Engstrom JL, 2003, J MIDWIFERY WOM HEAL, V48, P338, DOI 10.1016/S1526-9523(03)00281-2; Eskenazi B, 2013, BJOG-INT J OBSTET GY, V120, P129, DOI 10.1111/1471-0528.12430; Fraser A, 2011, AM J CLIN NUTR, V93, P1285, DOI 10.3945/ajcn.110.008326; Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; Guelinckx I, 2010, GYNECOL OBSTET INVES, V69, P57, DOI 10.1159/000255762; Harris HE, 1998, J NURSE-MIDWIFERY, V43, P97, DOI 10.1016/S0091-2182(97)00159-6; Hedderson MM, 2006, OBSTET GYNECOL, V108, P1153, DOI 10.1097/01.AOG.0000242568.75785.68; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; Holland E, 2013, MATERN CHILD HLTH J, V17, P1872, DOI 10.1007/s10995-012-1210-9; Hutcheon JA, 2013, AM J CLIN NUTR, V97, P1062, DOI 10.3945/ajcn.112.051706; Hynek M, 2010, EUR J BIOMED INFORM, V6, P51; Institute of Medicine (IOM-US) Committee on Nutritional Status During Pregnancy and Lactation, 1990, NUTR PREGN; Ismail LC, 2013, BJOG-INT J OBSTET GY, V120, P42, DOI 10.1111/1471-0528.12125; Ismail LC, 2013, BJOG-INT J OBSTET GY, V120, P48, DOI 10.1111/1471-0528.12127; Kramer MS, 1999, PEDIATRICS, V103, P599, DOI 10.1542/peds.103.3.599; KRAMER MS, 1995, OBSTET GYNECOL, V86, P744, DOI 10.1016/0029-7844(95)00267-U; Leckie G, 2013, J STAT SOFTW, V52, P1; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; McCowan L, 2009, BEST PRACT RES CL OB, V23, P779, DOI 10.1016/j.bpobgyn.2009.06.003; National Research Council (NRC-US) Committee on Maternal Nutrition, 1970, MAT NUTR COURS PREGN; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x; Ochsenbein-Kolble N, 2007, EUR J OBSTET GYN R B, V130, P180, DOI 10.1016/j.ejogrb.2006.03.024; Ohadike CO, ADV NUTR IN PRESS; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Pawlak MT, 2015, J IMMIGR MINOR HEALT, V17, P325, DOI 10.1007/s10903-013-9886-5; Rasmussen KM, 2009, FOOD NUTR BOARD CHIL; ROYSTON P, 1995, ULTRASOUND OBST GYN, V6, P307, DOI 10.1046/j.1469-0705.1995.06050307.x; Scott C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-167; Sherrard A, 2007, BJOG-INT J OBSTET GY, V114, P1088, DOI 10.1111/j.1471-0528.2007.01275.x; Takimoto H, 2006, INT J GYNECOL OBSTET, V92, P272, DOI 10.1016/j.ijgo.2005.12.023; Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047; Villar J, 2015, LANCET GLOB HEALTH, V3, pE681, DOI 10.1016/S2214-109X(15)00163-1; Villar J, 2014, LANCET DIABETES ENDO, V2, P781, DOI 10.1016/S2213-8587(14)70121-4; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; WHO, 2006, BMI CLASS; Wong W, 2000, J AM DIET ASSOC, V100, P791, DOI 10.1016/S0002-8223(00)00230-3; World Health Organization, 1995, WHO TECH REP SER, V854, P1; Wright EM, 1997, J R STAT SOC A STAT, V160, P47, DOI 10.1111/1467-985X.00045; Xu JJ, 2014, AM J CLIN NUTR, V99, P296, DOI 10.3945/ajcn.113.074120; Yan J, 2015, ECON HUM BIOL, V18, P1, DOI 10.1016/j.ehb.2015.03.002	61	93	94	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 29	2016	352								i555	10.1136/bmj.i555	http://dx.doi.org/10.1136/bmj.i555			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LH	26926301	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000371755800001
J	Farsi, Z; Preobraschenski, J; van den Bogaart, G; Riedel, D; Jahn, R; Woehler, A				Farsi, Zohreh; Preobraschenski, Julia; van den Bogaart, Geert; Riedel, Dietmar; Jahn, Reinhard; Woehler, Andrew			Single-vesicle imaging reveals different transport mechanisms between glutamatergic and GABAergic vesicles	SCIENCE			English	Article							SYNAPTIC VESICLES; QUANTAL SIZE; SYNAPTOPHLUORIN; HIPPOCAMPUS; GABA	Synaptic transmission is mediated by the release of neurotransmitters, which involves exo-endocytotic cycling of synaptic vesicles. To maintain synaptic function, synaptic vesicles are refilled with thousands of neurotransmitter molecules within seconds after endocytosis, using the energy provided by an electrochemical proton gradient. However, it is unclear how transmitter molecules carrying different net charges can be efficiently sequestered while maintaining charge neutrality and osmotic balance. We used single-vesicle imaging to monitor pH and electrical gradients and directly showed different uptake mechanisms for glutamate and g-aminobutyric acid (GABA) operating in parallel. In contrast to glutamate, GABA was exchanged for protons, with no other ions participating in the transport cycle. Thus, only a few components are needed to guarantee reliable vesicle filling with different neurotransmitters.	[Farsi, Zohreh; Preobraschenski, Julia; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [van den Bogaart, Geert] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 GA Nijmegen, Netherlands; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Lab, D-37077 Gottingen, Germany; [Woehler, Andrew] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; [Woehler, Andrew] Res Ctr Nanoscale Microscopy & Mol Physiol Brain, DFG, D-37073 Gottingen, Germany	Max Planck Society; Radboud University Nijmegen; Max Planck Society; Max Planck Society; German Research Foundation (DFG)	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de	van den Bogaart, Geert/GLV-3283-2022; van den Bogaart, Geert/A-1089-2014; Preobraschenski, Julia/AAD-8478-2022	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; Farsi, Zohreh/0000-0001-7274-981X; Woehler, Andrew/0000-0001-5157-9313; Jahn, Reinhard/0000-0003-1542-3498	Radboud University Medical Center; European Research Council (ERC) under the European Union [336479]; Cluster of Excellence; DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain	Radboud University Medical Center; European Research Council (ERC) under the European Union(European Research Council (ERC)); Cluster of Excellence; DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	The authors thank V. N. Murthy (Cambridge, MA) and W. Tyler (Roanoke, VA) for providing transgenic mice, U. Teichmann (Gottingen) for arranging animal delivery and husbandry, M. Kohansal-Nodehi (Gottingen) for mass spectrometry, L. Kastrup (Gottingen) for assistance in setting up total internal reflection fluorescence microscopy, S. Ahmed (Gottingen) for help in subcellular fractionation, and E. Neher (Gottingen) for scientific discussions. We thank V. N. Belov, J. Schimpfhauser, and J. Bienert (Facility for the Synthetic Chemistry of Max Planck Institute for Biophysical Chemistry) for the synthesis of VF2.1.Cl. G.v.d.B. is funded by a Hypatia fellowship from the Radboud University Medical Center and is the recipient of a Starting Grant from the European Research Council (ERC) under the European Union's Seventh Framework Programme (grant agreement 336479). A.W. is funded by the Cluster of Excellence and the DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain. Additional data described in the manuscript are presented in the supplementary materials.	Ahnert-Hilger G, 2011, NAT NEUROSCI, V14, P405, DOI 10.1038/nn.2786; Blakely RD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005595; Budzinski KL, 2011, BIOPHYS J, V101, P1580, DOI 10.1016/j.bpj.2011.08.032; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; Goh GY, 2011, NAT NEUROSCI, V14, P1285, DOI 10.1038/nn.2898; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; HELL JW, 1990, J BIOL CHEM, V265, P2111; Juge N, 2009, J BIOL CHEM, V284, P35073, DOI 10.1074/jbc.M109.062414; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Maresova L, 2010, YEAST, V27, P317, DOI 10.1002/yea.1755; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Preobraschenski J, 2014, NEURON, V84, P1287, DOI 10.1016/j.neuron.2014.11.008; Riazanski V, 2011, NAT NEUROSCI, V14, P487, DOI 10.1038/nn.2775; RIVEROS N, 1986, BRAIN RES, V386, P405, DOI 10.1016/0006-8993(86)90181-2; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Zander JF, 2010, J NEUROSCI, V30, P7634, DOI 10.1523/JNEUROSCI.0141-10.2010	21	46	47	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					981	984		10.1126/science.aad8142	http://dx.doi.org/10.1126/science.aad8142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26912364				2022-12-28	WOS:000370821400043
J	Conti, RM; Rosenthal, MB				Conti, Rena M.; Rosenthal, Meredith B.			Pharmaceutical Policy Reform - Balancing Affordability with Incentives for Innovation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Conti, Rena M.] Univ Chicago, Chicago, IL 60637 USA; [Rosenthal, Meredith B.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	University of Chicago; Harvard University; Harvard T.H. Chan School of Public Health	Conti, RM (corresponding author), Univ Chicago, Chicago, IL 60637 USA.			Conti, Rena/0000-0002-4190-1839				Daemmrich A., 2011, 12015 HARV BUS SCH; Department of Health and Human Services Office of the Inspector General, 2012, OEI121200210 DEP HLT; Frank RG, 2007, NEW ENGL J MED, V357, P1993, DOI 10.1056/NEJMp078193; Government Accountability Office, MED B; IMS Institute for Healthcare Informatics, MED US SHIFT COSTS H	5	18	18	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					703	706		10.1056/NEJMp1515068	http://dx.doi.org/10.1056/NEJMp1515068			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE6BB	26933845				2022-12-28	WOS:000370716600002
J	Fehr-Duda, H; Fehr, E				Fehr-Duda, Helga; Fehr, Ernst			Game human nature	NATURE			English	Editorial Material									[Fehr-Duda, Helga] Univ Zurich, Decis Theory & Expt Decis Res, CH-8006 Zurich, Switzerland; [Fehr, Ernst] Univ Zurich, Microecon & Expt Econ, CH-8006 Zurich, Switzerland	University of Zurich; University of Zurich	Fehr, E (corresponding author), Univ Zurich, Microecon & Expt Econ, CH-8006 Zurich, Switzerland.	helga.fehr@bf.uzh.ch						Allcott H, 2014, AM ECON REV, V104, P3003, DOI 10.1257/aer.104.10.3003; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fehr-Duda H., 2012, 96 U ZUR DEP EC; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Gollier C, 2015, ECON ENERGY ENV POL, V4, P5, DOI 10.5547/2160-5890.4.2.cgol; Pinker S., 2011, BETTER ANGELS OUR NA; Thaler RH, 1997, Q J ECON, V112, P647, DOI 10.1162/003355397555226; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; Von Peter G., 2012, 394 BANK INT SETTL	10	21	22	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					413	415		10.1038/530413a	http://dx.doi.org/10.1038/530413a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DE5RW	26911767	Green Published, Bronze			2022-12-28	WOS:000370690800017
J	Zaky, W				Zaky, Wafik			Revisiting Management of Pediatric Brain Tumors with New Molecular Insights	CELL			English	Editorial Material							PRIMITIVE NEUROECTODERMAL TUMORS; ACUTE MYELOID-LEUKEMIA; SURVIVAL	Pediatric central nervous system primitive neuro-ectodermal brain tumors (CNS-PNETs) are rare tumors with ill-defined biological features. In this issue of Cell, Sturm et al. used state-of-the-art methods to interrogate these tumors' biology. Their integrated molecular analyses led them to propose a new molecular classification, with four new entities identified, that should get oncologists' attention.	[Zaky, Wafik] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Zaky, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA.	wzaky@mdanderson.org						Behdad A, 2010, BRAIN PATHOL, V20, P441, DOI 10.1111/j.1750-3639.2009.00314.x; Chen M, 2015, GENE DEV, V29, P2123, DOI 10.1101/gad.267278.115; Jakacki RI, 2015, PEDIATR BLOOD CANCER, V62, P776, DOI 10.1002/pbc.25405; Langer C, 2009, J CLIN ONCOL, V27, P3198, DOI 10.1200/JCO.2008.20.6110; Massimino M, 2013, PEDIATR BLOOD CANCER, V60, P2031, DOI 10.1002/pbc.24540; Miller S, 2011, NEURO-ONCOLOGY, V13, P866, DOI 10.1093/neuonc/nor070; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Vanan MI, 2014, NEURO-ONCOL PRACT, V1, P145, DOI 10.1093/nop/npu022; von Bueren AO, 2012, J NEURO-ONCOL, V109, P415, DOI 10.1007/s11060-012-0911-7	10	3	3	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					844	846		10.1016/j.cell.2016.02.030	http://dx.doi.org/10.1016/j.cell.2016.02.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919424	Bronze			2022-12-28	WOS:000370867300009
J	Butt, CA				Butt, Carrie A.			Spine Patch Warrington Colescott	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					732	733		10.1001/jama.2015.14125	http://dx.doi.org/10.1001/jama.2015.14125			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903318				2022-12-28	WOS:000370700500001
J	Lowe, J; Howlett, DC				Lowe, James; Howlett, David C.			SPOT DIAGNOSIS Abnormality on a plain film chest radiograph	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lowe, James] Eastbourne Dist Gen Hosp, Eastbourne, England; [Howlett, David C.] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, England		Lowe, J (corresponding author), Eastbourne Dist Gen Hosp, Eastbourne, England.	james.lowe1@nhs.net							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2016	352								i1003	10.1136/bmj.i1003	http://dx.doi.org/10.1136/bmj.i1003			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6FD	26896432				2022-12-28	WOS:000370728200001
J	Wang, L; Siegenthaler, JA; Dowell, RD; Yi, R				Wang, Li; Siegenthaler, Julie A.; Dowell, Robin D.; Yi, Rui			Foxc1 reinforces quiescence in self-renewing hair follicle stem cells	SCIENCE			English	Article							NICHE; SKIN; ACTIVATION; CYCLE; REGENERATION; MECHANISM; CHROMATIN; PROTEINS; BINDING; FGF18	Stem cell quiescence preserves the cell reservoir by minimizing cell division over extended periods of time. Self-renewal of quiescent stem cells (SCs) requires the reentry into the cell cycle. In this study, we show that murine hair follicle SCs induce the Foxc1 transcription factor when activated. Deleting Foxc1 in activated, but not quiescent, SCs causes failure of the cells to reestablish quiescence and allows premature activation. Deleting Foxc1 in the SC niche of gene-targeted mice leads to loss of the old hair without impairing quiescence. In self-renewing SCs, Foxc1 activates Nfatc1 and bone morphogenetic protein (BMP) signaling, two key mechanisms that govern quiescence. These findings reveal a dynamic, cell-intrinsic mechanism used by hair follicle SCs to reinforce quiescence upon self-renewal and suggest a unique ability of SCs to maintain cell identity.	[Wang, Li; Dowell, Robin D.; Yi, Rui] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Siegenthaler, Julie A.] Univ Colorado, Dept Pediat, Denver Anschutz Med Campus, Aurora, CO 80045 USA; [Dowell, Robin D.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Yi, R (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	yir@colorado.edu	Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020; Wang, Li/P-5505-2016	YI, RUI/0000-0002-6934-7091; DOWELL, ROBIN/0000-0001-7665-9985; , Julie/0000-0003-3700-6441	NIH [AR066703, T32GM008759]; University of Colorado Boulder; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Boulder; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Yi laboratory for discussions, P. Muhlrad and T. Cech for critical reading of the manuscript, Y. Han for FACS, K. Diener and B. Gao for Illumina sequencing, J. Tyler for imaging, E. Fuchs (Rockefeller University) for K14-Cre and K14-H2BGFP mice, H. Chang (Stanford University) for help on ATAC-seq, N. Manley (University of Georgia) for Foxn1-Cre mice, and D. Roop and G. Bilousova (University of Colorado, Denver) for Krt6 antibody. This project was partly supported by NIH grant AR066703 and a start-up fund from the University of Colorado Boulder to R. Y. L. W. was supported by an NIH training grant T32GM008759. R. Y. and R. D. D. were coadvisors for L. W. All sequencing data are deposited to GEO with the accession numbers GSE67404 and GSE68288. The authors declare no conflicts of interest.	Amin S, 2015, DEV CELL, V32, P265, DOI 10.1016/j.devcel.2014.12.024; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Craven AJ, 2001, ENDOCRINOLOGY, V142, P2533, DOI 10.1210/en.142.6.2533; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Genander M, 2014, CELL STEM CELL, V15, P619, DOI 10.1016/j.stem.2014.09.009; Goldstein J, 2014, GENE DEV, V28, P983, DOI 10.1101/gad.236554.113; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110; Kimura-Ueki M, 2012, J INVEST DERMATOL, V132, P1338, DOI 10.1038/jid.2011.490; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Leishman E, 2013, DEVELOPMENT, V140, P3809, DOI 10.1242/dev.097477; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	31	80	90	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					613	617		10.1126/science.aad5440	http://dx.doi.org/10.1126/science.aad5440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912704	Green Accepted			2022-12-28	WOS:000369291600043
J	Willison, HJ; Jacobs, BC; van Doorn, PA				Willison, Hugh J.; Jacobs, Bart C.; van Doorn, Pieter A.			Guillain-Barre syndrome	LANCET			English	Review							CAMPYLOBACTER-JEJUNI INFECTION; REVERSIBLE CONDUCTION FAILURE; FISHER SYNDROME; PERIPHERAL NEUROPATHIES; HEPATITIS-E; ANTIBODY; GBS; PROTEINS; ANTIGENS; RANVIER	Guillain-Barre syndrome is the most common and most severe acute paralytic neuropathy, with about 100 000 people developing the disorder every year worldwide. Under the umbrella term of Guillain-Barre syndrome are several recognisable variants with distinct clinical and pathological features. The severe, generalised manifestation of Guillain-Barre syndrome with respiratory failure affects 20-30% of cases. Treatment with intravenous immunoglobulin or plasma exchange is the optimal management approach, alongside supportive care. Understanding of the infectious triggers and immunological and pathological mechanisms has advanced substantially in the past 10 years, and is guiding clinical trials investigating new treatments. Investigators of large, worldwide, collaborative studies of the spectrum of Guillain-Barre syndrome are accruing data for clinical and biological databases to inform the development of outcome predictors and disease biomarkers. Such studies are transforming the clinical and scientific landscape of acute autoimmune neuropathies.	[Willison, Hugh J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Jacobs, Bart C.; van Doorn, Pieter A.] Univ Med Ctr, Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Jacobs, Bart C.] Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands	University of Glasgow; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Willison, HJ (corresponding author), Univ Glasgow, Glasgow Biomed Res Ctr, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	Hugh.Willison@glasgow.ac.uk	willison, hugh/HCI-7819-2022; Jacobs, Bart/ABE-2210-2021					ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Benamer HTS, 2014, J NEUROL SCI, V343, P221, DOI 10.1016/j.jns.2014.05.065; Bernsen RAJAM, 1999, NEUROLOGY, V53, P409, DOI 10.1212/WNL.53.2.409; Blum S, 2014, J PERIPHER NERV SYST, V19, P88, DOI 10.1111/jns5.12074; Cashman CR, 2015, NEUROSCI LETT, V596, P33, DOI 10.1016/j.neulet.2015.01.048; CHIBA A, 1993, NEUROLOGY, V43, P1911, DOI 10.1212/WNL.43.10.1911; Darweesh SKL, 2014, J PERIPHER NERV SYST, V19, P24, DOI 10.1111/jns5.12051; Dionne A, 2010, MUSCLE NERVE, V41, P202, DOI 10.1002/mus.21480; Drenthen J, 2013, NEUROLOGY, V81, P1827, DOI 10.1212/01.wnl.0000436073.21406.e6; FEASBY TE, 1993, J NEUROL SCI, V116, P185, DOI 10.1016/0022-510X(93)90324-R; Fitzpatrick AM, 2011, J PERIPHER NERV SYST, V16, P84, DOI 10.1111/j.1529-8027.2011.00328.x; Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285; Funakoshi K, 2009, J NEUROL NEUROSUR PS, V80, P60, DOI 10.1136/jnnp.2008.154351; Galban-Horcajo F, 2014, CURR OPIN CHEM BIOL, V18, P78, DOI 10.1016/j.cbpa.2014.01.008; Geleijns K, 2004, NEUROLOGY, V63, P1747, DOI 10.1212/01.WNL.0000143055.09646.31; GeurtsvanKessel CH, 2013, CLIN INFECT DIS, V57, P1369, DOI 10.1093/cid/cit512; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316; HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6; Huang WC, 2015, NEUROEPIDEMIOLOGY, V44, P249, DOI 10.1159/000430917; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194; Hughes RAC, 1997, LANCET, V349, P225; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001446.pub4; Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub5; Huizinga R, 2015, ANN NEUROL, V78, P343, DOI 10.1002/ana.24442; Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735; Jackson BR, 2014, EPIDEMIOL INFECT, V142, P1089, DOI 10.1017/S0950268813001908; Jacobs BC, 2008, J NEUROIMMUNOL, V194, P181, DOI 10.1016/j.jneuroim.2007.11.017; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Jacobs BC, 1996, ANN NEUROL, V40, P181, DOI 10.1002/ana.410400209; Kaida K, 2004, ANN NEUROL, V56, P567, DOI 10.1002/ana.20222; Kaida Kenichi, 2013, Brain Nerve, V65, P413; KLEYWEG RP, 1991, J NEUROL NEUROSUR PS, V54, P957, DOI 10.1136/jnnp.54.11.957; Koga M, 2001, J NEUROL NEUROSUR PS, V70, P693, DOI 10.1136/jnnp.70.5.693; Kokubun N, 2013, J NEUROL SCI, V326, P111, DOI 10.1016/j.jns.2013.01.015; Kokubun N, 2010, BRAIN, V133, P2897, DOI 10.1093/brain/awq260; Korinthenberg R, 2005, PEDIATRICS, V116, P8, DOI 10.1542/peds.2004-1324; Kuitwaard K, 2009, J PERIPHER NERV SYST, V14, P310, DOI 10.1111/j.1529-8027.2009.00243.x; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Lim JP, 2014, AUTOIMMUN REV, V13, P1070, DOI 10.1016/j.autrev.2014.08.005; Liu J, 2015, COCHRANE DB SYST REV, V4; Liu JX, 2009, INVEST OPHTH VIS SCI, V50, P3226, DOI 10.1167/iovs.08-3333; Lyu RK, 1997, J NEUROL NEUROSUR PS, V63, P494, DOI 10.1136/jnnp.63.4.494; Makowska A, 2008, J NEUROL NEUROSUR PS, V79, P664, DOI 10.1136/jnnp.2007.123943; McCarthy N, 1999, EPIDEMIOL INFECT, V122, P15, DOI 10.1017/S0950268898001861; McGonigal R, 2010, BRAIN, V133, P1944, DOI 10.1093/brain/awq119; Merkies ISJ, 2012, NEUROMUSCULAR DISORD, V22, pS203, DOI 10.1016/j.nmd.2012.10.014; Miyaji K, 2014, HUM IMMUNOL, V75, P1089, DOI 10.1016/j.humimm.2014.09.010; Mori M, 2000, BRAIN, V123, P2171, DOI 10.1093/brain/123.10.2171; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; Naik KR, 2012, ANN INDIAN ACAD NEUR, V15, P44, DOI 10.4103/0972-2327.93278; Netto AB, 2011, ANN INDIAN ACAD NEUR, V14, P262, DOI 10.4103/0972-2327.91942; Oh SJ, 2003, NEUROLOGY, V61, P1507, DOI 10.1212/01.WNL.0000096166.28131.4C; Plomp JJ, 2009, J PHYSIOL-LONDON, V587, P3979, DOI 10.1113/jphysiol.2009.171702; Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882; Raphael JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub2; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; Rinaldi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082337; Roodbol J, 2011, NEUROLOGY, V76, P807, DOI 10.1212/WNL.0b013e31820e7b62; Roodbol J, 2014, J PERIPHER NERV SYST, V19, P121, DOI 10.1111/jns5.12068; Ruts L, 2010, NEUROLOGY, V75, P1439, DOI 10.1212/WNL.0b013e3181f88345; Ruts L, 2010, NEUROLOGY, V74, P1680, DOI 10.1212/WNL.0b013e3181e07d14; Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8; Samukawa M, 2014, J NEUROL SCI, V337, P55, DOI 10.1016/j.jns.2013.11.016; Sawai S, 2014, NEUROLOGY, V83, P113, DOI 10.1212/WNL.0000000000000566; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Soliven B, 2014, ILAR J, V54, P282, DOI 10.1093/ilar/ilt054; Stathopoulos P, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.260; Susuki K, 2012, EXP NEUROL, V233, P534, DOI 10.1016/j.expneurol.2011.11.039; Umapathi T, 2012, J NEUROL NEUROSUR PS, V83, P941, DOI 10.1136/jnnp-2012-303079; Uncini A, 2015, J NEUROL NEUROSUR PS, V86, P5, DOI 10.1136/jnnp-2014-308220; Uncini A, 2013, CLIN NEUROPHYSIOL, V124, P1928, DOI 10.1016/j.clinph.2013.03.025; Uncini A, 2012, EXP NEUROL, V235, P513, DOI 10.1016/j.expneurol.2012.03.023; van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121; van den Berg B, 2014, NEUROLOGY, V82, P1984, DOI 10.1212/WNL.0000000000000481; van den Berg B, 2014, NEUROLOGY, V82, P491, DOI 10.1212/WNL.0000000000000111; van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc; van Doorn Pieter A, 2013, Presse Med, V42, pe193, DOI 10.1016/j.lpm.2013.02.328; van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; Vanhoutte EK, 2013, NEUROMUSCULAR DISORD, V23, P924, DOI 10.1016/j.nmd.2013.06.006; Vucic S, 2004, CLIN NEUROPHYSIOL, V115, P2329, DOI 10.1016/j.clinph.2004.05.009; Wakerley Benjamin R, 2015, Pract Neurol, V15, P90, DOI 10.1136/practneurol-2014-000937; Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407; Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976; Webb AJS, 2015, J NEUROL NEUROSUR PS, V86, P1196, DOI 10.1136/jnnp-2014-309056; Willison HJ, 2005, J PERIPHER NERV SYST, V10, P94, DOI 10.1111/j.1085-9489.2005.0010202.x; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; Willison H, 2014, NEUROLOGY, V83, P106, DOI 10.1212/WNL.0000000000000581; Willison HJ, 2013, TRENDS IMMUNOL, V34, P453, DOI 10.1016/j.it.2013.05.001; Willison Hugh J, 2012, J Peripher Nerv Syst, V17 Suppl 3, P3, DOI 10.1111/j.1529-8027.2012.00423.x; Willison HJ, 2011, J PERIPHER NERV SYST, V16, P60, DOI 10.1111/j.1529-8027.2011.00310.x; Wong AHY, 2015, J PERIPHER NERV SYST, V20, P47, DOI 10.1111/jns.12104; Yang JJ, 2014, EXP THER MED, V8, P1397, DOI 10.3892/etm.2014.1955; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Yuki N, 2012, J NEUROL, V259, P1181, DOI 10.1007/s00415-011-6330-4	102	644	687	3	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					717	727		10.1016/S0140-6736(16)00339-1	http://dx.doi.org/10.1016/S0140-6736(16)00339-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UX	26948435	Bronze			2022-12-28	WOS:000381268700032
J	Louveau, A; Smirnov, I; Keyes, TJ; Eccles, JD; Rouhani, SJ; Peske, JD; Derecki, NC; Castle, D; Mandell, JW; Lee, KS; Harris, TH; Kipnis, J				Louveau, Antoine; Smirnov, Igor; Keyes, Timothy J.; Eccles, Jacob D.; Rouhani, Sherin J.; Peske, J. David; Derecki, Noel C.; Castle, David; Mandell, James W.; Lee, Kevin S.; Harris, Tajie H.; Kipnis, Jonathan			Structural and functional features of central nervous system lymphatic vessels (vol 523, pg 337, 2015)	NATURE			English	Correction													Peske, J David/HII-8405-2022; Kipnis, Jonathan/AGG-9735-2022; Rouhani, Sherin Juliet/GQI-0914-2022	Kipnis, Jonathan/0000-0002-3714-517X; Rouhani, Sherin Juliet/0000-0001-7248-847X; ECCLES, Jacob/0000-0002-4202-0355; Harris, Tajie/0000-0002-1355-2109				ANDRES KH, 1987, ANAT EMBRYOL, V175, P289, DOI 10.1007/BF00309843; FOLDI M, 1966, ACTA ANAT, V64, P498; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432	3	28	32	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602								10.1038/nature16999	http://dx.doi.org/10.1038/nature16999			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	26909581	Bronze			2022-12-28	WOS:000376007200058
J	Netto, GJ				Netto, George J.			Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma	LANCET			English	Editorial Material							SAFETY		[Netto, George J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA	Johns Hopkins University	Netto, GJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA.	gnetto1@jhmi.edu		Netto, George/0000-0003-3915-9134				Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Galsky Matthew D, 2013, Clin Adv Hematol Oncol, V11, P86; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Petrylak DP, 2015, J CLIN ONCOL S, V33, P4501; Plimack ER, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.4502; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Zibelman M, 2016, ONCOLOGY-NY, V30, P160	12	7	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1881	1882		10.1016/S0140-6736(16)00654-1	http://dx.doi.org/10.1016/S0140-6736(16)00654-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	26952549				2022-12-28	WOS:000375374200004
J	Badoux, S; Tabis, W; Laliberte, F; Grissonnanche, G; Vignolle, B; Vignolles, D; Beard, J; Bonn, DA; Hardy, WN; Liang, R; Doiron-Leyraud, N; Taillefer, L; Proust, C				Badoux, S.; Tabis, W.; Laliberte, F.; Grissonnanche, G.; Vignolle, B.; Vignolles, D.; Beard, J.; Bonn, D. A.; Hardy, W. N.; Liang, R.; Doiron-Leyraud, N.; Taillefer, Louis; Proust, Cyril			Change of carrier density at the pseudogap critical point of a cuprate superconductor	NATURE			English	Article							FERMI-SURFACE; QUANTUM OSCILLATIONS; SINGLE-CRYSTALS; STATE; DEPENDENCE; SCATTERING; ORDER; TL2BA2CUO6+DELTA; TRANSPORT; EVOLUTION	The pseudogap is a partial gap in the electronic density of states that opens in the normal (non-superconducting) state of cuprate superconductors and whose origin is a long-standing puzzle. Its connection to the Mott insulator phase at low doping (hole concentration, p) remains ambiguous(1) and its relation to the charge order(2-4) that reconstructs the Fermi surface(5,6) at intermediate doping is still unclear(7-10). Here we use measurements of the Hall coefficient in magnetic fields up to 88 tesla to show that Fermisurface reconstruction by charge order in the cuprate YBa2Cu3Oy ends sharply at a critical doping p = 0.16 that is distinctly lower than the pseudogap critical point p* = 0.19 (ref. 11). This shows that the pseudogap and charge order are separate phenomena. We find that the change in carrier density n from n = 1 + p in the conventional metal at high doping (ref. 12) to n = p at low doping (ref. 13) starts at the pseudogap critical point. This shows that the pseudogap and the antiferromagnetic Mott insulator are linked.	[Badoux, S.; Grissonnanche, G.; Doiron-Leyraud, N.; Taillefer, Louis] Univ Sherbrooke, Dept Phys, Regrp Quebecois Mat Pointe, Sherbrooke, PQ J1K 2R1, Canada; [Tabis, W.; Laliberte, F.; Vignolle, B.; Vignolles, D.; Beard, J.; Proust, Cyril] UPS, Lab Natl Champs Magnet Intenses, CNRS, EMFL,INSA,UGA, F-31400 Toulouse, France; [Tabis, W.] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, PL-30059 Krakow, Poland; [Bonn, D. A.; Hardy, W. N.; Liang, R.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Bonn, D. A.; Hardy, W. N.; Liang, R.; Taillefer, Louis; Proust, Cyril] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; AGH University of Science & Technology; University of British Columbia; Canadian Institute for Advanced Research (CIFAR)	Taillefer, L (corresponding author), Univ Sherbrooke, Dept Phys, Regrp Quebecois Mat Pointe, Sherbrooke, PQ J1K 2R1, Canada.; Proust, C (corresponding author), UPS, Lab Natl Champs Magnet Intenses, CNRS, EMFL,INSA,UGA, F-31400 Toulouse, France.; Taillefer, L; Proust, C (corresponding author), Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada.	louis.taillefer@usherbrooke.ca; cyril.proust@lncmi.cnrs.fr	Hardy, Walter Newbold/AAN-7827-2020; Tabis, Wojciech/AAE-8158-2019; Béard, Jérôme/ABG-2702-2021	Tabis, Wojciech/0000-0002-8827-9944; Béard, Jérôme/0000-0001-9089-6266; Vignolle, Baptiste/0000-0001-8775-1701; Badoux, Sven/0000-0003-0967-424X; Grissonnanche, Gael/0000-0002-5115-3125	LABEX NEXT; French ANR SUPERFIELD; EMFL; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institute for Advanced Research (CIFAR); NSERC; Fonds de recherche du Quebec - Nature et Technologies (FRQNT); Canada Foundation for Innovation (CFI); Canada Research Chair	LABEX NEXT; French ANR SUPERFIELD(French National Research Agency (ANR)); EMFL; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Nature et Technologies (FRQNT); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank the following for discussions: Y. Ando, D. Basov, G. Boebinger, C. Bourbonnais, J. P. Carbotte, A. Carrington, J. Chang, A. V. Chubukov, J. C. Davis, A. Georges, N. E. Hussey, M.-H. Julien, H.-Y. Kee, S. A. Kivelson, P. A. Lee, T. Loew, G. G. Lonzarich, W. Metzner, A. J. Millis, M. R. Norman, C. Pepin, J. Porras, B. J. Ramshaw, T. M. Rice, G. Rikken, S. Sachdev, D. J. Scalapino, C. B. Taillefer, J. L. Tallon, S. Todadri, and A.-M. S. Tremblay. We also thank P. Frings and J. P. Nicolin for help during the measurements in Toulouse. L. T. thanks the Laboratoire National des Champs Magnetiques Intenses (LNCMI) in Toulouse for their hospitality and LABEX NEXT for their support while this work was being performed. A portion of this work was performed at the LNCMI, which is supported by the French ANR SUPERFIELD, the EMFL, and the LABEX NEXT. R. L., D. A. B. and W. N. H. acknowledge funding from the Natural Sciences and Engineering Research Council of Canada (NSERC). L. T. acknowledges support from the Canadian Institute for Advanced Research (CIFAR) and funding from NSERC, the Fonds de recherche du Quebec - Nature et Technologies (FRQNT), the Canada Foundation for Innovation (CFI) and a Canada Research Chair.	Ando Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.197001; Balakirev FF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017004; Balakirev FF, 2003, NATURE, V424, P912, DOI 10.1038/nature01890; Blanco-Canosa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054513; Blanco-Canosa S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187001; Chowdhury D, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.245136; Croft TP, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.224513; Dagan Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.167001; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Ferrero M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.064501; Fournier D, 2010, NAT PHYS, V6, P905, DOI [10.1038/NPHYS1763, 10.1038/nphys1763]; Fujita K, 2014, SCIENCE, V344, P612, DOI 10.1126/science.1248783; GAGNON R, 1994, PHYS REV B, V50, P3458, DOI 10.1103/PhysRevB.50.3458; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Haug D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/105006; He Y, 2014, SCIENCE, V344, P608, DOI 10.1126/science.1248221; Hucker M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054514; Hussey NE, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/12/123201; Hussey NE, 2003, EUR PHYS J B, V31, P495, DOI 10.1140/epjb/e2003-00059-9; Hussey NE, 1996, PHYS REV LETT, V76, P122, DOI 10.1103/PhysRevLett.76.122; LeBoeuf D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054506; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Liang RX, 2012, PHILOS MAG, V92, P2563, DOI 10.1080/14786435.2012.669065; Mackenzie AP, 1996, PHYS REV B, V53, P5848, DOI 10.1103/PhysRevB.53.5848; MANAKO T, 1992, PHYS REV B, V46, P11019, DOI 10.1103/PhysRevB.46.11019; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Rice TM, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016502; Segawa K, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.104521; Senechal D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126401; Senthil T., 2014, PREPRINT; Taillefer L, 2010, ANNU REV CONDEN MA P, V1, P51, DOI 10.1146/annurev-conmatphys-070909-104117; Tallon JL, 1997, PHYS REV LETT, V79, P5294, DOI 10.1103/PhysRevLett.79.5294; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; Vignolle B, 2008, NATURE, V455, P952, DOI 10.1038/nature07323; Wu T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3113; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345	39	249	251	8	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					210	+		10.1038/nature16983	http://dx.doi.org/10.1038/nature16983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26901870	Green Submitted			2022-12-28	WOS:000371665100036
J	Atianand, MK; Fitzgerald, KA				Atianand, Maninjay K.; Fitzgerald, Katherine A.			An RNA twist to T(H)17 cells	SCIENCE			English	Editorial Material							DIFFERENTIATION; DDX5		[Atianand, Maninjay K.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Program Innate Immun,Dept Med, 364 Plantat St, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Program Innate Immun,Dept Med, 364 Plantat St, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Atianand, Maninjay/AAF-7823-2019	Atianand, Maninjay/0000-0003-4135-2515; Fitzgerald, Kate/0000-0003-3175-609X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI067497] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; HSIEH CL, 1990, GENOMICS, V6, P540, DOI 10.1016/0888-7543(90)90483-B; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jain R, 2016, IMMUNITY, V44, P131, DOI 10.1016/j.immuni.2015.11.009; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Martin AN, 2007, CELL RES, V17, P219, DOI 10.1038/sj.cr.7310120; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003	11	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1032	1032		10.1126/science.aaf4691	http://dx.doi.org/10.1126/science.aaf4691			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941307				2022-12-28	WOS:000371597500024
J	Gulland, A				Gulland, Anne			Seven day services: how are trusts doing against Keogh's clinical standards?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						*AC MED ROY COLL, 2012, 7 DAY CONS PRES CAR; *NHS ENGL, 2013, NHS SERV 7 DAYS WEEK	2	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2016	352								i1258	10.1136/bmj.i1258	http://dx.doi.org/10.1136/bmj.i1258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LJ	26931479				2022-12-28	WOS:000371756000013
J	Shankar-Hari, M; Phillips, GS; Levy, ML; Seymour, CW; Liu, VX; Deutschman, CS; Angus, DC; Rubenfeld, GD; Singer, M				Shankar-Hari, Manu; Phillips, Gary S.; Levy, Mitchell L.; Seymour, Christopher W.; Liu, Vincent X.; Deutschman, Clifford S.; Angus, Derek C.; Rubenfeld, Gordon D.; Singer, Mervyn		Sepsis Definitions Task Force	Developing a New Definition and Assessing New Clinical Criteria for Septic Shock For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE UNITS; INFLAMMATORY RESPONSE SYNDROME; INFECTION-ASSOCIATED SEPSIS; CRITICALLY-ILL PATIENTS; ACQUIRED SEVERE SEPSIS; LONG-TERM MORTALITY; EMERGENCY-DEPARTMENT; SURVIVING SEPSIS; ORGAN FAILURE; POSTOPERATIVE SEPSIS	IMPORTANCE Septic shock currently refers to a state of acute circulatory failure associated with infection. Emerging biological insights and reported variation in epidemiology challenge the validity of this definition. OBJECTIVE To develop a new definition and clinical criteria for identifying septic shock in adults. DESIGN, SETTING, AND PARTICIPANTS The Society of Critical Care Medicine and the European Society of Intensive Care Medicine convened a task force (19 participants) to revise current sepsis/septic shock definitions. Three sets of studies were conducted: (1) a systematic review and meta-analysis of observational studies in adults published between January 1, 1992, and December 25, 2015, to determine clinical criteria currently reported to identify septic shock and inform the Delphi process; (2) a Delphi study among the task force comprising 3 surveys and discussions of results from the systematic review, surveys, and cohort studies to achieve consensus on a new septic shock definition and clinical criteria; and (3) cohort studies to test variables identified by the Delphi process using Surviving Sepsis Campaign (SSC) (2005-2010; n = 28 150), University of Pittsburgh Medical Center (UPMC) (2010-2012; n = 1 309 025), and Kaiser Permanente Northern California (KPNC) (2009-2013; n = 1 847 165) electronic health record (EHR) data sets. MAIN OUTCOMES AND MEASURES Evidence for and agreement on septic shock definitions and criteria. RESULTS The systematic review identified 44 studies reporting septic shock outcomes (total of 166 479 patients) from a total of 92 sepsis epidemiology studies reporting different cutoffs and combinations for blood pressure (BP), fluid resuscitation, vasopressors, serum lactate level, and base deficit to identify septic shock. The septic shock-associated crude mortality was 46.5% (95% CI, 42.7%-50.3%), with significant between-study statistical heterogeneity (I-2 = 99.5%; tau(2) = 182.5; P < .001). The Delphi process identified hypotension, serum lactate level, and vasopressor therapy as variables to test using cohort studies. Based on these 3 variables alone or in combination, 6 patient groups were generated. Examination of the SSC database demonstrated that the patient group requiring vasopressors to maintain mean BP 65 mm Hg or greater and having a serum lactate level greater than 2 mmol/L (18mg/dL) after fluid resuscitation had a significantly higher mortality (42.3%[ 95% CI, 41.2%-43.3%]) in risk-adjusted comparisons with the other 5 groups derived using either serum lactate level greater than 2 mmol/L alone or combinations of hypotension, vasopressors, and serum lactate level 2 mmol/L or lower. These findings were validated in the UPMC and KPNC data sets. CONCLUSIONS AND RELEVANCE Based on a consensus process using results from a systematic review, surveys, and cohort studies, septic shock is defined as a subset of sepsis in which underlying circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than sepsis alone. Adult patients with septic shock can be identified using the clinical criteria of hypotension requiring vasopressor therapy to maintain mean BP 65 mm Hg or greater and having a serum lactate level greater than 2 mmol/L after adequate fluid resuscitation.	[Shankar-Hari, Manu] Guys & St Thomas NHS Fdn Trust, Dept Crit Care Med, London SE1 7EH, England; [Shankar-Hari, Manu] Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England; [Phillips, Gary S.] Ohio State Univ, Coll Med, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA; [Levy, Mitchell L.] Brown Univ, Rhode Isl Hosp, Sch Med, Providence, RI 02903 USA; [Seymour, Christopher W.; Angus, Derek C.] Univ Pittsburgh, Dept Crit Care & Emergency Med, Clin Res Invest & Syst Modeling Acute Illness Ctr, Pittsburgh, PA USA; [Liu, Vincent X.] Kaiser Permanente, Div Res, Oakland, CA USA; [Deutschman, Clifford S.] Steven & Alexandra Cohen Childrens Med Ctr, Hofstra North Shore Long Isl Jewish Hofstra Sch M, Dept Pediat, New Hyde Pk, NY USA; [Deutschman, Clifford S.] Steven & Alexandra Cohen Childrens Med Ctr, Hofstra North Shore Long Isl Jewish Hofstra Sch M, Dept Mol Med, New Hyde Pk, NY USA; [Deutschman, Clifford S.] Feinstein Inst Med Res, Manhasset, NY USA; [Rubenfeld, Gordon D.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Rubenfeld, Gordon D.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Singer, Mervyn] UCL, Bloomsbury Inst Intens Care Med, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University System of Ohio; Ohio State University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of London; University College London	Shankar-Hari, M (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Crit Care Med, London SE1 7EH, England.	manu.shankar-hari@kcl.ac.uk	Deutschman, Clifford/AAN-2742-2021; Angus, Derek C/E-9671-2012; Martin, Greg/B-4085-2009; Chiche, Jean-Daniel/P-5220-2017; Shankar-Hari, Manu/I-6948-2012; Singer, Mervyn/Q-6142-2019	Martin, Greg/0000-0002-9684-7593; Chiche, Jean-Daniel/0000-0002-6433-6254; Shankar-Hari, Manu/0000-0002-5338-2538; Singer, Mervyn/0000-0002-1042-6350; Vincent, Jean-Louis/0000-0001-6011-6951	European Society of Intensive Care Medicine; Society of Critical Care Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM104022, K23GM112018] Funding Source: NIH RePORTER	European Society of Intensive Care Medicine; Society of Critical Care Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Sepsis Definitions Task Force received unrestricted funding support from the European Society of Intensive Care Medicine and the Society of Critical Care Medicine (sponsors).	Adrie C, 2005, J CRIT CARE, V20, P46, DOI 10.1016/j.jcrc.2004.10.005; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Ballester JCA, 2008, INFECT CONT HOSP EP, V29, P630, DOI 10.1086/589583; Angkasekwinai Nasikarn, 2009, J Med Assoc Thai, V92 Suppl 2, pS68; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; [Anonymous], CRIT CARE MED; Baharoon S, 2009, TRAVEL MED INFECT DI, V7, P247, DOI 10.1016/j.tmaid.2008.09.002; Bastani A, 2012, AM J EMERG MED, V30, P1561, DOI 10.1016/j.ajem.2011.09.029; Bateman BT, 2010, ANESTHESIOLOGY, V112, P917, DOI 10.1097/ALN.0b013e3181cea3d0; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Beovic B, 2008, J CHEMOTHERAPY, V20, P134, DOI 10.1179/joc.2008.20.1.134; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bouza Carmen, 2014, BMC Infect Dis, V14, P3863, DOI 10.1186/s12879-014-0717-7; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Cross G, 2015, ANAESTH INTENS CARE, V43, P193, DOI 10.1177/0310057X1504300208; Czupryna Piotr, 2013, Przegl Epidemiol, V67, P429; DAHMASH NS, 1993, J INFECTION, V26, P159, DOI 10.1016/0163-4453(93)92815-E; Davis JS, 2011, MED J AUSTRALIA, V194, P519, DOI 10.5694/j.1326-5377.2011.tb03088.x; Degoricija V, 2006, CROAT MED J, V47, P385; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Esteban A, 2007, CRIT CARE MED, V35, P1284, DOI 10.1097/01.CCM.0000260960.94300.DE; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Flaatten H, 2004, CRIT CARE, V8, pR180, DOI 10.1186/cc2867; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Garcia-Alvarez M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0503-3; Gasparovic V, 2006, CROAT MED J, V47, P404; Goncalves-Pereira J, 2014, CLIN MICROBIOL INFEC, V20, P1308, DOI 10.1111/1469-0691.12738; Gray A, 2013, EMERG MED J, V30, P397, DOI 10.1136/emermed-2012-201361; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Husak Liudmila, 2010, Healthc Q, V13 Spec No, P35; Iwashyna TJ, 2014, AM J RESP CRIT CARE, V189, P1156, DOI 10.1164/rccm.201404-0632ED; Iwashyna TJ, 2014, JAMA-J AM MED ASSOC, V311, P1295, DOI 10.1001/jama.2014.2639; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kauss IAM, 2010, BRAZ J INFECT DIS, V14, P264, DOI 10.1590/S1413-86702010000300011; Khwannimit B, 2009, EPIDEMIOL INFECT, V137, P1333, DOI 10.1017/S0950268809002027; Klouwenberg PMCK, 2012, INTENS CARE MED, V38, P811, DOI 10.1007/s00134-012-2549-5; Koupetori M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-272; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Laupland KB, 2004, INFECTION, V32, P59, DOI 10.1007/s15010-004-3064-6; Laupland KB, 2005, INTENS CARE MED, V31, P213, DOI 10.1007/s00134-004-2544-6; Leligdowicz A, 2014, AM J RESP CRIT CARE, V189, P1204, DOI 10.1164/rccm.201310-1875OC; Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li P, 2015, JAMA-J AM MED ASSOC, V314, P1966, DOI 10.1001/jama.2015.15281; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Lundberg JS, 1998, CRIT CARE MED, V26, P1020, DOI 10.1097/00003246-199806000-00019; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; MCLAUCHLAN GJ, 1995, BRIT J SURG, V82, P524, DOI 10.1002/bjs.1800820429; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Moore LJ, 2011, J TRAUMA, V70, P672, DOI 10.1097/TA.0b013e31820e7803; Moss M, 2004, INTENS CARE MED, V30, P527, DOI 10.1007/s00134-004-2182-z; Nesseler N, 2013, INTENS CARE MED, V39, P881, DOI 10.1007/s00134-013-2815-1; Nichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888; Ogura H, 2014, J INFECT CHEMOTHER, V20, P157, DOI 10.1016/j.jiac.2013.07.006; Ortiz G, 2014, BIOMEDICA, V34, P40, DOI [10.7705/biomedica.v34i1.1439, 10.1590/S0120-41572014000100007]; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Park DW, 2012, J KOREAN MED SCI, V27, P1308, DOI 10.3346/jkms.2012.27.11.1308; Peake SL, 2009, RESUSCITATION, V80, P811, DOI 10.1016/j.resuscitation.2009.03.008; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; PITTET D, 1995, INTENS CARE MED, V21, P302, DOI 10.1007/BF01705408; Povoa PR, 2009, CRIT CARE MED, V37, P410, DOI 10.1097/CCM.0b013e3181958b1c; Quenot JP, 2013, CRIT CARE, V17, DOI 10.1186/cc12598; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rezende E, 2008, CLINICS, V63, P457, DOI 10.1590/S1807-59322008000400008; Rhee C, 2014, NEW ENGL J MED, V370, P1673, DOI 10.1056/NEJMp1400276; Rodriguez F, 2011, CRIT CARE MED, V39, P1675, DOI 10.1097/CCM.0b013e318218a35e; Rohde JM, 2013, J HOSP MED, V8, P243, DOI 10.1002/jhm.2012; Rosado Vera, 2011, Bol Asoc Med P R, V103, P35; Rudiger A, 2013, CLIN SCI, V124, P391, DOI 10.1042/CS20120334; Sakr Y, 2013, MINERVA ANESTESIOL, V79, P993; Sakr Y, 2007, SHOCK, V28, P636, DOI 10.1097/shk.0b013e3180cab855; SALVO I, 1995, INTENS CARE MED, V21, pS244, DOI 10.1007/BF01740762; Sancho S, 2012, EUR J CLIN MICROBIOL, V31, P1791, DOI 10.1007/s10096-011-1503-8; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; SASSE KC, 1995, CRIT CARE MED, V23, P1040, DOI 10.1097/00003246-199506000-00008; Schoenberg MH, 1998, LANGENBECK ARCH SURG, V383, P44, DOI 10.1007/s004230050090; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Seymour CW, 2012, AM J RESP CRIT CARE, V186, P1264, DOI 10.1164/rccm.201204-0713OC; Shankar-Hari M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1164-6; Shapiro N, 2006, ANN EMERG MED, V48, P583, DOI 10.1016/j.annemergmed.2006.07.007; Shen HN, 2010, CHEST, V138, P298, DOI 10.1378/chest.09-2205; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Stiermaier T, 2013, WIEN KLIN WOCHENSCHR, V125, P302, DOI 10.1007/s00508-013-0351-1; Storgaard M, 2013, SCAND J INFECT DIS, V45, P577, DOI 10.3109/00365548.2013.786836; Strehlow MC, 2006, ANN EMERG MED, V48, P326, DOI 10.1016/j.annemergmed.2006.05.003; Sundararajan V, 2005, CRIT CARE MED, V33, P71, DOI 10.1097/01.CCM.0000150027.98160.80; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; Tanriover MD, 2006, EPIDEMIOL INFECT, V134, P315, DOI 10.1017/S0950268805004978; van Gestel A, 2004, CRIT CARE, V8, pR153, DOI 10.1186/cc2858; Vesteinsdottir E, 2011, ACTA ANAESTH SCAND, V55, P722, DOI 10.1111/j.1399-6576.2011.02437.x; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Vincent JL, 2012, CRIT CARE, V16, DOI 10.1186/cc11510; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Vogel TR, 2009, SURG INFECT, V10, P71, DOI 10.1089/sur.2008.046; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Whittaker SA, 2015, J CRIT CARE, V30, P78, DOI 10.1016/j.jcrc.2014.07.012; Whittaker SA, 2013, CRIT CARE MED, V41, P945, DOI 10.1097/CCM.0b013e31827466f1; Wichmann MW, 2000, INTENS CARE MED, V26, P167, DOI 10.1007/s001340050041; Wilhelms SB, 2010, CRIT CARE MED, V38, P1442, DOI 10.1097/CCM.0b013e3181de4406; World Health Organization, 2015, HLTH STAT INF SYST D; Zahar JR, 2011, CRIT CARE MED, V39, P1886, DOI 10.1097/CCM.0b013e31821b827c; Zahorec R, 2005, INFECTION, V33, P122, DOI 10.1007/s15010-005-4019-2	120	1131	1288	15	173	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					775	787		10.1001/jama.2016.0289	http://dx.doi.org/10.1001/jama.2016.0289			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903336	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000370700500013
J	Bate, J; Schuman, A				Bate, Jonathan; Schuman, Andrew			Books do furnish a mind: the art and science of bibliotherapy	LANCET			English	Editorial Material									[Bate, Jonathan] Univ Oxford Worcester Coll, Oxford OX1 2HB, England; [Schuman, Andrew] Dr Kenyon & Partners, Oxford OX1 2NA, England	University of Oxford	Bate, J (corresponding author), Univ Oxford Worcester Coll, Oxford OX1 2HB, England.	provost@worc.ox.ac.uk	Bate, Jonathan/E-5181-2019	Bate, Jonathan/0000-0002-3894-8580				Cornett CE, 1980, ATLANTIC MONTHLY; Crothers Samuel McChord, 1916, ATLANTIC MONTHLY, P291; Jack SJ, 2008, SCHOOL PSYCHOL INT, V29, P161, DOI 10.1177/0143034308090058; Kelly R., 2014, BLACK RAINBOW WORDS; Latchem JM, 2014, AGING MENT HEALTH, V18, P731, DOI 10.1080/13607863.2013.875125	5	8	8	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					742	743		10.1016/S0140-6736(16)00337-8	http://dx.doi.org/10.1016/S0140-6736(16)00337-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE1WU	26913308				2022-12-28	WOS:000370418000019
J	Battiston, S; Farmer, JD; Flache, A; Garlaschelli, D; Haldane, AG; Heesterbeek, H; Hommes, C; Jaeger, C; May, R; Scheffer, M				Battiston, Stefano; Farmer, J. Doyne; Flache, Andreas; Garlaschelli, Diego; Haldane, Andrew G.; Heesterbeek, Hans; Hommes, Cars; Jaeger, Carlo; May, Robert; Scheffer, Marten			COMPLEX SYSTEMS Complexity theory and financial regulation	SCIENCE			English	Editorial Material									[Battiston, Stefano] Univ Zurich, Dept Banking & Finance, CH-8032 Zurich, Switzerland; [Farmer, J. Doyne] Univ Oxford, Inst New Econ Thinking, Oxford Martin Sch, S Parks Rd, Oxford OX1 2JD, England; [Farmer, J. Doyne] Univ Oxford, Math Inst, S Parks Rd, Oxford OX1 2JD, England; [Farmer, J. Doyne] Santa Fe Inst, Santa Fe, NM 87501 USA; [Flache, Andreas] Univ Groningen, Dept Sociol, NL-9712 TG Groningen, Netherlands; [Garlaschelli, Diego] Leiden Univ, Lorentz Inst Theoret Phys, NL-2333 CA Leiden, Netherlands; [Haldane, Andrew G.] Bank England, London EC2R 8AH, England; [Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, NL-3512 JE Utrecht, Netherlands; [Hommes, Cars] Univ Amsterdam, Amsterdam Sch Econ, NL-1018 WB Amsterdam, Netherlands; [Hommes, Cars] Tinbergen Inst, NL-1082 MS Amsterdam, Netherlands; [Jaeger, Carlo] Beijing Normal Univ, Beijing 100875, Peoples R China; [Jaeger, Carlo] Univ Potsdam, D-14469 Potsdam, Germany; [Jaeger, Carlo] Global Climate Forum, D-10178 Berlin, Germany; [May, Robert] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 2JD, England; [Scheffer, Marten] Wageningen Univ, Environm Sci, NL-6708 PB Wageningen, Netherlands	University of Zurich; University of Oxford; University of Oxford; The Santa Fe Institute; University of Groningen; Leiden University; Leiden University - Excl LUMC; Bank of England; Utrecht University; University of Amsterdam; Tinbergen Institute; Beijing Normal University; University of Potsdam; University of Oxford; Wageningen University & Research	Hommes, C (corresponding author), Univ Amsterdam, Amsterdam Sch Econ, NL-1018 WB Amsterdam, Netherlands.; Hommes, C (corresponding author), Tinbergen Inst, NL-1082 MS Amsterdam, Netherlands.	C.H.Hommes@uva.nl	/M-1612-2017; Flache, Andreas/E-2921-2013; Garlaschelli, Diego/P-2795-2019; Garlaschelli, Diego/O-4862-2014	/0000-0002-0051-973X; Flache, Andreas/0000-0002-8276-8819; Heesterbeek, Hans/0000-0001-8537-6418				Axtell R., 2014, ENDOGENOUS DYNAMICS; Aymanns C, 2015, J ECON DYN CONTROL, V50, P155, DOI 10.1016/j.jedc.2014.09.015; Bao T., 2015, 1510 CENDEF U AMST; Bao T, 2015, 20151072 TI; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Cimini G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15758; Flache A, 2011, J CONFLICT RESOLUT, V55, P970, DOI 10.1177/0022002711414371; Haldane A. G., 2015, WORKSH SOC COMPL LOR; Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339; Hommes C., 2013, BEHAV RATIONALITY HE; Lebaron B, 2006, HANDB ECON, V13, P1187; LUCAS RE, 1976, CARN ROCH CONF SERIE, V1, P19, DOI 10.1016/S0167-2231(76)80003-6; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Squartini T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03357; Thurner S, 2012, QUANT FINANC, V12, P695, DOI 10.1080/14697688.2012.674301	17	248	254	15	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					818	819		10.1126/science.aad0299	http://dx.doi.org/10.1126/science.aad0299			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DE0PB	26912882	Green Published, Green Submitted			2022-12-28	WOS:000370325700026
J	Fear, J; Oliver, B				Fear, Justin; Oliver, Brian			DEVELOPMENTAL BIOLOGY Females have a lot of guts	NATURE			English	Editorial Material							DROSOPHILA		[Fear, Justin; Oliver, Brian] NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Oliver, B (corresponding author), NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA.	briano@helix.nih.gov	Oliver, Brian/E-7939-2010	Oliver, Brian/0000-0002-7122-9262; Fear, Justin/0000-0002-2732-449X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arnold Arthur P, 2010, Biol Sex Differ, V1, P1, DOI 10.1186/2042-6410-1-1; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Bryant PJ, 2001, NOVART FDN SYMP, V237, P182, DOI 10.1002/0470846666.ch14; Clough E, 2012, BRIEF FUNCT GENOMICS, V11, P387, DOI 10.1093/bfgp/els019; El Ouaamari A, 2016, CELL METAB, V23, P194, DOI 10.1016/j.cmet.2015.12.001; Hudry B, 2016, NATURE, V530, P344, DOI 10.1038/nature16953; Lynch KW, 1996, GENE DEV, V10, P2089, DOI 10.1101/gad.10.16.2089; Mackay TFC, 2010, PHILOS T R SOC B, V365, P1229, DOI 10.1098/rstb.2009.0315; Reiff T, 2015, ELIFE, V4, DOI 10.7554/eLife.06930; Rideout EJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005683; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771	11	1	1	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					289	290		10.1038/530289a	http://dx.doi.org/10.1038/530289a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887491				2022-12-28	WOS:000370327100026
J	Hajdenberg, J				Hajdenberg, Julio			In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hajdenberg, Julio] UF Hlth Canc Ctr Orlando Hlth, Orlando, FL USA		Hajdenberg, J (corresponding author), UF Hlth Canc Ctr Orlando Hlth, Orlando, FL USA.			Hajdenberg, Julio/0000-0001-6346-1638				Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; Staples MP, 2006, MED J AUSTRALIA, V184, P6, DOI 10.5694/j.1326-5377.2006.tb00086.x	3	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					JC18	JC18		10.7326/ACPJC-2016-164-4-018	http://dx.doi.org/10.7326/ACPJC-2016-164-4-018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26882303				2022-12-28	WOS:000370135300005
J	Achkar, AJ; Zwiebler, M; McMahon, C; He, F; Sutarto, R; Djianto, I; Hao, ZH; Gingras, MJP; Hucker, M; Gu, GD; Revcolevschi, A; Zhang, H; Kim, YJ; Geck, J; Hawthorn, DG				Achkar, A. J.; Zwiebler, M.; McMahon, Christopher; He, F.; Sutarto, R.; Djianto, Isaiah; Hao, Zhihao; Gingras, Michel J. P.; Huecker, M.; Gu, G. D.; Revcolevschi, A.; Zhang, H.; Kim, Y. -J.; Geck, J.; Hawthorn, D. G.			Nematicity in stripe-ordered cuprates probed via resonant x-ray scattering	SCIENCE			English	Article							ROTATIONAL SYMMETRY; CHARGE ORDER; SUPERCONDUCTIVITY; PHASE	In underdoped cuprate superconductors, a rich competition occurs between superconductivity and charge density wave (CDW) order. Whether rotational symmetry-breaking (nematicity) occurs intrinsically and generically or as a consequence of other orders is under debate. Here, we employ resonant x-ray scattering in stripe-ordered superconductors (La,M)(2)CuO4 to probe the relationship between electronic nematicity of the Cu 3d orbitals, structure of the (La,M)(2)O-2 layers, and CDW order. We find distinct temperature dependences for the structure of the (La,M)(2)O-2 layers and the electronic nematicity of the CuO2 planes, with only the latter being enhanced by the onset of CDW order. These results identify electronic nematicity as an order parameter that is distinct from a purely structural order parameter in underdoped striped cuprates.	[Achkar, A. J.; McMahon, Christopher; Djianto, Isaiah; Hao, Zhihao; Gingras, Michel J. P.; Hawthorn, D. G.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Zwiebler, M.; Geck, J.] Leibniz Inst Solid State & Mat Res IFW Dresden, Helmholtzstr 20, D-01069 Dresden, Germany; [He, F.; Sutarto, R.] Canadian Light Source, Saskatoon, SK S7N 2V3, Canada; [Gingras, Michel J. P.; Hawthorn, D. G.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Gingras, Michel J. P.] Perimeter Inst Theoret Phys, 31 Caroline St North, Waterloo, ON N2L 2Y5, Canada; [Huecker, M.; Gu, G. D.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Revcolevschi, A.] Univ Paris Sud, UMR 8182, Synth Proprietes & Modelisat Mat SP2M, F-91405 Orsay, France; [Zhang, H.; Kim, Y. -J.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Geck, J.] Paris Lodron Univ Salzburg, Chem & Phys Mat, Hellbrunner Str 34, A-5020 Salzburg, Austria	University of Waterloo; Leibniz Institute for Solid State & Materials Research Dresden; University of Saskatchewan; Canadian Institute for Advanced Research (CIFAR); Perimeter Institute for Theoretical Physics; United States Department of Energy (DOE); Brookhaven National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; Salzburg University	Hawthorn, DG (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.; Hawthorn, DG (corresponding author), Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada.	dhawthor@uwaterloo.ca	He, Feizhou/G-8493-2015; Kim, Young-June/G-7196-2011; Geck, Jochen/AAC-7906-2022; Hawthorn, David G/I-6491-2012	He, Feizhou/0000-0002-3125-1406; Kim, Young-June/0000-0002-1172-8895; Geck, Jochen/0000-0002-2438-0672; Hawthorn, David G/0000-0002-7002-0416; McMahon, Christopher/0000-0001-7802-3016	Canada Foundation for Innovation (CFI); Canadian Institute for Advanced Research (CIFAR); Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair Program; CFI; NSERC; National Research Council Canada; Canadian Institutes of Health Research; Government of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Office of Basic Energy Sciences, Division of Materials Science and Engineering, U.S. Department of Energy [DE-AC02-98CH10886]; Canada Council for the Arts and the Perimeter Institute (PI) for Theoretical Physics; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Economic Development and Innovation; German Science Foundation (DFG) through the Emmy-Noether [GE1647/2-1]; German Science Foundation (DFG) through the D-A-CH program [GE 1647/3-1]; French Ministry of Education	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs); CFI(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Office of Basic Energy Sciences, Division of Materials Science and Engineering, U.S. Department of Energy(United States Department of Energy (DOE)); Canada Council for the Arts and the Perimeter Institute (PI) for Theoretical Physics; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Economic Development and Innovation; German Science Foundation (DFG) through the Emmy-Noether(German Research Foundation (DFG)); German Science Foundation (DFG) through the D-A-CH program(German Research Foundation (DFG)); French Ministry of Education	The authors acknowledge insightful discussions with J. Tranquada, S. A. Kivelson, L. Taillefer, I. Fischer, K. M. Shen, and G. A. Sawatzky. This work was supported by the Canada Foundation for Innovation (CFI), the Canadian Institute for Advanced Research (CIFAR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Canada Research Chair Program (M.J.P.G.). Research described in this paper was performed at the Canadian Light Source, which is funded by the CFI, the NSERC, the National Research Council Canada, the Canadian Institutes of Health Research, the Government of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The work at Brookhaven National Laboratory was supported by the Office of Basic Energy Sciences, Division of Materials Science and Engineering, U.S. Department of Energy, under contract DE-AC02-98CH10886. M.J.P.G. acknowledges support from the Canada Council for the Arts and the Perimeter Institute (PI) for Theoretical Physics. Research at PI is supported by the Government of Canada through Industry Canada and by the Province of Ontario through the Ministry of Economic Development and Innovation. J. G. and M. Z. were supported by the German Science Foundation (DFG) through the Emmy-Noether (GE1647/2-1) and the D-A-CH program (GE 1647/3-1). A.R. was supported by the French Ministry of Education.	Achkar AJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.017001; Achkar AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.167001; Achkar A. J., 2014, ARXIV14096787; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; AXE JD, 1989, PHYS REV LETT, V62, P2751, DOI 10.1103/PhysRevLett.62.2751; Blackburn E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.137004; Blanco-Canosa S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187001; Comin R, 2015, SCIENCE, V347, P1335, DOI 10.1126/science.1258399; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Cyr-Choiniere O, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.224502; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; DMITRIENKO VE, 1983, ACTA CRYSTALLOGR A, V39, P29, DOI 10.1107/S0108767383000057; Fink J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.092503; Fujita K., 2011, J PHYS SOC JPN, V81; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Haruta M, 2013, J APPL PHYS, V114, DOI 10.1063/1.4819397; Haverkort M., 2010, PHYS REV B; Hawthorn DG, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3607438; Hucker M, 2012, PHYSICA C, V481, P3, DOI 10.1016/j.physc.2012.04.035; Hucker M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.104506; Hucker M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057004; Kim YJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064520; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Mesaros A, 2011, SCIENCE, V333, P426, DOI 10.1126/science.1201082; SUZUKI T, 1989, J PHYS SOC JPN, V58, P1883, DOI 10.1143/JPSJ.58.1883; Tabis W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6875; TEMPLETON DH, 1980, ACTA CRYSTALLOGR A, V36, P237, DOI 10.1107/S0567739480000472; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Wilkins SB, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195101; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345	33	52	53	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					576	578		10.1126/science.aad1824	http://dx.doi.org/10.1126/science.aad1824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912696	Green Submitted			2022-12-28	WOS:000369291600033
J	Warshaw, DM				Warshaw, David M.			Throttling back the heart's molecular motor	SCIENCE			English	Editorial Material							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HEAVY-CHAIN GENE; CARDIAC MYOSIN; BETA-MYOSIN; MOUSE MODEL; MUTATIONS; EXPRESSION; MECHANICS; THICK		[Warshaw, David M.] Univ Vermont, Cardiovasc Res Inst, Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont	Warshaw, DM (corresponding author), Univ Vermont, Cardiovasc Res Inst, Mol Physiol & Biophys, Burlington, VT 05405 USA.	david.warshaw@med.uvm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059408, R01HL126909] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL126909, R01 HL126909, HL059408, P01 HL059408] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; Dearani JA, 2007, NAT CLIN PRACT CARD, V4, P503, DOI 10.1038/ncpcardio0965; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; EPSTEIN ND, 1992, CIRCULATION, V86, P345, DOI 10.1161/01.CIR.86.2.345; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; KLEIN MD, 1965, AM J CARDIOL, V15, P773, DOI 10.1016/0002-9149(65)90379-6; LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737	15	5	5	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					556	557		10.1126/science.aaf1636	http://dx.doi.org/10.1126/science.aaf1636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912685	Green Accepted			2022-12-28	WOS:000369291600019
J	Mol, BWJ; Daly, M; Dodd, JM				Mol, Ben W. J.; Daly, Mandy; Dodd, Jodie M.			Progestogens and preterm birth-not the hoped for panacea?	LANCET			English	Editorial Material							OUTCOMES; WOMEN		[Mol, Ben W. J.; Dodd, Jodie M.] Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA 5000, Australia; [Mol, Ben W. J.; Dodd, Jodie M.] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia; [Daly, Mandy] Irish Neonatal Hlth Alliance, Bray, Wicklow, Ireland	Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Mol, BWJ (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA 5000, Australia.; Mol, BWJ (corresponding author), South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia.	ben.mol@adelaide.edu.au	Dodd, Jodie/Y-6849-2019	Dodd, Jodie/0000-0002-6363-4874				Alfirevic Z, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6531; Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3; Duley L, 2014, LANCET, V383, P2041, DOI 10.1016/S0140-6736(14)60989-2; KEIRSE MJNC, 1990, BRIT J OBSTET GYNAEC, V97, P149, DOI 10.1111/j.1471-0528.1990.tb01740.x; Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Norman JE, 2016, LANCET; van 't Hooft J, 2016, OBSTET GYNECOL, V127, P49, DOI 10.1097/AOG.0000000000001195; Wapner RJ, 2007, NEW ENGL J MED, V357, P1190, DOI 10.1056/NEJMoa071453	12	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2066	2068		10.1016/S0140-6736(16)00543-2	http://dx.doi.org/10.1016/S0140-6736(16)00543-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	26921135	hybrid			2022-12-28	WOS:000376450800006
J	Majumder, S; Chari, ST				Majumder, Shounak; Chari, Suresh T.			Chronic pancreatitis	LANCET			English	Review							SUSPECTED CHRONIC-PANCREATITIS; LONG-TERM OUTCOMES; AUTOIMMUNE PANCREATITIS; ENDOSCOPIC TREATMENT; ALCOHOL-CONSUMPTION; SURGICAL-TREATMENT; REDUCE PAIN; RISK-FACTOR; FIBROSIS; EPIDEMIOLOGY	Chronic pancreatitis describes a wide spectrum of fibro-inflammatory disorders of the exocrine pancreas that includes calcifying, obstructive, and steroid-responsive forms. Use of the term chronic pancreatitis without qualification generally refers to calcifying chronic pancreatitis. Epidemiology is poorly defined, but incidence worldwide seems to be on the rise. Smoking, drinking alcohol, and genetic predisposition are the major risk factors for chronic calcifying pancreatitis. In this Seminar, we discuss the clinical features, diagnosis, and management of chronic calcifying pancreatitis, focusing on pain management, the role of endoscopic and surgical intervention, and the use of pancreatic enzyme-replacement therapy. Management of patients is often challenging and necessitates a multidisciplinary approach.	[Majumder, Shounak; Chari, Suresh T.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic	Chari, ST (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	chari.suresh@mayo.edu		Chari, Suresh/0000-0002-3924-0971				Akisik MF, 2006, RADIOGRAPHICS, V26, P665, DOI 10.1148/rg.263055077; Alexandre M, 2012, AM J PHYSIOL-GASTR L, V303, pG696, DOI 10.1152/ajpgi.00138.2012; Ali UA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007884.pub3; Amann ST, 1996, PANCREAS, V13, P226, DOI 10.1097/00006676-199610000-00002; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; Aoun E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002003; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Bachmann K, 2014, J AM COLL SURGEONS, V219, P208, DOI 10.1016/j.jamcollsurg.2014.03.040; Balci NC, 2008, J MAGN RESON IMAGING, V27, P125, DOI 10.1002/jmri.21241; Bertin C, 2012, AM J GASTROENTEROL, V107, P311, DOI 10.1038/ajg.2011.424; Bhardwaj P, 2009, GASTROENTEROLOGY, V136, P149, DOI 10.1053/j.gastro.2008.09.028; Bhatia E, 2002, GASTROENTEROLOGY, V123, P1020, DOI 10.1053/gast.2002.36028; Boerma D, 2003, DIGEST SURG, V20, P520, DOI 10.1159/000073688; Bramis K, 2012, BRIT J SURG, V99, P761, DOI 10.1002/bjs.8713; Cahen DL, 2007, NEW ENGL J MED, V356, P676, DOI 10.1056/NEJMoa060610; Cahen DL, 2011, GASTROENTEROLOGY, V141, P1690, DOI 10.1053/j.gastro.2011.07.049; Catalano MF, 2009, GASTROINTEST ENDOSC, V69, P1251, DOI 10.1016/j.gie.2008.07.043; Chowdhury P, 2008, LANGENBECK ARCH SURG, V393, P547, DOI 10.1007/s00423-007-0267-1; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Cote GA, 2011, CLIN GASTROENTEROL H, V9, P266, DOI 10.1016/j.cgh.2010.10.015; Cui YF, 2011, PANCREATOLOGY, V11, P279, DOI 10.1159/000329188; Czako L, 2001, PANCREAS, V23, P323, DOI 10.1097/00006676-200110000-00015; Demir IE, 2011, LANGENBECK ARCH SURG, V396, P151, DOI 10.1007/s00423-010-0731-1; Diener MK, 2008, ANN SURG, V247, P950, DOI 10.1097/SLA.0b013e3181724ee7; DIMAGNO EP, 1973, NEW ENGL J MED, V288, P813, DOI 10.1056/NEJM197304192881603; Dite P, 2003, ENDOSCOPY, V35, P553; Drewes AM, 2008, GUT, V57, P1616, DOI 10.1136/gut.2007.146621; Dumonceau JM, 2012, ENDOSCOPY, V44, P784, DOI 10.1055/s-0032-1309840; Dumonceau JM, 2007, GUT, V56, P545, DOI 10.1136/gut.2006.096883; Dumonceau Jean-Marc, 2013, Gastrointest Endosc Clin N Am, V23, P821, DOI 10.1016/j.giec.2013.06.004; Eloubeidi MA, 2004, GASTROINTEST ENDOSC, V60, P385, DOI 10.1016/S0016-5107(04)01714-6; Ewald N, 2013, WORLD J GASTROENTERO, V19, P7276, DOI 10.3748/wjg.v19.i42.7276; Fasanella KE, 2007, GASTROENTEROL CLIN N, V36, P335, DOI 10.1016/j.gtc.2007.03.011; Felderbauer P, 2006, SCAND J GASTROENTERO, V41, P343, DOI 10.1080/00365520510024214; Ferrone M, 2007, PHARMACOTHERAPY, V27, P910, DOI 10.1592/phco.27.6.910; Forsmark CE, 2013, GASTROENTEROLOGY, V144, P1282, DOI 10.1053/j.gastro.2013.02.008; Frokjaer JB, 2013, PANCREAS, V42, P1182, DOI 10.1097/MPA.0b013e31829628f4; Frulloni L, 2009, DIGEST LIVER DIS, V41, P311, DOI 10.1016/j.dld.2008.07.316; Frulloni L, 2010, DIGEST LIVER DIS, V42, pS381, DOI 10.1016/S1590-8658(10)60682-2; Hart PA, 2015, GASTROENTEROLOGY, V149, P39, DOI 10.1053/j.gastro.2015.03.010; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Irving HM, 2009, J PANCREAS, V10, P387; JAAKKOLA M, 1993, GUT, V34, P1255, DOI 10.1136/gut.34.9.1255; JOHNSON CD, 1991, GUT, V32, P1401, DOI 10.1136/gut.32.11.1401; Kamisawa T, 2015, LANCET, V385, P1460, DOI 10.1016/S0140-6736(14)60720-0; Kamisawa T, 2011, PANCREAS, V40, P809, DOI 10.1097/MPA.0b013e3182258a15; Kanth R, 2014, PANCREATOLOGY, V14, P244, DOI 10.1016/j.pan.2014.05.796; Kim DH, 2007, SURG CLIN N AM, V87, P1341, DOI 10.1016/j.suc.2007.08.005; KLOPPEL G, 1993, PANCREAS, V8, P659; Kutup A, 2010, J HEPATO-BIL-PAN SCI, V17, P758, DOI 10.1007/s00534-009-0184-5; Lankisch PG, 2002, PANCREAS, V25, P411, DOI 10.1097/00006676-200211000-00015; Levy P, 2014, UNITED EUR GASTROENT, V2, P345, DOI 10.1177/2050640614548208; MADSEN P, 1982, SCAND J GASTROENTERO, V17, P553, DOI 10.3109/00365528209182248; Majumder S, 2015, P 46 ANN M AM PANCR; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Muniraj T, 2014, DM-DIS MON, V60, P530, DOI 10.1016/j.disamonth.2014.11.002; Nojgaard C, 2011, PANCREAS, V40, P1195, DOI 10.1097/MPA.0b013e318221f569; Olesen SS, 2011, GASTROENTEROLOGY, V141, P536, DOI 10.1053/j.gastro.2011.04.003; Pandol SJ, 2010, DIGEST DIS, V28, P776, DOI 10.1159/000327212; Parsi MA, 2008, CLIN GASTROENTEROL H, V6, P1432, DOI 10.1016/j.cgh.2008.06.004; Pasricha PJ, 2012, NAT REV GASTRO HEPAT, V9, P140, DOI 10.1038/nrgastro.2011.274; PITCHUMONI CS, 1984, AM J GASTROENTEROL, V79, P382; Raimondi S, 2010, BEST PRACT RES CL GA, V24, P349, DOI 10.1016/j.bpg.2010.02.007; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; SAHEL J, 1979, DIGEST DIS SCI, V24, P897, DOI 10.1007/BF01311942; Schneider A, 2011, GASTROENTEROLOGY, V140, P162, DOI 10.1053/j.gastro.2010.10.045; Shimizu M, 1996, J CLIN PATHOL, V49, P913, DOI 10.1136/jcp.49.11.913; Shimosegawa T, 2010, J GASTROENTEROL, V45, P584, DOI 10.1007/s00535-010-0242-4; Siriwardena AK, 2012, GASTROENTEROLOGY, V143, P655, DOI 10.1053/j.gastro.2012.05.046; STAMM BH, 1984, HUM PATHOL, V15, P677, DOI 10.1016/S0046-8177(84)80294-4; Stevens T, 2012, CLIN GASTROENTEROL H, V10, P186, DOI 10.1016/j.cgh.2011.09.006; Stevens T, 2009, CLIN GASTROENTEROL H, V7, P114, DOI 10.1016/j.cgh.2008.09.002; Unnikrishnan R, 2015, ACTA DIABETOL, V52, P1, DOI 10.1007/s00592-014-0685-9; van der Gaag NA, 2012, ANN SURG, V255, P763, DOI 10.1097/SLA.0b013e31824b7697; van Geenen EJM, 2011, AM J GASTROENTEROL, V106, P1161, DOI 10.1038/ajg.2011.43; Varadarajulu S, 2007, GASTROINTEST ENDOSC, V66, P501, DOI 10.1016/j.gie.2006.12.043; WARSHAW AL, 1983, ANN SURG, V198, P443, DOI 10.1097/00000658-198310000-00004; Weiss FU, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00070; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Whitcomb DC, 1996, GASTROENTEROLOGY, V110, P1975, DOI 10.1053/gast.1996.v110.pm8964426; WHITE TT, 1970, SURG GYNECOL OBSTETR, V130, P275; Wilder-Smith CH, 1999, DIGEST DIS SCI, V44, P1107, DOI 10.1023/A:1026607703352; Whiny M, 2014, SURGERY, V155, P271, DOI 10.1016/j.surg.2013.08.012; Winstead NS, 2009, PANCREATOLOGY, V9, P344, DOI 10.1159/000212086; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yadav D, 2012, AM J GASTROENTEROL, V107, P1096, DOI 10.1038/ajg.2012.126; Yadav D, 2011, AM J GASTROENTEROL, V106, P2192, DOI 10.1038/ajg.2011.328; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125; Yin Z, 2012, ARCH SURG-CHICAGO, V147, P961, DOI 10.1001/archsurg.2012.2005; Zhou YM, 2015, PANCREATOLOGY, V15, P372, DOI 10.1016/j.pan.2015.05.466	91	200	217	8	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1957	1966		10.1016/S0140-6736(16)00097-0	http://dx.doi.org/10.1016/S0140-6736(16)00097-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	26948434				2022-12-28	WOS:000375374200040
J	Rosenberg, JE; Hoffman-Censits, J; Powles, T; van der Heijden, MS; Balar, AV; Necchi, A; Dawson, N; O'Donnell, PH; Balmanoukian, A; Loriot, Y; Srinivas, S; Retz, MM; Grivas, P; Joseph, RW; Galsky, MD; Fleming, MT; Petrylak, DP; Perez-Gracia, JL; Burris, HA; Castellano, D; Canil, C; Bellmunt, J; Bajorin, D; Nickles, D; Bourgon, R; Frampton, GM; Cui, N; Mariathasan, S; Abidoye, O; Fine, GD; Dreicer, R				Rosenberg, Jonathan E.; Hoffman-Censits, Jean; Powles, Tom; van der Heijden, Michiel S.; Balar, Arjun V.; Necchi, Andrea; Dawson, Nancy; O'Donnell, Peter H.; Balmanoukian, Ani; Loriot, Yohann; Srinivas, Sandy; Retz, Margitta M.; Grivas, Petros; Joseph, Richard W.; Galsky, Matthew D.; Fleming, Mark T.; Petrylak, Daniel P.; Perez-Gracia, Jose Luis; Burris, Howard A.; Castellano, Daniel; Canil, Christina; Bellmunt, Joaquim; Bajorin, Dean; Nickles, Dorothee; Bourgon, Richard; Frampton, Garrett M.; Cui, Na; Mariathasan, Sanjeev; Abidoye, Oyewale; Fine, Gregg D.; Dreicer, Robert			Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial	LANCET			English	Article							CELL LUNG-CANCER; IMMUNE-RELATED RESPONSE; UNTREATED MELANOMA; PROGRAMMED DEATH-1; RANDOMIZED-TRIAL; CTLA-4 BLOCKADE; BLADDER-CANCER; PD-1 BLOCKADE; SOLID TUMORS; NIVOLUMAB	Background Patients with metastatic urothelial carcinoma have few treatment options after failure of platinum-based chemotherapy. In this trial, we assessed treatment with atezolizumab, an engineered humanised immunoglobulin G1 monoclonal antibody that binds selectively to programmed death ligand 1 (PD-L1), in this patient population. Methods For this multicentre, single-arm, two-cohort, phase 2 trial, patients (aged >= 18 years) with inoperable locally advanced or metastatic urothelial carcinoma whose disease had progressed after previous platinum-based chemotherapy were enrolled from 70 major academic medical centres and community oncology practices in Europe and North America. Key inclusion criteria for enrolment were Eastern Cooperative Oncology Group performance status of 0 or 1, measurable disease defined by Response Evaluation Criteria In Solid Tumors version 1.1 (RECIST v1.1), adequate haematological and end-organ function, and no autoimmune disease or active infections. Formalin-fixed paraffin-embedded tumour specimens with sufficient viable tumour content were needed from all patients before enrolment. Patients received treatment with intravenous atezolizumab (1200 mg, given every 3 weeks). PD-L1 expression on tumour-infiltrating immune cells (ICs) was assessed prospectively by immunohistochemistry. The co-primary endpoints were the independent review facility-assessed objective response rate according to RECIST v1.1 and the investigator-assessed objective response rate according to immune-modified RECIST, analysed by intention to treat. A hierarchical testing procedure was used to assess whether the objective response rate was significantly higher than the historical control rate of 10% at an a level of 0.05. This study is registered with ClinicalTrials.gov, number NCT02108652. Findings Between May 13, 2014, and Nov 19, 2014, 486 patients were screened and 315 patients were enrolled into the study. Of these patients, 310 received atezolizumab treatment (five enrolled patients later did not meet eligibility criteria and were not dosed with study drug). The PD-L1 expression status on infiltrating immune cells (ICs) in the tumour microenvironment was defined by the percentage of PD-L1-positive immune cells: IC0 (<1%), IC1 (>= 1% but < 5%), and IC2/3 (>= 5%). The primary analysis (data cutoff May 5, 2015) showed that compared with a historical control overall response rate of 10%, treatment with atezolizumab resulted in a significantly improved RECIST v1.1 objective response rate for each prespecified immune cell group (IC2/3: 27% [95% CI 19-37], p< 0.0001; IC1/2/3: 18% [13-24], p= 0.0004) and in all patients (15% [11-20], p= 0.0058). With longer follow-up (data cutoff Sept 14, 2015), by independent review, objective response rates were 26% (95% CI 18-36) in the IC2/3 group, 18% (13-24) in the IC1/2/3 group, and 15% (11-19) overall in all 310 patients. With a median follow-up of 11.7 months (95% CI 11.4-12.2), ongoing responses were recorded in 38 (84%) of 45 responders. Exploratory analyses showed The Cancer Genome Atlas (TCGA) subtypes and mutation load to be independently predictive for response to atezolizumab. Grade 3-4 treatment-related adverse events, of which fatigue was the most common (five patients [2%]), occurred in 50 (16%) of 310 treated patients. Grade 3-4 immune-mediated adverse events occurred in 15 (5%) of 310 treated patients, with pneumonitis, increased aspartate aminotransferase, increased alanine aminotransferase, rash, and dyspnoea being the most common. No treatment-related deaths occurred during the study. Interpretation Atezolizumab showed durable activity and good tolerability in this patient population. Increased levels of PD-L1 expression on immune cells were associated with increased response. This report is the first to show the association of TCGA subtypes with response to immune checkpoint inhibition and to show the importance of mutation load as a biomarker of response to this class of agents in advanced urothelial carcinoma.	[Rosenberg, Jonathan E.; Bajorin, Dean] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Hoffman-Censits, Jean] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Powles, Tom] Queen Mary Univ London, Barts Hlth & Royal Free NHS Trust, Barts Canc Inst ECMC, London, England; [van der Heijden, Michiel S.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Balar, Arjun V.] NYU Langone Med Ctr, Perlmutter Canc Ctr, Genitourinary Canc Program, New York, NY USA; [Necchi, Andrea] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy; [Dawson, Nancy] Medstar Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC USA; [O'Donnell, Peter H.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Balmanoukian, Ani] Angeles Clin & Res Inst, Los Angeles, CA USA; [Loriot, Yohann] Villejuif Univ Paris Sud, Dept Canc Med, Gustave Roussy Canc Campus, Paris, France; [Srinivas, Sandy] Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA; [Retz, Margitta M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-80290 Munich, Germany; [Grivas, Petros] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44106 USA; [Joseph, Richard W.] Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA; [Galsky, Matthew D.] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY USA; [Fleming, Mark T.] US Oncol Res, Virginia Oncol Associates, Norfolk, VA USA; [Petrylak, Daniel P.] Yale Univ, Smilow Canc Ctr, New Haven, CT USA; [Perez-Gracia, Jose Luis] Univ Navarra, Clin Univ Navarra, Dept Oncol, E-31080 Pamplona, Navarre, Spain; [Burris, Howard A.] Sarah Cannon Res Inst, Nashville, TN USA; [Burris, Howard A.] Tennessee Oncol, Nashville, TN USA; [Castellano, Daniel] Univ Hosp 12 Octubre, Genitourinary Oncol Unit, Dept Med Oncol, Madrid, Spain; [Canil, Christina] Univ Ottawa, Dept Med, Div Med Oncol, Ottawa Hosp Res Inst,Ottawa Hosp Canc Ctr, 451 Smyth Rd, Ottawa, ON, Canada; [Bellmunt, Joaquim] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, 44 Binney St, Boston, MA 02115 USA; [Nickles, Dorothee; Bourgon, Richard; Cui, Na; Mariathasan, Sanjeev; Abidoye, Oyewale; Fine, Gregg D.] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA; [Frampton, Garrett M.] Fdn Med Inc, Cambridge, MA USA; [Dreicer, Robert] Univ Virginia, Sch Med, Div Hematol Oncol, Charlottesville, VA 22908 USA	Memorial Sloan Kettering Cancer Center; Jefferson University; Barts Health NHS Trust; University of London; Queen Mary University London; Netherlands Cancer Institute; NYU Langone Medical Center; Fondazione IRCCS Istituto Nazionale Tumori Milan; Georgetown University; University of Chicago; Angeles Clinic & Research Institute; Stanford University; Technical University of Munich; Cleveland Clinic Foundation; Mayo Clinic; Icahn School of Medicine at Mount Sinai; US Oncology Network; Yale University; University of Navarra; Sarah Cannon Research Institute; Tennessee Oncology; Hospital Universitario 12 de Octubre; University of Ottawa; Ottawa Hospital Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Roche Holding; Genentech; Foundation Medicine; University of Virginia	Rosenberg, JE (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA.	rosenbj1@mskcc.org	Loriot, Yohann/W-5572-2019; Bellmunt, Joaquim/B-8151-2019; Necchi, Andrea/L-6021-2017; Perez-Gracia, Jose Luis/I-8372-2017	Bellmunt, Joaquim/0000-0003-2328-3421; Necchi, Andrea/0000-0002-3007-2756; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Joseph, Richard/0000-0001-6102-4661; Bourgon, Richard/0000-0002-5890-4374; Balar, Arjun/0000-0003-3949-5656; Frampton, Garrett/0000-0002-2361-2750	F Hoffmann-La Roche Ltd.; NIH/NCI Cancer Center Support Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	F Hoffmann-La Roche Ltd.(Hoffmann-La Roche); NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	F Hoffmann-La Roche Ltd.; We thank the patients and their families who participated in the study, and all the investigators and their staff. We thank Mark Kockx at HistoGeneX for technical assistance; Fatema LeGrand, Xiaodong Shen, and Ann Christine Thastrom at Genentech for contributions to the study; Shi Li at Genentech for contributions to the primary data analysis; Priti Hegde at Genentech for input on biomarker strategy and the report; Zach Boyd at Genentech for contributions to the biomarker analysis; and Cathleen Ahearn and Daniel Chen at Genentech for input into the study design and the manuscript. Medical writing assistance for this report was provided by Peter Flanagan associated with Eolas Communications, and paid for by F Hoffmann-La Roche Ltd. This research was supported in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.	Agarwal N, 2014, CLIN GENITOURIN CANC, V12, P130, DOI 10.1016/j.clgc.2013.09.002; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bambury RM, 2015, ONCOLOGIST, V20, P508, DOI 10.1634/theoncologist.2014-0354; Bellmunt J, 2015, ANN ONCOL, V26, P812, DOI 10.1093/annonc/mdv009; Bellmunt J, 2009, J CLIN ONCOL, V27, P4454, DOI 10.1200/JCO.2008.20.5534; Boorjian SA, 2008, CLIN CANCER RES, V14, P4800, DOI 10.1158/1078-0432.CCR-08-0731; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Chiou VL, 2015, J CLIN ONCOL, V33, P3541, DOI 10.1200/JCO.2015.61.6870; Choueiri TK, 2012, J CLIN ONCOL, V30, P507, DOI 10.1200/JCO.2011.37.7002; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; De Santis M, 2012, J CLIN ONCOL, V30, P191, DOI 10.1200/JCO.2011.37.3571; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nishino M, 2015, EUR J RADIOL, V84, P1259, DOI 10.1016/j.ejrad.2015.03.017; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Petrylak DP, 2015, J CLIN ONCOL, V33; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; STERNBERG CN, 1985, J UROLOGY, V133, P403, DOI 10.1016/S0022-5347(17)48996-8; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	49	2429	2520	12	332	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1909	1920		10.1016/S0140-6736(16)00561-4	http://dx.doi.org/10.1016/S0140-6736(16)00561-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	26952546	Green Accepted			2022-12-28	WOS:000375374200035
J	Muir, KW; White, P				Muir, Keith W.; White, Philip			HERMES: messenger for stroke interventional treatment	LANCET			English	Editorial Material							ACUTE ISCHEMIC-STROKE; ENDOVASCULAR THERAPY; THROMBECTOMY; UPDATE; TRIAL; GUIDELINES		[Muir, Keith W.] Univ Glasgow, Queen Elizabeth Univ Hosp, Inst Neurosci & Psychol, Glasgow G51 4TF, Lanark, Scotland; [White, Philip] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Queen Elizabeth University Hospital (QEUH); University of Glasgow; Newcastle University - UK	Muir, KW (corresponding author), Univ Glasgow, Queen Elizabeth Univ Hosp, Inst Neurosci & Psychol, Glasgow G51 4TF, Lanark, Scotland.	keith.muir@glasgow.ac.uk	Muir, Keith W/A-7670-2011	Muir, Keith W/0000-0001-9535-022X; White, Philip/0000-0001-6007-6013	Department of Health [HTA/14/08/47] Funding Source: Medline; National Institute for Health Research [14/08/47] Funding Source: researchfish; Stroke Association [TSA2011/06] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association		Badhiwala JH, 2015, JAMA-J AM MED ASSOC, V314, P1832, DOI 10.1001/jama.2015.13767; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Casaubon LK, 2015, INT J STROKE, V10, P924, DOI 10.1111/ijs.12551; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET; Khatri P, 2015, STROKE, V46, P1727, DOI 10.1161/STROKEAHA.115.008782; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Wahlgren N, 2016, INT J STROKE, V11, P134, DOI 10.1177/1747493015609778	13	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1695	1697		10.1016/S0140-6736(16)00351-2	http://dx.doi.org/10.1016/S0140-6736(16)00351-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ9OD	26898854	Green Accepted, Green Published			2022-12-28	WOS:000374541900004
J	Falk, MJ; Decherney, A; Kahn, JP				Falk, Marni J.; Decherney, Alan; Kahn, Jeffrey P.			Mitochondrial Replacement Techniques - Implications for the Clinical Community	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASES		[Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA; [Falk, Marni J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Decherney, Alan] NICHD, NIH, Bethesda, MD 20892 USA; [Kahn, Jeffrey P.] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University	Falk, MJ (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA.; Falk, MJ (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.		DeCherney, Alan H/AAS-2944-2020	Falk, Marni/0000-0002-1723-6728; Kahn, Jeffrey/0000-0003-2493-2016	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984, ZIEHD008737] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HD999999] Funding Source: Medline; NICHD NIH HHS [U54 HD086984] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Engelstad K, HUM REPROD IN PRESS; Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126; Mitalipov S, 2014, CELL REP, V7, P935, DOI 10.1016/j.celrep.2014.05.004; National Academies of Sciences Engineering and Medicine, 2016, MIT REPL TECHN ETH S; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368	5	23	26	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1103	1106		10.1056/NEJMp1600893	http://dx.doi.org/10.1056/NEJMp1600893			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	26910290	Green Accepted			2022-12-28	WOS:000372585100002
J	Spellberg, B; Srinivasan, A; Chambers, HF				Spellberg, Brad; Srinivasan, Arjun; Chambers, Henry F.			New Societal Approaches to Empowering Antibiotic Stewardship	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Spellberg, Brad] Los Angeles Cty Univ Southern Calif, Med Ctr, Los Angeles, CA USA; [Spellberg, Brad] Univ So Calif, Keck Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90033 USA; [Srinivasan, Arjun] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Chambers, Henry F.] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California; Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Spellberg, B (corresponding author), LAC USC Med Ctr, 2051 Marengo St,C2K122, Los Angeles, CA 90033 USA.	bspellberg@dhs.lacounty.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117211, R01AI103342, R21AI127954] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI117211, R21 AI127954] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1945, NY TIMES; Centers for Disease Control and Prevention, 2015, COR EL HOSP ANT STEW; Centers for Disease Control and Prevention (U. S.), 2013, ANT RES THREATS US; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Executive Office of the President President's Council of Advisor on Science and Technology, 2014, REP PRES COMB ANT RE; MCDERMOTT W, 1982, JOHNS HOPKINS MED J, V151, P302; Spellberg B, 2014, JAMA INTERN MED, V174, P432, DOI 10.1001/jamainternmed.2013.14019	7	59	62	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1229	1230		10.1001/jama.2016.1346	http://dx.doi.org/10.1001/jama.2016.1346			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	26914942	Green Accepted			2022-12-28	WOS:000372511100004
J	Vourekas, A; Alexiou, P; Vrettos, N; Maragkakis, M; Mourelatos, Z				Vourekas, Anastassios; Alexiou, Panagiotis; Vrettos, Nicholas; Maragkakis, Manolis; Mourelatos, Zissimos			Sequence-dependent but not sequence-specific piRNA adhesion traps mRNAs to the germ plasm	NATURE			English	Article							DROSOPHILA-MELANOGASTER; STRUCTURAL BASIS; PIWI PROTEINS; CLIP-SEQ; REVEALS; LOCALIZATION; OSKAR; TUDOR; AUBERGINE; IDENTIFICATION	The conserved Piwi family of proteins and piwi-interacting RNAs (piRNAs) have a central role in genomic stability, which is inextricably linked to germ-cell formation, by forming Piwi ribonucleoproteins (piRNPs) that silence transposable elements(1). In Drosophila melanogaster and other animals, primordial germ-cell specification in the developing embryo is driven by maternal messenger RNAs and proteins that assemble into specialized messenger ribonucleoproteins (mRNPs) localized in the germ (pole) plasm at the posterior of the oocyte(2,3). Maternal piRNPs, especially those loaded on the Piwi protein Aubergine (Aub), are transmitted to the germ plasm to initiate transposon silencing in the offspring germ line(4-7). The transport of mRNAs to the oocyte by midoogenesis is an active, microtubule-dependent process(8); mRNAs necessary for primordial germ-cell formation are enriched in the germ plasm at late oogenesis via a diffusion and entrapment mechanism, the molecular identity of which remains unknown(8,9). Aub is a central component of germ granule RNPs, which house mRNAs in the germ plasm(10-12), and interactions between Aub and Tudor are essential for the formation of germ granules(13-16). Here we show that Aub-loaded piRNAs use partial base-pairing characteristics of Argonaute RNPs to bind mRNAs randomly in Drosophila, acting as an adhesive trap that captures mRNAs in the germ plasm, in a Tudor-dependent manner. Notably, germ plasm mRNAs in drosophilids are generally longer and more abundant than other mRNAs, suggesting that they provide more target sites for piRNAs to promote their preferential tethering in germ granules. Thus, complexes containing Tudor, Aub piRNPs and mRNAs couple piRNA inheritance with germline specification. Our findings reveal an unexpected function for piRNP complexes in mRNA trapping that may be generally relevant to the function of animal germ granules.	[Vourekas, Anastassios; Alexiou, Panagiotis; Vrettos, Nicholas; Maragkakis, Manolis; Mourelatos, Zissimos] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Dept Pathol & Lab Med,Div Neuropathol, Philadelphia, PA 19104 USA; [Vourekas, Anastassios; Alexiou, Panagiotis; Vrettos, Nicholas; Maragkakis, Manolis; Mourelatos, Zissimos] Univ Penn, PENN Genome Frontiers Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Mourelatos, Z (corresponding author), Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Dept Pathol & Lab Med,Div Neuropathol, Philadelphia, PA 19104 USA.; Mourelatos, Z (corresponding author), Univ Penn, PENN Genome Frontiers Inst, Philadelphia, PA 19104 USA.	mourelaz@uphs.upenn.edu	Maragkakis, Emmanouil/F-5427-2010; Maragkakis, Manolis/AAN-3407-2020; Vourekas, Anastassios/J-6108-2017; Vourekas, Anastasios/AAI-8278-2020; Alexiou, Panagiotis/ABB-6698-2020	Maragkakis, Emmanouil/0000-0002-3158-1763; Maragkakis, Manolis/0000-0002-3158-1763; Vourekas, Anastassios/0000-0002-1850-5635; Alexiou, Panagiotis/0000-0003-3437-7482; Mourelatos, Zissimos/0000-0002-9852-1845	Brody family fellowship; National Institutes of Health (NIH) [GM072777]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072777] Funding Source: NIH RePORTER	Brody family fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank former and current laboratory members for discussions; M. Siomi for the Tudor antibody; A. Arkov for tud flies; G. Dreyfuss for the PABP antibody; and J. Schug for Illumina sequencing. Work was supported by a Brody family fellowship to M. M., and a National Institutes of Health (NIH) grant GM072777 to Z.M.	Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; Barckmann B, 2015, CELL REP, V12, P1205, DOI 10.1016/j.celrep.2015.07.030; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; BUCHETON A, 1979, GENETICS, V93, P131; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Gavis ER, 1996, DEVELOPMENT, V122, P2791; Ghosh S, 2012, NAT STRUCT MOL BIOL, V19, P441, DOI 10.1038/nsmb.2257; Grentzinger T, 2012, GENOME RES, V22, P1877, DOI 10.1101/gr.136614.111; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Jambor H, 2015, ELIFE, V4, DOI 10.7554/eLife.05003; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Kirino Y, 2011, METHODS MOL BIOL, V725, P281, DOI 10.1007/978-1-61779-046-1_18; Kirino Y, 2010, RNA, V16, P70, DOI 10.1261/rna.1869710; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Kugler JM, 2009, FLY, V3, P15, DOI 10.4161/fly.3.1.7751; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Little SC, 2015, NAT CELL BIOL, V17, P558, DOI 10.1038/ncb3143; Liu HP, 2010, GENE DEV, V24, P1876, DOI 10.1101/gad.1956010; Mahowald AP, 2001, INT REV CYTOL, V203, P187; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Maragkakis M., 2015, GENOO MODERN PERL FR; Maragkakis M, 2016, RNA, V22, P1, DOI 10.1261/rna.052167.115; MATUNIS MJ, 1992, J CELL BIOL, V116, P245, DOI 10.1083/jcb.116.2.245; Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; Rangan P, 2009, CURR BIOL, V19, P72, DOI 10.1016/j.cub.2008.11.066; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; SCHUPBACH T, 1991, GENETICS, V129, P1119; Sinsimer KS, 2013, CELL REP, V5, P1169, DOI 10.1016/j.celrep.2013.10.045; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Thomson T, 2004, GENESIS, V40, P164, DOI 10.1002/gene.20079; Thomson T, 2008, MECH DEVELOP, V125, P865, DOI 10.1016/j.mod.2008.06.005; Trcek T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8962; Vourekas A, 2015, GENE DEV, V29, P617, DOI 10.1101/gad.254631.114; Vourekas A, 2014, METHODS MOL BIOL, V1093, P73, DOI 10.1007/978-1-62703-694-8_7; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Wilson JE, 1996, DEVELOPMENT, V122, P1631	44	73	76	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					390	+		10.1038/nature17150	http://dx.doi.org/10.1038/nature17150			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26950602	Green Accepted			2022-12-28	WOS:000372064300057
J	Friedberg, MW				Friedberg, Mark W.			What Do You Mean by Medical Home?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE; QUALITY; INTERVENTION		[Friedberg, Mark W.] RAND Corp, 20 Pk Plaza,Suite 920, Boston, MA 02115 USA; [Friedberg, Mark W.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Friedberg, Mark W.] Harvard Univ, Sch Med, Boston, MA USA	RAND Corporation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Friedberg, MW (corresponding author), RAND Corp, 20 Pk Plaza,Suite 920, Boston, MA 02115 USA.	mfriedbe@rand.org	Friedberg, Mark William/Y-2607-2019	Friedberg, Mark William/0000-0002-7907-8358				Edwards ST, 2014, HEALTH AFFAIR, V33, P1823, DOI 10.1377/hlthaff.2014.0351; Friedberg MW, 2015, JAMA INTERN MED, V175, P1362, DOI 10.1001/jamainternmed.2015.2047; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Friedberg MW, 2009, AM J MANAG CARE, V15, P137; Kern LM, 2016, ANN INTERN MED, V164, P395, DOI 10.7326/M14-2633; Paustian ML, 2014, HEALTH SERV RES, V49, P52, DOI 10.1111/1475-6773.12085; Romaire MA, 2010, ACAD PEDIATR, V10, P338, DOI 10.1016/j.acap.2010.06.010; Rosenthal MB, 2013, JAMA INTERN MED, V173, P1907, DOI 10.1001/jamainternmed.2013.10063; van Hasselt M, 2015, HEALTH SERV RES, V50, P253, DOI 10.1111/1475-6773.12217	9	7	7	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					444	445		10.7326/M16-0058	http://dx.doi.org/10.7326/M16-0058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26881766				2022-12-28	WOS:000372207200019
J	Barreto, ML; Barral-Netto, M; Stabeli, R; Almeida, N; Vasconcelos, PFC; Teixeira, M; Buss, P; Gadelha, PE				Barreto, Mauricio L.; Barral-Netto, Manoel; Stabeli, Rodrigo; Almeida-Filho, Naomar; Vasconcelos, Pedro F. C.; Teixeira, Mauro; Buss, Paulo; Gadelha, Paulo E.			Zika virus and microcephaly in Brazil: a scientific agenda	LANCET			English	Editorial Material									[Barreto, Mauricio L.; Barral-Netto, Manoel] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil; [Buss, Paulo] Fundacao Oswaldo Cruz, Ctr Int Relat Hlth, Rio De Janeiro, Brazil; [Stabeli, Rodrigo; Gadelha, Paulo E.] Fundacao Oswaldo Cruz, Off Presidency, Rio De Janeiro, Brazil; [Almeida-Filho, Naomar] Univ Fed Sul Bahia, Itabuna, Brazil; [Vasconcelos, Pedro F. C.] Inst Evandro Chagas, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Brazil; [Teixeira, Mauro] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Sul da Bahia; Instituto Evandro Chagas; Universidade Federal de Minas Gerais	Barreto, ML (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.	mauricio.barreto@bahia.fiocruz.br	Vasconcelos, Pedro/AAH-3142-2019; Almeida-Filho, Naomar M/C-1788-2013; Barral-Netto, Manoel/B-3904-2009; Barreto, Mauricio L/B-1752-2008; Teixeira, Mauro M/A-4587-2008; Stabeli, Rodrigo Guerino/G-1721-2017	Almeida-Filho, Naomar M/0000-0002-4435-755X; Barral-Netto, Manoel/0000-0002-5823-7903; Barreto, Mauricio L/0000-0002-0215-4930; Teixeira, Mauro M/0000-0002-6944-3008; Stabeli, Rodrigo Guerino/0000-0002-0476-920X				Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219; Horton R, 2016, LANCET, V387, P520, DOI 10.1016/S0140-6736(16)00229-4; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Lederberg J., 1992, I MED US COMMITTEE; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Ministerio da Saude Brazil, 2016, 11 MIN SAUD; Ministerio da Saude Brazil, 2015, 1813 MIN SAUD; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7	12	38	43	0	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					919	921		10.1016/S0140-6736(16)00545-6	http://dx.doi.org/10.1016/S0140-6736(16)00545-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF8XP	26921913	Green Published, Bronze			2022-12-28	WOS:000371644200005
J	Zoued, A; Durand, E; Brunet, YR; Spinelli, S; Douzi, B; Guzzo, M; Flaugnatti, N; Legrand, P; Journet, L; Fronzes, R; Mignot, T; Cambillau, C; Cascales, E				Zoued, Abdelrahim; Durand, Eric; Brunet, Yannick R.; Spinelli, Silvia; Douzi, Badreddine; Guzzo, Mathilde; Flaugnatti, Nicolas; Legrand, Pierre; Journet, Laure; Fronzes, Remi; Mignot, Tam; Cambillau, Christian; Cascales, Eric			Priming and polymerization of a bacterial contractile tail structure	NATURE			English	Article							VI SECRETION SYSTEM; SMALL-ANGLE SCATTERING; ESCHERICHIA-COLI; ANTIFEEDING PROPHAGE; HIGH-RESOLUTION; REVEALS; VISUALIZATION; ARCHITECTURE; COMPLEXES; MECHANISM	Contractile tails are composed of an inner tube wrapped by an outer sheath assembled in an extended, metastable conformation that stores mechanical energy necessary for its contraction. Contraction is used to propel the rigid inner tube towards target cells for DNA or toxin delivery. Although recent studies have revealed the structure of the contractile sheath of the type VI secretion system, the mechanisms by which its polymerization is controlled and coordinated with the assembly of the inner tube remain unknown. Here we show that the starfish-like TssA dodecameric complex interacts with tube and sheath components. Fluorescence microscopy experiments in enteroaggregative Escherichia coli reveal that TssA binds first to the type VI secretion system membrane core complex and then initiates tail polymerization. TssA remains at the tip of the growing structure and incorporates new tube and sheath blocks. On the basis of these results, we propose that TssA primes and coordinates tail tube and sheath biogenesis.	[Zoued, Abdelrahim; Durand, Eric; Brunet, Yannick R.; Douzi, Badreddine; Flaugnatti, Nicolas; Journet, Laure; Cascales, Eric] Aix Marseille Univ, CNRS, UMR7255, Lab Ingn Syst Macromol,Inst Microbiol Mediterrane, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France; [Durand, Eric; Spinelli, Silvia; Douzi, Badreddine; Cambillau, Christian] CNRS, UMR 7257, Architecture & Fonct Macromol Biol, Campus Luminy,Case 932, F-13288 Marseille 09, France; [Durand, Eric; Spinelli, Silvia; Douzi, Badreddine; Cambillau, Christian] Aix Marseille Univ, UMR 7257, Architecture & Fonct Macromol Biol, Campus Luminy,Case 932, F-13288 Marseille 09, France; [Durand, Eric; Fronzes, Remi] Inst Pasteur, Biol Struct Secret Bacterienne G5, 25-28 Rue Docteur Roux, F-75015 Paris, France; [Durand, Eric; Fronzes, Remi] Inst Pasteur, CNRS, UMR 3528, 25-28 Rue Docteur Roux, F-75015 Paris, France; [Guzzo, Mathilde; Mignot, Tam] Aix Marseille Univ, CNRS, UMR7283, Lab Chim Bacterienne,Inst Microbiol Mediterranee, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France; [Legrand, Pierre] Synchrotron Soleil, BP48, F-91192 Gif Sur Yvette, France; [Brunet, Yannick R.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; SOLEIL Synchrotron; Harvard University; Harvard Medical School	Durand, E; Cambillau, C; Cascales, E (corresponding author), Aix Marseille Univ, CNRS, UMR7255, Lab Ingn Syst Macromol,Inst Microbiol Mediterrane, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.; Durand, E; Cambillau, C (corresponding author), CNRS, UMR 7257, Architecture & Fonct Macromol Biol, Campus Luminy,Case 932, F-13288 Marseille 09, France.; Durand, E; Cambillau, C (corresponding author), Aix Marseille Univ, UMR 7257, Architecture & Fonct Macromol Biol, Campus Luminy,Case 932, F-13288 Marseille 09, France.; Durand, E (corresponding author), Inst Pasteur, Biol Struct Secret Bacterienne G5, 25-28 Rue Docteur Roux, F-75015 Paris, France.; Durand, E (corresponding author), Inst Pasteur, CNRS, UMR 3528, 25-28 Rue Docteur Roux, F-75015 Paris, France.	edurand@imm.cnrs.fr; cambillau@afmb.univ-mrs.fr; cascales@imm.cnrs.fr	douzi, Badreddine/Z-5707-2019; CASCALES, ERIC/G-7420-2011; LEGRAND, Pierre/G-7709-2011; Douzi, Badreddine/ABA-4540-2021; Durand, Eric/E-6739-2017; Fronzes, Rémi/GLS-0406-2022; Fronzes, Remi/T-2578-2019	CASCALES, ERIC/0000-0003-0611-9179; LEGRAND, Pierre/0000-0003-2431-2255; Douzi, Badreddine/0000-0003-3140-4713; Durand, Eric/0000-0002-0577-8220; Flaugnatti, Nicolas/0000-0002-6073-3340; Journet, Laure/0000-0002-5847-2962; Fronzes, Remi/0000-0003-3031-9824; Mignot, Tam/0000-0003-4338-9063; Zoued, Abdelrahim/0000-0002-6973-1755	Centre National de la Recherche Scientifique; Aix-Marseille Universite; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03, ANR-14-CE14-0006-02]; Fondation pour la Recherche Medicale [FRM DEQ2011-0421282, FDT20140931060, SPF20101221116]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; French Ministry of Research	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Infrastructure for Integrated Structural Biology (FRISBI); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was funded by the Centre National de la Recherche Scientifique, the Aix-Marseille Universite, and grants from the Agence Nationale de la Recherche to E.C. (ANR-10-JCJC-1303-03), to E.C. and C.C. (ANR-14-CE14-0006-02) and from the Fondation pour la Recherche Medicale to C.C. (FRM DEQ2011-0421282) and supported by the French Infrastructure for Integrated Structural Biology (FRISBI, ANR-10-INSB-05-01). A.Z. and Y.R.B. were supported by doctoral fellowships from the French Ministry of Research. A.Z. and E.D. were supported by end-of-thesis (FDT20140931060) and post-doctoral (SPF20101221116) fellowships from the Fondation pour la Recherche Medicale, respectively. We gratefully acknowledge the Soleil synchrotron radiation facility for beamtime allocation. We thank R. Lloubes, J. Sturgis and A. Galinier for constant support, the members of the Cascales, Cambillau, Lloubes, Sturgis and Bouveret research groups for helpful discussions, E. Bouveret for providing vectors, protocols and advice for the bacterial two-hybrid assay, C. Bebeacua for preliminary electron microscopy analyses, L. Espinosa for help regarding statistical analyses, R. Lebrun and S. Lignon (proteomic platform, IMM) for mass spectrometry analyses, Y. Cully for the Supplementary Video, O. Uderso, I. Bringer and A. Brun for technical assistance, and J. D. Barras-Elatable for encouragement.	Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Brunet YR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005545; Brunet YR, 2014, EMBO REP, V15, P315, DOI 10.1002/embr.201337936; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano W.L., PYMOL MOL GRAPHICS S; Douzi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086918; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English G, 2014, BIOCHEM J, V461, P291, DOI 10.1042/BJ20131426; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Ferguson PL, 2000, J MOL BIOL, V297, P99, DOI 10.1006/jmbi.2000.3551; Fokine A, 2013, J MOL BIOL, V425, P1731, DOI 10.1016/j.jmb.2013.02.012; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Ge P, 2015, NAT STRUCT MOL BIOL, V22, P377, DOI 10.1038/nsmb.2995; Gerc AJ, 2015, CELL REP, V12, P2131, DOI 10.1016/j.celrep.2015.08.053; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Heymann JB, 2013, J BIOL CHEM, V288, P25276, DOI 10.1074/jbc.M113.456145; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KING J, 1968, J MOL BIOL, V32, P231, DOI 10.1016/0022-2836(68)90007-7; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kube S, 2015, AIMS BIOPHYS, V2, P88, DOI 10.3934/biophy.2015.2.88; Kube S, 2014, CELL REP, V8, P20, DOI 10.1016/j.celrep.2014.05.034; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rybakova D, 2013, MOL MICROBIOL, V89, P702, DOI 10.1111/mmi.12305; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shikuma NJ, 2014, SCIENCE, V343, P529, DOI 10.1126/science.1246794; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	56	89	94	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					59	+		10.1038/nature17182	http://dx.doi.org/10.1038/nature17182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26909579	Green Submitted			2022-12-28	WOS:000371211900039
J	Billings, FT; Hendricks, PA; Schildcrout, JS; Shi, YP; Petracek, MR; Byrne, JG; Brown, NJ				Billings, Frederic T.; Hendricks, Patricia A.; Schildcrout, Jonathan S.; Shi, Yaping; Petracek, Michael R.; Byrne, John G.; Brown, Nancy J.			High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE STATIN THERAPY; COA REDUCTASE INHIBITORS; ARTERY-BYPASS SURGERY; ACUTE-RENAL-FAILURE; IMPROVES OUTCOMES; ACUTE DIALYSIS; HEART-SURGERY; RISK; DYSFUNCTION	IMPORTANCE Statins affect several mechanisms underlying acute kidney injury (AKI). OBJECTIVE To test the hypothesis that short-term high-dose perioperative atorvastatin would reduce AKI following cardiac surgery. DESIGN, SETTING, AND PARTICIPANTS Double-blinded, placebo-controlled, randomized clinical trial of adult cardiac surgery patients conducted from November 2009 to October 2014 at Vanderbilt University Medical Center. INTERVENTIONS Patients naive to statin treatment (n = 199) were randomly assigned 80 mg of atorvastatin the day before surgery, 40 mg of atorvastatin the morning of surgery, and 40 mg of atorvastatin daily following surgery (n = 102) or matching placebo (n = 97). Patients already taking a statin prior to study enrollment (n = 416) continued taking the preenrollment statin until the day of surgery, were randomly assigned 80 mg of atorvastatin the morning of surgery and 40 mg of atorvastatin the morning after (n = 206) or matching placebo (n = 210), and resumed taking the previously prescribed statin on postoperative day 2. MAIN OUTCOMES AND MEASURES Acute kidney injury defined as an increase of 0.3 mg/dL in serum creatinine concentration within 48 hours of surgery (Acute Kidney Injury Network criteria). RESULTS The data and safety monitoring board recommended stopping the group naive to statin treatment due to increased AKI among these participants with chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m(2)) receiving atorvastatin. The board later recommended stopping for futility after 615 participants (median age, 67 years; 188 [30.6%] were women; 202 [32.8%] had diabetes) completed the study. Among all participants (n = 615), AKI occurred in 64 of 308 (20.8%) in the atorvastatin group vs 60 of 307 (19.5%) in the placebo group (relative risk [RR], 1.06 [95% CI, 0.78 to 1.46]; P = .75). Among patients naive to statin treatment (n = 199), AM occurred in 22 of 102 (21.6%) in the atorvastatin group vs 13 of 97 (13.4%) in the placebo group (RR, 1.61 [0.86 to 3.01]; P = .15) and serum creatinine concentration increased by a median of 0.11 mg/dL (10th-90th percentile, -0.11 to 0.56 mg/dL) in the atorvastatin group vs by a median of 0.05 mg/dL (10th-90th percentile, -0.12 to 0.33 mg/dL) in the placebo group (mean difference, 0.08 mg/dL [95% CI, 0.01 to 0.15 mg/dL]; P = .007). Among patients already taking a statin (n = 416), AKI occurred in 42 of 206 (20.4%) in the atorvastatin group vs 47 of 210 (22.4%) in the placebo group (RR, 0.91 [0.63 to 1.32]; P = .63). CONCLUSIONS AND RELEVANCE Among patients undergoing cardiac surgery, high-dose perioperative atorvastatin treatment compared with placebo did not reduce the risk of AKI overall, among patients naive to treatment with statins, or in patients already taking a statin. These results do not support the initiation of statin therapy to prevent AKI following cardiac surgery.	[Billings, Frederic T.; Hendricks, Patricia A.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, 1211 21st Ave S,Ste 526, Nashville, TN 37212 USA; [Billings, Frederic T.; Brown, Nancy J.] Vanderbilt Univ, Sch Med, Dept Med, 1211 21st Ave S,Ste 526, Nashville, TN 37212 USA; [Schildcrout, Jonathan S.; Shi, Yaping] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Petracek, Michael R.] Vanderbilt Univ, Sch Med, Dept Cardiac Surg, Nashville, TN 37212 USA; [Byrne, John G.] Harvard Univ, Sch Med, Dept Cardiac Surg, Boston, MA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Harvard Medical School	Billings, FT (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, 1211 21st Ave S,Ste 526, Nashville, TN 37212 USA.; Billings, FT (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, 1211 21st Ave S,Ste 526, Nashville, TN 37212 USA.	frederic.t.billings@vanderbilt.edu		Billings, Josh/0000-0001-7135-7785	National Institutes of Health [K23GM102676, K12ES015855, R01GM112871, UL1RR024975]; Vanderbilt University Medical Center Department of Anesthesiology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000446] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024977, UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K12ES015855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112871, K23GM102676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Medical Center Department of Anesthesiology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants K23GM102676, K12ES015855, R01GM112871, and UL1RR024975 from the National Institutes of Health and by the Vanderbilt University Medical Center Department of Anesthesiology.	Argalious M, 2010, ANESTH ANALG, V111, P324, DOI 10.1213/ANE.0b013e3181d8a078; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Billings FT, 2012, J AM SOC NEPHROL, V23, P1221, DOI 10.1681/ASN.2011090940; Billings FT, 2010, J CARDIOTHOR VASC AN, V24, P913, DOI 10.1053/j.jvca.2010.03.024; Birnie K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0606-x; Chello M, 2006, CRIT CARE MED, V34, P660, DOI 10.1097/01.CCM.0000201407.89977.EA; Christenson JT, 1999, EUR J CARDIO-THORAC, V15, P394, DOI 10.1016/S1010-7940(99)00034-2; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Fedoruk LM, 2008, ANN THORAC SURG, V85, P1521, DOI 10.1016/j.athoracsur.2008.01.078; Heeschen C, 2002, CIRCULATION, V105, P1446, DOI 10.1161/01.CIR.0000012530.68333.C8; Huffmyer JL, 2009, J CARDIOTHOR VASC AN, V23, P468, DOI 10.1053/j.jvca.2008.11.005; Katz KA, 2006, ARCH DERMATOL, V142, P761, DOI 10.1001/archderm.142.6.761; Kor DJ, 2008, J CARDIOTHOR VASC AN, V22, P210, DOI 10.1053/j.jvca.2007.12.019; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Laufs U, 1997, J BIOL CHEM, V272, P31725, DOI 10.1074/jbc.272.50.31725; Layton JB, 2013, AM J CARDIOL, V111, P823, DOI 10.1016/j.amjcard.2012.11.047; Lennernas H, 2003, CLIN PHARMACOKINET, V42, P1141, DOI 10.2165/00003088-200342130-00005; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Molnar AO, 2014, ANN THORAC SURG, V97, P2081, DOI 10.1016/j.athoracsur.2014.02.033; Pan W, 2004, CIRCULATION, V110, pII45, DOI 10.1161/01.CIR.0000138316.24048.08; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Patti G, 2006, CIRCULATION, V114, P1455, DOI 10.1161/CIRCULATIONAHA.106.621763; Prowle JR, 2012, NEPHROLOGY, V17, P215, DOI 10.1111/j.1440-1797.2011.01546.x; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Ryckwaert F, 2002, CRIT CARE MED, V30, P1495, DOI 10.1097/00003246-200207000-00016; Siddiqui NF, 2012, CAN MED ASSOC J, V184, P1237, DOI 10.1503/cmaj.110895; Swaminathan M, 2007, CRIT CARE MED, V35, P2286, DOI 10.1097/01.CCM.0000282079.05994.57; Tabata M, 2007, AM J CARDIOL, V100, P442, DOI 10.1016/j.amjcard.2007.03.071; Thakar CV, 2003, KIDNEY INT, V64, P239, DOI 10.1046/j.1523-1755.2003.00040.x; Thielmann M, 2007, J THORAC CARDIOV SUR, V134, P1143, DOI 10.1016/j.jtcvs.2007.07.029; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Wagner AH, 2000, ARTERIOSCL THROM VAS, V20, P61, DOI 10.1161/01.ATV.20.1.61; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450	36	153	156	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					877	888		10.1001/jama.2016.0548	http://dx.doi.org/10.1001/jama.2016.0548			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26906014	Bronze, Green Accepted			2022-12-28	WOS:000371077500018
J	Liang, XT; Holy, TE; Taghert, PH				Liang, Xitong; Holy, Timothy E.; Taghert, Paul H.			Synchronous Drosophila circadian pacemakers display nonsynchronous Ca2+ rhythms in vivo	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; CLOCK NEURONS; MEMBRANE EXCITABILITY; NEUROPEPTIDE PDF; NETWORK; LIGHT; MELANOGASTER; OSCILLATORS; RECEPTOR; PERIOD	In Drosophila, molecular clocks control circadian rhythmic behavior through a network of similar to 150 pacemaker neurons. To explain how the network's neuronal properties encode time, we performed brainwide calcium imaging of groups of pacemaker neurons in vivo for 24 hours. Pacemakers exhibited daily rhythmic changes in intracellular Ca2+ that were entrained by environmental cues and timed by molecular clocks. However, these rhythms were not synchronous, as each group exhibited its own phase of activation. Ca2+ rhythms displayed by pacemaker groups that were associated with the morning or evening locomotor activities occurred similar to 4 hours before their respective behaviors. Loss of the receptor for the neuropeptide PDF promoted synchrony of Ca2+ waves. Thus, neuropeptide modulation is required to sequentially time outputs from a network of synchronous molecular pacemakers.	[Liang, Xitong; Holy, Timothy E.; Taghert, Paul H.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL)	Taghert, PH (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.	taghertp@pcg.wustl.edu	Liang, Xitong/ABE-3072-2021	Liang, Xitong/0000-0002-7537-1004	Washington University McDonnell Center for Cellular and Molecular Neurobiology; NIH [R01 NS068409, R01 DP1 DA035081, NIMH 2 R01 MH067122-11]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA035081] Funding Source: NIH RePORTER	Washington University McDonnell Center for Cellular and Molecular Neurobiology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank W. Li and D. Oakley for technical assistance; D. Dolezel for technical advice; the Holy and Taghert laboratories for advice; E. Herzog for comments on the manuscript; the Bloomington Stock Center, Janelia Research Center, J. Kim, and M. Affolter for sharing fly stocks; and M. Rosbash for antibodies to PER. Supported by the Washington University McDonnell Center for Cellular and Molecular Neurobiology and by NIH grants R01 NS068409 and R01 DP1 DA035081 (T.E.H.) and NIMH 2 R01 MH067122-11 (P.H.T.). Author contributions: X.L., T.E.H., and P.H.T. conceived the experiments; X.L. performed and analyzed all experiments; and X.L., T.E.H., and P.H.T. wrote the manuscript. T.E.H. has a patent on OCPI microscopy. Materials are available upon request.	Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Evans JA, 2013, NEURON, V80, P973, DOI 10.1016/j.neuron.2013.08.022; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Freeman GM, 2013, NEURON, V78, P799, DOI 10.1016/j.neuron.2013.04.003; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lim C, 2013, NAT NEUROSCI, V16, P1544, DOI 10.1038/nn.3543; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Roberts L, 2015, CURR BIOL, V25, P858, DOI 10.1016/j.cub.2015.01.056; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	28	109	109	5	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					976	981		10.1126/science.aad3997	http://dx.doi.org/10.1126/science.aad3997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917772	Green Accepted			2022-12-28	WOS:000370821400042
J	Gomez-Robles, A				Gomez-Robles, Aida			PALAEOANTHROPOLOGY What teeth tell us	NATURE			English	Editorial Material							LOS HUESOS; EVOLUTIONARY; HOMINIDS; PATTERNS; MOLARS; SIMA		[Gomez-Robles, Aida] George Washington Univ, Dept Anthropol, Ctr Adv Study Human Paleobiol, Washington, DC 20052 USA	George Washington University	Gomez-Robles, A (corresponding author), George Washington Univ, Dept Anthropol, Ctr Adv Study Human Paleobiol, Washington, DC 20052 USA.	agomezrobles@gwu.edu		Gomez-Robles, Aida/0000-0002-8719-2660				Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; DECASTRO JMB, 1995, AM J PHYS ANTHROPOL, V96, P335, DOI 10.1002/ajpa.1330960403; Evans AR, 2016, NATURE, V530, P477, DOI 10.1038/nature16972; Gomez-Robles A, 2015, J HUM EVOL, V82, P34, DOI 10.1016/j.jhevol.2015.02.013; Gomez-Robles A, 2012, EVOLUTION, V66, P1024, DOI 10.1111/j.1558-5646.2011.01508.x; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Schroer K, 2015, J ANAT, V226, P150, DOI 10.1111/joa.12264; WOOD BA, 1983, J ANAT, V136, P197; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732; Young NM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7690	11	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					425	426		10.1038/530425a	http://dx.doi.org/10.1038/530425a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911778				2022-12-28	WOS:000370690800022
J	[Anonymous]				[Anonymous]			Generation game	NATURE			English	Editorial Material																		WALLACE AR, 1870, NATURE          0317, V1, P501	1	0	0	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					381	382		10.1038/530381b	http://dx.doi.org/10.1038/530381b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911741	Bronze			2022-12-28	WOS:000370690800002
J	Costa, DK; Kahn, JM				Costa, Deena Kelly; Kahn, Jeremy M.			Organizing Critical Care for the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICINE		[Costa, Deena Kelly] Univ Michigan, Sch Nursing, Dept Syst Populat & Leadership, Ann Arbor, MI 48109 USA; [Costa, Deena Kelly] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Kahn, Jeremy M.] Univ Pittsburgh, Dept Crit Care Med, CRISMA Ctr, Sch Med, Pittsburgh, PA 15221 USA; [Kahn, Jeremy M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15221 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kahn, JM (corresponding author), Univ Pittsburgh, Dept Crit Care Med, 3550 Terrace St,Scaife Hall Room 602-B, Pittsburgh, PA 15221 USA.	kahnjm@upmc.edu		Kahn, Jeremy/0000-0001-9688-5576; Costa, Deena/0000-0002-7776-5349				Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Embriaco N, 2007, AM J RESP CRIT CARE, V175, P686, DOI 10.1164/rccm.200608-1184OC; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Gooch RA, 2014, JAMA-J AM MED ASSOC, V311, P567, DOI 10.1001/jama.2013.283800; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Kaplan LJ, 2011, JAMA-J AM MED ASSOC, V305, P296, DOI 10.1001/jama.2010.1997; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Nguyen YL, 2010, CURR OPIN CRIT CARE, V16, P487, DOI 10.1097/MCC.0b013e32833d9180; Ward NS, 2012, CRIT CARE MED, V40, P400, DOI 10.1097/CCM.0b013e318232d997	9	11	11	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					751	752		10.1001/jama.2016.0974	http://dx.doi.org/10.1001/jama.2016.0974			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903330				2022-12-28	WOS:000370700500007
J	Kusiak, A				Kusiak, Andrew			Put innovation science at the heart of discovery	NATURE			English	Editorial Material									[Kusiak, Andrew] Univ Iowa, Mech & Ind Engn, Iowa City, IA USA	University of Iowa	Kusiak, A (corresponding author), Univ Iowa, Mech & Ind Engn, Iowa City, IA USA.	andrew-kusiak@uiowa.edu	Kusiak, Andrew/F-7935-2015						0	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					255	255		10.1038/530255a	http://dx.doi.org/10.1038/530255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887456	Bronze			2022-12-28	WOS:000370327100004
J	Mammen, AL				Mammen, Andrew L.			Statin-Associated Autoimmune Myopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MEDIATED NECROTIZING MYOPATHY; CREATINE-KINASE; REDUCTASE ANTIBODIES; MUSCLE REGENERATION; ANTI-3-HYDROXY-3-METHYLGLUTARYL-COENZYME; AUTOANTIBODIES; COENZYME; MYOSITIS; OUTCOMES; THERAPY	Statins significantly reduce the incidence of cardiovascular disease, are generally safe, and have an acceptable side-effect profile. Indeed, a recent meta-analysis confirmed that mild musculoskeletal problems, such as myalgia, occur in approximately equal numbers of persons treated with statins and those given placebo. 1 Only in rare cases, in approximately 1 of 10,000 treated persons per year, 2 do statins cause serious muscle damage, with weakness and elevated levels of creatine kinase. In the majority of such cases, the patients recover spontaneously after the statin treatment is discontinued. 3,4 It is now recognized, however, that in very rare cases, an autoimmune myopathy develops in patients treated with statins; this disorder is characterized by muscle weakness, evidence of muscle-cell necrosis on biopsy, and the presence of autoantibodies against 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. 5-16 In contrast to most patients who have side effects from statin therapy, those with statin-ssociated autoimmune myopathy may have progressive weakness that must be controlled with immunosuppressive therapy. This review describes the clinical characteristics, diagnosis, proposed pathologic mechanisms, and treatment of statin-associated autoimmune myopathy.	[Mammen, Andrew L.] NIAMSD, NIH, Bethesda, MD 20892 USA; [Mammen, Andrew L.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Johns Hopkins University	Mammen, AL (corresponding author), NIAMSD, Muscle Dis Unit, Lab Muscle Stem Cells & Gene Express, NIH, 50 South Dr,Rm 1146,Bldg 50,MSC-8024, Bethesda, MD 20892 USA.	andrew.mammen@nih.gov	Mammen, Andrew/AAF-2885-2021		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041203] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alfirevic A, 2014, CLIN PHARMACOL THER, V96, P470, DOI 10.1038/clpt.2014.121; Allenbach Y, 2014, MEDICINE, V93, P150, DOI 10.1097/MD.0000000000000028; Allenbach Y, 2013, CURR OPIN NEUROL, V26, P554, DOI 10.1097/WCO.0b013e328364e9d9; Alshehri A, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000124; Brewster LM, 2007, AM HEART J, V154, P655, DOI 10.1016/j.ahj.2007.06.008; Christopher-Stine L, 2010, ARTHRITIS RHEUM-US, V62, P2757, DOI 10.1002/art.27572; Chung T, 2015, MUSCLE NERVE, V52, P189, DOI 10.1002/mus.24642; Dalakas MC, 2015, NEW ENGL J MED, V373, P393, DOI 10.1056/NEJMc1506827; Echaniz-Laguna A, 2010, NEW ENGL J MED, V362, P564, DOI 10.1056/NEJMc0908215; Ganga HV, 2014, AM HEART J, V168, P6, DOI 10.1016/j.ahj.2014.03.019; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grable-Esposito P, 2010, MUSCLE NERVE, V41, P185, DOI 10.1002/mus.21486; Hamann PDH, 2013, AUTOIMMUN REV, V12, P1177, DOI 10.1016/j.autrev.2013.07.001; Hansen KE, 2005, ARCH INTERN MED, V165, P2671, DOI 10.1001/archinte.165.22.2671; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Kassardjian CD, 2015, JAMA NEUROL, V72, P996, DOI 10.1001/jamaneurol.2015.1207; Klein M, 2015, RHEUMATOLOGY, V54, P2010, DOI 10.1093/rheumatology/kev229; Lahaye C, 2014, JOINT BONE SPINE, V81, P79, DOI 10.1016/j.jbspin.2013.06.008; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Limaye V, 2015, MUSCLE NERVE, V52, P196, DOI 10.1002/mus.24541; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Mammen AL, 2015, NEW ENGL J MED, V373, P1680, DOI 10.1056/NEJMc1506163; Mammen AL, 2012, ARTHRIT CARE RES, V64, P1233, DOI 10.1002/acr.21671; Mammen AL, 2012, ARTHRIT CARE RES, V64, P269, DOI 10.1002/acr.20662; Mammen AL, 2011, ARTHRITIS RHEUM-US, V63, P713, DOI 10.1002/art.30156; Martini C, 2009, J CELL PHYSIOL, V220, P524, DOI 10.1002/jcp.21810; Morikawa S, 2005, J ATHEROSCLER THROMB, V12, P121, DOI 10.5551/jat.12.121; Needham M, 2007, NEUROMUSCULAR DISORD, V17, P194, DOI 10.1016/j.nmd.2006.10.007; Padala S, 2012, ATHEROSCLEROSIS, V222, P15, DOI 10.1016/j.atherosclerosis.2011.11.005; Rider LG, 2011, JAMA-J AM MED ASSOC, V305, P183, DOI 10.1001/jama.2010.1977; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Trapani L, 2012, J CELL BIOCHEM, V113, P2057, DOI 10.1002/jcb.24077; Watanabe Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000416; Werner JL, 2012, ARTHRITIS RHEUM-US, V64, P4087, DOI 10.1002/art.34673	36	179	184	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					664	669		10.1056/NEJMra1515161	http://dx.doi.org/10.1056/NEJMra1515161			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26886523				2022-12-28	WOS:000370229000012
J	Winston, PH				Winston, Patrick Henry			Marvin L. Minsky (1927-2016) OBITUARY	NATURE			English	Biographical-Item									[Winston, Patrick Henry] MIT, Artificial Intelligence, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Winston, PH (corresponding author), MIT, Artificial Intelligence, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	phw@mit.edu						MINSKY M, PUBLICATION LIST	1	2	2	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					282	282		10.1038/530282a	http://dx.doi.org/10.1038/530282a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887486	Bronze			2022-12-28	WOS:000370327100021
J	Schattner, A				Schattner, Ami			Review: In rheumatoid arthritis, TNF-alpha inhibitors do not differ from placebo or DMARDs for all-cause mortality Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Schattner, Ami] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Schattner, A (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel.		Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Listing J, 2015, ANN RHEUM DIS, V74, P415, DOI 10.1136/annrheumdis-2013-204021; Michaud TL, 2014, AM J MED, V127, P1208, DOI 10.1016/j.amjmed.2014.06.012; Scire CA, 2014, ANN RHEUM DIS, V73, P1677, DOI 10.1136/annrheumdis-2013-203339	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					JC20	JC20		10.7326/ACPJC-2016-164-4-020	http://dx.doi.org/10.7326/ACPJC-2016-164-4-020			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26882305				2022-12-28	WOS:000370135300007
J	Delong, T; Wiles, TA; Baker, RL; Bradley, B; Barbour, G; Reisdorph, R; Armstrong, M; Powell, RL; Reisdorph, N; Kumar, N; Elso, CM; DeNicola, M; Bottino, R; Powers, AC; Harlan, DM; Kent, SC; Mannering, SI; Haskins, K				Delong, Thomas; Wiles, Timothy A.; Baker, Rocky L.; Bradley, Brenda; Barbour, Gene; Reisdorph, Richard; Armstrong, Michael; Powell, Roger L.; Reisdorph, Nichole; Kumar, Nitesh; Elso, Colleen M.; DeNicola, Megan; Bottino, Rita; Powers, Alvin C.; Harlan, David M.; Kent, Sally C.; Mannering, Stuart I.; Haskins, Kathryn			Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion	SCIENCE			English	Article							CHROMOGRANIN-A; ANTIGEN; HLA-DQ8; CLONES	T cell-mediated destruction of insulin-producing beta cells in the pancreas causes type 1 diabetes T1D). CD4 T cell responses play a central role in beta cell destruction, but the identity of the epitopes recognized by pathogenic CD4 T cells remains unknown. We found that diabetes-inducing CD4 T cell clones isolated from nonobese diabetic mice recognize epitopes formed by covalent cross-linking of proinsulin peptides to other peptides present in beta cell secretory granules. These hybrid insulin peptides HIPs) are antigenic for CD4 T cells and can be detected by mass spectrometry in beta cells. CD4 T cells from the residual pancreatic islets of two organ donors who had T1D also recognize HIPs. Autoreactive T cells targeting hybrid peptides may explain how immune tolerance is broken in T1D.	[Delong, Thomas; Wiles, Timothy A.; Baker, Rocky L.; Bradley, Brenda; Barbour, Gene; Haskins, Kathryn] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80045 USA; [Reisdorph, Richard; Armstrong, Michael; Powell, Roger L.; Reisdorph, Nichole] Univ Colorado, Sch Med, Pharmaceut Sci, Aurora, CO 80045 USA; [Kumar, Nitesh; Elso, Colleen M.; Mannering, Stuart I.] St Vincents Inst Med Res, Immunol & Diabet Unit, 9 Princes St, Fitzroy, Vic 3065, Australia; [DeNicola, Megan; Harlan, David M.; Kent, Sally C.] Univ Massachusetts, Sch Med, Dept Med, Diabet Div,Diabet Ctr Excellence, Worcester, MA USA; [Bottino, Rita] Allegheny Hlth Network, Inst Cellular Therapeut, Allegheny Singer Res Inst, Pittsburgh, PA USA; [Powers, Alvin C.] Vanderbilt Univ, Med Ctr, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN USA; [Powers, Alvin C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA; [Powers, Alvin C.] VA Tennessee Valley Healthcare Syst, Nashville, TN USA; [Mannering, Stuart I.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; St. Vincent's Institute of Medical Research; University of Massachusetts System; University of Massachusetts Worcester; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; St Vincent's Hospital Melbourne; University of Melbourne	Delong, T; Haskins, K (corresponding author), Univ Colorado, Sch Med, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80045 USA.	thomas.delong@ucdenver.edu; katie.haskins@ucdenver.edu	Kumar, Nitesh/AAR-9703-2021; Reisdorph, Nichole/AAX-8774-2020	Reisdorph, Nichole/0000-0002-0425-8012; Baker, Rocky/0000-0001-8361-8655; Wiles, Timothy/0000-0002-9059-0061	NIH [1K01DK094941, 1R01DK081166, 5U01DK89572, DK104211]; American Diabetes Association [1-15-ACE-14, 1-15-JF-04]; Australian National Health and Medical Research Council (NHMRC) [APP1061961]; Juvenile Diabetes Research Foundation [5-CDA2014210-A-N, 2-SRA-2015-68-Q-R]; Victorian State Government of Australia; Helmsley Charitable Trust [2015PG-T1D057]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072473, U01DK089572, UC4DK104211, P60DK020593, P30DK020593, R01DK081166, P30DK032520, K01DK094941] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Victorian State Government of Australia; Helmsley Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The following funding sources supported this research: NIH grant 1K01DK094941 (T.D.); American Diabetes Association Pathway to Stop Diabetes Grant 1-15-ACE-14 (T.D.); American Diabetes Association grant 1-15-JF-04 (R.L.B.); NIH grant 1R01DK081166 (K.H.); the Australian National Health and Medical Research Council (NHMRC) APP1061961 (S.M.); Juvenile Diabetes Research Foundation, Career Development Award 5-CDA2014210-A-N (S.M.); Operational Infrastructure Support Program from the Victorian State Government of Australia (S.M.); Helmsley Charitable Trust 2015PG-T1D057 (S.C.K.); Juvenile Diabetes Research Foundation grant 2-SRA-2015-68-Q-R (A.C.P., D.M.H.); NIH grant 5U01DK89572 (A.C.P., D.M.H.); NIH grant DK104211 (A.C.P). We thank the NIH tetramer core for providing tetramer reagents. A patent application related to the work on the hybrid peptides has been filed (Colorado University Technology Transfer Office file no. CU3769H-PPA1, Compositions and methods for diagnosing autoimmune diseases; T.D. and K.H. as inventors). The data presented in this manuscript are tabulated in the main paper and in the supplementary materials section.	Chang KY, 2009, INT IMMUNOL, V21, P705, DOI 10.1093/intimm/dxp039; Debug T, 2011, DIABETES, V60, P2325, DOI 10.2337/db11-0288; Delong T, 2012, DIABETES, V61, P3239, DOI 10.2337/db12-0112; Doyle HA, 2012, CURR OPIN IMMUNOL, V24, P112, DOI 10.1016/j.coi.2011.12.003; Gottlieb PA, 2014, J AUTOIMMUN, V50, P38, DOI 10.1016/j.jaut.2013.10.003; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Haskins K, 2005, ADV IMMUNOL, V87, P123, DOI 10.1016/S0065-2776(05)87004-X; Higham CE, 2000, EUR J BIOCHEM, V267, P4998, DOI 10.1046/j.1432-1327.2000.01548.x; Mannering SI, 2005, J EXP MED, V202, P1191, DOI 10.1084/jem.20051251; McGinty JW, 2014, DIABETES, V63, P3033, DOI 10.2337/db13-1952; Nepom GT, 2012, J IMMUNOL, V188, P2477, DOI 10.4049/jimmunol.1102398; Pathiraja V, 2015, DIABETES, V64, P172, DOI 10.2337/db14-0858; Somalinga BR, 2002, J BIOL CHEM, V277, P43253, DOI 10.1074/jbc.M207974200; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Stratmann T, 2003, J CLIN INVEST, V112, P902, DOI 10.1172/JCI200318337; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; Verchere CB, 1996, J BIOL CHEM, V271, P27475, DOI 10.1074/jbc.271.44.27475; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660	20	314	319	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					711	714		10.1126/science.aad2791	http://dx.doi.org/10.1126/science.aad2791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912858	Green Accepted			2022-12-28	WOS:000369810000041
J	Goyal, M; Menon, BK; van Zwam, WH; Dippel, DWJ; Mitchell, PJ; Demchuk, AM; Davalos, A; Majoie, CBLM; van der Lugt, A; de Miquel, MA; Donnan, GRA; Roos, YBWEM; Bonafe, A; Jahan, R; Diener, HC; van den Berg, LA; Levy, EI; Berkhemer, OA; Pereira, VM; Rempel, J; Millan, M; Davis, SM; Roy, D; Thornton, J; San Roman, L; Ribo, M; Beumer, D; Stouch, B; Brown, S; Campbell, BCV; van Oostenbrugge, RJ; Saver, JRL; Hill, MD; Jovin, TG				Goyal, Mayank; Menon, Bijoy K.; van Zwam, Wim H.; Dippel, Diederik W. J.; Mitchell, Peter J.; Demchuk, Andrew M.; Davalos, Antoni; Majoie, Charles B. L. M.; van der Lugt, Aad; de Miquel, Maria A.; Donnan, Geoff Rey A.; Roos, Yvo B. W. E. M.; Bonafe, Alain; Jahan, Reza; Diener, Hans-Christoph; van den Berg, Lucie A.; Levy, Elad I.; Berkhemer, Olvert A.; Pereira, Vitor M.; Rempel, Jeremy; Millan, Monica; Davis, Stephen M.; Roy, Daniel; Thornton, John; San Roman, Luis; Ribo, Marc; Beumer, Debbie; Stouch, Bruce; Brown, Scott; Campbell, Bruce C. V.; van Oostenbrugge, Robert J.; Saver, Jeff Rey L.; Hill, Michael D.; Jovin, Tudor G.		HERMES Collaborators	Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials	LANCET			English	Article							INTRAVENOUS T-PA; THERAPY; MANAGEMENT; RETRIEVER; TREAT; ONSET	Background In 2015, five randomised trials showed efficacy of endovascular thrombectomy over standard medical care in patients with acute ischaemic stroke caused by occlusion of arteries of the proximal anterior circulation. In this meta-analysis we, the trial investigators, aimed to pool individual patient data from these trials to address remaining questions about whether the therapy is efficacious across the diverse populations included. Methods We formed the HERMES collaboration to pool patient-level data from five trials (MR CLEAN, ESCAPE, REVASCAT, SWIFT PRIME, and EXTEND IA) done between December, 2010, and December, 2014. In these trials, patients with acute ischaemic stroke caused by occlusion of the proximal anterior artery circulation were randomly assigned to receive either endovascular thrombectomy within 12 h of symptom onset or standard care (control), with a primary outcome of reduced disability on the modified Rankin Scale (mRS) at 90 days. By direct access to the study databases, we extracted individual patient data that we used to assess the primary outcome of reduced disability on mRS at 90 days in the pooled population and examine heterogeneity of this treatment effect across prespecified subgroups. To account for between-trial variance we used mixed-effects modelling with random effects for parameters of interest. We then used mixed-effects ordinal logistic regression models to calculate common odds ratios (cOR) for the primary outcome in the whole population (shift analysis) and in subgroups after adjustment for age, sex, baseline stroke severity (National Institutes of Health Stroke Scale score), site of occlusion (internal carotid artery vs M1 segment of middle cerebral artery vs M2 segment of middle cerebral artery), intravenous alteplase (yes vs no), baseline Alberta Stroke Program Early CT score, and time from stroke onset to randomisation. Findings We analysed individual data for 1287 patients (634 assigned to endovascular thrombectomy, 653 assigned to control). Endovascular thrombectomy led to significantly reduced disability at 90 days compared with control (adjusted cOR 2.49, 95% CI 1.76-3.53; p<0.0001). The number needed to treat with endovascular thrombectomy to reduce disability by at least one level on mRS for one patient was 2.6. Subgroup analysis of the primary endpoint showed no heterogeneity of treatment effect across prespecified subgroups for reduced disability (p(interaction) = 0.43). Effect sizes favouring endovascular thrombectomy over control were present in several strata of special interest, including in patients aged 80 years or older (cOR 3.68, 95% CI 1.95-6.92), those randomised more than 300 min after symptom onset (1.76, 1.05-2.97), and those not eligible for intravenous alteplase (2.43, 1.30-4.55). Mortality at 90 days and risk of parenchymal haematoma and symptomatic intracranial haemorrhage did not differ between populations. Interpretation Endovascular thrombectomy is of benefit to most patients with acute ischaemic stroke caused by occlusion of the proximal anterior circulation, irrespective of patient characteristics or geographical location. These findings will have global implications on structuring systems of care to provide timely treatment to patients with acute ischaemic stroke due to large vessel occlusion.	[Goyal, Mayank; Menon, Bijoy K.; Demchuk, Andrew M.; Hill, Michael D.] Univ Calgary, Cummings Sch Med, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB, Canada; [Goyal, Mayank; Menon, Bijoy K.; Demchuk, Andrew M.; Hill, Michael D.] Univ Calgary, Cummings Sch Med, Dept Radiol, Hotchkiss Brain Inst, Calgary, AB, Canada; [van Zwam, Wim H.; Beumer, Debbie; van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht CARIM, NL-6200 MD Maastricht, Netherlands; [Dippel, Diederik W. J.; van der Lugt, Aad] Erasmus MC Univ Med Ctr, Rotterdam, Netherlands; [Mitchell, Peter J.] Univ Melbourne, Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic 3050, Australia; [Davis, Stephen M.; Campbell, Bruce C. V.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Neurol, Melbourne Brain Ctr, Melbourne, Vic 3050, Australia; [Davalos, Antoni] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; [Majoie, Charles B. L. M.; Roos, Yvo B. W. E. M.; van den Berg, Lucie A.; Berkhemer, Olvert A.] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [de Miquel, Maria A.] Bellvitge Hosp, Barcelona, Spain; [Donnan, Geoff Rey A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Bonafe, Alain] Hosp Guy de Chaulliac, Montpellier, France; [Jahan, Reza] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA; [Diener, Hans-Christoph] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Levy, Elad I.] SUNY Buffalo, Buffalo, NY USA; [Pereira, Vitor M.] Univ Toronto, Toronto, ON, Canada; [Rempel, Jeremy] Univ Edmonton, Edmonton, AB, Canada; [Millan, Monica] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; [Roy, Daniel] CHUM Notre Dame Hosp, Montreal, PQ, Canada; [Thornton, John] Beaumont Hosp, Dublin 9, Ireland; [San Roman, Luis] Hosp Clin Barcelona, Barcelona, Spain; [Ribo, Marc] Hosp Valle De Hebron, Barcelona, Spain; [Stouch, Bruce] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [Brown, Scott] Altair Biostat, St Louis Pk, MN USA; [Saver, Jeff Rey L.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Jovin, Tudor G.] Univ Pittsburgh, Presbyterian Univ Hosp, Med Ctr, Stroke Inst, Pittsburgh, PA 15213 USA	University of Calgary; University of Calgary; Maastricht University; Erasmus University Rotterdam; Erasmus MC; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Hospital Germans Trias i Pujol; University of Amsterdam; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Universite de Montpellier; CHU de Montpellier; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Duisburg Essen; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Toronto; Hospital Germans Trias i Pujol; Universite de Montreal; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitari Vall d'Hebron; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian	Jovin, TG (corresponding author), Univ Pittsburgh, Presbyterian Univ Hosp, Med Ctr, Stroke Inst, Pittsburgh, PA 15213 USA.	jovintg@upmc.edu	Field, Thalia S./GRR-7961-2022; Diener, Hans-Christoph/AAF-7275-2019; Roos, Yvo BWEM/B-9843-2013; Ribo, Marc/ABG-3202-2021; Goyal, Mayank/AAE-7323-2019; Field, Thalia/P-4103-2019; Demchuk, Andrew M/E-1103-2012; MENON, BIJOY K/B-7718-2014; Field, Thalia/G-8477-2019; Campbell, Bruce/AGY-4147-2022; Dippel, Diederik/AAJ-2192-2020; Campbell, Bruce/J-1220-2019; Hill, Michael D/C-9073-2012; Davis, Stephen/L-5260-2013	Field, Thalia S./0000-0002-1176-0633; Ribo, Marc/0000-0001-9242-043X; Field, Thalia/0000-0002-1176-0633; Demchuk, Andrew M/0000-0002-4930-7789; Field, Thalia/0000-0002-1176-0633; Dippel, Diederik/0000-0002-9234-3515; Campbell, Bruce/0000-0003-3632-9433; Hill, Michael D/0000-0002-6269-1543; Davis, Stephen/0000-0003-0962-2300; Munuera, Josep/0000-0001-5154-1796; San Roman, Luis/0000-0003-0735-4373; Donnan, Geoffrey/0000-0001-6324-3403	Medtronic; Alberta Innovates [201300690] Funding Source: researchfish	Medtronic(Medtronic); Alberta Innovates	Medtronic.	Badhiwala JH, 2015, JAMA-J AM MED ASSOC, V314, P1832, DOI 10.1001/jama.2015.13767; Balami JS, 2015, INT J STROKE, V10, P1168, DOI 10.1111/ijs.12618; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick JP, 2015, STROKE, V46, P3416, DOI 10.1161/STROKEAHA.115.011397; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Chaisinanunkul N, 2015, STROKE, V46, P2238, DOI 10.1161/STROKEAHA.114.008547; Chen CJ, 2015, NEUROLOGY, V85, P1980, DOI 10.1212/WNL.0000000000002176; Coutts SB, 2012, STROKE, V43, P1013, DOI 10.1161/STROKEAHA.111.637421; Elgendy IY, 2015, J AM COLL CARDIOL, V66, P2498, DOI 10.1016/j.jacc.2015.09.070; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2014, CIRCULATION, V130, P265, DOI 10.1161/CIRCULATIONAHA.113.007826; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; MacIsaac RL, 2015, INT J STROKE, V10, P136, DOI 10.1111/ijs.12622; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Saver JL, 2009, STROKE, V40, P2433, DOI 10.1161/STROKEAHA.108.543561; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; van der Hoeven EJRJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-200; Yarbrough CK, 2015, STROKE, V46, P3177, DOI 10.1161/STROKEAHA.115.009847	25	3626	3767	17	274	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1723	1731		10.1016/S0140-6736(16)00163-X	http://dx.doi.org/10.1016/S0140-6736(16)00163-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ9OD	26898852				2022-12-28	WOS:000374541900025
J	Bhangu, A; Morton, D				Bhangu, Aneel; Morton, Dion			Is this laparoscopic technique study the perfect surgical trial?	LANCET			English	Editorial Material									[Bhangu, Aneel; Morton, Dion] Queen Elizabeth Hosp, Acad Dept Surg, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Bhangu, A (corresponding author), Queen Elizabeth Hosp, Acad Dept Surg, Birmingham B15 2TH, W Midlands, England.	aneelbhangu@doctors.org.uk			National Institute for Health Research [NF-SI-0514-10066] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bhangu A, COLORECTAL IN PRESS; Bhangu A, 2013, LANCET, V382, P1091, DOI 10.1016/S0140-6736(13)62013-9; Blencowe NS, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0918-4; Chapman S, 2015, COLORECTAL DIS S2, V17, P35; Harrysson IJ, 2014, ANN SURG, V260, P37, DOI 10.1097/SLA.0000000000000596; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Stenberg E, 2016, LANCET	7	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1351	1352		10.1016/S0140-6736(16)00098-2	http://dx.doi.org/10.1016/S0140-6736(16)00098-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	26895676				2022-12-28	WOS:000373217500008
J	Tong, AJ; Liu, X; Thomas, BJ; Lissner, MM; Baker, MR; Senagolage, MD; Allred, AL; Barish, GD; Smale, ST				Tong, Ann-Jay; Liu, Xin; Thomas, Brandon J.; Lissner, Michelle M.; Baker, Mairead R.; Senagolage, Madhavi D.; Allred, Amanda L.; Barish, Grant D.; Smale, Stephen T.			A Stringent Systems Approach Uncovers Gene-Specific Mechanisms Regulating Inflammation	CELL			English	Article							NF-KAPPA-B; CHROMATIN IMMUNOPRECIPITATION; TRANSCRIPTION FACTORS; INTERFERON-BETA; EXPRESSION; CELLS; RECRUITMENT; MACROPHAGES; PRINCIPLES; DYNAMICS	Much has been learned about transcriptional cascades and networks from large-scale systems analyses of high-throughput datasets. However, analysis methods that optimize statistical power through simultaneous evaluation of thousands of ChIP-seq peaks or differentially expressed genes possess substantial limitations in their ability to uncover mechanistic principles of transcriptional control. By examining nascent transcript RNA-seq, ChIP-seq, and binding motif datasets from lipid A-stimulated macrophages with increased attention to the quantitative distribution of signals, we identified unexpected relationships between the in vivo binding properties of inducible transcription factors, motif strength, and transcription. Furthermore, rather than emphasizing common features of large clusters of co-regulated genes, our results highlight the extent to which unique mechanisms regulate individual genes with key biological functions. Our findings demonstrate the mechanistic value of stringent interrogation of well-defined sets of genes as a complement to broader systems analyses of transcriptional cascades and networks.	[Tong, Ann-Jay; Liu, Xin; Thomas, Brandon J.; Lissner, Michelle M.; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Tong, Ann-Jay; Liu, Xin; Thomas, Brandon J.; Lissner, Michelle M.; Smale, Stephen T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Baker, Mairead R.; Senagolage, Madhavi D.; Allred, Amanda L.; Barish, Grant D.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; Feinberg School of Medicine	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Smale, ST (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu			NIH [R01GM086372, P50AR063030, T32CA009120, T32GM008042]; China Scholarship Council; Whitcome pre-doctoral training program; NATIONAL CANCER INSTITUTE [T32CA009120, P30CA016042, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042, R01GM086372] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Whitcome pre-doctoral training program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Christopher Glass, Alexander Hoffmann, Steven Ley, Ranjan Sen, and Trevor Siggers for helpful discussions, and the UCLA Broad Stem Cell Research Center Core for sequencing. This work was supported by NIH grants R01GM086372 (S.T.S.), P50AR063030 (S.T.S.), T32CA009120 (A.-J.T.), and T32GM008042 (B.J.T.), and by the China Scholarship Council and Whitcome pre-doctoral training program (X.L.).	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Freaney JE, 2013, CELL REP, V4, P959, DOI 10.1016/j.celrep.2013.07.043; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Metcalfe SM, 2011, GENES IMMUN, V12, P157, DOI 10.1038/gene.2011.9; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shih HY, 2014, IMMUNOL REV, V261, P23, DOI 10.1111/imr.12208; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhao B, 2014, CELL REP, V8, P1595, DOI 10.1016/j.celrep.2014.07.037	31	99	101	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					165	179		10.1016/j.cell.2016.01.020	http://dx.doi.org/10.1016/j.cell.2016.01.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	26924576	Green Accepted, Bronze			2022-12-28	WOS:000372785600018
J	Corti, D; Misasi, J; Mulangu, S; Stanley, DA; Kanekiyo, M; Wollen, S; Ploquin, A; Doria-Rose, NA; Staupe, RP; Bailey, M; Shi, W; Choe, M; Marcus, H; Thompson, EA; Cagigi, A; Silacci, C; Fernandez-Rodriguez, B; Perez, L; Sallusto, F; Vanzetta, F; Agatic, G; Cameroni, E; Kisalu, N; Gordon, I; Ledgerwood, JE; Mascola, JR; Graham, BS; Muyembe-Tamfun, JJ; Trefry, JC; Lanzavecchia, A; Sullivan, NJ				Corti, Davide; Misasi, John; Mulangu, Sabue; Stanley, Daphne A.; Kanekiyo, Masaru; Wollen, Suzanne; Ploquin, Aurelie; Doria-Rose, Nicole A.; Staupe, Ryan P.; Bailey, Michael; Shi, Wei; Choe, Misook; Marcus, Hadar; Thompson, Emily A.; Cagigi, Alberto; Silacci, Chiara; Fernandez-Rodriguez, Blanca; Perez, Laurent; Sallusto, Federica; Vanzetta, Fabrizia; Agatic, Gloria; Cameroni, Elisabetta; Kisalu, Neville; Gordon, Ingelise; Ledgerwood, Julie E.; Mascola, John R.; Graham, Barney S.; Muyembe-Tamfun, Jean-Jacques; Trefry, John C.; Lanzavecchia, Antonio; Sullivan, Nancy J.			Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; OUTBREAK; MONKEYS; DISEASE; ZAIRE	Ebola virus disease in humans is highly lethal, with case fatality rates ranging from 25 to 90%. There is no licensed treatment or vaccine against the virus, underscoring the need for efficacious countermeasures. We ascertained that a human survivor of the 1995 Kikwit Ebola virus disease outbreak maintained circulating antibodies against the Ebola virus surface glycoprotein for more than a decade after infection. From this survivor we isolated monoclonal antibodies (mAbs) that neutralize recent and previous outbreak variants of Ebola virus and mediate antibody-dependent cell-mediated cytotoxicity in vitro. Strikingly, monotherapy with mAb114 protected macaques when given as late as 5 days after challenge. Treatment with a single human mAb suggests that a simplified therapeutic strategy for human Ebola infection may be possible.	[Corti, Davide; Silacci, Chiara; Fernandez-Rodriguez, Blanca; Perez, Laurent; Sallusto, Federica; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Corti, Davide; Vanzetta, Fabrizia; Agatic, Gloria; Cameroni, Elisabetta] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland; [Misasi, John; Mulangu, Sabue; Stanley, Daphne A.; Kanekiyo, Masaru; Ploquin, Aurelie; Doria-Rose, Nicole A.; Staupe, Ryan P.; Bailey, Michael; Shi, Wei; Choe, Misook; Marcus, Hadar; Thompson, Emily A.; Cagigi, Alberto; Kisalu, Neville; Gordon, Ingelise; Ledgerwood, Julie E.; Mascola, John R.; Graham, Barney S.; Sullivan, Nancy J.] NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Wollen, Suzanne; Trefry, John C.] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Kisalu, Neville; Muyembe-Tamfun, Jean-Jacques] Natl Lab Publ Hlth, Natl Inst Biomed Res, BP 1197, Kinshasa, DEM REP CONGO; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Institute Nacional de Recherche Biomedical; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sullivan, NJ (corresponding author), NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.	njsull@mail.nih.gov	Cagigi, Alberto/K-4824-2016; Perez, Laurent/ABA-4145-2021; Kanekiyo, Masaru/Y-9820-2018; Graham, Barney S./AAC-5898-2019; Mascola, John/AAI-7193-2021	Cagigi, Alberto/0000-0002-3567-9514; Perez, Laurent/0000-0002-8860-7928; Kanekiyo, Masaru/0000-0001-5767-1532; Graham, Barney S./0000-0001-8112-0853; Wollen-Roberts, Suzanne/0000-0002-9409-2756; Staupe, Ryan/0000-0003-0793-524X; Zatta, Fabrizia/0000-0003-4945-8058; Misasi, John/0000-0001-7169-2639	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005047] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Cichanowski for graphics, B. Hartman for manuscript preparation, A. Tislerics and J. McLellan for critical reading of the manuscript, A. R. Townsend for providing EBOV-GP expressing MDCK-SIAT cells, and the study volunteers for the donation of blood for these investigations. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. Antibody sequences have been deposited in GenBank with accession numbers KU594601, KU594602, KU594603, and KU594604. Supported by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases. N.J.S., S.M., B.S.G., J.E.L, D.A.S., J.-J.M.-T J.C.T., D.C., and A.L. are listed as inventors on patent applications related to anti-Ebola virus antibodies and their use. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Department of Defense or the U.S. Department of the Army.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Gulland A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1619; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Muyembe-Tamfum JJ, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.451; Muyembe-Tamfum JJ, 1999, J INFECT DIS, V179, pS259, DOI 10.1086/514302; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2011, CLIN IMMUNOL, V141, P218, DOI 10.1016/j.clim.2011.08.008; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664	19	263	269	5	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1339	1342		10.1126/science.aad5224	http://dx.doi.org/10.1126/science.aad5224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26917593				2022-12-28	WOS:000372397700047
J	Mavrakis, KJ; McDonald, ER; Schlabach, MR; Billy, E; Hoffman, GR; deWeck, A; Ruddy, DA; Venkatesan, K; Yu, JJ; McAllister, G; Stump, M; deBeaumont, R; Ho, S; Yue, YZ; Liu, Y; Yan-Neale, Y; Yang, GZ; Lin, F; Yin, H; Gao, H; Kipp, DR; Zhao, S; McNamara, JT; Sprague, ER; Zheng, B; Lin, Y; Cho, YS; Gu, J; Crawford, K; Ciccone, D; Vitari, AC; Lai, A; Capka, V; Hurov, K; Porter, JA; Tallarico, J; Mickanin, C; Lees, E; Pagliarini, R; Keen, N; Schmelzle, T; Hofmann, F; Stegmeier, F; Sellers, WR				Mavrakis, Konstantinos J.; McDonald, E. Robert, III; Schlabach, Michael R.; Billy, Eric; Hoffman, Gregory R.; deWeck, Antoine; Ruddy, David A.; Venkatesan, Kavitha; Yu, Jianjun; McAllister, Gregg; Stump, Mark; deBeaumont, Rosalie; Ho, Samuel; Yue, Yingzi; Liu, Yue; Yan-Neale, Yan; Yang, Guizhi; Lin, Fallon; Yin, Hong; Gao, Hui; Kipp, D. Randal; Zhao, Songping; McNamara, Joshua T.; Sprague, Elizabeth R.; Zheng, Bing; Lin, Ying; Cho, Young Shin; Gu, Justin; Crawford, Kenneth; Ciccone, David; Vitari, Alberto C.; Lai, Albert; Capka, Vladimir; Hurov, Kristen; Porter, Jeffery A.; Tallarico, John; Mickanin, Craig; Lees, Emma; Pagliarini, Raymond; Keen, Nicholas; Schmelzle, Tobias; Hofmann, Francesco; Stegmeier, Frank; Sellers, William R.			Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5	SCIENCE			English	Article							INHIBITOR; CELLS; 5-METHYLTHIOADENOSINE; PROLIFERATION; METHYLATION; MELANOMA	5-Methylthioadenosine phosphorylase (MTAP) is a key enzyme in the methionine salvage pathway. The MTAP gene is frequently deleted in human cancers because of its chromosomal proximity to the tumor suppressor gene CDKN2A. By interrogating data from a large-scale short hairpin RNA-mediated screen across 390 cancer cell line models, we found that the viability of MTAP-deficient cancer cells is impaired by depletion of the protein arginine methyltransferase PRMT5. MTAP-deleted cells accumulate the metabolite methylthioadenosine (MTA), which we found to inhibit PRMT5 methyltransferase activity. Deletion of MTAP in MTAP-proficient cells rendered them sensitive to PRMT5 depletion. Conversely, reconstitution of MTAP in an MTAP-deficient cell line rescued PRMT5 dependence. Thus, MTA accumulation in MTAP-deleted cancers creates a hypomorphic PRMT5 state that is selectively sensitized toward further PRMT5 inhibition. Inhibitors of PRMT5 that leverage this dysregulated metabolic state merit further investigation as a potential therapy for MTAP/CDKN2A-deleted tumors.	[Mavrakis, Konstantinos J.; McDonald, E. Robert, III; Schlabach, Michael R.; Hoffman, Gregory R.; Ruddy, David A.; Venkatesan, Kavitha; McAllister, Gregg; Stump, Mark; deBeaumont, Rosalie; Ho, Samuel; Yue, Yingzi; Liu, Yue; Yan-Neale, Yan; Yang, Guizhi; Lin, Fallon; Yin, Hong; Gao, Hui; Kipp, D. Randal; Zhao, Songping; McNamara, Joshua T.; Sprague, Elizabeth R.; Cho, Young Shin; Ciccone, David; Capka, Vladimir; Hurov, Kristen; Porter, Jeffery A.; Tallarico, John; Mickanin, Craig; Lees, Emma; Pagliarini, Raymond; Keen, Nicholas; Stegmeier, Frank; Sellers, William R.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Billy, Eric; deWeck, Antoine; Schmelzle, Tobias; Hofmann, Francesco] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Yu, Jianjun; Zheng, Bing; Crawford, Kenneth; Vitari, Alberto C.; Lai, Albert] Novartis Inst Biomed Res, Emeryville, CA 94608 USA; [Lin, Ying; Gu, Justin] China Novartis Inst Biomed Res, Shanghai 201203, Peoples R China	Novartis; Novartis; Novartis; Novartis	Stegmeier, F; Sellers, WR (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	fstegmeier@ksqtx.com; william.sellers@novartis.com		de Weck, Antoine/0000-0003-0887-6771; Sprague, Elizabeth/0000-0002-1603-3750; Billy, Eric/0000-0002-8859-0089	Hauptman-Woodward Medical Research Institute; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy [DE-AC02-06CH11357]	Hauptman-Woodward Medical Research Institute; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	Use of the Industrial Macromolecular Crystallography Association Collaborative Access Team (IMCA-CAT) beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy, under contract no. DE-AC02-06CH11357. Novartis has filed a patent application relating to the use of inhibitors to treat MTAP-deficient diseases (62/049004).	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; CHRISTA L, 1984, BIOCHIM BIOPHYS ACTA, V803, P7, DOI 10.1016/0167-4889(84)90048-X; CHRISTA L, 1988, BIOCHEM J, V255, P145, DOI 10.1042/bj2550145; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Li JR, 2007, J VIROL, V81, P4104, DOI 10.1128/JVI.02681-06; Limm K, 2013, EUR J CANCER, V49, P1305, DOI 10.1016/j.ejca.2012.11.026; MAHER PA, 1993, J BIOL CHEM, V268, P4244; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Stevens AP, 2009, J CELL BIOCHEM, V106, P210, DOI 10.1002/jcb.21984; Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200	17	246	252	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1208	1213		10.1126/science.aad5944	http://dx.doi.org/10.1126/science.aad5944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26912361				2022-12-28	WOS:000386158400048
J	McNutt, M; Lehnert, K; Hanson, B; Nosek, BA; Ellison, AM; King, JL				McNutt, Marcia; Lehnert, Kerstin; Hanson, Brooks; Nosek, Brian A.; Ellison, Aaron M.; King, John Leslie			Liberating field science samples and data	SCIENCE			English	Editorial Material									[McNutt, Marcia] Science, Washington, DC 20005 USA; [Lehnert, Kerstin] Columbia Univ, Palisades, NY 10964 USA; [Hanson, Brooks] Amer Geophys Union, Washington, DC 20009 USA; [Nosek, Brian A.] Univ Virginia, Charlottesville, VA 22903 USA; [Nosek, Brian A.] Ctr Open Sci, Charlottesville, VA 22903 USA; [Ellison, Aaron M.] Harvard Univ, Petersham, MA 01366 USA; [King, John Leslie] Univ Michigan, Ann Arbor, MI 48109 USA	Columbia University; University of Virginia; Harvard University; University of Michigan System; University of Michigan	McNutt, M (corresponding author), Science, Washington, DC 20005 USA.	mmcnutt@aaas.org		McNutt, Marcia/0000-0003-0117-7716; Ellison, Aaron/0000-0003-4151-6081; Lehnert, Kerstin/0000-0001-7036-1977; Nosek, Brian/0000-0001-6797-5476	Division Of Ocean Sciences [1561175] Funding Source: National Science Foundation; ICER [1440351] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Buck S, 2015, SCIENCE, V348, P1403, DOI 10.1126/science.aac8041; Hanson B., 2015, EOS, V96, DOI [10.1029/2015EO022207, DOI 10.1029/2015E0022207]; Lindenmayer D, 2013, ECOLOGICAL SOC AM, V94, P338, DOI DOI 10.1890/0012-9623-94.4.338); Martone M., 2014, JOINT DECLARATION DA; Mills JA, 2015, TRENDS ECOL EVOL, V30, P581, DOI 10.1016/j.tree.2015.07.006; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Piwowar HA, 2013, PEERJ, V1, DOI 10.7717/peerj.175; Roche DG, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002295	8	45	45	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1024	1026		10.1126/science.aad7048	http://dx.doi.org/10.1126/science.aad7048			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941302				2022-12-28	WOS:000371597500019
J	Buitink, S; Corstanje, A; Falcke, H; Horandel, JR; Huege, T; Nelles, A; Rachen, JP; Rossetto, L; Schellart, P; Scholten, O; ter Veen, S; Thoudam, S; Trinh, TNG; Anderson, J; Asgekar, A; Avruch, IM; Bell, ME; Bentum, MJ; Bernardi, G; Best, P; Bonafede, A; Breitling, F; Broderick, JW; Brouw, WN; Bruggen, M; Buteher, HR; Carbone, D; Ciardi, B; Conway, JE; de Gasperin, E; de Geus, E; Deller, A; Dettmar, RJ; van Diepen, G; Duscha, S; Eisloffel, J; Engels, D; Enriquez, JE; Fallows, RA; Fender, R; Ferrari, C; Frieswijk, W; Garrett, MA; Griessmeier, JM; Gunst, AW; van Haarlem, MP; Hassall, TE; Heald, G; Hessels, JWT; Hoeft, M; Horneffer, A; Iaeobelli, M; Intema, H; Juette, E; Karastergiou, A; Kondratiev, VI; Kramer, M; Kuniyoshi, M; Kuper, G; van Lecuwen, J; Loose, GM; Maat, P; Nann, G; Markoff, S; McFadden, R; McKay-Bukowski, D; McKean, JP; Mevius, M; Mulcahy, DD; Munk, H; Norden, MJ; Orru, E; Paas, H; Pandey-Pommier, M; Pandey, VN; Pietka, M; Pizzo, R; Polatidis, AG; Reich, W; Rotgering, HJA; Scaife, AMM; Schwarz, DJ; Serylak, M; Sluman, J; Smirnov, O; Stappers, BW; Steinmetz, M; Stewart, A; Swinbank, J; Tagger, M; Tang, Y; Tasse, C; Toribio, MC; Vermeulen, R; Vocks, C; Vogt, C; van Weeren, RJ; Wijers, RAMJ; Wijnholds, SJ; Wise, MW; Wucknitz, O; Yatawatta, S; Zarka, P; Zensuss, JA				Buitink, S.; Corstanje, A.; Falcke, H.; Hoerandel, J. R.; Huege, T.; Nelles, A.; Rachen, J. P.; Rossetto, L.; Schellart, P.; Scholten, O.; ter Veen, S.; Thoudam, S.; Trinh, T. N. G.; Anderson, J.; Asgekar, A.; Avruch, I. M.; Bell, M. E.; Bentum, M. J.; Bernardi, G.; Best, P.; Bonafede, A.; Breitling, F.; Broderick, J. W.; Brouw, W. N.; Brueggen, M.; Buteher, H. R.; Carbone, D.; Ciardi, B.; Conway, J. E.; de Gasperin, E.; de Geus, E.; Deller, A.; Dettmar, R. -J.; van Diepen, G.; Duscha, S.; Eisloeffel, J.; Engels, D.; Enriquez, J. E.; Fallows, R. A.; Fender, R.; Ferrari, C.; Frieswijk, W.; Garrett, M. A.; Griessmeier, J. M.; Gunst, A. W.; van Haarlem, M. P.; Hassall, T. E.; Heald, G.; Hessels, J. W. T.; Hoeft, M.; Horneffer, A.; Iaeobelli, M.; Intema, H.; Juette, E.; Karastergiou, A.; Kondratiev, V. I.; Kramer, M.; Kuniyoshi, M.; Kuper, G.; van Lecuwen, J.; Loose, G. M.; Maat, P.; Nann, G.; Markoff, S.; McFadden, R.; McKay-Bukowski, D.; McKean, J. P.; Mevius, M.; Mulcahy, D. D.; Munk, H.; Norden, M. J.; Orru, E.; Paas, H.; Pandey-Pommier, M.; Pandey, V. N.; Pietka, M.; Pizzo, R.; Polatidis, A. G.; Reich, W.; Roetgering, H. J. A.; Scaife, A. M. M.; Schwarz, D. J.; Serylak, M.; Sluman, J.; Smirnov, O.; Stappers, B. W.; Steinmetz, M.; Stewart, A.; Swinbank, J.; Tagger, M.; Tang, Y.; Tasse, C.; Toribio, M. C.; Vermeulen, R.; Vocks, C.; Vogt, C.; van Weeren, R. J.; Wijers, R. A. M. J.; Wijnholds, S. J.; Wise, M. W.; Wucknitz, O.; Yatawatta, S.; Zarka, P.; Zensuss, J. A.			A large light-mass component of cosmic rays at 10(17)-10(17.5) electronvolts from radio observations	NATURE			English	Article							AIR-SHOWERS; ENERGY-SPECTRUM; EMISSION; LOFAR; PULSES	Cosmic rays are the highest-energy particles found in nature. Measurements of the mass composition of cosmic rays with energies of 10(17)-10(18) electronvolts are essential to understanding whether they have galactic or extragalactic sources. It has also been proposed that the astrophysical neutrino signal1 comes from accelerators capable of producing cosmic rays of these energies(2). Cosmic rays initiate air showers-cascades of secondary particles in the atmosphere-and their masses can be inferred from measurements of the atmospheric depth of the shower maximum3 (Xmax; the depth of the air shower when it contains the most particles) or of the composition of shower particles reaching the ground(4). Current measurements(5) have either high uncertainty, or a low duty cycle and a high energy threshold. Radio detection of cosmic rays(6-8) is a rapidly developing technique(9) for determining Xmax (refs 10, 11) with a duty cycle of, in principle, nearly 100 per cent. The radiation is generated by the separation of relativistic electrons and positrons in the geomagnetic field and a negative charge excess in the shower front(6,12). Here we report radio measurements of X-max with a mean uncertainty of 16 grams per square centimetre for air showers initiated by cosmic rays with energies of 1017-1017.5 electronvolts. This high resolution in Xmax enables us to determine the mass spectrum of the cosmic rays: we find a mixed composition, with a light-mass fraction (protons and helium nuclei) of about 80 per cent. Unless, contrary to current expectations, the extragalactic component of cosmic rays contributes substantially to the total flux below 10(17.5) electronvolts, our measurements indicate the existence of an additional galactic component, to account for the light composition that we measured in the 10(17)-10(17.5) electronvolt range.	[Buitink, S.] Vrije Univ Brussel, Inst Astrophys, Pleinlaan 2, B-1050 Brussels, Belgium; [Buitink, S.; Corstanje, A.; Falcke, H.; Hoerandel, J. R.; Nelles, A.; Rachen, J. P.; Rossetto, L.; Schellart, P.; Thoudam, S.] Radboud Univ Nijmegen, IMAPP, Dept Astrophys, POB 9010, NL-6500 GL Nijmegen, Netherlands; [Falcke, H.; ter Veen, S.; Asgekar, A.; Bentum, M. J.; Brouw, W. N.; de Geus, E.; Deller, A.; van Diepen, G.; Duscha, S.; Enriquez, J. E.; Fallows, R. A.; Frieswijk, W.; Garrett, M. A.; Gunst, A. W.; van Haarlem, M. P.; Heald, G.; Hessels, J. W. T.; Iaeobelli, M.; Kondratiev, V. I.; Kuper, G.; van Lecuwen, J.; Loose, G. M.; Maat, P.; McFadden, R.; McKean, J. P.; Mevius, M.; Munk, H.; Norden, M. J.; Orru, E.; Pandey, V. N.; Pizzo, R.; Polatidis, A. G.; Sluman, J.; Tang, Y.; Toribio, M. C.; Vermeulen, R.; Vogt, C.; Wijnholds, S. J.; Wise, M. W.; Yatawatta, S.] Netherlands Inst Radio Astron, ASTRON, Postbus 2, NL-7990 AA Dwingeloo, Netherlands; [Falcke, H.; Hoerandel, J. R.] Nikhef, Sci Pk Amsterdam, NL-1098 XG Amsterdam, Netherlands; [Falcke, H.; Horneffer, A.; Kramer, M.; Reich, W.; Wucknitz, O.; Zensuss, J. A.] Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany; [Huege, T.] Karlsruhe Inst Technol, Inst Nucl Phys IKP, Postfach 3640, D-76021 Karlsruhe, Germany; [Nelles, A.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Scholten, O.; Trinh, T. N. G.] Univ Groningen, KVI Ctr Adv Radiat Technol, NL-9747 AA Groningen, Netherlands; [Scholten, O.] Vrije Univ Brussel, Dienst ELEM, B-1050 Brussels, Belgium; [Anderson, J.] Helmholtz Zentrum Potsdam, Deutsch GeoForschungsZentrum GEZ, Dept 1, Geodesy & Remote Sensing, Telegrafenberg A17, D-14473 Potsdam, Germany; [Asgekar, A.] Shell Technol Ctr, Bangalore 560048, Karnataka, India; [Avruch, I. M.] SRON Netherlands Inst Space Res, POB 800, NL-9700 AV Groningen, Netherlands; [Avruch, I. M.; Brouw, W. N.; Heald, G.; McKean, J. P.; Mevius, M.] Univ Groningen, Kapteyn Astron Inst, POB 800, NL-9700 AV Groningen, Netherlands; [Bell, M. E.] CSIRO Australia Telescope Natl Facil, POB 76, Epping, NSW 1710, Australia; [Bell, M. E.] Univ Twente, POB 217, NL-7500 AE Enschede, Netherlands; [Bernardi, G.; van Weeren, R. J.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Bernardi, G.; Smirnov, O.] SKA South Africa, 3rd Floor,Pk Rd, ZA-7405 Pinelands, South Africa; [Best, P.] Univ Edinburgh, Royal Observ Edinburgh, Inst Astron, Blackford Hill, Edinburgh EH9 3HJ, Midlothian, Scotland; [Bonafede, A.; Brueggen, M.; de Gasperin, E.] Univ Hamburg, Gojenbergsweg 112, D-21029 Hamburg, Germany; [Breitling, F.; Nann, G.; Steinmetz, M.; Vocks, C.] Leibniz Inst Astrophys Potsdam AIP, Sternwarte 16, D-14482 Potsdam, Germany; [Broderick, J. W.; Hassall, T. E.; Mulcahy, D. D.; Scaife, A. M. M.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Buteher, H. R.] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT 2611, Australia; [Carbone, D.; Hessels, J. W. T.; van Lecuwen, J.; Markoff, S.; Swinbank, J.; Wijers, R. A. M. J.; Wise, M. W.] Univ Amsterdam, Anton Pannekoek Inst Astron, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Ciardi, B.] Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85741 Garching, Germany; [Conway, J. E.] Chalmers Univ Technol, Dept Earth & Space Sci, Onsala Space Observ, SE-43992 Onsala, Sweden; [de Geus, E.] SmarterVision BV, Oostersingel 5, NL-9401 JX Assen, Netherlands; [Dettmar, R. -J.; Juette, E.] Ruhr Univ Bochum, Astron Inst, Univ Str 150, D-44780 Bochum, Germany; [Eisloeffel, J.; Hoeft, M.] Thuringer Landessternwarte, Sternwarte 5, D-07778 Tautenburg, Germany; [Engels, D.] Elamburger Sternwarte, Gojenbergsweg 112, D-21029 Hamburg, Germany; [Fender, R.; Karastergiou, A.; Pietka, M.; Serylak, M.; Stewart, A.] Univ Oxford, Dept Astrophys, Denys Wilkinson Bldg,Keble Rd, Oxford OX1 3RH, England; [Ferrari, C.] Univ Cote Azur, Observ Cote Azur, CNRS, Lab Lagrange, Blvd Observ,CS 34229, F-06304 Nice 4, France; [Garrett, M. A.; Intema, H.; Roetgering, H. J. A.; Toribio, M. C.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Griessmeier, J. M.; Tagger, M.] Univ Orleans, CNRS, LPC2E, F-45071 Orleans 2, France; [Griessmeier, J. M.] Univ Orleans, OSUC, Stn Radioastron Nancay, Observ Paris,CNRS,INSU,USR 704, Route Souesmes, F-18330 Nancay, France; [Intema, H.] Natl Radio Astron Observ, 1003 Lopezville Rd, Socorro, NM 87801 USA; [Kondratiev, V. I.] Ctr Astro Space, Lebeclev Phys Inst, Profsoyuznayast 84-32, Moscow 117997, Russia; [Kramer, M.; Stappers, B. W.] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Kuniyoshi, M.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [McKay-Bukowski, D.] Univ Oulu, Sodankyla Geophys Observ, Tahtelantie 62, Sodankyla 99600, Finland; [McKay-Bukowski, D.] STFC Rutherford Appleton Lab, Harwell Sci & Innovation Campus, Didcot OX11 0QX, Oxon, England; [Paas, H.] Univ Groningen, CIT, POB 72, NL-9700 AB Groningen, Netherlands; [Pandey-Pommier, M.] Observ Lyon, Ctr Rech Astrophys Lyon, 9 Ave Charles Andre, F-69561 St Gems Laval, France; [Schwarz, D. J.] Univ Bielefeld, Fak Phys, Postfach 100131, D-33501 Bielefeld, Germany; [Smirnov, O.; Tasse, C.] Rhodes Univ, Dept Phys & Elect, POB 94, ZA-6140 Grahamstown, South Africa; [Swinbank, J.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Tasse, C.] Univ Paris Diderot, CNRS, Observ Paris, GEPI, 5 Pl Jules Janssen, F-92190 Meudon, France; [Zarka, P.] UPMC, Univ Paris Diderot, CNRS, LESIA,Observ Paris, 5 Pl Jules Janssen, F-92190 Meudon, France	Vrije Universiteit Brussel; Radboud University Nijmegen; FOM National Institute for Subatomic Physics; Max Planck Society; Helmholtz Association; Karlsruhe Institute of Technology; University of California System; University of California Irvine; University of Groningen; Vrije Universiteit Brussel; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Royal Dutch Shell; University of Groningen; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Twente; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; SKA South Africa; University of Edinburgh; University of Hamburg; Leibniz Institut fur Astrophysik Potsdam (AIP); University of Southampton; Australian National University; University of Amsterdam; Max Planck Society; Chalmers University of Technology; Ruhr University Bochum; University of Oxford; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite de Orleans; National Radio Astronomy Observatory (NRAO); University of Manchester; Jodrell Bank Centre for Astrophysics; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Oulu; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Groningen; University of Bielefeld; Rhodes University; Princeton University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite	Buitink, S (corresponding author), Vrije Univ Brussel, Inst Astrophys, Pleinlaan 2, B-1050 Brussels, Belgium.; Buitink, S (corresponding author), Radboud Univ Nijmegen, IMAPP, Dept Astrophys, POB 9010, NL-6500 GL Nijmegen, Netherlands.	Stijn.Buitink@vub.ac.be	Hessels, Jason/GTO-3261-2022; Broderick, Jess/AAD-2450-2019; Rachen, Jörg Paul/AAR-4369-2020; Yatawatta, Sarod/E-6037-2013; Smirnov, Oleg/AEO-9012-2022; Steinmetz, Matthias/Q-7785-2019; Carbone, Dario/U-8296-2018; Buitink, Stijn/F-2113-2016; Rachen, Jörg P./P-4192-2018; Intema, Hubertus T/D-1438-2012; Nelles, Anna/AAU-1193-2020; Yatawatta, Sarod/N-1417-2019; Kondratiev, Vladislav I./N-1105-2015; Dettmar, Ralf-Juergen/F-2073-2018	Hessels, Jason/0000-0003-2317-1446; Broderick, Jess/0000-0002-2239-6099; Rachen, Jörg Paul/0000-0002-6310-3889; Yatawatta, Sarod/0000-0001-5619-4017; Steinmetz, Matthias/0000-0001-6516-7459; Carbone, Dario/0000-0002-6575-4642; Buitink, Stijn/0000-0002-6177-497X; Rachen, Jörg P./0000-0002-6310-3889; Intema, Hubertus T/0000-0002-5880-2730; Nelles, Anna/0000-0002-1720-6350; Yatawatta, Sarod/0000-0001-5619-4017; Kondratiev, Vladislav I./0000-0001-8864-7471; Dettmar, Ralf-Juergen/0000-0001-8206-5956; Deller, Adam/0000-0001-9434-3837; Mevius, Maaijke/0000-0002-3086-8455; Scholten, Olaf/0000-0003-3649-1254; mcfadden, Rebecca/0000-0003-4811-4202; Bonafede, Annalisa/0000-0002-5068-4581; Thoudam, Satyendra/0000-0002-7066-3614; Huege, Tim/0000-0002-2783-4772; Schwarz, Dominik/0000-0003-2413-0881; Wijers, Ralph/0000-0002-3101-1808; Bell, Martin/0000-0003-1767-5277; Hassall, Timothy/0000-0002-7883-3710; Fallows, Richard/0000-0002-5186-8040	Netherlands Organization for Scientific Research (NWO), VENI grant [639-041-130]; Netherlands Research School for Astronomy (NOVA); Samenwerkingsverband Noord-Nederland (SNN); Foundation for Fundamental Research on Matter (FOM); European Research Council under the European Union [227610, 640130]; STFC [ST/L000768/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000768/1] Funding Source: researchfish	Netherlands Organization for Scientific Research (NWO), VENI grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Research School for Astronomy (NOVA); Samenwerkingsverband Noord-Nederland (SNN); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); European Research Council under the European Union(European Research Council (ERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge financial support from the Netherlands Organization for Scientific Research (NWO), VENI grant 639-041-130, the Netherlands Research School for Astronomy (NOVA), the Samenwerkingsverband Noord-Nederland (SNN) and the Foundation for Fundamental Research on Matter (FOM). We acknowledge funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC (grant agreement no. 227610) and under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 640130). LOFAR, the Low Frequency Array designed and constructed by ASTRON, has facilities in several countries that are owned by various parties (each with their own funding sources) and that are collectively operated by the International LOFAR Telescope (ILT) foundation under a joint scientific policy.	Aab A, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.032003; Aab A, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.122006; Aartsen MG, 2013, SCIENCE, V342, P947, DOI 10.1126/science.1242856; Abreu P, 2012, ASTROPART PHYS, V35, P591, DOI 10.1016/j.astropartphys.2011.12.002; Abu-Zayyad T, 2001, ASTROPHYS J, V557, P686, DOI 10.1086/322240; Allan H. R., 1971, Progress in elementary and cosmic rays physics volume 10, P171; Aloisio R, 2007, ASTROPART PHYS, V27, P76, DOI 10.1016/j.astropartphys.2006.09.004; Alvarez-Muniz J, 2012, ASTROPART PHYS, V35, P325, DOI 10.1016/j.astropartphys.2011.10.005; Apel WD, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.062001; Apel WD, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.081101; Belov K., 2015, PHYS REV LE IN PRESS; Belov K, 2013, AIP CONF PROC, V1535, P209, DOI 10.1063/1.4807550; Berezhnev S. F., 2011, P 32 INT COSM RAY C, V1, P209; Buitink S, 2007, ASTRON ASTROPHYS, V467, P385, DOI 10.1051/0004-6361:20066006; Buitink S, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.082003; Calvez A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.091101; Falcke H, 2005, NATURE, V435, P313, DOI 10.1038/nature03614; Falcke H, 2003, ASTROPART PHYS, V19, P477, DOI 10.1016/S0927-6505(02)00245-1; Heck D., 1998, 6019 FZKA; Huege T, 2013, AIP CONF PROC, V1535, P128, DOI 10.1063/1.4807534; Huege T, 2012, NUCL INSTRUM METH A, V662, pS179, DOI 10.1016/j.nima.2010.11.041; Huege T, 2014, BRAZ J PHYS, V44, P520, DOI 10.1007/s13538-014-0226-6; James CW, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056602; JOKIPII JR, 1987, ASTROPHYS J, V312, P170, DOI 10.1086/164857; Kampert KH, 2012, ASTROPART PHYS, V35, P660, DOI 10.1016/j.astropartphys.2012.02.004; Knurenko S.P., 2011, ASTROPHYS SPACE SCI, V7, P251, DOI [DOI 10.5194/ASTRA-7-251-2011, 10.5194/astra-7-251-2011]; Letessier-Selvon A, 2014, BRAZ J PHYS, V44, P560, DOI 10.1007/s13538-014-0218-6; Murase K, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.121301; Ostapchenko S, 2006, NUCL PHYS B-PROC SUP, V151, P147, DOI 10.1016/j.nuclphysbps.2005.07.027; Pierog T, 2009, NUCL PHYS B-PROC SUP, V196, P102, DOI 10.1016/j.nuclphysbps.2009.09.017; Schellart P, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.165001; Schellart P, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/10/014; Schellart P, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322683; STANEV T, 1993, ASTRON ASTROPHYS, V274, P902; Thoudam S, 2016, ASTROPART PHYS, V73, P34, DOI 10.1016/j.astropartphys.2015.06.005; Thoudam S, 2014, NUCL INSTRUM METH A, V767, P339, DOI 10.1016/j.nima.2014.08.021; van Haarlem MP, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201220873; Werner K, 2008, ASTROPART PHYS, V29, P393, DOI 10.1016/j.astropartphys.2008.04.004; ZAS E, 1992, PHYS REV D, V45, P362, DOI 10.1103/PhysRevD.45.362	39	87	90	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					70	+		10.1038/nature16976	http://dx.doi.org/10.1038/nature16976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26935696	Green Submitted, Green Published			2022-12-28	WOS:000371211900041
J	Clark, BW				Clark, Bennett W.			A Place to Stay	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Clark, Bennett W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Clark, BW (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	bennett.clark@yale.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					871	872		10.1001/jama.2015.17476	http://dx.doi.org/10.1001/jama.2015.17476			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934256				2022-12-28	WOS:000371077500015
J	Ball, SL; Carrie, S				Ball, Stephen L.; Carrie, Sean			SPOT DIAGNOSIS Complications of rhinosinusitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ball, Stephen L.; Carrie, Sean] Freeman Rd Hosp, Ear Nose & Throat Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK	Ball, SL (corresponding author), Freeman Rd Hosp, Ear Nose & Throat Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	s.l.ball@ncl.ac.uk						Jung J, 2012, CLIN EXP OTORHINOLAR, V5, P112, DOI 10.3342/ceo.2012.5.2.112; Kennedy D, 2001, DIS SINUSES DIAGNOSI	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2016	352								i795	10.1136/bmj.i795	http://dx.doi.org/10.1136/bmj.i795			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1RM	26920823				2022-12-28	WOS:000371116900001
J	Bouuaert, CC; Keeney, S				Bouuaert, Corentin Claeys; Keeney, Scott			Breaking DNA	SCIENCE			English	Editorial Material							MEIOSIS		[Bouuaert, Corentin Claeys; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Claeys Bouuaert, Corentin/P-3497-2017	Claeys Bouuaert, Corentin/0000-0001-5801-7313	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bloomfield G, 2016, SEMIN CELL DEV BIOL, V54, P158, DOI 10.1016/j.semcdb.2016.01.026; Corbett KD, 2007, NAT STRUCT MOL BIOL, V14, P611, DOI 10.1038/nsmb1264; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Lam I, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016634; Robert T, 2016, SCIENCE, V351, P943, DOI 10.1126/science.aad5309; Vrielynck N, 2016, SCIENCE, V351, P939, DOI 10.1126/science.aad5196	8	7	7	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					916	917		10.1126/science.aaf2509	http://dx.doi.org/10.1126/science.aaf2509			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917753				2022-12-28	WOS:000370821400019
J	Mahamid, J; Pfeffer, S; Schaffer, M; Villa, E; Danev, R; Cuellar, LK; Forster, F; Hyman, AA; Plitzko, JM; Baumeister, W				Mahamid, Julia; Pfeffer, Stefan; Schaffer, Miroslava; Villa, Elizabeth; Danev, Radostin; Cuellar, Luis Kuhn; Foerster, Friedrich; Hyman, Anthony A.; Plitzko, Juergen M.; Baumeister, Wolfgang			Visualizing the molecular sociology at the HeLa cell nuclear periphery	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; PORE COMPLEX; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; INTERMEDIATE-FILAMENTS; MECHANICAL-PROPERTIES; STRUCTURAL-ANALYSIS; PHASE PLATE; LAMIN; ARRANGEMENT	The molecular organization of eukaryotic nuclear volumes remains largely unexplored. Here we combined recent developments in cryo-electron tomography (cryo-ET) to produce three-dimensional snapshots of the HeLa cell nuclear periphery. Subtomogram averaging and classification of ribosomes revealed the native structure and organization of the cytoplasmic translation machinery. Analysis of a large dynamic structure-the nuclear pore complex-revealed variations detectable at the level of individual complexes. Cryo-ET was used to visualize previously elusive structures, such as nucleosome chains and the filaments of the nuclear lamina, in situ. Elucidation of the lamina structure provides insight into its contribution to metazoan nuclear stiffness.	[Mahamid, Julia; Pfeffer, Stefan; Schaffer, Miroslava; Villa, Elizabeth; Danev, Radostin; Cuellar, Luis Kuhn; Foerster, Friedrich; Plitzko, Juergen M.; Baumeister, Wolfgang] Max Planck Inst Biochem, Dept Mol Struct Biol, Klopferspitz 18A, D-82162 Martinsried, Germany; [Villa, Elizabeth] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany	Max Planck Society; University of California System; University of California San Diego; Max Planck Society	Mahamid, J; Baumeister, W (corresponding author), Max Planck Inst Biochem, Dept Mol Struct Biol, Klopferspitz 18A, D-82162 Martinsried, Germany.	mahamid@biochem.mpg.de; baumeis@biochem.mpg.de	Hyman, Tony/F-1923-2011; Villa, Elizabeth/D-1811-2010; Plitzko, Juergen M/H-9576-2014; Pfeffer, Stefan/AAF-9790-2019; Foerster, Friedrich/D-3710-2009; Hyman, Anthony A/B-3917-2017	Villa, Elizabeth/0000-0003-4677-9809; Plitzko, Juergen M/0000-0002-6402-8315; Pfeffer, Stefan/0000-0001-5843-2795; Foerster, Friedrich/0000-0002-6044-2746; Hyman, Anthony A/0000-0003-3664-154X; Kuhn Cuellar, Luis/0000-0002-6950-6929; Schaffer, Miroslava/0000-0001-8748-1748	European Molecular Biology Organization; Human Frontier Science Program; Weizmann Institute Women in Science Program; Deutsche Forschungsgemeinschaft [FO 716/4]; Center for Integrated Protein Science Munich	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Weizmann Institute Women in Science Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich	We are grateful to I. Poser for providing the HeLa cells; Y. Fukuda for advice on plunging; the local workshop for the design and production of tools; F. Beck and F. Bauerlein for advice in data processing; P. Fratzl for advice on biomechanics; and D. Mastronarde for continuous developments in SerialEM and 3dmod. J.M. was supported by postdoctoral fellowships from the European Molecular Biology Organization and Human Frontier Science Program, and by the Weizmann Institute Women in Science Program. F.F. was supported by Deutsche Forschungsgemeinschaft grant FO 716/4. W.B. was supported by Center for Integrated Protein Science Munich. R.D. is a coinventor on a patent US 9129774 B2, "Method of using a phase plate in a transmission electron microscope," concerning the Volta phase plate. A.A.H. and W.B. are on the scientific advisory board of FEI Company. The supplementary materials contain additional data. EM densities have been deposited in the EMDataBank with the following accession numbers: EMD-8057, EMD-8056, EMD-8055, and EMD-8054.	AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; AKEY CW, 1989, J CELL BIOL, V109, P955, DOI 10.1083/jcb.109.3.955; Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Ben-Harush K, 2009, J MOL BIOL, V386, P1392, DOI 10.1016/j.jmb.2008.12.024; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111; Danev R, 2010, J STRUCT BIOL, V171, P174, DOI 10.1016/j.jsb.2010.03.013; Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; Fukuda Y, 2015, J STRUCT BIOL, V190, P143, DOI 10.1016/j.jsb.2015.03.004; Grossman E, 2012, J STRUCT BIOL, V177, P113, DOI 10.1016/j.jsb.2011.11.002; Hsieh C, 2014, J STRUCT BIOL, V185, P32, DOI 10.1016/j.jsb.2013.10.019; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mahamid J, 2015, J STRUCT BIOL, V192, P262, DOI 10.1016/j.jsb.2015.07.012; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014; McMullan G, 2014, ULTRAMICROSCOPY, V147, P156, DOI 10.1016/j.ultramic.2014.08.002; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9403; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Pfeffer S, 2012, STRUCTURE, V20, P1508, DOI 10.1016/j.str.2012.06.010; Rigort A, 2010, J STRUCT BIOL, V172, P169, DOI 10.1016/j.jsb.2010.02.011; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Schape J, 2009, BIOPHYS J, V96, P4319, DOI 10.1016/j.bpj.2009.02.048; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; WALTHER P, 1992, J MICROSC-OXFORD, V168, P169, DOI 10.1111/j.1365-2818.1992.tb03259.x; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42	28	303	309	13	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					969	972		10.1126/science.aad8857	http://dx.doi.org/10.1126/science.aad8857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917770				2022-12-28	WOS:000370821400040
J	Gupta, S; Maitra, A				Gupta, Sonal; Maitra, Anirban			EMT: Matter of Life or Death?	CELL			English	Editorial Material							TO-MESENCHYMAL TRANSITION; CANCER; METASTASIS; CELLS	TGF-beta is long considered a "protean" cytokine in cancer, changing its role from anti-to pro-tumorigenic in a context-dependent manner. In this issue of Cell, David et al. use mouse models of pancreatic cancer to shed light on the mechanistic basis of how TGF-beta-induced EMT is coupled to either apoptosis or tumor progression.	[Gupta, Sonal; Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Sheikh Ahmed Pancreat Canc Res Ctr, Houston, TX 77030 USA; [Gupta, Sonal; Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Sheikh Ahmed Pancreat Canc Res Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Maitra, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Sheikh Ahmed Pancreat Canc Res Ctr, Houston, TX 77030 USA.; Maitra, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Sheikh Ahmed Pancreat Canc Res Ctr, Houston, TX 77030 USA.	amaitra@mdanderson.org						Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bialkowska AB, 2011, MOL CANCER THER, V10, P2043, DOI 10.1158/1535-7163.MCT-11-0550; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	10	38	40	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					840	842		10.1016/j.cell.2016.02.024	http://dx.doi.org/10.1016/j.cell.2016.02.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919422	Bronze			2022-12-28	WOS:000370867300007
J	Sekulic, A; Von Hoff, D				Sekulic, Aleksandar; Von Hoff, Daniel			Hedgehog Pathway Inhibition	CELL			English	Editorial Material									[Sekulic, Aleksandar] Mayo Clin, Dept Dermatol, Scottsdale, AZ 85259 USA; [Von Hoff, Daniel] Translat Genom Res Inst TGen, Phoenix, AZ 85004 USA	Mayo Clinic; Mayo Clinic Phoenix; Translational Genomics Research Institute	Sekulic, A (corresponding author), Mayo Clin, Dept Dermatol, Scottsdale, AZ 85259 USA.	sekulic@mayo.edu							0	47	50	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					831	831		10.1016/j.cell.2016.02.021	http://dx.doi.org/10.1016/j.cell.2016.02.021			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919418	Bronze			2022-12-28	WOS:000370867300003
J	Bruns, TD; Taylor, JW				Bruns, Thomas D.; Taylor, John W.			FUNGAL SYMBIONTS Comment on "Global assessment of arbuscular mycorrhizal fungus diversity reveals very low endemism"	SCIENCE			English	Editorial Material							POPULATIONS; PATTERNS	Davison et al. (Reports, 28 August 2015, p. 970) claim that virtual taxa of Glomeromycota show little endemism and that endemism that exists is similar to the levels seen in plant families. We show that this is likely due to the conservative species definition rather than to any ecological pattern.	[Bruns, Thomas D.; Taylor, John W.] Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA		Bruns, TD (corresponding author), Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	pogon@berkeley.edu			Direct For Biological Sciences [1257528] Funding Source: National Science Foundation; Division Of Environmental Biology [1046115] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Baas Becking LGM, 1934, GEOBIOLOGIE INLEIDIN; Branco S, 2015, MOL ECOL, V24, P2747, DOI 10.1111/mec.13132; Davison J, 2015, SCIENCE, V349, P970, DOI 10.1126/science.aab1161; Ellison CE, 2011, P NATL ACAD SCI USA, V108, P2831, DOI 10.1073/pnas.1014971108; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Gladieux P, 2015, MOL ECOL, V24, P5657, DOI 10.1111/mec.13417; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Peay KG, 2010, ECOLOGY, V91, P3631, DOI 10.1890/09-2237.1; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; Robeson MS, 2011, P NATL ACAD SCI USA, V108, P4406, DOI 10.1073/pnas.1012678108; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	12	52	52	2	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275								10.1126/science.aad4228	http://dx.doi.org/10.1126/science.aad4228			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912889				2022-12-28	WOS:000370325700034
J	Kuhn, C; Weiner, HL				Kuhn, Chantal; Weiner, Howard L.			IMMUNOLOGY How does the immune system tolerate food?	SCIENCE			English	Editorial Material							REGULATORY T-CELLS; ORAL TOLERANCE; RETINOIC-ACID; REG-CELLS; POPULATION		[Kuhn, Chantal; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Weiner, HL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu						Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Lu JL, 2015, CELL IMMUNOL, V297, P53, DOI 10.1016/j.cellimm.2015.06.005; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	11	8	8	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					810	811		10.1126/science.aaf2167	http://dx.doi.org/10.1126/science.aaf2167			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912876				2022-12-28	WOS:000370325700020
J	Chinthapalli, K				Chinthapalli, Krishna			HEADS UP Voting for change in Myanmar	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chinthapalli, Krishna] Royal N Shore Hosp, Sydney, NSW, Australia	Royal North Shore Hospital; University of Sydney	Chinthapalli, K (corresponding author), Royal N Shore Hosp, Sydney, NSW, Australia.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				World Health Organization, WORLD HLTH REP 2000	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2016	352								i705	10.1136/bmj.i705	http://dx.doi.org/10.1136/bmj.i705			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EY	26888773				2022-12-28	WOS:000370727700009
J	Green, EM; Wakimoto, H; Anderson, RL; Evanchik, MJ; Gorham, JM; Harrison, BC; Henze, M; Kawas, R; Oslob, JD; Rodriguez, HM; Song, YH; Wan, W; Leinwand, LA; Spudich, JA; McDowell, RS; Seidman, JG; Seidman, CE				Green, Eric M.; Wakimoto, Hiroko; Anderson, Robert L.; Evanchik, Marc J.; Gorham, Joshua M.; Harrison, Brooke C.; Henze, Marcus; Kawas, Raja; Oslob, Johan D.; Rodriguez, Hector M.; Song, Yonghong; Wan, William; Leinwand, Leslie A.; Spudich, James A.; McDowell, Robert S.; Seidman, J. G.; Seidman, Christine E.			A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice	SCIENCE			English	Article							SYSTOLIC HEART-FAILURE; SUBAORTIC STENOSIS; MYOSIN MUTATIONS; HEAVY; BETA; GENOTYPE; R453C; MOTOR	Hypertrophic cardiomyopathy (HCM) is an inherited disease of heart muscle that can be caused by mutations in sarcomere proteins. Clinical diagnosis depends on an abnormal thickening of the heart, but the earliest signs of disease are hyperdynamic contraction and impaired relaxation. Whereas some in vitro studies of power generation by mutant and wild-type sarcomere proteins are consistent with mutant sarcomeres exhibiting enhanced contractile power, others are not. We identified a small molecule, MYK-461, that reduces contractility by decreasing the adenosine triphosphatase activity of the cardiac myosin heavy chain. Here we demonstrate that early, chronic administration of MYK-461 suppresses the development of ventricular hypertrophy, cardiomyocyte disarray, and myocardial fibrosis and attenuates hypertrophic and profibrotic gene expression in mice harboring heterozygous human mutations in the myosin heavy chain. These data indicate that hyperdynamic contraction is essential for HCM pathobiology and that inhibitors of sarcomere contraction may be a valuable therapeutic approach for HCM.	[Green, Eric M.; Anderson, Robert L.; Evanchik, Marc J.; Henze, Marcus; Kawas, Raja; Oslob, Johan D.; Rodriguez, Hector M.; Song, Yonghong; McDowell, Robert S.] MyoKardia, San Francisco, CA 94080 USA; [Wakimoto, Hiroko; Gorham, Joshua M.; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Harrison, Brooke C.; Wan, William; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Harrison, Brooke C.; Wan, William; Leinwand, Leslie A.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Spudich, James A.] Stanford Univ, Sch Chem, Dept Biochem, Stanford, CA 94305 USA; [Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Seidman, Christine E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Stanford University; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	McDowell, RS (corresponding author), MyoKardia, San Francisco, CA 94080 USA.; Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.; Seidman, CE (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.; Seidman, CE (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	rmcdowell@myokardia.com; cseidman@genetics.harvard.edu		Green, Eric/0000-0001-7874-9482	MyoKardia; NIH [5K01AR055676]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084553, R01HL117138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER	MyoKardia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Homcy, J. Fox, K. Ruppel, S. Ingle, and A. Pollen for advice; H. Ghermazien, M. Lun, S. Markova, A. Sran, and C. Zambataro for technical assistance; and J. Hartman, J. Schaletzky, P. Lu, L. Ashcroft, and others from Cytokinetics for assistance during the early stages of this work. E. M. G., R. L. A., M. J. E., M. H., R. K., J. D. O., H. M. R., Y. S., and R. S. M. are employees and own shares of MyoKardia, a biotechnology company developing small molecules that target the sarcomere for treatment of inherited cardiomyopathy. L. A. L., J. A. S., J. G. S., and C. E. S. are founders and own shares of MyoKardia. MyoKardia holds the rights to published patents on MYK-461 (U.S. Pub. App. Nos. 20140378464 and 20140378491). MYK-461 is available from MyoKardia under a material transfer agreement. Support for these studies was provided by MyoKardia. B. C. H. was supported by NIH grant 5K01AR055676.	Abramochkin DV, 2014, J MOL CELL CARDIOL, V70, P27, DOI 10.1016/j.yjmcc.2013.12.020; Aksel T, 2015, CELL REP, V11, P910, DOI 10.1016/j.celrep.2015.04.006; Alfares AA, 2015, GENET MED, V17, P880, DOI [10.1038/gim.2014.205, 10.1038/gim.2015.16]; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; Bos JM, 2014, MAYO CLIN PROC, V89, P727, DOI 10.1016/j.mayocp.2014.01.025; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; CUMMINS P, 1986, CIRC RES, V58, P846, DOI 10.1161/01.RES.58.6.846; Forsey J, 2014, J AM SOC ECHOCARDIOG, V27, P215, DOI 10.1016/j.echo.2013.10.012; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; KLEIN MD, 1965, AM J CARDIOL, V15, P773, DOI 10.1016/0002-9149(65)90379-6; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; Nag S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500511; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Palmer BM, 2004, AM J PHYSIOL-HEART C, V287, pH91, DOI 10.1152/ajpheart.01015.2003; Russel IK, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-3; Ruwhof C, 2000, MOL CELL BIOCHEM, V208, P89, DOI 10.1023/A:1007046105745; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Spoladore R, 2012, EUR HEART J, V33, P1724, DOI 10.1093/eurheartj/ehs150; Spudich JA, 2015, BIOCHEM SOC T, V43, P64, DOI 10.1042/BST20140324; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; STEWART S, 1968, CIRCULATION, V37, P8, DOI 10.1161/01.CIR.37.1.8; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Wan W, 2012, BIOPHYS J, V102, P2916, DOI 10.1016/j.bpj.2012.04.035; WILSON WS, 1967, AM HEART J, V73, P4, DOI 10.1016/0002-8703(67)90303-1	33	297	312	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					617	621		10.1126/science.aad3456	http://dx.doi.org/10.1126/science.aad3456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912705	Green Accepted			2022-12-28	WOS:000369291600044
J	Lei, MX; Chuong, CM				Lei, Mingxing; Chuong, Cheng-Ming			Aging, alopecia, and stem cells	SCIENCE			English	Editorial Material							HAIR REGENERATION; ACTIVATION; HOMEOSTASIS; REVEALS; NICHE; SKIN; MICE		[Lei, Mingxing; Chuong, Cheng-Ming] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Lei, Mingxing] Chongqing Univ, Coll Bioengn, Project Lab Biomech & Tissue Repair 111, Chongqing 630044, Peoples R China; [Chuong, Cheng-Ming] China Med Univ, Integrat Stem Cell Ctr, Taichung, Taiwan	University of Southern California; Chongqing University; China Medical University Taiwan	Chuong, CM (corresponding author), China Med Univ, Integrat Stem Cell Ctr, Taichung, Taiwan.	cmchuong@usc.edu	Lei, Mingxing/K-1804-2016	Lei, Mingxing/0000-0002-4271-2714	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060306, R01AR042177] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR60306, AR42177] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Botchkarev VA, 2012, J INVEST DERMATOL, V132, P2505, DOI 10.1038/jid.2012.182; Chen CC, 2014, J INVEST DERMATOL, V134, P2086, DOI 10.1038/jid.2014.139; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110; Li J, 2012, J INVEST DERMATOL, V132, P2681, DOI 10.1038/jid.2012.206; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Matsumura H, 2016, SCIENCE, V351, DOI 10.1126/science.aad4395; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Wang L, 2016, SCIENCE, V351, P613, DOI 10.1126/science.aad5440	15	34	37	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					559	560		10.1126/science.aaf1635	http://dx.doi.org/10.1126/science.aaf1635			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912687				2022-12-28	WOS:000369291600021
J	Simon, M				Simon, Melvin			Alfred Gilman (1941-2015)	SCIENCE			English	Biographical-Item									[Simon, Melvin] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Simon, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	simonm@caltech.edu						GILMAN A, PUBLICATION LIST	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					566	566		10.1126/science.aaf2848	http://dx.doi.org/10.1126/science.aaf2848			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912691				2022-12-28	WOS:000369291600025
J	Padwal, R; Leslie, WD; Lix, LM; Majumdar, SR				Padwal, Raj; Leslie, William D.; Lix, Lisa M.; Majumdar, Sumit R.			Relationship Among Body Fat Percentage, Body Mass Index, and All-Cause Mortality	ANNALS OF INTERNAL MEDICINE			English	Article							SYSTOLIC HEART-FAILURE; OBESITY PARADOX; CARDIORESPIRATORY FITNESS; FRACTURE PREDICTION; BONE-DENSITY; RISK-FACTOR; PROGNOSIS; POPULATION; METAANALYSIS; ASSOCIATION	Background: Prior mortality studies have concluded that elevated body mass index (BMI) may improve survival. These studies were limited because they did not measure adiposity directly. Objective: To examine associations of BMI and body fat percentage (separately and together) with mortality. Design: Observational study. Setting: Manitoba, Canada. Participants: Adults aged 40 years or older referred for bone mineral density (BMD) testing. Measurements: Participants had dual-energy x-ray absorptiometry (DXA), entered a clinical BMD registry, and were followed using linked administrative databases. Adjusted, sex-stratified Cox models were constructed. Body mass index and DXA-derived body fat percentage were divided into quintiles, with quintile 1 as the lowest, quintile 5 as the highest, and quintile 3 as the reference. Results: The final cohort included 49 476 women (mean age, 63.5 years; mean BMI, 27.0 kg/m(2); mean body fat, 32.1%) and 4944 men (mean age, 65.5 years; mean BMI, 27.4 kg/m(2); mean body fat, 29.5%). Death occurred in 4965 women over a median of 6.7 years and 984 men over a median of 4.5 years. In fully adjusted mortality models containing both BMI and body fat percentage, low BMI (hazard ratio [HR], 1.44 [95% CI, 1.30 to 1.59] for quintile 1 and 1.12 [CI, 1.02 to 1.23] for quintile 2) and high body fat percentage (HR, 1.19 [CI, 1.08 to 1.32] for quintile 5) were associated with higher mortality in women. In men, low BMI (HR, 1.45 [CI, 1.17 to 1.79] for quintile 1) and high body fat percentage (HR, 1.59 [CI, 1.28 to 1.96] for quintile 5) were associated with increased mortality. Limitations: All participants were referred for BMD testing, which may limit generalizability. Serial measures of BMD and weight were not used. Some measures, such as physical activity and smoking, were unavailable. Conclusion: Low BMI and high body fat percentage are independently associated with increased mortality. These findings may help explain the counterintuitive relationship between BMI and mortality.	Univ Alberta, Edmonton, AB, Canada; Univ Manitoba, Winnipeg, MB R2H 2A6, Canada; [Leslie, William D.] Univ Manitoba, Dept Med C5121, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada; [Padwal, Raj; Majumdar, Sumit R.] Univ Alberta, Gen Internal Med, 5-134 Clin Sci Bldg,8440 112th St, Edmonton, AB T6G 2G3, Canada; [Lix, Lisa M.] Univ Manitoba, Dept Community Hlth Sci, S113-750 Bannatyne Ave, Winnipeg, MB R3P 2H5, Canada	University of Alberta; University of Manitoba; University of Manitoba; University of Alberta; University of Manitoba	Leslie, WD (corresponding author), Univ Manitoba, Dept Med C5121, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	bleslie@sbgh.mb.ca	; Padwal, Raj/G-6903-2016	Leslie, William/0000-0002-1056-1691; Padwal, Raj/0000-0003-3541-2817	Health Information Privacy Committee [2011/2012-31]; Manitoba Research Chair from Research Manitoba	Health Information Privacy Committee; Manitoba Research Chair from Research Manitoba	The authors thank the Manitoba Centre for Health Policy for the use of data contained in the Population Health Research Data Repository (Health Information Privacy Committee project number 2011/2012-31). The authors also thank Dr. Shuman Yang for assisting with R programming and figure preparation. Dr. Majumdar holds the Endowed Chair in Patient Health Management from the Faculties of Medicine and Dentistry and Pharmacy and Pharmaceutical Sciences, University of Alberta. Dr. Lix is supported by a Manitoba Research Chair from Research Manitoba.	Agarwal R, 2010, HYPERTENSION, V56, P893, DOI 10.1161/HYPERTENSIONAHA.110.160747; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Austin PC, 2011, MED CARE, V49, P940, DOI 10.1097/MLR.0b013e318229360e; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Clark AL, 2012, AM J CARDIOL, V110, P77, DOI 10.1016/j.amjcard.2012.02.050; Costanzo P, 2015, ANN INTERN MED, V162, P610, DOI 10.7326/M14-1551; Coutinho T, 2013, J AM COLL CARDIOL, V61, P553, DOI 10.1016/j.jacc.2012.10.035; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Flegal KM, 2013, OBESITY, V21, P1744, DOI 10.1002/oby.20588; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fraser LA, 2011, OSTEOPOROSIS INT, V22, P829, DOI 10.1007/s00198-010-1465-1; Greenberg JA, 2013, AM J CLIN NUTR, V97, P1195, DOI 10.3945/ajcn.112.045815; Habbu A, 2006, AM J CARDIOL, V98, P944, DOI 10.1016/j.amjcard.2006.04.039; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594; Lavie CJ, 2013, JACC-HEART FAIL, V1, P93, DOI 10.1016/j.jchf.2013.01.006; Lavie CJ, 2013, PREV MED, V57, P1, DOI 10.1016/j.ypmed.2013.03.010; Lavie CJ, 2013, MAYO CLIN PROC, V88, P251, DOI 10.1016/j.mayocp.2012.11.020; Lavie CJ, 2010, MAYO CLIN PROC, V85, P605, DOI 10.4065/mcp.2010.0333; Lavie CJ, 2005, EUR HEART J, V26, P5, DOI 10.1093/eurheartj/ehi055; Lavie CJ, 2003, AM J CARDIOL, V91, P891, DOI 10.1016/S0002-9149(03)00031-6; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P391, DOI 10.1007/s00198-011-1592-3; Leslie WD, 2005, J CLIN DENSITOM, V8, P25, DOI 10.1385/JCD:8:1:025; Leslie WD, 2007, ARCH INTERN MED, V167, P1641, DOI 10.1001/archinte.167.15.1641; Leslie WD, 2014, J BONE MINER RES, V29, P2511, DOI 10.1002/jbmr.2280; Leslie WD, 2010, J BONE MINER RES, V25, P2350, DOI 10.1002/jbmr.123; Leslie WD, 2010, J CLIN ENDOCR METAB, V95, P3272, DOI 10.1210/jc.2009-2794; McAuley PA, 2012, MAYO CLIN PROC, V87, P443, DOI 10.1016/j.mayocp.2012.01.013; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Oreopoulos Antigone, 2011, Congest Heart Fail, V17, P90, DOI 10.1111/j.1751-7133.2010.00204.x; Oreopoulos A, 2010, MAYO CLIN PROC, V85, P609, DOI 10.4065/mcp.2010.0103; Oreopoulos A, 2009, CLIN GERIATR MED, V25, P643, DOI 10.1016/j.cger.2009.07.005; Roos NP, 1999, MED CARE, V37, pJS10, DOI 10.1097/00005650-199906001-00005; Statistics Canada, 2015, CANSIM DAT TABL 102; Vapattanawong P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-604; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	37	131	138	2	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					532	+		10.7326/M15-1181	http://dx.doi.org/10.7326/M15-1181			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	26954388				2022-12-28	WOS:000374257900012
J	Mecharles, S; Herrmann, C; Poullain, P; Tran, TH; Deschamps, N; Mathon, G; Landais, A; Breurec, S; Lannuzel, A				Mecharles, Sylvie; Herrmann, Cecile; Poullain, Pascale; Tran, Tuan-Huy; Deschamps, Nathalie; Mathon, Gregory; Landais, Anne; Breurec, Sebastien; Lannuzel, Annie			Acute myelitis due to Zika virus infection	LANCET			English	Editorial Material									[Mecharles, Sylvie; Tran, Tuan-Huy; Deschamps, Nathalie; Landais, Anne; Lannuzel, Annie] Ctr Hosp Univ Pointe A Pitre, Serv Neurol, Pointe A Pitre 97159, Guadeloupe, France; [Herrmann, Cecile; Breurec, Sebastien] Ctr Hosp Univ Pointe A Pitre, Lab Microbiol Clin & Environm, Pointe A Pitre 97159, Guadeloupe, France; [Poullain, Pascale; Mathon, Gregory] Ctr Hosp Univ Pointe A Pitre, Serv Radiol, Pointe A Pitre 97159, Guadeloupe, France; [Breurec, Sebastien; Lannuzel, Annie] Univ Antilles, Fac Med, Antilles, Guadeloupe, France; [Breurec, Sebastien] Inst Pasteur Guadeloupe, Unite Sante & Environm, Pointe A Pitre, Guadeloupe, France; [Lannuzel, Annie] Univ Paris 04, INSERM, U1127, CNRS,UMR 7225,Inst Cerveau & Moelle Epiniere,ICM, Paris, France	CHU Guadeloupe; CHU Guadeloupe; CHU Guadeloupe; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Lannuzel, A (corresponding author), Ctr Hosp Univ Pointe A Pitre, Serv Neurol, Pointe A Pitre 97159, Guadeloupe, France.	annie.lannuzel@chu-guadeloupe.fr	lannuzel, annie/AAB-6253-2021	LANDAIS, Anne/0000-0003-1037-3356				Ali M, 2005, AM J NEURORADIOL, V26, P289; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Larik A, 2012, BMJ CASE REP, DOI [10.1136/bcr.12.2011.53783, DOI 10.1136/BCR.12.2011.53783]; Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104; Verma Rajesh, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-007094	5	240	250	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1481	1481		10.1016/S0140-6736(16)00644-9	http://dx.doi.org/10.1016/S0140-6736(16)00644-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	26946926	Bronze			2022-12-28	WOS:000373217500036
J	Hein, G; Morishima, Y; Leiberg, S; Sul, S; Fehr, E				Hein, Grit; Morishima, Yosuke; Leiberg, Susanne; Sul, Sunhae; Fehr, Ernst			The brain's functional network architecture reveals human motives	SCIENCE			English	Article							NEURAL RESPONSES; HUMAN ALTRUISM; NEUROBIOLOGY; PREFERENCES; RECIPROCITY; DECISION; EMPATHY; REWARD; GAME; PAIN	Goal-directed human behaviors are driven by motives. Motives are, however, purely mental constructs that are not directly observable. Here, we show that the brain's functional network architecture captures information that predicts different motives behind the same altruistic act with high accuracy. In contrast, mere activity in these regions contains no information about motives. Empathy-based altruism is primarily characterized by a positive connectivity from the anterior cingulate cortex (ACC) to the anterior insula (AI), whereas reciprocity-based altruism additionally invokes strong positive connectivity from the AI to the ACC and even stronger positive connectivity from the AI to the ventral striatum. Moreover, predominantly selfish individuals show distinct functional architectures compared to altruists, and they only increase altruistic behavior in response to empathy inductions, but not reciprocity inductions.	[Hein, Grit; Morishima, Yosuke; Leiberg, Susanne; Fehr, Ernst] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, CH-8006 Zurich, Switzerland; [Morishima, Yosuke] Univ Bern, Univ Hosp Psychiat, Translat Res Ctr, Div Syst Neurosci Psychopathol, CH-3012 Bern, Switzerland; [Morishima, Yosuke] Japanese Sci & Technol Agcy, PRESTO, Tokyo, Japan; [Sul, Sunhae] Pusan Natl Univ, Dept Psychol, Pusan 609735, South Korea	University of Zurich; University of Bern; University Hospital of Bern; Japan Science & Technology Agency (JST); Pusan National University	Hein, G; Fehr, E (corresponding author), Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, CH-8006 Zurich, Switzerland.	grit.hein@econ.uzh.ch; ernst.fehr@econ.uzh.ch	Morishima, Yosuke/K-8258-2013; Hein, Grit/AAF-7964-2019; Sul, Sunhae/AAD-4085-2021	Morishima, Yosuke/0000-0001-9363-697X; Sul, Sunhae/0000-0001-5286-4343; Leiberg, Susanne/0000-0001-9427-7614	European Research Council [CRSII3_141965]	European Research Council(European Research Council (ERC)European Commission)	We thank K. E. Stephan for useful comments on early versions of the manuscript and K. Treiber and S. Klein for assistance with data collection. We also thank two anonymous referees for their helpful comments. The paper is part of the advanced European Research Council grant on the "Foundations of Economic Preferences and the Synergia grant of the Swiss National Science Foundation on the neuroeconomics of value-based decision making (CRSII3_141965)." The data are stored on the server of the Laboratory for Social and Neural Systems Research at the University of Zurich.	Batson CD., 1991, ALTRUISM QUESTION SO; Brodersen KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002079; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Emmons R.A., 2004, PSYCHOL GRATITUDE, DOI [10.1093/acprof:oso/9780195150100.001.0001, DOI 10.1093/ACPROF:OSO/9780195150100.001.0001]; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2011, J ECON PERSPECT, V25, P3, DOI 10.1257/jep.25.4.3; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lewin K., 1951, FIELD THEORY SOCIAL; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Phan KL, 2010, P NATL ACAD SCI USA, V107, P13099, DOI 10.1073/pnas.1008137107; RABIN M, 1993, AM ECON REV, V83, P1281; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rilling JK, 2008, NEUROPSYCHOLOGIA, V46, P1256, DOI 10.1016/j.neuropsychologia.2007.11.033; Samuelson PA, 1948, ECONOMICA-NEW SER, V15, P243, DOI 10.2307/2549561; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Tusche A, 2013, NEUROIMAGE, V72, P174, DOI 10.1016/j.neuroimage.2013.01.020; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	30	80	86	3	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1074	1078		10.1126/science.aac7992	http://dx.doi.org/10.1126/science.aac7992			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941317				2022-12-28	WOS:000371597500042
J	Moll, PJW; Kushwaha, P; Nandi, N; Schmidt, B; Mackenzie, AP				Moll, Philip J. W.; Kushwaha, Pallavi; Nandi, Nabhanila; Schmidt, Burkhard; Mackenzie, Andrew P.			Evidence for hydrodynamic electron flow in PdCoO2	SCIENCE			English	Article							SCATTERING	Electron transport is conventionally determined by the momentum-relaxing scattering of electrons by the host solid and its excitations. Hydrodynamic fluid flow through channels, in contrast, is determined partly by the viscosity of the fluid, which is governed by momentum-conserving internal collisions. A long-standing question in the physics of solids has been whether the viscosity of the electron fluid plays an observable role in determining the resistance. We report experimental evidence that the resistance of restricted channels of the ultrapure two-dimensional metal palladium cobaltate (PdCoO2) has a large viscous contribution. Comparison with theory allows an estimate of the electronic viscosity in the range between 6 x 10(-3) kg m(-1) s(-1) and 3 x 10(-4) kg m(-1) s(-1), versus 1 x 10(-3) kg m(-1) s(-1) for water at room temperature.	[Moll, Philip J. W.] ETH, Solid State Phys Lab, CH-8093 Zurich, Switzerland; [Moll, Philip J. W.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Moll, Philip J. W.; Kushwaha, Pallavi; Nandi, Nabhanila; Schmidt, Burkhard; Mackenzie, Andrew P.] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Mackenzie, Andrew P.] Univ St Andrews, Sch Phys & Astron, Scottish Univ Phys Alliance, St Andrews KY16 9SS, Fife, Scotland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley; Max Planck Society; University of St Andrews	Mackenzie, AP (corresponding author), Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany.; Mackenzie, AP (corresponding author), Univ St Andrews, Sch Phys & Astron, Scottish Univ Phys Alliance, St Andrews KY16 9SS, Fife, Scotland.	andy.mackenzie@cpfs.mpg.de	Kushwaha, Pallavi/J-9119-2015; Schmidt, Burkhard/M-3457-2015; Mackenzie, Andrew P/K-6742-2015	Kushwaha, Pallavi/0000-0002-6323-3384; Mackenzie, Andrew P/0000-0001-8000-4949; Moll, Philip/0000-0002-7616-5886	UK Engineering and Physical Sciences Research Council; SCOPE-M center for electron microscopy at ETH Zurich; EPSRC [EP/I031014/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I031014/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); SCOPE-M center for electron microscopy at ETH Zurich; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank J. C. Davis, C. Geibel, A. G. Green, S. A. Hartnoll, C. W. Hicks, S. A. Kivelson, Y. Maeno, T. Oka, J. W. Orenstein, and S. H. Simon for stimulating discussions and the UK Engineering and Physical Sciences Research Council for financial support. The FIB work was supported by the SCOPE-M center for electron microscopy at ETH Zurich. We thank P. Gasser, J. Reuteler, and B. Batlogg for FIB support. The data and/or materials supporting this publication can be accessed at http://dx.doi.org/10.17630/cdc6c488-2ea4-440e-a68d-e2a426709171.	Andreev AV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.256804; BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; Bruin JAN, 2013, SCIENCE, V339, P804, DOI 10.1126/science.1227612; Daou R, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.041113; Davison RA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.245116; DEJONG MJM, 1995, PHYS REV B, V51, P13389, DOI 10.1103/PhysRevB.51.13389; DITLEFSEN E, 1966, PHILOS MAG, V14, P759, DOI 10.1080/14786436608211970; Eyert V, 2008, CHEM MATER, V20, P2370, DOI 10.1021/cm703404e; GURZHI RN, 1963, SOV PHYS JETP-USSR, V17, P521; GURZHI RN, 1968, SOV PHYS USPEKHI, V11, P255, DOI 10.1070/PU1968v011n02ABEH003815; Hartnoll SA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144502; Hartnoll SA, 2015, NAT PHYS, V11, P54, DOI [10.1038/NPHYS3174, 10.1038/nphys3174]; Hasegawa M, 2002, SOLID STATE COMMUN, V121, P203, DOI 10.1016/S0038-1098(01)00484-7; Hasegawa M, 2001, MATER TRANS, V42, P961, DOI 10.2320/matertrans.42.961; Hicks CW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116401; Kim K, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.035116; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Mahajan R, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125107; Masubuchi S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.036601; MOLENKAMP LW, 1994, PHYS REV B, V49, P5038, DOI 10.1103/PhysRevB.49.5038; Noh HJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256404; Ong KP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.176601; Ong KP, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115120; SHANNON RD, 1971, INORG CHEM, V10, P713, DOI 10.1021/ic50098a011; Takatsu H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.056601; Takatsu H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.137201; Takatsu H, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.104701; THORNTON TJ, 1989, PHYS REV LETT, V63, P2128, DOI 10.1103/PhysRevLett.63.2128; Weber CP, 2005, NATURE, V437, P1330, DOI 10.1038/nature04206	30	271	271	4	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1061	1064		10.1126/science.aac8385	http://dx.doi.org/10.1126/science.aac8385			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26912359	Green Accepted, Green Submitted			2022-12-28	WOS:000371597500038
J	Pennisi, E				Pennisi, Elizabeth			Making a game of science	SCIENCE			English	Editorial Material												SciCareerEditor@aaas.org							0	1	1	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1106	1106		10.1126/science.351.6277.1106	http://dx.doi.org/10.1126/science.351.6277.1106			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF8HE	26941322				2022-12-28	WOS:000371597500048
J	Freakley, SJ; He, Q; Harrhy, JH; Lu, L; Crole, DA; Morgan, DJ; Ntainjua, EN; Edwards, JK; Carley, AF; Borisevich, AY; Kiely, CJ; Hutchings, GJ				Freakley, Simon J.; He, Qian; Harrhy, Jonathan H.; Lu, Li; Crole, David A.; Morgan, David J.; Ntainjua, Edwin N.; Edwards, Jennifer K.; Carley, Albert F.; Borisevich, Albina Y.; Kiely, Christopher J.; Hutchings, Graham J.			Palladium-tin catalysts for the direct synthesis of H2O2 with high selectivity	SCIENCE			English	Article							METAL-SUPPORT INTERACTIONS; AU-PD CATALYSTS; HYDROGEN-PEROXIDE; H-2; O-2; OXIDATION	The direct synthesis of hydrogen peroxide (H2O2) from H-2 and O-2 represents a potentially atom-efficient alternative to the current industrial indirect process. We show that the addition of tin to palladium catalysts coupled with an appropriate heat treatment cycle switches off the sequential hydrogenation and decomposition reactions, enabling selectivities of >95% toward H2O2. This effect arises from a tin oxide surface layer that encapsulates small Pd-rich particles while leaving larger Pd-Sn alloy particles exposed. We show that this effect is a general feature for oxide-supported Pd catalysts containing an appropriate second metal oxide component, and we set out the design principles for producing high-selectivity Pd-based catalysts for direct H2O2 production that do not contain gold.	[Freakley, Simon J.; Harrhy, Jonathan H.; Crole, David A.; Morgan, David J.; Ntainjua, Edwin N.; Edwards, Jennifer K.; Carley, Albert F.; Hutchings, Graham J.] Cardiff Univ, Cardiff Catalysis Inst, Cardiff CF10 3AT, S Glam, Wales; [Freakley, Simon J.; Harrhy, Jonathan H.; Crole, David A.; Morgan, David J.; Ntainjua, Edwin N.; Edwards, Jennifer K.; Carley, Albert F.; Hutchings, Graham J.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales; [He, Qian; Lu, Li; Kiely, Christopher J.] Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA; [He, Qian; Borisevich, Albina Y.] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; [Borisevich, Albina Y.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA	Cardiff University; Cardiff University; Lehigh University; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences	Freakley, SJ; Hutchings, GJ (corresponding author), Cardiff Univ, Cardiff Catalysis Inst, Cardiff CF10 3AT, S Glam, Wales.; Freakley, SJ; Hutchings, GJ (corresponding author), Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales.	freakleys@cf.ac.uk; hutch@cf.ac.uk	He, Qian/AAK-8732-2020; Lu, Li/H-3078-2016; Morgan, David John/F-6285-2010; Borisevich, Albina Y/B-1624-2009; He, Qian/U-1329-2019	He, Qian/0000-0003-4891-3581; Lu, Li/0000-0001-9636-3014; Morgan, David John/0000-0002-6571-5731; Borisevich, Albina Y/0000-0002-3953-8460; Freakley, Simon/0000-0002-6395-6646; Harrhy, Jonathan/0000-0001-7691-064X; Kiely, Christopher/0000-0001-5412-0970	NSF [MRI/DMR-1040229]; U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division; Oak Ridge National Laboratory's Center for Nanophase Materials Sciences - Scientific User Facilities Division, Office of Science, Basic Energy Sciences, U.S. Department of Energy; European Research Council [291319]; Engineering and Physical Sciences Research Council [EP/L027240/1] Funding Source: researchfish; EPSRC [EP/L027240/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Oak Ridge National Laboratory's Center for Nanophase Materials Sciences - Scientific User Facilities Division, Office of Science, Basic Energy Sciences, U.S. Department of Energy; European Research Council(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by NSF Major Research Instrumentation Program grant MRI/DMR-1040229 (C.J.K.); the U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division (Q.H. and A.Y.B.); a user project supported by Oak Ridge National Laboratory's Center for Nanophase Materials Sciences, sponsored by the Scientific User Facilities Division, Office of Science, Basic Energy Sciences, U.S. Department of Energy; and European Research Council grant ERC-2011ADG, grant agreement no. 291319, acronym "AFTERTHEGOLDRUSH" (G.J.H.). The data contained in this paper are archived at DOI: 10.17035/d.2016.0008119507.	Choudhary VR, 2007, APPL CATAL A-GEN, V317, P234, DOI 10.1016/j.apcata.2006.10.022; Dissanayake DP, 2002, J CATAL, V206, P173, DOI 10.1006/jcat.2001.3501; Edwards JK, 2014, ACCOUNTS CHEM RES, V47, P845, DOI 10.1021/ar400177c; Edwards JK, 2013, CATAL SCI TECHNOL, V3, P812, DOI 10.1039/c2cy20767b; Edwards JK, 2012, J CATAL, V292, P227, DOI 10.1016/j.jcat.2012.05.018; Edwards JK, 2008, ANGEW CHEM INT EDIT, V47, P9192, DOI 10.1002/anie.200802818; Edwards JK, 2009, SCIENCE, V323, P1037, DOI 10.1126/science.1168980; Edwards JK, 2005, J CATAL, V236, P69, DOI 10.1016/j.jcat.2005.09.015; Fu Q, 2005, J PHYS CHEM B, V109, P944, DOI 10.1021/jp046091u; Fu Q, 2007, SURF SCI REP, V62, P431, DOI 10.1016/j.surfrep.2007.07.001; Goodman DW, 2005, CATAL LETT, V99, P1, DOI 10.1007/s10562-004-0768-2; HALLER GL, 1989, ADV CATAL, V36, P173, DOI 10.1016/S0360-0564(08)60018-8; Henkel H., 1914, US Pat, Patent No. [1 108 752, 1108752, 1,108,752]; Liu JY, 2011, CHEMCATCHEM, V3, P934, DOI 10.1002/cctc.201100090; Lunsford JH, 2003, J CATAL, V216, P455, DOI 10.1016/S0021-9517(02)00070-2; Pattamakomsan K, 2011, CATAL TODAY, V164, P28, DOI 10.1016/j.cattod.2010.10.013; Pritchard J, 2010, LANGMUIR, V26, P16568, DOI 10.1021/la101597q; Sales EA, 2000, J CATAL, V195, P88, DOI 10.1006/jcat.2000.2967; Stassi JP, 2013, J CATAL, V306, P11, DOI 10.1016/j.jcat.2013.05.029; TAUSTER SJ, 1987, ACCOUNTS CHEM RES, V20, P389, DOI 10.1021/ar00143a001; TAUSTER SJ, 1978, J AM CHEM SOC, V100, P170, DOI 10.1021/ja00469a029	21	344	352	51	694	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					965	968		10.1126/science.aad5705	http://dx.doi.org/10.1126/science.aad5705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917769	Green Submitted			2022-12-28	WOS:000370821400039
J	Li, BX; Tadross, MR; Tsien, RW				Li, Boxing; Tadross, Michael R.; Tsien, Richard W.			Sequential ionic and conformational signaling by calcium channels drives neuronal gene expression	SCIENCE			English	Article							CREB PHOSPHORYLATION; TIMOTHY-SYNDROME; HIPPOCAMPAL-NEURONS; MAP KINASE; VOLTAGE; LONG; NUCLEUS; DEPENDENCE; ARRHYTHMIA; MOVEMENT	Voltage-gated Ca(V)1.2 channels (L-type calcium channel alpha 1C subunits) are critical mediators of transcription-dependent neural plasticity. Whether these channels signal via the influx of calcium ion (Ca2+), voltage-dependent conformational change (VDC), or a combination of the two has thus far been equivocal. We fused Ca(V)1.2 to a ligand-gated Ca2+-permeable channel, enabling independent control of localized Ca2+ and VDC signals. This revealed an unexpected dual requirement: Ca2+ must first mobilize actin-bound Ca2+/ calmodulin-dependent protein kinase II, freeing it for subsequent VDC-mediated accumulation. Neither signal alone sufficed to activate transcription. Signal order was crucial: Efficiency peaked when Ca2+ preceded VDC by 10 to 20 seconds. CaV1.2 VDC synergistically augmented signaling by N-methyl-D-aspartate receptors. Furthermore, VDC mistuning correlated with autistic symptoms in Timothy syndrome. Thus, nonionic VDC signaling is vital to the function of Ca(V)1.2 in synaptic and neuropsychiatric processes.	[Li, Boxing; Tsien, Richard W.] Dept Neurosci & Physiol, New York, NY 10016 USA; [Li, Boxing; Tsien, Richard W.] NYU, Inst Neurosci, 550 1St Ave, New York, NY 10016 USA; [Tadross, Michael R.; Tsien, Richard W.] Stanford Univ, Beckman Ctr, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Tadross, Michael R.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	New York University; Stanford University; Howard Hughes Medical Institute	Tadross, MR (corresponding author), Stanford Univ, Beckman Ctr, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.; Tadross, MR (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	tadrossm@janelia.hhmi.org			National Institute of General Medical Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Simons Foundation; Mathers Foundation; Burnett Family Foundation; Howard Hughes Medical Institute; Jane Coffin Childs Fellowship; Stanford Dean's Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071739] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; Mathers Foundation; Burnett Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs Fellowship; Stanford Dean's Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Mensh, A. Lee, N. Spruston, and H. Bito for critical feedback on the manuscript; R. Groth, S. Sanchez, S. Cohen, J. Emery, and B. Shields for assistance with primary neuronal cultures; and H. Ma and other Tsien laboratory members for discussions throughout the execution of this project. The chimera construct is available from M.R.T. upon request. This work was supported by research grants to R.W.T. from the National Institute of General Medical Sciences; the National Institute of Mental Health; the National Institute of Neurological Disorders and Stroke; and the Simons, Mathers, and Burnett Family Foundations. M.R.T. was supported by the Howard Hughes Medical Institute, the Jane Coffin Childs Fellowship, and the Stanford Dean's Fellowship. The authors declare no conflicts. Author contributions were as follows: R.W.T. framed the question and provided overall guidance. M.R.T. conceived of the approach, engineered the chimera, discovered the coincidence of Ca<SUP>2+</SUP> and V Delta C in activating CREB in WT and TS Ca<INF>V</INF>1.2, and designed the Delta t and NMDAR experiments. B.L. showed that coincidence detection was mediated by CaMKII signaling, implemented the Delta t and NMDAR experiments, and performed biochemistry analyses. M.R.T. led the writing, B.L. shortened the manuscript to its published form, and R.W.T. provided editorial oversight. The data are included in the main manuscript and the supplementary materials.	ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Atlas D, 2013, ANNU REV BIOCHEM, V82, P607, DOI 10.1146/annurev-biochem-080411-121438; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Erxleben C, 2006, P NATL ACAD SCI USA, V103, P3932, DOI 10.1073/pnas.0511322103; Frohler S, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-48; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HADLEY RW, 1995, AM J PHYSIOL-HEART C, V269, pH1784, DOI 10.1152/ajpheart.1995.269.5.H1784; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kobrinsky E, 2003, J BIOL CHEM, V278, P5021, DOI 10.1074/jbc.M211254200; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; Lynagh T, 2010, J BIOL CHEM, V285, P14890, DOI 10.1074/jbc.M110.107789; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Nabavi S, 2013, P NATL ACAD SCI USA, V110, P4027, DOI 10.1073/pnas.1219454110; Pinggera A, 2015, BIOL PSYCHIAT, V77, P816, DOI 10.1016/j.biopsych.2014.11.020; Raymond CR, 2007, TRENDS NEUROSCI, V30, P167, DOI 10.1016/j.tins.2007.01.007; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Tadross MR, 2013, P NATL ACAD SCI USA, V110, P15794, DOI 10.1073/pnas.1313898110; Tadross MR, 2010, J GEN PHYSIOL, V135, P197, DOI 10.1085/jgp.200910308; Tallila J, 2014, HEART LUNG CIRC, V23, pe4; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659	33	66	69	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					863	867		10.1126/science.aad3647	http://dx.doi.org/10.1126/science.aad3647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912895	Green Accepted, Green Submitted			2022-12-28	WOS:000370325700045
J	Morgan, MT; Haj-Yahya, M; Ringel, AE; Bandi, P; Brik, A; Wolberger, C				Morgan, Michael T.; Haj-Yahya, Mahmood; Ringel, Alison E.; Bandi, Prasanthi; Brik, Ashraf; Wolberger, Cynthia			Structural basis for histone H2B deubiquitination by the SAGA DUB module	SCIENCE			English	Article							NUCLEOSOME; TRANSCRIPTION; COMPLEX; FACT; UBIQUITYLATION; ELONGATION; BINDING; ARCHITECTURE; RECOGNITION; METHYLATION	Monoubiquitinated histone H2B plays multiple roles in transcription activation. H2B is deubiquitinated by the Spt-Ada-Gcn5 acetyltransferase (SAGA) coactivator, which contains a four-protein subcomplex known as the deubiquitinating (DUB) module. The crystal structure of the Ubp8/Sgf11/Sus1/Sgf73 DUB module bound to a ubiquitinated nucleosome reveals that the DUB module primarily contacts H2A/H2B, with an arginine cluster on the Sgf11 zinc finger domain docking on the conserved H2A/H2B acidic patch. The Ubp8 catalytic domain mediates additional contacts with H2B, as well as with the conjugated ubiquitin. We find that the DUB module deubiquitinates H2B both in the context of the nucleosome and in H2A/H2B dimers complexed with the histone chaperone, FACT, suggesting that SAGA could target H2B at multiple stages of nucleosome disassembly and reassembly during transcription.	[Morgan, Michael T.; Ringel, Alison E.; Bandi, Prasanthi; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Haj-Yahya, Mahmood] Ben Gurion Univ Negev, Dept Chem, IL-8410501 Beer Sheva, Israel; [Brik, Ashraf] Technion Israel Inst Technol, Schulich Fac Chem, IL-3200008 Haifa, Israel	Johns Hopkins University; Ben Gurion University; Technion Israel Institute of Technology	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		Ringel, Alison/0000-0002-6451-9376; Wolberger, Cynthia/0000-0001-8578-2969	National Institute of General Medical Sciences [GM-095822, Y1-GM-1104]; Ruth L. Kirschstein National Research Service Award; National Cancer Institute [Y1-CO-1020]; U.S. Department of Energy, Basic Energy Sciences, Office of Science, [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095822, T32GM008403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy, Basic Energy Sciences, Office of Science,(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Formosa for the generous gift of purified FACT and S. Tan for the plasmid, pST55-16x601. We thank X. Zhang for assistance with protein purification, P. Lombardi for assistance with data collection, and D. Leahy for helpful discussions. Supported by grant GM-095822 from the National Institute of General Medical Sciences (C.W.) and by a Ruth L. Kirschstein National Research Service Award (M.M.). A.B. is a Neubauer Professor and a Taub Foundation Fellow. GM/CA @ APS has been funded by the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. Coordinates and data have been deposited in the Protein Data Bank with accession code 4ZUX. Plasmid pST55-16xNCP601 expressing the Widom 601 DNA fragment was obtained from S. Tan under a material transfer agreement with Pennsylvania State University.	Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Basnet H, 2014, NATURE, V516, P267, DOI 10.1038/nature13736; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bonnet Jacques, 2014, Drug Discov Today Technol, V12, pe19, DOI 10.1016/j.ddtec.2012.09.002; Cucinotta CE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005420; Durand A, 2014, STRUCTURE, V22, P1553, DOI 10.1016/j.str.2014.07.017; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Fuchs G, 2014, BBA-GENE REGUL MECH, V1839, P694, DOI 10.1016/j.bbagrm.2014.01.002; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Kemble DJ, 2015, MOL CELL, V60, P294, DOI 10.1016/j.molcel.2015.09.008; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Koehler C, 2014, J BIOL CHEM, V289, P8989, DOI 10.1074/jbc.M113.500868; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Samara NL, 2012, STRUCTURE, V20, P1414, DOI 10.1016/j.str.2012.05.015; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yan M, 2015, J MOL BIOL, V427, P1765, DOI 10.1016/j.jmb.2014.12.004; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015	32	158	162	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					725	728		10.1126/science.aac5681	http://dx.doi.org/10.1126/science.aac5681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912860	Green Accepted			2022-12-28	WOS:000369810000044
J	Workman, JL				Workman, Jerry L.			It takes teamwork to modify chromatin	SCIENCE			English	Editorial Material							SAGA; COMPLEX; SUBUNIT		[Workman, Jerry L.] Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Workman, JL (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	jlw@stowers.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099945] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM099945] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Kamata K, 2013, GENES CELLS, V18, P823, DOI 10.1111/gtc.12075; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Mohan RD, 2014, GENE DEV, V28, P259, DOI 10.1101/gad.225151.113; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Weake VM, 2012, TRENDS CELL BIOL, V22, P177, DOI 10.1016/j.tcb.2011.11.005; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035	12	3	5	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					667	667		10.1126/science.aaf1495	http://dx.doi.org/10.1126/science.aaf1495			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912847				2022-12-28	WOS:000369810000023
J	Misasi, J; Gilman, MSA; Kanekiyo, M; Gui, M; Cagigi, A; Mulangu, S; Corti, D; Ledgerwood, JE; Lanzavecchia, A; Cunningham, J; Muyembe-Tamfun, JJ; Baxa, U; Graham, BS; Xiang, Y; Sullivan, NJ; McLellan, JS				Misasi, John; Gilman, Morgan S. A.; Kanekiyo, Masaru; Gui, Miao; Cagigi, Alberto; Mulangu, Sabue; Corti, Davide; Ledgerwood, Julie E.; Lanzavecchia, Antonio; Cunningham, James; Muyembe-Tamfun, Jean Jacques; Baxa, Ulrich; Graham, Barney S.; Xiang, Ye; Sullivan, Nancy J.; McLellan, Jason S.			Structural and molecular basis for Ebola virus neutralization by protective human antibodies	SCIENCE			English	Article							MEDIATED NEUTRALIZATION; CONFORMATIONAL EPITOPE; ENTRY REQUIRES; GLYCOPROTEIN; RESIDUES; INFECTION; COMPLEX	Ebola virus causes hemorrhagic fever with a high case fatality rate for which there is no approved therapy. Two human monoclonal antibodies, mAb100 and mAb114, in combination, protect nonhuman primates against all signs of Ebola virus disease, including viremia. Here, we demonstrate that mAb100 recognizes the base of the Ebola virus glycoprotein (GP) trimer, occludes access to the cathepsin-cleavage loop, and prevents the proteolytic cleavage of GP that is required for virus entry. We show that mAb114 interacts with the glycan cap and inner chalice of GP, remains associated after proteolytic removal of the glycan cap, and inhibits binding of cleaved GP to its receptor. These results define the basis of neutralization for two protective antibodies and may facilitate development of therapies and vaccines.	[Misasi, John; Kanekiyo, Masaru; Cagigi, Alberto; Mulangu, Sabue; Ledgerwood, Julie E.; Graham, Barney S.; Sullivan, Nancy J.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gilman, Morgan S. A.; McLellan, Jason S.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Baxa, Ulrich] Leidos Biomed Res Inc, Electron Microscopy Lab, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Gui, Miao; Xiang, Ye] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol, Ctr Infect Dis Res,Dept Basic Med Sci,Sch Med, Beijing 100084, Peoples R China; [Misasi, John; Cunningham, James] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Corti, Davide; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Muyembe-Tamfun, Jean Jacques] Natl Lab Publ Hlth, Natl Inst Biomed Res, BP 1197, Kinshasa, DEM REP CONGO; [Misasi, John] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02215 USA; [Lanzavecchia, Antonio] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universita della Svizzera Italiana; Institute Nacional de Recherche Biomedical; Harvard University; Boston Children's Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sullivan, NJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Xiang, Y (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol, Ctr Infect Dis Res,Dept Basic Med Sci,Sch Med, Beijing 100084, Peoples R China.	yxiang@mail.tsinghua.edu.cn; njsull@mail.nih.gov	Cagigi, Alberto/K-4824-2016; Gui, Miao/AAU-6300-2021; Graham, Barney S./AAC-5898-2019; Kanekiyo, Masaru/Y-9820-2018	Cagigi, Alberto/0000-0002-3567-9514; Graham, Barney S./0000-0001-8112-0853; Kanekiyo, Masaru/0000-0001-5767-1532; Misasi, John/0000-0001-7169-2639; Xiang, Ye/0000-0003-0230-9522; Gui, Miao/0000-0001-9113-8029; McLellan, Jason/0000-0003-3991-542X; Baxa, Ulrich/0000-0002-7263-5078	Boston Children's Hospital Faculty Development award; National Institute of General Medical Sciences of the National Institutes of Health [T32GM008704]; 973 program [2015CB14010102]; National Natural Science Foundation of China [81550001, 31470721]; Junior Thousand Talents Program of China [20131770418]; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; UChicago Argonne, LLC, for the US. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357];  [NIH-5K08AI079381]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005047, K08AI079381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER	Boston Children's Hospital Faculty Development award; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Junior Thousand Talents Program of China; Frederick National Laboratory for Cancer Research, National Institutes of Health; UChicago Argonne, LLC, for the US. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the 19-ID beamline staff at the Structural Biology Center at the Advanced Photon Source Argonne National Laboratory. We thank W. Shi and M. Choe for preparation of antibodies, J. Mascot and K Leigh for critical reading, M. Cichanowski for graphics, and B. Hartman for manuscript preparation,. The data presented in this manuscript am tabulated in the main paper and in the supplementaiy materials. Atomic coordinates and structure factors for the crystal structures of Fab114, Fab100 and the ternary complex of these Fabs bound to Ebola virus GP have been deposited in the Protein Data Bank under accession codes 5FHA, 5FHB, and 5FHC, respectively. Cryo-EM maps and related materials have been deposited to the EM Data Bank under accession codes EMD-3310 and EMD-3311. This work was supported by the Intramural Research Program of the Vaccine Research Center, the National Institute of Allergy and Infectious Diseases, and the National Institutes of Health. J.M. received grant support from NIH-5K08AI079381 and a Boston Children's Hospital Faculty Development award. M.S.A.G. was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award T32GM008704. TA. received grant support from the 973 program (2015CB14010102), the National Natural Science Foundation of China (81550001 and 31470721), and the Junior Thousand Talents Program of China (20131770418). This work was funded in part with federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. We thank the Tsinghua University Branch of China. National Center for Protein Sciences (Beijing) for providing the EM facility support. Argonne is operated by UChicago Argonne, LLC, for the US. Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. N.S., S.M., B.G., J.L., J.J.M.T., D.C., and A.L. are listed as inventors on patent applications related to antibodies to Ebola virus and their use. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Brecher M., 2012, J VIROL, V86, P364; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Gilman MSA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005035; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JE, 2008, J MOL BIOL, V375, P202, DOI 10.1016/j.jmb.2007.10.017; Lee JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9167; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Maruyama T, 1999, J INFECT DIS, V179, pS235, DOI 10.1086/514280; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Misasi J, 2014, CELL, V159, P477, DOI 10.1016/j.cell.2014.10.006; Misasi J, 2012, J VIROL, V86, P3284, DOI 10.1128/JVI.06346-11; Mpanju OM, 2006, VIRUS RES, V121, P205, DOI 10.1016/j.virusres.2006.06.002; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Muyembe-Tamfum JJ, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.451; Olal D, 2012, J VIROL, V86, P2809, DOI 10.1128/JVI.05549-11; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Shedlock DJ, 2010, VIROLOGY, V401, P228, DOI 10.1016/j.virol.2010.02.029; Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664	35	130	134	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1343	1346		10.1126/science.aad6117	http://dx.doi.org/10.1126/science.aad6117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26917592	Green Accepted, Green Submitted			2022-12-28	WOS:000372397700048
J	Bandurin, DA; Torre, I; Kumar, RK; Ben Shalom, M; Tomadin, A; Principi, A; Auton, GH; Khestanova, E; Novoselov, KS; Grigorieva, IV; Ponomarenko, LA; Geim, AK; Polini, M				Bandurin, D. A.; Torre, I.; Kumar, R. Krishna; Ben Shalom, M.; Tomadin, A.; Principi, A.; Auton, G. H.; Khestanova, E.; Novoselov, K. S.; Grigorieva, I. V.; Ponomarenko, L. A.; Geim, A. K.; Polini, M.			Negative local resistance caused by viscous electron backflow in graphene	SCIENCE			English	Article							TEMPERATURE	Graphene hosts a unique electron system in which electron-phonon scattering is extremely weak but electron-electron collisions are sufficiently frequent to provide local equilibrium above the temperature of liquid nitrogen. Under these conditions, electrons can behave as a viscous liquid and exhibit hydrodynamic phenomena similar to classical liquids. Here we report strong evidence for this transport regime. We found that doped graphene exhibits an anomalous (negative) voltage drop near current-injection contacts, which is attributed to the formation of submicrometer-size whirlpools in the electron flow. The viscosity of graphene's electron liquid is found to be similar to 0.1 squaremeters per second, an order of magnitude higher than that of honey, in agreement with many-body theory. Our work demonstrates the possibility of studying electron hydrodynamics using high-quality graphene.	[Bandurin, D. A.; Kumar, R. Krishna; Ben Shalom, M.; Khestanova, E.; Grigorieva, I. V.; Ponomarenko, L. A.; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Oxford Rd, Manchester M13 9PL, Lancs, England; [Torre, I.] Scuola Normale Super Pisa, Natl Enterprise NanoSci & NanoTechnol, Piazza Cavalieri 7, I-56126 Pisa, Italy; [Kumar, R. Krishna; Ponomarenko, L. A.] Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England; [Ben Shalom, M.; Auton, G. H.; Khestanova, E.; Novoselov, K. S.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England; [Tomadin, A.] CNR, Ist Nanosci, Natl Enterprise NanoSci & NanoTechnol, I-56126 Pisa, Italy; [Tomadin, A.] Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy; [Principi, A.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Polini, M.] Ist Italiano Tecnol, Graphene Labs, Via Morego 30, I-16163 Genoa, Italy	University of Manchester; Scuola Normale Superiore di Pisa; Lancaster University; University of Manchester; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa; Radboud University Nijmegen; Istituto Italiano di Tecnologia - IIT	Geim, AK (corresponding author), Univ Manchester, Sch Phys & Astron, Oxford Rd, Manchester M13 9PL, Lancs, England.; Polini, M (corresponding author), Ist Italiano Tecnol, Graphene Labs, Via Morego 30, I-16163 Genoa, Italy.	geim@man.ac.uk; marco.polini@iit.it	Polini, Marco/L-3419-2013; Khestanova, Ekaterina/G-2115-2018; Torre, Iacopo/AAK-3233-2021; Ponomarenko, Leonid/AAF-1731-2021; Ben Shalom, Moshe/ABC-3999-2021; Geim, Andre K/J-7888-2012; Novoselov, Kostya S/G-9581-2014; Tomadin, Andrea/C-1617-2015; Bandurin, Denis/T-3401-2019	Khestanova, Ekaterina/0000-0002-0270-8550; Torre, Iacopo/0000-0001-6515-181X; Geim, Andre K/0000-0003-2861-8331; Novoselov, Kostya S/0000-0003-4972-5371; Tomadin, Andrea/0000-0001-9117-9891; Ben Shalom, Moshe/0000-0001-5781-0037; Bandurin, Denis/0000-0001-9257-4105; hai yan, he/0000-0003-0366-6185	European Research Council; Royal Society; Lloyd's Register Foundation; Graphene Flagship; Italian Ministry of Education, University and Research; Marie Curie program SPINOGRAPH (Spintronics in Graphene); Nederlandse Wetenschappelijk Organisatie; Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [1353100, 1082880, EP/K005014/1, EP/G02491X/1, EP/M003167/1] Funding Source: researchfish; EPSRC [EP/G02491X/1, EP/K005014/1, EP/M003167/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Lloyd's Register Foundation; Graphene Flagship; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Marie Curie program SPINOGRAPH (Spintronics in Graphene); Nederlandse Wetenschappelijk Organisatie(Netherlands Organization for Scientific Research (NWO)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Research Council, the Royal Society, Lloyd's Register Foundation, the Graphene Flagship, and the Italian Ministry of Education, University and Research through the program Progetti Premiali 2012 (project ABNANOTECH). D.A.B. and I.V.G. acknowledge support from the Marie Curie program SPINOGRAPH (Spintronics in Graphene). A.P. received support from the Nederlandse Wetenschappelijk Organisatie. R.K.K. received support from the Engineering and Physical Sciences Research Council.	Abanin DA, 2011, SCIENCE, V332, P328, DOI 10.1126/science.1199595; Andreev AV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.256804; Batchelor G.K., 2000, INTRO FLUID DYNAMICS; Bistritzer R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.085109; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; DEJONG MJM, 1995, PHYS REV B, V51, P13389, DOI 10.1103/PhysRevB.51.13389; Elliott E, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.020406; Giuliani G.F., 2005, QUANTUM THEORY ELECT; Gorbachev RV, 2012, NAT PHYS, V8, P896, DOI [10.1038/NPHYS2441, 10.1038/nphys2441]; Govorov AO, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.026803; GURZHI RN, 1968, SOV PHYS USPEKHI, V11, P255, DOI 10.1070/PU1968v011n02ABEH003815; Jacak BV, 2012, SCIENCE, V337, P310, DOI 10.1126/science.1215901; Landau L.D., 1987, PHYS TODAY, V6; Li QZ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085406; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Muller M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.025301; Narozhny BN, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.035414; Schafer T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126001; Song JCW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.236602; Tomadin A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.235901; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358	22	387	392	6	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1055	1058		10.1126/science.aad0201	http://dx.doi.org/10.1126/science.aad0201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26912363	Green Submitted			2022-12-28	WOS:000371597500036
J	Park, KC; Kim, P; Grinthal, A; He, N; Fox, D; Weaver, JC; Aizenberg, J				Park, Kyoo-Chul; Kim, Philseok; Grinthal, Alison; He, Neil; Fox, David; Weaver, James C.; Aizenberg, Joanna			Condensation on slippery asymmetric bumps	NATURE			English	Article							SUPERHYDROPHOBIC SURFACES; NANOSTRUCTURED SURFACES; WATER COLLECTION; DESERT BEETLE; ENHANCED CONDENSATION; DROPWISE CONDENSATION; CAPTURE; GROWTH; ENERGY	Controlling dropwise condensation is fundamental to water-harvesting systems(1-3), desalination(4), thermal power generation(4-8), air conditioning(9), distillation towers(10), and numerous other applications(4,5,11). For any of these, it is essential to design surfaces that enable droplets to grow rapidly and to be shed as quickly as possible(4-7). However, approaches(4-8,10-21) based on microscale, nanoscale or molecular-scale textures suffer from intrinsic tradeoffs that make it difficult to optimize both growth and transport at once. Here we present a conceptually different design approachbased on principles derived from Namib desert beetles(3,22-24), cacti(25), and pitcher plants(17,26)-that synergistically combines these aspects of condensation and substantially outperforms other synthetic surfaces. Inspired by an unconventional interpretation of the role of the beetle's bumpy surface geometry in promoting condensation, and using theoretical modelling, we show how to maximize vapour diffusion flux(20,27,28) at the apex of convex millimetric bumps by optimizing the radius of curvature and cross-sectional shape. Integrating this apex geometry with a widening slope, analogous to cactus spines, directly couples facilitated droplet growth with fast directional transport, by creating a free-energy profile that drives the droplet down the slope before its growth rate can decrease. This coupling is further enhanced by a slippery, pitcher-plant-inspired nanocoating that facilitates feedback between coalescence-driven growth and capillary-driven motion on the way down. Bumps that are rationally designed to integrate these mechanisms are able to grow and transport large droplets even against gravity and overcome the effect of an unfavourable temperature gradient. We further observe an unprecedented sixfold-higher exponent of growth rate, faster onset, higher steady-state turnover rate, and a greater volume of water collected compared to other surfaces. We envision that this fundamental understanding and rational design strategy can be applied to a wide range of water-harvesting and phase-change heat-transfer applications.	[Park, Kyoo-Chul; Grinthal, Alison; He, Neil; Fox, David; Aizenberg, Joanna] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Park, Kyoo-Chul; Kim, Philseok; Weaver, James C.; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Aizenberg, Joanna] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Park, KC; Aizenberg, J (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Park, KC; Aizenberg, J (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.; Aizenberg, J (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kpark@seas.harvard.edu; jaiz@seas.harvard.edu	Park, Kyoo-Chul/L-9955-2017; Weaver, James C./AAE-7870-2019		Department of Energy/ARPA-E award [DE-AR0000326]; National Science Foundation [DMR-1420570]	Department of Energy/ARPA-E award; National Science Foundation(National Science Foundation (NSF))	We thank M. Khan, J. Alvarenga, D. Daniel, S. H. Kang, M. Hoang, and J. Timonen for discussions and technical assistance. This research was supported by the Department of Energy/ARPA-E award number DE-AR0000326. N.H. thanks the Research Experiences for Undergraduates programme supported by the National Science Foundation award number DMR-1420570.	Anand S, 2012, ACS NANO, V6, P10122, DOI 10.1021/nn303867y; Beysens D, 2006, CR PHYS, V7, P1082, DOI 10.1016/j.crhy.2006.10.020; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Carlson A, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/34008; Clus O, 2008, J HYDROL, V361, P159, DOI 10.1016/j.jhydrol.2008.07.038; Courbin L, 2007, NAT MATER, V6, P661, DOI 10.1038/nmat1978; Daniel S, 2001, SCIENCE, V291, P633, DOI 10.1126/science.291.5504.633; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Guadarrama-Cetina J, 2014, EUR PHYS J E, V37, DOI 10.1140/epje/i2014-14109-y; Ju J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2253; Kim P, 2012, ACS NANO, V6, P6569, DOI 10.1021/nn302310q; Krupenkin TN, 2004, LANGMUIR, V20, P3824, DOI 10.1021/la036093q; Malik FT, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/031002; Medici MG, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062403; Miljkovic N, 2013, NANO LETT, V13, P179, DOI 10.1021/nl303835d; Mishchenko L, 2013, ADV FUNCT MATER, V23, P4577, DOI 10.1002/adfm.201300418; Norgaard T, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-23; Nosonovsky M, 2009, CURR OPIN COLLOID IN, V14, P270, DOI 10.1016/j.cocis.2009.05.004; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Perez-Lombard L, 2008, ENERG BUILDINGS, V40, P394, DOI 10.1016/j.enbuild.2007.03.007; Qian M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3146810; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Rose JW, 2002, P I MECH ENG A-J POW, V216, P115, DOI 10.1243/09576500260049034; Rykaczewski K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04158; Varanasi KK, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3200951; VIOVY JL, 1988, PHYS REV A, V37, P4965, DOI 10.1103/PhysRevA.37.4965; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Xiao R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01988; Zhai L, 2006, NANO LETT, V6, P1213, DOI 10.1021/nl060644q; Zheng YM, 2010, NATURE, V463, P640, DOI 10.1038/nature08729	30	489	502	65	998	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					78	82		10.1038/nature16956	http://dx.doi.org/10.1038/nature16956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26909575	Green Submitted			2022-12-28	WOS:000371211900043
J	Hennigan, T				Hennigan, Tom			ZIKA VIRUS Brazil struggles to cope with Zika epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												hennigantom@gmail.com						Monteiro MFG, 2015, REPROD CLIM, V30, P11	1	2	2	1	64	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2016	352								i1226	10.1136/bmj.i1226	http://dx.doi.org/10.1136/bmj.i1226			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LJ	26931360	Green Published, Bronze			2022-12-28	WOS:000371756000008
J	Luzuriaga, K; Mofenson, LM				Luzuriaga, Katherine; Mofenson, Lynne M.			Challenges in the Elimination of Pediatric HIV-1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; EARLY ANTIRETROVIRAL THERAPY; HIV-1-INFECTED CHILDREN; VIROLOGICAL CONTROL; TRANSMISSION; DYNAMICS; INFANTS; WOMEN; RESERVOIR; PREVENTION		[Luzuriaga, Katherine] Univ Massachusetts, Sch Med, Program Mol Med, Biotech 2,Suite 318,373 Plantat St, Worcester, MA 01605 USA; [Mofenson, Lynne M.] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA	University of Massachusetts System; University of Massachusetts Worcester	Luzuriaga, K (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Biotech 2,Suite 318,373 Plantat St, Worcester, MA 01605 USA.	katherine.luzuriaga@umassmed.edu	Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808				Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Ananworanich J, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19859; Ananworanich J, 2014, AIDS, V28, P1015, DOI 10.1097/QAD.0000000000000178; [Anonymous], 2014, 2014 PROGR REP GLOB; [Anonymous], 2014, GLOB UPT HLTH SECT R; Barker PM, 2011, JAIDS-J ACQ IMM DEF, V56, pE45, DOI 10.1097/QAI.0b013e3181fdbf20; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P665; Chadwick EG, 2011, AIDS, V25, P643, DOI 10.1097/QAD.0b013e32834403f6; Ciaranello AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001156; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Department of Health and Human Services, 2015, REC US ANT DRUGS PRE; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Fowler MG, 2015, 22 C RETR OPP INF SE; Goujard C, 2012, ANTIVIR THER, V17, P1001, DOI 10.3851/IMP2273; Hainaut M, 2005, CLIN INFECT DIS, V41, P1820, DOI 10.1086/498313; Huang SH, 2008, J IMMUNOL, V181, P8103, DOI 10.4049/jimmunol.181.11.8103; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Luzuriaga K, 1999, J VIROL, V73, P362, DOI 10.1128/JVI.73.1.362-367.1999; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; Luzuriaga K, 2014, 21 C RETR OPP INF BO; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Luzuriaga K, 2014, J INFECT DIS, V210, P1529, DOI 10.1093/infdis/jiu297; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Mandelbrot L, 2015, CLIN INFECT DIS, V61, P1715, DOI 10.1093/cid/civ578; Martinez-Bonet M, 2015, CLIN INFECT DIS, V61, P1169, DOI 10.1093/cid/civ456; Mofenson LM, 2015, J INFECT DIS; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Palumbo P, 2007, J INFECT DIS, V196, P23, DOI 10.1086/518508; Penazzato M, 2014, AIDS, V28, pS445, DOI 10.1097/QAD.0000000000000481; Persaud D, 2014, JAMA PEDIATR, V168, P1138, DOI 10.1001/jamapediatrics.2014.1560; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Persaud D, 2012, AIDS, V26, P1483, DOI 10.1097/QAD.0b013e3283553638; Pikora CA, 1997, J EXP MED, V185, P1153, DOI 10.1084/jem.185.7.1153; Psaros C, 2015, CURR HIV-AIDS REP, V12, P1, DOI 10.1007/s11904-014-0252-6; Richardson BA, 2003, J VIROL, V77, P7120, DOI 10.1128/JVI.77.12.7120-7123.2003; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212; Tsague L, 2014, AIDS, V28, pS119, DOI 10.1097/QAD.0000000000000234; Uprety P, 2015, CLIN INFECT DIS, V61, P1862, DOI 10.1093/cid/civ688; van Zyl GU, 2015, J INFECT DIS, V212, P39, DOI 10.1093/infdis/jiu827; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; White AB, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011323; World Health Organisation, 2015, WHO VAL EL MOTH TO C; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2010, WHO REC DIAGN HIV IN; Zanchetta M, 2008, ANTIVIR THER, V13, P47	59	85	89	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					761	770		10.1056/NEJMra1505256	http://dx.doi.org/10.1056/NEJMra1505256			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6BB	26933850				2022-12-28	WOS:000370716600009
J	Schaletzky, J; Rape, M				Schaletzky, Julia; Rape, Michael			Getting a Grip on Microtubules	CELL			English	Editorial Material								Posttranslational modifications control microtubule behavior, yet assigning roles to particular signals was hampered by lack of defined in vitro systems. In this issue of Cell, Valenstein and Roll-Mecak establish a biochemical platform to interrogate consequences of microtubule polyglutamylation, thereby providing important insights into the specificity and quantitative nature of cellular information transfer.	[Schaletzky, Julia] Cytokinetics, 280 East Grand Ave, San Francisco, CA 94080 USA; [Rape, Michael] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rape, M (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Rape, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	mrape@berkeley.edu		Rape, Michael/0000-0003-4849-6343	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Johnson V, 2011, BIOCHEMISTRY-US, V50, P8636, DOI 10.1021/bi2005174; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Valenstein ML, 2016, CELL, V164, P911, DOI 10.1016/j.cell.2016.01.019	10	6	6	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					836	837		10.1016/j.cell.2016.02.016	http://dx.doi.org/10.1016/j.cell.2016.02.016			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919420	Bronze			2022-12-28	WOS:000370867300005
J	Singer, M; Deutschman, CS; Seymour, CW; Shankar-Hari, M; Annane, D; Bauer, M; Bellomo, R; Bernard, GR; Chiche, JD; Coopersmith, CM; Hotchkiss, RS; Levy, MM; Marshall, JC; Martin, GS; Opal, SM; Rubenfeld, GD; van der Poll, T; Vincent, JL; Angus, DC				Singer, Mervyn; Deutschman, Clifford S.; Seymour, Christopher Warren; Shankar-Hari, Manu; Annane, Djillali; Bauer, Michael; Bellomo, Rinaldo; Bernard, Gordon R.; Chiche, Jean-Daniel; Coopersmith, Craig M.; Hotchkiss, Richard S.; Levy, Mitchell M.; Marshall, John C.; Martin, Greg S.; Opal, Steven M.; Rubenfeld, Gordon D.; van der Poll, Tom; Vincent, Jean-Louis; Angus, Derek C.			The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLAMMATORY RESPONSE SYNDROME; INTENSIVE-CARE; ORGAN FAILURE; DYSFUNCTIONS; SOCIETY; BURDEN; SCORE; TIME	IMPORTANCE Definitions of sepsis and septic shock were last revised in 2001. Considerable advances have since been made into the pathobiology (changes in organ function, morphology, cell biology, biochemistry, immunology, and circulation), management, and epidemiology of sepsis, suggesting the need for reexamination. OBJECTIVE To evaluate and, as needed, update definitions for sepsis and septic shock. PROCESS A task force (n = 19) with expertise in sepsis pathobiology, clinical trials, and epidemiology was convened by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine. Definitions and clinical criteria were generated through meetings, Delphi processes, analysis of electronic health record databases, and voting, followed by circulation to international professional societies, requesting peer review and endorsement (by 31 societies listed in the Acknowledgment). KEY FINDINGS FROMEVIDENCE SYNTHESIS Limitations of previous definitions included an excessive focus on inflammation, the misleading model that sepsis follows a continuum through severe sepsis to shock, and inadequate specificity and sensitivity of the systemic inflammatory response syndrome (SIRS) criteria. Multiple definitions and terminologies are currently in use for sepsis, septic shock, and organ dysfunction, leading to discrepancies in reported incidence and observed mortality. The task force concluded the term severe sepsis was redundant. RECOMMENDATIONS Sepsis should be defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. For clinical operationalization, organ dysfunction can be represented by an increase in the Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score of 2 points or more, which is associated with an in-hospital mortality greater than 10%. Septic shock should be defined as a subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone. Patients with septic shock can be clinically identified by a vasopressor requirement to maintain a mean arterial pressure of 65mmHg or greater and serum lactate level greater than 2 mmol/L (> 18mg/dL) in the absence of hypovolemia. This combination is associated with hospital mortality rates greater than 40%. In out-of-hospital, emergency department, or general hospital ward settings, adult patients with suspected infection can be rapidly identified as being more likely to have poor outcomes typical of sepsis if they have at least 2 of the following clinical criteria that together constitute a new bedside clinical score termed quickSOFA (qSOFA): respiratory rate of 22/min or greater, altered mentation, or systolic blood pressure of 100mmHg or less. CONCLUSIONS AND RELEVANCE These updated definitions and clinical criteria should replace previous definitions, offer greater consistency for epidemiologic studies and clinical trials, and facilitate earlier recognition and more timely management of patients with sepsis or at risk of developing sepsis.	[Singer, Mervyn] UCL, Bloomsbury Inst Intens Care Med, London, England; [Deutschman, Clifford S.] Feinstein Inst Med Res, Hofstra Northwell Sch Med, 269-01,6th Ave, New Hyde Pk, NY 11040 USA; [Seymour, Christopher Warren] Univ Pittsburgh, Sch Med, Dept Crit Care & Emergency Med, Pittsburgh, PA USA; [Shankar-Hari, Manu] Guys & St Thomas NHS Fdn Trust, Dept Crit Care Med, London, England; [Annane, Djillali] Univ Versailles, Dept Crit Care Med, Versailles, France; [Bauer, Michael] Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Bellomo, Rinaldo] Austin Hosp, Melbourne, Vic 3084, Australia; [Bernard, Gordon R.] Vanderbilt Univ, Vanderbilt Inst Clin & Translat Res, 221 Kirkland Hall, Nashville, TN 37235 USA; [Chiche, Jean-Daniel] Descartes Univ, Reanimat Med Hop Cochin, Cochin Inst, Paris, France; [Coopersmith, Craig M.] Emory Univ, Sch Med, Crit Care Ctr, Atlanta, GA USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, St Louis, MO USA; [Levy, Mitchell M.; Opal, Steven M.] Brown Univ, Sch Med, Infect Dis Sect, Div Pulm & Crit Care Med, Providence, RI 02912 USA; [Marshall, John C.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Martin, Greg S.] Emory Univ, Sch Med, Atlanta, GA USA; [Martin, Greg S.] Grady Mem Hosp, Atlanta, GA USA; [Rubenfeld, Gordon D.] Sunnybrook Hlth Sci Ctr, Trauma Emergency & Crit Care Program, Toronto, ON M4N 3M5, Canada; [Rubenfeld, Gordon D.] Univ Toronto, Interdepartmental Div Crit Care, Amsterdam, Netherlands; [van der Poll, Tom] Acad Medisch Centrum, Dept Infect Dis, Amsterdam, Netherlands; [Vincent, Jean-Louis] Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium; [Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Angus, Derek C.] UPMC Hlth Syst, Pittsburgh, PA USA; [Deutschman, Clifford S.] Feinstein Inst Med Res, Dept Pediat, 269-01,6th Ave, New Hyde Pk, NY 11040 USA; [Deutschman, Clifford S.] Feinstein Inst Med Res, Dept Mol Med, Hofstra Northwell Sch Med, 269-01,6th Ave, New Hyde Pk, NY 11040 USA	University of London; University College London; Northwell Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Guy's & St Thomas' NHS Foundation Trust; UDICE-French Research Universities; Universite Paris Saclay; Friedrich Schiller University of Jena; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Emory University; Washington University (WUSTL); Brown University; University of Toronto; Emory University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Amsterdam; Academic Medical Center Amsterdam; Universite Libre de Bruxelles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwell Health; Northwell Health	Deutschman, CS (corresponding author), Feinstein Inst Med Res, Dept Pediat, 269-01,6th Ave, New Hyde Pk, NY 11040 USA.; Deutschman, CS (corresponding author), Feinstein Inst Med Res, Dept Mol Med, Hofstra Northwell Sch Med, 269-01,6th Ave, New Hyde Pk, NY 11040 USA.	cdeutschman@nshs.edu	Singer, Mervyn/Q-6142-2019; Deutschman, Clifford/AAN-2742-2021; Chiche, Jean-Daniel/P-5220-2017; Shankar-Hari, Manu/I-6948-2012; Annane, Djillali/R-7947-2019; Martin, Greg/B-4085-2009; Angus, Derek C/E-9671-2012	Singer, Mervyn/0000-0002-1042-6350; Chiche, Jean-Daniel/0000-0002-6433-6254; Shankar-Hari, Manu/0000-0002-5338-2538; Martin, Greg/0000-0002-9684-7593; Vincent, Jean-Louis/0000-0001-6011-6951; Bauer, Michael/0000-0002-1521-3514	Society of Critical Care Medicine (SCCM); European Society of Intensive Care Medicine (ESICM); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044118, K23GM104022] Funding Source: NIH RePORTER	Society of Critical Care Medicine (SCCM); European Society of Intensive Care Medicine (ESICM); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM).	Ait-Oufella H, 2014, INTENS CARE MED, V40, P958, DOI 10.1007/s00134-014-3326-4; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; Chan JK, 2012, J CLIN INVEST, V122, P2711, DOI 10.1172/JCI62423; Churpek MM, 2015, AM J RESP CRIT CARE, V192, P958, DOI 10.1164/rccm.201502-0275OC; Czura CJ, 2011, MOL MED, V17, P2, DOI 10.2119/molmed.2010.00001.commentary; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Kwan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060501; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Rhee C, 2014, NEW ENGL J MED, V370, P1673, DOI 10.1056/NEJMp1400276; Rubulotta FM, 2009, CRIT CARE MED, V37, P167, DOI 10.1097/CCM.0b013e3181926883; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shah RU, 2015, JACC-CARDIOVASC INTE, V8, P139, DOI 10.1016/j.jcin.2014.07.017; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Wong HR, 2015, AM J RESP CRIT CARE, V191, P309, DOI 10.1164/rccm.201410-1864OC; [No title captured]	35	10805	12055	106	826	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					801	810		10.1001/jama.2016.0287	http://dx.doi.org/10.1001/jama.2016.0287			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903338	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-28	WOS:000370700500015
J	Fang, XJ; Yu, P; Morandi, B				Fang, Xianjie; Yu, Peng; Morandi, Bill			ORGANIC CHEMISTRY Catalytic reversible alkene-nitrile interconversion through controllable transfer hydrocyanation	SCIENCE			English	Article							C-H; BOND ACTIVATION; OLEFINS; DEHYDROGENATION; CARBOCYANATION; LIGANDS; ALKYNES	Nitriles and alkenes are important synthetic intermediates with complementary reactivity that play a central role in the preparation of materials, pharmaceuticals, cosmetics, and agrochemicals. Here, we report a nickel-catalyzed transfer hydrocyanation reaction between a wide range (60 examples) of alkyl nitriles and alkenes. This strategy not only overcomes the toxicity challenge posed by the use of HCN in traditional approaches, but also encompasses distinct chemical advances, including retro-hydrocyanation and anti-Markovnikov regioselectivity. In a broader context, this work highlights an approach to the reversible hydrofunctionalization of alkenes through thermodynamically controlled transfer reactions to circumvent the use of volatile and hazardous reagents in the laboratory.	[Fang, Xianjie; Yu, Peng; Morandi, Bill] Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Nordrhein Westf, Germany	Max Planck Society	Morandi, B (corresponding author), Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Nordrhein Westf, Germany.	morandi@kofo.mpg.de		Yu, Peng/0000-0002-2198-5350; Morandi, Bill/0000-0003-3968-1424	Max-Planck-Society; Max-Planck-Institut fur Kohlenforschung; China Scholarship Council	Max-Planck-Society(Max Planck Society); Max-Planck-Institut fur Kohlenforschung; China Scholarship Council(China Scholarship Council)	We thank Z. K. Wickens (Harvard University) and R. H. Grubbs (California Institute of Technology) for critical proofreading of this manuscript. Generous funding from the Max-Planck-Society and the Max-Planck-Institut fur Kohlenforschung is acknowledged. We thank B. List for sharing analytical equipment, and our nuclear magnetic resonance, gas chromatography, and mass spectrometry departments for technical assistance. P.Y. thanks the China Scholarship Council for a scholarship. A provisional patent application has been filed on this reaction.	[Anonymous], MED MAN CHEM CAS HDB; BACKVALL JE, 1986, ORGANOMETALLICS, V5, P2350, DOI 10.1021/om00142a030; BAKER MJ, 1991, J CHEM SOC CHEM COMM, P1292, DOI 10.1039/c39910001292; Beller M, 2004, ANGEW CHEM INT EDIT, V43, P3368, DOI 10.1002/anie.200300616; Bini L, 2010, CHEMCATCHEM, V2, P590, DOI 10.1002/cctc.201000034; Bolm C., 2008, TRANSITION METALS OR; Brunkan NM, 2004, J AM CHEM SOC, V126, P3627, DOI 10.1021/ja037002e; BUCHWALD SL, 1987, TETRAHEDRON LETT, V28, P295, DOI 10.1016/S0040-4039(00)95711-3; CASALNUOVO AL, 1994, J AM CHEM SOC, V116, P9869, DOI 10.1021/ja00101a007; de Greef M, 2009, ANGEW CHEM INT EDIT, V48, P551, DOI 10.1002/anie.200805092; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; Drinkard Jr W. C., 1970, [No title captured], Patent No. [US 3496218A, 3496218]; Falk A, 2013, ANGEW CHEM INT EDIT, V52, P1576, DOI 10.1002/anie.201208082; Gaspar B, 2007, ANGEW CHEM INT EDIT, V46, P4519, DOI 10.1002/anie.200700575; Goertz W, 1998, J CHEM SOC DALTON, P2981, DOI 10.1039/a802269k; Goldman AS, 2006, SCIENCE, V312, P257, DOI 10.1126/science.1123787; Groutas W. C., 2001, E EROS ENCY REAGENTS; Grubbs R. H., 2003, HDB METATHESIS; Haroutounian S. A., 2001, E EROS ENCY REAGENTS; Hartwig J. F., 2009, ORGANOTRANSITION MET, P668; Khoury PR, 2004, TETRAHEDRON, V60, P8103, DOI 10.1016/j.tet.2004.06.100; Kusumoto S, 2015, ANGEW CHEM INT EDIT, V54, P8458, DOI 10.1002/anie.201503620; Landis CR, 2015, SCIENCE, V347, P29, DOI 10.1126/science.aaa2329; Lide D.R., 2005, CRC HDB CHEM PHYS IN; Liu YY, 2015, ANGEW CHEM INT EDIT, V54, P11800, DOI 10.1002/anie.201505161; Lo JC, 2014, J AM CHEM SOC, V136, P1304, DOI 10.1021/ja4117632; Murphy SK, 2015, SCIENCE, V347, P56, DOI 10.1126/science.1261232; Nakao Y, 2007, J AM CHEM SOC, V129, P2428, DOI 10.1021/ja067364x; Park YJ, 2008, ACCOUNTS CHEM RES, V41, P222, DOI 10.1021/ar700133y; Patai S, 1970, PATAIS CHEM FUNCTION; Pollak P., 1985, ULLMANS ENCY IND CHE, VA17, P363; Rajanbabu T. V., 2011, ORG REACT, V75, P1; Romeder G., 2001, E EROS ENCY REAGENTS; Smith M. B, 2007, MARCHS ADV ORGANIC C; TOLMAN CA, 1984, ORGANOMETALLICS, V3, P33, DOI 10.1021/om00079a008; TOLMAN CA, 1985, ADV CATAL, V33, P1, DOI 10.1016/S0360-0564(08)60257-6; van Leeuwen P. W. N. M., 2004, HOMOGENOUS CATALYSIS; Yada A, 2010, B CHEM SOC JPN, V83, P619, DOI 10.1246/bcsj.20100023; Zbieg JR, 2012, SCIENCE, V336, P324, DOI 10.1126/science.1219274	39	177	179	8	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					832	836		10.1126/science.aae0427	http://dx.doi.org/10.1126/science.aae0427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912891				2022-12-28	WOS:000370325700038
J	Opik, M; Davison, J; Moora, M; Partel, M; Zobel, M				Oepik, Maarja; Davison, John; Moora, Mari; Paertel, Meelis; Zobel, Martin			FUNGAL SYMBIONTS Response to Comment on "Global assessment of arbuscular mycorrhizal fungus diversity reveals very low endemism"	SCIENCE			English	Editorial Material							GENE	Bruns and Taylor argue that our finding of widespread distribution among Glomeromycota "virtual taxa" is undermined by the species definition applied. Although identifying appropriate species concepts and accessing taxonomically informative traits are challenges for microorganism biogeography, the virtual taxa represent a pragmatic classification that corresponds approximately to the species rank of classical Glomeromycota taxonomy, yet is applicable to environmental DNA.	[Oepik, Maarja; Davison, John; Moora, Mari; Paertel, Meelis; Zobel, Martin] Univ Tartu, Dept Bot, 40 Lai St, EE-51005 Tartu, Estonia	University of Tartu	Opik, M (corresponding author), Univ Tartu, Dept Bot, 40 Lai St, EE-51005 Tartu, Estonia.	maarja.opik@ut.ee	Moora, Mari/D-1961-2009; Pärtel, Meelis/D-5493-2012; Zobel, Martin/H-1336-2015; Öpik, Maarja/A-1765-2008	Moora, Mari/0000-0002-4819-7506; Pärtel, Meelis/0000-0002-5874-0138; Zobel, Martin/0000-0001-7957-6704; Öpik, Maarja/0000-0001-8025-7460				Bills RJ, 2015, MYCORRHIZA, V25, P485, DOI 10.1007/s00572-015-0626-7; Borriello R, 2014, MOL PHYLOGENET EVOL, V75, P1, DOI 10.1016/j.ympev.2014.02.012; Bruns TD, 2016, SCIENCE, V351, DOI 10.1126/science.aad4228; Davison J, 2015, SCIENCE, V349, P970, DOI 10.1126/science.aab1161; den Bakker HC, 2010, MOL BIOL EVOL, V27, P2474, DOI 10.1093/molbev/msq155; Herr JR, 2015, NEW PHYTOL, V205, P27, DOI 10.1111/nph.13180; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Opik M, 2014, BOTANY, V92, P135, DOI 10.1139/cjb-2013-0110; Rosendahl S, 2009, MOL ECOL, V18, P4316, DOI 10.1111/j.1365-294X.2009.04359.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Stajich JE, 2009, CURR BIOL, V19, pR840, DOI 10.1016/j.cub.2009.07.004; Stockinger H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107783; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228	14	16	16	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275								10.1126/science.aad5495	http://dx.doi.org/10.1126/science.aad5495			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912890				2022-12-28	WOS:000370325700035
J	Galvin, R				Galvin, Robert			How Employers Are Responding to the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Galvin, Robert] Blackstone Grp, New York, NY USA; [Galvin, Robert] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA	Yale University	Galvin, R (corresponding author), Blackstone Grp, New York, NY USA.; Galvin, R (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.							[Anonymous], 2015, TRUVEN HLTH ANAL; [Anonymous], 2014, EX PRIV EXCH EMPL SP; Brot-Goldberg ZC, 2015, 21632 NBER; Levitt L, 2015, MANY EMPLOYERS COULD; Whaley C, 2014, JAMA-J AM MED ASSOC, V312, P1670, DOI 10.1001/jama.2014.13373	5	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					604	606		10.1056/NEJMp1514649	http://dx.doi.org/10.1056/NEJMp1514649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD9ER	26886518				2022-12-28	WOS:000370229000004
J	Brasil, P; Pereira, JP; Moreira, ME; Nogueira, RMR; Damasceno, L; Wakimoto, M; Rabello, RS; Valderramos, SG; Halai, UA; Salles, TS; Zin, AA; Horovitz, D; Daltro, P; Boechat, M; Gabaglia, CR; de Sequeira, PC; Pilotto, JH; Medialdea-Carrera, R; da Cunha, DC; de Carvalho, LMA; Pone, M; Siqueira, AM; Calvet, GA; Baiao, AER; Neves, ES; de Carvalho, PRN; Hasue, RH; Marschik, PB; Einspieler, C; Janzen, C; Cherry, JD; de Filippis, AMB; Nielsen-Saines, K				Brasil, P.; Pereira, J. P., Jr.; Moreira, M. E.; Ribeiro Nogueira, R. M.; Damasceno, L.; Wakimoto, M.; Rabello, R. S.; Valderramos, S. G.; Halai, U. -A.; Salles, T. S.; Zin, A. A.; Horovitz, D.; Daltro, P.; Boechat, M.; Gabaglia, C. Raja; Carvalho de Sequeira, P.; Pilotto, J. H.; Medialdea-Carrera, R.; Cotrim da Cunha, D.; Abreu de Carvalho, L. M.; Pone, M.; Machado Siqueira, A.; Calvet, G. A.; Rodrigues Baiao, A. E.; Neves, E. S.; Nassar de Carvalho, P. R.; Hasue, R. H.; Marschik, P. B.; Einspieler, C.; Janzen, C.; Cherry, J. D.; Bispo de Filippis, A. M.; Nielsen-Saines, K.			Zika Virus Infection in Pregnant Women in Rio de Janeiro	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSION; BRAZIL	BACKGROUND Zika virus (ZIKV) has been linked to central nervous system malformations in fetuses. To characterize the spectrum of ZIKV disease in pregnant women and infants, we followed patients in Rio de Janeiro to describe clinical manifestations in mothers and repercussions of acute ZIKV infection in infants. METHODS We enrolled pregnant women in whom a rash had developed within the previous 5 days and tested blood and urine specimens for ZIKV by reverse-transcriptase-polymerase-chain-reaction assays. We followed women prospectively to obtain data on pregnancy and infant outcomes. RESULTS A total of 345 women were enrolled from September 2015 through May 2016; of these, 182 women (53%) tested positive for ZIKV in blood, urine, or both. The timing of acute ZIKV infection ranged from 6 to 39 weeks of gestation. Predominant maternal clinical features included a pruritic descending macular or maculopapular rash, arthralgias, conjunctival injection, and headache; 27% had fever (short-term and low-grade). By July 2016, a total of 134 ZIKV-affected pregnancies and 73 ZIKV-unaffected pregnancies had reached completion, with outcomes known for 125 ZIKV-affected and 61 ZIKV-unaffected pregnancies. Infection with chikungunya virus was identified in 42% of women without ZIKV infection versus 3% of women with ZIKV infection (P<0.001). Rates of fetal death were 7% in both groups; overall adverse outcomes were 46% among offspring of ZIKV-positive women versus 11.5% among offspring of ZIKV-negative women (P<0.001). Among 117 live infants born to 116 ZIKV-positive women, 42% were found to have grossly abnormal clinical or brain imaging findings or both, including 4 infants with microcephaly. Adverse outcomes were noted regardless of the trimester during which the women were infected with ZIKV (55% of pregnancies had adverse outcomes after maternal infection in the first trimester, 52% after infection in the second trimester, and 29% after infection in the third trimester). CONCLUSIONS Despite mild clinical symptoms in the mother, ZIKV infection during pregnancy is deleterious to the fetus and is associated with fetal death, fetal growth restriction, and a spectrum of central nervous system abnormalities. (Funded by Ministerio da Saude do Brasil and others.)	[Brasil, P.; Pereira, J. P., Jr.; Moreira, M. E.; Ribeiro Nogueira, R. M.; Damasceno, L.; Wakimoto, M.; Rabello, R. S.; Salles, T. S.; Zin, A. A.; Horovitz, D.; Boechat, M.; Carvalho de Sequeira, P.; Pilotto, J. H.; Medialdea-Carrera, R.; Cotrim da Cunha, D.; Abreu de Carvalho, L. M.; Pone, M.; Machado Siqueira, A.; Calvet, G. A.; Rodrigues Baiao, A. E.; Neves, E. S.; Nassar de Carvalho, P. R.; Bispo de Filippis, A. M.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Daltro, P.] Clin Diagnost Imagem, Rio De Janeiro, Brazil; [Valderramos, S. G.; Halai, U. -A.; Janzen, C.; Cherry, J. D.; Nielsen-Saines, K.] David Geffen UCLA Sch Med, Los Angeles, CA USA; [Gabaglia, C. Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA; [Hasue, R. H.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil; [Marschik, P. B.; Einspieler, C.] Med Univ Graz, Graz, Austria; [Marschik, P. B.] Karolinska Inst, Stockholm, Sweden	Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade de Sao Paulo; Medical University of Graz; Karolinska Institutet	Brasil, P (corresponding author), Fiocruz MS, INI, Lab Doencas Febris Agudas, 4365 Av Brasil, BR-21040900 Rio De Janeiro, RJ, Brazil.; Nielsen-Saines, K (corresponding author), UCLA, David Geffen Sch Med, Div Pediat Infectious Dis, MDCC 22-442,10833 LeConte Ave, Los Angeles, CA 90095 USA.	patricia.brasil33@gmail.com; knielsen@mednet.ucla.edu	da Silva Pone, Marcos Vinicius/N-1285-2019; Einspieler, Christa/HHS-6481-2022; Calvet, GA/G-6959-2013; Gaw, Stephanie/K-4592-2019; Brasil, Patricia/P-3536-2014; Pilotto, Jose Henrique/AAD-9773-2019; Pone, Marcos/ABF-2743-2022; de Carvalho, Liege Maria/AAV-8922-2021; Rabello, Renata/AAI-8408-2021; Siqueira, Andre M/G-1340-2010; Hasue, Renata Hydee/B-2328-2013; Marschik, Peter B/F-8195-2011	Calvet, GA/0000-0002-3545-5238; Gaw, Stephanie/0000-0003-0891-6964; Pilotto, Jose Henrique/0000-0003-0521-8597; Pone, Marcos/0000-0002-5152-2242; Siqueira, Andre M/0000-0003-2208-0294; Hasue, Renata Hydee/0000-0002-7717-6042; Marschik, Peter B/0000-0001-8932-0980; Brasil, Patricia/0000-0001-9555-7976; Medialdea-Carrera, Raquel/0000-0002-0371-5138	Ministerio da Saude do Brasil; Medical Research Council [MC_PC_15101] Funding Source: researchfish; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1128871] Funding Source: researchfish; MRC [MC_PC_15101] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697, R21AI129534] Funding Source: NIH RePORTER	Ministerio da Saude do Brasil; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Ministerio da Saude do Brasil and others.	[Anonymous], 2015, EP AL NEUR SYNDR CON; Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901; Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367; Cherry JD, 2014, FEIGIN CHERRYS TXB P, P741; de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584; Ebbing C, 2007, ULTRASOUND OBST GYN, V30, P287, DOI 10.1002/uog.4088; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125; NAEYE RL, 1965, J AMER MED ASSOC, V194, P1277, DOI 10.1001/jama.194.12.1277; Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037; PLOTKIN SA, 1965, AM J EPIDEMIOL, V81, P71, DOI 10.1093/oxfordjournals.aje.a120499; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; SEVER JL, 1964, OBSTET GYNECOL, V23, P153; Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	28	1181	1221	5	230	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2321	2334		10.1056/NEJMoa1602412	http://dx.doi.org/10.1056/NEJMoa1602412			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SO	26943629	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000390036500004
J	Walker, KF; Thornton, JG				Walker, Kate F.; Thornton, Jim G.			Tocolysis and preterm labour	LANCET			English	Editorial Material							ATOSIBAN; NIFEDIPINE		[Walker, Kate F.; Thornton, Jim G.] Univ Nottingham, Sch Med, Div Child Hlth Obstet & Gynaecol, Nottingham NG5 1PB, England; [Walker, Kate F.] Chesterfield Royal Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Chesterfield, England	University of Nottingham	Thornton, JG (corresponding author), Univ Nottingham, Sch Med, Div Child Hlth Obstet & Gynaecol, Nottingham NG5 1PB, England.	jim.thornton@nottingham.ac.uk	Thornton, Jim/B-8336-2008	Thornton, Jim/0000-0001-9764-6876; Walker, Kate F./0000-0001-5794-7324	Department of Health [PB-PG-0610-22275] Funding Source: Medline; National Institute for Health Research [PB-PG-0610-22275] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Al-Omari WR, 2006, EUR J OBSTET GYN R B, V128, P129, DOI 10.1016/j.ejogrb.2005.12.010; American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V119, P1308, DOI 10.1097/AOG.0b013e31825af2f0; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Coomarasamy A, 2003, BJOG-INT J OBSTET GY, V110, P1045, DOI 10.1016/S1470-0328(03)03971-5; Crowther CA, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001060; De Heus R, 2009, J MATERN-FETAL NEO M, V22, P485, DOI 10.1080/14767050802702349; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Kashanian M, 2005, INT J GYNECOL OBSTET, V91, P10, DOI 10.1016/j.ijgo.2005.06.005; National Institute for Health and Care Excellence, 2022, PRET LAB BIRTH; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Salim R, 2012, OBSTET GYNECOL, V120, P1323, DOI [10.1097/AOG.0b013e3182755dff, http://10.1097/AOG.0b013e3182755dff]; van Veen AJ, 2005, BJOG-INT J OBSTET GY, V112, P509, DOI 10.1111/j.1471-0528.2004.00480.x; van Vliet EO, 2016, LANCET	14	15	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2068	2070		10.1016/S0140-6736(16)00590-0	http://dx.doi.org/10.1016/S0140-6736(16)00590-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	26944025				2022-12-28	WOS:000376450800007
J	Floege, J; Amann, K				Floege, Juergen; Amann, Kerstin			Primary glomerulonephritides	LANCET			English	Review							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; SOLUBLE UROKINASE RECEPTOR; DEPENDENT NEPHROTIC SYNDROME; BASEMENT-MEMBRANE DISEASE; MINIMAL CHANGE DISEASE; COMPLEMENT FACTOR-H; RANDOMIZED CONTROLLED-TRIAL; GALACTOSE-DEFICIENT IGA1; DENSE DEPOSIT DISEASE; LONG-TERM OUTCOMES	Most glomerulonephritides, even the more common types, are rare diseases. They are nevertheless important since they frequently affect young people, often cannot be cured, and can lead to chronic kidney disease, including end-stage renal failure, with associated morbidity and cost. For example, in young adults, IgA nephropathy is the most common cause of end-stage renal disease. In this Seminar, we summarise existing knowledge of clinical signs, pathogenesis, prognosis, and treatment of glomerulonephritides, with a particular focus on data published between 2008 and 2015, and the most common European glomerulonephritis types, namely IgA nephropathy, membranous glomerulonephritis, minimal change disease, focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis, and the rare complement-associated glomerulonephritides such as dense deposit disease and C3 glomerulonephritis.	[Floege, Juergen] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, Univ Hosp, D-52062 Aachen, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Nephropathol, Dept Pathol, D-91054 Erlangen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Erlangen Nuremberg	Floege, J (corresponding author), Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52057 Aachen, Germany.	juergen.floege@rwth-aachen.de			German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB TRR57]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) grant SFB TRR57, project p25.	Abrera-Abeleda MA, 2011, J AM SOC NEPHROL, V22, P1551, DOI 10.1681/ASN.2010080795; Barbour SJ, 2015, KIDNEY INT, V88, P1392, DOI 10.1038/ki.2015.241; Barbour SJ, 2012, KIDNEY INT, V81, P190, DOI 10.1038/ki.2011.312; Barua M, 2014, J AM SOC NEPHROL, V25, P1942, DOI 10.1681/ASN.2013070686; Barua M, 2014, KIDNEY INT, V85, P124, DOI 10.1038/ki.2013.354; Basu B, 2014, NEW ENGL J MED, V370, P1268, DOI 10.1056/NEJMc1308488; Bech AP, 2014, CLIN J AM SOC NEPHRO, V9, P1386, DOI 10.2215/CJN.10471013; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Benigni A, 2014, NEW ENGL J MED, V370, P1261, DOI 10.1056/NEJMc1400502; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Bock ME, 2013, CLIN J AM SOC NEPHRO, V8, P1304, DOI 10.2215/CJN.07680712; Bomback AS, 2012, CLIN J AM SOC NEPHRO, V7, P748, DOI 10.2215/CJN.12901211; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1016/S0272-6386(01)80120-7; Braun N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003233.pub2; Bu FX, 2016, J AM SOC NEPHROL, V27, P1245, DOI 10.1681/ASN.2015040385; Cathelin D, 2014, J AM SOC NEPHROL, V25, P1662, DOI 10.1681/ASN.2013040425; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chen Q, 2014, J CLIN INVEST, V124, P145, DOI 10.1172/JCI71866; Chen Q, 2011, NEW ENGL J MED, V365, P2340, DOI 10.1056/NEJMc1107484; Chen YZ, 2013, CLIN J AM SOC NEPHRO, V8, P787, DOI 10.2215/CJN.07570712; Choudhry S, 2009, AM J KIDNEY DIS, V53, P760, DOI 10.1053/j.ajkd.2008.11.033; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Cong EH, 2014, J AM SOC NEPHROL, V25, P2435, DOI 10.1681/ASN.2013101126; Coppo R, 2014, KIDNEY INT, V86, P828, DOI 10.1038/ki.2014.63; Cui Z, 2011, MEDICINE, V90, P303, DOI 10.1097/MD.0b013e31822f6f68; Cui Z, 2011, AM J KIDNEY DIS, V57, P575, DOI 10.1053/j.ajkd.2010.09.022; Daina E, 2012, NEW ENGL J MED, V366, P1161, DOI 10.1056/NEJMc1112273; Debiec H, 2011, NEW ENGL J MED, V364, P2101, DOI 10.1056/NEJMoa1013792; Deegens JKJ, 2011, KIDNEY INT, V80, P798, DOI 10.1038/ki.2011.191; Du Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104936; Dussol B, 2008, AM J KIDNEY DIS, V52, P699, DOI 10.1053/j.ajkd.2008.04.013; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eitner F, 2008, J NEPHROL, V21, P284; Fervenza FC, 2012, NEPHROL DIAL TRANSPL, V27, P4288, DOI 10.1093/ndt/gfs288; Floege J, 2016, NAT REV NEPHROL, V12, P147, DOI 10.1038/nrneph.2015.208; Floege J, 2013, NAT REV NEPHROL, V9, P320, DOI 10.1038/nrneph.2013.59; Floege J, 2011, AM J KIDNEY DIS, V58, P992, DOI 10.1053/j.ajkd.2011.05.033; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Fresquet M, 2015, J AM SOC NEPHROL, V26, P302, DOI 10.1681/ASN.2014050502; Frisch G, 2005, NEPHROL DIAL TRANSPL, V20, P2139, DOI 10.1093/ndt/gfh974; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; Garin EH, 2015, PEDIATR NEPHROL, V30, P469, DOI 10.1007/s00467-014-2957-6; Garin EH, 2010, KIDNEY INT, V78, P296, DOI 10.1038/ki.2010.143; Gast C, 2016, NEPHROL DIAL TRANSPL, V31, P961, DOI 10.1093/ndt/gfv325; Gbadegesin RA, 2014, J AM SOC NEPHROL, V25, P1991, DOI 10.1681/ASN.2013090976; Gipson DS, 2011, KIDNEY INT, V80, P868, DOI 10.1038/ki.2011.195; Gulati A, 2010, CLIN J AM SOC NEPHRO, V5, P2207, DOI 10.2215/CJN.03470410; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Hakroush S, 2014, J AM SOC NEPHROL, V25, P927, DOI 10.1681/ASN.2013070687; Hall G, 2015, J AM SOC NEPHROL, V26, P831, DOI 10.1681/ASN.2013101053; Hergesell O, 1998, NEPHROL DIAL TRANSPL, V13, P975, DOI 10.1093/ndt/13.4.975; Herlitz LC, 2014, CLIN J AM SOC NEPHRO, V9, P1033, DOI 10.2215/CJN.11951113; Herlitz LC, 2012, J AM SOC NEPHROL, V23, P1229, DOI 10.1681/ASN.2011121186; Herlitz LC, 2010, J AM SOC NEPHROL, V21, P163, DOI 10.1681/ASN.2009040450; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hofstra JM, 2010, NEPHROL DIAL TRANSPL, V25, P129, DOI 10.1093/ndt/gfp390; Hogg RJ, 2015, AM J KIDNEY DIS, V66, P783, DOI 10.1053/j.ajkd.2015.06.013; Howman A, 2013, LANCET, V381, P744, DOI 10.1016/S0140-6736(12)61566-9; Hoxha E, 2015, NEPHROL DIAL TRANSPL, V30, P1862, DOI 10.1093/ndt/gfv228; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Iijima K, 2014, LANCET, V384, P1273, DOI 10.1016/S0140-6736(14)60541-9; Javaugue V, 2013, AM J KIDNEY DIS, V62, P679, DOI 10.1053/j.ajkd.2013.03.031; Jia XY, 2014, KIDNEY INT, V85, P945, DOI 10.1038/ki.2013.364; Johnson RJ, 2003, AM J KIDNEY DIS, V42, P575, DOI 10.1016/S0272-6386(03)00801-1; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; Kao LY, 2015, J AM SOC NEPHROL, V26, P291, DOI 10.1681/ASN.2013121315; Kattah A, 2015, AM J TRANSPLANT, V15, P1349, DOI 10.1111/ajt.13133; Kawamura T, 2014, NEPHROL DIAL TRANSPL, V29, P1546, DOI 10.1093/ndt/gfu020; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; KOHLER H, 1991, KIDNEY INT, V40, P115, DOI 10.1038/ki.1991.188; Kopp JB, 2015, J AM SOC NEPHROL, V26, P1443, DOI 10.1681/ASN.2013111242; Korkmaz E, 2016, J AM SOC NEPHROL, V27, P63, DOI 10.1681/ASN.2014121240; Laurin LP, 2014, NEPHROL DIAL TRANSPL, V29, P2062, DOI 10.1093/ndt/gft532; Lee T, 2014, KIDNEY INT, V85, P1412, DOI 10.1038/ki.2013.476; Leeaphorn N, 2014, AM J NEPHROL, V40, P29, DOI 10.1159/000364782; Li LM, 2015, J AM SOC NEPHROL, V26, P2183, DOI 10.1681/ASN.2014050468; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8270; Li XY, 2013, NEPHROL DIAL TRANSPL, V28, P2306, DOI 10.1093/ndt/gft207; Liu HH, 2012, AM J NEPHROL, V36, P377, DOI 10.1159/000342233; Lv JC, 2008, NEPHROL DIAL TRANSPL, V23, P2868, DOI 10.1093/ndt/gfn161; Lv JC, 2013, J AM SOC NEPHROL, V24, P2118, DOI 10.1681/ASN.2012101017; Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112; Lv JC, 2009, AM J KIDNEY DIS, V53, P26, DOI 10.1053/j.ajkd.2008.07.029; Maas RJ, 2014, NEPHROL DIAL TRANSPL, V29, P2207, DOI 10.1093/ndt/gfu355; Maes BD, 2004, KIDNEY INT, V65, P1842, DOI 10.1111/j.1523-1755.2004.00588.x; Manno C, 2009, NEPHROL DIAL TRANSPL, V24, P3694, DOI 10.1093/ndt/gfp356; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Medjeral-Thomas NR, 2014, CLIN J AM SOC NEPHRO, V9, P46, DOI 10.2215/CJN.04700513; Meijers B, 2014, KIDNEY INT, V85, P636, DOI 10.1038/ki.2013.505; Munyentwali H, 2013, KIDNEY INT, V83, P511, DOI 10.1038/ki.2012.444; Nasr SH, 2011, CLIN J AM SOC NEPHRO, V6, P775, DOI 10.2215/CJN.08300910; Nicholson ML, 2000, KIDNEY INT, V58, P390, DOI 10.1046/j.1523-1755.2000.00177.x; Ohlsson S, 2014, AM J KIDNEY DIS, V63, P289, DOI 10.1053/j.ajkd.2013.08.032; Orth SR, 1997, KIDNEY INT, V51, P1669, DOI 10.1038/ki.1997.232; Palmer SC, 2011, AM J KIDNEY DIS, V58, P335, DOI 10.1053/j.ajkd.2011.06.006; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; Pozzi C, 2010, J AM SOC NEPHROL, V21, P1783, DOI 10.1681/ASN.2010010117; Rabasco C, 2015, KIDNEY INT, V88, P1153, DOI 10.1038/ki.2015.227; Rauen T, 2015, NEW ENGL J MED, V373, P2225, DOI 10.1056/NEJMoa1415463; Ravani P, 2011, CLIN J AM SOC NEPHRO, V6, P1308, DOI 10.2215/CJN.09421010; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Ruggenenti P, 2015, J AM SOC NEPHROL, V26, P2545, DOI 10.1681/ASN.2014070640; Ruggenenti P, 2014, J AM SOC NEPHROL, V25, P850, DOI 10.1681/ASN.2013030251; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1416, DOI 10.1681/ASN.2012020181; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Sethi S, 2012, KIDNEY INT, V81, P434, DOI 10.1038/ki.2011.399; Sethi S, 2011, SEMIN NEPHROL, V31, P341, DOI 10.1016/j.semnephrol.2011.06.005; Sethi S, 2011, CLIN J AM SOC NEPHRO, V6, P1009, DOI 10.2215/CJN.07110810; Sethi S, 2010, CLIN J AM SOC NEPHRO, V5, P770, DOI 10.2215/CJN.06760909; Shankland SJ, 2014, NAT REV NEPHROL, V10, P158, DOI 10.1038/nrneph.2014.1; Sinha A, 2014, KIDNEY INT, V85, P649, DOI 10.1038/ki.2013.546; Smeets B, 2014, AM J PATHOL, V184, P3239, DOI 10.1016/j.ajpath.2014.08.007; Smerud HK, 2011, NEPHROL DIAL TRANSPL, V26, P3237, DOI 10.1093/ndt/gfr052; Smerud HK, 2009, NEPHROL DIAL TRANSPL, V24, P2476, DOI 10.1093/ndt/gfp133; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Tang SCW, 2010, KIDNEY INT, V77, P543, DOI 10.1038/ki.2009.499; Tang W, 2013, KIDNEY INT, V83, P503, DOI 10.1038/ki.2012.375; Tesar V, 2015, J AM SOC NEPHROL, V26, P2248, DOI 10.1681/ASN.2014070697; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; Touzot M, 2015, J AUTOIMMUN, V60, P74, DOI 10.1016/j.jaut.2015.04.003; Trachtman H, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0094-5; van den Brand JAJG, 2014, J AM SOC NEPHROL, V25, P150, DOI 10.1681/ASN.2013020185; van den Brand JAJG, 2011, CLIN J AM SOC NEPHRO, V6, P2846, DOI 10.2215/CJN.04020411; Vizjak A, 2008, J AM SOC NEPHROL, V19, P2237, DOI 10.1681/ASN.2007080929; Wada T, 2014, KIDNEY INT, V85, P641, DOI 10.1038/ki.2013.544; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Whittier WL, 2004, J AM SOC NEPHROL, V15, P142, DOI 10.1097/01.ASN.0000102472.37947.14; Wilmer WA, 2003, J AM SOC NEPHROL, V14, P3217, DOI 10.1097/01.ASN.0000100145.27188.33; Yamaguchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100835; Yu CC, 2013, NEW ENGL J MED, V369, P2416, DOI 10.1056/NEJMoa1304572; Zand L, 2014, J AM SOC NEPHROL, V25, P1110, DOI 10.1681/ASN.2013070715; Zhang YZ, 2012, CLIN J AM SOC NEPHRO, V7, P265, DOI 10.2215/CJN.07900811; Zhao J, 2009, KIDNEY INT, V76, P1108, DOI 10.1038/ki.2009.348; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197; Zhu L, 2015, J AM SOC NEPHROL, V26, P1195, DOI 10.1681/ASN.2014010096	145	130	141	7	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					2036	2048		10.1016/S0140-6736(16)00272-5	http://dx.doi.org/10.1016/S0140-6736(16)00272-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	26921911				2022-12-28	WOS:000375881500033
J	Stempel, DA; Raphiou, IH; Kral, KM; Yeakey, AM; Emmett, AH; Prazma, CM; Buaron, KS; Pascoe, SJ				Stempel, David A.; Raphiou, Ibrahim H.; Kral, Kenneth M.; Yeakey, Anne M.; Emmett, Amanda H.; Prazma, Charlene M.; Buaron, Kathleen S.; Pascoe, Steven J.		AUSTRI Investigators	Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTING BETA-AGONISTS; INHALED CORTICOSTEROIDS; RISK; EXACERBATIONS; METAANALYSIS; MORTALITY; SAFETY; DEATH; FDA	BACKGROUND The safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of asthma has been widely debated. In two large clinical trials, investigators found a potential risk of serious asthma-related events associated with LABAs. This study was designed to evaluate the risk of administering the LABA salmeterol in combination with an inhaled glucocorticoid, fluticasone propionate. METHODS In this multicenter, randomized, double-blind trial, adolescent and adult patients (age, >= 12 years) with persistent asthma were assigned to receive either fluticasone with salmeterol or fluticasone alone for 26 weeks. All the patients had a history of a severe asthma exacerbation in the year before randomization but not during the previous month. Patients were excluded from the trial if they had a history of life-threatening or unstable asthma. The primary safety end point was the first serious asthma-related event (death, endotracheal intubation, or hospitalization). Noninferiority of fluticasone-salmeterol to fluticasone alone was defined as an upper boundary of the 95% confidence interval for the risk of the primary safety end point of less than 2.0. The efficacy end point was the first severe asthma exacerbation. RESULTS Of 11,679 patients who were enrolled, 67 had 74 serious asthma-related events, with 36 events in 34 patients in the fluticasone-salmeterol group and 38 events in 33 patients in the fluticasone-only group. The hazard ratio for a serious asthma-related event in the fluticasone-salmeterol group was 1.03 (95% confidence interval [CI], 0.64 to 1.66), and noninferiority was achieved (P = 0.003). There were no asthma-related deaths; 2 patients in the fluticasone-only group underwent asthma-related intubation. The risk of a severe asthma exacerbation was 21% lower in the fluticasone-salmeterol group than in the fluticasone-only group (hazard ratio, 0.79; 95% CI, 0.70 to 0.89), with at least one severe asthma exacerbation occurring in 480 of 5834 patients (8%) in the fluticasone-salmeterol group, as compared with 597 of 5845 patients (10%) in the fluticasone-only group (P<0.001). CONCLUSIONS Patients who received salmeterol in a fixed-dose combination with fluticasone did not have a significantly higher risk of serious asthma-related events than did those who received fluticasone alone. Patients receiving fluticasone-salmeterol had fewer severe asthma exacerbations than did those in the fluticasone-only group.	[Stempel, David A.; Raphiou, Ibrahim H.; Yeakey, Anne M.; Prazma, Charlene M.; Buaron, Kathleen S.; Pascoe, Steven J.] GlaxoSmith Kline, Resp Clin Dev, 5 Moore Dr,POB 13398,Res Triangle Pk, Durham, NC 27709 USA; [Kral, Kenneth M.; Emmett, Amanda H.] GlaxoSmith Kline, Res & Dev, Clin Platforms & Sci, Clin Stat, Durham, NC 27709 USA	GlaxoSmithKline; GlaxoSmithKline	Stempel, DA (corresponding author), GlaxoSmith Kline, Resp Clin Dev, 5 Moore Dr,POB 13398,Res Triangle Pk, Durham, NC 27709 USA.	david.a.stempel@gsk.com	Jahnz-Różyk, Karina/AAA-2560-2021; Zhebel, Vadym/Q-7058-2019; Shirinsky, Valery/I-5653-2018; Barbé, Ferran/A-5988-2010; Kryuchko, T. A./W-4506-2017; Upham, John/F-4420-2010; Panina, Svitlana/W-2900-2019; Arnedillo, Aurelio/AAK-7390-2020; Blazowski, Lukasz/AAO-9756-2020; Shpagina, Lyubov/Y-7864-2018; Esposito, Susanna/K-3475-2016	Jahnz-Różyk, Karina/0000-0002-3505-1858; Zhebel, Vadym/0000-0002-6542-9313; Shirinsky, Valery/0000-0002-4922-9303; Barbé, Ferran/0000-0002-2340-8928; Kryuchko, T. A./0000-0002-5034-4181; Upham, John/0000-0002-0017-3433; Panina, Svitlana/0000-0003-1080-7185; Arnedillo, Aurelio/0000-0002-2267-057X; Shpagina, Lyubov/0000-0003-0871-7551; Soler-Sempere, MariaJose/0000-0002-6607-2037; , iemoli/0000-0003-1510-9677; Valdes, Luis/0000-0003-2540-8013; Blazowski, Lukasz/0000-0002-6387-2768; Bozek, Andrzej/0000-0003-2263-2263; Antuni, Julio Daniel/0000-0002-9069-0855; Seddon, Paul/0000-0003-2136-958X; Comellas, Alejandro/0000-0003-1521-7520; Esposito, Susanna/0000-0003-4103-2837; Robinson, Paul/0000-0001-7397-105X; Ioachimescu, Octavian/0000-0001-9047-6894; Vukcevic, Miodrag/0000-0002-6218-3848; /0000-0002-8537-9165	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Supported by GlaxoSmithKline.	[Anonymous], 2007, CYTEL E 5 USER MANUA; Bateman E, 2008, ANN INTERN MED, V149, P33, DOI 10.7326/0003-4819-149-1-200807010-00229; Bateman ED, 2014, THORAX, V69, P312, DOI 10.1136/thoraxjnl-2013-203600; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; Cates CJ, 2008, COCHRANE DB SYST REV, V3; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; CRANE J, 1989, LANCET, V1, P917; ERNST P, 1993, AM REV RESPIR DIS, V148, P75, DOI 10.1164/ajrccm/148.1.75; *GINA, 2007, GLOB STRAT ASTHM MAN; Jennison C, 2000, GROUP SEQUENTIAL MET; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kuna P, 2007, INT J CLIN PRACT, V61, P725, DOI 10.1111/j.1742-1241.2007.01338.x; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; McMahon AW, 2011, PEDIATRICS, V128, pE1147, DOI 10.1542/peds.2010-1720; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; National Institute of Health, 2007, GUID DIAGN MAN ASTHM; Nelson H, 2010, J ALLERGY CLIN IMMUN, V125, P390, DOI 10.1016/j.jaci.2009.11.036; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Sadatsafavi M, 2014, THORAX, V69, P328, DOI 10.1136/thoraxjnl-2013-203998; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Salpeter SR, 2010, EXPERT OPIN DRUG SAF, V9, P407, DOI 10.1517/14740330903535852; Schatz M, 2014, J ALLER CL IMM-PRACT, V2, P570, DOI 10.1016/j.jaip.2014.05.002; SPEIZER FE, 1968, BRIT MED J, V1, P335, DOI 10.1136/bmj.1.5588.335; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; SUISSA S, 1994, AM J RESP CRIT CARE, V149, P604, DOI 10.1164/ajrccm.149.3.8118625; Weatherall M, 2010, THORAX, V65, P39, DOI 10.1136/thx.2009.116608	27	114	115	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1822	1830		10.1056/NEJMoa1511049	http://dx.doi.org/10.1056/NEJMoa1511049			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	26949137	Green Published, Bronze			2022-12-28	WOS:000375746100005
J	Gould, IM; Lawes, T				Gould, Ian M.; Lawes, Timothy			Antibiotic stewardship: prescribing social norms	LANCET			English	Editorial Material							RESISTANCE		[Gould, Ian M.] Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen, Scotland; [Lawes, Timothy] Royal Aberdeen Childrens Hosp, Aberdeen AB25 2ZN, Scotland	University of Aberdeen; University of Aberdeen	Lawes, T (corresponding author), Royal Aberdeen Childrens Hosp, Aberdeen AB25 2ZN, Scotland.	t.lawes@nhs.net		Lawes, Timothy/0000-0003-4393-245X				Cole A, 2014, BMJ-BRIT MED J, V349, P5238; Dar OA, 2016, LANCET, V387, P285, DOI 10.1016/S0140-6736(15)00520-6; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Department of Health and Department for Environment Food and Rural Afairs, 2013, UK 5 YEAR ANT RES AM; European Centre for Disease prevention and Control, ANT CONS INT DAT ESA; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hallsworth M, 2016, LANCET; Health Protection Scotland and Information Services Division, 2014, REP ANT US RES HUM 2; Lawes T, 2015, LANCET INFECT DIS, V15, P1438, DOI 10.1016/S1473-3099(15)00315-1; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Outterson K, 2010, CLIN INFECT DIS, V51, P751, DOI 10.1086/655955; Peterson LR, 2005, CLIN MICROBIOL INFEC, V11, P4, DOI 10.1111/j.1469-0691.2005.01238.x; Teillant A, 2015, LANCET INFECT DIS, V15, P1429, DOI 10.1016/S1473-3099(15)00270-4	13	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1699	1701		10.1016/S0140-6736(16)00007-6	http://dx.doi.org/10.1016/S0140-6736(16)00007-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ9OD	26898851	hybrid			2022-12-28	WOS:000374541900006
J	Emanuel, EJ				Emanuel, Ezekiel J.			How Well Is the Affordable Care Act Doing? Reasons for Optimism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 3401 Market St,Ste 320, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 3401 Market St,Ste 320, Philadelphia, PA 19104 USA.; Emanuel, EJ (corresponding author), Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA.	zemanuel@upenn.edu						Buttegens M, 2015, MEDICAID EXPANSION H; Congressional Budget Office, 2015, INS COV PROV AFF CAR; Emanuel EJ, 2016, ANN INTERN MED, V164, P114, DOI 10.7326/M15-1330; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gormley B., 2016, WALL STREET J; Marken S., 2016, GALLUP          0107; Martin AB, 2016, HEALTH AFFAIR, V35, P150, DOI 10.1377/hlthaff.2015.1194	7	7	7	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1331	1332		10.1001/jama.2016.2556	http://dx.doi.org/10.1001/jama.2016.2556			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	26940834				2022-12-28	WOS:000373381500011
J	Rainer, TH; Cheng, CH; Janssens, HJEM; Man, CY; Tam, LS; Choi, YF; Yau, WH; Lee, KH; Graham, CA				Rainer, Timothy Hudson; Cheng, Chi Hung; Janssens, Hein J. E. M.; Man, Chi Yin; Tam, Lai Shan; Choi, Yu Fai; Yau, Wah Hon; Lee, Ka Hing; Graham, Colin Alexander			Oral Prednisolone in the Treatment of Acute Gout A Pragmatic, Multicenter, Double-Blind, Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							EVIDENCE BASED RECOMMENDATIONS; MIDDLE-AGED MEN; DIAGNOSTIC RULE; TASK-FORCE; ARTHRITIS; MANAGEMENT; COLCHICINE; RHEUMATOLOGY; THERAPY; RISK	Background: Two recent double-blind, randomized, controlled trials (RCTs) showed that oral steroids and nonsteroidal antiinflammatory drugs have similar analgesic effectiveness for management of gout, but the trials had small sample sizes and other methodological limitations. Objective: To compare the effectiveness and safety of oral prednisolone versus oral indomethacin in patients presenting to emergency departments (EDs) with acute gout. Design: Multicenter, double-blind, randomized equivalence trial. Patients were randomly assigned (1: 1 ratio) to receive either indomethacin or prednisolone. (ISRCTN registry number: ISRCTN45724113) Setting: Four EDs in Hong Kong. Participants: 416 patients aged 18 years or older. Measurements: Analgesic effectiveness was defined as changes in pain (at rest or with activity) greater than 13 mm on a 100-mm visual analogue scale. Outcomes were measured during the first 2 hours in the ED and from days 1 to 14. Results: 376 patients completed the study. Equivalent and clinically significant within-group reductions in mean pain score were observed with indomethacin and prednisolone in the ED (approximately 10 mm [rest] and 20 mm [activity]) and from days 1 to 14 (approximately 25 mm [rest] and 45 mm [activity]). No major adverse events occurred during the study. During the ED phase, patients in the indomethacin group had more minor adverse events than those in the prednisolone group (19% vs. 6%; P < 0.001). During days 1 to 14, 37% of patients in each group had minor adverse events. Limitation: Diagnosis of gout was usually based on clinical criteria rather than examination of joint fluid. Conclusion: Oral prednisolone and indomethacin had similar analgesic effectiveness among patients with acute gout. Prednisolone is a safe, effective first-line option for treatment of acute gout.	[Cheng, Chi Hung; Graham, Colin Alexander] Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China; Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Man, Chi Yin] North Dist Hosp, Hosp Adm, 11 Chuen On Rd, Tai Po, Hong Kong, Peoples R China; [Choi, Yu Fai] Pamela Youde Nethersole Eastern Hosp, Dept Accid & Emergency, 3 Lok Man Rd, Chaiwan, Hong Kong, Peoples R China; Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China; [Lee, Ka Hing] United Christian Hosp, Dept Accid & Emergency, 130 Hip Woo St, Kowloon, Hong Kong, Peoples R China; [Janssens, Hein J. E. M.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, ELG 117,POB 9101, NL-6500 Nijmegen, Netherlands; Primary Hlth Care Ctr Lobede, Lobith Tolkamer, Netherlands; [Tam, Lai Shan] Chinese Univ Hong Kong, Dept Med & Therapeut, 9-F,Lui Che Woo Clin Sci Bldg, Shatin, Hong Kong, Peoples R China; [Yau, Wah Hon] Hong Kong Sanat & Hosp, Outpatient Dept, 2 Village Rd, Happy Valley, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Pamela Youde Nethersole Eastern Hospital; United Christian Hospital; Radboud University Nijmegen; Chinese University of Hong Kong	Rainer, TH (corresponding author), Cardiff Univ, Emergency Med Acad Unit, Room 127,Sir Geraint Evans Bldg, Cardiff CF10 3AX, S Glam, Wales.	rainerth@cardiff.ac.uk	Tam, Lai-Shan/U-7044-2019; Rainer, Timothy/I-2591-2013; Janssens, Hein J.E.M./E-3519-2016; Graham, Colin A/B-4535-2013; Tam, Lai-Shan/K-4980-2014	Tam, Lai-Shan/0000-0001-6410-8852; Rainer, Timothy/0000-0003-3355-3237; Graham, Colin A/0000-0002-4381-7470; Tam, Lai-Shan/0000-0001-6410-8852	Health and Health Services Research Grant Committee of the Hong Kong Government	Health and Health Services Research Grant Committee of the Hong Kong Government	Health and Health Services Research Grant Committee of the Hong Kong Government.	AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; Bennett PH, 1968, POPULATION STUDIES R, P457; Bidaut-Russell M, 2001, BEST PRACT RES CL GA, V15, P739, DOI 10.1053/bega.2001.0232; Choi HK, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8190; Dorlo Thomas P C, 2013, Ned Tijdschr Geneeskd, V157, pA5540; FERRANNINI E, 1984, CLIN EXP RHEUMATOL, V2, P173; Health Grades, 2015, STAT COUNTR GOUT; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; James David S, 1999, J Am Osteopath Assoc, V99, pS1, DOI 10.7556/jaoa.1999.99.11.S1; Janssens HJEM, 2008, LANCET, V371, P1854, DOI 10.1016/S0140-6736(08)60799-0; Janssens HJEM, 2010, ARCH INTERN MED, V170, P1120, DOI 10.1001/archinternmed.2010.196; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Kienhorst LBE, 2015, RHEUMATOLOGY, V54, P609, DOI 10.1093/rheumatology/keu378; Krishnan E, 2008, ARCH INTERN MED, V168, P1104, DOI 10.1001/archinte.168.10.1104; Krishnan E, 2013, ARTHRITIS RHEUM-US, V65, P3271, DOI 10.1002/art.38171; Man CY, 2007, ANN EMERG MED, V49, P670, DOI 10.1016/j.annemergmed.2006.11.014; McGettigan P, 2000, CURR PHARM DESIGN, V6, P1693, DOI 10.2174/1381612003398690; Rainer TH, 2008, LANCET, V371, P1816, DOI 10.1016/S0140-6736(08)60775-8; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; ROBERTS WN, 1987, JAMA-J AM MED ASSOC, V257, P1920, DOI 10.1001/jama.257.14.1920; Roddy E, 2014, RHEUM DIS CLIN N AM, V40, P155, DOI 10.1016/j.rdc.2014.01.001; Roddy E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5648; Rodriguez LAG, 2001, ARTHRITIS RES, V3, P98, DOI 10.1186/ar146; Rott KT, 2003, JAMA-J AM MED ASSOC, V289, P2857, DOI 10.1001/jama.289.21.2857; Schumacher HR, 1996, AM J MED, V100, pS46, DOI 10.1016/S0002-9343(97)89546-0; Sealed Envelope, 2012, POW CALC BIN OUTC EQ; Sturrock RD, 2000, BRIT MED J, V320, P132, DOI 10.1136/bmj.320.7228.132; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251	31	50	58	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2016	164	7					464	+		10.7326/M14-2070	http://dx.doi.org/10.7326/M14-2070			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI6QP	26903390				2022-12-28	WOS:000373625300008
J	Lei, L; Spradling, AC				Lei, Lei; Spradling, Allan C.			Mouse oocytes differentiate through organelle enrichment from sister cyst germ cells	SCIENCE			English	Article							BALBIANI BODY; OOGENESIS; FOLLICLES; PATHWAYS; MEIOSIS; MICE	Oocytes differentiate in diverse species by receiving organelles and cytoplasm from sister germ cells while joined in germline cysts or syncytia. Mouse primordial germ cells form germline cysts, but the role of cysts in oogenesis is unknown. We find that mouse germ cells receive organelles from neighboring cyst cells and build a Balbiani body to become oocytes, whereas nurselike germ cells die. Organelle movement, Balbiani body formation, and oocyte fate determination are selectively blocked by low levels of microtubule-dependent transport inhibitors. Membrane breakdown within the cyst and an apoptosis-like process are associated with organelle transfer into the oocyte, events reminiscent of nurse cell dumping in Drosophila. We propose that cytoplasmic and organelle transport plays an evolutionarily conserved and functionally important role in mammalian oocyte differentiation.	[Lei, Lei; Spradling, Allan C.] Carnegie Inst Sci, Howard Hughes Med Inst, Res Labs, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA; [Lei, Lei] Univ Michigan, Sch Med, Dept Cell & Dev Biol, 109 Zina Pitcher Pl,3045 Biomed Sci Res Bldg, Ann Arbor, MI 48109 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Lei, L; Spradling, AC (corresponding author), Carnegie Inst Sci, Howard Hughes Med Inst, Res Labs, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.; Lei, L (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, 109 Zina Pitcher Pl,3045 Biomed Sci Res Bldg, Ann Arbor, MI 48109 USA.	leile@med.umich.edu; spradling@ciwemb.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute. We thank E. Dikovskaia and the Carnegie mouse facility staff for invaluable advice and assistance. C.-M. Fan and C. Lepper contributed helpful advice on mouse husbandry. Members of the Spradling lab provided useful comments on the manuscript. We are grateful to Y. Zheng for providing the anti-Pericentrin antibody.	Alexandrova O, 2005, DEV BIOL, V281, P91, DOI 10.1016/j.ydbio.2005.02.015; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Buning J., 1994, THE INSECT OVARY; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Greenbaum MP, 2009, BIOL REPROD, V80, P449, DOI 10.1095/biolreprod.108.070649; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; Jenkins VK, 2013, TRENDS CELL BIOL, V23, P567, DOI 10.1016/j.tcb.2013.07.005; KLOC M, 1995, DEVELOPMENT, V121, P287; Lei L, 2013, DEVELOPMENT, V140, P2075, DOI 10.1242/dev.093864; Lim AK, 2013, DEVELOPMENT, V140, P3819, DOI 10.1242/dev.099184; MAHOWALD AP, 1970, J CELL BIOL, V45, P306, DOI 10.1083/jcb.45.2.306; Malki S, 2014, DEV CELL, V29, P521, DOI 10.1016/j.devcel.2014.04.027; Matova N, 2001, DEV BIOL, V231, P291, DOI 10.1006/dbio.2000.0120; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Rose CM, 2013, BIOCHEM SOC T, V41, P809, DOI 10.1042/BST20120356; Sun YC, 2014, J GENET GENOMICS, V41, P87, DOI 10.1016/j.jgg.2013.12.008	18	149	152	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					95	99		10.1126/science.aad2156	http://dx.doi.org/10.1126/science.aad2156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	26917595	Green Accepted			2022-12-28	WOS:000373039600043
J	Hnisz, D; Weintraub, AS; Day, DS; Valton, AL; Bak, RO; Li, CH; Goldmann, J; Lajoie, BR; Fan, ZP; Sigova, AA; Reddy, J; Borges-Rivera, D; Lee, TI; Jaenisch, R; Porteus, MH; Dekker, J; Young, RA				Hnisz, Denes; Weintraub, Abraham S.; Day, Daniel S.; Valton, Anne-Laure; Bak, Rasmus O.; Li, Charles H.; Goldmann, Johanna; Lajoie, Bryan R.; Fan, Zi Peng; Sigova, Alla A.; Reddy, Jessica; Borges-Rivera, Diego; Lee, Tong Ihn; Jaenisch, Rudolf; Porteus, Matthew H.; Dekker, Job; Young, Richard A.			Activation of proto-oncogenes by disruption of chromosome neighborhoods	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; 3D GENOME; REGULATORY LANDSCAPE; SUPER-ENHANCERS; CANCER GENOME; CELL IDENTITY; TRANSCRIPTION; ARCHITECTURE; ONCOGENES; TOPOLOGY	Oncogenes are activated through well-known chromosomal alterations such as gene fusion, translocation, and focal amplification. In light of recent evidence that the control of key genes depends on chromosome structures called insulated neighborhoods, we investigated whether proto-oncogenes occur within these structures and whether oncogene activation can occur via disruption of insulated neighborhood boundaries in cancer cells. We mapped insulated neighborhoods in Tcell acute lymphoblastic leukemia (T-ALL) and found that tumor cell genomes contain recurrent microdeletions that eliminate the boundary sites of insulated neighborhoods containing prominent T-ALL proto-oncogenes. Perturbation of such boundaries in nonmalignant cells was sufficient to activate proto-oncogenes. Mutations affecting chromosome neighborhood boundaries were found in many types of cancer. Thus, oncogene activation can occur via genetic alterations that disrupt insulated neighborhoods in malignant cells.	[Hnisz, Denes; Weintraub, Abraham S.; Day, Daniel S.; Li, Charles H.; Goldmann, Johanna; Fan, Zi Peng; Sigova, Alla A.; Reddy, Jessica; Borges-Rivera, Diego; Lee, Tong Ihn; Jaenisch, Rudolf; Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Weintraub, Abraham S.; Li, Charles H.; Reddy, Jessica; Borges-Rivera, Diego; Jaenisch, Rudolf; Young, Richard A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Valton, Anne-Laure; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, Worcester, MA 01605 USA; [Bak, Rasmus O.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Fan, Zi Peng] MIT, Computat & Syst Biol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dekker, Job] Howard Hughes Med Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; Stanford University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Young, RA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	young@wi.mit.edu	Bak, Rasmus O./AAH-9748-2021; Hnisz, Denes/AAE-9592-2019; Young, Richard A/F-6495-2012	Bak, Rasmus O./0000-0002-7383-0297; Hnisz, Denes/0000-0002-6256-1693; Young, Richard A/0000-0001-8855-8647; Valton, Anne-Laure/0000-0001-6496-8430; Li, Charles/0000-0001-8091-6112	NIH [HG002668, CA109901, NS088538, MH104610, AI120766, U54 DK107980, U01 DA 040588]; Austrian Science Fund (FWF) [J3490]; Ludwig Graduate Fellowship funds; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; Hyundai Hope on Wheels; Danish Council for Independent Research, Medical Sciences [DFF-1333-00106B, DFF-1331-00735B]; National Human Genome Research Institute [R01 HG003143, U54 HG007010, U01 HG007910]; National Cancer Institute [U54 CA193419]; National Institute of General Medical Sciences [R01 GM 112720]; National Institute of Allergy and Infectious Diseases [U01 R01 AI 117839]; Austrian Science Fund (FWF) [J 3490] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA109901, P30CA014051, U54CA193419] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668, U54HG007010, R25HG007631, U01HG007910, R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120766, R01AI117839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112720, T32GM007287, T32GM087237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA040588] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Ludwig Graduate Fellowship funds; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; Hyundai Hope on Wheels; Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIH grants HG002668 (R.A.Y.), CA109901 (R.A.Y.), NS088538 (R.J.), MH104610 (R.J.), and AI120766 (M.H.P.); an Erwin Schrodinger Fellowship (J3490) from the Austrian Science Fund (FWF) (D.H.); Ludwig Graduate Fellowship funds (A.S.W.); the Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research (M.H.P.); Hyundai Hope on Wheels (M.H.P.); and Danish Council for Independent Research, Medical Sciences, individual postdoctoral grant DFF-1333-00106B and Sapere Aude Research Talent grant DFF-1331-00735B (R.O.B.). Work in the Dekker lab is supported by the National Human Genome Research Institute (R01 HG003143, U54 HG007010, U01 HG007910), the National Cancer Institute (U54 CA193419), the NIH Common Fund (U54 DK107980, U01 DA 040588), the National Institute of General Medical Sciences (R01 GM 112720), and the National Institute of Allergy and Infectious Diseases (U01 R01 AI 117839). J.D. is an investigator of the Howard Hughes Medical Institute. We thank R. Fitzgerald, S. Grimmond, and the ICGC Genome Projects ESAD-UK and OV-AU for permission to use genome sequence data. Data sets generated in this study have been deposited in the Gene Expression Omnibus under accession number GSE68978. The Whitehead Institute filed a patent application based on this paper. R.A.Y. is a founder of Syros Pharmaceuticals, and R.J. is a founder of Fate Therapeutics.	Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	26	544	557	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1454	1458		10.1126/science.aad9024	http://dx.doi.org/10.1126/science.aad9024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	26940867	Green Accepted, Green Submitted			2022-12-28	WOS:000372756200050
J	Cole, TB				Cole, Thomas B.			Pinkerton Riot, Pittsburgh	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					964	965		10.1001/jama.2015.14151	http://dx.doi.org/10.1001/jama.2015.14151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954397				2022-12-28	WOS:000371540200001
J	Monz, T; Nigg, D; Martinez, EA; Brandl, MF; Schindler, P; Rines, R; Wang, SX; Chuang, IL; Blatt, R				Monz, Thomas; Nigg, Daniel; Martinez, Esteban A.; Brandl, Matthias F.; Schindler, Philipp; Rines, Richard; Wang, Shannon X.; Chuang, Isaac L.; Blatt, Rainer			Realization of a scalable Shor algorithm	SCIENCE			English	Article							QUANTUM FACTORING ALGORITHM; FOURIER-TRANSFORM; QUBIT	Certain algorithms for quantumcomputers are able to outperform their classical counterparts. In 1994, Peter Shor came up with a quantum algorithm that calculates the prime factors of a large number vastly more efficiently than a classical computer. For general scalability of such algorithms, hardware, quantum error correction, and the algorithmic realization itself need to be extensible. Herewe present the realization of a scalable Shor algorithm, as proposed by Kitaev. We factor the number 15 by effectively employing and controlling seven qubits and four "cache qubits" and by implementing generalized arithmetic operations, known as modular multipliers. This algorithm has been realized scalably within an ion-trap quantum computer and returns the correct factors with a confidence level exceeding 99%.	[Monz, Thomas; Nigg, Daniel; Martinez, Esteban A.; Brandl, Matthias F.; Schindler, Philipp; Blatt, Rainer] Univ Innsbruck, Inst Phys Expt, Technikerstr 25, A-6020 Innsbruck, Austria; [Rines, Richard; Wang, Shannon X.; Chuang, Isaac L.] MIT, Ctr Ultracold Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Blatt, Rainer] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, Otto Hittmair Pl 1, A-6020 Innsbruck, Austria	University of Innsbruck; Massachusetts Institute of Technology (MIT); Austrian Academy of Sciences	Monz, T (corresponding author), Univ Innsbruck, Inst Phys Expt, Technikerstr 25, A-6020 Innsbruck, Austria.	thomas.monz@uibk.ac.at	Blatt, Rainer/H-9527-2014; Monz, Thomas/E-1285-2017; Schindler, Philipp/E-1485-2017; Schindler, Philipp/AAB-4803-2019	Schindler, Philipp/0000-0002-9461-9650; Schindler, Philipp/0000-0002-9461-9650; Martinez, Esteban/0000-0002-0803-4024; /0000-0001-7296-523X; Monz, Thomas/0000-0001-7410-4804	Austrian Science Fund (FWF), through the SFB FoQus (FWF) [F4002-N16]; European Commission (AQUTE); NSF Interdisciplinary Quantum Information Science and Engineering (iQuISE) Integrative Graduate Education and Research Traineeship (IGERT); Institut fur Quantenoptik und Quanteninformation; DOC Fellowship of the Austrian Academy of Sciences; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through Army Research Office [W911NF-10-1-0284]; Austrian Science Fund (FWF) [J 3600] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1125846] Funding Source: National Science Foundation	Austrian Science Fund (FWF), through the SFB FoQus (FWF)(Austrian Science Fund (FWF)); European Commission (AQUTE)(European CommissionEuropean Commission Joint Research Centre); NSF Interdisciplinary Quantum Information Science and Engineering (iQuISE) Integrative Graduate Education and Research Traineeship (IGERT); Institut fur Quantenoptik und Quanteninformation; DOC Fellowship of the Austrian Academy of Sciences; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through Army Research Office; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from the Austrian Science Fund (FWF), through the SFB FoQus (FWF project no. F4002-N16); the European Commission (AQUTE), the NSF Interdisciplinary Quantum Information Science and Engineering (iQuISE) Integrative Graduate Education and Research Traineeship (IGERT); and the Institut fur Quantenoptik und Quanteninformation. E.A.M. is a recipient of a DOC Fellowship of the Austrian Academy of Sciences. This research was funded by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through Army Research Office grant W911NF-10-1-0284. All statements of fact, opinion, or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI, or the U.S. government. T.M., D.N., and P.S. developed the research, on the basis of theoretical ideas derived with R.R., S.X.W., and I.L.C; T.M., D.N., E.A.M., M.F.B., P.S., and S.X.W. performed the experiments; T.M. and D.N. analyzed the data; T.M., D.N., E.A.M., P.S., M.F.B., and R.B. contributed to the experiment; T.M., D.N., R.R., M.F.B., I.L.C., and R.B. wrote the manuscript; and all authors contributed to discussions about the results and the manuscript. We declare no competing financial interests.	Chiaverini J, 2005, SCIENCE, V308, P997, DOI 10.1126/science.1110335; DEHMELT H, 1975, B AM PHYS SOC, V20, P60; Griffiths RB, 1996, PHYS REV LETT, V76, P3228, DOI 10.1103/PhysRevLett.76.3228; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Lanyon BP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250505; Lu CY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250504; Lucero E, 2012, NAT PHYS, V8, P719, DOI [10.1038/nphys2385, 10.1038/NPHYS2385]; Martin-Lopez E, 2012, NAT PHOTONICS, V6, P773, DOI [10.1038/NPHOTON.2012.259, 10.1038/nphoton.2012.259]; MARZOLI I, 1994, PHYS REV A, V49, P2771, DOI 10.1103/PhysRevA.49.2771; Mosca M, 1999, LECT NOTES COMPUT SC, V1509, P174; Nebendahl V, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.012312; Nielsen M. A., 2004, CAMBRIDGE SERIES INF; Parker S, 2000, PHYS REV LETT, V85, P3049, DOI 10.1103/PhysRevLett.85.3049; Politi A, 2009, SCIENCE, V325, P1221, DOI 10.1126/science.1173731; Rieffel EG, 2011, SCI ENG COMPUTATION; Schindler P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/123012; SHOR PW, 1994, AN S FDN CO, P124; Smolin JA, 2013, NATURE, V499, P163, DOI 10.1038/nature12290; Stajic J, 2013, SCIENCE, V339, P1163, DOI 10.1126/science.339.6124.1163; Van Meter R, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.052320; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Vedral V, 1996, PHYS REV A, V54, P147, DOI 10.1103/PhysRevA.54.147	24	202	207	11	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1068	1070		10.1126/science.aad9480	http://dx.doi.org/10.1126/science.aad9480			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941315	Green Submitted			2022-12-28	WOS:000371597500040
J	Beyaz, S; Mana, MD; Roper, J; Kedrin, D; Saadatpour, A; Hong, SJ; Bauer-Rowe, KE; Xifaras, ME; Akkad, A; Arias, E; Pinello, L; Katz, Y; Shinagare, S; Abu-Remaileh, M; Mihaylova, MM; Lamming, DW; Dogum, R; Guo, GJ; Bell, GW; Selig, M; Nielsen, GP; Gupta, N; Ferrone, CR; Deshpande, V; Yuan, GC; Orkin, SH; Sabatini, DM; Yilmaz, OH				Beyaz, Semir; Mana, Miyeko D.; Roper, Jatin; Kedrin, Dmitriy; Saadatpour, Assieh; Hong, Sue Jean; Bauer-Rowe, Khristian E.; Xifaras, Michael E.; Akkad, Adam; Arias, Erika; Pinello, Luca; Katz, Yarden; Shinagare, Shweta; Abu-Remaileh, Monther; Mihaylova, Maria M.; Lamming, Dudley W.; Dogum, Rizkullah; Guo, Guoji; Bell, George W.; Selig, Martin; Nielsen, G. Petur; Gupta, Nitin; Ferrone, Cristina R.; Deshpande, Vikram; Yuan, Guo-Cheng; Orkin, Stuart H.; Sabatini, David M.; Yilmaz, Oemer H.			High-fat diet enhances stemness and tumorigenicity of intestinal progenitors	NATURE			English	Article							ACTIVATED-RECEPTOR-DELTA; COLORECTAL-CANCER; GENETIC DISRUPTION; IN-VITRO; CELLS; PROGRESSION; EXPRESSION; LGR5; MECHANISMS; PLASTICITY	Little is known about how pro-obesity diets regulate tissue stem and progenitor cell function. Here we show that high-fat diet (HFD)-induced obesity augments the numbers and function of Lgr5(+) intestinal stem cells of the mammalian intestine. Mechanistically, a HFD induces a robust peroxisome proliferator-activated receptor delta (PPAR-delta) signature in intestinal stem cells and progenitor cells (non-intestinal stem cells), and pharmacological activation of PPAR-delta recapitulates the effects of a HFD on these cells. Like a HFD, ex vivo treatment of intestinal organoid cultures with fatty acid constituents of the HFD enhances the self-renewal potential of these organoid bodies in a PPAR-delta-dependent manner. Notably, HFD- and agonist-activated PPAR-delta signalling endow organoid-initiating capacity to progenitors, and enforced PPAR-delta signalling permits these progenitors to form in vivo tumours after loss of the tumour suppressor Apc. These findings highlight how diet-modulated PPAR-delta activation alters not only the function of intestinal stem and progenitor cells, but also their capacity to initiate tumours.	[Beyaz, Semir; Mana, Miyeko D.; Roper, Jatin; Kedrin, Dmitriy; Bauer-Rowe, Khristian E.; Xifaras, Michael E.; Akkad, Adam; Arias, Erika; Shinagare, Shweta; Abu-Remaileh, Monther; Mihaylova, Maria M.; Dogum, Rizkullah; Sabatini, David M.; Yilmaz, Oemer H.] MIT, Dept Biol, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Beyaz, Semir; Guo, Guoji; Orkin, Stuart H.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Beyaz, Semir; Guo, Guoji; Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol,Howard Hughes Med Inst,Harvard, 44 Binney St, Boston, MA 02115 USA; [Roper, Jatin] Tufts Med Ctr, Div Gastroenterol, Boston, MA 02111 USA; [Roper, Jatin] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Kedrin, Dmitriy; Selig, Martin; Nielsen, G. Petur; Ferrone, Cristina R.; Deshpande, Vikram; Yilmaz, Oemer H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kedrin, Dmitriy; Selig, Martin; Nielsen, G. Petur; Ferrone, Cristina R.; Deshpande, Vikram; Yilmaz, Oemer H.] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA; [Kedrin, Dmitriy; Selig, Martin; Nielsen, G. Petur; Ferrone, Cristina R.; Deshpande, Vikram; Yilmaz, Oemer H.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Kedrin, Dmitriy; Selig, Martin; Nielsen, G. Petur; Ferrone, Cristina R.; Deshpande, Vikram; Yilmaz, Oemer H.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Saadatpour, Assieh; Pinello, Luca; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Saadatpour, Assieh; Pinello, Luca; Yuan, Guo-Cheng] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Hong, Sue Jean; Abu-Remaileh, Monther; Mihaylova, Maria M.; Bell, George W.; Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, 77 Massachusetts Ave, Cambridge, MA 02142 USA; [Katz, Yarden; Sabatini, David M.; Yilmaz, Oemer H.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Lamming, Dudley W.] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Gupta, Nitin] Univ Mississippi, Med Ctr, Div Digest Dis, Jackson, MS 39216 USA	Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Tufts Medical Center; Tufts Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Wisconsin System; University of Wisconsin Madison; University of Mississippi; University of Mississippi Medical Center	Sabatini, DM; Yilmaz, OH (corresponding author), MIT, Dept Biol, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Yilmaz, OH (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Yilmaz, OH (corresponding author), Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA.; Yilmaz, OH (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.; Sabatini, DM (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, 77 Massachusetts Ave, Cambridge, MA 02142 USA.; Sabatini, DM; Yilmaz, OH (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu; ohyilmaz@mit.edu	Abu-Remaileh, Monther/M-3747-2016; Lamming, Dudley/O-7191-2015; Mihaylova, Maria M./ACZ-4949-2022; Gupta, Nitin/A-1076-2016	Lamming, Dudley/0000-0002-0079-4467; Mihaylova, Maria M./0000-0002-2725-767X; Gupta, Nitin/0000-0002-4471-2363; Beyaz, Semir/0000-0003-4730-4012; Mana, Miyeko/0000-0002-5516-4008; /0000-0002-1446-7256; Guo, Guoji/0000-0002-1716-4621; Pinello, Luca/0000-0003-1109-3823; Abu-Remaileh, Monther/0000-0003-3772-0477; Roper, Jatin/0000-0002-8851-1352	Howard Hughes Medical Institute; Ellison Medical Foundation Aging; NIH [R01 CA103866, A147389, K08 CA198002, ROD AG045144, ROD AG041765]; Department of Defense PRCRP Career Development Award [CA120198]; Center for the Study of Inflammatory Bowel Diseases from the Massachusetts General Hospital NIH [DK043351]; NIH Cancer Center Support [P30-CA14051]; Kathy and Curt Marble Cancer Research Fund; American Federation of Aging Research (AFAR); V Foundation Scholar grant; Koch MIT Ludwig Center; MGH [T32DK007191]; Damon Runyon Cancer Research Foundation; Hope Babette Tang Histology Facility and Kathleen Cormier; NATIONAL CANCER INSTITUTE [P30CA014051, K08CA198002, R01CA129105, R01CA103866, R01CA120198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG045144, R00AG041765, R00AG045144, K99AG041765] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ellison Medical Foundation Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense PRCRP Career Development Award; Center for the Study of Inflammatory Bowel Diseases from the Massachusetts General Hospital NIH; NIH Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kathy and Curt Marble Cancer Research Fund; American Federation of Aging Research (AFAR); V Foundation Scholar grant; Koch MIT Ludwig Center; MGH; Damon Runyon Cancer Research Foundation; Hope Babette Tang Histology Facility and Kathleen Cormier; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Howard Hughes Medical Institute (S.H.O. and D.M.S.), Ellison Medical Foundation Aging grant (D.M.S.), NIH (R01 CA103866 and A147389; D.M.S.), NIH (K08 CA198002; J.R.), Department of Defense PRCRP Career Development Award CA120198 (J.R.), NIH (ROD AG045144; O.H.Y.), NIH (ROD AG041765; D.W.L.), Center for the Study of Inflammatory Bowel Diseases from the Massachusetts General Hospital NIH (DK043351; O.H.Y.), NIH Cancer Center Support (core) grant P30-CA14051 (O.H.Y.), Kathy and Curt Marble Cancer Research Fund (O.H.Y.), American Federation of Aging Research (AFAR; O.H.Y.), and V Foundation Scholar grant (J.R. and O.H.Y.). M.G.M. is supported by a Koch MIT Ludwig Center post-doctoral fellowship, D.K. receives fellowship support from MGH (T32DK007191), and M.M.M. is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation. We thank the Koch Institute Swanson Biotechnology Center (SBC) for technical support specifically the Hope Babette Tang (1983) Histology Facility and Kathleen Cormier. We thank S. Holder for superior histology and help with special stains. We thank P. Wisniewski and G. Paradis of the Whitehead flow cytometry and Koch core facilities, respectively, for their expertise in cell sorting We thank members of the Yilmaz laboratory for discussions.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baltgalvis KA, 2009, CANCER PREV RES, V2, P641, DOI 10.1158/1940-6207.CAPR-09-0017; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gregorieff A, 2010, CURR PROTOC STEM CEL; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Johnson AMF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122195; Kim JS, 2002, CANCER RES, V62, P2744; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Mah AT, 2014, ENDOCRINOLOGY, V155, P3302, DOI 10.1210/en.2014-1112; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Neels JG, 2014, PHYSIOL REV, V94, P795, DOI 10.1152/physrev.00027.2013; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Pinello L, 2014, P NATL ACAD SCI USA, V111, pE344, DOI 10.1073/pnas.1322570111; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scholtysek C, 2013, NAT MED, V19, P608, DOI 10.1038/nm.3146; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang DZ, 2014, P NATL ACAD SCI USA, V111, P7084, DOI 10.1073/pnas.1324233111; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zuo XS, 2009, JNCI-J NATL CANCER I, V101, P762, DOI 10.1093/jnci/djp078	48	401	410	10	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					53	+		10.1038/nature17173	http://dx.doi.org/10.1038/nature17173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26935695	Green Submitted, Green Accepted			2022-12-28	WOS:000371211900038
J	Dance, A				Dance, Amber			A dose of intelligence	NATURE			English	Editorial Material																		Battleday RM, 2015, EUR NEUROPSYCHOPHARM, V25, P1865, DOI 10.1016/j.euroneuro.2015.07.028; Esposito R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069224; Franke AG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-102; Singh I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105969; Urban KR, 2012, BIOL PSYCHIAT, V72, P880, DOI 10.1016/j.biopsych.2012.04.018	5	20	21	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S2	S3		10.1038/531S2a	http://dx.doi.org/10.1038/531S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26934523				2022-12-28	WOS:000371211900001
J	Kashiwagi, K; Takahashi, M; Nishimoto, M; Hiyama, TB; Higo, T; Umehara, T; Sakamoto, K; Ito, T; Yokoyama, S				Kashiwagi, Kazuhiro; Takahashi, Mari; Nishimoto, Madoka; Hiyama, Takuya B.; Higo, Toshiaki; Umehara, Takashi; Sakamoto, Kensaku; Ito, Takuhiro; Yokoyama, Shigeyuki			Crystal structure of eukaryotic translation initiation factor 2B	NATURE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; FACTOR EIF 2B; ALPHA-SUBUNIT; REGULATORY SUBCOMPLEX; PROTEIN-SYNTHESIS; GENETIC-CODE; REVEALS; IDENTIFICATION; MUTATIONS; EIF2-ALPHA	Eukaryotic cells restrict protein synthesis under various stress conditions, by inhibiting the eukaryotic translation initiation factor 2B (eIF2B)(1,2). eIF2B is the guanine nucleotide exchange factor for eIF2, a heterotrimeric G protein consisting of alpha-, beta- and gamma-subunits. eIF2B exchanges GDP for GTP on the.-subunit of eIF2 (eIF2.), and is inhibited by stress-induced phosphorylation of eIF2 alpha. eIF2B is a heterodecameric complex of two copies each of the alpha-, beta- and gamma-and e-subunits(3); its alpha-, beta- and delta-subunits constitute the regulatory subcomplex(4), while the gamma-and epsilon-subunits form the catalytic subcomplex(5). The three-dimensional structure of the entire eIF2B complex has not been determined. Here we present the crystal structure of Schizosaccharomyces pombe eIF2B with an unprecedented subunit arrangement, in which the alpha(2)beta(2)delta(2) hexameric regulatory subcomplex binds two.e dimeric catalytic subcomplexes on its opposite sides. A structure-based in vitro analysis by a surface-scanning site-directed photo-cross-linking method identified the eIF2a-binding and eIF2 gamma-binding interfaces, located far apart on the regulatory and catalytic subcomplexes, respectively. The eIF2 gamma-binding interface is located close to the conserved ` NF motif', which is important for nucleotide exchange. A structural model was constructed for the complex of eIF2B with phosphorylated eIF2 alpha, which binds to eIF2B more strongly than the unphosphorylated form. These results indicate that the eIF2 alpha phosphorylation generates the ` nonproductive' eIF2-eIF2B complex(5), which prevents nucleotide exchange on eIF2 gamma, and thus provide a structural framework for the eIF2B-mediated mechanism of stress-induced translational control.	[Kashiwagi, Kazuhiro; Hiyama, Takuya B.; Ito, Takuhiro; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kashiwagi, Kazuhiro; Hiyama, Takuya B.; Higo, Toshiaki; Umehara, Takashi; Sakamoto, Kensaku; Ito, Takuhiro; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kashiwagi, Kazuhiro; Takahashi, Mari; Nishimoto, Madoka; Higo, Toshiaki; Umehara, Takashi; Sakamoto, Kensaku; Ito, Takuhiro] RIKEN Ctr Life Sci Technol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] RIKEN Struct Biol Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	University of Tokyo; RIKEN; RIKEN; RIKEN	Ito, T; Yokoyama, S (corresponding author), Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan.; Ito, T; Yokoyama, S (corresponding author), RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.; Ito, T; Yokoyama, S (corresponding author), RIKEN Ctr Life Sci Technol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.; Yokoyama, S (corresponding author), RIKEN Struct Biol Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	takuhiro.ito@riken.jp; yokoyama@riken.jp	Kashiwagi, Kazuhiro/ABB-4052-2020; Kashiwagi, Kazuhiro/D-2174-2017; Yokoyama, Shigeyuki/N-6911-2015; Umehara, Takashi/AHB-1730-2022; Umehara, Takashi/N-5683-2015; Sakamoto, Kensaku/N-7496-2015; Ito, Takuhiro/N-6893-2015	Kashiwagi, Kazuhiro/0000-0001-6470-5817; Kashiwagi, Kazuhiro/0000-0001-6470-5817; Yokoyama, Shigeyuki/0000-0003-3133-7338; Umehara, Takashi/0000-0003-3464-2960; Umehara, Takashi/0000-0003-3464-2960; Sakamoto, Kensaku/0000-0003-2866-5031; Ito, Takuhiro/0000-0003-3704-5205; Takahashi, Mari/0000-0002-9995-0019	JSPS KAKENHI [23687013, 25121737]; Targeted Proteins Research Program (TPRP); Platform for Drug Discovery, Informatics and Structural Life Science, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; UT-RIKEN Cooperation Laboratory of Structural Biology	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics and Structural Life Science, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; UT-RIKEN Cooperation Laboratory of Structural Biology	We thank the staff of the beamline BL41XU at SPring-8 for their support. This work was performed with the approval of the Japan Synchrotron Radiation Research Institute (proposals 2012A1335 and 2012B1572). This work was supported by JSPS KAKENHI grants 23687013 and 25121737 (to T.I.), the Targeted Proteins Research Program (TPRP) and the Platform for Drug Discovery, Informatics and Structural Life Science, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to S.Y.), and a research program of the UT-RIKEN Cooperation Laboratory of Structural Biology (to S.Y.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bogorad AM, 2014, BIOCHEMISTRY-US, V53, P3432, DOI 10.1021/bi500346u; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DEALDANA CRV, 1994, MOL CELL BIOL, V14, P3208, DOI 10.1128/MCB.14.5.3208; DEALDANA CRV, 1993, P NATL ACAD SCI USA, V90, P7215; Dev K, 2009, J MOL BIOL, V392, P701, DOI 10.1016/j.jmb.2009.07.030; Dey M, 2005, MOL CELL BIOL, V25, P3063, DOI 10.1128/MCB.25.8.3063-3075.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Geva M, 2010, BRAIN, V133, P2448, DOI 10.1093/brain/awq180; Gomez E, 2002, EMBO J, V21, P5292, DOI 10.1093/emboj/cdf515; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; Gordiyenko Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4902; Higo Toshiaki, 2014, Journal of Structural and Functional Genomics, V15, P191, DOI 10.1007/s10969-014-9190-1; Hiyama TB, 2009, J MOL BIOL, V392, P937, DOI 10.1016/j.jmb.2009.07.054; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jennings MD, 2013, GENE DEV, V27, P2696, DOI 10.1101/gad.231514.113; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Kuhle B, 2015, NUCLEIC ACIDS RES, V43, P9994, DOI 10.1093/nar/gkv930; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Liu R, 2011, HUM MUTAT, V32, P1036, DOI 10.1002/humu.21535; Matsui T, 2001, BIOCHEM BIOPH RES CO, V284, P798, DOI 10.1006/bbrc.2001.5039; Mukai T, 2011, BIOCHEM BIOPH RES CO, V411, P757, DOI 10.1016/j.bbrc.2011.07.020; Nakamura A, 2012, J BIOL CHEM, V287, P20784, DOI 10.1074/jbc.M112.349423; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Reid PJ, 2012, J BIOL CHEM, V287, P8275, DOI 10.1074/jbc.M111.331645; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang XM, 2012, J BIOL CHEM, V287, P8263, DOI 10.1074/jbc.M111.331553; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wortham NC, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0204-z; Wortham NC, 2014, FASEB J, V28, P2225, DOI 10.1096/fj.13-243329; Yang WM, 1996, MOL CELL BIOL, V16, P6603; Yatime L, 2007, P NATL ACAD SCI USA, V104, P18445, DOI 10.1073/pnas.0706784104	47	68	71	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					122	+		10.1038/nature16991	http://dx.doi.org/10.1038/nature16991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26901872				2022-12-28	WOS:000371211900053
J	Kirchdoerfer, RN; Cottrell, CA; Wang, NS; Pallesen, J; Yassine, HM; Turner, HL; Corbett, KS; Graham, BS; McLellan, JS; Ward, AB				Kirchdoerfer, Robert N.; Cottrell, Christopher A.; Wang, Nianshuang; Pallesen, Jesper; Yassine, Hadi M.; Turner, Hannah L.; Corbett, Kizzmekia S.; Graham, Barney S.; McLellan, Jason S.; Ward, Andrew B.			Pre-fusion structure of a human coronavirus spike protein	NATURE			English	Article							RECEPTOR-BINDING DOMAIN; CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPE; VIRUS; GLYCOPROTEIN; HEMAGGLUTININ; VISUALIZATION; VALIDATION; MECHANISMS	HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease1, and is related to the zoonotic SARS(2) and MERS3 betacoronaviruses, which have high fatality rates and pandemic potential. Cell tropism and host range is determined in part by the coronavirus spike (S) protein(4), which binds cellular receptors and mediates membrane fusion. As the largest known class I fusion protein, its size and extensive glycosylation have hindered structural studies of the full ectodomain, thus preventing a molecular understanding of its function and limiting development of effective interventions. Here we present the 4.0 resolution structure of the trimeric HKU1 S protein determined using singleparticle cryo-electron microscopy. In the pre-fusion conformation, the receptor-binding subunits, S1, rest above the fusion-mediating subunits, S2, preventing their conformational rearrangement. Surprisingly, the S1 C-terminal domains are interdigitated and form extensive quaternary interactions that occlude surfaces known in other coronaviruses to bind protein receptors. These features, along with the location of the two protease sites known to be important for coronavirus entry, provide a structural basis to support a model of membrane fusion mediated by progressive S protein destabilization through receptor binding and proteolytic cleavage. These studies should also serve as a foundation for the structure-based design of betacoronavirus vaccine immunogens.	[Kirchdoerfer, Robert N.; Cottrell, Christopher A.; Pallesen, Jesper; Turner, Hannah L.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Wang, Nianshuang; McLellan, Jason S.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Yassine, Hadi M.; Corbett, Kizzmekia S.; Graham, Barney S.] NIAID, Viral Pathogenesis Lab, Bldg 40,Room 2502,40 Convent Dr, Bethesda, MD 20892 USA; [Yassine, Hadi M.] Qatar Univ, Biomed Res Ctr, QU NRC, Zone 5,Room D130, Doha, Qatar	Scripps Research Institute; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Qatar University	Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.; McLellan, JS (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	Jason.S.McLellan@Dartmouth.edu; ABWard@Scripps.edu	Ward, Andrew/ABD-7728-2021; Cottrell, Christopher A/P-3514-2015; Graham, Barney S./AAC-5898-2019; Wang, Nianshuang/C-1463-2010; Ward, Andrew B/F-9203-2014; YASSINE, HADI M./AAW-6475-2020	Ward, Andrew/0000-0001-7153-3769; Cottrell, Christopher A/0000-0002-3364-3083; Graham, Barney S./0000-0001-8112-0853; Wang, Nianshuang/0000-0002-7569-011X; Ward, Andrew B/0000-0001-7153-3769; YASSINE, HADI M./0000-0001-7592-2788; McLellan, Jason/0000-0003-3991-542X; Pallesen, Jesper/0000-0002-3270-1587	Scripps Research Institute; Geisel School of Medicine at Dartmouth; intramural NIAID; NIH [R56 AI118016]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005125, R56AI118016] Funding Source: NIH RePORTER	Scripps Research Institute; Geisel School of Medicine at Dartmouth; intramural NIAID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank colleagues and members of our laboratories for critical reading of the manuscript. This work was supported by start-up funds to A.B.W. from the Scripps Research Institute and to J.S.M from the Geisel School of Medicine at Dartmouth, and funding from intramural NIAID to B.S.G. Partial salary support for R.N.K. was provided by NIH grant R56 AI118016. This is manuscript 29286 from TSRI.	Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christian MD, 2004, CLIN INFECT DIS, V38, P1420, DOI 10.1086/420743; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Duquerroy S, 2005, VIROLOGY, V335, P276, DOI 10.1016/j.virol.2005.02.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Huang XC, 2015, J VIROL, V89, P7202, DOI 10.1128/JVI.00854-15; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kong L, 2015, ACTA CRYSTALLOGR D, V71, P2099, DOI 10.1107/S1399004715013917; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4614; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Lu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4067; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Matsuyama S, 2009, J VIROL, V83, P11133, DOI 10.1128/JVI.00959-09; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mou H, 2013, J VIROL, V87, P9379, DOI 10.1128/JVI.01277-13; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Peng GQ, 2012, J BIOL CHEM, V287, P41931, DOI 10.1074/jbc.M112.418210; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian ZH, 2015, J VIROL, V89, P8816, DOI 10.1128/JVI.03737-14; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schrodinger L, 2012, PYMOL MOL GRAPHICS S; Sievers F., 2014, CURR PROTOC BIOINFOR, V48, P31311; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Welch BD, 2012, P NATL ACAD SCI USA, V109, P16672, DOI 10.1073/pnas.1213802109; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wong JJW, 2016, P NATL ACAD SCI USA, V113, P1056, DOI 10.1073/pnas.1523303113; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Xu K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005322; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zimmer G, 2001, J BIOL CHEM, V276, P31642, DOI 10.1074/jbc.M102633200	57	417	432	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					118	121		10.1038/nature17200	http://dx.doi.org/10.1038/nature17200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26935699	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000371211900052
J	McGilvray, A				McGilvray, Annabel			Restoration project	NATURE			English	Editorial Material							FEMALE RHESUS-MONKEYS; COGNITIVE FUNCTION											Hao JD, 2006, J NEUROSCI, V26, P2571, DOI 10.1523/JNEUROSCI.3440-05.2006; Hara Y, 2011, J NEUROSCI, V31, P7737, DOI 10.1523/JNEUROSCI.0822-11.2011; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	5	6	6	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S4	S5		10.1038/531S4a	http://dx.doi.org/10.1038/531S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26934524	Bronze			2022-12-28	WOS:000371211900002
J	Sugiyama, M; Sakata, I; Shiroyama, H; Yoshikawa, H; Taniguchi, T				Sugiyama, Masahiro; Sakata, Ichiro; Shiroyama, Hideaki; Yoshikawa, Hisashi; Taniguchi, Taketoshi			Five years on from Fukushima	NATURE			English	Editorial Material							SCIENCE; SUSTAINABILITY		[Sugiyama, Masahiro; Sakata, Ichiro; Yoshikawa, Hisashi; Taniguchi, Taketoshi] Univ Tokyo, Policy Alternat Res Inst, Tokyo 1138654, Japan; [Sakata, Ichiro] Univ Tokyo, Grad Sch Engn, Tokyo 1138654, Japan; [Shiroyama, Hideaki; Yoshikawa, Hisashi] Univ Tokyo, Grad Sch Publ Policy, Tokyo 1138654, Japan; [Shiroyama, Hideaki] Univ Tokyo, Grad Sch Law, Tokyo 1138654, Japan; [Shiroyama, Hideaki] Univ Tokyo, Grad Sch Polit, Tokyo 1138654, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Sugiyama, M (corresponding author), Univ Tokyo, Policy Alternat Res Inst, Tokyo 1138654, Japan.	masahiro_sugiyama@alum.mit.edu	Sugiyama, Masahiro/ABD-3698-2021	Sugiyama, Masahiro/0000-0002-2038-1045; SAKATA, ICHIRO/0000-0001-5881-3790				Arimoto T, 2012, SCIENCE, V337, P1176, DOI 10.1126/science.1224004; Fujigaki Y, 2015, LESSONS FUKUSHIMA JA; Igami M, 2016, SCIENTOMETRICS, V106, P383, DOI 10.1007/s11192-015-1648-9; International Atomic Energy Agency, 2011, REV INES RAT EFF NUC; Kajikawa Y, 2008, SUSTAIN SCI, V3, P215, DOI 10.1007/s11625-008-0053-1; Ofuji K, 2015, WIRES ENERGY ENVIRON, V4, P307, DOI 10.1002/wene.139; Shiroyama H., 2015, FUKUSHIMA DAIICHI NU; Yasunari T, 2013, CURR OPIN ENV SUST, V5, P288, DOI 10.1016/j.cosust.2013.08.002; Yoshikawa H., 2002, TRENDS SCI, V7, P25	9	9	10	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					29	31		10.1038/531029a	http://dx.doi.org/10.1038/531029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2YW	26935680	Bronze			2022-12-28	WOS:000371211900022
J	Wald, C				Wald, Chelsea			Better together	NATURE			English	Editorial Material							SOCIAL NETWORK SIZE; DEMENTIA; OTHERS											Cotten SR, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2306; Dodge H. H., 2015, ALZHEIMERS DEMENT, V1, P112; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Kanai R, 2012, P ROY SOC B-BIOL SCI, V279, P1327, DOI 10.1098/rspb.2011.1959; Lewis PA, 2011, NEUROIMAGE, V57, P1624, DOI 10.1016/j.neuroimage.2011.05.030; Molesworth T, 2015, SOC COGN AFFECT NEUR, V10, P1169, DOI 10.1093/scan/nsv001; Seeman TE, 2011, J GERONTOL B-PSYCHOL, V66, P141, DOI 10.1093/geronb/gbq091; Stiller J, 2007, SOC NETWORKS, V29, P93, DOI 10.1016/j.socnet.2006.04.001; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081	10	5	5	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S14	S15		10.1038/531S14a	http://dx.doi.org/10.1038/531S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2YW	26934520				2022-12-28	WOS:000371211900007
J	Patel, MS; Steinberg, MB				Patel, Manish S.; Steinberg, Michael B.			Smoking Cessation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HELPING SMOKERS QUIT; UNITED-STATES; NICOTINE PATCH; TOBACCO USE; VARENICLINE; CIGARETTE; ADULTS; RISK; COMBINATION; MORTALITY	Although tobacco use in the United States has been reduced by more than half since 1965, it remains the principal cause of preventable death, with an estimated 480 000 premature deaths per year, and accounts for more than $289 billion in health care expenditures and productivity losses (1). The latest figures from the Centers for Disease Control and Prevention (CDC) show that 17.8% of adults and 9.2% of high school students smoke cigarettes (2, 3). However, when all tobacco products are included, the prevalence is 21.3% and 24.6%, respectively (2, 4). In 2014, the most commonly used tobacco products by high school students were electronic cigarettes (13.4%), followed by hookah (9.4%), highlighting an increasingly challenging landscape for clinicians (2). In addition, many physicians report inadequate training in tobacco treatment and many smokers do not receive assistance to quit.							American College of Physicians	American College of Physicians	American College of Physicians.	ACOG Committee on Health Care for Underdeserved Women, 2005, Obstet Gynecol, V106, P883; Agaku IT, 2014, MMWR-MORBID MORTAL W, V63, P542; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2010, TOB CONTR PREV; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Barnes J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001008.pub2; Brandon TH, 2012, AM J PUBLIC HEALTH, V102, P2109, DOI 10.2105/AJPH.2012.300653; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Cahill K, 2014, JAMA-J AM MED ASSOC, V311, P193, DOI 10.1001/jama.2013.283787; Carson KV, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000214.pub2; Cheng TR, 2014, TOB CONTROL, V23, P11, DOI 10.1136/tobaccocontrol-2013-051482; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; DOBSON AJ, 1991, J CLIN EPIDEMIOL, V44, P1247, DOI 10.1016/0895-4356(91)90157-5; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Ebbert JO, 2014, JAMA-J AM MED ASSOC, V311, P155, DOI 10.1001/jama.2013.283185; Farley AC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006219.pub3; Fiore MC, 2008, RESP CARE, V53, P1217; Gibbons RD, 2013, AM J PSYCHIAT, V170, P1460, DOI 10.1176/appi.ajp.2013.12121599; Glassman AH, 2001, LANCET, V357, P1929, DOI 10.1016/S0140-6736(00)05064-9; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Greenland S, 1998, DRUG SAFETY, V18, P297, DOI 10.2165/00002018-199818040-00005; Hajek P, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-140; Hajek P, 2011, ARCH INTERN MED, V171, P770, DOI 10.1001/archinternmed.2011.138; Hajek P, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003999.pub3, 10.1002/14651858.CD003999.pub4]; Hartmann-Boyce J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001118.pub3; Homa DM, 2015, MMWR-MORBID MORTAL W, V64, P103; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Jacobs EJ, 2015, ANN EPIDEMIOL, V25, P179, DOI 10.1016/j.annepidem.2014.11.008; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Kroon LA, 2007, AM J HEALTH-SYST PH, V64, P1917, DOI 10.2146/ajhp060414; Lai DTC, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006936.pub2, 10.1002/14651858.CD006936.pub3]; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; McAfee T, 2015, NEW ENGL J MED, V372, P5, DOI 10.1056/NEJMp1411437; McRobbie Hayden, 2014, Cochrane Database Syst Rev, pCD010216, DOI 10.1002/14651858.CD010216.pub2; Orleans CT, 2003, NICOTINE ADDICTION P, P24; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Rigotti NA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub3; Schnoll RA, 2010, ANN INTERN MED, V152, P144, DOI 10.7326/0003-4819-152-3-201002020-00005; Shah RS, 2010, EXPERT REV CARDIOVAS, V8, P917, DOI 10.1586/ERC.10.56; Shiffman S, 2008, ADDICTION, V103, P557, DOI 10.1111/j.1360-0443.2008.02138.x; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2; Stead L F, 2005, Cochrane Database Syst Rev, pCD001007; Stead LF, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Steinberg MB, 2014, J GEN INTERN MED, V29, P1444, DOI 10.1007/s11606-014-2889-7; Steinberg MB, 2009, ANN INTERN MED, V150, P447, DOI 10.7326/0003-4819-150-7-200904070-00004; Thomas KH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5704; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Toll BA, 2013, CLIN CANCER RES, V19, P1941, DOI 10.1158/1078-0432.CCR-13-0666; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; United States Public Health Service Office of the Surgeon General, 2014, HLTH CONS SMOK 50 YE; Vidrine JI, 2013, JAMA INTERN MED, V173, P458, DOI 10.1001/jamainternmed.2013.3751; Wheaton AG, 2015, MMWR-MORBID MORTAL W, V64, P289; White AR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000009.pub4; Whittaker R, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006611.pub2, 10.1002/14651858.CD006611.pub3]	61	17	17	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2016	164	5					ITC33	+		10.7326/AITC201603010	http://dx.doi.org/10.7326/AITC201603010			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI1ZA	26926702				2022-12-28	WOS:000373294300001
J	Canedo-Arguelles, M; Hawkins, CP; Kefford, BJ; Schafer, RB; Dyack, BJ; Brucet, S; Buchwalter, D; Dunlop, J; Fror, O; Lazorchak, J; Coring, E; Fernandez, HR; Goodfellow, W; Achem, ALG; Hatfield-Dodds, S; Karimov, BK; Mensah, P; Olson, JR; Piscart, C; Prat, N; Ponsa, S; Schulz, CJ; Timpano, AJ				Canedo-Argueelles, M.; Hawkins, C. P.; Kefford, B. J.; Schaefer, R. B.; Dyack, B. J.; Brucet, S.; Buchwalter, D.; Dunlop, J.; Froer, O.; Lazorchak, J.; Coring, E.; Fernandez, H. R.; Goodfellow, W.; Gonzalez Achem, A. L.; Hatfield-Dodds, S.; Karimov, B. K.; Mensah, P.; Olson, J. R.; Piscart, C.; Prat, N.; Ponsa, S.; Schulz, C. -J.; Timpano, A. J.			Saving freshwater from salts	SCIENCE			English	Editorial Material							RIVERS		[Canedo-Argueelles, M.; Brucet, S.; Ponsa, S.] Univ Vic Cent Univ Catalonia, Vic 08500, Spain; [Canedo-Argueelles, M.; Prat, N.] Univ Barcelona, E-08028 Barcelona, Spain; [Hawkins, C. P.] Utah State Univ, Logan, UT 84322 USA; [Kefford, B. J.; Dyack, B. J.] Univ Canberra, Canberra, ACT 2601, Australia; [Schaefer, R. B.; Froer, O.] Univ Koblenz Landau, D-76829 Landau, Germany; [Brucet, S.] Catalan Inst Res & Adv Studies, Barcelona 08010, Spain; [Buchwalter, D.] N Carolina State Univ, Raleigh, NC 27695 USA; [Dunlop, J.] Queensland Govt, Brisbane, Qld, Australia; [Lazorchak, J.] US EPA, Cincinnati, OH 45268 USA; [Coring, E.] EcoRing, D-37181 Hardegsen, Germany; [Fernandez, H. R.; Gonzalez Achem, A. L.] Inst Biodiversidad Neotrop, San Miguel De Tucuman, Argentina; [Goodfellow, W.] Exponent Inc, Alexandria, VA 22314 USA; [Hatfield-Dodds, S.] CSIRO Land & Water, Canberra, ACT 2601, Australia; [Karimov, B. K.] Uzbek Acad Sci, Tashkent, Uzbekistan; [Mensah, P.] Rhodes Univ, ZA-6140 Grahamstown, South Africa; [Olson, J. R.] Desert Res Inst, Las Vegas, NV 89119 USA; [Piscart, C.] Univ Rennes, F-35042 Rennes, France; [Schulz, C. -J.] Thuringian State Inst Environm & Geol, D-07745 Jena, Germany; [Timpano, A. J.] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Barcelona; Utah System of Higher Education; Utah State University; University of Canberra; University of Koblenz & Landau; ICREA; University of North Carolina; North Carolina State University; United States Environmental Protection Agency; Exponent; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Academy of Sciences of Uzbekistan; Rhodes University; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Universite de Rennes; Virginia Polytechnic Institute & State University	Canedo-Arguelles, M (corresponding author), Univ Vic Cent Univ Catalonia, Vic 08500, Spain.	mcanedo.fem@gmail.com	Ponsa, Sergio/ABH-6003-2020; Hatfield-Dodds, Steve/K-1067-2013; Cañedo-Argüelles, Miguel/L-6365-2014; Olson, John R./B-3710-2009; Schaefer, Ralf/E-1926-2011; Prat, Narcis/D-4405-2014; Piscart, christophe/AAD-8973-2019; Karimov, Bakhtiyor/B-4653-2019; Hawkins, Charles P/A-4530-2008; Lazorchak, James/E-2363-2016	Ponsa, Sergio/0000-0001-5212-3860; Cañedo-Argüelles, Miguel/0000-0003-3864-7451; Olson, John R./0000-0003-2928-7669; Schaefer, Ralf/0000-0003-3510-1701; Prat, Narcis/0000-0002-1550-1305; Piscart, christophe/0000-0002-4054-4542; Hawkins, Charles P/0000-0003-1247-0248; Dodds, Walter/0000-0002-6666-8930; Lazorchak, James/0000-0002-7354-7571; Kefford, Ben/0000-0001-6789-4254; Karimov, Bakhtiyor/0000-0003-0545-4733; Buchwalter, David/0000-0002-4372-1268	ICREA Funding Source: Custom	ICREA(ICREA)		ANZECC ARMCANZ, 2000, AUSTR NZ GUID FRESHW, V1; Bathe J, 2011, LIMNOLOGICA, V41, P125, DOI 10.1016/j.limno.2010.07.005; Canadian Council of Ministers of the Environment, 1999, CAN WAT QUAL GUID PR; Canedo-Arguelles M, 2013, ENVIRON POLLUT, V173, P157, DOI 10.1016/j.envpol.2012.10.011; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Hawkins CP, 2010, J N AM BENTHOL SOC, V29, P312, DOI 10.1899/09-092.1; Herbert ER, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00534.1; Intergovernmental Panel on Climate Change, 2013, CLIM CHANG 2013 PHYS; Khan AE, 2011, ENVIRON HEALTH PERSP, V119, P1328, DOI 10.1289/ehp.1002804; Krausmann F, 2009, ECOL ECON, V68, P2696, DOI 10.1016/j.ecolecon.2009.05.007; Kunz JL, 2013, ENVIRON TOXICOL CHEM, V32, P2826, DOI 10.1002/etc.2391; Micklin P, 2007, ANNU REV EARTH PL SC, V35, P47, DOI 10.1146/annurev.earth.35.031306.140120; Murray-Darling Basin Ministerial Council, 2015, BAS SAL MAN 2030; U. S. Environmental Protection Agency, 2002, 822R02047 EPA; Uinta Basin Salinity Study Team, 2014, FIN REP FIND STRAT U; van Dam RA, 2010, ENVIRON TOXICOL CHEM, V29, P410, DOI 10.1002/etc.56; Wilson S. M., 2004, DRYLAND URBAN SALINI	17	177	177	4	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					914	916		10.1126/science.aad3488	http://dx.doi.org/10.1126/science.aad3488			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917752				2022-12-28	WOS:000370821400018
J	Duke, T				Duke, Trevor			New WHO guidelines on emergency triage assessment and treatment	LANCET			English	Editorial Material							CHILDREN		[Duke, Trevor] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, MCRI,Intens Care Unit, Melbourne, Vic 3052, Australia; [Duke, Trevor] Univ Papua New Guinea, Sch Med & Hlth Sci, Child Hlth Discipline, Port Moresby, Papua N Guinea	Royal Children's Hospital Melbourne; University of Melbourne; University of Papua New Guinea	Duke, T (corresponding author), Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, MCRI,Intens Care Unit, Melbourne, Vic 3052, Australia.; Duke, T (corresponding author), Univ Papua New Guinea, Sch Med & Hlth Sci, Child Hlth Discipline, Port Moresby, Papua N Guinea.	trevor.duke@rch.org.au						[Anonymous], 2016, UPD GUID PAED EM TRI; Arikan AA, 2008, SIGNA VITAE, V3, P13; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Ceneviva G, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e19; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; Inwald DP, 2009, ARCH DIS CHILD, V94, P348, DOI 10.1136/adc.2008.153064; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Tamburlini G, 1999, ARCH DIS CHILD, V81, P478, DOI 10.1136/adc.81.6.478; WHO, 2016, WHORSD8515; World Health Organization, 2016, E POCK BOOK HOSP CAR; World Health Organization, 2014, EM TRIAG ASS TREATM; World Health Organization, 2013, HOSP CAR CHILDR GUID; World Health Organization, 2005, TREATM DIARRH MAN PH	14	25	26	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					721	724		10.1016/S0140-6736(16)00148-3	http://dx.doi.org/10.1016/S0140-6736(16)00148-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE1WU	26906655				2022-12-28	WOS:000370418000005
J	Pringsheim, T; Kelly, M; Barbui, C				Pringsheim, Tamara; Kelly, Martina; Barbui, Corrado			10-MINUTE CONSULTATION Stopping antidepressants following depression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PSYCHIATRY WFSBP GUIDELINES; BIOLOGICAL TREATMENT; WORLD FEDERATION; SOCIETIES		[Pringsheim, Tamara] Univ Calgary, Dept Clin Neurosci Psychiat & Community Hlth Sci, Calgary, AB, Canada; [Kelly, Martina] Univ Calgary, Dept Family Med, Calgary, AB, Canada; [Barbui, Corrado] Univ Verona, Sect Psychiat, Dept Publ Hlth & Community Med, I-37100 Verona, Italy	University of Calgary; University of Calgary; University of Verona	Pringsheim, T (corresponding author), Mathison Ctr Mental Hlth Res & Educ, TRW Bldg,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	tmprings@ucalgary.ca	Pringsheim, Tamara/L-5955-2019	Pringsheim, Tamara/0000-0002-8229-8431; Kelly, Martina/0000-0002-8763-7092				Bauer M, 2015, WORLD J BIOL PSYCHIA, V16, P76, DOI 10.3109/15622975.2014.1001786; Bauer M, 2013, WORLD J BIOL PSYCHIA, V14, P334, DOI 10.3109/15622975.2013.804195; Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122; Furukawa TA, 2007, CAN J PSYCHIAT, V52, P545, DOI 10.1177/070674370705200902; Kaymaz N, 2008, J CLIN PSYCHIAT, V69, P1423, DOI 10.4088/JCP.v69n0910; National Institute for Health and Care Excellence, 2009, DEPR AD REC MAN CLIN	6	1	1	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2016	352								i220	10.1136/bmj.i220	http://dx.doi.org/10.1136/bmj.i220			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6FB	26891905				2022-12-28	WOS:000370728000004
J	Stokes, CR; Margold, M; Clark, CD; Tarasov, L				Stokes, C. R.; Margold, M.; Clark, C. D.; Tarasov, L.			Ice stream activity scaled to ice sheet volume during Laurentide Ice Sheet deglaciation	NATURE			English	Article							SEA-LEVEL RISE; GLACIAL LINEATIONS; COLLAPSE; INSTABILITY; FLOW; REORGANIZATION; IDENTIFICATION; SURFACE; BED	The contribution of the Greenland and West Antarctic ice sheets to sea level has increased in recent decades, largely owing to the thinning and retreat of outlet glaciers and ice streams(1-4). This dynamic loss is a serious concern, with some modelling studies suggesting that the collapse of a major ice sheet could be imminent(5,6) or potentially underway(7) in West Antarctica, but others predicting a more limited response(8). A major problem is that observations used to initialize and calibrate models typically span only a few decades, and, at the ice-sheet scale, it is unclear how the entire drainage network of ice streams evolves over longer timescales. This represents one of the largest sources of uncertainty when predicting the contributions of ice sheets to sea-level rise(8-10). A key question is whether ice streams might increase and sustain rates of mass loss over centuries or millennia, beyond those expected for a given ocean-climate forcing(5-10). Here we reconstruct the activity of 117 ice streams that operated at various times during deglaciation of the Laurentide Ice Sheet (from about 22,000 to 7,000 years ago) and show that as they activated and deactivated in different locations, their overall number decreased, they occupied a progressively smaller percentage of the ice sheet perimeter and their total discharge decreased. The underlying geology and topography clearly influenced ice stream activity, but-at the ice-sheet scale-their drainage network adjusted and was linked to changes in ice sheet volume. It is unclear whether these findings can be directly translated to modern ice sheets. However, contrary to the view that sees ice streams as unstable entities that can accelerate ice-sheet deglaciation, we conclude that ice streams exerted progressively less influence on ice sheet mass balance during the retreat of the Laurentide Ice Sheet.	[Stokes, C. R.; Margold, M.] Univ Durham, Dept Geog, Durham, England; [Clark, C. D.] Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; [Tarasov, L.] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada; [Margold, M.] Stockholm Univ, Dept Phys Geog, S-10691 Stockholm, Sweden	Durham University; University of Sheffield; Memorial University Newfoundland; Stockholm University	Stokes, CR (corresponding author), Univ Durham, Dept Geog, Durham, England.	c.r.stokes@durham.ac.uk	Stokes, Chris R/A-1957-2011; Margold, Martin/V-4634-2018; Clark, Chris/C-3830-2009	Stokes, Chris R/0000-0003-3355-1573; Margold, Martin/0000-0001-5834-850X; Clark, Chris/0000-0002-1021-6679	NERC [NE/J007455/1, NE/J00782X/1] Funding Source: UKRI; Natural Environment Research Council [NE/J007455/1, NE/J00782X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Bamber JL, 2013, CRYOSPHERE, V7, P499, DOI 10.5194/tc-7-499-2013; Batchelor CL, 2014, QUATERNARY SCI REV, V92, P68, DOI 10.1016/j.quascirev.2013.05.025; Briner JP, 2006, GEOL SOC AM BULL, V118, P406, DOI 10.1130/B25716.1; Carlson AE, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040948; Clark CD, 2001, QUATERN INT, V86, P81, DOI 10.1016/S1040-6182(01)00052-0; CLARK CD, 1993, EARTH SURF PROCESSES, V18, P1, DOI 10.1002/esp.3290180102; CLARK PU, 1992, GEOL SOC AM BULL, V104, P595, DOI 10.1130/0016-7606(1992)104<0595:SFOTSL>2.3.CO;2; Cofaigh CO, 2008, EARTH SURF PROC LAND, V33, P513, DOI 10.1002/esp.1669; Cofaigh CO, 2010, GEOL SOC AM BULL, V122, P743, DOI 10.1130/B26476.1; Deschamps P, 2012, NATURE, V483, P559, DOI 10.1038/nature10902; DYKE AS, 1988, CAN GEOGR-GEOGR CAN, V32, P86, DOI 10.1111/j.1541-0064.1988.tb00860.x; Dyke AS, 2003, 1574 GEOL SURV CAN; Feldmann J, 2015, P NATL ACAD SCI USA, V112, P14191, DOI 10.1073/pnas.1512482112; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Gregoire LJ, 2012, NATURE, V487, P219, DOI 10.1038/nature11257; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; HODGSON DA, 1994, BOREAS, V23, P14, DOI 10.1111/j.1502-3885.1994.tb00582.x; Jakobsson M, 2014, QUATERNARY SCI REV, V92, P40, DOI 10.1016/j.quascirev.2013.07.033; Jakobsson M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052219; Joughin I., 2010, MEASURES GREENLAND I; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; King EC, 2009, NAT GEOSCI, V2, P585, DOI 10.1038/NGEO581; Kleman J, 2014, QUATERNARY SCI REV, V92, P32, DOI 10.1016/j.quascirev.2013.07.030; Kleman J, 2010, QUATERNARY SCI REV, V29, P2036, DOI 10.1016/j.quascirev.2010.04.021; Lakeman TR, 2013, QUATERNARY RES, V80, P99, DOI 10.1016/j.yqres.2013.02.001; Lakeman TR, 2012, QUATERNARY SCI REV, V47, P82, DOI 10.1016/j.quascirev.2012.04.018; Marcott SA, 2011, P NATL ACAD SCI USA, V108, P13415, DOI 10.1073/pnas.1104772108; Margold M, 2015, EARTH-SCI REV, V143, P117, DOI 10.1016/j.earscirev.2015.01.011; Margold M, 2015, J MAPS, V11, P380, DOI 10.1080/17445647.2014.912036; Mooers HD, 1997, GEOLOGY, V25, P987, DOI 10.1130/0091-7613(1997)025<0987:TROLIS>2.3.CO;2; Nghiem SV, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053611; Nixon FC, 2014, QUATERNARY SCI REV, V91, P146, DOI 10.1016/j.quascirev.2013.10.036; Patterson W. S. B., 1994, PHYS GLACIERS, P301; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2011, MEASURES INSAR BASED; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Ritz C, 2015, NATURE, V528, P115, DOI 10.1038/nature16147; Rose K. E., 1979, J GLACIOL, V24, P63; Shaw J, 2000, QUATERNARY SCI REV, V19, P959, DOI 10.1016/S0277-3791(99)00027-X; Stokes CR, 2009, QUATERNARY SCI REV, V28, P721, DOI 10.1016/j.quascirev.2008.07.019; Stokes CR, 2003, GEOLOGY, V31, P347, DOI 10.1130/0091-7613(2003)031<0347:LISOTC>2.0.CO;2; Stokes CR, 2002, EARTH SURF PROC LAND, V27, P547, DOI 10.1002/esp.326; Stokes CR, 2002, INT J REMOTE SENS, V23, P1557, DOI 10.1080/01431160110107815; Stokes CR, 2001, QUATERNARY SCI REV, V20, P1437, DOI 10.1016/S0277-3791(01)00003-8; Stokes CR, 1999, ANN GLACIOL, V28, P67, DOI 10.3189/172756499781821625; Storrar RD, 2014, GEOLOGY, V42, P239, DOI 10.1130/G35092.1; Tarasov L, 2012, EARTH PLANET SC LETT, V315, P30, DOI 10.1016/j.epsl.2011.09.010; Ullman DJ, 2015, NAT GEOSCI, V8, P534, DOI [10.1038/ngeo2463, 10.1038/NGEO2463]; Winsborrow MCM, 2010, EARTH-SCI REV, V103, P45, DOI 10.1016/j.earscirev.2010.07.003	55	72	74	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					322	+		10.1038/nature16947	http://dx.doi.org/10.1038/nature16947			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887494	Green Accepted			2022-12-28	WOS:000370327100034
J	Wang, CX; Youle, R				Wang, Chunxin; Youle, Richard			CELL BIOLOGY Form follows function for mitochondria	NATURE			English	Editorial Material							MAMMALIAN-CELLS; FISSION; DRP1; MORPHOLOGY; FUSION; PHOSPHORYLATION; DEGRADATION; SUBSTRATE; AUTOPHAGY; STRESS		[Wang, Chunxin; Youle, Richard] Natl Inst Neurol Disorders & Stroke, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wang, CX (corresponding author), Natl Inst Neurol Disorders & Stroke, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	wangchu@ninds.nih.gov; youler@ninds.nih.gov	Wang, Chunxin/B-9312-2016	Wang, Chunxin/0000-0001-6015-6806	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003123] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Das S, 2012, PFLUG ARCH EUR J PHY, V464, P101, DOI 10.1007/s00424-012-1100-4; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wikstrom JD, 2013, MOL ENDOCRINOL, V27, P1706, DOI 10.1210/me.2013-1109; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	16	25	25	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					288	289		10.1038/530288a	http://dx.doi.org/10.1038/530288a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887490				2022-12-28	WOS:000370327100025
J	Collister, D; Komenda, P; Hiebert, B; Gunasekara, R; Xu, Y; Eng, F; Lerner, B; Macdonald, K; Rigatto, C; Tangri, N				Collister, David; Komenda, Paul; Hiebert, Brett; Gunasekara, Ravindi; Xu, Yang; Eng, Fredrick; Lerner, Blake; Macdonald, Kerry; Rigatto, Claudio; Tangri, Navdeep			The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							RECOMBINANT-HUMAN-ERYTHROPOIETIN; LEFT-VENTRICULAR MASS; EPOETIN-ALPHA; HEMODIALYSIS-PATIENTS; DARBEPOETIN ALPHA; RENAL-DISEASE; TARGET LEVEL; DOUBLE-BLIND; HEMOGLOBIN; DIALYSIS	Background: The efficacy of erythropoietin-stimulating agents (ESAs) for improving health-related quality of life (HRQOL) in anemia of chronic kidney disease (CKD) is unclear. Purpose: To determine the effect of ESAs on HRQOL at different hemoglobin targets in adults with CKD who were receiving or not receiving dialysis. Data Sources: Searches of PubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov from inception to 1 November 2015, supplemented with manual screening. Study Selection: Randomized, controlled trials that evaluated the treatment of anemia with ESAs, including erythropoietin and darbepoetin, targeted higher versus lower hemoglobin levels, and used validated HRQOL metrics. Data Extraction: Study characteristics, quality, and data were assessed independently by 2 reviewers. Outcome measures were scores on the Short Form-36 Health Survey (SF-36), Kidney Dialysis Questionnaire (KDQ), and other tools. Data Synthesis: Of 17 eligible studies, 13 reported SF-36 outcomes and 4 reported KDQ outcomes. Study populations consisted of patients not undergoing dialysis (n = 12), those undergoing dialysis (n = 4), or a mixed sample (n = 1). Only 4 studies had low risk of bias. Pooled analyses showed that higher hemoglobin targets resulted in no statistically or clinically significant differences in SF-36 or KDQ domains. Differences in HRQOL were further attenuated in studies at low risk of bias and in subgroups of dialysis recipients. Limitation: Statistically significant heterogeneity among studies, few good-quality studies, and possible publication bias. Conclusion: ESA treatment of anemia to obtain higher hemoglobin targets does not result in important differences in HRQOL in patients with CKD.	Univ Manitoba, Winnipeg, MB, Canada; [Collister, David; Komenda, Paul; Gunasekara, Ravindi; Xu, Yang; Eng, Fredrick; Lerner, Blake; Rigatto, Claudio; Tangri, Navdeep] Seven Oaks Gen Hosp, Renal Program, 2300 McPhillips St,2PD13, Winnipeg, MB R2V 3M3, Canada; [Hiebert, Brett] Cardiac Sci Program, CR1038 Asper Clin Res Bldg,369 Tache Ave, Winnipeg, MB R2H 2A6, Canada; [Macdonald, Kerry] St Boniface Hosp & Res Campus, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Tangri, N (corresponding author), Seven Oaks Gen Hosp, Renal Program, 2300 McPhillips St,2PD13, Winnipeg, MB R2V 3M3, Canada.	ntangri@sogh.mb.ca	Macdonald, Kerry/F-7706-2015	Macdonald, Kerry/0000-0001-8237-3035; Gunasekara, Ravindi/0000-0002-7914-3578	KRESCENT; Manitoba Health Research Council Establishment	KRESCENT; Manitoba Health Research Council Establishment	KRESCENT and Manitoba Health Research Council Establishment.	Akizawa T, 2011, THER APHER DIAL, V15, P431, DOI 10.1111/j.1744-9987.2011.00931.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Canadian Institute for Health Information, 2014, CAN ORG REPL REG ANN; Clement FM, 2009, ARCH INTERN MED, V169, P1104, DOI 10.1001/archinternmed.2009.112; Coyne DW, 2012, KIDNEY INT, V82, P235, DOI 10.1038/ki.2012.76; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Foley RN, 2000, KIDNEY INT, V58, P1325, DOI 10.1046/j.1523-1755.2000.00289.x; Foley RN, 2009, CLIN J AM SOC NEPHRO, V4, P726, DOI 10.2215/CJN.04950908; Furuland H, 2003, NEPHROL DIAL TRANSPL, V18, P353, DOI 10.1093/ndt/18.2.353; Gandra SR, 2010, AM J KIDNEY DIS, V55, P519, DOI 10.1053/j.ajkd.2009.09.019; Hays RD, 2000, PHARMACOECONOMICS, V18, P419, DOI 10.2165/00019053-200018050-00001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jassal SV, 2009, NEW ENGL J MED, V361, P1612, DOI 10.1056/NEJMc0905289; Johansen KL, 2012, NEPHROL DIAL TRANSPL, V27, P2418, DOI 10.1093/ndt/gfr697; Johansen KL, 2010, AM J KIDNEY DIS, V55, P535, DOI 10.1053/j.ajkd.2009.12.018; Keown PA, 2010, HEMODIAL INT, V14, P168, DOI 10.1111/j.1542-4758.2009.00422.x; Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group, 2012, KIDNEY INT SUPPL, V2, P279, DOI DOI 10.1038/kisup.2012.37; KLEINMAN KS, 1989, AM J KIDNEY DIS, V14, P486, DOI 10.1016/S0272-6386(89)80149-0; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; LAUPACIS A, 1992, NEPHRON, V60, P302, DOI 10.1159/000186769; Leaf DE, 2009, KIDNEY INT, V75, P15, DOI 10.1038/ki.2008.414; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Levin A, 2007, AM J KIDNEY DIS, V50, P471; Lewis EF, 2011, CLIN J AM SOC NEPHRO, V6, P845, DOI 10.2215/CJN.06450710; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Muirhead N, 2011, HEMODIAL INT, V15, P87, DOI 10.1111/j.1542-4758.2010.00508.x; Murtagh FEM, 2011, J AM GERIATR SOC, V59, P304, DOI 10.1111/j.1532-5415.2010.03248.x; National Institute for Health and Care Excellence, 2015, CHRON KIDN DIS MAN A; Palmer SC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010590.pub2; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; REVICKI DA, 1995, AM J KIDNEY DIS, V25, P548, DOI 10.1016/0272-6386(95)90122-1; Ritz E, 2007, AM J KIDNEY DIS, V49, P194, DOI 10.1053/j.ajkd.2006.11.032; Roger SD, 2004, J AM SOC NEPHROL, V15, P148, DOI 10.1097/01.ASN.0000102471.89084.8B; Roger SD, 2014, INT UROL NEPHROL, V46, P469, DOI 10.1007/s11255-013-0512-1; Rossert J, 2006, AM J KIDNEY DIS, V47, P738, DOI 10.1053/j.ajkd.2006.02.170; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003967.pub2; TEEHAN BP, 1991, AM J KIDNEY DIS, V18, P50; Tonelli M, 2008, 106 CAN AG DRUGS TEC; U.S. Food and Drug Administration, 2011, FDA DRUG SAF COMM MO; United States Renal Data System, 2014, 2014 ANN DAT REP OV; Weisstein EW, 2015, NORMAL DIFFERENCE DI	53	49	51	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2016	164	7					472	+		10.7326/M15-1839	http://dx.doi.org/10.7326/M15-1839			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI6QP	26881842				2022-12-28	WOS:000373625300009
J	Agafonov, DE; Kastner, B; Dybkov, O; Hofele, RV; Liu, WT; Urlaub, H; Luhrmann, R; Stark, H				Agafonov, Dmitry E.; Kastner, Berthold; Dybkov, Olexandr; Hofele, Romina V.; Liu, Wen-Ti; Urlaub, Henning; Luehrmann, Reinhard; Stark, Holger			Molecular architecture of the human U4/U6.U5 tri-snRNP	SCIENCE			English	Article							TRANSFER-RNA TRANSLOCATION; ELECTRON CRYOMICROSCOPY; SACCHAROMYCES-CEREVISIAE; SPLICEOSOMAL COMPONENTS; CONFORMATIONAL-CHANGES; RIBOSOMAL TRANSLOCASE; STRUCTURAL BASIS; U5 SNRNP; PROTEIN; BRR2	The U4/U6.U5 triple small nuclear ribonucleoprotein (tri-snRNP) is a major spliceosome building block. We obtained a three-dimensional structure of the 1.8-megadalton human tri-snRNP at a resolution of 7 angstroms using single-particle cryo-electron microscopy (cryo-EM). We fit all known high-resolution structures of tri-snRNP components into the EM density map and validated them by protein cross-linking. Our model reveals how the spatial organization of Brr2 RNA helicase prevents premature U4/U6 RNA unwinding in isolated human tri-snRNPs and how the ubiquitin C-terminal hydrolase-like protein Sad1 likely tethers the helicase Brr2 to its preactivation position. Comparison of our model with cryo-EM three-dimensional structures of the Saccharomyces cerevisiae tri-snRNP and Schizosaccharomyces pombe spliceosome indicates that Brr2 undergoes a marked conformational change during spliceosome activation, and that the scaffolding protein Prp8 is also rearranged to accommodate the spliceosome's catalytic RNA network.	[Agafonov, Dmitry E.; Kastner, Berthold; Dybkov, Olexandr; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Hofele, Romina V.; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; [Hofele, Romina V.; Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt Grp, D-37075 Gottingen, Germany; [Liu, Wen-Ti; Stark, Holger] Univ Gottingen, Dept Electron Cryomicroscopy 3D, D-37077 Gottingen, Germany; [Liu, Wen-Ti; Stark, Holger] Max Planck Inst Biophys Chem, Dept Struct Dynam, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen; University of Gottingen; Max Planck Society	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany.; Urlaub, H (corresponding author), Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany.; Urlaub, H (corresponding author), Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt Grp, D-37075 Gottingen, Germany.; Stark, H (corresponding author), Univ Gottingen, Dept Electron Cryomicroscopy 3D, D-37077 Gottingen, Germany.; Stark, H (corresponding author), Max Planck Inst Biophys Chem, Dept Struct Dynam, D-37077 Gottingen, Germany.	henning.urlaub@mpibpc.mpg.de; reinhard.luehrmann@mpi-bpc.mpg.de; hstark1@gwdg.de		Holger, Stark/0000-0002-6161-1118	Deutsche Forschungsgemeinschaft [SFB 860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank T. Conrad for HeLa cell production in a bioreactor; H. Kohansal for preparing HeLa cell nuclear extract; I. Ochsner, U. Steuerwald, W. Lendeckel, M. Raabe, and U. Plessmann for excellent technical assistance; and C. L. Will, K. Hartmuth, N. Fischer, D. Haselbach, M. Wahl, and A. Chari for advice and many helpful discussions. Supported by Deutsche Forschungsgemeinschaft grant SFB 860 (R.L., H.S., and H.U.). EM raw data are available at the Electron Microscopy Pilot Image Archive under the code EMPIAR-10056. The EM map has been deposited in the Electron Microscopy Data Bank with accession code EMD-6581. The atomic coordinates have been deposited in the Protein Data Bank with accession code 3JCR.	Absmeier E, 2015, GENE DEV, V29, P2576, DOI 10.1101/gad.271528.115; Absmeier E, 2015, ACTA CRYSTALLOGR D, V71, P762, DOI 10.1107/S1399004715001005; Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; BEHRENS SE, 1991, GENE DEV, V5, P1439, DOI 10.1101/gad.5.8.1439; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; FABRIZIO P, 1994, SCIENCE, V264, P261, DOI 10.1126/science.8146658; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Galej WP, 2014, CURR OPIN STRUC BIOL, V25, P57, DOI 10.1016/j.sbi.2013.12.002; GALISSON F, 1993, NUCLEIC ACIDS RES, V21, P1555, DOI 10.1093/nar/21.7.1555; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Huang YH, 2014, MOL CELL BIOL, V34, P210, DOI 10.1128/MCB.00837-13; Jacewicz A, 2014, NUCLEIC ACIDS RES, V42, P12885, DOI 10.1093/nar/gku930; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Lin JZ, 2015, CELL, V160, P219, DOI 10.1016/j.cell.2014.11.049; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Makarov EM, 2000, J MOL BIOL, V298, P567, DOI 10.1006/jmbi.2000.3685; Mohlmann S, 2014, ACTA CRYSTALLOGR D, V70, P1622, DOI 10.1107/S1399004714006439; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Reyes JL, 1999, RNA, V5, P167, DOI 10.1017/S1355838299981785; Sander B, 2006, MOL CELL, V24, P267, DOI 10.1016/j.molcel.2006.08.021; Sander B, 2010, STRUCTURE, V18, P667, DOI 10.1016/j.str.2010.05.001; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Stevens SW, 2001, RNA, V7, P1543; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629	36	130	132	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1416	1420		10.1126/science.aad2085	http://dx.doi.org/10.1126/science.aad2085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	26912367				2022-12-28	WOS:000372756200039
J	Telley, L; Govindan, S; Prados, J; Stevant, I; Nef, S; Dermitzakis, E; Dayer, A; Jabaudon, D				Telley, Ludovic; Govindan, Subashika; Prados, Julien; Stevant, Isabelle; Nef, Serge; Dermitzakis, Emmanouil; Dayer, Alexandre; Jabaudon, Denis			Sequential transcriptional waves direct the differentiation of newborn neurons in the mouse neocortex	SCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; CELL RNA-SEQ; RADIAL GLIA; IN-VIVO; NEUROGENESIS; DYNAMICS; EVOLUTION; MIGRATION; IDENTITY; PAX6	During corticogenesis, excitatory neurons are born from progenitors located in the ventricular zone (VZ), from where they migrate to assemble into circuits. How neuronal identity is dynamically specified upon progenitor division is unknown. Here, we study this process using a high-temporal-resolution technology allowing fluorescent tagging of isochronic cohorts of newborn VZ cells. By combining this in vivo approach with single-cell transcriptomics in mice, we identify and functionally characterize neuron-specific primordial transcriptional programs as they dynamically unfold. Our results reveal early transcriptional waves that instruct the sequence and pace of neuronal differentiation events, guiding newborn neurons toward their final fate, and contribute to a road map for the reverse engineering of specific classes of cortical neurons from undifferentiated cells.	[Telley, Ludovic; Govindan, Subashika; Prados, Julien; Dayer, Alexandre; Jabaudon, Denis] Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; [Stevant, Isabelle; Nef, Serge; Dermitzakis, Emmanouil] Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Dayer, Alexandre] Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland; [Jabaudon, Denis] Univ Hosp Geneva, Neurol Clin, Geneva, Switzerland; [Dermitzakis, Emmanouil] Acad Athens, Biomed Res Fdn, Athens, Greece; [Dermitzakis, Emmanouil] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Riyadh, Saudi Arabia; [Telley, Ludovic; Govindan, Subashika; Prados, Julien; Stevant, Isabelle; Nef, Serge; Dermitzakis, Emmanouil; Dayer, Alexandre; Jabaudon, Denis] Univ Geneva, Inst Genet & Genom Geneva iGE3, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; Academy of Athens; King Abdulaziz University; University of Geneva	Jabaudon, D (corresponding author), Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland.; Jabaudon, D (corresponding author), Univ Hosp Geneva, Neurol Clin, Geneva, Switzerland.; Jabaudon, D (corresponding author), Univ Geneva, Inst Genet & Genom Geneva iGE3, CH-1211 Geneva 4, Switzerland.	denis.jabaudon@unige.ch	Nef, Serge/AAV-6445-2020; Jabaudon, Denis/B-8802-2014	Nef, Serge/0000-0001-5462-0676; Jabaudon, Denis/0000-0003-2438-4769; Telley, Ludovic/0000-0002-5041-1997; Dayer, Alexandre/0000-0002-4490-9780; Stevant, Isabelle/0000-0002-0193-2526; Prados, Julien/0000-0002-8546-241X; Govindan, Subashika/0000-0002-0546-4096	Swiss National Science Foundation [PP00P3_123447]; Synapsis Foundation; Brain and Behavior Foundation (NARSAD Grant); Swiss SystemsX Interdisciplinary PhD Grant [51PHI0-141994]; iGe3 PhD Award; Swiss National Science Foundation; National Center of Competence in Research (NCCR) Synapsy	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Synapsis Foundation; Brain and Behavior Foundation (NARSAD Grant); Swiss SystemsX Interdisciplinary PhD Grant; iGe3 PhD Award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) Synapsy(Swiss National Science Foundation (SNSF))	Annotated data are available at http://genebrowser.unige.ch/science2016. We thank R. Hevner for the gift of the TBR1 antibody; A. Benoit, M. Lanzillo, and the Genomics Platform and FACS Facility of the University of Geneva for technical assistance; and E. Azim, A. Carleton, S. Tole, and the members of the Jabaudon laboratory for comments on the manuscript. Work in the Jabaudon laboratory is supported by the Swiss National Science Foundation (PP00P3_123447), the Synapsis Foundation, and the Brain and Behavior Foundation (NARSAD Grant). S.N. is funded by the Swiss SystemsX Interdisciplinary PhD Grant 51PHI0-141994. S.G. and I.S. are supported by the iGe3 PhD Award. A.D. is funded by the Swiss National Science Foundation and the National Center of Competence in Research (NCCR) Synapsy. The authors declare no competing interests. The supplementary materials contain additional data.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bayam E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1882-9; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Ince-Dunn G, 2006, NEURON, V49, P683, DOI 10.1016/j.neuron.2006.01.031; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McKinnon PJ, 2013, NAT NEUROSCI, V16, P1523, DOI 10.1038/nn.3537; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Namba T, 2014, NEURON, V81, P814, DOI 10.1016/j.neuron.2013.12.015; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Pouchelon G, 2014, NATURE, V511, P471, DOI 10.1038/nature13390; Quah B. J. C., 2010, JOVE-J VIS EXP, V2010, pe2259; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sato H, 2012, J NEUROSCI, V32, P15388, DOI 10.1523/JNEUROSCI.0293-12.2012; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	25	166	166	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1443	1446		10.1126/science.aad8361	http://dx.doi.org/10.1126/science.aad8361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	26940868				2022-12-28	WOS:000372756200047
J	Zhao, BY; Sedlak, JC; Srinivas, R; Creixell, P; Pritchard, JR; Tidor, B; Lauffenburger, DA; Hemann, MT				Zhao, Boyang; Sedlak, Joseph C.; Srinivas, Raja; Creixell, Pau; Pritchard, Justin R.; Tidor, Bruce; Lauffenburger, Douglas A.; Hemann, Michael T.			Exploiting Temporal Collateral Sensitivity in Tumor Clonal Evolution	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; BCR-ABL1 COMPOUND MUTATIONS; KINASE DOMAIN MUTATIONS; IMATINIB RESISTANCE; CROSS-RESISTANCE; THERAPY; CANCER; HETEROGENEITY; DETERMINANTS	The prevailing approach to addressing secondary drug resistance in cancer focuses on treating the resistance mechanisms at relapse. However, the dynamic nature of clonal evolution, along with potential fitness costs and cost compensations, may present exploitable vulnerabilities-a notion that we term "temporal collateral sensitivity.'' Using a combined pharmacological screen and drug resistance selection approach in a murine model of Ph+ acute lymphoblastic leukemia, we indeed find that temporal and/or persistent collateral sensitivity to non-classical BCR-ABL1 drugs arises in emergent tumor subpopulations during the evolution of resistance toward initial treatment with BCR-ABL1-targeted inhibitors. We determined the sensitization mechanism via genotypic, phenotypic, signaling, and binding measurements in combination with computational models and demonstrated significant overall survival extension in mice. Additional stochastic mathematical models and small-molecule screens extended our insights, indicating the value of focusing on evolutionary trajectories and pharmacological profiles to identify new strategies to treat dynamic tumor vulnerabilities.	[Zhao, Boyang] MIT, Computat & Syst Biol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zhao, Boyang; Creixell, Pau; Pritchard, Justin R.; Lauffenburger, Douglas A.; Hemann, Michael T.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Pritchard, Justin R.; Lauffenburger, Douglas A.; Hemann, Michael T.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Srinivas, Raja; Tidor, Bruce; Lauffenburger, Douglas A.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Srinivas, Raja; Tidor, Bruce] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Tidor, Bruce] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Sedlak, Joseph C.] Harvard Univ, Sch Med, Harvard MIT MD PhD Program, Boston, MA 02115 USA; [Pritchard, Justin R.] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Takeda Oncology	Lauffenburger, DA; Hemann, MT (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lauffenburger, DA; Hemann, MT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lauffenburger, DA (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lauffen@mit.edu; hemann@mit.edu	Pritchard, Justin/AAI-2475-2021	Pritchard, Justin/0000-0001-7749-4473; Sedlak, Joseph/0000-0002-7989-4515; /0000-0003-4610-1707	Koch Institute Support (core) grant from National Cancer Institute [P30-CA14051]; Integrative Cancer Biology Program [U54-CA112967]; National Institutes of General Medical Sciences [GM082209]; Ludwig Foundation; Go Mitch Go Foundation; NIH/NIGMS Interdepartmental Biotechnology Training Program [5T32GM008334]; National Science Foundation Research Fellowship [1122374]; Ludwig Fund; Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE [U54CA112967, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM087237, R01GM082209, T32GM008313, T32GM008334] Funding Source: NIH RePORTER	Koch Institute Support (core) grant from National Cancer Institute; Integrative Cancer Biology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ludwig Foundation; Go Mitch Go Foundation; NIH/NIGMS Interdepartmental Biotechnology Training Program; National Science Foundation Research Fellowship(National Science Foundation (NSF)); Ludwig Fund; Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Peter Bruno and Christian Braun for critical review and feedback on this manuscript, and Stuart Levine and Jie Wu from the MIT BioMicroCenter and Glen Paradis from the Koch Institute Flow Cytometry Core for services and advice. This work was supported by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, the Integrative Cancer Biology Program grant U54-CA112967 (to M.T.H., D.A.L., and B.T.), the National Institutes of General Medical Sciences GM082209 (to B.T.), the Ludwig Foundation (to M.T.H.) and the Go Mitch Go Foundation (to M.T.H.). B.Z. and R.S. are supported by the NIH/NIGMS Interdepartmental Biotechnology Training Program 5T32GM008334. B.Z. is also supported by the National Science Foundation Research Fellowship under grant 1122374. P.C. is supported by postdoctoral fellowships of the Ludwig Fund and Helen Hay Whitney Foundation. B.Z. is a consultant for ARIAD Pharmaceuticals, Inc. J.R.P. is an employee and shareholder of ARIAD Pharmaceuticals, Inc. D.A.L. is a consultant/advisory board member of Merrimack Pharmaceuticals, Genentech, and Complete Genomics.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Boulos N, 2011, BLOOD, V117, P3585, DOI 10.1182/blood-2010-08-301267; Chen GB, 2015, CELL, V160, P771, DOI 10.1016/j.cell.2015.01.026; Cortez D, 1997, ONCOGENE, V15, P2333, DOI 10.1038/sj.onc.1201400; Creixell P, 2015, CELL, V163, P187, DOI 10.1016/j.cell.2015.08.057; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dufies M, 2011, CELL CYCLE, V10, P4138, DOI 10.4161/cc.10.23.18323; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Hill JA, 2015, CELL REP, V10, P809, DOI 10.1016/j.celrep.2015.01.009; Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609; Jabbour E, 2012, BLOOD, V120, P3382, DOI 10.1182/blood-2012-04-424192; Jensen PB, 1997, BRIT J CANCER, V75, P869, DOI 10.1038/bjc.1997.154; Khorashad JS, 2013, BLOOD, V121, P489, DOI 10.1182/blood-2012-05-431379; Kim S, 2014, P NATL ACAD SCI USA, V111, P14494, DOI 10.1073/pnas.1409800111; Lazar V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5352; Levinson NM, 2014, NAT CHEM BIOL, V10, P127, DOI [10.1038/NCHEMBIO.1404, 10.1038/nchembio.1404]; Levinson NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029828; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; Ottmann Oliver G, 2009, Hematology Am Soc Hematol Educ Program, P371, DOI 10.1182/asheducation-2009.1.371; Pemovska T, 2015, NATURE, V519, P102, DOI 10.1038/nature14119; Ravandi F, 2010, BLOOD, V116, P2070, DOI 10.1182/blood-2009-12-261586; Rickardson L, 2006, CANCER CHEMOTH PHARM, V58, P749, DOI 10.1007/s00280-006-0216-7; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; SWAN GW, 1990, MATH BIOSCI, V101, P237, DOI 10.1016/0025-5564(90)90021-P; Valent P, 2015, BLOOD, V125, P901, DOI 10.1182/blood-2014-09-594432; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Zabriskie MS, 2014, CANCER CELL, V26, P428, DOI 10.1016/j.ccr.2014.07.006; Zhao BY, 2014, CANCER DISCOV, V4, P166, DOI 10.1158/2159-8290.CD-13-0465	39	68	68	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					234	246		10.1016/j.cell.2016.01.045	http://dx.doi.org/10.1016/j.cell.2016.01.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	26924578	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000372785600023
J	Kay, K; Sosa, M; Chung, JE; Karlsson, MP; Larkin, MC; Frank, LM				Kay, Kenneth; Sosa, Marielena; Chung, Jason E.; Karlsson, Mattias P.; Larkin, Margaret C.; Frank, Loren M.			A hippocampal network for spatial coding during immobility and sleep	NATURE			English	Article							SHARP-WAVE RIPPLES; PYRAMIDAL CELLS; THETA OSCILLATIONS; ENTORHINAL CORTEX; PATH-INTEGRATION; RAT HIPPOCAMPUS; DENTATE GYRUS; BEHAVING RAT; CA1 NEURONS; PLACE CELLS	How does an animal know where it is when it stops moving? Hippocampal place cells fire at discrete locations as subjects traverse space, thereby providing an explicit neural code for current location during locomotion. In contrast, during awake immobility, the hippocampus is thought to be dominated by neural firing representing past and possible future experience. The question of whether and how the hippocampus constructs a representation of current location in the absence of locomotion has been unresolved. Here we report that a distinct population of hippocampal neurons, located in the CA2 subregion, signals current location during immobility, and does so in association with a previously unidentified hippocampus-wide network pattern. In addition, signalling of location persists into brief periods of desynchronization prevalent in slow-wave sleep. The hippocampus thus generates a distinct representation of current location during immobility, pointing to mnemonic processing specific to experience occurring in the absence of locomotion.	[Kay, Kenneth; Sosa, Marielena; Chung, Jason E.; Karlsson, Mattias P.; Larkin, Margaret C.; Frank, Loren M.] Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, San Francisco, CA 94158 USA; [Kay, Kenneth; Sosa, Marielena; Chung, Jason E.; Karlsson, Mattias P.; Larkin, Margaret C.; Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Frank, Loren M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Kay, K; Frank, LM (corresponding author), Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, San Francisco, CA 94158 USA.; Kay, K; Frank, LM (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.; Frank, LM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	kenneth.kay@ucsf.edu; loren@phy.ucsf.edu	Core, Vector/CAF-4832-2022	Frank, Loren/0000-0002-1752-5677; Sosa, Marielena/0000-0003-0762-1128	Howard Hughes Medical Institute; NIH [R01 MH090188]; McKnight Foundation Cognitive and Memory Disorders Award; Ruth L. Kirchstein National Research Service Award Fellowship (NIH/NIMH); UCSF Medical Scientist Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH097356, R01MH090188] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation Cognitive and Memory Disorders Award; Ruth L. Kirchstein National Research Service Award Fellowship (NIH/NIMH); UCSF Medical Scientist Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank G. Rothschild, D. Liu, J. Yu, S. Jadhav, E. Anderson, P. Sabes, C. Schreiner, M. Stryker, R. Knight, J. O'Doherty, E. Phillips, K. Kay, and B. Mensh for discussion and suggestions, and I. Grossrubatscher, C. Lykken, and S. Harris for technical assistance. This work was supported by the Howard Hughes Medical Institute, an NIH grant (R01 MH090188) and a McKnight Foundation Cognitive and Memory Disorders Award ( L. M. F.). K. K. is supported by a Ruth L. Kirchstein National Research Service Award Fellowship (NIH/NIMH) and the UCSF Medical Scientist Training Program.	Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bittner KC, 2015, NAT NEUROSCI, V18, P1133, DOI 10.1038/nn.4062; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Chen ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021408; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cui ZZ, 2013, J COMP NEUROL, V521, P1844, DOI 10.1002/cne.23263; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Diba K, 2014, J NEUROSCI, V34, P14984, DOI 10.1523/JNEUROSCI.1091-14.2014; Dudek SM, 2016, NAT REV NEUROSCI, V17, P89, DOI 10.1038/nrn.2015.22; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H, 2014, NEURON, V83, P764, DOI 10.1016/j.neuron.2014.07.032; EILAM D, 1989, BEHAV BRAIN RES, V34, P199, DOI 10.1016/S0166-4328(89)80102-0; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hattori S, 2015, HIPPOCAMPUS, V25, P655, DOI 10.1002/hipo.22401; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Ito HT, 2015, NATURE, V522, P50, DOI 10.1038/nature14396; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jarosiewicz B, 2002, J NEUROSCI, V22, P1373, DOI 10.1523/JNEUROSCI.22-04-01373.2002; Jutras MJ, 2013, P NATL ACAD SCI USA, V110, P13144, DOI 10.1073/pnas.1302351110; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kemere C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073114; Kim SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005494; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee H, 2015, NEURON, V87, P1093, DOI 10.1016/j.neuron.2015.07.012; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Lu L, 2015, NEURON, V87, P1078, DOI 10.1016/j.neuron.2015.07.007; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; MacDonald CJ, 2013, J NEUROSCI, V33, P14607, DOI 10.1523/JNEUROSCI.1537-13.2013; Mankin EA, 2015, NEURON, V85, P190, DOI 10.1016/j.neuron.2014.12.001; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Neunuebel JP, 2012, J NEUROSCI, V32, P3848, DOI 10.1523/JNEUROSCI.6038-11.2012; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pentkowski NS, 2006, EUR J NEUROSCI, V23, P2185, DOI 10.1111/j.1460-9568.2006.04754.x; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Rowland DC, 2013, J NEUROSCI, V33, P14889, DOI 10.1523/JNEUROSCI.1046-13.2013; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SUZUKI SS, 1987, ELECTROEN CLIN NEURO, V67, P348, DOI 10.1016/0013-4694(87)90123-4; Takahashi M, 2009, J NEUROPHYSIOL, V102, P556, DOI 10.1152/jn.91159.2008; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Valero M, 2015, NAT NEUROSCI, V18, P1281, DOI 10.1038/nn.4074; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wallace DG, 2006, ANIM COGN, V9, P219, DOI 10.1007/s10071-006-0023-x; Watrous AJ, 2013, HIPPOCAMPUS, V23, P656, DOI 10.1002/hipo.22124; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; WOODHAMS PL, 1993, HIPPOCAMPUS, V3, P303; Zheng CG, 2015, HIPPOCAMPUS, V25, P924, DOI 10.1002/hipo.22415	82	102	103	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					185	+		10.1038/nature17144	http://dx.doi.org/10.1038/nature17144			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26934224	Green Submitted, Green Accepted			2022-12-28	WOS:000371665100031
J	Spitler, LG; Scholz, P; Hessels, JWT; Bogdanov, S; Brazier, A; Camilo, F; Chatterjee, S; Cordes, JM; Crawford, F; Deneva, J; Ferdman, RD; Freire, PCC; Kaspi, VM; Lazarus, P; Lynch, R; Madsen, EC; McLaughlin, MA; Patel, C; Ransom, SM; Seymour, A; Stairs, IH; Stappers, BW; van Leeuwen, J; Zhu, WW				Spitler, L. G.; Scholz, P.; Hessels, J. W. T.; Bogdanov, S.; Brazier, A.; Camilo, F.; Chatterjee, S.; Cordes, J. M.; Crawford, F.; Deneva, J.; Ferdman, R. D.; Freire, P. C. C.; Kaspi, V. M.; Lazarus, P.; Lynch, R.; Madsen, E. C.; McLaughlin, M. A.; Patel, C.; Ransom, S. M.; Seymour, A.; Stairs, I. H.; Stappers, B. W.; van Leeuwen, J.; Zhu, W. W.			A repeating fast radio burst	NATURE			English	Article							PULSAR; DISCOVERY; SIGNATURES; EMISSION; ORIGIN; ALPHA	Fast radio bursts are millisecond-duration astronomical radio pulses of unknown physical origin that appear to come from extragalactic distances(1-8). Previous follow-up observations have failed to find additional bursts at the same dispersion measure (that is, the integrated column density of free electrons between source and telescope) and sky position as the original detections(9). The apparent non-repeating nature of these bursts has led to the suggestion that they originate in cataclysmic events(10). Here we report observations of ten additional bursts from the direction of the fast radio burst FRB 121102. These bursts have dispersion measures and sky positions consistent with the original burst(4). This unambiguously identifies FRB 121102 as repeating and demonstrates that its source survives the energetic events that cause the bursts. Additionally, the bursts from FRB 121102 show a wide range of spectral shapes that appear to be predominantly intrinsic to the source and which vary on timescales of minutes or less. Although there may be multiple physical origins for the population of fast radio bursts, these repeat bursts with high dispersion measure and variable spectra specifically seen from the direction of FRB 121102 support an origin in a young, highly magnetized, extragalactic neutron star(11,12).	[Spitler, L. G.; Freire, P. C. C.; Lazarus, P.; Zhu, W. W.] Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany; [Scholz, P.; Ferdman, R. D.; Kaspi, V. M.; Madsen, E. C.; Patel, C.; Stairs, I. H.] McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada; [Scholz, P.; Ferdman, R. D.; Kaspi, V. M.; Madsen, E. C.; Patel, C.; Stairs, I. H.] McGill Univ, McGill Space Inst, 3600 Univ St, Montreal, PQ H3A 2T8, Canada; [Hessels, J. W. T.; van Leeuwen, J.] Netherlands Inst Radio Astron, ASTRON, Postbus 2, NL-7990 AA Dwingeloo, Netherlands; [Hessels, J. W. T.; van Leeuwen, J.] Univ Amsterdam, Astron Inst Anton Pannekoek, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Bogdanov, S.; Camilo, F.] Columbia Univ, Columbia Astrophys Lab, 538 W 120th St, New York, NY 10027 USA; [Brazier, A.; Chatterjee, S.; Cordes, J. M.] Cornell Univ, Dept Astron & Space Sci, Ithaca, NY 14853 USA; [Brazier, A.] Cornell Univ, Cornell Ctr Adv Comp, Ithaca, NY 14853 USA; [Camilo, F.] Square Kilometre Array South Africa, ZA-7405 Pinelands, South Africa; [Crawford, F.] Franklin & Marshall Coll, Dept Phys & Astron, Lancaster, PA 17604 USA; [Deneva, J.] Naval Res Lab, Natl Res Council, 4555 Overlook Ave SW, Washington, DC 20375 USA; [Lynch, R.] Natl Radio Astron Observ, POB 2, Green Bank, WV 24944 USA; [Lynch, R.; McLaughlin, M. A.] W Virginia Univ, Dept Phys & Astron, Morgantown, WV 26506 USA; [Ransom, S. M.] Natl Radio Astron Observ, Edgemont Rd, Charlottesville, VA 22903 USA; [Seymour, A.] Arecibo Observ, HC3 Box 53995, Arecibo, PR 00612 USA; [Stairs, I. H.] Univ British Columbia, Dept Phys & Astron, 6224 Agr Rd, Vancouver, BC V6T 1Z1, Canada; [Stappers, B. W.] Univ Manchester, Sch Phys & Astron, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England	Max Planck Society; McGill University; McGill University; University of Amsterdam; Columbia University; Cornell University; Cornell University; Franklin & Marshall College; National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; National Radio Astronomy Observatory (NRAO); West Virginia University; National Radio Astronomy Observatory (NRAO); National Aeronautics & Space Administration (NASA); University of British Columbia; University of Manchester; Jodrell Bank Centre for Astrophysics	Hessels, JWT (corresponding author), Netherlands Inst Radio Astron, ASTRON, Postbus 2, NL-7990 AA Dwingeloo, Netherlands.; Hessels, JWT (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	j.w.t.hessels@uva.nl	Crawford, Fronefield/AAX-1677-2021; Hessels, Jason/GTO-3261-2022; Freire, Paulo/ABE-8926-2021; Chatterjee, Shami/AAE-8374-2022	Crawford, Fronefield/0000-0002-2578-0360; Hessels, Jason/0000-0003-2317-1446; Freire, Paulo/0000-0003-1307-9435; van Leeuwen, Joeri/0000-0001-8503-6958; Spitler, Laura G/0000-0002-3775-8291; Chatterjee, Shami/0000-0002-2878-1502; Ferdman, Robert/0000-0002-2223-1235; Ransom, Scott/0000-0001-5799-9714; McLaughlin, Maura/0000-0001-7697-7422; Bogdanov, Slavko/0000-0002-9870-2742	National Science Foundation [AST-1100968]; European Research Council (ERC) under the European Union; ERC Starting Grant BEACON [279702]; ERC Starting Grant DRAGNET [337062]; NSF [AST-1104617, AST-1008213]; NSERC; FQRNT via the Centre de Recherche Astrophysique de Quebec; Canadian Institute for Advanced Research; ERC Consolidator Grant [617199]; NSERC Discovery Grant; Science and Technology Facilities Council [ST/L000768/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1430284] Funding Source: National Science Foundation; STFC [ST/L000768/1] Funding Source: UKRI	National Science Foundation(National Science Foundation (NSF)); European Research Council (ERC) under the European Union(European Research Council (ERC)); ERC Starting Grant BEACON; ERC Starting Grant DRAGNET; NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT via the Centre de Recherche Astrophysique de Quebec(FQRNT); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); ERC Consolidator Grant(European Research Council (ERC)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the staff of the Arecibo Observatory, and in particular A. Venkataraman, H. Hernandez, P. Perillat and J. Schmelz, for their continued support and dedication to enabling observations like those presented here. We also thank our commensal observing partners from the Arecibo 'Zone of Avoidance' team, in particular T. McIntyre and T. Henning. We thank M. Kramer for suggestions. The Arecibo Observatory is operated by SRI International under a cooperative agreement with the National Science Foundation (AST-1100968), and in alliance with Ana G. Mendez-Universidad Metropolitana, and the Universities Space Research Association. These data were processed using the McGill University High Performance Computing Centre operated by Compute Canada and Calcul Quebec. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013). L. G. S., P. C. C. F. and P. L. gratefully acknowledge financial support from the ERC Starting Grant BEACON under contract number 279702. J. W. T. H. is an NWO Vidi Fellow and gratefully acknowledges funding for this work from ERC Starting Grant DRAGNET under contract number 337062. Work at Cornell (J. M. C., S. C., A. B.) was supported by NSF grants AST-1104617 and AST-1008213. V. M. K. holds the Lorne Trottier Chair in Astrophysics and Cosmology and a Canadian Research Chair in Observational Astrophysics and received additional support from NSERC via a Discovery Grant and Accelerator Supplement, by FQRNT via the Centre de Recherche Astrophysique de Quebec, and by the Canadian Institute for Advanced Research. J. v. L. acknowledges funding for this research from an ERC Consolidator Grant under contract number 617199. Pulsar research at UBC is supported by an NSERC Discovery Grant and by the Canadian Institute for Advanced Research.	Arzoumanian Z, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/1/65; Bannister KW, 2014, MON NOT R ASTRON SOC, V440, P353, DOI 10.1093/mnras/stu220; Burke-Spolaor S, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/19; Camilo F, 2006, NATURE, V442, P892, DOI 10.1038/nature04986; Champion D. J., 2015, PREPRINT; Cordes JM, 2016, MON NOT R ASTRON SOC, V457, P232, DOI 10.1093/mnras/stv2948; Cordes J. M., 2002, PREPRINT; Cordes JM, 2006, ASTROPHYS J, V637, P446, DOI 10.1086/498335; Falcke H, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201321996; Hankins TH, 2007, ASTROPHYS J, V670, P693, DOI 10.1086/522362; Hansen BMS, 2001, MON NOT R ASTRON SOC, V322, P695, DOI 10.1046/j.1365-8711.2001.04103.x; Karako-Argaman C, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/1/67; Karuppusamy R, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913729; Keane EF, 2012, MON NOT R ASTRON SOC, V425, pL71, DOI 10.1111/j.1745-3933.2012.01306.x; Lazarus P, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/81; Loeb A, 2014, MON NOT R ASTRON SOC, V439, pL46, DOI 10.1093/mnrasl/slt177; Lorimer DR, 2007, SCIENCE, V318, P777, DOI 10.1126/science.1147532; Lyubarsky Y, 2014, MON NOT R ASTRON SOC, V442, pL9, DOI 10.1093/mnrasl/slu046; Masui K, 2015, NATURE, V528, P523, DOI 10.1038/nature15769; McLaughlin MA, 2006, NATURE, V439, P817, DOI 10.1038/nature04440; Mottez F, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424104; Neill J. D., 2015, PREPRINT; Pen UL, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/179; Petroff E, 2015, MON NOT R ASTRON SOC, V454, P457, DOI 10.1093/mnras/stv1953; Petroff E, 2015, MON NOT R ASTRON SOC, V447, P246, DOI 10.1093/mnras/stu2419; Ransom S.M., 2001, THESIS HARVARD U; Ravi V, 2015, ASTROPHYS J LETT, V799, DOI 10.1088/2041-8205/799/1/L5; RICKETT BJ, 1990, ANNU REV ASTRON ASTR, V28, P561, DOI 10.1146/annurev.aa.28.090190.003021; Scholz P, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/1/85; Spitler LG, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/101; Theureau G, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015317; Thornton D, 2013, SCIENCE, V341, P53, DOI 10.1126/science.1236789; WOLSZCZAN A, 1987, ASTROPHYS J, V320, pL35, DOI 10.1086/184972; You XP, 2012, MON NOT R ASTRON SOC, V422, P1160, DOI 10.1111/j.1365-2966.2012.20688.x	34	536	542	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					202	+		10.1038/nature17168	http://dx.doi.org/10.1038/nature17168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26934226	Green Accepted, Green Submitted			2022-12-28	WOS:000371665100034
J	Crossno, J; Shi, JK; Wang, K; Liu, XM; Harzheim, A; Lucas, A; Sachdev, S; Kim, P; Taniguchi, T; Watanabe, K; Ohki, TA; Fong, KC				Crossno, Jesse; Shi, Jing K.; Wang, Ke; Liu, Xiaomeng; Harzheim, Achim; Lucas, Andrew; Sachdev, Subir; Kim, Philip; Taniguchi, Takashi; Watanabe, Kenji; Ohki, Thomas A.; Fong, Kin Chung			Observation of the Dirac fluid and the breakdown of the Wiedemann-Franz law in graphene	SCIENCE			English	Article							QUANTUM; VIOLATION	Interactions between particles in quantum many-body systems can lead to collective behavior described by hydrodynamics. One such system is the electron-hole plasma in graphene near the charge-neutrality point, which can form a strongly coupled Dirac fluid. This charge-neutral plasma of quasi-relativistic fermions is expected to exhibit a substantial enhancement of the thermal conductivity, thanks to decoupling of charge and heat currents within hydrodynamics. Employing high-sensitivity Johnson noise thermometry, we report an order of magnitude increase in the thermal conductivity and the breakdown of the Wiedemann-Franz law in the thermally populated charge-neutral plasma in graphene. This result is a signature of the Dirac fluid and constitutes direct evidence of collective motion in a quantum electronic fluid.	[Crossno, Jesse; Shi, Jing K.; Wang, Ke; Liu, Xiaomeng; Harzheim, Achim; Lucas, Andrew; Sachdev, Subir; Kim, Philip] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Crossno, Jesse; Kim, Philip] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Sachdev, Subir] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Taniguchi, Takashi; Watanabe, Kenji] Natl Inst Mat Sci, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan; [Ohki, Thomas A.; Fong, Kin Chung] Raytheon BBN Technol, Quantum Informat Proc Grp, Cambridge, MA 02138 USA	Harvard University; Harvard University; Perimeter Institute for Theoretical Physics; National Institute for Materials Science; Raytheon Technologies; Raytheon BBN Technologies	Kim, P (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Kim, P (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Fong, KC (corresponding author), Raytheon BBN Technol, Quantum Informat Proc Grp, Cambridge, MA 02138 USA.	pkim@physics.harvard.edu; kc.fong@bbn.com	Shi, Jing K/GYD-6505-2022; Wang, Ke/N-9265-2016; lan, A/HHZ-6588-2022; TANIGUCHI, Takashi/H-2718-2011; Kim, Philip/N-1886-2013	Shi, Jing K/0000-0002-2277-7684; Kim, Philip/0000-0002-8255-0086; Wang, Ke/0000-0002-0895-4445	U.S. Department of Energy [DE-SC0012260]; Internal Research and Development; Function Accelerated nanoMaterial Engineering (FAME) Center; Semiconductor Research Corporation MARCO and Defense Advanced Research Projects Agency; Army Research Office (ARO) Multidisciplinary University Research Initiative (MURI) [W911NF-14-1-0247]; ARO [W911NF-14-1-0638]; Agency for Science, Technology and Research (A*STAR); Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4543]; Nano Material Technology Development Program through the National Research Foundation of Korea [2012M3A7B4049966]; NSF [DMR-1360789, ECS-0335765]; Templeton Foundation; MURI from ARO [W911NF-14-1-0003]; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation; Elemental Strategy Initiative; Japan Society for the Promotion of Science [262480621, 25106006]; Raytheon BBN Technologies; Direct For Mathematical & Physical Scien [1360789] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); Internal Research and Development; Function Accelerated nanoMaterial Engineering (FAME) Center; Semiconductor Research Corporation MARCO and Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office (ARO) Multidisciplinary University Research Initiative (MURI); ARO; Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Gordon and Betty Moore Foundation's EPiQS Initiative; Nano Material Technology Development Program through the National Research Foundation of Korea(National Research Foundation of Korea); NSF(National Science Foundation (NSF)); Templeton Foundation; MURI from ARO; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Elemental Strategy Initiative; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Raytheon BBN Technologies; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank M. Foster, D. Efetov, and G.-H. Lee for helpful discussions. The major experimental work at Harvard University is supported by the U.S. Department of Energy (grant DE-SC0012260) and at Raytheon BBN Technologies by Internal Research and Development. J.C. acknowledges support from the Function Accelerated nanoMaterial Engineering (FAME) Center, sponsored by Semiconductor Research Corporation MARCO and Defense Advanced Research Projects Agency. K.W. is supported by Army Research Office (ARO) Multidisciplinary University Research Initiative (MURI) (grant W911NF-14-1-0247). J.K.S. is supported by ARO (grant W911NF-14-1-0638) and the Agency for Science, Technology and Research (A*STAR). P.K. acknowledges partial support from the Gordon and Betty Moore Foundation's EPiQS Initiative (grant GBMF4543) and the Nano Material Technology Development Program through the National Research Foundation of Korea (grant 2012M3A7B4049966). A.L. and S.S. are supported by the NSF under grant DMR-1360789, the Templeton Foundation, and MURI grant W911NF-14-1-0003 from ARO. Research at the Perimeter Institute for Theoretical Physics is supported by the Government of Canada through Industry Canada and by the Province of Ontario through the Ministry of Research and Innovation. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the Ministry of Education, Culture, Sports, Science and Technology, Japan. T.T. acknowledges support from a Grant-in-Aid for Scientific Research (grant 262480621) and a grant on Innovative Areas "Nano Informatics" (grant 25106006) from the Japan Society for the Promotion of Science. T.A.O. and K.C.F. acknowledge support from Raytheon BBN Technologies. This work was performed, in part, at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network, which is supported by the NSF under award no. ECS-0335765. CNS is part of Harvard University.	Adam S, 2007, P NATL ACAD SCI USA, V104, P18392, DOI 10.1073/pnas.0704772104; Apostolov SS, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.121104; Ashcroft N.W., 1976, SOLID STATE PHYS; Betz AC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.056805; Breusing M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086809; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; Couto NJG, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041019; Crossno J, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905926; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; DEJONG MJM, 1995, PHYS REV B, V51, P13389, DOI 10.1103/PhysRevB.51.13389; Fong KC, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041008; Fong KC, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031006; Foster MS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085415; Fritz L, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085416; Hartnoll SA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144502; Johannsen JC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027403; KADANOFF LP, 1963, ANN PHYS-NEW YORK, V24, P419, DOI 10.1016/0003-4916(63)90078-2; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Laitinen A, 2014, NANO LETT, V14, P3009, DOI 10.1021/nl404258a; Lucas A, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.075426; Lucas A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/11/113007; Lui CH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.127404; Martin J, 2008, NAT PHYS, V4, P144, DOI 10.1038/nphys781; McKitterick CB, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.075410; Muller M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.115406; Muller M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.025301; Narozhny BN, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.035414; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Sachdev S, 2011, PHYS TODAY, V64, P29, DOI 10.1063/1.3554314; Sheehy DE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226803; Shuryak E, 2004, PROG PART NUCL PHYS, V53, P273, DOI 10.1016/j.ppnp.2004.02.025; Siegel DA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.146802; Smith RP, 2008, NATURE, V455, P1220, DOI 10.1038/nature07401; Tanatar MA, 2007, SCIENCE, V316, P1320, DOI 10.1126/science.1140762; Tielrooij KJ, 2013, NAT PHYS, V9, P248, DOI [10.1038/nphys2564, 10.1038/NPHYS2564]; Wakeham N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1406; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Xue JM, 2011, NAT MATER, V10, P282, DOI 10.1038/NMAT2968; Yigen S, 2014, NANO LETT, V14, P289, DOI 10.1021/nl403967z; Yoshino H, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.024601; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhang YB, 2009, NAT PHYS, V5, P722, DOI 10.1038/NPHYS1365	43	376	377	6	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1058	1061		10.1126/science.aad0343	http://dx.doi.org/10.1126/science.aad0343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26912362	Green Submitted			2022-12-28	WOS:000371597500037
J	Staiger, DO; Marshall, SM; Goodman, DC; Auerbach, DI; Buerhaus, PI				Staiger, Douglas O.; Marshall, Samuel M.; Goodman, David C.; Auerbach, David I.; Buerhaus, Peter I.			Association Between Having a Highly Educated Spouse and Physician Practice in Rural Underserved Areas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Staiger, Douglas O.] Dartmouth Coll, Dept Econ, 6106 Rockefeller Hall, Hanover, NH 03755 USA; [Marshall, Samuel M.] Arizona State Univ, Tempe, AZ USA; [Goodman, David C.] Geisel Sch Med Dartmouth, Hanover, NH USA; [Auerbach, David I.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Buerhaus, Peter I.] Montana State Univ, Bozeman, MT 59717 USA	Dartmouth College; Arizona State University; Arizona State University-Tempe; Dartmouth College; Vanderbilt University; Montana State University System; Montana State University Bozeman	Staiger, DO (corresponding author), Dartmouth Coll, Dept Econ, 6106 Rockefeller Hall, Hanover, NH 03755 USA.	doug.staiger@dartmouth.edu	Goodman, David/AAG-7497-2020	Marshall, Samuel/0000-0002-9630-1072				Costa DL, 2000, Q J ECON, V115, P1287, DOI 10.1162/003355300555079; Health Resources and Services Administration, 10 HLTH RES SERV ADM; Health Resources and Services Administration, SHORT DES HLTH PROF; Robert Graham Center, SPEC GEOGR DISTR PHY; Ruggles Steven, 2015, INTEGRATED PUBLIC US	5	11	12	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					939	941		10.1001/jama.2015.16972	http://dx.doi.org/10.1001/jama.2015.16972			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934264	Bronze			2022-12-28	WOS:000371077500025
J	Cordova, FA				Cordova, France A.			Embrace uncertainty	SCIENCE			English	Editorial Material									[Cordova, France A.] Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA	National Science Foundation (NSF)	Cordova, FA (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	SciCareerEditor@aaas.org							0	0	0	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					994	994		10.1126/science.351.6276.994	http://dx.doi.org/10.1126/science.351.6276.994			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DE7MO	26917773				2022-12-28	WOS:000370821400044
J	Hirano, T				Hirano, Tatsuya			Condensin-Based Chromosome Organization from Bacteria to Vertebrates	CELL			English	Review							STRUCTURAL MAINTENANCE; MOLECULAR-BASIS; X-CHROMOSOMES; COHESIN RING; DNA-BINDING; SMC-ATPASE; COMPLEX; REPLICATION; SEGREGATION; PROMOTES	Condensins are large protein complexes that play a central role in chromosome organization and segregation in the three domains of life. They display highly characteristic, rod-shaped structures with SMC (structural maintenance of chromosomes) ATPases as their core subunits and organize large-scale chromosome structure through active mechanisms. Most eukaryotic species have two distinct condensin complexes whose balanced usage is adapted flexibly to different organisms and cell types. Studies of bacterial condensins provide deep insights into the fundamental mechanisms of chromosome segregation. This Review surveys both conserved features and rich variations of condensin-based chromosome organization and discusses their evolutionary implications.	[Hirano, Tatsuya] RIKEN, Chromosome Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	RIKEN	Hirano, T (corresponding author), RIKEN, Chromosome Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hiranot@riken.jp	Hirano, Tatsuya/F-6008-2011	Hirano, Tatsuya/0000-0002-4219-6473	JSPS [26251003, 15K14455, 15H05971]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	I am grateful to H. Niki for fruitful discussions and insightful comments on the manuscript. I also thank members of the Hirano laboratory for critically reading the manuscript. I apologize to many colleagues in the field whose excellent work could not be cited because of space limitations. The work of the author's laboratory was supported by JSPS Grant-in-Aid for Scientific Research (Grant Numbers 26251003, 15K14455, and 15H05971).	Akai Y, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110023; Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Barysz H, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150005; Bauer CR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002873; Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538; Belmont AS, 2002, P NATL ACAD SCI USA, V99, P15855, DOI 10.1073/pnas.262672799; Borgmann LAKK, 2013, CELL REP, V3, P1483, DOI 10.1016/j.celrep.2013.04.005; Buster DW, 2013, J CELL BIOL, V201, P49, DOI 10.1083/jcb.201207183; Charbin A, 2014, NUCLEIC ACIDS RES, V42, P340, DOI 10.1093/nar/gkt882; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Dobzhansky T, 2013, AM BIOL TEACH, V75, P87, DOI 10.2307/4444260; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Eng T, 2015, MOL BIOL CELL, V26, P4224, DOI 10.1091/mbc.E15-06-0331; Fujiwara T, 2013, MOL BIOL CELL, V24, P2515, DOI 10.1091/mbc.E13-04-0208; Gassmann R, 2004, EXP CELL RES, V296, P35, DOI 10.1016/j.yexcr.2004.03.006; Gligoris TG, 2014, SCIENCE, V346, P963, DOI 10.1126/science.1256917; Green LC, 2012, J CELL SCI, V125, P1591, DOI 10.1242/jcs.097790; Griese JJ, 2010, NUCLEIC ACIDS RES, V38, P3454, DOI 10.1093/nar/gkq038; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Gruber S, 2014, CURR BIOL, V24, P293, DOI 10.1016/j.cub.2013.12.049; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hartl TA, 2008, SCIENCE, V322, P1384, DOI 10.1126/science.1164216; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Hirano T, 2014, TRENDS CELL BIOL, V24, P727, DOI 10.1016/j.tcb.2014.06.007; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Houlard M, 2015, NAT CELL BIOL, V17, P771, DOI 10.1038/ncb3167; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Joyce EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002667; Kamada K, 2013, STRUCTURE, V21, P581, DOI 10.1016/j.str.2013.02.016; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10200; Kim JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3537; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kinoshita K, 2015, DEV CELL, V33, P94, DOI 10.1016/j.devcel.2015.01.034; Kranz AL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r112; Kschonsak M, 2015, BIOESSAYS, V37, P755, DOI 10.1002/bies.201500020; Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5; Marbouty M, 2015, MOL CELL, V59, P588, DOI 10.1016/j.molcel.2015.07.020; Marko JF, 2015, PHYSICA A, V418, P126, DOI 10.1016/j.physa.2014.07.045; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Murayama Y, 2015, CELL, V163, P1628, DOI 10.1016/j.cell.2015.11.030; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nakazawa N, 2015, GENES CELLS, V20, P481, DOI 10.1111/gtc.12239; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nicolas E, 2014, MBIO, V5, DOI 10.1128/mBio.01001-13; Nishide K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004847; Oliveira RA, 2007, CHROMOSOMA, V116, P259, DOI 10.1007/s00412-007-0097-5; Ono T, 2013, J CELL BIOL, V200, P429, DOI 10.1083/jcb.201208008; Palecek JJ, 2015, STRUCTURE, V23, P2183, DOI 10.1016/j.str.2015.10.004; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Pferdehirt RR, 2011, GENE DEV, V25, P499, DOI 10.1101/gad.2016011; Piazza I, 2014, NAT STRUCT MOL BIOL, V21, P560, DOI 10.1038/nsmb.2831; Reyes-Lamothe R, 2012, ANNU REV GENET, V46, P121, DOI 10.1146/annurev-genet-110711-155421; Sakamoto T, 2011, PLANT CELL, V23, P3533, DOI 10.1105/tpc.111.086314; Shintomi K, 2007, TRENDS BIOCHEM SCI, V32, P154, DOI 10.1016/j.tibs.2007.02.002; Shintomi K, 2015, NAT CELL BIOL, V17, P1014, DOI 10.1038/ncb3187; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Sutani T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8815; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Vlijm R, 2015, CELL REP, V10, P216, DOI 10.1016/j.celrep.2014.12.022; Vos SM, 2013, EMBO J, V32, P2950, DOI 10.1038/emboj.2013.218; Wang XD, 2015, GENE DEV, V29, P1661, DOI 10.1101/gad.265876.115; Wang XD, 2014, CURR BIOL, V24, P287, DOI 10.1016/j.cub.2013.11.050; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamashita D, 2011, J CELL BIOL, V194, P841, DOI 10.1083/jcb.201106141; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4; Yoshimura SH, 2014, STRUCTURE, V22, P1699, DOI 10.1016/j.str.2014.10.009	85	217	221	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					847	857		10.1016/j.cell.2016.01.033	http://dx.doi.org/10.1016/j.cell.2016.01.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919425	Bronze			2022-12-28	WOS:000370867300010
J	Dondorp, AM; Iyer, SS; Schultz, MJ				Dondorp, Arjen M.; Iyer, Shivakumar S.; Schultz, Marcus J.			Critical Care in Resource-Restricted Settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dondorp, Arjen M.; Schultz, Marcus J.] Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; [Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Iyer, Shivakumar S.] Bharati Vidyapeeth Univ, Coll Med, Dept Intens Care, Pune, Maharashtra, India; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands	Mahidol University; University of Oxford; Bharati Vidyapeeth Deemed University; University of Amsterdam; Academic Medical Center Amsterdam	Dondorp, AM (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	arjen@tropmedres.ac	Schultz, Marcus/AAB-6379-2021	Schultz, Marcus/0000-0003-3969-7792				Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Ashley EA, 2011, TROP MED INT HEALTH, V16, P1167, DOI 10.1111/j.1365-3156.2011.02822.x; Austin S, 2014, INTENS CARE MED, V40, P342, DOI 10.1007/s00134-013-3174-7; Divatia JV, 2015, INTENS CARE MED, V41, P1468, DOI 10.1007/s00134-014-3618-8; Kulkarni AP, 2013, INDIAN J CRIT CARE M, V17, P292, DOI 10.4103/0972-5229.120321; Neto AS, 2016, INTENS CARE MED, V42, P100, DOI 10.1007/s00134-015-4070-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385	7	39	39	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					753	754		10.1001/jama.2016.0976	http://dx.doi.org/10.1001/jama.2016.0976			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903331				2022-12-28	WOS:000370700500008
J	Matthay, MA; Liu, KD				Matthay, Michael A.; Liu, Kathleen D.			New Strategies for Effective Therapeutics in Critically Ill Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SEVERE SEPSIS; SEPTIC SHOCK; MORTALITY; TRIAL		[Matthay, Michael A.; Liu, Kathleen D.] Univ Calif San Francisco, Dept Med, 505 Parnassus Ave,Rm M-917, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Liu, Kathleen D.] Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Matthay, MA (corresponding author), Univ Calif San Francisco, Dept Med, 505 Parnassus Ave,Rm M-917, San Francisco, CA 94143 USA.; Matthay, MA (corresponding author), Univ Calif San Francisco, Dept Anesthesia, 505 Parnassus Ave,Rm M-917, San Francisco, CA 94143 USA.	michael.matthay@ucsf.edu		Liu, Kathleen/0000-0003-4891-8649				Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Janz DR, 2015, CRIT CARE MED, V43, P534, DOI 10.1097/CCM.0000000000000718; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Lee CR, 2015, NEW ENGL J MED, V373, P2183, DOI 10.1056/NEJMcibr1511280; Opal SM, 2014, CRIT CARE MED, V42, P1714, DOI 10.1097/CCM.0000000000000325; Walter J, 2014, LANCET RESP MED, V2, P1016, DOI 10.1016/S2213-2600(14)70217-6	9	14	14	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					747	748		10.1001/jama.2016.0661	http://dx.doi.org/10.1001/jama.2016.0661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903328				2022-12-28	WOS:000370700500005
J	Briner, JP				Briner, Jason P.			CLIMATE SCIENCE Ice streams waned as ice sheets shrank	NATURE			English	Editorial Material									[Briner, Jason P.] SUNY Buffalo, Dept Geol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Briner, JP (corresponding author), SUNY Buffalo, Dept Geol Sci, Buffalo, NY 14260 USA.	jbriner@buffalo.edu						Bennett MR, 2003, EARTH-SCI REV, V61, P309, DOI 10.1016/S0012-8252(02)00130-7; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; DYKE A.S., 2003, 1574 NAT RES CAN; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Joughin I, 2014, CRYOSPHERE, V8, P209, DOI 10.5194/tc-8-209-2014; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Stokes CR, 2016, NATURE, V530, P322, DOI 10.1038/nature16947; Stokes CR, 1999, ANN GLACIOL, V28, P67, DOI 10.3189/172756499781821625; Truffer M, 2003, ANN GLACIOL, V36, P66, DOI 10.3189/172756403781816347	9	4	4	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					287	288		10.1038/530287a	http://dx.doi.org/10.1038/530287a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887489				2022-12-28	WOS:000370327100024
J	Wan, Z; Zhu, M; Chen, S; Sperling, D				Wan, Zheng; Zhu, Mo; Chen, Shun; Sperling, Daniel			Three steps to a green shipping industry	NATURE			English	Editorial Material							EMISSIONS		[Wan, Zheng; Zhu, Mo; Chen, Shun] Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China; [Sperling, Daniel] Univ Calif Davis, Civil Engn & Environm Sci & Policy, Davis, CA 95616 USA; [Sperling, Daniel] Univ Calif Davis, Inst Transportat Studies, Davis, CA 95616 USA	Shanghai Maritime University; University of California System; University of California Davis; University of California System; University of California Davis	Wan, Z (corresponding author), Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China.	mrwan@ucdavis.edu						Anderson K, 2012, CARBON MANAG, V3, P615, DOI [10.4155/cmt.12.63, 10.4155/CMT.12.63]; Corbett JJ, 2007, ENVIRON SCI TECHNOL, V41, P8512, DOI 10.1021/es071686z; Demaria F., 2016, NATURE EC SOC, P273; Hong Kong Environmental Protection Department, 2015, 2013 HONG KONG EM IN; Hossain K.A., 2015, J ENV ANAL TOXICOL, V5, DOI [10.4172/2161-0525.1000312, DOI 10.4172/2161-0525.1000312]; Levinson M., 2010, BOX SHIPPING CONTAIN; Meyer A, 2014, NATURE, V506, P287, DOI 10.1038/506287a; Polemis SM, 2012, BALANCING ENV ASPIRA; Singh SP, 2012, PACKAG TECHNOL SCI, V25, P149, DOI 10.1002/pts.968; Smith TW, 2014, 3 IMO GREENHOUSE GAS	10	93	98	16	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					275	277		10.1038/530275a	http://dx.doi.org/10.1038/530275a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887477	Bronze, Green Published			2022-12-28	WOS:000370327100013
J	Chen, RJ; Desai, NR; Ross, JS; Zhang, WW; Chau, KH; Wayda, B; Murugiah, K; Lu, DY; Mittal, A; Krumholz, HM				Chen, Ruijun; Desai, Nihar R.; Ross, Joseph S.; Zhang, Weiwei; Chau, Katherine H.; Wayda, Brian; Murugiah, Karthik; Lu, Daniel Y.; Mittal, Amit; Krumholz, Harlan M.			Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OPEN SCIENCE; TIME; ACCESS	OBJECTIVE To determine rates of publication and reporting of results within two years for all completed clinical trials registered in ClinicalTrials.gov across leading academic medical centers in the United States. DESIGN Cross sectional analysis. SETTING Academic medical centers in the United States. PARTICIPANTS Academic medical centers with 40 or more completed interventional trials registered on ClinicalTrials.gov. METHODS Using the Aggregate Analysis of ClinicalTrials.gov database and manual review, we identified all interventional clinical trials registered on ClinicalTrials.gov with a primary completion date between October 2007 and September 2010 and with a lead investigator affiliated with an academic medical center. MAIN OUTCOME MEASURES The proportion of trials that disseminated results, defined as publication or reporting of results on ClinicalTrials.gov, overall and within 24 months of study completion. RESULTS We identified 4347 interventional clinical trials across 51 academic medical centers. Among the trials, 1005 (23%) enrolled more than 100 patients, 1216 (28%) were double blind, and 2169 (50%) were phase II through IV. Overall, academic medical centers disseminated results for 2892 (66%) trials, with 1560 (35.9%) achieving this within 24 months of study completion. The proportion of clinical trials with results disseminated within 24 months of study completion ranged from 16.2% (6/37) to 55.3% (57/103) across academic medical centers. The proportion of clinical trials published within 24 months of study completion ranged from 10.8% (4/37) to 40.3% (31/77) across academic medical centers, whereas results reporting on ClinicalTrials.gov ranged from 1.6% (2/122) to 40.7% (72/177). CONCLUSIONS Despite the ethical mandate and expressed values and mission of academic institutions, there is poor performance and noticeable variation in the dissemination of clinical trial results across leading academic medical centers.	[Chen, Ruijun] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Desai, Nihar R.; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Desai, Nihar R.; Ross, Joseph S.; Zhang, Weiwei; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Wayda, Brian] Columbia Univ, Med Ctr, Dept Internal Med, Div Gen Med, New York, NY USA; [Murugiah, Karthik; Mittal, Amit] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Lu, Daniel Y.] Univ Penn Hlth Syst, Dept Med, Philadelphia, PA USA	University of California System; University of California San Francisco; Yale University; Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Columbia University; Yale University; University of Pennsylvania	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.	krumholz@yale.edu	, Harlan/AAI-2875-2020	Lu, Daniel/0000-0001-9824-3956; Chen, RuiJun/0000-0001-5281-4143; Ross, Joseph/0000-0002-9218-3320; Wayda, Brian/0000-0001-7005-9938; Murugiah, Karthik/0000-0001-7932-382X	Agency for Healthcare Research and Quality [K12 HS023000-01]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research; National Heart, Lung, and Blood Institute, Center for Cardiovascular Outcomes Research at Yale University [U01 HL105270-05]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS023000] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; National Heart, Lung, and Blood Institute, Center for Cardiovascular Outcomes Research at Yale University; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study received no specific funding or grant from any agency in the public, commercial, or not for profit sectors. NRD is supported by the Agency for Healthcare Research and Quality (grant K12 HS023000-01) supports NRD. JSR is supported by the National Institute on Aging (grant K08 AG032886) and by the American Federation for Aging Research through the Paul B Beeson career development award programme. HMK is supported by the National Heart, Lung, and Blood Institute (grant U01 HL105270-05, Center for Cardiovascular Outcomes Research at Yale University). These sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; [Anonymous], 2014, SCOPUS; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Gill CJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001186; Gopal RK, 2012, CONTEMP CLIN TRIALS, V33, P486, DOI 10.1016/j.cct.2012.02.001; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Groves T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6276; Hudson KL, 2015, JAMA-J AM MED ASSOC, V313, P355, DOI 10.1001/jama.2014.10716; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Krumholz HM, 2013, ANN INTERN MED, V158, P910, DOI 10.7326/0003-4819-158-12-201306180-00009; Krumholz HM, 2012, CIRC-CARDIOVASC QUAL, V5, P141, DOI 10.1161/CIRCOUTCOMES.112.965848; Law MR, 2011, HEALTH AFFAIR, V30, P2338, DOI 10.1377/hlthaff.2011.0172; Lo B, 2015, JAMA-J AM MED ASSOC, V313, P793, DOI 10.1001/jama.2015.292; Moorthy VS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001819; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Ross JS, 2013, JAMA INTERN MED, V173, P825, DOI 10.1001/jamainternmed.2013.136; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; Ross JS, 2012, CIRC-CARDIOVASC QUAL, V5, P238, DOI 10.1161/CIRCOUTCOMES.112.965798; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Saito H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101826; Spertus JA, 2012, CIRC-CARDIOVASC QUAL, V5, P143, DOI 10.1161/CIRCOUTCOMES.112.965814	22	136	138	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2016	352								i637	10.1136/bmj.i637	http://dx.doi.org/10.1136/bmj.i637			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EY	26888209	Green Published, hybrid			2022-12-28	WOS:000370727700008
J	Edwards, N				Edwards, Nigel			THE BEST POLICY Involve clinicians to avert a digital disaster	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Edwards, Nigel] Nuffield Trust, London, England		Edwards, N (corresponding author), Nuffield Trust, London, England.	nigel.edwards@nuffieldtrust.org.uk						Block L, 2013, J GEN INTERN MED, V28, P1042, DOI 10.1007/s11606-013-2376-6; Imison C., 2016, DELIVERING BENEFITS; MORI Social Research Institute, BAS STUD NAT PROGR I	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2016	352								i888	10.1136/bmj.i888	http://dx.doi.org/10.1136/bmj.i888			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EY	26888860				2022-12-28	WOS:000370727700014
J	Peterson, JLH				Peterson, Jennifer L. H.			SPOT DIAGNOSIS Hypopigmentation of newborn skin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPOMELANOSIS; ITO		[Peterson, Jennifer L. H.] John Radcliffe Hosp, Neonatal Dept, Oxford OX3 9DU, England	University of Oxford	Peterson, JLH (corresponding author), John Radcliffe Hosp, Neonatal Dept, Oxford OX3 9DU, England.	jennifer.peterson@hotmail.co.uk						Ruggieri M, 2000, J CHILD NEUROL, V15, P635, DOI 10.1177/088307380001501001; RUIZMALDONADO R, 1992, PEDIATR DERMATOL, V9, P1, DOI 10.1111/j.1525-1470.1992.tb00317.x; ZVULUNOV A, 1995, J AM ACAD DERMATOL, V32, P915, DOI 10.1016/0190-9622(95)91325-4	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2016	352								i860	10.1136/bmj.i860	http://dx.doi.org/10.1136/bmj.i860			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EW	26884417				2022-12-28	WOS:000370727500008
J	Woodward, A; Porter, JR				Woodward, Alistair; Porter, John R.			Food, hunger, health, and climate change	LANCET			English	Editorial Material									[Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat, Auckland 1050, New Zealand; [Porter, John R.] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Porter, John R.] Univ Greenwich, Nat Resource Inst, Chatham Maritime, OH USA	University of Auckland; University of Copenhagen	Woodward, A (corresponding author), Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat, Auckland 1050, New Zealand.	a.woodward@auckland.ac.nz		Woodward, Alistair/0000-0001-5425-6018				[Anonymous], 2015, C PART 21 SESS PAR 3; Brown A, 2007, PUBLIC HEALTH, V121, P603, DOI 10.1016/j.puhe.2007.01.008; Cramer W, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P979; King D., 2015, CLIMATE CHANGE RISK; Mclver L, 2015, ENV HLTH PERSPECT, DOI DOI 10.1289/EHP.1509756; Naylor RL, 2007, ENVIRONMENT, V49, P30, DOI 10.3200/ENVT.49.9.30-43; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Sanchez B, 2014, GLOBAL CHANGE BIOL, V20, P408, DOI 10.1111/gcb.12389; Springmann M, 2016, LANCET, V387, P1937, DOI 10.1016/S0140-6736(15)01156-3; Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6	11	14	14	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1886	1887		10.1016/S0140-6736(16)00349-4	http://dx.doi.org/10.1016/S0140-6736(16)00349-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL1EE	26947321				2022-12-28	WOS:000375374200007
J	Basu, R; Whitlock, BM; Husson, J; Le Floc'h, A; Jin, WY; Oyler-Yaniv, A; Dotiwala, F; Giannone, G; Hivroz, C; Biais, N; Lieberman, J; Kam, LC; Huse, M				Basu, Roshni; Whitlock, Benjamin M.; Husson, Julien; Le Floc'h, Audrey; Jin, Weiyang; Oyler-Yaniv, Alon; Dotiwala, Farokh; Giannone, Gregory; Hivroz, Claire; Biais, Nicolas; Lieberman, Judy; Kam, Lance C.; Huse, Morgan			Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing	CELL			English	Article							MEMBRANE TENSION; PLASMA-MEMBRANE; CENTROSOME POLARIZATION; IMMUNOLOGICAL SYNAPSE; ACTIN POLYMERIZATION; GRANULE SECRETION; RETROGRADE FLOW; DEFORMABILITY; ACCUMULATION; TRIGGERS	The immunological synapse formed between a cytotoxic T lymphocyte (CTL) and an infected or transformed target cell is a physically active structure capable of exerting mechanical force. Here, we investigated whether synaptic forces promote the destruction of target cells. CTLs kill by secreting toxic proteases and the pore forming protein perforin into the synapse. Biophysical experiments revealed a striking correlation between the magnitude of force exertion across the synapse and the speed of perforin pore formation on the target cell, implying that force potentiates cytotoxicity by enhancing perforin activity. Consistent with this interpretation, we found that increasing target cell tension augmented pore formation by perforin and killing by CTLs. Our data also indicate that CTLs coordinate perforin release and force exertion in space and time. These results reveal an unappreciated physical dimension to lymphocyte function and demonstrate that cells use mechanical forces to control the activity of outgoing chemical signals.	[Basu, Roshni; Le Floc'h, Audrey; Huse, Morgan] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Whitlock, Benjamin M.] Weill Cornell Med Coll, Biochem & Mol Biol Grad Program, New York, NY 10065 USA; [Husson, Julien] Ecole Polytech, Hydrodynam Lab LadHyX, Dept Mech, F-91128 Palaiseau, France; [Jin, Weiyang; Kam, Lance C.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Oyler-Yaniv, Alon] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Dotiwala, Farokh; Lieberman, Judy] Harvard Univ, Program Cellular & Mol Med, Sch Med, Boston, MA 02115 USA; [Giannone, Gregory] Univ Bordeaux, Interdisciplinary Inst Neurosci, UMR 5297, CNRS, F-33000 Bordeaux, France; [Hivroz, Claire] PSL Res Univ, INSERM, U932, Inst Curie, F-75005 Paris, France; [Biais, Nicolas] CUNY Brooklyn Coll, Dept Biol, New York, NY 11201 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Institut Polytechnique de Paris; Columbia University; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; City University of New York (CUNY) System	Huse, M (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	husem@mskcc.org	Dotiwala, Farokh/S-5367-2019; Husson, Julien/B-8466-2018; Lieberman, Judy/A-2717-2015; Hivroz, Claire/H-2711-2014	Dotiwala, Farokh/0000-0002-7387-2219; Husson, Julien/0000-0002-8230-1469; Hivroz, Claire/0000-0002-6794-2890; Giannone, Gregory/0000-0002-0932-1690	NIH [R01-AI087644, R01-AI088377, PN2-EY016586, P30-CA008748]; AXA-Ecole Polytechnique Chair; Labex LaSIPS MECALEUCO; French National Research Agency [ANR-13-BSV2-0018]; French Foundation for Medical Research [FRM DEQ20140329513]; Geoffrey Beene Cancer Research Center; Starr Cancer Consortium; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087644, R01AI088377, SC2AI116566] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AXA-Ecole Polytechnique Chair; Labex LaSIPS MECALEUCO; French National Research Agency(French National Research Agency (ANR)); French Foundation for Medical Research(Fondation pour la Recherche Medicale); Geoffrey Beene Cancer Research Center; Starr Cancer Consortium; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Bantilan and M. Kaissar for technical support; U. Bandyopadhyay and M. Overholtzer for assistance with nitrogen cavitation; A. Gondarenko for assistance with micropillar fabrication; the Molecular Cytology Core Facility for help with imaging; the Antibody and Bioresource Core Facility for fluorescently conjugated F<INF>ab</INF> fragments; S. Budhu and J. Wolchok for providing B16 cells; E. Mace and J. Orange for pHluorin-Lamp1; S. Rudensky and K. Pham for critical reading of the manuscript; and members of the M.H., L.C.K., M.O. Li, and G. Altan-Bonnet labs for advice. This work was supported in part by the NIH (R01-AI087644 to M.H., R01-AI088377 to L.C.K., PN2-EY016586 to L.C.K., and P30-CA008748 to Memorial Sloan-Kettering Cancer Center), the AXA-Ecole Polytechnique Chair (J.H.), Labex LaSIPS MECALEUCO (J.H.), the French National Research Agency (ANR-13-BSV2-0018 to C.H.), the French Foundation for Medical Research (FRM DEQ20140329513 to C.H.), the Geoffrey Beene Cancer Research Center (M.H.), the Starr Cancer Consortium (M.H.), and the Leukemia and Lymphoma Society (M.H.).	Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Bashour KT, 2014, P NATL ACAD SCI USA, V111, P2241, DOI 10.1073/pnas.1315606111; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Bertrand F, 2013, P NATL ACAD SCI USA, V110, P6073, DOI 10.1073/pnas.1218640110; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Comrie WA, 2015, J CELL BIOL, V208, P475, DOI 10.1083/jcb.201406121; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grupp SA, 2011, CURR TOP MICROBIOL, V344, P149, DOI 10.1007/82_2010_94; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hammer JA, 2013, CURR OPIN IMMUNOL, V25, P300, DOI 10.1016/j.coi.2013.03.010; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Huang HW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198304; Hui KL, 2015, MOL BIOL CELL, V26, P685, DOI 10.1091/mbc.E14-03-0830; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Le Floc'h A, 2015, CELL MOL LIFE SCI, V72, P537, DOI 10.1007/s00018-014-1760-7; Le Floc'h A, 2013, J EXP MED, V210, P2721, DOI 10.1084/jem.20131324; Lee CY, 2011, J CELL SCI, V124, P1106, DOI 10.1242/jcs.078592; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Liu X, 2013, P NATL ACAD SCI USA, V110, P11976, DOI 10.1073/pnas.1306180110; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; Masters TA, 2013, P NATL ACAD SCI USA, V110, P11875, DOI 10.1073/pnas.1301766110; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; Natkanski E, 2013, SCIENCE, V340, P1587, DOI [10.1126/science.1237572, 10.1126/science.1238328]; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; OSTERGAARD HL, 1987, NATURE, V330, P71, DOI 10.1038/330071a0; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Polozov IV, 2001, BIOPHYS J, V81, P949, DOI 10.1016/S0006-3495(01)75753-0; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Ritter AT, 2015, IMMUNITY, V42, P864, DOI 10.1016/j.immuni.2015.04.013; Sage PT, 2012, J IMMUNOL, V188, P3686, DOI 10.4049/jimmunol.1102594; Sanderson NSR, 2012, P NATL ACAD SCI USA, V109, P7835, DOI 10.1073/pnas.1116058109; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Ueda H, 2011, P NATL ACAD SCI USA, V108, P17099, DOI 10.1073/pnas.1113703108; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Woodsworth DJ, 2015, BIOPHYS J, V109, P477, DOI 10.1016/j.bpj.2015.06.045; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731	56	205	206	3	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					100	110		10.1016/j.cell.2016.01.021	http://dx.doi.org/10.1016/j.cell.2016.01.021			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	26924577	Green Accepted, Bronze			2022-12-28	WOS:000372785600013
J	Kryukov, GV; Wilson, FH; Ruth, JR; Paulk, J; Tsherniak, A; Marlow, SE; Vazquez, F; Weir, BA; Fitzgerald, ME; Tanaka, M; Bielski, CM; Scott, JM; Dennis, C; Cowley, GS; Boehm, JS; Root, DE; Golub, TR; Clish, CB; Bradner, JE; Hahn, WC; Garraway, LA				Kryukov, Gregory V.; Wilson, Frederick H.; Ruth, Jason R.; Paulk, Joshiawa; Tsherniak, Aviad; Marlow, Sara E.; Vazquez, Francisca; Weir, Barbara A.; Fitzgerald, Mark E.; Tanaka, Minoru; Bielski, Craig M.; Scott, Justin M.; Dennis, Courtney; Cowley, Glenn S.; Boehm, Jesse S.; Root, David E.; Golub, Todd R.; Clish, Clary B.; Bradner, James E.; Hahn, William C.; Garraway, Levi A.			MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells	SCIENCE			English	Article							METHYLTHIOADENOSINE PHOSPHORYLASE; HOMOZYGOUS DELETION; TUMOR-SUPPRESSOR; GENE; METHYLATION; METHYLOSOME; CODELETION; INHIBITOR; DEFICIENT; HISTONE	The discovery of cancer dependencies has the potential to inform therapeutic strategies and to identify putative drug targets. Integrating data from comprehensive genomic profiling of cancer cell lines and from functional characterization of cancer cell dependencies, we discovered that loss of the enzyme methylthioadenosine phosphorylase (MTAP) confers a selective dependence on protein arginine methyltransferase 5 (PRMT5) and its binding partner WDR77. MTAP is frequently lost due to its proximity to the commonly deleted tumor suppressor gene, CDKN2A. We observed increased intracellular concentrations of methylthioadenosine (MTA, the metabolite cleaved by MTAP) in cells harboring MTAP deletions. Furthermore, MTA specifically inhibited PRMT5 enzymatic activity. Administration of either MTA or a small-molecule PRMT5 inhibitor showed a modest preferential impairment of cell viability for MTAP-null cancer cell lines compared with isogenic MTAP-expressing counterparts. Together, our findings reveal PRMT5 as a potential vulnerability across multiple cancer lineages augmented by a common "passenger" genomic alteration.	[Kryukov, Gregory V.; Wilson, Frederick H.; Ruth, Jason R.; Paulk, Joshiawa; Marlow, Sara E.; Vazquez, Francisca; Weir, Barbara A.; Tanaka, Minoru; Bielski, Craig M.; Bradner, James E.; Hahn, William C.; Garraway, Levi A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Kryukov, Gregory V.; Wilson, Frederick H.; Ruth, Jason R.; Paulk, Joshiawa; Tsherniak, Aviad; Marlow, Sara E.; Vazquez, Francisca; Weir, Barbara A.; Fitzgerald, Mark E.; Tanaka, Minoru; Bielski, Craig M.; Scott, Justin M.; Dennis, Courtney; Cowley, Glenn S.; Boehm, Jesse S.; Root, David E.; Golub, Todd R.; Clish, Clary B.; Bradner, James E.; Hahn, William C.; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Garraway, LA (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Garraway, LA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	levi_garraway@dfci.harvard.edu	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Vazquez, Francisca/ABC-4620-2020; Vazquez, Francisca/AAA-3751-2020	Clish, Clary B/0000-0001-8259-9245; Vazquez, Francisca/0000-0002-2857-4685; Kryukov, Gregory/0000-0002-6131-9483; Tsherniak, Aviad/0000-0002-3797-1877; Wilson, Frederick/0000-0002-5019-0186	Slim Initiative in Genomic Medicine for the Americas project; Novartis Institutes for BioMedical Research; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Melanoma Research Alliance; NIH; Integrative Cancer Biology Program [U54 CA112962]; NIH [U01 CA176058]; Conquer Cancer Foundation of the American Society of Clinical Oncology; AACR-Bristol-Myers Squibb [14-40-15-WILS]; Karin Grunebaum Cancer Research Foundation; Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH) [KL2 TR001100]; Novartis; Boehringer Ingelheim; Foundation Medicine; NATIONAL CANCER INSTITUTE [U54CA112962, P01CA163222, U01CA176058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER	Slim Initiative in Genomic Medicine for the Americas project; Novartis Institutes for BioMedical Research; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrative Cancer Biology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conquer Cancer Foundation of the American Society of Clinical Oncology; AACR-Bristol-Myers Squibb; Karin Grunebaum Cancer Research Foundation; Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH); Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Foundation Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Data from Project Achilles and the Cancer Cell Line Encyclopedia can be accessed at www.broadinstitute.org/achilles and www.broadinstitute.org/ccle/home, respectively. We thank members of the Garraway laboratory for helpful discussion. We thank D. Hernandez for assistance with seeding cell lines for metabolomics studies. We gratefully acknowledge the Carlos Slim Foundation for providing access to shRNA screening data (funded in part by the Slim Initiative in Genomic Medicine for the Americas project) for validation studies. Funding for this work was provided by the Novartis Institutes for BioMedical Research, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the Melanoma Research Alliance, a NIH PO1 Research Program Project grant (each to L.A.G.), an Integrative Cancer Biology Program grant (U54 CA112962 to T.R.G.), and an NIH U01 CA176058 (to W.C.H.). F.H.W. is supported by a Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award, the 2014 AACR-Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research (grant 14-40-15-WILS), a grant from the Karin Grunebaum Cancer Research Foundation, and a KL2/Catalyst Medical Research Investigator Training award (an appointed KL2 award) from Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH Award KL2 TR001100). G.V.K., A.T., F.V., B.A.W., and C.M.B. performed computational analysis of data sets generated from Project Achilles and CCLE under the supervision of J.S.B., T.R.G., W.C.H., and L.A.G. G.S.C., D.E.R., and W.C.H. supervised the generation of Project Achilles screening data. F.H.W. and S.E.M. performed experiments to validate the computational shRNA screening findings. G.V.K., F.H.W., S.E.M., J.M.S., C.D., and C.B.C. performed metabolomic studies and analyzed data. Isogenic cell line pairs were generated and characterized by F.H.W. and J.R.R. J.R.R. conducted cell viability IC<INF>50</INF> experiments and the MTA methyltransferase selectivity assay. J.P. performed the MTA mechanism of action study under the supervision of J.E.B. M.E.F. and M.T. synthesized EPZ015666 under the supervision of J.E.B. F.H.W., G.V.K., J.R.R., and L.A.G. wrote the manuscript. L.A.G. is a paid consultant for Novartis and Boehringer Ingelheim; he holds equity in, and is a paid consultant for, Foundation Medicine; and he is a recipient of a grant from Novartis. W.C.H. is a paid consultant for Novartis and recipient of a grant from Novartis. M.T. is a visiting scientist from Mitsubishi Tanabe Pharma Corporation (MTPC) and a recipient of nonresearch support from MTPC. The Broad Institute and the authors (L.A.G., F.H.W., G.V.K., and J.R.R.) have filed a patent application (BI2015/040 46783.00.2109 US PRO Pending 62/131,825) relating to the use of PRMT5 inhibitors to treat MTAP-deficient tumors.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bertino JR, 2011, CANCER BIOL THER, V11, P627, DOI 10.4161/cbt.11.7.14948; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen ZH, 1996, CANCER RES, V56, P1083; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Christopher SA, 2002, CANCER RES, V62, P6639; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Horiuchi KY, 2013, ASSAY DRUG DEV TECHN, V11, P227, DOI 10.1089/adt.2012.480; Hustinx SR, 2005, CANCER BIOL THER, V4, P83, DOI 10.4161/cbt.4.1.1380; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Karikari CA, 2005, MOL CANCER THER, V4, P1860, DOI 10.1158/1535-7163.MCT-05-0103; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Kindler H, 2009, INVEST NEW DRUG, V27, P75, DOI 10.1007/s10637-008-9160-1; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Lim JH, 2014, BIOCHEM BIOPH RES CO, V452, P1016, DOI 10.1016/j.bbrc.2014.09.033; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; Munshi PN, 2014, ONCOLOGIST, V19, P760, DOI 10.1634/theoncologist.2014-0178; Nobori T, 1996, P NATL ACAD SCI USA, V93, P6203, DOI 10.1073/pnas.93.12.6203; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Powell EL, 2005, AM J SURG PATHOL, V29, P1497, DOI 10.1097/01.pas.0000170349.47680.e8; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	33	239	244	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1214	1218		10.1126/science.aad5214	http://dx.doi.org/10.1126/science.aad5214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26912360	Green Accepted			2022-12-28	WOS:000386158400049
J	Ma, C; Kesarwala, AH; Eggert, T; Medina-Echeverz, J; Kleiner, DE; Jin, P; Stroncek, DF; Terabe, M; Kapoor, V; ElGindi, M; Han, MJ; Thornton, AM; Zhang, HB; Egger, M; Luo, J; Felsher, DW; McVicar, DW; Weber, A; Eikenwalder, MH; Greten, TF				Ma, Chi; Kesarwala, Aparna H.; Eggert, Tobias; Medina-Echeverz, Jose; Kleiner, David E.; Jin, Ping; Stroncek, David F.; Terabe, Masaki; Kapoor, Veena; ElGindi, Mei; Han, Miaojun; Thornton, Angela M.; Zhang, Haibo; Egger, Michele; Luo, Ji; Felsher, Dean W.; McVicar, Daniel W.; Weber, Achim; Eikenwalder, Mathias H.; Greten, Tim F.			NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis	NATURE			English	Article							NONALCOHOLIC STEATOHEPATITIS; SUPPRESSOR-CELLS; HEPATOCELLULAR-CARCINOMA; LIPID-METABOLISM; LIVER-CANCER; FATTY-ACIDS; INFLAMMATION; OBESITY; NASH; MICE	Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death. Non-alcoholic fatty liver disease (NAFLD) affects a large proportion of the US population and is considered to be a metabolic predisposition to liver cancer(1-5). However, the role of adaptive immune responses in NAFLD-promoted HCC is largely unknown. Here we show, in mouse models and human samples, that dysregulation of lipid metabolism in NAFLD causes a selective loss of intrahepatic CD4+ but not CD8+ T lymphocytes, leading to accelerated hepatocarcinogenesis. We also demonstrate that CD4+ T lymphocytes have greater mitochondrial mass than CD8+ T lymphocytes and generate higher levels of mitochondrially derived reactive oxygen species (ROS). Disruption of mitochondrial function by linoleic acid, a fatty acid accumulated in NAFLD, causes more oxidative damage than other free fatty acids such as palmitic acid, and mediates selective loss of intrahepatic CD4+ T lymphocytes. In vivo blockade of ROS reversed NAFLD-induced hepatic CD4+ T lymphocyte decrease and delayed NAFLD-promoted HCC. Our results provide an unexpected link between lipid dysregulation and impaired anti-tumour surveillance.	[Ma, Chi; Eggert, Tobias; Medina-Echeverz, Jose; ElGindi, Mei; Han, Miaojun; Greten, Tim F.] NCI, Gastrointestinal Malignancy Sect, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Kesarwala, Aparna H.] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Stroncek, David F.] NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA; [Jin, Ping; Stroncek, David F.] NIH, Cell Proc Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Terabe, Masaki] NCI, Vaccine Branch, NIH, Bethesda, MD 20892 USA; [Kapoor, Veena] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Thornton, Angela M.] NIAID, Lab Immunol, NIH, Bethesda, MD 20892 USA; [Zhang, Haibo; Luo, Ji] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Egger, Michele; Weber, Achim] Univ Zurich, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Egger, Michele; Weber, Achim] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Felsher, Dean W.] Stanford Univ, Dept Pathol & Med, Div Oncol, Stanford, CA 94305 USA; [McVicar, Daniel W.] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Eikenwalder, Mathias H.] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-81675 Munich, Germany; [Eikenwalder, Mathias H.] German Canc Res Ctr, Div Chron Inflammat & Canc, D-69120 Heidelberg, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Zurich; University of Zurich; University Zurich Hospital; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Greten, TF (corresponding author), NCI, Gastrointestinal Malignancy Sect, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	tim.greten@nih.gov	Kleiner, David E/N-2770-2013; Greten, Tim F/B-3127-2015; zhang, haibo/K-5146-2019; Grieshaber-Bouyer, Ricardo/R-7512-2016	Kleiner, David E/0000-0003-3442-4453; Greten, Tim F/0000-0002-0806-2535; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; , Chi/0000-0002-4171-0813; Kesarwala, Aparna/0000-0001-8297-9643; ElGindi, Mei/0000-0003-1508-0560; Weber, Achim/0000-0003-0073-3637; McVicar, Daniel/0000-0002-1112-5111	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases; Intramural Program Grant, NIH, National Cancer Institute (NCI) [ZIABC011303]; European Research Council; Stiftung Experimentelle Biomedizin (Hofschneider Stiftung); Pre-clinical Comprehensive Center (PCCC); Helmholtz foundation; Krebsliga Schweiz (Oncosuisse); Promedica Stiftung, Switzerland; Intramural Research Program of the NIH, NCI; NATIONAL CANCER INSTITUTE [ZIABC011303, ZIABC011345, ZIABC010300, ZIABC011502, ZIABC011575] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases; Intramural Program Grant, NIH, National Cancer Institute (NCI); European Research Council(European Research Council (ERC)European Commission); Stiftung Experimentelle Biomedizin (Hofschneider Stiftung); Pre-clinical Comprehensive Center (PCCC); Helmholtz foundation(Helmholtz Association); Krebsliga Schweiz (Oncosuisse); Promedica Stiftung, Switzerland; Intramural Research Program of the NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank J. Berzofsky, W. Stoffel, E. M. Shevach and S. Thorgeirsson for helpful discussion. A.M.T. was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases. J.L. was supported by the Intramural Program Grant ZIABC011303, NIH, National Cancer Institute (NCI). M.H. was supported by a European Research Council starting grant (LiverCancerMechanism), the Stiftung Experimentelle Biomedizin (Hofschneider Stiftung), the Pre-clinical Comprehensive Center (PCCC) and the Helmholtz foundation. A. W. was supported by grants from the Krebsliga Schweiz (Oncosuisse) and the Promedica Stiftung, Switzerland. D.E.K., A.H.K., D.W.M. and T.F.G. were supported by the Intramural Research Program of the NIH, NCI.	Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Beraza N, 2008, GUT, V57, P655, DOI 10.1136/gut.2007.134288; Cao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104104; CHEN RF, 1967, J BIOL CHEM, V242, P173; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; Giesbertz P, 2015, DIABETOLOGIA, V58, P2133, DOI 10.1007/s00125-015-3656-y; Greten TF, 2015, GUT, V64, P842, DOI 10.1136/gutjnl-2014-307990; Greten TF, 2013, CLIN CANCER RES, V19, P6678, DOI 10.1158/1078-0432.CCR-13-1721; Hanczko R, 2009, J CLIN INVEST, V119, P1546, DOI 10.1172/JCI35722; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Henning JR, 2013, HEPATOLOGY, V58, P589, DOI 10.1002/hep.26267; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Ikehara Y, 2000, J CLIN INVEST, V105, P1761, DOI 10.1172/JCI8922; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kapanadze T, 2013, J HEPATOL, V59, P1007, DOI 10.1016/j.jhep.2013.06.010; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pelletier M, 2014, METHOD ENZYMOL, V542, P125, DOI 10.1016/B978-0-12-416618-9.00007-8; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sumida Y, 2013, FREE RADICAL RES, V47, P869, DOI 10.3109/10715762.2013.837577; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698	41	387	401	9	146	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					253	+		10.1038/nature16969	http://dx.doi.org/10.1038/nature16969			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26934227	Green Submitted, Green Accepted			2022-12-28	WOS:000371665100046
J	Rimmer, A				Rimmer, Abi			WEEKEND MORTALITY The BMJ paper and seven day services	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						Bloch S., 2015, BBC NEWS; Department of Health, 2015, HIGH RISK DEATH ASS; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; House of Commons Health Committee, CURR ISS NHS ENGL IN; Hunt J., 2016, COMMUNICATION; NHS Pay Review Body, 2015, EN DEL HEALTHC SERV; O'Brien L, 2016, 7 DAY NHS NO SOURCE; UK Statistics Authority, 2015, COMMUNICATION; UK Statistics Authority, 2015, EST EXC DEATHS UNPUB	10	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2016	352								i1193	10.1136/bmj.i1193	http://dx.doi.org/10.1136/bmj.i1193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LO	26939594				2022-12-28	WOS:000371756700002
J	Bach, PB; Conti, RM; Muller, RJ; Schnorr, GC; Saltz, LB				Bach, Peter B.; Conti, Rena M.; Muller, Raymond J.; Schnorr, Geoffrey C.; Saltz, Leonard B.			Overspending driven by oversized single dose vials of cancer drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bach, Peter B.; Schnorr, Geoffrey C.; Saltz, Leonard B.] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 485 Lexington Ave, New York, NY 10017 USA; [Conti, Rena M.] Univ Chicago, Dept Pediat Hematol Oncol, Chicago, IL 60637 USA; [Conti, Rena M.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Muller, Raymond J.] Mem Sloan Kettering Canc Ctr, Res Pharm, New York, NY 10017 USA; [Saltz, Leonard B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10017 USA	Memorial Sloan Kettering Cancer Center; University of Chicago; University of Chicago; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 485 Lexington Ave, New York, NY 10017 USA.	bachp@mskcc.org		Saltz, Leonard/0000-0001-8353-4670; Conti, Rena/0000-0002-4190-1839	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; CDC, 2012, PROT PAT PREV HARM I; Center for Medicare and Medicaid Services, 2015, MED PART B DRUG AV S; Centers for Disease Control and Prevention, 2012, PROT PAT PREV HARM I; Centers for Medicare and Medicaid Services, 2012, SAF US SINGL DOS SIN; Centre for Medicare and Medicaid Services, SAF US SINGL DOS SIN; Conti RM, 2014, HEALTH AFFAIR, V33, P1786, DOI 10.1377/hlthaff.2014.0540; Conti RM, 2013, JAMA-J AM MED ASSOC, V309, P1995, DOI 10.1001/jama.2013.4156; European Medicines Agency, EPAR SUMM PUBL VELC; Fasola G, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-57; IMS Institute for Healthcare Informatics, 2015, MED US SPEND SHIFTS; Kaiser Family Foundation, 2014, MED REF SETT CONT UN; Krapcho, 2017, SEER CANC STAT REV 1; Lien K, 2015, J ONCOL PRACT; Newcomer LN, 2012, HEALTH AFFAIR, V31, P780, DOI 10.1377/hlthaff.2012.0002; Office of Inspector General, 2015, PART B PAYM 340B PUR; Smith RSV, 2015, EUR J HOSP PHARM, V22, P161, DOI 10.1136/ejhpharm-2014-000547; United States Pharmacopeia, 2008, USP 797 GUID PHARM C; US Department of Health and Human Services, 2004, NAT HLTH NUTR EX SUR; US Food and Drug Administration, 2015, DRUGS FDA FDA APPR D; US Food and Drug Administration, 2013, COD FED REG TITL 21; USDHHS. FDA CDER CBER, 2015, ALL EXC VOL LAB VIAL	22	88	89	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2016	352								i788	10.1136/bmj.i788	http://dx.doi.org/10.1136/bmj.i788			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LJ	26932932	Green Published			2022-12-28	WOS:000371756000002
J	Basarab, M; Bowman, C; Aarons, EJ; Cropley, I				Basarab, Marina; Bowman, Conor; Aarons, Emma J.; Cropley, Ian			Zika virus	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TRANSMISSION; OUTBREAK; INFECTION; BRAZIL; FEVER		[Basarab, Marina; Bowman, Conor; Cropley, Ian] Royal Free London NHS Fdn Trust, Dept Infect Dis, London NW3 2QG, England; [Aarons, Emma J.] Publ Hlth England, Rare & Imported Pathogens Lab, Porton Down, England	University of London; University College London; Royal Free London NHS Foundation Trust; Public Health England	Cropley, I (corresponding author), Royal Free London NHS Fdn Trust, Dept Infect Dis, London NW3 2QG, England.	iancropley@nhs.net						Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062; Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107; Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751; BOORMAN J. P. T., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P238, DOI 10.1016/0035-9203(56)90029-3; BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Centres for Disease Control, REV DIAGN TEST ZIK C; Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207; Da Saude M., 2015, SITUACAO CONFIRMACAO; DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; ECDC, COUNTR TERR LOC ZIK; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Freire CCDM., 2015, BIORXIV, P32839, DOI [10.1101/032839, DOI 10.1101/032839]; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; JAN C, 1978, B SOC PATHOL EXOT, V71, P140; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; Mallet HP, 2015, BISES B INFORM SANIT; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4; Mlakar J, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1600651.26862926, DOI 10.1056/NEJMOA1600651.26862926]; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0; Pan American Health Organization. World Health Organization, 2015, EP AL NEUR SYNDR CON; Regis CT, 2016, B WORLD HEALTH ORGAN, P4, DOI [DOI 10.2471/BLT.16.170639, 10.2471/BLT.16.170639]; Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Scotland HP, NHS NAT SERV SCOTL F; SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9; Smithburn KC, 1954, NEUTRALISING ANTIBOD; Stanczyk NM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h99; Symmes Cobb J, COLOMBIAS FORECAST Z; Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2; Tognarelli J, 2014, ARCH VIROL, V2015; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; World Health Organization, DIS OUTBR NEWS GUILL; World Health Organization, 2016, ZIK SIT REP WHO; World Health Organization, 2016, EM COMM ZIK VIR OBS; World Health Organization, ZIK VIR NEWS UPD; World Health Organization, DIS OUTBR NEWS ZIK V	58	61	67	0	74	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2016	352								i1049	10.1136/bmj.i1049	http://dx.doi.org/10.1136/bmj.i1049			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1RM	26921241	Green Published, Bronze			2022-12-28	WOS:000371116900003
J	Cooper, A; Turney, C; Hughen, K				Cooper, Alan; Turney, Chris; Hughen, Konrad			Response to Comment on "Abrupt warming events drove Late Pleistocene Holarctic megafaunal turnover"	SCIENCE			English	Editorial Material								Rasmussen and Svensson correctly point out that there is currently no satisfactory method to fully align the Greenland and Cariaco Basin records of climate change. However, our approach using interstadial onsets as tie-points allows direct comparison between radiocarbon dates and Greenland climate records. Crucially, both the standard Greenland and the merged Greenland-Cariaco time scales show that interstadial warming was associated with megafaunal genetic transitions.	[Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Cooper, Alan] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Turney, Chris] Univ New S Wales, Sch Biol Earth & Environm Sci, Climate Change Res Ctr, Sydney, NSW, Australia; [Hughen, Konrad] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	University of Adelaide; University of Adelaide; University of New South Wales Sydney; Woods Hole Oceanographic Institution	Cooper, A (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia.; Cooper, A (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA, Australia.	alan.cooper@adelaide.edu.au	Turney, Chris S M/P-8701-2018	Turney, Chris S M/0000-0001-6733-0993; Cooper, Alan/0000-0002-7738-7851				Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; Muscheler R, 2014, QUATERNARY SCI REV, V106, P81, DOI 10.1016/j.quascirev.2014.08.017; Rasmussen SO, 2016, SCIENCE, V351, DOI 10.1126/science.aad3573; Torbenson MCA, 2015, GEOLOGY, V43, P799, DOI 10.1130/G36914.1; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013	5	0	0	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276								10.1126/science.aad8016	http://dx.doi.org/10.1126/science.aad8016			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917762				2022-12-28	WOS:000370821400030
J	Paul-Emile, K; Smith, AK; Lo, B; Fernandez, A				Paul-Emile, Kimani; Smith, Alexander K.; Lo, Bernard; Fernandez, Alicia			Dealing with Racist Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Paul-Emile, Kimani] Fordham Univ, Sch Law, New York, NY 10023 USA; [Lo, Bernard] Greenwall Fdn, New York, NY USA; [Smith, Alexander K.] Univ Calif San Francisco, Div Geriatr, Dept Med, San Francisco, CA 94143 USA; [Fernandez, Alicia] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; [Smith, Alexander K.] San Francisco VA Med Ctr, San Francisco, CA USA	Fordham University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Paul-Emile, K (corresponding author), Fordham Univ, Sch Law, New York, NY 10023 USA.							Cooper LA, 2003, ANN INTERN MED, V139, P907, DOI 10.7326/0003-4819-139-11-200312020-00009; Jain SH, 2013, ANN INTERN MED, V158, P632, DOI 10.7326/0003-4819-158-8-201304160-00010; Paul-Emile K, 2012, UCLA LAW REV, V60, P462	3	71	71	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					708	711		10.1056/NEJMp1514939	http://dx.doi.org/10.1056/NEJMp1514939			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE6BB	26933847				2022-12-28	WOS:000370716600004
J	Simon, DJ; Pitts, J; Hertz, NT; Yang, J; Yamagishi, Y; Olsen, O; Mark, MT; Molina, H; Tessier-Lavigne, M				Simon, David J.; Pitts, Jason; Hertz, Nicholas T.; Yang, Jing; Yamagishi, Yuya; Olsen, Olav; Mark, Milica Tesic; Molina, Henrik; Tessier-Lavigne, Marc			Axon Degeneration Gated by Retrograde Activation of Somatic Pro-apoptotic Signaling	CELL			English	Article							CASPASE ACTIVITY; NEURONAL APOPTOSIS; PATHWAY; DEATH; DLK; SUPPRESSES; INHIBITOR; INJURY; PUMA	During development, sensory axons compete for limiting neurotrophic support, and local neurotrophin insufficiency triggers caspase-dependent axon degeneration. The signaling driving axon degeneration upon local deprivation is proposed to reside within axons. Our results instead support a model in which, despite the apoptotic machinery being present in axons, the cell body is an active participant in gating axonal caspase activation and axon degeneration. Loss of trophic support in axons initiates retrograde activation of a somatic pro-apoptotic pathway, which, in turn, is required for distal axon degeneration via an anterograde pro-degenerative factor. At a molecular level, the cell body is the convergence point of two signaling pathways whose integrated action drives upregulation of pro-apoptotic Puma, which, unexpectedly, is confined to the cell body. Puma then overcomes inhibition by pro-survival Bcl-xL and Bcl-w and initiates the anterograde prodegenerative program, highlighting the role of the cell body as an arbiter of large-scale axon removal.	[Simon, David J.; Pitts, Jason; Hertz, Nicholas T.; Yang, Jing; Yamagishi, Yuya; Olsen, Olav; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, 1230 York Ave, New York, NY 10065 USA; [Mark, Milica Tesic; Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10065 USA; [Yang, Jing] Peking Univ, IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Rockefeller University; Rockefeller University; Peking University	Tessier-Lavigne, M (corresponding author), Rockefeller Univ, Lab Brain Dev & Repair, 1230 York Ave, New York, NY 10065 USA.	marctl@rockefeller.edu	Yang, Jing/M-2831-2017	Yang, Jing/0000-0002-2048-735X; Simon, David/0000-0002-2683-5757; Hertz, Nicholas/0000-0002-6527-6898	Rockefeller University; NIH [1R01NS089786]; Leon Levy Foundation; Helen Hay Whitney Foundation; Japan Society for the Promotion of Science; International Human Frontier Science Program Organization; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089786] Funding Source: NIH RePORTER	Rockefeller University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leon Levy Foundation; Helen Hay Whitney Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to thank the members of the Tessier-Lavigne laboratory for insightful discussions. A. Ding, A. Strasser, M. Merad, N. Danial, E. Wagner, J. Stoller, A. DiAntonio, J. Milbrandt, and D. Ginty generously provided mice. Research was supported by the Rockefeller University and the NIH (1R01NS089786). D.J.S. was supported in part by a fellowship from the Leon Levy Foundation. N.T.H. was supported by a fellowship from the Helen Hay Whitney Foundation. Y.Y. was supported by the Japan Society for the Promotion of Science and the International Human Frontier Science Program Organization.	Akhter R, 2015, J NEUROCHEM, V134, P1091, DOI 10.1111/jnc.13128; Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campbell DS, 2013, J CELL BIOL, V203, P657, DOI 10.1083/jcb.201303072; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Chen M, 2012, J NEUROSCI, V32, P13439, DOI 10.1523/JNEUROSCI.2039-12.2012; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Courchesne SL, 2011, J NEUROSCI, V31, P1624, DOI 10.1523/JNEUROSCI.3347-10.2011; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Ghosh AS, 2011, J CELL BIOL, V194, P751, DOI 10.1083/jcb.201103153; Huntwork-Rodriguez S, 2013, J CELL BIOL, V202, P747, DOI 10.1083/jcb.201303066; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Schuldiner O, 2015, CELL MOL LIFE SCI, V72, P101, DOI 10.1007/s00018-014-1729-6; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Unsain N, 2013, CELL REP, V4, P751, DOI 10.1016/j.celrep.2013.07.015; Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010; Wang XJ, 2015, ANNU REV PHARMACOL, V55, P553, DOI 10.1146/annurev-pharmtox-010814-124414; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Wu CC, 2015, CELL CYCLE, V14, P1207, DOI 10.1080/15384101.2015.1014144; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; Yang J, 2013, NEURON, V80, P1175, DOI 10.1016/j.neuron.2013.08.034; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024	30	82	83	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					1031	1045		10.1016/j.cell.2016.01.032	http://dx.doi.org/10.1016/j.cell.2016.01.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26898330	Green Accepted, Bronze			2022-12-28	WOS:000370867300024
J	Watts, G				Watts, Geoff			Jeroen Herman Jan Ensink Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					744	744		10.1016/S0140-6736(16)00293-2	http://dx.doi.org/10.1016/S0140-6736(16)00293-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26913309	Bronze			2022-12-28	WOS:000370418000020
J	Blanton, LV; Charbonneau, MR; Salih, T; Barratt, MJ; Venkatesh, S; Ilkaveya, O; Subramanian, S; Manary, MJ; Trehan, I; Jorgensen, JM; Fan, YM; Henrissat, B; Leyn, SA; Rodionov, DA; Osterman, AL; Maleta, K; Newgard, CB; Ashorn, P; Dewey, KG; Gordon, JI				Blanton, Laura V.; Charbonneau, Mark R.; Salih, Tarek; Barratt, Michael J.; Venkatesh, Siddarth; Ilkaveya, Olga; Subramanian, Sathish; Manary, Mark J.; Trehan, Indi; Jorgensen, Josh M.; Fan, Yue-mei; Henrissat, Bernard; Leyn, Semen A.; Rodionov, Dmitry A.; Osterman, Andrei L.; Maleta, KennethM.; Newgard, Christopher B.; Ashorn, Per; Dewey, Kathryn G.; Gordon, Jeffrey I.			Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children	SCIENCE			English	Article							ENVIRONMENTAL ENTERIC DYSFUNCTION; UNDERNUTRITION; MALNUTRITION	Undernourished children exhibit impaired development of their gut microbiota. Transplanting microbiota from 6- and 18-month-old healthy or undernourished Malawian donors into young germ-free mice that were fed a Malawian diet revealed that immature microbiota from undernourished infants and children transmit impaired growth phenotypes. The representation of several age-discriminatory taxa in recipient animals correlated with lean body mass gain; liver, muscle, and brain metabolism; and bone morphology. Mice were cohoused shortly after receiving microbiota from healthy or severely stunted and underweight infants; age-and growth-discriminatory taxa from the microbiota of the former were able to invade that of the latter, which prevented growth impairments in recipient animals. Adding two invasive species, Ruminococcus gnavus and Clostridium symbiosum, to the microbiota from undernourished donors also ameliorated growth and metabolic abnormalities in recipient animals. These results provide evidence that microbiota immaturity is causally related to undernutrition and reveal potential therapeutic targets and agents.	[Blanton, Laura V.; Charbonneau, Mark R.; Salih, Tarek; Barratt, Michael J.; Venkatesh, Siddarth; Subramanian, Sathish; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Blanton, Laura V.; Charbonneau, Mark R.; Salih, Tarek; Barratt, Michael J.; Venkatesh, Siddarth; Subramanian, Sathish; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63108 USA; [Ilkaveya, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Ilkaveya, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Manary, Mark J.; Trehan, Indi] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Manary, Mark J.; Maleta, KennethM.] Univ Malawi, Sch Publ Hlth & Family Med, Coll Med, Blantyre 3, Malawi; [Trehan, Indi] Univ Malawi, Dept Paediat & Child Hlth, Coll Med, Blantyre 3, Malawi; [Jorgensen, Josh M.; Dewey, Kathryn G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Jorgensen, Josh M.; Dewey, Kathryn G.] Univ Calif Davis, Program Int & Community Nutr, Davis, CA 95616 USA; [Fan, Yue-mei; Ashorn, Per] Univ Tampere, Dept Int Hlth, Sch Med, Tampere 33014, Finland; [Henrissat, Bernard] CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille 9, France; [Henrissat, Bernard] Aix Marseille Univ, F-13288 Marseille 9, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia; [Leyn, Semen A.; Rodionov, Dmitry A.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow 127994, Russia; [Rodionov, Dmitry A.; Osterman, Andrei L.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Ashorn, Per] Tampere Univ Hosp, Dept Pediat, Tampere 33521, Finland	Washington University (WUSTL); Washington University (WUSTL); Duke University; Duke University; Washington University (WUSTL); University of Malawi; University of Malawi; University of California System; University of California Davis; University of California System; University of California Davis; Tampere University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Sanford Burnham Prebys Medical Discovery Institute; Duke University; Duke University; Tampere University; Tampere University Hospital	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.; Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63108 USA.	jgordon@wustl.edu	Maleta, Ken M/J-2821-2016; Henrissat, Bernard/J-2475-2012; Rodionov, Dmitry A/V-2688-2018; Leyn, Semen A/J-1069-2019	Maleta, Ken M/0000-0002-2536-3938; Henrissat, Bernard/0000-0002-3434-8588; Leyn, Semen A/0000-0002-9886-9120; Ashorn, Per/0000-0003-2311-2593; Manary, Mark/0000-0003-2733-9568	Bill and Melinda Gates Foundation; NIH [DK30292, P30 AR057235, T32 AI007172, T32 GM007067]; Office of Health, Infectious Diseases and Nutrition, Bureau for Global Health, U.S. Agency for International Development through Food and Nutrition Technical Assistance III Project [AID-OAA-A-12-00005]; Academy of Finland [252075]; Medical Research Fund of Tampere University Hospital [9M004]; Lucille P. Markey Special Emphasis Pathway in Human Pathobiology; Russian Science Foundation [14-14-00289]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, R37DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Health, Infectious Diseases and Nutrition, Bureau for Global Health, U.S. Agency for International Development through Food and Nutrition Technical Assistance III Project(United States Agency for International Development (USAID)); Academy of Finland(Academy of Finland); Medical Research Fund of Tampere University Hospital; Lucille P. Markey Special Emphasis Pathway in Human Pathobiology; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to the parents and children from Malawi for their participation in this study. We thank S. Wagoner, D. O'Donnell, M. Karlsson, and J. Serugo for their assistance with gnotobiotic mouse husbandry; D. Leib and M. Silva for their assistance with bone morphology assays; J. Guruge for help with anaerobic microbiology; B. Dankenbring for assistance with maintenance of the biospecimen repository; and M. Meier, S. Deng, and J. Hoisington-Lopez for their contribution to various facets of the DNA sequencing pipeline. This work was supported by the Bill and Melinda Gates Foundation and the NIH (grant DK30292). Additional funding was provided by the Office of Health, Infectious Diseases and Nutrition, Bureau for Global Health, U.S. Agency for International Development under the terms of cooperative agreement no. AID-OAA-A-12-00005, through the Food and Nutrition Technical Assistance III Project managed by FHI 360. Data management and statistical analysis for the iLiNS-DYAD-M clinical study were also funded by the Academy of Finland (grant 252075) and the Medical Research Fund of Tampere University Hospital (grant 9M004). Micro-CT analysis was performed in the Washington University Musculoskeletal Research Center, which is supported by NIH grant P30 AR057235. L.V.B. received stipend support from NIH predoctoral training grants NIH T32 AI007172 and T32 GM007067 and from the Lucille P. Markey Special Emphasis Pathway in Human Pathobiology. D.A.R. and S.A.L. were supported by the Russian Science Foundation (grant 14-14-00289). Collection of the human specimens included in this study was approved by the University of Malawi College of Medicine Research Ethics Committee. Specimens were provided to Washington University in St. Louis under a materials transfer agreement (MTA) between the University of Malawi and Washington University, and their collection and use for this study was approved by the Washington University Human Research Protection Office (Federalwide Assurance no. FWA00002284). 16S rRNA sequences, generated from fecal samples in raw format before post-processing and data analysis, and shotgun sequencing data sets, generated from the R. gnavus TS8243C and C. symbiosum TS8243C genomes, have been deposited in the European Nucleotide Archive under accession number PRJEB9853. J.I.G. is a cofounder of Matatu, a company characterizing the role of diet-by-microbiota interactions in animal health. A.L.O. is an adjunct vice president for research for Buffalo BioLabs. L.V.B., M.R.C., and J. I. G. designed the gnotobiotic mouse studies; L.V.B. and M.R.C. performed the experiments with gnotobiotic animals; I.T. and M.J.M. designed and implemented the clinical monitoring and sampling for the twin study and participated in patient recruitment, sample collection and preservation, and/or clinical evaluations; K.M.M., Y.F., J. M. J., K.G.D., and P. A. designed and oversaw the clinical studies, sample collection and processing, and/or clinical monitoring and evaluations in the iLiNS-DYAD-M study; L.V.B. generated the 16S rRNA data; L.V.B., M. R. C., S.V., and O.I. generated the metabolomics data; T.S. and L.V.B. cultured bacterial isolates; B.H., D. A. R., S.A.L., and A.L.O. performed metabolic reconstructions of the R. gnavus and C. symbiosum genomes; L.V.B., M. R. C., M. J. B., S. S., C.B.N., and J. I. G. analyzed the data; and L.V.B. and J. I. G. wrote the paper.	Ashorn P, 2015, AM J CLIN NUTR, V101, P387, DOI 10.3945/ajcn.114.088617; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cleary B, 2015, NAT BIOTECHNOL, V33, P1053, DOI 10.1038/nbt.3329; Crane RJ, 2015, FOOD NUTR BULL, V36, pS76, DOI 10.1177/15648265150361S113; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dewey KG, 2013, J NUTR, V143, P2050, DOI 10.3945/jn.113.182527; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gaayeb L, 2014, AM J TROP MED HYG, V90, P566, DOI 10.4269/ajtmh.12-0657; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Richard SA, 2014, CLIN INFECT DIS, V59, pS255, DOI 10.1093/cid/ciu436; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sjogren K, 2012, BONE, V50, pS91, DOI [10.1016/j.bone.2012.02.272, 10.1002/jbmr.1588]; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Waber DP, 2014, NUTR NEUROSCI, V17, P58, DOI 10.1179/1476830513Y.0000000061; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	23	386	407	13	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275							aad3311	10.1126/science.aad3311	http://dx.doi.org/10.1126/science.aad3311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912898	Green Accepted			2022-12-28	WOS:000370325700036
J	Stevens, B; Muthukumar, AK				Stevens, Beth; Muthukumar, Allie K.			CELLULAR NEUROSCIENCE Differences among astrocytes	SCIENCE			English	Editorial Material							CNS; HETEROGENEITY		[Stevens, Beth; Muthukumar, Allie K.] Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Stevens, B (corresponding author), Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	beth.stevens@childrens.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD090255] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; McKhann GM, 1997, J NEUROSCI, V17, P6850; Perego C, 2000, J NEUROCHEM, V75, P1076, DOI 10.1046/j.1471-4159.2000.0751076.x; Poopalasundaram S, 2000, GLIA, V30, P362, DOI 10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	11	5	5	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					813	813		10.1126/science.aaf2849	http://dx.doi.org/10.1126/science.aaf2849			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912878				2022-12-28	WOS:000370325700022
J	Keung, AJ; Khalil, AS				Keung, Albert J.; Khalil, Ahmad S.			A unifying model of epigenetic regulation	SCIENCE			English	Editorial Material							METHYLATION; INHERITANCE; DYNAMICS; MEMORY; CELLS		[Keung, Albert J.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Khalil, Ahmad S.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Khalil, Ahmad S.] Boston Univ, Biol Design Ctr, Boston, MA 02215 USA; [Khalil, Ahmad S.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	University of North Carolina; North Carolina State University; Boston University; Boston University; Harvard University	Khalil, AS (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Khalil, AS (corresponding author), Boston Univ, Biol Design Ctr, Boston, MA 02215 USA.; Khalil, AS (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	akhalil@bu.edu	Keung, Albert/AAU-3870-2021		NIGMS NIH HHS [F32 GM105272] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105272] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699	12	7	8	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					661	662		10.1126/science.aaf1647	http://dx.doi.org/10.1126/science.aaf1647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912843	Green Accepted			2022-12-28	WOS:000369810000019
J	Mallet, V; Sberro-Soussan, R; Vallet-Pichard, A; Roque-Afonso, AM; Pol, S				Mallet, Vincent; Sberro-Soussan, Rebecca; Vallet-Pichard, Anais; Roque-Afonso, Anne-Marie; Pol, Stanislas			Transmission of Hepatitis E Virus by Plasma Exchange: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter									[Mallet, Vincent; Vallet-Pichard, Anais; Pol, Stanislas] Univ Paris 05, Grp Hosp Cochin Port Royal, AP HP, Inst Pasteur,Unite Mixte Serv 020, Paris, France; [Sberro-Soussan, Rebecca] Hop Necker Enfants Malad, AP HP, Paris, France; [Roque-Afonso, Anne-Marie] Univ Paris 11, INSERM, Unite 1193, AP HP, F-1193 Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Mallet, V (corresponding author), Univ Paris 05, Grp Hosp Cochin Port Royal, AP HP, Inst Pasteur,Unite Mixte Serv 020, Paris, France.		Roque-Afonso, Anne-Marie/AAF-9706-2021; Mallet, Vincent/G-4623-2011	Mallet, Vincent/0000-0003-2219-9201				Andonov A, 2014, VOX SANG, V107, P213, DOI 10.1111/vox.12156; Gallian P, 2014, EMERG INFECT DIS, V20, P1914, DOI 10.3201/eid2011.140516; Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013	5	17	18	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					851	852		10.7326/L15-0502	http://dx.doi.org/10.7326/L15-0502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	26926359				2022-12-28	WOS:000379343000022
J	Norman, JE; Marlow, N; Messow, CM; Shennan, A; Bennett, PR; Thornton, S; Robson, SC; McConnachie, A; Petrou, S; Sebire, NJ; Lavender, T; Whyte, S; Norrie, J				Norman, Jane Elizabeth; Marlow, Neil; Messow, Claudia-Martina; Shennan, Andrew; Bennett, Phillip R.; Thornton, Steven; Robson, Stephen C.; McConnachie, Alex; Petrou, Stavros; Sebire, Neil J.; Lavender, Tina; Whyte, Sonia; Norrie, John		OPPTIMUM Study Grp	Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial	LANCET			English	Article							FOLLOW-UP; PREVENTION; WOMEN; LABOR; ANTIBIOTICS; DELIVERY; OUTCOMES; RISK	Background Progesterone administration has been shown to reduce the risk of preterm birth and neonatal morbidity in women at high risk, but there is uncertainty about longer term effects on the child. Methods We did a double-blind, randomised, placebo-controlled trial of vaginal progesterone, 200 mg daily taken from 22-24 to 34 weeks of gestation, on pregnancy and infant outcomes in women at risk of preterm birth (because of previous spontaneous birth at <= 34 weeks and 0 days of gestation, or a cervical length <= 25 mm, or because of a positive fetal fibronectin test combined with other clinical risk factors for preterm birth [any one of a history in a previous pregnancy of preterm birth, second trimester loss, preterm premature fetal membrane rupture, or a history of a cervical procedure to treat abnormal smears]). The objective of the study was to determine whether vaginal progesterone prophylaxis given to reduce the risk of preterm birth affects neonatal and childhood outcomes. We defined three primary outcomes: fetal death or birth before 34 weeks and 0 days gestation (obstetric), a composite of death, brain injury, or bronchopulmonary dysplasia (neonatal), and a standardised cognitive score at 2 years of age (childhood), imputing values for deaths. Randomisation was done through a web portal, with participants, investigators, and others involved in giving the intervention, assessing outcomes, or analysing data masked to treatment allocation until the end of the study. Analysis was by intention to treat. This trial is registered at ISRCTN. com, number ISRCTN14568373. Findings Between Feb 2, 2009, and April 12, 2013, we randomly assigned 1228 women to the placebo group (n=610) and the progesterone group (n=618). In the placebo group, data from 597, 587, and 439 women or babies were available for analysis of obstetric, neonatal, and childhood outcomes, respectively; in the progesterone group the corresponding numbers were 600, 589, and 430. After correction for multiple outcomes, progesterone had no significant effect on the primary obstetric outcome (odds ratio adjusted for multiple comparisons [OR] 0.86, 95% CI 0.61-1.22) or neonatal outcome (OR 0.62, 0.38-1.03), nor on the childhood outcome (cognitive score, progesterone group vs placebo group, 97.3 [SD 17.9] vs 97.7 [17.5]; difference in means -0.48, 95% CI -2.77 to 1.81). Maternal or child serious adverse events were reported in 70 (11%) of 610 patients in the placebo group and 59 (10%) of 616 patients in the progesterone group (p=0.27). Interpretation Vaginal progesterone was not associated with reduced risk of preterm birth or composite neonatal adverse outcomes, and had no long-term benefit or harm on outcomes in children at 2 years of age. Copyright (C) Norman et al. Open Access article distributed under the terms of CC BY.	[Norman, Jane Elizabeth; Whyte, Sonia] Univ Edinburgh, Tommys Ctr Maternal & Fetal Hlth, MRC, Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland; [Marlow, Neil; Sebire, Neil J.] UCL, London, England; [Messow, Claudia-Martina; McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Shennan, Andrew] Kings Coll London, Womens Hlth Acad Ctr, London WC2R 2LS, England; [Bennett, Phillip R.] Univ London Imperial Coll Sci Technol & Med, London, England; [Thornton, Steven] Queen Mary Univ London, London, England; [Robson, Stephen C.] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Petrou, Stavros] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Lavender, Tina] Univ Manchester, Sch Nursing, Manchester, Lancs, England; [Norrie, John] Univ Aberdeen, Ctr Healthcare Randomised Trials, Hlth Serv Res Unit, Aberdeen, Scotland	University of Edinburgh; University of London; University College London; University of Glasgow; University of London; King's College London; Imperial College London; University of London; Queen Mary University London; Newcastle University - UK; University of Warwick; University of Manchester; University of Aberdeen	Norman, JE (corresponding author), Univ Edinburgh, Tommys Ctr Maternal & Fetal Hlth, Ctr Reprod Hlth, MRC,Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TY, Midlothian, Scotland.	jane.norman@ed.ac.uk	Thornton, Jim/B-8336-2008; Petrou, Stavros/ABD-8323-2021; Whyte, Sonia/ABB-3075-2021; Whyte, Sonia/ABC-9345-2021; Marlow, Neil/D-2918-2009	Thornton, Jim/0000-0001-9764-6876; Petrou, Stavros/0000-0003-3121-6050; Whyte, Sonia/0000-0003-0878-4244; Marlow, Neil/0000-0001-5890-2953; Sebire, Neil/0000-0001-5348-9063; Norman, Jane/0000-0001-6031-6953; Hagberg, Henrik/0000-0003-3962-1448; Shennan, Andrew/0000-0001-5273-3132; Bennett, Phillip/0000-0002-6253-4919	Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council (MRC); National Institute for Health Research (NIHR) partnership [G0700452, 09/800/27]; MRC; NIHR; Chief Scientist Office in Scotland; National Institute for Social Care and Research in Wales; MRC [MR/N022556/1, G0501681, G0700452, G1002033] Funding Source: UKRI; Economic and Social Research Council [1499410] Funding Source: researchfish; Medical Research Council [G0700452, G1002033, G0501681, MR/N022556/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10046] Funding Source: researchfish	Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council (MRC); National Institute for Health Research (NIHR) partnership; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Chief Scientist Office in Scotland; National Institute for Social Care and Research in Wales; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council (MRC) and National Institute for Health Research (NIHR) partnership. The EME Programme is funded by the MRC and NIHR, with contributions from the Chief Scientist Office in Scotland and National Institute for Social Care and Research in Wales.r We thank the members of the Trial Steering and Data Monitoring Committee and all the people who helped in the conduct of the study (including the OPPTIMUM collaborative group and other clinicians listed in the appendix). We are grateful to Paul Piette (Besins Healthcare Corporate, Brussels, Belgium) and Besins Healthcare for their kind donation of active and placebo drug for use in the study, and to staff of the pharmacy and research and development departments of the participating hospitals. We are also grateful to the many people who helped in this study but who we have been unable to name, and in particular all the women (and their babies) who participated in OPPTIMUM. OPPTIMUM was funded by the Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council (MRC) and National Institute of Health Research (NIHR) partnership, award number G0700452, revised to 09/800/27. The EME Programme is funded by the MRC and NIHR, with contributions from the Chief Scientist Office in Scotland and National Institute for Social Care and Research in Wales. The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, National Health Service, NIHR, or the Department of Health. The funder had no involvement in data collection, analysis or interpretation, and no role in the writing of this manuscript or the decision to submit for publication.	Berghella V, 2012, AM J OBSTET GYNECOL, V206, P376, DOI 10.1016/j.ajog.2012.03.010; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Dodd JM, 2008, OBSTET GYNECOL, V112, P127, DOI 10.1097/AOG.0b013e31817d0262; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; HOLM S, 1979, SCAND J STAT, V6, P65; Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430; Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9; Kenyon SL, 2001, LANCET, V357, P989, DOI 10.1016/S0140-6736(00)04234-3; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; Marlow N, 2013, ARCH DIS CHILD-FETAL, V98, pF554, DOI 10.1136/archdischild-2012-302970; McNamara HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122341; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; National Statistics Office, 2015, BIRTH CHAR ENGL WAL; Norman JE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-79; Northen AT, 2007, OBSTET GYNECOL, V110, P865, DOI 10.1097/01.AOG.0000281348.51499.bc; Rode L, 2011, ULTRASOUND OBST GYN, V38, P272, DOI 10.1002/uog.9093; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Schmidt B, 2001, NEW ENGL J MED, V344, P1966, DOI 10.1056/NEJM200106283442602; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Soule S., 2012, M ADV COMM REPR HLTH; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Wapner RJ, 2007, NEW ENGL J MED, V357, P1190, DOI 10.1056/NEJMoa071453	26	227	234	2	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2106	2116		10.1016/S0140-6736(16)00350-0	http://dx.doi.org/10.1016/S0140-6736(16)00350-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	26921136	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000376450800034
J	Nuyt, AM; Thebaud, B				Nuyt, Anne Monique; Thebaud, Bernard			Not another steroid trial: early low-dose hydrocortisone in preterm infants	LANCET			English	Editorial Material							BRONCHOPULMONARY DYSPLASIA; MULTICENTER		[Nuyt, Anne Monique] Univ Montreal, Dept Pediat, Res Ctr, St Justine Univ Hosp,Fac Med, Montreal, PQ H3T 1C5, Canada; [Thebaud, Bernard] Univ Ottawa, Dept Pediat, Fac Med, Ottawa Hosp Res Inst, Ottawa, ON K1N 6N5, Canada	Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute	Nuyt, AM (corresponding author), Univ Montreal, Dept Pediat, Res Ctr, St Justine Univ Hosp,Fac Med, Montreal, PQ H3T 1C5, Canada.	anne-monique.nuyt@recherche-ste-justine.qc.ca						Baud O, 2016, LANCET, V2016; Blackmon LR, 2002, PEDIATRICS, V109, P330; CLYMAN RI, 1981, AM J PHYSIOL, V241, pH415, DOI 10.1152/ajpheart.1981.241.3.H415; DeMauro SB, 2014, J PEDIATR-US, V164, P9, DOI 10.1016/j.jpeds.2013.10.020; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Doyle LW, 2006, PEDIATRICS, V117, P75, DOI 10.1542/peds.2004-2843; Jobe AH, 2004, NEW ENGL J MED, V350, P1349, DOI 10.1056/NEJMe048031; LUCEY JF, 1992, PEDIATRICS, V89, P159; STERN L, 1973, PEDIATR CLIN N AM, V20, P447; Walsh MC, 2006, PEDIATRICS, V118, pE1328, DOI 10.1542/peds.2006-0359; Watterberg KL, 2004, PEDIATRICS, V114, P1649, DOI 10.1542/peds.2004-1159; Watterberg KL, 2000, PEDIATRICS, V105, P320, DOI 10.1542/peds.105.2.320	12	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1793	1794		10.1016/S0140-6736(16)00503-1	http://dx.doi.org/10.1016/S0140-6736(16)00503-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	26916175				2022-12-28	WOS:000375056100006
J	Winkelman, JT; Vvedenskaya, IO; Zhang, YC; Zhang, Y; Bird, JG; Taylor, DM; Gourse, RL; Ebright, RH; Nickels, BE				Winkelman, Jared T.; Vvedenskaya, Irina O.; Zhang, Yuanchao; Zhang, Yu; Bird, Jeremy G.; Taylor, Deanne M.; Gourse, Richard L.; Ebright, Richard H.; Nickels, Bryce E.			Multiplexed protein-DNA cross-linking: Scrunching in transcription start site selection	SCIENCE			English	Article							RNA-POLYMERASE; ESCHERICHIA-COLI; AMINO-ACID; PROMOTER; INITIATION; SEQUENCE; RECOGNITION; ELEMENT	In bacterial transcription initiation, RNA polymerase (RNAP) selects a transcription start site (TSS) at variable distances downstream of core promoter elements. Using next-generation sequencing and unnatural amino acid-mediated protein-DNA cross-linking, we have determined, for a library of 410 promoter sequences, the TSS, the RNAP leading-edge position, and the RNAP trailing-edge position. We find that a promoter element upstream of the TSS, the "discriminator," participates in TSS selection, and that, as the TSS changes, the RNAP leading-edge position changes, but the RNAP trailing-edge position does not change. Changes in the RNAP leading-edge position, but not the RNAP trailing-edge position, are a defining hallmark of the "DNA scrunching" that occurs concurrent with RNA synthesis in initial transcription. We propose that TSS selection involves DNA scrunching prior to RNA synthesis.	[Winkelman, Jared T.; Vvedenskaya, Irina O.; Zhang, Yuanchao; Bird, Jeremy G.; Taylor, Deanne M.; Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Winkelman, Jared T.; Zhang, Yu; Bird, Jeremy G.; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Winkelman, Jared T.; Vvedenskaya, Irina O.; Zhang, Yu; Bird, Jeremy G.; Ebright, Richard H.; Nickels, Bryce E.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Winkelman, Jared T.; Gourse, Richard L.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53705 USA; [Taylor, Deanne M.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Taylor, Deanne M.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Taylor, Deanne M.] Rutgers Robert Wood Johnson Med Sch, Dept Obstet Gynecol & Reprod Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Nickels, BE (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.; Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.; Ebright, RH; Nickels, BE (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu; bnickels@waksman.rutgers.edu	Taylor, Deanne/AAY-6296-2020; Zhang, Yu/AAV-5722-2021; Ebright, Richard/O-3321-2019; Nickels, Bryce/AAF-2549-2020; Taylor, Deanne M/Q-4777-2017	Taylor, Deanne/0000-0002-3302-4610; Zhang, Yu/0000-0002-1778-8389; Ebright, Richard/0000-0001-8915-7140; Taylor, Deanne M/0000-0002-3302-4610; Nickels, Bryce/0000-0001-7449-8831; Bird, Jeremy/0000-0003-2690-8474	NIH [GM37048, GM041376, GM088343, GM115910]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, R01GM088343, R37GM037048, R01GM041376, R01GM037048, R37GM041376, T32GM007215, R01GM115910] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by NIH grants GM37048 (R.L.G.), GM041376 (R.H.E.), GM088343 (B.E.N.), and GM115910 (BEN). Protein Data Bank accession codes are 5E17 and 5E18.	Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Fazal FM, 2015, NATURE, V525, P274, DOI 10.1038/nature14882; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; JEONG W, 1994, NUCLEIC ACIDS RES, V22, P4667, DOI 10.1093/nar/22.22.4667; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Lewis DEA, 2004, MOL MICROBIOL, V54, P692, DOI 10.1111/j.1365-2958.2004.04318.x; LIU J, 1994, J BACTERIOL, V176, P2938, DOI 10.1128/JB.176.10.2938-2945.1994; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Robb NC, 2013, J MOL BIOL, V425, P875, DOI 10.1016/j.jmb.2012.12.015; Ruff EF, 2015, BIOMOLECULES, V5, P1035, DOI 10.3390/biom5021035; TRAVERS AA, 1980, J BACTERIOL, V141, P973, DOI 10.1128/JB.141.2.973-976.1980; Vvedenskaya IO, 2015, MOL CELL, V60, P953, DOI 10.1016/j.molcel.2015.10.029; Walker KA, 2002, J BACTERIOL, V184, P4783, DOI 10.1128/JB.184.17.4783-4791.2002; Winkelman JT, 2015, MOL CELL, V59, P768, DOI 10.1016/j.molcel.2015.06.037; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	17	43	44	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1090	1093		10.1126/science.aad6881	http://dx.doi.org/10.1126/science.aad6881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941320	Green Accepted			2022-12-28	WOS:000371597500046
J	Keane, EF; Johnston, S; Bhandari, S; Barr, E; Bhat, NDR; Burgay, M; Caleb, M; Flynn, C; Jameson, A; Kramer, M; Petroff, E; Possenti, A; van Straten, W; Bailes, M; Burke-Spolaor, S; Eatough, RP; Stappers, BW; Totani, T; Honma, M; Furusawa, H; Hattori, T; Morokuma, T; Niino, Y; Sugai, H; Terai, T; Tominaga, N; Yamasaki, S; Yasuda, N; Allen, R; Cooke, J; Jencson, J; Kasliwal, MM; Kaplan, DL; Tingay, SJ; Williams, A; Wayth, R; Chandra, P; Perrodin, D; Berezina, M; Mickaliger, M; Bassa, C				Keane, E. F.; Johnston, S.; Bhandari, S.; Barr, E.; Bhat, N. D. R.; Burgay, M.; Caleb, M.; Flynn, C.; Jameson, A.; Kramer, M.; Petroff, E.; Possenti, A.; van Straten, W.; Bailes, M.; Burke-Spolaor, S.; Eatough, R. P.; Stappers, B. W.; Totani, T.; Honma, M.; Furusawa, H.; Hattori, T.; Morokuma, T.; Niino, Y.; Sugai, H.; Terai, T.; Tominaga, N.; Yamasaki, S.; Yasuda, N.; Allen, R.; Cooke, J.; Jencson, J.; Kasliwal, M. M.; Kaplan, D. L.; Tingay, S. J.; Williams, A.; Wayth, R.; Chandra, P.; Perrodin, D.; Berezina, M.; Mickaliger, M.; Bassa, C.			The host galaxy of a fast radio burst	NATURE			English	Article							GAMMA-RAY BURST; REIONIZATION HISTORY; DISPERSION MEASURE; MISSING BARYONS; SEARCH; CONSTRAINTS; AFTERGLOWS; ENERGETICS; EMISSION	In recent years, millisecond-duration radio signals originating in distant galaxies appear to have been discovered in the so-called fast radio bursts(1-9). These signals are dispersed according to a precise physical law and this dispersion is a key observable quantity, which, in tandem with a redshift measurement, can be used for fundamental physical investigations(10,11). Every fast radio burst has a dispersion measurement, but none before now have had a redshift measurement, because of the difficulty in pinpointing their celestial coordinates. Here we report the discovery of a fast radio burst and the identification of a fading radio transient lasting similar to 6 days after the event, which we use to identify the host galaxy; we measure the galaxy's redshift to be z = 0.492 +/- 0.008. The dispersion measure and redshift, in combination, provide a direct measurement of the cosmic density of ionized baryons in the intergalactic medium of Omega(IGM) = 4.9 +/- 1.3 per cent, in agreement with the expectation from the Wilkinson Microwave Anisotropy Probe(12), and including all of the so-called 'missing baryons'. The similar to 6-day radio transient is largely consistent with the radio afterglow of a short gamma-ray burst(13), and its existence and timescale do not support progenitor models such as giant pulses from pulsars, and supernovae. This contrasts with the interpretation(8) of another recently discovered fast radio burst, suggesting that there are at least two classes of bursts.	[Keane, E. F.] Jodrell Bank Observ, Square Kilometre Array Org, Macclesfield SK11 9DL, Cheshire, England; [Keane, E. F.; Bhandari, S.; Barr, E.; Caleb, M.; Flynn, C.; Jameson, A.; Petroff, E.; van Straten, W.; Bailes, M.; Allen, R.; Cooke, J.] Swinburne Univ Technol, Ctr Astrophys & Supercomputing, Mail H29 POB 218, Victoria 3122, Australia; [Keane, E. F.; Bhandari, S.; Bhat, N. D. R.; Caleb, M.; Flynn, C.; Jameson, A.; Petroff, E.; Bailes, M.; Cooke, J.; Tingay, S. J.; Wayth, R.] Australian Res Council Ctr Excellence All Sky Ast, Sydney, NSW, Australia; [Johnston, S.; Petroff, E.] CSIRO, Australia Telescope Natl Facil, Astron & Space Sci, POB 76, Epping, NSW 1710, Australia; [Bhat, N. D. R.; Tingay, S. J.; Williams, A.; Wayth, R.] Curtin Univ Technol, Int Ctr Radio Astron Res, Bentley, WA 6102, Australia; [Burgay, M.; Possenti, A.; Perrodin, D.] INAF, Osservat Astronomico Cagliari, Via Sci 5, I-09047 Selargius, CA, Italy; [Caleb, M.] Australian Capital Terr, Australian Natl Univ Canberra, Res Sch Astron & Astrophys, Canberra, ACT 2611, Australia; [Kramer, M.; Eatough, R. P.; Berezina, M.] Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany; [Kramer, M.; Stappers, B. W.; Mickaliger, M.] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Burke-Spolaor, S.] Natl Radio Astron Observ, Socorro, NM, Mexico; [Totani, T.; Yamasaki, S.] Univ Tokyo, Dept Astron, Hongo, Tokyo 1130033, Japan; [Honma, M.; Furusawa, H.; Niino, Y.] Natl Astron Observ Japan, 2 Chome 21-1, Mitaka, Tokyo 1818588, Japan; [Honma, M.] SOKENDAI, Grad Univ Adv Study, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Hattori, T.; Terai, T.] Subaru Telescope, Natl Astron Observ Japan, 650 N Aohoku Pl, Hilo, HI 96720 USA; [Morokuma, T.] Univ Tokyo, Grad Sch Sci, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Morokuma, T.; Sugai, H.; Tominaga, N.; Yasuda, N.] Univ Tokyo, Inst Adv Study, Kavli Inst Phys & Math Univ WPI, Kashiwa, Chiba 2778583, Japan; [Tominaga, N.] Konan Univ, Fac Sci & Engn, Dept Phys, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan; [Jencson, J.; Kasliwal, M. M.] CALTECH, Cahill Ctr Astrophys, 1200 East Calif Blvd, Pasadena, CA 91125 USA; [Kaplan, D. L.] Univ Wisconsin, Dept Phys, Milwaukee, WI 53201 USA; [Chandra, P.] Tata Inst Fundamental Res, Natl Ctr Radio Astrophys, Pune 411007, Maharashtra, India; [Bassa, C.] ASTRON, Netherlands Inst Radio Astron, NL-7990 AA Dwingeloo, Netherlands	University of Manchester; Jodrell Bank Centre for Astrophysics; Swinburne University of Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Curtin University; Istituto Nazionale Astrofisica (INAF); Australian National University; Max Planck Society; University of Manchester; Jodrell Bank Centre for Astrophysics; National Radio Astronomy Observatory (NRAO); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Tokyo; University of Tokyo; Konan University; California Institute of Technology; University of Wisconsin System; University of Wisconsin Milwaukee; Tata Institute of Fundamental Research (TIFR); National Centre for Radio Astrophysics (NCRA), Pune	Keane, EF (corresponding author), Jodrell Bank Observ, Square Kilometre Array Org, Macclesfield SK11 9DL, Cheshire, England.	e.keane@skatelescope.org	Perrodin, Delphine L/L-1916-2016; Williams, Andrew J/K-2931-2013; Trott, Cathryn M/B-5325-2013; Wayth, Randall/B-2444-2013; Johnston, Simon/AAW-8490-2020; Tingay, Steven J/B-5271-2013	Perrodin, Delphine L/0000-0002-1806-2483; Williams, Andrew J/0000-0001-9080-0105; Trott, Cathryn M/0000-0001-6324-1766; Wayth, Randall/0000-0002-6995-4131; Johnston, Simon/0000-0002-7122-4963; Tingay, Steven J/0000-0002-8195-7562; Bhat, Ramesh/0000-0002-8383-5059; Furusawa, Hisanori/0000-0002-6174-8165; Kramer, Michael/0000-0002-4175-2271; van Straten, Willem/0000-0003-2519-7375; Spolaor, Sarah/0000-0003-4052-7838; Chandra, Poonam/0000-0002-0844-6563; Tominaga, Nozomu/0000-0001-8537-3153; Bailes, Matthew/0000-0003-3294-3081; Kasliwal, Tamay/0000-0001-5634-7167; Burgay, Marta/0000-0002-8265-4344; Caleb, Manisha/0000-0002-4079-4648; Keane, Evan/0000-0002-4553-655X; Bassa, Cees/0000-0002-1429-9010; Bhandari, Shivani/0000-0003-3460-506X; Mickaliger, Mitchell/0000-0001-6798-5682	Commonwealth of Australia; STFC [ST/L000768/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000768/1] Funding Source: researchfish; Division Of Astronomical Sciences [1412421] Funding Source: National Science Foundation	Commonwealth of Australia(Australian Government); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The Parkes radio telescope and the Australia Telescope Compact Array are part of the Australia Telescope National Facility, which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. Parts of this research were conducted by the Australian Research Council Centre of Excellence for All-sky Astrophysics (CAASTRO) and used the gSTAR national facility at Swinburne University of Technology. Parts of this work are based on data collected at the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan, the Murchison Radio-astronomy Observatory operated by CSIRO, the Giant Metrewave Radio Telescope (GMRT), which is run by the National Centre for Radio Astrophysics of the Tata Institute of Fundamental Research, the Sardinia Radio Telescope as part of scientific commissioning of the telescope, and the 100-m telescope of the MPIfR at Effelsberg. We acknowledge the Wajarri Yamatji people as the traditional owners of the MWA Observatory site.	Abbott BP, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/7/076901; Becker RH, 2010, ASTRON J, V140, P157, DOI 10.1088/0004-6256/140/1/157; Bell ME, 2015, MON NOT R ASTRON SOC, V450, P4221, DOI 10.1093/mnras/stv882; Berger E, 2014, ANNU REV ASTRON ASTR, V52, P43, DOI 10.1146/annurev-astro-081913-035926; Bhat NDR, 2004, ASTROPHYS J, V605, P759, DOI 10.1086/382680; Brammer GB, 2008, ASTROPHYS J, V686, P1503, DOI 10.1086/591786; Bregman JN, 2007, ANNU REV ASTRON ASTR, V45, P221, DOI 10.1146/annurev.astro.45.051806.110619; Brown MJI, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/2/L41; Bullock JS, 2001, MON NOT R ASTRON SOC, V321, P559, DOI 10.1046/j.1365-8711.2001.04068.x; Burke-Spolaor S, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/19; Champion D., 2015, MON NOT R ASTR UNPUB; Chandra P, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/156; Cohen M, 2003, ASTRON J, V126, P1090, DOI 10.1086/376474; Cordes J. M., 2002, PREPRINT; Croft S, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/93; da Cunha E, 2008, MON NOT R ASTRON SOC, V388, P1595, DOI 10.1111/j.1365-2966.2008.13535.x; Davenport JRA, 2014, MON NOT R ASTRON SOC, V440, P3430, DOI 10.1093/mnras/stu466; Dennison B, 2014, MON NOT R ASTRON SOC, V443, pL11, DOI 10.1093/mnrasl/slu072; Dolag K, 2015, MON NOT R ASTRON SOC, V451, P4277, DOI 10.1093/mnras/stv1190; FABER SM, 1976, ASTROPHYS J, V204, P668, DOI 10.1086/154215; Fong W, 2015, ASTROPHYS J, V815, DOI 10.1088/0004-637X/815/2/102; Frail DA, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/70; Frail DA, 1997, NATURE, V389, P261, DOI 10.1038/38451; Fukugita M, 2004, ASTROPHYS J, V616, P643, DOI 10.1086/425155; Gal-Yam A, 2006, ASTROPHYS J, V639, P331, DOI 10.1086/499157; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Hotan AW, 2004, PUBL ASTRON SOC AUST, V21, P302, DOI 10.1071/AS04022; Inoue S, 2004, MON NOT R ASTRON SOC, V348, P999, DOI 10.1111/j.1365-2966.2004.07359.x; Ioka K, 2003, ASTROPHYS J, V598, pL79, DOI 10.1086/380598; Jarrett TH, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/112; Keane EF, 2012, MON NOT R ASTRON SOC, V425, pL71, DOI 10.1111/j.1745-3933.2012.01306.x; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Lorimer DR, 2007, SCIENCE, V318, P777, DOI 10.1126/science.1147532; Masui K, 2015, NATURE, V528, P523, DOI 10.1038/nature15769; McQuinn M, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L33; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833, DOI 10.1093/pasj/54.6.833; Mooley K. P., 2016, ASTROPHYS J IN PRESS; Neill J. D., 2015, PREPRINT; Ofek EO, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/65; Petroff E, 2015, MON NOT R ASTRON SOC, V447, P246, DOI 10.1093/mnras/stu2419; Pietka M, 2015, MON NOT R ASTRON SOC, V446, P3687, DOI 10.1093/mnras/stu2335; Ravi V, 2015, ASTROPHYS J LETT, V799, DOI 10.1088/2041-8205/799/1/L5; Spitler LG, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/101; StaveleySmith L, 1996, PUBL ASTRON SOC AUST, V13, P243, DOI 10.1017/S1323358000020919; Thornton D, 2013, SCIENCE, V341, P53, DOI 10.1126/science.1236789; Tingay SJ, 2013, PUBL ASTRON SOC AUST, V30, DOI 10.1017/pasa.2012.007; Xu J, 2015, RES ASTRON ASTROPHYS, V15, P1629, DOI 10.1088/1674-4527/15/10/002; Zheng Z, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/71; Zhou B, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.107303	49	194	198	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					453	+		10.1038/nature17140	http://dx.doi.org/10.1038/nature17140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911781	Green Submitted			2022-12-28	WOS:000370690800029
J	Rosenberg, M; Stephens, E				Rosenberg, Mark; Stephens, Elizabeth			In resistant hypertension, add-on spironolactone reduced SBP more than placebo, doxazosin, or bisoprolol over 12wk Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Rosenberg, Mark; Stephens, Elizabeth] Providence Portland Med Ctr, Portland, OR USA	Providence Portland Medical Center	Rosenberg, M (corresponding author), Providence Portland Med Ctr, Portland, OR USA.							Dahal K, 2015, AM J HYPERTENS, V28, P1376, DOI 10.1093/ajh/hpv031; Guo HY, 2015, INT J CLIN EXP MED, V8, P7270	2	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					JC16	JC16		10.7326/ACPJC-2016-164-4-016	http://dx.doi.org/10.7326/ACPJC-2016-164-4-016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26882301				2022-12-28	WOS:000370135300003
J	Ben-Sahra, I; Hoxhaj, G; Ricoult, SJH; Asara, JM; Manning, BD				Ben-Sahra, Issam; Hoxhaj, Gerta; Ricoult, Stephane J. H.; Asara, John M.; Manning, Brendan D.			mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle	SCIENCE			English	Article							NOVO PYRIMIDINE SYNTHESIS; MAMMALIAN-CELLS; METABOLISM; SERINE; CANCER; PROLIFERATION; TRANSLATION; EXPRESSION; NETWORK; GLYCINE	In response to growth signals, mechanistic target of rapamycin complex 1 (mTORC1) stimulates anabolic processes underlying cell growth. We found that mTORC1 increases metabolic flux through the de novo purine synthesis pathway in various mouse and human cells, thereby influencing the nucleotide pool available for nucleic acid synthesis. mTORC1 had transcriptional effects on multiple enzymes contributing to purine synthesis, with expression of the mitochondrial tetrahydrofolate (mTHF) cycle enzyme methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) being closely associated with mTORC1 signaling in both normal and cancer cells. MTHFD2 expression and purine synthesis were stimulated by activating transcription factor 4 (ATF4), which was activated by mTORC1 independent of its canonical induction downstream of eukaryotic initiation factor 2 alpha eIF2 alpha phosphorylation. Thus, mTORC1 stimulates the mTHF cycle, which contributes one-carbon units to enhance production of purine nucleotides in response to growth signals.	[Ben-Sahra, Issam; Hoxhaj, Gerta; Ricoult, Stephane J. H.; Manning, Brendan D.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Manning, BD (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956; Ben-Sahra, Issam/0000-0001-9333-4162; Hoxhaj, Gerta/0000-0001-6179-3583	Bettencourt Foundation; LAM Foundation; TS Alliance; NSF [DGE-1144152]; NIH [K99-CA194192, P01-CA120964, P30-CA006516, R01-CA181390, R35-CA197459]; NATIONAL CANCER INSTITUTE [R35CA197459, P01CA120964, R01CA181390, K99CA194192, P30CA006516] Funding Source: NIH RePORTER	Bettencourt Foundation; LAM Foundation; TS Alliance; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. J. Kwiatkowski and R. J. Kaufman for materials and M. Yuan, S. Breitkopf, J. J. Howell, M. Turner, and Y. Zhang for technical assistance. This research was supported by grants from the Bettencourt Foundation and LAM Foundation (I.B.-S.), TS Alliance (G.H.), NSF fellowship DGE-1144152 (S.J.H.R.), and NIH grants K99-CA194192 (I.B.-S.), P01-CA120964 (J. M. A. and B.D.M.), P30-CA006516 (J. M. A.), and R01-CA181390 and R35-CA197459 (B.D.M.). I.B.-S. and G.H. conceived, performed, and analyzed all experiments and prepared the manuscript. S.J.H.R performed the Cancer Genome Atlas analysis. J. M. A. performed LC-MS/MS experiments. B.D.M. directed research, reviewed all data, and prepared the manuscript. All authors reviewed the manuscript and declare no competing financial interests.	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Csibi A, 2014, CURR BIOL, V24, P2274, DOI 10.1016/j.cub.2014.08.007; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yuan E, 2012, HUM MOL GENET, V21, P4286, DOI 10.1093/hmg/dds262; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	21	424	436	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					728	733		10.1126/science.aad0489	http://dx.doi.org/10.1126/science.aad0489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912861	Green Accepted			2022-12-28	WOS:000369810000045
J	Elbarbary, RA; Lucas, BA; Maquat, LE				Elbarbary, Reyad A.; Lucas, Bronwyn A.; Maquat, Lynne E.			Retrotransposons as regulators of gene expression	SCIENCE			English	Review							MESSENGER-RNA TRANSCRIPTION; L1 RETROTRANSPOSITION; TRANSPOSABLE ELEMENTS; ALU ELEMENTS; SOMATIC RETROTRANSPOSITION; ADENOSINE DEAMINASES; NUCLEAR RETENTION; HUMAN MICRORNAS; BINDING; RETROELEMENTS	Transposable elements (TEs) are both a boon and a bane to eukaryotic organisms, depending on where they integrate into the genome and how their sequences function once integrated. We focus on two types of TEs: long interspersed elements (LINEs) and short interspersed elements (SINEs). LINEs and SINEs are retrotransposons; that is, they transpose via an RNA intermediate. We discuss how LINEs and SINEs have expanded in eukaryotic genomes and contribute to genome evolution. An emerging body of evidence indicates that LINEs and SINEs function to regulate gene expression by affecting chromatin structure, gene transcription, pre-mRNA processing, or aspects of mRNA metabolism. We also describe how adenosine-to-inosine editing influences SINE function and how ongoing retrotransposition is countered by the body's defense mechanisms.	[Elbarbary, Reyad A.; Lucas, Bronwyn A.; Maquat, Lynne E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY USA; [Elbarbary, Reyad A.; Lucas, Bronwyn A.; Maquat, Lynne E.] Univ Rochester, Ctr RNA Biol, Rochester, NY USA; [Maquat, Lynne E.] Univ Rochester, Sch Med & Dent, Dept Oncol, Wilmot Canc Inst, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester	Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY USA.; Maquat, LE (corresponding author), Univ Rochester, Ctr RNA Biol, Rochester, NY USA.; Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Oncol, Wilmot Canc Inst, Rochester, NY USA.	lynne_maquat@urmc.rochester.edu		Maquat, Lynne/0000-0002-2789-2075; Lucas, Bronwyn/0000-0001-9162-0421; Rzq, kareem/0000-0003-3784-9430	NIH [R37 GM074593, P30 AR061307]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM074593] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Eickbush, X. Li, and M. Popp for critically reading the manuscript. We apologize to our colleagues whose work we were unable to include because of space restrictions. Research on SINEs in the Maquat lab is supported by NIH grant R37 GM074593 (L.E.M.). R.A.E. is supported by NIH Pilot Award P30 AR061307.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; An HJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-97; Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Bundo M, 2014, NEURON, V81, P306, DOI 10.1016/j.neuron.2013.10.053; Capshew CR, 2012, NUCLEIC ACIDS RES, V40, P8637, DOI 10.1093/nar/gks590; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Chen LL, 2008, CELL CYCLE, V7, P3294, DOI 10.4161/cc.7.21.6927; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Claycomb JM, 2014, CURR BIOL, V24, pR703, DOI 10.1016/j.cub.2014.06.009; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Crichton J, 2014, CELL MOL LIFE SCI, V71, P1581, DOI 10.1007/s00018-013-1468-0; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Denli AM, 2015, CELL, V163, P583, DOI 10.1016/j.cell.2015.09.025; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Elbarbary RA, 2015, GENE DEV, V29, P687, DOI 10.1101/gad.261438.115; Elbarbary RA, 2014, CELL CYCLE, V13, P345, DOI 10.4161/cc.27512; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Estecio MRH, 2012, MOL CANCER RES, V10, P1332, DOI 10.1158/1541-7786.MCR-12-0351; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Fitzpatrick T, 2012, NUCLEUS-PHILA, V3, P359, DOI 10.4161/nucl.20827; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Gleghorn ML, 2013, NAT STRUCT MOL BIOL, V20, P515, DOI 10.1038/nsmb.2528; Gong CG, 2013, NAT STRUCT MOL BIOL, V20, P1214, DOI 10.1038/nsmb.2664; Gong CG, 2012, METHODS, V58, P88, DOI 10.1016/j.ymeth.2012.06.020; Gong CG, 2011, CELL CYCLE, V10, P1882, DOI 10.4161/cc.10.12.15589; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guo H, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5986, 10.1038/ncomms6276]; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Helman E, 2014, GENOME RES, V24, P1053, DOI 10.1101/gr.163659.113; Heras SR, 2013, NAT STRUCT MOL BIOL, V20, P1173, DOI 10.1038/nsmb.2658; Hoffman Y, 2013, BIOINFORMATICS, V29, P894, DOI 10.1093/bioinformatics/btt044; Hu SB, 2015, GENE DEV, V29, P630, DOI 10.1101/gad.257048.114; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Ichiyanagi K, 2013, GENES GENET SYST, V88, P19, DOI 10.1266/ggs.88.19; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kaer K, 2013, GENE, V518, P231, DOI 10.1016/j.gene.2013.01.008; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kapitonov VV, 2003, MOL BIOL EVOL, V20, P694, DOI 10.1093/molbev/msg075; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kim Y, 2014, GENE DEV, V28, P1310, DOI 10.1101/gad.242644.114; Kramerov DA, 2011, HEREDITY, V107, P487, DOI 10.1038/hdy.2011.43; Kroutter EN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000458; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Lehnert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004456; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; LIU WM, 1995, NUCLEIC ACIDS RES, V23, P1758, DOI 10.1093/nar/23.10.1758; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Mallela A, 2012, CRIT REV BIOCHEM MOL, V47, P493, DOI 10.3109/10409238.2012.714350; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Moller-Krull M, 2008, J MOL BIOL, V382, P601, DOI 10.1016/j.jmb.2008.07.014; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Park E, 2013, P NATL ACAD SCI USA, V110, P405, DOI 10.1073/pnas.1213508110; Piatek MJ, 2014, BIOCHEM SOC T, V42, P1174, DOI 10.1042/BST20140068; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Roy-Engel AM, 2005, CYTOGENET GENOME RES, V110, P365, DOI 10.1159/000084968; Rubin CM, 2002, NUCLEIC ACIDS RES, V30, P3253, DOI 10.1093/nar/gkf419; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Tashiro K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028497; Varshney D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7569; Wang JS, 2013, GENE DEV, V27, P793, DOI 10.1101/gad.212639.112; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001	100	219	223	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274							aac7247	10.1126/science.aac7247	http://dx.doi.org/10.1126/science.aac7247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912865	Green Accepted			2022-12-28	WOS:000369810000031
J	Kim, Y; Macfarlane, RJ; Jones, MR; Mirkin, CA				Kim, Youngeun; Macfarlane, Robert J.; Jones, Matthew R.; Mirkin, Chad A.			Transmutable nanoparticles with reconfigurable surface ligands	SCIENCE			English	Article							PROGRAMMABLE ATOM EQUIVALENTS; COLLOIDAL CRYSTALLIZATION; STRAND-DISPLACEMENT; DNA; SUPERLATTICES; NANOCRYSTALS; CRYSTALS	Unlike conventional inorganic materials, biological systems are exquisitely adapted to respond to their surroundings. Proteins and other biological molecules can process a complex set of chemical binding events as informational inputs and respond accordingly via a change in structure and function. We applied this principle to the design and synthesis of inorganic materials by preparing nanoparticles with reconfigurable surface ligands, where interparticle bonding can be programmed in response to specific chemical cues in a dynamic manner. As a result, a nascent set of "transmutable nanoparticles" can be driven to crystallize along multiple thermodynamic trajectories, resulting in rational control over the phase and time evolution of nanoparticle-based matter.	[Kim, Youngeun; Jones, Matthew R.; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Kim, Youngeun; Macfarlane, Robert J.; Jones, Matthew R.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Macfarlane, Robert J.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Macfarlane, Robert J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Jones, Matthew R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Northwestern University; Northwestern University; Northwestern University; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010	Jones, Matthew/0000-0002-9289-291X; Mirkin, Chad/0000-0002-6634-7627	Air Force Office of Scientific Research award [FA9550-11-1-0275]; Center for Bio-Inspired Energy Science (CBES), an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0000989-0002]; Northwestern University; NSF; E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	Air Force Office of Scientific Research award(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Center for Bio-Inspired Energy Science (CBES), an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences; Northwestern University; NSF(National Science Foundation (NSF)); E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This material is based on work supported by Air Force Office of Scientific Research award FA9550-11-1-0275 (C. A. M., Y. K., R. J. M., M. R. J.) and by the Center for Bio-Inspired Energy Science (CBES), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Basic Energy Sciences under award DE-SC0000989-0002 (C. A. M., Y. K.). Y. K., R. J. M., and M. R. J. acknowledge the Ryan Fellowship at Northwestern University. M. R. J. acknowledges the NSF for a graduate research fellowship. Portions of this work were carried out at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) beamline located at Sector 5 of the Advanced Photon Source. DND-CAT is supported by E. I. DuPont de Nemours & Co., Dow Chemical Company, and the state of Illinois.	Angioletti-Uberti S, 2012, NAT MATER, V11, P518, DOI [10.1038/NMAT3314, 10.1038/nmat3314]; Auyeung E, 2014, NATURE, V505, P73, DOI 10.1038/nature12739; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Brodin JD, 2015, P NATL ACAD SCI USA, V112, P4564, DOI 10.1073/pnas.1503533112; Grzybowski BA, 2003, NAT MATER, V2, P241, DOI 10.1038/nmat860; Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Kim Y, 2013, J AM CHEM SOC, V135, P10342, DOI 10.1021/ja405988r; Knorowski C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215501; Kundu PK, 2015, NAT CHEM, V7, P646, DOI [10.1038/NCHEM.2303, 10.1038/nchem.2303]; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Macfarlane RJ, 2013, SCIENCE, V341, P1222, DOI 10.1126/science.1241402; Macfarlane RJ, 2013, ANGEW CHEM INT EDIT, V52, P5688, DOI 10.1002/anie.201209336; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Macfarlane RJ, 2010, ANGEW CHEM INT EDIT, V49, P4589, DOI 10.1002/anie.201000633; Macfarlane RJ, 2009, P NATL ACAD SCI USA, V106, P10493, DOI 10.1073/pnas.0900630106; Maye MM, 2010, NAT NANOTECHNOL, V5, P116, DOI [10.1038/NNANO.2009.378, 10.1038/nnano.2009.378]; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; O'Brien MN, 2015, NAT MATER, V14, P833, DOI [10.1038/NMAT4293, 10.1038/nmat4293]; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Rogers WB, 2015, SCIENCE, V347, P639, DOI 10.1126/science.1259762; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang C, 2013, NAT MATER, V12, P741, DOI [10.1038/NMAT3647, 10.1038/nmat3647]; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s; Zhang K., 2013, J AM CHEM SOC, V135; Zhang YG, 2015, NAT MATER, V14, P840, DOI [10.1038/NMAT4296, 10.1038/nmat4296]; Zhang YG, 2013, NAT NANOTECHNOL, V8, P865, DOI [10.1038/nnano.2013.209, 10.1038/NNANO.2013.209]	35	131	136	5	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					579	582		10.1126/science.aad2212	http://dx.doi.org/10.1126/science.aad2212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912697				2022-12-28	WOS:000369291600034
J	Smith, DW; Mackenzie, J				Smith, David W.; Mackenzie, John			Zika virus and Guillain-Barre syndrome: another viral cause to add to the list	LANCET			English	Editorial Material									[Smith, David W.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Mackenzie, John] Curtin Univ, Fac Hlth Sci, Bentley, WA, Australia	University of Western Australia; Curtin University	Smith, DW (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia.	david.smith@health.wa.gov.au	/S-4986-2019	/0000-0002-5918-2190; Smith, David/0000-0002-3107-5182				[Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Pan American Health Organization (PAHO); World Health Organization, 2016, EPIDEMIOLOGICAL UPDA; WHO. WHO statement on the first meeting of the International Health Regulations, 2005, EM COMM ZIKA VIR OBS; World Health Organization, GUILL BARR SYNDR COL; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525	11	52	54	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1486	1488		10.1016/S0140-6736(16)00564-X	http://dx.doi.org/10.1016/S0140-6736(16)00564-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	26948432	Bronze, Green Submitted			2022-12-28	WOS:000373741600005
J	Kernan, WN; Viscoli, CM; Furie, KL; Young, LH; Inzucchi, SE; Gorman, M; Guarino, PD; Lovejoy, AM; Peduzzi, PN; Conwit, R; Brass, LM; Schwartz, GG; Adams, HP; Berger, L; Carolei, A; Clark, W; Coull, B; Ford, GA; Kleindorfer, D; O'Leary, JR; Parsons, MW; Ringleb, P; Sen, S; Spence, JD; Tanne, D; Wang, D; Winder, TR				Kernan, W. N.; Viscoli, C. M.; Furie, K. L.; Young, L. H.; Inzucchi, S. E.; Gorman, M.; Guarino, P. D.; Lovejoy, A. M.; Peduzzi, P. N.; Conwit, R.; Brass, L. M.; Schwartz, G. G.; Adams, H. P., Jr.; Berger, L.; Carolei, A.; Clark, W.; Coull, B.; Ford, G. A.; Kleindorfer, D.; O'Leary, J. R.; Parsons, M. W.; Ringleb, P.; Sen, S.; Spence, J. D.; Tanne, D.; Wang, D.; Winder, T. R.		IRIS Trial Investigators	Pioglitazone after Ischemic Stroke or Transient Ischemic Attack	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; NONDIABETIC PATIENTS; BLADDER-CANCER; MACROVASCULAR EVENTS; SECONDARY PREVENTION; CLINICAL-TRIAL; RISK; THIAZOLIDINEDIONES; SENSITIVITY	BACKGROUND Patients with ischemic stroke or transient ischemic attack (TIA) are at increased risk for future cardiovascular events despite current preventive therapies. The identification of insulin resistance as a risk factor for stroke and myocardial infarction raised the possibility that pioglitazone, which improves insulin sensitivity, might benefit patients with cerebrovascular disease. METHODS In this multicenter, double-blind trial, we randomly assigned 3876 patients who had had a recent ischemic stroke or TIA to receive either pioglitazone (target dose, 45 mg daily) or placebo. Eligible patients did not have diabetes but were found to have insulin resistance on the basis of a score of more than 3.0 on the homeostasis model assessment of insulin resistance (HOMA-IR) index. The primary outcome was fatal or nonfatal stroke or myocardial infarction. RESULTS By 4.8 years, a primary outcome had occurred in 175 of 1939 patients (9.0%) in the pioglitazone group and in 228 of 1937 (11.8%) in the placebo group (hazard ratio in the pioglitazone group, 0.76; 95% confidence interval [CI], 0.62 to 0.93; P = 0.007). Diabetes developed in 73 patients (3.8%) and 149 patients (7.7%), respectively (hazard ratio, 0.48; 95% CI, 0.33 to 0.69; P<0.001). There was no significant between-group difference in all-cause mortality (hazard ratio, 0.93; 95% CI, 0.73 to 1.17; P = 0.52). Pioglitazone was associated with a greater frequency of weight gain exceeding 4.5 kg than was placebo (52.2% vs. 33.7%, P<0.001), edema (35.6% vs. 24.9%, P<0.001), and bone fracture requiring surgery or hospitalization (5.1% vs. 3.2%, P = 0.003). CONCLUSIONS In this trial involving patients without diabetes who had insulin resistance along with a recent history of ischemic stroke or TIA, the risk of stroke or myocardial infarction was lower among patients who received pioglitazone than among those who received placebo. Pioglitazone was also associated with a lower risk of diabetes but with higher risks of weight gain, edema, and fracture. (Funded by the National Institute of Neurological Disorders and Stroke; ClinicalTrials.gov number, NCT00091949.)	[Kernan, W. N.; Viscoli, C. M.; Young, L. H.; Inzucchi, S. E.; Lovejoy, A. M.; Brass, L. M.; O'Leary, J. R.] Yale Univ, Sch Med, New Haven, CT USA; [Guarino, P. D.; Peduzzi, P. N.; O'Leary, J. R.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Guarino, P. D.; Peduzzi, P. N.] Connecticut HealthCare Syst, Cooperat Studies Program Coordinating Ctr, VA, West Haven, CT USA; [Furie, K. L.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Gorman, M.] Vermont Coll Med, Burlington, VT USA; [Conwit, R.] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Schwartz, G. G.] VA Med Ctr, Denver, CO USA; [Schwartz, G. G.] Univ Colorado, Sch Med, Denver, CO USA; [Adams, H. P., Jr.] Univ Iowa, Iowa City, IA USA; [Berger, L.] Hop Charles LeMoyne, Greenfield Pk, IN USA; [Spence, J. D.] Univ Western Ontario, London, ON N6A 3K7, Canada; [Winder, T. R.] Ctr Neurol Res, Lethbridge, AB, Canada; [Carolei, A.] Univ Aquila, I-67100 Laquila, Italy; [Clark, W.] Oregon Hlth & Sci Univ, Portland, OR USA; [Coull, B.] Univ Arizona, Tucson, AZ USA; [Ford, G. A.] Univ Oxford, Oxford OX1 2JD, Oxon, England; [Ford, G. A.] Oxford Univ Hosp NHS Fdn Trust, Oxford, Oxon, England; [Kleindorfer, D.] Univ Cincinnati, Cincinnati, OH USA; [Parsons, M. W.] Univ Newcastle, John Hunter Hosp, New Lambton Hts, NSW, Australia; [Ringleb, P.] Heidelberg Univ, Heidelberg, Germany; [Sen, S.] Univ S Carolina, Sch Med, Columbia, SC 29208 USA; [Tanne, D.] Tel Aviv Univ, Sheba Med Ctr, IL-69978 Tel Aviv, Israel; [Wang, D.] Univ Illinois, Coll Med, OSF St Francis Med Ctr, Illinois Neurol Inst, Peoria, IL 61656 USA; [Wang, D.] Univ Illinois, Coll Med, Dept Neurol, Peoria, IL 61656 USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Iowa; Western University (University of Western Ontario); University of L'Aquila; Oregon Health & Science University; University of Arizona; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University System of Ohio; University of Cincinnati; John Hunter Hospital; University of Newcastle; Ruprecht Karls University Heidelberg; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Chaim Sheba Medical Center; Tel Aviv University; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Kernan, WN (corresponding author), 2 Church St S,Suite 515, New Haven, CT 06519 USA.	walter.kernan@yale.edu	Di Lazzaro, Vincenzo/L-3731-2018; Witte, Otto/P-4127-2018; Tervola, Ned/AAB-4434-2020; Sacco, Simona/I-5253-2012; Spence, J. David/K-6396-2013; Canavero, Isabella/AAL-6021-2021; Ford, Gary/AAY-6405-2020; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Inzucchi, Silvio/ABF-4121-2021; Gröschel, Klaus/ABC-4777-2021; Tanne, David/F-2560-2010; Buse, John Bernard/J-9742-2019; Toni, Danilo/K-3151-2016; Strain, William/Y-9858-2019; Carolei, Antonio/K-4223-2016	Di Lazzaro, Vincenzo/0000-0002-9113-5925; Witte, Otto/0000-0003-2101-4105; Sacco, Simona/0000-0003-0651-1939; Spence, J. David/0000-0001-7478-1098; Canavero, Isabella/0000-0002-0141-0437; Ford, Gary/0000-0001-8719-4968; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Gröschel, Klaus/0000-0002-0244-6116; Tanne, David/0000-0002-6699-2220; Buse, John Bernard/0000-0002-9723-3876; Toni, Danilo/0000-0003-2735-8427; Strain, William/0000-0002-6826-418X; Carolei, Antonio/0000-0001-9251-2633; Cordina, Steve/0000-0001-7931-8983; Gutmann, Laurie/0000-0003-3926-4209; Jickling, Glen/0000-0003-3543-0820; Meisel, Andreas/0000-0001-7233-5342; Sabetay, Sergiu/0000-0003-2815-5971	National Institute of Neurological Disorders and Stroke [U01NS044876]; Merck; Mifcor; Janssen; Sanofi; Poxel; Boehringer Ingelheim; Eli Lilly; AstraZeneca; Novo Nordisk; Intarcia; Lexicon; Abbott; Millennium; Cerenis; Roche; Resverlogix; Medicines Company; Lundbeck; Cerevast; Pfizer; Athersys; Daiichi Sankyo; Covidien; Bayer; Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS044876] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0512-10089] Funding Source: researchfish	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Merck(Merck & Company); Mifcor; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Sanofi; Poxel; Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); Novo Nordisk(Novo Nordisk); Intarcia; Lexicon; Abbott(Abbott Laboratories); Millennium(Takeda Pharmaceutical Company Ltd); Cerenis; Roche(Roche Holding); Resverlogix; Medicines Company; Lundbeck(Lundbeck Corporation); Cerevast; Pfizer(Pfizer); Athersys; Daiichi Sankyo(Daiichi Sankyo Company Limited); Covidien; Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by a grant (U01NS044876) from the National Institute of Neurological Disorders and Stroke. Pioglitazone and placebo were provided by Takeda Pharmaceuticals International.; Dr. Young reports receiving grant support through his institution from Merck and Mifcor; Dr. Inzucchi, receiving fees for serving on advisory boards from Merck, Janssen, Sanofi, Poxel, Boehringer Ingelheim, Eli Lilly, and AstraZeneca, fees for serving on a data monitoring committee from Novo Nordisk and Intarcia, and fees for serving on a steering committee from Lexicon, serving as an expert witness on behalf of Takeda in a patent litigation deposition, and participating in projects for which funding for continuing medical education has been provided to Yale University by Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Abbott, Merck, and Sanofi; Dr. Peduzzi, receiving consulting fees from Millennium; Dr. Schwartz, receiving grant support from Cerenis, Roche, Resverlogix, Sanofi, and the Medicines Company; Dr. Ford, receiving fees for serving on a trial steering committee from Lundbeck, fees for serving on a data safety monitoring board from Cerevast, fees for serving on advisory boards from Pfizer, Athersys, and Daiichi Sankyo, consulting fees from Pfizer, and lecture fees and travel support from AstraZeneca and Boehringer Ingelheim; Dr. Ringleb, receiving fees for serving on advisory boards from Boehringer Ingelheim, Covidien, Bayer, and Daiichi Sankyo and lecture fees and travel support from Boehringer Ingelheim, Bayer, and Daiichi Sankyo; Dr. Spence, receiving consulting and lecture fees from Bayer and Bristol-Myers Squibb, serving as an officer of and having an equity interest in Vascularis, and performing contract research for Bayer, Bristol-Myers Squibb, Pfizer, Acasti Pharma, POM Wonderful, CVRx, AGA Medical, and W.L. Gore. No other potential conflict of interest relevant to this article was reported.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Aronoff S, 2000, DIABETES CARE, V23, P1605, DOI 10.2337/diacare.23.11.1605; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Balkau B, 1999, DIABETIC MED, V16, P442; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Basu R, 2008, DIABETES, V57, P24, DOI 10.2337/db07-0827; Bone HG, 2013, J CLIN ENDOCR METAB, V98, P4691, DOI 10.1210/jc.2012-4096; Campia U, 2006, CIRCULATION, V113, P867, DOI 10.1161/CIRCULATIONAHA.105.549618; Chen SW, 2013, DIABETES CARE, V36, P369, DOI 10.2337/dc11-2197; Colmers IN, 2012, DIABETES METAB, V38, P475, DOI 10.1016/j.diabet.2012.06.003; COX DR, 1972, J R STAT SOC B, V34, P187; Dhamoon MS, 2006, NEUROLOGY, V66, P641, DOI 10.1212/01.wnl.0000201253.93811.f6; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Efird Jimmy Thomas, 2008, Int J Environ Res Public Health, V5, P394; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Grey A, 2014, EUR J ENDOCRINOL, V170, P255, DOI 10.1530/EJE-13-0793; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Huff TA, 1972, STROKE, V3, P543, DOI 10.1161/01.STR.3.5.543; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Ivey FM, 2007, STROKE, V38, P2752, DOI 10.1161/STROKEAHA.107.490391; Johnston SC, 2002, NEW ENGL J MED, V347, P1687, DOI 10.1056/NEJMcp020891; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kernan WN, 2003, STROKE, V34, P1431, DOI 10.1161/01.STR.0000071108.00234.0E; Kernan WN, 2003, NEUROLOGY, V60, P1447, DOI 10.1212/01.WNL.0000063318.66140.A3; Kernan WN, 2002, NEUROLOGY, V59, P809, DOI 10.1212/WNL.59.6.809; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Lorenzo C, 2010, J CLIN ENDOCR METAB, V95, P5082, DOI 10.1210/jc.2010-1144; Mather KJ, 2013, J CLIN INVEST, V123, P1003, DOI 10.1172/JCI67166; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Saremi A, 2013, ARTERIOSCL THROM VAS, V33, P393, DOI 10.1161/ATVBAHA.112.300346; Semenkovich CF, 2006, J CLIN INVEST, V116, P1813, DOI 10.1172/JCI29024; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Viscoli CM, 2014, AM HEART J, V168, P823, DOI 10.1016/j.ahj.2014.07.016; Wilcox R, 2007, STROKE, V38, P865, DOI 10.1161/01.STR.0000257974.06317.49; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhu ZN, 2014, BONE, V68, P115, DOI 10.1016/j.bone.2014.08.010	52	654	666	1	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1321	1331		10.1056/NEJMoa1506930	http://dx.doi.org/10.1056/NEJMoa1506930			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3UW	26886418	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000373425000006
J	Kodali, S; Williams, MR; Doshi, D; Hahn, RT; Humphries, KH; Nkomo, VT; Cohen, DJ; Douglas, PS; Mack, M; Xu, K; Svensson, L; Thourani, VH; Tuzcu, EM; Weissman, NJ; Leon, M; Kirtane, AJ				Kodali, Susheel; Williams, Mathew R.; Doshi, Darshan; Hahn, Rebecca T.; Humphries, Karin H.; Nkomo, Vuyisile T.; Cohen, David J.; Douglas, Pamela S.; Mack, Michael; Xu, Ke; Svensson, Lars; Thourani, Vinod H.; Tuzcu, E. Murat; Weissman, Neil J.; Leon, Martin; Kirtane, Ajay J.			Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; LEFT-VENTRICULAR FUNCTION; VASCULAR COMPLICATIONS; GENDER-DIFFERENCES; CLINICAL PRESENTATION; IMPLANTATION; STENOSIS; WOMEN; PREDICTORS; MORTALITY	Background: Female sex is associated with poorer outcomes after surgical aortic valve replacement (SAVR). Data on sex-specific differences after transcatheter aortic valve replacement (TAVR) are conflicting. Objective: To examine sex-specific differences in patients undergoing TAVR in the PARTNER (Placement of Aortic Transcatheter Valves) trial. Design: Secondary analysis of the randomized and nonrandomized portions of the PARTNER trial. (ClinicalTrials.gov: NCT00530894) Setting: 25 hospitals in the United States, Canada, and Germany. Patients: High-risk and inoperable patients (1220 women and 1339 men). Intervention: TAVR. Measurements: Demographic characteristics, cardiac and non-cardiac comorbidities, mortality, stroke, rehospitalization, vascular complications, bleeding complications, and echocardiographic valve parameters. Results: At baseline, women had lower rates of hyperlipidemia, diabetes, smoking, and renal disease but higher Society of Thoracic Surgeons Predicted Risk of Mortality scores (11.9% vs. 11.1%; P < 0.001). After TAVR, women had more vascular com-plications (17.3% vs. 10.0%; difference, 7.29 percentage points [95% CI, 4.63 to 9.95 percentage points]; P < 0.001) and major bleeding (10.5% vs. 7.7%; difference, 2.8 percentage points [CI, 0.57 to 5.04 percentage points]; P = 0.012) but less frequent moderate and severe paravalvular regurgitation (6.0% vs. 14.3%; difference, -8.3 percentage points [CI, -11.7 to -5.0 percentage points]; P < 0.001). At 30 days, the unadjusted all-cause mortality rate (6.5% vs. 5.9%; difference, 0.6 percentage point [CI, -1.29 to 2.45 percentage points]; P = 0.52) and stroke incidence (3.8% vs. 3.0%; difference, 0.8 percentage point [CI, -0.62 to 2.19 percentage points]; P = 0.28) were similar. At 1 year, all-cause mortality was significantly lower in women than in men (19.0% vs. 25.9%; hazard ratio, 0.72 [CI, 0.61 to 0.85]; P < 0.001). Limitation: Secondary analysis that included nonrandomized trial data. Conclusion: Despite a higher incidence of vascular and bleeding complications, women having TAVR had lower mortality than men at 1 year. Thus, sex-specific risk in TAVR is the opposite of that in SAVR, for which female sex has been shown to be independently associated with an adverse prognosis.	Columbia Univ, Med Ctr, New York Presbyterian Hosp, Langone Med Ctr, New York, NY 10032 USA; Cardiovasc Res Fdn, New York, NY USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Mayo Clin, Rochester, MN USA; St Lukes Mid Amer Heart Inst, Kansas City, MO USA; Duke Clin Res Inst, Durham, NC USA; Baylor Healthcare Syst, Dallas, TX USA; Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; Emory Univ, Sch Med, Atlanta, GA USA; MedStar Hlth Res Inst, Washington, DC USA	Columbia University; NewYork-Presbyterian Hospital; NYU Langone Medical Center; Cardiovascular Research Foundation (CRF); University of British Columbia; Mayo Clinic; Saint Luke's Mid America Heart Institute; Duke University; Baylor Health Care System; Cleveland Clinic Foundation; Emory University; MedStar Health Research Institute	Kodali, S (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, 177 Ft Washington Ave,Room 501, New York, NY 10032 USA.	skodali@columbia.edu	Hahn, Rebecca/ABE-6221-2020; thourani, vinod/AAP-5968-2020	Douglas, Pamela/0000-0001-9876-4049; Hahn, Rebecca/0000-0003-1342-9191; Williams, Mathew/0000-0003-2055-8741	Edwards Lifesciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007854] Funding Source: NIH RePORTER	Edwards Lifesciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The PARTNER trial was funded by Edwards Lifesciences and designed collaboratively by the steering committee and the sponsor. All data analyses were done independently at the Cardiovascular Research Foundation (New York, New York) and were supported by an unrestricted research grant from Edwards Lifesciences. The authors had unrestricted access to the study data, drafted the manuscript, made the decision to submit it for publication, and guarantee the completeness and accuracy of its content.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Ahmed B, 2010, J INVASIVE CARDIOL, V22, P512; Ahmed B, 2009, CIRC-CARDIOVASC INTE, V2, P423, DOI 10.1161/CIRCINTERVENTIONS.109.860494; Applegate Robert J, 2007, J Invasive Cardiol, V19, P369; Argulian E, 2006, AM J CARDIOL, V98, P48, DOI 10.1016/j.amjcard.2006.01.048; Buchanan GL, 2011, EUROINTERVENTION, V7, P556, DOI 10.4244/EIJV7I5A91; Buja P, 2013, AM J CARDIOL, V111, P88, DOI 10.1016/j.amjcard.2012.08.051; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Chieffo A, 2010, EUROINTERVENTION, V5, P773, DOI 10.4244/EIJV5I7A130; Cohen M, 2000, AM HEART J, V139, P282, DOI 10.1016/S0002-8703(00)90237-0; Connolly HM, 1997, CIRCULATION, V95, P2395, DOI 10.1161/01.CIR.95.10.2395; Conrotto F, 2014, AM J CARDIOL, V114, P1269, DOI 10.1016/j.amjcard.2014.07.053; Diemert P, 2013, J HEART VALVE DIS, V22, P789; Douglas PS, 2013, J AM SOC ECHOCARDIOG, V26, P348, DOI 10.1016/j.echo.2013.01.013; Duncan AI, 2006, ANESTH ANALG, V103, P800, DOI 10.1213/01.ane.0000231890.95212.12; Fuchs C, 2010, HEART, V96, P539, DOI 10.1136/hrt.2009.186650; Genereux P, 2012, J AM COLL CARDIOL, V60, P1043, DOI 10.1016/j.jacc.2012.07.003; Hayashida K, 2012, J AM COLL CARDIOL, V59, P566, DOI 10.1016/j.jacc.2011.10.877; Houthuizen P, 2012, CIRCULATION, V126, P720, DOI 10.1161/CIRCULATIONAHA.112.101055; Humphries KH, 2012, J AM COLL CARDIOL, V60, P882, DOI 10.1016/j.jacc.2012.05.009; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Klodas E, 1996, CIRCULATION, V94, P2472, DOI 10.1161/01.CIR.94.10.2472; Kodali S, 2015, EUR HEART J, V36, P449, DOI 10.1093/eurheartj/ehu384; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Ndrepepa G, 2013, AM HEART J, V166, P534, DOI 10.1016/j.ahj.2013.07.006; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Onorati F, 2014, J THORAC CARDIOV SUR, V147, P1529, DOI 10.1016/j.jtcvs.2013.05.039; Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Schwertz DW, 2001, HEART LUNG, V30, P401, DOI 10.1067/mhl.2001.118764; Sherif MA, 2014, CLIN RES CARDIOL, V103, P613, DOI 10.1007/s00392-014-0690-6; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tchetche D, 2012, AM HEART J, V164, P402, DOI 10.1016/j.ahj.2012.07.003; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Van Mieghem NM, 2012, AM J CARDIOL, V110, P1361, DOI 10.1016/j.amjcard.2012.06.042; VILLARI B, 1995, EUR HEART J, V16, P1410, DOI 10.1093/oxfordjournals.eurheartj.a060749; Williams M, 2014, J AM COLL CARDIOL, V63, P1522, DOI 10.1016/j.jacc.2014.01.036; Zahn R, 2013, AM J CARDIOL, V112, P272, DOI 10.1016/j.amjcard.2013.03.024	44	82	83	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					377	+		10.7326/M15-0121	http://dx.doi.org/10.7326/M15-0121			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26903039				2022-12-28	WOS:000372207200011
J	Levasseur, A; Bekliz, M; Chabriere, E; Pontarotti, P; La Scola, B; Raoult, D				Levasseur, Anthony; Bekliz, Meriem; Chabriere, Eric; Pontarotti, Pierre; La Scola, Bernard; Raoult, Didier			MIMIVIRE is a defence system in mimivirus that confers resistance to virophage	NATURE			English	Article							CRISPR-CAS SYSTEMS; GIANT VIRUSES; EVOLUTIONARY NETWORK; RNA-INTERFERENCE; PROKARYOTES; IMMUNITY; AMEBAS; CLASSIFICATION; BACTERIA; ELEMENTS	Since their discovery, giant viruses have revealed several unique features that challenge the conventional definition of a virus, such as their large and complex genomes, their infection by virophages and their presence of transferable short element transpovirons(1-5). Here we investigate the sensitivity of mimivirus to virophage infection in a collection of 59 viral strains and demonstrate lineage specificity in the resistance of mimivirus to Zamilon(6), a unique virophage that can infect lineages B and C of mimivirus but not lineage A. We hypothesized that mimiviruses harbour a defence mechanism resembling the clustered regularly interspaced short palindromic repeat (CRISPR)-Cas system that is widely present in bacteria and archaea(7-10). We performed de novo sequencing of 45 new mimivirus strains and searched for sequences specific to Zamilon in a total of 60 mimivirus genomes. We found that lineage A strains are resistant to Zamilon and contain the insertion of a repeated Zamilon sequence within an operon, here named the 'mimivirus virophage resistance element' (MIMIVIRE). Further analyses of the surrounding sequences showed that this locus is reminiscent of a defence mechanism related to the CRISPR-Cas system. Silencing the repeated sequence and the MIMIVIRE genes restores mimivirus susceptibility to Zamilon. The MIMIVIRE proteins possess the typical functions (nuclease and helicase) involved in the degradation of foreign nucleic acids. The viral defence system, MIMIVIRE, represents a nucleic-acid-based immunity against virophage infection.	[Levasseur, Anthony; Bekliz, Meriem; Chabriere, Eric; La Scola, Bernard; Raoult, Didier] Aix Marseille Univ, URMITE, INSERM, UM63,CNRS 7278,IRD 198,U1095, Marseille, France; [Levasseur, Anthony; Bekliz, Meriem; Chabriere, Eric; La Scola, Bernard; Raoult, Didier] IHU Mediterranee Infect, Assistance Publ Hop Marseille, Fac Med, 27 Blvd Jean Moulin, F-13005 Marseille, France; [Pontarotti, Pierre] Aix Marseille Univ, CNRS, Cent Marseille, I2M,UMR7373,FR 4213,FR Eccorev 3098,Equipe EBM, F-13331 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Aix-Marseille Universite	La Scola, B; Raoult, D (corresponding author), Aix Marseille Univ, URMITE, INSERM, UM63,CNRS 7278,IRD 198,U1095, Marseille, France.; La Scola, B; Raoult, D (corresponding author), IHU Mediterranee Infect, Assistance Publ Hop Marseille, Fac Med, 27 Blvd Jean Moulin, F-13005 Marseille, France.	bernard.la-scola@univ-amu.fr; didier.raoult@gmail.com	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008; , pontarotti/ABB-1753-2021	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974; Pierre, Pontarotti/0000-0001-7202-3648; BEKLIZ, Meriem/0000-0003-3186-1877; Levasseur, Anthony/0000-0003-2989-7539				Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Filee J, 2010, INTERVIROLOGY, V53, P354, DOI 10.1159/000312920; Forterre P, 2010, INTERVIROLOGY, V53, P362, DOI 10.1159/000312921; Gaia M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094923; Koonin EV, 2014, MICROBIOL MOL BIOL R, V78, P278, DOI 10.1128/MMBR.00049-13; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Pourcel C, 2012, CRISPR CAS SYSTEMS, P33; Raoult D, 2015, VIROLOGY, V477, P119, DOI 10.1016/j.virol.2014.11.014; Raoult D, 2013, INTERVIROLOGY, V56, P349, DOI 10.1159/000354269; Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Slimani M, 2013, J VIROL, V87, P4783, DOI 10.1128/JVI.02948-12; Sobhy H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00345; Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-158; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047232	22	68	75	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					249	+		10.1038/nature17146	http://dx.doi.org/10.1038/nature17146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26934229				2022-12-28	WOS:000371665100045
J	Anderson, CJ; Bahnik, S; Barnett-Cowan, M; Bosco, FA; Chandler, J; Chartier, CR; Cheung, F; Christopherson, CD; Cordes, A; Cremata, EJ; Della Penna, N; Estel, V; Fedor, A; Fitneva, SA; Frank, MC; Grange, JA; Hartshorne, JK; Hasselman, F; Henninger, F; van der Hulst, M; Jonas, KJ; Lai, CK; Levitan, CA; Miller, JK; Moore, KS; Meixner, JM; Munafo, MR; Neijenhuijs, KI; Nilsonne, G; Nosek, BA; Plessow, F; Prenoveau, JM; Ricker, AA; Schmidt, K; Spies, JR; Stieger, S; Strohminger, N; Sullivan, GB; van Aert, RCM; van Assen, MALM; Vanpaemel, W; Vianello, M; Voracek, M; Zuni, K				Anderson, Christopher J.; Bahnik, Stepan; Barnett-Cowan, Michael; Bosco, Frank A.; Chandler, Jesse; Chartier, Christopher R.; Cheung, Felix; Christopherson, Cody D.; Cordes, Andreas; Cremata, Edward J.; Della Penna, Nicolas; Estel, Vivien; Fedor, Anna; Fitneva, Stanka A.; Frank, Michael C.; Grange, James A.; Hartshorne, Joshua K.; Hasselman, Fred; Henninger, Felix; van der Hulst, Marije; Jonas, Kai J.; Lai, Calvin K.; Levitan, Carmel A.; Miller, Jeremy K.; Moore, Katherine S.; Meixner, Johannes M.; Munafo, Marcus R.; Neijenhuijs, Koen I.; Nilsonne, Gustav; Nosek, Brian A.; Plessow, Franziska; Prenoveau, Jason M.; Ricker, Ashley A.; Schmidt, Kathleen; Spies, Jeffrey R.; Stieger, Stefan; Strohminger, Nina; Sullivan, Gavin B.; van Aert, Robbie C. M.; van Assen, Marcel A. L. M.; Vanpaemel, Wolf; Vianello, Michelangelo; Voracek, Martin; Zuni, Kellylynn			Response to Comment on "Estimating the reproducibility of psychological science"	SCIENCE			English	Editorial Material							REPLICATION	Gilbert et al. conclude that evidence from the Open Science Collaboration's Reproducibility Project: Psychology indicates high reproducibility, given the study methodology. Their very optimistic assessment is limited by statistical misconceptions and by causal inferences from selectively interpreted, correlational data. Using the Reproducibility Project: Psychology data, both optimistic and pessimistic conclusions about reproducibility are possible, and neither are yet warranted.	[Anderson, Christopher J.] Russell Sage Coll, Troy, NY USA; [Bahnik, Stepan] Univ Wurzburg, D-97070 Wurzburg, Germany; [Barnett-Cowan, Michael] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Bosco, Frank A.] Virginia Commonwealth Univ, Richmond, VA USA; [Chandler, Jesse] Univ Michigan, Ann Arbor, MI 48104 USA; [Chandler, Jesse] Mathemat Policy Res, Washington, DC USA; [Chartier, Christopher R.] Ashland Univ, Ashland, OH USA; [Cheung, Felix] Michigan State Univ, E Lansing, MI 48824 USA; [Christopherson, Cody D.] Southern Oregon Univ, Ashland, OR USA; [Cordes, Andreas] Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany; [Cremata, Edward J.] Univ So Calif, Los Angeles, CA USA; [Della Penna, Nicolas] Australian Natl Univ, Canberra, ACT, Australia; [Estel, Vivien] Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany; [Fedor, Anna] Parmenides Stiftung, Munich, Germany; [Fitneva, Stanka A.] Queens Univ, Kingston, ON, Canada; [Frank, Michael C.] Stanford Univ, Stanford, CA 94305 USA; [Grange, James A.] Keele Univ, Keele ST5 5BG, Staffs, England; [Hartshorne, Joshua K.] Boston Coll, Chestnut Hill, MA 02167 USA; [Hasselman, Fred] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Henninger, Felix] Univ Koblenz Landau, Landau, Germany; [van der Hulst, Marije] Erasmus MC, Rotterdam, Netherlands; [Jonas, Kai J.] Univ Amsterdam, Amsterdam, Netherlands; [Lai, Calvin K.] Harvard Univ, Cambridge, MA 02138 USA; [Levitan, Carmel A.] Occidental Coll, Los Angeles, CA 90041 USA; [Miller, Jeremy K.] Willamette Univ, Salem, OR 97301 USA; [Moore, Katherine S.] Arcadia Univ, Glenside, PA USA; [Meixner, Johannes M.] Univ Potsdam, Potsdam, Germany; [Munafo, Marcus R.] Univ Bristol, Bristol, Avon, England; [Neijenhuijs, Koen I.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Nilsonne, Gustav] Stockholm Univ, Karolinska Inst, S-10691 Stockholm, Sweden; [Nosek, Brian A.; Spies, Jeffrey R.] Ctr Open Sci, Charlottesville, VA USA; [Nosek, Brian A.; Spies, Jeffrey R.] Univ Virginia, Charlottesville, VA USA; [Plessow, Franziska] Harvard Univ, Sch Med, Boston, MA USA; [Prenoveau, Jason M.] Loyola Univ, Baltimore, MD USA; [Ricker, Ashley A.] Univ Calif Riverside, Riverside, CA 92521 USA; [Schmidt, Kathleen] Wesleyan Univ, Middletown, CT USA; [Stieger, Stefan] Univ Konstanz, Constance, Germany; [Strohminger, Nina] Yale Univ, New Haven, CT USA; [Sullivan, Gavin B.] Coventry Univ, Coventry, W Midlands, England; [van Aert, Robbie C. M.; van Assen, Marcel A. L. M.] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [van Assen, Marcel A. L. M.] Univ Utrecht, Utrecht, Netherlands; [Vanpaemel, Wolf] Univ Leuven, Leuven, Belgium; [Vianello, Michelangelo] Univ Padua, Padua, Italy; [Voracek, Martin] Univ Vienna, Vienna, Austria; [Zuni, Kellylynn] Adams State Univ, Alamosa, CO USA	University of Wurzburg; University of Waterloo; Virginia Commonwealth University; University of Michigan System; University of Michigan; Mathematica; Ashland University; Michigan State University; University of Gottingen; University of Southern California; Australian National University; Braunschweig University of Technology; Queens University - Canada; Stanford University; Keele University; Boston College; Radboud University Nijmegen; University of Koblenz & Landau; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Harvard University; Occidental College; Willamette University; University of Potsdam; University of Bristol; Vrije Universiteit Amsterdam; Karolinska Institutet; Stockholm University; University of Virginia; Harvard University; Harvard Medical School; Loyola University Maryland; University of California System; University of California Riverside; Wesleyan University; University of Konstanz; Yale University; Coventry University; Tilburg University; Utrecht University; KU Leuven; University of Padua; University of Vienna	Nosek, BA (corresponding author), Ctr Open Sci, Charlottesville, VA USA.; Nosek, BA (corresponding author), Univ Virginia, Charlottesville, VA USA.	nosek@virginia.edu	Voracek, Martin/S-5865-2016; Plessow, Franziska/AAE-8754-2019; vanpaemel, wolf/AAC-9834-2022; Meixner, Johannes M/GZK-3202-2022; Munafo, Marcus/AAE-2306-2020; Sullivan, Gavin Brent/W-4876-2019; Cheung, Felix/R-1726-2018; Hasselman, Fred/P-2479-2019; Prenoveau, Jason/N-2097-2019; Fedor, Anna/B-8984-2009; Moore, Katherine Sledge/B-8445-2009; Jonas, Kai/AAB-3120-2021; Christopherson, Cody/W-4107-2019; Sullivan, Gavin Brent/P-7885-2019; Stieger, Stefan/G-2572-2012; Vianello, Michelangelo/G-8919-2013	Voracek, Martin/0000-0001-6109-6155; vanpaemel, wolf/0000-0002-5855-3885; Munafo, Marcus/0000-0002-4049-993X; Sullivan, Gavin Brent/0000-0003-0146-5953; Cheung, Felix/0000-0002-7826-7405; Hasselman, Fred/0000-0003-1384-8361; Fedor, Anna/0000-0003-2290-2323; Moore, Katherine Sledge/0000-0001-7982-1140; Jonas, Kai/0000-0001-6607-1993; Christopherson, Cody/0000-0002-0461-0135; Stieger, Stefan/0000-0002-7784-6624; Vianello, Michelangelo/0000-0002-1530-1469; Nosek, Brian/0000-0001-6797-5476; Fitneva, Stanka/0000-0002-6687-948X; van Assen, Marcel/0000-0002-7517-6081; Frank, Michael/0000-0002-7551-4378; Bahnik, Stepan/0000-0002-0579-6808; Bosco, Frank/0000-0002-3497-4335; Grange, James/0000-0002-8352-8390; Meixner, Johannes/0000-0001-6772-6429; Hartshorne, Joshua/0000-0003-1240-3598; Ricker, Ashley/0000-0002-5549-2247; Neijenhuijs, Koen/0000-0002-6664-3514; Schmidt, Kathleen/0000-0002-9946-5953				Alexander A, 2012, PERSPECT PSYCHOL SCI, V7, P657, DOI 10.1177/1745691612462588; [Anonymous], 2015, SCIENCE, DOI [DOI 10.1126/SCIENCE.AAC4716, DOI 10.1126/science.aac4716]; Cumming G., 2004, UNDERSTANDING STAT, V3, P299, DOI DOI 10.1207/S15328031US0304_; Cumming G, 2006, PSYCHOL METHODS, V11, P217, DOI 10.1037/1082-989X.11.3.217; Dreber A, 2015, P NATL ACAD SCI USA, V112, P15343, DOI 10.1073/pnas.1516179112; Ebersole C. R., 2016, J EXP SOC PSYCHOL, V65; Gilbert DT, 2016, SCIENCE, V351, DOI 10.1126/science.aad7243; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Nosek BA, 2014, SOC PSYCHOL-GERMANY, V45, P137, DOI 10.1027/1864-9335/a000192; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108	10	100	103	7	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277								10.1126/science.aad9163	http://dx.doi.org/10.1126/science.aad9163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF8HE	26941312	Green Submitted, Green Accepted			2022-12-28	WOS:000371597500031
J	Bornholdt, ZA; Turner, HL; Murin, CD; Li, W; Sok, D; Souders, CA; Piper, AE; Goff, A; Shamblin, JD; Wollen, SE; Sprague, TR; Fusco, ML; Pommert, KBJ; Cavacini, LA; Smith, HL; Klempner, M; Reimann, KA; Krauland, E; Gerngross, TU; Wittrup, KD; Saphire, EO; Burton, DR; Glass, PJ; Ward, AB; Walker, LM				Bornholdt, Zachary A.; Turner, Hannah L.; Murin, Charles D.; Li, Wen; Sok, Devin; Souders, Colby A.; Piper, Ashley E.; Goff, Arthur; Shamblin, Joshua D.; Wollen, Suzanne E.; Sprague, Thomas R.; Fusco, Marnie L.; Pommert, Kathleen B. J.; Cavacini, Lisa A.; Smith, Heidi L.; Klempner, Mark; Reimann, Keith A.; Krauland, Eric; Gerngross, Tillman U.; Wittrup, Karl D.; Saphire, Erica Ollmann; Burton, Dennis R.; Glass, Pamela J.; Ward, Andrew B.; Walker, Laura M.			Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; NONHUMAN-PRIMATES; B-CELLS; INFECTION; REARRANGEMENTS; SELECTION; MACAQUES; COCKTAIL; DISEASE	Antibodies targeting the Ebola virus surface glycoprotein (EBOV GP) are implicated in protection against lethal disease, but the characteristics of the human antibody response to EBOV GP remain poorly understood. We isolated and characterized 349 GP-specific monoclonal antibodies (mAbs) from the peripheral B cells of a convalescent donor who survived the 2014 EBOV Zaire outbreak. Remarkably, 77% of the mAbs neutralize live EBOV, and several mAbs exhibit unprecedented potency. Structures of selected mAbs in complex with GP reveal a site of vulnerability located in the GP stalk region proximal to the viral membrane. Neutralizing antibodies targeting this site show potent therapeutic efficacy against lethal EBOV challenge in mice. The results provide a framework for the design of new EBOV vaccine candidates and immunotherapies.	[Bornholdt, Zachary A.; Murin, Charles D.; Sok, Devin; Fusco, Marnie L.; Pommert, Kathleen B. J.; Saphire, Erica Ollmann; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Turner, Hannah L.; Murin, Charles D.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Li, Wen; Krauland, Eric; Gerngross, Tillman U.; Wittrup, Karl D.; Walker, Laura M.] Adimab, Lebanon, NH 03766 USA; [Souders, Colby A.; Cavacini, Lisa A.; Smith, Heidi L.; Klempner, Mark; Reimann, Keith A.] Univ Massachusetts, Sch Med, MassBiol, Boston, MA 02126 USA; [Piper, Ashley E.; Goff, Arthur; Shamblin, Joshua D.; Wollen, Suzanne E.; Sprague, Thomas R.; Glass, Pamela J.] US Army, Med Res Inst Infect Dis, Frederick, MD 21702 USA; [Burton, Dennis R.] MIT, Ragon Inst, Massachusetts Gen Hosp, Cambridge, MA 02142 USA; [Burton, Dennis R.] Harvard Univ, Cambridge, MA 02142 USA	Scripps Research Institute; Scripps Research Institute; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Walker, LM (corresponding author), Adimab, Lebanon, NH 03766 USA.	laura.walker@adimab.com	Glass, Pamela/AAN-5555-2020; Ward, Andrew/ABD-7728-2021; Murin, Charles Daniel/ABA-2861-2020; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Saphire, Erica Ollmann/0000-0002-1206-7451; Wollen-Roberts, Suzanne/0000-0002-9409-2756; Bornholdt, Zachary/0000-0002-7557-9219	NIH/National Institute of Allergy and Infectious Diseases Center for Excellence in Translational Research [U19AI109762]; NSF; U.S. NIH grants [U19 AI109762, R01 AI067927]; Defense Advanced Research Projects Agency [DARPA-BAA-13-03]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [UM1AI100663];  [R01AI067927]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067927, UM1AI100663, T32AI007244, U19AI109762] Funding Source: NIH RePORTER	NIH/National Institute of Allergy and Infectious Diseases Center for Excellence in Translational Research; NSF(National Science Foundation (NSF)); U.S. NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Boland and M. Vasquez for assistance with antibody sequence analysis, C. Williams and S. M. Eagol for assistance with figure preparation, R. Pejchal for providing helpful comments on the manuscript, and M. Haynes for assistance with flow cytometry. All of the IgGs were sequenced by Adimab's Molecular Core and produced by the High Throughput Expression group. BLI binding experiments were performed by Adimab's protein analytics group. The ZMapp cocktail mAb 2G4 was generously provided by Mapp Biopharmaceutical. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. GenBank accession numbers for the antibody variable-region gene sequences reported in this study can be found in table S7. The cryo-EM maps have been deposited to the Electron Microscopy Data Bank (accession numbers EMD-6586, EMD-6587, EMD-6588, and EMD-6589). E.O.S., Z.A.B., M.L.F., K.B.J.P., A.B.W., H.L.T., and C.D.M. acknowledge support from the NIH/National Institute of Allergy and Infectious Diseases Center for Excellence in Translational Research Grant U19AI109762, "Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers." E.O.S. was also supported by R01AI067927. C.D.M. was supported by a predoctoral fellowship from NSF. This study was supported in part by U.S. NIH grants U19 AI109762 and R01 AI067927 awarded to E.O.S. Research was funded in part by the Defense Advanced Research Projects Agency (DARPA-BAA-13-03). D.R.B. and D.S. acknowledge support from Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1AI100663. This is manuscript no. 29237 from The Scripps Research Institute. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army.	Audet J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06881; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Jackson KJL, 2012, IMMUNOGENETICS, V64, P3, DOI 10.1007/s00251-011-0559-z; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001575; Roddy P, 2014, VIRUSES-BASEL, V6, P3699, DOI 10.3390/v6103699; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Xu YD, 2013, PROTEIN ENG DES SEL, V26, P663, DOI 10.1093/protein/gzt047	30	147	158	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1078	1083		10.1126/science.aad5788	http://dx.doi.org/10.1126/science.aad5788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26912366	Green Accepted			2022-12-28	WOS:000371597500043
J	Chuong, EB; Elde, NC; Feschotte, C				Chuong, Edward B.; Elde, Nels C.; Feschotte, Cedric			Regulatory evolution of innate immunity through co-option of endogenous retroviruses	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; ACTIVATION; NETWORK; GENES; CELLS; INFLAMMASOME; MECHANISMS; ENHANCERS; RESPONSES	Endogenous retroviruses (ERVs) are abundant in mammalian genomes and contain sequences modulating transcription. The impact of ERV propagation on the evolution of gene regulation remains poorly understood. We found that ERVs have shaped the evolution of a transcriptional network underlying the interferon (IFN) response, a major branch of innate immunity, and that lineage-specific ERVs have dispersed numerous IFN-inducible enhancers independently in diverse mammalian genomes. CRISPR-Cas9 deletion of a subset of these ERV elements in the human genome impaired expression of adjacent IFN-induced genes and revealed their involvement in the regulation of essential immune functions, including activation of the AIM2 inflammasome. Although these regulatory sequences likely arose in ancient viruses, they now constitute a dynamic reservoir of IFN-inducible enhancers fueling genetic innovation in mammalian immune defenses.	[Chuong, Edward B.; Elde, Nels C.; Feschotte, Cedric] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Elde, NC; Feschotte, C (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA.	nelde@genetics.utah.edu; cedric@genetics.utah.edu		Chuong, Edward/0000-0002-5392-937X	Pew Charitable Trusts; NIH [GM082545, GM114514, GM112972, GM059290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114514, R01GM112972, R01GM059290, P50GM082545] Funding Source: NIH RePORTER	Pew Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Accession numbers for the published data sets analyzed in this study are available in the supplementary materials. We thank all members of the Elde and Feschotte labs for insightful discussions. We thank A. Kapusta, A. Lewis, D. Downhour, J. Carleton, and K. Cone for technical assistance, and D. Hancks and J. F. McCormick for their critical input. Supported by a Pew Charitable Trusts award and NIH grants GM082545 and GM114514 (N.C.E.) and by NIH grants GM112972 and GM059290 (C.F.). E.B.C. is a Howard Hughes Medical Institute postdoctoral fellow of the Jane Coffin Childs Fund. N.C.E. is a Pew Scholar in the Biomedical Sciences and Mario R. Capecchi Endowed Chair in Genetics. The authors declare no financial conflicts of interest.	Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Barreiro LB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001249; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jacques PE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003504; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meyer K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09012; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Notwell JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7644; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Schmid CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011425; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Sundaram V, 2014, GENOME RES, V24, P1963, DOI 10.1101/gr.168872.113; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Wang T, 2012, J LEUKOCYTE BIOL, V91, P449, DOI 10.1189/jlb.1011498; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104	33	453	462	0	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1083	1087		10.1126/science.aad5497	http://dx.doi.org/10.1126/science.aad5497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941318	Green Accepted			2022-12-28	WOS:000371597500044
J	Larson, C; Peele, B; Li, S; Robinson, S; Totaro, M; Beccai, L; Mazzolai, B; Shepherd, R				Larson, C.; Peele, B.; Li, S.; Robinson, S.; Totaro, M.; Beccai, L.; Mazzolai, B.; Shepherd, R.			Highly stretchable electroluminescent skin for optical signaling and tactile sensing	SCIENCE			English	Article							ARTIFICIAL SKIN; SOFT MACHINES; LARGE-AREA; ELECTRONICS; CAMOUFLAGE; MATRIX; CONDUCTORS; PRESSURE; DISPLAYS; DESIGN	Cephalopods such as octopuses have a combination of a stretchable skin and colortuning organs to control both posture and color for visual communication and disguise. We present an electroluminescent material that is capable of large uniaxial stretching and surface area changes while actively emitting light. Layers of transparent hydrogel electrodes sandwich a ZnS phosphor-doped dielectric elastomer layer, creating thin rubber sheets that change illuminance and capacitance under deformation. Arrays of individually controllable pixels in thin rubber sheets were fabricated using replica molding and were subjected to stretching, folding, and rolling to demonstrate their use as stretchable displays. These sheets were then integrated into the skin of a soft robot, providing it with dynamic coloration and sensory feedback from external and internal stimuli.	[Larson, C.; Peele, B.; Shepherd, R.] Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Li, S.; Robinson, S.; Shepherd, R.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Totaro, M.; Beccai, L.; Mazzolai, B.] Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy	Cornell University; Cornell University; Istituto Italiano di Tecnologia - IIT	Shepherd, R (corresponding author), Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA.; Shepherd, R (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	rfs247@cornell.edu	Li, Shuo/Y-4581-2018; Shepherd, Robert/A-7081-2018; Mazzolai, Barbara/I-8876-2016; Totaro, Massimo/F-4746-2018; Totaro, Massimo/S-3817-2019	Li, Shuo/0000-0003-4913-730X; Shepherd, Robert/0000-0002-0631-9587; Mazzolai, Barbara/0000-0003-0722-8350; Totaro, Massimo/0000-0002-0630-7383; Totaro, Massimo/0000-0002-0630-7383; Beccai, Lucia/0000-0002-8754-5155	Army Research Office [W911NF-15-1-0464]; Air Force Office of Scientific Research [FA9550-15-1-0160]; NSF MRSEC program [DMR-1120296]; NSF Graduate Research Fellowship [DGE-1144153]	Army Research Office; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF MRSEC program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NSF Graduate Research Fellowship(National Science Foundation (NSF))	Data reported in the paper are included in the supplementary materials. This work was supported by the Army Research Office (grant no. W911NF-15-1-0464), the Air Force Office of Scientific Research (grant no. FA9550-15-1-0160), the NSF MRSEC program (DMR-1120296), and an NSF Graduate Research Fellowship (grant no. DGE-1144153). The hyperelastic electroluminescent capacitors presented in this work have been filed under a provisional patent application, no. 62/250,172 for Stretchable Electroluminescent Devices. The listed inventors are Chris Larson, Shuo Li, Bryan Peele, Sanlin Robinson, and Robert Shepherd.	ALFREY GF, 1955, P PHYS SOC LOND B, V68, P775, DOI 10.1088/0370-1301/68/10/310; Bai YY, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4898189; Barbosa A, 2012, P ROY SOC B-BIOL SCI, V279, P84, DOI 10.1098/rspb.2011.0196; Burrows PE, 2001, DISPLAYS, V22, P65, DOI 10.1016/S0141-9382(00)00064-0; Cotton DPJ, 2009, IEEE SENS J, V9, P2008, DOI 10.1109/JSEN.2009.2030709; Han TH, 2012, NAT PHOTONICS, V6, P105, DOI [10.1038/NPHOTON.2011.318, 10.1038/nphoton.2011.318]; Hu LB, 2010, ACS NANO, V4, P2955, DOI 10.1021/nn1005232; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; Keplinger C, 2013, SCIENCE, V341, P984, DOI 10.1126/science.1240228; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6747; Kitai A., 2008, LUMINESCENT MAT APPL, P249; Kreit E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0601; Liang JJ, 2013, NAT PHOTONICS, V7, P817, DOI [10.1038/NPHOTON.2013.242, 10.1038/nphoton.2013.242]; Morin SA, 2012, SCIENCE, V337, P828, DOI 10.1126/science.1222149; Park YL, 2012, IEEE SENS J, V12, P2711, DOI 10.1109/JSEN.2012.2200790; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/NMAT2459, 10.1038/nmat2459]; Shepherd RF, 2013, ADV MATER, V25, P6709, DOI 10.1002/adma.201303175; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Shin MK, 2010, ADV MATER, V22, P2663, DOI 10.1002/adma.200904270; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Spenko MJ, 2008, J FIELD ROBOT, V25, P223, DOI 10.1002/rob.20238; Sun JY, 2014, ADV MATER, V26, P7608, DOI 10.1002/adma.201403441; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Wang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5899; White MS, 2013, NAT PHOTONICS, V7, P811, DOI [10.1038/NPHOTON.2013.188, 10.1038/nphoton.2013.188]; Yu CJ, 2014, P NATL ACAD SCI USA, V111, P12998, DOI 10.1073/pnas.1410494111	31	857	880	93	1349	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1071	1074		10.1126/science.aac5082	http://dx.doi.org/10.1126/science.aac5082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941316				2022-12-28	WOS:000371597500041
J	Fitz, NS; Reiner, PB				Fitz, Nicholas S.; Reiner, Peter B.			Time to expand the mind	NATURE			English	Editorial Material									[Fitz, Nicholas S.; Reiner, Peter B.] Univ British Columbia, Natl Core Neuroeth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Reiner, PB (corresponding author), Univ British Columbia, Natl Core Neuroeth, Vancouver, BC V5Z 1M9, Canada.	peter.reiner@ubc.ca						[Anonymous], 2004, REALITY RES CHILDREN; Atchley P, 2014, PSYCHOL LEARN MOTIV, V61, P133, DOI 10.1016/B978-0-12-800283-4.00004-6; Farah MJ, 2015, SCIENCE, V350, P379, DOI 10.1126/science.aad5893; Reiner P. B., 2015, THE NEUROETHICS BLOG; Weiser M., 1995, DESIGNING CALM TECHN	5	7	8	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S9	S9		10.1038/531S9a	http://dx.doi.org/10.1038/531S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2YW	26934526	Bronze			2022-12-28	WOS:000371211900004
J	Neuberger, D				Neuberger, David			Stop needless dispute of science in the courts	NATURE			English	Editorial Material									[Neuberger, David] UK Supreme Court, London, England		Neuberger, D (corresponding author), UK Supreme Court, London, England.	jackie.sears@supremecourt.uk							0	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					9	9		10.1038/531009a	http://dx.doi.org/10.1038/531009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2YW	26935661	Bronze			2022-12-28	WOS:000371211900013
J	Lingvay, I; Manghi, FP; Garcia-Hernandez, P; Norwood, P; Lehmann, L; Tarp-Johansen, MJ; Buse, JB				Lingvay, Ildiko; Perez Manghi, Federico; Garcia-Hernandez, Pedro; Norwood, Paul; Lehmann, Lucine; Tarp-Johansen, Mads Jeppe; Buse, John B.		DUAL V Investigators	Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes The DUAL V Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BASAL INSULIN; COMBINATION; LIRAGLUTIDE; MANAGEMENT; THERAPY	IMPORTANCE Achieving glycemic control remains a challenge for patients with type 2 diabetes, even with insulin therapy. OBJECTIVE To assess whether a fixed ratio of insulin degludec/liraglutide was noninferior to continued titration of insulin glargine in patients with uncontrolled type 2 diabetes treated with insulin glargine and metformin. DESIGN, SETTING, AND PARTICIPANTS Phase 3, multinational, multicenter, 26-week, randomized, open-label, 2-group, treat-to-target trial conducted at 75 centers in 10 countries from September 2013 to November 2014 among 557 patients with uncontrolled diabetes treated with glargine (20-50 U) and metformin mg/d) with glycated hemoglobin (HbA(1c)) levels of 7% to 10% and a body mass index of 40 or lower. INTERVENTIONS 1:1 randomization to degludec/liraglutide (n = 278; maximum dose, 50 U of degludec/1.8 mg of liraglutide) or glargine (n = 279; no maximum dose), with twice-weekly titration to a glucose target of 72 to 90 mg/dL. MAIN OUTCOMES AND MEASURES Primary outcome measure was change in HbA(1c) level after 26 weeks, with a noninferiority margin of 0.3% (upper bound of 95% CI, <0.3%). If noninferiority of degludec/liraglutide was achieved, secondary end points were tested for statistical superiority and included change in HbA(1c) level, change in body weight, and rate of confirmed hypoglycemic episodes. RESULTS Among 557 randomized patients (mean; age, 58.8 years; women, 49.7%), 92.5% of patients completed the trial and provided data at 26 weeks. Baseline HbA(1c) level was 8.4% for the degludec/liraglutide group and 8.2% for the glargine group. HbA(1c) level reduction was greater with degludec/liraglutide vs glargine (-1.81% for the degludec/liraglutide group vs-1.13% for the glargine group; estimated treatment difference [ETD],-0.59% [95% CI,-0.74% to -0.45%]), meeting criteria for noninferiority (P < .001), and also meeting criteria for statistical superiority (P < .001). Treatment with degludec/liraglutide was also associated with weight loss compared with weight gain with glargine (-1.4 kg for degludec/liraglutide vs 1.8 kgfor glargine; ETD, -3.20 kg [95% Cl, -3.77 to -2.64], P < .001) and fewer confirmed hypoglycemic episodes (episodes/patient-year exposure, 2.23 for degludec/liraglutide vs 5.05 for glargine; estimated rate ratio, 0.43 [95% CI, 0.30 to 0.61] P < .001). Overall and serious adverse event rates were similar in the 2 groups, except for more nonserious gastrointestinal adverse events reported with degludec/liraglutide (adverse events, 79 for degludec/liraglutide vs 18 for glargine). CONCLUSIONS AND RELEVANCE Among patients with uncontrolled type 2 diabetes taking glargine and metformin, treatment with degludec/liraglutide compared with up-titration of glargine resulted in noninferior HbA(1c) levels, with secondary analyses indicating greater HbA(1c) level reduction after 26 weeks of treatment. Further studies are needed to assess longer-term efficacy and safety.	[Lingvay, Ildiko] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Lingvay, Ildiko] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Perez Manghi, Federico] Ctr Invest Metab, Buenos Aires, DF, Argentina; [Garcia-Hernandez, Pedro] Hosp Univ Monterrey Dr Jose Eleuterio Gonzalez, Serv Endocrinol, Monterrey, Nuevo Leon, Mexico; [Norwood, Paul] Valley Res, Fresno, CA USA; [Lehmann, Lucine; Tarp-Johansen, Mads Jeppe] Novo Nordisk AS, Soborg, Denmark; [Buse, John B.] Univ N Carolina, Sch Med, 160 Dent Cir,CB 7172,Burnett Womack 8027, Chapel Hill, NC 27599 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Novo Nordisk; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Buse, JB (corresponding author), Univ N Carolina, Sch Med, 160 Dent Cir,CB 7172,Burnett Womack 8027, Chapel Hill, NC 27599 USA.	jbuse@med.unc.edu	Klimontov, Vadim/R-7689-2017; Nedogoda, Sergey V/O-4656-2014; Merino-Torres, Juan F/T-8698-2018; Buse, John Bernard/J-9742-2019; Norwood, Paul/L-6088-2019; Tigas, Stelios/H-9478-2019	Klimontov, Vadim/0000-0002-5407-8722; Nedogoda, Sergey V/0000-0001-5981-1754; Merino-Torres, Juan F/0000-0002-0191-4504; Buse, John Bernard/0000-0002-9723-3876; Tigas, Stelios/0000-0001-7325-8983; TOFE, SANTIAGO/0000-0003-3034-4667	Novo Nordisk	Novo Nordisk(Novo Nordisk)	This study was funded by Novo Nordisk.	Abdi H., 2010, ENCY RES DESIGN; Blak BT, 2012, DIABETIC MED, V29, pE13, DOI 10.1111/j.1464-5491.2012.03586.x; Buse JB, 2014, DIABETES CARE, V37, P2926, DOI 10.2337/dc14-0785; Carver C, 2006, DIABETES EDUCATOR, V32, P910, DOI 10.1177/0145721706294259; Clinicaltrials.gov, CLIN TRIAL COMP EFF; Cuddihy RM, 2011, DIABETES EDUCATOR, V37, P111, DOI 10.1177/0145721710388426; Curtis Bradley, 2014, J Med Econ, V17, P21, DOI 10.3111/13696998.2013.862538; Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0; European Medicines Agency, GUID CLIN INV MED PR; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Keene ON, 2014, PHARM STAT, V13, P258, DOI 10.1002/pst.1624; Koch GG, 2008, STAT MED, V27, P333, DOI 10.1002/sim.2923; Kunt T, 2009, INT J CLIN PRACT, V63, P6, DOI 10.1111/j.1742-1241.2009.02176.x; Liu FP, 2015, J DIABETES, V7, P322, DOI 10.1111/1753-0407.12200; Luo JX, 2013, PHARM STAT, V12, P233, DOI 10.1002/pst.1576; OKelly M, 2014, STAT PRACT, P1, DOI 10.1002/9781118762516; Peyrot M, 2012, DIABETIC MED, V29, P682, DOI 10.1111/j.1464-5491.2012.03605.x; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; US Department of Health and Human Services, GUID IND DIAB MELL D; Vijan S, 2005, J GEN INTERN MED, V20, P479, DOI 10.1111/j.1525-1497.2005.0117.x; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	21	129	140	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					898	907		10.1001/jama.2016.1252	http://dx.doi.org/10.1001/jama.2016.1252			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934259	Bronze			2022-12-28	WOS:000371077500020
J	Li, YJ; Han, JM; Zhang, YB; Cao, F; Liu, ZJ; Li, S; Wu, J; Hu, CY; Wang, Y; Shuai, J; Chen, J; Cao, LR; Li, DS; Shi, P; Tian, CL; Zhang, J; Dou, YL; Li, GH; Chen, Y; Lei, M				Li, Yanjing; Han, Jianming; Zhang, Yuebin; Cao, Fang; Liu, Zhijun; Li, Shuai; Wu, Jian; Hu, Chunyi; Wang, Yan; Shuai, Jin; Chen, Juan; Cao, Liaoran; Li, Dangsheng; Shi, Pan; Tian, Changlin; Zhang, Jian; Dou, Yali; Li, Guohui; Chen, Yong; Lei, Ming			Structural basis for activity regulation of MLL family methyltransferases	NATURE			English	Article							LINEAGE LEUKEMIA PROTEIN-1; HISTONE-MODIFYING GENES; H3K4 METHYLATION; SET1 FAMILY; EXPRESSION; COMPLEX; DOMAIN; RBBP5; ACTIVATION; CHROMATIN	The mixed lineage leukaemia (MLL) family of proteins (including MLL1-MLL4, SET1A and SET1B) specifically methylate histone 3 Lys4, and have pivotal roles in the transcriptional regulation of genes involved in haematopoiesis and development. The methyltransferase activity of MLL1, by itself severely compromised, is stimulated by the three conserved factors WDR5, RBBP5 and ASH2L, which are shared by all MLL family complexes. However, the molecular mechanism of how these factors regulate the activity of MLL proteins still remains poorly understood. Here we show that a minimized human RBBP5-ASH2L heterodimer is the structural unit that interacts with and activates all MLL family histone methyltransferases. Our structural, biochemical and computational analyses reveal a two-step activation mechanism of MLL family proteins. These findings provide unprecedented insights into the common theme and functional plasticity in complex assembly and activity regulation of MLL family methyltransferases, and also suggest a universal regulation mechanism for most histone methyltransferases.	[Li, Yanjing; Han, Jianming; Liu, Zhijun; Wu, Jian; Hu, Chunyi; Wang, Yan; Shuai, Jin; Chen, Juan; Chen, Yong; Lei, Ming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai,State Key Lab Mol Biol, 333 Haike Rd, Shanghai 201210, Peoples R China; [Li, Yanjing; Han, Jianming; Liu, Zhijun; Wu, Jian; Hu, Chunyi; Wang, Yan; Shuai, Jin; Chen, Juan; Chen, Yong; Lei, Ming] Chinese Acad Sci, Shanghai Sci Res Ctr, Shanghai 201204, Peoples R China; [Zhang, Yuebin; Cao, Liaoran; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian 116023, Liaoning, Peoples R China; [Cao, Fang; Dou, Yali] Univ Michigan, Dept Pathol, Sch Med, 1301 Catherine, Ann Arbor, MI 48109 USA; [Li, Shuai; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai 200025, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China; [Shi, Pan; Tian, Changlin] Chinese Acad Sci, High Field Magnet Lab, Hefei 230031, Peoples R China; [Tian, Changlin] Univ Sci & Technol China, Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of Michigan System; University of Michigan; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Chen, Y; Lei, M (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai,State Key Lab Mol Biol, 333 Haike Rd, Shanghai 201210, Peoples R China.; Chen, Y; Lei, M (corresponding author), Chinese Acad Sci, Shanghai Sci Res Ctr, Shanghai 201204, Peoples R China.; Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian 116023, Liaoning, Peoples R China.	ghli@dicp.ac.cn; yongchen@sibcb.ac.cn; leim@sibcb.ac.cn	Chen, Yong/AAF-9915-2020; Zhang, Jian/GXA-1303-2022	Chen, Yong/0000-0001-5857-6086; Zhang, Jian/0000-0002-6558-791X; Hu, Chunyi/0000-0003-4509-4840	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010201, XDB08030302]; Ministry of Science and Technology of China [2013CB910402, 2013CB910401, 2012AA01A305, 2012CB721002, 2011CB910400]; National Science and Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China [2014ZX09507002-005]; National Natural Science Foundation of China [31330040, 31470737, 91430110]; Basic Research Project of Shanghai Science and Technology Commission [14JC1407200]; National Institutes of Health [R01 GM082856]; Fundamental Research for the Central University [WK2340000064]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082856] Funding Source: NIH RePORTER	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research for the Central University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank staffs of beamlines BL18U, BL19U1 and 17U at the National Center for Protein Sciences Shanghai and Shanghai Synchrotron Radiation Facility for their assistance in data collection. We are grateful to protein expression, protein purification and mass spectrometry facilities at the National Center for Protein Sciences Shanghai for their instrument support and technical assistance. This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08010201 to M.L. and Y.C., XDB08030302 to C.T.), the Ministry of Science and Technology of China (2013CB910402 to M.L., 2013CB910401 to Y.C., 2012AA01A305 and 2012CB721002 to G.L., 2011CB910400 to C.T.), the National Science and Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China (2014ZX09507002-005 to M.L.), the National Natural Science Foundation of China (31330040 to M.L., 31470737 to Y.C., and 91430110 to G.L.), the Basic Research Project of Shanghai Science and Technology Commission (14JC1407200 to Y.C.), the National Institutes of Health (R01 GM082856 to Y.D.), and Fundamental Research for the Central University (WK2340000064 to C.T.). Y.C. is a recipient of the Thousand Young Talents Program of the Chinese government.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Ansari KI, 2009, FRONT BIOSCI-LANDMRK, V14, P3483, DOI 10.2741/3466; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chen Y, 2012, CELL RES, V22, P598, DOI 10.1038/cr.2012.9; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dou YL, 2008, INT J HEMATOL, V87, P10, DOI 10.1007/s12185-007-0009-8; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gan Q, 2011, J BIOL CHEM, V286, P21853, DOI 10.1074/jbc.M111.233098; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Li Y, 2011, HUM GENET, V130, P715, DOI 10.1007/s00439-011-1004-y; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Odho Z, 2010, J BIOL CHEM, V285, P32967, DOI 10.1074/jbc.M110.159921; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shi P, 2011, PROTEIN SCI, V20, P224, DOI 10.1002/pro.545; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shinsky SA, 2015, J BIOL CHEM, V290, P25819, DOI 10.1074/jbc.M115.684142; Shinsky SA, 2015, J BIOL CHEM, V290, P6361, DOI 10.1074/jbc.M114.627646; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhang P, 2015, GENE DEV, V29, P123, DOI 10.1101/gad.254870.114; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhang Y, 2015, STRUCTURE, V23, P1921, DOI 10.1016/j.str.2015.07.018	41	125	130	5	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					447	+		10.1038/nature16952	http://dx.doi.org/10.1038/nature16952			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26886794	Green Accepted			2022-12-28	WOS:000370690800028
J	Olenchock, BA; Moslehi, J; Baik, AH; Davidson, SM; Williams, J; Gibson, WJ; Pierce, KA; Miller, CM; Hanse, EA; Kelekar, A; Sullivan, LB; Wagers, AJ; Clish, CB; Vander Heiden, MG; Kaelin, WG				Olenchock, Benjamin A.; Moslehi, Javid; Baik, Alan H.; Davidson, Shawn M.; Williams, Jeremy; Gibson, William J.; Pierce, Kerry A.; Miller, Christine M.; Hanse, Eric A.; Kelekar, Ameeta; Sullivan, Lucas B.; Wagers, Amy J.; Clish, Clary B.; Vander Heiden, Matthew G.; Kaelin, William G., Jr.			EGLN1 Inhibition and Rerouting of alpha-Ketoglutarate Suffice for Remote Ischemic Protection	CELL			English	Article							REDUCTIVE GLUTAMINE-METABOLISM; PROLYL HYDROXYLASE-ACTIVITY; MYOCARDIAL-INFARCTION; HYPOXIA; HEART; 4-HYDROXYLASE; ALTERS; ERYTHROPOIETIN; EXPRESSION; PROFILES	Ischemic preconditioning is the phenomenon whereby brief periods of sublethal ischemia protect against a subsequent, more prolonged, ischemic insult. In remote ischemic preconditioning (RIPC), ischemia to one organ protects others organs at a distance. We created mouse models to ask if inhibition of the alpha-ketoglutarate (alpha KG)-dependent dioxygenase Egln1, which senses oxygen and regulates the hypoxia-inducible factor (HIF) transcription factor, could suffice to mediate local and remote ischemic preconditioning. Using somatic gene deletion and a pharmacological inhibitor, we found that inhibiting Egln1 systemically or in skeletal muscles protects mice against myocardial ischemia-reperfusion (I/R) injury. Parabiosis experiments confirmed that RIPC in this latter model was mediated by a secreted factor. Egln1 loss causes accumulation of circulating alpha KG, which drives hepatic production and secretion of kynurenic acid (KYNA) that is necessary and sufficient to mediate cardiac ischemic protection in this setting.	[Olenchock, Benjamin A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Olenchock, Benjamin A.; Gibson, William J.; Kaelin, William G., Jr.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Olenchock, Benjamin A.; Davidson, Shawn M.; Sullivan, Lucas B.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Moslehi, Javid] Vanderbilt Univ Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37235 USA; [Baik, Alan H.] Univ San Francisco, Dept Med, San Francisco, CA 94117 USA; [Williams, Jeremy; Gibson, William J.; Vander Heiden, Matthew G.; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Pierce, Kerry A.; Clish, Clary B.] Broad Inst, Metabol Platform, Cambridge, MA 02142 USA; [Miller, Christine M.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Miller, Christine M.; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Hanse, Eric A.; Kelekar, Ameeta] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Hanse, Eric A.; Kelekar, Ameeta] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Vanderbilt University; University of San Francisco; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Kaelin, WG (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	william_kaelin@dfci.harvard.edu	Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021	Clish, Clary B/0000-0001-8259-9245; Hanse, Eric/0000-0002-1234-0198; Sullivan, Lucas/0000-0002-6745-8222	NIH [K08 HL119355, K08 HL097031, UO1 HL100402, R01 CA157971]; Gilead Sciences Research Scholars Program in Cardiovascular Disease; Heart Failure Society of America Research Fellowship; Watkins Cardiovascular Discovery Award; Sarnoff Cardiovascular Research Foundation; Broad Institute SPARC program; Burrough's Wellcome Fund; F31 award [CA177119]; Fibrogen, Inc.; NATIONAL CANCER INSTITUTE [F31CA177119, R01CA068490, R01CA157971, F30CA192725, T32CA009361] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL097031, U01HL100402, K08HL119355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences Research Scholars Program in Cardiovascular Disease; Heart Failure Society of America Research Fellowship; Watkins Cardiovascular Discovery Award; Sarnoff Cardiovascular Research Foundation; Broad Institute SPARC program; Burrough's Wellcome Fund(Burroughs Wellcome Fund); F31 award; Fibrogen, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Gerald Wogan, Laura Trudel, and Luiz Godoy for measuring nitrite, Rongli Lao and Souen Ngoy (Brigham and Women's Hospital, BWH) for help with cardiac I/R injury studies, Tom Cooper (Baylor College of Medicine) for the HSA-Cre<SUP>ER</SUP> mice and Lee Flippin and Michael Arend (Fibrogen) for FG-4497. B.A.O. was supported by NIH K08 HL119355 and the Gilead Sciences Research Scholars Program in Cardiovascular Disease. J.M. was supported by NIH K08 HL097031, Heart Failure Society of America Research Fellowship, and the Watkins Cardiovascular Discovery Award (BWH). A.H.B. was supported by a grant from the Sarnoff Cardiovascular Research Foundation. A.J.W. received grant support from NIH UO1 HL100402. M.G.V.H. was supported by the Broad Institute SPARC program and the Burrough's Wellcome Fund. A.J.W. was supported by a grant from the NIH. A.K. was funded by NIH R01 CA157971, E.A.H. by F31 award (CA177119). W.G.K. was supported by grants from the NIH and is an HHMI Investigator. W.G.K. has a financial interest in Fibrogen, Inc., which is developing EGLN inhibitors for treating anemia and ischemic diseases.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; Avanesov AS, 2014, ELIFE, V3, DOI 10.7554/eLife.02077; Bao WK, 2010, J CARDIOVASC PHARM, V56, P147, DOI 10.1097/FJC.0b013e3181e2bfef; Bekeredjian R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011693; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Cai ZQ, 2013, P NATL ACAD SCI USA, V110, P17462, DOI 10.1073/pnas.1317158110; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Coulet F, 2003, J BIOL CHEM, V278, P46230, DOI 10.1074/jbc.M305420200; Davies WR, 2013, CIRC-CARDIOVASC INTE, V6, P246, DOI 10.1161/CIRCINTERVENTIONS.112.000184; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; GERMANO IM, 1987, ANN NEUROL, V22, P730, DOI 10.1002/ana.410220609; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Holscher M, 2011, J BIOL CHEM, V286, P11185, DOI 10.1074/jbc.M110.186809; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kalakech H, 2013, J MOL CELL CARDIOL, V65, P98, DOI 10.1016/j.yjmcc.2013.10.001; KLONER RA, 1995, CIRCULATION, V91, P37, DOI 10.1161/01.CIR.91.1.37; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Kottenberg E, 2014, J THORAC CARDIOV SUR, V147, P376, DOI 10.1016/j.jtcvs.2013.01.005; Kummitha CM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12159; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Liao RL, 2012, AM J PHYSIOL-HEART C, V303, pH156, DOI 10.1152/ajpheart.00333.2012; Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Moslehi J, 2010, CIRCULATION, V122, P1004, DOI 10.1161/CIRCULATIONAHA.109.922427; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27; Nwogu JI, 2001, CIRCULATION, V104, P2216, DOI 10.1161/hc4301.097193; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Przyklenk K, 2013, ANESTH ANALG, V117, P891, DOI 10.1213/ANE.0b013e318294fc63; Pundir M, 2013, J SURG RES, V183, P668, DOI 10.1016/j.jss.2013.01.040; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Ronkainen VP, 2014, CARDIOVASC RES, V101, P69, DOI 10.1093/cvr/cvt226; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Schuler M, 2005, GENESIS, V41, P165, DOI 10.1002/gene.20107; STOLL B, 1989, EUR J BIOCHEM, V181, P709, DOI 10.1111/j.1432-1033.1989.tb14781.x; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	57	80	83	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					884	895		10.1016/j.cell.2016.02.006	http://dx.doi.org/10.1016/j.cell.2016.02.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919427	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000370867300013
J	Derry, S; Wiffen, P; Moore, A				Derry, Sheena; Wiffen, Philip; Moore, Andrew			Topical Nonsteroidal Anti- inflammatory Drugs for AcuteMusculoskeletal Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Are topical nonsteroidal anti-inflammatory drugs (NSAIDs) associated with reduced pain intensity in acute musculoskeletal conditions, but without increased adverse events? BOTTOM LINE When treating musculoskeletal conditions such as sprains, strains, and contusions, topical NSAIDs are associated with greater pain relief, but are not associated with an increase in adverse events compared with placebo.	Univ Oxford, Pain Res, Oxford, England; Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England	University of Oxford; University of Oxford	Derry, S (corresponding author), Churchill Hosp, Pain Res, Oxford OX3 7LE, England.	sheena.derry@ndcn.ox.ac.uk	Wiffen, Philip/GNP-1768-2022		Reckitt Benckiser; Menarini	Reckitt Benckiser; Menarini(Menarini Group)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported. Dr Moore reported receiving a grant and personal fees from Reckitt Benckiser and personal fees from Menarini. No other disclosures were reported.	Derry S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007402.pub3; Massey T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007402.pub2; Moore RA, 2013, ANAESTHESIA, V68, P400, DOI 10.1111/anae.12148; National Institute for Health and Care Excellence, CLIN KNOWL SUMM SPRA; Roosen P, ANKLE SPRAINS DIAGNO	5	11	12	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					813	814		10.1001/jama.2016.0249	http://dx.doi.org/10.1001/jama.2016.0249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903340				2022-12-28	WOS:000370700500017
J	Levin, M; Anavy, L; Cole, AG; Winter, E; Mostov, N; Khair, S; Senderovich, N; Kovalev, E; Silver, DH; Feder, M; Fernandez-Valverde, SL; Nakanishi, N; Simmons, D; Simakov, O; Larsson, T; Liu, SY; Jerafi-Vider, A; Yaniv, K; Ryan, JF; Martindale, MQ; Rink, JC; Arendt, D; Degnan, SM; Degnan, BM; Hashimshony, T; Yanai, I				Levin, Michal; Anavy, Leon; Cole, Alison G.; Winter, Eitan; Mostov, Natalia; Khair, Sally; Senderovich, Naftalie; Kovalev, Ekaterina; Silver, David H.; Feder, Martin; Fernandez-Valverde, Selene L.; Nakanishi, Nagayasu; Simmons, David; Simakov, Oleg; Larsson, Tomas; Liu, Shang-Yun; Jerafi-Vider, Ayelet; Yaniv, Karina; Ryan, Joseph F.; Martindale, Mark Q.; Rink, Jochen C.; Arendt, Detlev; Degnan, Sandie M.; Degnan, Bernard M.; Hashimshony, Tamar; Yanai, Itai			The mid-developmental transition and the evolution of animal body plans	NATURE			English	Article							GENE-EXPRESSION; RNA-SEQ; ALIGNMENT; ORIGIN	Animals are grouped into similar to 35 'phyla' based upon the notion of distinct body plans(1-4). Morphological and molecular analyses have revealed that a stage in the middle of development-known as the phylotypic period-is conserved among species within some phyla(5-9). Although these analyses provide evidence for their existence, phyla have also been criticized as lacking an objective definition, and consequently based on arbitrary groupings of animals(10). Here we compare the developmental transcriptomes of ten species, each annotated to a different phylum, with a wide range of life histories and embryonic forms. We find that in all ten species, development comprises the coupling of early and late phases of conserved gene expression. These phases are linked by a divergent 'mid-developmental transition' that uses species-specific suites of signalling pathways and transcription factors. This mid-developmental transition overlaps with the phylotypic period that has been defined previously for three of the ten phyla, suggesting that transcriptional circuits and signalling mechanisms active during this transition are crucial for defining the phyletic body plan and that the mid-developmental transition may be used to define phylotypic periods in other phyla. Placing these observations alongside the reported conservation of mid-development within phyla, we propose that a phylum may be defined as a collection of species whose gene expression at the mid-developmental transition is both highly conserved among them, yet divergent relative to other species.	[Levin, Michal; Anavy, Leon; Cole, Alison G.; Winter, Eitan; Mostov, Natalia; Khair, Sally; Senderovich, Naftalie; Kovalev, Ekaterina; Silver, David H.; Feder, Martin; Hashimshony, Tamar; Yanai, Itai] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Fernandez-Valverde, Selene L.; Nakanishi, Nagayasu; Degnan, Sandie M.; Degnan, Bernard M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Simmons, David; Ryan, Joseph F.; Martindale, Mark Q.] Univ Florida, Whitney Lab Marine Biosci, 9505 N Ocean Shore Blvd, St Augustine, FL 32080 USA; [Simakov, Oleg; Larsson, Tomas; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany; [Liu, Shang-Yun; Rink, Jochen C.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Jerafi-Vider, Ayelet; Yaniv, Karina] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Levin, Michal] Univ Med Ctr Mainz, CTH, Mainz, Germany; [Fernandez-Valverde, Selene L.] IPN, Ctr Invest Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Nakanishi, Nagayasu] Univ Florida, Whitney Lab Marine Biosci, 9505 N,Ocean Shore Blvd, St Augustine, FL 32080 USA	Technion Israel Institute of Technology; University of Queensland; State University System of Florida; University of Florida; European Molecular Biology Laboratory (EMBL); Max Planck Society; Weizmann Institute of Science; Johannes Gutenberg University of Mainz; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; State University System of Florida; University of Florida	Yanai, I (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	yanai@technion.ac.il	Cole, Alison G./J-8436-2019; Degnan, Sandie/G-7338-2012; Fernandez-Valverde, Selene Lizbeth/AAF-4949-2019; Simakov, Oleg/AAV-2494-2020; Simakov, Oleg/G-4572-2015	Cole, Alison G./0000-0002-7515-7489; Degnan, Sandie/0000-0001-8003-0426; Fernandez-Valverde, Selene Lizbeth/0000-0002-9020-1716; Simakov, Oleg/0000-0002-3585-4511; Simakov, Oleg/0000-0002-3585-4511; Levin, Michal/0000-0003-3484-890X; Yanai, Itai/0000-0002-8438-2741; Silver, David/0000-0002-3071-304X; Degnan, Bernard/0000-0001-7573-8518; Ryan, Joseph/0000-0001-5478-0522; Anavy, Leon/0000-0002-6681-7377	European Research Council grant (EvoDevoPaths); EMBO Young Investigator Program; Australian Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093116] Funding Source: NIH RePORTER	European Research Council grant (EvoDevoPaths); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Rockman and B. de Bivort for helpful discussions. We also thank U. Gat, A. Salzberg, S. B. Tabou De Leon, M. Blaxter, G. Koutsovoulos, S. Mansour, and B. Goldstein for materials and reagents. We thank the Technion Genome Center for technical assistance and the Radcliffe Institute for Advanced Studies at Harvard University for hosting the analysis phase. This work was supported by a European Research Council grant (EvoDevoPaths), the EMBO Young Investigator Program, and a grant from the Australian Research Council.	Abzhanov A, 2013, TRENDS GENET, V29, P712, DOI 10.1016/j.tig.2013.09.004; Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anavy L, 2014, DEVELOPMENT, V141, P1161, DOI 10.1242/dev.105288; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; BALLARD WW, 1981, AM ZOOL, V21, P391; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boothby TC, 2015, P NATL ACAD SCI USA, V112, P15976, DOI 10.1073/pnas.1510461112; Cardona A, 2006, DEV GENES EVOL, V216, P667, DOI 10.1007/s00427-006-0094-3; Darwin Charles, 1859, ORIGIN SPECIES MEANS; Davidson EH, 2006, REG GEN GEN REG; Detrich H. W., 2009, ESSENTIAL ZEBRAFISH; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fischer AHL, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-31; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gould S. J., 1977, ONTOGENY PHYLOGENY; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haeckel E., 1879, THE EVOLUTION OF MAN, V1; Hashimshony T, 2015, NATURE, V519, P219, DOI 10.1038/nature13996; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Joshi N.A., 2011, SICKLE SLIDING WINDO; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kiehart D. P., 2007, COLD SPRING HARB PRO; Koutsovoulos G., 2015, PREPRINT; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Martin-Duran JM, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-7; Martin-Duran JM, 2010, DEV BIOL, V340, P145, DOI 10.1016/j.ydbio.2010.01.018; Martin-Duran JM, 2008, J EXP ZOOL PART B, V310B, P668, DOI 10.1002/jez.b.21243; Pang K., 2008, COLD SPRING HARB PRO; PATEL NH, 1994, SCIENCE, V266, P581, DOI 10.1126/science.7939712; Raff R. A., 1996, SHAPE LIFE GENES DEV; Richardson MK, 1999, BIOESSAYS, V21, P604, DOI 10.1002/(SICI)1521-1878(199907)21:7<604::AID-BIES9>3.0.CO;2-U; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Sander K., 1983, DEV EVOLUTION, P137; Scholtz G, 2004, CRUSTACEAN ISS, V15, P3; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Slack J. M. W., 2003, KEYWORDS CONCEPTS EV, P476; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Sullivan JC, 2008, NUCLEIC ACIDS RES, V36, pD607, DOI 10.1093/nar/gkm941; VALENTINE JW, 2004, ORIGIN PHYLA; Vince B., 2011, SCYTHE BAYESIAN ADAP	52	141	142	0	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					637	+		10.1038/nature16994	http://dx.doi.org/10.1038/nature16994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	26886793	Green Accepted			2022-12-28	WOS:000373027400038
J	Lough, JM				Lough, Janice M.			CORAL REEFS Turning back time	NATURE			English	Editorial Material							OCEAN ACIDIFICATION; CARBON-DIOXIDE		[Lough, Janice M.] James Cook Univ, Australian Inst Marine Sci, Townsville, Qld 4811, Australia; [Lough, Janice M.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	Australian Institute of Marine Science; James Cook University; James Cook University	Lough, JM (corresponding author), James Cook Univ, Australian Inst Marine Sci, Townsville, Qld 4811, Australia.; Lough, JM (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	j.lough@aims.gov.au	Lough, Janice M/L-1682-2013	Lough, Janice M/0000-0002-3789-1009				Albright R, 2016, NATURE, V531, P362, DOI 10.1038/nature17155; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Jiang LQ, 2015, GLOBAL BIOGEOCHEM CY, V29, P1656, DOI 10.1002/2015GB005198; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Lough JM, 2014, BIOL BULL-US, V226, P187, DOI 10.1086/BBLv226n3p187; Tierney JE, 2015, PALEOCEANOGRAPHY, V30, P226, DOI 10.1002/2014PA002717	10	6	6	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					314	315		10.1038/nature17302	http://dx.doi.org/10.1038/nature17302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26909580				2022-12-28	WOS:000372064300041
J	Topczewski, JJ; Cabrera, PJ; Saper, NI; Sanford, MS				Topczewski, Joseph J.; Cabrera, Pablo J.; Saper, Noam I.; Sanford, Melanie S.			Palladium-catalysed transannular C-H functionalization of alicyclic amines	NATURE			English	Article							C(SP(3))-H ARYLATION; BOND FUNCTIONALIZATION; ALIPHATIC-AMINES; ALPHA-ARYLATION; ACTIVATION; MOLECULES; ACID	Discovering pharmaceutical candidates is a resource-intensive enterprise that frequently requires the parallel synthesis of hundreds or even thousands of molecules. C-H bonds are present in almost all pharmaceutical agents. Consequently, the development of selective, rapid and efficient methods for converting these bonds into new chemical entities has the potential to streamline pharmaceutical development(1-4). Saturated nitrogen-containing heterocycles (alicyclic amines) feature prominently in pharmaceuticals, such as treatments for depression (paroxetine, amitifadine), diabetes (gliclazide), leukaemia (alvocidib), schizophrenia (risperidone, belaperidone), malaria (mefloquine) and nicotine addiction (cytisine, varenicline)(5). However, existing methods for the C-H functionalization of saturated nitrogen heterocycles, particularly at sites remote to nitrogen, remain extremely limited(6,7). Here we report a transannular approach to selectively manipulate the C-H bonds of alicyclic amines at sites remote to nitrogen. Our reaction uses the boat conformation of the substrates to achieve palladium-catalysed amine-directed conversion of C-H bonds to C-C bonds on various alicyclic amine scaffolds. We demonstrate this approach by synthesizing new derivatives of several bioactive molecules, including varenicline.	[Topczewski, Joseph J.; Cabrera, Pablo J.; Saper, Noam I.; Sanford, Melanie S.] Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sanford, MS (corresponding author), Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA.	mssanfor@umich.edu	Sanford, Melanie/G-8619-2016	Sanford, Melanie/0000-0001-9342-9436; Saper, Noam/0000-0001-6177-2432	NIH [F32 GM109479]; NIGMS grant [GM073836]; NSF [CHE-0840456]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM109479, R01GM073836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS grant; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge J. W. Kampf for X-ray crystallographic analyses of 4a, 11b, an analogue of 11g, 11h and 14a. J. T. T. was supported by an NIH post-doctoral fellowship (F32 GM109479). This work was supported by NIGMS grant GM073836. We acknowledge funding from NSF grant CHE-0840456 for X-ray instrumentation.	Affron DP, 2014, ORG LETT, V16, P4956, DOI 10.1021/ol502511g; ASENSIO G, 1993, J AM CHEM SOC, V115, P7250, DOI 10.1021/ja00069a025; Beer B, 2004, J CLIN PHARMACOL, V44, P1360, DOI 10.1177/0091270004269560; Bercaw JE, 2009, ORGANOMETALLICS, V28, P5017, DOI 10.1021/om900240a; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Cui W, 2014, ORG LETT, V16, P4288, DOI 10.1021/ol502011k; EPSTEIN JW, 1981, J MED CHEM, V24, P481, DOI 10.1021/jm00137a002; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P2112, DOI 10.1002/anie.200462884; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; He J, 2014, SCIENCE, V343, P1216, DOI 10.1126/science.1249198; He J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6943; Hirsch J. A., 1967, TOP STEREOCHEM, V3, P199, DOI [10.1002/9780470147108.ch4, DOI 10.1002/9780470147108.CH4]; Juaristi E., 1995, CONFORMATIONAL BEHAV; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Lee M, 2015, J AM CHEM SOC, V137, P12796, DOI 10.1021/jacs.5b09099; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; McMurray L, 2011, CHEM SOC REV, V40, P1885, DOI 10.1039/c1cs15013h; McNally A, 2014, NATURE, V510, P129, DOI 10.1038/nature13389; Mitchell EA, 2012, CHEM-EUR J, V18, P10092, DOI 10.1002/chem.201201539; Nadres ET, 2013, J ORG CHEM, V78, P9689, DOI 10.1021/jo4013628; Pastine SJ, 2006, J AM CHEM SOC, V128, P14220, DOI 10.1021/ja064481j; Rouquet G, 2013, ANGEW CHEM INT EDIT, V52, P11726, DOI 10.1002/anie.201301451; Shi L, 2012, CHEM SOC REV, V41, P7687, DOI 10.1039/c2cs35203f; Singer RA, 2004, ORG LETT, V6, P2357, DOI 10.1021/ol049316s; Spangler JE, 2015, J AM CHEM SOC, V137, P11876, DOI 10.1021/jacs.5b06740; Taylor RD, 2014, J MED CHEM, V57, P5845, DOI 10.1021/jm4017625; Wasa M, 2012, J AM CHEM SOC, V134, P18570, DOI 10.1021/ja309325e; Wencel-Delord J, 2013, NAT CHEM, V5, P369, DOI 10.1038/nchem.1607; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Zaitsev VG, 2005, J AM CHEM SOC, V127, P13154, DOI 10.1021/ja054549f	30	222	225	7	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					220	224		10.1038/nature16957	http://dx.doi.org/10.1038/nature16957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26886789	Green Accepted			2022-12-28	WOS:000371665100038
J	Jin, XZ; Jones, G; Cicuttini, FM; Wluka, A; Zhu, ZH; Han, WY; Antony, B; Wang, X; Winzenberg, T; Blizzard, L; Ding, CH				Jin, Xingzhong; Jones, Graeme; Cicuttini, Flavia M.; Wluka, Anita; Zhu, Zhaohua; Han, Weiyu; Antony, Benny; Wang, Xia; Winzenberg, Tania; Blizzard, Leigh; Ding, Changhai			Effect of Vitamin D Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients With Symptomatic Knee Osteoarthritis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERUM-LEVELS; OLDER-ADULTS; PROGRESSION; CRITERIA; WOMAC; HIP; ASSOCIATION	IMPORTANCE Observational studies suggest that vitamin D supplementation is associated with benefits for knee osteoarthritis, but current trial evidence is contradictory. OBJECTIVE To compare the effects of vitamin D supplementation vs placebo on knee pain and knee cartilage volume in patients with symptomatic knee osteoarthritis and low vitamin D levels. DESIGN, SETTING, AND PARTICIPANTS A multicenter randomized, double-blind, placebo-controlled clinical trial in Tasmania and Victoria, Australia. Participants with symptomatic knee osteoarthritis and low 25-hydroxyvitamin D (12.5-60 nmol/L) were enrolled from June 2010 to December 2011. The trial was completed in December 2013. INTERVENTIONS Participants were randomly assigned to receive monthly treatment with oral vitamin D-3 (50 000 IU; n = 209) or an identical placebo (n = 204) for 2 years. MAIN OUTCOMES AND MEASURES Primary outcomeswere change in tibial cartilage volume (assessed using magnetic resonance imaging [MRI]) and change in the Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain score (0 [no pain] to 500 [worst pain]) from baseline to month 24. Secondary outcomes were cartilage defects and bone marrow lesions (assessed using MRI). RESULTS Of 413 enrolled participants (mean age, 63.2 years; 50% women), 340 (82.3%) completed the study. The level of 25-hydroxyvitamin D increased more in the vitamin D group (40.6 nmol/L) than in the placebo group (6.7 nmol/L) (P<.001) over 2 years. There were no significant differences in annual change of tibial cartilage volume orWOMAC pain score. There were no significant differences in change of tibiofemoral cartilage defects or change in tibiofemoral bone marrow lesions. Adverse events (>= 1 per patient) occurred in 56 participants in the vitamin D group and in 37 participants in the placebo group (P=.04). [GRAPHICS] CONCLUSIONS AND RELEVANCE Among patients with symptomatic knee osteoarthritis and low serum 25-hydroxyvitamin D levels, vitamin D supplementation, compared with placebo, did not result in significant differences in change in MRI-measured tibial cartilage volume or WOMAC knee pain score over 2 years. These findings do not support the use of vitamin D supplementation for preventing tibial cartilage loss or improving WOMAC knee pain in patients with knee osteoarthritis.	[Jin, Xingzhong; Jones, Graeme; Zhu, Zhaohua; Han, Weiyu; Antony, Benny; Wang, Xia; Winzenberg, Tania; Blizzard, Leigh; Ding, Changhai] Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia; [Cicuttini, Flavia M.; Wluka, Anita; Ding, Changhai] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Winzenberg, Tania] Univ Tasmania, Fac Hlth, Hobart, Tas 7000, Australia; [Ding, Changhai] Anhui Med Univ, Arthrit Res Inst, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Ding, Changhai] Anhui Med Univ, Dept Rheumatol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China	University of Tasmania; Menzies Institute for Medical Research; Monash University; University of Tasmania; Anhui Medical University; Anhui Medical University	Ding, CH (corresponding author), Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia.	changhai.ding@utas.edu.au	Wluka, Anita E/H-5349-2011; Zhu, Zhaohua/AAN-9717-2020; Zhu, Zhaohua/AAM-2254-2020; Wang, Xia/AFL-8460-2022; Jin, Xingzhong/I-4261-2013; Cicuttini, Flavia/H-4978-2014; Ding, Changhai/J-7730-2014	Wluka, Anita E/0000-0001-8024-9049; Zhu, Zhaohua/0000-0003-3913-2564; Wang, Xia/0000-0003-3172-9390; Jin, Xingzhong/0000-0003-4293-8665; Cicuttini, Flavia/0000-0002-8200-1618; Ding, Changhai/0000-0002-9479-730X; Winzenberg, Tania/0000-0002-4112-3491; Eathakkattu Antony, Benny Samuel/0000-0001-8704-6084	Australian National Health and Medical Research Council (NHMRC) [605501]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the Australian National Health and Medical Research Council (NHMRC) (project code 605501).	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Baysal O, 2004, SWISS MED WKLY, V134, P283; Bellamy N, 2005, ANN RHEUM DIS, V64, P881, DOI 10.1136/ard.2004.026443; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bellamy N, 2014, WOMAC OSTEOARTHRITIS; Bergink AP, 2009, JCR-J CLIN RHEUMATOL, V15, P230, DOI 10.1097/RHU.0b013e3181b08f20; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Cao YL, 2013, RHEUMATOLOGY, V52, P1323, DOI 10.1093/rheumatology/ket132; Cao YL, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-131; Chel V, 2008, OSTEOPOROSIS INT, V19, P663, DOI 10.1007/s00198-007-0465-2; Cicuttini FM, 2004, ANN RHEUM DIS, V63, P1124, DOI 10.1136/ard.2004.021253; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conaghan PG, 2011, OSTEOARTHR CARTILAGE, V19, P606, DOI 10.1016/j.joca.2011.02.018; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Ding CH, 2013, JAMA-J AM MED ASSOC, V309, P1583, DOI 10.1001/jama.2013.3775; Ding CH, 2013, CURR OPIN RHEUMATOL, V25, P127, DOI 10.1097/BOR.0b013e32835a0fe1; Ding C, 2009, ARTHRITIS RHEUM-US, V60, P1381, DOI 10.1002/art.24486; Eckstein F, 2007, OSTEOARTHR CARTILAGE, V15, P1326, DOI 10.1016/j.joca.2007.04.007; Goldzieher J W, 1999, Endocr Pract, V5, P229; Heidari B, 2011, INT ORTHOP, V35, P1627, DOI 10.1007/s00264-010-1186-2; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Jones G, 2000, ARTHRITIS RHEUM-US, V43, P2543, DOI 10.1002/1529-0131(200011)43:11<2543::AID-ANR23>3.0.CO;2-K; Kersten P, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-80; Laslett LL, 2014, ANN RHEUM DIS, V73, P697, DOI 10.1136/annrheumdis-2012-202831; McAlindon TE, 1996, ANN INTERN MED, V125, P353, DOI 10.7326/0003-4819-125-5-199609010-00001; McAlindon T, 2013, JAMA-J AM MED ASSOC, V309, P155, DOI 10.1001/jama.2012.164487; Muraki S, 2011, OSTEOARTHR CARTILAGE, V19, P1301, DOI 10.1016/j.joca.2011.07.017; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Sanghi D, 2013, CLIN ORTHOP RELAT R, V471, P3556, DOI 10.1007/s11999-013-3201-6; Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567; Wigg AER, 2006, MED J AUSTRALIA, V185, P195, DOI 10.5694/j.1326-5377.2006.tb00530.x; Wluka A, 2002, ARTHRITIS RHEUM-US, V46, P2065, DOI 10.1002/art.10460; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	36	115	124	2	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					1005	1013		10.1001/jama.2016.1961	http://dx.doi.org/10.1001/jama.2016.1961			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954409	Bronze			2022-12-28	WOS:000371540200013
J	Patel, RM; Knezevic, A; Shenvi, N; Hinkes, M; Keene, S; Roback, JD; Easley, KA; Josephson, CD				Patel, Ravi M.; Knezevic, Andrea; Shenvi, Neeta; Hinkes, Michael; Keene, Sarah; Roback, John D.; Easley, Kirk A.; Josephson, Cassandra D.			Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREMATURE-INFANTS; FEEDING PRACTICES; TRIAL; RISK; NEED	IMPORTANCE Data regarding the contribution of red blood cell (RBC) transfusion and anemia to necrotizing enterocolitis (NEC) are conflicting. These associations have not been prospectively evaluated, accounting for repeated, time-varying exposures. OBJECTIVE To determine the relationship between RBC transfusion, severe anemia, and NEC. DESIGN, SETTING, AND PARTICIPANTS In a secondary, prospective, multicenter observational cohort study from January 2010 to February 2014, very low-birth-weight (VLBW, <= 1500 g) infants, within 5 days of birth, were enrolled at 3 level III neonatal intensive care units in Atlanta, Georgia. Two hospitals were academically affiliated and lwas a community hospital. Infants received follow-up until 90 days, hospital discharge, transfer to a non-study-affiliated hospital, or death (whichever came first). Multivariable competing-risks Cox regression was used, including adjustment for birth weight, center, breastfeeding, illness severity, and duration of initial antibiotic treatment, to evaluate the association between RBC transfu on, severe anemia, and NEC. EXPOSURES The primary exposure was RBC transfusion. The secondary exposure was severe anemia, defined a priori as a hemoglobin level of 8 g/dL or less. Both exposures were evaluated as time-varying covariates at weekly intervals. MAIN OUTCOMES AND MEASURES Necrotizing enterocolitis, defined as Bell stage 2 or greater by preplanned adjudication. Mortality was evaluated as a competing risk. RESULTS Of 600 VLBW infants enrolled, 598 were evaluated. Forty-four (7.4%) infants developed NEC. Thirty-two (5.4%) infants died (all cause). Fifty-three percent of infants (319) received a total of 1430 RBC transfusion exposures. The unadjusted cumulative incidence of NEC at week 8 among RBC transfusion-exposed infants was 9.9% (95% CI, 6.9%-14.2%) vs 4.6% (95% CI, 2.6%-8.0%) among those who were unexposed. In multivariable analysis, RBC transfusion in a given week was not significantly related to the rate of NEC (adjusted cause-specific hazard ratio, 0.44 [95% CI, 0.17-1.12]; P = .09). Based on evaluation of 4565 longitudinal measurements of hemoglobin (median, 7 per infant), the rate of NEC was significantly increased among VLBW infants with severe anemia in a given week compared with those who did not have severe anemia (adjusted cause-specific hazard ratio, 5.99 [95% CI, 2.00-18.0]; P = .001). CONCLUSIONS AND RELEVANCE Among VLBW infants, severe anemia, but not RBC transfusion, was associated with an increased risk of NEC. Further studies are needed to evaluate whether preventing severe anemia is more important than minimizing RBC transfusion.	[Patel, Ravi M.; Keene, Sarah; Josephson, Cassandra D.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Patel, Ravi M.; Keene, Sarah; Josephson, Cassandra D.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Knezevic, Andrea; Shenvi, Neeta; Easley, Kirk A.] Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA USA; [Hinkes, Michael] Northside Hosp, Dept Neonatol, Atlanta, GA USA; [Roback, John D.; Josephson, Cassandra D.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Roback, John D.; Josephson, Cassandra D.] Emory Univ, Sch Med, Ctr Transfus & Cellular Therapies, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Rollins School Public Health; Emory University; Emory University	Patel, RM (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, 2015 Uppergate Dr NE,Third Flr, Atlanta, GA 30322 USA.	rmpatel@emory.edu	Patel, Ravi/B-7218-2011; Josephson, Cassandra/AFS-2243-2022; Easley, Kirk A/K-6910-2015	Patel, Ravi/0000-0002-7444-5550; Easley, Kirk A/0000-0003-4419-2617; Knezevic, Andrea/0000-0002-0741-2150	National Institutes of Health; National Heart, Lung, and Blood Institute [P01 HL086773]; National Center for Advancing Translational Sciences [UL1 TR000454, KL2 TR000455]; Emory Children's Center for Clinical and Translational Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000455, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086773, P01HL046925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Emory Children's Center for Clinical and Translational Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health. The National Heart, Lung, and Blood Institute provided funding for the parent study under award number P01 HL086773. The National Center for Advancing Translational Sciences provided support for this study and for Dr Patel under award numbers UL1 TR000454 and KL2 TR000455. Dr Patel reports receipt of research support from the Emory Children's Center for Clinical and Translational Research.	AlFaleh K, 2014, J Neonatal Perinatal Med, V7, P193, DOI 10.3233/NPM-14814048; Allison P. D., 2010, SURVIVAL ANAL USING, VSecond; Bell EF, 2005, PEDIATRICS, V115, P1685, DOI 10.1542/peds.2004-1884; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Blackstone EH, 2001, J THORAC CARDIOV SUR, V122, P430, DOI 10.1067/mtc.2001.117536; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; DeRienzo C, 2014, EARLY HUM DEV, V90, P237, DOI 10.1016/j.earlhumdev.2014.02.003; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Josephson CD, 2014, JAMA PEDIATR, V168, P1054, DOI 10.1001/jamapediatrics.2014.1360; Josephson CD, 2011, TRANSFUS MED REV, V25, P125, DOI 10.1016/j.tmrv.2010.11.004; Kirpalani H, 2006, J PEDIATR-US, V149, P301, DOI 10.1016/j.jpeds.2006.05.011; Kirpalani H, 2012, SEMIN PERINATOL, V36, P269, DOI 10.1053/j.semperi.2012.04.007; Klein HG, 2015, JAMA-J AM MED ASSOC, V314, P1557, DOI 10.1001/jama.2015.10890; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Mohamed A, 2012, PEDIATRICS, V129, P529, DOI 10.1542/peds.2011-2872; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Ramani M, 2013, CLIN PERINATOL, V40, P1, DOI 10.1016/j.clp.2012.12.001; RICHARDSON DK, 1993, PEDIATRICS, V91, P617; Sharma R, 2014, J PERINATOL, V34, P858, DOI 10.1038/jp.2014.59; Singh R, 2011, J PERINATOL, V31, P176, DOI 10.1038/jp.2010.145; Sood BG, 2016, J MATERN-FETAL NEO M, V29, P737, DOI 10.3109/14767058.2015.1016422; Strauss RG, 1997, AM J CLIN PATHOL, V107, pS57; Wallenstein MB, 2014, J PEDIATR-US, V165, P678, DOI 10.1016/j.jpeds.2014.06.012	26	156	169	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					889	897		10.1001/jama.2016.1204	http://dx.doi.org/10.1001/jama.2016.1204			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934258	Green Accepted, Bronze			2022-12-28	WOS:000371077500019
J	Biller, JA; Butros, SR; Chan-Smutko, G; Abrams, AN; Chung, DC; Hagen, CE				Biller, Jeffrey A.; Butros, S. Reha; Chan-Smutko, Gayun; Abrams, Annah N.; Chung, Daniel C.; Hagen, Catherine E.			Case 6-2016: A 10-Year-Old Boy with Abdominal Cramping and Fevers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EUROPEAN CONSORTIUM CARE; EARLY-ONSET; MICROSATELLITE INSTABILITY; COLORECTAL-CARCINOMA; LYNCH-SYNDROME; CHILDREN; NEUROFIBROMATOSIS; CANCERS; INTUSSUSCEPTION; TUBERCULOSIS		[Biller, Jeffrey A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Butros, S. Reha] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Abrams, Annah N.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Chung, Daniel C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hagen, Catherine E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Chan-Smutko, Gayun; Chung, Daniel C.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Biller, Jeffrey A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Butros, S. Reha] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Abrams, Annah N.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Chung, Daniel C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hagen, Catherine E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Biller, JA (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							Alkhouri N, 2010, J PEDIATR GASTR NUTR, V51, P727, DOI 10.1097/MPG.0b013e3181e1a224; Bairey O, 2006, ISR MED ASSOC J, V8, P832; Bakry D, 2014, EUR J CANCER, V50, P987, DOI 10.1016/j.ejca.2013.12.005; BALTHAZAR EJ, 1990, AM J ROENTGENOL, V154, P499, DOI 10.2214/ajr.154.3.2106212; Bandipalliam P, 2005, FAM CANCER, V4, P323, DOI 10.1007/s10689-005-8351-6; Boland CR, 1998, CANCER RES, V58, P5248; Bozzao C, 2011, CURR GENOMICS, V12, P451, DOI 10.2174/138920211797904070; COHEN DM, 1992, J PEDIATR GASTR NUTR, V14, P101, DOI 10.1097/00005176-199201000-00019; Gallinger S, 2004, GASTROENTEROLOGY, V126, P576, DOI 10.1053/j.gastro.2003.11.008; Gupta A, 2008, INTERNET J PEDIAT NE, V10; Herkert JC, 2011, EUR J CANCER, V47, P965, DOI 10.1016/j.ejca.2011.01.013; Heyman MB, 2005, J PEDIATR-US, V146, P35, DOI 10.1016/j.jpeds.2004.08.043; Hill DA, 2007, J CLIN ONCOL, V25, P5808, DOI 10.1200/JCO.2007.12.6102; Huang SC, 2014, J PEDIATR GASTR NUTR, V58, P144, DOI 10.1097/MPG.0000000000000179; Kravarusic D, 2007, J PEDIATR GASTR NUTR, V44, P209, DOI 10.1097/01.mpg.0000252195.84084.52; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Mandeville K, 2012, PEDIATR EMERG CARE, V28, P842, DOI 10.1097/PEC.0b013e318267a75e; MARSHALL JB, 1993, AM J GASTROENTEROL, V88, P989; Nathan K, 1999, J CLIN GASTROENTEROL, V29, P86, DOI 10.1097/00004836-199907000-00022; PECK DA, 1972, DIS COLON RECTUM, V15, P23, DOI 10.1007/BF02587664; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Stockinger ZT, 2004, DIS COLON RECTUM, V47, P527, DOI 10.1007/s10350-003-0072-z; Vasen HFA, 2014, J MED GENET, V51, P283, DOI 10.1136/jmedgenet-2013-102238; Wang Q, 1999, CANCER RES, V59, P294; Wimmer K, 2014, J MED GENET, V51, P355, DOI 10.1136/jmedgenet-2014-102284	26	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					772	781		10.1056/NEJMcpc1408597	http://dx.doi.org/10.1056/NEJMcpc1408597			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6BB	26933852				2022-12-28	WOS:000370716600012
J	McKinley, GA; Pilcher, DJ; Fay, AR; Lindsay, K; Long, MC; Lovenduski, NS				McKinley, Galen A.; Pilcher, Darren J.; Fay, Amanda R.; Lindsay, Keith; Long, Matthew C.; Lovenduski, Nicole S.			Timescales for detection of trends in the ocean carbon sink	NATURE			English	Article							EARTH SYSTEM MODEL; SOUTHERN-OCEAN; ANTHROPOGENIC CO2; NATURAL VARIABILITY; CLIMATE; FLUXES; ATLANTIC; LEARN; CMIP5	The ocean has absorbed 41 per cent of all anthropogenic carbon emitted as a result of fossil fuel burning and cement manufacture(1,2). The magnitude and the large-scale distribution of the ocean carbon sink is well quantified for recent decades(3,4). In contrast, temporal changes in the oceanic carbon sink remain poorly understood(5-7). It has proved difficult to distinguish between air-to-sea carbon flux trends that are due to anthropogenic climate change and those due to internal climate variability(5,6,8-13). Here we use a modelling approach that allows for this separation(14), revealing how the ocean carbon sink may be expected to change throughout this century in different oceanic regions. Our findings suggest that, owing to large internal climate variability, it is unlikely that changes in the rate of anthropogenic carbon uptake can be directly observed in most oceanic regions at present, but that this may become possible between 2020 and 2050 in some regions.	[McKinley, Galen A.; Pilcher, Darren J.] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI USA; [McKinley, Galen A.] Univ Wisconsin, Ctr Climat Res, Madison, WI USA; [McKinley, Galen A.; Fay, Amanda R.] Univ Wisconsin, Space Sci & Engn Ctr, Madison, WI USA; [Pilcher, Darren J.] NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA; [Lindsay, Keith; Long, Matthew C.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Lovenduski, Nicole S.] Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Lovenduski, Nicole S.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Oceanic Atmospheric Admin (NOAA) - USA; National Center Atmospheric Research (NCAR) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McKinley, GA (corresponding author), Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI USA.; McKinley, GA (corresponding author), Univ Wisconsin, Ctr Climat Res, Madison, WI USA.; McKinley, GA (corresponding author), Univ Wisconsin, Space Sci & Engn Ctr, Madison, WI USA.	gamckinley@wisc.edu	Lovenduski, Nicole/AAS-3216-2020; Long, Matthew/H-4632-2016; Lovenduski, Nicole S/A-6226-2011; Lovenduski, Nicole/V-4014-2019	Lovenduski, Nicole/0000-0001-5893-1009; Long, Matthew/0000-0003-1273-2957; Lovenduski, Nicole S/0000-0001-5893-1009; Pilcher, Darren/0000-0002-0763-3236; McKinley, Galen/0000-0002-4072-9221	National Science Foundation; NSF; NCAR's Advanced Study Program; NASA [NNX11AF53G, NNX13AC53G]; NSF [OCE-1155240]; NOAA [NA12OAR4310058]; Directorate For Geosciences [1155240] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NCAR's Advanced Study Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The National Science Foundation sponsors National Center for Atmospheric Research, where the Community Earth System Model is developed. Computing resources were provided by the Climate Simulation Laboratory at NCAR's Computational and Information Systems Laboratory, sponsored by the NSF and other agencies. NCAR's Advanced Study Program sponsored D.J.P., K.L., M.C.L. and G.A.M. to initiate this analysis. We also thank NASA for funding (grants NNX11AF53G and NNX13AC53G to G.A.M., D.J.P., A.R.F. and N.S.L.). N.S.L. also thanks the NSF (grant OCE-1155240) and NOAA (grant NA12OAR4310058).	Bakker DCE, 2014, EARTH SYST SCI DATA, V6, P69, DOI 10.5194/essd-6-69-2014; Bates NR, 2014, OCEANOGRAPHY, V27, P126, DOI 10.5670/oceanog.2014.16; Chylek P., 2011, ATMOS CHEM PHYS DISC, V11, P22893, DOI 10.5194/acpd-11-22893-2011; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Danabasoglu G, 2012, J CLIMATE, V25, P1361, DOI 10.1175/JCLI-D-11-00091.1; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Deser C, 2012, CLIM DYNAM, V38, P527, DOI 10.1007/s00382-010-0977-x; DeVries T, 2014, GLOBAL BIOGEOCHEM CY, V28, P631, DOI 10.1002/2013GB004739; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Dunne JP, 2012, J CLIMATE, V25, P6646, DOI 10.1175/JCLI-D-11-00560.1; Fay AR, 2014, EARTH SYST SCI DATA, V6, P273, DOI 10.5194/essd-6-273-2014; Fay AR, 2013, GLOBAL BIOGEOCHEM CY, V27, P541, DOI 10.1002/gbc.20051; Fay AR, 2014, GEOPHYS RES LETT, V41, P6833, DOI 10.1002/2014GL061324; Fogli P. G, 2009, 61 CMCC; Frolicher TL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003316; Frolicher TL, 2015, J CLIMATE, V28, P862, DOI 10.1175/JCLI-D-14-00117.1; Giorgetta M, 2012, CMIP5 SIMULATIONS M; Gruber N, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003349; Hawkins E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050087; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1; Ji D, 2014, GEOSCI MODEL DEV, V7, P2039, DOI 10.5194/gmd-7-2039-2014; Kay JE, 2015, B AM METEOROL SOC, V96, P1333, DOI 10.1175/BAMS-D-13-00255.1; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Landschutzer P, 2014, GLOBAL BIOGEOCHEM CY, V28, P927, DOI 10.1002/2014GB004853; Landschutzer P, 2015, SCIENCE, V349, P1221, DOI 10.1126/science.aab2620; Le Quere C, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003599; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lindsay K, 2014, J CLIMATE, V27, P8981, DOI 10.1175/JCLI-D-12-00565.1; Long MC, 2013, J CLIMATE, V26, P6775, DOI 10.1175/JCLI-D-12-00184.1; Lovenduski NS, 2015, GLOBAL BIOGEOCHEM CY, V29, P416, DOI 10.1002/2014GB004933; Lovenduski NS, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003139; McKinley GA, 2011, NAT GEOSCI, V4, P606, DOI 10.1038/ngeo1193; Moore JK, 2013, J CLIMATE, V26, P9291, DOI 10.1175/JCLI-D-12-00566.1; Munro DR, 2015, GEOPHYS RES LETT, V42, P7623, DOI 10.1002/2015GL065194; Randerson JT, 2015, GLOBAL BIOGEOCHEM CY, V29, P744, DOI 10.1002/2014GB005079; Resplandy L, 2015, J GEOPHYS RES-OCEANS, V120, P384, DOI 10.1002/2014JC010463; Rodgers KB, 2015, BIOGEOSCIENCES, V12, P3301, DOI 10.5194/bg-12-3301-2015; Sarmiento JL, 1996, SCIENCE, V274, P1346, DOI 10.1126/science.274.5291.1346; Schuster U, 2013, BIOGEOSCIENCES, V10, P607, DOI 10.5194/bg-10-607-2013; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tjiputra JF, 2013, GEOSCI MODEL DEV, V6, P301, DOI 10.5194/gmd-6-301-2013; Ullman DJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003383; Volodin EM, 2010, IZV ATMOS OCEAN PHY+, V46, P414, DOI 10.1134/S000143381004002X; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Wu TW, 2013, J GEOPHYS RES-ATMOS, V118, P4326, DOI 10.1002/jgrd.50320	48	86	89	6	136	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					469	472		10.1038/nature16958	http://dx.doi.org/10.1038/nature16958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911782				2022-12-28	WOS:000370690800033
J	Myles, PS; Smith, JA; Forbes, A; Silbert, B; Jayarajah, M; Painter, T; Cooper, DJ; Marasco, S; McNeil, J; Bussieres, JS; Wallace, S				Myles, Paul S.; Smith, Julian A.; Forbes, Andrew; Silbert, Brendan; Jayarajah, Mohandas; Painter, Thomas; Cooper, D. James; Marasco, Silvana; McNeil, John; Bussieres, Jean S.; Wallace, Sophie		ANZCA Clinical Trials Network	Stopping vs. Continuing Aspirin before Coronary Artery Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; PREOPERATIVE ASPIRIN; BYPASS-SURGERY; MORTALITY; AGENTS; RISK; DEFINITION; WITHDRAWAL; GUIDELINE	BACKGROUND Most patients with coronary artery disease receive aspirin for primary or secondary prevention of myocardial infarction, stroke, and death. Aspirin poses a risk of bleeding in patients undergoing surgery, but it is unclear whether aspirin should be stopped before coronary artery surgery. METHODS We used a 2-by-2 factorial trial design to randomly assign patients who were scheduled to undergo coronary artery surgery and were at risk for perioperative complications to receive aspirin or placebo and tranexamic acid or placebo. The results of the aspirin trial are reported here. Patients were randomly assigned to receive 100 mg of aspirin or matched placebo preoperatively. The primary outcome was a composite of death and thrombotic complications (nonfatal myocardial infarction, stroke, pulmonary embolism, renal failure, or bowel infarction) within 30 days after surgery. RESULTS Among 5784 eligible patients, 2100 were enrolled; 1047 were randomly assigned to receive aspirin and 1053 to receive placebo. A primary outcome event occurred in 202 patients in the aspirin group (19.3%) and in 215 patients in the placebo group (20.4%) (relative risk, 0.94; 95% confidence interval, 0.80 to 1.12; P = 0.55). Major hemorrhage leading to reoperation occurred in 1.8% of patients in the aspirin group and in 2.1% of patients in the placebo group (P = 0.75), and cardiac tamponade occurred at rates of 1.1% and 0.4%, respectively (P = 0.08). CONCLUSIONS Among patients undergoing coronary artery surgery, the administration of preoperative aspirin resulted in neither a lower risk of death or thrombotic complications nor a higher risk of bleeding than that with placebo. (Funded by the Australian National Health and Medical Research Council and others; Australia New Zealand Clinical Trials Registry number, ACTRN12605000557639.)	[Myles, Paul S.; Cooper, D. James; Marasco, Silvana; Wallace, Sophie] Alfred Hosp, Melbourne, Vic 3004, Australia; [Myles, Paul S.; Smith, Julian A.; Forbes, Andrew; Cooper, D. James; Marasco, Silvana; McNeil, John] Monash Univ, Melbourne, Vic, Australia; [Silbert, Brendan] St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Painter, Thomas] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Jayarajah, Mohandas] Plymouth Med Sch, Plymouth, Devon, England; [Bussieres, Jean S.] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Florey Institute of Neuroscience & Mental Health; Monash University; St Vincent's Hospital Melbourne; Royal Adelaide Hospital	Myles, PS (corresponding author), Alfred Hosp, Dept Anaesthesia & Perioperat Med, Commercial Rd, Melbourne, Vic 3004, Australia.	p.myles@alfred.org.au	Painter, Thomas/K-3899-2019; McNeil, John/L-6440-2019; Myles, Paul/AAU-9524-2020; Chan, Matthew/J-2884-2013; Cooper, D. James/G-7961-2013; Giovanni, Landoni/AAH-1881-2019; Marasco, Silvana F/ABB-8672-2020; Painter, Thomas/K-6311-2017	Painter, Thomas/0000-0003-2216-2046; McNeil, John/0000-0002-1049-5129; Myles, Paul/0000-0002-3324-5456; Chan, Matthew/0000-0002-3574-7855; Cooper, D. James/0000-0002-5872-9051; Giovanni, Landoni/0000-0002-8594-5980; Painter, Thomas/0000-0003-2216-2046; Forbes, Andrew/0000-0003-4269-914X; Bannon, Paul/0000-0002-3117-7250; Smith, Julian/0000-0003-1244-4277	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funded by the Australian National Health and Medical Research Council and others; Australia New Zealand Clinical Trials Registry number, ACTRN12605000557639.	Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bell AD, 2011, CAN J CARDIOL, V27, pS1, DOI 10.1016/j.cjca.2010.12.015; Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805; Cahill RA, 2005, J AM COLL SURGEONS, V200, P564, DOI 10.1016/j.jamcollsurg.2004.11.002; Collet JP, 2004, CIRCULATION, V110, P2361, DOI 10.1161/01.CIR.0000145171.89690.B4; Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; Ferraris VA, 2005, ANN THORAC SURG, V79, P1454, DOI 10.1016/j.athoracsur.2005.01.008; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Fransen EJ, 2002, CHEST, V122, P1316, DOI 10.1378/chest.122.4.1316; GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324; Hastings S, 2015, BRIT J ANAESTH, V115, P376, DOI 10.1093/bja/aev164; Hillis LD, 2012, J THORAC CARDIOV SUR, V143, P4, DOI 10.1016/j.jtcvs.2011.10.015; Jacob M, 2011, CIRCULATION, V123, P577, DOI 10.1161/CIRCULATIONAHA.110.957373; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Mohammed AA, 2009, CIRCULATION, V120, P843, DOI 10.1161/CIRCULATIONAHA.108.837278; Myles PS, 2008, AM HEART J, V155, P224, DOI 10.1016/j.ahj.2007.10.003; Myles PS, 2011, CIRCULATION, V123, P571, DOI 10.1161/CIRCULATIONAHA.110.010470; Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7; Parr KG, 2003, J CARDIOTHOR VASC AN, V17, P176, DOI 10.1053/jcan.2003.44; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Petricevic M, 2012, EUR J CARDIO-THORAC, V42, P760, DOI 10.1093/ejcts/ezs227; Serebruany VL, 2004, AM J HEMATOL, V75, P40, DOI 10.1002/ajh.10451; Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104; Thielmann M, 2005, EUR HEART J, V26, P2440, DOI 10.1093/eurheartj/ehi437; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Wong CK, 2005, POSTGRAD MED J, V81, P552, DOI 10.1136/pgmj.2005.035071	29	115	121	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					728	737		10.1056/NEJMoa1507688	http://dx.doi.org/10.1056/NEJMoa1507688			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6BB	26933848	Bronze			2022-12-28	WOS:000370716600006
J	Rajalingam, K; Dikic, I				Rajalingam, Krishnaraj; Dikic, Ivan			SnapShot: Expanding the Ubiquitin Code	CELL			English	Editorial Material							CANCER; PROTEINS		[Rajalingam, Krishnaraj] JGU, Univ Med Ctr Mainz, Mol Signaling Unit, FZI,Inst Immunol, Langenbeck Str 1, Mainz, Germany; [Dikic, Ivan] Goethe Univ, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Dikic, Ivan] Buchmann Inst Mol Life Sci, Max von Laue Str 15, D-60438 Frankfurt, Germany	Johannes Gutenberg University of Mainz; Goethe University Frankfurt	Rajalingam, K (corresponding author), JGU, Univ Med Ctr Mainz, Mol Signaling Unit, FZI,Inst Immunol, Langenbeck Str 1, Mainz, Germany.		Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511	Cluster of Excellence "Macromolecular Complexes" [EXC115];  [SFB1177 DFG]	Cluster of Excellence "Macromolecular Complexes"; 	We would like to thank Daniela Hoeller for her excellent assistance with the SnapShot. Research in the lab of I.D. is supported by the Cluster of Excellence "Macromolecular Complexes" (EXC115), SFB1177 DFG grant, LOEWE Ub-Net, and LOEWE Centrum for Gene and Cell Therapy Frankfurt. K.R. is a Heisenberg professor-DFG, a BIS-PLUS3, and a GFK fellow.	Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Herhaus L, 2015, EMBO REP, V16, P1071, DOI 10.15252/embr.201540891; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Pal A, 2014, CANCER RES, V74, P4955, DOI 10.1158/0008-5472.CAN-14-1211; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhao YJ, 2015, J MED CHEM, V58, P1038, DOI 10.1021/jm501092z	10	32	33	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5							1074.e1	10.1016/j.cell.2016.02.019	http://dx.doi.org/10.1016/j.cell.2016.02.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ0YZ	26919436	Bronze			2022-12-28	WOS:000392938500001
J	Eastley, N; Green, PN; Ashford, RU				Eastley, N.; Green, P. N.; Ashford, R. U.			Soft tissue sarcoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; DELAY; BONE		[Eastley, N.; Ashford, R. U.] Leicester Royal Infirm, East Midlands Sarcoma Serv, Leicester LE1 5WW, Leics, England; [Eastley, N.; Ashford, R. U.] Leicester Royal Infirm, Leicester Orthopaed, Leicester LE1 5WW, Leics, England; [Eastley, N.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Green, P. N.; Ashford, R. U.] Syston Hlth Ctr, Syston LE7 2EQ, Leics, England; [Ashford, R. U.] Univ Nottingham, Queens Med Ctr, Acad Orthopaed, Nottingham NG7 2UH, England	University of Leicester; University of Leicester; University of Leicester; University of Nottingham	Ashford, RU (corresponding author), Leicester Royal Infirm, East Midlands Sarcoma Serv, Leicester LE1 5WW, Leics, England.; Ashford, RU (corresponding author), Leicester Royal Infirm, Leicester Orthopaed, Leicester LE1 5WW, Leics, England.; Ashford, RU (corresponding author), Univ Nottingham, Queens Med Ctr, Acad Orthopaed, Nottingham NG7 2UH, England.	robert.ashford@sky.com	Bauer, Sebastian/D-8120-2012; Ashford, Robert U./AAT-2468-2021	Bauer, Sebastian/0000-0001-5949-8120; Ashford, Robert U./0000-0002-8246-2334				Brouns F, 2003, EUR J SURG ONCOL, V29, P440, DOI 10.1016/S0748-7983(03)00006-4; Cancer Research UK, 2015, RISKS CAUS SOFT TISS; Clark MA, 2005, EJSO-EUR J SURG ONC, V31, P443, DOI 10.1016/j.ejso.2004.11.016; ESMO/European Sarcoma Network Working Group, 2012, ANN ONCOL S7, V23; George A, 2012, ANN ROY COLL SURG, V94, P261, DOI 10.1308/003588412X13171221590016; Grimer RJ, 2010, J BONE JOINT SURG BR, V92B, P1489, DOI 10.1302/0301-620X.92B11.24326; Grimer RJ, 2006, ANN ROY COLL SURG, V88, P519, DOI 10.1308/003588406X130651; Johnson G. D., 2008, Sarcoma, V2008, P1, DOI 10.1155/2008/378574; Lakkaraju A, 2009, CLIN RADIOL, V64, P615, DOI 10.1016/j.crad.2009.01.012; Nandra R, 2015, EJSO-EUR J SURG ONC, V41, P1400, DOI 10.1016/j.ejso.2015.05.017; National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF; Park JH, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-84; Pisters PWT, 1996, J CLIN ONCOL, V14, P1679, DOI 10.1200/JCO.1996.14.5.1679	13	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2016	352								i436	10.1136/bmj.i436	http://dx.doi.org/10.1136/bmj.i436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1QZ	26911154				2022-12-28	WOS:000371115600008
J	Alhamdi, Y; Abrams, ST; Lane, S; Wang, GZ; Toh, CH				Alhamdi, Yasir; Abrams, Simon T.; Lane, Steven; Wang, Guozheng; Toh, Cheng-Hock			Histone-Associated Thrombocytopenia in Patients Who Are Critically Ill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CIRCULATING HISTONES; MAJOR MEDIATORS; INJURY; SEPSIS		[Alhamdi, Yasir; Abrams, Simon T.; Wang, Guozheng; Toh, Cheng-Hock] Univ Liverpool, Inst Infect & Global Hlth, Ronald Ross Bldg,8 West Derby St, Liverpool L69 7BE, Merseyside, England; [Lane, Steven] Univ Liverpool, Inst Translat Med, Liverpool L69 7BE, Merseyside, England	University of Liverpool; University of Liverpool	Toh, CH (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Ronald Ross Bldg,8 West Derby St, Liverpool L69 7BE, Merseyside, England.	Toh@liverpool.ac.uk		Abrams, Simon/0000-0003-3949-2455	National Institute for Health Research [II-FS-0509-12093, II-LS-1010-10045] Funding Source: researchfish; British Heart Foundation [PG/16/65/32313, PG/14/19/30751] Funding Source: Medline; Department of Health [II-FS-0110-14061, II-FS-0509-12093, II-LS-1010-10045] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Department of Health		Abrams ST, 2013, J IMMUNOL, V191, P2495, DOI 10.4049/jimmunol.1203181; Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Alhamdi Y, 2015, CRIT CARE MED, V43, P2094, DOI 10.1097/CCM.0000000000001162; De Labriolle A, 2010, EUR HEART J, V31, P1079, DOI 10.1093/eurheartj/ehp594; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053	6	31	32	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					817	819		10.1001/jama.2016.0136	http://dx.doi.org/10.1001/jama.2016.0136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903341	Green Accepted, Bronze			2022-12-28	WOS:000370700500018
J	Tasker, RC; Menon, DK				Tasker, Robert C.; Menon, David K.			Critical Care and the Brain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; INJURY; OUTCOMES; FAILURE		[Tasker, Robert C.] Boston Childrens Hosp, Dept Anesthesia Perioperat & Pain Med, Div Crit Care Med, Dept Neurol, Boston, MA 02115 USA; [Tasker, Robert C.] Harvard Univ, Sch Med, Boston, MA USA; [Menon, David K.] Univ Cambridge, Sch Clin, Div Anaesthesia, Cambridge, England; [Menon, David K.] Addenbrookes Hosp, Cambridge, England	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Tasker, RC (corresponding author), Boston Childrens Hosp, Div Crit Care Med, Bader 621,300 Longwood Ave, Boston, MA 02115 USA.	robert.tasker@childrens.harvard.edu	Tasker, Robert C/R-5837-2019	Tasker, Robert/0000-0003-3647-8113	National Institute for Health Research [NF-SI-0512-10090] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Curley MAQ, 2015, JAMA-J AM MED ASSOC, V313, P379, DOI 10.1001/jama.2014.18399; Mehta S, 2015, CRIT CARE MED, V43, P557, DOI 10.1097/CCM.0000000000000727; Miller CM, 2015, NEUROCRIT CARE S2, V23, P1; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Riech S, 2015, CRIT CARE MED, V43, pE386, DOI 10.1097/CCM.0000000000001150; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090	8	21	22	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					749	750		10.1001/jama.2016.0701	http://dx.doi.org/10.1001/jama.2016.0701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903329				2022-12-28	WOS:000370700500006
J	Cowper, A				Cowper, Andy			JUNIOR DOCTORS' STRIKE Megaphone diplomacy fails in junior doctor contract dispute	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												andycowper@hotmail.com						Campbell D, 2016, GUARDIAN; Clover B, 2016, HSJ             0211; Department of Health, 2016, J HUNT UPD PARL JUN; Ipsos MORI, 2016, WID PUBL SUPP JUN DO; Ipsos MORI, 2016, POL AR STILL TRUST L; Ipsos MORI, 2016, SUPP JUN DOCT REM ST; Lintern S, 2016, HSJ             0212; NHS Employers, 2015, DDRB REP CONS JUN DO; NHS England, 2016, BOARD PAP; NHS Trust Development Authority, 2015, CHALL ENV NHS PROV; Rimmer A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i885; Rimmer A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5624; YouGov, 2016, SURV RES	13	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2016	352								i961	10.1136/bmj.i961	http://dx.doi.org/10.1136/bmj.i961			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6FB	26892315				2022-12-28	WOS:000370728000009
J	Terry, AR; Kahle, KT; Larvie, M; Vyas, JM; Stemmer-Rachamimov, A				Terry, Anna R.; Kahle, Kristopher T.; Larvie, Mykol; Vyas, Jatin M.; Stemmer-Rachamimov, Anat			Case 5-2016: A 43-Year-Old Man with Altered Mental Status and a History of Alcohol Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BACTERIAL-MENINGITIS; GLIOMATOSIS CEREBRI; THERAPY; ADULTS		[Terry, Anna R.] Duke Univ, Sch Med, Dept Neurosurg, Raleigh, NC USA; [Terry, Anna R.] Duke Raleigh Hosp, Raleigh, NC USA; [Kahle, Kristopher T.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Kahle, Kristopher T.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Kahle, Kristopher T.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Larvie, Mykol] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Vyas, Jatin M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Stemmer-Rachamimov, Anat] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Larvie, Mykol] Harvard Univ, Dept Radiol, Sch Med, Boston, MA 02115 USA; [Vyas, Jatin M.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA; [Stemmer-Rachamimov, Anat] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02115 USA	Duke University; Yale University; Yale University; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Terry, AR (corresponding author), Duke Univ, Sch Med, Dept Neurosurg, Raleigh, NC USA.; Terry, AR (corresponding author), Duke Raleigh Hosp, Raleigh, NC USA.		Vyas, Jatin/Q-1627-2016	Vyas, Jatin/0000-0002-9985-9565				Bhimraj A, 2012, CLEV CLIN J MED, V79, P393, DOI 10.3949/ccjm.79gr.12003; Brancusi F, 2012, FUTURE MICROBIOL, V7, P1101, DOI [10.2217/fmb.12.86, 10.2217/FMB.12.86]; Kandula S, 2014, CANCER-AM CANCER SOC, V120, P2713, DOI 10.1002/cncr.28785; Knox MK, 2010, J NEURO-ONCOL, V100, P145, DOI 10.1007/s11060-010-0138-4; Malik Athar N, 2014, Clin Neurol Neurosurg, V124, P102, DOI 10.1016/j.clineuro.2014.06.022; Perfect JR, 2014, CLIN INFECT DIS, V59, pS352, DOI 10.1093/cid/ciu639; Smith RM, 2013, NEW ENGL J MED, V368, P2535, DOI 10.1056/NEJMc1306560; STAVE GM, 1989, AM J MED, V86, P115, DOI 10.1016/0002-9343(89)90242-8; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P502, DOI 10.3171/2011.8.PEDS11221; Woehrl B, 2011, EXPERT REV ANTI-INFE, V9, P1053, DOI [10.1586/ERI.11.129, 10.1586/eri.11.129]	10	6	6	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					671	680		10.1056/NEJMcpc1509361	http://dx.doi.org/10.1056/NEJMcpc1509361			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26886525				2022-12-28	WOS:000370229000014
J	Lawrence, HC				Lawrence, Hal C.			Unfettered Access to Reliable Contraception: Pharmacist Prescription Derails a Definitive Solution	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lawrence, Hal C.] Amer Congress Obstetricians & Gynecologists, 409 12th St Southwest, Washington, DC 20024 USA		Lawrence, HC (corresponding author), Amer Congress Obstetricians & Gynecologists, 409 12th St Southwest, Washington, DC 20024 USA.	hlawrence@acog.org						American College of Obstetricians and Gynecologists, 2015, COMM OP OV THE COUNT; Daniels Kimberly, 2013, Natl Health Stat Report, P1; Farley TMM, 1999, HUM REPROD UPDATE, V5, P721, DOI 10.1093/humupd/5.6.721; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Shotorbani S, 2006, CONTRACEPTION, V73, P501, DOI 10.1016/j.contraception.2005.12.001; U.S. Department of Health and Human Services, 2015, FAQS AFF CAR ACT IMP	6	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					59	+		10.7326/M15-3003	http://dx.doi.org/10.7326/M15-3003			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	26925820				2022-12-28	WOS:000379215800011
J	Jain, IH; Zazzeron, L; Goli, R; Alexa, K; Schatzman-Bone, S; Dhillon, H; Goldberger, O; Peng, J; Shalem, O; Sanjana, NE; Zhang, F; Goessling, W; Zapol, WM; Mootha, VK				Jain, Isha H.; Zazzeron, Luca; Goli, Rahul; Alexa, Kristen; Schatzman-Bone, Stephanie; Dhillon, Harveen; Goldberger, Olga; Peng, Jun; Shalem, Ophir; Sanjana, Neville E.; Zhang, Feng; Goessling, Wolfram; Zapol, Warren M.; Mootha, Vamsi K.			Hypoxia as a therapy for mitochondrial disease	SCIENCE			English	Article							COMPLEX-I DEFICIENCY; INDUCIBLE FACTORS; PROTEIN; INHIBITION; ADAPTATION; INDUCTION; DOMAIN; MODEL; MICE	Defects in the mitochondrial respiratory chain (RC) underlie a spectrum of human conditions, ranging from devastating inborn errors of metabolism to aging. We performed a genome-wide Cas9-mediated screen to identify factors that are protective during RC inhibition. Our results highlight the hypoxia response, an endogenous program evolved to adapt to limited oxygen availability. Genetic or small-molecule activation of the hypoxia response is protective against mitochondrial toxicity in cultured cells and zebrafish models. Chronic hypoxia leads to a marked improvement in survival, body weight, body temperature, behavior, neuropathology, and disease biomarkers in a genetic mouse model of Leigh syndrome, the most common pediatric manifestation of mitochondrial disease. Further preclinical studies are required to assess whether hypoxic exposure can be developed into a safe and effective treatment for human diseases associated with mitochondrial dysfunction.	[Jain, Isha H.; Goli, Rahul; Dhillon, Harveen; Goldberger, Olga; Peng, Jun; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Jain, Isha H.; Goli, Rahul; Dhillon, Harveen; Goldberger, Olga; Peng, Jun; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Jain, Isha H.; Goli, Rahul; Dhillon, Harveen; Goldberger, Olga; Peng, Jun; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Jain, Isha H.; Goli, Rahul; Dhillon, Harveen; Goldberger, Olga; Peng, Jun; Shalem, Ophir; Sanjana, Neville E.; Zhang, Feng; Goessling, Wolfram; Mootha, Vamsi K.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Zazzeron, Luca; Zapol, Warren M.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Alexa, Kristen; Schatzman-Bone, Stephanie; Goessling, Wolfram] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; [Shalem, Ophir; Sanjana, Neville E.; Zhang, Feng] McGovern Inst Brain Res, Cambridge, MA USA; [Shalem, Ophir; Sanjana, Neville E.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Shalem, Ophir; Sanjana, Neville E.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Goessling, Wolfram] Dana Farber Canc Inst, Gastrointestinal Canc Ctr, Boston, MA 02115 USA; [Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Mootha, VK (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.; Mootha, VK (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA USA.	vamsi@hms.harvard.edu	Macrae, Rhiannon/AAX-1536-2020	Jain, Isha/0000-0001-5053-0964; Goessling, Wolfram/0000-0001-9972-1569; Shalem, Ophir/0000-0002-2267-0801	Department of Energy Computational Science Graduate Fellowship Program [DE-FG02-97ER25308]; National Institutes of Health (NIH) through a NHGRI [K99-HG008171]; Simons Center for the Social Brain at the Massachusetts Institute of Technology; NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; NIDDK [5R01DK097768-03]; NSF; New York Stem Cell; Simons, Paul G. Allen Family Foundation; Vallee Foundation; NIH [R01DK090311, R24OD017870]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG008171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK097768, R01DK090311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD017870] Funding Source: NIH RePORTER	Department of Energy Computational Science Graduate Fellowship Program; National Institutes of Health (NIH) through a NHGRI; Simons Center for the Social Brain at the Massachusetts Institute of Technology; NIH through NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NSF(National Science Foundation (NSF)); New York Stem Cell; Simons, Paul G. Allen Family Foundation; Vallee Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank W. Kaelin Jr. and members of the Mootha lab for valuable feedback; R. Sharma, M. Ferrari, A. Rogers, and the MGH animal facility for assistance with experiments; and F. van Eeden for Tg(phd3::EGFP) zebrafish. I.H.J. is supported by the Department of Energy Computational Science Graduate Fellowship Program (grant DE-FG02-97ER25308). N.E.S. is supported by the National Institutes of Health (NIH) through a NHGRI Pathway to Independence Award (K99-HG008171) and a postdoctoral fellowship from the Simons Center for the Social Brain at the Massachusetts Institute of Technology. F. Z. is supported by NIH through NIMH (grants 5DP1-MH100706 and 1R01-MH110049) and NIDDK (grant 5R01DK097768-03); a Waterman Award from NSF; the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and B. Metcalfe. F. Z. is a New York Stem Cell Foundation Robertson Investigator. W. G. is supported by NIH grants R01DK090311 and R24OD017870 and is a Pew Scholar in the Biomedical Sciences. This work was supported by a gift from the Marriott Mitochondrial Disorders Research Fund (V. K. M.) and a gift in memory of Daniel Garland (V. K. M.). V. K. M. is an Investigator of the Howard Hughes Medical Institute. V. K. M. is a founder of and paid scientific advisor for Raze Therapeutics. W. G. is a paid consultant for FATE Therapeutics. F. Z. is a founder of and a scientific advisor for Editas Medicine and a scientific advisor for Horizon Discovery. V. K. M., I. H. J., L. Z., and W. M. Z. are listed as inventors on a patent application filed by Massachusetts General Hospital related to technology reported in this paper on the use of hypoxia and the hypoxia response in the treatment of mitochondrial dysfunction. F.Z., O.S., and N.E.S. are listed as inventors on a patent application (PCT/US2013/074800) filed by The Broad Institute/MIT related to the genome-scale CRISPR knockout screening technology used in this study. The CRISPR knockout library is available through a Uniform Biological Materials Transfer Agreement from Addgene. The Ndufs4 KO mice were a kind gift of R. Palmiter and are available under a materials transfer agreement with the University of Washington, Seattle.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Buckley DL, 2012, J AM CHEM SOC, V134, P4465, DOI 10.1021/ja209924v; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; CASTON J, 1995, NEUROBIOL LEARN MEM, V64, P195, DOI 10.1006/nlme.1995.0002; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391; Harris JM, 2013, BLOOD, V121, P2483, DOI 10.1182/blood-2012-12-471201; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195; Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177; PAWSON IG, 1976, PROC R SOC SER B-BIO, V194, P83, DOI 10.1098/rspb.1976.0067; Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3; Pinho BR, 2013, BRIT J PHARMACOL, V169, P1072, DOI 10.1111/bph.12186; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; Rich P, 2003, NATURE, V421, P583, DOI 10.1038/421583a; Robinson CM, 2014, FEBS LETT, V588, P2704, DOI 10.1016/j.febslet.2014.02.026; Santhakumar K, 2012, CANCER RES, V72, P4017, DOI 10.1158/0008-5472.CAN-11-3148; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Simon MC, 2006, CELL METAB, V3, P150, DOI 10.1016/j.cmet.2006.02.007; Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; van Rooijen E, 2009, BLOOD, V113, P6449, DOI 10.1182/blood-2008-07-167890; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	40	251	258	9	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					54	61		10.1126/science.aad9642	http://dx.doi.org/10.1126/science.aad9642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	26917594	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-28	WOS:000373039600033
J	Conley, S; Franco, G; Faloona, I; Blake, DR; Peischl, J; Ryerson, TB				Conley, S.; Franco, G.; Faloona, I.; Blake, D. R.; Peischl, J.; Ryerson, T. B.			Methane emissions from the 2015 Aliso Canyon blowout in Los Angeles, CA	SCIENCE			English	Article							OZONE FORMATION; FLOW-RATE; OIL	Single-point failures of natural gas infrastructure can hamper methane emission control strategies designed to mitigate climate change. The 23 October 2015 blowout of a well connected to the Aliso Canyon underground storage facility in California resulted in a massive release of natural gas. Analysis of methane and ethane data from dozens of plume transects, collected during 13 research-aircraft flights between 7 November 2015 and 13 February 2016, shows atmospheric leak rates of up to 60 metric tons of methane and 4.5 metric tons of ethane per hour. At its peak, this blowout effectively doubled the methane emission rate of the entire Los Angeles basin and, in total, released 97,100 metric tons of methane to the atmosphere.	[Conley, S.] Sci Aviat, 3335 Airport Rd, Boulder, CO 80301 USA; [Conley, S.; Faloona, I.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Franco, G.] Calif Energy Commiss, Res & Dev Div, Sacramento, CA 95814 USA; [Blake, D. R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92617 USA; [Peischl, J.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Peischl, J.; Ryerson, T. B.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA	University of California System; University of California Davis; University of California System; University of California Irvine; University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA	Conley, S (corresponding author), Sci Aviat, 3335 Airport Rd, Boulder, CO 80301 USA.; Conley, S (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	sconley@scientificaviation.com	Ryerson, Tom/AAA-8399-2021; Ryerson, Thomas/C-9611-2009; Peischl, Jeff/E-7454-2010; Hou, Yu/U-8661-2019	Ryerson, Thomas/0000-0003-2800-7581; Peischl, Jeff/0000-0002-9320-7101; Blake, Donald/0000-0002-8283-5014	California Energy Commission through University of California-Davis [201401201]; Southern California Gas Company; Aliso Canyon; California Agricultural Experiment Station (Hatch project) [CA-D-LAW-2229-H]; NOAA Climate Program Office; NOAA Atmospheric Chemistry, Carbon Cycle, and Climate program	California Energy Commission through University of California-Davis; Southern California Gas Company; Aliso Canyon; California Agricultural Experiment Station (Hatch project); NOAA Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA Atmospheric Chemistry, Carbon Cycle, and Climate program	The first two Scientific Aviation flights were funded by the California Energy Commission through University of California-Davis project #201401201. Subsequent flights were funded by the Southern California Gas Company, the operator of the Aliso Canyon storage facility. I.F. was supported in part by the California Agricultural Experiment Station (Hatch project CA-D-LAW-2229-H). J.P. and T.R. were supported in part by the NOAA Climate Program Office and the NOAA Atmospheric Chemistry, Carbon Cycle, and Climate program. We acknowledge the contributions of M. Trainer for scientific input and K. Aikin and S. Wolter for time-critical technical support. The views expressed here are those of the authors and do net constitute endorsement by their funding agencies. Data used in this report are posted at esrldioaa.gov/csd/scientificaviation.	[Anonymous], 2015, NAT GAS ANN RESP QUE; Bevinton P. R., 2003, DATA REDUCTION ERROR; Brandt AR, 2014, SCIENCE, V343, P733, DOI 10.1126/science.1247045; Butz A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047888; Cornot-Gandolpne S., 2013, UNDERGROUND GAS STOR; EDGAR, 2016, EDGAR EM DAT GLOB AT; Green RO, 1998, REMOTE SENS ENVIRON, V65, P227, DOI 10.1016/S0034-4257(98)00064-9; Jeong S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016896; Karion A, 2015, ENVIRON SCI TECHNOL, V49, P8124, DOI 10.1021/acs.est.5b00217; Karion A, 2013, GEOPHYS RES LETT, V40, P4393, DOI 10.1002/grl.50811; Kort EA, 2014, GEOPHYS RES LETT, V41, P6898, DOI 10.1002/2014GL061503; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Miller SM, 2013, P NATL ACAD SCI USA, V110, P20018, DOI 10.1073/pnas.1314392110; Miyazaki B, 2009, GEOL SOC SPEC PUBL, V313, P163, DOI 10.1144/SP313.11; Pacific Gas and Electric Company, 2015, GAS SYST SULF SURV R; Peischl J, 2015, J GEOPHYS RES-ATMOS, V120, P2119, DOI 10.1002/2014JD022697; Peischl J, 2013, J GEOPHYS RES-ATMOS, V118, P4974, DOI 10.1002/jgrd.50413; Petron G, 2014, J GEOPHYS RES-ATMOS, V119, P6836, DOI 10.1002/2013JD021272; Ryerson TB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003070; Ryerson TB, 2001, SCIENCE, V292, P719, DOI 10.1126/science.1058113; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; SoCalGas, 2016, AL CAN AIR SAMPL RES; Southh. Coast Al' Quality Management District, 2016, LAB RES; State of California Department of Conservation, 1991, REP PROP CHANG WELL; U. S. Environmental Protection Agency (EPA), 2014, BENZ; U.S. EPA, 2014, GREENH GAS EM TYP PA; United Nations Framework Convention on Climate Change, 2015, AD PAR AGR; Washenfelder RA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017969; WHITE WH, 1976, SCIENCE, V194, P187, DOI 10.1126/science.959846; Wong KW, 2015, ATMOS CHEM PHYS, V15, P241, DOI 10.5194/acp-15-241-2015	30	155	157	2	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1317	1320		10.1126/science.aaf2348	http://dx.doi.org/10.1126/science.aaf2348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26917596	Green Published			2022-12-28	WOS:000372397700042
J	Qian, G; Ji, J; Wu, JB				Qian, Ge; Ji, Jiang; Wu, Jianbo			Sudden Onset of Generalized Pustules in a Newborn	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ERYTHEMA TOXICUM NEONATORUM; PREDISPOSING FACTORS		[Qian, Ge] Childrens Hosp Zhengzhou, Dept Dermatol, Zhengzhou, Peoples R China; [Ji, Jiang] Soochow Univ, Affiliated Hosp 2, Dept Dermatol, Suzhou, Peoples R China; [Wu, Jianbo] Wuhan Univ, Zhongnan Hosp, Dept Dermatol, 169 Donghu Rd, Wuhan 430071, Peoples R China	Soochow University - China; Wuhan University	Wu, JB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Dermatol, 169 Donghu Rd, Wuhan 430071, Peoples R China.	wurudai@163.com						BERG FJ, 1987, ARCH DIS CHILD, V62, P327, DOI 10.1136/adc.62.4.327; CARR JA, 1966, AM J DIS CHILD, V112, P129, DOI 10.1001/archpedi.1966.02090110073006; Ghosh S, 2015, INDIAN J DERMATOL, V60, DOI 10.4103/0019-5154.152558; Liu C, 2005, DERMATOLOGY, V210, P269, DOI 10.1159/000084749; Monteagudo B, 2012, PEDIATR DERMATOL, V29, P166, DOI 10.1111/j.1525-1470.2011.01536.x; O'Connor NR, 2008, AM FAM PHYSICIAN, V77, P47; vanPraag MCG, 1997, PEDIATR DERMATOL, V14, P131	7	1	1	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					934	935		10.1001/jama.2016.0006	http://dx.doi.org/10.1001/jama.2016.0006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934262				2022-12-28	WOS:000371077500023
J	Currie, J; Grenfell, B; Farrar, J				Currie, Janet; Grenfell, Bryan; Farrar, Jeremy			INFECTIOUS DISEASES Beyond Ebola	SCIENCE			English	Editorial Material							HEALTH		[Currie, Janet; Grenfell, Bryan] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08540 USA; [Farrar, Jeremy] Wellcome Trust Res Labs, 215 Euston Rd, London NW1 2BE, England	Princeton University	Currie, J (corresponding author), Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08540 USA.	jcurrie@princeton.edu	Farrar, Jeremy J./HGA-7610-2022		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NICHD NIH HHS [P2C HD047879] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2015, ACH MAL MDG TARG REV; Bendavid E, 2014, JAMA INTERN MED, V174, P881, DOI 10.1001/jamainternmed.2014.292; Cronin DT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134464; Currie J, 2013, ANNU REV ECON, V5, P1, DOI 10.1146/annurev-economics-081412-103704; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Institute of Medicine, 2015, OP FRAM ID EFF RESP; Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; National Academy of Medicine Secretariat, 2016, NEGL DIM GLOB SEC FR; Pigott DM, 2014, ELIFE, V3, DOI 10.7554/eLife.04395; Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820; Takahashi S, 2015, SCIENCE, V347, P1240, DOI 10.1126/science.aaa3438; WHO, 2015, REP EB INT ASS PAN	13	17	17	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					815	816		10.1126/science.aad8521	http://dx.doi.org/10.1126/science.aad8521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912880	Green Accepted			2022-12-28	WOS:000370325700024
J	Sanyaolu, LN; Farmer, SEJ				Sanyaolu, Leigh N.; Farmer, Sarah E. J.			CASE REVIEW Acute otalgia and otorrhoea in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE OTITIS-EXTERNA; MICROBIOLOGY; MANAGEMENT		[Sanyaolu, Leigh N.; Farmer, Sarah E. J.] Royal Gwent Hosp, Dept Otolaryngol, Newport NP20 2UB, Gwent, Wales	Royal Gwent Hospital	Sanyaolu, LN (corresponding author), Royal Gwent Hosp, Dept Otolaryngol, Newport NP20 2UB, Gwent, Wales.	lnsanyaolu@doctors.org.uk		Sanyaolu, Leigh/0000-0002-6762-6986				Collier SA, 2013, OTOLARYNG HEAD NECK, V148, P128, DOI 10.1177/0194599812467000; Hollis S, 2011, J LARYNGOL OTOL, V125, P1212, DOI 10.1017/S0022215110002550; Kaushik V, 2010, COCHRANE DB SYST REV; Llor C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5259; Ninkovic G, 2008, AURIS NASUS LARYNX, V35, P480, DOI 10.1016/j.anl.2007.09.013; Osguthorpe JD, 2006, AM FAM PHYSICIAN, V74, P1510; Pabla L, 2012, EUR ARCH OTO-RHINO-L, V269, P753, DOI 10.1007/s00405-011-1687-7; Public Health England (HPA), 2013, MAN INF GUID PRIM CA; Roland PS, 2002, LARYNGOSCOPE, V112, P1166, DOI 10.1097/00005537-200207000-00005; Rosenfeld RM, 2006, OTOLARYNG HEAD NECK, V134, pS4, DOI [10.1177/0194599813517083, 10.1016/j.otohns.2006.02.014]; Rowlands S, 2001, BRIT J GEN PRACT, V51, P533; van Balen FAM, 2003, BRIT MED J, V327, P1201, DOI 10.1136/bmj.327.7425.1201; Walton L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3623	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2016	352								i844	10.1136/bmj.i844	http://dx.doi.org/10.1136/bmj.i844			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6FB	26891987				2022-12-28	WOS:000370728000006
J	Hvidberg, CS				Hvidberg, Christine S.			Ice sheet in peril	SCIENCE			English	Editorial Material							GREENLAND; RATES		[Hvidberg, Christine S.] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Hvidberg, CS (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-2100 Copenhagen, Denmark.	ch@nbi.ku.dk	Hvidberg, Christine S./E-8934-2015	Hvidberg, Christine S./0000-0002-9665-1339				Box JE, 2013, J CLIMATE, V26, P3919, DOI 10.1175/JCLI-D-12-00373.1; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; DahlJensen D, 1998, SCIENCE, V282, P268, DOI 10.1126/science.282.5387.268; Gkinis V, 2014, EARTH PLANET SC LETT, V405, P132, DOI 10.1016/j.epsl.2014.08.022; MacGregor JA, 2016, SCIENCE, V351, P590, DOI 10.1126/science.aab1702; MacGregor JA, 2015, J GEOPHYS RES-EARTH, V120, P212, DOI 10.1002/2014JF003215; Members N, 2013, NATURE, V493, P489; Nielsen LT, 2015, ANN GLACIOL, V56, P70, DOI 10.3189/2015AoG70A062; REEH N, 1985, NATURE, V317, P797, DOI 10.1038/317797a0; Vinther BM, 2009, NATURE, V461, P385, DOI 10.1038/nature08355	10	2	2	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					562	563		10.1126/science.aad9997	http://dx.doi.org/10.1126/science.aad9997			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912689				2022-12-28	WOS:000369291600023
J	MacGregor, JA; Colgan, WT; Fahnestock, MA; Morlighem, M; Catania, GA; Paden, JD; Gogineni, SP				MacGregor, Joseph A.; Colgan, William T.; Fahnestock, Mark A.; Morlighem, Mathieu; Catania, Ginny A.; Paden, John D.; Gogineni, S. Prasad			Holocene deceleration of the Greenland Ice Sheet	SCIENCE			English	Article							MASS-BALANCE; INFERENCE; RETREAT; LAYERS	Recent peripheral thinning of the Greenland Ice Sheet is partly offset by interior thickening and is overprinted on its poorly constrained Holocene evolution. On the basis of the ice sheet's radiostratigraphy, ice flow in its interior is slower now than the average speed over the past nine millennia. Generally higher Holocene accumulation rates relative to modern estimates can only partially explain this millennial-scale deceleration. The ice sheet's dynamic response to the decreasing proportion of softer ice from the last glacial period and the deglacial collapse of the ice bridge across Nares Strait also contributed to this pattern. Thus, recent interior thickening of the Greenland Ice Sheet is partly an ongoing dynamic response to the last deglaciation that is large enough to affect interpretation of its mass balance from altimetry.	[MacGregor, Joseph A.; Catania, Ginny A.] Univ Texas Austin, Inst Geophys, Austin, TX 78758 USA; [Colgan, William T.] Geol Survey Denmark & Greenland, DK-1350 Copenhagen, Denmark; [Fahnestock, Mark A.] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Morlighem, Mathieu] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Catania, Ginny A.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Paden, John D.; Gogineni, S. Prasad] Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; [Colgan, William T.] York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 1P3, Canada	University of Texas System; University of Texas Austin; Geological Survey Of Denmark & Greenland; University of Alaska System; University of Alaska Fairbanks; University of California System; University of California Irvine; University of Texas System; University of Texas Austin; University of Kansas; York University - Canada	MacGregor, JA (corresponding author), Univ Texas Austin, Inst Geophys, Austin, TX 78758 USA.	joemac@ig.utexas.edu	Catania, Ginny/B-9787-2008; Colgan, William/H-1570-2014; Morlighem, Mathieu/O-9942-2014	Catania, Ginny/0000-0002-7561-5902; Colgan, William/0000-0001-6334-1660; Morlighem, Mathieu/0000-0001-5219-1310	NSF [ARC 1107753, ARC 1108058, ANT 0424589]; NASA [NNX12AB71G, NNX15AD55G]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NSF (grants ARC 1107753, ARC 1108058, and ANT 0424589) and NASA (grants NNX12AB71G and NNX15AD55G). We thank the organizations (Center for Remote Sensing of Ice Sheets and Operation IceBridge) and innumerable individuals who aided in the collection and processing of radar data used in this study. Most of the early radar data used in this study were collected as part of NASA's Program for Arctic Regional Climate Assessment, which was initiated by Dr. Robert Thomas. We also thank I. Joughin for providing the updated surface-velocity composite. J. A. M., M. A. F., and G. A. C. designed this study; J. D. P. and S. P. G. contributed to the collection and processing of the radar data; J. A. M., W. T. C., M. A. F., M. M., and G. A. C. analyzed the results and wrote the manuscript; and all authors discussed the results and edited the manuscript. Data are archived at the National Snow and Ice Data Center (http://nsidc.org/data/rrrag4).	Andrews LC, 2014, NATURE, V514, P80, DOI 10.1038/nature13796; Boschung J, 2013, CLIM CHANG 2013 PHYS, DOI 10.1017/CBO9781107415324.012; Box JE, 2013, J CLIMATE, V26, P6990, DOI 10.1175/JCLI-D-12-00546.1; Colgan W, 2015, ANN GLACIOL, V56, P105, DOI 10.3189/2015AoG70A967; Csatho BM, 2014, P NATL ACAD SCI USA, V111, P18478, DOI 10.1073/pnas.1411680112; Dahl-Jensen D, 2013, NATURE, V493, P489, DOI 10.1038/nature11789; England J, 2006, QUATERNARY SCI REV, V25, P689, DOI 10.1016/j.quascirev.2005.08.007; Ettema J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038110; Fahnestock M, 2001, SCIENCE, V294, P2338, DOI 10.1126/science.1065370; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Kjeldsen KK, 2015, NATURE, V528, P396, DOI 10.1038/nature16183; Le Brocq AM, 2006, COMPUT GEOSCI-UK, V32, P1780, DOI 10.1016/j.cageo.2006.05.003; MacGregor JA, 2015, J GEOPHYS RES-EARTH, V120, P212, DOI 10.1002/2014JF003215; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; McConnell JR, 2000, NATURE, V406, P877, DOI 10.1038/35022555; MEESE DA, 1994, SCIENCE, V266, P1680, DOI 10.1126/science.266.5191.1680; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Morlighem M, 2014, NAT GEOSCI, V7, P418, DOI [10.1038/NGEO2167, 10.1038/ngeo2167]; Mouginot J, 2015, SCIENCE, V350, P1357, DOI 10.1126/science.aac7111; Paterson WSB, 2001, NATURE, V414, P60, DOI 10.1038/35102044; PATERSON WSB, 1991, COLD REG SCI TECHNOL, V20, P75, DOI 10.1016/0165-232X(91)90058-O; Rasmussen SO, 2013, CLIM PAST, V9, P2713, DOI 10.5194/cp-9-2713-2013; REEH N, 1985, NATURE, V317, P797, DOI 10.1038/317797a0; Schenk T, 2012, IEEE T GEOSCI REMOTE, V50, P3302, DOI 10.1109/TGRS.2011.2182357; Seroussi H, 2013, J GLACIOL, V59, P1024, DOI 10.3189/2013JoG13J054; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Tedstone AJ, 2015, NATURE, V526, P692, DOI 10.1038/nature15722; Thomas R, 2000, SCIENCE, V289, P426, DOI 10.1126/science.289.5478.426; van de Berg WJ, 2011, NAT GEOSCI, V4, P679, DOI [10.1038/ngeo1245, 10.1038/NGEO1245]; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Vinther BM, 2009, NATURE, V461, P385, DOI 10.1038/nature08355; Waddington ED, 2007, J GLACIOL, V53, P694, DOI 10.3189/002214307784409351; WHILLANS IM, 1976, NATURE, V264, P152, DOI 10.1038/264152a0; Zreda M, 1999, NATURE, V398, P139, DOI 10.1038/18197; Zwally H.J., 2012, ANTARCTIC GREENLAND	37	34	34	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					590	593		10.1126/science.aab1702	http://dx.doi.org/10.1126/science.aab1702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912699	Green Published			2022-12-28	WOS:000369291600037
J	Ortiz, E; James, PA				Ortiz, Eduardo; James, Paul A.			Let's Not SPRINT to Judgment About New Blood Pressure Goals	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ortiz, Eduardo; James, Paul A.] Univ Iowa, 200 Hawkins Dr,01286-D PFP, Iowa City, IA 52242 USA; [Ortiz, Eduardo] 2318 Mill Rd,Suite 800, Alexandria, VA 22314 USA	University of Iowa	James, PA (corresponding author), Univ Iowa, 200 Hawkins Dr,01286-D PFP, Iowa City, IA 52242 USA.	paul-james@uiowa.edu	James, Paul/ABB-2761-2020					Hensley S., 2015, NPR HLTH NEWS   1109; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Montgomery AA, 2001, QUAL HEALTH CARE, V10, pI39; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Welch HG., 2012, OVERDIAGNOSED MAKING, V1st	7	18	18	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					692	+		10.7326/M15-3123	http://dx.doi.org/10.7326/M15-3123			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	26902415				2022-12-28	WOS:000375878500020
J	Chamberlain, JJ; Rhinehart, AS; Shaefer, CF; Neuman, A				Chamberlain, James J.; Rhinehart, Andrew S.; Shaefer, Charles F., Jr.; Neuman, Annie			Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							GLUCOSE CONTROL; CARDIOVASCULAR OUTCOMES; PERIPHERAL NEUROPATHY; SUBCUTANEOUS INSULIN; KIDNEY-DISEASE; OLDER-ADULTS; MELLITUS; HYPERGLYCEMIA; RISK; COMPLICATIONS	Description: The American Diabetes Association (ADA) published the 2016 Standards of Medical Care in Diabetes (Standards) to provide clinicians, patients, researchers, payers, and other interested parties with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. Methods: The ADA Professional Practice Committee performed a systematic search on MEDLINE to revise or clarify recommendations based on new evidence. The committee assigns the recommendations a rating of A, B, or C, depending on the quality of evidence. The E rating for expert opinion is assigned to recommendations based on expert consensus or clinical experience. The Standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community was incorporated into the 2016 revision. Recommendations: The synopsis focuses on 8 key areas that are important to primary care providers. The recommendations highlight individualized care to manage the disease, prevent or delay complications, and improve outcomes.	[Chamberlain, James J.; Neuman, Annie] St Marks Hosp, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA; St Marks Diabet Ctr, Salt Lake City, UT 84124 USA; [Rhinehart, Andrew S.] Glytec, 770 Pelham Rd,Suite 210, Greenville, SC 29615 USA; [Shaefer, Charles F., Jr.] Univ Phys Primary Care, 820 St Sebastian Way,Suite 4C, Augusta, GA 30901 USA; [Chamberlain, James J.; Neuman, Annie] St Marks Diabet Ctr, Internal Med St Marks, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA		Chamberlain, JJ (corresponding author), St Marks Hosp, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA.; Chamberlain, JJ (corresponding author), St Marks Diabet Ctr, Internal Med St Marks, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA.	jimchammd@yahoo.com			Merck; Sanofi Aventis; Janssen; Sanofi; Eli Lilly; AstraZeneca; Boehringer Ingelheim; Forest Pharmaceuticals; Vivus	Merck(Merck & Company); Sanofi Aventis(Sanofi-Aventis); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Sanofi; Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Forest Pharmaceuticals; Vivus	Dr. Chamberlain reports personal fees (speakers bureau) from Merck, Sanofi Aventis, and Janssen during the conduct of the study. Dr. Rhinehart reports personal fees from Sanofi, Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Janssen, Eli Lilly, Forest, and Glytec outside the submitted work. Dr. Shaefer reports personal fees from Sanofi, Eli Lilly, AstraZeneca, Boehringer Ingelheim, Janssen, Forest Pharmaceuticals, and Vivus; and nonfinancial support from Sanofi outside the submitted work. Ms. Neuman has disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-3016.	Arguedas JA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008277.pub2; Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS86, DOI 10.2337/dc16-S014; Ang L, 2014, CURR DIABETES REP, V14, P1, DOI 10.1007/s11892-014-0528-7; [Anonymous], 2014, CRUD AG ADJ HOSP DIS; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Chamberlain JJ, 2015, J DIABETES SCI TECHN; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Curll M, 2010, QUAL SAF HEALTH CARE, V19, P355, DOI 10.1136/qshc.2008.027441; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Draznin B, 2013, DIABETES CARE, V36, P1807, DOI 10.2337/dc12-2508; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0; Erickson SC, 2012, J AM GERIATR SOC, V60, P474, DOI 10.1111/j.1532-5415.2011.03842.x; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; Freeman R, 2009, CURR DIABETES REP, V9, P423, DOI 10.1007/s11892-009-0069-7; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Gerstein HC, 2000, LANCET, V355, P253; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hooper P, 2012, CAN J OPHTHALMOL, V47, pS1, DOI 10.1016/j.jcjo.2011.12.025; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Lambert AP, 2003, DIABETES CARE, V26, P333, DOI 10.2337/diacare.26.2.333; Lipska KJ, 2015, JAMA INTERN MED, V175, P356, DOI 10.1001/jamainternmed.2014.7345; Lipsky BA, 2012, CLIN INFECT DIS, V54, pE132, DOI [10.1093/cid/cis346, 10.1093/cid/cis460]; MannKind Corporation, 2014, BRIEF DOC END MET DR; Martin CL, 2014, DIABETES CARE, V37, P31, DOI 10.2337/dc13-2114; Maynard G, 2008, J HOSP MED, V3, pS29, DOI 10.1002/jhm.354; McBrien K, 2012, ARCH INTERN MED, V172, P1296, DOI 10.1001/archinternmed.2012.3147; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pop-Busui R, 2010, DIABETES CARE, V33, P1578, DOI 10.2337/dc10-0125; Rosenstock J, 2005, DIABETES CARE, V28, P950, DOI 10.2337/diacare.28.4.950; Sadosky A, 2013, DIABET METAB SYND OB, V6, P79, DOI 10.2147/DMSO.S37415; Schmeltz LR, 2007, DIABETES CARE, V30, P823, DOI 10.2337/dc06-2184; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; Shomali ME, 2011, DIABETES TECHNOL THE, V13, P121, DOI 10.1089/dia.2010.0124; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tuttle KR, 2014, AM J KIDNEY DIS, V64, P510, DOI [10.1053/j.ajkd.2014.08.001, 10.2337/dc14-1296]; Umpierrez GE, 2013, DIABETES CARE, V36, P2169, DOI 10.2337/dc12-1988; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vandorsten James P, 2013, NIH Consens State Sci Statements, V29, P1; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894; Wei N, 2014, DIABETES CARE, V37, P1048, DOI 10.2337/dc13-2173; Yeh Hsin-Chieh, 2012, Ann Intern Med, V157, P336; Young LH, 2009, JAMA-J AM MED ASSOC, V301, P1547, DOI 10.1001/jama.2009.476; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	65	384	419	4	69	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					542	+		10.7326/M15-3016	http://dx.doi.org/10.7326/M15-3016			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	26928912				2022-12-28	WOS:000374257900013
J	Solomon, KV; Haitjema, CH; Henske, JK; Gilmore, SP; Borges-Rivera, D; Lipzen, A; Brewer, HM; Purvine, SO; Wright, AT; Theodorou, MK; Grigoriev, IV; Regev, A; Thompson, DA; O'Malley, MA				Solomon, Kevin V.; Haitjema, Charles H.; Henske, John K.; Gilmore, Sean P.; Borges-Rivera, Diego; Lipzen, Anna; Brewer, Heather M.; Purvine, Samuel O.; Wright, Aaron T.; Theodorou, Michael K.; Grigoriev, Igor V.; Regev, Aviv; Thompson, Dawn A.; O'Malley, Michelle A.			Early-branching gut fungi possess a large, comprehensive array of biomass-degrading enzymes	SCIENCE			English	Article							CELL-WALL; ANTISENSE TRANSCRIPTS; GENOME; RNA; EXPRESSION; RUMEN; ORPINOMYCES; DISCOVERY; REVEALS; HISTORY	The fungal kingdom is the source of almost all industrial enzymes in use for lignocellulose bioprocessing. We developed a systems-level approach that integrates transcriptomic sequencing, proteomics, phenotype, and biochemical studies of relatively unexplored basal fungi. Anaerobic gut fungi isolated from herbivores produce a large array of biomass-degrading enzymes that synergistically degrade crude, untreated plant biomass and are competitive with optimized commercial preparations from Aspergillus and Trichoderma. Compared to these model platforms, gut fungal enzymes are unbiased in substrate preference due to a wealth of xylan-degrading enzymes. These enzymes are universally catabolite-repressed and are further regulated by a rich landscape of noncoding regulatory RNAs. Additionally, we identified several promising sequence-divergent enzyme candidates for lignocellulosic bioprocessing.	[Solomon, Kevin V.; Haitjema, Charles H.; Henske, John K.; Gilmore, Sean P.; O'Malley, Michelle A.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Borges-Rivera, Diego; Regev, Aviv; Thompson, Dawn A.] Broad Inst MIT & Harvard, Cambridge, MA 02143 USA; [Lipzen, Anna; Grigoriev, Igor V.] US DOE, Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA; [Brewer, Heather M.; Purvine, Samuel O.; Wright, Aaron T.] Pacific Northwest Natl Lab, Earth & Biol Sci Div, Richland, WA 99352 USA; [Brewer, Heather M.; Purvine, Samuel O.] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Theodorou, Michael K.] Harper Adams Univ, Anim Prod Welf & Vet Sci, Newport TF10 8NB, Shrops, England; [Solomon, Kevin V.] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Thompson, Dawn A.] Ginkgo Bioworks, Boston, MA 02210 USA	University of California System; University of California Santa Barbara; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus	O'Malley, MA (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	momalley@engineering.ucsb.edu	Henske, John/GQP-2638-2022; Purvine, Samuel O/O-3358-2017; Henske, John/ABH-3620-2020	Purvine, Samuel O/0000-0002-2257-2400; Grigoriev, Igor/0000-0002-3136-8903; Lipzen, Anna/0000-0003-2293-9329; Olson, Heather/0000-0002-4501-9587; Wright, Aaron/0000-0002-3172-5253; Solomon, Kevin/0000-0003-2904-9118	Office of Science [Biological and Environmental Research (BER) program], DOE [DE-SC0010352]; U.S. Department of Agriculture [2011-67017-20459]; Institute for Collaborative Biotechnologies [W911NF-09-0001]; Office of Science BER program [DE-AC02-05CH11231, DE-AC05-76RL01830]; EPSRC [EP/M007359/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/M007359/1] Funding Source: researchfish	Office of Science [Biological and Environmental Research (BER) program], DOE; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Institute for Collaborative Biotechnologies; Office of Science BER program; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank C. Ngan, C. Daum, E. Lindquist, and K. Barry for supervising library construction, transcriptome sequencing and analysis, and project management; K. Lee and L. Choe for proteomics support; P. Weimer for lignocellulosic substrates; and the Broad Institute core facilities for sequencing and computational assistance. Sequence and cluster descriptions are included in data S1 to S3, S8, and S9 in the supplementary materials. Raw sequence data and transcriptomic profiles reported in this study are deposited under BioProject accession no. PRJNA 291757 (www.ncbi.nlm.nih.gov/bioproject/291757). Expression data are deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) (29) and are accessible through GEO Series accession no. GSE64834 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64834). K.V.S., C.H.H., J.K.H., and M.A.O. are inventors on patent applications (UCSB 2014-075 and UCSB 2015-334), filed by The Reagents of the University of California, related to the production of anaerobic fungal enzymes. This work was supported by the Office of Science [Biological and Environmental Research (BER) program], DOE (grant DE-SC0010352); the U.S. Department of Agriculture (Award 2011-67017-20459); and the Institute for Collaborative Biotechnologies (grant W911NF-09-0001). A portion of this research was performed under the Joint Genome Institute (JGI)-Environmental Molecular Sciences Laboratory (EMSL) Collaborative Science Initiative and used resources at the DOE JGI and the EMSL, which are DOE Office of Science user facilities. Both facilities are sponsored by the Office of Science BER program and operated under contract nos. DE-AC02-05CH11231 (JGI) and DE-AC05-76RL01830 (EMSL). K.V.S., C.H.H., D.A.T., M.K.T., and M.A.O. planned the experiments. M.A.O., J.K.H., C.H.H., M.K.T., and K.V.S. isolated pure cultures of gut fungi. K.V.S., C.H.H., J.K.H., and M.A.O. performed growth and transcriptomic experiments. A.L. analyzed transcriptome sequencing. C.H.H., H.M.B., S.O.P., and A.T.W. performed proteomic analyses. S.P.G. performed enzyme characterization. K.V.S., D.B.-R., J.K.H., A.R., I.V.G., S.O.P., and S.P.G. facilitated bioinformatics analyses of the data sets. K.V.S., D.A.T., and M.A.O. wrote the manuscript.	Bakir U, 2001, ENZYME MICROB TECH, V29, P328, DOI 10.1016/S0141-0229(01)00379-9; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Dodds DR, 2007, SCIENCE, V318, P1250, DOI 10.1126/science.1146356; Donaldson ME, 2012, MOL MICROBIOL, V85, P405, DOI 10.1111/j.1365-2958.2012.08125.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finehout EJ, 2003, ELECTROPHORESIS, V24, P3508, DOI 10.1002/elps.200305615; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Haitjema CH, 2014, BIOTECHNOL BIOENG, V111, P1471, DOI 10.1002/bit.25264; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; King BC, 2009, BIOTECHNOL BIOENG, V102, P1033, DOI 10.1002/bit.22151; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; Lavergne S, 2004, CRIT REV PLANT SCI, V23, P415, DOI 10.1080/07352680490505934; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Nicholson MJ, 2005, MICROBIOL-SGM, V151, P121, DOI 10.1099/mic.0.27353-0; ORPIN CG, 1977, J GEN MICROBIOL, V99, P107, DOI 10.1099/00221287-99-1-107; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Raghothama S, 2001, NAT STRUCT BIOL, V8, P775, DOI 10.1038/nsb0901-775; Sanderson K, 2011, NATURE, V474, pS12, DOI 10.1038/474S012a; SCHULEIN M, 1988, METHOD ENZYMOL, V160, P234; Solomon KV, 2014, CURR OPIN BIOTECH, V28, P103, DOI 10.1016/j.copbio.2014.01.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Theodorou MK, 1996, P NUTR SOC, V55, P913, DOI 10.1079/PNS19960088; Todero Ritter C. E., 2013, ENZYME RES, V2013; Tuckwell DS, 2005, MICROBIOL-SGM, V151, P1557, DOI 10.1099/mic.0.27689-0; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Youssef NH, 2013, APPL ENVIRON MICROB, V79, P4620, DOI 10.1128/AEM.00821-13	29	160	175	6	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1192	1195		10.1126/science.aad1431	http://dx.doi.org/10.1126/science.aad1431			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26912365	Green Accepted, Green Submitted			2022-12-28	WOS:000386158400044
J	Huete, A				Huete, Alfredo			ECOLOGY Vegetation's responses to climate variability	NATURE			English	Editorial Material									[Huete, Alfredo] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Ultimo, NSW 2007, Australia	University of Technology Sydney	Huete, A (corresponding author), Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Ultimo, NSW 2007, Australia.	alfredo.huete@uts.edu.au	Huete, Alfredo R/C-1294-2008	Huete, Alfredo R/0000-0003-2809-2376				Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; De Keersmaecker W, 2014, GLOBAL CHANGE BIOL, V20, P2149, DOI 10.1111/gcb.12495; Guan KY, 2015, NAT GEOSCI, V8, P284, DOI 10.1038/NGEO2382; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Levine NM, 2016, P NATL ACAD SCI USA, V113, P793, DOI 10.1073/pnas.1511344112; Ma XL, 2015, J GEOPHYS RES-BIOGEO, V120, P2036, DOI 10.1002/2015JG003144; Musavi T, 2015, INT J APPL EARTH OBS, V43, P119, DOI 10.1016/j.jag.2015.05.009; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Ogle K, 2015, ECOL LETT, V18, P221, DOI 10.1111/ele.12399; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seddon AWR, 2016, NATURE, V531, P229, DOI 10.1038/nature16986	11	40	41	5	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					181	182		10.1038/nature17301	http://dx.doi.org/10.1038/nature17301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26886792				2022-12-28	WOS:000371665100029
J	Pattabiraman, DR; Bierie, B; Kober, KI; Thiru, P; Krall, JA; Zill, C; Reinhardt, F; Tam, WL; Weinberg, RA				Pattabiraman, Diwakar R.; Bierie, Brian; Kober, Katharina Isabelle; Thiru, Prathapan; Krall, Jordan A.; Zill, Christina; Reinhardt, Ferenc; Tam, Wai Leong; Weinberg, Robert A.			Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; BREAST-CANCER CELLS; CYCLIC-AMP; STEM-CELLS; SIGNALING AXIS; EXPRESSION; GROWTH; PHOSPHORYLATION; MECHANISMS; REPRESSION	The epithelial-to-mesenchymal transition enables carcinoma cells to acquire malignancy-associated traits and the properties of tumor-initiating cells (TICs). TICs have emerged in recent years as important targets for cancer therapy, owing to their ability to drive clinical relapse and enable metastasis. Here, we propose a strategy to eliminate mesenchymal TICs by inducing their conversion to more epithelial counterparts that have lost tumor-initiating ability. We report that increases in intracellular levels of the second messenger, adenosine 3', 5'-monophosphate, and the subsequent activation of protein kinase A (PKA) induce a mesenchymal-to-epithelial transition (MET) in mesenchymal human mammary epithelial cells. PKA activation triggers epigenetic reprogramming of TICs by the histone demethylase PHF2, which promotes their differentiation and loss of tumor-initiating ability. This study provides proof-of-principle for inducing an MET as differentiation therapy for TICs and uncovers a role for PKA in enforcing and maintaining the epithelial state.	[Pattabiraman, Diwakar R.; Bierie, Brian; Kober, Katharina Isabelle; Thiru, Prathapan; Krall, Jordan A.; Zill, Christina; Reinhardt, Ferenc; Tam, Wai Leong; Weinberg, Robert A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Tam, Wai Leong] Genome Inst Singapore, 60 Biopolis St, Singapore, Singapore; [Tam, Wai Leong] Canc Sci Inst Singapore, 14 Med Dr, Singapore, Singapore; [Weinberg, Robert A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Weinberg, RA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Weinberg, RA (corresponding author), MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Pattabiraman, Diwakar/AAE-6338-2020; Tam, Wai Leong/P-1497-2019	Pattabiraman, Diwakar/0000-0002-2418-6458; Tam, Wai Leong/0000-0003-2365-5264; Kober, Katharina Isabelle/0000-0002-8076-3379	C. J. Martin Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia [NHMRC APP1071853]; National Research Foundation, Singapore [NRF-NRFF2015-04]; National Medical Research Council, Singapore [NMRC/TCR/007-NCC/2013]; Ludwig Center for Molecular Oncology at MIT; Breast Cancer Research Foundation; Samuel Waxman Cancer Research Foundation; NIH [R01-CA078461]; NATIONAL CANCER INSTITUTE [R01CA078461] Funding Source: NIH RePORTER	C. J. Martin Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Research Foundation, Singapore(National Research Foundation, Singapore); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ludwig Center for Molecular Oncology at MIT; Breast Cancer Research Foundation; Samuel Waxman Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Keck Microscopy Facility, Metabolite Profiling Core Facility, Genome Technology Core, Bioinformatics and Research Computing Core, and Proteomics Core Facility at the Whitehead Institute; the Koch Institute Swanson Biotechnology Center (SBC), specifically the Histology Facility and the High-Throughput Screening Facility; J. Benson (SBC) for providing the compound library; D. Bachovchin (Broad Institute) for assistance with automation; and T. DiCesare for assistance with scientific illustration. We thank A. Dongre, S. Iyer, and J. Frose for technical assistance; all members of the Weinberg laboratory for helpful discussions; and A. Lambert, K. Krishnan, and S. Rajavasireddy for critical reading of the manuscript. D.R.P is supported by a C. J. Martin Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia (NHMRC APP1071853). W.L.T. is supported by the National Research Foundation, Singapore (NRF-NRFF2015-04); and National Medical Research Council, Singapore (NMRC/TCR/007-NCC/2013). This research was supported by the Ludwig Center for Molecular Oncology at MIT (R.A.W.), Breast Cancer Research Foundation (R.A.W.), Samuel Waxman Cancer Research Foundation (R.A.W.) and NIH R01-CA078461 (R.A.W.). R.A.W. is an American Cancer Society and D.K. Ludwig Foundation Cancer Research Professor. R.A.W. is a shareholder in and the chairman of the Scientific Advisory Board of Verastem, Inc., a company focused on developing drugs to treat cancer by the targeted killing of cancer stem cells. The Whitehead Institute and the authors (R.A.W., D.R.P., B.B., and W.L.T.) have filed a patent application (PCT/US2015/028239) that covers methods of differentiating cancer stem cells through the induction of a MET and the use of these methods for treating cancer. RNA-Seq and ChIP-Seq data from this study have been deposited at GEO under accession number GSE74883.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Anastassiou D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-529; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Broillet MC, 1999, ANN NY ACAD SCI, V868, P730, DOI 10.1111/j.1749-6632.1999.tb11352.x; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016466; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ellenrieder V, 2001, CANCER RES, V61, P4222; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREEN H, 1978, CELL, V15, P801, DOI 10.1016/0092-8674(78)90265-9; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HOLLESTELLE A, 2010, CANCER RES TREAT, V121, P53, DOI DOI 10.1007/S10549-009-0460-8; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Linnemann JR, 2015, DEVELOPMENT, V142, P3239, DOI 10.1242/dev.123554; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MEYER RB, 1974, LIFE SCI, V14, P1019, DOI 10.1016/0024-3205(74)90228-8; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nadella KS, 2008, CANCER RES, V68, P2671, DOI 10.1158/0008-5472.CAN-07-6002; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Propper DJ, 1999, CLIN CANCER RES, V5, P1682; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saunders MP, 1997, J CLIN ENDOCR METAB, V82, P4044, DOI 10.1210/jc.82.12.4044; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shaikh D, 2012, CELL SIGNAL, V24, P2396, DOI 10.1016/j.cellsig.2012.08.007; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Singh R, 2014, CELL SIGNAL, V26, P1604, DOI 10.1016/j.cellsig.2014.03.028; SOMMERS CL, 1990, CANCER RES, V50, P67; SOULE HD, 1990, CANCER RES, V50, P6075; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; TAYLORPAPADIMITRIOU J, 1980, J CELL PHYSIOL, V102, P317, DOI 10.1002/jcp.1041020306; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	60	211	216	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1042	+		10.1126/science.aad3680	http://dx.doi.org/10.1126/science.aad3680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941323	Green Accepted, Green Published			2022-12-28	WOS:000371597500033
J	Gu, YH; Li, HY; Dong, HH; Zeng, Y; Zhang, ZY; Paterson, NG; Stansfeld, PJ; Wang, ZS; Zhang, YZ; Wang, WJ; Dong, CJ				Gu, Yinghong; Li, Huanyu; Dong, Haohao; Zeng, Yi; Zhang, Zhengyu; Paterson, Neil G.; Stansfeld, Phillip J.; Wang, Zhongshan; Zhang, Yizheng; Wang, Wenjian; Dong, Changjiang			Structural basis of outer membrane protein insertion by the BAM complex	NATURE			English	Article							BARREL ASSEMBLY MACHINERY; ESCHERICHIA-COLI BAMB; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; ESSENTIAL COMPONENT; IN-VITRO; BIOGENESIS; SEQUENCE; DOMAIN; SIMULATIONS	All Gram-negative bacteria, mitochondria and chloroplasts have outer membrane proteins (OMPs) that perform many fundamental biological processes. The OMPs in Gram-negative bacteria are inserted and folded into the outer membrane by the beta-barrel assembly machinery (BAM). The mechanism involved is poorly understood, owing to the absence of a structure of the entire BAM complex. Here we report two crystal structures of the Escherichia coli BAM complex in two distinct states: an inward-open state and a lateral-open state. Our structures reveal that the five polypeptide transport-associated domains of BamA form a ring architecture with four associated lipoproteins, BamB-BamE, in the periplasm. Our structural, functional studies and molecular dynamics simulations indicate that these subunits rotate with respect to the integral membrane beta-barrel of BamA to induce movement of the beta-strands of the barrel and promote insertion of the nascent OMP.	[Gu, Yinghong; Li, Huanyu; Dong, Haohao; Zeng, Yi; Zhang, Zhengyu; Wang, Zhongshan; Dong, Changjiang] Univ E Anglia, Norwich Med Sch, Biomed Res Ctr, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Paterson, Neil G.] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England; [Wang, Zhongshan] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Peoples R China; [Wang, Zhongshan; Zhang, Yizheng] Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Minist Educ,Sichuan Key Lab Mol Biol & Biotechnol, Chengdu 610064, Peoples R China; [Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China	University of East Anglia; Diamond Light Source; University of Oxford; Xuzhou Medical University; Sichuan University; Sun Yat Sen University	Dong, CJ (corresponding author), Univ E Anglia, Norwich Med Sch, Biomed Res Ctr, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.; Wang, WJ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	w166w2000@aliyun.com; c.dong@uea.ac.uk	GU, Yinghong/D-2433-2010; Stansfeld, Phill/C-6213-2011; Stansfeld, Phillip James/AAA-9228-2020	GU, Yinghong/0000-0002-9364-1389; Stansfeld, Phill/0000-0001-8800-7669; Stansfeld, Phillip James/0000-0001-8800-7669; Paterson, Neil/0000-0003-4292-6971; Wang, Zhongshan/0000-0002-1321-3916	Wellcome Trust [WT106121MA]; Medical research council [G1100110/1]; Science and Technology Program of Guangzhou, China [201510010040]; China National Natural Science Foundation of Guangdong [2015A030313152]; MRC [G1100110] Funding Source: UKRI; Medical Research Council [G1100110] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical research council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Science and Technology Program of Guangzhou, China; China National Natural Science Foundation of Guangdong(National Natural Science Foundation of China (NSFC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. D. Bernstein for providing HDB150 strain and plasmid pJH114 and T. J. Silhavy for providing JCM166 cells. We appreciate the staff at I24, I02 and I03 of Diamond Light Source UK for beamtime (proposal mx9475) and their assistance with data collection. C.D. is a recipient of the Wellcome Trust investigator award (WT106121MA), and is supported by Medical research council (G1100110/1). W.W. acknowledges the support of the Science and Technology Program of Guangzhou, China (201510010040) and China National Natural Science Foundation of Guangdong (2015A030313152).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bender A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062277; Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Domanski J, 2010, J MEMBRANE BIOL, V236, P255, DOI 10.1007/s00232-010-9296-8; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P1134, DOI 10.1107/S0907444912023141; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P95, DOI 10.1107/S0907444911051031; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Hagan CL, 2013, BIOCHEMISTRY-US, V52, P6108, DOI 10.1021/bi400865z; Hagan CL, 2011, BIOCHEMISTRY-US, V50, P7444, DOI 10.1021/bi2010784; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Jansen KB, 2015, J BIOL CHEM, V290, P2126, DOI 10.1074/jbc.M114.584524; Jefferys E, 2015, J CHEM THEORY COMPUT, V11, P2743, DOI 10.1021/ct501111d; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; McMorran LM, 2014, ARCH BIOCHEM BIOPHYS, V564, P265, DOI 10.1016/j.abb.2014.02.011; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Misra R, 2015, J MOL BIOL, V427, P1061, DOI 10.1016/j.jmb.2014.04.021; Ni DC, 2014, FASEB J, V28, P2677, DOI 10.1096/fj.13-248450; Noinaj N, 2015, CURR OPIN STRUC BIOL, V31, P35, DOI 10.1016/j.sbi.2015.02.012; Noinaj N, 2014, CURR OPIN STRUC BIOL, V27, P8, DOI 10.1016/j.sbi.2014.02.007; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Piggot TJ, 2012, J CHEM THEORY COMPUT, V8, P4593, DOI 10.1021/ct3003157; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; Rigel NW, 2012, J BACTERIOL, V194, P1002, DOI 10.1128/JB.06426-11; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Sasaki K, 2012, AM J PHYSIOL-CELL PH, V303, pC1055, DOI 10.1152/ajpcell.00087.2012; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Stansfeld PJ, 2015, STRUCTURE, V23, P1350, DOI 10.1016/j.str.2015.05.006; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Tellez R, 2012, J BACTERIOL, V194, P317, DOI 10.1128/JB.06192-11; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Warner LR, 2011, J MOL BIOL, V411, P83, DOI 10.1016/j.jmb.2011.05.022; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; YORK DM, 1994, P NATL ACAD SCI USA, V91, P8715, DOI 10.1073/pnas.91.18.8715	65	176	181	13	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					64	+		10.1038/nature17199	http://dx.doi.org/10.1038/nature17199			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26901871	Green Accepted, Green Submitted			2022-12-28	WOS:000371211900040
J	McMahon, LF; Tipirneni, R; Chopra, V				McMahon, Laurence F., Jr.; Tipirneni, Renuka; Chopra, Vineet			Health System Loyalty Programs An Innovation in Customer Care and Service	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McMahon, Laurence F., Jr.; Tipirneni, Renuka; Chopra, Vineet] Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA; [McMahon, Laurence F., Jr.; Tipirneni, Renuka; Chopra, Vineet] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chopra, V (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, 2800 Plymouth Rd,Bldg 16,Rm 432 W, Ann Arbor, MI 48109 USA.	vineetc@umich.edu		Chopra, Vineet/0000-0001-8670-9376	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS022835] Funding Source: NIH RePORTER; AHRQ HHS [1-K08-HS022835-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bolton RN, 2000, J ACAD MARKET SCI, V28, P95, DOI 10.1177/0092070300281009; Clarke Shoa L., 2015, NY TIMES; Evaluation of the Medicare Physician Group Practice Demonstration, 2015, EV MED PHYS GROUP PR; L & MPolicy Research, 2015, EV CMMI ACC CAR ORG; Starvish M., 2011, CUSTOMER LOYALTY PRO; Yakovenko A., 2015, WHAT DRIVES CONSUMER	6	1	1	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					863	864		10.1001/jama.2015.19463	http://dx.doi.org/10.1001/jama.2015.19463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934255	Green Published			2022-12-28	WOS:000371077500011
J	Kietrys, AM; Kool, ET				Kietrys, Anna M.; Kool, Eric T.			EPIGENETICS A new methyl mark on messengers	NATURE			English	Editorial Material							RNA; REPAIR; DAMAGE; DNA		[Kietrys, Anna M.; Kool, Eric T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Kietrys, AM; Kool, ET (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	akietrys@stanford.edu; kool@stanford.edu		Kietrys, Anna M/0000-0002-8725-9079; Kool, Eric/0000-0002-7310-2935	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106067, R01GM110050] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM106067, R01 GM110050] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Li X., 2016, NATURE CHEM BIOL; MACON JB, 1968, BIOCHEMISTRY-US, V7, P3453, DOI 10.1021/bi00850a021; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Mishima E, 2014, J AM SOC NEPHROL, V25, P2316, DOI 10.1681/ASN.2013091001; Singer B., 1983, MOL BIOL MUTAGENS CA	11	7	7	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					423	424		10.1038/530423a	http://dx.doi.org/10.1038/530423a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911777	Green Accepted			2022-12-28	WOS:000370690800021
J	Semlow, DR; Blanco, MR; Walter, NG; Staley, JP				Semlow, Daniel R.; Blanco, Mario R.; Walter, Nils G.; Staley, Jonathan P.			Spliceosomal DEAH-Box ATPases Remodel Pre-mRNA to Activate Alternative Splice Sites	CELL			English	Article							CONFORMATIONAL DYNAMICS; DEPENDENT ATPASE; DISCARD PATHWAY; EXON LIGATION; IN-VITRO; YEAST; SELECTION; PRP16; FIDELITY; STEP	During pre-mRNA splicing, a central step in the expression and regulation of eukaryotic genes, the spliceosome selects splice sites for intron excision and exon ligation. In doing so, the spliceosome must distinguish optimal from suboptimal splice sites. At the catalytic stage of splicing, suboptimal splice sites are repressed by the DEAH-box ATPases Prp16 and Prp22. Here, using budding yeast, we show that these ATPases function further by enabling the spliceosome to search for and utilize alternative branch sites and 30 splice sites. The ATPases facilitate this search by remodeling the splicing substrate to disengage candidate splice sites. Our data support a mechanisminvolving 30 to 50 translocation of the ATPases along substrate RNA and toward a candidate site, but, surprisingly, not across the site. Thus, our data implicate DEAH-box ATPases in acting at a distance by pulling substrate RNA from the catalytic core of the spliceosome.	[Semlow, Daniel R.] Univ Chicago, Grad Program Cell & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA; [Blanco, Mario R.] Univ Michigan, Cellular & Mol Biol, 930 North Univ Ave, Ann Arbor, MI 48109 USA; [Blanco, Mario R.; Walter, Nils G.] Univ Michigan, Dept Chem, Single Mol Anal Grp, 930 North Univ Ave, Ann Arbor, MI 48109 USA; [Staley, Jonathan P.] Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA	University of Chicago; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Chicago	Staley, JP (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.	jstaley@uchicago.edu	Walter, Nils/P-3163-2019; Walter, Nils G/G-7504-2016	Walter, Nils/0000-0002-7301-1275; Walter, Nils G/0000-0002-7301-1275	Genetics and Regulation Training Grant from the NIH [T32GM07197]; Cellular and Molecular Biology Training Grant from the NIH [T32GM007315]; NIH [R01GM062264, R01GM062264-08S1, R01GM098023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, R01GM098023, T32GM007197, R01GM062264] Funding Source: NIH RePORTER	Genetics and Regulation Training Grant from the NIH; Cellular and Molecular Biology Training Grant from the NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Schwer and C. Guthrie for plasmids and antibodies, J. Abelson and C. Guthrie for sharing unpublished data, the members of the J.P.S. and N.G.W. laboratories for helpful discussions, especially S. Fica, M. Kahlscheuer, and R. Toroney, who also provided experimental assistance, and C. Guthrie, A. Hoskins, and J. Piccirilli for comments on the manuscript. D.R.S. and M.R.B. were supported by a Genetics and Regulation Training Grant (T32GM07197) and a Cellular and Molecular Biology Training Grant (T32GM007315), respectively, both from the NIH. This work was funded by grants from the NIH (R01GM062264 and R01GM062264-08S1 to J.P.S.; R01GM098023 to N.G.W.).	Abelson J, 2010, NAT STRUCT MOL BIOL, V17, P504, DOI 10.1038/nsmb.1767; Blanco M, 2010, METHOD ENZYMOL, V472, P153, DOI 10.1016/S0076-6879(10)72011-5; Blanco MR, 2015, NAT METHODS, V12, P1077, DOI [10.1038/NMETH.3602, 10.1038/nmeth.3602]; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Chen SY, 2000, P NATL ACAD SCI USA, V97, P593, DOI 10.1073/pnas.97.2.593; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; Crawford DJ, 2013, P NATL ACAD SCI USA, V110, P6783, DOI 10.1073/pnas.1219305110; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Hilliker AK, 2007, GENE DEV, V21, P821, DOI 10.1101/gad.1536107; James SA, 2002, RNA, V8, P1068, DOI 10.1017/S1355838202022033; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kannan R, 2013, GENE DEV, V27, P627, DOI 10.1101/gad.212738.112; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; Krishnan R, 2013, NAT STRUCT MOL BIOL, V20, P1450, DOI 10.1038/nsmb.2704; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; McPheeters DS, 2003, MOL CELL BIOL, V23, P4174, DOI 10.1128/MCB.23.12.4174-4186.2003; Mefford MA, 2009, RNA, V15, P1386, DOI 10.1261/rna.1582609; Ohrt T, 2013, RNA, V19, P902, DOI 10.1261/rna.039024.113; Ohrt T, 2012, RNA, V18, P1244, DOI 10.1261/rna.033316.112; Ozgur S, 2015, FEBS J, V282, P850, DOI 10.1111/febs.13198; PATTERSON B, 1991, CELL, V64, P181, DOI 10.1016/0092-8674(91)90219-O; Perez-Valle J, 2012, WIRES RNA, V3, P707, DOI 10.1002/wrna.1131; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Prabu JR, 2015, MOL CELL, V60, P487, DOI 10.1016/j.molcel.2015.10.011; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; Smith DJ, 2007, MOL CELL, V26, P883, DOI 10.1016/j.molcel.2007.05.020; Smith DJ, 2009, MOL CELL, V34, P333, DOI 10.1016/j.molcel.2009.03.012; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; Umen JG, 1995, RNA, V1, P869; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang Y, 1998, CURR BIOL, V8, P441, DOI 10.1016/S0960-9822(98)70178-2; Warkocki Z, 2015, GENE DEV, V29, P94, DOI 10.1101/gad.253070.114; Wlodaver AM, 2014, RNA, V20, P282, DOI 10.1261/rna.042598.113	42	93	93	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					985	998		10.1016/j.cell.2016.01.025	http://dx.doi.org/10.1016/j.cell.2016.01.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919433	Green Accepted, Bronze			2022-12-28	WOS:000370867300021
J	Tang, W; Tu, S; Lee, HC; Weng, ZP; Mello, CC				Tang, Wen; Tu, Shikui; Lee, Heng-Chi; Weng, Zhiping; Mello, Craig C.			The RNase PARN-1 Trims piRNA 3 ' Ends to Promote Transcriptome Surveillance in C. elegans	CELL			English	Article							PIWI-INTERACTING RNAS; GERMLINE GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; POLY(A)-SPECIFIC RIBONUCLEASE; EPIGENETIC MEMORY; BIOGENESIS; DROSOPHILA; MICRORNAS; ZUCCHINI; PATHWAY	Piwi-interacting RNAs (piRNAs) engage Piwi proteins to suppress transposons and are essential for fertility in diverse organisms. An interesting feature of piRNAs is that, while piRNA lengths are stereotypical within a species, they can differ widely between species. For example, piRNAs are mainly 29 and 30 nucleotides in humans, 24 to 30 nucleotides in D. melanogaster, and uniformly 21 nucleotides in C. elegans. However, how piRNA length is determined and whether length impacts function remains unknown. Here, we show that C. elegans deficient for PARN-1, a conserved RNase, accumulate untrimmed piRNAs with 3' extensions. Surprisingly, these longer piRNAs are stable and associate with the Piwi protein PRG-1 but fail to robustly recruit downstream silencing factors. Our findings identify PARN-1 as a key regulator of piRNA length in C. elegans and suggest that length is regulated to promote efficient transcriptome surveillance.	[Tang, Wen; Lee, Heng-Chi; Mello, Craig C.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Tu, Shikui; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Mello, Craig C.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Lee, Heng-Chi] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Chicago; University of Chicago	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA.; Mello, CC (corresponding author), Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA.	craig.mello@umassmed.edu		Lee, Heng-Chi/0000-0001-8154-906X	Hope Funds for Cancer Research Postdoctoral fellowship; NIH Pathway to Independence Award [GM108866]; NIH [HD078253, GM058800]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD078253] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058800, K99GM108866, R01GM058800, R00GM108866] Funding Source: NIH RePORTER	Hope Funds for Cancer Research Postdoctoral fellowship; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tomari for sharing unpublished data; S. Mitani for parn-1 (tm869) and parn-2 (tm1339) strains; J. Kim for the henn-1 (tm4477) mutant; E. Kittler and the University of Massachusetts Deep Sequencing Core for Illumina sequencing; M. Shirayama for his assistance with molecular cloning and generating parn-1; parn-2 double mutants; W. Gu for bioinformatic analysis; D. Conte for comments on the text; and members of the Mello and Ambros labs and Y. Zhang for discussion. Some of the strains were provided by the Caenorhabditis Genetics Center. This work was supported in part by a Hope Funds for Cancer Research Postdoctoral fellowship to W.T.; an NIH Pathway to Independence Award (GM108866) to H.-C.L.; an NIH grant (HD078253) to Z.W.; and NIH grants (GM058800 and HD078253) to C.C.M. C.C.M. is a Howard Hughes Medical Institute Investigator.	Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; ASTROM J, 1992, J BIOL CHEM, V267, P18154; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Barberan-Soler S, 2014, CELL REP, V8, P1609, DOI 10.1016/j.celrep.2014.08.016; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berndt H, 2012, RNA, V18, P958, DOI 10.1261/rna.032292.112; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRENNER S, 1974, GENETICS, V77, P71; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Conine CC, 2013, CELL, V155, P1532, DOI 10.1016/j.cell.2013.11.032; Conte Jr D., 2015, CURR PROTOC MOL BIOL, V109, P1; Conte Jr D., 2015, CURR PROTOC MOL BIOL, V109, P30; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Deerberg A, 2013, P NATL ACAD SCI USA, V110, P17850, DOI 10.1073/pnas.1217838110; Feltzin VL, 2015, AGING CELL, V14, P443, DOI 10.1111/acel.12323; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gu WF, 2012, CELL, V151, P1488, DOI 10.1016/j.cell.2012.11.023; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Honda S, 2013, RNA, V19, P1405, DOI 10.1261/rna.040428.113; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Izumi N, 2016, CELL, V164, P962, DOI 10.1016/j.cell.2016.01.008; Kamminga LM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002702; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002901; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu L, 2011, DEVELOPMENT, V138, P1863, DOI 10.1242/dev.059287; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marasovic M, 2013, MOL CELL, V52, P173, DOI 10.1016/j.molcel.2013.08.046; Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Nousch M, 2013, J CELL SCI, V126, P4274, DOI 10.1242/jcs.132936; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Ren YG, 2004, J BIOL CHEM, V279, P48702, DOI 10.1074/jbc.M403858200; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Saxe JP, 2013, EMBO J, V32, P1869, DOI 10.1038/emboj.2013.121; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Simon B, 2011, STRUCTURE, V19, P172, DOI 10.1016/j.str.2010.11.015; Simon M, 2014, CELL REP, V7, P762, DOI 10.1016/j.celrep.2014.03.056; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tian YA, 2011, P NATL ACAD SCI USA, V108, P903, DOI 10.1073/pnas.1017762108; van der Heijden GW, 2010, CURR OPIN CELL BIOL, V22, P752, DOI 10.1016/j.ceb.2010.08.014; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016; Weick EM, 2014, GENE DEV, V28, P783, DOI 10.1101/gad.238105.114; Yoda M, 2013, CELL REP, V5, P715, DOI 10.1016/j.celrep.2013.09.029; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	79	77	80	2	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					974	984		10.1016/j.cell.2016.02.008	http://dx.doi.org/10.1016/j.cell.2016.02.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919432	Green Accepted, Bronze			2022-12-28	WOS:000370867300020
J	Koven, S				Koven, Suzanne			The Doctor's New Dilemma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koven, Suzanne] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Koven, S (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; WEINBERG RB, 1995, ANN INTERN MED, V123, P804, DOI 10.7326/0003-4819-123-10-199511150-00011	2	10	10	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					608	609		10.1056/NEJMp1513708	http://dx.doi.org/10.1056/NEJMp1513708			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD9ER	26886520				2022-12-28	WOS:000370229000006
J	Ma, EH; Jones, RG				Ma, Eric H.; Jones, Russell G.			(TORC)ing up purine biosynthesis	SCIENCE			English	Editorial Material							MTOR		[Ma, Eric H.; Jones, Russell G.] McGill Univ, Dept Physiol, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Ma, Eric H.; Jones, Russell G.] McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Jones, RG (corresponding author), McGill Univ, Dept Physiol, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; Jones, RG (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	russell.jones@mcgill.ca	Jones, Russell Graham/ABD-5261-2021; Jones, Russell/AAC-2861-2022	Jones, Russell Graham/0000-0003-2250-4675; 				An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Cunningham JT, 2014, CELL, V157, P1088, DOI 10.1016/j.cell.2014.03.052; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Yamaoka T, 1997, J BIOL CHEM, V272, P17719, DOI 10.1074/jbc.272.28.17719	12	6	6	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					670	671		10.1126/science.aaf1929	http://dx.doi.org/10.1126/science.aaf1929			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912848				2022-12-28	WOS:000369810000025
J	Rivera, P; Seyler, KL; Yu, HY; Schaibley, JR; Yan, JQ; Mandrus, DG; Yao, W; Xu, XD				Rivera, Pasqual; Seyler, Kyle L.; Yu, Hongyi; Schaibley, John R.; Yan, Jiaqiang; Mandrus, David G.; Yao, Wang; Xu, Xiaodong			Valley-polarized exciton dynamics in a 2D semiconductor heterostructure	SCIENCE			English	Article							MOLYBDENUM-DISULFIDE; DIRAC FERMIONS; WAALS; GENERATION; TRANSPORT; MOS2	Heterostructures comprising different monolayer semiconductors provide an attractive setting for fundamental science and device technologies, such as in the emerging field of valleytronics. We realized valley-specific interlayer excitons in monolayer WSe2-MoSe2 vertical heterostructures. We created interlayer exciton spin-valley polarization by means of circularly polarized optical pumping and determined a valley lifetime of 40 nanoseconds. This long-lived polarization enables the visualization of the expansion of a valley-polarized exciton cloud over several micrometers. The spatial pattern of the polarization evolves into a ring with increasing exciton density, a manifestation of valley exciton exchange interactions. Our work introduces van der Waals heterostructures as a promising platform from which to study valley exciton physics.	[Rivera, Pasqual; Seyler, Kyle L.; Schaibley, John R.; Xu, Xiaodong] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Yu, Hongyi; Yao, Wang] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Yu, Hongyi; Yao, Wang] Univ Hong Kong, Ctr Theoret & Computat Phys, Hong Kong, Hong Kong, Peoples R China; [Yan, Jiaqiang; Mandrus, David G.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Yan, Jiaqiang; Mandrus, David G.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Mandrus, David G.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Xu, Xiaodong] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Hong Kong; University of Hong Kong; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Washington; University of Washington Seattle	Xu, XD (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.; Xu, XD (corresponding author), Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.	xuxd@uw.edu	Yao, Wang/C-1353-2008; Yu, Hongyi/ABD-5124-2021	Yao, Wang/0000-0003-2883-4528; Yu, Hongyi/0000-0002-4121-3294; Yan, Jiaqiang/0000-0001-6625-4706	U.S. Department of Energy (DOE), Basic Energy Sciences (BES), Materials Sciences and Engineering Division [DE-SC0008145, SC0012509]; Croucher Foundation; Research Grants Council; University Grants Committee of Hong Kong [HKU17305914P, HKU9/CRF/13G, AoE/P-04/08]; DOE, BES, Materials Sciences and Engineering Division; Cottrell Scholar Award; State of Washington; NSF;  [NSF-EFRI-1433496]	U.S. Department of Energy (DOE), Basic Energy Sciences (BES), Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Croucher Foundation; Research Grants Council(Hong Kong Research Grants Council); University Grants Committee of Hong Kong; DOE, BES, Materials Sciences and Engineering Division; Cottrell Scholar Award; State of Washington; NSF(National Science Foundation (NSF)); 	We thank D. Cobden and F. Wang for helpful discussion. This work is mainly supported by the U.S. Department of Energy (DOE), Basic Energy Sciences (BES), Materials Sciences and Engineering Division (DE-SC0008145 and SC0012509). The spectroscopy work is partially supported by NSF-EFRI-1433496. H.Y. and W.Y. were supported by the Croucher Foundation (Croucher Innovation Award), and the Research Grants Counciland University Grants Committee of Hong Kong (HKU17305914P, HKU9/CRF/13G, AoE/P-04/08). J.Y. and D.G.M. were supported by the DOE, BES, Materials Sciences and Engineering Division. X.X. acknowledges a Cottrell Scholar Award and support from the State of Washington-funded Clean Energy Institute. Device fabrication was performed at the University of Washington Microfabrication Facility and NSF-funded Nanotech User Facility. Data described in this paper are presented in the supplementary materials and are available upon request. X.X. and W.Y. conceived and supervised the project. P.R. and K.L.S. fabricated the samples and performed the experiments, assisted by J.R.S. P.R., K.L.S., and X.X. analyzed data. H.Y. and W.Y. provided theoretical support and performed the simulation. J.Y. and D.G.M. synthesized and characterized the bulk crystal. P.R., K.L.S., X.X., W.Y., and H.Y. cowrote the paper. All authors discussed the results.	Butov LV, 2002, NATURE, V418, P751, DOI 10.1038/nature00943; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Ceballos F, 2014, ACS NANO, V8, P12717, DOI 10.1021/nn505736z; Cheng R, 2014, NANO LETT, V14, P5590, DOI 10.1021/nl502075n; Chiu MH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8666; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Fang H, 2014, P NATL ACAD SCI USA, V111, P6198, DOI 10.1073/pnas.1405435111; FINKMAN E, 1986, APPL PHYS LETT, V49, P1299, DOI 10.1063/1.97392; Fogler MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5555; Furchi MM, 2014, NANO LETT, V14, P4785, DOI 10.1021/nl501962c; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; GILLILAND GD, 1993, PHYS REV LETT, V71, P3717, DOI 10.1103/PhysRevLett.71.3717; Gong YJ, 2014, NAT MATER, V13, P1135, DOI [10.1038/NMAT4091, 10.1038/nmat4091]; Hong XP, 2014, NAT NANOTECHNOL, V9, P682, DOI [10.1038/NNANO.2014.167, 10.1038/nnano.2014.167]; Hsu WT, 2014, ACS NANO, V8, P2951, DOI 10.1021/nn500228r; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Kang J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4774090; Kosmider K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.075451; Lee CH, 2014, NAT NANOTECHNOL, V9, P676, DOI [10.1038/NNANO.2014.150, 10.1038/nnano.2014.150]; Leonard JR, 2009, NANO LETT, V9, P4204, DOI 10.1021/nl9024227; Lin YC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8311; Liu KH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5966; Mai C, 2014, NANO LETT, V14, P202, DOI 10.1021/nl403742j; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Rivera P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7242; Snoke D, 2002, NATURE, V418, P754, DOI 10.1038/nature00940; Terrones H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01549; van der Zande AM, 2014, NANO LETT, V14, P3869, DOI 10.1021/nl501077m; Wang QS, 2013, ACS NANO, V7, P11087, DOI 10.1021/nn405419h; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhu CR, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.161302; Zomer PJ, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4886096	35	498	505	45	638	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					688	691		10.1126/science.aac7820	http://dx.doi.org/10.1126/science.aac7820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912854				2022-12-28	WOS:000369810000035
J	Warren, KE; Tay, S; Wen, LS				Warren, Katherine E.; Tay, Shirli; Wen, Leana S.			Patient and Public Risks of Powdered Alcohol: A Citywide Case Study to Prevent Abuse	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Warren, Katherine E.; Tay, Shirli; Wen, Leana S.] Baltimore City Dept Hlth, 1001 East Fayette St, Baltimore, MD 21202 USA		Wen, LS (corresponding author), Baltimore City Dept Hlth, 1001 East Fayette St, Baltimore, MD 21202 USA.	health.commissioner@baltimorecity.gov						*CDCP, 2015, FACT SHEETS UND DRIN; Choi C., 2015, HUFFINGTON POST; Harrington PM, 2015, GETTING SERIOUS PALC; Metzner C, 2008, ALCOHOL ALCOHOLISM, V43, P230, DOI 10.1093/alcalc/agm148; Naimi TS, 2015, JAMA-J AM MED ASSOC, V314, P119, DOI 10.1001/jama.2015.6450; Schmidt S, 2014, 2014 NAT C STAT LEG; Stogner J, 2015, BEVERAGES, V1, P329, DOI 10.3390/beverages1040329	7	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					685	+		10.7326/M15-2291	http://dx.doi.org/10.7326/M15-2291			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL8GF	26881915				2022-12-28	WOS:000375878500017
J	Hallsworth, M; Chadborn, T; Sallis, A; Sanders, M; Berry, D; Greaves, F; Clements, L; Davies, SC				Hallsworth, Michael; Chadborn, Tim; Sallis, Anna; Sanders, Michael; Berry, Daniel; Greaves, Felix; Clements, Lara; Davies, Sally C.			Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial	LANCET			English	Article							INTERVENTIONS; RESISTANCE	Background Unnecessary antibiotic prescribing contributes to antimicrobial resistance. In this trial, we aimed to reduce unnecessary prescriptions of antibiotics by general practitioners (GPs) in England. Methods In this randomised, 2 x 2 factorial trial, publicly available databases were used to identify GP practices whose prescribing rate for antibiotics was in the top 20% for their National Health Service (NHS) Local Area Team. Eligible practices were randomly assigned (1: 1) into two groups by computer-generated allocation sequence, stratified by NHS Local Area Team. Participants, but not investigators, were blinded to group assignment. On Sept 29, 2014, every GP in the feedback intervention group was sent a letter from England's Chief Medical Officer and a leaflet on antibiotics for use with patients. The letter stated that the practice was prescribing antibiotics at a higher rate than 80% of practices in its NHS Local Area Team. GPs in the control group received no communication. The sample was re-randomised into two groups, and in December, 2014, GP practices were either sent patient-focused information that promoted reduced use of antibiotics or received no communication. The primary outcome measure was the rate of antibiotic items dispensed per 1000 weighted population, controlling for past prescribing. Analysis was by intention to treat. This trial is registered with the ISRCTN registry, number ISRCTN32349954, and has been completed. Findings Between Sept 8 and Sept 26, 2014, we recruited and assigned 1581 GP practices to feedback intervention (n=791) or control (n=790) groups. Letters were sent to 3227 GPs in the intervention group. Between October, 2014, and March, 2015, the rate of antibiotic items dispensed per 1000 population was 126.98 (95% CI 125.68-128.27) in the feedback intervention group and 131.25 (130.33-132.16) in the control group, a difference of 4.27 (3.3%; incidence rate ratio [IRR] 0.967 [95% CI 0.957-0.977]; p<0.0001), representing an estimated 73 406 fewer antibiotic items dispensed. In December, 2014, GP practices were re-assigned to patient-focused intervention (n=777) or control (n=804) groups. The patient-focused intervention did not significantly affect the primary outcome measure between December, 2014, and March, 2015 (antibiotic items dispensed per 1000 population: 135.00 [95% CI 133.77-136.22] in the patient-focused intervention group and 133.98 [133.06-134.90] in the control group; IRR for difference between groups 1.01, 95% CI 1.00-1.02; p=0.105). Interpretation Social norm feedback from a high-profile messenger can substantially reduce antibiotic prescribing at low cost and at national scale; this outcome makes it a worthwhile addition to antimicrobial stewardship programmes. Copyright (C) Hallsworth et al. Open Access article distributed under the terms of CC BY-NC-ND.	[Hallsworth, Michael; Sanders, Michael] Behav Insights Team, 33 Greycoat St, London SW1P 2QF, England; [Chadborn, Tim; Sallis, Anna; Greaves, Felix; Clements, Lara] Publ Hlth England, London, England; [Berry, Daniel; Davies, Sally C.] Dept Hlth, London SE1 6TE, England; [Hallsworth, Michael] Univ London Imperial Coll Sci Technol & Med, London, England; [Sanders, Michael] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Public Health England; Imperial College London; Harvard University	Hallsworth, M (corresponding author), Behav Insights Team, 33 Greycoat St, London SW1P 2QF, England.	michael.hallsworth@behaviouralinsights.co.uk	Greaves, Felix/A-1324-2012; Greaves, Felix/AAL-5891-2021	Greaves, Felix/0000-0001-9393-3122; Greaves, Felix/0000-0001-9393-3122	Public Health England; National Institute for Health Research [ACF-2009-21-030] Funding Source: researchfish	Public Health England; National Institute for Health Research(National Institute for Health Research (NIHR))	Public Health England.	Arnold SR, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003539.PUB2; Arroll B, 2005, RESP MED, V99, P255, DOI 10.1016/j.rmed.2004.11.004; Brinol P, 2009, EUR REV SOC PSYCHOL, V20, P49, DOI 10.1080/10463280802643640; Coenen S, 2006, BRIT J GEN PRACT, V56, P183; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Davies SC, 2013, LANCET, V381, P1606, DOI 10.1016/S0140-6736(13)60604-2; Drekonja DM, 2015, INFECT CONT HOSP EP, V36, P142, DOI 10.1017/ice.2014.41; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Hawker JI, 2014, J ANTIMICROB CHEMOTH, V69, P3423, DOI 10.1093/jac/dku291; Health and Social Care Information Centre, 2013, PRESCR GP PRACT; Health and Social Care Information Centre, 2015, PRESCR DISP COMM ENG; HM Government, 2014, UK 5 YEAR ANT RES AM; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Kazdin AE., 2001, BEHAV MODIFICATION A; Lay P, 1997, CAMBRIDGE HDB PSYCHO, P331; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Naughton C, 2009, J EVAL CLIN PRACT, V15, P807, DOI 10.1111/j.1365-2753.2008.01099.x; NHS Business Services Authority, 2015, AM DRUG TAR APR 2 3A; Pinder R., 2015, BEHAV CHANGE ANTIBIO; Public Health England, 2014, MAN INF GUID PRIM CA; Public Health England, ENGL SURV PROGR ANT; Ranji SR, 2008, MED CARE, V46, P847, DOI 10.1097/MLR.0b013e318178eabd; The National Institute for Health and Care Excellence, 2015, SELF LIM RESP TRACT; Tonkin-Crine S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3413; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; Wang J., 2014, USE DESCRIPTIVE NORM; Wang KY, 2009, BRIT J GEN PRACT, V59, P724, DOI 10.3399/bjgp09X472593; World Health Organization, 2016, ANTIMICROBIAL RESIST	30	232	232	2	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1743	1752		10.1016/S0140-6736(16)00215-4	http://dx.doi.org/10.1016/S0140-6736(16)00215-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ9OD	26898856	Green Published, hybrid			2022-12-28	WOS:000374541900027
J	Llambi, F; Wang, YM; Victor, B; Yang, M; Schneider, DM; Gingras, S; Parsons, MJ; Zheng, JH; Brown, SA; Pelletier, S; Moldoveanu, T; Chen, TS; Green, DR				Llambi, Fabien; Wang, Yue-Ming; Victor, Bernadette; Yang, Mao; Schneider, Desiree M.; Gingras, Sebastien; Parsons, Melissa J.; Zheng, Janet H.; Brown, Scott A.; Pelletier, Stephane; Moldoveanu, Tudor; Chen, Taosheng; Green, Douglas R.			BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation	CELL			English	Article							UNFOLDED-PROTEIN-RESPONSE; MEMBER BOK; DIFFERENTIAL REGULATION; PROTEASOME INHIBITORS; OXIDATIVE STRESS; BAX; INITIATION; CELLS; OLIGOMERIZATION; EXPRESSION	The mitochondrial pathway of apoptosis is initiated by mitochondrial outer membrane permeabilization (MOMP). The BCL-2 family effectors BAX and BAK are thought to be absolutely required for this process. Here, we report that BCL-2 ovarian killer (BOK) is a bona fide yet unconventional effector of MOMP that can trigger apoptosis in the absence of both BAX and BAK. However, unlike the canonical effectors, BOK appears to be constitutively active and unresponsive to antagonistic effects of the antiapoptotic BCL-2 proteins. Rather, BOK is controlled at the level of protein stability by components of the endoplasmic reticulum (ER)-associated degradation pathway. BOK is ubiquitylated by the AMFR/gp78 E3 ubiquitin ligase complex and targeted for proteasomal degradation in a VCP/p97-dependent manner, which allows survival of the cell. When proteasome function, VCP, or gp78 activity is compromised, BOK is stabilized to induce MOMP and apoptosis independently of other BCL-2 proteins.	[Llambi, Fabien; Victor, Bernadette; Yang, Mao; Schneider, Desiree M.; Gingras, Sebastien; Parsons, Melissa J.; Brown, Scott A.; Pelletier, Stephane; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Yue-Ming; Zheng, Janet H.; Moldoveanu, Tudor; Chen, Taosheng] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zheng, Janet H.; Moldoveanu, Tudor] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Schneider, Desiree M.] Univ Freiburg, Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Hugstetter Str 55, D-79106 Freiburg, Germany; [Parsons, Melissa J.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Parsons, Melissa J.] Baylor Coll Med, Dept Pediat Hematol, Houston, TX 77030 USA; [Gingras, Sebastien] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Freiburg; Baylor College of Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Llambi, F (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	fabien.llambi@stjude.org; douglas.green@stjude.org	Moldoveanu, Tudor/N-8173-2018; Chen, Taosheng/I-6351-2013; Green, Douglas R/N-8083-2018	Moldoveanu, Tudor/0000-0003-0791-318X; Chen, Taosheng/0000-0001-6420-3809; Green, Douglas R/0000-0002-7332-1417; Zheng, Janet/0000-0001-8838-1263; Pelletier, Stephane/0000-0002-1127-0212	National Institutes of Health [GM 096208, GM 110034]; ALSAC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096208, R01GM110034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Abbvie for providing ABT-737 and Richard Youle for providing the WT and DKO HCT116 lines. We thank Linda M. Hendershot, Helen M. Beere, Katherine Baran, and Guiovanni Quarato for discussions and careful reading of the manuscript. We thank Vani J. Shanker (Scientific Editing, St. Jude) for editing this manuscript; Richard Cross, Greig Lennon, and Parker Ingle (Microfluorimetry, St. Jude) for cell sorting; Ashutosh Mishra and Vishwajeeth Pagala (Proteomics, St. Jude) for LC-MS/MS analysis; Cliff Guy (Confocal Imaging, St. Jude) for confocal microscopy analysis; Asli Goktug (Department of Chemical Biology and Therapeutics, St. Jude) for assistance with automation of HTS; Brett Waddell (Molecular Interaction Analysis, St. Jude) for SRP analysis; and Shantel Brown, Allison Weaver, Melissa D. Johnson, Ecklin Crenshaw, and Christopher Calabrese (Small Animal Imaging, St. Jude) for flank tumor imaging. This work was supported by National Institutes of Health grants GM 096208 (D.R.G.), GM 110034 (T.C.), and ALSAC.	Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Asciolla JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4291; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Carpio MA, 2015, P NATL ACAD SCI USA, V112, P7201, DOI 10.1073/pnas.1421063112; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Echeverry N, 2013, CELL DEATH DIFFER, V20, P785, DOI 10.1038/cdd.2013.10; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Green DR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006080; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Ke F, 2012, CELL DEATH DIFFER, V19, P915, DOI 10.1038/cdd.2011.210; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Rodriguez DA, 2012, EMBO J, V31, P2322, DOI 10.1038/emboj.2012.84; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang C, 2012, ONCOGENE, V31, P3177, DOI 10.1038/onc.2011.497; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200	46	147	155	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					421	433		10.1016/j.cell.2016.02.026	http://dx.doi.org/10.1016/j.cell.2016.02.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	26949185	Green Accepted, Bronze			2022-12-28	WOS:000374123000020
J	Stenberg, E; Szabo, E; Agren, G; Ottosson, J; Marsk, R; Lonroth, H; Boman, L; Magnuson, A; Thorell, A; Naslund, I				Stenberg, Erik; Szabo, Eva; Agren, Goeran; Ottosson, Johan; Marsk, Richard; Loenroth, Hans; Boman, Lars; Magnuson, Anders; Thorell, Anders; Naeslund, Ingmar			Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial	LANCET			English	Article							QUALITY-OF-LIFE; OBESITY SURGERY REGISTRY; SMALL-BOWEL OBSTRUCTION; BARIATRIC SURGERY; INTERNAL HERNIAS; METAANALYSIS; COMPLICATIONS	Background Small bowel obstruction due to internal hernia is a common and potentially serious complication after laparoscopic gastric bypass surgery. Whether closure of surgically created mesenteric defects might reduce the incidence is unknown, so we did a large randomised trial to investigate. Method This study was a multicentre, randomised trial with a two-arm, parallel design done at 12 centres for bariatric surgery in Sweden. Patients planned for laparoscopic gastric bypass surgery at any of the participating centres were off ered inclusion. During the operation, a concealed envelope was opened and the patient was randomly assigned to either closure of mesenteric defects beneath the jejunojejunostomy and at Petersen's space or non-closure. After surgery, assignment was open label. The main outcomes were reoperation for small bowel obstruction and severe postoperative complications. Outcome data and safety were analysed in the intention-to-treat population. This trial is registered with ClinicalTrials. gov, number NCT01137201. Findings Between May 1, 2010, and Nov 14, 2011, 2507 patients were recruited to the study and randomly assigned to closure of the mesenteric defects (n= 1259) or non-closure (n= 1248). 2503 (99.8%) patients had follow-up for severe postoperative complications at day 30 and 2482 (99.0%) patients had follow-up for reoperation due to small bowel obstruction at 25 months. At 3 years after surgery, the cumulative incidence of reoperation because of small bowel obstruction was signifi cantly reduced in the closure group (cumulative probability 0.055 for closure vs 0.102 for non-closure, hazard ratio 0.56, 95% CI 0.41-0.76, p= 0.0002). Closure of mesenteric defects increased the risk for severe postoperative complications (54 [4.3%] for closure vs 35 [2.8%] for non-closure, odds ratio 1.55, 95% CI 1.01-2.39, p= 0.044), mainly because of kinking of the jejunojejunostomy. Interpretation The results of our study support the routine closure of the mesenteric defects in laparoscopic gastric bypass surgery. However, closure of the mesenteric defects might be associated with increased risk of early small bowel obstruction caused by kinking of the jejunojejunostomy.	[Stenberg, Erik; Szabo, Eva; Agren, Goeran; Ottosson, Johan; Naeslund, Ingmar] Univ Orebro, Dept Surg, Fac Med & Hlth, SE-70182 Orebro, Sweden; [Magnuson, Anders] Univ Orebro, Fac Med & Hlth, Dept Clin Epidemiol & Biostat, SE-70182 Orebro, Sweden; [Marsk, Richard; Thorell, Anders] Karolinska Inst, Div Surg, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden; [Loenroth, Hans] Univ Gothenburg, Inst Surg, Sahlgrenska Acad, Gothenburg, Sweden; [Boman, Lars] Lycksele Hosp, Dept Surg, Lycksele, Sweden; [Thorell, Anders] Ersta Hosp, Dept Surg, Stockholm, Sweden	Orebro University; Orebro University; Danderyds Hospital; Karolinska Institutet; University of Gothenburg; Ersta Sjukhus	Stenberg, E (corresponding author), Orebro Univ Hosp, Dept Surg, Fac Med & Hlth, SE-70185 Orebro, Sweden.	erik.stenberg@regionorebrolan.se	Ottosson, Johan/AAF-7258-2020; Marsk, Richard/GPP-2864-2022; Stenberg, Erik/D-3820-2016	Ottosson, Johan/0000-0002-9243-2390; Marsk, Richard/0000-0001-9814-3357; Stenberg, Erik/0000-0001-9189-0093; Thorell, Anders/0000-0001-7238-1728	Orebro County Council; Stockholm City Council; Erling-Persson Family Foundation	Orebro County Council; Stockholm City Council; Erling-Persson Family Foundation	Orebro County Council, Stockholm City Council, and the Erling-Persson Family Foundation.	Abasbassi M, 2011, OBES SURG, V21, P1822, DOI 10.1007/s11695-011-0462-6; Aghajani E, 2012, J GASTROINTEST SURG, V16, P641, DOI 10.1007/s11605-011-1790-5; Ahmed AR, 2007, OBES SURG, V17, P1563, DOI 10.1007/s11695-007-9260-6; Bauman RW, 2009, SURG OBES RELAT DIS, V5, P565, DOI 10.1016/j.soard.2008.10.013; BROLIN RE, 1995, AM J SURG, V169, P355, DOI 10.1016/S0002-9610(99)80175-5; Champion JK, 2003, OBES SURG, V13, P596, DOI 10.1381/096089203322190808; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; de la Cruz-Munoz N, 2011, SURG OBES RELAT DIS, V7, P176, DOI 10.1016/j.soard.2010.10.003; Ekelund M, 2015, BRIT J SURG, V102, P460, DOI 10.1002/bjs.9771; Ekelund M, 2015, BRIT J SURG, V102, P451; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Garrard CL, 1999, SURG ENDOSC-ULTRAS, V13, P10, DOI 10.1007/s004649900887; Geubbels N, 2015, BRIT J SURG, V102, P451, DOI 10.1002/bjs.9738; Hedenbro JL, 2015, OBES SURG, V25, P1893, DOI 10.1007/s11695-015-1619-5; Higa KD, 2003, OBES SURG, V13, P350, DOI 10.1381/096089203765887642; Higa K, 2011, SURG OBES RELAT DIS, V7, P516, DOI 10.1016/j.soard.2010.10.019; HOLM S, 1979, SCAND J STAT, V6, P65; Hope WW, 2010, JSLS-J SOC LAPAROEND, V14, P213, DOI 10.4293/108680810X12785289144151; Jacobsen H, 2013, OBES SURG, V23, P320, DOI 10.1007/s11695-012-0800-3; Kolotkin RL, 2009, SURG OBES RELAT DIS, V5, P250, DOI 10.1016/j.soard.2009.01.009; Lockhart ME, 2007, AM J ROENTGENOL, V188, P745, DOI 10.2214/AJR.06.0541; Loux TJ, 2008, J PEDIATR SURG, V43, P1275, DOI 10.1016/j.jpedsurg.2008.02.078; Martin MJ, 2013, SURG OBES RELAT DIS, V9, P854, DOI 10.1016/j.soard.2012.12.002; Nguyen NT, 2001, ANN SURG, V234, P279, DOI 10.1097/00000658-200109000-00002; Olbers T, 2003, OBES SURG, V13, P364, DOI 10.1381/096089203765887679; Ortega E, 2012, SURG ENDOSC, V26, P1744, DOI 10.1007/s00464-011-2104-4; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rodriguez A, 2010, OBES SURG, V20, P1380, DOI 10.1007/s11695-010-0164-5; Schneider C, 2011, SURG ENDOSC, V25, P1594, DOI 10.1007/s00464-010-1444-9; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Stenberg E, 2014, ANN SURG, V260, P1040, DOI 10.1097/SLA.0000000000000431	31	143	145	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1397	1404		10.1016/S0140-6736(15)01126-5	http://dx.doi.org/10.1016/S0140-6736(15)01126-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	26895675				2022-12-28	WOS:000373217500032
J	Bikoff, JB; Gabitto, MI; Rivard, AF; Drobac, E; Machado, TA; Miri, A; Brenner-Morton, S; Famojure, E; Diaz, C; Alvarez, FJ; Mentis, GZ; Jessell, TM				Bikoff, Jay B.; Gabitto, Mariano I.; Rivard, Andre F.; Drobac, Estelle; Machado, Timothy A.; Miri, Andrew; Brenner-Morton, Susan; Famojure, Erica; Diaz, Carolyn; Alvarez, Francisco J.; Mentis, George Z.; Jessell, Thomas M.			Spinal Inhibitory Interneuron Diversity Delineates Variant Motor Microcircuits	CELL			English	Article							RENSHAW CELLS; RECURRENT INHIBITION; SYNAPTIC ACTIONS; CONNECTIVITY; ENGRAILED-1; SPECIFICITY; NEURONS; HIP; MOTONEURONES; IMPULSES	Animals generate movement by engaging spinal circuits that direct precise sequences of muscle contraction, but the identity and organizational logic of local interneurons that lie at the core of these circuits remain unresolved. Here, we show that V1 interneurons, a major inhibitory population that controls motor output, fractionate into highly diverse subsets on the basis of the expression of 19 transcription factors. Transcriptionally defined V1 subsets exhibit distinct physiological signatures and highly structured spatial distributions with mediolateral and dorsoventral positional biases. These positional distinctions constrain patterns of input from sensory and motor neurons and, as such, suggest that interneuron position is a determinant of microcircuit organization. Moreover, V1 diversity indicates that different inhibitory microcircuits exist for motor pools controlling hip, ankle, and foot muscles, revealing a variable circuit architecture for interneurons that control limb movement.	[Bikoff, Jay B.; Gabitto, Mariano I.; Machado, Timothy A.; Miri, Andrew; Brenner-Morton, Susan; Famojure, Erica; Diaz, Carolyn; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Bikoff, Jay B.; Gabitto, Mariano I.; Machado, Timothy A.; Miri, Andrew; Brenner-Morton, Susan; Famojure, Erica; Diaz, Carolyn; Jessell, Thomas M.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Bikoff, Jay B.; Gabitto, Mariano I.; Machado, Timothy A.; Miri, Andrew; Brenner-Morton, Susan; Famojure, Erica; Diaz, Carolyn; Jessell, Thomas M.] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA; [Bikoff, Jay B.; Gabitto, Mariano I.; Machado, Timothy A.; Miri, Andrew; Brenner-Morton, Susan; Famojure, Erica; Diaz, Carolyn; Jessell, Thomas M.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Bikoff, Jay B.; Gabitto, Mariano I.; Machado, Timothy A.; Miri, Andrew; Brenner-Morton, Susan; Famojure, Erica; Diaz, Carolyn; Jessell, Thomas M.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Rivard, Andre F.; Alvarez, Francisco J.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30319 USA; [Drobac, Estelle; Mentis, George Z.] Columbia Univ, Dept Pathol & Cell Biol, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Drobac, Estelle; Mentis, George Z.] Columbia Univ, Dept Neurol, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; Emory University; Columbia University; Columbia University	Bikoff, JB; Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.; Bikoff, JB; Jessell, TM (corresponding author), Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA.; Bikoff, JB; Jessell, TM (corresponding author), Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA.; Bikoff, JB; Jessell, TM (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.; Bikoff, JB; Jessell, TM (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	jb3098@cumc.columbia.edu; tmj1@cumc.columbia.edu	Alvarez, Francisco/GZL-1953-2022; Bikoff, Jay/N-8107-2018; Alvarez, Francisco J/H-4929-2011	Alvarez, Francisco J/0000-0001-7011-3244; Machado, Tim/0000-0003-3762-1460	NIH-NINDS [R01-NS047357]; NIH [R01-NS078375, R21-NS079981, R01-NS033245]; Department of Defense [GR.10235006]; Brain Research Foundation; Harold and Leila Y. Mathers Foundation; Project A.L.S.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047357, R37NS033245, R01NS080932, R01NS078375, R01NS033245, R21NS079981] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Brain Research Foundation; Harold and Leila Y. Mathers Foundation; Project A.L.S.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to I. Schieren for help with FACS, B. Han, and M. Mendelsohn for help generating transgenic mice, and K. MacArthur for manuscript preparation. We thank A. Joyner for advice on generating FlpoER<SUP>T2</SUP>, G. Fishell for RCE.dual.GFP mice, and K. Campbell for Sp8<SUP>fl/fl</SUP> mice. J. Nathans provided anti-Nr3b2, and S. Ross provided anti-Bhlhb5 and anti-Prdm8 antibodies. We thank R. Axel, E. Azim, N. Balaskas, R. Brownstone, and J. de Nooij for discussions and comments on the manuscript. F.J.A. was supported by NIH-NINDS (R01-NS047357.) G.Z.M. was supported by the NIH (R01-NS078375 and R21-NS079981) and the Department of Defense (GR.10235006). T.M.J was supported by an NIH grant (R01-NS033245), the Brain Research Foundation, the Harold and Leila Y. Mathers Foundation, and Project A.L.S. and is an HHMI investigator.	Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; Benito-Gonzalez A, 2012, J NEUROSCI, V32, P1156, DOI 10.1523/JNEUROSCI.3630-12.2012; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brown, 1981, ORG SPINAL CORD ANAT; Demireva EY, 2011, CELL, V147, P641, DOI 10.1016/j.cell.2011.09.037; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P479, DOI 10.1113/jphysiol.1961.sp006822; ECCLES JC, 1957, J PHYSIOL-LONDON, V138, P227, DOI 10.1113/jphysiol.1957.sp005849; ECCLES RM, 1958, J PHYSIOL-LONDON, V144, P271, DOI 10.1113/jphysiol.1958.sp006101; Francius C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070325; Fukuhara K, 2013, CELL REP, V5, P748, DOI 10.1016/j.celrep.2013.10.005; FYFFE REW, 1990, BRAIN RES, V536, P301, DOI 10.1016/0006-8993(90)90038-D; Gabitto MI, 2016, CELL, V165, P220, DOI 10.1016/j.cell.2016.01.026; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Gonzalez-Forero D, 2005, J NEUROSCI, V25, P2010, DOI 10.1523/JNEUROSCI.2383-04.2005; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Goulding M, 2014, CURR OPIN NEUROBIOL, V26, P161, DOI 10.1016/j.conb.2014.03.006; Grillner S, 1972, Prog Brain Res, V37, P243, DOI 10.1016/S0079-6123(08)63906-0; HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P613, DOI 10.1113/jphysiol.1971.sp009488; ILLERT M, 1989, PROG BRAIN RES, V80, P273; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Knikou M, 2002, EXP BRAIN RES, V143, P149, DOI 10.1007/s00221-001-0978-4; LAGERBACK PA, 1985, J COMP NEUROL, V240, P368, DOI 10.1002/cne.902400405; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Matise MP, 1997, J NEUROSCI, V17, P7805; MCCURDY ML, 1992, J NEUROPHYSIOL, V67, P1359, DOI 10.1152/jn.1992.67.5.1359; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; McVea DA, 2005, J NEUROPHYSIOL, V94, P3497, DOI 10.1152/jn.00511.2005; Mentis GZ, 2006, J NEUROSCI, V26, P13297, DOI 10.1523/JNEUROSCI.2945-06.2006; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; RYALL RW, 1971, J NEUROPHYSIOL, V34, P242, DOI 10.1152/jn.1971.34.2.242; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013	46	145	146	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					207	219		10.1016/j.cell.2016.01.027	http://dx.doi.org/10.1016/j.cell.2016.01.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	26949184	Green Accepted, Bronze			2022-12-28	WOS:000372785600021
J	Dewey, FF; Gusarova, V; O'Dushlaine, C; Gottesman, O; Trejos, J; Hunt, C; Van Hout, CV; Habegger, L; Buckler, D; Lai, KMV; Leader, JB; Murray, MF; Ritchie, MD; Kirchner, HL; Ledbetter, DH; Penn, J; Lopez, A; Borecki, IB; Overton, JD; Reid, JG; Carey, DJ; Murphy, AJ; Yancopoulos, GD; Baras, A; Gromada, J; Shuldiner, AR				Dewey, Frederick F.; Gusarova, Viktoria; O'Dushlaine, Colm; Gottesman, Omri; Trejos, Jesus; Hunt, Charleen; Van Hout, Cristopher V.; Habegger, Lukas; Buckler, David; Lai, Ka-Man V.; Leader, Joseph B.; Murray, Michael F.; Ritchie, Marylyn D.; Kirchner, H. Lester; Ledbetter, David H.; Penn, John; Lopez, Alexander; Borecki, Ingrid B.; Overton, John D.; Reid, Jeffrey G.; Carey, David J.; Murphy, Andrew J.; Yancopoulos, George D.; Baras, Aris; Gromada, Jesper; Shuldiner, Alan R.			Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANGIOPOIETIN-LIKE PROTEIN-4; LIPOPROTEIN-LIPASE; HEART-DISEASE; TRIGLYCERIDES; MUTATIONS; LIPIDS; GENE; MICE; PARTICIPANTS; CHOLESTEROL	BACKGROUND Higher-than-normal levels of circulating triglycerides are a risk factor for ischemic cardiovascular disease. Activation of lipoprotein lipase, an enzyme that is inhibited by angiopoietin-like 4 (ANGPTL4), has been shown to reduce levels of circulating triglycerides. METHODS We sequenced the exons of ANGPTL4 in samples obtain from 42,930 participants of predominantly European ancestry in the DiscovEHR human genetics study. We performed tests of association between lipid levels and the missense E40K variant (which has been associated with reduced plasma triglyceride levels) and other inactivating mutations. We then tested for associations between coronary artery disease and the E40K variant and other inactivating mutations in 10,552 participants with coronary artery disease and 29,223 controls. We also tested the effect of a human monoclonal antibody against ANGPTL4 on lipid levels in mice and monkeys. RESULTS We identified 1661 heterozygotes and 17 homozygotes for the E40K variant and 75 participants who had 13 other monoallelic inactivating mutations in ANGPTL4. The levels of triglycerides were 13% lower and the levels of high-density lipoprotein (HDL) cholesterol were 7% higher among carriers of the E40K variant than among noncarriers. Carriers of the E40K variant were also significantly less likely than noncarriers to have coronary artery disease (odds ratio, 0.81; 95% confidence interval, 0.70 to 0.92; P = 0.002). K40 homozygotes had markedly lower levels of triglycerides and higher levels of HDL cholesterol than did heterozygotes. Carriers of other inactivating mutations also had lower triglyceride levels and higher HDL cholesterol levels and were less likely to have coronary artery disease than were noncarriers. Monoclonal antibody inhibition of Angptl4 in mice and monkeys reduced triglyceride levels. CONCLUSIONS Carriers of E40K and other inactivating mutations in ANGPTL4 had lower levels of triglycerides and a lower risk of coronary artery disease than did noncarriers. The inhibition of Angptl4 in mice and monkeys also resulted in corresponding reductions in these values.	[Dewey, Frederick F.; O'Dushlaine, Colm; Gottesman, Omri; Van Hout, Cristopher V.; Habegger, Lukas; Penn, John; Lopez, Alexander; Borecki, Ingrid B.; Overton, John D.; Reid, Jeffrey G.; Murphy, Andrew J.; Yancopoulos, George D.; Baras, Aris; Gromada, Jesper; Shuldiner, Alan R.] Regeneron Genet Ctr, Tarrytown, NY USA; [Gusarova, Viktoria; Trejos, Jesus; Hunt, Charleen; Buckler, David; Lai, Ka-Man V.; Murphy, Andrew J.; Yancopoulos, George D.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Leader, Joseph B.; Murray, Michael F.; Ritchie, Marylyn D.; Kirchner, H. Lester; Ledbetter, David H.; Carey, David J.] Geisinger Hlth Syst, Danville, PA USA	Regeneron; Regeneron; Geisinger Health System	Dewey, FF (corresponding author), 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	frederick.dewey@regeneron.com	Girelli, Domenico/B-1183-2008; Van Hout, Cristopher V./AAQ-3494-2021	Girelli, Domenico/0000-0001-9684-1899; Van Hout, Cristopher V./0000-0001-9689-5344; Murphy, Andrew/0000-0003-4152-4081; Shuldiner, Alan/0000-0001-9921-4305	Regeneron Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER	Regeneron Pharmaceuticals(Regeneron); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Regeneron Pharmaceuticals.	Adachi H, 2009, BIOCHEM BIOPH RES CO, V379, P806, DOI 10.1016/j.bbrc.2008.12.018; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Folsom AR, 2008, METABOLISM, V57, P1591, DOI 10.1016/j.metabol.2008.06.016; Gusarova V, 2015, J LIPID RES, V56, P1308, DOI 10.1194/jlr.M054890; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Jensen MK, 2009, AM HEART J, V157, P384, DOI 10.1016/j.ahj.2008.10.008; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Mattijssen F, 2014, MOL METAB, V3, P135, DOI 10.1016/j.molmet.2013.11.004; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Minicocci I, 2012, J CLIN ENDOCR METAB, V97, pE1266, DOI 10.1210/jc.2012-1298; Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Rana JS, 2012, CURR ATHEROSCLER REP, V14, P130, DOI 10.1007/s11883-011-0224-x; Rip J, 2006, ARTERIOSCL THROM VAS, V26, P1236, DOI 10.1161/01.ATV.0000219283.10832.43; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Talmud PJ, 2008, ARTERIOSCL THROM VAS, V28, P2319, DOI 10.1161/ATVBAHA.108.176917; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yin W, 2012, J LIPID RES, V53, P51, DOI 10.1194/jlr.M019927; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	40	295	307	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1123	1133		10.1056/NEJMoa1510926	http://dx.doi.org/10.1056/NEJMoa1510926			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	26933753	Green Accepted, Bronze			2022-12-28	WOS:000372585100005
J	Gluth, S; Fontanesi, L				Gluth, Sebastian; Fontanesi, Laura			Wiring the altruistic brain	SCIENCE			English	Editorial Material									[Gluth, Sebastian; Fontanesi, Laura] Univ Basel, Dept Psychol, Missionsstr 62a, CH-4055 Basel, Switzerland	University of Basel	Gluth, S (corresponding author), Univ Basel, Dept Psychol, Missionsstr 62a, CH-4055 Basel, Switzerland.	sebastian.gluth@unibas.ch		Gluth, Sebastian/0000-0003-2241-5103; Fontanesi, Laura/0000-0001-5067-9451				Batson CD., 1991, ALTRUISM QUESTION SO; Brodersen KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002079; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gluth S, 2015, NEURON, V86, P1078, DOI 10.1016/j.neuron.2015.04.023; Hein G, 2016, SCIENCE, V351, P1074, DOI 10.1126/science.aac7992; Hutcherson CA, 2015, NEURON, V87, P451, DOI 10.1016/j.neuron.2015.06.031; Phan KL, 2010, P NATL ACAD SCI USA, V107, P13099, DOI 10.1073/pnas.1008137107; Samuelson PA, 1938, ECONOMICA-NEW SER, V5, P61, DOI 10.2307/2548836; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006	11	7	8	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1028	1029		10.1126/science.aaf4688	http://dx.doi.org/10.1126/science.aaf4688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941304				2022-12-28	WOS:000371597500021
J	Uphoff, S; Lord, ND; Okumus, B; Potvin-Trottier, L; Sherratt, DJ; Paulsson, J				Uphoff, Stephan; Lord, Nathan D.; Okumus, Burak; Potvin-Trottier, Laurent; Sherratt, David J.; Paulsson, Johan			Stochastic activation of a DNA damage response causes cell-to-cell mutation rate variation	SCIENCE			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; STRESS-RESPONSE; SINGLE-CELL; REPAIR; BACTERIA; AGENTS; FATE	Cells rely on the precise action of proteins that detect and repair DNA damage. However, gene expression noise causes fluctuations in protein abundances that may compromise repair. For the Ada protein in Escherichia coli, which induces its own expression upon repairing DNA alkylation damage, we found that undamaged cells on average produce one Ada molecule per generation. Because production is stochastic, many cells have no Ada molecules and cannot induce the damage response until the first expression event occurs, which sometimes delays the response for generations. This creates a subpopulation of cells with increased mutation rates. Nongenetic variation in protein abundances thus leads to genetic heterogeneity in the population. Our results further suggest that cells balance reliable repair against toxic side effects of abundant DNA repair proteins.	[Uphoff, Stephan; Sherratt, David J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Uphoff, Stephan; Lord, Nathan D.; Okumus, Burak; Potvin-Trottier, Laurent; Paulsson, Johan] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Potvin-Trottier, Laurent] Harvard Univ, Sch Med, Biophys PhD Program, Cambridge, MA 02138 USA	University of Oxford; Harvard University; Harvard Medical School; Harvard University	Uphoff, S (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.; Uphoff, S; Paulsson, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	stephan.uphoff@bioch.ox.ac.uk; johan_paulsson@harvard.edu	Potvin-Trottier, Laurent/AAL-3122-2021	Potvin-Trottier, Laurent/0000-0001-7876-2820; Uphoff, Stephan/0000-0002-3579-0888; Lord, Nathan/0000-0001-9553-2779; Sherratt, David/0000-0002-2104-5430	Wellcome Trust [091911, 099204/Z/12Z]; Medical Research Council [MR/K01577X/1]; Sir Henry Wellcome Fellowship by the Wellcome Trust; Junior Research Fellowship at St John's College, Oxford; NIH [GM095784]; Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de recherche du Quebec-Nature et technologies; BBSRC [BB/I004785/1] Funding Source: UKRI; MRC [MR/K01577X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095784] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Henry Wellcome Fellowship by the Wellcome Trust; Junior Research Fellowship at St John's College, Oxford; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec-Nature et technologies; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Reyes-Lamothe, U. Alon, J.-Y. Bouet, A. Kapanidis, C. Lesterlin, A. Upton, and P. Zawadzki for reagents and discussions. We thank C. Saenz and the Microfluidics Core Facility at Harvard Medical School. Microscopy at Micron Oxford was supported by a Wellcome Trust Strategic Award (091911) and Medical Research Council grant (MR/K01577X/1). S.U. is funded by a Sir Henry Wellcome Fellowship by the Wellcome Trust and a Junior Research Fellowship at St John's College, Oxford. J.P., N.D.L., L.P-T., and B.O. are funded by NIH grant GM095784. L.P.-T. acknowledges fellowship support from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Fonds de recherche du Quebec-Nature et technologies. D.J.S. is funded by a Wellcome Trust Investigator Award (099204/Z/12Z). The primary data described in the manuscript is available upon request. Author contributions: S.U. conceived the study, generated cell strains, and designed and performed experiments and analysis. S.U., D.J.S., and J.P. interpreted the data. N.L. and L.P.-T. developed the microfluidic imaging methods. B.O. developed the single-molecule counting method. S.U., D.J.S., and J.P. wrote the manuscript. The authors declare competing financial interests. A U.S. Patent Application 20150247790 entitled "Microfluidic assisted cell screening" was filed on behalf of B.O., J.P., and co-workers by the President and Fellows of Harvard College.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Elez M, 2010, CURR BIOL, V20, P1432, DOI 10.1016/j.cub.2010.06.071; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Kad NM, 2012, PROG MOL BIOL TRANSL, V110, P1, DOI 10.1016/B978-0-12-387665-2.00001-8; Landini P, 2000, J BACTERIOL, V182, P6543, DOI 10.1128/JB.182.23.6543-6549.2000; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Liao Y, 2015, P NATL ACAD SCI USA, V112, pE6898, DOI 10.1073/pnas.1507386112; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Norman TM, 2013, NATURE, V503, P481, DOI 10.1038/nature12804; SAGET BM, 1994, P NATL ACAD SCI USA, V91, P9730, DOI 10.1073/pnas.91.21.9730; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; SHEVELL DE, 1988, J BACTERIOL, V170, P5263, DOI 10.1128/jb.170.11.5263-5271.1988; Uphoff S, 2014, DNA REPAIR, V20, P32, DOI 10.1016/j.dnarep.2014.02.015; Uphoff S, 2013, P NATL ACAD SCI USA, V110, P8063, DOI 10.1073/pnas.1301804110; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045	26	78	79	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1094	1097		10.1126/science.aac9786	http://dx.doi.org/10.1126/science.aac9786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941321	Green Accepted			2022-12-28	WOS:000371597500047
J	Robert, T; Nore, A; Brun, C; Maffre, C; Crimi, B; Bourbon, HM; de Massy, B				Robert, T.; Nore, A.; Brun, C.; Maffre, C.; Crimi, B.; Bourbon, H. -M.; de Massy, B.			The TopoVIB-Like protein family is required for meiotic DNA double-strand break formation	SCIENCE			English	Article							TOPOISOMERASE-VI; CHROMOSOME SYNAPSIS; SPO11 GENE; RECOMBINATION; INITIATION; MEIOSIS; MOUSE; CONSERVATION; MAMMALS; ARCHAEA	Meiotic recombination is induced by the formation of DNA double-strand breaks (DSBs) catalyzed by SPO11, the ortholog of subunit A of TopoVI DNA topoisomerase (TopoVIA). TopoVI activity requires the interaction between A and B subunits. We identified a conserved family of plant and animal proteins [the TOPOVIB-Like (TOPOVIBL) family] that share strong structural similarity to the TopoVIB subunit of TopoVI DNA topoisomerase. We further characterize the meiotic recombination proteins Rec102 (Saccharomyces cerevisiae), Rec6 (Schizosaccharomyces pombe), and MEI-P22 (Drosophila melanogaster) as homologs to the transducer domain of TopoVIB. We demonstrate that the mouse TOPOVIBL protein interacts and forms a complex with SPO11 and is required for meiotic DSB formation. We conclude that meiotic DSBs are catalyzed by a complex involving SPO11 and TOPOVIBL.	[Robert, T.; Nore, A.; Brun, C.; Maffre, C.; Crimi, B.; de Massy, B.] CNRS, Inst Human Genet, UPR 1142, 141 Rue Cardonille, F-34396 Montpellier 05, France; [Bourbon, H. -M.] Univ Fed Toulouse, Ctr Biol Dev, Paul Sabatier Campus,118 Route Narbonne, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	de Massy, B (corresponding author), CNRS, Inst Human Genet, UPR 1142, 141 Rue Cardonille, F-34396 Montpellier 05, France.; Bourbon, HM (corresponding author), Univ Fed Toulouse, Ctr Biol Dev, Paul Sabatier Campus,118 Route Narbonne, F-31062 Toulouse, France.	henri-marc.bourbon@univ-tlse3.fr; bernard.de-massy@igh.cnrs.fr		Nore, alexandre/0000-0003-1882-8917; Robert, Thomas/0000-0002-2458-7454	CNRS; European Research Council Executive Agency under the European Community [322788]	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council Executive Agency under the European Community	We thank M. Grelon for communicating information about the sequence of the A. thaliana MTOPVIB gene before publication, D. Gadelle and P. Forterre for numerous discussions and technical advice, all laboratory members for stimulating discussions and suggestions, M. A. Handel for the anti-H1t antibody, J. Cau from Montpellier RIO Imaging for image analysis, and the Cryopreservation Distribution Typage Archivage Animal Transgenese et Archivage d'Animaux Modeles and Reseau d'Histologie Experimentale de Montpellier facilities for services. H.-M.B. was funded by grants from CNRS. B.d.M. was funded by grants from CNRS and the European Research Council Executive Agency under the European Community's Seventh Framework Programme [FP7/2007-2013 grant agreement no. 322788]. T.R., H.-M.B., and B.d.M. supervised the project and wrote the manuscript. T.R., H.-M.B, A.N., C.M., B.C., and C.B. performed experiments.	Bates AD, 2011, NUCLEIC ACIDS RES, V39, P6327, DOI 10.1093/nar/gkr258; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Buhler C, 1998, NUCLEIC ACIDS RES, V26, P5157, DOI 10.1093/nar/26.22.5157; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Corbett KD, 2005, STRUCTURE, V13, P873, DOI 10.1016/j.str.2005.03.013; Corbett KD, 2007, NAT STRUCT MOL BIOL, V14, P611, DOI 10.1038/nsmb1264; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Gadelle D, 2003, BIOESSAYS, V25, P232, DOI 10.1002/bies.10245; Gadelle D, 2014, NUCLEIC ACIDS RES, V42, P8578, DOI 10.1093/nar/gku568; Graille M, 2008, STRUCTURE, V16, P360, DOI 10.1016/j.str.2007.12.020; Jiao K, 2003, MOL CELL BIOL, V23, P5928, DOI 10.1128/MCB.23.16.5928-5938.2003; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kumar R, 2015, J CELL SCI, V128, P1800, DOI 10.1242/jcs.165464; Kumar R, 2010, GENES-BASEL, V1, P521, DOI 10.3390/genes1030521; Kumar R, 2010, GENE DEV, V24, P1266, DOI 10.1101/gad.571710; Liu H, 2002, GENETICS, V162, P245; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Malik SB, 2007, MOL BIOL EVOL, V24, P2827, DOI 10.1093/molbev/msm217; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Vrielynck N, 2016, SCIENCE, V351, P939, DOI 10.1126/science.aad5196	29	159	169	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					943	949		10.1126/science.aad5309	http://dx.doi.org/10.1126/science.aad5309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917764				2022-12-28	WOS:000370821400034
J	Sarrazin, F; Lecomte, J				Sarrazin, Francois; Lecomte, Jane			Evolution in the Anthropocene	SCIENCE			English	Editorial Material							CONSERVATION; ECOLOGY		[Sarrazin, Francois] Univ Paris 06, Sorbonne Univ, Museum Natl Hist Nat, CNRS,CESCO,UMR 7204, F-75005 Paris, France; [Lecomte, Jane] Univ Paris Saclay, Ecol Syst Evolut, Univ Paris Sud, CNRS,AgroParisTech, F-91400 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Sarrazin, F (corresponding author), Univ Paris 06, Sorbonne Univ, Museum Natl Hist Nat, CNRS,CESCO,UMR 7204, F-75005 Paris, France.	sarrazin@mnhn.fr	Sarrazin, François/AAB-4227-2019; Sarrazin, Francois/B-7593-2013	Sarrazin, François/0000-0001-5901-4819; Sarrazin, Francois/0000-0001-5901-4819				Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Clarke E, 2014, J BIOSCIENCES, V39, P303, DOI 10.1007/s12038-013-9375-y; Corlett RT, 2015, TRENDS ECOL EVOL, V30, P36, DOI 10.1016/j.tree.2014.10.007; Darimont CT, 2015, SCIENCE, V349, P858, DOI 10.1126/science.aac4249; Diaz S, 2015, CURR OPIN ENV SUST, V14, P1, DOI 10.1016/j.cosust.2014.11.002; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Veron S, 2017, BIOL REV, V92, P271, DOI 10.1111/brv.12228; Vucetich JA, 2015, CONSERV BIOL, V29, P321, DOI 10.1111/cobi.12464	12	49	50	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					922	+		10.1126/science.aad6756	http://dx.doi.org/10.1126/science.aad6756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DE7MO	26917757	Green Submitted			2022-12-28	WOS:000370821400023
J	Izumi, N; Shoji, K; Sakaguchi, Y; Honda, S; Kirino, Y; Suzuki, T; Katsuma, S; Tomari, Y				Izumi, Natsuko; Shoji, Keisuke; Sakaguchi, Yuriko; Honda, Shozo; Kirino, Yohei; Suzuki, Tsutomu; Katsuma, Susumu; Tomari, Yukihide			Identification and Functional Analysis of the Pre-piRNA 3 ' Trimmer in Silkworms	CELL			English	Article							PIWI-INTERACTING RNAS; ARGONAUTE PROTEINS; NUAGE FORMATION; MOUSE TESTES; BIOGENESIS; DROSOPHILA; GERMLINE; ELEMENTS; SPERMATOGENESIS; MICRORNAS	PIWI-interacting RNAs (piRNAs) play a crucial role in transposon silencing in animal germ cells. In piRNA biogenesis, single-stranded piRNA intermediates are loaded into PIWI-clade proteins and cleaved by Zucchini/MitoPLD, yielding precursor piRNAs (pre-piRNAs). Pre-piRNAs that are longer than the mature piRNA length are then trimmed at their 3' ends. Although recent studies implicated the Tudor domain protein Papi/Tdrkh in pre-piRNA trimming, the identity of Trimmer and its relationship with Papi/Tdrkh remain unknown. Here, we identified PNLDC1, an uncharacterized 3'-5' exonuclease, as Trimmer in silkworms. Trimmer is enriched in the mitochondrial fraction and binds to Papi/Tdrkh. Depletion of Trimmer and Papi/Tdrkh additively inhibits trimming, causing accumulation of similar to 35-40-nt pre-piRNAs that are impaired for target cleavage and prone to degradation. Our results highlight the cooperative action of Trimmer and Papi/Tdrkh in piRNA maturation.	[Izumi, Natsuko; Tomari, Yukihide] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Shoji, Keisuke; Katsuma, Susumu] Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Sakaguchi, Yuriko; Suzuki, Tsutomu] Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1130032, Japan; [Honda, Shozo; Kirino, Yohei] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Computat Med Ctr, Philadelphia, PA 19107 USA; [Tomari, Yukihide] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Jefferson University; University of Tokyo	Tomari, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.; Tomari, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Bunkyo Ku, Tokyo 1130032, Japan.	tomari@iam.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015; Tomari, Yukihide/A-8009-2009	Suzuki, Tsutomu/0000-0002-9731-1731; Tomari, Yukihide/0000-0001-8442-0851; Shoji, Keisuke/0000-0003-0183-654X; Kirino, Yohei/0000-0001-5232-4742	NIH [GM106047]; JSPS Research Fellowship for Young Researchers; JSPS Postdoctoral Fellowship for Research Abroad; Grants-in-Aid for Scientific Research [26113007] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Research Fellowship for Young Researchers; JSPS Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Wen Tang and Craig Mello for sharing unpublished data, Yuki Okada for providing mouse spermatogonial stem cells, Shinpei Kawaoka for the Mili construct and helpful discussion, and the IMCB Research Center for Epigenetic Disease for sequencing of small RNA libraries. We also thank all of the members of our laboratories for critical comments on the manuscript. This work was in part supported by Grant-in-Aids for Scientific Research on Innovative Areas "Functional machinery for non-coding RNAs" to S.K. and Y.T. and "Non-coding RNA neo-taxonomy" to Y.T., a Grant-in-Aid for Research Activity Start-up to N.I., an NIH grant (GM106047) to Y.K., a JSPS Research Fellowship for Young Researchers to K.S., and a JSPS Postdoctoral Fellowship for Research Abroad to S.H.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; Feltzin VL, 2015, AGING CELL, V14, P443, DOI 10.1111/acel.12323; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Homolka D, 2015, CELL REP, V12, P418, DOI 10.1016/j.celrep.2015.06.030; Honda S, 2013, RNA, V19, P1405, DOI 10.1261/rna.040428.113; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Kamminga LM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002702; Kamminga LM, 2010, EMBO J, V29, P3688, DOI 10.1038/emboj.2010.233; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Liu L, 2011, DEVELOPMENT, V138, P1863, DOI 10.1242/dev.059287; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marasovic M, 2013, MOL CELL, V52, P173, DOI 10.1016/j.molcel.2013.08.046; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Osanai-Futahashi M, 2008, INSECT BIOCHEM MOLEC, V38, P1046, DOI 10.1016/j.ibmb.2008.05.012; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saxe JP, 2013, EMBO J, V32, P1869, DOI 10.1038/emboj.2013.121; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Yoda M, 2013, CELL REP, V5, P715, DOI 10.1016/j.celrep.2013.09.029; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757	57	107	117	5	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					962	973		10.1016/j.cell.2016.01.008	http://dx.doi.org/10.1016/j.cell.2016.01.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919431	Green Accepted, Bronze			2022-12-28	WOS:000370867300019
J	Schewe, M; Nematian-Ardestani, E; Sun, H; Musinszki, M; Cordeiro, S; Bucci, G; de Groot, BL; Tucker, SJ; Rapedius, M; Baukrowitz, T				Schewe, Marcus; Nematian-Ardestani, Ehsan; Sun, Han; Musinszki, Marianne; Cordeiro, Soenke; Bucci, Giovanna; de Groot, Bert L.; Tucker, Stephen J.; Rapedius, Markus; Baukrowitz, Thomas			A Non-canonical Voltage-Sensing Mechanism Controls Gating in K2P K+ Channels	CELL			English	Article							DOMAIN POTASSIUM CHANNELS; CLC CHLORIDE CHANNELS; C-TYPE INACTIVATION; SELECTIVITY FILTER; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; K-2P CHANNELS; ION-BINDING; PORE; OCCUPANCY	Two-pore domain (K2P) K+ channels are major regulators of excitability that endow cells with an outwardly rectifying background "leak" conductance. In some K2P channels, strong voltage-dependent activation has been observed, but the mechanism remains unresolved because they lack a canonical voltage-sensing domain. Here, we show voltage-dependent gating is common to most K2P channels and that this voltage sensitivity originates from the movement of three to four ions into the high electric field of an inactive selectivity filter. Overall, this ion-flux gating mechanism generates a oneway "check valve" within the filter because outward movement of K+ induces filter opening, whereas inward movement promotes inactivation. Furthermore, many physiological stimuli switch off this flux gating mode to convert K2P channels into a leak conductance. These findings provide insight into the functional plasticity of a K+-selective filter and also refine our understanding of K2P channels and the mechanisms by which ion channels can sense voltage.	[Schewe, Marcus; Nematian-Ardestani, Ehsan; Musinszki, Marianne; Cordeiro, Soenke; Rapedius, Markus; Baukrowitz, Thomas] Univ Kiel, Inst Physiol, Olshaussenstr 40, D-24118 Kiel, Germany; [Sun, Han; de Groot, Bert L.] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany; [Sun, Han] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Bucci, Giovanna; Tucker, Stephen J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Tucker, Stephen J.] Univ Oxford, OXION Initiat, Oxford OX1 3PU, England; [Rapedius, Markus] Nan Technol GmbH, D-80636 Munich, Germany	University of Kiel; Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Oxford; University of Oxford	Baukrowitz, T (corresponding author), Univ Kiel, Inst Physiol, Olshaussenstr 40, D-24118 Kiel, Germany.	t.baukrowitz@physiologie.uni-kiel.de	Cordeiro, Soenke/A-1782-2012; Tucker, Stephen J./ABE-7468-2020; Musinszki, Marianne A/O-7584-2018; Tucker, Stephen J./ABE-6741-2020	Tucker, Stephen J./0000-0001-8996-2000; Musinszki, Marianne A/0000-0002-5597-6735; Tucker, Stephen J./0000-0001-8996-2000; Baukrowitz, Thomas/0000-0003-4562-0505; Schewe, Marcus/0000-0002-6192-5651; Sun, Han/0000-0002-1655-0838; Nematian-Ardestani, Ehsan/0000-0001-9674-6138	DFG; BBSRC Industrial Partnership Award; Pfizer Neusentis; Wellcome Trust; BBSRC [BB/N009274/1, BB/N000145/1, BB/J00037X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N000145/1, BB/N009274/1, BB/J00037X/1] Funding Source: researchfish; British Heart Foundation [PG/09/016/26992] Funding Source: researchfish	DFG(German Research Foundation (DFG)); BBSRC Industrial Partnership Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer Neusentis; Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	T.B. was supported by the DFG; S.J.T. was supported by a BBSRC Industrial Partnership Award with Pfizer Neusentis and by the Wellcome Trust.	Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; Bockenhauer D, 2001, NAT NEUROSCI, V4, P486, DOI 10.1038/87434; Boiteux C, 2011, STRUCTURE, V19, P70, DOI 10.1016/j.str.2010.10.008; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Chen HJ, 2014, TRENDS PHARMACOL SCI, V35, P461, DOI 10.1016/j.tips.2014.06.002; Contreras JE, 2010, BIOPHYS J, V99, P2863, DOI 10.1016/j.bpj.2010.08.053; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Dahlmann A, 2004, J GEN PHYSIOL, V123, P441, DOI 10.1085/jgp.200308989; De Jesus-Perez JJ, 2016, J GEN PHYSIOL, V147, P25, DOI 10.1085/jgp.201511424; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; Loukin SH, 1999, BIOPHYS J, V77, P3060, DOI 10.1016/S0006-3495(99)77137-7; MacKenzie G, 2015, PFLUG ARCH EUR J PHY, V467, P989, DOI 10.1007/s00424-014-1660-6; Maingret F, 2002, BIOCHEM BIOPH RES CO, V292, P339, DOI 10.1006/bbrc.2002.6674; Matulef K, 2013, P NATL ACAD SCI USA, V110, P17886, DOI 10.1073/pnas.1314356110; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Pusch M, 2004, BIOCHEMISTRY-US, V43, P1135, DOI 10.1021/bi0359776; Rapedius M, 2012, CHANNELS, V6, P473, DOI 10.4161/chan.22153; Scholle A, 2004, J MEMBRANE BIOL, V198, P103, DOI 10.1007/s00232-004-0664-0; Seebohm G, 2003, J PHYSIOL-LONDON, V552, P369, DOI 10.1113/jphysiol.2003.046490; Sigg D, 1997, J GEN PHYSIOL, V109, P27, DOI 10.1085/jgp.109.1.27; Thomson AS, 2010, J GEN PHYSIOL, V136, P569, DOI 10.1085/jgp.201010507; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	46	112	113	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					937	949		10.1016/j.cell.2016.02.002	http://dx.doi.org/10.1016/j.cell.2016.02.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919430	Green Published, hybrid			2022-12-28	WOS:000370867300017
J	Rimmer, A				Rimmer, Abi			What next for the junior doctor contract?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						Iacobucci G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i918; Rimmer A., 2016, BMJ CAREERS	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2016	352								i991	10.1136/bmj.i991	http://dx.doi.org/10.1136/bmj.i991			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6FB	26896254	Green Published			2022-12-28	WOS:000370728000012
J	Keene, DJ; Alsousou, J; Willett, K				Keene, David J.; Alsousou, Joseph; Willett, Keith			UNCERTAINTIES How effective are platelet rich plasma injections in treating musculoskeletal soft tissue injuries?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ROTATOR CUFF TEARS; ARTHROSCOPIC REPAIR; MANAGEMENT; TRIAL; BLIND		[Keene, David J.; Willett, Keith] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskele, Oxford OX1 2JD, England; [Alsousou, Joseph] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England	University of Oxford; University of Liverpool	Keene, DJ (corresponding author), John Radcliffe Hosp, Kadoorie Ctr Crit Care Res & Educ, Oxford OX3 9DU, England.	david.keene@ndorms.ox.ac.uk	Keene, David J/B-5282-2013; Keene, David/P-9055-2019	Keene, David/0000-0001-7249-6496	MRC [MC_PC_14143] Funding Source: UKRI; Medical Research Council [MC_PC_14143] Funding Source: researchfish; National Institute for Health Research [3532, ACF-2014-07-008] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Alsousou J, 2013, PLATELETS, V24, P173, DOI 10.3109/09537104.2012.684730; Alsousou J, 2009, J BONE JOINT SURG BR, V91B, P987, DOI 10.1302/0301-620X.91B8.22546; Dhillon RS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3914; Drago L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107813; Engebretsen L, 2010, BRIT J SPORT MED, V44, P1072, DOI 10.1136/bjsm.2010.079822; Hamid MSA, 2014, AM J SPORT MED, V42, P2410, DOI 10.1177/0363546514541540; Harm SK, 2015, TRANSFUSION, V55, P1596, DOI 10.1111/trf.13160; Jo CH, 2013, AM J SPORT MED, V41, P2240, DOI 10.1177/0363546513497925; Kesikburun S, 2013, AM J SPORT MED, V41, P2609, DOI 10.1177/0363546513496542; Moraes VY, 2014, COCHRANE DB SYST REV, P4; Mosca MJ, 2015, CURR REV MUSCULOSKE, V8, P145, DOI 10.1007/s12178-015-9259-x; National Institute for Health and Care Excellence, 2013, AUT BLOOD INJ PLANT; National Institute for Health and Care Excellence, 2013, AUT BLOOD INJ TEND I; Raeissadat SA, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-12; Rajaratnam K, 2013, ARTHROSCOPY S1, V29, pe46, DOI [10.1016/j.arthro.2013.07.025, DOI 10.1016/J.ARTHRO.2013.07.025]; Rangan A, 2014, BONE JOINT RES, V3, P169, DOI 10.1302/2046-3758.35.2000265; Reurink G, 2014, NEW ENGL J MED, V370, P2546, DOI 10.1056/NEJMc1402340; Rha DW, 2013, CLIN REHABIL, V27, P113, DOI 10.1177/0269215512448388; Ruiz-Moneo P, 2013, ARTHROSCOPY, V29, P2, DOI 10.1016/j.arthro.2012.08.014; Schepull T, 2011, AM J SPORT MED, V39, P38, DOI 10.1177/0363546510383515; Wallis C, 2015, SCI AM, V312, P25, DOI 10.1038/scientificamerican0315-25; Weber SC, 2013, AM J SPORT MED, V41, P263, DOI 10.1177/0363546512467621; Zumstein MA, 2014, J SHOULDER ELB SURG, V23, P3, DOI 10.1016/j.jse.2013.08.017	23	6	7	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2016	352								i517	10.1136/bmj.i517	http://dx.doi.org/10.1136/bmj.i517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EY	26888826	Green Published			2022-12-28	WOS:000370727700005
J	Chatterjee, S; Sardar, P; Chakraborty, A; Chatterjee, S				Chatterjee, Saurav; Sardar, Partha; Chakraborty, Anasua; Chatterjee, Sanjay			Review: More- vs less-intensive BP-lowering regimens reduce major CV events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chatterjee, Saurav] Mt Sinai St Lukes Roosevelt Hosp, New York, NY USA; [Sardar, Partha] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [Chakraborty, Anasua] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Chatterjee, Sanjay] Apollo Gleneagles Hosp, Kolkata, India	Mount Sinai St. Luke's; Mount Sinai West; Utah System of Higher Education; University of Utah; Jefferson University	Chatterjee, S (corresponding author), Mt Sinai St Lukes Roosevelt Hosp, New York, NY USA.							Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					JC14	+		10.7326/ACPJC-2016-164-4-014	http://dx.doi.org/10.7326/ACPJC-2016-164-4-014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26882299				2022-12-28	WOS:000370135300002
J	Berwick, DM				Berwick, Donald M.			Era 3 for Medicine and Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berwick, Donald M.] Inst Healthcare Improvement, 20 Univ Rd, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, 20 Univ Rd, Cambridge, MA 02138 USA.	donberwick@gmail.com						Batalden M, 2016, BMJ QUAL SAF, V25, P509, DOI 10.1136/bmjqs-2015-004315; Freidson EL, 1970, PROFESSION OF MEDICI; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023	3	167	169	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1329	+		10.1001/jama.2016.1509	http://dx.doi.org/10.1001/jama.2016.1509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	26940610				2022-12-28	WOS:000373381500010
J	Gutig, R				Guetig, Robert			Spiking neurons can discover predictive features by aggregate-label learning	SCIENCE			English	Article							TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; NEURAL-NETWORKS; VISUAL-CORTEX; SYNAPTIC PLASTICITY; MODELS; REWARD; CLASSIFICATION; ORGANIZATION; DEPRESSION	The brain routinely discovers sensory clues that predict opportunities or dangers. However, it is unclear how neural learning processes can bridge the typically long delays between sensory clues and behavioral outcomes. Here, I introduce a learning concept, aggregate-label learning, that enables biologically plausible model neurons to solve this temporal credit assignment problem. Aggregate-label learning matches a neuron's number of output spikes to a feedback signal that is proportional to the number of clues but carries no information about their timing. Aggregate-label learning outperforms stochastic reinforcement learning at identifying predictive clues and is able to solve unsegmented speech-recognition tasks. Furthermore, it allows unsupervised neural networks to discover reoccurring constellations of sensory features even when they are widely dispersed across space and time.	[Guetig, Robert] Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany	Max Planck Society	Gutig, R (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	guetig@em.mpg.de						Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Amores J, 2013, ARTIF INTELL, V201, P81, DOI 10.1016/j.artint.2013.06.003; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Barber D., 2002, ADV NEURAL INFORM PR, V15, P149; BECKER S, 1992, NATURE, V355, P161, DOI 10.1038/355161a0; Becker S, 1996, NETWORK-COMP NEURAL, V7, P7, DOI [10.1088/0954-898X/7/1/003, 10.1080/0954898X.1996.11978653]; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Florian RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040233; Friedrich J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002092; Gutig R, 2014, CURR OPIN NEUROBIOL, V25, P134, DOI 10.1016/j.conb.2014.01.004; Gutig R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000141; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Gutig R, 2003, J NEUROSCI, V23, P3697; Hertz JA, 2018, INTRO THEORY NEURAL; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Leonard R. G., 1993, TIDIGITS; Li N, 2008, SCIENCE, V321, P1502, DOI 10.1126/science.1160028; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; LINSKER R, 1990, ANNU REV NEUROSCI, V13, P257, DOI 10.1146/annurev.neuro.13.1.257; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Masquelier T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001377; Memmesheimer RM, 2014, NEURON, V82, P925, DOI 10.1016/j.neuron.2014.03.026; Min R, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00093; Nessler B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003037; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Pawlak V, 2013, ELIFE, V2, DOI 10.7554/eLife.00012; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Van Hooser SD, 2012, J NEUROSCI, V32, P7258, DOI 10.1523/JNEUROSCI.0230-12.2012; WIDROW B, 1990, P IEEE, V78, P1415, DOI 10.1109/5.58323; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Xu Y, 2013, NEURAL COMPUT, V25, P1472, DOI 10.1162/NECO_a_00450; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	44	66	67	6	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277							aab4113	10.1126/science.aab4113	http://dx.doi.org/10.1126/science.aab4113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941324				2022-12-28	WOS:000371597500032
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: The real world for NHS doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2016	352								i1041	10.1136/bmj.i1041	http://dx.doi.org/10.1136/bmj.i1041			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LQ	26944951	Green Published, hybrid			2022-12-28	WOS:000371756900001
J	Miller, MC				Miller, M. Coleman			Dawn of a new astronomy	NATURE			English	Editorial Material								The discovery of gravitational waves from a merging black-hole system opens a window on the Universe that promises to test gravity at its strongest, and to reveal many surprises about black holes and other astrophysical systems.	[Miller, M. Coleman] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Miller, M. Coleman] Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Miller, MC (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.; Miller, MC (corresponding author), Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA.	miller@astro.umd.edu		Miller, Cole/0000-0002-2666-728X				Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.061102; Einstein A, 1918, SITZBER K PREUSS AKA, P154; Einstein A, 1916, SITZBER K PREUSS AKA, P688; Kreidberg L, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/36; The LIGO Scientific Collaboration the Virgo Collaboration, PREPRINT; The LIGO Scientific Collaboration the Virgo Collaboration, 2016, PREPRINT	6	5	5	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					40	42		10.1038/nature17306	http://dx.doi.org/10.1038/nature17306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26909571				2022-12-28	WOS:000371211900033
J	Gulland, A				Gulland, Anne			Seven day NHS services: what trusts are doing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Iacobucci G, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6842; *NHS ENGL, 2013, NHS SERV 7 DAYS WEEK; Royal College of Physicians, 2013, FUT HOSP CAR MED PAT	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2016	352								i1256	10.1136/bmj.i1256	http://dx.doi.org/10.1136/bmj.i1256			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LJ	26931126				2022-12-28	WOS:000371756000012
J	Bosveld, F; Markova, O; Guirao, B; Martin, C; Wang, ZM; Pierre, A; Balakireva, M; Gaugue, I; Ainslie, A; Christophorou, N; Lubensky, DK; Minc, N; Bellaiche, Y				Bosveld, Floris; Markova, Olga; Guirao, Boris; Martin, Charlotte; Wang, Zhimin; Pierre, Anaelle; Balakireva, Maria; Gaugue, Isabelle; Ainslie, Anna; Christophorou, Nicolas; Lubensky, David K.; Minc, Nicolas; Bellaiche, Yohanns			Epithelial tricellular junctions act as interphase cell shape sensors to orient mitosis	NATURE			English	Article							REGULATES SPINDLE ORIENTATION; MITOTIC SPINDLE; DROSOPHILA-MELANOGASTER; POLARITY PATHWAY; CLEAVAGE PLANE; PROTEIN; DIVISIONS; TISSUE; MORPHOGENESIS; LOCALIZATION	The orientation of cell division along the long axis of the interphase cell-the century-old Hertwig's rule-has profound roles in tissue proliferation, morphogenesis, architecture and mechanics(1,2). In epithelial tissues, the shape of the interphase cell is influenced by cell adhesion, mechanical stress, neighbour topology, and planar polarity pathways(3-12). At mitosis, epithelial cells usually adopt a rounded shape to ensure faithful chromosome segregation and to promote morphogenesis(1). The mechanisms underlying interphase cell shape sensing in tissues are therefore unknown. Here we show that in Drosophila epithelia, tricellular junctions (TCJs) localize force generators, pulling on astral microtubules and orienting cell division via the Dynein-associated protein Mud independently of the classical Pins/G alpha(i) pathway. Moreover, as cells round up during mitosis, TCJs serve as spatial landmarks, encoding information about interphase cell shape anisotropy to orient division in the rounded mitotic cell. Finally, experimental and simulation data show that shape and mechanical strain sensing by the TCJs emerge from a general geometric property of TCJ distributions in epithelial tissues. Thus, in addition to their function as epithelial barrier structures, TCJs serve as polarity cues promoting geometry and mechanical sensing in epithelial tissues.	[Bosveld, Floris; Markova, Olga; Guirao, Boris; Martin, Charlotte; Wang, Zhimin; Balakireva, Maria; Gaugue, Isabelle; Ainslie, Anna; Christophorou, Nicolas; Lubensky, David K.; Bellaiche, Yohanns] Inst Curie, CNRS UMR 3215, INSERM U934, Polar,Div & Morphogenesis Team, 26 Rue Ulm, F-75248 Paris 05, France; [Pierre, Anaelle; Minc, Nicolas] Inst Jacques Monod, CNRS UMR7592, 15 Rue Helene Brion, F-75205 Paris 13, France; [Lubensky, David K.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Martin, Charlotte] Univ Paris Sud, CNRS UMR 3348, Inst Curie, Batiment 110, F-91405 Orsay, France; [Christophorou, Nicolas] Inst Jean Pierre Bourgin, INRA, UMR 1318, ERL CNRS 3559,Saclay Plant Sci,RD10, Versailles, France; [Ainslie, Anna] Lincolns Inn Fields Lab, Francis Crick Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Francis Crick Institute	Bosveld, F (corresponding author), Inst Curie, CNRS UMR 3215, INSERM U934, Polar,Div & Morphogenesis Team, 26 Rue Ulm, F-75248 Paris 05, France.	floris.bosveld@curie.fr; yohanns.bellaiche@curie.fr		Isabelle, Gaugue/0000-0001-6618-3899; bellaiche, yohanns/0000-0003-1686-2943; Lubensky, David/0000-0002-4619-116X; bosveld, floris/0000-0002-4733-9074; Ainslie, Anna/0000-0002-4209-0150; Minc, Nicolas/0000-0002-5543-7950; Guirao, Boris/0000-0002-5583-0226	CePoDro ANR; MorphoDro ERC Advanced; ARC [SL220130607097]; Curie Mayent-Rothschild; Labex DEEP; NSF [DMR1056456]; ICAM; Direct For Mathematical & Physical Scien [1056456] Funding Source: National Science Foundation	CePoDro ANR(French National Research Agency (ANR)); MorphoDro ERC Advanced; ARC(Australian Research Council); Curie Mayent-Rothschild; Labex DEEP; NSF(National Science Foundation (NSF)); ICAM; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank V. Auld, A. Bardin, R. Basto, B. Edgar, S. Luschnig, F. Schweisguth, the Bloomington Stock Center and Developmental Studies Hybridoma Bank for reagents; M. Manil-Segalen, S. Rigaud. T. Piolot and I. Bonnet for input and data analyses; the Developmental Biology Curie imaging facility (PICT-IBiSA@BDD); F. Graner, A. Guichet, S. Herszterg, J.-L. Maitre, M. Piel and M. Thery for comments; CePoDro ANR, MorphoDro ERC Advanced, ARC (SL220130607097), Curie Mayent-Rothschild, Labex DEEP, NSF DMR1056456 and ICAM grants for funding.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Allen MJ, 1999, J NEUROSCI, V19, P9374; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Bardet PL, 2013, DEV CELL, V25, P534, DOI 10.1016/j.devcel.2013.04.020; Bergstralh DT, 2013, CURR BIOL, V23, P1707, DOI 10.1016/j.cub.2013.07.017; Bonnet I, 2012, J R SOC INTERFACE, V9, P2614, DOI 10.1098/rsif.2012.0263; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Boulanger J, 2010, IEEE T MED IMAGING, V29, P442, DOI 10.1109/TMI.2009.2033991; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Byri S, 2015, DEV CELL, V33, P535, DOI 10.1016/j.devcel.2015.03.023; Cadart C, 2014, DEV CELL, V29, P159, DOI 10.1016/j.devcel.2014.04.009; Campinho P, 2013, NAT CELL BIOL, V15, P1405, DOI 10.1038/ncb2869; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Furuse M, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28960; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Herszterg S, 2013, DEV CELL, V24, P256, DOI 10.1016/j.devcel.2012.11.019; Hertwig O, 1884, JENAISCHE Z NATURWIS; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Jiang Y, 1999, PHYS REV E, V59, P5819, DOI 10.1103/PhysRevE.59.5819; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Kwon MJ, 2015, DEV CELL, V34, P323, DOI 10.1016/j.devcel.2015.06.013; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Lye CM, 2014, DEVELOPMENT, V141, P4006, DOI 10.1242/dev.111310; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Morelli LG, 2012, SCIENCE, V336, P187, DOI 10.1126/science.1215478; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Nakajima Y, 2013, NATURE, V500, P359, DOI 10.1038/nature12335; Oda Y, 2014, J CELL SCI, V127, P4201, DOI 10.1242/jcs.150607; Raufaste C, 2007, EUR PHYS J E, V23, P217, DOI 10.1140/epje/i2006-10178-9; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Schulte J, 2006, J CELL SCI, V119, P4391, DOI 10.1242/jcs.03208; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Tamada M, 2015, DEV CELL, V35, P151, DOI 10.1016/j.devcel.2015.09.015; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024; Wyatt TPJ, 2015, P NATL ACAD SCI USA, V112, P5726, DOI 10.1073/pnas.1420585112; Xiong FZ, 2014, CELL, V159, P415, DOI 10.1016/j.cell.2014.09.007; XU T, 1993, DEVELOPMENT, V117, P1223; Yu JX, 2006, GENETICS, V173, P243, DOI 10.1534/genetics.105.051557; Zielke N, 2014, CELL REP, V7, P588, DOI 10.1016/j.celrep.2014.03.020	60	146	146	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					495	+		10.1038/nature16970	http://dx.doi.org/10.1038/nature16970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26886796	Green Accepted			2022-12-28	WOS:000370690800039
J	Jain, M; Wernick, R				Jain, Meera; Wernick, Richard			In abstinent adults with type 2 diabetes, a daily glass of wine (vs mineral water) improved cardiometabolic factors Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jain, Meera; Wernick, Richard] Providence Portland Med Ctr, Portland, OR USA	Providence Portland Medical Center	Jain, M (corresponding author), Providence Portland Med Ctr, Portland, OR USA.							Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	4	2	2	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					JC17	JC17		10.7326/ACPJC-2016-164-4-017	http://dx.doi.org/10.7326/ACPJC-2016-164-4-017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26882302				2022-12-28	WOS:000370135300004
J	Reager, JT; Gardner, AS; Famiglietti, JS; Wiese, DN; Eicker, A; Lo, MH				Reager, J. T.; Gardner, A. S.; Famiglietti, J. S.; Wiese, D. N.; Eicker, A.; Lo, M. -H.			A decade of sea level rise slowed by climate-driven hydrology	SCIENCE			English	Article							GROUNDWATER DEPLETION; WATER STORAGE; RECONCILED ESTIMATE; ICE CAPS; GRACE; IRRIGATION; MANAGEMENT; GLACIERS	Climate-driven changes in land water storage and their contributions to sea level rise have been absent from Intergovernmental Panel on Climate Change sea level budgets owing to observational challenges. Recent advances in satellite measurement of time-variable gravity combined with reconciled global glacier loss estimates enable a disaggregation of continental land mass changes and a quantification of this term. We found that between 2002 and 2014, climate variability resulted in an additional 3200 +/- 900 gigatons of water being stored on land. This gain partially offset water losses from ice sheets, glaciers, and groundwater pumping, slowing the rate of sea level rise by 0.71 +/- 0.20 millimeters per year. These findings highlight the importance of climate-driven changes in hydrology when assigning attribution to decadal changes in sea level.	[Reager, J. T.; Gardner, A. S.; Famiglietti, J. S.; Wiese, D. N.] CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA; [Famiglietti, J. S.] Univ Calif Irvine, Dept Civil & Environm Engn, Dept Earth Syst Sci, Irvine, CA USA; [Eicker, A.] Univ Bonn, Inst Geodesy & Geoinformat, Bonn, Germany; [Lo, M. -H.] Natl Taiwan Univ, Dept Atmospher Sci, Taipei 10764, Taiwan	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Irvine; University of Bonn; National Taiwan University	Reager, JT (corresponding author), CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA.	john.reager@jpl.nasa.gov	Eicker, Annette/B-6076-2014; Famiglietti, James S/G-7383-2017	Eicker, Annette/0000-0002-9087-1445; Famiglietti, James S/0000-0002-6053-5379; Gardner, Alex/0000-0002-8394-8889; LO, MIN-HUI/0000-0002-8653-143X	NASA; NASA GRACE Science Team; University of California Multicampus Research Programs and Initiatives; Ministry of Science and Technology (MOST), Taiwan [MOST 103-2111-M-002-006]	NASA(National Aeronautics & Space Administration (NASA)); NASA GRACE Science Team; University of California Multicampus Research Programs and Initiatives; Ministry of Science and Technology (MOST), Taiwan(Ministry of Science and Technology, Taiwan)	We thank M. Watkins, E. Ivins, D. Argus, G. Cogley, A. Richey, Y. Wada, R. Nerem, and D. Chambers for their contributions and discussion. This work was supported by funding from the NASA NEWS, Sea Level, and Cryosphere programs; the NASA GRACE Science Team; and the University of California Multicampus Research Programs and Initiatives. This multidisciplinary collaboration grew from the interactions of the NASA Sea Level Change Team. The research was conducted at the University of California, Irvine and at the Jet Propulsion Laboratory, California Institute of Technology under contract with NASA. M.-H. Lo was supported by the Ministry of Science and Technology (MOST), Taiwan, MOST 103-2111-M-002-006. GRACE RL05M data are available at podaac.jpl.nasa.gov. The authors declare no competing interests.	Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053055; Cazenave A, 2014, NAT CLIM CHANGE, V4, P358, DOI [10.1038/nclimate2159, 10.1038/NCLIMATE2159]; Chambers DP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020461; Chao BF, 2008, SCIENCE, V320, P212, DOI 10.1126/science.1154580; Chen JL, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009383; Cheng MK, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003028; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Doll P, 2014, WATER RESOUR RES, V50, P5698, DOI 10.1002/2014WR015595; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Fasullo JT, 2013, GEOPHYS RES LETT, V40, P4368, DOI 10.1002/grl.50834; Feng W, 2013, WATER RESOUR RES, V49, P2110, DOI 10.1002/wrcr.20192; Forootan E, 2014, REMOTE SENS ENVIRON, V140, P580, DOI 10.1016/j.rse.2013.09.025; Forootan E, 2014, SURV GEOPHYS, V35, P913, DOI 10.1007/s10712-014-9292-0; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Gardner AS, 2011, NATURE, V473, P357, DOI 10.1038/nature10089; Goncalves J, 2013, GEOPHYS RES LETT, V40, P2673, DOI 10.1002/grl.50478; Han SC, 2013, J GEOPHYS RES-SOL EA, V118, P1240, DOI 10.1002/jgrb.50116; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Jensen L, 2013, J GEOPHYS RES-OCEANS, V118, P212, DOI 10.1002/jgrc.20058; Kim H, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039006; Konikow LF, 2013, NAT GEOSCI, V6, P2, DOI 10.1038/ngeo1659; Konikow LF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048604; Lettenmaier DP, 2009, NAT GEOSCI, V2, P452, DOI 10.1038/ngeo567; Llovel W, 2014, NAT CLIM CHANGE, V4, P1031, DOI 10.1038/NCLIMATE2387; Llovel W, 2010, CR GEOSCI, V342, P179, DOI 10.1016/j.crte.2009.12.004; Lo MH, 2013, GEOPHYS RES LETT, V40, P301, DOI 10.1002/grl.50108; Luthcke SB, 2008, J GLACIOL, V54, P767, DOI 10.3189/002214308787779933; Milly PCD, 2003, P NATL ACAD SCI USA, V100, P13158, DOI 10.1073/pnas.2134014100; Milly PCD, 2010, UNDERSTANDING SEA LE, P226, DOI DOI 10.1002/9781444323276.CH8; Niu GY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030413; Peltier WR, 2015, J GEOPHYS RES-SOL EA, V120, P450, DOI 10.1002/2014JB011176; Pokhrel YN, 2012, NAT GEOSCI, V5, P389, DOI [10.1038/ngeo1476, 10.1038/NGEO1476]; Ramillien G, 2008, GLOBAL PLANET CHANGE, V60, P381, DOI 10.1016/j.gloplacha.2007.04.002; Ramillien G, 2014, REMOTE SENS-BASEL, V6, P7379, DOI 10.3390/rs6087379; Reager JT, 2014, NAT GEOSCI, V7, P589, DOI [10.1038/ngeo2203, 10.1038/NGEO2203]; Reager JT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040826; Richey AS, 2015, WATER RESOUR RES, V51, P5217, DOI 10.1002/2015WR017349; Rietbroek R, 2016, P NATL ACAD SCI USA, V113, P1504, DOI 10.1073/pnas.1519132113; Riva REM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044770; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Scanlon BR, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011312; Scanlon BR, 2012, P NATL ACAD SCI USA, V109, P9320, DOI 10.1073/pnas.1200311109; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Swenson S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005338; Syed TH, 2010, P NATL ACAD SCI USA, V107, P17916, DOI 10.1073/pnas.1003292107; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Voss KA, 2013, WATER RESOUR RES, V49, P904, DOI 10.1002/wrcr.20078; Wada Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051230; Wahr J, 2015, J GEOPHYS RES-SOL EA, V120, P4597, DOI 10.1002/2015JB011986; Watkins MM, 2015, J GEOPHYS RES-SOL EA, V120, P2648, DOI 10.1002/2014JB011547; Wouters B, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046128	54	158	159	9	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					699	703		10.1126/science.aad8386	http://dx.doi.org/10.1126/science.aad8386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912856	Green Published			2022-12-28	WOS:000369810000038
J	Simonti, CN; Vernot, B; Bastarache, L; Bottinger, E; Carrell, DS; Chisholm, RL; Crosslin, DR; Hebbring, SJ; Jarvik, GP; Kullo, IJ; Li, RL; Pathak, J; Ritchie, MD; Roden, DM; Verma, SS; Tromp, G; Prato, JD; Bush, WS; Akey, JM; Denny, JC; Capra, JA				Simonti, Corinne N.; Vernot, Benjamin; Bastarache, Lisa; Bottinger, Erwin; Carrell, David S.; Chisholm, Rex L.; Crosslin, David R.; Hebbring, Scott J.; Jarvik, Gail P.; Kullo, Iftikhar J.; Li, Rongling; Pathak, Jyotishman; Ritchie, Marylyn D.; Roden, Dan M.; Verma, Shefali S.; Tromp, Gerard; Prato, Jeffrey D.; Bush, William S.; Akey, Joshua M.; Denny, Joshua C.; Capra, John A.			The phenotypic legacy of admixture between modern humans and Neandertals	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; ANCESTRY; EVOLUTION; SEQUENCE	Many modern human genomes retain DNA inherited from interbreeding with archaic hominins, such as Neandertals, yet the influence of this admixture on human traits is largely unknown. We analyzed the contribution of common Neandertal variants to over 1000 electronic health record (EHR)-derived phenotypes in similar to 28,000 adults of European ancestry. We discovered and replicated associations of Neandertal alleles with neurological, psychiatric, immunological, and dermatological phenotypes. Neandertal alleles together explained a significant fraction of the variation in risk for depression and skin lesions resulting from sun exposure (actinic keratosis), and individual Neandertal alleles were significantly associated with specific human phenotypes, including hypercoagulation and tobacco use. Our results establish that archaic admixture influences disease risk in modern humans, provide hypotheses about the effects of hundreds of Neandertal haplotypes, and demonstrate the utility of EHR data in evolutionary analyses.	[Simonti, Corinne N.; Roden, Dan M.; Denny, Joshua C.; Capra, John A.] Vanderbilt Univ, Vanderbilt Genet Inst, 221 Kirkland Hall, Nashville, TN 37235 USA; [Vernot, Benjamin; Crosslin, David R.; Jarvik, Gail P.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bastarache, Lisa; Roden, Dan M.; Prato, Jeffrey D.; Denny, Joshua C.; Capra, John A.] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Bottinger, Erwin] Mt Sinai Sch Med, New York, NY USA; [Carrell, David S.; Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Med Ctr, Dept Med Med Genet, Seattle, WA 98195 USA; [Chisholm, Rex L.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Hebbring, Scott J.] Marshfield Clin Fdn Med Res & Educ, Ctr Human Genet, Marshfield, WI USA; [Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Li, Rongling] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Pathak, Jyotishman] Mayo Clin, Div Hlth Sci Res, Rochester, MN USA; [Ritchie, Marylyn D.; Verma, Shefali S.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ritchie, Marylyn D.] Geisinger Hlth Syst, Biomed & Translat Informat, Danville, PA USA; [Roden, Dan M.; Denny, Joshua C.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Tromp, Gerard] Geisinger Hlth Syst, Weis Ctr Res, Danville, PA USA; [Tromp, Gerard] Univ Stellenbosch, Dept Biomed Sci, Div Mol Biol & Human Genet, Fac Hlth Sci, ZA-7505 Tygerberg, South Africa; [Bush, William S.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Capra, John A.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Capra, John A.] Vanderbilt Univ, Ctr Quantitat Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Pathak, Jyotishman] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA	Vanderbilt University; University of Washington; University of Washington Seattle; Vanderbilt University; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; Northwestern University; Feinberg School of Medicine; Marshfield Clinic; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Geisinger Health System; Vanderbilt University; Vanderbilt University; Geisinger Health System; Stellenbosch University; Case Western Reserve University; Vanderbilt University; Vanderbilt University; Cornell University	Capra, JA (corresponding author), Vanderbilt Univ, Vanderbilt Genet Inst, 221 Kirkland Hall, Nashville, TN 37235 USA.	tony.capra@vanderbilt.edu	Tromp, Gerard/B-2677-2017; Bush, William/N-1369-2019; Vernot, Benjamin/ABH-1495-2021; Denny, Josh/AAL-3359-2021; Roden, Dan/ABD-5412-2021; Chisholm, Rex/B-3418-2009	Tromp, Gerard/0000-0002-7761-0806; Bush, William/0000-0002-9729-6519; Vernot, Benjamin/0000-0002-6820-2181; Denny, Josh/0000-0002-3049-7332; Akey, Joshua/0000-0002-4411-1330; Chisholm, Rex/0000-0002-5638-3990	NIH [5T32EY021453, R01GM110068, 1R01GM114128]; Vanderbilt Center for Quantitative Sciences; National Human Genome Research Institute [U01HG004438, U01HG004610, U01HG008657, U01HG004608, 1K22LM011938, U01HG006389, U01HG04599, U01HG006379, U01HG004609, U01HG006388, U01HG04603, U01HG006378, U01HG006385, U01HG006382, U01HG006380]; Glenview Capital;  [R01LM010685]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY021453] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006378, U01HG004599, U01HG006375, U01HG008657, U01HG006389, U01HG004609, U01HG004610, U01HG004608, U01HG006388, U01HG006380, U01HG006382, U01HG006385, U01HG008672, U01HG004603, U01HG006379, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110068, R01GM114128] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685, K22LM011938] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Center for Quantitative Sciences; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Glenview Capital; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The data reported in this paper are available in the supplementary materials and in the Neandertal PheWAS Catalog (https://phewas.mc.vanderbilt.edu/neanderthal). The raw genotype and phenotype data used in this study are subject to the data use and availability requirements of the eMERGE network outlined at https://emerge.mc.vanderbilt.edu/collaborate. We thank A. Fish, J. Hall, D. Mortlock, D. Samuels, M. Sivley, and P. Wu for helpful discussions. C.N.S. was supported by NIH grant 5T32EY021453 to Vanderbilt University and a pilot project award from the Vanderbilt Center for Quantitative Sciences. The eMERGE Network was initiated and funded by the National Human Genome Research Institute through the following grants: U01HG004438 to Johns Hopkins University; U01HG004610 and U01HG008657 to Group Health Cooperative and University of Washington, Seattle; U01HG004608 and 1K22LM011938 to the Marshfield Clinic; U01HG006389 to the Essentia Institute of Rural Health; U01HG04599 and U01HG006379 to the Mayo Clinic; U01HG004609 and U01HG006388 to Northwestern University; U01HG04603 and U01HG006378 to Vanderbilt University; U01HG006385 to the Coordinating Center of the eMERGE Network; U01HG006382 to the Geisinger Clinic; and U01HG006380 to the Mount Sinai School of Medicine. J. M. A. is a paid consultant for Glenview Capital and provides advice on next-generation sequencing technologies. PheWAS method development was supported by grant R01LM010685. J. M. A. was supported in part by NIH grant R01GM110068. S.J.H was supported in part by NIH grant 1R01GM114128. The authors report no conflicts of interest.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Heit JA, 2012, J THROMB HAEMOST, V10, P1521, DOI 10.1111/j.1538-7836.2012.04810.x; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Khrameeva EE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4584; Martin PR, 2003, ALCOHOL RES HEALTH, V27, P134; Oksenberg N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003221; Pazo JH, 2002, CELL MOL NEUROBIOL, V22, P645, DOI 10.1023/A:1021844605250; Pickering C, 2008, PROG NEURO-PSYCHOPH, V32, P1521, DOI 10.1016/j.pnpbp.2008.05.011; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rallapalli PM, 2014, MOL BIOL EVOL, V31, P3040, DOI 10.1093/molbev/msu248; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schroeder LF, 2014, J CLIN MICROBIOL, V52, P489, DOI 10.1128/JCM.02777-13; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	25	146	150	4	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					737	741		10.1126/science.aad2149	http://dx.doi.org/10.1126/science.aad2149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912863	Green Accepted			2022-12-28	WOS:000369810000047
J	Wilkes, R				Wilkes, Rima			Retire the letter of reference	SCIENCE			English	Editorial Material									[Wilkes, Rima] Univ British Columbia, Sociol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Wilkes, R (corresponding author), Univ British Columbia, Sociol, Vancouver, BC V5Z 1M9, Canada.	SciCareerEditor@aaas.org							0	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					630	630		10.1126/science.351.6273.630	http://dx.doi.org/10.1126/science.351.6273.630			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC5WO	26912706				2022-12-28	WOS:000369291600045
J	Barry, MJ; Albertsen, PC				Barry, Michael J.; Albertsen, Peter C.			Is Prostate-Specific Antigen Screening "Proven Ineffective Care"?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CANCER		Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Connecticut, Sch Med, Farmington, CT USA; [Barry, Michael J.] Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,Suite 802, Boston, MA 02114 USA; [Albertsen, Peter C.] Univ Connecticut, Ctr Hlth, Dept Surg, 263 Farmington Ave, Farmington, CT 06030 USA	Harvard University; Massachusetts General Hospital; University of Connecticut; Harvard University; Massachusetts General Hospital; University of Connecticut	Barry, MJ (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,Suite 802, Boston, MA 02114 USA.	mbarry@mgh.harvard.edu						Barry MJ, 2015, AM J PREV MED, V49, P520, DOI 10.1016/j.amepre.2015.03.002; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Heijnsdijk EAM, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju366; National Committee for Quality Assurance, 2015, HEDIS 2015 NONR PSA; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; US Preventative Services Task Force, 2012, PROST CANC SCREEN	7	0	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					687	+		10.7326/M15-3025	http://dx.doi.org/10.7326/M15-3025			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	26902323				2022-12-28	WOS:000375878500018
J	Albright, R; Caldeira, L; Hosfelt, J; Kwiatkowski, L; Maclaren, JK; Mason, BM; Nebuchina, Y; Ninokawa, A; Pongratz, J; Ricke, KL; Rivlin, T; Schneider, K; Sesboue, M; Shamberger, K; Silverman, J; Wolfe, K; Zhu, K; Caldeira, K				Albright, Rebecca; Caldeira, Lilian; Hosfelt, Jessica; Kwiatkowski, Lester; Maclaren, Jana K.; Mason, Benjamin M.; Nebuchina, Yana; Ninokawa, Aaron; Pongratz, Julia; Ricke, Katharine L.; Rivlin, Tanya; Schneider, Kenneth; Sesbouee, Marine; Shamberger, Kathryn; Silverman, Jacob; Wolfe, Kennedy; Zhu, Kai; Caldeira, Ken			Reversal of ocean acidification enhances net coral reef calcification	NATURE			English	Article							MASSIVE PORITES; CARBONIC-ACID; GROWTH-RATES; SEAWATER; DISSOCIATION; MARINE; CHEMISTRY; CONSTANTS; DYNAMICS; ISLAND	Approximately one-quarter of the anthropogenic carbon dioxide released into the atmosphere each year is absorbed by the global oceans, causing measurable declines in surface ocean pH, carbonate ion concentration ([CO32-]), and saturation state of carbonate minerals (Omega)(1). This process, referred to as ocean acidification, represents a major threat to marine ecosystems, in particular marine calcifiers such as oysters, crabs, and corals. Laboratory and field studies(2,3) have shown that calcification rates of many organisms decrease with declining pH, [CO32-], and Omega. Coral reefs are widely regarded as one of the most vulnerable marine ecosystems to ocean acidification, in part because the very architecture of the ecosystem is reliant on carbonate-secreting organisms(4). Acidification-induced reductions in calcification are projected to shift coral reefs from a state of net accretion to one of net dissolution this century(5). While retrospective studies show large-scale declines in coral, and community, calcification over recent decades(6-12), determining the contribution of ocean acidification to these changes is difficult, if not impossible, owing to the confounding effects of other environmental factors such as temperature. Here we quantify the net calcification response of a coral reef flat to alkalinity enrichment, and show that, when ocean chemistry is restored closer to pre-industrial conditions, net community calcification increases. In providing results from the first seawater chemistry manipulation experiment of a natural coral reef community, we provide evidence that net community calcification is depressed compared with values expected for pre-industrial conditions, indicating that ocean acidification may already be impairing coral reef growth.	[Albright, Rebecca; Caldeira, Lilian; Kwiatkowski, Lester; Maclaren, Jana K.; Nebuchina, Yana; Pongratz, Julia; Ricke, Katharine L.; Schneider, Kenneth; Sesbouee, Marine; Zhu, Kai; Caldeira, Ken] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Hosfelt, Jessica; Ninokawa, Aaron] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Maclaren, Jana K.] Stanford Univ, Stanford Nano Shared Facil, Stanford, CA 94305 USA; [Mason, Benjamin M.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Pongratz, Julia] Max Planck Inst Meteorol, Bundesstr 53, D-20146 Hamburg, Germany; [Ricke, Katharine L.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Rivlin, Tanya] Hebrew Univ Jerusalem, Interuniv Inst Marine Sci, H Steinitz Marine Biol Lab, Elat, Israel; [Rivlin, Tanya] Hebrew Univ Jerusalem, Fredy & Nadine Herrman Inst Earth Sci, Edmond J Safra Campus, Jerusalem, Israel; [Schneider, Kenneth] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Shamberger, Kathryn] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Shamberger, Kathryn] Texas A&M Univ, College Stn, TX 77843 USA; [Silverman, Jacob] Inst Oceanog & Limnol Res, Haifa, Israel; [Wolfe, Kennedy] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Zhu, Kai] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Zhu, Kai] Rice Univ, Dept BioSci, Houston, TX 77005 USA	Carnegie Institution for Science; University of California System; University of California Davis; Stanford University; Stanford University; Max Planck Society; Cornell University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Woods Hole Oceanographic Institution; Texas A&M University System; Texas A&M University College Station; University of Sydney; Stanford University; Rice University	Albright, R (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	ralbright@carnegiescience.edu	Shamberger, Kathryn E F/C-9531-2014; Zhu, Kai/H-1022-2013; Kwiatkowski, Lester/O-2618-2017; Pongratz, Julia/AAG-3274-2019; Caldeira, Ken/E-7914-2011; Ninokawa, Aaron/AAC-6979-2022; Maclaren, Jana/I-2268-2013	Shamberger, Kathryn E F/0000-0002-2927-3657; Zhu, Kai/0000-0003-1587-3317; Kwiatkowski, Lester/0000-0002-6769-5957; Caldeira, Ken/0000-0002-4591-643X; Albright, Rebecca/0000-0003-3409-8766; Wolfe, Kennedy/0000-0002-9502-6769; Pongratz, Julia/0000-0003-0372-3960; Ninokawa, Aaron/0000-0002-8259-0889; Maclaren, Jana/0000-0002-5173-2290; Silverman, Jacob/0000-0001-5910-1234	Fund for Innovative Climate and Energy Research	Fund for Innovative Climate and Energy Research	We thank R. Dunbar for the use of his laboratory and D. Mucciarone for laboratory training and assistance; the Australian Institute of Marine Science for scientific and technical support; Y. Estrada for graphics assistance; and the following people for their support in the field and/or laboratory: M. Byrne, A. Chai, R. Graham, T. Hill, D. Kline, B. Kravitz, J. Reiffel, D. Ross, E. Shaw, and the staff of the One Tree Island Research Station. Expedition and staff support was provided by the Carnegie Institution for Science. Some additional support for staff, but not expedition expenses, was provided by the Fund for Innovative Climate and Energy Research. This work was permitted by the Great Barrier Reef Marine Park Authority under permit G14/36863.1.	Albright R, 2013, BIOGEOSCIENCES, V10, P6747, DOI 10.5194/bg-10-6747-2013; Albright R, 2015, GEOPHYS RES LETT, V42, P3980, DOI 10.1002/2015GL063488; ANDERSON LG, 1992, MAR CHEM, V37, P179, DOI 10.1016/0304-4203(92)90077-N; Andersson AJ, 2012, BIOGEOSCIENCES, V9, P893, DOI 10.5194/bg-9-893-2012; Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Cao L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035072; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Cyronak T., 2015, ICES J MAR SCI; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Falter JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053303; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; FRIEDLANDER SK, 1986, J AEROSOL SCI, V17, P240, DOI 10.1016/0021-8502(86)90075-3; Grasshoff K, 1999, METHODS SEAWATER ANA; Helmle KP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1222; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; KINSEY DW, 1978, LIMNOL OCEANOGR, V23, P989, DOI 10.4319/lo.1978.23.5.0989; Kline DI, 2012, SCI REP-UK, V2, DOI 10.1038/srep00413; Koweek D, 2015, CORAL REEFS, V34, P339, DOI 10.1007/s00338-014-1217-3; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P47, DOI 10.5194/essd-7-47-2015; Lewis E., 1998, PROGRAM DEV CO2 SYST; Lough JM, 2011, EARTH-SCI REV, V108, P170, DOI 10.1016/j.earscirev.2011.07.001; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; National Research Council, 2015, CLIM INT CARB DIOX R, DOI [10.17226/18805, DOI 10.17226/18805]; Ricke KL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034003; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Shaw EC, 2015, LIMNOL OCEANOGR, V60, P777, DOI 10.1002/lno.10048; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Silverman J, 2014, GEOCHIM COSMOCHIM AC, V144, P72, DOI 10.1016/j.gca.2014.09.011; Silverman J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001974; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Tanzil JT, 2013, GLOBAL CHANGE BIOL, V19, P3011, DOI 10.1111/gcb.12279; Tierney JE, 2015, PALEOCEANOGRAPHY, V30, P226, DOI 10.1002/2014PA002717; Wilson J. F., 1968, TECHNIQUES WATER RES	43	172	178	54	657	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					362	+		10.1038/nature17155	http://dx.doi.org/10.1038/nature17155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26909578				2022-12-28	WOS:000372064300051
J	Brehaut, JC; Colquhoun, HL; Eva, KW; Carroll, K; Sales, A; Michie, S; Ivers, N; Grimshaw, JM				Brehaut, Jamie C.; Colquhoun, Heather L.; Eva, Kevin W.; Carroll, Kelly; Sales, Anne; Michie, Susan; Ivers, Noah; Grimshaw, Jeremy M.			Practice Feedback Interventions: 15 Suggestions for Optimizing Effectiveness	ANNALS OF INTERNAL MEDICINE			English	Article							REMINDER MESSAGES; GENERAL-PRACTICE; PRIMARY-CARE; PERFORMANCE; BEHAVIOR; AUDIT; CONSENSUS; QUALITY; METAANALYSIS; FREQUENCY	Electronic practice data are increasingly being used to provide feedback to encourage practice improvement. However, evidence suggests that despite decades of experience, the effects of such interventions vary greatly and are not improving over time. Guidance on providing more effective feedback does exist, but it is distributed across a wide range of disciplines and theoretical perspectives. Through expert interviews; systematic reviews; and experience with providing, evaluating, and receiving practice feedback, 15 suggestions that are believed to be associated with effective feedback interventions have been identified. These suggestions are intended to provide practical guidance to quality improvement professionals, information technology developers, educators, administrators, and practitioners who receive such interventions. Designing interventions with these suggestions in mind should improve their effect, and studying the mechanisms underlying these suggestions will advance a stagnant literature.	Ottawa Gen Hosp, Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; Univ Toronto, Occupat Sci & Occupat Therapy, Toronto, ON, Canada; Womens Coll Hosp, Toronto, ON, Canada; Univ British Columbia, Ctr Hlth Educ Scholarship, Vancouver, BC V5Z 1M9, Canada; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; UCL, London, England	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of British Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of London; University College London	Brehaut, JC (corresponding author), Ottawa Gen Hosp, Ottawa Hosp Res Inst, Ctr Practice Changing Res, Clin Epidemiol Program, Gen Campus,501 Smyth Rd,Box 201B, Ottawa, ON K1H 8L6, Canada.	jbrehaut@ohri.ca	Greiver, Michelle/N-8764-2015; Sales, Anne E/D-9678-2012; Ivers, Noah/O-7643-2018	Greiver, Michelle/0000-0001-8957-0285; Sales, Anne E/0000-0001-9360-3334; Ivers, Noah/0000-0003-2500-2435	Canadian Institutes of Health Research; Canada Research Chair in Health Knowledge Transfer and Uptake; Department of Family and Community Medicine, University of Toronto; Canadian Institutes of Health Research (MOP) [30354]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Knowledge Transfer and Uptake(Canada Research Chairs); Department of Family and Community Medicine, University of Toronto(University of Toronto); Canadian Institutes of Health Research (MOP)(Canadian Institutes of Health Research (CIHR))	By the Canadian Institutes of Health Research (MOP#130354). Dr. Ivers is supported by New Investigator Awards from the Canadian Institutes of Health Research and the Department of Family and Community Medicine, University of Toronto. Dr. Grimshaw is supported by a Canada Research Chair in Health Knowledge Transfer and Uptake.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Ajzen I., 1985, ACTION CONTROL, P11; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Anseel F, 2009, ORGAN BEHAV HUM DEC, V110, P23, DOI 10.1016/j.obhdp.2009.05.003; ARCHERKATH J, 1994, J SOC PSYCHOL, V134, P681, DOI 10.1080/00224545.1994.9922999; Boud D, 2013, ASSESS EVAL HIGH EDU, V38, P698, DOI 10.1080/02602938.2012.691462; Brehaut JC, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-114; Brinol P, 2012, J PERS SOC PSYCHOL, V102, P925, DOI 10.1037/a0027231; Brown JD, 2002, J PERS, V70, P127, DOI 10.1111/1467-6494.00181; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Cantillon P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1961; Carless D, 2011, STUD HIGH EDUC, V36, P395, DOI 10.1080/03075071003642449; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Colquhoun HL, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-66; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Eccles M, 2001, LANCET, V357, P1406, DOI 10.1016/S0140-6736(00)04564-5; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Elwyn G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004705; Eva KW, 2012, ADV HEALTH SCI EDUC, V17, P15, DOI 10.1007/s10459-011-9290-7; Exworthy M, 2003, SOC SCI MED, V56, P1493, DOI 10.1016/S0277-9536(02)00151-X; Fidler M, 1999, ACAD MED, V74, P702, DOI 10.1097/00001888-199906000-00019; Foy R, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-50; Gardner B, 2010, SOC SCI MED, V70, P1618, DOI 10.1016/j.socscimed.2010.01.039; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Goldstein E B, 2009, SENSATION PERCEPTION; Hibbard J H, 2001, Jt Comm J Qual Improv, V27, P591; Hysong SJ, 2009, MED CARE, V47, P356, DOI 10.1097/MLR.0b013e3181893f6b; ILGEN DR, 1979, J APPL PSYCHOL, V64, P349, DOI 10.1037/0021-9010.64.4.349; Ivanovic J, 2015, ANN THORAC SURG, V100, P1188, DOI 10.1016/j.athoracsur.2015.04.012; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Ivers NM, 2014, J GEN INTERN MED, V29, P1534, DOI 10.1007/s11606-014-2913-y; Ivers NM, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-142; Ivers NM, 2014, IMPLEMENT SCI, V9, DOI [10.1186/1748-5908-9-14, 10.1186/1748-5908-9-51]; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Kluger AN, 2010, MED EDUC, V44, P1166, DOI 10.1111/j.1365-2923.2010.03849.x; Lam CF, 2011, ORGAN BEHAV HUM DEC, V116, P217, DOI 10.1016/j.obhdp.2011.05.002; Lavis JN, 2010, INT J TECHNOL ASSESS, V26, P405, DOI 10.1017/S026646231000108X; LOCKE EA, 1991, MOTIV EMOTION, V15, P9, DOI 10.1007/BF00991473; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Logan J, 1998, SCI COMMUN, V20, P227, DOI 10.1177/1075547098020002004; Lurie NH, 2009, ORGAN BEHAV HUM DEC, V108, P315, DOI 10.1016/j.obhdp.2008.05.005; Mayer RE, 2001, MULTIMEDIA LEARNING, P63; Metcalfe J, 2007, EUR J COGN PSYCHOL, V19, P743, DOI 10.1080/09541440701326063; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mitchell E, 2005, BRIT J GEN PRACT, V55, P94; Nielsen J., 2000, DESIGNING WEB USABIL; Opiyo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055067; Overeem K, 2010, MED EDUC, V44, P140, DOI 10.1111/j.1365-2923.2009.03580.x; Reiter HI, 2004, ADV HEALTH SCI EDUC, V9, P189, DOI 10.1023/B:AHSE.0000038172.97337.d5; Sales AE, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0208-2; Sargeant J, 2015, ACAD MED, V90, P1698, DOI 10.1097/ACM.0000000000000809; Sheeran P, 2005, PREDICTING HLTH BEHA, P276; Shute VJ, 2008, REV EDUC RES, V78, P153, DOI 10.3102/0034654307313795; Stull M K, 1986, J Nurs Adm, V16, P39; Stull MK., 1986, J NURS ADMIN, V16, P39; Sweller J, 1998, EDUC PSYCHOL REV, V10, P251, DOI 10.1023/A:1022193728205; Thomas RE, 2006, LANCET, V367, P1990, DOI 10.1016/S0140-6736(06)68888-0; TIERNEY WM, 1986, MED CARE, V24, P659, DOI 10.1097/00005650-198608000-00001; Tufte Edward R., 2004, VISUAL DISPLAY QUANT; Van der Sijs H, 2006, J AM MED INFORM ASSN, V13, P138, DOI 10.1197/jamia.M1809; Veloski J, 2006, MED TEACH, V28, P117, DOI 10.1080/01421590600622665; Vredenburg K., 2002, USER CTR DESIGN INTE	67	189	191	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					435	+		10.7326/M15-2248	http://dx.doi.org/10.7326/M15-2248			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG6PG	26903136	Green Submitted			2022-12-28	WOS:000372207200017
J	Geller, AC; Rees, VW; Brooks, DR				Geller, Alan C.; Rees, Vaughan W.; Brooks, Daniel R.			The Proposal for Smoke-Free Public Housing Benefits, Challenges, and Opportunities for 2 Million Residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Geller, Alan C.; Rees, Vaughan W.] Harvard Univ, Ctr Global Tobacco Control, Dept Social & Behav Sci, TH Chan Sch Publ Hlth, 677 Huntington Ave,Kresge 718, Boston, MA 02115 USA; [Brooks, Daniel R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Geller, AC (corresponding author), Harvard Univ, Ctr Global Tobacco Control, Dept Social & Behav Sci, TH Chan Sch Publ Hlth, 677 Huntington Ave,Kresge 718, Boston, MA 02115 USA.	ageller@hsph.harvard.edu	Rees, Vaughan/AGX-0619-2022	Rees, Vaughan/0000-0002-9939-6740; Brooks, Daniel/0000-0001-6220-6889				Cummings KM, 2006, AM J PREV MED, V31, P181, DOI 10.1016/j.amepre.2006.03.027; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; King BA, 2010, NICOTINE TOB RES, V12, P598, DOI 10.1093/ntr/ntq053; Rokicki S, 2016, NICOTINE TOB RES, V18, P1282, DOI 10.1093/ntr/ntv239; Stein AH, 2015, AM J HLTH PROMOT, DOI [10.4278/ajhp.140929-QUAN-480, DOI 10.4278/AJHP.140929-QUAN-480]; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; US Department of Housing and Urban Development (HUD), I SMOK FREE PUBL HOU	8	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1105	1106		10.1001/jama.2016.1380	http://dx.doi.org/10.1001/jama.2016.1380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26882206				2022-12-28	WOS:000372159800010
J	Rasmussen, SO; Svensson, AM				Rasmussen, Sune O.; Svensson, Anders M.			Comment on "Abrupt warming events drove Late Pleistocene Holarctic megafaunal turnover"	SCIENCE			English	Editorial Material							CORE; CHRONOLOGY; RECORDS	Cooper et al. (Research Article, 7 August 2015, p. 602) combined the annual-layer-counted Greenland Ice Core Chronology 2005 with chronological information from the Hulu Cave and Cariaco Basin records to produce a "revised" time scale. We argue that their time scale is incompatible with the nature of annual-layer-counted time scales and may lead to seriously flawed conclusions if used elsewhere at face value.	[Rasmussen, Sune O.; Svensson, Anders M.] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, Juliane Maries Vej 30, DK-2100 Copenhagen O, Denmark	University of Copenhagen; Niels Bohr Institute	Rasmussen, SO (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, Juliane Maries Vej 30, DK-2100 Copenhagen O, Denmark.	olander@nbi.ku.dk	Rasmussen, Sune Olander/AAA-3190-2021; Rasmussen, Sune/B-5560-2008; Svensson, Anders/A-2643-2010	Rasmussen, Sune Olander/0000-0002-4177-3611; Rasmussen, Sune/0000-0002-4177-3611; Svensson, Anders/0000-0002-4364-6085				Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; [Anonymous], 2015, OCTOBER, DOI 10.1126/science.aad3573; Brauer A, 2014, QUATERNARY SCI REV, V106, P47, DOI 10.1016/j.quascirev.2014.07.006; Buizert C, 2015, CLIM PAST, V11, P153, DOI 10.5194/cp-11-153-2015; Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Vinther BM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006921; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013	10	1	1	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276								10.1126/science.aad3573	http://dx.doi.org/10.1126/science.aad3573			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917761				2022-12-28	WOS:000370821400029
J	Sontheimer, EJ; Marraffini, LA				Sontheimer, Erik J.; Marraffini, Luciano A.			CRISPR goes retro	SCIENCE			English	Editorial Material							RNA CLEAVAGE; MECHANISM; SYSTEM; DNA		[Sontheimer, Erik J.] Univ Massachusetts, Sch Med, Program Mol Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	University of Massachusetts System; University of Massachusetts Worcester; Rockefeller University	Sontheimer, EJ (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, RNA Therapeut Inst, Worcester, MA 01605 USA.	erik.sontheimer@umassmed.edu; marrafni@rockefeller.edu						Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Nunez J. K., 2015, NATURE, V519, P193; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027	15	2	2	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					920	921		10.1126/science.aaf2851	http://dx.doi.org/10.1126/science.aaf2851			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917756				2022-12-28	WOS:000370821400022
J	Wraith, D				Wraith, David			AUTOIMMUNITY Antigen-specific immunotherapy	NATURE			English	Editorial Material							TH1 CELLS; DISEASES		[Wraith, David] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England	University of Bristol	Wraith, D (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England.	d.c.wraith@bristol.ac.uk		Wraith, David/0000-0003-2147-5614				Baxter AG, 2002, NAT REV IMMUNOL, V2, P439, DOI 10.1038/nri823; Burton BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5741; Clemente-Casares X, 2016, NATURE, V530, P434, DOI 10.1038/nature16962; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Larche M, 2005, NAT MED, V11, pS69, DOI 10.1038/nm1226; Noon L, 1911, LANCET, V1, P1572; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Sabatos-Peyton CA, 2010, CURR OPIN IMMUNOL, V22, P609, DOI 10.1016/j.coi.2010.08.006; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104	11	28	30	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					422	423		10.1038/nature17300	http://dx.doi.org/10.1038/nature17300			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26886797				2022-12-28	WOS:000370690800020
J	Zhong, ZY; Umemura, A; Sanchez-Lopez, E; Liang, S; Shalapour, S; Wong, J; He, F; Boassa, D; Perkins, G; Ali, SR; McGeough, MD; Ellisman, MH; Seki, E; Gustafsson, AB; Hoffman, HM; Diaz-Meco, MT; Moscat, J; Karin, M				Zhong, Zhenyu; Umemura, Atsushi; Sanchez-Lopez, Elsa; Liang, Shuang; Shalapour, Shabnam; Wong, Jerry; He, Feng; Boassa, Daniela; Perkins, Guy; Ali, Syed Raza; McGeough, Matthew D.; Ellisman, Mark H.; Seki, Ekihiro; Gustafsson, Asa B.; Hoffman, Hal M.; Diaz-Meco, Maria T.; Moscat, Jorge; Karin, Michael			NF-kappa B Restricts Inflammasome Activation via Elimination of Damaged Mitochondria	CELL			English	Article							NLRP3 INFLAMMASOME; PINK1/PARKIN-MEDIATED MITOPHAGY; NALP3 INFLAMMASOME; AUTOPHAGY; PARKIN; ROLES; P62; PANCREATITIS; RECOGNITION; P62/SQSTM1	Nuclear factor kappa B (NF-kappa B), a key activator of inflammation, primes the NLRP3-inflammasome for activation by inducing pro-IL-1 beta and NLRP3 expression. NF-kappa B, however, also prevents excessive inflammation and restrains NLRP3-inflammasome activation through a poorly defined mechanism. We now show that NF-kappa B exerts its anti-inflammatory activity by inducing delayed accumulation of the autophagy receptorp62/SQSTM1. ExternalNLRP3-activating stimuli trigger a form of mitochondrial (mt) damage that is caspase-1-and NLRP3-independent and causes release of direct NLRP3-inflammasome activators, includingmtDNAandmtROS. Damaged mitochondria undergo Parkin-dependent ubiquitin conjugation and are specifically recognized by p62, which induces their mitophagic clearance. Macrophage-specific p62 ablation causes pronounced accumulation of damaged mitochondria and excessive IL-1 beta-dependent inflammation, enhancing macrophage death. Therefore, the "NF-kappa B-p62-mitophagy" pathway is a macrophage-intrinsic regulatory loop through which NF-kappa B restrains its own inflammation-promoting activity and orchestrates a self-limiting host response that maintains homeostasis and favors tissue repair.	[Zhong, Zhenyu; Umemura, Atsushi; Sanchez-Lopez, Elsa; Shalapour, Shabnam; Wong, Jerry; He, Feng; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Zhong, Zhenyu; Umemura, Atsushi; Sanchez-Lopez, Elsa; Shalapour, Shabnam; Wong, Jerry; He, Feng; Karin, Michael] Univ Calif San Diego, Dept Pathol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Umemura, Atsushi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kamigyo Ku, 465 Kajii Cho,Kawaramachi Hirokoji, Kyoto 6028566, Japan; [Liang, Shuang; Seki, Ekihiro] Univ Calif San Diego, Dept Med, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Boassa, Daniela; Perkins, Guy; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Ali, Syed Raza; McGeough, Matthew D.; Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Seki, Ekihiro] Cedars Sinai Med Ctr, Dept Med, Div Gastroenterol, Los Angeles, CA 90048 USA; [Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Diaz-Meco, Maria T.; Moscat, Jorge] Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Kyoto Prefectural University of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cedars Sinai Medical Center; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Karin, M (corresponding author), Univ Calif San Diego, Dept Pathol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	He, Feng/J-6984-2019; Zhong, Zhenyu/A-8339-2017; Sanchez-Lopez, Elsa/A-7131-2017; Seki, Ekihiro/K-2481-2016	He, Feng/0000-0003-0276-3303; Sanchez-Lopez, Elsa/0000-0002-4236-1985; Seki, Ekihiro/0000-0002-9472-6085; Umemura, Atsushi/0000-0002-7433-8501; Perkins, Guy/0000-0002-1834-6646; Diaz-Meco, Maria/0000-0003-0147-0998; Zhong, Zhenyu/0000-0002-9441-7645	Cancer Research Institute (CRI) Irvington postdoctoral fellowship; JSPS KAKENHI [15H06547]; Kanae Foundation for the Promotion of Medical Science; Rotary Foundation; Sara Borrell fellowship under ISCIII/MICINN program; CRI-Irvington; German Research Foundation [SH721/1-1]; Canadian Institutes of Health Research [MFE-135425]; NIH [AI043477, CA163798, GM103412, AA020172, DK085252, ES010337, HL087023, AI52430, CA192642, CA030199, CA132847, CA172025]; Leukemia and Lymphoma Society SCOR [20132569]; Alliance for Lupus Research [257214]; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA163798, R01CA192642, R01CA155120, R01CA172025, R01CA132847] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052430, R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085252, P01DK098108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020172] Funding Source: NIH RePORTER	Cancer Research Institute (CRI) Irvington postdoctoral fellowship; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kanae Foundation for the Promotion of Medical Science; Rotary Foundation; Sara Borrell fellowship under ISCIII/MICINN program; CRI-Irvington; German Research Foundation(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); Alliance for Lupus Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank M.K. lab members for helpful discussions and eBioscience, Cell Signaling Technologies, Santa Cruz Technologies, and Life Technologies for gifts of antibodies and other reagents. Z.Z. was supported by Cancer Research Institute (CRI) Irvington postdoctoral fellowship; A.U. was supported by JSPS KAKENHI (15H06547), Kanae Foundation for the Promotion of Medical Science, and a Global Grant Scholarship from The Rotary Foundation; E.S.-L. was supported by Sara Borrell fellowship under ISCIII/MICINN program; S.S. was supported by fellowships from CRI-Irvington and German Research Foundation (SH721/1-1); and J.W. was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (MFE-135425). Research was supported by grants from the NIH (AI043477 and CA163798) to M.K., (GM103412) to M.H.E. for support of the National Center for Microscopy and Imaging Research, (AA020172 and DK085252) to E.S., (ES010337) to M.K. and E.S., (HL087023) to A.B.G., (AI52430) to H.M.H., (CA192642) to M.T.D.-M., (CA030199) to M.T.D-M. and J.M., (CA132847, CA172025) to J.M., Leukemia and Lymphoma Society SCOR (20132569) to Tom Kipps and M.K., and the Alliance for Lupus Research (257214) to M.K., who is an American Cancer Research Professor and holds the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Kim SJ, 2013, FREE RADICAL BIO MED, V65, P997, DOI 10.1016/j.freeradbiomed.2013.08.178; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Li N, 2013, J CLIN INVEST, V123, P2231, DOI 10.1172/JCI64498; Licastro Federico, 2005, Immun Ageing, V2, P8; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Muller TD, 2013, J CLIN INVEST, V123, P469, DOI 10.1172/JCI64209; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Stumptner C, 2007, HEPATOLOGY, V46, P851, DOI 10.1002/hep.21744; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vance RE, 2015, CURR OPIN IMMUNOL, V32, P84, DOI 10.1016/j.coi.2015.01.010; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Vonlaufen A, 2007, GASTROENTEROLOGY, V133, P1293, DOI 10.1053/j.gastro.2007.06.062; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	52	644	693	17	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					896	910		10.1016/j.cell.2015.12.057	http://dx.doi.org/10.1016/j.cell.2015.12.057			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919428	Bronze, Green Accepted			2022-12-28	WOS:000370867300014
J	Chen, HF; Bailey, S				Chen, Hongfan; Bailey, Scott			STRUCTURAL BIOLOGY Cas9, poised for DNA cleavage	SCIENCE			English	Editorial Material							TARGET DNA; CRYSTAL-STRUCTURE; COMPLEX; RNA; ENDONUCLEASE; RECOGNITION; CRISPR-CAS9; NUCLEASES; IMMUNITY		[Chen, Hongfan; Bailey, Scott] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bailey, S (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	scott.bailey@jhu.edu	Bailey, Scott/N-7248-2019		NIGMS NIH HHS [R01 GM097330] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Callaway E, 2015, NATURE, V525, P172, DOI 10.1038/525172a; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Travis J, 2015, SCIENCE, V350, P1456, DOI 10.1126/science.350.6267.1456	13	4	3	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					811	812		10.1126/science.aaf2089	http://dx.doi.org/10.1126/science.aaf2089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912877				2022-12-28	WOS:000370325700021
J	Azoulay, L; Filion, KB; Platt, RW; Dahl, M; Dormuth, CR; Clemens, KK; Durand, M; Juurlink, DN; Targownik, LE; Turin, TC; Paterson, JM; Ernst, P				Azoulay, Laurent; Filion, Kristian B.; Platt, Robert W.; Dahl, Matthew; Dormuth, Colin R.; Clemens, Kristin K.; Durand, Madeleine; Juurlink, David N.; Targownik, Laura E.; Turin, Tanvir C.; Paterson, J. Michael; Ernst, Pierre		Canadian Network For Observational	Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TYPE-2; SAFETY; CLAIMS; METAANALYSIS; SITAGLIPTIN; INHIBITORS; ONSET	OBJECTIVE To determine whether the use of incretin based drugs compared with sulfonylureas is associated with an increased risk of incident pancreatic cancer in people with type 2 diabetes. DESIGN Population based cohort. SETTING Large, international, multicentre study combining the health records from six participating sites in Canada, the United States, and the United Kingdom. PARTICIPANTS A cohort of 972 384 patients initiating antidiabetic drugs between 1 January 2007 and 30 June 2013, with follow-up until 30 June 2014. MAIN OUTCOME MEASURES Within each cohort we conducted nested case-control analyses, where incident cases of pancreatic cancer were matched with up to 20 controls on sex, age, cohort entry date, duration of treated diabetes, and duration of follow-up. Hazard ratios and 95% confidence intervals for incident pancreatic cancer were estimated, comparing use of incretin based drugs with use of sulfonylureas, with drug use lagged by one year for latency purposes. Secondary analyses assessed whether the risk varied by class (dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists) or by duration of use (cumulative duration of use and time since treatment initiation). Site specific hazard ratios were pooled using random effects models. RESULTS During 2 024 441 person years of follow-up (median follow-up ranging from 1.3 to 2.8 years; maximum 8 years), 1221 patients were newly diagnosed as having pancreatic cancer (incidence rate 0.60 per 1000 person years). Compared with sulfonylureas, incretin based drugs were not associated with an increased risk of pancreatic cancer (pooled adjusted hazard ratio 1.02, 95% confidence interval 0.84 to 1.23). Similarly, the risk did not vary by class and evidence of a duration-response relation was lacking. CONCLUSIONS In this large, population based study the use of incretin based drugs was not associated with an increased risk of pancreatic cancer compared with sulfonylureas. Although this potential adverse drug reaction will need to be monitored long term owing to the latency of the cancer, these findings provide some reassurance on the safety of incretin based drugs.	[Azoulay, Laurent; Filion, Kristian B.; Ernst, Pierre] Jewish Gen Hosp, Lady Davis Res Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Filion, Kristian B.; Ernst, Pierre] McGill Univ, Dept Med, Montreal, PQ, Canada; [Platt, Robert W.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Platt, Robert W.] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Platt, Robert W.] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Platt, Robert W.] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada; [Platt, Robert W.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Dahl, Matthew; Targownik, Laura E.] Univ Manitoba, Dept Community Hlth Sci, Manitoba Ctr Hlth Policy, Winnipeg, MB R3T 2N2, Canada; [Dahl, Matthew; Targownik, Laura E.] McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; [Dormuth, Colin R.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Clemens, Kristin K.] Univ Western Ontario, Dept Med, London, ON, Canada; [Durand, Madeleine] Ctr Hosp Univ Montreal, Dept Internal Med, Montreal, PQ, Canada; [Juurlink, David N.; Paterson, J. Michael] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Targownik, Laura E.] Univ Manitoba, Gastroenterol Sect, Div Internal Med, Winnipeg, MB, Canada; [Turin, Tanvir C.] Univ Calgary, Dept Family Med, Calgary, AB, Canada; [Paterson, J. Michael] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; University of Manitoba; McMaster University; University of British Columbia; Western University (University of Western Ontario); Universite de Montreal; University of Toronto; University of Manitoba; University of Calgary; University of Toronto	Azoulay, L (corresponding author), Jewish Gen Hosp, Lady Davis Res Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada.; Azoulay, L (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.	laurent.azoulay@mcgill.ca	Targownik, Laura/ABD-2427-2021; Clemens, Kristin K/K-8898-2016; Durand, Madeleine/AAB-3989-2019; Turin, Tanvir C/L-7617-2016; Azoulay, Laurent/Z-4421-2019	Targownik, Laura/0000-0002-4366-9076; Turin, Tanvir C/0000-0002-7499-5050; Filion, Kristian/0000-0001-6055-0088; Azoulay, Laurent/0000-0001-5162-3556	Canadian Institutes of Health Research [DSE-111845]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Network for Observational Drug Effect Studies, a collaborating centre of the Drug Safety and Effectiveness Network, is funded by the Canadian Institutes of Health Research (grant No DSE-111845). The sponsor had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. This study was made possible through data sharing agreements between CNODES member research centres and the respective provincial governments of Alberta, Manitoba, Ontario, and Quebec. The opinions, results, and conclusions reported in this paper are those of the authors. No endorsement by the provinces is intended or should be inferred.	Azoulay L, 2015, DIABETES CARE, V38, P951, DOI 10.2337/dc15-0347; Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dore DD, 2012, THER ADV DRUG SAF, V3, P157, DOI 10.1177/2042098612446473; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Funch D, 2014, DIABETES OBES METAB, V16, P273, DOI 10.1111/dom.12230; Gale EAM, 2012, DIABETES, V61, P986, DOI 10.2337/db11-1838; Gokhale M, 2014, DIABETES OBES METAB, V16, P1247, DOI 10.1111/dom.12379; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Jeong KH, 2011, INT J CLIN PHARM-NET, V33, P740, DOI 10.1007/s11096-011-9552-8; Johnson JA, 2011, DIABETOLOGIA, V54, P2263, DOI 10.1007/s00125-011-2242-1; Knapen LM, 2016, DIABETES OBES METAB, V18, P258, DOI 10.1111/dom.12605; Labuzek K, 2013, EUR J INTERN MED, V24, P207, DOI 10.1016/j.ejim.2013.01.009; Monami M, 2011, CURR MED RES OPIN, V27, P57, DOI 10.1185/03007995.2011.602964; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Romley JA, 2012, DIABETES TECHNOL THE, V14, P904, DOI 10.1089/dia.2012.0075; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Shyangdan DS, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-20; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Suissa S, 2015, EPIDEMIOLOGY, V26, P242, DOI 10.1097/EDE.0000000000000221; Suissa Samy, 2012, Open Med, V6, pe134; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; Tseng CH, 2016, EUR J CLIN INVEST, V46, P70, DOI 10.1111/eci.12570; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889	35	65	68	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2016	352								i581	10.1136/bmj.i581	http://dx.doi.org/10.1136/bmj.i581			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EY	26888382	Green Published, hybrid			2022-12-28	WOS:000370727700006
J	Suri, A				Suri, Arjun			Social medicine: lessons from Cuba	LANCET			English	Editorial Material									[Suri, Arjun] UCSF Sch Med, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Suri, A (corresponding author), UCSF Sch Med, San Francisco, CA 94110 USA.	arjun.suri@ucsf.edu						Brouwer S., 2011, REVOLUTIONARY DOCTOR; Chan M, 2009, REMARKS LATIN AM SCH; ESCUELA LATINOAMERIC	3	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					641	642		10.1016/S0140-6736(16)00292-0	http://dx.doi.org/10.1016/S0140-6736(16)00292-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3QH	26885551				2022-12-28	WOS:000369837100014
J	Huang, P; Lethien, C; Pinaud, S; Brousse, K; Laloo, R; Turq, V; Respaud, M; Demortiere, A; Daffos, B; Taberna, PL; Chaudret, B; Gogotsi, Y; Simon, P				Huang, P.; Lethien, C.; Pinaud, S.; Brousse, K.; Laloo, R.; Turq, V.; Respaud, M.; Demortiere, A.; Daffos, B.; Taberna, P. L.; Chaudret, B.; Gogotsi, Y.; Simon, P.			On-chip and freestanding elastic carbon films for micro-supercapacitors	SCIENCE			English	Article							HIGH-ENERGY-DENSITY; ELECTROCHEMICAL CAPACITORS; VOLUMETRIC CAPACITANCE; HIGH-PERFORMANCE; RUTHENIUM OXIDE; MICROSUPERCAPACITORS; FABRICATION; ELECTRODES; CARBIDE; STORAGE	Integration of electrochemical capacitors with silicon-based electronics is a major challenge, limiting energy storage on a chip. We describe a wafer-scale process for manufacturing strongly adhering carbide-derived carbon films and interdigitated micro-supercapacitors with embedded titanium carbide current collectors, fully compatible with current microfabrication and silicon-based device technology. Capacitance of those films reaches 410 farads per cubic centimeter/200 millifarads per square centimeter in aqueous electrolyte and 170 farads per cubic centimeter/85 millifarads per square centimeter in organic electrolyte. We also demonstrate preparation of self-supported, mechanically stable, micrometer-thick porous carbon films with a Young's modulus of 14.5 gigapascals, with the possibility of further transfer onto flexible substrates. These materials are interesting for applications in structural energy storage, tribology, and gas separation.	[Huang, P.; Brousse, K.; Laloo, R.; Turq, V.; Daffos, B.; Taberna, P. L.; Simon, P.] Univ Toulouse 3, Lab Ctr Interuniv Rech & Ingn Mat CIRIMAT, CNRS, UMR 5085, 118 Route Narbonne, F-31062 Toulouse, France; [Huang, P.; Lethien, C.; Brousse, K.; Laloo, R.; Turq, V.; Demortiere, A.; Daffos, B.; Taberna, P. L.; Simon, P.] CNRS, FR 3459, Reseau Stockage Electrochim Energie, F-75700 Paris, France; [Lethien, C.] Univ Lille 1 Sci & Technol, Lab Inst Elect Microelect & Nanotechnol IEMN, CNRS, UMR 8520, Ave Henri Poincare,CS 60069, F-59652 Villeneuve Dascq, France; [Pinaud, S.; Respaud, M.; Chaudret, B.] Univ Toulouse, Univ Toulouse 3, LPCNO, CNRS,UMR 5215,INSA, 135 Ave Rangueil, F-31077 Toulouse, France; [Respaud, M.] Univ Toulouse, AIME, INSA, UPS,INP, 135 Ave Rangueil, F-31077 Toulouse 4, France; [Demortiere, A.] Univ Picardie Jules Verne, CNRS, UMR 7314, Lab Chim & React Solides, F-80039 Amiens, France; [Gogotsi, Y.] Drexel Univ, Dept Mat Sci & Engn, 3141 Chestnut St, Philadelphia, PA 19104 USA; [Gogotsi, Y.] Drexel Univ, AJ Drexel Nanomat Inst, 3141 Chestnut St, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lille - ISITE; Universite de Lille; Universite Polytechnique Hauts-de-France; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Drexel University; Drexel University	Simon, P (corresponding author), Univ Toulouse 3, Lab Ctr Interuniv Rech & Ingn Mat CIRIMAT, CNRS, UMR 5085, 118 Route Narbonne, F-31062 Toulouse, France.	simon@chimie.ups-tlse.fr	Gogotsi, Yury/B-2167-2008; Lethien, Christophe/AAL-2809-2021; SIMON, Patrice/N-6777-2016	Gogotsi, Yury/0000-0001-9423-4032; SIMON, Patrice/0000-0002-0461-8268; Taberna, Pierre-Louis/0000-0002-5310-0481; Lethien, christophe/0000-0001-8906-8308	French Government [L'Agence Nationale de la Recherche (ANR) ASTRID program, MISE project]; Chair of Excellence from the Airbus Group; European Research Council (ERC); Fluid Interface Reactions, Structures and Transport (FIRST) Center, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences; French RENATECH network; ANR (Labex Store-Ex); ANR (MISE project)	French Government [L'Agence Nationale de la Recherche (ANR) ASTRID program, MISE project](French National Research Agency (ANR)); Chair of Excellence from the Airbus Group; European Research Council (ERC)(European Research Council (ERC)); Fluid Interface Reactions, Structures and Transport (FIRST) Center, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); French RENATECH network; ANR (Labex Store-Ex)(French National Research Agency (ANR)); ANR (MISE project)(French National Research Agency (ANR))	P.H. was supported by the French Government [L'Agence Nationale de la Recherche (ANR) ASTRID program, MISE project]. K.B. was supported by the Chair of Excellence from the Airbus Group. P.S. acknowledges funding from the European Research Council (ERC Advanced Grant, "Ionaces" project). Y.G. was supported by Fluid Interface Reactions, Structures and Transport (FIRST) Center, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences. C.L was supported by the French RENATECH network. P.S., P.L.T., A.D., and C.L. thank the ANR (Labex Store-Ex and MISE project) for its support. The authors thank C. Brillard and J. P. Nys for atomic force microscopy and Auger analyses, D. Troadec for the Focus ion beam preparation, F. Guerin and R. P. Tan for microfabrication support, O. Mashtalir for XPS analyses of the TiC and CDC films, and K. Maleski for helpful comments on the manuscript.	Beguin F, 2006, ELECTROCHIM ACTA, V51, P2161, DOI 10.1016/j.electacta.2005.03.086; Beidaghi M, 2014, ENERG ENVIRON SCI, V7, P867, DOI 10.1039/c3ee43526a; Beidaghi M, 2012, ADV FUNCT MATER, V22, P4501, DOI 10.1002/adfm.201201292; Beidaghi M, 2011, ELECTROCHIM ACTA, V56, P9508, DOI 10.1016/j.electacta.2011.08.054; Chmiola J, 2006, SCIENCE, V313, P1760, DOI [10.1126/science.1132195, 10.1126/science/1132195]; Chmiola J, 2010, SCIENCE, V328, P480, DOI 10.1126/science.1184126; Dinh TM, 2014, NANO ENERGY, V10, P288, DOI 10.1016/j.nanoen.2014.10.003; Dunn B., 2008, INTERFACE, V17, P49; El-Kady MF, 2015, P NATL ACAD SCI USA, V112, P4233, DOI 10.1073/pnas.1420398112; El-Kady MF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2446; El-Kady MF, 2012, SCIENCE, V335, P1326, DOI 10.1126/science.1216744; Eustache E, 2013, ELECTROCHEM COMMUN, V28, P104, DOI 10.1016/j.elecom.2012.12.015; Ferris A, 2015, ADV MATER, V27, P6625, DOI 10.1002/adma.201503054; Gogotsi Y, 2011, SCIENCE, V334, P917, DOI 10.1126/science.1213003; Gogotsi Y, 2001, NATURE, V411, P283, DOI 10.1038/35077031; Guan C, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/9/094001; Heon M, 2011, ENERG ENVIRON SCI, V4, P135, DOI 10.1039/c0ee00404a; Hsia B, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/5/055401; Huang P, 2013, J POWER SOURCES, V225, P240, DOI 10.1016/j.jpowsour.2012.10.020; Kim MS, 2014, CARBON, V74, P163, DOI 10.1016/j.carbon.2014.03.019; Li SW, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/11/114013; Lin J, 2013, NANO LETT, V13, P72, DOI 10.1021/nl3034976; Lohse BH, 2007, J ALLOY COMPD, V434, P405, DOI 10.1016/j.jallcom.2006.08.216; Meng CZ, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301269; Pech D, 2010, NAT NANOTECHNOL, V5, P651, DOI [10.1038/nnano.2010.162, 10.1038/NNANO.2010.162]; Peng ZW, 2015, ACS APPL MATER INTER, V7, P3414, DOI 10.1021/am509065d; Prinz VY, 2003, MICROELECTRON ENG, V69, P466, DOI 10.1016/S0167-9317(03)00336-8; Shen CW, 2013, J POWER SOURCES, V234, P302, DOI 10.1016/j.jpowsour.2012.10.101; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Tao Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02975; Wang XF, 2014, J POWER SOURCES, V252, P64, DOI 10.1016/j.jpowsour.2013.11.109; Wang X, 2013, NANOSCALE, V5, P4119, DOI 10.1039/c3nr00210a; Warren R, 2015, J MATER CHEM A, V3, P15568, DOI 10.1039/c5ta03742e; Wei L, 2013, ACS NANO, V7, P6498, DOI 10.1021/nn4028129; Wu ZS, 2015, ADV MATER, V27, P4054, DOI 10.1002/adma.201501643; Xiong GP, 2014, ELECTROANAL, V26, P30, DOI 10.1002/elan.201300238; Yoo JJ, 2011, NANO LETT, V11, P1423, DOI 10.1021/nl200225J; Zhang C, 2015, ENERG ENVIRON SCI, V8, P1390, DOI 10.1039/c5ee00389j	38	527	535	24	933	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					691	695		10.1126/science.aad3345	http://dx.doi.org/10.1126/science.aad3345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912855	Green Submitted			2022-12-28	WOS:000369810000036
J	Plutzer, E; McCaffrey, M; Hannah, AL; Rosenau, J; Berbeco, M; Reid, AH				Plutzer, Eric; McCaffrey, Mark; Hannah, A. Lee; Rosenau, Joshua; Berbeco, Minda; Reid, Ann H.			Climate confusion among US teachers	SCIENCE			English	Editorial Material									[Plutzer, Eric] Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA; [McCaffrey, Mark; Rosenau, Joshua; Berbeco, Minda; Reid, Ann H.] Natl Ctr Sci Educ, Oakland, CA 94609 USA; [Hannah, A. Lee] Wright State Univ, Dept Polit Sci, Dayton, OH 45435 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; Wright State University Dayton	Plutzer, E (corresponding author), Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA.	plutzer@psu.edu		Hannah, A. Lee/0000-0003-3332-3220; Plutzer, Eric/0000-0002-5456-7227				Berkman M., 2010, EVOLUTION CREATIONIS; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Desimone LM, 2002, EDUC EVAL POLICY AN, V24, P81, DOI 10.3102/01623737024002081; Dietz T, 2013, P NATL ACAD SCI USA, V110, P14081, DOI 10.1073/pnas.1212740110; Funk C., 2015, PUBLIC SCI VIEWS SCI; Hestness E., 2014, J GEOSCI ED, V62, P319, DOI [10.5408/13-049.1, DOI 10.5408/13-049.1]; Johnson R., 2011, NATL EARTH SCI TEACH; Kahan DM, 2014, CULTURE, POLITICS AND CLIMATE CHANGE: HOW INFORMATION SHAPES OUR COMMON FUTURE, P203; KAHAN DM, 2015, ADV POLIT PSYCHOL, V36, P1; National Center for Education Statistics, 1990, HIGH SCH TRNSCR STUD; National Center for Education Statistics, 2009, HIGH SCH TRANSCR STU; National Center for Education Statistics, 2013, DIG ED STAT 2012, P252; National Research Council, 2012, FRAM K 12 SCI ED PRA; Wise S.B., 2010, J GEOSCIENCE ED, V58, P297, DOI [10.5408/1.3559695, DOI 10.5408/1.3559695]; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	15	110	110	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					664	665		10.1126/science.aab3907	http://dx.doi.org/10.1126/science.aab3907			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD3GL	26912845				2022-12-28	WOS:000369810000021
J	Marrows, C				Marrows, Christopher			Addressing an antiferromagnetic memory	SCIENCE			English	Editorial Material							ROOM-TEMPERATURE; MAGNETORESISTANCE		[Marrows, Christopher] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Marrows, C (corresponding author), Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England.	c.h.marrows@leeds.ac.uk	Marrows, Christopher/AAE-9269-2019	Marrows, Christopher/0000-0003-4812-6393				Barthem VMTS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3892; DIENY B, 1991, PHYS REV B, V43, P1297, DOI 10.1103/PhysRevB.43.1297; Hoffmann A, 2015, PHYS REV APPL, V4, DOI 10.1103/PhysRevApplied.4.047001; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; Marti X, 2014, NAT MATER, V13, P367, DOI [10.1038/nmat3861, 10.1038/NMAT3861]; MOODERA JS, 1995, PHYS REV LETT, V74, P3273, DOI 10.1103/PhysRevLett.74.3273; Park BG, 2011, NAT MATER, V10, P347, DOI [10.1038/nmat2983, 10.1038/NMAT2983]; Wadley P, 2016, SCIENCE, V351, P587, DOI 10.1126/science.aab1031; Wadley P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3322; Zelezny J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.157201	11	35	35	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					558	559		10.1126/science.aad8211	http://dx.doi.org/10.1126/science.aad8211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC5WO	26912686				2022-12-28	WOS:000369291600020
J	Petrou, VI; Herrera, CM; Schultz, KM; Clarke, OB; Vendome, J; Tomasek, D; Banerjee, S; Rajashankar, KR; Dufrisne, MB; Kloss, B; Kloppmann, E; Rost, B; Klug, CS; Trent, MS; Shapiro, L; Mancia, F				Petrou, Vasileios I.; Herrera, Carmen M.; Schultz, Kathryn M.; Clarke, Oliver B.; Vendome, Jeremie; Tomasek, David; Banerjee, Surajit; Rajashankar, Kanagalaghatta R.; Dufrisne, Meagan Belcher; Kloss, Brian; Kloppmann, Edda; Rost, Burkhard; Klug, Candice S.; Trent, M. Stephen; Shapiro, Lawrence; Mancia, Filippo			Structures of aminoarabinose transferase ArnT suggest a molecular basis for lipid A glycosylation	SCIENCE			English	Article							ESCHERICHIA-COLI; SALMONELLA; 4-AMINO-4-DEOXY-L-ARABINOSE; PROTEINS; PURIFICATION; ACTIVATION; EXPRESSION; RESISTANCE; MUTANTS	Polymyxins are antibiotics used in the last line of defense to combat multidrug-resistant infections by Gram-negative bacteria. Polymyxin resistance arises through charge modification of the bacterial outer membrane with the attachment of the cationic sugar 4-amino-4-deoxy-L-arabinose to lipid A, a reaction catalyzed by the integral membrane lipid-to-lipid glycosyltransferase 4-amino-4-deoxy-L-arabinose transferase (ArnT). Here, we report crystal structures of ArnT from Cupriavidus metallidurans, alone and in complex with the lipid carrier undecaprenyl phosphate, at 2.8 and 3.2 angstrom resolution, respectively. The structures show cavities for both lipidic substrates, which converge at the active site. A structural rearrangement occurs on undecaprenyl phosphate binding, which stabilizes the active site and likely allows lipid A binding. Functional mutagenesis experiments based on these structures suggest a mechanistic model for ArnT family enzymes.	[Petrou, Vasileios I.; Tomasek, David; Dufrisne, Meagan Belcher; Mancia, Filippo] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Herrera, Carmen M.; Trent, M. Stephen] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Schultz, Kathryn M.; Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Clarke, Oliver B.; Vendome, Jeremie; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Vendome, Jeremie] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Banerjee, Surajit; Rajashankar, Kanagalaghatta R.] Cornell Univ, Northeastern Collaborat Access Team, Dept Chem & Chem Biol, Adv Photon Source, Argonne, IL 60439 USA; [Kloss, Brian] New York Consortium Membrane Prot Struct, New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA; [Kloppmann, Edda; Rost, Burkhard] Tech Univ Munich, Dept Informat Bioinformat & Computat Biol, Boltzmannstr 3, D-85748 Garching, Germany; [Rost, Burkhard] Tech Univ Munich, IAS, Boltzmannstr 3, D-85748 Garching, Germany	Columbia University; University System of Georgia; University of Georgia; Medical College of Wisconsin; Columbia University; Columbia University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Technical University of Munich; Technical University of Munich	Mancia, F (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	fm123@cumc.columbia.edu	Petrou, Vasileios/U-5296-2017; Shapiro, Lawrence/AAE-7172-2019	Petrou, Vasileios/0000-0002-3194-9863; Kloss, Brian/0000-0003-0130-8739; Mancia, Filippo/0000-0003-3293-2200; Tomasek, David/0000-0003-1212-4601; Belcher Dufrisne, Meagan/0000-0002-7961-4405	National Institute of General Medical Sciences (NIGMS), NIH at the Advanced Photon Source [P41 GM103403]; Office of Research Infrastructure High-End Instrumentation, NIH [S10 RR029205]; NIGMS initiative [U54 GM095315]; NIGMS [R01 GM111980]; NIH [AI064184, AI076322]; Army Research Office [W911NF-12-1-0390]; Charles H. Revson Senior Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076322, R56AI076322, R01AI064184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, U54GM095315, R01GM111980] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS), NIH at the Advanced Photon Source; Office of Research Infrastructure High-End Instrumentation, NIH; NIGMS initiative; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; Charles H. Revson Senior Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Crystallographic data for this study were collected at the Northeastern Collaborative Access Team beamlines 24ID-C and E, supported by National Institute of General Medical Sciences (NIGMS), NIH, grant P41 GM103403, at the Advanced Photon Source. The Pilatus 6M detector on 24-ID-C beam line is funded by an Office of Research Infrastructure High-End Instrumentation, NIH, grant S10 RR029205. This work was supported by an NIGMS initiative to the New York Consortium on Membrane Protein Structure (NYCOMPS; U54 GM095315) and by NIGMS grant R01 GM111980 (F. M.). Also acknowledged are NIH grants AI064184 and AI076322 (M. S. T.), and grant W911NF-12-1-0390 from the Army Research Office (M. S. T.). O. B. C. was supported by a Charles H. Revson Senior Fellowship. We thank W. Hendrickson for his leadership of NYCOMPS and continuous support and advice, A. Palmer and P. Loria for helpful discussions, and L. Hamberger for her assistance managing the Mancia laboratory. PDB accession codes: 5EZM (apo ArnT<INF>Cm</INF>) and 5F15 (UndP-bound ArnT<INF>Cm</INF>).	Bretscher LE, 2006, PROTEIN EXPRES PURIF, V46, P33, DOI 10.1016/j.pep.2005.08.028; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; Herrera CM, 2010, MOL MICROBIOL, V76, P1444, DOI 10.1111/j.1365-2958.2010.07150.x; Impellitteri NA, 2010, BIOCHEMISTRY-US, V49, P29, DOI 10.1021/bi901572f; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Landman D, 2008, CLIN MICROBIOL REV, V21, P449, DOI 10.1128/CMR.00006-08; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Mancia F, 2010, J STRUCT BIOL, V172, P85, DOI 10.1016/j.jsb.2010.03.021; Mares J, 2009, J BIOL CHEM, V284, P11498, DOI 10.1074/jbc.M806587200; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Tavares-Carreon F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10773; Thoden JB, 2007, PROTEIN SCI, V16, P1379, DOI 10.1110/ps.072864707; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wang XY, 2006, J BIOL CHEM, V281, P9321, DOI 10.1074/jbc.M600435200; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	25	67	68	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					608	612		10.1126/science.aad1172	http://dx.doi.org/10.1126/science.aad1172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912703	Green Submitted, Green Accepted			2022-12-28	WOS:000369291600042
J	Baeten, JM; Palanee-Phillips, T; Brown, ER; Schwartz, K; Soto-Torres, LE; Govender, V; Mgodi, NM; Kiweewa, FM; Nair, G; Mhlanga, F; Siva, S; Bekker, LG; Jeenarain, N; Gaffoor, Z; Martinson, F; Makanani, B; Pather, A; Naidoo, L; Husnik, M; Richardson, BA; Parikh, UM; Mellors, JW; Marzinke, MA; Hendrix, CW; van der Straten, A; Ramjee, G; Chirenje, ZM; Nakabiito, C; Taha, TE; Jones, J; Mayo, A; Scheckter, R; Berthiaume, J; Livant, E; Jacobson, C; Ndase, P; White, R; Patterson, K; Germuga, D; Galaska, B; Bunge, K; Singh, D; Szydlo, DW; Montgomery, ET; Mensch, BS; Torjesen, K; Grossman, CI; Chakhtoura, N; Nel, A; Rosenberg, Z; McGowan, I; Hillier, S				Baeten, J. M.; Palanee-Phillips, T.; Brown, E. R.; Schwartz, K.; Soto-Torres, L. E.; Govender, V.; Mgodi, N. M.; Kiweewa, F. Matovu; Nair, G.; Mhlanga, F.; Siva, S.; Bekker, L. -G.; Jeenarain, N.; Gaffoor, Z.; Martinson, F.; Makanani, B.; Pather, A.; Naidoo, L.; Husnik, M.; Richardson, B. A.; Parikh, U. M.; Mellors, J. W.; Marzinke, M. A.; Hendrix, C. W.; van der Straten, A.; Ramjee, G.; Chirenje, Z. M.; Nakabiito, C.; Taha, T. E.; Jones, J.; Mayo, A.; Scheckter, R.; Berthiaume, J.; Livant, E.; Jacobson, C.; Ndase, P.; White, R.; Patterson, K.; Germuga, D.; Galaska, B.; Bunge, K.; Singh, D.; Szydlo, D. W.; Montgomery, E. T.; Mensch, B. S.; Torjesen, K.; Grossman, C. I.; Chakhtoura, N.; Nel, A.; Rosenberg, Z.; McGowan, I.; Hillier, S.		MTN-020-ASPIRE Study Team	Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL PROPHYLAXIS; CLINICAL-TRIALS; AFRICAN WOMEN; DOUBLE-BLIND; INFECTION; TENOFOVIR; THAILAND; SAFETY; MEN	BACKGROUND Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence. Longer-acting methods of drug delivery, such as vaginal rings, may simplify use of antiretroviral medications and provide HIV-1 protection. METHODS We conducted a phase 3, randomized, double-blind, placebo-controlled trial of a monthly vaginal ring containing dapivirine, a non-nucleoside HIV-1 reverse-transcriptase inhibitor, involving women between the ages of 18 and 45 years in Malawi, South Africa, Uganda, and Zimbabwe. RESULTS Among the 2629 women who were enrolled, 168 HIV-1 infections occurred: 71 in the dapivirine group and 97 in the placebo group (incidence, 3.3 and 4.5 per 100 personyears, respectively). The incidence of HIV-1 infection in the dapivirine group was lower by 27% (95% confidence interval [ CI], 1 to 46; P = 0.046) than that in the placebo group. In an analysis that excluded data from two sites that had reduced rates of retention and adherence, the incidence of HIV-1 infection in the dapivirine group was lower by 37% (95% CI, 12 to 56; P = 0.007) than that in the placebo group. In a post hoc analysis, higher rates of HIV-1 protection were observed among women over the age of 21 years (56%; 95% CI, 31 to 71; P < 0.001) but not among those 21 years of age or younger (-27%; 95% CI, -133 to 31; P = 0.45), a difference that was correlated with reduced adherence. The rates of adverse medical events and antiretroviral resistance among women who acquired HIV-1 infection were similar in the two groups. CONCLUSIONS A monthly vaginal ring containing dapivirine reduced the risk of HIV-1 infection among African women, with increased efficacy in subgroups with evidence of increased adherence. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT01617096.)	[Baeten, J. M.; Richardson, B. A.; Ndase, P.] Univ Washington, Dept Global Hlth, 325 Ninth Ave,Box 359927, Seattle, WA 98104 USA; [Baeten, J. M.] Univ Washington, Dept Med, 325 Ninth Ave,Box 359927, Seattle, WA 98104 USA; [Baeten, J. M.; Husnik, M.] Univ Washington, Dept Epidemiol, 325 Ninth Ave,Box 359927, Seattle, WA 98104 USA; [Brown, E. R.; Richardson, B. A.] Univ Washington, Dept Biostat, 325 Ninth Ave,Box 359927, Seattle, WA 98104 USA; [Brown, E. R.; Husnik, M.; Richardson, B. A.; Berthiaume, J.; Patterson, K.; Szydlo, D. W.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1124 Columbia St, Seattle, WA 98104 USA; [Palanee-Phillips, T.] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Govender, V.; Siva, S.; Jeenarain, N.; Gaffoor, Z.; Pather, A.; Naidoo, L.; Ramjee, G.] South African Med Res Council, HIV Prevent Res Unit, Durban, South Africa; [Nair, G.] Ctr AIDS Programme Res South Africa, Durban, South Africa; [Bekker, L. -G.] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Schwartz, K.; Mayo, A.; Scheckter, R.; White, R.; Torjesen, K.] FHI 360, Durham, NC USA; [Soto-Torres, L. E.; Germuga, D.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Grossman, C. I.] NIMH, NIH, Bethesda, MD 20892 USA; [Chakhtoura, N.] Eunice Kennedy Shiver Natl Inst Child Hlth & Huma, NIH, Bethesda, MD USA; [Marzinke, M. A.; Hendrix, C. W.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Taha, T. E.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Nel, A.; Rosenberg, Z.] Int Partnership Microbicides, Silver Spring, MD USA; [Mgodi, N. M.; Mhlanga, F.; Chirenje, Z. M.] Univ Zimbabwe Univ Calif San Francisco Collaborat, Harare, Zimbabwe; [Kiweewa, F. Matovu; Nakabiito, C.] Makerere Univ Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Martinson, F.] Univ North Carolina Project, Lilongwe, Malawi; [Makanani, B.; Taha, T. E.] Queen Elizabeth Cent Hosp, Malawi Coll Med Johns Hopkins Univ Res Project, Blantyre, Malawi; [Parikh, U. M.; Mellors, J. W.; McGowan, I.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Bunge, K.; Hillier, S.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Jones, J.; Livant, E.; Jacobson, C.; Galaska, B.; Singh, D.] Magee Womens Res Inst, Pittsburgh, PA USA; [van der Straten, A.; Montgomery, E. T.] RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA; [van der Straten, A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Mensch, B. S.] Populat Council, 1230 York Ave, New York, NY 10021 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Witwatersrand; South African Medical Research Council; University of Cape Town; FHI 360; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins University; Makerere University; University of Malawi; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Research Triangle Institute; University of California System; University of California San Francisco; Population Council	Baeten, JM (corresponding author), Univ Washington, Dept Global Hlth, Int Clin Res Ctr, 325 Ninth Ave,Box 359927, Seattle, WA 98104 USA.	jbaeten@uw.edu	Ndwandwe, Duduzile/L-2296-2013; Palanee-Phillips, Thesla/ABD-2449-2020; M, Ian/AAP-1032-2021; Hendrix, Craig W/G-4182-2014; M, i/HCI-9242-2022; Bekker, Linda-Gail/AAZ-8929-2020; M.J Matyanga, Celia/K-8888-2017	Ndwandwe, Duduzile/0000-0001-7129-3865; M, Ian/0000-0002-6470-8476; Hendrix, Craig W/0000-0002-5696-8665; Palanee-Phillips, Thesla/0000-0002-0052-5830; Taha, Taha/0000-0001-9814-4894; M.J Matyanga, Celia/0000-0002-9799-136X; Montgomery, Elizabeth/0000-0002-5477-4445; van der Straten, Ariane/0000-0001-8536-648X; Ggita, Joseph/0000-0001-9282-563X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	National Institute of Allergy and Infectious Diseases [UM1AI068633, UM1AI068615, UM1AI106707]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Mental Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069422, UM1AI069519, UM1AI069463, U01AI068633, UM1AI069518, UM1AI068633, UM1AI069469, UM1AI106707, UM1AI069436, P30AI094189, UM1AI069423, UM1AI068615, UM1AI069530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants (UM1AI068633, UM1AI068615, and UM1AI106707) from the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; [Anonymous], 2014, GUID IND VAG MICR DE; [Anonymous], 2014, THE GAP REP; Baeten J HRea, 2015, C RETR OPP INF SEATT; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Bekker LG, 2015, C RETR OPP INF SEATT; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; Bunge KE, 2015, J ACQUIR IMMUNE DEFI; Chen BA, 2015, JAIDS-J ACQ IMM DEF, V70, P242, DOI 10.1097/QAI.0000000000000702; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Corneli A, 2015, J ACQUIR IMMUNE DEFI; Devlin B, 2013, ANTIVIR RES, V100, pS3, DOI 10.1016/j.antiviral.2013.09.025; Donnell D, 2014, JAIDS-J ACQ IMM DEF, V66, P340, DOI 10.1097/QAI.0000000000000172; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Nel AKM, 2012, 19 C RETR OPP INF CR; Nel A, 2014, AIDS, V28, P1479, DOI 10.1097/QAD.0000000000000280; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Palanee-Phillips T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128857; Rees H, 2015, C RETR OPP INF BOST; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Seserko LA, 2013, BIOANALYSIS, V5, P2771, DOI 10.4155/bio.13.256; STEIN ZA, 1990, AM J PUBLIC HEALTH, V80, P460, DOI 10.2105/AJPH.80.4.460; Thomson KA, 2016, CURR OPIN HIV AIDS, V11, P18, DOI 10.1097/COH.0000000000000207; Thurman AR, 2013, INT J WOMENS HEALTH, V5, P695, DOI 10.2147/IJWH.S34030; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272	33	475	483	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					2121	2132		10.1056/NEJMoa1506110	http://dx.doi.org/10.1056/NEJMoa1506110			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED7GN	26900902	Green Accepted, Bronze			2022-12-28	WOS:000389030400004
J	Alvin, MD; Miller, PE				Alvin, Matthew D.; Miller, P. Elliott			Compensated hydrocephalus	LANCET			English	Editorial Material									[Alvin, Matthew D.; Miller, P. Elliott] Johns Hopkins Univ Hosp, Dept Internal Med, 1800 Orleans St, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Alvin, MD (corresponding author), Johns Hopkins Univ Hosp, Dept Internal Med, 1800 Orleans St, Baltimore, MD 21287 USA.	malvin2@jhmi.edu	Miller, Elliott/AAM-5774-2021	Alvin, Matthew/0000-0003-0362-1526					0	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2422	2422		10.1016/S0140-6736(16)00089-1	http://dx.doi.org/10.1016/S0140-6736(16)00089-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1ST	26946927				2022-12-28	WOS:000377560100035
J	Bouley, S; Baratoux, D; Matsuyama, I; Forget, F; Sejourne, A; Turbet, M; Costard, F				Bouley, Sylvain; Baratoux, David; Matsuyama, Isamu; Forget, Francois; Sejourne, Antoine; Turbet, Martin; Costard, Francois			Late Tharsis formation and implications for early Mars	NATURE			English	Article							PLANETS; HISTORY; CLIMATE; RETREAT; TIME	The Tharsis region is the largest volcanic complex on Mars and in the Solar System. Young lava flows cover its surface (from the Amazonian period, less than 3 billion years ago) but its growth started during the Noachian era (more than 3.7 billion years ago). Its position has induced a reorientation of the planet with respect to its spin axis (true polar wander, TPW), which is responsible for the present equatorial position of the volcanic province. It has been suggested that the Tharsis load on the lithosphere influenced the orientation of the Noachian/Early Hesperian (more than 3.5 billion years ago) valley networks(1) and therefore that most of the topography of Tharsis was completed before fluvial incision. Here we calculate the rotational figure of Mars (that is, its equilibrium shape) and its surface topography before Tharsis formed, when the spin axis of the planet was controlled by the difference in elevation between the northern and southern hemispheres (hemispheric dichotomy). We show that the observed directions of valley networks are also consistent with topographic gradients in this configuration and thus do not require the presence of the Tharsis load. Furthermore, the distribution of the valleys along a small circle tilted with respect to the equator is found to correspond to a southern-hemisphere latitudinal band in the pre-TPW geographical frame. Preferential accumulation of ice or water in a south tropical band is predicted by climate model simulations of early Mars applied to the pre-TPW topography. A late growth of Tharsis, contemporaneous with valley incision, has several implications for the early geological history of Mars, including the existence of glacial environments near the locations of the pre-TPW poles of rotation, and a possible link between volcanic outgassing from Tharsis and the stability of liquid water at the surface of Mars.	[Bouley, Sylvain; Sejourne, Antoine; Costard, Francois] Univ Paris Saclay, Univ Paris Sud, CNRS, GEOPS Geosci Paris Sud, Rue Belvedere,Batiment 504-509, F-91405 Orsay, France; [Bouley, Sylvain] Inst Mecan Celeste & Calcul Ephemerides, UMR8028, 77 Ave Denfert Rochereau, F-75014 Paris, France; [Baratoux, David] Univ Toulouse 3, Geosci Environm Toulouse, UMR 5563, 14 Ave Edouard Belin, F-31400 Toulouse, France; [Baratoux, David] Inst Rech Dev, Dakar, Senegal; [Baratoux, David] Inst Fondamental Afrique Noire, Dakar, Senegal; [Matsuyama, Isamu] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Forget, Francois; Turbet, Martin] Univ Paris 06, CNRS, Inst Pierre Simon Laplace, Lab Meteorol Dynam, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); University of Arizona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Bouley, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, GEOPS Geosci Paris Sud, Rue Belvedere,Batiment 504-509, F-91405 Orsay, France.; Bouley, S (corresponding author), Inst Mecan Celeste & Calcul Ephemerides, UMR8028, 77 Ave Denfert Rochereau, F-75014 Paris, France.	sylvain.bouley@u-psud.fr	Baratoux, David/AAB-8531-2019; Baratoux, David/H-6006-2012	Baratoux, David/0000-0002-1785-5262; Baratoux, David/0000-0002-1785-5262; Turbet, Martin/0000-0003-2260-9856; Matsuyama, Isamu/0000-0002-2917-8633	GEOPS laboratory; Programme National de Planetologie of INSU-CNRS; Centre National d'Etude Spatiale (CNES)	GEOPS laboratory; Programme National de Planetologie of INSU-CNRS; Centre National d'Etude Spatiale (CNES)(Centre National D'etudes Spatiales)	This research was funded by the GEOPS laboratory, the Programme National de Planetologie of INSU-CNRS and the Centre National d'Etude Spatiale (CNES).	Anderson RC, 2001, J GEOPHYS RES-PLANET, V106, P20563, DOI 10.1029/2000JE001278; [Anonymous], 2005, MATH METHODS PHYS; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bouley S, 2014, J GEOPHYS RES-PLANET, V119, P1302, DOI 10.1002/2013JE004571; CARR MH, 1995, J GEOPHYS RES-PLANET, V100, P7479, DOI 10.1029/95JE00260; Chan NH, 2014, J GEOPHYS RES-PLANET, V119, P169, DOI 10.1002/2013JE004466; COSTARD FM, 1989, EARTH MOON PLANETS, V45, P265, DOI 10.1007/BF00057747; ESRI, 2004, ARC HYDR TOOLS OV; Fassett CI, 2008, ICARUS, V195, P61, DOI 10.1016/j.icarus.2007.12.009; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; Fishbaugh KE, 2000, J GEOPHYS RES-PLANET, V105, P22455, DOI 10.1029/1999JE001230; Forget F, 2013, ICARUS, V222, P81, DOI 10.1016/j.icarus.2012.10.019; GRIMM RE, 1986, ICARUS, V65, P110, DOI 10.1016/0019-1035(86)90066-7; Grott M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024492; Grott M, 2013, SPACE SCI REV, V174, P49, DOI 10.1007/s11214-012-9948-3; Head JW, 2001, J GEOPHYS RES-PLANET, V106, P12275, DOI 10.1029/2000JE001359; Hynek BM, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003548; Irwin RP, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003620; Jenness J. S., 2005, REMOTELY WILD; KARGEL JS, 1992, GEOLOGY, V20, P3, DOI 10.1130/0091-7613(1992)020<0003:AGOM>2.3.CO;2; Kaula W.M., 1968, INTRO PLANETARY PHYS; Kress AM, 2015, PLANET SPACE SCI, V109, P1, DOI 10.1016/j.pss.2014.11.025; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Lemoine F.G., 2008, MROMRSS5SDPV10 NASA; Matsuyama I, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003686; MELOSH HJ, 1980, ICARUS, V44, P745, DOI 10.1016/0019-1035(80)90141-4; Nahm AL, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003327; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Putzig NE, 2014, J GEOPHYS RES-PLANET, V119, P1936, DOI 10.1002/2014JE004646; Roberts JH, 2007, ICARUS, V190, P24, DOI 10.1016/j.icarus.2007.03.002; Rouby H, 2008, EARTH PLANET SC LETT, V272, P212, DOI 10.1016/j.epsl.2008.04.044; Sabadini R., 2004, GLOBAL YDNAMICA EAR; Smith D. E., 1999, MGSMMOLA5IEGDRL3V10; Tanaka KL, 2011, PLANET SPACE SCI, V59, P1128, DOI 10.1016/j.pss.2010.11.004; Tanaka KL, 2001, ICARUS, V154, P3, DOI 10.1006/icar.2001.6675; Tsai VC, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB003923; Weiss DK, 2013, GEOPHYS RES LETT, V40, P3819, DOI 10.1002/grl.50778; Wieczorek M., 2007, TREATISE GEOPHYS, V2, P165, DOI [10.1016/B978-044452748-6.00156-5, DOI 10.1016/B978-044452748-6.00156-5, DOI 10.1016/B978-044452748-6/00156-5, 10.1016/b978-044452748-6/00156-5]; WILLEMANN RJ, 1984, ICARUS, V60, P701, DOI 10.1016/0019-1035(84)90174-X; Wordsworth R, 2013, ICARUS, V222, P1, DOI 10.1016/j.icarus.2012.09.036; Wordsworth RD, 2015, J GEOPHYS RES-PLANET, V120, P1201, DOI 10.1002/2015JE004787	41	54	54	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					344	+		10.1038/nature17171	http://dx.doi.org/10.1038/nature17171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26934230				2022-12-28	WOS:000372064300047
J	Sugiura, T; Wang, H; Barsacchi, R; Simon, A; Tanaka, EM				Sugiura, Takuji; Wang, Heng; Barsacchi, Rico; Simon, Andras; Tanaka, Elly M.			MARCKS-like protein is an initiating molecule in axolotl appendage regeneration	NATURE			English	Article							LIMB REGENERATION; AMBYSTOMA-MEXICANUM; CDNA LIBRARIES; CELLS; EXPRESSION; FAMILY; BRAIN	Identifying key molecules that launch regeneration has been a long-sought goal. Multiple regenerative animals show an initial wound-associated proliferative response that transits into sustained proliferation if a considerable portion of the body part has been removed(1-3). In the axolotl, appendage amputation initiates a round of wound-associated cell cycle induction followed by continued proliferation that is dependent on nerve-derived signals(4,5). A wound-associated molecule that triggers the initial proliferative response to launch regeneration has remained obscure. Here, using an expression cloning strategy followed by in vivo gain-and loss-of-function assays, we identified axolotl MARCKS-like protein (MLP) as an extracellularly released factor that induces the initial cell cycle response during axolotl appendage regeneration. The identification of a regeneration-initiating molecule opens the possibility of understanding how to elicit regeneration in other animals.	[Sugiura, Takuji; Tanaka, Elly M.] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies CRTD, Fetscherstr 105, D-01307 Dresden, Germany; [Sugiura, Takuji; Barsacchi, Rico; Tanaka, Elly M.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Wang, Heng; Simon, Andras] Karolinska Inst, Dept Cell & Mol Biol, Ctr Dev Biol Regenerat Med, SE-17177 Stockholm, Sweden; [Sugiura, Takuji; Tanaka, Elly M.] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, Fetscherstr 105, D-01307 Dresden, Germany	Technische Universitat Dresden; Max Planck Society; Karolinska Institutet; Technische Universitat Dresden	Sugiura, T; Tanaka, EM (corresponding author), Tech Univ Dresden, DFG Res Ctr Regenerat Therapies CRTD, Fetscherstr 105, D-01307 Dresden, Germany.; Sugiura, T; Tanaka, EM (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.; Sugiura, T; Tanaka, EM (corresponding author), Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, Fetscherstr 105, D-01307 Dresden, Germany.	takuji.sugiura@crt-dresden.de; elly.tanaka@crt-dresden.de	Tanaka, Elly M/F-8572-2010	Tanaka, Elly/0000-0003-4240-2158; Simon, Andras/0000-0002-1018-1891	German Federal Ministry of Education and Research (BMBF) Biofutures grant; German Research Foundation (DFG) [TA274/5-1]; European Research Council; Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); DFG Research Center for Regenerative Therapies Dresden (CRTD); Swedish Research Council; Cancerfonden	German Federal Ministry of Education and Research (BMBF) Biofutures grant(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); DFG Research Center for Regenerative Therapies Dresden (CRTD)(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society)	We thank A. Tazaki, Y. Taniguchi, I. Wagner, A. Rodrigo-Albors, D. Knapp, P. Murawala, B. Borgonovo and D. Drechsel for technical advice and important discussions; M. Schuez, A. Telzerow and Y. Taniguchi for assistance; B. Gruhl, A. Wagner, S. Mogel for animal care; and J. Currie, T. Sandoval-Guzman and E. Nacu for comments on the manuscript. E. M. T. was supported by a German Federal Ministry of Education and Research (BMBF) Biofutures grant, German Research Foundation (DFG) grant TA274/5-1, European Research Council Advanced Grant, Institutional funding from the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), and the DFG Research Center for Regenerative Therapies Dresden (CRTD) and A.S. by the Swedish Research Council and Cancerfonden.	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Albors AR, 2015, ELIFE, V4, DOI 10.7554/eLife.10230; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; FERRETTI P, 1988, J EXP ZOOL, V247, P77, DOI 10.1002/jez.1402470111; Gruber C E, 1995, Methods Mol Biol, V47, P67; Habermann B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r67; HOLTZER SYBIL W., 1956, J MORPH, V99, P1, DOI 10.1002/jmor.1050990102; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Khattak S, 2013, STEM CELL REP, V1, P90, DOI 10.1016/j.stemcr.2013.03.002; Khattak S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-17; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Maden M, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-1; Rodrigo-Albors A., 2015, SALAMANDERS REGENERA, P115; Roensch K, 2013, SCIENCE, V342, P1375, DOI 10.1126/science.1241796; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; Schnapp E, 2005, DEV DYNAM, V232, P162, DOI 10.1002/dvdy.20203; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; TASSAVA RA, 1975, DIFFERENTIATION, V4, P23, DOI 10.1111/j.1432-0436.1975.tb01439.x; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; Zarzosa A, 2014, DEV BIOL, V394, P65, DOI 10.1016/j.ydbio.2014.08.001	27	81	83	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					237	+		10.1038/nature16974	http://dx.doi.org/10.1038/nature16974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26934225	Green Accepted			2022-12-28	WOS:000371665100042
J	Shen, H				Shen, Helen			Lone-parent scientist	NATURE			English	Editorial Material																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					129	131		10.1038/nj7592-129a	http://dx.doi.org/10.1038/nj7592-129a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2YW	26942239	Bronze			2022-12-28	WOS:000371211900059
J	Taylor, AM				Taylor, Andrew M.			Cosmic rays beyond the knees	NATURE			English	Editorial Material							RADIO-EMISSION; SHOWERS	The development of a radio technique for detecting cosmic rays casts fresh light on the origins of some of these accelerated particles, and suggests that they might have travelled much farther than was previously thought.	[Taylor, Andrew M.] Dublin Inst Adv Studies, Sch Cosm Phys, High Energy Astrophys Grp, Dublin 2, Ireland	Dublin Institute for Advanced Studies	Taylor, AM (corresponding author), Dublin Inst Adv Studies, Sch Cosm Phys, High Energy Astrophys Grp, Dublin 2, Ireland.	taylora@cp.dias.ie						Abu-Zayyad T, 2001, ASTROPHYS J, V557, P686, DOI 10.1086/322240; Alvarez-Muniz J, 2012, ASTROPART PHYS, V35, P325, DOI 10.1016/j.astropartphys.2011.10.005; ASKARYAN GA, 1962, SOV PHYS JETP-USSR, V14, P441; Bell AR, 2013, MON NOT R ASTRON SOC, V431, P415, DOI 10.1093/mnras/stt179; Berezhnev S. F., 2011, P 32 INT COSM RAY C, V1, P209; Buitink S, 2016, NATURE, V531, P70, DOI 10.1038/nature16976; HILLAS AM, 1984, ANNU REV ASTRON ASTR, V22, P425, DOI 10.1146/annurev.aa.22.090184.002233; Huege T, 2013, AIP CONF PROC, V1535, P128, DOI 10.1063/1.4807534; WAXMAN E, 1995, PHYS REV LETT, V75, P386, DOI 10.1103/PhysRevLett.75.386	9	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					43	44		10.1038/531043a	http://dx.doi.org/10.1038/531043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26935694				2022-12-28	WOS:000371211900035
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Passing the patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 29	2016	352								i1065	10.1136/bmj.i1065	http://dx.doi.org/10.1136/bmj.i1065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LH	26926482	Green Published, hybrid			2022-12-28	WOS:000371755800003
J	Greif, D; Parsons, MF; Mazurenko, A; Chiu, CS; Blatt, S; Huber, F; Ji, G; Greiner, M				Greif, Daniel; Parsons, Maxwell F.; Mazurenko, Anton; Chiu, Christie S.; Blatt, Sebastian; Huber, Florian; Ji, Geoffrey; Greiner, Markus			Site-resolved imaging of a fermionic Mott insulator	SCIENCE			English	Article							3D OPTICAL LATTICE; ATOMS; SUPERCONDUCTIVITY; DYNAMICS; ENTROPY; GASES	The complexity of quantum many-body systems originates from the interplay of strong interactions, quantum statistics, and the large number of quantum-mechanical degrees of freedom. Probing these systems on a microscopic level with single-site resolution offers important insights. Here we report site-resolved imaging of two-component fermionic Mott insulators, metals, and band insulators, using ultracold atoms in a square lattice. For strong repulsive interactions, we observed two-dimensional Mott insulators containing over 400 atoms. For intermediate interactions, we observed a coexistence of phases. From comparison to theory, we find trap-averaged entropies per particle of 1.0 times the Boltzmann constant (k(B)). In the band insulator, we find local entropies as low as 0.5 k(B). Access to local observables will aid the understanding of fermionic many-body systems in regimes inaccessible by modern theoretical methods.	[Greif, Daniel; Parsons, Maxwell F.; Mazurenko, Anton; Chiu, Christie S.; Blatt, Sebastian; Huber, Florian; Ji, Geoffrey; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Blatt, Sebastian] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Harvard University; Max Planck Society	Ji, G (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu	Parsons, Maxwell/GWC-8748-2022; Blatt, Sebastian/F-8986-2012; Greif, Daniel/M-4480-2017; Greiner, Markus/E-9512-2017	Blatt, Sebastian/0000-0003-2466-9967; Greif, Daniel/0000-0002-0721-7726; Chiu, Christie/0000-0002-0000-9107	Army Research Office Defense Advanced Research Projects Agency Optical Lattice Emulator; Air Force Office of Scientific Research; Multi University Research Initiative; Office of Naval Research Defense University Research Instrumentation Program; NSF; Harvard Quantum Optics Center; Swiss National Foundation; Direct For Mathematical & Physical Scien [1125846] Funding Source: National Science Foundation	Army Research Office Defense Advanced Research Projects Agency Optical Lattice Emulator(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Multi University Research Initiative(MURI); Office of Naval Research Defense University Research Instrumentation Program; NSF(National Science Foundation (NSF)); Harvard Quantum Optics Center; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge insightful discussions with I. Bloch, S. Dickerson, M. Endres, G. Jotzu, and A. Kaufman. We acknowledge support from the Army Research Office Defense Advanced Research Projects Agency Optical Lattice Emulator, the Air Force Office of Scientific Research, the Multi University Research Initiative, the Office of Naval Research Defense University Research Instrumentation Program, and NSF. D.G. acknowledges support from the Harvard Quantum Optics Center and the Swiss National Foundation. M.P, A.M. and C.C acknowlege support from the NSF Graduate Research Fellowship Program. The authors declare no competing financial interests.	ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bakr WS, 2011, NATURE, V480, P500, DOI 10.1038/nature10668; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Bernier JS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061601; Cheuk LW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.193001; DePue MT, 1999, PHYS REV LETT, V82, P2262, DOI 10.1103/PhysRevLett.82.2262; Duarte PM, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.070403; Edge GJA, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.063406; Fuchs S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.030401; Fukuhara T, 2013, NATURE, V502, P76, DOI 10.1038/nature12541; Fukuhara T, 2013, NAT PHYS, V9, P235, DOI [10.1038/nphys2561, 10.1038/NPHYS2561]; Greif D, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.260401; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Gukelberger J., 2015, FULDE FERRELL LARKIN; Haller E, 2015, NAT PHYS, V11, P738, DOI [10.1038/nphys3403, 10.1038/NPHYS3403]; Hart RA, 2015, NATURE, V519, P211, DOI 10.1038/nature14223; Ho TL, 2009, P NATL ACAD SCI USA, V106, P6916, DOI 10.1073/pnas.0809862105; Imriska J., 2015, THERMODYNAMICS HUBBA; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; Jordens R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.180401; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Koetsier A, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.023628; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lubasch M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.165301; Ma PN, 2012, NAT PHYS, V8, P601, DOI [10.1038/NPHYS2348, 10.1038/nphys2348]; Messer M, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.115303; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Oitmaa J., 2006, SERIES EXPANSION MET; Omran A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.263001; Parsons MF, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.213002; Preiss PM, 2015, SCIENCE, V347, P1229, DOI 10.1126/science.1260364; Scarola VW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.135302; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Snoek M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/093008; Taie S, 2012, NAT PHYS, V8, P825, DOI [10.1038/NPHYS2430, 10.1038/nphys2430]; Tang BM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.205301; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; Uehlinger T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185307; Wunsch B, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.013616; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301	44	122	123	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					953	957		10.1126/science.aad9041	http://dx.doi.org/10.1126/science.aad9041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917766	Green Submitted			2022-12-28	WOS:000370821400036
J	Kawai, S; Benassi, A; Gnecco, E; Sode, H; Pawlak, R; Feng, XL; Mullen, K; Passerone, D; Pignedoli, CA; Ruffieux, P; Fasel, R; Meyer, E				Kawai, Shigeki; Benassi, Andrea; Gnecco, Enrico; Soede, Hajo; Pawlak, Remy; Feng, Xinliang; Muellen, Klaus; Passerone, Daniele; Pignedoli, Carlo A.; Ruffieux, Pascal; Fasel, Roman; Meyer, Ernst			Superlubricity of graphene nanoribbons on gold surfaces	SCIENCE			English	Article							FRICTION	The state of vanishing friction known as superlubricity has important applications for energy saving and increasing the lifetime of devices. Superlubricity, as detected with atomic force microscopy, appears when sliding large graphite flakes or gold nanoclusters across surfaces, for example. However, the origin of the behavior is poorly understood because of the lack of a controllable nanocontact. We demonstrated the superlubricity of graphene nanoribbons when sliding on gold with a joint experimental and computational approach. The atomically well-defined contact allows us to trace the origin of superlubricity, unraveling the role played by ribbon size and elasticity, as well as by surface reconstruction. Our results pave the way to the scale-up of superlubricity and thus to the realization of frictionless coatings.	[Kawai, Shigeki; Pawlak, Remy; Meyer, Ernst] Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland; [Kawai, Shigeki] Japan Sci & Technol Agcy, PRESTO Precursory Res Embryon Sci & Technol, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Benassi, Andrea; Soede, Hajo; Passerone, Daniele; Pignedoli, Carlo A.; Ruffieux, Pascal; Fasel, Roman] Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, Uberlandstr 129, CH-8600 Dubendorf, Switzerland; [Benassi, Andrea] Tech Univ Dresden, Inst Mat Sci, D-01062 Dresden, Germany; [Benassi, Andrea] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01062 Dresden, Germany; [Gnecco, Enrico] Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain; [Gnecco, Enrico] Univ Jena, Otto Schott Inst Mat Res, D-07743 Jena, Germany; [Feng, Xinliang] Tech Univ Dresden, Ctr Adv Elect Dresden, Dept Chem & Food Chem, D-01062 Dresden, Germany; [Muellen, Klaus] Max Planck Inst Polymer Res, D-55124 Mainz, Germany; [Fasel, Roman] Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland	University of Basel; Japan Science & Technology Agency (JST); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Technische Universitat Dresden; Technische Universitat Dresden; Friedrich Schiller University of Jena; Technische Universitat Dresden; Max Planck Society; University of Bern	Kawai, S (corresponding author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.; Kawai, S (corresponding author), Japan Sci & Technol Agcy, PRESTO Precursory Res Embryon Sci & Technol, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.; Benassi, A (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, Uberlandstr 129, CH-8600 Dubendorf, Switzerland.; Benassi, A (corresponding author), Tech Univ Dresden, Inst Mat Sci, D-01062 Dresden, Germany.; Benassi, A (corresponding author), Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01062 Dresden, Germany.	shigeki.kawai@unibas.ch; andrea.benassi@nano.tu-dresden.de	pignedoli, carlo antonio/J-9732-2014; Fasel, Roman/B-5396-2011; Ruffieux, Pascal/E-8227-2010; KAWAI, Shigeki/N-3447-2016; Meyer, Ernst/L-3873-2016; Rémy, Pawlak/E-5480-2010; Fasel, Roman/M-9992-2019; Gnecco, Enrico/H-5419-2013; Passerone, Daniele/C-2494-2011	Fasel, Roman/0000-0002-1553-6487; Ruffieux, Pascal/0000-0001-5729-5354; KAWAI, Shigeki/0000-0003-2128-0120; Meyer, Ernst/0000-0001-6385-3412; Rémy, Pawlak/0000-0001-8295-7241; Fasel, Roman/0000-0002-1553-6487; Gnecco, Enrico/0000-0002-3053-923X; Pignedoli, Carlo Antonio/0000-0002-8273-6390; Passerone, Daniele/0000-0001-5690-9000; Benassi, Andrea/0000-0002-2597-9644; Feng, Xinliang/0000-0003-3885-2703	Japan Science and Technology Agency PRESTO program, under the project "Molecular technology and creation of new function"; National Center of Competence in Research Nanoscale Science program; Swiss National Science Foundation [CRSII2 136287/1]; Swiss Nanoscience Institute; COST (European Cooperation in Science and Technology) Action [MP1303]; European Commission, under the Graphene Flagship [CNECT-ICT-604391]; U.S. Office of Naval Research Basic Research Challenge program; Comunidad de Madrid under the MAD2D-CM [S2013/MIT-3007]; Partnership for Advanced Computing in Europe [2012071262]	Japan Science and Technology Agency PRESTO program, under the project "Molecular technology and creation of new function"; National Center of Competence in Research Nanoscale Science program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Nanoscience Institute; COST (European Cooperation in Science and Technology) Action(European Cooperation in Science and Technology (COST)); European Commission, under the Graphene Flagship; U.S. Office of Naval Research Basic Research Challenge program(Office of Naval Research); Comunidad de Madrid under the MAD2D-CM(Comunidad de Madrid); Partnership for Advanced Computing in Europe	This work was supported in part by the Japan Science and Technology Agency PRESTO program, under the project "Molecular technology and creation of new function;" the National Center of Competence in Research Nanoscale Science program; grant CRSII2 136287/1 from the Swiss National Science Foundation; the Swiss Nanoscience Institute; COST (European Cooperation in Science and Technology) Action MP1303; the European Commission, under the Graphene Flagship (award no. CNECT-ICT-604391); the U.S. Office of Naval Research Basic Research Challenge program; and Comunidad de Madrid under the MAD2D-CM (S2013/MIT-3007) project. The Partnership for Advanced Computing in Europe (project 2012071262) and the Empa high-performance computing facility Hypatia are acknowledged for computational resources. All data are tabulated in the main text and the supplementary materials.	BALASUBRAMANIAN S, 1995, J CHEM PHYS, V103, P3184, DOI 10.1063/1.470251; Berman D, 2014, MATER TODAY, V17, P31, DOI 10.1016/j.mattod.2013.12.003; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Dienwiebel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126101; Dietzel D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.235502; Feng XF, 2013, ACS NANO, V7, P1718, DOI 10.1021/nn305722d; Filippov AE, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046102; Hod O, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.075444; Kawai S, 2014, P NATL ACAD SCI USA, V111, P3968, DOI 10.1073/pnas.1319938111; Koren E, 2015, SCIENCE, V348, P679, DOI 10.1126/science.aaa4157; Langewisch G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.036101; Langewisch G, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300013; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Ma M, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.055501; Mao HQ, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/8/084004; Matsushita K, 2005, SOLID STATE COMMUN, V136, P51, DOI 10.1016/j.ssc.2005.05.052; Muser MH, 2004, EUROPHYS LETT, V66, P97, DOI 10.1209/epl/i2003-10139-6; PEYRARD M, 1983, J PHYS C SOLID STATE, V16, P1593, DOI 10.1088/0022-3719/16/9/005; Rafiee MA, 2010, ACS NANO, V4, P7415, DOI 10.1021/nn102529n; Socoliuc A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.134301; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; Terrones M, 2010, NANO TODAY, V5, P351, DOI 10.1016/j.nantod.2010.06.010; Vanossi A, 2013, REV MOD PHYS, V85, P529, DOI 10.1103/RevModPhys.85.529; Varini N, 2015, NANOSCALE, V7, P2093, DOI 10.1039/c4nr06521b; Verhoeven GS, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.165418; Wei DC, 2009, J AM CHEM SOC, V131, P11147, DOI 10.1021/ja903092k; Zhang RF, 2013, NAT NANOTECHNOL, V8, P912, DOI [10.1038/nnano.2013.217, 10.1038/NNANO.2013.217]	27	238	247	27	607	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					957	961		10.1126/science.aad3569	http://dx.doi.org/10.1126/science.aad3569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917767	Green Accepted, Green Submitted			2022-12-28	WOS:000370821400037
J	Asoklis, R; Malysko, K				Asoklis, Rimvydas; Malysko, Kristina			Ocular Rosacea	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Asoklis, Rimvydas; Malysko, Kristina] Vilnius Univ Hosp, Santariskiu Klin, Vilnius, Lithuania	Vilnius University Hospital Santariskiu Klinikos	Asoklis, R (corresponding author), Vilnius Univ Hosp, Santariskiu Klin, Vilnius, Lithuania.	rimvydas.asoklis@santa.lt							0	0	0	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					771	771		10.1056/NEJMicm1504309	http://dx.doi.org/10.1056/NEJMicm1504309			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6BB	26933851				2022-12-28	WOS:000370716600010
J	Charbonneau, MR; O'Donnell, D; Blanton, LV; Totten, SM; Davis, JCC; Barratt, MJ; Cheng, JY; Guruge, J; Talcott, M; Bain, JR; Muehlbauer, MJ; Ilkayeva, O; Wu, C; Struckmeyer, T; Barile, D; Mangani, C; Jorgensen, J; Fan, YM; Maleta, K; Dewey, KG; Ashorn, P; Newgard, CB; Lebrilla, C; Mills, DA; Gordon, JI				Charbonneau, Mark R.; O'Donnell, David; Blanton, Laura V.; Totten, Sarah M.; Davis, Jasmine C. C.; Barratt, Michael J.; Cheng, Jiye; Guruge, Janaki; Talcott, Michael; Bain, James R.; Muehlbauer, Michael J.; Ilkayeva, Olga; Wu, Chao; Struckmeyer, Tedd; Barile, Daniela; Mangani, Charles; Jorgensen, Josh; Fan, Yue-mei; Maleta, Kenneth; Dewey, Kathryn G.; Ashorn, Per; Newgard, Christopher B.; Lebrilla, Carlito; Mills, David A.; Gordon, Jeffrey I.			Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in Models of Infant Undernutrition	CELL			English	Article							SIALIC-ACID; CHILD UNDERNUTRITION; HUMAN-NUTRITION; RURAL MALAWI; BONE; MICE; BIFIDOBACTERIA; MALNUTRITION; COUNTRIES; INSULIN	Identifying interventions that more effectively promote healthy growth of children with undernutrition is a pressing global health goal. Analysis of human milk oligosaccharides (HMOs) from 6-month-post-partum mothers in two Malawian birth cohorts revealed that sialylated HMOs are significantly less abundant in those with severely stunted infants. To explore this association, we colonized young germ-free mice with a consortium of bacterial strains cultured from the fecal microbiota of a 6-month-old stunted Malawian infant and fed recipient animals a prototypic Malawian diet with or without purified sialylated bovine milk oligosaccharides (S-BMO). S-BMO produced a microbiotadependent augmentation of lean body mass gain, changed bone morphology, and altered liver, muscle, and brain metabolism in ways indicative of a greater ability to utilize nutrients for anabolism. These effects were also documented in gnotobiotic piglets using the same consortium and Malawian diet. These preclinical models indicate a causal, microbiota-dependent relationship between S-BMO and growth promotion.	[Charbonneau, Mark R.; O'Donnell, David; Blanton, Laura V.; Barratt, Michael J.; Cheng, Jiye; Guruge, Janaki; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Charbonneau, Mark R.; O'Donnell, David; Blanton, Laura V.; Barratt, Michael J.; Cheng, Jiye; Guruge, Janaki; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA; [Talcott, Michael] Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA; [Totten, Sarah M.; Davis, Jasmine C. C.; Lebrilla, Carlito] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Totten, Sarah M.; Davis, Jasmine C. C.; Barile, Daniela; Lebrilla, Carlito; Mills, David A.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Barile, Daniela; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Jorgensen, Josh; Dewey, Kathryn G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Bain, James R.; Muehlbauer, Michael J.; Ilkayeva, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Bain, James R.; Muehlbauer, Michael J.; Ilkayeva, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Wu, Chao; Struckmeyer, Tedd] Hilmar Cheese Co, Hilmar Ingredients, Hilmar, CA 95324 USA; [Mangani, Charles; Maleta, Kenneth] Univ Malawi, Coll Med, Blantyre 3, Malawi; [Fan, Yue-mei; Ashorn, Per] Univ Tampere, Sch Med, Dept Int Hlth, FI-33521 Tampere, Finland; [Ashorn, Per] Tampere Univ Hosp, Dept Paediat, FI-33521 Tampere, Finland	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Duke University; Duke University; Duke University; Duke University; University of Malawi; Tampere University; Tampere University; Tampere University Hospital	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.; Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA.	jgordon@wustl.edu	Lebrilla, Carlito Bangeles/ABE-6369-2020; Mills, David Andrew/G-2282-2011; Maleta, Ken M/J-2821-2016; barile, daniela/AAA-3892-2020; Mills, David/GXF-1821-2022	Mills, David Andrew/0000-0003-1913-9865; Maleta, Ken M/0000-0002-2536-3938; barile, daniela/0000-0002-3889-1596; Bain, James R./0000-0002-8917-9187; Mangani, Charles/0000-0002-7228-5215; Ashorn, Per/0000-0003-2311-2593	Bill and Melinda Gates Foundation; NIH [DK30292, DK70977, P30 AR057235]; Office of Health, Infectious Diseases and Nutrition, Bureau for Global Health, USAID through the Food and Nutrition Technical Assistance II and III Projects (FANTA) [GHN-A-00-08-00001-00, AID-OAA-A-12-00005]; Academy of Finland [252075]; Medical Research Fund of Tampere University Hospital [9M004]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK070977, R01DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Health, Infectious Diseases and Nutrition, Bureau for Global Health, USAID through the Food and Nutrition Technical Assistance II and III Projects (FANTA)(United States Agency for International Development (USAID)); Academy of Finland(Academy of Finland); Medical Research Fund of Tampere University Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Sabrina Wagoner, Maria Karlsson, Justin Serugo, Siddarth Venkatesh, Jeanette Gehrig, and Josh Sommovilla for assistance with gnoto-biotic mouse and piglet husbandry, Jeremiah Faith for assistance generating the culture collection, plus Marty Meier, Su Deng, Jessica Hoisington-Lopez, Paras Vora, and Daniel Leib for superb technical assistance. This work was supported in part by grants from the Bill and Melinda Gates Foundation and the NIH (DK30292, DK70977, P30 AR057235), with additional funding from the Office of Health, Infectious Diseases and Nutrition, Bureau for Global Health, USAID under terms of Cooperative Agreements GHN-A-00-08-00001-00 and AID-OAA-A-12-00005, through the Food and Nutrition Technical Assistance II and III Projects (FANTA) managed by the Academy for Educational Development (AED) and FHI 360. Data management and statistical analysis for the iILNS-DYAD-M clinical study were supported by grants from the Academy of Finland (252075) and the Medical Research Fund of Tampere University Hospital (9M004). J.I.G. is a co-founder of Matatu, Inc., a company characterizing the role of diet-by-microbiota interactions in animal health. D.A.M., D.B., and C.B. are co-founders of Evolve Biosystems, Inc., a company focused on diet-based manipulation of the gut microbiota.	Aldredge DL, 2013, GLYCOBIOLOGY, V23, P664, DOI 10.1093/glycob/cwt007; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashorn P, 2015, AM J CLIN NUTR, V101, P387, DOI 10.3945/ajcn.114.088617; Bartz S, 2014, J CLIN ENDOCR METAB, V99, P2128, DOI 10.1210/jc.2013-4018; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Coppa GV, 2011, J PEDIATR GASTR NUTR, V53, P80, DOI 10.1097/MPG.0b013e3182073103; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gal B, 1997, COMP BIOCHEM PHYS B, V118, P13, DOI 10.1016/S0305-0491(97)00016-3; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; Kodama Y, 1999, BONE, V25, P183, DOI 10.1016/S8756-3282(99)00155-6; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Mangani C, 2015, MATERN CHILD NUTR, V11, P132, DOI 10.1111/mcn.12068; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; MCFIE J, 1962, J NUTR, V76, P97, DOI 10.1093/jn/76.2.97; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Scholtens DM, 2014, DIABETES CARE, V37, P158, DOI 10.2337/dc13-0989; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; Smilowitz JT, 2014, ANNU REV NUTR, V34, P143, DOI 10.1146/annurev-nutr-071813-105721; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Tao N, 2009, J DAIRY SCI, V92, P2991, DOI 10.3168/jds.2008-1642; Thomas T, 2001, BONE, V29, P114, DOI 10.1016/S8756-3282(01)00487-2; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang B, 2003, EUR J CLIN NUTR, V57, P1351, DOI 10.1038/sj.ejcn.1601704; Wang B, 2001, AM J CLIN NUTR, V74, P510; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wijtten PJA, 2011, BRIT J NUTR, V105, P967, DOI 10.1017/S0007114510005660; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yonekawa T, 2014, BRAIN, V137, P2670, DOI 10.1093/brain/awu210	43	363	373	15	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					859	871		10.1016/j.cell.2016.01.024	http://dx.doi.org/10.1016/j.cell.2016.01.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26898329	Green Accepted, Bronze			2022-12-28	WOS:000370867300011
J	Lorimer, D				Lorimer, Duncan			COSMOLOGY Home of a fast radio burst	NATURE			English	Editorial Material									[Lorimer, Duncan] W Virginia Univ, Dept Phys & Astron, Morgantown, WV 26506 USA	West Virginia University	Lorimer, D (corresponding author), W Virginia Univ, Dept Phys & Astron, Morgantown, WV 26506 USA.	duncan.lorimer@mail.wvu.edu	Lorimer, Duncan/ABH-7909-2020					Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.061102; ABRAMOVICI A, 1992, SCIENCE, V256, P325, DOI 10.1126/science.256.5055.325; Cen RY, 1999, ASTROPHYS J, V514, P1, DOI 10.1086/306949; CORDES JM, 1991, NATURE, V354, P121, DOI 10.1038/354121a0; Hansen BMS, 2001, MON NOT R ASTRON SOC, V322, P695, DOI 10.1046/j.1365-8711.2001.04103.x; Keane EF, 2016, NATURE, V530, P453, DOI 10.1038/nature17140; Kulkarni SR, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/70; Lorimer DR, 2007, SCIENCE, V318, P777, DOI 10.1126/science.1147532; Masui KW, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.121301; Petroff E., 2016, PREPRINT; Thornton D, 2013, SCIENCE, V341, P53, DOI 10.1126/science.1236789; Wei JJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.261101; Zhou B, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.107303	13	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					427	428		10.1038/530427a	http://dx.doi.org/10.1038/530427a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26911780				2022-12-28	WOS:000370690800024
J	Bellani, G; Laffey, JG; Pham, T; Fan, E; Brochard, L; Esteban, A; Gattinoni, L; van Haren, F; Larsson, A; McAuley, DF; Ranieri, M; Rubenfeld, G; Thompson, BT; Wrigge, H; Slutsky, AS; Pesenti, A				Bellani, Giacomo; Laffey, John G.; Pham, Tai; Fan, Eddy; Brochard, Laurent; Esteban, Andres; Gattinoni, Luciano; van Haren, Frank; Larsson, Anders; McAuley, Daniel F.; Ranieri, Marco; Rubenfeld, Gordon; Thompson, B. Taylor; Wrigge, Hermann; Slutsky, Arthur S.; Pesenti, Antonio		LUNG SAFE Investigators & ESICM	Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE LUNG INJURY; VENTILATION; UNDERRECOGNITION; PRESSURE; UNDERUSE	IMPORTANCE Limited information exists about the epidemiology, recognition, management, and outcomes of patients with the acute respiratory distress syndrome (ARDS). OBJECTIVES To evaluate intensive care unit (ICU) incidence and outcome of ARDS and to assess clinician recognition, ventilation management, and use of adjuncts-for example prone positioning-in routine clinical practice for patients fulfilling the ARDS Berlin Definition. DESIGN, SETTING, AND PARTICIPANTS The Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) was an international, multicenter, prospective cohort study of patients undergoing invasive or noninvasive ventilation, conducted during 4 consecutive weeks in the winter of 2014 in a convenience sample of 459 ICUs from 50 countries across 5 continents. EXPOSURES Acute respiratory distress syndrome. MAIN OUTCOMES AND MEASURES The primary outcome was ICU incidence of ARDS. Secondary outcomes included assessment of clinician recognition of ARDS, the application of ventilatory management, the use of adjunctive interventions in routine clinical practice, and clinical outcomes from ARDS. RESULTS Of 29 144 patients admitted to participating ICUs, 3022 (10.4%) fulfilled ARDS criteria. Of these, 2377 patients developed ARDS in the first 48 hours and whose respiratory failure was managed with invasive mechanical ventilation. The period prevalence of mild ARDS was 30.0%(95% CI, 28.2%-31.9%); of moderate ARDS, 46.6%(95% CI, 44.5%-48.6%); and of severe ARDS, 23.4%(95% CI, 21.7%-25.2%). ARDS represented 0.42 cases per ICU bed over 4 weeks and represented 10.4%(95% CI, 10.0%-10.7%) of ICU admissions and 23.4% of patients requiring mechanical ventilation. Clinical recognition of ARDS ranged from 51.3% (95% CI, 47.5%-55.0%) in mild to 78.5%(95% CI, 74.8%-81.8%) in severe ARDS. Less than two-thirds of patients with ARDS received a tidal volume 8 of mL/kg or less of predicted body weight. Plateau pressure was measured in 40.1%(95% CI, 38.2-42.1), whereas 82.6%(95% CI, 81.0%-84.1%) received a positive end-expository pressure (PEEP) of less than 12 cm H2O. Prone positioning was used in 16.3%(95% CI, 13.7%-19.2%) of patients with severe ARDS. Clinician recognition of ARDS was associated with higher PEEP, greater use of neuromuscular blockade, and prone positioning. Hospital mortality was 34.9%(95% CI, 31.4%-38.5%) for those with mild, 40.3%(95% CI, 37.4%-43.3%) for those with moderate, and 46.1%(95% CI, 41.9%-50.4%) for those with severe ARDS. CONCLUSIONS AND RELEVANCE Among ICUs in 50 countries, the period prevalence of ARDS was 10.4% of ICU admissions. This syndrome appeared to be underrecognized and undertreated and associated with a high mortality rate. These findings indicate the potential for improvement in the management of patients with ARDS.	[Bellani, Giacomo] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Bellani, Giacomo] San Gerardo Hosp, Dept Emergency & Intens Care, Monza, Italy; [Laffey, John G.] St Michaels Hosp, Dept Anesthesia & Crit Care Med, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Laffey, John G.] Univ Toronto, Dept Anesthesia, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Laffey, John G.] Univ Toronto, Dept Physiol, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Laffey, John G.; Fan, Eddy; Brochard, Laurent; Esteban, Andres; Rubenfeld, Gordon; Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Pham, Tai] Grp Hosp Hop Univ Est Parisien, Hop Tenon, AP HP, Unite Reanimat Med Chirurgicale,Pole Thorax Voies, Paris, France; [Pham, Tai] Univ Paris Diderot, Sorbonne Paris Cite, ECSTRA Team, UMR 1153,Inserm, Paris, France; [Pham, Tai] Univ Paris Est Creteil, UMR 915, INSERM, Creteil, France; [Fan, Eddy] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Fan, Eddy] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Fan, Eddy] Univ Toronto, Inst Hlth Policy Management & Evaluat, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Brochard, Laurent] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Esteban, Andres] Hosp Univ Getafe, CIBER Enfermedades Respiratorias, Madrid, Spain; [Gattinoni, Luciano; Pesenti, Antonio] Univ Milan, Ist Anestesia & Rianimaz, Osped Maggiore, Ist Ricovero & Cura Carattere Sci, Milan, Italy; [van Haren, Frank] Canberra Hosp, Intens Care Unit, Canberra, ACT, Australia; [van Haren, Frank] Australian Natl Univ, Canberra, ACT, Australia; [Larsson, Anders] Uppsala Univ, Sect Anesthesiol & Intens Care, Dept Surg Sci, Uppsala, Sweden; [McAuley, Daniel F.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland; [McAuley, Daniel F.] Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland; [McAuley, Daniel F.] Royal Victoria Hosp, Reg Intens Care Unit, Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland; [Ranieri, Marco] Policlin Umberto 1, SAPIENZA Univ ROMA, Dipartimento Anestesia & Rianimaz, Viale Policlin 155, I-00161 Rome, Italy; [Rubenfeld, Gordon] Sunnybrook Hlth Sci Ctr, Program Trauma Emergency & Crit Care, Toronto, ON M4N 3M5, Canada; [Thompson, B. Taylor] Harvard Univ, Sch Med, Div Pulm, Boston, MA USA; [Thompson, B. Taylor] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Crit Care Unit,Dept Med, Boston, MA USA; [Wrigge, Hermann] Univ Leipzig, Dept Anesthesiol & Intens Care Med, Liebigstr 20, D-04103 Leipzig, Germany; [Slutsky, Arthur S.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada	University of Milano-Bicocca; San Gerardo Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitario de Getafe; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Australian National University; Canberra Hospital; Australian National University; Uppsala University; Queens University Belfast; Sapienza University Rome; University Hospital Sapienza Rome; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Leipzig University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Laffey, JG (corresponding author), Univ Toronto, Dept Anesthesia, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Laffey, JG (corresponding author), Univ Toronto, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Laffey, JG (corresponding author), Univ Toronto, Dept Crit Care Med, Keenan Res Ctr Biomed Sci, St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	laffeyj@smh.ca	Colombo, Riccardo/AAK-9081-2020; Roux, Damien/C-5618-2014; CORNECI, DAN/ABG-1803-2021; Conti, Sara/J-4891-2019; Volta, Carlo A/G-5981-2012; Ranieri, Marco/AFX-8152-2022; Laake, Jon Henrik/L-3224-2019; Biondi, Rodrigo S/H-5212-2016; Szakmany, Tamas/I-5546-2019; TERZI, Nicolas/AAD-4348-2019; Pesenti, Antonio/H-7483-2012; Rialp, Gemma/I-3353-2016; Occhipinti, Giovanna/K-7307-2016; Reske, Andreas W/E-8141-2010; Slutsky, Arthur/M-3325-2019; Roux, Damien/L-3671-2014; Martinez, Felipe/ABF-5868-2021; Unal, Necmettin/AAH-6241-2019; Grigoryev, Evgeny/A-2321-2017; Brown, Samuel M/E-6846-2015; Cinnella, Gilda/O-2987-2016; Battle, Ceri/AAK-5856-2021; Ferguson, Niall/D-7619-2019; Meybohm, Patrick/K-4066-2017; Ulatan, Jeffrey/AAM-5560-2020; POTA, VINCENZO/C-4837-2013; Chiche, Jean-Daniel/P-5220-2017; Cortegiani, Andrea/H-4902-2016; Simon, Philipp/AAL-5318-2021; Van Haren, Frank/G-1335-2015; Rylander, Christian/AAV-3713-2020; Frendl, Gyorgy/AAE-5345-2020; Berger-Estilita, Joana/AAB-4497-2021; Mehta, Sangeeta/C-4623-2015; erbabacan, safak emre/D-4940-2019; Tomescu, Dana/J-9941-2013; Wrigge, Hermann/AAJ-8985-2021; Albaiceta, Guillermo/AAU-5069-2020; jochmans, sebastien/Y-3897-2019; Máca, Jan/E-4868-2017; Spadaro, Savino/K-9070-2016; Gritsan, Alexey/M-4261-2014; HASHEMIAN, SEYED MOHAMMAD REZA/C-1224-2018	Colombo, Riccardo/0000-0002-9616-803X; Roux, Damien/0000-0002-6103-6416; CORNECI, DAN/0000-0002-1170-0614; Conti, Sara/0000-0002-5774-3740; Volta, Carlo A/0000-0003-3533-6121; Laake, Jon Henrik/0000-0001-6157-5359; Biondi, Rodrigo S/0000-0002-9242-6062; Szakmany, Tamas/0000-0003-3632-8844; TERZI, Nicolas/0000-0003-4036-6245; Pesenti, Antonio/0000-0003-2593-729X; Rialp, Gemma/0000-0003-3614-3639; Occhipinti, Giovanna/0000-0003-3507-0036; Reske, Andreas W/0000-0002-2759-0245; Roux, Damien/0000-0002-6103-6416; Martinez, Felipe/0000-0002-9857-8403; Unal, Necmettin/0000-0002-9440-7893; Grigoryev, Evgeny/0000-0001-8370-3083; Brown, Samuel M/0000-0003-1206-6261; Cinnella, Gilda/0000-0001-9864-2893; Battle, Ceri/0000-0002-7503-1931; Ferguson, Niall/0000-0002-6213-5264; Meybohm, Patrick/0000-0002-2666-8696; Ulatan, Jeffrey/0000-0002-3756-0568; POTA, VINCENZO/0000-0001-9999-3388; Chiche, Jean-Daniel/0000-0002-6433-6254; Cortegiani, Andrea/0000-0003-1416-9993; Van Haren, Frank/0000-0001-8037-4229; Rylander, Christian/0000-0002-4534-7150; Frendl, Gyorgy/0000-0001-8918-8553; Berger-Estilita, Joana/0000-0002-8695-4264; erbabacan, safak emre/0000-0001-9314-9178; Tomescu, Dana/0000-0001-9673-5754; Wrigge, Hermann/0000-0002-9035-6822; Albaiceta, Guillermo/0000-0002-9276-3253; jochmans, sebastien/0000-0002-7111-4107; Máca, Jan/0000-0002-9771-0468; McAuley, Daniel/0000-0002-3283-1947; Hedlund, Lars/0000-0002-0403-8749; Grigoriev, Evgeny/0000-0002-3898-0740; Laffey, John/0000-0002-1246-9573; de Prost, Nicolas/0000-0002-4833-4320; de Haro, Candelaria/0000-0002-2668-1030; Nitta, Kenichi/0000-0002-9906-5861; Harrois, Anatole/0000-0002-5098-4656; Grelon, Fabien/0000-0002-2606-9933; Kander, Thomas/0000-0002-5404-2981; Bihari, Shailesh/0000-0001-7553-8620; Protti, Alessandro/0000-0002-0172-6079; Aneman, Anders/0000-0003-2096-5304; Schultz, Marcus/0000-0003-3969-7792; Banner-Goodspeed, Valerie/0000-0002-7644-2521; Whitehead, Christina/0000-0003-4561-7082; Kakar, Vivek/0000-0001-6353-3283; Spadaro, Savino/0000-0001-5027-5318; Gritsan, Alexey/0000-0002-0500-2887; Gomez Brey, Aroa/0000-0002-1223-1186; Hormis, Anil/0000-0001-5510-7639; MONTINI, Luca/0000-0003-4602-5134; Barros, Nelson/0000-0001-7919-2591; Aguirre-Bermeo, Hernan/0000-0001-7205-7020; PHAM, Tai/0000-0002-4373-0711; herbrecht, jean-etienne/0000-0002-6415-5330; Knowles, Serena/0000-0002-5028-3825; Tainter, Christopher/0000-0002-9639-2795; Breen, Dorothy/0000-0001-5010-4017; Holzgraefe, Bernhard/0000-0002-5654-7764; FOLLIN, Arnaud/0000-0002-6496-3135; Humphreys, Sally/0000-0002-4397-6404; Michel, Philippe/0000-0003-2392-7186; HASHEMIAN, SEYED MOHAMMAD REZA/0000-0002-0768-9168; Lanspa, Michael/0000-0003-0968-4755; carteaux, guillaume/0000-0003-1175-8821; Kulkarni, Shreedhar/0000-0002-9521-8461; foti, giuseppe/0000-0002-8698-2046; Gattinoni, Luciano/0000-0001-5380-2494; Plotnikow, Gustavo A./0000-0003-0115-870X; Nichol, Alistair/0000-0002-4689-1238; DANIN, Pierre-Eric/0000-0003-4234-7726; Chelly, Jonathan/0000-0002-8198-1239; Al-Dorzi, Hasan M/0000-0002-3772-8949	European Society of Intensive Care Medicine (ESICM), Brussels, Belgium; St Michael's Hospital, Toronto, Canada; University of Milan-Bicocca, Monza, Italy	European Society of Intensive Care Medicine (ESICM), Brussels, Belgium; St Michael's Hospital, Toronto, Canada; University of Milan-Bicocca, Monza, Italy	This work was funded and supported by the European Society of Intensive Care Medicine (ESICM), Brussels, Belgium, by St Michael's Hospital, Toronto, Canada, and by the University of Milan-Bicocca, Monza, Italy.	Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; [Anonymous], 2012, JAMA-J AM MED ASSOC, DOI 10.1001/jama.2012.5669; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Choi WI, 2014, J CRIT CARE, V29, P797, DOI 10.1016/j.jcrc.2014.05.017; Ferguson ND, 2005, CRIT CARE MED, V33, P2228, DOI 10.1097/01.CCM.0000181529.08630.49; Frohlich S, 2013, J CRIT CARE, V28, P663, DOI 10.1016/j.jcrc.2013.05.012; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Herasevich V, 2009, INTENS CARE MED, V35, P1018, DOI 10.1007/s00134-009-1460-1; Hernu R, 2013, INTENS CARE MED, V39, P2161, DOI 10.1007/s00134-013-3122-6; Irish Critical Care Trials Group, 2008, CRIT CARE, V12, pR30; Kalhan R, 2006, CRIT CARE MED, V34, P300, DOI 10.1097/01.CCM.0000198328.83571.4A; Li GX, 2011, AM J RESP CRIT CARE, V183, P59, DOI 10.1164/rccm.201003-0436OC; McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285; Mikkelsen ME, 2008, RESP CARE, V53, P455; Needham DM, 2015, AM J RESP CRIT CARE, V191, P177, DOI 10.1164/rccm.201409-1598OC; Ortiz JR, 2014, CRIT CARE MED, V42, P2325, DOI 10.1097/CCM.0000000000000545; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2004, INTENS CARE MED, V30, P4, DOI 10.1007/s00134-003-2081-8; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	27	2379	2602	13	205	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					788	800		10.1001/jama.2016.0291	http://dx.doi.org/10.1001/jama.2016.0291			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903337	Bronze, Green Published			2022-12-28	WOS:000370700500014
J	Mota, B; Herculano-Houzel, S				Mota, Bruno; Herculano-Houzel, Suzana			BRAIN STRUCTURE Response to Comments on "Cortical folding scales universally with surface area and thickness, not number of neurons"	SCIENCE			English	Editorial Material							CRANIAL ENDOCAST; EVOLUTION	De Lussanet claims that our model that accounts for the degree of folding of the cerebral cortex based on the product of cortical surface area and the square root of cortical thickness is better reduced to the product of gray-matter proportion and folding index. Lewitus et al., in turn, claim that the assumptions of our model are in conflict with experimental data; that the model does not accurately fit the data; and that the ancestral mammalian brain was gyrencephalic. Here, we show that both claims are inappropriate.	[Mota, Bruno] Univ Fed Rio de Janeiro, Inst Fis, BR-21941 Rio De Janeiro, Brazil; [Herculano-Houzel, Suzana] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Herculano-Houzel, S (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil.	suzanahh@gmail.com	Mota, Bruno/AAW-6044-2020	Mota, Bruno/0000-0002-6950-4106				de Lussanet MHE, 2016, SCIENCE, V351, DOI 10.1126/science.aad0127; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; Kelava I, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00016; Kirk EC, 2014, J HUM EVOL, V74, P82, DOI 10.1016/j.jhevol.2014.03.007; Lewitus E, 2016, SCIENCE, V351, DOI 10.1126/science.aad2029; Lewitus E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002000; Lewitus E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00424; Macrini TE, 2007, ANAT REC, V290, P875, DOI 10.1002/ar.20551; Macrini TE, 2007, J VERTEBR PALEONTOL, V27, P99, DOI 10.1671/0272-4634(2007)27[99:DCEOPA]2.0.CO;2; Mota B, 2015, SCIENCE, V349, P74, DOI 10.1126/science.aaa9101; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Ventura-Antunes L, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00003	13	4	4	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275								10.1126/science.aad2346	http://dx.doi.org/10.1126/science.aad2346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912888	Bronze			2022-12-28	WOS:000370325700033
J	Dear, AE				Dear, Anthony E.			Epigenetic Modulators and the New Immunotherapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER		[Dear, Anthony E.] Monash Univ, Dept Med, Eastern Hlth Clin Sch, Eastern Clin Res Unit,Translat Res Div, Melbourne, Vic, Australia	Monash University	Dear, AE (corresponding author), Monash Univ, Dept Med, Eastern Hlth Clin Sch, Eastern Clin Res Unit,Translat Res Div, Melbourne, Vic, Australia.							Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Kelderman S, 2014, MOL ONCOL, V8, P1132, DOI 10.1016/j.molonc.2014.07.011; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sathyanarayanan V, 2015, MOL ONCOL	5	36	41	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					684	686		10.1056/NEJMcibr1514673	http://dx.doi.org/10.1056/NEJMcibr1514673			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26886527				2022-12-28	WOS:000370229000016
J	Iacobucci, G				Iacobucci, Gareth			Junior doctors' contract: the key questions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com						Black D., 2016, GUARDIAN; Campbell D, 2016, GUARDIAN; Iacobucci G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i918; Iacobucci G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i827; McTernan J., 2016, GUARDIAN; NHS Employers, JUN DOCT CONTR SUMM; Rimmer A, 2015, BMJ CAREERS	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2016	352								i990	10.1136/bmj.i990	http://dx.doi.org/10.1136/bmj.i990			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EY	26888799				2022-12-28	WOS:000370727700023
J	Rotaru, AE; Thamdrup, B				Rotaru, Amelia-Elena; Thamdrup, Bo			A new diet for methane oxidizers	SCIENCE			English	Editorial Material							INTERSPECIES ELECTRON-TRANSFER; ANAEROBIC OXIDATION; REDUCTION		[Rotaru, Amelia-Elena; Thamdrup, Bo] Univ Southern Denmark, Dept Biol, DK-5230 Odense, Denmark	University of Southern Denmark	Rotaru, AE (corresponding author), Univ Southern Denmark, Dept Biol, DK-5230 Odense, Denmark.	arotaru@biology.sdu.dk	Rotaru, Amelia-Elena/C-4782-2014; Thamdrup, Bo/F-3889-2016	Rotaru, Amelia-Elena/0000-0003-2415-8585; Thamdrup, Bo/0000-0002-1221-7077	Novo Nordisk Fonden [NNF15OC0015220] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; Lovley DR, 1998, ACTA HYDROCH HYDROB, V26, P152, DOI 10.1002/(SICI)1521-401X(199805)26:3&lt;152::AID-AHEH152&gt;3.0.CO;2-D; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Rotaru AE, 2014, APPL ENVIRON MICROB, V80, P4599, DOI 10.1128/AEM.00895-14; Rotaru AE, 2014, ENERG ENVIRON SCI, V7, P408, DOI 10.1039/c3ee42189a; Scheller S, 2016, SCIENCE, V351, P703, DOI 10.1126/science.aad7154; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Wegener G, 2015, NATURE, V526, P587, DOI 10.1038/nature15733	11	13	19	4	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					658	659		10.1126/science.aaf0741	http://dx.doi.org/10.1126/science.aaf0741			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912841				2022-12-28	WOS:000369810000017
J	Peyvandi, F; Garagiola, I; Young, G				Peyvandi, Flora; Garagiola, Isabella; Young, Guy			The past and future of haemophilia: diagnosis, treatments, and its complications	LANCET			English	Review							FACTOR-VIII GENE; RECOMBINANT FACTOR-VIII; PREVIOUSLY UNTREATED PATIENTS; FETAL SEX DETERMINATION; COAGULATION-FACTOR IX; FC FUSION PROTEIN; LONG-TERM SAFETY; INHIBITOR DEVELOPMENT; A PATIENTS; BLEEDING PHENOTYPE	Haemophilia A and B are hereditary haemorrhagic disorders characterised by deficiency or dysfunction of coagulation protein factors VIII and IX, respectively. Recurrent joint and muscle bleeds lead to severe and progressive musculoskeletal damage. Existing treatment relies on replacement therapy with clotting factors, either at the time of bleeding (ie, on demand) or as part of a prophylactic schedule. The major complication of such therapy is the development of neutralising antibodies (ie, inhibitors), which is most frequent in haemophilia A. Treatment might improve considerably with the availability of new modified drugs, which might overcome existing prophylaxis limitations by reducing dosing frequency and thereby rendering therapy less distressing for the patient. Subcutaneous administration of some new therapies would also simplify prophylaxis in children with poor venous access. Gene therapy has the potential for a definitive cure, and important results have been obtained in haemophilia B. Despite improvements in haemophilia care, the availability of clotting factor concentrates for all affected individuals worldwide remains the biggest challenge.	[Peyvandi, Flora] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan 9, Italy; [Peyvandi, Flora; Garagiola, Isabella] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Young, Guy] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Young, Guy] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Children's Hospital Los Angeles; University of Southern California	Peyvandi, F (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan 9, Italy.	flora.peyvandi@unimi.it	Peyvandi, Flora/AAK-7437-2020	Peyvandi, Flora/0000-0001-7423-9864	Alexion; Biotest; Kedrion Biopharma; Novo Nordisk; Laboratoire francais du Fractionnement et des Biotechnologie; Baxter; Bayer; Biogen Idec; Kedrion	Alexion; Biotest; Kedrion Biopharma; Novo Nordisk(Novo Nordisk); Laboratoire francais du Fractionnement et des Biotechnologie; Baxter; Bayer(Bayer AG); Biogen Idec(Biogen); Kedrion	FP has received honoraria for participating in educational meetings and satellite symposia organised by Baxter, Bayer, Biotest, CSL Behring, Grifols, Novo Nordisk, Roche, and Sobi; research grants from Alexion, Biotest, Kedrion Biopharma, and Novo Nordisk; and consulting fees from Kedrion Biopharma and Laboratoire francais du Fractionnement et des Biotechnologie. GY has received honoraria and consulting fees from Baxter, Bayer, Biogen Idec, Kedrion, and Novo Nordisk. IG declares no competing interests.	ALEDORT LM, 1994, J INTERN MED, V236, P391, DOI 10.1111/j.1365-2796.1994.tb00815.x; Aledort LM, 1998, HAEMOPHILIA, V4, P68; Antunes SV, 2014, HAEMOPHILIA, V20, P65, DOI 10.1111/hae.12246; Astermark J, 2007, J THROMB HAEMOST, V5, P263, DOI 10.1111/j.1538-7836.2007.02290.x; Astermark J, 2006, BLOOD, V107, P3167, DOI 10.1182/blood-2005-09-3918; Astermark J, 2007, BLOOD, V109, P546, DOI 10.1182/blood-2006-04-017988; Astermark J, 2006, BLOOD, V108, P3739, DOI 10.1182/blood-2006-05-024711; Attard C, 2013, J THROMB HAEMOST, V11, P1850, DOI 10.1111/jth.12372; Bagnall RD, 2002, BLOOD, V99, P168, DOI 10.1182/blood.V99.1.168; Barrowcliffe TW, 2004, HAEMOPHILIA, V10, P109, DOI 10.1111/j.1365-2516.2004.00985.x; Barrowcliffe TW, 2003, HAEMOPHILIA, V9, P397, DOI 10.1046/j.1365-2516.2003.00773.x; Berntorp E, 2003, HAEMOPHILIA, V9, P1, DOI 10.1046/j.1365-2516.9.s1.17.x; Bogdanova N, 2007, HUM MUTAT, V28, P54, DOI 10.1002/humu.20403; Calvez T, 2014, BLOOD, V124, P3398, DOI 10.1182/blood-2014-07-586347; Carcao MD, 2012, SEMIN THROMB HEMOST, V38, P727, DOI 10.1055/s-0032-1326786; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Casana P, 2009, TRANSL RES, V153, P114, DOI 10.1016/j.trsl.2008.12.006; Chalmers E, 2011, BRIT J HAEMATOL, V154, P208, DOI 10.1111/j.1365-2141.2010.08545.x; Chandler WL, 2003, AM J CLIN PATHOL, V120, P34, DOI 10.1309/C8T8YNB4G3W45PRF; Chowdary P, 2015, J THROMB HAEMOST, V13, P743, DOI 10.1111/jth.12864; Clausen N, 2014, HAEMOPHILIA, V20, P747, DOI 10.1111/hae.12470; Collins PW, 2012, J THROMB HAEMOST, V10, P2305, DOI 10.1111/jth.12000; Collins PW, 2012, HAEMOPHILIA, V18, P131, DOI 10.1111/j.1365-2516.2012.02838.x; Collins PW, 2014, BLOOD, V124, P3880, DOI 10.1182/blood-2014-05-573055; Collins PW, 2014, BLOOD, V124, P3389, DOI 10.1182/blood-2014-07-580498; Coyle TE, 2014, J THROMB HAEMOST, V12, P488, DOI 10.1111/jth.12506; CROSSLEY M, 1992, SCIENCE, V257, P377, DOI 10.1126/science.1631558; Darby SC, 2004, J THROMB HAEMOST, V2, P1047, DOI 10.1046/j.1538-7836.2004.00710.x; Devaney SA, 2011, JAMA-J AM MED ASSOC, V306, P627, DOI 10.1001/jama.2011.1114; Di Minno MND, 2013, SEMIN THROMB HEMOST, V39, P723, DOI 10.1055/s-0033-1354422; Dimichele D, 2009, HAEMOPHILIA, V15, P320, DOI 10.1111/j.1365-2516.2008.01880.x; Eckhardt CL, 2015, J THROMB HAEMOST, V13, P1217, DOI 10.1111/jth.12990; Eckhardt CL, 2014, J THROMB HAEMOST, V12, P1294, DOI 10.1111/jth.12631; Eckhardt CL, 2013, BLOOD, V122, P1954, DOI 10.1182/blood-2013-02-483263; El-Maarri O, 2005, J THROMB HAEMOST, V3, P332, DOI 10.1111/j.1538-7836.2005.01140.x; Ewing N, 2015, HAEMOPHILIA, V21, P358, DOI 10.1111/hae.12602; Fischer K, 2011, HAEMOPHILIA, V17, P433, DOI 10.1111/j.1365-2516.2010.02450.x; Fischer K, 2002, HAEMOPHILIA, V8, P753, DOI 10.1046/j.1365-2516.2002.00694.x; Fischer K, 2001, HAEMOPHILIA, V7, P446, DOI 10.1046/j.1365-2516.2001.00545.x; Fischer K, 2015, THROMB HAEMOSTASIS, V114, P670, DOI 10.1160/TH14-12-1044; Fischer K, 2015, THROMB HAEMOSTASIS, V113, P968, DOI 10.1160/TH14-10-0826; Franchini M, 2014, BRIT J HAEMATOL, V165, P600, DOI 10.1111/bjh.12829; Franchini M, 2013, SEMIN THROMB HEMOST, V39, P772, DOI 10.1055/s-0033-1354425; Funnell APW, 2014, TRENDS GENET, V30, P18, DOI 10.1016/j.tig.2013.09.007; Funnell APW, 2013, AM J HUM GENET, V92, P460, DOI 10.1016/j.ajhg.2013.02.003; Giles AR, 1998, THROMB HAEMOSTASIS, V79, P872; Goddard N, 2010, TXB HAEMOPHILIA, P176; Goodeve AC, 2015, J THROMB HAEMOST, V13, P1184, DOI 10.1111/jth.12958; Goudemand J, 2006, BLOOD, V107, P46, DOI 10.1182/blood-2005-04-1371; Gouw SC, 2007, BLOOD, V109, P4648, DOI 10.1182/blood-2006-11-056291; Gouw SC, 2013, NEW ENGL J MED, V368, P231, DOI 10.1056/NEJMoa1208024; Gouw SC, 2012, BLOOD, V119, P2922, DOI 10.1182/blood-2011-09-379453; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Hay CRM, 2012, BLOOD, V119, P1335, DOI 10.1182/blood-2011-08-369132; High KH, 2014, HAEMOPHILIA, V20, P43, DOI 10.1111/hae.12411; Ingerslev J, 2011, BRIT J HAEMATOL, V155, P256, DOI 10.1111/j.1365-2141.2011.08854.x; Iorio A, 2010, J THROMB HAEMOST, V8, P1256, DOI 10.1111/j.1538-7836.2010.03823.x; Jayandharan G, 2005, HAEMOPHILIA, V11, P481, DOI 10.1111/j.1365-2516.2005.01121.x; Jenkins PV, 2008, HAEMOPHILIA, V14, P717, DOI 10.1111/j.1365-2516.2008.01765.x; Kamal AH, 2007, MAYO CLIN PROC, V82, P864, DOI 10.4065/82.7.864; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Key NS, 2004, BRIT J HAEMATOL, V127, P379, DOI 10.1111/j.1365-2141.2004.05168.x; Key NS, 1998, THROMB HAEMOSTASIS, V80, P912; Kitazawa T, 2012, NAT MED, V18, P1570, DOI 10.1038/nm.2942; Konkle BA, 2007, J THROMB HAEMOST, V5, P1904, DOI 10.1111/j.1538-7836.2007.02663.x; Kreuz W, 2016, HAEMOPHILIA, V22, P87, DOI 10.1111/hae.12774; Kulkarni R, 2009, HAEMOPHILIA, V15, P1281, DOI 10.1111/j.1365-2516.2009.02074.x; Kulkarni R, 2001, BRIT J HAEMATOL, V112, P264, DOI 10.1046/j.1365-2141.2001.02362.x; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Lannoy N, 2009, HAEMOPHILIA, V15, P797, DOI 10.1111/j.1365-2516.2008.01974.x; LECHNER K, 1979, THROMB HAEMOSTASIS, V40, P478; Leissinger C, 2014, THROMB HAEMOSTASIS, V112, P445, DOI 10.1160/TH14-01-0078; Leissinger C, 2011, NEW ENGL J MED, V365, P1684, DOI 10.1056/NEJMoa1104435; Ljung R, 2001, BRIT J HAEMATOL, V113, P81, DOI 10.1046/j.1365-2141.2001.02759.x; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Luck JV, 2004, J AM ACAD ORTHOP SUR, V12, P234, DOI 10.5435/00124635-200407000-00004; Mahlangu J, 2014, BLOOD, V123, P317, DOI 10.1182/blood-2013-10-529974; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Mancuso ME, 2009, HAEMATOL-HEMATOL J, V94, P687, DOI 10.3324/haematol.2008.001594; Mannucci P.M., 2012, DESMOPRESSIN DDAVP T; MANNUCCI PM, 1977, LANCET, V1, P869; Mannucci PM, 2003, J THROMB HAEMOST, V1, P1, DOI 10.1046/j.1538-7836.2003.00073.x; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; Martinowitz U, 2015, HAEMOPHILIA, V21, P784, DOI 10.1111/hae.12721; Martinowitz U, 2009, HAEMOPHILIA, V15, P904, DOI 10.1111/j.1365-2516.2009.02028.x; Matsui H, 2011, MOL THER, V19, P723, DOI 10.1038/mt.2010.290; McIntosh J, 2013, BLOOD, V121, P3335, DOI 10.1182/blood-2012-10-462200; Mei BS, 2010, BLOOD, V116, P270, DOI 10.1182/blood-2009-11-254755; Miller CH, 2012, HAEMOPHILIA, V18, P375, DOI 10.1111/j.1365-2516.2011.02700.x; Monahan PE, 2011, AM J PREV MED, V41, pS360, DOI 10.1016/j.amepre.2011.09.017; Morfini M, 2007, HAEMOPHILIA, V13, P606, DOI 10.1111/j.1365-2516.2007.01518.x; Morfini M, 2014, EUR J HAEMATOL, V93, P361, DOI 10.1111/ejh.12359; Mortarino M, 2011, HAEMOPHILIA, V17, P952, DOI 10.1111/j.1365-2516.2011.02537.x; Nagel K, 2011, HAEMOPHILIA, V17, P872, DOI 10.1111/j.1365-2516.2011.02506.x; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Negrier C, 1997, THROMB HAEMOSTASIS, V77, P1113; NILSSON IM, 1992, J INTERN MED, V232, P25, DOI 10.1111/j.1365-2796.1992.tb00546.x; Oldenburg J, 2014, HAEMOPHILIA, V20, P83, DOI 10.1111/hae.12263; Oldenburg J, 2010, HAMOSTASEOLOGIE, V30, P207; Oldenburg J, 2001, J BIOCHEM BIOPH METH, V47, P39, DOI 10.1016/S0165-022X(00)00150-0; Ostergaard H, 2011, BLOOD, V118, P2333, DOI 10.1182/blood-2011-02-336172; Paroskie A, 2015, BRIT J HAEMATOL, V170, P223, DOI 10.1111/bjh.13423; Pavlova A, 2014, THROMB HAEMOSTASIS, V111, P851, DOI 10.1160/TH13-08-0690; Peerlinck K, 1999, BLOOD, V93, P2267, DOI 10.1182/blood.V93.7.2267.407k21_2267_2273; Peyvandi F, 2011, HAEMOPHILIA, V17, P14, DOI 10.1111/j.1365-2516.2011.02559.x; Peyvandi F, 2015, 57 ANN M EXP AM SOC; Peyvandi F, 2013, BLOOD, V122, P3423, DOI 10.1182/blood-2013-05-505511; POOL JG, 1965, NEW ENGL J MED, V273, P1443, DOI 10.1056/NEJM196512302732701; Poon MC, 2002, THROMB HAEMOSTASIS, V87, P431; Powell JS, 2013, NEW ENGL J MED, V369, P2313, DOI 10.1056/NEJMoa1305074; Richards M, 2012, BRIT J HAEMATOL, V156, P374, DOI 10.1111/j.1365-2141.2011.08967.x; ROSENDAAL FR, 1990, THROMB HAEMOSTASIS, V63, P145; Santacroce R, 2008, J HUM GENET, V53, P275, DOI 10.1007/s10038-007-0238-y; Santagostino E, 2013, HAEMOPHILIA, V19, P8, DOI 10.1111/hae.12050; Santagostino E, 2010, J THROMB HAEMOST, V8, P737, DOI 10.1111/j.1538-7836.2010.03767.x; Santagostino E, 2013, SEMIN THROMB HEMOST, V39, P697, DOI 10.1055/s-0033-1353996; Santagostino E, 2012, BLOOD, V120, P2405, DOI 10.1182/blood-2012-05-429688; Schneiderman J, 2007, HAEMOPHILIA, V13, P244, DOI 10.1111/j.1365-2516.2007.01451.x; Sermon K, 2004, LANCET, V363, P1633, DOI 10.1016/S0140-6736(04)16209-0; Sharathkumar A, 2003, J THROMB HAEMOST, V1, P1228, DOI 10.1046/j.1538-7836.2003.00230.x; Shima M, 2015, J THROMB HAEMOST, V13, P6; SJAMSOEDIN LJM, 1981, NEW ENGL J MED, V305, P717, DOI 10.1056/NEJM198109243051301; Srivastava A, 2013, HAEMOPHILIA, V19, pE1, DOI 10.1111/j.1365-2516.2012.02909.x; Stephensen D, 2009, HAEMOPHILIA, V15, P1210, DOI 10.1111/j.1365-2516.2008.01876.x; Tabor A, 2009, ULTRASOUND OBST GYN, V34, P19, DOI 10.1002/uog.6377; Tagariello Giuseppe, 2007, Blood Transfus, V5, P158, DOI 10.2450/2007.0024-07; Tang L, 2013, HAEMOPHILIA, V19, P27, DOI 10.1111/j.1365-2516.2012.02926.x; Thompson AR, 1997, BLOOD, V90, P1902, DOI 10.1182/blood.V90.5.1902; THOMPSON AR, 1990, LANCET, V335, P418, DOI 10.1016/0140-6736(90)90259-8; Tiede A, 2013, J THROMB HAEMOST, V11, P670, DOI 10.1111/jth.12161; Valentino LA, 2010, J THROMB HAEMOST, V8, P1895, DOI 10.1111/j.1538-7836.2010.03962.x; Van den Berg HM, 2007, J THROMB HAEMOST, V5, P151, DOI 10.1111/j.1538-7836.2007.02503.x; van Dijk K, 2005, HAEMOPHILIA, V11, P438, DOI 10.1111/j.1365-2516.2005.01124.x; Vinciguerra C, 2006, THROMB HAEMOSTASIS, V95, P593, DOI 10.1160/TH05-05-0379; Walsh CE, 2015, AM J HEMATOL, V90, P400, DOI 10.1002/ajh.23957; Wang QZ, 2014, HUM GENE THER METHOD, V25, P261, DOI 10.1089/hgtb.2014.093; WEBSTER WP, 1965, AM J MED SCI, V250, P643, DOI 10.1097/00000441-196512000-00005; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621; Witmer C, 2013, THER ADV HEMATOL, V4, P59, DOI 10.1177/2040620712464509; Young G, 2008, HAEMOPHILIA, V14, P287, DOI 10.1111/j.1365-2516.2007.01601.x	141	227	239	13	176	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					187	197		10.1016/S0140-6736(15)01123-X	http://dx.doi.org/10.1016/S0140-6736(15)01123-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5TZ	26897598				2022-12-28	WOS:000379269200034
J	Perkin, MR; Logan, K; Tseng, A; Raji, B; Ayis, S; Peacock, J; Brough, H; Marrs, T; Radulovic, S; Craven, J; Flohr, C; Lack, G				Perkin, Michael R.; Logan, Kirsty; Tseng, Anna; Raji, Bunmi; Ayis, Salma; Peacock, Janet; Brough, Helen; Marrs, Tom; Radulovic, Suzana; Craven, Joanna; Flohr, Carsten; Lack, Gideon		Eat Study Team	Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEANUT CONSUMPTION; PREVALENCE; PROTEIN	BACKGROUND The age at which allergenic foods should be introduced into the diet of breast-fed infants is uncertain. We evaluated whether the early introduction of allergenic foods in the diet of breast-fed infants would protect against the development of food allergy. METHODS We recruited, from the general population, 1303 exclusively breast-fed infants who were 3 months of age and randomly assigned them to the early introduction of six allergenic foods (peanut, cooked egg, cow's milk, sesame, whitefish, and wheat; early-introduction group) or to the current practice recommended in the United Kingdom of exclusive breast-feeding to approximately 6 months of age (standard-introduction group). The primary outcome was food allergy to one or more of the six foods between 1 year and 3 years of age. RESULTS In the intention-to-treat analysis, food allergy to one or more of the six intervention foods developed in 7.1% of the participants in the standard-introduction group (42 of 595 participants) and in 5.6% of those in the early-introduction group (32 of 567) (P = 0.32). In the per-protocol analysis, the prevalence of any food -allergy was significantly lower in the early-introduction group than in the standard-introduction group (2.4% vs. 7.3%, P = 0.01), as was the prevalence of peanut allergy (0% vs. 2.5%, P = 0.003) and egg allergy (1.4% vs. 5.5%, P = 0.009); there were no significant effects with respect to milk, sesame, fish, or wheat. The consumption of 2 g per week of peanut or egg-white protein was associated with a significantly lower prevalence of these respective allergies than was less consumption. The early introduction of all six foods was not easily achieved but was safe. CONCLUSIONS The trial did not show the efficacy of early introduction of allergenic foods in an intention-to-treat analysis. Further analysis raised the question of whether the prevention of food allergy by means of early introduction of multiple allergenic foods was dose-dependent.	[Perkin, Michael R.] Univ London, Populat Hlth Res Inst, London WC1E 7HU, England; [Perkin, Michael R.; Logan, Kirsty; Tseng, Anna; Raji, Bunmi; Brough, Helen; Marrs, Tom; Radulovic, Suzana; Craven, Joanna; Flohr, Carsten; Lack, Gideon] Kings Coll London, Div Asthma Allergy & Lung Biol, Dept Paediat Allergy, London WC2R 2LS, England; [Perkin, Michael R.; Logan, Kirsty; Tseng, Anna; Raji, Bunmi; Brough, Helen; Marrs, Tom; Radulovic, Suzana; Craven, Joanna; Flohr, Carsten; Lack, Gideon] Guys & St Thomas NHS Fdn Trust, London, England; [Ayis, Salma; Peacock, Janet] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Flohr, Carsten] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London, England	University of London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lack, G (corresponding author), St Thomas Hosp, Childrens Allergy Unit, Westminster Bridge Rd, London SE1 7EH, England.	gideon.lack@kcl.ac.uk	Perkin, Michael/AID-7491-2022; Ayis, Salma/AAD-5336-2019	Lack, Gideon/0000-0001-7350-4021; Tonner, Sharon/0000-0002-7775-9926; Perkin, Michael/0000-0001-9272-2585; Ayis, Salma/0000-0002-0449-869X; Peacock, Janet/0000-0002-0310-2518	Food Standards Agency; Medical Research Council [MC_PC_15020, MC_G1001205] Funding Source: researchfish; National Institute for Health Research [CS/08/08/09] Funding Source: researchfish; British Skin Foundation [5047i] Funding Source: researchfish; MRC [MC_G1001205] Funding Source: UKRI	Food Standards Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); British Skin Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Food Standards Agency and others	Bellach J, 2015, EARLY INTRO HENS EGG; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P630, DOI 10.1016/j.jaci.2013.02.034; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P623, DOI 10.1016/j.jaci.2013.02.035; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Du Toit G, 2013, J ALLERGY CLIN IMMUN, V131, P135, DOI 10.1016/j.jaci.2012.09.015; Eigenmann PA, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e8; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Koplin JJ, 2010, J ALLERGY CLIN IMMUN, V126, P807, DOI 10.1016/j.jaci.2010.07.028; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; McAndrew F, 2012, INFACT FEEDING SURVE; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Perkin MR, 2016, J ALLERGY CLIN IMMUN; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED	15	472	497	4	109	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1733	1743		10.1056/NEJMoa1514210	http://dx.doi.org/10.1056/NEJMoa1514210			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL0RY	26943128	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000375341500006
J	Adibi, JJ; Marques, ETA; Cartus, A; Beigi, RH				Adibi, Jennifer J.; Marques, Ernesto T. A., Jr.; Cartus, Abigail; Beigi, Richard H.			Teratogenic effects of the Zika virus and the role of the placenta	LANCET			English	Article							CEREBRAL-CORTEX; INFECTION; PATHOGENESIS; ABNORMALITIES; EXOSOMES; FETUS; STEM	The mechanism by which the Zika virus can cause fetal microcephaly is not known. Reports indicate that Zika is able to evade the normal immunoprotective responses of the placenta. Microcephaly has genetic causes, some associated with maternal exposures including radiation, tobacco smoke, alcohol, and viruses. Two hypotheses regarding the role of the placenta are possible: one is that the placenta directly conveys the Zika virus to the early embryo or fetus. Alternatively, the placenta itself might be mounting a response to the exposure; this response might be contributing to or causing the brain defect. This distinction is crucial to the diagnosis of fetuses at risk and the design of therapeutic strategies to prevent Zika-induced teratogenesis.	[Adibi, Jennifer J.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Adibi, Jennifer J.; Beigi, Richard H.] Univ Pittsburgh, Dept Obstet & Gynecol & Reprod Sci, Pittsburgh, PA USA; [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Marques, Ernesto T. A., Jr.] Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil; [Cartus, Abigail] Univ Texas Hlth Sci Ctr Houston, Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fundacao Oswaldo Cruz; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Adibi, JJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15261 USA.	adibij@pitt.edu	Adibi, Jennifer/I-8077-2016; Marques, Ernesto T. A/L-4967-2013	Adibi, Jennifer/0000-0001-6562-8315; Marques, Ernesto T. A/0000-0003-3826-9358				Adibi JJ, 2015, J CLIN ENDOCR METAB, V100, pE1216, DOI 10.1210/jc.2015-2370; Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]; Burton GJ, 2001, PLACENTA, V22, pS70, DOI 10.1053/plac.2001.0639; Calvet G, 2016, LANCET INFECT DIS; Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289; Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770; DEKABAN AS, 1968, J NUCL MED, V9, P471; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x; Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026; Garcez PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7474; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; HADEED AJ, 1989, PEDIATRICS, V84, P205; Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021; KENNEDY LA, 1984, TERATOLOGY, V29, P363, DOI 10.1002/tera.1420290306; Leviton A, 2010, EARLY HUM DEV, V86, P515, DOI 10.1016/j.earlhumdev.2010.07.001; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Montiel JF, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00022; MOSTOUFIZADEH M, 1984, ARCH PATHOL LAB MED, V108, P403; Nascimento EJM, 2014, CRIT REV IMMUNOL, V34, P227, DOI 10.1615/CritRevImmunol.2014010212; Pulyers JN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00092; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/ror.0.0040081; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x; Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446	29	110	116	1	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1587	1590		10.1016/S0140-6736(16)00650-4	http://dx.doi.org/10.1016/S0140-6736(16)00650-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	26952548	Bronze, Green Published			2022-12-28	WOS:000373741600034
J	McGranahan, N; Furness, AJS; Rosenthal, R; Ramskov, S; Lyngaa, R; Saini, SK; Jamal-Hanjani, M; Wilson, GA; Birkbak, NJ; Hiley, CT; Watkins, TBK; Shafi, S; Murugaesu, N; Mitter, R; Akarca, AU; Linares, J; Marafioti, T; Henry, JY; Van Allen, EM; Miao, DN; Schilling, B; Schadendorf, D; Garraway, LA; Makarov, V; Rizvi, NA; Snyder, A; Hellmann, MD; Merghoub, T; Wolchok, JD; Shukla, SA; Wu, CJ; Peggs, KS; Chan, TA; Hadrup, SR; Quezada, SA; Swanton, C				McGranahan, Nicholas; Furness, Andrew J. S.; Rosenthal, Rachel; Ramskov, Sofie; Lyngaa, Rikke; Saini, Sunil Kumar; Jamal-Hanjani, Mariam; Wilson, Gareth A.; Birkbak, Nicolai J.; Hiley, Crispin T.; Watkins, Thomas B. K.; Shafi, Seema; Murugaesu, Nirupa; Mitter, Richard; Akarca, Ayse U.; Linares, Joseph; Marafioti, Teresa; Henry, Jake Y.; Van Allen, Eliezer M.; Miao, Diana; Schilling, Bastian; Schadendorf, Dirk; Garraway, Levi A.; Makarov, Vladimir; Rizvi, Naiyer A.; Snyder, Alexandra; Hellmann, Matthew D.; Merghoub, Taha; Wolchok, Jedd D.; Shukla, Sachet A.; Wu, Catherine J.; Peggs, Karl S.; Chan, Timothy A.; Hadrup, Sine R.; Quezada, Sergio A.; Swanton, Charles			Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade	SCIENCE			English	Article							ANALYSIS REVEALS; CTLA-4 BLOCKADE; CANCER	As tumors grow, they acquire mutations, some of which create neoantigens that influence the response of patients to immune checkpoint inhibitors. We explored the impact of neoantigen intratumor heterogeneity (ITH) on antitumor immunity. Through integrated analysis of ITH and neoantigen burden, we demonstrate a relationship between clonal neoantigen burden and overall survival in primary lung adenocarcinomas. CD8+ tumor-infiltrating lymphocytes reactive to clonal neoantigens were identified in early-stage non-small cell lung cancer and expressed high levels of PD-1. Sensitivity to PD-1 and CTLA-4 blockade in patients with advanced NSCLC and melanoma was enhanced in tumors enriched for clonal neoantigens. T cells recognizing clonal neoantigens were detectable in patients with durable clinical benefit. Cytotoxic chemotherapy-induced subclonal neoantigens, contributing to an increased mutational load, were enriched in certain poor responders. These data suggest that neoantigen heterogeneity may influence immune surveillance and support therapeutic developments targeting clonal neoantigens.	[McGranahan, Nicholas; Wilson, Gareth A.; Birkbak, Nicolai J.; Hiley, Crispin T.; Watkins, Thomas B. K.; Mitter, Richard; Swanton, Charles] Francis Crick Inst, London WC2A 3LY, England; [McGranahan, Nicholas] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, Mortimer St, London WC1E 6BT, England; [McGranahan, Nicholas; Furness, Andrew J. S.; Rosenthal, Rachel; Jamal-Hanjani, Mariam; Wilson, Gareth A.; Birkbak, Nicolai J.; Hiley, Crispin T.; Watkins, Thomas B. K.; Shafi, Seema; Murugaesu, Nirupa; Henry, Jake Y.; Peggs, Karl S.; Quezada, Sergio A.; Swanton, Charles] UCL Canc Inst, Canc Res UK Lung Canc Ctr Excellence, London WC1E 6BT, England; [Furness, Andrew J. S.; Akarca, Ayse U.; Linares, Joseph; Marafioti, Teresa; Henry, Jake Y.; Peggs, Karl S.; Quezada, Sergio A.] UCL, UCL Canc Inst, Canc Immunol Unit, Mortimer St, London WC1E 6BT, England; [Ramskov, Sofie; Lyngaa, Rikke; Saini, Sunil Kumar; Hadrup, Sine R.] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, DK-1970 Frederiksberg C, Denmark; [Akarca, Ayse U.; Linares, Joseph; Marafioti, Teresa] UCL, Dept Cellular Pathol, Mortimer St, London WC1E 6BT, England; [Van Allen, Eliezer M.; Miao, Diana; Garraway, Levi A.; Shukla, Sachet A.; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Van Allen, Eliezer M.; Miao, Diana; Garraway, Levi A.; Shukla, Sachet A.; Wu, Catherine J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Van Allen, Eliezer M.; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02215 USA; [Schilling, Bastian; Schadendorf, Dirk] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, D-45147 Essen, Germany; [Schilling, Bastian; Schadendorf, Dirk] German Canc Consortium DKTK, D-69121 Heidelberg, Germany; [Makarov, Vladimir; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rizvi, Naiyer A.] Columbia Univ, Hematol Oncol Div, 177 Ft Washington Ave, New York, NY 10032 USA; [Snyder, Alexandra; Hellmann, Matthew D.; Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Snyder, Alexandra; Hellmann, Matthew D.; Wolchok, Jedd D.] Weill Cornell Med Coll, New York, NY 10065 USA; [Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat Lab, New York, NY 10065 USA; [Wu, Catherine J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Wu, Catherine J.] Brigham & Womens Hosp, Dept Internal Med, 75 Francis St, Boston, MA 02115 USA	Francis Crick Institute; University of London; University College London; Cancer Research UK; University of London; University College London; University of London; University College London; Technical University of Denmark; University of London; University College London; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Memorial Sloan Kettering Cancer Center; Columbia University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Swanton, C (corresponding author), Francis Crick Inst, London WC2A 3LY, England.; Quezada, SA; Swanton, C (corresponding author), UCL Canc Inst, Canc Res UK Lung Canc Ctr Excellence, London WC1E 6BT, England.; Quezada, SA (corresponding author), UCL, UCL Canc Inst, Canc Immunol Unit, Mortimer St, London WC1E 6BT, England.	s.quezada@ucl.ac.uk; charles.swanton@crick.ac.uk	Quezada, Sergio/ABF-6466-2020; Marafioti, Teresa/AAA-4652-2019; Schilling, Bastian/AAY-8646-2020; Chan, Timothy A/ABD-5850-2021; Merghoub, Taha/ABD-8362-2021; McGranahan, Nicholas/ABD-6561-2021; Schadendorf, Dirk/AAE-8206-2019; Marafioti, Teresa/B-4493-2009; Hadrup, Sine Reker/P-3388-2014	Quezada, Sergio/0000-0002-9763-1700; Marafioti, Teresa/0000-0003-1223-6275; Schilling, Bastian/0000-0001-8859-4103; McGranahan, Nicholas/0000-0001-9537-4045; Marafioti, Teresa/0000-0003-1223-6275; Hadrup, Sine Reker/0000-0002-5937-4344; Birkbak, Nicolai/0000-0003-1613-9587; Saini, Sunil Kumar/0000-0003-3382-9432; Hiley, Crispin/0000-0002-5869-0775; Ramskov, Sofie/0000-0001-9413-8673; Mitter, Richard/0000-0002-1279-3760; Swanton, Charles/0000-0002-4299-3018; Henry, Jake/0000-0003-0435-3308	CRUK (TRACERx); CRUK Lung Cancer Centre of Excellence; Stand Up 2 Cancer Laura Ziskin prize (SU2C); Rosetrees Trust; NovoNordisk Foundation [16584]; Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council (THESEUS); EU FP7 (PREDICT); CRUK Career Development Fellowship; CRUK Biotherapeutic Programme Grant; World Wide Cancer Research; Cancer Research Institute; Sam Keen Foundation; TRACERx CRUK grant; FP7-People-ITN [(2013)607722 - PloidyNet]; Blavatnik Family Foundation; NIH/National Heart, Lung, and Blood Institute [1R01CA155010-02]; NIH/National Cancer Institute [1R01CA182461-01, 1R01CA184922-01]; Cancer Research UK-UCL Centre; CRUK-UCL Centre Clinical Research Fellowship; Cancer Research UK-UCL Centre Cancer Immuno-Therapy Accelerator Award; National Institute for Health Research; University College London Hospitals Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Medicine Centre; Janssen; Boerhinger Ingelheim; Ventana; Novartis; Roche; Sequenom; Natera; Grail; Apogen Biotechnologies; Epic Biosciences; Sarah Cannon Research Institute; Bristol-Myers Squibb; Merck; Amgen; Geneocea; OncoSpire; Cancer Genetics; Syapse; Roche Ventana; Takeda; Third Rock Ventures; Genentech; AstraZeneca; Neon; Boehringer Ingelheim; Foundation Medicine; Warp Drive Bio; Academy of Medical Sciences (AMS) [AMS-SGCL7-Murugaesu] Funding Source: researchfish; Cancer Research UK [20466, 12100] Funding Source: researchfish; Lundbeck Foundation [R181-2014-3828] Funding Source: researchfish; National Institute for Health Research [CL-2011-18-001, CL-2015-17-002] Funding Source: researchfish; Versus Arthritis [20265] Funding Source: researchfish; The Francis Crick Institute [10002] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA184922, R01CA205426, R01CA155010, R01CA182461] Funding Source: NIH RePORTER	CRUK (TRACERx); CRUK Lung Cancer Centre of Excellence; Stand Up 2 Cancer Laura Ziskin prize (SU2C); Rosetrees Trust(Rosetrees Trust); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council (THESEUS)(European Research Council (ERC)); EU FP7 (PREDICT); CRUK Career Development Fellowship; CRUK Biotherapeutic Programme Grant; World Wide Cancer Research; Cancer Research Institute; Sam Keen Foundation; TRACERx CRUK grant; FP7-People-ITN; Blavatnik Family Foundation; NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK-UCL Centre; CRUK-UCL Centre Clinical Research Fellowship; Cancer Research UK-UCL Centre Cancer Immuno-Therapy Accelerator Award; National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK University College London Experimental Cancer Medicine Centre; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boerhinger Ingelheim; Ventana; Novartis(Novartis); Roche(Roche Holding); Sequenom; Natera; Grail; Apogen Biotechnologies; Epic Biosciences; Sarah Cannon Research Institute; Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Amgen(Amgen); Geneocea; OncoSpire; Cancer Genetics; Syapse; Roche Ventana; Takeda(Takeda Pharmaceutical Company Ltd); Third Rock Ventures; Genentech(Roche HoldingGenentech); AstraZeneca(AstraZeneca); Neon; Boehringer Ingelheim(Boehringer Ingelheim); Foundation Medicine; Warp Drive Bio; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Cancer Research UK(Cancer Research UK); Lundbeck Foundation(Lundbeckfonden); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	C.S. is a senior Cancer Research UK (CRUK) clinical research fellow and is funded by CRUK (TRACERx), the CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer Laura Ziskin prize (SU2C), the Rosetrees Trust, NovoNordisk Foundation (ID 16584), the Prostate Cancer Foundation, the Breast Cancer Research Foundation, the European Research Council (THESEUS), and EU FP7 (PREDICT). S.A.Q is funded by a CRUK Career Development Fellowship, CRUK Biotherapeutic Programme Grant, World Wide Cancer Research, and a Cancer Research Institute Investigator Award. A.J.S.F receives support from the Sam Keen Foundation. R.R., N.M., N.J.B., and G.A.W. are funded by the TRACERx CRUK grant. T.B.K.W. is funded by the FP7-People-2013-ITN [grant (2013)607722 - PloidyNet]. C.T.H. is funded by the Rosetrees Trust. C.J.W. is a Scholar of the Leukemia and Lymphoma Society and acknowledges support from the Blavatnik Family Foundation, NIH/National Heart, Lung, and Blood Institute (grant 1R01CA155010-02) and NIH/National Cancer Institute (grants 1R01CA182461-01 and 1R01CA184922-01). S.S. is funded by the Cancer Research UK-UCL Centre, and M.J.H. is funded by a CRUK-UCL Centre Clinical Research Fellowship. A.A. is funded by the Cancer Research UK-UCL Centre Cancer Immuno-Therapy Accelerator Award. We thank N. Hacohen and S. Turajlic for helpful advice on the manuscript. This research is supported by the National Institute for Health Research, the University College London Hospitals Biomedical Research Centre, and the Cancer Research UK University College London Experimental Cancer Medicine Centre. Certain data were received under a material transfer agreement with Memorial Sloan Kettering Cancer Center. Data from multiregion sequenced NSCLC are available at the European Bioinformatics Institute (accession no. EGAS00001000809). Data from the Rizvi cohort (2) are available at the database of Genotypes and Phenotypes (dbGAP) (accession no. phs000980.v1.p1). Data from the Snyder cohort (4) are available at dbGAP (accession no. phs001041.v1.p1). Data from the Van Allen cohort (17) are available at dbGAP (accession no. phs000452.v2.p1). The results published here are in part based on data generated by a TCGA pilot project established by the National Cancer Institute and National Human Genome Research Institute. The data were retrieved through dbGaP authorization (accession no. phs000178.v9.p8). Information about TCGA and the investigators and institutions that constitute the TCGA research network can be found at http://cancergenome.nih.gov. C.S. is a paid advisor for Janssen, Boerhinger Ingelheim, Ventana, Novartis, Roche, Sequenom, Natera, Grail, Apogen Biotechnologies, Epic Biosciences, and the Sarah Cannon Research Institute. D.S. is a paid advisor for Bristol-Myers Squibb, Roche, Novartis, Merck, and Amgen. B.S. is a paid advisor for Bristol-Myers Squibb. T.A.C. is a cofounder of and holds equity in Gritstone Oncology; is a paid advisor for Geneocea, OncoSpire, and Cancer Genetics; and receives funding from Bristol-Myers Squibb for research on the genomics of immune response. N.A.R. is a cofounder of and holds equity in Gritstone Oncology. E.M.V.A. is a paid advisor for Syapse, Roche Ventana, Takeda, and Third Rock Ventures. M.D.H is a paid advisor for Bristol-Myers Squibb, Merck, Genentech, AstraZeneca, and Neon. J.D.W is a paid advisor for Bristol-Myers Squibb. L.A.G. is a paid scientific advisor for Novartis, Boehringer Ingelheim, Foundation Medicine, and Warp Drive Bio. C.S., N.M., R.R., S.A.Q., and K.S.P. are co-inventors on UK patent applications (1516047.; 6, 1601098.5, 1601098.5, and 1601099.3) filed by Cancer Research Technology relating to methods for identifying and targeting neoantigens, methods of predicting prognosis of cancer patients, and/or identifying cancer patients who will benefit from treatment that involves determining the number of neoantigens.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Greaves M, 2015, CANCER DISCOV, V5, P806, DOI 10.1158/2159-8290.CD-15-0439; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Jamal-Hanjani M., 2016, ANN ONCOL; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	20	1822	1890	12	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1463	1469		10.1126/science.aaf1490	http://dx.doi.org/10.1126/science.aaf1490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	26940869	Green Accepted, Green Submitted			2022-12-28	WOS:000372756200052
J	Rosenfield, K; Matsumura, JS; Chaturvedi, S; Riles, T; Ansel, GM; Metzger, DC; Wechsler, L; Jaff, MR; Gray, W				Rosenfield, Kenneth; Matsumura, Jon S.; Chaturvedi, Seemant; Riles, Tom; Ansel, Gary M.; Metzger, D. Chris; Wechsler, Lawrence; Jaff, Michael R.; Gray, William		ACT I Investigators	Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERY STENOSIS; MEDICAL THERAPY; STROKE PREVENTION; ENDARTERECTOMY; DISEASE; RISK; INTERVENTION; ANGIOPLASTY; LESSONS	BACKGROUND Previous clinical trials have suggested that carotid-artery stenting with a device to capture and remove emboli ("embolic protection") is an effective alternative to carotid endarterectomy in patients at average or high risk for surgical complications. METHODS In this trial, we compared carotid-artery stenting with embolic protection and carotid endarterectomy in patients 79 years of age or younger who had severe carotid stenosis and were asymptomatic (i.e., had not had a stroke, transient ischemic attack, or amaurosis fugax in the 180 days before enrollment) and were not considered to be at high risk for surgical complications. The trial was designed to enroll 1658 patients but was halted early, after 1453 patients underwent randomization, because of slow enrollment. Patients were followed for up to 5 years. The primary composite end point of death, stroke, or myocardial infarction within 30 days after the procedure or ipsilateral stroke within 1 year was tested at a noninferiority margin of 3 percentage points. RESULTS Stenting was noninferior to endarterectomy with regard to the primary composite end point (event rate, 3.8% and 3.4%, respectively; P = 0.01 for noninferiority). The rate of stroke or death within 30 days was 2.9% in the stenting group and 1.7% in the endarterectomy group (P = 0.33). From 30 days to 5 years after the procedure, the rate of freedom from ipsilateral stroke was 97.8% in the stenting group and 97.3% in the endarterectomy group (P = 0.51), and the overall survival rates were 87.1% and 89.4%, respectively (P = 0.21). The cumulative 5-year rate of stroke-free survival was 93.1% in the stenting group and 94.7% in the endarterectomy group (P = 0.44). CONCLUSIONS In this trial involving asymptomatic patients with severe carotid stenosis who were not at high risk for surgical complications, stenting was noninferior to endarterectomy with regard to the rate of the primary composite end point at 1 year. In analyses that included up to 5 years of follow-up, there were no significant differences between the study groups in the rates of non-procedure-related stroke, all stroke, and survival.	[Rosenfield, Kenneth; Jaff, Michael R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Matsumura, Jon S.] Univ Wisconsin, Madison, WI 53706 USA; [Chaturvedi, Seemant] Univ Miami, Miami, FL USA; [Riles, Tom] NYU, Langone Sch Med, New York, NY USA; [Ansel, Gary M.] Ohio Hlth Syst, Columbus, OH USA; [Metzger, D. Chris] Wellmont Cardiovasc Associates Heart Inst, Kingsport, TN USA; [Wechsler, Lawrence] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Gray, William] Main Line Hlth Syst, Philadelphia, PA USA; [Rosenfield, Kenneth] Massachusetts Gen Hosp, Div Cardiol, 55 Fruit St, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Miami; New York University; NYU Langone Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital	Rosenfield, K (corresponding author), Massachusetts Gen Hosp, Div Cardiol, 55 Fruit St, Boston, MA 02114 USA.		Wechsler, Lawrence/AAB-9176-2020		Abbott Vascular; ACT I	Abbott Vascular(Abbott Laboratories); ACT I	Funded by Abbott Vascular; ACT I ClinicalTrials.gov number, NCT00106938.	Abbott AL, 2009, STROKE, V40, pE573, DOI 10.1161/STROKEAHA.109.556068; Amarenco P, 2007, STROKE, V38, P3198, DOI 10.1161/STROKEAHA.107.493106; Amarenco P, 2010, LANCET, V376, P1028, DOI 10.1016/S0140-6736(10)61415-8; Bangalore S, 2011, ARCH NEUROL-CHICAGO, V68, P172, DOI 10.1001/archneurol.2010.262; Blackshear JL, 2011, CIRCULATION, V123, P2571, DOI 10.1161/CIRCULATIONAHA.110.008250; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brooks WH, 2001, J AM COLL CARDIOL, V38, P1589, DOI 10.1016/S0735-1097(01)01595-9; Brott TG, 2016, NEW ENGL J MED, V374, P1021, DOI 10.1056/NEJMoa1505215; Brott TG, 2011, J AM COLL CARDIOL, V57, P1002, DOI 10.1016/j.jacc.2010.11.005; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Brown MM, 2001, LANCET, V357, P1729; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; den Hartog AG, 2013, STROKE, V44, P1002, DOI 10.1161/STROKEAHA.111.669267; Giacovelli JK, 2010, J VASC SURG, V52, P906, DOI 10.1016/j.jvs.2010.05.010; Gray WA, 2011, JACC-CARDIOVASC INTE, V4, P235, DOI 10.1016/j.jcin.2010.10.009; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; Kinlay S, 2011, CIRCULATION, V123, P2522, DOI 10.1161/CIRCULATIONAHA.111.034314; Landesberg G, 2003, J AM COLL CARDIOL, V42, P1547, DOI 10.1016/j.jacc.2003.05.001; Marquardt L, 2010, STROKE, V41, pE11, DOI 10.1161/STROKEAHA.109.561837; Naylor AR, 2015, STROKE, V46, P9, DOI 10.1161/STROKEAHA.114.007637; Pahigiannis K, 2014, STROKE, V45, pE40, DOI 10.1161/STROKEAHA.114.003891; Paraskevas KI, 2014, STROKE, V45, P3720, DOI 10.1161/STROKEAHA.114.006912; Spence JD, 2010, ARCH NEUROL-CHICAGO, V67, P180, DOI 10.1001/archneurol.2009.289; Vikatmaa P, 2012, EUR J VASC ENDOVASC, V44, P11, DOI 10.1016/j.ejvs.2012.04.013; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035	27	334	355	1	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1011	1020		10.1056/NEJMoa1515706	http://dx.doi.org/10.1056/NEJMoa1515706			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26886419	Bronze			2022-12-28	WOS:000372066100005
J	Mayer, KH				Mayer, Kenneth H.			NextGen HIV prevention: new possibilities and questions	LANCET			English	Editorial Material							PREEXPOSURE PROPHYLAXIS; AFRICAN WOMEN; INFECTION		[Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA; [Mayer, Kenneth H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mayer, KH (corresponding author), Fenway Hlth, Fenway Inst, Boston, MA 02215 USA.; Mayer, KH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.	kmayer@fenwayhealth.org						Beaten JM, 2016, 2016 C RETR OPP INF; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cranston R, 2016, 2016 C RETR OPP INF; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gulick R, 2016, 2016 C RETR OPP INF, P103; Markowitz M, 2016, 2016 C RETR OPP INF, P106; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mascola JR, 2016, 2016 C RETR OPP INF, P15; Mayer KH, 2015, CURR OPIN HIV AIDS, V10, P226, DOI 10.1097/COH.0000000000000170; Mayer KH, 2016, 2016 C RETR OPP INF, P90; McCormack S, 2015, 2015 C RETR OPP INF; Murphy DJ, 2016, J CONTROL RELEASE, V226, P138, DOI 10.1016/j.jconrel.2016.02.020; Nel A, 2016, 2016 C RETR OPP INF; Rees H, 2015, 2015 C RETR OPP INF; Sugarman J, 2016, CURR OPIN HIV AIDS, V11, P109, DOI 10.1097/COH.0000000000000214; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	16	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1036	1038		10.1016/S0140-6736(16)00655-3	http://dx.doi.org/10.1016/S0140-6736(16)00655-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	26952545				2022-12-28	WOS:000371775000008
J	Choe, YJ; Park, SH; Hassemer, T; Korner, R; Vincenz-Donnelly, L; Hayer-Hartl, M; Hartl, FU				Choe, Young-Jun; Park, Sae-Hun; Hassemer, Timm; Koerner, Roman; Vincenz-Donnelly, Lisa; Hayer-Hartl, Manajit; Hartl, F. Ulrich			Failure of RQC machinery causes protein aggregation and proteotoxic stress	NATURE			English	Article							QUALITY-CONTROL COMPLEX; UBIQUITIN-PROTEASOME-SYSTEM; MESSENGER-RNA SURVEILLANCE; SACCHAROMYCES-CEREVISIAE; SUBUNIT DISSOCIATION; BUDDING YEAST; RIBOSOME; DEGRADATION; TRANSLATION; CHAPERONE	Translation of messenger RNAs lacking a stop codon results in the addition of a carboxy-terminal poly-lysine tract to the nascent polypeptide, causing ribosome stalling. Non-stop proteins and other stalled nascent chains are recognized by the ribosome quality control (RQC) machinery and targeted for proteasomal degradation. Failure of this process leads to neurodegeneration by unknown mechanisms. Here we show that deletion of the E3 ubiquitin ligase Ltn1p in yeast, a key RQC component, causes stalled proteins to form detergent-resistant aggregates and inclusions. Aggregation is dependent on a C-terminal alanine/threonine tail that is added to stalled polypeptides by the RQC component, Rqc2p. Formation of inclusions additionally requires the poly-lysine tract present in non-stop proteins. The aggregates sequester multiple cytosolic chaperones and thereby interfere with general protein quality control pathways. These findings can explain the proteotoxicity of ribosome-stalled polypeptides and demonstrate the essential role of the RQC in maintaining proteostasis.	[Choe, Young-Jun; Park, Sae-Hun; Hassemer, Timm; Koerner, Roman; Vincenz-Donnelly, Lisa; Hayer-Hartl, Manajit; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Körner, Roman/G-8565-2011; Hayer-Hartl, Manajit/V-8078-2017	Körner, Roman/0000-0001-9285-9290; Hayer-Hartl, Manajit/0000-0001-8213-6742; Choe, Young Jun/0000-0003-3062-057X; Park, Sae-Hun/0000-0002-8277-0732; Vincenz-Donnelly, Lisa/0000-0001-8825-7166	European Commission [ERC-2012-SyG_318987-ToPAG]; Munich Cluster for Systems Neurology (SyNergy); Center for integrated Protein Science Munich (CiPSM)	European Commission(European CommissionEuropean Commission Joint Research Centre); Munich Cluster for Systems Neurology (SyNergy); Center for integrated Protein Science Munich (CiPSM)	We thank D. Cyr, T. Inada, A. van Hoof and D. H. Wolf for reagents, and M. S. Hipp for discussions. Assistance by A. Ries and M.-J. Yoon is gratefully acknowledged. This work was supported by the European Commission under FP7 GA noERC-2012-SyG_318987-ToPAG, the Munich Cluster for Systems Neurology (SyNergy) and the Center for integrated Protein Science Munich (CiPSM).	Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; FOROOD B, 1995, BIOCHEM BIOPH RES CO, V211, P7, DOI 10.1006/bbrc.1995.1770; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito Y, 1999, BIOCHEM BIOPH RES CO, V264, P556, DOI 10.1006/bbrc.1999.1541; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Koutmou KS, 2015, ELIFE, V4, DOI 10.7554/eLife.05534; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Lykke-Andersen J, 2014, J CELL BIOL, V204, P467, DOI 10.1083/jcb.201311103; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Scazzari M, 2015, J BIOL CHEM, V290, P4677, DOI 10.1074/jbc.M114.596064; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Shao SC, 2015, MOL CELL, V57, P433, DOI 10.1016/j.molcel.2014.12.015; Shao SC, 2014, MOL CELL, V55, P880, DOI 10.1016/j.molcel.2014.07.006; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wang MC, 2015, PROTEOMICS, V15, P3163, DOI 10.1002/pmic.201400441; Yan W, 1999, MOL CELL BIOL, V19, P7751; Young CL, 2012, YEAST, V29, P119, DOI 10.1002/yea.2895; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	55	130	135	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					191	+		10.1038/nature16973	http://dx.doi.org/10.1038/nature16973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26934223	Green Submitted			2022-12-28	WOS:000371665100032
J	Grayson, M				Grayson, Michelle			COGNITIVE HEALTH	NATURE			English	Editorial Material																			0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S1	S1		10.1038/531S1a	http://dx.doi.org/10.1038/531S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26934517	Bronze			2022-12-28	WOS:000371211900062
J	Jousilahti, P; Laatikainen, T; Peltonen, M; Borodulin, K; Mannisto, S; Jula, A; Salomaa, V; Harald, K; Puska, P; Vartiainen, E				Jousilahti, Pekka; Laatikainen, Tiina; Peltonen, Markku; Borodulin, Katja; Mannisto, Satu; Jula, Antti; Salomaa, Veikko; Harald, Kennet; Puska, Pekka; Vartiainen, Erkki			Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SERUM-CHOLESTEROL RESPONSE; FOLLOW-UP; VASCULAR MORTALITY; INDIVIDUAL DATA; BLOOD-PRESSURE; DECLINE; SMOKING; METAANALYSIS; COMMUNITY; GUIDELINES	OBJECTIVE To estimate how much changes in the main risk factors of cardiovascular disease (smoking prevalence, serum cholesterol, and systolic blood pressure) can explain the reduction in coronary heart disease mortality observed among working aged men and women in eastern Finland. DESIGN Population based observational study. SETTING Eastern Finland. PARTICIPANTS 34 525 men and women aged 30-59 years who participated in the national FINRISK studies between 1972 and 2012. INTERVENTIONS Change in main cardiovascular risk factors through population based primary prevention. MAIN OUTCOME MEASURES Predicted and observed age standardised mortality due to coronary heart disease. Predicted change was estimated with a logistic regression model using risk factor data collected in nine consecutive, population based, risk factor surveys conducted every five years since 1972. Data on observed mortality were obtained from the National Causes of Death Register. RESULTS During the 40 year study period, levels of the three major cardiovascular risk factors decreased except for a small increase in serum cholesterol levels between 2007 and 2012. From years 1969-1972 to 2012, coronary heart disease mortality decreased by 82% (from 643 to 118 deaths per 100 000 people) and 84% (114 to 17) among men and women aged 35-64 years, respectively. During the first 10 years of the study, changes in these three target risk factors contributed to nearly all of the observed mortality reduction. Since the mid-1980s, the observed reduction in mortality has been larger than predicted. In the last 10 years of the study, about two thirds (69% in men and 66% in women) of the reduction could be explained by changes in the three main risk factors, and the remaining third by other factors. CONCLUSION Reductions in disease burden and mortality due to coronary heart disease can be achieved through the use of population based primary prevention programmes. Secondary prevention among high risk individuals and treatment of acute events of coronary heart disease could confer additional benefit.	[Jousilahti, Pekka; Peltonen, Markku; Borodulin, Katja; Mannisto, Satu; Jula, Antti; Salomaa, Veikko; Harald, Kennet; Puska, Pekka; Vartiainen, Erkki] Natl Inst Hlth & Welf, Dept Hlth, POB 30, Helsinki 00271, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland	Finland National Institute for Health & Welfare; University of Eastern Finland	Jousilahti, P (corresponding author), Natl Inst Hlth & Welf, Dept Hlth, POB 30, Helsinki 00271, Finland.	pekka.jousilahti@thl.fi	Laatikainen, Tiina/ABD-6622-2021; Peltonen, Markku/F-3037-2015	Laatikainen, Tiina/0000-0002-6614-4782; Peltonen, Markku/0000-0002-3767-4223; Mannisto, Satu/0000-0002-8668-3046; Borodulin, Katja/0000-0001-9529-2592				[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; [Anonymous], 2012, EUR J PREV CARDIOL, V19, P585, DOI [10.1177/2047487312450228, DOI 10.1177/2047487312450228]; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bjorck L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124769; Borodulin K, 2016, SCAND J MED SCI SPOR, V26, P93, DOI 10.1111/sms.12401; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; DAWSONHUGHES BF, 1981, CLIN SCI, V61, P527, DOI 10.1042/cs0610527; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ganesh, 2014, CIRCULATION, V129, pE398, DOI 10.1161/CIR.0000000000000026; Ganesh SK, 2013, CIRCULATION, V128, P2813, DOI 10.1161/01.cir.0000437913.98912.1d; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; HEGSTED DM, 1986, AM J CLIN NUTR, V44, P299, DOI 10.1093/ajcn/44.2.299; Helakorpi S, 2004, J EPIDEMIOL COMMUN H, V58, P649, DOI 10.1136/jech.2003.015925; Jousilahti P, 2005, J EPIDEMIOL COMMUN H, V59, P310, DOI 10.1136/jech.2004.024349; Jousilahti P, 1998, CIRCULATION, V97, P1087, DOI 10.1161/01.CIR.97.11.1087; Jousilahti P, 1999, J CARDIOVASC RISK, V6, P293; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; KEYS A, 1965, METABOLIS, V14, P776, DOI 10.1016/0026-0495(65)90004-1; Keys A, 1997, Nutrition, V13, P250; Koskinen S, 2012, NATIONAL INSTITUTE F; Laatikainen T, 2006, EUR J CLIN NUTR, V60, P965, DOI 10.1038/sj.ejcn.1602406; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Mahonen M, 2014, SUOM LAAKARILEHTI, V69, P1953; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; Mannisto S, 2010, PUBLIC HEALTH NUTR, V13, P907, DOI 10.1017/S1368980010001084; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NISSINEN A, 1988, AM J EPIDEMIOL, V127, P488, DOI 10.1093/oxfordjournals.aje.a114825; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Pekka P, 2002, PUBLIC HEALTH NUTR, V5, P245, DOI 10.1079/PHN2001300; Pereira M, 2013, CIRC-CARDIOVASC QUAL, V6, P634, DOI 10.1161/CIRCOUTCOMES.113.000264; PUSKA P, 1985, ANNU REV PUBL HEALTH, V6, P147, DOI 10.1146/annurev.pu.06.050185.001051; Puska P, 2009, THE NORTH KARELIA PR; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; ROSE G, 1989, J HUM HYPERTENS, V3, P283; Safar ME, 2000, CARDIOVASC RES, V46, P269, DOI 10.1016/S0008-6363(99)00426-5; Salomaa V, 2013, HEART, V99, P954, DOI 10.1136/heartjnl-2012-303216; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sundvall J, 2007, CLIN CHIM ACTA, V378, P93, DOI 10.1016/j.cca.2006.10.021; Thom TJ, 1992, NIH PUBLICATIONS; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Unal B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1135; Valsta LM, 2010, PUBLIC HEALTH NUTR, V13, P932, DOI 10.1017/S1368980010001126; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 2013, GLOBAL ACTION PLAN F	50	73	75	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2016	352								i721	10.1136/bmj.i721	http://dx.doi.org/10.1136/bmj.i721			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG0LJ	26932978	Green Published, hybrid			2022-12-28	WOS:000371756000001
J	Kashanian, JA; Brannigan, RE				Kashanian, James A.; Brannigan, Robert E.			Gonadotropin Interpretation in a 25-Year-Old Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KLINEFELTER-SYNDROME; MALE-INFERTILITY; PREVALENCE; MEN		[Kashanian, James A.] Weill Cornell Med, Dept Urol & Reprod Med, New York, NY USA; [Brannigan, Robert E.] Northwestern Univ, Feinberg Sch Med, Dept Urol, 675 N St Clair St,Gaiter Pavil,Ste 20-150, Chicago, IL 60611 USA	Cornell University; Northwestern University; Feinberg School of Medicine	Brannigan, RE (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, 675 N St Clair St,Gaiter Pavil,Ste 20-150, Chicago, IL 60611 USA.	r-brannigan@northwestern.edu	Kashanian, James/ABF-6730-2020					Barbotin AL, 2015, EUR J ENDOCRINOL, V172, P669, DOI 10.1530/EJE-14-0932; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Gordetsky J, 2012, BJU INT, V110, P568, DOI 10.1111/j.1464-410X.2011.10783.x; Morris JK, 2008, EUR J HUM GENET, V16, P163, DOI 10.1038/sj.ejhg.5201956; Ramasamy R, 2009, J UROLOGY, V182, P1108, DOI 10.1016/j.juro.2009.05.019; Schoor RA, 2002, J UROLOGY, V167, P197, DOI 10.1016/S0022-5347(05)65411-0; SPRATT DI, 1988, AM J PHYSIOL, V254, pE658, DOI 10.1152/ajpendo.1988.254.5.E658; Stahl PJ, 2010, FERTIL STERIL, V94, P1753, DOI 10.1016/j.fertnstert.2009.09.006; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; WILLOTT GM, 1982, FORENSIC SCI INT, V20, P9, DOI 10.1016/0379-0738(82)90099-8	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					936	937		10.1001/jama.2015.18157	http://dx.doi.org/10.1001/jama.2015.18157			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934263				2022-12-28	WOS:000371077500024
J	Mayer, KH; Krakower, DS; Boswell, SL				Mayer, Kenneth H.; Krakower, Douglas S.; Boswell, Stephen L.			Antiretroviral Preexposure Prophylaxis Opportunities and Challenges for Primary Care Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV-INFECTION; UNITED-STATES; PREVENTION; MEN; SEX		[Mayer, Kenneth H.; Krakower, Douglas S.; Boswell, Stephen L.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.; Krakower, Douglas S.; Boswell, Stephen L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mayer, KH (corresponding author), 1340 Boylston St, Boston, MA 02215 USA.	kmayer@fenwayhealth.org			NIAID NIH HHS [5P30AI060354-12] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Krakower DS, 2015, DRUGS, V75, P243, DOI 10.1007/s40265-015-0355-4; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Moore RD, 2011, CLIN INFECT DIS, V52, pS208, DOI 10.1093/cid/ciq044; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Walensky RP, 2015, J INFECT DIS	8	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					867	868		10.1001/jama.2016.0318	http://dx.doi.org/10.1001/jama.2016.0318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26893026				2022-12-28	WOS:000371077500013
J	Dumoulin, A; Masson, G				Dumoulin, Audrey; Masson, Geraldine			Lewis acids turn unreactive substrates into pure enantiomers	SCIENCE			English	Editorial Material							ASYMMETRIC CATALYSIS		[Dumoulin, Audrey; Masson, Geraldine] Univ Paris Saclay, Inst Chim Subst Nat, Univ Paris Sud, CNRS UPR 2301, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Masson, G (corresponding author), Univ Paris Saclay, Inst Chim Subst Nat, Univ Paris Sud, CNRS UPR 2301, Gif Sur Yvette, France.	geraldine.masson@cnrs.fr	Masson, Géraldine GM/A-2838-2017	Masson, Géraldine GM/0000-0003-2333-7047				Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; Dilman AD, 2003, CHEM REV, V103, P733, DOI 10.1021/cr020003p; Garcia-Garcia P, 2009, ANGEW CHEM INT EDIT, V48, P4363, DOI 10.1002/anie.200901768; Gatzenmeier T, 2016, SCIENCE, V351, P949, DOI 10.1126/science.aae0010; Jacobsen E. N., 2004, COMPREHENSIVE ASY S1; Klare HFT, 2010, DALTON T, V39, P9176, DOI 10.1039/c003097j; Mahlau M, 2013, ANGEW CHEM INT EDIT, V52, P518, DOI 10.1002/anie.201205343; Mathieu B, 2000, TETRAHEDRON LETT, V41, P9561, DOI 10.1016/S0040-4039(00)01694-4; Phipps RJ, 2012, NAT CHEM, V4, P603, DOI [10.1038/NCHEM.1405, 10.1038/nchem.1405]; Ryu DH, 2003, J AM CHEM SOC, V125, P6388, DOI 10.1021/ja035393r	10	0	0	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					918	919		10.1126/science.aaf2577	http://dx.doi.org/10.1126/science.aaf2577			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917754				2022-12-28	WOS:000370821400020
J	Kermisch, C				Kermisch, Celine			Can today's decisions really be future-proofed?	NATURE			English	Editorial Material									[Kermisch, Celine] Univ Libre Bruxelles, Brussels, Belgium	Universite Libre de Bruxelles	Kermisch, C (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	Celine.Kermisch@ulb.ac.be							0	1	1	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					383	383		10.1038/530383a	http://dx.doi.org/10.1038/530383a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DE5RW	26911743	Bronze			2022-12-28	WOS:000370690800004
J	Oliver, D				Oliver, David			What would a "responsible health secretary" do?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Davidoliver372@googlemail.com						[Anonymous], 2015, BBC NEWS; Appleby John, 2016, BMJ, V532, pi404, DOI 10.1136/bmj.i404; Boseley S, 2016, GUARDIAN; Campbell D., 2015, GUARDIAN; Dearden L., 2016, INDEPENDENT; Elgot J, 2016, GUARDIAN; Owen C., 1989, Thatcheria, V24, P1; Jamieson Sophie, 2016, DAILY TELEGRAPH; Kirkland F, 2015, GUARDIAN; NHS England, NHS SERV 7 DAYS WEEK; Smith J, 2016, INDEPENDENT; Triggle N, 2015, BBC NEWS; Walters S, 2015, MAIL SUNDAY     1122	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2016	352								i1133	10.1136/bmj.i1133	http://dx.doi.org/10.1136/bmj.i1133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1RH	26917803	Bronze, Green Published			2022-12-28	WOS:000371116400008
J	Pearce, N				Pearce, Neil			Analysis of matched case-control studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DESIGNS		[Pearce, Neil] Univ London London Sch Hyg & Trop Med, Dept Med Stat, Keppel St, London WC1E 7HT, England; [Pearce, Neil] Univ London London Sch Hyg & Trop Med, Ctr Global NCDs, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England; [Pearce, Neil] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Massey University	Pearce, N (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Med Stat, Keppel St, London WC1E 7HT, England.; Pearce, N (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Global NCDs, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.; Pearce, N (corresponding author), Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand.	neil.pearce@lshtm.ac.uk		Pearce, Neil/0000-0002-9938-7852	Wellcome Trust Institutional Strategic Support Fund [097834/Z/11/B]	Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust)	I thank Simon Cousens, Deborah Lawlor, Lorenzo Richiardi, and Jan Vandenbroucke for their comments on the draft manuscript. The Centre for Global NCDs is supported by the Wellcome Trust Institutional Strategic Support Fund, 097834/Z/11/B.	Breslow N E, 1987, IARC Sci Publ, P1; BROOKMEYER R, 1986, AM J EPIDEMIOL, V124, P693, DOI 10.1093/oxfordjournals.aje.a114443; Cardis E, 2007, EUR J EPIDEMIOL, V22, P647, DOI 10.1007/s10654-007-9152-z; dos Santos Silva I, 1999, CANC EPIDEMIOLOGY PR; Greenland S, 2008, MODERN EPIDEMIOLOGY, P258; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Keogh RH, 2014, CASE CONTROL STUDIES, DOI [10.1017/CBO9781139094757, DOI 10.1017/CB09781139094757]; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; LILIENFELD DE, 1994, FDN EPIDEMIOLOGY; MacMahon B., 1996, EPIDEMIOLOGY PRINCIP, V2nd; Mansournia MA, 2013, INT J EPIDEMIOL, V42, P860, DOI 10.1093/ije/dyt083; MANTEL N, 1959, J NATL CANCER I, V22, P719; PIKE MC, 1980, INT J EPIDEMIOL, V9, P89, DOI 10.1093/ije/9.1.89; ROBINS J, 1986, AM J EPIDEMIOL, V124, P719, DOI 10.1093/oxfordjournals.aje.a114447; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0	17	376	378	2	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2016	352								i969	10.1136/bmj.i969	http://dx.doi.org/10.1136/bmj.i969			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1RH	26916049	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000371116400004
J	Abraham, E				Abraham, Edward			New Definitions for Sepsis and Septic Shock Continuing Evolution but With Much Still to Be Done	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THERAPIES; MEDICINE		[Abraham, Edward] Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA	Wake Forest University	Abraham, E (corresponding author), Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	eabraham@wakehealth.edu						BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Buehler SS, 2016, CLIN MICROBIOL REV, V29, P59, DOI 10.1128/CMR.00053-14; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7	11	76	92	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2016	315	8					757	759		10.1001/jama.2016.0290	http://dx.doi.org/10.1001/jama.2016.0290			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5VH	26903333				2022-12-28	WOS:000370700500010
J	Vogeley, L; El Arnaout, T; Bailey, J; Stansfeld, PJ; Boland, C; Caffrey, M				Vogeley, Lutz; El Arnaout, Toufic; Bailey, Jonathan; Stansfeld, Phillip J.; Boland, Coilin; Caffrey, Martin			Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin	SCIENCE			English	Article							DISCOVERY; MECHANISM; MEMBRANE	With functions that range from cell envelope structure to signal transduction and transport, lipoproteins constitute 2 to 3% of bacterial genomes and play critical roles in bacterial physiology, pathogenicity, and antibiotic resistance. Lipoproteins are synthesized with a signal peptide securing them to the cytoplasmic membrane with the lipoprotein domain in the periplasmor outside the cell. Posttranslational processing requires a signal peptidase II (LspA) that removes the signal peptide. Here, we report the crystal structure of LspA from Pseudomonas aeruginosa complexed with the antimicrobial globomycin at 2.8 angstrom resolution. Mutagenesis studies identify LspA as an aspartyl peptidase. In an example of molecular mimicry, globomycin appears to inhibit by acting as a noncleavable peptide that sterically blocks the active site. This structure should inform rational antibiotic drug discovery.	[Vogeley, Lutz; El Arnaout, Toufic; Bailey, Jonathan; Boland, Coilin; Caffrey, Martin] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Vogeley, Lutz; El Arnaout, Toufic; Bailey, Jonathan; Boland, Coilin; Caffrey, Martin] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England	Trinity College Dublin; Trinity College Dublin; University of Oxford	Caffrey, M (corresponding author), Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland.; Caffrey, M (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	martin.caffrey@tcd.ie	Stansfeld, Phill/C-6213-2011; Stansfeld, Phillip James/AAA-9228-2020	Stansfeld, Phill/0000-0001-8800-7669; Stansfeld, Phillip James/0000-0001-8800-7669; BAILEY, JONATHAN/0000-0003-4088-8094; Boland, Coilin/0000-0001-6763-3767; El Arnaout, Toufic/0000-0003-2570-9668	Science Foundation Ireland [12/IA/1255]; Biotechnology and Biological Sciences Research Council [BB/I019855/1]; BBSRC [BB/I019855/1] Funding Source: UKRI	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank past and present members (D. Aragao, D. Doyle, A. Haffner, N. Howe, C-Y. Huang, J. Lyons, P. Ma, V. Pye, D. Weichert, and M. Wiktor) of the Membrane Structural and Functional Biology group for their assorted contributions to this study. The assistance and support of beamline scientists at the Swiss Light Source (PXII), Diamond Light Source (I24), and the Advanced Photon Source (23-ID) are acknowledged. The work was funded by Science Foundation Ireland grant 12/IA/1255. P.J.S. is supported by Biotechnology and Biological Sciences Research Council grant BB/I019855/1. All MDS were performed by using the Irish Centre for High-End Computing (ICHEC) facilities. Atomic coordinates and structure factors for the LspA-globomycin complex are deposited in the Protein Data Bank under accession code 5DIR. Correspondence and requests for materials should be addressed to M.C.	ABDELMEGUID SS, 1993, MED RES REV, V13, P731, DOI 10.1002/med.2610130605; Brik A, 2003, ORG BIOMOL CHEM, V1, P5, DOI 10.1039/b208248a; Buddelmeijer N, 2015, FEMS MICROBIOL REV, V39, P246, DOI 10.1093/femsre/fuu006; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Das A, 2010, J AM CHEM SOC, V132, P6366, DOI 10.1021/ja100002b; El Arnaout T., 2013, THESIS TRINITY COLL; Fu Y., 2009, THESIS U GLASGOW; GREENLEE WJ, 1992, ANNU REP MED CHEM, V27, P59; Kiho T, 2004, BIOORGAN MED CHEM, V12, P337, DOI 10.1016/j.bmc.2003.10.055; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Remans K, 2010, MICROBIOL-SGM, V156, P2597, DOI 10.1099/mic.0.040659-0; Remaut H., 2014, BACTERIAL MEMBRANES, P55; Tjalsma H, 1999, J BIOL CHEM, V274, P28191, DOI 10.1074/jbc.274.40.28191; Zuckert WR, 2014, BBA-MOL CELL RES, V1843, P1509, DOI 10.1016/j.bbamcr.2014.04.022	15	77	80	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					876	880		10.1126/science.aad3747	http://dx.doi.org/10.1126/science.aad3747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912896	Green Accepted			2022-12-28	WOS:000370325700048
J	Mullard, A				Mullard, Asher			DNA TAGS HELP THE HUNT FOR DRUGS	NATURE			English	Editorial Material							SELECTION; LIBRARIES; DESIGN											Blakskjaer P, 2015, CURR OPIN CHEM BIOL, V26, P62, DOI 10.1016/j.cbpa.2015.02.003; BRENNER S, 1992, P NATL ACAD SCI USA, V89, P5381, DOI 10.1073/pnas.89.12.5381; Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; Lazaar A. L., 2016, BR J CLIN PHARM; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Tse BN, 2008, J AM CHEM SOC, V130, P15611, DOI 10.1021/ja805649f; Wu ZN, 2015, ACS COMB SCI, V17, P722, DOI 10.1021/acscombsci.5b00124	7	43	47	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					367	369		10.1038/530367a	http://dx.doi.org/10.1038/530367a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887498	Bronze			2022-12-28	WOS:000370327100044
J	Yin, ZQ; Shi, K; Banerjee, S; Pandey, KK; Bera, S; Grandgenett, DP; Aihara, H				Yin, Zhiqi; Shi, Ke; Banerjee, Surajit; Pandey, Krishan K.; Bera, Sibes; Grandgenett, Duane P.; Aihara, Hideki			Crystal structure of the Rous sarcoma virus intasome	NATURE			English	Article							TARGET DNA RECOGNITION; MURINE LEUKEMIA-VIRUS; RETROVIRAL INTEGRATION; SYNAPTIC COMPLEX; TYPE-1 INTEGRASE; HIV-1 INTEGRASE; POL GENE; PROTEIN; DOMAIN; DETERMINANTS	Integration of the reverse-transcribed viral DNA into the host genome is an essential step in the life cycle of retroviruses. Retrovirus integrase catalyses insertions of both ends of the linear viral DNA into a host chromosome1. Integrase from HIV-1 and closely related retroviruses share the three-domain organization, consisting of a catalytic core domain flanked by amino-and carboxy-terminal domains essential for the concerted integration reaction. Although structures of the tetrameric integrase-DNA complexes have been reported for integrase from prototype foamy virus featuring an additional DNA-binding domain and longer interdomain linkers(2-5), the architecture of a canonical three-domain integrase bound to DNA remained elusive. Here we report a crystal structure of the three-domain integrase from Rous sarcoma virus in complex with viral and target DNAs. The structure shows an octameric assembly of integrase, in which a pair of integrase dimers engage viral DNA ends for catalysis while another pair of non-catalytic integrase dimers bridge between the two viral DNA molecules and help capture target DNA. The individual domains of the eight integrase molecules play varying roles to hold the complex together, making an extensive network of protein-DNA and protein-protein contacts that show both conserved and distinct features compared with those observed for prototype foamy virus integrase. Our work highlights the diversity of retrovirus intasome assembly and provides insights into the mechanisms of integration by HIV-1 and related retroviruses.	[Yin, Zhiqi; Shi, Ke; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Yin, Zhiqi; Shi, Ke; Aihara, Hideki] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Yin, Zhiqi; Shi, Ke; Aihara, Hideki] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Banerjee, Surajit] Cornell Univ, Northeastern Collaborat Access Team, Adv Photon Source, Lemont, IL 60439 USA; [Pandey, Krishan K.; Bera, Sibes; Grandgenett, Duane P.] St Louis Univ, Hlth Sci Ctr, Inst Mol Virol, St Louis, MO 63104 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Argonne National Laboratory; Saint Louis University	Aihara, H (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.; Aihara, H (corresponding author), Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA.; Aihara, H (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	aihar001@umn.edu		Pandey, Krishan/0000-0002-3973-9844; , Ke/0000-0003-4175-3714	National Institutes of Health [GM109770, AI087098, AI100682];  [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI087098, R21AI087098, R21AI100682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118047, P41GM103403, R01GM109770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Kurahashi for generating many mutant IN expression plasmids, J. Kankanala and Z. Wang for synthesizing Pt-modified oligonucleotides, and J. Nix for help with X-ray data collection. X-ray data were collected at the Advanced Photon Source (APS) NE-CAT beamlines, which are supported by the National Institute of General Medical Sciences (P41 GM103403). APS is a US Department of Energy Office of Science User Facility operated by Argonne National Laboratory under contract DE-AC02-06CH11357. This research was supported by National Institutes of Health grants GM109770, AI087098 to H.A. and AI100682 to D.P.G.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aiyer S, 2015, NUCLEIC ACIDS RES, V43, P5647, DOI 10.1093/nar/gkv410; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; Chen HM, 1999, J BIOL CHEM, V274, P17358, DOI 10.1074/jbc.274.24.17358; Chiu R, 2003, J VIROL, V77, P6482, DOI 10.1128/JVI.77.11.6482-6492.2003; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; DONEHOWER LA, 1984, P NATL ACAD SCI-BIOL, V81, P6461, DOI 10.1073/pnas.81.20.6461; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; GRANDGENETT DP, 1978, VIROLOGY, V89, P119, DOI 10.1016/0042-6822(78)90046-6; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Harper AL, 2003, J VIROL, V77, P3838, DOI 10.1128/JVI.77.6.3838-3845.2003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Maskell DP, 2015, NATURE, V523, P366, DOI 10.1038/nature14495; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey KK, 2014, J BIOL CHEM, V289, P19648, DOI 10.1074/jbc.M114.573311; PANGANIBAN AT, 1984, P NATL ACAD SCI-BIOL, V81, P7885, DOI 10.1073/pnas.81.24.7885; Peletskaya E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027751; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHWARTZBERG P, 1984, CELL, V37, P1043, DOI 10.1016/0092-8674(84)90439-2; Serrao E, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0167-3; Shi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056892; TEMIN HM, 1964, VIROLOGY, V23, P486, DOI 10.1016/0042-6822(64)90232-6; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Vora AC, 1997, J BIOL CHEM, V272, P23938, DOI 10.1074/jbc.272.38.23938; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yin ZQ, 2012, PROTEIN SCI, V21, P1849, DOI 10.1002/pro.2166	41	61	61	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					362	+		10.1038/nature16950	http://dx.doi.org/10.1038/nature16950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887497	Green Accepted, Green Submitted			2022-12-28	WOS:000370327100043
J	Greaney, MF				Greaney, Michael F.			Copper catalysis in a blue light	SCIENCE			English	Editorial Material							VISIBLE-LIGHT; PHOTOREDOX CATALYSIS; PHOTOCATALYSIS		[Greaney, Michael F.] Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England	University of Manchester	Greaney, MF (corresponding author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	michael.greaney@manchester.ac.uk						Huo HH, 2014, NATURE, V515, P100, DOI 10.1038/nature13892; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Kainz QM, 2016, SCIENCE, V351, P681, DOI 10.1126/science.aad8313; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Paria S, 2014, CHEMCATCHEM, V6, P2477, DOI 10.1002/cctc.201402237; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r	6	26	27	15	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					666	666		10.1126/science.aaf1071	http://dx.doi.org/10.1126/science.aaf1071			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912846				2022-12-28	WOS:000369810000022
J	Scheller, S; Yu, H; Chadwick, GL; McGlynn, SE; Orphan, VJ				Scheller, Silvan; Yu, Hang; Chadwick, Grayson L.; McGlynn, Shawn E.; Orphan, Victoria J.			Artificial electron acceptors decouple archaeal methane oxidation from sulfate reduction	SCIENCE			English	Article							ANAEROBIC OXIDATION; REDUCING BACTERIA; METHANOTROPHIC ARCHAEA; MICROBIAL CONSORTIA; ANME-2 ARCHAEA; GROWTH; METHANOGENESIS; CONSTRAINTS; ENRICHMENT; SULFUR	The oxidation of methane with sulfate is an important microbial metabolism in the global carbon cycle. In marine methane seeps, this process is mediated by consortia of anaerobic methanotrophic archaea (ANME) that live in syntrophy with sulfate-reducing bacteria (SRB). The underlying interdependencies within this uncultured symbiotic partnership are poorly understood. We used a combination of rate measurements and single-cell stable isotope probing to demonstrate that ANME in deep-sea sediments can be catabolically and anabolically decoupled from their syntrophic SRB partners using soluble artificial oxidants. The ANME still sustain high rates of methane oxidation in the absence of sulfate as the terminal oxidant, lending support to the hypothesis that interspecies extracellular electron transfer is the syntrophic mechanism for the anaerobic oxidation of methane.	[Scheller, Silvan; Yu, Hang; Chadwick, Grayson L.; McGlynn, Shawn E.; Orphan, Victoria J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [McGlynn, Shawn E.] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; [McGlynn, Shawn E.] RIKEN, Ctr Sustainable Resource Sci, Biofunct Catalyst Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	California Institute of Technology; Tokyo Metropolitan University; RIKEN	Scheller, S; Orphan, VJ (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	scheller@caltech.edu; vorphan@gps.caltech.edu	McGlynn, Shawn/Y-5831-2019; Scheller, Silvan/M-8899-2017; Orphan, Victoria/AAS-5989-2020; Chadwick, Grayson/AAE-1585-2019	McGlynn, Shawn/0000-0002-8199-7011; Orphan, Victoria/0000-0002-5374-6178; Chadwick, Grayson/0000-0003-0700-9350; Scheller, Silvan/0000-0002-0667-9224; Yu, Hang/0000-0002-7600-1582	U.S. Department of Energy Biological and Environmental Research program [DE-SC0010574, DE-SC0004940]; Gordon and Betty Moore Foundation [GBMF3306, GBMF3780]; Swiss National Science Foundation [PBEZP2_142903]	U.S. Department of Energy Biological and Environmental Research program(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Y. Guan for assistance with the nanoSIMS, the Beckman Resource Center (BRCem) for sectioning, M. Aoki for FISH analysis of ANME-2a and ANME-2c consortia, and S. Goffredi and C. Skennerton for editorial comments. We are grateful to P. Brewer from the Monterey Bay Aquarium Research Institute for providing the opportunity to participate in the 2013 research expedition and A. Pasulka and K. Dawson for their contributions in shipboard sample processing. This work was supported by the U.S. Department of Energy Biological and Environmental Research program (grants DE-SC0010574 and DE-SC0004940) and funding by the Gordon and Betty Moore Foundation through grants GBMF3306 and GBMF3780 (to V.J.O.). S.S. was supported in part by the Swiss National Science Foundation (grant no. PBEZP2_142903). All data are available in the supplementary materials. Archaeal 16S rRNA, mcrA genes, and bacterial 16S rRNA genes were deposited with the National Center for Biotechnology Information under accession numbers KU324182 to KU324260, KU324346 to KU324428, and KU324261 to KU324345, respectively. S.S., H.Y., and V.J.O. devised the study, and S.S., H.Y., G.L.C., and S.M. conducted the experiments and analyses. S.S. and V.J.O. wrote the manuscript, with contributions from all authors to data analysis, figure generation, and the final manuscript.	Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bond DR, 2002, ENVIRON MICROBIOL, V4, P115, DOI 10.1046/j.1462-2920.2002.00279.x; Girguis PR, 2005, APPL ENVIRON MICROB, V71, P3725, DOI 10.1128/AEM.71.7.3725-3733.2005; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Holler T, 2011, ISME J, V5, P1946, DOI 10.1038/ismej.2011.77; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Meulepas RJW, 2010, APPL MICROBIOL BIOT, V87, P1499, DOI 10.1007/s00253-010-2597-0; Meulepas RJW, 2009, BIOTECHNOL BIOENG, V104, P458, DOI 10.1002/bit.22412; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; Orphan VJ, 2009, ENVIRON MICROBIOL, V11, P1777, DOI 10.1111/j.1462-2920.2009.01903.x; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pirbadian S, 2012, PHYS CHEM CHEM PHYS, V14, P13802, DOI 10.1039/c2cp41185g; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; Voordeckers JW, 2010, APPL ENVIRON MICROB, V76, P2371, DOI 10.1128/AEM.02250-09; Wang FP, 2014, ISME J, V8, P1069, DOI 10.1038/ismej.2013.212; Wegener G, 2015, NATURE, V526, P587, DOI 10.1038/nature15733; WILSON LG, 1958, J BIOL CHEM, V233, P975; Yoshinaga MY, 2014, NAT GEOSCI, V7, P190, DOI [10.1038/NGEO2069, 10.1038/ngeo2069]	29	240	264	41	556	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					703	707		10.1126/science.aad7154	http://dx.doi.org/10.1126/science.aad7154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912857				2022-12-28	WOS:000369810000039
J	Naudts, K; Chen, YY; McGrath, MJ; Ryder, J; Valade, A; Otto, J; Luyssaert, S				Naudts, Kim; Chen, Yiying; McGrath, Matthew J.; Ryder, James; Valade, Aude; Otto, Juliane; Luyssaert, Sebastiaan			Europe's forest management did not mitigate climate warming	SCIENCE			English	Article							COVER CHANGES; CARBON; ECOSYSTEMS; ENERGY; SYSTEM; WATER	Afforestation and forest management are considered to be key instruments in mitigating climate change. Here we show that since 1750, in spite of considerable afforestation, wood extraction has led to Europe's forests accumulating a carbon debt of 3.1 petagrams of carbon. We found that afforestation is responsible for an increase of 0.12 watts per square meter in the radiative imbalance at the top of the atmosphere, whereas an increase of 0.12 kelvin in summertime atmospheric boundary layer temperature was mainly caused by species conversion. Thus, two and a half centuries of forest management in Europe have not cooled the climate. The political imperative to mitigate climate change through afforestation and forest management therefore risks failure, unless it is recognized that not all forestry contributes to climate change mitigation.	[Naudts, Kim; Chen, Yiying; McGrath, Matthew J.; Ryder, James; Otto, Juliane; Luyssaert, Sebastiaan] Univ Paris Saclay, Univ Versailles St Quentin, Lab Sci Climat & Environm,CNRS, Inst Pierre Simon Laplace,Commissariat Energie A, F-91191 Gif Sur Yvette, France; [Valade, Aude] Inst Pierre Simon Laplace, F-75010 Paris, France; [Naudts, Kim] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Chen, Yiying] Natl Univ Singapore, Singapore 119077, Singapore; [Otto, Juliane] Helmholtz Zentrum Geesthacht, Climate Serv Ctr Germany, D-20095 Hamburg, Germany; [Luyssaert, Sebastiaan] Vrije Univ Amsterdam, Dept Ecol Sci, NL-1081 HV Amsterdam, Netherlands	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; National University of Singapore; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Vrije Universiteit Amsterdam	Naudts, K (corresponding author), Univ Paris Saclay, Univ Versailles St Quentin, Lab Sci Climat & Environm,CNRS, Inst Pierre Simon Laplace,Commissariat Energie A, F-91191 Gif Sur Yvette, France.	kim.naudts@mpimet.mpg.de	valade, aude/Q-2299-2018; Valade, Aude/AAD-9269-2021; Chen, Yi-Ying/AAZ-3646-2020; Chen, Yi-Ying/A-4892-2017; Naudts, Kim/AAN-6015-2020; Luyssaert, Sebastiaan/F-6684-2011; Naudts, Kim/O-4551-2017	valade, aude/0000-0001-6098-0643; Chen, Yi-Ying/0000-0003-4747-5313; Chen, Yi-Ying/0000-0003-4747-5313; Naudts, Kim/0000-0001-6108-180X; Luyssaert, Sebastiaan/0000-0003-1121-1869; Naudts, Kim/0000-0001-6108-180X; McGrath, Matthew/0000-0003-3431-8466	European Research Council [242564]; French Environment and Energy Management Agency (ADEME, Bilan Carbone de la Foret Francaise program); Essential Climate Variables land cover program; German Research Foundation's Emmy Noether Program [PO 1751/1-1]; Short-Term Scientific Mission [COST (European Cooperation in Science and Technology) TERRABITES (Terrestrial Biosphere in the Earth System) [ES805]	European Research Council(European Research Council (ERC)European Commission); French Environment and Energy Management Agency (ADEME, Bilan Carbone de la Foret Francaise program); Essential Climate Variables land cover program; German Research Foundation's Emmy Noether Program(German Research Foundation (DFG)); Short-Term Scientific Mission [COST (European Cooperation in Science and Technology) TERRABITES (Terrestrial Biosphere in the Earth System)	K.N., J. R., Y. C., M. J. M., J. O., and S. L. were funded through European Research Council starting grant 242564 [DOFOCO (Do Forests Cool the Earth) program]. A. V. was funded through the French Environment and Energy Management Agency (ADEME, Bilan Carbone de la Foret Francaise program). K. N. received additional funding through the Essential Climate Variables land cover program and the German Research Foundation's Emmy Noether Program (grant PO 1751/1-1). The study benefited from a Short-Term Scientific Mission [COST (European Cooperation in Science and Technology) TERRABITES (Terrestrial Biosphere in the Earth System) grant ES805] offered to K. N. Precipitation data from the Global Precipitation Climatology Centre were made available by the National Oceanic and Atmospheric Administration's Earth System Research Laboratory (Physical Science Division), Boulder, CO (www.esrl.noaa.gov/psd/). The ORCHIDEE and LMDZ project teams as well as the Centre de Calcul Recherche et Technologie provided the run environment that is essential for the type of coupled land-atmosphere simulations that were conducted in this study. The code and the run environment are open source and distributed under the CeCILL (CEA CNRS INRIA Logiciel Libre) license (http://labex.ipsl.fr/orchidee/). M. J. M., J. O., J. R., Y. C., K. N., A. V., and S. L designed the study and/or contributed to the interpretation of the results. M. J. M., J. O., J. R., Y. C., K. N., A. V., and S. L. developed, parameterized, and validated ORCHIDEE-CAN. M. J. M., Y. C., and S. L. conducted the simulation experiment. K. N., Y. C., M. J. M, J. O., S. L., and J. R. analyzed the data.	Amiro BD, 2006, AGR FOREST METEOROL, V136, P237, DOI 10.1016/j.agrformet.2004.11.012; BRUTSAERT W, 1975, WATER RESOUR RES, V11, P742, DOI 10.1029/WR011i005p00742; Burgi M, 2003, FOREST ECOL MANAG, V176, P173, DOI 10.1016/S0378-1127(02)00270-0; Farrell EP, 2000, FOREST ECOL MANAG, V132, P5, DOI 10.1016/S0378-1127(00)00375-3; Food and Agriculture Organization of the United Nations (FAO), 2006, 147 FAO; Gimmi U, 2008, ECOSYSTEMS, V11, P113, DOI 10.1007/s10021-007-9111-2; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Hudiburg TW, 2011, NAT CLIM CHANGE, V1, P419, DOI 10.1038/NCLIMATE1264; Juang JY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031296; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Li Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7603; Luyssaert S, 2010, GLOBAL CHANGE BIOL, V16, P1429, DOI 10.1111/j.1365-2486.2009.02056.x; Luyssaert S, 2014, NAT CLIM CHANGE, V4, P389, DOI [10.1038/nclimate2196, 10.1038/NCLIMATE2196]; Mahmood R, 2014, INT J CLIMATOL, V34, P929, DOI 10.1002/joc.3736; McGrath MJ, 2015, BIOGEOSCIENCES, V12, P4291, DOI 10.5194/bg-12-4291-2015; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Naudts K, 2015, GEOSCI MODEL DEV, V8, P2035, DOI 10.5194/gmd-8-2035-2015; Otto J, 2014, BIOGEOSCIENCES, V11, P2411, DOI 10.5194/bg-11-2411-2014; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Pielke RA, 2011, WIRES CLIM CHANGE, V2, P828, DOI 10.1002/wcc.144; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; Pongratz J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036394; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; Schlamadinger B, 1996, BIOMASS BIOENERG, V10, P275, DOI 10.1016/0961-9534(95)00113-1; *UN, 1998, KYOT PROT UN FRAM CO, DOI [10.51663/pnz.58.2.07, DOI 10.51663/PNZ.58.2.07]; Zhang M, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034002	26	215	223	13	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					597	600		10.1126/science.aad7270	http://dx.doi.org/10.1126/science.aad7270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912701				2022-12-28	WOS:000369291600039
J	Yudell, M; Roberts, D; DeSalle, R; Tishkoff, S				Yudell, Michael; Roberts, Dorothy; DeSalle, Rob; Tishkoff, Sarah			Taking race out of human genetics	SCIENCE			English	Editorial Material							ETHNICITY; POPULATIONS; ANCESTRY; HEALTH		[Yudell, Michael] Drexel Univ, Philadelphia, PA 19104 USA; [Roberts, Dorothy; Tishkoff, Sarah] Univ Penn, Philadelphia, PA 19104 USA; [DeSalle, Rob] Amer Museum Nat Hist, New York, NY 10024 USA	Drexel University; University of Pennsylvania; American Museum of Natural History (AMNH)	Yudell, M (corresponding author), Drexel Univ, Philadelphia, PA 19104 USA.	myudell@drexel.edu						Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Braun L, 2008, SOC SCI MED, V67, P1580, DOI 10.1016/j.socscimed.2008.07.018; BREMER K, 1979, SYST ZOOL, V28, P624, DOI 10.2307/2412572; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Burghardt Dti Bois W.E., 1906, HLTH PHYS NEGRO AM, V11; Byrd WC, 2015, ANN AM ACAD POLIT SS, V661, P8, DOI 10.1177/0002716215591476; Chow-White PA, 2013, INT J COMMUN-US, V7, P556; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Coop G., 2014, NY TIMES BK REV, pBR6; Dobzhansky T, 1962, MANKIND EVOLVING EVO; Dobzhansky T., 1937; Foster MW, 2004, NAT REV GENET, V5, P790, DOI 10.1038/nrg1452; Fullerton SM, 2010, HUM GENET, V127, P563, DOI 10.1007/s00439-010-0800-0; Hunt LM, 2008, J MED ETHICS, V34, P495, DOI 10.1136/jme.2007.021295; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Ng PC, 2008, CLIN PHARMACOL THER, V84, P306, DOI 10.1038/clpt.2008.114; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Rebbeck TR, 2005, CANCER EPIDEM BIOMAR, V14, P2467, DOI 10.1158/1055-9965.EPI-05-0649; Roberts D., 2012, FATAL INVENTION SCI; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Smart A, 2008, SOC STUD SCI, V38, P407, DOI 10.1177/0306312707083759; Stewart C, 2015, GENET MED; Yudell M., 2014, RACE UNMASKED BIOL R	24	302	306	3	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					564	565		10.1126/science.aac4951	http://dx.doi.org/10.1126/science.aac4951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC5WO	26912690				2022-12-28	WOS:000369291600024
J	Baud, O; Maury, L; Lebail, F; Ramful, D; El Moussawi, F; Nicaise, C; Zupan-Simunek, V; Coursol, A; Beuchee, A; Bolot, P; Andrini, P; Mohamed, D; Alberti, C				Baud, Olivier; Maury, Laure; Lebail, Florence; Ramful, Duksha; El Moussawi, Fatima; Nicaise, Claire; Zupan-Simunek, Veronique; Coursol, Anne; Beuchee, Alain; Bolot, Pascal; Andrini, Pierre; Mohamed, Damir; Alberti, Corinne		PREMILOC Trial Study Grp	Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial	LANCET			English	Article							EARLY ADRENAL INSUFFICIENCY; PROPHYLAXIS; OUTCOMES; BORN	Background Bronchopulmonary dysplasia, a major complication of extreme prematurity, has few treatment options. Postnatal steroid use is controversial, but low-dose hydrocortisone might prevent the harmful effects of inflammation on the developing lung. In this study, we aimed to assess whether low-dose hydrocortisone improved survival without bronchopulmonary dysplasia in extremely preterm infants. Methods In this double-blind, placebo-controlled, randomised trial done at 21 French tertiary-care neonatal intensive care units (NICUs), we randomly assigned (1: 1), via a secure study website, extremely preterm infants inborn (born in a maternity ward at the same site as the NICU) at less than 28 weeks of gestation to receive either intravenous low-dose hydrocortisone or placebo during the first 10 postnatal days. Infants randomly assigned to the hydrocortisone group received 1 mg/kg of hydrocortisone hemisuccinate per day divided into two doses per day for 7 days, followed by one dose of 0.5 mg/kg per day for 3 days. Randomisation was stratified by gestational age and all infants were enrolled by 24 h after birth. Study investigators, parents, and patients were masked to treatment allocation. The primary outcome was survival without bronchopulmonary dysplasia at 36 weeks of postmenstrual age. We used a sequential analytical design, based on intention to treat, to avoid prolonging the trial after either efficacy or futility had been established. This trial is registered with ClinicalTrials.gov, number NCT00623740. Findings 1072 neonates were screened between May 25, 2008, and Jan 31, 2014, of which 523 were randomly assigned (256 hydrocortisone, 267 placebo). 255 infants on hydrocortisone and 266 on placebo were included in analyses after parents withdrew consent for one child in each group. Of the 255 infants assigned to hydrocortisone, 153 (60%) survived without bronchopulmonary dysplasia, compared with 136 (51%) of 266 infants assigned to placebo (odds ratio [OR] adjusted for gestational age group and interim analyses 1.48, 95% CI 1.02-2.16, p=0.04). The number of patients needed to treat to gain one bronchopulmonary dysplasia-free survival was 12 (95% CI 6-200). Sepsis rate was not significantly different in the study population as a whole, but subgroup analyses showed a higher rate only in infants born at 24-25 weeks gestational age who were treated with hydrocortisone (30 [40%] of 83 vs 21 [23%] of 90 infants; sub-hazard ratio 1.87, 95% CI 1.09-3.21, p=0.02). Other potential adverse events, including notably gastrointestinal perforation, did not differ significantly between groups. Interpretation In extremely preterm infants, the rate of survival without bronchopulmonary dysplasia at 36 weeks of postmenstrual age was significantly increased by prophylactic low-dose hydrocortisone. This strategy, based on a physiological rationale, could lead to substantial improvements in the management of the most premature neonates.	[Baud, Olivier; Maury, Laure] Univ Paris Diderot, Neonatal Intens Care Unit, Ctr Hosp Univ Robert Debre, AP HP,Sorbonne Paris Cite,INSERM,U1141, Paris, France; [Lebail, Florence] Ctr Hosp Corbeil Essonnes, Neonatal Intens Care Unit, Sud Francilien, France; [Ramful, Duksha] CHR St Denis, Neonatal & Pediat Intens Care Unit, St Denis, Reunion, France; [El Moussawi, Fatima] Ctr Hosp Intercommunal Poissy, Neonatal Intens Care Unit, Poissy, France; [Nicaise, Claire] Ctr Hosp Univ Hop Nord, Assistance Publ Hop Marseille, Neonatal Intens Care Unit, Marseille, France; [Zupan-Simunek, Veronique] Ctr Hosp Univ Antoine Beclere, AP HP, Neonatal Intens Care Unit, Paris, France; [Coursol, Anne] Ctr Hosp Pontoise, Neonatal Intens Care Unit, Pontoise, France; [Beuchee, Alain] Ctr Hosp Univ Rennes, Neonatal Intens Care Unit, Rennes, France; [Bolot, Pascal] Ctr Hosp St Denis, Neonatal Intens Care Unit, St Denis, Reunion, France; [Andrini, Pierre] CHU Grenoble, Neonatal Intens Care Unit, La Tronche, France; [Mohamed, Damir; Alberti, Corinne] Univ Paris Diderot, Clin Epidemiol Unit, Ctr Hosp Univ Robert Debre, AP HP,Sorbonne Paris Cite,INSERM,U1123, Paris, France; [Mohamed, Damir; Alberti, Corinne] CIC EC 1426, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Sud Francilien; CHU Reunion; Hospital Chi of Poissy Saint Germain; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Centre Hospitalier Rene Dubos, Pontoise; CHU Rennes; Universite de Rennes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Baud, O (corresponding author), Hop Robert Debre, INSERM, U1141, Reanimat & Pediat Neonat, F-75019 Paris, France.	olivier.baud@rdb.aphp.fr	Beuchée, Alain/AAB-7024-2021; Boileau, Pascal/H-7508-2015; Boileau, Pascal/AAG-9683-2021	Beuchée, Alain/0000-0003-0064-7085; Boileau, Pascal/0000-0001-9755-6467; Boileau, Pascal/0000-0001-9755-6467; Meau-Petit, Virginie/0000-0002-2725-7522; Razafimahefa, Hasinirina/0000-0001-9183-3523; CAMBONIE, GILLES/0000-0002-1360-7915; Marret, Stephane/0000-0002-2858-148X	French Ministry of Health; Departement de la Recherche Clinique et du Developpement, Assistance Publique-Hopitaux de Paris [AOM 06 025, AOM 11 129]; Assistance Publique - Hopitaux de Paris	French Ministry of Health; Departement de la Recherche Clinique et du Developpement, Assistance Publique-Hopitaux de Paris; Assistance Publique - Hopitaux de Paris	The trial was supported by a research grant from the French Ministry of Health and funded by the Departement de la Recherche Clinique et du Developpement, Assistance Publique-Hopitaux de Paris (AOM 06 025 and AOM 11 129). We thank John Whitehead, Lisa Hampson, and Jemma Hudson for their contribution to analysis and interpretation of the data. We thank Sowmyalakshmi Rasika, who was funded by Assistance Publique - Hopitaux de Paris, for the editing of the manuscript draft. This work was presented orally at the Pediatric Academic Societies Meeting, San Diego, CA, USA, 2015.	Alberti C, 2003, J CLIN EPIDEMIOL, V56, P536, DOI 10.1016/S0895-4356(03)00058-1; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Autret-Leca E, 2008, ARCH DIS CHILD-FETAL, V93, pF398, DOI 10.1136/adc.2008.141085; Bonsante F, 2007, NEONATOLOGY, V91, P217, DOI 10.1159/000098168; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Heine VM, 2009, J CLIN INVEST, V119, P267, DOI 10.1172/JCI36376; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kersbergen KJ, 2013, J PEDIATR-US, V163, P666, DOI 10.1016/j.jpeds.2013.04.001; Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P61; MPS Research Unit, 2000, PEST 4 OP MAN; Parikh NA, 2013, J PEDIATR-US, V162, P685, DOI 10.1016/j.jpeds.2012.09.054; Peltoniemi O, 2005, J PEDIATR-US, V146, P632, DOI 10.1016/j.jpeds.2004.12.040; Peltoniemi OM, 2009, NEONATOLOGY, V95, P240, DOI 10.1159/000164150; Rademaker KJ, 2007, J PEDIATR-US, V150, P351, DOI 10.1016/j.jpeds.2006.10.051; Rademaker KJ, 2009, SEMIN FETAL NEONAT M, V14, P171, DOI 10.1016/j.siny.2008.11.004; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Shah SS, 2012, COCHRANE DB SYST REV, V5; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Tam EWY, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002884; Walsh MC, 2006, PEDIATRICS, V118, pE1328, DOI 10.1542/peds.2006-0359; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; Watterberg KL, 1999, PEDIATRICS, V104, P1258, DOI 10.1542/peds.104.6.1258; Watterberg KL, 2005, J CLIN ENDOCR METAB, V90, P6380, DOI 10.1210/jc.2005-0734; Watterberg KL, 2004, PEDIATRICS, V114, P1649, DOI 10.1542/peds.2004-1159; WATTERBERG KL, 1995, PEDIATRICS, V95, P120; Watterberg K, 2012, CLIN PERINATOL, V39, P47, DOI 10.1016/j.clp.2011.12.017; Watterberg KL, 2007, PEDIATRICS, V120, P40, DOI 10.1542/peds.2006-3158; Whitehead J, 1997, DESIGN ANAL SEQUENTI; Whitehead J, 2011, STAT METHODS MED RES, V20, P635, DOI 10.1177/0962280210379036	30	170	178	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1827	1836		10.1016/S0140-6736(16)00202-6	http://dx.doi.org/10.1016/S0140-6736(16)00202-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	26916176				2022-12-28	WOS:000375056100031
J	Narasimhan, VM; Hunt, KA; Mason, D; Baker, CL; Karczewski, KJ; Barnes, MER; Barnett, AH; Bates, C; Bellary, S; Bockett, NA; Giorda, K; Griffiths, CJ; Hemingway, H; Jia, ZL; Kelly, MA; Khawaja, HA; Lek, M; McCarthy, S; McEachan, R; O'Donnell-Luria, A; Paigen, K; Parisinos, CA; Sheridan, E; Southgate, L; Tee, L; Thomas, M; Xue, YL; Schnall-Levin, M; Petkov, PM; -Smith, CT; Maher, ER; Trembath, RC; MacArthur, DG; Wright, J; Durbin, R; Heel, DA				Narasimhan, Vagheesh M.; Hunt, Karen A.; Mason, Dan; Baker, Christopher L.; Karczewski, Konrad J.; Barnes, Mi El R.; Barnett, Anthony H.; Bates, Chris; Bellary, Srikanth; Bockett, Nicholas A.; Giorda, Kristina; Griffiths, Christopher J.; Hemingway, Harry; Jia, Zhilong; Kelly, M. Ann; Khawaja, Hajrah A.; Lek, Monkol; McCarthy, Shane; McEachan, Rosie; O'Donnell-Luria, Anne; Paigen, Kenneth; Parisinos, Constantinos A.; Sheridan, Eamonn; Southgate, Laura; Tee, Louise; Thomas, Mark; Xue, Yali; Schnall-Levin, Michael; Petkov, Petko M.; -Smith, Chris Tyler; Maher, Eamonn R.; Trembath, Richard C.; MacArthur, Daniel G.; Wright, John; Durbin, Richard; van Heel, David A.			Health and population effects of rare gene knockouts in adult humans with related parents	SCIENCE			English	Article							RECOMBINATION HOTSPOTS; MEIOTIC RECOMBINATION; PRDM9; VARIANTS; GENOME; PHENOTYPES; MUTATIONS; COSTS; MICE	Examining complete gene knockouts within a viable organism can inform on gene function. We sequenced the exomes of 3222 British adults of Pakistani heritage with high parental relatedness, discovering 1111 rare-variant homozygous genotypes with predicted loss of function (knockouts) in 781 genes. We observed 13.7% fewer homozygous knockout genotypes than we expected, implying an average load of 1.6 recessive-lethal-equivalent loss-of-function (LOF) variants per adult. When genetic data were linked to the individuals' lifelong health records, we observed no significant relationship between gene knockouts and clinical consultation or prescription rate. In this data set, we identified a healthy PRDM9-knockout mother and performed phased genome sequencing on her, her child, and control individuals. Our results show that meiotic recombination sites are localized away from PRDM9-dependent hotspots. Thus, natural LOF variants inform on essential genetic loci and demonstrate PRDM9 redundancy in humans.	[Narasimhan, Vagheesh M.; McCarthy, Shane; Thomas, Mark; Xue, Yali; -Smith, Chris Tyler; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Hunt, Karen A.; Bockett, Nicholas A.; Griffiths, Christopher J.; Parisinos, Constantinos A.; Southgate, Laura; Trembath, Richard C.; van Heel, David A.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England; [Mason, Dan; McEachan, Rosie; Sheridan, Eamonn; Wright, John] Bradford Teaching Hosp Natl Hlth Serv NHS Fdn Tru, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England; [Baker, Christopher L.; Paigen, Kenneth; Petkov, Petko M.] Jackson Lab, Ctr Genome Dynam, Bar Harbor, ME 04609 USA; [Karczewski, Konrad J.; Lek, Monkol; O'Donnell-Luria, Anne; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Karczewski, Konrad J.; Lek, Monkol; O'Donnell-Luria, Anne; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Barnes, Mi El R.; Jia, Zhilong; Khawaja, Hajrah A.] Queen Mary Univ London, Darts & London Sch Med & Dent, William Harvey Res Inst, London E1 2AT, England; [Barnett, Anthony H.] Heart England NHS Fdn Trust, Diabet & Endocrine Ctr, Birmingham B9 5SS, W Midlands, England; [Barnett, Anthony H.] Univ Birmingham, Birmingham B9 5SS, W Midlands, England; [Bates, Chris] TPP, Mill House,Troy Rd, Troy, NY USA; [Bellary, Srikanth] Aston Univ, Aston Res Ctr Healthy Ageing, Birmingham B4 7ET, W Midlands, England; [Giorda, Kristina; Schnall-Levin, Michael] 10X Genom, 7068 Koll Ctr Pkwy,Suite 415, Pleasanton, CA 94566 USA; [Hemingway, Harry] Farr Inst Hlth Informat Res, London NW1 2DA, England; [Hemingway, Harry] UCL, Inst Hlth Informat, London NW1 2DA, England; [Kelly, M. Ann; Tee, Louise] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Maher, Eamonn R.] Univ Cambridge, Dept Med Genet, Box 238,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Maher, Eamonn R.] NIHR, Cambridge Biomed Res Ctr, Box 238,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Maher, Eamonn R.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Trembath, Richard C.] Kings Coll London, Fac Life Sci & Med, London SE1 1UL, England	Wellcome Trust Sanger Institute; University of London; Queen Mary University London; Jackson Laboratory; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; Queen Mary University London; Heart of England NHS Foundation Trust; University of Birmingham; Aston University; University of London; University College London; University of Birmingham; University of Cambridge; University of Cambridge; University of Cambridge; University of London; King's College London	Durbin, R (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.; Heel, DA (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England.	rd@sanger.ac.uk; d.vanheel@qmul.ac.uk	Southgate, Laura/H-7924-2019; Durbin, Richard/AAE-7178-2019; Jia, Zhilong/ABA-9776-2020; MAHER, EAMONN R/A-9507-2008; Wright, John/H-1624-2012; Bellary, Srikanth/ABA-1977-2020; Karczewski, Jakub/L-7326-2018; Hemingway, Harry/C-1219-2009	Southgate, Laura/0000-0002-2090-1450; Durbin, Richard/0000-0002-9130-1006; Jia, Zhilong/0000-0003-2370-5073; MAHER, EAMONN R/0000-0002-6226-6918; Wright, John/0000-0001-9572-7293; Bellary, Srikanth/0000-0002-5924-5278; Trembath, Richard/0000-0003-0550-3400; Narasimhan, Vagheesh/0000-0001-8651-8844; Khawaja, Hajrah/0000-0001-6015-259X; Bockett, Nicholas/0000-0002-7630-7637; Mason, Dan/0000-0002-0026-9216; Karczewski, Konrad/0000-0003-2878-4671; Parisinos, Constantinos Athos/0000-0003-1844-9263; O'Donnell-Luria, Anne/0000-0001-6418-9592; McEachan, Rosemary/0000-0003-1302-6675; Thomas, Mark/0000-0001-7267-6884; Karczewski, Jakub/0000-0001-9322-7842; MacArthur, Daniel/0000-0002-5771-2290; van Heel, David/0000-0002-0637-2265; Hemingway, Harry/0000-0003-2279-0624; McCarthy, Shane/0000-0002-2715-4187; Barnes, Michael/0000-0001-9097-7381	Wellcome Trust [WT102627, WT098051, WT101597, WT099769]; Barts Charity [845/1796]; UK Medical Research Council [MR/M009017/1]; NIHR under its Collaboration for Applied Health Research and Care for Yorkshire and Humber; NIH National Institute of General Medical Sciences [R01GM104371]; NIHR Cambridge Biomedical Research Centre; UK Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; NIHR; National Institute for Social Care and Health Research; Wellcome Trust; NIH [GM 099640]; AstraZeneca; Pfizer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK105566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099640, R01GM104371] Funding Source: NIH RePORTER; Medical Research Council [MR/K006665/1, MC_PC_13042, MR/K006584/1, MR/M009017/1] Funding Source: researchfish; National Institute for Health Research [ACF-2013-19-001] Funding Source: researchfish; MRC [MR/K006665/1, MR/M009017/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Barts Charity; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR under its Collaboration for Applied Health Research and Care for Yorkshire and Humber; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); Pfizer(Pfizer); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Wellcome Trust (grants WT102627 and WT098051), Barts Charity (grant 845/1796), and the UK Medical Research Council (grant MR/M009017/1). This paper presents independent research funded by the NIHR under its Collaboration for Applied Health Research and Care for Yorkshire and Humber. Core support for Born in Bradford is also provided by the Wellcome Trust (grant WT101597). V.M.N. was supported by the Wellcome Trust Ph.D. Studentship (grant WT099769). D.G.M. and K.J.K. were supported by the NIH National Institute of General Medical Sciences under award R01GM104371. E.R.M. is funded by the NIHR Cambridge Biomedical Research Centre. H.H. is supported by awards to establish the Farr Institute of Health Informatics Research, London, from the UK Medical Research Council, Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Chief Scientist Office, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, NIHR, the National Institute for Social Care and Health Research, and the Wellcome Trust. C.L.B., K.P., and P.M.P. are supported by the NIH (grant GM 099640). Born in Bradford is only possible because of the enthusiasm and commitment of the children and parents who are part of the study. We are grateful to all of the participants, health professionals, and researchers who took part in the Born in Bradford study. We thank B. MacLaughlin (Queen Mary University of London) for assistance and J. Rogers (Health & Social Care Information Centre) for advice. We would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about. R.D. declares that he is a founder and nonexecutive director of Congenica, owns stock in Illumina from previous consulting work, and is a scientific advisory board member of Dovetail. M.S.-L. and K.G. are employees of 10X Genomics. H.H. discloses paid consulting for AstraZeneca, and R.C.T. discloses a paid advisory role with Pfizer. Data reported in the paper are presented in the supplementary materials and are available under a data access agreement at the European Genotype-phenome Archive (www.ebi.ac.uk/ega) under accession numbers EGAS00001000462, EGAS00001000511, EGAS00001000567, EGAS00001000717, and EGAS00001001301.	Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Baker CL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005512; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Brilleman SL, 2013, BRIT J GEN PRACT, V63, pE274, DOI 10.3399/bjgp13X665242; CHAKRABORTY R, 1977, HUM GENET, V36, P47, DOI 10.1007/BF00390435; Exome Aggregation Consortium, 2015, AN PROT COD GEN VAR, DOI [10.1101/030338, DOI 10.1101/030338]; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Johnston JJ, 2015, AM J HUM GENET, V96, P913, DOI 10.1016/j.ajhg.2015.04.013; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Lichten M, 2015, SCIENCE, V350, P913, DOI 10.1126/science.aad5404; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McCune AR, 2002, SCIENCE, V296, P2398, DOI 10.1126/science.1071757; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Van Driest SL, 2016, JAMA-J AM MED ASSOC, V315, P47, DOI 10.1001/jama.2015.17701; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962	25	169	172	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					474	477		10.1126/science.aac8624	http://dx.doi.org/10.1126/science.aac8624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	26940866	Green Submitted, Green Accepted			2022-12-28	WOS:000374479700051
J	Rodriguez-Gutierrez, R; Lipska, KJ; Mccoy, RG; Ospina, NS; Ting, HH; Montori, VM				Rodriguez-Gutierrez, Rene; Lipska, Kasia J.; Mccoy, Rozalina G.; Ospina, Naykky Singh; Ting, Henry H.; Montori, Victor M.			Hypoglycemia as an indicator of good diabetes care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-LIFE; EPIDEMIOLOGIC ANALYSIS; GLYCEMIC CONTROL; ASSOCIATION; TIME; MANAGEMENT; MORTALITY; EVENTS; TYPE-1; RISK		[Rodriguez-Gutierrez, Rene; Ospina, Naykky Singh; Montori, Victor M.] Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Rodriguez-Gutierrez, Rene] Autonomous Univ Nuevo Leon, Univ Hosp Dr Jose E Gonzalez, Div Endocrinol, Monterrey, Mexico; [Lipska, Kasia J.] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT USA; [Mccoy, Rozalina G.] Mayo Clin, Div Primary Care Internal Med, Rochester, MN USA; [Mccoy, Rozalina G.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Ting, Henry H.] New York Presbyterian Hosp, New York, NY USA	Mayo Clinic; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Yale University; Mayo Clinic; Mayo Clinic; NewYork-Presbyterian Hospital	Montori, VM (corresponding author), Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA.	montori.victor@mayo.edu		Montori, Victor/0000-0003-0595-2898	NATIONAL INSTITUTE ON AGING [K23AG048359, P30AG021342] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS39, DOI 10.2337/dc16-S008; [Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Coca SG, 2012, ARCH INTERN MED, V172, P761, DOI 10.1001/archinternmed.2011.2230; Crasto W, 2011, DIABETES RES CLIN PR, V93, P328, DOI 10.1016/j.diabres.2011.05.008; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Frier BM, 2014, NAT REV ENDOCRINOL, V10, P711, DOI 10.1038/nrendo.2014.170; Garber AJ, 2016, ENDOCR PRACT, V22, P84, DOI 10.4158/EP151126.CS; Geelhoed-Duijvestijn Petronella H, 2013, J Med Econ, V16, P1453, DOI 10.3111/13696998.2013.852098; Geller AI, 2014, JAMA INTERN MED, V174, P678, DOI 10.1001/jamainternmed.2014.136; Goto A, 2013, BMJ-BRIT MED J, V347, pf4533, DOI DOI 10.1136/BMJ.F4533; Green AJ, 2012, DIABETES RES CLIN PR, V96, P313, DOI 10.1016/j.diabres.2012.01.002; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Johnston SS, 2012, DIABETES OBES METAB, V14, P634, DOI 10.1111/j.1463-1326.2012.01583.x; McCoy RG, 2013, ENDOCR PRACT, V19, P792, DOI 10.4158/EP12382.OR; McCoy RG, 2012, DIABETES CARE, V35, P1897, DOI 10.2337/dc11-2054; Miller ME, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5444; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; National Committee for Quality Assurance, 2015, DIAB REC PROGR DRP; National Institute for Health and Care Excellance, 2011, DIAB AD; National Quality Forum, 2014, END MEAS; National Quality Forum, 2011, CONS TASK FORC; Pedersen-Bjergaard U, 2015, DIABETES CARE, V38, P29, DOI 10.2337/dc14-1417; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; The National Institute for Health and Care Excellence, 2015, TYP 2 DIAB AD MAN NI; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Department Veterans Affairs, 2015, HYP SAF IN HSI; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; Zhang YH, 2014, DIABETES CARE, V37, P1338, DOI 10.2337/dc13-1901; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	39	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2016	352								i1084	10.1136/bmj.i1084	http://dx.doi.org/10.1136/bmj.i1084			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NH	26951142	Green Published			2022-12-28	WOS:000372048400002
J	Timmins, N				Timmins, Nicholas			NICE At last, NICE to take over the Cancer Drugs Fund	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Timmins, Nicholas] Kings Fund Inst, London NW1 7NF, England		Timmins, N (corresponding author), Kings Fund Inst, London NW1 7NF, England.	n.timmins@kingsfund.org.uk						Mayor S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1208; Timmins N, 2016, TERRIBLE BEAUTY SHOR	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2016	352								i1324	10.1136/bmj.i1324	http://dx.doi.org/10.1136/bmj.i1324			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NH	26951838				2022-12-28	WOS:000372048400005
J	Tas, JMJ; Mesin, L; Pasqual, G; Targ, S; Jacobsen, JT; Mano, YM; Chen, CS; Weill, JC; Reynaud, CA; Browne, EP; Meyer-Hermann, M; Victora, GD				Tas, Jeroen M. J.; Mesin, Luka; Pasqual, Giulia; Targ, Sasha; Jacobsen, Johanne T.; Mano, Yasuko M.; Chen, Casie S.; Weill, Jean-Claude; Reynaud, Claude-Agnes; Browne, Edward P.; Meyer-Hermann, Michael; Victora, Gabriel D.			Visualizing antibody affinity maturation in germinal centers	SCIENCE			English	Article							PRIMARY IMMUNE-RESPONSE; IN-SITU; CLONAL SELECTION; DYNAMICS; (4-HYDROXY-3-NITROPHENYL)ACETYL; CELLS; DIVERSITY; ORIGIN; MEMORY; MYC	Antibodies somatically mutate to attain high affinity in germinal centers (GCs). There, competition between B cell clones and among somatic mutants of each clone drives an increase in average affinity across the population. The extent to which higher-affinity cells eliminating competitors restricts clonal diversity is unknown. By combining multiphoton microscopy and sequencing, we show that tens to hundreds of distinct B cell clones seed each GC and that GCs lose clonal diversity at widely disparate rates. Furthermore, efficient affinity maturation can occur in the absence of homogenizing selection, ensuring that many clones can mature in parallel within the same GC. Our findings have implications for development of vaccines in which antibodies with nonimmunodominant specificities must be elicited, as is the case for HIV-1 and influenza.	[Tas, Jeroen M. J.; Mesin, Luka; Pasqual, Giulia; Targ, Sasha; Jacobsen, Johanne T.; Mano, Yasuko M.; Chen, Casie S.; Victora, Gabriel D.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Weill, Jean-Claude; Reynaud, Claude-Agnes] Univ Paris 05, Fac Med, Inst Necker Enfants Malad, INSERM,U1151,CNRS,UMR 8253,Sorbonne Paris Cite, F-75014 Paris, France; [Browne, Edward P.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Browne, Edward P.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Braunschweig Integrated Ctr Syst Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Meyer-Hermann, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Victora, GD (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	victora@wi.mit.edu	Pasqual, Giulia/AAD-8378-2022	Pasqual, Giulia/0000-0002-1476-2669; Mano, Yasuko/0000-0001-9276-9527; Victora, Gabriel/0000-0001-8807-348X; Jacobsen, Johanne/0000-0001-9757-1923	NIH [5DP5OD012146, S10 OD016326]; Human Frontier Science Program [RGP0033/2015]; German Federal Ministry of Education and Research within the Measures for the Establishment of Systems Medicine, eMed project SYSIMIT [FKZ: 01ZX1308B]; Swiss National Science Foundation Postdoctoral Mobility Fellowship; Cancer Research Institute Irvington Postdoctoral Fellowship; Norwegian Research Council Fri Prosjektstotte (FRIPRO) mobility grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012146, S10OD016326] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); German Federal Ministry of Education and Research within the Measures for the Establishment of Systems Medicine, eMed project SYSIMIT; Swiss National Science Foundation Postdoctoral Mobility Fellowship; Cancer Research Institute Irvington Postdoctoral Fellowship; Norwegian Research Council Fri Prosjektstotte (FRIPRO) mobility grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Carroll, A. Schmidt, and S. Harrison (Harvard Medical School), H. Wardemann (German Cancer Research Center), and K. Hasenkrug (National Institute of Allergy and Infectious Diseases) for essential reagents, and R. K. Colwell (University of Connecticut) and S. Binder (Helmholtz Centre for Infection Research) for help with statistical analysis. We are especially thankful to the late Herman N. Eisen (1918-2014) for the lengthy discussions of affinity maturation on which the present study is based. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Antibody sequences are also available from the GenBank database, accession numbers KU613419 to KU615568. Aicda-CreERT2 mice are available from C. A. Reynaud and J. C. Weill under a material transfer agreement with INSERM. This work was supported by NIH grant 5DP5OD012146 (G.D.V.), with additional support from Human Frontier Science Program Grant RGP0033/2015 (G.D.V. and M.M.H.), German Federal Ministry of Education and Research within the Measures for the Establishment of Systems Medicine, eMed project SYSIMIT, FKZ: 01ZX1308B (M.M.H.), Swiss National Science Foundation Postdoctoral Mobility Fellowship and Cancer Research Institute Irvington Postdoctoral Fellowship (G.P.), and Norwegian Research Council Fri Prosjektstotte (FRIPRO) mobility grant (J.T.J.). The Octet RED96 Bio-Layer Interferometry System was supported by NIH grant S10 OD016326 to the MIT Biophysical Instrumentation Facility.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Faro J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S8; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gotelli Nicholas J., 2011, P39; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Nair S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-76; Pasqual G, 2015, METHODS MOL BIOL, V1291, P125, DOI 10.1007/978-1-4939-2498-1_10; Radmacher MD, 1998, IMMUNOL CELL BIOL, V76, P373, DOI 10.1046/j.1440-1711.1998.00753.x; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; Victora GD, 2014, CURR OPIN IMMUNOL, V28, P90, DOI 10.1016/j.coi.2014.02.010; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; ZIEGNER M, 1994, EUR J IMMUNOL, V24, P2393, DOI 10.1002/eji.1830241020	32	237	239	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1048	1054		10.1126/science.aad3439	http://dx.doi.org/10.1126/science.aad3439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26912368	Green Accepted, Green Submitted			2022-12-28	WOS:000371597500035
J	Bourzac, K				Bourzac, Katherine			Bright sparks	NATURE			English	Editorial Material							CURRENT STIMULATION TDCS; OSCILLATIONS											Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Jwa A, 2015, J LAW BIOSCI, V2, P292, DOI 10.1093/jlb/lsv017; Lustenberger C, 2015, CORTEX, V67, P74, DOI 10.1016/j.cortex.2015.03.012; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Sellers KK, 2015, BEHAV BRAIN RES, V290, P32, DOI 10.1016/j.bbr.2015.04.031	5	10	13	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S6	S8		10.1038/531S6a	http://dx.doi.org/10.1038/531S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26934525	Bronze			2022-12-28	WOS:000371211900003
J	Chi, KR				Chi, Kelly Rae			Abstractions of the mind	NATURE			English	Editorial Material																		Chaudhuri R, 2015, NEURON, V88, P419, DOI 10.1016/j.neuron.2015.09.008; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Sanders L., 2012, SCI NEWS	4	6	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					S16	S17		10.1038/531S16a	http://dx.doi.org/10.1038/531S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26934521	Bronze			2022-12-28	WOS:000371211900008
J	Cressey, D				Cressey, Daniel			Better designs for animal studies	NATURE			English	Editorial Material																			0	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					128	128		10.1038/531128a	http://dx.doi.org/10.1038/531128a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26949773	Bronze			2022-12-28	WOS:000371211900058
J	Xiang, LM; Tao, NJ				Xiang, Limin; Tao, N. J.			Reactions triggered electrically	NATURE			English	Editorial Material							JUNCTIONS	Single-molecule experiments have revealed that chemical reactions can be controlled using electric fields - and that the reaction rate is sensitive to both the direction and the strength of the applied field.	[Xiang, Limin] Arizona State Univ, Biodesign Inst, Ctr Biosensors & Bioelect, Tempe, AZ 85287 USA; [Tao, N. J.] Nanjing Univ, State Key Lab Analyt Chem Life Sci, Nanjing, Peoples R China	Arizona State University; Arizona State University-Tempe; Nanjing University	Tao, NJ (corresponding author), Nanjing Univ, State Key Lab Analyt Chem Life Sci, Nanjing, Peoples R China.	njtao@asu.edu		Xiang, Limin/0000-0003-1488-2705				Aragones AC, 2016, NATURE, V531, P88, DOI 10.1038/nature16989; Darwish N, 2014, ACCOUNTS CHEM RES, V47, P385, DOI 10.1021/ar400127g; Huang ZF, 2007, NAT NANOTECHNOL, V2, P698, DOI 10.1038/nnano.2007.345; Meir R, 2010, CHEMPHYSCHEM, V11, P301, DOI 10.1002/cphc.200900848; Nicolaou KC, 2002, ANGEW CHEM INT EDIT, V41, P1668, DOI 10.1002/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO;2-Z; Sini G., 1991, J MOL STRUCT THEOCHE, V229, P163, DOI [10.1016/0166-1280(91)90144-9, DOI 10.1016/0166-1280(91)90144-9]; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481	7	10	10	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					38	39		10.1038/531038a	http://dx.doi.org/10.1038/531038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26935691				2022-12-28	WOS:000371211900031
J	Smith, JM				Smith, Jeanette M.			March 1957 (Starbotton)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					848	849		10.1001/jama.2015.14138	http://dx.doi.org/10.1001/jama.2015.14138			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934244				2022-12-28	WOS:000371077500001
J	[Anonymous]				[Anonymous]			The Examination of School Children's Eyes and Ears (Reprinted from JAMA, vol 42, pg 1146, 1904)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1904, JAMA, V42, P1146	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					946	946		10.1001/jama.2015.17076	http://dx.doi.org/10.1001/jama.2015.17076			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26934272				2022-12-28	WOS:000371077500032
J	Gatzenmeier, T; van Gemmeren, M; Xie, YW; Hofler, D; Leutzsch, M; List, B				Gatzenmeier, Tim; van Gemmeren, Manuel; Xie, Youwei; Hoefler, Denis; Leutzsch, Markus; List, Benjamin			Asymmetric Lewis acid organocatalysis of the Diels-Alder reaction by a silylated C-H acid	SCIENCE			English	Article							MUKAIYAMA ALDOL; CATALYSIS; SEARCH	Silylium ion equivalents have shown promise as Lewis acid catalysts for a range of important C-C bond-forming reactions. Here we describe chiral C-H acids that upon in situ silylation, generate silylium-carbanion pairs, which are extremely active Lewis acid catalysts for enantioselective Diels-Alder reactions of cinnamates with cyclopentadiene. Enantiomeric ratios of up to 97: 3 and diastereomeric ratios of more than 20: 1 are observed across a diverse set of substitution patterns with 1 mole percent (mol %) of C-H acid catalyst and 10 mol % of a silylating reagent. The results show promise for broad applications of such C-H acid-derived silylium ion equivalents in asymmetric Lewis acid catalysis.	[Gatzenmeier, Tim; van Gemmeren, Manuel; Xie, Youwei; Hoefler, Denis; Leutzsch, Markus; List, Benjamin] Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Germany	Max Planck Society	List, B (corresponding author), Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Germany.	list@kofo.mpg.de	van Gemmeren, Manuel/AAA-9608-2019; Höfler, Denis/AAJ-1816-2020	van Gemmeren, Manuel/0000-0003-3080-3579; Hofler, Denis/0000-0001-8470-1063; Leutzsch, Markus/0000-0001-8171-9399	Max Planck Society; Stiftung Industrieforschung; Fonds der Chemischen Industrie; European Research Council; Deutsche Forschungsgemeinschaft [EXC 1069]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Stiftung Industrieforschung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Generous support from the Max Planck Society, the Stiftung Industrieforschung (Fellowship to T.G.), the Fonds der Chemischen Industrie (Kekule Fellowship to M.v.G.), and the European Research Council (Advanced Grant "High Performance Lewis Acid Organocatalysis, HIPOCAT") are gratefully acknowledged. This work is part of the Cluster of Excellence RESOLV (EXC 1069) funded by Deutsche Forschungsgemeinschaft. We thank S. Dehn and A. Dohring for superb technical support. We are also very thankful to our analytical scientists at the institute, especially J. B. Lingnau and C. Fares (NMR department) for excellent structural assignments, A. Deege (HPLC), and all the other members of our HPLC, gas chromatography, NMR, mass sprectrometry, and x-ray departments. Metrical parameters for the structure of 3o are available free of charge from the Cambridge Crystallographic Data Centre under accession number CCDC 1448254.	Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; CARREIRA EM, 1994, TETRAHEDRON LETT, V35, P4323, DOI 10.1016/S0040-4039(00)73344-2; Corey EJ, 2009, ANGEW CHEM INT EDIT, V48, P2100, DOI 10.1002/anie.200805374; EVANS DA, 1988, J AM CHEM SOC, V110, P1238, DOI 10.1021/ja00212a037; Garcia-Garcia P, 2009, ANGEW CHEM INT EDIT, V48, P4363, DOI 10.1002/anie.200901768; Hasegawa A, 2003, ANGEW CHEM INT EDIT, V42, P5731, DOI 10.1002/anie.200352382; Hasegawa A, 2006, ORG LETT, V8, P3175, DOI 10.1021/ol060939a; HOLLIS TK, 1993, TETRAHEDRON, V49, P5415; HOLLIS TK, 1995, J AM CHEM SOC, V117, P4570, DOI 10.1021/ja00121a015; James T, 2015, CHEM REV, V115, P9388, DOI 10.1021/acs.chemrev.5b00128; Mahlau M, 2013, ANGEW CHEM INT EDIT, V52, P518, DOI 10.1002/anie.201205343; Mathieu B, 2000, TETRAHEDRON LETT, V41, P9561, DOI 10.1016/S0040-4039(00)01694-4; Mayer S, 2006, ANGEW CHEM INT EDIT, V45, P4193, DOI 10.1002/anie.200600512; Phipps RJ, 2012, NAT CHEM, V4, P603, DOI [10.1038/NCHEM.1405, 10.1038/nchem.1405]; Ratjen L, 2014, ANGEW CHEM INT EDIT, V53, P8765, DOI 10.1002/anie.201402765; Ryu DH, 2003, J AM CHEM SOC, V125, P6388, DOI 10.1021/ja035393r; Ryu DH, 2002, J AM CHEM SOC, V124, P9992, DOI 10.1021/ja027468h; Sai M, 2014, CHEM COMMUN, V50, P15206, DOI 10.1039/c4cc05807k; Tang Z, 2007, TETRAHEDRON, V63, P8449, DOI 10.1016/j.tet.2007.05.086; van Gemmeren M, 2014, ALDRICHIM ACTA, V47, P3; Wang QG, 2015, SYNLETT, V26, P1525, DOI 10.1055/s-0034-1380145; Wang QG, 2015, SYNLETT, V26, P807, DOI 10.1055/s-0034-1379999; Yamamoto H., 2000, LEWIS ACIDS ORGANIC, V2; Yamamoto H., 2000, LEWIS ACIDS ORGANIC, V1-2; Yanai H, 2015, SYNLETT, V26, P2457, DOI 10.1055/s-0035-1560478	25	91	91	6	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					949	952		10.1126/science.aae0010	http://dx.doi.org/10.1126/science.aae0010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917765				2022-12-28	WOS:000370821400035
J	Rosario-Ortiz, F; Rose, J; Speight, V; von Gunten, U; Schnoor, J				Rosario-Ortiz, Fernando; Rose, Joan; Speight, Vanessa; von Gunten, Urs; Schnoor, Jerald			How do you like your tap water?	SCIENCE			English	Editorial Material							DRINKING-WATER; OUTBREAKS		[Rosario-Ortiz, Fernando] Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA; [Rosario-Ortiz, Fernando; von Gunten, Urs; Schnoor, Jerald] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Rose, Joan] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Speight, Vanessa] Univ Sheffield, Dept Civil & Struct Engn, Sheffield S10 2TN, S Yorkshire, England; [von Gunten, Urs] Ecole Polytech Fed Lausanne, Sch Architecture Cibil & Environm Engn ENAC, CH-1015 Lausanne, Switzerland; [Schnoor, Jerald] Univ Iowa, Dept Civil & Environm Engn, Iowa City, IA 52242 USA	University of Colorado System; University of Colorado Boulder; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Michigan State University; University of Sheffield; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Iowa	Schnoor, J (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.; Schnoor, J (corresponding author), Univ Iowa, Dept Civil & Environm Engn, Iowa City, IA 52242 USA.	jerald-schnoor@uiowa.edu	Schnoor, Jerald L/B-1951-2008; von Gunten, Urs/O-1637-2013	von Gunten, Urs/0000-0001-6852-8977; Speight, Vanessa/0000-0001-7780-7863	Engineering and Physical Sciences Research Council [EP/I029346/1] Funding Source: researchfish; EPSRC [EP/I029346/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Beer KD, 2015, MMWR-MORBID MORTAL W, V64, P842, DOI 10.1111/ajt.13602; Carrington D., 2012, GUARDIAN; Edwards M, 2009, ENVIRON SCI TECHNOL, V43, P1618, DOI 10.1021/es802789w; Folkman S, 2018, WATER MAIN BREAK RAT; Guzman-Herrador B, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21160; Hanna-Attisha M, 2016, AM J PUBLIC HEALTH, V106, P283, DOI 10.2105/AJPH.2015.303003; Hrovatin N., 2001, UTIL POLICY, V10, P13; Mackey E. D., 2005, PUBLIC PERCEPTION TA; Medema GJ, 2014, MICROBIAL GROWTH IN DRINKING-WATER SUPPLIES: PROBLEMS, CAUSES, CONTROL AND RESEARCH NEEDS, P95; Rhoads WJ, 2016, ENVIRON SCI-WAT RES, V2, P164, DOI [10.1039/c5ew00221d, 10.1039/C5EW00221D]; Sedlak DL, 2011, SCIENCE, V331, P42, DOI 10.1126/science.1196397; UKWIR, 2011, 08RG0526 UKWIR; USEPA, 2013, 816F13002 USEPA	13	86	87	13	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					912	914		10.1126/science.aaf0953	http://dx.doi.org/10.1126/science.aaf0953			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917751				2022-12-28	WOS:000370821400017
J	Czech, B; Hannon, GJ				Czech, Benjamin; Hannon, Gregory J.			A Happy 3 ' Ending to the piRNA Maturation Story	CELL			English	Editorial Material							BIOGENESIS; LENGTH	For a decade, mystery has surrounded the mechanisms by which piRNA biogenesis yields distinct size classes of small RNAs within individual PIWI proteins. In this issue of Cell, two studies shed light on this process, identifying conserved PARN-family exonucleases that trim piRNAs to their mature size in silkworms and C. elegans.	[Czech, Benjamin; Hannon, Gregory J.] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Czech, B; Hannon, GJ (corresponding author), Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England.	benjamin.czech@cruk.cam.ac.uk; greg.hannon@cruk.cam.ac.uk	Czech, Benjamin/AAJ-8592-2020; Hannon, Gregory/AAB-3568-2019	Czech, Benjamin/0000-0001-8471-0007; 	Cancer Research UK [21143] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Czech B., 2016, TRENDS BIOCH SCI; Feltzin VL, 2015, AGING CELL, V14, P443, DOI 10.1111/acel.12323; Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264; Homolka D, 2015, CELL REP, V12, P418, DOI 10.1016/j.celrep.2015.06.030; Honda S, 2013, RNA, V19, P1405, DOI 10.1261/rna.040428.113; Izumi N, 2016, CELL, V164, P962, DOI 10.1016/j.cell.2016.01.008; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039; Saxe JP, 2013, EMBO J, V32, P1869, DOI 10.1038/emboj.2013.121; Tang W, 2016, CELL, V164, P974, DOI 10.1016/j.cell.2016.02.008	10	11	11	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					838	840		10.1016/j.cell.2016.02.012	http://dx.doi.org/10.1016/j.cell.2016.02.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26919421	Bronze			2022-12-28	WOS:000370867300006
J	Jordan, JJ; Hoffman, M; Bloom, P; Rand, DG				Jordan, Jillian J.; Hoffman, Moshe; Bloom, Paul; Rand, David G.			Third-party punishment as a costly signal of trustworthiness	NATURE			English	Article							NORM ENFORCEMENT; COOPERATION; RECIPROCITY; REPUTATION; EVOLUTION; FAIRNESS	Third-party punishment (TPP)(1-7), in which unaffected observers punish selfishness, promotes cooperation by deterring defection. But why should individuals choose to bear the costs of punishing? We present a game theoretic model of TPP as a costly signal(8-10) of trustworthiness. Our model is based on individual differences in the costs and/ or benefits of being trustworthy. We argue that individuals for whom trustworthiness is payoff-maximizing will find TPP to be less net costly (for example, because mechanisms(11) that incentivize some individuals to be trustworthy also create benefits for deterring selfishness via TPP). We show that because of this relationship, it can be advantageous for individuals to punish selfishness in order to signal that they are not selfish themselves. We then empirically validate our model using economic game experiments. We show that TPP is indeed a signal of trustworthiness: third-party punishers are trusted more, and actually behave in a more trustworthy way, than non-punishers. Furthermore, as predicted by our model, introducing a more informative signal-the opportunity to help directly-attenuates these signalling effects. When potential punishers have the chance to help, they are less likely to punish, and punishment is perceived as, and actually is, a weaker signal of trustworthiness. Costly helping, in contrast, is a strong and highly used signal even when TPP is also possible. Together, our model and experiments provide a formal reputational account of TPP, and demonstrate how the costs of punishing may be recouped by the long-run benefits of signalling one's trustworthiness.	[Jordan, Jillian J.; Bloom, Paul; Rand, David G.] Yale Univ, Dept Psychol, New Haven, CT 06511 USA; [Hoffman, Moshe] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Rand, David G.] Yale Univ, Dept Econ, New Haven, CT 06511 USA; [Rand, David G.] Yale Univ, Sch Management, New Haven, CT 06511 USA	Yale University; Harvard University; Yale University; Yale University	Jordan, JJ; Rand, DG (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06511 USA.; Rand, DG (corresponding author), Yale Univ, Dept Econ, New Haven, CT 06511 USA.; Rand, DG (corresponding author), Yale Univ, Sch Management, New Haven, CT 06511 USA.	jillian.jordan@yale.edu; david.rand@yale.edu		Rand, David/0000-0001-8975-2783	John Templeton Foundation	John Templeton Foundation	We gratefully acknowledge the John Templeton Foundation for financial support; A. Bear, R. Boyd, M. Crockett, J. Cone, F. Cushman, E. Fehr, M. Krasnow, R. Kurzban, J. Martin, M. Nowak, N. Raihani, L. Santos, and A. Shaw for helpful feedback; and A. Arechar, Z. Epstein, and G. Kraft-Todd for technical assistance.	Balafoutas L, 2012, EUR ECON REV, V56, P1773, DOI 10.1016/j.euroecorev.2012.09.008; Barclay P, 2006, EVOL HUM BEHAV, V27, P325, DOI 10.1016/j.evolhumbehav.2006.01.003; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Bear A, 2016, P NATL ACAD SCI USA, V113, P936, DOI 10.1073/pnas.1517780113; Boyd R., 2014, NATURE, V108, P432; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; FeldmanHall O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6306; Fessler DMT, 2003, DAHL WS ENV, P7; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Guala F, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11000069; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Horita Y, 2010, LETT EVOLUTIONARY BE, V1, P6; Jordan J. J., 2015, EXP EC; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; Nelissen RMA, 2008, EVOL HUM BEHAV, V29, P242, DOI 10.1016/j.evolhumbehav.2008.01.001; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Peysakhovich A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5939; Peysakhovich P., 2015, MANAGEMENT SCI; Raihani NJ, 2015, EVOLUTION, V69, P993, DOI 10.1111/evo.12637; Raihani NJ, 2015, TRENDS ECOL EVOL, V30, P98, DOI 10.1016/j.tree.2014.12.003; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; van Veelen M, 2012, GAME ECON BEHAV, V74, P382, DOI 10.1016/j.geb.2011.05.010; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	27	212	219	10	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					473	+		10.1038/nature16981	http://dx.doi.org/10.1038/nature16981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DE5RW	26911783				2022-12-28	WOS:000370690800034
J	Mant, J; McManus, RJ; Roalfe, A; Fletcher, K; Taylor, CJ; Martin, U; Virdee, S; Greenfield, S; Hobbs, FDR				Mant, Jonathan; McManus, Richard J.; Roalfe, Andrea; Fletcher, Kate; Taylor, Clare J.; Martin, Una; Virdee, Satnam; Greenfield, Sheila; Hobbs, F. D. Richard			Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke-Blood Pressure) randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; HYPERTENSION; GUIDELINES; MORTALITY; CARE	OBJECTIVE To assess whether using intensive blood pressure targets leads to lower blood pressure in a community population of people with prevalent cerebrovascular disease. DESIGN Open label randomised controlled trial. SETTING 99 general practices in England, with participants recruited in 2009-11. PARTICIPANTS People with a history of stroke or transient ischaemic attack whose systolic blood pressure was 125 mm Hg or above. INTERVENTIONS Intensive systolic blood pressure target (< 130 mm Hg or 10 mm Hg reduction from baseline if this was < 140 mm Hg) or standard target (< 140 mm Hg). Apart from the different target, patients in both arms were actively managed in the same way with regular reviews by the primary care team. MAINOUTCOME MEASURE Change in systolic blood pressure between baseline and 12 months. RESULTS 529 patients (mean age 72) were enrolled, 266 to the intensive target arm and 263 to the standard target arm, of whom 379 were included in the primary analysis (182 (68%) intensive arm; 197 (75%) standard arm). 84 patients withdrew from the study during the follow-up period (52 intensive arm; 32 standard arm). Mean systolic blood pressure dropped by 16.1 mm Hg to 127.4 mm Hg in the intensive target arm and by 12.8 mm Hg to 129.4 mm Hg in the standard arm (difference between groups 2.9 (95% confidence interval 0.2 to 5.7) mm Hg; P=0.03). CONCLUSIONS Aiming for target below 130 mm Hg rather than 140 mm Hg for systolic blood pressure in people with cerebrovascular disease in primary care led to a small additional reduction in blood pressure. Active management of systolic blood pressure in this population using a < 140 mm Hg target led to a clinically important reduction in blood pressure.	[Mant, Jonathan] Univ Cambridge, Primary Care Unit, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [McManus, Richard J.; Hobbs, F. D. Richard] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, NIHR Sch Primary Care Res, Oxford OX2 6GG, England; [Roalfe, Andrea; Fletcher, Kate; Taylor, Clare J.; Virdee, Satnam; Greenfield, Sheila] Univ Birmingham, Primary Care Clin Sci, Birmingham B15 2TT, W Midlands, England; [Martin, Una] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England	University of Cambridge; University of Oxford; University of Birmingham; University of Birmingham	Mant, J (corresponding author), Univ Cambridge, Primary Care Unit, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England.	jm677@medschl.cam.ac.uk		hobbs, richard/0000-0001-7976-7172	National Institute for Health Research (NIHR) [RP-PG-06061153]; NIHR Professorship (RJMcM); NIHR School for Primary Care Research; University of Birmingham; National Institute for Health Research [CL-2015-13-006, NIHR-RP-02-12-015, DRF-2012-05-407, RP-PG-0606-1153, CDF/01/017] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Professorship (RJMcM); NIHR School for Primary Care Research; University of Birmingham; National Institute for Health Research(National Institute for Health Research (NIHR))	This report is of independent research funded by the National Institute for Health Research (NIHR; Stroke Prevention in Primary Care, Programme Grant for Applied Research, RP-PG-06061153) and by an NIHR Professorship (RJMcM). FDRH is part funded as director of the NIHR School for Primary Care Research, theme leader of the NIHR Oxford Biomedical Research Centre, and director of the NIHR Collaboration for Leadership in Applied Health Research and Care, Oxford. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS. The study sponsor was the University of Birmingham. The study funder and sponsor had no role in the study design; the collection, analysis, or interpretation of data; the writing of the report; or the decision to submit for publication. The researchers are independent of the funders.	Arima H, 2006, J HYPERTENS, V24, P1201, DOI 10.1097/01.hjh.0000226212.34055.86; Asayama K, 2012, HYPERTENS RES, V35, P1102, DOI 10.1038/hr.2012.125; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Fletcher K, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-37; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Kerry SM, 2013, CAN MED ASSOC J, V185, P23, DOI 10.1503/cmaj.120832; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mant J, 2006, BMJ-BRIT MED J, V332, P635, DOI 10.1136/bmj.38758.600116.AE; Mattu GS, 2004, BLOOD PRESS MONIT, V9, P47, DOI 10.1097/00126097-200402000-00009; McManus RJ, 2014, JAMA-J AM MED ASSOC, V312, P799, DOI 10.1001/jama.2014.10057; National Collaborating Centre for Chronic Conditions, 2006, MAN HYP AD PRIM CAR; Ovbiagele B, 2011, JAMA-J AM MED ASSOC, V306, P2137, DOI 10.1001/jama.2011.1650; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Rothwell PM, 2011, LANCET, V377, P1681, DOI 10.1016/S0140-6736(11)60516-3; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Wennberg R, 2004, BMJ-BRIT MED J, V329, P968, DOI 10.1136/bmj.329.7472.968; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Zanchetti A, 2014, J HYPERTENS, V32, P1888, DOI 10.1097/HJH.0000000000000254; Zanchetti A, 2009, J HYPERTENS, V27, P923, DOI 10.1097/HJH.0b013e32832aa6b5	23	37	39	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2016	352								i708	10.1136/bmj.i708	http://dx.doi.org/10.1136/bmj.i708			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1RH	26919870	Green Published, hybrid			2022-12-28	WOS:000371116400001
J	Mathai, SC; Danoff, SK				Mathai, Stephen C.; Danoff, Sonye K.			Management of interstitial lung disease associated with connective tissue disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IDIOPATHIC PULMONARY-FIBROSIS; RESOLUTION COMPUTED-TOMOGRAPHY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; EULAR SCLERODERMA TRIALS; OBSTRUCTIVE SLEEP-APNEA; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; ARTERIAL-HYPERTENSION; MYCOPHENOLATE-MOFETIL	The lung is a common site of complications of systemic connective tissue disease (CTD), and lung involvement can present in several ways. Interstitial lung disease (ILD) and pulmonary hypertension are the most common lung manifestations in CTD. Although it is generally thought that interstitial lung disease develops later on in CTD it is often the initial presentation ("lung dominant" CTD). ILD can be present in most types of CTD, including rheumatoid arthritis, scleroderma, systemic lupus erythematosus, polymyositis or dermatomyositis, Sjogren's syndrome, and mixed connective tissue disease. Despite similarities in clinical and pathologic presentation, the prognosis and treatment of CTD associated ILD (CTD-ILD) can differ greatly from that of other forms of ILD, such as idiopathic pulmonary fibrosis. Pulmonary hypertension (PH) can present as a primary vasculopathy in pulmonary arterial hypertension or in association with ILD (PH-ILD). Therefore, detailed history, physical examination, targeted serologic testing, and, occasionally, lung biopsy are needed to diagnose CTD-ILD, whereas both non-invasive and invasive assessments of pulmonary hemodynamics are needed to diagnose pulmonary hypertension. Immunosuppression is the mainstay of treatment for ILD, although data from randomized controlled trials (RCTs) to support specific treatments are lacking. Furthermore, treatment strategies vary according to the clinical situation-for example, the treatment of a patient newly diagnosed as having CTD-ILD differs from that of someone with an acute exacerbation of the disease. Immunosuppression is indicated only in select cases of pulmonary arterial hypertension related to CTD; more commonly, selective pulmonary vasodilators are used. For both diseases, comorbidities such as sleep disordered breathing, symptoms of dyspnea, and cough should be evaluated and treated. Lung transplantation should be considered in patients with advanced disease but is not always feasible because of other manifestations of CTD and comorbidities. Clinical trials of novel therapies including immunosuppressive therapies are needed to inform best treatment strategies.	[Mathai, Stephen C.; Danoff, Sonye K.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University	Mathai, SC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	smathai4@jhmi.edu		Danoff, Sonye K./0000-0001-9172-8977	NIH/NHLBI; Scleroderma Foundation; Boehringer-Ingelheim; Huayi Zhang Discovery Fund; Cecilia Fisher Rudman Fund	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Scleroderma Foundation; Boehringer-Ingelheim(Boehringer Ingelheim); Huayi Zhang Discovery Fund; Cecilia Fisher Rudman Fund	We have read and understood BMJ policy on declaration of interests and declare the following interests: SCM: paid consultancies for Actelion, Bayer, and Gilead; research funding from NIH/NHLBI and the Scleroderma Foundation; unpaid officerships of the Pulmonary Hypertension Association and the American College of Chest Physicians. SKD: paid consultancies for Boehringer-Ingelheim; research funding from the Huayi Zhang Discovery Fund and the Cecilia Fisher Rudman Fund; unpaid officerships of the American College of Chest Physicians and American Thoracic Society.	Aggarwal R, 2012, CURR OPIN RHEUMATOL, V24, P635, DOI 10.1097/BOR.0b013e328358ac72; Ando K, 2013, RESPIR INVESTIG, V51, P69, DOI 10.1016/j.resinv.2012.12.002; Bajwah S, 2013, PALLIATIVE MED, V27, P869, DOI 10.1177/0269216313497226; Bajwah S, 2013, THORAX, V68, P867, DOI 10.1136/thoraxjnl-2012-202040; Bennett CL, 2002, AM J MED, V113, P603, DOI 10.1016/S0002-9343(02)01300-1; Berezne A, 2008, J RHEUMATOL, V35, P1064; Bernstein EJ, 2015, ARTHRITIS RHEUMATOL, V67, P1314, DOI 10.1002/art.39021; Bertoli AM, 2007, ANN RHEUM DIS, V66, P12, DOI 10.1136/ard.2006.055343; Boddana P, 2011, CLIN TRANSPLANT, V25, P417, DOI 10.1111/j.1399-0012.2010.01255.x; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Boitiaux JF, 2011, RHEUMATOLOGY, V50, P2245, DOI 10.1093/rheumatology/ker267; BRIGGS DC, 1991, LANCET, V338, P661, DOI 10.1016/0140-6736(91)91235-M; Broad K, 2010, MED SCI MONITOR, V16, pRA187; Cain HC, 1998, CLIN CHEST MED, V19, P687, DOI 10.1016/S0272-5231(05)70110-6; Carmier D, 2011, EXPERT REV RESP MED, V5, P33, DOI [10.1586/ers.10.84, 10.1586/ERS.10.84]; CARSON CW, 1987, SEMIN ARTHRITIS RHEU, V16, P186, DOI 10.1016/0049-0172(87)90021-7; CERVANTESPEREZ P, 1980, JAMA-J AM MED ASSOC, V243, P1715, DOI 10.1001/jama.243.17.1715; Chen IJ, 2009, CLIN RHEUMATOL, V28, P639, DOI 10.1007/s10067-009-1110-6; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Chua F, 2012, RHEUMATOLOGY, V51, P1870, DOI 10.1093/rheumatology/kes167; Condliffe R, 2009, AM J RESP CRIT CARE, V179, P151, DOI 10.1164/rccm.200806-953OC; Connors GR, 2010, CHEST, V138, P1464, DOI 10.1378/chest.10-0180; Coppo P, 2002, RHEUMATOLOGY, V41, P1040, DOI 10.1093/rheumatology/41.9.1040; Cortet B, 1997, ANN RHEUM DIS, V56, P596, DOI 10.1136/ard.56.10.596; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; Daoussis D, 2012, CLIN EXP RHEUMATOL, V30, pS17; Dawson JK, 2001, THORAX, V56, P622, DOI 10.1136/thorax.56.8.622; Diot E, 2011, CHEST, V140, P562, DOI 10.1378/chest.11-0492; Domiciano DS, 2011, CLIN RHEUMATOL, V30, P223, DOI 10.1007/s10067-010-1493-4; EISENBERG H, 1973, ANN INTERN MED, V79, P37, DOI 10.7326/0003-4819-79-1-37; Fassbinder T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0603-8; Fathi M, 2004, ANN RHEUM DIS, V63, P297, DOI 10.1136/ard.2003.006122; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Fischer A, 2013, J RHEUMATOL, V40, P640, DOI 10.3899/jrheum.121043; Fujisawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098824; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Ghatol A, 2012, LUNG, V190, P373, DOI 10.1007/s00408-012-9389-5; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Gordon P, 2015, RHEUMATOLOGY, V54, P3, DOI 10.1093/rheumatology/keu335; Gordon PA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003643.pub4; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; Gunnarsson R, 2016, RHEUMATOLOGY, V55, P103, DOI 10.1093/rheumatology/kev300; Gunnarsson R, 2012, ANN RHEUM DIS, V71, P1966, DOI 10.1136/annrheumdis-2011-201253; Hall JC, 2013, ARTHRIT CARE RES, V65, P1307, DOI 10.1002/acr.21992; Hayashi S, 2008, J RHEUMATOL, V35, P260; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Herazo-Maya JD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005964; Hershcovici T, 2011, ALIMENT PHARM THER, V34, P1295, DOI 10.1111/j.1365-2036.2011.04870.x; Higginson IJ, 2014, LANCET RESP MED, V2, P979, DOI 10.1016/S2213-2600(14)70226-7; Horai Y, 2012, J CLIN PHARM THER, V37, P117, DOI 10.1111/j.1365-2710.2010.01234.x; Horton MR, 2012, ANN INTERN MED, V157, P398, DOI 10.7326/0003-4819-157-6-201209180-00003; Hoshi K, 2004, CLIN RHEUMATOL, V23, P252, DOI 10.1007/s10067-003-0859-2; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; Hu PQ, 2003, ARTHRITIS RHEUM, V48, P1363, DOI 10.1002/art.10977; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Ito I, 2005, AM J RESP CRIT CARE, V171, P632, DOI 10.1164/rccm.200403-417OC; Iudici Michele, 2013, Clin Exp Rheumatol, V31, P31; Ji SY, 2010, CHINESE MED J-PEKING, V123, P517, DOI 10.3760/cma.j.issn.0366-6999.2010.05.002; Johannson Kerri, 2013, Curr Respir Care Rep, V2, DOI 10.1007/s13665-013-0065-x; Johannson KA, 2014, EUR RESPIR J, V43, P1124, DOI 10.1183/09031936.00122213; Judge EP, 2012, EUR RESPIR J, V40, P93, DOI 10.1183/09031936.00115511; Keir GJ, 2014, RESPIROLOGY, V19, P353, DOI 10.1111/resp.12214; Keir GJ, 2012, EUR RESPIR J, V40, P641, DOI 10.1183/09031936.00163911; Khanna D, 2013, ARTHRITIS RHEUM-US, V65, P3194, DOI 10.1002/art.38172; Khanna D, 2011, ARTHRITIS RHEUM-US, V63, P3540, DOI 10.1002/art.30548; Kilduff Claire E, 2014, Cough, V10, P4, DOI 10.1186/1745-9974-10-4; Kowal-Bielecka O, 2009, ANN RHEUM DIS, V68, P620, DOI 10.1136/ard.2008.096677; Kurita T, 2015, LUPUS, V24, P3, DOI 10.1177/0961203314554849; Labirua-Iturburu A, 2013, CLIN EXP RHEUMATOL, V31, P436; Lamblin C, 2001, EUR RESPIR J, V18, p69S; Lancaster LH, 2009, CHEST, V136, P772, DOI 10.1378/chest.08-2776; Lara AR, 2010, CHEST, V137, P1164, DOI 10.1378/chest.08-2084; Launay D, 2011, CHEST, V140, P1016, DOI 10.1378/chest.10-2473; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Le Pavec J, 2011, ARTHRITIS RHEUM-US, V63, P2456, DOI 10.1002/art.30423; Lee CS, 2002, CLIN RHEUMATOL, V21, P391, DOI 10.1007/s100670200104; Lee JS, 2013, LANCET RESP MED, V1, P369, DOI 10.1016/S2213-2600(13)70105-X; Luo Q, 2014, HEART LUNG CIRC, V23, P778, DOI 10.1016/j.hlc.2014.02.014; Mathai SC, 2014, PULMONARY MANIFESTAT, P139; Mathai SC, 2009, ARTHRITIS RHEUM-US, V60, P569, DOI 10.1002/art.24267; MATTHAY RA, 1975, MEDICINE, V54, P397, DOI 10.1097/00005792-197509000-00003; MCDONAGH J, 1994, BRIT J RHEUMATOL, V33, P118; Mermigkis C, 2007, LUNG, V185, P173, DOI 10.1007/s00408-007-9004-3; Mira-Avendano IC, 2013, RESP MED, V107, P890, DOI 10.1016/j.rmed.2013.02.015; Mittoo S, 2014, SEMIN RESP CRIT CARE, V35, P249, DOI 10.1055/s-0034-1371537; Miura Y, 2014, SARCOIDOSIS VASC DIF, V31, P235; Oddis CV, 2013, ARTHRITIS RHEUM-US, V65, P314, DOI 10.1002/art.37754; Olson AL, 2011, AM J RESP CRIT CARE, V183, P372, DOI 10.1164/rccm.201004-0622OC; Palm O, 2013, RHEUMATOLOGY, V52, P173, DOI 10.1093/rheumatology/kes311; Panopoulos ST, 2013, LUNG, V191, P483, DOI 10.1007/s00408-013-9499-8; Paone C, 2007, CLIN EXP RHEUMATOL, V25, P613; Parambil JG, 2006, CHEST, V130, P1489, DOI 10.1378/chest.130.5.1489; Parambil JG, 2006, CHEST, V130, P553, DOI 10.1378/chest.130.2.553; Park IN, 2007, CHEST, V132, P214, DOI 10.1378/chest.07-0323; Perez-Alvarez R, 2011, SEMIN ARTHRITIS RHEU, V41, P256, DOI 10.1016/j.semarthrit.2010.11.002; Pihtili A, 2013, SLEEP BREATH, V17, P1281, DOI 10.1007/s11325-013-0834-3; Prado Gilmar F, 2002, Sleep Med, V3, P341, DOI 10.1016/S1389-9457(02)00013-8; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ramos-Casals M, 2008, MEDICINE, V87, P210, DOI 10.1097/MD.0b013e318181e6af; Rolla G, 1996, LUPUS, V5, P38, DOI 10.1177/096120339600500108; Roubille C, 2014, SEMIN ARTHRITIS RHEU, V43, P613, DOI 10.1016/j.semarthrit.2013.09.005; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Saggar R, 2010, EUR RESPIR J, V36, P893, DOI 10.1183/09031936.00139809; Sathi N, 2012, CLIN RHEUMATOL, V31, P79, DOI 10.1007/s10067-011-1758-6; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Schachna L, 2006, ARTHRITIS RHEUM-US, V54, P3954, DOI 10.1002/art.22264; SHARP GC, 1972, AM J MED, V52, P148, DOI 10.1016/0002-9343(72)90064-2; Shitrit D, 2009, CLIN TRANSPLANT, V23, P178, DOI 10.1111/j.1399-0012.2009.00958.x; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Smolen JS, 2013, ANN RHEUM DIS, V72, P482, DOI 10.1136/annrheumdis-2012-202469; Sottile PD, 2013, TRANSPLANTATION, V95, P975, DOI 10.1097/TP.0b013e3182845f23; Spiera RF, 2011, ANN RHEUM DIS, V70, P1003, DOI 10.1136/ard.2010.143974; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; SUZUKI A, 1994, J RHEUMATOL, V21, P33; Suzuki Y, 2009, LUNG, V187, P201, DOI 10.1007/s00408-009-9146-6; Szodoray P, 2012, LUPUS, V21, P1412, DOI 10.1177/0961203312456751; Tachikawa R, 2012, RESPIRATION, V83, P20, DOI 10.1159/000329893; Taichman DB, 2014, CHEST, V146, P449, DOI 10.1378/chest.14-0793; Tani C, 2014, J AUTOIMMUN, V48-49, P46, DOI 10.1016/j.jaut.2014.01.008; Tanizawa K, 2013, RESP MED, V107, P745, DOI 10.1016/j.rmed.2013.01.014; Tanner K, 2013, LARYNGOSCOPE, V123, P2787, DOI 10.1002/lary.24148; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Tashkin DP, 2007, AM J RESP CRIT CARE, V176, P1026, DOI 10.1164/rccm.200702-326OC; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; TERBORG EJ, 1990, SEMIN ARTHRITIS RHEU, V20, P164, DOI 10.1016/0049-0172(90)90057-M; Trad S, 2006, ARTHRITIS RHEUM-US, V54, P184, DOI 10.1002/art.21538; Tzouvelekis A, 2012, PULM MED, V2012, DOI 10.1155/2012/143637; Uffmann M, 2001, J THORAC IMAG, V16, P282, DOI 10.1097/00005382-200110000-00009; Ungprasert P, 2015, MOD RHEUMATOL; van Laar JM, 2014, JAMA-J AM MED ASSOC, V311, P2490, DOI 10.1001/jama.2014.6368; Volkmann ER, 2014, ARTHRITIS RHEUMATOL, V66, P1900, DOI 10.1002/art.38623; Walker KM, 2012, SEMIN ARTHRITIS RHEU, V42, P42, DOI 10.1016/j.semarthrit.2012.01.003; Walker UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ard.2006.062901; Wanchu A, 2009, INT J RHEUM DIS, V12, P239, DOI 10.1111/j.1756-185X.2009.01417.x; WARD MM, 1989, ARTHRITIS RHEUM, V32, P1226, DOI 10.1002/anr.1780321007; Wells AU, 2007, AM J RESP CRIT CARE, V176, P952, DOI 10.1164/rccm.200708-1185ED; Wells AU, 2014, SEMIN RESP CRIT CARE, V35, P213, DOI 10.1055/s-0034-1371541; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; Winstone TA, 2014, CHEST, V146, P422, DOI 10.1378/chest.13-2626; Won CHJ, 2014, CLIN CHEST MED, V35, P505, DOI 10.1016/j.ccm.2014.06.006; Yazisiz V, 2010, RHEUMATOL INT, V30, P1317, DOI 10.1007/s00296-009-1152-8; Ye S, 2007, CLIN RHEUMATOL, V26, P1647, DOI 10.1007/s10067-007-0562-9; Yilmaz N, 2014, INT J RHEUM DIS, V17, P923, DOI 10.1111/1756-185X.12399; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253; Yu KH, 2011, CLIN RHEUMATOL, V30, P1595, DOI 10.1007/s10067-011-1840-0; Yunt ZX, 2015, RHEUM DIS CLIN N AM, V41, P225, DOI 10.1016/j.rdc.2014.12.004; Zhang XJ, 2013, J RHEUMATOL, V40, P850, DOI 10.3899/jrheum.120705	149	157	174	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2016	352								h6819	10.1136/bmj.h6819	http://dx.doi.org/10.1136/bmj.h6819			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1QZ	26912511	Green Published			2022-12-28	WOS:000371115600001
J	de Lussanet, MHE				de Lussanet, Marc H. E.			BRAIN STRUCTURE Comment on "Cortical folding scales universally with surface area and thickness, not number of neurons"	SCIENCE			English	Editorial Material							CEREBRAL-CORTEX; SHAPE; EVOLUTION; GEOMETRY; MAMMALS; SIZE	The cerebrum of largemammals is convoluted, whereas that of smallmammals is smooth. Mota and Herculano-Houzel (Reports, 3 July 2015, p. 74) inspired a model on an old theory that proposed a fractal geometry. I show that their model reduces to the product of gray-matter proportion times the folding index. This proportional relation describes the available data even better than the fractal model.	[de Lussanet, Marc H. E.] Univ Munster, Inst Sports Sci, Horstmarer Landweg 62b, D-48149 Munster, Germany	University of Munster	de Lussanet, MHE (corresponding author), Univ Munster, Inst Sports Sci, Horstmarer Landweg 62b, D-48149 Munster, Germany.	lussanet@uni-muenster.de						Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; de Lussanet M. H. E., 2015, PEERJ PREPRINTS, V3, pe1518; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; HOFMAN MA, 1989, PROG NEUROBIOL, V32, P137, DOI 10.1016/0301-0082(89)90013-0; HOFMAN MA, 1991, J HIRNFORSCH, V32, P103; MANDELBROT BB, 1975, P NATL ACAD SCI USA, V72, P3825, DOI 10.1073/pnas.72.10.3825; Manger PR, 2006, BIOL REV, V81, P293, DOI 10.1017/S1464793106007019; Mota B, 2015, SCIENCE, V349, P74, DOI 10.1126/science.aaa9101; RYS FS, 1986, PHYS REV LETT, V56, P784, DOI 10.1103/PhysRevLett.56.784; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	12	5	5	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275								10.1126/science.aad0127	http://dx.doi.org/10.1126/science.aad0127			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912885				2022-12-28	WOS:000370325700031
J	Farmer, WT; Abrahamsson, T; Chierzi, S; Lui, C; Zaelzer, C; Jones, EV; Bally, BP; Chen, GG; Theroux, JF; Peng, J; Bourque, CW; Charron, F; Ernst, C; Sjostrom, PJ; Murai, KK				Farmer, W. Todd; Abrahamsson, Therese; Chierzi, Sabrina; Lui, Christopher; Zaelzer, Cristian; Jones, Emma V.; Bally, Blandine Ponroy; Chen, Gary G.; Theroux, Jean-Francois; Peng, Jimmy; Bourque, Charles W.; Charron, Frederic; Ernst, Carl; Sjoestroem, P. Jesper; Murai, Keith K.			Neurons diversify astrocytes in the adult brain through sonic hedgehog signaling	SCIENCE			English	Article							SPECIFICATION; TRANSCRIPTOME; INHIBITION; DATABASE; CIRCUIT; CELLS; MODEL; GLIA	Astrocytes are specialized and heterogeneous cells that contribute to central nervous system function and homeostasis. However, the mechanisms that create and maintain differences among astrocytes and allow them to fulfill particular physiological roles remain poorly defined. We reveal that neurons actively determine the features of astrocytes in the healthy adult brain and define a role for neuron-derived sonic hedgehog (Shh) in regulating the molecular and functional profile of astrocytes. Thus, the molecular and physiological program of astrocytes is not hardwired during development but, rather, depends on cues from neurons that drive and sustain their specialized properties.	[Farmer, W. Todd; Abrahamsson, Therese; Chierzi, Sabrina; Lui, Christopher; Zaelzer, Cristian; Jones, Emma V.; Bally, Blandine Ponroy; Bourque, Charles W.; Sjoestroem, P. Jesper; Murai, Keith K.] McGill Univ, Montreal Gen Hosp, Ctr Res Neurosci, Ctr Hlth,Res Inst,Dept Neurol & Neurosurg,Brain R, Montreal, PQ H3G 1A4, Canada; [Chen, Gary G.; Theroux, Jean-Francois; Ernst, Carl] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Chen, Gary G.; Theroux, Jean-Francois; Ernst, Carl] Douglas Hosp, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Peng, Jimmy; Charron, Frederic] Univ Montreal, Dept Med, Inst Rech Clin Montreal, Mol Biol Neural Dev, Montreal, PQ H3C 3J7, Canada; [Peng, Jimmy; Charron, Frederic] McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada; [Ernst, Carl] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Ernst, Carl] Douglas Hosp, Res Inst, Verdun, PQ, Canada	McGill University; McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; McGill University	Murai, KK (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Res Neurosci, Ctr Hlth,Res Inst,Dept Neurol & Neurosurg,Brain R, Montreal, PQ H3G 1A4, Canada.	keith.murai@mcgill.ca	Charron, Frederic/D-2140-2009; Charron, Frederic/O-8017-2019; Sjöström, Per Jesper/B-9696-2019	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Sjöström, Per Jesper/0000-0001-7085-2223; Bourque, Charles/0000-0002-1594-742X	Canadian Institutes of Health Research [FDN 143337, MOP 126137/NIA 288936, MOP 111152/MOP 123390]; Natural Sciences and Engineering Research Council of Canada [DG 418546-2, 4080442011]; Canada Research Chairs Program; Brain Canada/W. Garfield Weston Foundation; James McGill Chair Program; Canadian Foundation for Innovation [LOF 28331]; Research Institute of the McGill University Health Centre; Vanier fellowship; Biotechnology and Biological Sciences Research Council [1068928] Funding Source: researchfish; Medical Research Council [G0700188] Funding Source: researchfish; MRC [G0700188] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Brain Canada/W. Garfield Weston Foundation; James McGill Chair Program; Canadian Foundation for Innovation(Canada Foundation for Innovation); Research Institute of the McGill University Health Centre; Vanier fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Glast-CreERT2 mice are available from M. Gotz under a material transfer agreement with Helmholtz Zentrum Munchen-Deutsches Forschungszentrum fur Gesundheit und Umwelt. This work was supported by the Canadian Institutes of Health Research (FDN 143337 to C.W.B., MOP 126137/NIA 288936 to P.J.S., and MOP 111152/MOP 123390 to K.K.M.); Natural Sciences and Engineering Research Council of Canada (DG 418546-2 to P.J.S. and 4080442011 to K.K.M.); Canada Research Chairs Program (F.C., C.E., and K.K.M.); Brain Canada/W. Garfield Weston Foundation (F.C. and K.K.M.); James McGill Chair Program (C.W.B.); and Canadian Foundation for Innovation (LOF 28331 to P.J.S.). W.T.F was supported by a postdoctoral fellowship from the Research Institute of the McGill University Health Centre. J.P. was supported by a Vanier fellowship. We thank M. Gotz for GLAST CreERT2 mice; G. Quesseveur for help with tissue processing; L. Li for mouse technical assistance; S. Scales (Genentech) for Shh antibody; T. Alves-Ferreira for ImageJ support; A. Montpetit, A. Staffa, and staff at Genome Quebec and the Research Institute of McGill University Hospital Centre Molecular Imaging Platform for support and use of instrumentation; and E. Ruthazer and D. van Meyel for helpful feedback on the manuscript. The authors declare no conflicts of interest.	Briscoe J, 2009, EMBO J, V28, P457, DOI 10.1038/emboj.2009.12; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Gonzalez-Reyes LE, 2012, NEURON, V75, P306, DOI 10.1016/j.neuron.2012.05.018; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Harwell CC, 2012, NEURON, V73, P1116, DOI 10.1016/j.neuron.2012.02.009; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Hoogland TM, 2010, CEREBELLUM, V9, P264, DOI 10.1007/s12311-009-0139-z; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Kita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070091; Long FX, 2001, DEVELOPMENT, V128, P5099; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Pearse RV, 2001, DEV BIOL, V239, P15, DOI 10.1006/dbio.2001.0430; Rohner A, 2012, MOL CANCER THER, V11, P57, DOI 10.1158/1535-7163.MCT-11-0691; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	30	155	159	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					849	854		10.1126/science.aab3103	http://dx.doi.org/10.1126/science.aab3103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912893				2022-12-28	WOS:000370325700042
J	Parak, WJ				Parak, Wolfgang J.			NANOMATERIALS Controlled interaction of nanoparticles with cells	SCIENCE			English	Editorial Material							DNA; SHAPES		[Parak, Wolfgang J.] Univ Marburg, Fachbereich Phys, D-35037 Marburg, Germany; [Parak, Wolfgang J.] CIC Biomagune, San Sebastian, Spain	Philipps University Marburg; CIC biomaGUNE	Parak, WJ (corresponding author), Univ Marburg, Fachbereich Phys, D-35037 Marburg, Germany.; Parak, WJ (corresponding author), CIC Biomagune, San Sebastian, Spain.	wolfgang.parak@physik-uni-marburg.de	biomaGUNE, CIC/J-9136-2014	biomaGUNE, CIC/0000-0001-7690-0660				Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Ballas ZK, 2001, J IMMUNOL, V167, P4878, DOI 10.4049/jimmunol.167.9.4878; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Kreyling WG, 2015, NAT NANOTECHNOL, V10, P619, DOI [10.1038/NNANO.2015.111, 10.1038/nnano.2015.111]; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Ohta S, 2016, SCIENCE, V351, P841, DOI 10.1126/science.aad4925; Parak WJ, 2011, SCIENCE, V334, P1359, DOI 10.1126/science.1215080; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	12	21	21	0	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					814	815		10.1126/science.aaf0751	http://dx.doi.org/10.1126/science.aaf0751			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912879				2022-12-28	WOS:000370325700023
J	Schwarzer, M; Makki, K; Storelli, G; Machuca-Gayet, I; Srutkova, D; Hermanova, P; Martino, ME; Balmand, S; Hudcovic, T; Heddi, A; Rieusset, J; Kozakova, H; Vidal, H; Leulier, F				Schwarzer, Martin; Makki, Kassem; Storelli, Gilles; Machuca-Gayet, Irma; Srutkova, Dagmar; Hermanova, Petra; Martino, Maria Elena; Balmand, Severine; Hudcovic, Tomas; Heddi, Abdelaziz; Rieusset, Jennifer; Kozakova, Hana; Vidal, Hubert; Leulier, Francois			Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition	SCIENCE			English	Article							FACTOR-I; SOMATOTROPIC AXIS; MOUSE GROWTH; BODY GROWTH; HORMONE; METABOLISM; EXPRESSION; RESISTANCE; MICROBIOTA; RECEPTOR	In most animal species, juvenile growth is marked by an exponential gain in body weight and size. Here we show that the microbiota of infant mice sustains both weight gain and longitudinal growth when mice are fed a standard laboratory mouse diet or a nutritionally depleted diet. We found that the intestinal microbiota interacts with the somatotropic hormone axis to drive systemic growth. Using monocolonized mouse models, we showed that selected lactobacilli promoted juvenile growth in a strain-dependent manner that recapitulated the microbiota's effect on growth and the somatotropic axis. These findings show that the host's microbiota supports juvenile growth. Moreover, we discovered that lactobacilli strains buffered the adverse effects of chronic undernutrition on the postnatal growth of germ-free mice.	[Schwarzer, Martin; Makki, Kassem; Storelli, Gilles; Machuca-Gayet, Irma; Martino, Maria Elena; Leulier, Francois] Univ Lyon 1, CNRS, Inst Genom Fonct Lyon, Unite Mixte Rech 5242,Ecole Normale Super Lyon, 46 Allee Italie, F-69364 Lyon 07, France; [Schwarzer, Martin; Srutkova, Dagmar; Hermanova, Petra; Hudcovic, Tomas; Kozakova, Hana] Acad Sci Czech Republic, Inst Microbiol, Lab Gnotobiol, Vvi, Novy Hradek, Czech Republic; [Makki, Kassem; Rieusset, Jennifer; Vidal, Hubert] Univ Lyon 1, Lab CarMeN, Unite Mixte Rech INSERM U1060, Chemin Grand Revoyet, F-69600 Oullins, France; [Makki, Kassem; Rieusset, Jennifer; Vidal, Hubert] Fac Med Lyon Sud, INRA U1397, Chemin Grand Revoyet, F-69600 Oullins, France; [Balmand, Severine; Heddi, Abdelaziz] Univ Lyon, INRA, INSA Lyon, UMR203 BF2I,Biol Fonct Insectes & Interact, F-69621 Villeurbanne, France; [Machuca-Gayet, Irma] Univ Lyon 1, Unite Mixte Rech 1033, Fac Med Lyon Est, INSERM, Rue Guillaume Paradin, F-69372 Lyon 08, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Schwarzer, M; Leulier, F (corresponding author), Univ Lyon 1, CNRS, Inst Genom Fonct Lyon, Unite Mixte Rech 5242,Ecole Normale Super Lyon, 46 Allee Italie, F-69364 Lyon 07, France.; Schwarzer, M (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Lab Gnotobiol, Vvi, Novy Hradek, Czech Republic.	martin.schwarzer@ens-lyon.fr; francois.leulier@ens-lyon.fr	Kozakova, Hana/I-1153-2014; Carmen, Team2/Y-7383-2019; Šrůtková, Dagmar/H-8511-2014; Storelli, Gilles/AAS-7573-2021; Hermanová, Petra/K-6260-2017; Vidal, Hubert/M-6674-2017; Schwarzer, Martin/P-9871-2017; Storelli, Gilles/Y-5263-2019; Hudcovic, Tomas/H-7917-2014; Rieusset, Jennifer/F-1595-2018; Carmen, Team1/Y-7382-2019; martino, maria elena/R-5272-2018	Kozakova, Hana/0000-0001-7352-5922; Carmen, Team2/0000-0001-9867-5724; Šrůtková, Dagmar/0000-0003-0054-5396; Hermanová, Petra/0000-0003-0751-076X; Vidal, Hubert/0000-0002-9467-0317; Schwarzer, Martin/0000-0002-1401-6578; Hudcovic, Tomas/0000-0002-4761-5040; Rieusset, Jennifer/0000-0002-1587-2253; Carmen, Team1/0000-0003-4234-1746; Machuca- Gayet, irma/0000-0002-3010-9774; martino, maria elena/0000-0003-2939-0375; MARTINO, MARIA ELENA/0000-0001-5038-5605; Leulier, Francois/0000-0002-4542-3053; Lab, Carmen/0000-0002-5935-3236; Storelli, Gilles/0000-0002-3558-390X	European Research Council [309704]; CNRS grant Echange chercheur CNRS/AVCR [13-14]; Czech Science Foundation [P303-12-0535]; Fondation Innovations en Infectiologie (FINOVI); Concept [RVO 61388971]; ATIP/Avenir program; FINOVI foundation; Fondation Schlumberger pour l'Education et la Recherche; European Molecular Biology Organization's Young Investigator Program	European Research Council(European Research Council (ERC)European Commission); CNRS grant Echange chercheur CNRS/AVCR; Czech Science Foundation(Grant Agency of the Czech Republic); Fondation Innovations en Infectiologie (FINOVI); Concept; ATIP/Avenir program; FINOVI foundation; Fondation Schlumberger pour l'Education et la Recherche; European Molecular Biology Organization's Young Investigator Program	The authors thank B. Prud'homme and colleagues at the Institut de Genomique Fonctionnelle de Lyon for critical reading of the manuscript and the Arthro-Tools and ANIRA-ImmOs platforms of Structure Federative de Recherche Biosciences (UMS3444/US8) for providing Drosophila and bone microtomography facilities. This work was funded by a European Research Council starting grant (FP7/2007-2013-No309704) (to F.L.), CNRS grant Echange chercheur CNRS/AVCR 13-14 (to F.L. and H.K.), grant P303-12-0535 of the Czech Science Foundation (to T.H.), a 2014 grant from the Fondation Innovations en Infectiologie (FINOVI, to H.V.), and the Institutional Research Concept grant RVO 61388971 (to H.K.). F.L.'s lab is supported by the ATIP/Avenir program, FINOVI foundation, the Fondation Schlumberger pour l'Education et la Recherche, and the European Molecular Biology Organization's Young Investigator Program. The authors declare no conflicts of interest. A pending patent (WO 2015/173386 A1) applies to methods and data presented in this manuscript. F.L. directed the study, which was designed with M.S.; M.S., K.M., I. M.-G., A. H., J.R., H. K., H.V., and F.L. analyzed and interpreted the data; M.S., D.S., P.H., and T.H. performed the mouse work and animal macroscopic analysis; K.M. and M.S. performed the molecular phenotyping; G.S. and M.E.M. performed the Drosophila work; I. M.-G. performed the study of bone parameters; S.B. performed FISH analyses; and M.S. and F.L. wrote the paper.	Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Breier BH, 1999, DOMEST ANIM ENDOCRIN, V17, P209, DOI 10.1016/S0739-7240(99)00038-7; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Fazeli PK, 2014, J ENDOCRINOL, V220, pR56, DOI 10.1530/JOE-13-0477; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Hizli Samil, 2007, Pediatr Endocrinol Rev, V4, P186; Hyun S, 2013, CELL MOL LIFE SCI, V70, P2351, DOI 10.1007/s00018-013-1313-5; Kaplan SA, 2007, J CLIN ENDOCR METAB, V92, P4529, DOI 10.1210/jc.2007-0526; Klover P, 2007, ENDOCRINOLOGY, V148, P1489, DOI 10.1210/en.2006-1431; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Matos RC, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S6; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Renaville R, 2002, DOMEST ANIM ENDOCRIN, V23, P351, DOI 10.1016/S0739-7240(02)00170-4; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933; Yin SC, 2013, BIOCHEM BIOPH RES CO, V439, P1, DOI 10.1016/j.bbrc.2013.08.050	28	318	338	14	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					854	857		10.1126/science.aad8588	http://dx.doi.org/10.1126/science.aad8588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26912894				2022-12-28	WOS:000370325700043
J	Ball, SG; Bhattacharya, D; Weber, APM				Ball, Steven G.; Bhattacharya, Debashish; Weber, Andreas P. M.			Pathogen to powerhouse	SCIENCE			English	Editorial Material							EUKARYOTES; ENDOSYMBIOSIS; ORIGIN		[Ball, Steven G.] Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France; [Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Weber, Andreas P. M.] Univ Dusseldorf, Ctr Excellence Plant Sci, Inst Plant Biochem, Univ Str 1, D-40225 Dusseldorf, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Rutgers State University New Brunswick; Heinrich Heine University Dusseldorf	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.	debash.bhattacharya@gmail.com	Weber, Andreas PM/A-6250-2011; Weber, Andreas Paul Michael/O-3043-2019	Weber, Andreas PM/0000-0003-0970-4672; Weber, Andreas Paul Michael/0000-0003-0970-4672; Ball, Steven/0000-0003-1629-1650				Ball SG, 2013, PLANT CELL, V25, P7, DOI 10.1105/tpc.112.101329; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Facchinelli F, 2013, TRENDS PLANT SCI, V18, P673, DOI 10.1016/j.tplants.2013.09.006; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Gray MW, 1998, NATURE, V396, P109, DOI 10.1038/24030; Huang JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r99; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Martijn J., 2015, ISME J, V46, P1; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Nowack ECM, 2008, CURR BIOL, V18, P410, DOI 10.1016/j.cub.2008.02.051; Poole A, 2007, NATURE, V447, P913, DOI 10.1038/447913a; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep07949	13	21	21	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					659	660		10.1126/science.aad8864	http://dx.doi.org/10.1126/science.aad8864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912842				2022-12-28	WOS:000369810000018
J	Springmann, M; Mason-D'Croz, D; Robinson, S; Garnett, T; Godfray, HCJ; Gollin, D; Rayner, M; Ballon, P; Scarborough, P				Springmann, Marco; Mason-D'Croz, Daniel; Robinson, Sherman; Garnett, Tara; Godfray, H. Charles J.; Gollin, Douglas; Rayner, Mike; Ballon, Paola; Scarborough, Peter			Global and regional health effects of future food production under climate change: a modelling study	LANCET			English	Article							PROCESSED MEAT CONSUMPTION; CORONARY-HEART-DISEASE; VEGETABLE CONSUMPTION; RISK; AGRICULTURE; METAANALYSIS; STROKE; WASTE; FRUIT; RED	Background One of the most important consequences of climate change could be its effects on agriculture. Although much research has focused on questions of food security, less has been devoted to assessing the wider health impacts of future changes in agricultural production. In this modelling study, we estimate excess mortality attributable to agriculturally mediated changes in dietary and weight-related risk factors by cause of death for 155 world regions in the year 2050. Methods For this modelling study, we linked a detailed agricultural modelling framework, the International Model for Policy Analysis of Agricultural Commodities and Trade (IMPACT), to a comparative risk assessment of changes in fruit and vegetable consumption, red meat consumption, and bodyweight for deaths from coronary heart disease, stroke, cancer, and an aggregate of other causes. We calculated the change in the number of deaths attributable to climate-related changes in weight and diets for the combination of four emissions pathways (a high emissions pathway, two medium emissions pathways, and a low emissions pathway) and three socioeconomic pathways (sustainable development, middle of the road, and more fragmented development), which each included six scenarios with variable climatic inputs. Findings The model projects that by 2050, climate change will lead to per-person reductions of 3.2% (SD 0.4%) in global food availability, 4.0% (0.7%) in fruit and vegetable consumption, and 0.7% (0.1%) in red meat consumption. These changes will be associated with 529 000 climate-related deaths worldwide (95% CI 314 000-736 000), representing a 28% (95% CI 26-33) reduction in the number of deaths that would be avoided because of changes in dietary and weight-related risk factors between 2010 and 2050. Twice as many climate-related deaths were associated with reductions in fruit and vegetable consumption than with climate-related increases in the prevalence of underweight, and most climate-related deaths were projected to occur in south and east Asia. Adoption of climate-stabilisation pathways would reduce the number of climate-related deaths by 29-71%, depending on their stringency. Interpretation The health effects of climate change from changes in dietary and weight-related risk factors could be substantial, and exceed other climate-related health impacts that have been estimated. Climate change mitigation could prevent many climate-related deaths. Strengthening of public health programmes aimed at preventing and treating diet and weight-related risk factors could be a suitable climate change adaptation strategy.	[Springmann, Marco; Rayner, Mike; Scarborough, Peter] Univ Oxford, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford Martin Programme Future Food, British Heart Fdn,Nuffield Dept Populat Hlth, Old Rd Campus, Oxford OX3 7LF, England; [Garnett, Tara] Univ Oxford, Environm Change Inst, Food Climate Res Network, Oxford, England; [Godfray, H. Charles J.] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Gollin, Douglas; Ballon, Paola] Univ Oxford, Oxford Dept Int Dev, Oxford, England; [Mason-D'Croz, Daniel; Robinson, Sherman] Int Food Policy Res Inst, Washington, DC 20036 USA	University of Oxford; University of Oxford; University of Oxford; University of Oxford; CGIAR; International Food Policy Research Institute (IFPRI)	Springmann, M (corresponding author), Univ Oxford, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford Martin Programme Future Food, British Heart Fdn,Nuffield Dept Populat Hlth, Old Rd Campus, Oxford OX3 7LF, England.	marco.springmann@dph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021; Mason-D'Croz, Daniel/M-4254-2016	Scarborough, Peter/0000-0002-2378-2944; Mason-D'Croz, Daniel/0000-0003-0673-2301	Oxford Martin Programme on the Future of Food; EPSRC [EP/G013446/1] Funding Source: UKRI; ESRC [ES/M010163/1] Funding Source: UKRI; NERC [NE/M021386/1] Funding Source: UKRI; British Heart Foundation [FS/15/34/31656] Funding Source: researchfish; Economic and Social Research Council [ES/M010163/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G013446/1] Funding Source: researchfish; Natural Environment Research Council [NE/M021386/1] Funding Source: researchfish; Directorate For Geosciences [1531086] Funding Source: National Science Foundation	Oxford Martin Programme on the Future of Food; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Oxford Martin Programme on the Future of Food.	Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Chateau J, 2012, LONG TERM EC GROWTH; Chen GC, 2013, EUR J CLIN NUTR, V67, P91, DOI 10.1038/ejcn.2012.180; Collins M., 2013, CLIM CHANG 2013 PHYS, P1029; Confalonieri U, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P391; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Cover TM, 1991, ELEMENTS INFORM THEO; Dangour AD, 2012, P NUTR SOC, V71, P222, DOI 10.1017/S0029665112000213; Dauchet L, 2005, NEUROLOGY, V65, P1193, DOI 10.1212/01.wnl.0000180600.09719.53; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Ebi KL, 2014, CLIMATIC CHANGE, V122, P363, DOI 10.1007/s10584-013-0912-3; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hawkesworth S, 2010, PHILOS T R SOC B, V365, P3083, DOI 10.1098/rstb.2010.0122; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; KC S, 2017, GLOBAL ENVIRON CHANG, V42, P181, DOI DOI 10.1016/J.GLOENVCHA.2014.06.004; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Muller C, 2014, AGR ECON-BLACKWELL, V45, P37, DOI 10.1111/agec.12088; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Nelson G.C, 2010, FOOD SECURITY FARMIN; Nelson GC, 2014, P NATL ACAD SCI USA, V111, P3274, DOI 10.1073/pnas.1222465110; Nugent R., 2011, BRINGING AGR TABLE A; ONeill BC, 2012, M WORKSH NAT US NEW; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Robinson S, 2015, IFPRI DISCUSSION PAP; Rosengrant MW., 2012, INT MODEL POLICY ANA; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Scarborough P, 2012, J EPIDEMIOL COMMUN H, V66, P420, DOI 10.1136/jech.2010.114520; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Valin H, 2014, AGR ECON-BLACKWELL, V45, P51, DOI 10.1111/agec.12089; van Vuuren DP, 2014, CLIMATIC CHANGE, V122, P373, DOI 10.1007/s10584-013-0906-1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2014, QUNAT RISK ASS EFF C; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 1990, DIET NUTR PREV CHRON	46	191	196	4	177	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1937	1946		10.1016/S0140-6736(15)01156-3	http://dx.doi.org/10.1016/S0140-6736(15)01156-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	26947322	Green Submitted			2022-12-28	WOS:000375374200038
J	Stitziel, NO; Stirrups, KE; Masca, NGD; Erdmann, J; Ferrario, PG; Konig, IR; Weeke, PE; Webb, TR; Auer, PL; Schick, UM; Lu, YC; Zhang, H; Dube, MP; Goel, A; Farrall, M; Peloso, GM; Won, HH; Do, R; van Iperen, E; Kanoni, S; Kruppa, J; Mahajan, A; Scott, RA; Willenborg, C; Braund, PS; van Capelleveen, JC; Doney, ASF; Donnelly, LA; Asselta, R; Merlini, PA; Duga, S; Marziliano, N; Denny, JC; Shaffer, CM; El-Mokhtari, NE; Franke, A; Gottesman, O; Heilmann, S; Hengstenberg, C; Hoffmann, P; Holmen, OL; Hveem, K; Jansson, JH; Jockel, KH; Kessler, T; Kriebel, J; Laugwitz, KL; Marouli, E; Martinelli, N; McCarthy, MI; Van Zuydam, NR; Meisinger, C; Esko, T; Mihailov, E; Escher, SA; Alver, M; Moebus, S; Morris, AD; Muller-Nurasyid, M; Nikpay, M; Olivieri, O; Perreault, LPL; AlQarawi, A; Robertson, NR; Akinsanya, KO; Reilly, DF; Vogt, TF; Yin, W; Asselbergs, FW; Kooperberg, C; Jackson, RD; Stahl, E; Strauch, K; Varga, TV; Waldenberger, M; Zeng, LY; Kraja, AT; Liu, CY; Ehret, GB; Newton-Cheh, C; Chasman, DI; Chowdhury, R; Ferrario, M; Ford, I; Jukema, JW; Kee, F; Kuulasmaa, K; Nordestgaard, BG; Perola, M; Saleheen, D; Sattar, N; Surendran, P; Tregouet, D; Young, R; Howson, JMM; Butterworth, AS; Danesh, J; Ardissino, D; Bottinger, EP; Erbel, R; Franks, PW; Girelli, D; Hall, AS; Hovingh, GK; Kastrati, A; Lieb, W; Meitinger, T; Kraus, WE; Shah, SH; McPherson, R; Orho-Melander, M; Melander, O; Metspalu, A; Palmer, CNA; Peters, A; Rader, DJ; Reilly, MP; Loos, RJF; Reiner, AP; Roden, DM; Tardif, JC; Thompson, JR; Wareham, NJ; Watkins, H; Willer, CJ; Kathiresan, S; Deloukas, P; Samani, NJ; Schunkert, H				Stitziel, Nathan O.; Stirrups, Kathleen E.; Masca, Nicholas G. D.; Erdmann, Jeanette; Ferrario, Paola G.; Koenig, Inke R.; Weeke, Peter E.; Webb, Thomas R.; Auer, Paul L.; Schick, Ursula M.; Lu, Yingchang; Zhang, He; Dube, Marie-Pierre; Goel, Anuj; Farrall, Martin; Peloso, Gina M.; Won, Hong-Hee; Do, Ron; van Iperen, Erik; Kanoni, Stavroula; Kruppa, Jochen; Mahajan, Anubha; Scott, Robert A.; Willenborg, Christina; Braund, Peter S.; van Capelleveen, Julian C.; Doney, Alex S. F.; Donnelly, Louise A.; Asselta, Rosanna; Merlini, Piera A.; Duga, Stefano; Marziliano, Nicola; Denny, Josh C.; Shaffer, Christian M.; El-Mokhtari, Nour Eddine; Franke, Andre; Gottesman, Omri; Heilmann, Stefanie; Hengstenberg, Christian; Hoffmann, Per; Holmen, Oddgeir L.; Hveem, Kristian; Jansson, Jan-Hakan; Joeckel, Karl-Heinz; Kessler, Thorsten; Kriebel, Jennifer; Laugwitz, Karl L.; Marouli, Eirini; Martinelli, Nicola; McCarthy, Mark I.; Van Zuydam, Natalie R.; Meisinger, Christa; Esko, Tonu; Mihailov, Evelin; Escher, Stefan A.; Alver, Maris; Moebus, Susanne; Morris, Andrew D.; Mueller-Nurasyid, Martina; Nikpay, Majid; Olivieri, Oliviero; Perreault, Louis-Philippe Lemieux; AlQarawi, Alaa; Robertson, Neil R.; Akinsanya, Karen O.; Reilly, Dermot F.; Vogt, Thomas F.; Yin, Wu; Asselbergs, Folkert W.; Kooperberg, Charles; Jackson, Rebecca D.; Stahl, Eli; Strauch, Konstantin; Varga, Tibor V.; Waldenberger, Melanie; Zeng, Lingyao; Kraja, Aldi T.; Liu, Chunyu; Ehret, Georg B.; Newton-Cheh, Christopher; Chasman, Daniel I.; Chowdhury, Rajiv; Ferrario, Marco; Ford, Ian; Jukema, J. Wouter; Kee, Frank; Kuulasmaa, Kari; Nordestgaard, Borge G.; Perola, Markus; Saleheen, Danish; Sattar, Naveed; Surendran, Praveen; Tregouet, David; Young, Robin; Howson, Joanna M. M.; Butterworth, Adam S.; Danesh, John; Ardissino, Diego; Bottinger, Erwin P.; Erbel, Raimund; Franks, Paul W.; Girelli, Domenico; Hall, Alistair S.; Hovingh, G. Kees; Kastrati, Adnan; Lieb, Wolfgang; Meitinger, Thomas; Kraus, William E.; Shah, Svati H.; McPherson, Ruth; Orho-Melander, Marju; Melander, Olle; Metspalu, Andres; Palmer, Colin N. A.; Peters, Annette; Rader, Daniel J.; Reilly, Muredach P.; Loos, Ruth J. F.; Reiner, Alex P.; Roden, Dan M.; Tardif, Jean-Claude; Thompson, John R.; Wareham, Nicholas J.; Watkins, Hugh; Willer, Cristen J.; Kathiresan, Sekar; Deloukas, Panos; Samani, Nilesh J.; Schunkert, Heribert			Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIPOPROTEIN-LIPASE; PCSK9; INHIBITION; MUTATIONS; VARIANT	BACKGROUND The discovery of low-frequency coding variants affecting the risk of coronary artery disease has facilitated the identification of therapeutic targets. METHODS Through DNA genotyping, we tested 54,003 coding-sequence variants covering 13,715 human genes in up to 72,868 patients with coronary artery disease and 120,770 controls who did not have coronary artery disease. Through DNA sequencing, we studied the effects of loss-of-function mutations in selected genes. RESULTS We confirmed previously observed significant associations between coronary artery disease and low-frequency missense variants in the genes LPA and PCSK9. We also found significant associations between coronary artery disease and low-frequency missense variants in the genes SVEP1 (p.D2702G; minor-allele frequency, 3.60%; odds ratio for disease, 1.14; P = 4.2x10(-10)) and ANGPTL4 (p.E40K; minor-allele frequency, 2.01%; odds ratio, 0.86; P = 4.0x10(-8)), which encodes angiopoietin-like 4. Through sequencing of ANGPTL4, we identified 9 carriers of loss-of-function mutations among 6924 patients with myocardial infarction, as compared with 19 carriers among 6834 controls (odds ratio, 0.47; P = 0.04); carriers of ANGPTL4 loss-of-function alleles had triglyceride levels that were 35% lower than the levels among persons who did not carry a loss-of-function allele (P = 0.003). ANGPTL4 inhibits lipoprotein lipase; we therefore searched for mutations in LPL and identified a loss-of-function variant that was associated with an increased risk of coronary artery disease (p.D36N; minor-allele frequency, 1.9%; odds ratio, 1.13; P = 2.0x10(-4)) and a gain-of-function variant that was associated with protection from coronary artery disease (p.S447*; minor-allele frequency, 9.9%; odds ratio, 0.94; P = 2.5x10(-7)). CONCLUSIONS We found that carriers of loss-of-function mutations in ANGPTL4 had triglyceride levels that were lower than those among noncarriers; these mutations were also associated with protection from coronary artery disease.	[Stitziel, Nathan O.] Washington Univ, Sch Med, Div Cardiovasc, Dept Med, St Louis, MO 63130 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63130 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63130 USA; [Kraja, Aldi T.] Washington Univ, Sch Med, Div Stat Genom, Dept Genet, St Louis, MO 63130 USA; [Kraja, Aldi T.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA; [Stirrups, Kathleen E.; Kanoni, Stavroula; Marouli, Eirini; Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Asselbergs, Folkert W.] UCL, Inst Cardiovasc Sci, Fac Populat Hlth Sci, London, England; [Stirrups, Kathleen E.] Univ Cambridge, Dept Haematol, Cambridge, England; [Braund, Peter S.; Chowdhury, Rajiv; Young, Robin; Howson, Joanna M. M.; Butterworth, Adam S.; Danesh, John] Univ Cambridge, Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care, Cambridge, England; [Danesh, John] Univ Cambridge, Natl Inst Hlth Res Blood & Transplant Res Unit Do, Cambridge, England; [Scott, Robert A.; Wareham, Nicholas J.] Addenbrookes Hosp, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Danesh, John] Wellcome Trust Sanger Inst, Cambridge, England; [Masca, Nicholas G. D.; Webb, Thomas R.; Braund, Peter S.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Masca, Nicholas G. D.; Webb, Thomas R.; Braund, Peter S.; Thompson, John R.; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Goel, Anuj; Farrall, Martin; Mahajan, Anubha; McCarthy, Mark I.; Robertson, Neil R.; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.; Van Zuydam, Natalie R.; Robertson, Neil R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford OX3 7LJ, England; [Doney, Alex S. F.; Donnelly, Louise A.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Morris, Andrew D.] Univ Edinburgh, Sch Med, Sch Mol Genet & Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Sattar, Naveed] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Hall, Alistair S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Erdmann, Jeanette; Willenborg, Christina] Med Univ Lubeck, Inst Integrat & Expt Genom, D-23538 Lubeck, Germany; [Erdmann, Jeanette; Ferrario, Paola G.; Koenig, Inke R.; Willenborg, Christina] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Lubeck Kiel, Lubeck, Germany; [Ferrario, Paola G.; Koenig, Inke R.; Kruppa, Jochen] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Kruppa, Jochen] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [El-Mokhtari, Nour Eddine] Kreiskrankenhaus Rendsburg, Innere Med Klin, Rendsburg, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol & Biobank Popgen, Kiel, Germany; [Heilmann, Stefanie; Hoffmann, Per] Univ Bonn, Inst Human Genet, Bonn, Germany; [Heilmann, Stefanie; Hoffmann, Per] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Hengstenberg, Christian; Kessler, Thorsten; Zeng, Lingyao; Kastrati, Adnan; Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Hengstenberg, Christian; Laugwitz, Karl L.; Mueller-Nurasyid, Martina; Meitinger, Thomas; Peters, Annette; Schunkert, Heribert] DZHK Partner Site Munich Heart Alliance, Munich, Germany; [Laugwitz, Karl L.] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 1, D-80290 Munich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Dept Med 1, Munich, Germany; [Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Joeckel, Karl-Heinz; Moebus, Susanne; Erbel, Raimund] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Kriebel, Jennifer; Waldenberger, Melanie] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Kriebel, Jennifer; Meisinger, Christa; Waldenberger, Melanie; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Mueller-Nurasyid, Martina; Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Kriebel, Jennifer] German Ctr Diabet Res, Neuherberg, Germany; [Weeke, Peter E.; Denny, Josh C.; Shaffer, Christian M.; Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Denny, Josh C.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Weeke, Peter E.] Copenhagen Univ Hosp, Rigshosp, Mol Cardiol Lab, Dept Cardiol, Copenhagen, Denmark; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen, Denmark; [Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Auer, Paul L.] Univ Wisconsin, Sch Publ Heath, Milwaukee, WI 53201 USA; [Schick, Ursula M.; Kooperberg, Charles; Reiner, Alex P.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Schick, Ursula M.; Lu, Yingchang; Do, Ron; Gottesman, Omri; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Do, Ron] Icahn Sch Med Mt Sinai, Ctr Stat Genet, New York, NY 10029 USA; [Do, Ron] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, Michael A Weiner Cardiovasc Inst, New York, NY 10029 USA; [Stahl, Eli] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Zhang, He; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Dube, Marie-Pierre; Tardif, Jean-Claude] Univ Montreal, Dept Med, Fac Med, Montreal, PQ H3C 3J7, Canada; [Dube, Marie-Pierre; Perreault, Louis-Philippe Lemieux; Tardif, Jean-Claude] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Nikpay, Majid; McPherson, Ruth] Univ Ottawa, Inst Heart, Ruddy Canadian Cardiovasc Genet Ctr, Ottawa, ON, Canada; [Peloso, Gina M.; Won, Hong-Hee; Newton-Cheh, Christopher; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Peloso, Gina M.; Won, Hong-Hee; Newton-Cheh, Christopher; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Peloso, Gina M.; Won, Hong-Hee; Newton-Cheh, Christopher; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Franks, Paul W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Peloso, Gina M.; Won, Hong-Hee; Newton-Cheh, Christopher; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Esko, Tonu] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Liu, Chunyu] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Won, Hong-Hee] Sungkyunkwan Univ, Samsung Med Ctr, SAIHST, Seoul, South Korea; [van Iperen, Erik] Univ Amsterdam, Acad Med Ctr, Dept Biostat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van Capelleveen, Julian C.; Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Asselbergs, Folkert W.] UMC Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Asselta, Rosanna; Duga, Stefano] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Asselta, Rosanna; Duga, Stefano] Humanitas Clin & Res Ctr, Milan, Italy; [Merlini, Piera A.] Osped Niguarda Ca Granda, Div Cardiol, Milan, Italy; [Marziliano, Nicola; Ardissino, Diego] Univ Parma, Azienda Osped, Div Cardiol, I-43100 Parma, Italy; [Marziliano, Nicola; Ardissino, Diego] Assoc Studio Trombosi Cardiol, Pavia, Italy; [Marziliano, Nicola; Olivieri, Oliviero; Girelli, Domenico] Univ Verona, Sect Internal Med, Dept Med, I-37100 Verona, Italy; [Ferrario, Marco] Univ Insubria, EPIMED Res Ctr, Dept Clin & Expt Med, Varese, Italy; [Hoffmann, Per] Univ Basel, Div Med Genet, Dept Biomed, Basel, Switzerland; [Ehret, Georg B.] Univ Hosp Geneva, Dept Med, Div Cardiol, Geneva, Switzerland; [Holmen, Oddgeir L.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Levanger, Norway; [Hveem, Kristian] Nord Trondelag Hlth Trust Norway, Levanger Hosp, Dept Med, Levanger, Norway; [Holmen, Oddgeir L.] Univ Trondheim Hosp, St Olav Hosp, Trondheim, Norway; [Jansson, Jan-Hakan] Umea Univ, Res Unit Skelleftea, Dept Publ Hlth & Clin Med, Umea, Sweden; [Franks, Paul W.] Umea Univ Hosp, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden; [Escher, Stefan A.; Varga, Tibor V.; Franks, Paul W.] Lund Univ, Ctr Diabet, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Orho-Melander, Marju; Melander, Olle] Lund Univ, Ctr Diabet, Clin Res Ctr, Skane Univ Hosp,Dept Clin Sci Malmo, Malmo, Sweden; [Esko, Tonu; Mihailov, Evelin; Alver, Maris; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Ulikooli 18, EE-50090 Tartu, Estonia; [Alver, Maris; Metspalu, Andres] Inst Mol & Cell Biol, Tartu, Estonia; [AlQarawi, Alaa; Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21413, Saudi Arabia; [Akinsanya, Karen O.; Reilly, Dermot F.; Vogt, Thomas F.; Yin, Wu] Merck Sharp & Dohme Ltd, Pob 2000, Rahway, NJ 07065 USA; [Jackson, Rebecca D.] Ohio State Univ, Dept Med, Div Endocrinol Diabet & Metab, Columbus, OH USA; [Liu, Chunyu] NHLBI, Populat Sci Branch, Bldg 10, Bethesda, MD 20892 USA; [Ehret, Georg B.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Kee, Frank] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Kuulasmaa, Kari; Perola, Markus] Natl Inst Hlth & Welf, Helsinki, Finland; [Saleheen, Danish] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Reilly, Muredach P.] Univ Penn, Perelman Sch Med, Dept Genet, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Tregouet, David] Univ Paris 06, Sorbonne Univ, ICAN Inst Cardiometab & Nutr, Paris, France; [Kraus, William E.; Shah, Svati H.] Duke Univ, Duke Mol Physiol Inst, Durham, NC USA; [Kraus, William E.; Shah, Svati H.] Duke Univ, Dept Med, Div Cardiol, Durham, NC USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of London; Queen Mary University London; University of London; University College London; University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Dundee; University of Edinburgh; University of Glasgow; University of Glasgow; University of Leeds; University of Lubeck; German Centre for Cardiovascular Research; University of Lubeck; University of Gottingen; University of Kiel; University of Kiel; University of Bonn; University of Bonn; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Technical University of Munich; University of Munich; University of Munich; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Vanderbilt University; Vanderbilt University; Vanderbilt University; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Wisconsin System; University of Wisconsin Milwaukee; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universite de Montreal; Universite de Montreal; University of Ottawa; University of Ottawa Heart Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Framingham Heart Study; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Humanitas University; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Parma; University Hospital of Parma; University of Verona; University of Insubria; University of Basel; University of Geneva; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Umea University; Umea University; Lund University; Lund University; Skane University Hospital; University of Tartu; King Abdulaziz University; Merck & Company; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Queens University Belfast; Finland National Institute for Health & Welfare; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; UDICE-French Research Universities; Sorbonne Universite; Duke University; Duke University	Stitziel, NO (corresponding author), Washington Univ, Sch Med, Div Cardiovasc, Dept Med, St Louis, MO 63130 USA.; Stitziel, NO (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63130 USA.; Stitziel, NO (corresponding author), Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63130 USA.; Deloukas, P (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.; Samani, NJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.; Samani, NJ (corresponding author), Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England.; Schunkert, H (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany.; Schunkert, H (corresponding author), DZHK Partner Site Munich Heart Alliance, Munich, Germany.; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.; Kathiresan, S (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.; Kathiresan, S (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA USA.; Deloukas, P (corresponding author), King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21413, Saudi Arabia.	nstitziel@wustl.edu; skathiresan@partners.org; p.deloukas@qmul.ac.uk; njs@le.ac.uk; schunkert@dhm.mhn.de	Kriebel, Jennifer/N-4782-2017; Auer, Paul/AAC-5060-2019; EHRET, Georg B/A-9532-2009; Webb, Tom/C-6237-2011; Meitinger, Thomas/O-1318-2015; Roden, Dan/ABD-5412-2021; Franks, Paul/AAA-3300-2020; Palmer, Colin NA/C-7053-2008; Lieb, Wolfgang/AAC-7650-2022; Loos, Ruth/GON-5877-2022; Ferrario, Marco M./ABH-2115-2021; Asselbergs, Folkert W./ABD-6752-2021; Ford, Ian/ABE-6145-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; König, Inke R/A-4544-2009; Tregouet, David-Alexandre/E-3961-2016; Waldenberger, Melanie/B-5355-2014; Erdmann, Jeanette/P-7513-2014; Willenborg, Christina/D-2668-2012; Hall, Alistair/K-1953-2019; Franke, Andre/B-2151-2010; Trégouët, David-Alexandre/P-9210-2019; Peters, Annette/A-6117-2011; Study, GoDARTS/K-9448-2016; Meisinger, Christine/B-5358-2014; Stitziel, Nathan/AAL-8413-2021; Duga, Stefano/F-8173-2014; Ardissino, Diego/AAC-4041-2022; Ferrario, Paola G./AAR-8775-2020; Olivieri, Oliviero/A-9126-2008; Kessler, Thorsten/O-7426-2015; Loos, Ruth J F/Q-2862-2016; Kessler, Thorsten/AAI-7292-2021; Nicola, Marziliano/ABF-9518-2021; Asselta, Rosanna/AAC-2367-2019; Chowdhury, Rajiv/AHB-1253-2022; , Kastrati/Y-2389-2019; Webb, Tom/GMW-5311-2022; Hengstenberg, Christian/U-5485-2019; Won, Hong-Hee/D-2672-2011; Hoffmann, Per/A-5149-2010; Martinelli, Nicola/J-5622-2016; Deloukas, Panos/B-2922-2013; Müller-Nurasyid, Martina/I-8735-2018; Jukema, J. Wouter/ABD-6503-2021; Heilmann-Heimbach, Stefanie/H-5942-2018; Hveem, Kristian/AFV-4683-2022; Doney, Alexander SF/P-7437-2017; Erdmann, Jeanette/A-4417-2009; Dubé, Marie-Pierre/B-9364-2008; Varga, Tibor/AAE-8035-2020; Kanoni, Stavroula/AAN-7161-2021; Denny, Josh/AAL-3359-2021; Girelli, Domenico/B-1183-2008; McCarthy, Mark/M-3763-2015	Kriebel, Jennifer/0000-0003-4270-018X; EHRET, Georg B/0000-0002-5730-0675; Palmer, Colin NA/0000-0002-6415-6560; Asselbergs, Folkert W./0000-0002-1692-8669; König, Inke R/0000-0003-0504-6465; Waldenberger, Melanie/0000-0003-0583-5093; Erdmann, Jeanette/0000-0002-4486-6231; Willenborg, Christina/0000-0001-5217-6882; Franke, Andre/0000-0003-1530-5811; Trégouët, David-Alexandre/0000-0001-9084-7800; Peters, Annette/0000-0001-6645-0985; Stitziel, Nathan/0000-0002-4963-8211; Duga, Stefano/0000-0003-3457-1410; Ferrario, Paola G./0000-0003-1769-6799; Olivieri, Oliviero/0000-0001-8209-9056; Loos, Ruth J F/0000-0002-8532-5087; Kessler, Thorsten/0000-0003-3326-1621; Asselta, Rosanna/0000-0001-5351-0619; Won, Hong-Hee/0000-0001-5719-0552; Hoffmann, Per/0000-0002-6573-983X; Martinelli, Nicola/0000-0001-6465-5119; Deloukas, Panos/0000-0001-9251-070X; Müller-Nurasyid, Martina/0000-0003-3793-5910; Jukema, J. Wouter/0000-0002-3246-8359; Heilmann-Heimbach, Stefanie/0000-0003-1057-465X; Doney, Alexander SF/0000-0002-6210-5620; Dubé, Marie-Pierre/0000-0001-8442-4393; Kanoni, Stavroula/0000-0002-1691-9615; Denny, Josh/0000-0002-3049-7332; Girelli, Domenico/0000-0001-9684-1899; Meitinger, Thomas/0000-0002-8838-8403; Webb, Tom/0000-0001-5998-8226; Watkins, Hugh/0000-0002-5287-9016; Franks, Paul/0000-0002-0520-7604; Kruppa, Jochen/0000-0001-8376-8864; Meisinger, Christa/0000-0002-9026-6544; Reilly, Muredach/0000-0002-3035-9386; V. Varga, Tibor/0000-0002-2383-699X; Moebus, Susanne/0000-0002-0072-5410; Marziliano, Nicola/0000-0001-6800-089X; Zhang, He/0000-0001-9198-6503; Howson, Joanna/0000-0001-7618-0050; Melander, Olle/0000-0002-2581-484X; Marouli, Eirini/0000-0001-6179-1609; Butterworth, Adam/0000-0002-6915-9015; Nordestgaard, Borge/0000-0002-1954-7220; solinas, emilia/0000-0003-3532-1317; McCarthy, Mark/0000-0002-4393-0510; Kuulasmaa, Kari/0000-0003-2165-1411; Ferrario, Marco M/0000-0003-2741-7124; Hall, Alistair/0000-0003-0306-7887; Goel, Anuj/0000-0003-2307-4021; Mahajan, Anubha/0000-0001-5585-3420	National Heart, Lung, and Blood Institute, National Institutes of Health (NIH) [K08HL114642]; Foundation for Barnes Jewish Hospital; National Heart, Lung, and Blood Institute of the NIH [K01HL125751]; Massachusetts General Hospital; Donovan Family Foundation; NIH [R01HL107816, R01HL127564]; Fondation Leducq; Merck; Italian Ministry of Health [RFPS-2007-3-644382]; Regione Emilia Romagna Area; Wellcome Trust [090532/Z/09/Z, 098381]; British Heart Foundation (BHF) Centre of Research Excellence; National Cancer Institute [R25CA094880]; EU FP7 AMP; Wellcome Trust Institutional; National Institute for Health Research (NIHR); British Heart Foundation; NIHR Leicester Cardiovascular Biomedical Research Unit (BRU); BRU; American Heart Association [15POST23280019]; European Union [261123]; Fondation Leducq (CADgenomics) [12CVD02]; German Federal Ministry of Education and Research e:Med program (e:AtheroSysMed and sysINFLAME); Deutsche Forschungsgemeinschaft cluster of excellence "Inflammation at Interfaces"; SFB [1123]; DZHK; BHF [RG/14/5/30893]; NATIONAL CANCER INSTITUTE [R25CA094880] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125751, R01HL127564, K08HL114642, R01HL107816] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008672] Funding Source: NIH RePORTER; MRC [MR/N005813/1, G0800270, MR/L003120/1, MC_UU_12015/1] Funding Source: UKRI; British Heart Foundation [RG/13/13/30194, RG/08/014/24067, RG/14/5/30893] Funding Source: researchfish; Medical Research Council [G0800270, MR/N005813/1, MC_UU_12015/1, MR/L003120/1, MC_PC_13048] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, NF-SI-0611-10170, NF-SI-0611-10099] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011049, NNF16OC0021370, NNF15OC0016320] Funding Source: researchfish	National Heart, Lung, and Blood Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for Barnes Jewish Hospital; National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Massachusetts General Hospital(General Electric); Donovan Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); Merck(Merck & Company); Italian Ministry of Health(Ministry of Health, Italy); Regione Emilia Romagna Area; Wellcome Trust(Wellcome Trust); British Heart Foundation (BHF) Centre of Research Excellence(British Heart Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EU FP7 AMP; Wellcome Trust Institutional; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); NIHR Leicester Cardiovascular Biomedical Research Unit (BRU); BRU; American Heart Association(American Heart Association); European Union(European Commission); Fondation Leducq (CADgenomics)(Leducq Foundation); German Federal Ministry of Education and Research e:Med program (e:AtheroSysMed and sysINFLAME); Deutsche Forschungsgemeinschaft cluster of excellence "Inflammation at Interfaces"(German Research Foundation (DFG)); SFB(Austrian Science Fund (FWF)); DZHK; BHF(British Heart Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by a career development award from the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH) (K08HL114642 to Dr. Stitziel) and by the Foundation for Barnes Jewish Hospital. Dr. Peloso is supported by the National Heart, Lung, and Blood Institute of the NIH (award number K01HL125751). Dr. Kathiresan is supported by a Research Scholar award from the Massachusetts General Hospital, the Donovan Family Foundation, grants from the NIH (R01HL107816 and R01HL127564), a grant from Fondation Leducq, and an investigator-initiated grant from Merck. Dr. Merlini was supported by a grant from the Italian Ministry of Health (RFPS-2007-3-644382). Drs. Ardissino and Marziliano were supported by Regione Emilia Romagna Area 1 Grants. Drs. Farrall and Watkins acknowledge the support of the Wellcome Trust core award (090532/Z/09/Z), the British Heart Foundation (BHF) Centre of Research Excellence. Dr. Schick is supported in part by a grant from the National Cancer Institute (R25CA094880). Dr. Goel acknowledges EU FP7 & Wellcome Trust Institutional strategic support fund. Dr. Deloukas's work forms part of the research themes contributing to the translational research portfolio of Barts Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute for Health Research (NIHR). Drs. Webb and Samani are funded by the British Heart Foundation, and Dr. Samani is an NIHR Senior Investigator. Dr. Masca was supported by the NIHR Leicester Cardiovascular Biomedical Research Unit (BRU), and this work forms part of the portfolio of research supported by the BRU. Dr. Won was supported by a postdoctoral award from the American Heart Association (15POST23280019). Dr. McCarthy is a Wellcome Trust Senior Investigator (098381) and an NIHR Senior Investigator. Dr. Danesh is a British Heart Foundation Professor, European Research Council Senior Investigator, and NIHR Senior Investigator. Drs. Erdmann, Webb, Samani, and Schunkert are supported by the FP7 European Union project CVgenes@target (261123) and the Fondation Leducq (CADgenomics, 12CVD02). Drs. Erdmann and Schunkert are also supported by the German Federal Ministry of Education and Research e:Med program (e:AtheroSysMed and sysINFLAME), and Deutsche Forschungsgemeinschaft cluster of excellence "Inflammation at Interfaces" and SFB 1123. Dr. Kessler received a DZHK Rotation Grant. The analysis was funded, in part, by a Programme Grant from the BHF (RG/14/5/30893 to Dr. Deloukas). Additional funding is listed in the Supplementary Appendix.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Folsom AR, 2008, METABOLISM, V57, P1591, DOI 10.1016/j.metabol.2008.06.016; Gaudet D, 2015, NEW ENGL J MED, V373, P438, DOI 10.1056/NEJMoa1400283; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; KOZAKI K, 1993, J LIPID RES, V34, P1765; Lafferty MJ, 2013, J BIOL CHEM, V288, P28524, DOI 10.1074/jbc.M113.497602; MAILLY F, 1995, ARTERIOSCL THROM VAS, V15, P468, DOI 10.1161/01.ATV.15.4.468; Nakada TA, 2015, CRIT CARE MED, V43, P101, DOI 10.1097/CCM.0000000000000604; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sato-Nishiuchi R, 2012, J BIOL CHEM, V287, P25615, DOI 10.1074/jbc.M112.355016; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Talmud PJ, 2008, ARTERIOSCL THROM VAS, V28, P2319, DOI 10.1161/ATVBAHA.108.176917; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200	23	222	225	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1134	1144		10.1056/NEJMoa1507652	http://dx.doi.org/10.1056/NEJMoa1507652			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	26934567	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000372585100006
J	Manrai, AK; Ioannidis, JPA; Kohane, IS				Manrai, Arjun K.; Ioannidis, John P. A.; Kohane, Isaac S.			Clinical Genomics From Pathogenicity Claims to Quantitative Risk Estimates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION		[Manrai, Arjun K.; Kohane, Isaac S.] Harvard Univ, Dept Biomed Informat, Sch Med, Boston, MA USA; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Kohane, Isaac S.] 10 Shattuck St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Stanford University; Stanford University	Kohane, IS (corresponding author), 10 Shattuck St, Boston, MA 02115 USA.	isaac_kohane@hms.harvard.edu	Ioannidis, John P. A./G-9836-2011	Manrai, Arjun/0000-0001-9657-9800				Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Mandl KD, 2015, NAT BIOTECHNOL, V33, P360, DOI 10.1038/nbt.3180; Panagiotou OA, 2013, ANNU REV GENOM HUM G, V14, P441, DOI 10.1146/annurev-genom-091212-153520; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Van Driest SL, 2016, JAMA-J AM MED ASSOC, V315, P47, DOI 10.1001/jama.2015.17701	6	28	30	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1233	1234		10.1001/jama.2016.1519	http://dx.doi.org/10.1001/jama.2016.1519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	26925924				2022-12-28	WOS:000372511100006
J	Brott, TG; Howard, G; Roubin, GS; Meschia, JF; Mackey, A; Brooks, W; Moore, WS; Hill, MD; Mantese, VA; Clark, WM; Timaran, CH; Heck, D; Leimgruber, PP; Sheffet, AJ; Howard, VJ; Chaturvedi, S; Lal, BK; Voeks, JH; Hobson, RW				Brott, Thomas G.; Howard, George; Roubin, Gary S.; Meschia, James F.; Mackey, Ariane; Brooks, William; Moore, Wesley S.; Hill, Michael D.; Mantese, Vito A.; Clark, Wayne M.; Timaran, Carlos H.; Heck, Donald; Leimgruber, Pierre P.; Sheffet, Alice J.; Howard, Virginia J.; Chaturvedi, Seemant; Lal, Brajesh K.; Voeks, Jenifer H.; Hobson, Robert W., II		CREST Investigators	Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVASCULARIZATION ENDARTERECTOMY; EMBOLIC PROTECTION; TRIAL; STROKE; MULTICENTER; PREVENTION	BACKGROUND In the Carotid Revascularization Endarterectomy versus Stenting Trial, we found no significant difference between the stenting group and the endarterectomy group with respect to the primary composite end point of stroke, myocardial infarction, or death during the periprocedural period or any subsequent ipsilateral stroke during 4 years of follow-up. We now extend the results to 10 years. METHODS Among patients with carotid-artery stenosis who had been randomly assigned to stenting or endarterectomy, we evaluated outcomes every 6 months for up to 10 years at 117 centers. In addition to assessing the primary composite end point, we assessed the primary end point for the long-term extension study, which was ipsilateral stroke after the periprocedural period. RESULTS Among 2502 patients, there was no significant difference in the rate of the primary composite end point between the stenting group (11.8%; 95% confidence interval [CI], 9.1 to 14.8) and the endarterectomy group (9.9%; 95% CI, 7.9 to 12.2) over 10 years of follow-up (hazard ratio, 1.10; 95% CI, 0.83 to 1.44). With respect to the primary long-term end point, postprocedural ipsilateral stroke over the 10-year follow-up occurred in 6.9% (95% CI, 4.4 to 9.7) of the patients in the stenting group and in 5.6% (95% CI, 3.7 to 7.6) of those in the endarterectomy group; the rates did not differ significantly between the groups (hazard ratio, 0.99; 95% CI, 0.64 to 1.52). No significant between-group differences with respect to either end point were detected when symptomatic patients and asymptomatic patients were analyzed separately. CONCLUSIONS Over 10 years of follow-up, we did not find a significant difference between patients who underwent stenting and those who underwent endarterectomy with respect to the risk of periprocedural stroke, myocardial infarction, or death and subsequent ipsilateral stroke. The rate of postprocedural ipsilateral stroke also did not differ between groups.	[Brott, Thomas G.; Meschia, James F.] Mayo Clin, Griffin Bldg 1st Fl,Rm 170,4500 San Pablo Rd S, Jacksonville, FL 32224 USA; [Howard, George; Howard, Virginia J.] Univ Alabama Birmingham, Birmingham, AL USA; [Roubin, Gary S.] Cardiovasc Associates Southeast, Birmingham, AL USA; [Mackey, Ariane] Univ Laval, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Hill, Michael D.] Univ Calgary, Calgary, AB, Canada; [Brooks, William] Baptist Hlth Lexington, Lexington, KY USA; [Moore, Wesley S.] Univ Calif Los Angeles, Los Angeles, CA USA; [Mantese, Vito A.] Mercy Hosp St Louis, St Louis, MO USA; [Clark, Wayne M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Timaran, Carlos H.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Heck, Donald] Novant Hlth Clin Res, Winston Salem, NC USA; [Leimgruber, Pierre P.] Providence Sacred Heart Med Ctr & Childrens Hosp, Spokane, WA USA; [Sheffet, Alice J.; Hobson, Robert W., II] Rutgers New Jersey Med Sch, Newark, NJ USA; [Chaturvedi, Seemant] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Lal, Brajesh K.] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; [Voeks, Jenifer H.] Med Univ S Carolina, Charleston, SC 29425 USA	Mayo Clinic; University of Alabama System; University of Alabama Birmingham; Laval University; University of Calgary; Central Baptist Hospital; University of California System; University of California Los Angeles; Saint Johns Mercy Medical Center; Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Miami; University System of Maryland; University of Maryland Baltimore; Medical University of South Carolina	Brott, TG (corresponding author), Mayo Clin, Griffin Bldg 1st Fl,Rm 170,4500 San Pablo Rd S, Jacksonville, FL 32224 USA.	brott.thomas@mayo.edu	Meschia, James/GPP-1636-2022; Lal, Brajesh/AAA-2620-2022; Hill, Michael D/C-9073-2012	Meschia, James/0000-0002-4475-8142; Hill, Michael D/0000-0002-6269-1543; Howard, George/0000-0002-3068-5720	National Institutes of Health; Abbott Vascular Solutions; CREST; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038384, U01NS038384] Funding Source: NIH RePORTER; Alberta Innovates [201300690] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Vascular Solutions; CREST(Core Research for Evolutional Science and Technology (CREST)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates	Funded by the National Institutes of Health and Abbott Vascular Solutions; CREST ClinicalTrials.gov number, NCT00004732.	Arias Elizabeth, 2014, Natl Vital Stat Rep, V63, P1; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bonati LH, 2015, LANCET, V385, P529, DOI 10.1016/S0140-6736(14)61184-3; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Cronenwett JL, 2012, J VASC SURG, V55, P1529, DOI 10.1016/j.jvs.2012.03.016; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Giri J, 2015, JACC-CARDIOVASC INTE, V8, P609, DOI 10.1016/j.jcin.2015.02.001; Gurm HS, 2008, NEW ENGL J MED, V358, P1572, DOI 10.1056/NEJMoa0708028; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Hill MD, 2012, CIRCULATION, V126, P3054, DOI 10.1161/CIRCULATIONAHA.112.120030; Hobson R W 2nd, 2000, Semin Vasc Surg, V13, P139; Hopkins LN, 2010, J STROKE CEREBROVASC, V19, P153, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.001; Jalbert JJ, 2015, JAMA NEUROL, V72, P276, DOI 10.1001/jamaneurol.2014.3638; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Meschia JF, 2000, STROKE, V31, P1076, DOI 10.1161/01.STR.31.5.1076; MOORE WS, 1991, STROKE, V22, P1353, DOI 10.1161/01.STR.22.11.1353; Office of the Chief Actuary (U.S.), 2011, ACT LIF TABL PER LIF; RAUTAHARJU PM, 1990, METHOD INFORM MED, V29, P362; Rosenfield K, 2016, NEW ENGL J MED, V374, P1011, DOI 10.1056/NEJMoa1515706; Schofer J, 2015, JACC-CARDIOVASC INTE, V8, P1229, DOI 10.1016/j.jcin.2015.04.016; Sheffet AJ, 2010, INT J STROKE, V5, P40, DOI 10.1111/j.1747-4949.2009.00405.x; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035	24	412	453	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1021	1031		10.1056/NEJMoa1505215	http://dx.doi.org/10.1056/NEJMoa1505215			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26890472	Green Accepted, Bronze			2022-12-28	WOS:000372066100006
J	Li, L; Park, E; Ling, JJ; Ingram, J; Ploegh, H; Rapoport, TA				Li, Long; Park, Eunyong; Ling, JingJing; Ingram, Jessica; Ploegh, Hidde; Rapoport, Tom A.			Crystal structure of a substrate-engaged SecY protein-translocation channel	NATURE			English	Article							SIGNAL SEQUENCE RECOGNITION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; IN-VIVO; COMPLEX; MECHANISM; CRYSTALLIZATION; VISUALIZATION; PEPTIDES; SYSTEM	Hydrophobic signal sequences target secretory polypeptides to a protein-conducting channel formed by a heterotrimeric membrane protein complex, the prokaryotic SecY or eukaryotic Sec61 complex. How signal sequences are recognized is poorly understood, particularly because they are diverse in sequence and length. Structures of the inactive channel show that the largest subunit, SecY or Sec61 alpha, consists of two halves that form an hourglass-shaped pore with a constriction in the middle of the membrane and a lateral gate that faces lipid(1-10). The cytoplasmic funnel is empty, while the extracellular funnel is filled with a plug domain. In bacteria, the SecY channel associates with the translating ribosome in co-translational translocation, and with the SecA ATPase in post-translational translocation(11). How a translocating polypeptide inserts into the channel is uncertain, as cryo-electron microscopy structures of the active channel have a relatively low resolution (similar to 10 angstrom) or are of insufficient quality(6-8). Here we report a crystal structure of the active channel, assembled from SecY complex, the SecA ATPase, and a segment of a secretory protein fused into SecA. The translocating protein segment inserts into the channel as a loop, displacing the plug domain. The hydrophobic core of the signal sequence forms a helix that sits in a groove outside the lateral gate, while the following polypeptide segment intercalates into the gate. The carboxy (C)-terminal section of the polypeptide loop is located in the channel, surrounded by residues of the pore ring. Thus, during translocation, the hydrophobic segments of signal sequences, and probably bilayer-spanning domains of nascent membrane proteins, exit the lateral gate and dock at a specific site that faces the lipid phase.	[Li, Long; Park, Eunyong; Rapoport, Tom A.] Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA; [Li, Long; Park, Eunyong; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Ling, JingJing; Ingram, Jessica; Ploegh, Hidde] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Park, Eunyong] Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA; [Park, Eunyong] Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA	Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Rockefeller University; Howard Hughes Medical Institute	Li, L; Rapoport, TA (corresponding author), Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.; Li, L; Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	long_li@hms.harvard.edu; tom_rapoport@hms.harvard.edu			National Institutes of Health [GM052586]; Pioneer Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106409, R01GM052586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pioneer Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Martone and for help with nanobody generation and cloning, C. Shoemaker and J. Mukherjee for their assistance in alpaca immunization, A. Whynot for cloning G. thermodenitrificans SecY, and H. Suzuki and T. Walz for help with fluorescence size-exclusion chromatography. We thank the staff at Northeastern Collaborative Access Team (NE-CAT) of the Advanced Photon Source, the SBGrid consortium at Harvard Medical School, the organizers of the CCP4/Advanced Photon Source summer school 2015, and the beam host at GMCA-CAT. We thank A. Salic and T. Guettler for reading the manuscript. The work was supported by National Institutes of Health grants to T.A.R. (GM052586) and by a Pioneer Award to H.P. T.A.R. is a Howard Hughes Medical Institute investigator.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banumathi S, 2003, ACTA CRYSTALLOGR D, V59, P492, DOI 10.1107/S0907444903000064; Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; Bischoff L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5103; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FIKES JD, 1990, J BIOL CHEM, V265, P3417; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Guimaraes CP, 2013, NAT PROTOC, V8, P1787, DOI 10.1038/nprot.2013.101; Hari SB, 2010, PROTEIN SCI, V19, P670, DOI 10.1002/pro.342; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCKNIGHT CJ, 1989, J BIOL CHEM, V264, P17293; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Paetzel M, 2014, BBA-MOL CELL RES, V1843, P1497, DOI 10.1016/j.bbamcr.2013.12.003; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9403; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; RIZO J, 1993, BIOCHEMISTRY-US, V32, P4881, DOI 10.1021/bi00069a025; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Tanaka Y, 2015, CELL REP, V13, P1561, DOI 10.1016/j.celrep.2015.10.025; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; YAMAMOTO Y, 1990, BIOCHEMISTRY-US, V29, P8998, DOI 10.1021/bi00490a017; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	51	104	104	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					395	+		10.1038/nature17163	http://dx.doi.org/10.1038/nature17163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26950603	Green Submitted, Green Accepted			2022-12-28	WOS:000372064300058
J	Zheng, ZG; Li, YN; Bisoyi, HK; Wang, L; Bunning, TJ; Li, Q				Zheng, Zhi-gang; Li, Yannian; Bisoyi, Hari Krishna; Wang, Ling; Bunning, Timothy J.; Li, Quan			Three-dimensional control of the helical axis of a chiral nematic liquid crystal by light	NATURE			English	Article							DIFFRACTION GRATINGS; HANDEDNESS INVERSION; POLYMER	Chiral nematic liquid crystals-otherwise referred to as cholesteric liquid crystals (CLCs)-are self-organized helical superstructures that find practical application in, for example, thermography(1), reflective displays(2), tuneable colour filters(3,4) and mirrorless lasing(5,6). Dynamic, remote and three-dimensional control over the helical axis of CLCs is desirable, but challenging(7,8). For example, the orientation of the helical axis relative to the substrate can be changed from perpendicular to parallel by applying an alternating-current electric field(9), by changing the anchoring conditions of the substrate, or by altering the topography of the substrate's surface(10-16); separately, in-plane rotation of the helical axis parallel to the substrate can be driven by a direct-current field(17-19). Here we report three-dimensional manipulation of the helical axis of a CLC, together with inversion of its handedness, achieved solely with a light stimulus. We use this technique to carry out light-activated, wide-area, reversible two-dimensional beam steering-previously accomplished using complex integrated systems(20) and optical phased arrays(21). During the three-dimensional manipulation by light, the helical axis undergoes, in sequence, a reversible transition from perpendicular to parallel, followed by in-plane rotation on the substrate surface. Such reversible manipulation depends on experimental parameters such as cell thickness, surface anchoring condition, and pitch length. Because there is no thermal relaxation, the system can be driven either forwards or backwards from any light-activated intermediate state. We also describe reversible photocontrol between a two-dimensional diffraction state, a one-dimensional diffraction state and a diffraction 'off' state in a bilayer cell.	[Zheng, Zhi-gang; Li, Yannian; Bisoyi, Hari Krishna; Wang, Ling; Li, Quan] Kent State Univ, Inst Liquid Crystal, Kent, OH 44242 USA; [Zheng, Zhi-gang; Li, Yannian; Bisoyi, Hari Krishna; Wang, Ling; Li, Quan] Kent State Univ, Chem Phys Interdisciplinary Program, Kent, OH 44242 USA; [Bunning, Timothy J.] US Air Force, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, OH 45433 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; United States Department of Defense; United States Air Force	Li, Q (corresponding author), Kent State Univ, Inst Liquid Crystal, Kent, OH 44242 USA.; Li, Q (corresponding author), Kent State Univ, Chem Phys Interdisciplinary Program, Kent, OH 44242 USA.	qli1@kent.edu	Zheng, Zhi-gang/H-7246-2018; Wang, Ling/I-6272-2019	Zheng, Zhi-gang/0000-0001-5609-5369; Wang, Ling/0000-0003-1035-5633; Bisoyi, Hari Krishna/0000-0002-9775-6757	Air Force Office of Scientific Research (AFOSR) [FA9950-09-1-0193]; Air Force Research Laboratory; China Scholarship Council; Materials and Manufacturing Directorate; AFOSR	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Air Force Research Laboratory; China Scholarship Council(China Scholarship Council); Materials and Manufacturing Directorate; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Q.L. acknowledges support from the Air Force Office of Scientific Research (AFOSR; grant no. FA9950-09-1-0193) and the Air Force Research Laboratory. Z.Z. acknowledges receipt of a Scholarship supported by the China Scholarship Council. T.J.B. acknowledges support from the Materials and Manufacturing Directorate and the AFOSR.	Bisoyi HK, 2014, ACCOUNTS CHEM RES, V47, P3184, DOI 10.1021/ar500249k; Carbone G, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3159624; Chen LJ, 2014, ADV OPT MATER, V2, P845, DOI 10.1002/adom.201400166; Coles H, 2010, NAT PHOTONICS, V4, P676, DOI 10.1038/NPHOTON.2010.184; CRISSEY JT, 1965, J INVEST DERMATOL, V45, P329, DOI 10.1038/jid.1965.139; Eelkema R, 2006, NATURE, V440, P163, DOI 10.1038/440163a; Gvozdovskyy I, 2012, OPT EXPRESS, V20, P3499, DOI 10.1364/OE.20.003499; Ha NY, 2008, NAT MATER, V7, P43, DOI 10.1038/nmat2045; Hegde G, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3357420; Hrozhyk UA, 2007, OPT EXPRESS, V15, P9273, DOI 10.1364/OE.15.009273; Hulme JC, 2015, OPT EXPRESS, V23, P5861, DOI 10.1364/OE.23.005861; Jau HC, 2015, ADV OPT MATER, V3, P166, DOI 10.1002/adom.201400457; Kang SW, 2000, APPL PHYS LETT, V76, P3516, DOI 10.1063/1.126692; Kim SH, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1897057; Li YN, 2013, ANGEW CHEM INT EDIT, V52, P13703, DOI 10.1002/anie.201306396; Lin CH, 2012, OPT EXPRESS, V20, P26837, DOI 10.1364/OE.20.026837; Outram BI, 2013, J APPL PHYS, V113, DOI 10.1063/1.4808341; PATEL JS, 1987, PHYS REV LETT, V58, P1538, DOI 10.1103/PhysRevLett.58.1538; Ponti S, 1999, LIQ CRYST, V26, P1171, DOI 10.1080/026782999204192; Ryabchun A, 2015, ADV OPT MATER, V3, P1462, DOI 10.1002/adom.201500293; Ryabchun A, 2015, ADV OPT MATER, V3, P1273, DOI 10.1002/adom.201500159; SACKMANN E, 1971, J AM CHEM SOC, V93, P7088, DOI 10.1021/ja00754a068; Subacius D, 1997, APPL PHYS LETT, V71, P3323, DOI 10.1063/1.120325; Sun J, 2013, NATURE, V493, P195, DOI 10.1038/nature11727; Wang L, 2015, ADV MATER, V27, P2065, DOI 10.1002/adma.201405690; Wu S.-T., 2001, WILEY S DISP TECHNOL; Xiang J, 2015, ADV MATER, V27, P3014, DOI 10.1002/adma.201500340; Yeh HC, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2798103; Zola RS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.057801	29	344	353	37	586	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					352	+		10.1038/nature17141	http://dx.doi.org/10.1038/nature17141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26950601				2022-12-28	WOS:000372064300049
J	Goddard, MR				Goddard, Matthew R.			MOLECULAR EVOLUTION Sex accelerates adaptation	NATURE			English	Editorial Material							EXPERIMENTAL YEAST POPULATIONS; SELECTION; MUTATIONS; EFFICACY		[Goddard, Matthew R.] Lincoln Univ, Sch Life Sci, Lincoln LN6 7TS, England; [Goddard, Matthew R.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Lincoln; University of Auckland	Goddard, MR (corresponding author), Lincoln Univ, Sch Life Sci, Lincoln LN6 7TS, England.; Goddard, MR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	mgoddard@lincoln.ac.uk	Goddard, Matthew/C-7462-2014	Goddard, Matthew/0000-0002-7482-4438				Burt A, 2000, EVOLUTION, V54, P337; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Fisher R. A., 2013, GENETICAL THEORY NAT; Giraldo-Perez P, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1875; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Gray JC, 2012, ECOL LETT, V15, P955, DOI 10.1111/j.1461-0248.2012.01814.x; Gray JC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-43; Hickey DA, 1988, EVOLUTION SEX, P161; McDonald MJ, 2016, NATURE, V531, P233, DOI 10.1038/nature17143; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; PECK JR, 1994, GENETICS, V137, P597	12	10	10	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					176	177		10.1038/nature17304	http://dx.doi.org/10.1038/nature17304			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26909572	Green Accepted			2022-12-28	WOS:000371665100025
J	Welck, M; Zinchenko, R; Tudor, F				Welck, Matthew; Zinchenko, Ruslan; Tudor, Francois			CASE REVIEW A painful foot: Lisfranc fracture-dislocations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERNAL-FIXATION; JOINT INJURIES; OPEN REDUCTION; PRIMARY ARTHRODESIS; STABILIZATION; DIAGNOSIS		[Welck, Matthew] West Herts NHS Trust, Watford WD18 0HB, England; [Zinchenko, Ruslan] Univ London St Georges Hosp, London, England; [Tudor, Francois] Gold Coast Univ Hosp, Southport, Qld, Australia	St Georges University London; Gold Coast University Hospital	Welck, M (corresponding author), West Herts NHS Trust, Watford WD18 0HB, England.	matthewwelck@doctors.org.uk	Tudor, Francois/AAX-7604-2021					Alberta FG, 2005, FOOT ANKLE INT, V26, P462, DOI 10.1177/107110070502600607; Aronow Michael S, 2006, Foot Ankle Clin, V11, P127, DOI 10.1016/j.fcl.2005.12.005; Benirschke Stephen K, 2012, J Bone Joint Surg Am, V94, P1325, DOI 10.2106/JBJS.L00413; Chaney D Martin, 2010, Clin Podiatr Med Surg, V27, P547, DOI 10.1016/j.cpm.2010.06.005; Coetzee J Chris, 2008, Foot Ankle Clin, V13, P695, DOI 10.1016/j.fcl.2008.07.001; Cosculluela PE, 2009, TECH FOOT ANKLE SURG, V8, P215, DOI 10.1097/BTF.0b013e3181c266cd; Crim J, 2008, MAGN RESON IMAGING C, V16, P19, DOI 10.1016/j.mric.2008.02.007; Davies MS, 1999, FOOT ANKLE INT, V20, P606, DOI 10.1177/107110079902000912; DeOrio M, 2009, FOOT ANKLE CLIN, V14, P169, DOI 10.1016/j.fcl.2009.03.008; Desmond EA, 2006, FOOT ANKLE INT, V27, P653, DOI 10.1177/107110070602700819; Eleftheriou KI, 2013, KNEE SURG SPORT TR A, V21, P1434, DOI 10.1007/s00167-013-2491-2; Gupta RT, 2008, CURR PROBL DIAGN RAD, V37, P115, DOI 10.1067/j.cpradiol.2007.08.012; Haapamaki V, 2004, FOOT ANKLE INT, V25, P614, DOI 10.1177/107110070402500903; Hatem SF, 2008, RADIOL CLIN N AM, V46, P1045, DOI 10.1016/j.rcl.2008.09.003; Henning JA, 2009, FOOT ANKLE INT, V30, P913, DOI 10.3113/FAI.2009.0913; Kadel N, 2005, FOOT ANKLE INT, V26, P394, DOI 10.1177/107110070502600510; Kalia V, 2012, SKELETAL RADIOL, V41, P129, DOI 10.1007/s00256-011-1131-5; Kuo RS, 2000, J BONE JOINT SURG AM, V82A, P1609, DOI 10.2106/00004623-200011000-00015; Lee CA, 2004, FOOT ANKLE INT, V25, P365, DOI 10.1177/107110070402500515; Ly TV, 2006, J BONE JOINT SURG AM, V88A, P514, DOI 10.2106/JBJS.E.00228; Nunley JA, 2002, AM J SPORT MED, V30, P871, DOI 10.1177/03635465020300061901; Peicha G, 2002, J BONE JOINT SURG BR, V84B, P981, DOI 10.1302/0301-620X.84B7.12587; Purushothaman Balaji, 2010, Surg Technol Int, V19, P199; Regauer M, 2015, UNFALLCHIRURG, V118, P727, DOI 10.1007/s00113-014-2685-1; Rosenbaum A, 2011, ORTHOPEDICS, V34, P882, DOI 10.3928/01477447-20110922-23; Ross G, 1996, J ORTHOP TRAUMA, V10, P119, DOI 10.1097/00005131-199602000-00008; Sands Andrew K, 2004, Injury, V35 Suppl 2, pSB71; Scolaro J, 2011, CLIN ORTHOP RELAT R, V469, P2078, DOI 10.1007/s11999-010-1586-z; Sheibani-Rad S, 2012, ORTHOPEDICS, V35, pE868, DOI 10.3928/01477447-20120525-26; Stavlas P, 2010, INT ORTHOP, V34, P1083, DOI 10.1007/s00264-010-1101-x; Tadros AMA, 2008, SINGAP MED J, V49, pE234; Vertullo CJ, 2002, FOOT ANKLE INT, V23, P420, DOI 10.1177/107110070202300509; Wright MP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4561	33	1	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2016	352								i882	10.1136/bmj.i882	http://dx.doi.org/10.1136/bmj.i882			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NH	26951155				2022-12-28	WOS:000372048400001
J	Lynch, VJ				Lynch, Vincent J.			A copy-and-paste gene regulatory network	SCIENCE			English	Editorial Material							TRANSPOSABLE ELEMENTS; EVOLUTION; SEQUENCES; CELLS		[Lynch, Vincent J.] Univ Chicago, Dept Human Genet, 920 East 58th St,CLSC 319C, Chicago, IL 60637 USA	University of Chicago	Lynch, VJ (corresponding author), Univ Chicago, Dept Human Genet, 920 East 58th St,CLSC 319C, Chicago, IL 60637 USA.	vjlynch@uchicago.edu						BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; DAVIDSON EH, 1979, SCIENCE, V204, P1052, DOI 10.1126/science.451548; de Souza FSJ, 2013, MOL BIOL EVOL, V30, P1239, DOI 10.1093/molbev/mst045; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Wagner GP, 2010, CURR BIOL, V20, pR48, DOI 10.1016/j.cub.2009.11.010	14	16	17	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1029	1030		10.1126/science.aaf2977	http://dx.doi.org/10.1126/science.aaf2977			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941305				2022-12-28	WOS:000371597500022
J	Zaanen, J				Zaanen, Jan			Electrons go with the flow in exotic material systems	SCIENCE			English	Editorial Material									[Zaanen, Jan] Leiden Univ, Inst Lorentz Theoret Phys, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Zaanen, J (corresponding author), Leiden Univ, Inst Lorentz Theoret Phys, Leiden, Netherlands.	jan@lorentz.leidenuniv.nl						Bandurin DA, 2016, SCIENCE, V351, P1055, DOI 10.1126/science.aad0201; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Crossno J, 2016, SCIENCE, V351, P1058, DOI 10.1126/science.aad0343; DEJONG MJM, 1995, PHYS REV B, V51, P13389, DOI 10.1103/PhysRevB.51.13389; Foster MS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085415; Hartnoll SA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144502; Hazzard KRA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.049902; Moll PJW, 2016, SCIENCE, V351, P1061, DOI 10.1126/science.aac8385; Zaanen J., 2015, HOLOGRAPHIC DUALITY	9	20	20	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2016	351	6277					1026	1027		10.1126/science.aaf2487	http://dx.doi.org/10.1126/science.aaf2487			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8HE	26941303	Green Published			2022-12-28	WOS:000371597500020
J	Bassett, D; Sandwell, DT; Fialko, Y; Watts, AB				Bassett, Dan; Sandwell, David T.; Fialko, Yuri; Watts, Anthony B.			Upper-plate controls on co-seismic slip in the 2011 magnitude 9.0 Tohoku-oki earthquake	NATURE			English	Article							MEDIAN TECTONIC LINE; FORE-ARC REGION; STRUCTURAL CHARACTERISTICS; EAST SHIKOKU; FAULT; RUPTURE; INVERSION; GRAVITY; ZONE; REFLECTION	The March 2011 Tohoku-oki earthquake was only the second giant (moment magnitude M-w >= 9.0) earthquake to occur in the last 50 years and is the most recent to be recorded using modern geophysical techniques. Available data place high-resolution constraints on the kinematics of earthquake rupture(1), which have challenged prior knowledge about how much a fault can slip in a single earthquake and the seismic potential of a partially coupled megathrust interface(2). But it is not clear what physical or structural characteristics controlled either the rupture extent or the amplitude of slip in this earthquake. Here we use residual topography and gravity anomalies to constrain the geological structure of the overthrusting (upper) plate offshore northeast Japan. These data reveal an abrupt southwest-northeast-striking boundary in upperplate structure, across which gravity modelling indicates a south-tonorth increase in the density of rocks overlying the megathrust of 150-200 kilograms per cubic metre. We suggest that this boundary represents the offshore continuation of the Median Tectonic Line, which onshore juxtaposes geological terranes composed of granite batholiths (in the north) and accretionary complexes (in the south) 3. The megathrust north of the Median Tectonic Line is interseismically locked(2), has a history of large earthquakes (18 with M-w >= 7 since 1896) and produced peak slip exceeding 40 metres in the Tohoku-oki earthquake(1). In contrast, the megathrust south of this boundary has higher rates of interseismic creep(2), has not generated an earthquake with M-J > 7 (local magnitude estimated by the Japan Meteorological Agency) since 1923, and experienced relatively minor (if any) co-seismic slip in 2011(1). We propose that the structure and frictional properties of the overthrusting plate control megathrust coupling and seismogenic behaviour in northeast Japan.	[Bassett, Dan; Sandwell, David T.; Fialko, Yuri] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Watts, Anthony B.] Univ Oxford, Dept Earth Sci, S Parks Rd, Oxford OX1 3PR, England	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Oxford	Bassett, D (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	dbassett@ucsd.edu	Fialko, Yuri/B-9567-2012	Fialko, Yuri/0000-0002-6161-8467; Sandwell, David/0000-0001-5657-8707	University of Oxford; Green Foundation; National Geospatial Agency [HM01771310008]; Scripps Seafloor Electromagnetics Consortium; Directorate For Geosciences [1128801] Funding Source: National Science Foundation; Natural Environment Research Council [NE/F005318/1] Funding Source: researchfish; NERC [NE/F005318/1] Funding Source: UKRI	University of Oxford; Green Foundation; National Geospatial Agency; Scripps Seafloor Electromagnetics Consortium; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Naif, C. Davies, C. Twardzik and S. Das for suggestions. Figures and grid processing was conducted using the Generic Mapping Tools (GMT) (http://gmt.soest.hawaii.edu/). D.B. was supported by a University of Oxford Clarendon Scholarship, by a Green Foundation Postdoctoral Fellowship in the Institute of Geophysics and Planetary Physics, Scripps Institution of Oceanography, University of California, San Diego, by the National Geospatial Agency (HM01771310008), and by the Scripps Seafloor Electromagnetics Consortium (http://marineemlab.ucsd.edu/semc.html).	Aki K., 1966, B EARTHQ RES I, V44, P23; Ammon CJ, 2011, EARTH PLANETS SPACE, V63, P693, DOI 10.5047/eps.2011.05.015; Asano Y, 2011, EARTH PLANETS SPACE, V63, P669, DOI 10.5047/eps.2011.06.016; BARRIENTOS SE, 1990, GEOPHYS J INT, V103, P589, DOI 10.1111/j.1365-246X.1990.tb05673.x; Bassett D, 2015, GEOCHEM GEOPHY GEOSY, V16, P1541, DOI 10.1002/2014GC005685; Bassett D, 2015, GEOCHEM GEOPHY GEOSY, V16, P1508, DOI 10.1002/2014GC005684; BECK SL, 1991, J GEOPHYS RES-SOLID, V96, P2205, DOI 10.1029/90JB02092; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Delouis B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043899; den Hartog SAM, 2012, EARTH PLANET SC LETT, V353, P240, DOI 10.1016/j.epsl.2012.08.022; FINN C, 1994, J GEOPHYS RES-SOL EA, V99, P22165, DOI 10.1029/94JB00855; Fujie G, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013764; Fujie G, 2013, EARTH PLANETS SPACE, V65, P75, DOI 10.5047/eps.2012.06.003; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Goto T, 1998, EARTH PLANETS SPACE, V50, P405, DOI 10.1186/BF03352127; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Henry C, 2001, GEOPHYS J INT, V147, P272, DOI 10.1046/j.1365-246X.2001.00522.x; Hetland EA, 2010, GEOPHYS J INT, V181, P99, DOI 10.1111/j.1365-246X.2009.04482.x; Hillers G, 2008, B SEISMOL SOC AM, V98, P1085, DOI 10.1785/0120070200; Intergovernmental Oceanographic Commission International Hydrographic Organisation and British Oceanographic Data Centre, 2003, CENT ED GEBCO DIG AT; Isozaki Y, 2010, GONDWANA RES, V18, P82, DOI 10.1016/j.gr.2010.02.015; Ito A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022307; Ito A, 2004, EARTH PLANET SC LETT, V223, P163, DOI 10.1016/j.epsl.2004.04.007; Johnson JM, 1996, J GEOPHYS RES-SOL EA, V101, P523, DOI 10.1029/95JB02806; Johnson JM, 1999, PURE APPL GEOPHYS, V154, P541, DOI 10.1007/s000240050243; JOHNSON JM, 1994, PURE APPL GEOPHYS, V142, P3, DOI 10.1007/BF00875966; Kanamori H., 1981, Earthquake Prediction. An International Review. Symposium on Earthquake Prediction, P1, DOI 10.1029/ME004p0001; Kanazawa T, 2013, 2013 IEEE INT UNDERW, P1, DOI DOI 10.1109/UT.2013.6519911; Kaneko Y, 2013, J GEOPHYS RES-SOL EA, V118, P316, DOI 10.1029/2012JB009661; Kaneko Y, 2010, NAT GEOSCI, V3, P363, DOI 10.1038/NGEO843; Katsumata A., 2010, J GEOPHYS RES, V115, P1, DOI DOI 10.1029/2008JB005864; Kawamura T, 2003, EARTH PLANETS SPACE, V55, P549, DOI 10.1186/BF03351787; KELLEHER J, 1974, J GEOPHYS RES, V79, P4889, DOI 10.1029/JB079i032p04889; KNOPOFF L, 1958, GEOPHYS J ROY ASTR S, V1, P44, DOI 10.1111/j.1365-246X.1958.tb00033.x; Lapusta N, 2000, J GEOPHYS RES-SOL EA, V105, P23765, DOI 10.1029/2000JB900250; Melgar D, 2015, J GEOPHYS RES-SOL EA, V120, P3324, DOI 10.1002/2014JB011832; Minson SE, 2014, GEOPHYS J INT, V198, P922, DOI 10.1093/gji/ggu170; Mitchell EK, 2013, GEOCHEM GEOPHY GEOSY, V14, P567, DOI 10.1029/2012GC004241; Miura S, 2005, TECTONOPHYSICS, V407, P165, DOI 10.1016/j.tecto.2005.08.001; Miura S, 2003, TECTONOPHYSICS, V363, P79, DOI 10.1016/S0040-1951(02)00655-8; Morrow CA, 2000, GEOPHYS RES LETT, V27, P815, DOI 10.1029/1999GL008401; Murata Y., 1991, ROCK PHYS PROPERTIES; Numelin T, 2007, TECTONICS, V26, DOI 10.1029/2005TC001916; Okuma S., 2011, PETROPHYSICAL DATA B, V87; Ozawa S., 2012, J GEOPHYS RES, V117, P1; PLOUFF D, 1976, GEOPHYSICS, V41, P727, DOI 10.1190/1.1440645; Robinson DP, 2006, SCIENCE, V312, P1203, DOI 10.1126/science.1125771; Sandwell DT, 2014, SCIENCE, V346, P65, DOI 10.1126/science.1258213; Sato H, 2015, TECTONOPHYSICS, V644, P58, DOI 10.1016/j.tecto.2014.12.020; Sato T, 2013, B SEISMOL SOC AM, V103, P3104, DOI 10.1785/0120130042; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Song TRA, 2003, SCIENCE, V301, P630, DOI 10.1126/science.1085557; Sparkes R, 2010, EARTH PLANET SC LETT, V298, P89, DOI 10.1016/j.epsl.2010.07.029; Sun THZ, 2015, J GEOPHYS RES-SOL EA, V120, P1329, DOI 10.1002/2014JB011707; Suwa Y, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003203; Tajima F, 2013, TECTONOPHYSICS, V586, P15, DOI 10.1016/j.tecto.2012.09.014; Takahashi N, 2004, GEOPHYS J INT, V159, P129, DOI 10.1111/j.1365-246X.2004.02350.x; Tinti E, 2005, ANN GEOPHYS-ITALY, V48, P327; Uieda L., 2013, P 12 PYTH SCI C, P96; Wallace LM, 2009, GEOLOGY, V37, P143, DOI 10.1130/G25221A.1; Wang KL, 2014, TECTONOPHYSICS, V610, P1, DOI 10.1016/j.tecto.2013.11.024; Wang Z, 2005, PHYS EARTH PLANET IN, V152, P144, DOI 10.1016/j.pepi.2005.06.010; WELLS RE, 2003, J GEOPHYS RES, V108, P1; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683; Yamazaki Y, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016487; Yue H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048700	66	59	60	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					92	+		10.1038/nature16945	http://dx.doi.org/10.1038/nature16945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26935698				2022-12-28	WOS:000371211900046
J	Wallis, CJD; Mahar, AL; Choo, R; Herschorn, S; Kodama, RT; Shah, PS; Danjoux, C; Narod, SA; Nam, RK				Wallis, Christopher J. D.; Mahar, Alyson L.; Choo, Richard; Herschorn, Sender; Kodama, Ronald T.; Shah, Prakesh S.; Danjoux, Cyril; Narod, Steven A.; Nam, Robert K.			Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RADICAL PROSTATECTOMY; RADIATION-THERAPY; BLADDER-CANCER; INCREASED RISK; COMPLICATIONS; BRACHYTHERAPY; OUTCOMES; MEN; ASSOCIATION; IMPACT	Objective To determine the association between exposure to radiotherapy for the treatment of prostate cancer and subsequent second malignancies (second primary cancers). Design Systematic review and meta-analysis of observational studies. Data sources Medline and Embase up to 6 April 2015 with no restrictions on year or language. Study selection Comparative studies assessing the risk of second malignancies in patients exposed or unexposed to radiotherapy in the course of treatment for prostate cancer were selected by two reviewers independently with any disagreement resolved by consensus. Data extraction and synthesis Two reviewers independently extracted study characteristics and outcomes. Risk of bias was assessed with the New-castle-Ottawa scale. Outcomes were synthesized with random effects models and Mantel-Haenszel weighting. Unadjusted odds ratios and multivariable adjusted hazard ratios, when available, were pooled. Main outcome measures Second cancers of the bladder, colorectal tract, rectum, lung, and hematologic system. Results Of 3056 references retrieved, 21 studies were selected for analysis. Most included studies were large multi-institutional reports but had moderate risk of bias. The most common type of radiotherapy was external beam; 13 studies used patients treated with surgery as controls and eight used patients who did not undergo radiotherapy as controls. The length of follow-up among studies varied. There was increased risk of cancers of the bladder (four studies; adjusted hazard ratio 1.67, 95% confidence interval 1.55 to 1.80), colorectum (three studies; 1.79, 1.34 to 2.38), and rectum (three studies; 1.79, 1.34 to 2.38), but not cancers of the hematologic system (one study; 1.64, 0.90 to 2.99) or lung (two studies; 1.45, 0.70 to 3.01), after radiotherapy compared with the risk in those unexposed to radiotherapy. The odds of a second cancer varied depending on type of radiotherapy: treatment with external beam radiotherapy was consistently associated with increased odds while brachytherapy was not. Among the patients who underwent radiotherapy, from individual studies, the highest absolute rates reported for bladder, colorectal, and rectal cancers were 3.8%, 4.2%, and 1.2%, respectively, while the lowest reported rates were 0.1%, 0.3%, and 0.3%. Conclusion Radiotherapy for prostate cancer was associated with higher risks of developing second malignancies of the bladder, colon, and rectum compared with patients unexposed to radiotherapy, but the reported absolute rates were low. Further studies with longer follow-up are required to confirm these findings.	[Wallis, Christopher J. D.; Mahar, Alyson L.; Herschorn, Sender; Kodama, Ronald T.; Nam, Robert K.] Univ Toronto, Sunnybrook Res Inst, Div Urol, Sunnybrook Hlth Sci Ctr, Room MG-406,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Wallis, Christopher J. D.; Shah, Prakesh S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Suite 425,155 Coll St, Toronto, ON M5T 3M6, Canada; [Choo, Richard] Mayo Clin, Dept Radiat Oncol, 200 1st St Southwest, Rochester, MN 55902 USA; [Shah, Prakesh S.] Univ Toronto, Mt Sinai Hosp, Dept Pediat, 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Danjoux, Cyril] Univ Toronto, Sunnybrook Res Inst, Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol, Room MG-406,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Narod, Steven A.] Univ Toronto, Dept Publ Hlth Sci, 7th Floor,790 Bay St, Toronto, ON M5G 1N8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Mayo Clinic; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Nam, RK (corresponding author), Univ Toronto, Sunnybrook Res Inst, Div Urol, Sunnybrook Hlth Sci Ctr, Room MG-406,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	Robert.nam@utoronto.ca	Shah, Prakesh S/I-8098-2013; Shah, Prakesh/AAA-9884-2020; Narod, Steven A/AAA-6112-2022	Mahar, Alyson/0000-0002-6862-3760	Ajmera Family chair in urologic oncology award; Canadian Institutes of Health Research	Ajmera Family chair in urologic oncology award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Ajmera Family chair in urologic oncology awarded to RKN. The funder had no input in the design or conduct of the study, the interpretation of the results, the preparation of the manuscript or the decision to submit for publication. PS is supported by an applied research chair in reproductive and child health services and policy research from the Canadian Institutes of Health Research.	Abdel-Wahab M, 2008, INT J RADIAT ONCOL, V72, P58, DOI 10.1016/j.ijrobp.2007.12.043; Abern MR, 2013, UROL ONCOL-SEMIN ORI, V31, P1628, DOI 10.1016/j.urolonc.2012.04.006; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Baxter NN, 2005, GASTROENTEROLOGY, V128, P819, DOI 10.1053/j.gastro.2004.12.038; Bhojani N, 2010, INT J RADIAT ONCOL, V76, P342, DOI 10.1016/j.ijrobp.2009.02.011; Boorjian S, 2007, J UROLOGY, V177, P883, DOI 10.1016/j.juro.2006.10.071; Bostrom PJ, 2007, EUR UROL, V52, P973, DOI 10.1016/j.eururo.2007.07.002; Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V; CAHAN WG, 1948, CANCER, V1, P3, DOI 10.1002/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7; Davis EJ, 2014, CANCER-AM CANCER SOC, V120, P2735, DOI 10.1002/cncr.28769; de Gonzalez AB, 2011, LANCET ONCOL, V12, P353, DOI 10.1016/S1470-2045(11)70061-4; Deeks J J, 2003, Health Technol Assess, V7, piii; Engeland A, 2003, BRIT J CANCER, V89, P1237, DOI 10.1038/sj.bjc.6601206; Frezza EE, 2006, GUT, V55, P285, DOI 10.1136/gut.2005.073163; Frieben H, 1902, ROFO FORTSCHR RONTG, V6, P106; Goldstraw MA, 2006, BJU INT, V98, P489, DOI 10.1111/j.1464-410X.2006.06288.x; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hinnen KA, 2011, J CLIN ONCOL, V29, P4510, DOI 10.1200/JCO.2011.35.0991; Huang JY, 2011, RADIOTHER ONCOL, V98, P81, DOI 10.1016/j.radonc.2010.09.012; Huo DZ, 2009, CANCER EPIDEM BIOMAR, V18, P1979, DOI 10.1158/1055-9965.EPI-09-0241; Jin T, 2014, UROL INT, V93, P279, DOI 10.1159/000356115; Kendal WS, 2008, INT J RADIAT ONCOL, V70, P1294, DOI 10.1016/j.ijrobp.2008.01.001; Kendal WS, 2006, INT J RADIAT ONCOL, V65, P661, DOI 10.1016/j.ijrobp.2005.11.013; Lehnert BE, 1997, CANCER RES, V57, P2164; Margel D, 2011, ANN SURG, V254, P947, DOI 10.1097/SLA.0b013e3182382fd5; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moon K, 2006, CANCER-AM CANCER SOC, V107, P991, DOI 10.1002/cncr.22083; Muller AC, 2007, STRAHLENTHER ONKOL, V183, P605, DOI 10.1007/s00066-007-1786-y; Murray EM, 1999, INT J RADIAT ONCOL, V45, P951, DOI 10.1016/S0360-3016(99)00279-5; Murray L, 2014, RADIOTHER ONCOL, V110, P213, DOI 10.1016/j.radonc.2013.12.012; Nam RK, 2014, LANCET ONCOL, V15, P223, DOI 10.1016/S1470-2045(13)70606-5; Narayanan PK, 1997, CANCER RES, V57, P3963; Narayanan PK, 1999, RADIAT RES, V152, P57, DOI 10.2307/3580049; Nguyen PL, 2011, J CLIN ONCOL, V29, P1517, DOI 10.1200/JCO.2010.31.1217; Nieder AM, 2008, J UROLOGY, V180, P2005, DOI 10.1016/j.juro.2008.07.038; Overholser L, 2010, J GEN INTERN MED, V25, P527; Pickles T, 2002, RADIOTHER ONCOL, V65, P145, DOI 10.1016/S0167-8140(02)00307-9; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Rapiti E, 2008, INT J CANCER, V123, P1141, DOI 10.1002/ijc.23601; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; ROBINS J, 1986, BIOMETRICS, V42, P311, DOI 10.2307/2531052; Sale KA, 2004, OTOLARYNG HEAD NECK, V131, P643, DOI 10.1016/j.otohns.2004.05.012; Singh A, 2008, J UROLOGY, V179, pS2, DOI 10.1016/j.juro.2008.03.130; Singh AK, 2010, INT J RADIAT ONCOL, V78, P1086, DOI 10.1016/j.ijrobp.2009.09.055; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takam R, 2009, PHYS MED BIOL, V54, P611, DOI 10.1088/0031-9155/54/3/009; Van Hemelrijck M, 2014, EUR J CANCER, V50, pS230, DOI 10.1016/S0959-8049(14)50838-6; Wallis CJD, 2015, BRIT J CANCER, V112, P977, DOI 10.1038/bjc.2015.54; Wallis CJD, 2015, UROLOGY, V85, P621, DOI 10.1016/j.urology.2014.11.037; Wells GA, 2011, THE NEWCASTLE OTTAWA; Zelefsky MJ, 2012, BJU INT, V110, P1696, DOI 10.1111/j.1464-410X.2012.11385.x	52	121	122	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2016	352								i851	10.1136/bmj.i851	http://dx.doi.org/10.1136/bmj.i851			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0LN	26936410	Green Published, hybrid			2022-12-28	WOS:000371756500004
J	Vrielynck, N; Chambon, A; Vezon, D; Pereira, L; Chelysheva, L; De Muyt, A; Mezard, C; Mayer, C; Grelon, M				Vrielynck, Nathalie; Chambon, Aurelie; Vezon, Daniel; Pereira, Lucie; Chelysheva, Liudmila; De Muyt, Arnaud; Mezard, Christine; Mayer, Claudine; Grelon, Mathilde			A DNA topoisomerase VI-like complex initiates meiotic recombination	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; ARABIDOPSIS; MEIOSIS; PLANTS; SPO11; EUKARYOTES; SUBUNIT; FAMILY; CELLS	The SPO11 protein catalyzes the formation of meiotic DNA double strand breaks (DSBs) and is homologous to theAsubunit of an archaeal topoisomerase (topo VI). Topo VI are heterotetrameric enzymes comprising two A and two B subunits; however, no topo VIBinvolved inmeiotic recombination had been identified. We characterized a structural homolog of the archaeal topo VIB subunit [meiotic topoisomerase VIB-like (MTOPVIB)], which is essential for meiotic DSB formation. It forms a complexwith the two Arabidopsis thaliana SPO11 orthologs required for meiotic DSB formation (SPO11-1 and SPO11-2) and is absolutely required for the formation of the SPO11-1/SPO11-2 heterodimer. These findings suggest that the catalytic core complex responsible for meiotic DSB formation in eukaryotes adopts a topo VI-like structure.	[Vrielynck, Nathalie; Chambon, Aurelie; Vezon, Daniel; Pereira, Lucie; Chelysheva, Liudmila; De Muyt, Arnaud; Mezard, Christine; Grelon, Mathilde] Univ Paris Saclay, IJPB, INRA, AgroParisTech,CNRS, RD10, F-78026 Versailles, France; [Mayer, Claudine] Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris, France; [Mayer, Claudine] Inst Pasteur, Dept Biotechnol, CNRS, UMR 3528, F-75724 Paris 15, France; [Mayer, Claudine] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [De Muyt, Arnaud] PSL Res Univ, CNRS, Inst Curie, UMR3664, F-75005 Paris, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Grelon, M (corresponding author), Univ Paris Saclay, IJPB, INRA, AgroParisTech,CNRS, RD10, F-78026 Versailles, France.	mathilde.grelon@versailles.inra.fr		chambon, aurelie/0000-0003-2984-2108; De Muyt, Arnaud/0000-0002-1379-5709; Chelysheva, Liudmila/0000-0002-7538-2184	Labex Saclay Plat Sciences-SPS [ANR-10-LABX-0040-SPS]	Labex Saclay Plat Sciences-SPS	We are grateful to D. Gaddelle, P. Forterre, R. Mercier, and R. Kumar for helpful discussions and constructive reading of the manuscript. We thank O. Grandjean and L. Gissot from the Imaging and Cytology platform of IJPB for providing help and technical support for the BiFC experiments. We also thank F. Hartung for providing the TOP6B cDNA end L. Gebbie (LKG Scientific Editing & Translation) for correcting the manuscript. IJPB benefits from the support of the Labex Saclay Plat Sciences-SPS (ANR-10-LABX-0040-SPS).	Bates AD, 2011, NUCLEIC ACIDS RES, V39, P6327, DOI 10.1093/nar/gkr258; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Corbett KD, 2005, STRUCTURE, V13, P873, DOI 10.1016/j.str.2005.03.013; Corbett KD, 2007, NAT STRUCT MOL BIOL, V14, P611, DOI 10.1038/nsmb1264; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; De Muyt A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000654; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Graille M, 2008, STRUCTURE, V16, P360, DOI 10.1016/j.str.2007.12.020; Grelon M, 2001, EMBO J, V20, P589, DOI 10.1093/emboj/20.3.589; Hartung F, 2002, CURR BIOL, V12, P1787, DOI 10.1016/S0960-9822(02)01218-6; Hartung F, 2001, GENE, V271, P81, DOI 10.1016/S0378-1119(01)00496-6; Hartung F, 2007, PLANT CELL, V19, P3090, DOI 10.1105/tpc.107.054817; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Li WX, 2004, P NATL ACAD SCI USA, V101, P10596, DOI 10.1073/pnas.0404110101; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Puizina J, 2004, PLANT CELL, V16, P1968, DOI 10.1105/tpc.104.022749; Robert T, 2016, SCIENCE, V351, P943, DOI 10.1126/science.aad5309; Stacey NJ, 2006, PLANT J, V48, P206, DOI 10.1111/j.1365-313X.2006.02867.x; Sugimoto-Shirasu K, 2002, CURR BIOL, V12, P1782, DOI 10.1016/S0960-9822(02)01198-3; Yin YH, 2002, P NATL ACAD SCI USA, V99, P10191, DOI 10.1073/pnas.152337599	22	132	138	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					939	943		10.1126/science.aad5196	http://dx.doi.org/10.1126/science.aad5196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26917763				2022-12-28	WOS:000370821400033
J	Blencowe, M				Blencowe, Miles			QUANTUM PHYSICS Photons paired with phonons	NATURE			English	Editorial Material							CAVITY		[Blencowe, Miles] Dartmouth Coll, Dept Phys & Astron, Wilder Lab 6127, Hanover, NH 03755 USA	Dartmouth College	Blencowe, M (corresponding author), Dartmouth Coll, Dept Phys & Astron, Wilder Lab 6127, Hanover, NH 03755 USA.	miles.p.blencowe@dartmouth.edu			Division Of Materials Research [1507383] Funding Source: National Science Foundation	Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eichenfield M, 2009, NATURE, V459, P550, DOI 10.1038/nature08061; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Lee KC, 2011, SCIENCE, V334, P1253, DOI 10.1126/science.1211914; Riedinger R, 2016, NATURE, V530, P313, DOI 10.1038/nature16536; Stannigel K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220501	7	2	3	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					284	285		10.1038/530284a	http://dx.doi.org/10.1038/530284a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26887487				2022-12-28	WOS:000370327100022
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Mindful of mindfulness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2013, GUARDIAN; de Vibe M., 2012, MINDFULNESS BASED ST, V8, P1, DOI [10.4073/csr.2012.3, DOI 10.4073/CSR.2012.3]; Fort-Catanese K, 2014, HUFFINGTON POST; Macaro A, 2015, FINANCIAL TIMES; Mindfulness All-Party Parliamentary Group (MAPPG), 2015, MINDF NAT UK; Mindfulness in Schools Project, WHAT IS B PRON DOT B; Zenner C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00603	7	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2016	352								i839	10.1136/bmj.i839	http://dx.doi.org/10.1136/bmj.i839			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6EY	26888083	Bronze, Green Published			2022-12-28	WOS:000370727700013
J	Kim, SH; Qi, D; Ashfield, T; Helm, M; Innes, RW				Kim, Sang Hee; Qi, Dong; Ashfield, Tom; Helm, Matthew; Innes, Roger W.			Using decoys to expand the recognition specificity of a plant disease resistance protein	SCIENCE			English	Article							PSEUDOMONAS-SYRINGAE EFFECTOR; ARABIDOPSIS PBS1; CLEAVAGE SITES; GENE; INFECTION; DEFENSE; ACTIVATION; RESPONSES; REVEAL; RIN4	Maintaining high crop yields in an environmentally sustainable manner requires the development of disease-resistant crop varieties. We describe a method to engineer disease resistance in plants by means of an endogenous disease resistance gene from Arabidopsis thaliana named RPS5, which encodes a nucleotide-binding leucine-rich repeat (NLR) protein. RPS5 is normally activated when a second host protein, PBS1, is cleaved by the pathogen-secreted protease AvrPphB. We show that the AvrPphB cleavage site within PBS1 can be substituted with cleavage sites for other pathogen proteases, which then enables RPS5 to be activated by these proteases, thereby conferring resistance to new pathogens. This "decoy" approach may be applicable to other NLR proteins and should enable engineering of resistance in plants to diseases for which we currently lack robust genetic resistance.	[Kim, Sang Hee; Qi, Dong; Ashfield, Tom; Helm, Matthew; Innes, Roger W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Kim, Sang Hee] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Qi, Dong] Altria Grp, Ctr Res & Technol, Richmond, VA 23219 USA	Indiana University System; Indiana University Bloomington; University of Missouri System; University of Missouri Columbia; Altria Client Services, Inc.	Innes, RW (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	rinnes@indiana.edu		Kim, Sang Hee/0000-0003-1831-4633	National Institute of General Medical Sciences [R01 GM046451]; NSF [IOS-1339348]; Indiana University Office of the Vice Provost for Research Faculty Research Support Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046451] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Indiana University Office of the Vice Provost for Research Faculty Research Support Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Pottinger for assistance with statistical analyses. T-DNA insertion mutants of Arabidopsis were obtained from the Arabidopsis Biological Resource Center at Ohio State. pCambiaTuMV/6K2:GFP was kindly provided by A. Laliberte. Supported by National Institute of General Medical Sciences grant R01 GM046451, NSF Plant Genome Research Program grant IOS-1339348, and the Indiana University Office of the Vice Provost for Research Faculty Research Support Program. A patent application has been submitted covering the RPS5-PBS1 protease recognition system (U.S. Patent App. 14/427,753). Author contributions: S.H.K., D.Q., T.A., M.H., and R.W.I. designed and performed the experiments; R.W.I. and S.H.K. wrote the manuscript with editing provided by D.Q., T.A., and M.H. Supplement contains additional data.	Adams MJ, 2005, MOL PLANT PATHOL, V6, P471, DOI 10.1111/J.1364-3703.2005.00296.X; Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Caldwell KS, 2009, GENETICS, V181, P671, DOI 10.1534/genetics.108.097279; Casteel CL, 2015, PLANT PHYSIOL, V169, P209, DOI 10.1104/pp.15.00332; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; DeYoung BJ, 2012, CELL MICROBIOL, V14, P1071, DOI 10.1111/j.1462-5822.2012.01779.x; Segretin ME, 2014, MOL PLANT MICROBE IN, V27, P624, DOI 10.1094/MPMI-02-14-0040-R; Giannakopoulou A, 2015, MOL PLANT MICROBE IN, V28, P1316, DOI 10.1094/MPMI-07-15-0147-R; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Jiang J, 2015, J VIROL, V89, P6695, DOI 10.1128/JVI.00503-15; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Lim HS, 2011, PLANT PATHOLOGY J, V27, P315, DOI 10.5423/PPJ.2011.27.4.315; Nam M, 2011, MOL CELLS, V32, P421, DOI 10.1007/s10059-011-0101-z; Qi D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00348; Qi D, 2014, PLANT PHYSIOL, V164, P340, DOI 10.1104/pp.113.227686; Qi D, 2012, PLANT PHYSIOL, V158, P1819, DOI 10.1104/pp.112.194035; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; RESTREPO MA, 1990, PLANT CELL, V2, P987, DOI 10.1105/tpc.2.10.987; Russell Andrew R, 2015, Mol Plant Microbe Interact, V28, P727, DOI 10.1094/MPMI-08-14-0248-R; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wan J, 2015, PLANT PHYSIOL, V167, P1374, DOI 10.1104/pp.15.00097; Whigham E, 2015, MOL PLANT MICROBE IN, V28, P968, DOI 10.1094/MPMI-02-15-0027-FI; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007	30	112	118	7	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					684	687		10.1126/science.aad3436	http://dx.doi.org/10.1126/science.aad3436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26912853				2022-12-28	WOS:000369810000034
J	Scott, A				Scott, Andrew			Science in the shadows	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					782	782		10.1126/science.351.6274.782	http://dx.doi.org/10.1126/science.351.6274.782			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD3GL	26912864				2022-12-28	WOS:000369810000049
J	Palacin, MR; de Guibert, A				Palacin, M. R.; de Guibert, A.			Why do batteries fail?	SCIENCE			English	Review							LITHIUM-ION BATTERIES; AGING MECHANISMS; CAPACITY FADE; HIGH-POWER; DEGRADATION MECHANISMS; POSITIVE ELECTRODE; HIGH-ENERGY; LI; CELLS; CALENDAR	Battery failure and gradual performance degradation (aging) are the result of complex interrelated phenomena that depend on battery chemistry, design, environment, and the actual operation conditions. The current available knowledge on these matters results from a vast combination of experimental and modeling approaches. We explore the state of the art with respect to materials as well as usage (temperature, charge/discharge rate, etc.) for lead-acid, nickel-cadmium, nickel-metal hydride, and lithium-ion chemistries. Battery diagnosis strategies and plausible developments related to large-scale battery applications are also discussed.	[Palacin, M. R.] Inst Ciencia Mat Barcelona ICMAB CSIC, ALISTORE ERI, Campus UAB, E-08193 Bellaterra, Catalonia, Spain; [de Guibert, A.] SAFT Res Dept, 111 Blvd Alfred Daney, F-33074 Bordeaux, France	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB)	Palacin, MR (corresponding author), Inst Ciencia Mat Barcelona ICMAB CSIC, ALISTORE ERI, Campus UAB, E-08193 Bellaterra, Catalonia, Spain.	rosa.palacin@icmab.es	Palacin, Maria Rosa/H-2163-2012	Palacin, Maria Rosa/0000-0001-7351-2005	Ministerio de Ciencia e Innovacion (Spain) [MAT2014-53500-R]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank ALISTORE-ERI academic and industrial members for sharing fruitful discussions; P. Bernard and P. Johansson for valuable comments and critical reading of the text; and Ministerio de Ciencia e Innovacion (Spain) grant MAT2014-53500-R (M.R.P.).	Arora P, 1998, J ELECTROCHEM SOC, V145, P3647, DOI 10.1149/1.1838857; Aurbach D, 2000, J POWER SOURCES, V89, P206, DOI 10.1016/S0378-7753(00)00431-6; Belt J, 2011, J POWER SOURCES, V196, P10213, DOI 10.1016/j.jpowsour.2011.08.067; Bernard P, 1998, J ELECTROCHEM SOC, V145, P456, DOI 10.1149/1.1838284; Berndt D, 2001, J POWER SOURCES, V100, P29, DOI 10.1016/S0378-7753(01)00881-3; Berndt D., 1997, MAINTENANCE FREE BAT; Bloom I, 2005, J POWER SOURCES, V139, P295, DOI 10.1016/j.jpowsour.2004.07.021; Blyr A, 1998, J ELECTROCHEM SOC, V145, P194, DOI 10.1149/1.1838235; Bodenes L, 2013, J POWER SOURCES, V236, P265, DOI 10.1016/j.jpowsour.2013.02.067; Bourlot S, 2011, J POWER SOURCES, V196, P6841, DOI 10.1016/j.jpowsour.2010.09.103; Broussely M, 2005, J POWER SOURCES, V146, P90, DOI 10.1016/j.jpowsour.2005.03.172; Broussely M, 2002, ADVANCES IN LITHIUM-ION BATTERIES, P393, DOI 10.1007/0-306-47508-1_14; Brown S, 2008, J ELECTROCHEM SOC, V155, pA320, DOI 10.1149/1.2832654; BULLOCK KR, 1994, J POWER SOURCES, V51, P1, DOI 10.1016/0378-7753(94)01952-5; Burns JC, 2013, J ELECTROCHEM SOC, V160, pA1451, DOI 10.1149/2.060309jes; Casas-Cabanas M, 2007, J AM CHEM SOC, V129, P5840, DOI 10.1021/ja068433a; Croguennec L, 2015, J AM CHEM SOC, V137, P3140, DOI 10.1021/ja507828x; Dahn HM, 2012, J ELECTROCHEM SOC, V159, pA1405, DOI 10.1149/2.013209jes; Dell RM, 2001, ROY S CH P, P25; Dubarry M, 2014, J POWER SOURCES, V258, P408, DOI 10.1016/j.jpowsour.2014.02.052; Dubarry M, 2012, J POWER SOURCES, V219, P204, DOI 10.1016/j.jpowsour.2012.07.016; Dubarry M, 2011, J POWER SOURCES, V196, P3420, DOI 10.1016/j.jpowsour.2010.07.029; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Fathi R, 2014, J ELECTROCHEM SOC, V161, pA1572, DOI 10.1149/2.0321410jes; Grolleau S, 2014, J POWER SOURCES, V255, P450, DOI 10.1016/j.jpowsour.2013.11.098; Honkura K, 2014, J POWER SOURCES, V264, P140, DOI 10.1016/j.jpowsour.2014.04.036; HOOVER JH, 1991, J POWER SOURCES, V33, P257, DOI 10.1016/0378-7753(91)85064-4; Kobayashi Y, 2013, J ELECTROCHEM SOC, V160, pA1415, DOI 10.1149/2.053309jes; Krause LJ, 2012, J ELECTROCHEM SOC, V159, pA937, DOI 10.1149/2.021207jes; Lam LT, 2004, J POWER SOURCES, V133, P126, DOI 10.1016/j.jpowsour.2003.11.048; Le Guenne L, 2002, J POWER SOURCES, V105, P134, DOI 10.1016/S0378-7753(01)00931-4; Leblanc P, 1998, J ELECTROCHEM SOC, V145, P860, DOI 10.1149/1.1838358; Linden D., 2002, HDB BATTERIES; Lu LG, 2013, J POWER SOURCES, V226, P272, DOI 10.1016/j.jpowsour.2012.10.060; Melot BC, 2013, ACCOUNTS CHEM RES, V46, P1226, DOI 10.1021/ar300088q; Moseley PT, 2012, J POWER SOURCES, V219, P75, DOI 10.1016/j.jpowsour.2012.07.040; Notten P., 2009, ENCY ELECTROCHEMICAL, V4, P502; Novak P, 2000, J POWER SOURCES, V90, P52, DOI 10.1016/S0378-7753(00)00447-X; Peled E, 1996, J ELECTROCHEM SOC, V143, pL4, DOI 10.1149/1.1836372; Pillot C., 2014, CHIN INT BATT FAIR 1; Roth EP, 2012, ELECTROCHEM SOC INTE, V21, P45, DOI 10.1149/2.F04122if; Sato Y., 2009, ENCY ELECTROCHEMICAL, V4, P534; Schulte D, 2014, J POWER SOURCES, V269, P704, DOI 10.1016/j.jpowsour.2014.06.155; Shim J, 2002, J POWER SOURCES, V112, P222, DOI 10.1016/S0378-7753(02)00363-4; Smith AJ, 2012, J ELECTROCHEM SOC, V159, pA705, DOI 10.1149/2.056206jes; Stiaszny B, 2014, J POWER SOURCES, V258, P61, DOI 10.1016/j.jpowsour.2014.02.019; Tuck C. D. S., 1991, MODERN BATTERY TECHN; Vetter J, 2005, J POWER SOURCES, V147, P269, DOI 10.1016/j.jpowsour.2005.01.006; Waldmann T, 2014, J ELECTROCHEM SOC, V161, pA1742, DOI 10.1149/2.1001410jes; Waldmann T, 2014, J POWER SOURCES, V262, P129, DOI 10.1016/j.jpowsour.2014.03.112; Wang J, 2014, J POWER SOURCES, V269, P937, DOI 10.1016/j.jpowsour.2014.07.030; Wang J, 2011, J POWER SOURCES, V196, P3942, DOI 10.1016/j.jpowsour.2010.11.134; Wang QS, 2012, J POWER SOURCES, V208, P210, DOI 10.1016/j.jpowsour.2012.02.038; Xu K, 2014, CHEM REV, V114, P11503, DOI 10.1021/cr500003w; Xu K, 2011, J MATER CHEM, V21, P9849, DOI 10.1039/c0jm04309e; Zhang SS, 2006, J POWER SOURCES, V162, P1379, DOI 10.1016/j.jpowsour.2006.07.074; Zinth V, 2014, J POWER SOURCES, V271, P152, DOI 10.1016/j.jpowsour.2014.07.168	57	458	470	68	1004	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273							1253292	10.1126/science.1253292	http://dx.doi.org/10.1126/science.1253292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912708	Green Published			2022-12-28	WOS:000369291600032
J	Wilfert, L; Long, G; Leggett, HC; Schmid-Hempel, P; Butlin, R; Martin, SJM; Boots, M				Wilfert, L.; Long, G.; Leggett, H. C.; Schmid-Hempel, P.; Butlin, R.; Martin, S. J. M.; Boots, M.			Deformed wing virus is a recent global epidemic in honeybees driven by Varroa mites	SCIENCE			English	Article							APIS-MELLIFERA; RED SQUIRRELS; POLLINATORS; COLONIES; DISEASE; EVOLUTIONARY; JACOBSONI; DECLINES; BRITAIN	Deformed wing virus (DWV) and its vector, the mite Varroa destructor, are a major threat to the world's honeybees. Although the impact of Varroa on colony-level DWV epidemiology is evident, we have little understanding of wider DWV epidemiology and the role that Varroa has played in its global spread. A phylogeographic analysis shows that DWV is globally distributed in honeybees, having recently spread from a common source, the European honeybee Apis mellifera. DWV exhibits epidemic growth and transmission that is predominantly mediated by European and North American honeybee populations and driven by trade and movement of honeybee colonies. DWV is now an important reemerging pathogen of honeybees, which are undergoing a worldwide manmade epidemic fueled by the direct transmission route that the Varroa mite provides.	[Wilfert, L.; Boots, M.] Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn TR11 9FE, England; [Long, G.; Leggett, H. C.; Butlin, R.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Schmid-Hempel, P.] Swiss Fed Inst Technol, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Martin, S. J. M.] Univ Salford, Sch Environm & Life Sci, Manchester M5 4WT, Lancs, England; [Leggett, H. C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Boots, M.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Exeter; University of Sheffield; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Manchester; University of Salford; University of Cambridge; University of California System; University of California Berkeley	Wilfert, L (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn TR11 9FE, England.	lena.wilfert@ex.ac.uk	Chen, Yi-Ying/AAZ-3646-2020; Chen, Yi-Ying/A-4892-2017; Long, Gráinne H/B-3635-2012; Butlin, Roger K/F-7709-2013	Chen, Yi-Ying/0000-0003-4747-5313; Chen, Yi-Ying/0000-0003-4747-5313; Long, Gráinne H/0000-0001-5080-9885; Butlin, Roger K/0000-0003-4736-0954; Martin, Stephen/0000-0001-9418-053X	Natural Environment Research Council [NE/F019610/1]; Royal Society Dorothy Hodgkin Fellowship; Biotechnology and Biological Sciences Research Council [BB/L010879/1] Funding Source: researchfish; BBSRC [BB/L010879/1] Funding Source: UKRI; NERC [NE/F019610/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The data reported in this paper are available on GenBank (accession numbers KP734326 to KP734846 and KP765048 to KP765235), in the supplementary materials, and in database S1. We thank numerous beekeepers for samples (see supplementary materials). We are grateful to A. Cowley and M. D. Sharma for informatics support and to F. Bayer for help in the laboratory. This work was funded by a Natural Environment Research Council grant to M. B., S. M., and R. B. (NE/F019610/1); L. W. was funded by a Royal Society Dorothy Hodgkin Fellowship. G. L. has been employed by Roche Pharmaceuticals since July 2014; all the work reported here was conducted while she was at the University of Sheffield.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Berenyi O, 2007, APPL ENVIRON MICROB, V73, P3605, DOI 10.1128/AEM.00696-07; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cardoen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020043; Carvalheiro LG, 2013, ECOL LETT, V16, P1416, DOI 10.1111/ele.12175; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Erban T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13907; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Li JL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047955, 10.1371/journal.pone.0052699]; Manley R, 2015, J APPL ECOL, V52, P331, DOI 10.1111/1365-2664.12385; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; Mondet F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004323; Mouret C, 2013, REV MED VET-TOULOUSE, V164, P577; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Shutler D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098599; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Thompson CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105164; Tompkins DM, 2002, P ROY SOC B-BIOL SCI, V269, P529, DOI 10.1098/rspb.2001.1897; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Zhang X, 2012, J INVERTEBR PATHOL, V109, P156, DOI 10.1016/j.jip.2011.09.010	39	266	285	10	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					594	597		10.1126/science.aac9976	http://dx.doi.org/10.1126/science.aac9976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26912700	Green Submitted			2022-12-28	WOS:000369291600038
J	Scheltens, P; Blennow, K; Breteler, MMB; de Strooper, B; Frisoni, GB; Salloway, S; Van der Flier, WM				Scheltens, Philip; Blennow, Kaj; Breteler, Monique M. B.; de Strooper, Bart; Frisoni, Giovanni B.; Salloway, Stephen; Van der Flier, Wiesje Maria			Alzheimer's disease	LANCET			English	Review							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID BIOMARKER; SUBJECTIVE MEMORY IMPAIRMENT; POSTERIOR CORTICAL ATROPHY; ADNI HARMONIZED PROTOCOL; EARLY-ONSET DEMENTIA; A-BETA; AMYLOID-BETA; HIPPOCAMPAL SEGMENTATION; ASSOCIATION WORKGROUPS	Although the prevalence of dementia continues to increase worldwide, incidence in the western world might have decreased as a result of better vascular care and improved brain health. Alzheimer's disease, the most prevalent cause of dementia, is still defined by the combined presence of amyloid and tau, but researchers are gradually moving away from the simple assumption of linear causality as proposed in the original amyloid hypothesis. Age-related, protective, and disease-promoting factors probably interact with the core mechanisms of the disease. Amyloid beta 42, and tau proteins are established core cerebrospinal biomarkers; novel candidate biomarkers include amyloid beta oligomers and synaptic markers. MRI and fluorodeoxyglucose PET are established imaging techniques for diagnosis of Alzheimer's disease. Amyloid PET is gaining traction in the clinical arena, but validity and cost-effectiveness remain to be established. Tau PET might off er new insights and be of great help in differential diagnosis and selection of patients for trials. In the search for understanding the disease mechanism and keys to treatment, research is moving increasingly into the earliest phase of disease. Preclinical Alzheimer's disease is defined as biomarker evidence of Alzheimer's pathological changes in cognitively healthy individuals. Patients with subjective cognitive decline have been identified as a useful population in whom to look for preclinical Alzheimer's disease. Moderately positive results for interventions targeting several lifestyle factors in non-demented elderly patients and moderately positive interim results for lowering amyloid in pre-dementia Alzheimer's disease suggest that, ultimately, there will be a future in which specific anti-Alzheimer's therapy will be combined with lifestyle interventions targeting general brain health to jointly combat the disease. In this Seminar, we discuss the main developments in Alzheimer's research.	[Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Neurosci Campus Amsterdam,De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, NL-1081 HV Amsterdam, Netherlands; [Van der Flier, Wiesje Maria] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands; [Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Gothenburg, Sweden; [Breteler, Monique M. B.] Univ Bonn, German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Breteler, Monique M. B.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [de Strooper, Bart] VIB Leuven, Ctr Biol Dis, Leuven, Belgium; [de Strooper, Bart] LIND Univ Ziekenhuizen, KU Leuven, Ctr Human Genet, Leuven, Belgium; [de Strooper, Bart] UCL, Inst Neurol, London, England; [Frisoni, Giovanni B.] Univ Hosp, Geneva, Switzerland; [Frisoni, Giovanni B.] Univ Geneva, Geneva, Switzerland; [Frisoni, Giovanni B.] IRCCS Fatebenefratelli, Brescia, Italy; [Salloway, Stephen] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Gothenburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; Flanders Institute for Biotechnology (VIB); KU Leuven; University of London; University College London; University of Geneva; University of Geneva; IRCCS Fatebenefratelli; Brown University	Scheltens, P (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Neurosci Campus Amsterdam,De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	p.scheltens@vumc.nl	de+Strooper, Bart/Z-1638-2019; Frisoni, Giovanni B./K-1360-2016; Breteler, Monique M.B./J-5058-2014	van der Flier, Wiesje/0000-0001-8766-6224; Hogh, Peter/0000-0002-8478-8098; Frisoni, Giovanni B./0000-0002-6419-1753; Scheltens, Philip/0000-0002-1046-6408; Breteler, Monique M.B./0000-0002-0626-9305	Merck; GE Healthcare; Piramal; Alzheimer Nederland; Dioraphte; Stichting VUmc Fonds; Stichting Alzheimer & Neuropsychiatrie; Fujirebio Europe; Lundbeck; Janssen; NIA ADNI; DIAN; A4; Alz Assoc DIAN; Lilly; Biogen; Genentech; Bayer; Avid; Roche; Functional Neuromodulation; ZonMW; NWO; EU-FP7; CardioVascular Onderzoek Nederland; Stichting Dioraphte; Gieskes-Strijbis fonds; Boehringer Ingelheim; Piramal Neuroimaging; Janssen Stellar	Merck(Merck & Company); GE Healthcare(General ElectricGE Healthcare); Piramal; Alzheimer Nederland; Dioraphte; Stichting VUmc Fonds; Stichting Alzheimer & Neuropsychiatrie; Fujirebio Europe; Lundbeck(Lundbeck Corporation); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NIA ADNI; DIAN; A4; Alz Assoc DIAN; Lilly(Eli Lilly); Biogen(Biogen); Genentech(Roche HoldingGenentech); Bayer(Bayer AG); Avid; Roche(Roche Holding); Functional Neuromodulation; ZonMW(Netherlands Organization for Health Research and Development); NWO(Netherlands Organization for Scientific Research (NWO)); EU-FP7(European Commission); CardioVascular Onderzoek Nederland; Stichting Dioraphte; Gieskes-Strijbis fonds; Boehringer Ingelheim(Boehringer Ingelheim); Piramal Neuroimaging; Janssen Stellar	PS has received research support from Merck, GE Healthcare, Piramal, Alzheimer Nederland, Dioraphte, Stichting VUmc Fonds and Stichting Alzheimer & Neuropsychiatrie; served as a consultant for AbbVie, Avraham, ARC, Janssen Research Foundation, MD Start, Nutricia, Takeda, Probiodrug, and EIP Pharma; and received speaker fees from Piramal and GE Healthcare. He is co-editor-in-chief of Alzheimer's Research e Therapy and associate editor of Alzheimer's Disease and Associated Disorders. KB has served as a consultant for Eli Lilly, Novartis, Roche Diagnostics, Sanofi-Aventis, Amgen, and IBL International; has received speaker fees from Fujirebio Europe and Lundbeck; and is cofounder of Brain Biomarker Solutions. BdS has received research support from Janssen and served as a consultant for Janssen, Remynd, and Forum. SS has received research support from NIA ADNI, DIAN, A4, Alz Assoc DIAN; been involved in clinical trials sponsored by Lilly, Biogen, Genentech, Bayer, Avid, Roche, Merck, and Functional Neuromodulation; served as a consultant for Avid-Lilly, GE, Baxter, Biogen, Roche, Genentech, Forum, Piramal, and Merck; and been on the editorial boards of the Journal of Neuropsychiatry and Clinical Neurosciences, Journal of Prevention of Alzheimer's Disease, and Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. WMYdF has received research support from ZonMW, NWO, EU-FP7, Alzheimer Nederland, CardioVascular Onderzoek Nederland, Stichting Dioraphte, Gieskes-Strijbis fonds, Boehringer Ingelheim, Piramal Neuroimaging, Roche, Janssen Stellar, Stichting VUmc Fonds, and Stichting Alzheimer & Neuropsychiatrie, and speaker fees from Boehringer Ingelheim. MMBB and GBF declare no competing interests.	Aguzzi A, 2014, NATURE, V512, P32, DOI 10.1038/512032a; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 2014, J PREV ALZ DIS, V1, P214; Atri A, 2014, J PREVENT ALZHEIMER, V3, P220; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Barnes J, 2015, ALZHEIMERS DEMENT, V11, P1349, DOI 10.1016/j.jalz.2014.12.007; Barrado LG, 2016, J ALZHEIMERS DIS, V49, P187, DOI 10.3233/JAD-150511; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Benedictus MR, 2015, JAMA NEUROL, V72, P539, DOI 10.1001/jamaneurol.2015.14; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Blennow K, 2015, ALZHEIMERS DEMENT, V11, P58, DOI 10.1016/j.jalz.2014.02.004; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P175, DOI 10.1016/j.jalz.2014.12.002; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P126, DOI 10.1016/j.jalz.2014.02.009; Boyle PA, 2013, ANN NEUROL, V74, P478, DOI 10.1002/ana.23964; Brinkmalm A, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-53; Brodaty H, 2014, ANN EPIDEMIOL, V24, P63, DOI 10.1016/j.annepidem.2013.10.005; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Catindig JAS, 2012, J NEUROL SCI, V321, P11, DOI 10.1016/j.jns.2012.07.023; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Committee for Medicinal Products for Human Use, 2011, QUAL OP LOW HIPP VOL; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Crutch SJ, 2013, ALZHEIMERS DEMENT, V9, P463, DOI 10.1016/j.jalz.2012.11.004; Curtis C, 2015, JAMA NEUROL, V72, P287, DOI 10.1001/jamaneurol.2014.4144; de Bruijn RFAG, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0377-5; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Duits FH, 2015, ALZHEIMERS DEMENT, V11, P523, DOI 10.1016/j.jalz.2014.05.1753; Dukart J, 2013, PSYCHIAT RES-NEUROIM, V212, P230, DOI 10.1016/j.pscychresns.2012.04.007; Exalto LG, 2013, LANCET DIABETES ENDO, V1, P183, DOI 10.1016/S2213-8587(13)70048-2; Falk EB, 2013, P NATL ACAD SCI USA, V110, P17615, DOI 10.1073/pnas.1310134110; Filser S, 2015, BIOL PSYCHIAT, V77, P729, DOI 10.1016/j.biopsych.2014.10.013; Frisoni GB, 2015, ALZHEIMERS DEMENT, V11, P111, DOI 10.1016/j.jalz.2014.05.1756; Frisoni GB, 2013, NEUROLOGY, V81, P487, DOI 10.1212/WNL.0b013e31829d86e8; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Galasko D, 2014, NEUROLOGY, V82, P1536, DOI 10.1212/WNL.0000000000000364; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Guerreiro R, 2014, NEUROTHERAPEUTICS, V11, P732, DOI 10.1007/s13311-014-0295-9; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Henriksen K, 2014, ALZHEIMERS DEMENT, V10, P115, DOI 10.1016/j.jalz.2013.01.013; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; Hill DLG, 2014, ALZHEIMERS DEMENT, V10, P421, DOI 10.1016/j.jalz.2013.07.003; Holtta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066381; Jack CR, 2015, JAMA NEUROL, V72, P511, DOI 10.1001/jamaneurol.2014.4821; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Karran E, 2014, NEW ENGL J MED, V370, P377, DOI 10.1056/NEJMe1313943; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim YJ, 2014, J KOREAN MED SCI, V29, P903, DOI 10.3346/jkms.2014.29.7.903; Knopman DS, 2012, NEUROLOGY, V78, P1576, DOI 10.1212/WNL.0b013e3182563bbe; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; Kozauer N, 2013, NEW ENGL J MED, V368, P1169, DOI 10.1056/NEJMp1302513; Kvartsberg H, 2015, ALZHEIMERS DEMENT, V11, P1180, DOI 10.1016/j.jalz.2014.10.009; Lambert MA, 2014, EUR J NEUROL, V21, P563, DOI 10.1111/ene.12325; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Lehmann M, 2011, NEUROBIOL AGING, V33, pe1; Leinenbach A, 2014, CLIN CHEM, V60, P987, DOI 10.1373/clinchem.2013.220392; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lyketsos Constantine G, 2012, Innov Clin Neurosci, V9, P10; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Marchant NL, 2012, NEUROBIOL AGING, V33, P1006, DOI DOI 10.1016/J.NEUR0BI0LAGING.2011.10.001; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; Mattsson N, 2014, ANN CLIN TRANSL NEUR, V1, P534, DOI 10.1002/acn3.81; Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mills SM, 2013, REV NEUROL-FRANCE, V169, P737, DOI 10.1016/j.neurol.2013.07.017; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Nyberg J, 2014, BRAIN, V137, P1514, DOI 10.1093/brain/awu041; O'Bryant SE, 2015, ALZHEIMERS DEMENT, V11, P549, DOI 10.1016/j.jalz.2014.08.099; Ossenkoppele R, 2015, JAMA-J AM MED ASSOC, V313, P1939, DOI 10.1001/jama.2015.4669; Ossenkoppele R, 2015, ANN NEUROL, V77, P338, DOI 10.1002/ana.24321; Overk CR, 2014, BIOCHEM PHARMACOL, V88, P508, DOI 10.1016/j.bcp.2014.01.015; Palmqvist S, 2014, JAMA NEUROL, V71, P1282, DOI 10.1001/jamaneurol.2014.1358; Perani D, 2014, NEUROIMAGE-CLIN, V6, P445, DOI 10.1016/j.nicl.2014.10.009; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Prestia A, 2013, NEUROLOGY, V80, P1048, DOI 10.1212/WNL.0b013e3182872830; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Rikkert MGMO, 2015, J ALZHEIMERS DIS, V44, P471, DOI 10.3233/JAD-141305; Ritchie CW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001893; Salloway S, 2011, NEUROLOGY, V77, P1253, DOI 10.1212/WNL.0b013e3182309fa5; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Savage MJ, 2014, J NEUROSCI, V34, P2884, DOI 10.1523/JNEUROSCI.1675-13.2014; Scheef L, 2012, NEUROLOGY, V79, P1332, DOI 10.1212/WNL.0b013e31826c1a8d; SCHELTENS P, 1995, J NEUROL, V242, P557, DOI 10.1007/BF00868807; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Sharma A, 2014, AM J ALZHEIMERS DIS, V29, P409, DOI 10.1177/1533317513518650; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stephenson D, 2015, EXPERT REV NEUROTHER, V15, P107, DOI 10.1586/14737175.2015.995168; Stromberg K, 2015, FEBS J, V282, P65, DOI 10.1111/febs.13103; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; van der Flier WM, 2011, LANCET NEUROL, V10, P280, DOI 10.1016/S1474-4422(10)70306-9; van Harten AC, 2013, ALZHEIMERS DEMENT, V9, P481, DOI 10.1016/j.jalz.2012.08.004; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Villemagne VL, 2015, LANCET NEUROL, V14, P114, DOI 10.1016/S1474-4422(14)70252-2; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Vos SJB, 2015, BRAIN, V138, P1327, DOI 10.1093/brain/awv029; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wahlster L, 2013, ACTA NEUROPATHOL, V125, P187, DOI 10.1007/s00401-012-1065-6; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Welsh-Bohmer K, 2014, J PREVENT ALZHEIMER, V3, P215; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Womack KB, 2011, ARCH NEUROL-CHICAGO, V68, P329, DOI 10.1001/archneurol.2010.295; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Wu YT, 2016, LANCET NEUROL, V15, P116, DOI 10.1016/S1474-4422(15)00092-7; Wu YT, 2014, INT J GERIATR PSYCH, V29, P1212, DOI 10.1002/gps.4148; Yang LPH, 2015, DRUGS, V75, P83, DOI 10.1007/s40265-014-0328-z; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zago Wagner, 2013, Alzheimers Dement, V9, pS105, DOI 10.1016/j.jalz.2012.11.010; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao XM, 2015, J ALZHEIMERS DIS, V43, P549, DOI 10.3233/JAD-141149; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	142	1763	1850	86	1562	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					505	517		10.1016/S0140-6736(15)01124-1	http://dx.doi.org/10.1016/S0140-6736(15)01124-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	28330540				2022-12-28	WOS:000380559400031
J	Perkel, JM				Perkel, Jeffrey M.			THE MANUSCRIPT-EDITING MARKETPLACE	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	14	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					127	128		10.1038/531127a	http://dx.doi.org/10.1038/531127a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2YW	26949772	Bronze			2022-12-28	WOS:000371211900057
